Citrus Sinensis ID: 011582
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 482 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LET1 | 577 | CDPK-related kinase 7 OS= | yes | no | 0.929 | 0.776 | 0.765 | 0.0 | |
| O80673 | 576 | CDPK-related kinase 1 OS= | no | no | 0.929 | 0.777 | 0.769 | 0.0 | |
| Q9SCS2 | 601 | CDPK-related kinase 5 OS= | no | no | 0.929 | 0.745 | 0.680 | 0.0 | |
| Q10KY3 | 600 | Calcium/calmodulin-depend | yes | no | 0.869 | 0.698 | 0.741 | 0.0 | |
| P53681 | 602 | CDPK-related protein kina | N/A | no | 0.892 | 0.714 | 0.701 | 0.0 | |
| Q9LJL9 | 599 | CDPK-related kinase 2 OS= | no | no | 0.935 | 0.752 | 0.619 | 1e-169 | |
| Q9FX86 | 606 | CDPK-related kinase 8 OS= | no | no | 0.937 | 0.745 | 0.614 | 1e-168 | |
| Q9ZUZ2 | 595 | CDPK-related kinase 3 OS= | no | no | 0.929 | 0.752 | 0.585 | 1e-147 | |
| Q9FIM9 | 594 | CDPK-related kinase 4 OS= | no | no | 0.935 | 0.759 | 0.537 | 1e-137 | |
| Q9SG12 | 594 | CDPK-related kinase 6 OS= | no | no | 0.831 | 0.675 | 0.582 | 1e-130 |
| >sp|Q9LET1|CAMK7_ARATH CDPK-related kinase 7 OS=Arabidopsis thaliana GN=CRK7 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 753 bits (1945), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/486 (76%), Positives = 414/486 (85%), Gaps = 38/486 (7%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYENE----PQPNSQKSKASNFPFYSPSPLPSLFKNSPA 56
MGLCHGKP+E Q++ LP NE P+ +SQK+K+S FPFYSPSPLPSLFK SPA
Sbjct: 1 MGLCHGKPIEQ-----QSKNLPISNEIEETPKNSSQKAKSSGFPFYSPSPLPSLFKTSPA 55
Query: 57 IPSVNSTP--LRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFG 114
+ S + + LR FKRPFPPPSPAKHIR+LLARRHGSVKPNEASIPEG+E ++GLDK FG
Sbjct: 56 VSSSSVSSTPLRIFKRPFPPPSPAKHIRALLARRHGSVKPNEASIPEGSECEVGLDKKFG 115
Query: 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHE 174
FSKQF +HYE+ EVGRGHFGYTCSAK KKGSLKGQDVAVKVIPK
Sbjct: 116 FSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQDVAVKVIPKSK------------- 162
Query: 175 NHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELC 234
MTTAIAIEDVRREVKILRALTGHKNLVQFYDA+EDD+N+YIVMELC
Sbjct: 163 --------------MTTAIAIEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVMELC 208
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
+GGELLD+IL RGGKYSE DAK VM+QILSVVA+CH QGVVHRDLKPENFLFT+K+E+S
Sbjct: 209 QGGELLDKILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDESSP 268
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPF 354
LKAIDFGLSDYV+PDERLNDIVGSAYYVAPEVLHR+YGTEADMWSIGVIAYILLCGSRPF
Sbjct: 269 LKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPF 328
Query: 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
WAR+ESGIFRAVLKA+P+F+EAPWPSLSP+A+DFVKRLLNKDYRKRLTAAQAL HPWL
Sbjct: 329 WARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQALCHPWLVG 388
Query: 415 SHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFI 474
SH++KIPSDMI+YKL+K YI SSSLRK+AL ALAKTLTVPQL YL+EQF LL P+KNG+I
Sbjct: 389 SHELKIPSDMIIYKLVKVYIMSSSLRKSALAALAKTLTVPQLTYLQEQFNLLGPSKNGYI 448
Query: 475 SMQNYK 480
SMQNYK
Sbjct: 449 SMQNYK 454
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O80673|CAMK1_ARATH CDPK-related kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 749 bits (1934), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/485 (76%), Positives = 413/485 (85%), Gaps = 37/485 (7%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYE---NEPQPNSQK-SKASNFPFYSPSPLPSLFKNSPA 56
MG+CHGKPVE Q+++LP NE NSQ +K+S FPFYSPSP+PSLFK+SP+
Sbjct: 1 MGICHGKPVEQ-----QSKSLPVSGETNEAPTNSQPPAKSSGFPFYSPSPVPSLFKSSPS 55
Query: 57 IPSVNS-TPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGF 115
+ S S TPLR FKRPFPPPSPAKHIR+ LARR+GSVKPNE SIPEG E +IGLDK+FGF
Sbjct: 56 VSSSVSSTPLRIFKRPFPPPSPAKHIRAFLARRYGSVKPNEVSIPEGKECEIGLDKSFGF 115
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
SKQF +HYE+ EVGRGHFGYTCSAK KKGSLKGQ+VAVKVIPK
Sbjct: 116 SKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAVKVIPKSK-------------- 161
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCK 235
MTTAIAIEDV REVK+LRALTGHKNLVQFYDA+EDD+N+YIVMELCK
Sbjct: 162 -------------MTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCK 208
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
GGELLD+IL RGGKYSE+DAK VMVQILSVVA+CH QGVVHRDLKPENFLF++K+E S L
Sbjct: 209 GGELLDKILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPL 268
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFW 355
KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR+YGTEADMWSIGVIAYILLCGSRPFW
Sbjct: 269 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFW 328
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415
ARTESGIFRAVLKA+P+F+EAPWPSLSPEA+DFVKRLLNKDYRKRLTAAQAL HPWL S
Sbjct: 329 ARTESGIFRAVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLVGS 388
Query: 416 HDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFIS 475
H++KIPSDMI+YKL+K YI S+SLRK+AL ALAKTLTVPQLAYLREQFTLL P+KNG+IS
Sbjct: 389 HELKIPSDMIIYKLVKVYIMSTSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNGYIS 448
Query: 476 MQNYK 480
MQNYK
Sbjct: 449 MQNYK 453
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3. Confers thermotolerance; involved in the heat-shock-mediated calmodulin-dependent signal transduction leading to the activation of heat-shock transcription factors (HSFs); phosphorylates HSFA1A. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SCS2|CAMK5_ARATH CDPK-related kinase 5 OS=Arabidopsis thaliana GN=CRK5 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 681 bits (1757), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/510 (68%), Positives = 388/510 (76%), Gaps = 62/510 (12%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYENEPQP----------------------NSQKSKASN 38
MGLC KP NS N Q P N P P N++ K+
Sbjct: 1 MGLCTSKP--NSSNSDQT---PARNSPLPASESVKPSSSSVNGEDQCVTTTNNEGKKSPF 55
Query: 39 FPFYSPSPLPSLFKN-----SPAIPSVNSTPLRFFKRPFPPPSPAKHIRSLLARRHGSVK 93
FPFYSPSP F SPA S NSTP RFFKRPFPPPSPAKHIR++LARRHGSVK
Sbjct: 56 FPFYSPSPAHYFFSKKTPARSPATNSTNSTPKRFFKRPFPPPSPAKHIRAVLARRHGSVK 115
Query: 94 PNEASIPEGNESD---IGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQ 150
PN ++IPEG+E++ +GLDK+FGFSK F + YELG+EVGRGHFGYTC+AK KKG KGQ
Sbjct: 116 PNSSAIPEGSEAEGGGVGLDKSFGFSKSFASKYELGDEVGRGHFGYTCAAKFKKGDNKGQ 175
Query: 151 DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTG 210
VAVKVIPK MTTAIAIEDVRREVKILRAL+G
Sbjct: 176 QVAVKVIPKAK---------------------------MTTAIAIEDVRREVKILRALSG 208
Query: 211 HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCH 270
H NL FYDAYED DN+YIVMELC+GGELLDRILSRGGKY+EEDAK VM+QIL+VVAFCH
Sbjct: 209 HNNLPHFYDAYEDHDNVYIVMELCEGGELLDRILSRGGKYTEEDAKTVMIQILNVVAFCH 268
Query: 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS 330
QGVVHRDLKPENFLFTSKE+ S LKAIDFGLSDYV+PDERLNDIVGSAYYVAPEVLHRS
Sbjct: 269 LQGVVHRDLKPENFLFTSKEDTSQLKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRS 328
Query: 331 YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVK 390
Y TEAD+WS+GVI YILLCGSRPFWARTESGIFRAVLKADPSFD+ PWP LS EA DFVK
Sbjct: 329 YSTEADIWSVGVIVYILLCGSRPFWARTESGIFRAVLKADPSFDDPPWPLLSSEARDFVK 388
Query: 391 RLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKT 450
RLLNKD RKRLTAAQALSHPW+ +S+D K+P D++V+KL++AY+ SSSLRKAAL AL+KT
Sbjct: 389 RLLNKDPRKRLTAAQALSHPWIKDSNDAKVPMDILVFKLMRAYLRSSSLRKAALRALSKT 448
Query: 451 LTVPQLAYLREQFTLLAPNKNGFISMQNYK 480
LTV +L YLREQF LL P+KNG IS++N K
Sbjct: 449 LTVDELFYLREQFALLEPSKNGTISLENIK 478
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q10KY3|CAMK1_ORYSJ Calcium/calmodulin-dependent serine/threonine-protein kinase 1 OS=Oryza sativa subsp. japonica GN=CAMK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 656 bits (1692), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 332/448 (74%), Positives = 368/448 (82%), Gaps = 29/448 (6%)
Query: 35 KASNFPFYSPSPLP-SLFKNSPAIPSVNSTPLRF-FKRPFPPPSPAKHIRSLLARRHGSV 92
K FPFY PSPLP S +K SPA SV STP R FKRPFPPPSPAKHIR+LLARRHGSV
Sbjct: 57 KQHKFPFYLPSPLPASSYKGSPANSSVASTPARGGFKRPFPPPSPAKHIRALLARRHGSV 116
Query: 93 KPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDV 152
KPNEASIPE E + LDK FGFS+ F A YELG EVGRGHFGYTC+A KKG LKG DV
Sbjct: 117 KPNEASIPESGEPGVALDKGFGFSRHFAAKYELGREVGRGHFGYTCAATCKKGELKGDDV 176
Query: 153 AVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHK 212
AVKVIPK MTTAIAIEDVRREV+IL +L GH
Sbjct: 177 AVKVIPKAK---------------------------MTTAIAIEDVRREVRILSSLAGHS 209
Query: 213 NLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272
NLVQFYDAYED++N+YIVMELCKGGELLDRIL+RGGKYSEEDAK+VM QILSV +FCH Q
Sbjct: 210 NLVQFYDAYEDEENVYIVMELCKGGELLDRILARGGKYSEEDAKVVMRQILSVASFCHLQ 269
Query: 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYG 332
GVVHRDLKPENFLF+SK+ENS++K IDFGLSD+VKPDERLNDIVGSAYYVAPEVLHRSYG
Sbjct: 270 GVVHRDLKPENFLFSSKDENSAMKVIDFGLSDFVKPDERLNDIVGSAYYVAPEVLHRSYG 329
Query: 333 TEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRL 392
TEADMWSIGVI YILLCGSRPFWARTESGIFRAVLKADPSF+EAPWP+LS EA DFV+RL
Sbjct: 330 TEADMWSIGVIVYILLCGSRPFWARTESGIFRAVLKADPSFEEAPWPTLSAEAKDFVRRL 389
Query: 393 LNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLT 452
LNKDYRKR+TAAQAL HPW+ + +VK+P DMI+Y+L++AYISSSSLR+AAL ALAKTLT
Sbjct: 390 LNKDYRKRMTAAQALCHPWIRGTEEVKLPLDMIIYRLMRAYISSSSLRRAALRALAKTLT 449
Query: 453 VPQLAYLREQFTLLAPNKNGFISMQNYK 480
Q+ YLREQF L+ PNK+ I++QN K
Sbjct: 450 TDQIYYLREQFELIGPNKSDLITLQNLK 477
|
Possesses kinase activity in vitro. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 EC: 7 |
| >sp|P53681|CRK_DAUCA CDPK-related protein kinase OS=Daucus carota GN=CRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 647 bits (1668), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 329/469 (70%), Positives = 370/469 (78%), Gaps = 39/469 (8%)
Query: 20 ALPYENEPQPNSQKSKASNFPFYSPSPLPSLFK------NSPAIPSVNSTPLRFFKRPFP 73
A+P ++ +P +KS PFYSPSP LF SPA S NSTP R F PFP
Sbjct: 41 AIPAQDNNKPPGKKSPF--LPFYSPSPAHFLFSKKSPAVGSPAAGSSNSTPKRLF--PFP 96
Query: 74 PPSPAKHIRSLLARRHGSVKPNEASIPEGNESD--IGLDKNFGFSKQFVAHYELGEEVGR 131
PPSPAKHI++ ARRHGSVKPNEA+IPE NE D GLDK+FGFSK+F + +E+GEEVGR
Sbjct: 97 PPSPAKHIKAAWARRHGSVKPNEAAIPENNEVDGGAGLDKSFGFSKKFGSKFEVGEEVGR 156
Query: 132 GHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTT 191
GHFGYTC AK KKG KGQDVAVKVIPK MTT
Sbjct: 157 GHFGYTCRAKFKKGEFKGQDVAVKVIPKAK---------------------------MTT 189
Query: 192 AIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYS 251
AIAIEDVRREVKILRALTGH NLVQFYDA+ED N+Y+VMELC+GGELLDRILSRGGKY+
Sbjct: 190 AIAIEDVRREVKILRALTGHNNLVQFYDAFEDHTNVYVVMELCEGGELLDRILSRGGKYT 249
Query: 252 EEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER 311
E+DAK VM+QIL+VVAFCH QGVVHRDLKPENFLF SK+E+S LKAIDFGLSDYVKPDER
Sbjct: 250 EDDAKAVMIQILNVVAFCHLQGVVHRDLKPENFLFKSKDEDSQLKAIDFGLSDYVKPDER 309
Query: 312 LNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 371
LNDIVGSAYYVAPEVLHRSY TEAD+WSIGVI+YILLCGSRPFWARTESGIFRAVLKA+
Sbjct: 310 LNDIVGSAYYVAPEVLHRSYSTEADVWSIGVISYILLCGSRPFWARTESGIFRAVLKANL 369
Query: 372 SFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIK 431
SFDE PWPS+S EA DFVKRLLNKD RKR+TAAQAL H W+ NS+D+K P D++V+KL+K
Sbjct: 370 SFDEPPWPSVSSEAKDFVKRLLNKDPRKRMTAAQALCHSWIKNSNDIKFPLDILVFKLMK 429
Query: 432 AYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYK 480
Y+ SS LRKAAL AL+KTLTV +L YL+EQF LL P KNG IS++N K
Sbjct: 430 VYMRSSPLRKAALRALSKTLTVDELFYLKEQFVLLEPTKNGTISLENIK 478
|
Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LJL9|CAMK2_ARATH CDPK-related kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 595 bits (1533), Expect = e-169, Method: Compositional matrix adjust.
Identities = 314/507 (61%), Positives = 363/507 (71%), Gaps = 56/507 (11%)
Query: 1 MGLCHGKPVENS------------QNRSQNEALPYENEPQPNSQKSKASNF-PFYSPSPL 47
MG C KP + QN A P ++ P +S KAS F PFY+PSP
Sbjct: 1 MGGCTSKPSSSVKPNPYAPKDAVLQNDDSTPAHPGKS-PVRSSPAVKASPFFPFYTPSPA 59
Query: 48 -----PSLFKNSPAIPSVNSTPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEG 102
S SV STPLR R F PPSPA+HIR +L RR + EA++P
Sbjct: 60 RHRRNKSRDGGGGESKSVTSTPLRQLARAFHPPSPARHIRDVLRRRK---EKKEAALPAA 116
Query: 103 NESD-------IGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVK 155
+ +GLDK FGFSK+ + ELGEE+GRGHFGYTCSAK KKG LK Q+VAVK
Sbjct: 117 RQQKEEEEREEVGLDKRFGFSKELQSRIELGEEIGRGHFGYTCSAKFKKGELKDQEVAVK 176
Query: 156 VIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLV 215
VIPK MT+AI+IEDVRREVKILRAL+GH+NLV
Sbjct: 177 VIPKSK---------------------------MTSAISIEDVRREVKILRALSGHQNLV 209
Query: 216 QFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275
QFYDA+ED+ N+YIVMELC GGELLDRIL+RGGKYSE+DAK V++QIL+VVAFCH QGVV
Sbjct: 210 QFYDAFEDNANVYIVMELCGGGELLDRILARGGKYSEDDAKAVLIQILNVVAFCHLQGVV 269
Query: 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEA 335
HRDLKPENFL+TSKEENS LK IDFGLSD+V+PDERLNDIVGSAYYVAPEVLHRSY TEA
Sbjct: 270 HRDLKPENFLYTSKEENSMLKVIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSYTTEA 329
Query: 336 DMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNK 395
D+WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWPSLS EA DFVKRLL K
Sbjct: 330 DVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPSLSFEAKDFVKRLLYK 389
Query: 396 DYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQ 455
D RKR+TA+QAL HPW+A + IP D++++K IKAY+ SSSLRKAAL AL+KTLT +
Sbjct: 390 DPRKRMTASQALMHPWIAGYKKIDIPFDILIFKQIKAYLRSSSLRKAALMALSKTLTTDE 449
Query: 456 LAYLREQFTLLAPNKNGFISMQNYKMT 482
L YL+ QF LAPNKNG I++ + ++
Sbjct: 450 LLYLKAQFAHLAPNKNGLITLDSIRLA 476
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FX86|CAMK8_ARATH CDPK-related kinase 8 OS=Arabidopsis thaliana GN=CRK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 590 bits (1521), Expect = e-168, Method: Compositional matrix adjust.
Identities = 314/511 (61%), Positives = 367/511 (71%), Gaps = 59/511 (11%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYENEPQ--------------PNSQKSKASNF-PFYSPS 45
MG C KP +S N P + PQ P +KAS F PFY+PS
Sbjct: 1 MGGCTSKPSTSSGR--PNPFAPGNDYPQIDDFAPDHPGKSPIPTPSAAKASPFFPFYTPS 58
Query: 46 PLPSLFKNSPAI------PSVNSTPLRFFKRPFPPPSPAKHIRSLLARRHG-------SV 92
P S + S+ STPLR +R F PPSPAKHIR+ L RR G V
Sbjct: 59 PARHRRNKSRDVGGGGESKSLTSTPLRQLRRAFHPPSPAKHIRAALRRRKGKKEAALSGV 118
Query: 93 KPNEASIPE-GNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQD 151
+P+ E ++GLDK FGFSK+F + ELGEE+GRGHFGYTCSAK KKG LKGQ
Sbjct: 119 TQLTTEVPQREEEEEVGLDKRFGFSKEFHSRVELGEEIGRGHFGYTCSAKFKKGELKGQV 178
Query: 152 VAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGH 211
VAVK+IPK MTTAIAIEDVRREVKIL+AL+GH
Sbjct: 179 VAVKIIPKSK---------------------------MTTAIAIEDVRREVKILQALSGH 211
Query: 212 KNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271
KNLVQFYDA+ED+ N+YI MELC+GGELLDRIL+RGGKYSE DAK V++QIL+VVAFCHF
Sbjct: 212 KNLVQFYDAFEDNANVYIAMELCEGGELLDRILARGGKYSENDAKPVIIQILNVVAFCHF 271
Query: 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSY 331
QGVVHRDLKPENFL+TSKEENS LKAIDFGLSD+V+PDERLNDIVGSAYYVAPEVLHRSY
Sbjct: 272 QGVVHRDLKPENFLYTSKEENSQLKAIDFGLSDFVRPDERLNDIVGSAYYVAPEVLHRSY 331
Query: 332 GTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKR 391
TEAD+WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE PWP LS +A DFVKR
Sbjct: 332 TTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEPPWPFLSSDAKDFVKR 391
Query: 392 LLNKDYRKRLTAAQALSHPWL-ANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKT 450
LL KD R+R++A+QAL HPW+ A + D+ IP D+++++ +KAY+ SSSLRKAAL AL+KT
Sbjct: 392 LLFKDPRRRMSASQALMHPWIRAYNTDMNIPFDILIFRQMKAYLRSSSLRKAALRALSKT 451
Query: 451 LTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481
L ++ YL+ QF+LLAPNK+G I+M +M
Sbjct: 452 LIKDEILYLKTQFSLLAPNKDGLITMDTIRM 482
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUZ2|CAMK3_ARATH CDPK-related kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 522 bits (1344), Expect = e-147, Method: Compositional matrix adjust.
Identities = 295/504 (58%), Positives = 358/504 (71%), Gaps = 56/504 (11%)
Query: 1 MGLCHGKPVENSQN-RSQNEALPY-----ENEPQPNS--QKSKASNFPFY---------- 42
MG C+GK ++ QN + Y N+ QP + +A N P
Sbjct: 1 MGQCYGKVNQSKQNGEEEANTTTYVVSGDGNQIQPLTPVNYGRAKNTPARSSNPSPWPSP 60
Query: 43 ----SPSPLPSLFKNSPAIPSVNSTPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEAS 98
S SPLPS SPA STP RFF+RPFPPPSPAKHI++ L +R G VKP E
Sbjct: 61 FPHGSASPLPSGVSPSPA---RTSTPRRFFRRPFPPPSPAKHIKASLIKRLG-VKPKEGP 116
Query: 99 IPE--GNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKV 156
IPE G E + LDK+FG+ K F A YELG+EVGRGHFG+TCS + KKG +K +AVK+
Sbjct: 117 IPEERGTEPEQSLDKSFGYGKNFGAKYELGKEVGRGHFGHTCSGRGKKGDIKDHPIAVKI 176
Query: 157 IPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQ 216
I K MTTAIAIEDVRREVK+L++L+GHK L++
Sbjct: 177 ISKAK---------------------------MTTAIAIEDVRREVKLLKSLSGHKYLIK 209
Query: 217 FYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276
+YDA ED +N+YIVMELC GGELLDRIL+RGGKY E+DAK ++VQIL+VV+FCH QGVVH
Sbjct: 210 YYDACEDANNVYIVMELCDGGELLDRILARGGKYPEDDAKAIVVQILTVVSFCHLQGVVH 269
Query: 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEAD 336
RDLKPENFLFTS E+S LK IDFGLSD+++PDERLNDIVGSAYYVAPEVLHRSY EAD
Sbjct: 270 RDLKPENFLFTSSREDSDLKLIDFGLSDFIRPDERLNDIVGSAYYVAPEVLHRSYSLEAD 329
Query: 337 MWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKD 396
+WSIGVI YILLCGSRPFWARTESGIFR VL+ +P++D+ PWPS S E DFVKRLLNKD
Sbjct: 330 IWSIGVITYILLCGSRPFWARTESGIFRTVLRTEPNYDDVPWPSCSSEGKDFVKRLLNKD 389
Query: 397 YRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQL 456
YRKR++A QAL+HPWL + V IP D+++YKL+KAY+ ++ LR+AAL ALAK LT +L
Sbjct: 390 YRKRMSAVQALTHPWLRDDSRV-IPLDILIYKLVKAYLHATPLRRAALKALAKALTENEL 448
Query: 457 AYLREQFTLLAPNKNGFISMQNYK 480
YLR QF LL PNK+G +S++N+K
Sbjct: 449 VYLRAQFMLLGPNKDGSVSLENFK 472
|
May play a role in signal transduction pathways that involve calcium as a second messenger (By similarity). Serine/threonine kinase that phosphorylates histone H3 an GLN1-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIM9|CAMK4_ARATH CDPK-related kinase 4 OS=Arabidopsis thaliana GN=CRK4 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1260), Expect = e-137, Method: Compositional matrix adjust.
Identities = 271/504 (53%), Positives = 346/504 (68%), Gaps = 53/504 (10%)
Query: 1 MGLCHGK---PVENSQNRSQNEALPYENEPQPNSQKSKASNFPFYSPSPLPSLFKNSP-- 55
MG C+ + VE+ + + N + N+P N + + P S +P + + SP
Sbjct: 1 MGHCYSRNISAVEDDEIPTGNGEV--SNQPSQNHRHASIPQSPVASGTPEVNSYNISPFQ 58
Query: 56 ------AIPSVNSTPLRFFKRPFPPPSPAKHIRSLLARRHGSV-KPNEASIPEGNE---- 104
PS TP R FK PFPPPSPAK I + L RR G+ +P + IPE +E
Sbjct: 59 SPLPAGVAPSPARTPGRKFKWPFPPPSPAKPIMAALRRRRGAPPQPRDEPIPEDSEDVVD 118
Query: 105 --SDIG----LDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIP 158
D G LDKNFGF K F YELG+EVGRGHFG+TC AKAKKG +K Q VAVK+I
Sbjct: 119 HGGDSGGGERLDKNFGFGKNFEGKYELGKEVGRGHFGHTCWAKAKKGKMKNQTVAVKIIS 178
Query: 159 KMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFY 218
K MT+ ++IEDVRREVK+L+AL+GH+++V+FY
Sbjct: 179 KAK---------------------------MTSTLSIEDVRREVKLLKALSGHRHMVKFY 211
Query: 219 DAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278
D YED DN+++VMELC+GGELLDRIL+RGG+Y E DAK ++VQILS AF H QGVVHRD
Sbjct: 212 DVYEDADNVFVVMELCEGGELLDRILARGGRYPEVDAKRILVQILSATAFFHLQGVVHRD 271
Query: 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMW 338
LKPENFLFTS+ E++ LK IDFGLSD+++ D+RLND+VGSAYYVAPEVLHRSY TEADMW
Sbjct: 272 LKPENFLFTSRNEDAILKVIDFGLSDFIRYDQRLNDVVGSAYYVAPEVLHRSYSTEADMW 331
Query: 339 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYR 398
SIGVI+YILLCGSRPF+ RTES IFR VL+A+P+F++ PWPS+SP A DFVKRLLNKD+R
Sbjct: 332 SIGVISYILLCGSRPFYGRTESAIFRCVLRANPNFEDMPWPSISPTAKDFVKRLLNKDHR 391
Query: 399 KRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAY 458
KR+TAAQAL+HPWL + + + D VYKL+K+YI +S R++AL AL+K + +L +
Sbjct: 392 KRMTAAQALAHPWLRD-ENPGLLLDFSVYKLVKSYIRASPFRRSALKALSKAIPDEELVF 450
Query: 459 LREQFTLLAPNKNGFISMQNYKMT 482
L+ QF LL P K+G +S+ + M
Sbjct: 451 LKAQFMLLDP-KDGGLSLNCFTMA 473
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SG12|CAMK6_ARATH CDPK-related kinase 6 OS=Arabidopsis thaliana GN=CRK6 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1198), Expect = e-130, Method: Compositional matrix adjust.
Identities = 258/443 (58%), Positives = 322/443 (72%), Gaps = 42/443 (9%)
Query: 45 SPLPSLFKNSPAIPSVNSTPLRFFKRPFPPPSPAKHIRSLLARRHGSV-KPNEASIPEGN 103
SPLP+ SPA TP R FK PFPPPSPAK I + L RR G+ P + IPE +
Sbjct: 61 SPLPAGVAPSPA-----RTPGRKFKWPFPPPSPAKPIMAALRRRRGTAPHPRDGPIPEDS 115
Query: 104 ESDIG-------LDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKV 156
E+ LDKNFGF+K F YELG EVGRGHFG+TC AKAKKG +KGQ VAVK+
Sbjct: 116 EAGGSGGGIGERLDKNFGFAKNFEGKYELGREVGRGHFGHTCWAKAKKGKIKGQTVAVKI 175
Query: 157 IPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQ 216
I K MT+A++IEDVRREVK+L+AL+GH ++V+
Sbjct: 176 ISKSK---------------------------MTSALSIEDVRREVKLLKALSGHSHMVK 208
Query: 217 FYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276
FYD +ED DN+++VMELC+GGELLD IL+RGG+Y E +AK ++VQILS AF H QGVVH
Sbjct: 209 FYDVFEDSDNVFVVMELCEGGELLDSILARGGRYPEAEAKRILVQILSATAFFHLQGVVH 268
Query: 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEAD 336
RDLKPENFLFTSK E++ LK IDFGLSDY + D+RLND+VGSAYYVAPEVLHRSY TEAD
Sbjct: 269 RDLKPENFLFTSKNEDAVLKVIDFGLSDYARFDQRLNDVVGSAYYVAPEVLHRSYSTEAD 328
Query: 337 MWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKD 396
+WSIGVI+YILLCGSRPF+ RTES IFR VL+A+P+FD+ PWPS+SP A DFVKRLLNKD
Sbjct: 329 IWSIGVISYILLCGSRPFYGRTESAIFRCVLRANPNFDDLPWPSISPIAKDFVKRLLNKD 388
Query: 397 YRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQL 456
+RKR+TAAQAL+HPWL + + + D +YKL+K+YI +S R+AAL +L+K + +L
Sbjct: 389 HRKRMTAAQALAHPWLRDE-NPGLLLDFSIYKLVKSYIRASPFRRAALKSLSKAIPEEEL 447
Query: 457 AYLREQFTLLAPNKNGFISMQNY 479
+L+ QF LL P ++G + + N+
Sbjct: 448 VFLKAQFMLLEP-EDGGLHLHNF 469
|
May play a role in signal transduction pathways that involve calcium as a second messenger. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 482 | ||||||
| 224137674 | 578 | predicted protein [Populus trichocarpa] | 0.939 | 0.783 | 0.848 | 0.0 | |
| 224089983 | 562 | CPK related protein kinase 1 [Populus tr | 0.939 | 0.806 | 0.825 | 0.0 | |
| 225440085 | 575 | PREDICTED: calcium/calmodulin-dependent | 0.939 | 0.787 | 0.808 | 0.0 | |
| 297741652 | 593 | unnamed protein product [Vitis vinifera] | 0.935 | 0.760 | 0.805 | 0.0 | |
| 449446726 | 573 | PREDICTED: calcium/calmodulin-dependent | 0.921 | 0.774 | 0.761 | 0.0 | |
| 15229002 | 577 | protein kinase-domain containing protein | 0.929 | 0.776 | 0.765 | 0.0 | |
| 15226841 | 576 | CDPK-related kinase 1 [Arabidopsis thali | 0.929 | 0.777 | 0.769 | 0.0 | |
| 297820446 | 577 | hypothetical protein ARALYDRAFT_486115 [ | 0.937 | 0.783 | 0.761 | 0.0 | |
| 297824057 | 577 | hypothetical protein ARALYDRAFT_483182 [ | 0.939 | 0.785 | 0.754 | 0.0 | |
| 357509349 | 595 | Calcium-dependent protein kinase-like pr | 0.939 | 0.761 | 0.739 | 0.0 |
| >gi|224137674|ref|XP_002322616.1| predicted protein [Populus trichocarpa] gi|222867246|gb|EEF04377.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 832 bits (2149), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 409/482 (84%), Positives = 427/482 (88%), Gaps = 29/482 (6%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYENE-PQP-NSQKSKASNFPFYSPSPLPSLFKNSPAIP 58
MGLCHGKP+E +N+S+N L E + QP NS SK SNFPFYSPSPLPSLFK SPAI
Sbjct: 1 MGLCHGKPIELQKNQSKNNTLSIETDSTQPANSHTSKTSNFPFYSPSPLPSLFKTSPAIS 60
Query: 59 SVNSTPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQ 118
SV+STPLR FKRPFPPPSPAKHIR+LLARRHGSVKPNEASIPEG+ESDI LDKNFGFSKQ
Sbjct: 61 SVSSTPLRIFKRPFPPPSPAKHIRALLARRHGSVKPNEASIPEGSESDIALDKNFGFSKQ 120
Query: 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQF 178
FV+HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPK
Sbjct: 121 FVSHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKSK----------------- 163
Query: 179 TILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGE 238
MTTAIAIEDVRREVKILRALTGH NLVQFYDAYEDDDN+Y+VMELCKGGE
Sbjct: 164 ----------MTTAIAIEDVRREVKILRALTGHNNLVQFYDAYEDDDNVYVVMELCKGGE 213
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
LLDRILSRGGKYSEEDAK VMVQILSVVA+CH QGVVHRDLKPENFLFT+KEENS LKAI
Sbjct: 214 LLDRILSRGGKYSEEDAKTVMVQILSVVAYCHLQGVVHRDLKPENFLFTTKEENSPLKAI 273
Query: 299 DFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWART 358
DFGLSDYVK DERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWART
Sbjct: 274 DFGLSDYVKLDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWART 333
Query: 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDV 418
ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN HD+
Sbjct: 334 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANHHDL 393
Query: 419 KIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQN 478
KIP DMIVYKL+KAYISSSSLRK+ALGALAKTLTV QLAYLREQFTLL P+KNGFISMQN
Sbjct: 394 KIPLDMIVYKLVKAYISSSSLRKSALGALAKTLTVAQLAYLREQFTLLGPSKNGFISMQN 453
Query: 479 YK 480
+K
Sbjct: 454 FK 455
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224089983|ref|XP_002308892.1| CPK related protein kinase 1 [Populus trichocarpa] gi|222854868|gb|EEE92415.1| CPK related protein kinase 1 [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 817 bits (2111), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 398/482 (82%), Positives = 420/482 (87%), Gaps = 29/482 (6%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYENEPQ--PNSQKSKASNFPFYSPSPLPSLFKNSPAIP 58
MGLCHGKPVE QN+S+N L E + PNS K SNFPFYSPSPL SLFK SPA+
Sbjct: 1 MGLCHGKPVELQQNQSKNNTLSIETDSTKPPNSHTRKNSNFPFYSPSPLSSLFKTSPAVS 60
Query: 59 SVNSTPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQ 118
SV STPLR FKRPFPPPSPAKHIR+LLARRHGSVKPNEASIPEGNE DIGLDKNFGFSKQ
Sbjct: 61 SVRSTPLRIFKRPFPPPSPAKHIRALLARRHGSVKPNEASIPEGNEIDIGLDKNFGFSKQ 120
Query: 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQF 178
F +HYELGEEVGRGHFGYTCSAKAKKGSLKGQ+VAVKVIPK
Sbjct: 121 FASHYELGEEVGRGHFGYTCSAKAKKGSLKGQNVAVKVIPKSK----------------- 163
Query: 179 TILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGE 238
MTT +AIEDVRREVKILRALTGHKNLVQFYDAYEDDDN+Y +MELC+GGE
Sbjct: 164 ----------MTTVVAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNVYAIMELCEGGE 213
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
LLDRILSRGGKYSEEDA+ VMVQILSVVA+CH QGVVHRDLKPENFLFT+KE+NS+LKAI
Sbjct: 214 LLDRILSRGGKYSEEDARTVMVQILSVVAYCHLQGVVHRDLKPENFLFTTKEDNSTLKAI 273
Query: 299 DFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWART 358
DFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWART
Sbjct: 274 DFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWART 333
Query: 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDV 418
ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN HD+
Sbjct: 334 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANHHDI 393
Query: 419 KIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQN 478
KIP DMIVYKL KAYI SSSLRK+AL ALAKTLTV Q+A+LREQFTLL P+KNGFISMQN
Sbjct: 394 KIPLDMIVYKLAKAYIYSSSLRKSALRALAKTLTVAQIAFLREQFTLLGPSKNGFISMQN 453
Query: 479 YK 480
+K
Sbjct: 454 FK 455
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225440085|ref|XP_002282577.1| PREDICTED: calcium/calmodulin-dependent serine/threonine-protein kinase 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 800 bits (2065), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/480 (80%), Positives = 417/480 (86%), Gaps = 27/480 (5%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYENEPQPNSQKSKASNFPFYSPSPLPSLFKNSPAIPSV 60
MGLC GKP+EN Q +SQ+ +P + E N+Q +K FPFYSPSPLPS FKNSPA SV
Sbjct: 1 MGLCQGKPIENPQTQSQDLIIPGDGELSTNTQTTKTPKFPFYSPSPLPSGFKNSPANSSV 60
Query: 61 NSTPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFV 120
+STPLR FKRPFPPPSPAKHIR+LLARRHGSVKPNEA+IPEGNE ++GLDKNFGFSKQFV
Sbjct: 61 SSTPLRIFKRPFPPPSPAKHIRALLARRHGSVKPNEATIPEGNECEVGLDKNFGFSKQFV 120
Query: 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
AHYE+GEEVGRGHFGYT SAKAKKGSLKGQDVAVKVI K
Sbjct: 121 AHYEMGEEVGRGHFGYTSSAKAKKGSLKGQDVAVKVIAKSK------------------- 161
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
MTTAIAIEDVRREVKILRALTGHKNLVQFY+AYEDDDN+YIVMELC+GGELL
Sbjct: 162 --------MTTAIAIEDVRREVKILRALTGHKNLVQFYEAYEDDDNVYIVMELCRGGELL 213
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
DRIL+RGGKYSEEDAK VMVQIL+V AFCH QGVVHRDLKPENFLF SKEENS LKAIDF
Sbjct: 214 DRILARGGKYSEEDAKAVMVQILNVTAFCHLQGVVHRDLKPENFLFISKEENSPLKAIDF 273
Query: 301 GLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTES 360
GLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWS+GVIAYILLCGSRPFWARTES
Sbjct: 274 GLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSVGVIAYILLCGSRPFWARTES 333
Query: 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKI 420
GIF+AVLKADPSFDEAPWPSLS +AIDFVKRLLNKDYRKRLTAAQALSHPWLAN HDVKI
Sbjct: 334 GIFKAVLKADPSFDEAPWPSLSSDAIDFVKRLLNKDYRKRLTAAQALSHPWLANYHDVKI 393
Query: 421 PSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYK 480
P DMIVYKL+KAYI SSSLRK+AL ALAKTL++ QLAY REQFTLL PNK+GF+S+QN+K
Sbjct: 394 PLDMIVYKLVKAYIFSSSLRKSALAALAKTLSIAQLAYFREQFTLLGPNKSGFVSLQNFK 453
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741652|emb|CBI32784.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2042), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 385/478 (80%), Positives = 414/478 (86%), Gaps = 27/478 (5%)
Query: 3 LCHGKPVENSQNRSQNEALPYENEPQPNSQKSKASNFPFYSPSPLPSLFKNSPAIPSVNS 62
L GKP+EN Q +SQ+ +P + E N+Q +K FPFYSPSPLPS FKNSPA SV+S
Sbjct: 21 LTAGKPIENPQTQSQDLIIPGDGELSTNTQTTKTPKFPFYSPSPLPSGFKNSPANSSVSS 80
Query: 63 TPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFVAH 122
TPLR FKRPFPPPSPAKHIR+LLARRHGSVKPNEA+IPEGNE ++GLDKNFGFSKQFVAH
Sbjct: 81 TPLRIFKRPFPPPSPAKHIRALLARRHGSVKPNEATIPEGNECEVGLDKNFGFSKQFVAH 140
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE+GEEVGRGHFGYT SAKAKKGSLKGQDVAVKVI K
Sbjct: 141 YEMGEEVGRGHFGYTSSAKAKKGSLKGQDVAVKVIAKSK--------------------- 179
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
MTTAIAIEDVRREVKILRALTGHKNLVQFY+AYEDDDN+YIVMELC+GGELLDR
Sbjct: 180 ------MTTAIAIEDVRREVKILRALTGHKNLVQFYEAYEDDDNVYIVMELCRGGELLDR 233
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
IL+RGGKYSEEDAK VMVQIL+V AFCH QGVVHRDLKPENFLF SKEENS LKAIDFGL
Sbjct: 234 ILARGGKYSEEDAKAVMVQILNVTAFCHLQGVVHRDLKPENFLFISKEENSPLKAIDFGL 293
Query: 303 SDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGI 362
SDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWS+GVIAYILLCGSRPFWARTESGI
Sbjct: 294 SDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSVGVIAYILLCGSRPFWARTESGI 353
Query: 363 FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPS 422
F+AVLKADPSFDEAPWPSLS +AIDFVKRLLNKDYRKRLTAAQALSHPWLAN HDVKIP
Sbjct: 354 FKAVLKADPSFDEAPWPSLSSDAIDFVKRLLNKDYRKRLTAAQALSHPWLANYHDVKIPL 413
Query: 423 DMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYK 480
DMIVYKL+KAYI SSSLRK+AL ALAKTL++ QLAY REQFTLL PNK+GF+S+QN+K
Sbjct: 414 DMIVYKLVKAYIFSSSLRKSALAALAKTLSIAQLAYFREQFTLLGPNKSGFVSLQNFK 471
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449446726|ref|XP_004141122.1| PREDICTED: calcium/calmodulin-dependent serine/threonine-protein kinase 1-like [Cucumis sativus] gi|449489494|ref|XP_004158329.1| PREDICTED: calcium/calmodulin-dependent serine/threonine-protein kinase 1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1946), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 370/486 (76%), Positives = 407/486 (83%), Gaps = 42/486 (8%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYENEPQPNS-----QKSKASNFPFYSPSPLPSLFKNS- 54
MGLCHGKP+E QN P N PNS +NFPFYSPSPLP+LFK+S
Sbjct: 1 MGLCHGKPIE------QN---PKPNSENPNSVIQSETPKTPTNFPFYSPSPLPNLFKSSS 51
Query: 55 PAIPSVNSTPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFG 114
PA S+ STPLR FKRPFPPPSPAKHIR+LLARRHGSVKPNEASIPEG+E D+ LDKNFG
Sbjct: 52 PANSSITSTPLRLFKRPFPPPSPAKHIRALLARRHGSVKPNEASIPEGSECDVALDKNFG 111
Query: 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHE 174
+SK F AHY+LG+EVGRGHFGYTCSA+AKKGS KGQ VAVK+IPK
Sbjct: 112 YSKHFAAHYDLGDEVGRGHFGYTCSARAKKGSFKGQQVAVKIIPKSK------------- 158
Query: 175 NHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELC 234
MTTAIAIEDVRREVKILRALTGHKNLVQFYD+YED++NIY+VMELC
Sbjct: 159 --------------MTTAIAIEDVRREVKILRALTGHKNLVQFYDSYEDEENIYVVMELC 204
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
+GGELLDRILSRGGKYSEEDAK++MVQILSVVA+CH QGVVHRDLKPENFLFTSK+E S+
Sbjct: 205 EGGELLDRILSRGGKYSEEDAKVIMVQILSVVAYCHLQGVVHRDLKPENFLFTSKDETST 264
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPF 354
LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPF
Sbjct: 265 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPF 324
Query: 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
WARTESGIFRAVLKADP+F+EAPWPSLS +AIDFVKRLLNKDYRKRLTAAQAL HPWLA+
Sbjct: 325 WARTESGIFRAVLKADPNFEEAPWPSLSIDAIDFVKRLLNKDYRKRLTAAQALCHPWLAD 384
Query: 415 SHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFI 474
D+KIP D I +KL+++YI SSSLRK+ALGALAKTL+ QL YL++QFTLL PNKNG I
Sbjct: 385 HQDIKIPLDTITFKLVRSYICSSSLRKSALGALAKTLSAVQLGYLQKQFTLLGPNKNGLI 444
Query: 475 SMQNYK 480
SMQN+K
Sbjct: 445 SMQNFK 450
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15229002|ref|NP_191235.1| protein kinase-domain containing protein [Arabidopsis thaliana] gi|75334901|sp|Q9LET1.1|CAMK7_ARATH RecName: Full=CDPK-related kinase 7; Short=AtCRK7; AltName: Full=Calcium/calmodulin-dependent protein kinase CRK7 gi|9662995|emb|CAC00739.1| calcium-dependent protein kinase-like [Arabidopsis thaliana] gi|332646041|gb|AEE79562.1| protein kinase-domain containing protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 753 bits (1945), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 372/486 (76%), Positives = 414/486 (85%), Gaps = 38/486 (7%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYENE----PQPNSQKSKASNFPFYSPSPLPSLFKNSPA 56
MGLCHGKP+E Q++ LP NE P+ +SQK+K+S FPFYSPSPLPSLFK SPA
Sbjct: 1 MGLCHGKPIEQ-----QSKNLPISNEIEETPKNSSQKAKSSGFPFYSPSPLPSLFKTSPA 55
Query: 57 IPSVNSTP--LRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFG 114
+ S + + LR FKRPFPPPSPAKHIR+LLARRHGSVKPNEASIPEG+E ++GLDK FG
Sbjct: 56 VSSSSVSSTPLRIFKRPFPPPSPAKHIRALLARRHGSVKPNEASIPEGSECEVGLDKKFG 115
Query: 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHE 174
FSKQF +HYE+ EVGRGHFGYTCSAK KKGSLKGQDVAVKVIPK
Sbjct: 116 FSKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQDVAVKVIPKSK------------- 162
Query: 175 NHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELC 234
MTTAIAIEDVRREVKILRALTGHKNLVQFYDA+EDD+N+YIVMELC
Sbjct: 163 --------------MTTAIAIEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVMELC 208
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
+GGELLD+IL RGGKYSE DAK VM+QILSVVA+CH QGVVHRDLKPENFLFT+K+E+S
Sbjct: 209 QGGELLDKILQRGGKYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDESSP 268
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPF 354
LKAIDFGLSDYV+PDERLNDIVGSAYYVAPEVLHR+YGTEADMWSIGVIAYILLCGSRPF
Sbjct: 269 LKAIDFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPF 328
Query: 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
WAR+ESGIFRAVLKA+P+F+EAPWPSLSP+A+DFVKRLLNKDYRKRLTAAQAL HPWL
Sbjct: 329 WARSESGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQALCHPWLVG 388
Query: 415 SHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFI 474
SH++KIPSDMI+YKL+K YI SSSLRK+AL ALAKTLTVPQL YL+EQF LL P+KNG+I
Sbjct: 389 SHELKIPSDMIIYKLVKVYIMSSSLRKSALAALAKTLTVPQLTYLQEQFNLLGPSKNGYI 448
Query: 475 SMQNYK 480
SMQNYK
Sbjct: 449 SMQNYK 454
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15226841|ref|NP_181647.1| CDPK-related kinase 1 [Arabidopsis thaliana] gi|75318680|sp|O80673.1|CAMK1_ARATH RecName: Full=CDPK-related kinase 1; Short=AtCRK1; AltName: Full=Calcium/calmodulin-dependent protein kinase 3; AltName: Full=Calmodulin-binding protein kinase 3; Short=AtCBK3; Short=CaM-binding protein kinase 3 gi|5020366|gb|AAD38058.1|AF153351_1 CDPK-related kinase 1 [Arabidopsis thaliana] gi|16904218|gb|AAL30816.1|AF435448_1 calcium/calmodulin-dependent protein kinase CaMK3 [Arabidopsis thaliana] gi|3402722|gb|AAD12016.1| CPDK-related protein kinase [Arabidopsis thaliana] gi|330254842|gb|AEC09936.1| CDPK-related kinase 1 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 749 bits (1934), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/485 (76%), Positives = 413/485 (85%), Gaps = 37/485 (7%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYE---NEPQPNSQK-SKASNFPFYSPSPLPSLFKNSPA 56
MG+CHGKPVE Q+++LP NE NSQ +K+S FPFYSPSP+PSLFK+SP+
Sbjct: 1 MGICHGKPVEQ-----QSKSLPVSGETNEAPTNSQPPAKSSGFPFYSPSPVPSLFKSSPS 55
Query: 57 IPSVNS-TPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGF 115
+ S S TPLR FKRPFPPPSPAKHIR+ LARR+GSVKPNE SIPEG E +IGLDK+FGF
Sbjct: 56 VSSSVSSTPLRIFKRPFPPPSPAKHIRAFLARRYGSVKPNEVSIPEGKECEIGLDKSFGF 115
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
SKQF +HYE+ EVGRGHFGYTCSAK KKGSLKGQ+VAVKVIPK
Sbjct: 116 SKQFASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQEVAVKVIPKSK-------------- 161
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCK 235
MTTAIAIEDV REVK+LRALTGHKNLVQFYDA+EDD+N+YIVMELCK
Sbjct: 162 -------------MTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCK 208
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
GGELLD+IL RGGKYSE+DAK VMVQILSVVA+CH QGVVHRDLKPENFLF++K+E S L
Sbjct: 209 GGELLDKILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPL 268
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFW 355
KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR+YGTEADMWSIGVIAYILLCGSRPFW
Sbjct: 269 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFW 328
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415
ARTESGIFRAVLKA+P+F+EAPWPSLSPEA+DFVKRLLNKDYRKRLTAAQAL HPWL S
Sbjct: 329 ARTESGIFRAVLKAEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLVGS 388
Query: 416 HDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFIS 475
H++KIPSDMI+YKL+K YI S+SLRK+AL ALAKTLTVPQLAYLREQFTLL P+KNG+IS
Sbjct: 389 HELKIPSDMIIYKLVKVYIMSTSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNGYIS 448
Query: 476 MQNYK 480
MQNYK
Sbjct: 449 MQNYK 453
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297820446|ref|XP_002878106.1| hypothetical protein ARALYDRAFT_486115 [Arabidopsis lyrata subsp. lyrata] gi|297323944|gb|EFH54365.1| hypothetical protein ARALYDRAFT_486115 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 749 bits (1933), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 367/482 (76%), Positives = 412/482 (85%), Gaps = 30/482 (6%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYENEPQPNSQKSKASNFPFYSPSPLPSLFKNSPAIPSV 60
MGLCHGKP+E Q+++ + E P+ +SQK+K+S FPFYSPSPLPSLFK SPA+ S
Sbjct: 1 MGLCHGKPIEQ-QSKNLQISNEIEESPKNSSQKAKSSGFPFYSPSPLPSLFKTSPAVSSS 59
Query: 61 NSTP--LRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQ 118
+ + LR FKRPFPPPSPAKHIR+LLARRHG VKPNEASIPEG+E ++GLDK FGFSKQ
Sbjct: 60 SVSSTPLRIFKRPFPPPSPAKHIRALLARRHGFVKPNEASIPEGSECEVGLDKKFGFSKQ 119
Query: 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQF 178
F +HYE+ EVGRGHFGYTCSAK KKGSLKGQDVAVKVIPK
Sbjct: 120 FASHYEIDGEVGRGHFGYTCSAKGKKGSLKGQDVAVKVIPKSK----------------- 162
Query: 179 TILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGE 238
MTTAIAIEDVRREVKILRALTGHKNLVQFYDA+EDD+N+YIVMELC+GGE
Sbjct: 163 ----------MTTAIAIEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVMELCQGGE 212
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
LLD+IL RGGKYSE DAK VMVQILSVVA+CH QGVVHRDLKPENFLFT+K+E+S LKAI
Sbjct: 213 LLDKILQRGGKYSEVDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFTTKDESSPLKAI 272
Query: 299 DFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWART 358
DFGLSDYV+PDERLNDIVGSAYYVAPEVLHR+YGTEADMWSIGVIAYILLCGSRPFWAR+
Sbjct: 273 DFGLSDYVRPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARS 332
Query: 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDV 418
ESGIFRAVLKA+P+F+EAPWPS+SP+A+DFVKRLLNKDYRKRLTAAQAL HPWL SH++
Sbjct: 333 ESGIFRAVLKAEPNFEEAPWPSISPDAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHEL 392
Query: 419 KIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQN 478
KIPSDMI+YKL+K YI SS+LRK+AL ALAKTLTVPQL YL+EQF LL P+KNG+ISMQN
Sbjct: 393 KIPSDMIIYKLVKVYIMSSALRKSALAALAKTLTVPQLTYLQEQFNLLGPSKNGYISMQN 452
Query: 479 YK 480
YK
Sbjct: 453 YK 454
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297824057|ref|XP_002879911.1| hypothetical protein ARALYDRAFT_483182 [Arabidopsis lyrata subsp. lyrata] gi|297325750|gb|EFH56170.1| hypothetical protein ARALYDRAFT_483182 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1921), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 363/481 (75%), Positives = 409/481 (85%), Gaps = 28/481 (5%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYENEPQPNSQKSKASNFPFYSPSPLPSLFKNSPAIPSV 60
MG+CHGKP+E Q++S + + P + +K+S FPFYSPSP+PSLFK+SP++ S
Sbjct: 1 MGICHGKPIEQQQSKSLPVSGETDEAPTNSQPPAKSSGFPFYSPSPVPSLFKSSPSVSSS 60
Query: 61 NS-TPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQF 119
S TPLR FKRPFPPPSPAKHIR+ LARR+GSVKPN SIPEG E +IGLDK+FGFSKQF
Sbjct: 61 VSSTPLRIFKRPFPPPSPAKHIRAFLARRYGSVKPNAVSIPEGKECEIGLDKSFGFSKQF 120
Query: 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
+HYE+ EVGRGHFGYTCSAK KKG+LKGQ+VAVKVIPK
Sbjct: 121 ASHYEIDGEVGRGHFGYTCSAKGKKGTLKGQEVAVKVIPKSK------------------ 162
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
MTTAIAIEDV REVK+LRALTGHKNLVQFYDA+EDD+N+YIVMELCKGGEL
Sbjct: 163 ---------MTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGEL 213
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
LD+IL RGGKYSE+DAK VMVQILSVVA+CH QGVVHRDLKPENFLF++K+E S LKAID
Sbjct: 214 LDKILQRGGKYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAID 273
Query: 300 FGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTE 359
FGLSDYVKPDERLNDIVGSAYYVAPEVLHR+YGTEADMWSIGVIAYILLCGSRPFWARTE
Sbjct: 274 FGLSDYVKPDERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTE 333
Query: 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVK 419
SGIFRAVLKA+P+F+EAPWPSLSP+A+DFVKRLLNKDYRKRLTAAQAL HPWL SH++K
Sbjct: 334 SGIFRAVLKAEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELK 393
Query: 420 IPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNY 479
IPSDMI+YKL+K YI S+SLRK+AL ALAKTLTVPQLAYL+EQFTLL P+KNG+ISMQNY
Sbjct: 394 IPSDMIIYKLVKVYIMSTSLRKSALAALAKTLTVPQLAYLQEQFTLLGPSKNGYISMQNY 453
Query: 480 K 480
K
Sbjct: 454 K 454
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357509349|ref|XP_003624963.1| Calcium-dependent protein kinase-like protein [Medicago truncatula] gi|87241164|gb|ABD33022.1| Protein kinase; Calcium-binding EF-hand [Medicago truncatula] gi|355499978|gb|AES81181.1| Calcium-dependent protein kinase-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 744 bits (1920), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 369/499 (73%), Positives = 410/499 (82%), Gaps = 46/499 (9%)
Query: 1 MGLCHGKPVENSQNRSQNEALPYENEP------------QPNSQKSKASNFPFYSPSPLP 48
MGLCHGKP+E S+ + E NE ++ +S FPF+SPSPLP
Sbjct: 1 MGLCHGKPIETSRRERERERENSTNEEILQLPPPPSSSHHHHAPTKSSSKFPFFSPSPLP 60
Query: 49 SLFKNSPAIPSVNS------TPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEG 102
S FKNSPA +V+S TPLR FKRPFPPPSPAKHIR+LLARRHGSVKPNEA+IPEG
Sbjct: 61 SFFKNSPANSTVSSNSTPLRTPLRIFKRPFPPPSPAKHIRALLARRHGSVKPNEATIPEG 120
Query: 103 NESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIG 162
+E ++GLDK+FGFSK FV ++ELG+EVGRGHFGYTCSAK KKGS KG DVAVKVIPK
Sbjct: 121 SECEVGLDKSFGFSKHFVTNFELGQEVGRGHFGYTCSAKGKKGSFKGLDVAVKVIPKSK- 179
Query: 163 VIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYE 222
MTTAIAIEDVRREVKILRALTGHKNLVQFY+AYE
Sbjct: 180 --------------------------MTTAIAIEDVRREVKILRALTGHKNLVQFYEAYE 213
Query: 223 DDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282
D++N+Y+VMELCKGGELLD+ILSRGGKY EEDA++V++QILSVVA+CH QGVVHRDLKPE
Sbjct: 214 DEENVYVVMELCKGGELLDKILSRGGKYPEEDARVVLIQILSVVAYCHLQGVVHRDLKPE 273
Query: 283 NFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGV 342
NFLF+S++ENS+LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGV
Sbjct: 274 NFLFSSEDENSTLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGV 333
Query: 343 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT 402
IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS +A DFVKRLLNKDYRKRLT
Sbjct: 334 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSADAKDFVKRLLNKDYRKRLT 393
Query: 403 AAQALSHPWLANS-HDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLRE 461
AAQALSHPWL N D+KIP DMI++KLIK YI SSSLRK+ALGALAKTLT+ QLAYLRE
Sbjct: 394 AAQALSHPWLVNHLEDIKIPFDMIIHKLIKTYICSSSLRKSALGALAKTLTLVQLAYLRE 453
Query: 462 QFTLLAPNKNGFISMQNYK 480
QFTLL PNK+G ISMQN+K
Sbjct: 454 QFTLLGPNKSGLISMQNFK 472
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 482 | ||||||
| TAIR|locus:2103655 | 577 | AT3G56760 [Arabidopsis thalian | 0.605 | 0.506 | 0.811 | 2.5e-175 | |
| TAIR|locus:2063197 | 576 | CRK1 "AT2G41140" [Arabidopsis | 0.605 | 0.506 | 0.828 | 7.5e-174 | |
| TAIR|locus:2094053 | 599 | AT3G19100 [Arabidopsis thalian | 0.607 | 0.489 | 0.730 | 2.4e-138 | |
| TAIR|locus:2012232 | 606 | AT1G49580 [Arabidopsis thalian | 0.607 | 0.483 | 0.724 | 3.1e-138 | |
| TAIR|locus:2062764 | 595 | CRK3 "AT2G46700" [Arabidopsis | 0.603 | 0.489 | 0.681 | 2.1e-135 | |
| TAIR|locus:2082931 | 594 | AT3G49370 [Arabidopsis thalian | 0.599 | 0.486 | 0.625 | 8.4e-121 | |
| TAIR|locus:2152876 | 594 | AT5G24430 [Arabidopsis thalian | 0.603 | 0.489 | 0.631 | 1.4e-120 | |
| TAIR|locus:2827826 | 571 | CPK16 "AT2G17890" [Arabidopsis | 0.605 | 0.511 | 0.568 | 1.4e-95 | |
| TAIR|locus:2156947 | 523 | CPK28 "calcium-dependent prote | 0.655 | 0.604 | 0.514 | 8.9e-92 | |
| TAIR|locus:2054386 | 530 | CPK14 "calcium-dependent prote | 0.595 | 0.541 | 0.474 | 3e-77 |
| TAIR|locus:2103655 AT3G56760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1274 (453.5 bits), Expect = 2.5e-175, Sum P(2) = 2.5e-175
Identities = 237/292 (81%), Positives = 262/292 (89%)
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
MTTAIAIEDVRREVKILRALTGHKNLVQFYDA+EDD+N+YIVMELC+GGELLD+IL RGG
Sbjct: 163 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAFEDDENVYIVMELCQGGELLDKILQRGG 222
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
KYSE DAK VM+QILSVVA+CH QGVVHRDLKPENFLFT+K+E+S LKAIDFGLSDYV+P
Sbjct: 223 KYSEVDAKKVMIQILSVVAYCHLQGVVHRDLKPENFLFTTKDESSPLKAIDFGLSDYVRP 282
Query: 309 DERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
DERLNDIVGSAYYVAPEVLHR+YGTEADMWSIGVIAYILLCGSRPFWAR+ESGIFRAVLK
Sbjct: 283 DERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARSESGIFRAVLK 342
Query: 369 ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYK 428
A+P+F+EAPWPSLSP+A+DFVKRLLNKDYRKRLTAAQAL HPWL SH++KIPSDMI+YK
Sbjct: 343 AEPNFEEAPWPSLSPDAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIPSDMIIYK 402
Query: 429 LIKAYIXXXXXXXXXXXXXXXXXXVPQLAYLREQFTLLAPNKNGFISMQNYK 480
L+K YI VPQL YL+EQF LL P+KNG+ISMQNYK
Sbjct: 403 LVKVYIMSSSLRKSALAALAKTLTVPQLTYLQEQFNLLGPSKNGYISMQNYK 454
|
|
| TAIR|locus:2063197 CRK1 "AT2G41140" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1292 (459.9 bits), Expect = 7.5e-174, Sum P(2) = 7.5e-174
Identities = 242/292 (82%), Positives = 263/292 (90%)
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
MTTAIAIEDV REVK+LRALTGHKNLVQFYDA+EDD+N+YIVMELCKGGELLD+IL RGG
Sbjct: 162 MTTAIAIEDVSREVKMLRALTGHKNLVQFYDAFEDDENVYIVMELCKGGELLDKILQRGG 221
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
KYSE+DAK VMVQILSVVA+CH QGVVHRDLKPENFLF++K+E S LKAIDFGLSDYVKP
Sbjct: 222 KYSEDDAKKVMVQILSVVAYCHLQGVVHRDLKPENFLFSTKDETSPLKAIDFGLSDYVKP 281
Query: 309 DERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
DERLNDIVGSAYYVAPEVLHR+YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK
Sbjct: 282 DERLNDIVGSAYYVAPEVLHRTYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 341
Query: 369 ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYK 428
A+P+F+EAPWPSLSPEA+DFVKRLLNKDYRKRLTAAQAL HPWL SH++KIPSDMI+YK
Sbjct: 342 AEPNFEEAPWPSLSPEAVDFVKRLLNKDYRKRLTAAQALCHPWLVGSHELKIPSDMIIYK 401
Query: 429 LIKAYIXXXXXXXXXXXXXXXXXXVPQLAYLREQFTLLAPNKNGFISMQNYK 480
L+K YI VPQLAYLREQFTLL P+KNG+ISMQNYK
Sbjct: 402 LVKVYIMSTSLRKSALAALAKTLTVPQLAYLREQFTLLGPSKNGYISMQNYK 453
|
|
| TAIR|locus:2094053 AT3G19100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1131 (403.2 bits), Expect = 2.4e-138, Sum P(2) = 2.4e-138
Identities = 214/293 (73%), Positives = 246/293 (83%)
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
MT+AI+IEDVRREVKILRAL+GH+NLVQFYDA+ED+ N+YIVMELC GGELLDRIL+RGG
Sbjct: 183 MTSAISIEDVRREVKILRALSGHQNLVQFYDAFEDNANVYIVMELCGGGELLDRILARGG 242
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
KYSE+DAK V++QIL+VVAFCH QGVVHRDLKPENFL+TSKEENS LK IDFGLSD+V+P
Sbjct: 243 KYSEDDAKAVLIQILNVVAFCHLQGVVHRDLKPENFLYTSKEENSMLKVIDFGLSDFVRP 302
Query: 309 DERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
DERLNDIVGSAYYVAPEVLHRSY TEAD+WSIGVIAYILLCGSRPFWARTESGIFRAVLK
Sbjct: 303 DERLNDIVGSAYYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 362
Query: 369 ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYK 428
ADPSFDE PWPSLS EA DFVKRLL KD RKR+TA+QAL HPW+A + IP D++++K
Sbjct: 363 ADPSFDEPPWPSLSFEAKDFVKRLLYKDPRKRMTASQALMHPWIAGYKKIDIPFDILIFK 422
Query: 429 LIKAYIXXXXXXXXXXXXXXXXXXVPQLAYLREQFTLLAPNKNGFISMQNYKM 481
IKAY+ +L YL+ QF LAPNKNG I++ + ++
Sbjct: 423 QIKAYLRSSSLRKAALMALSKTLTTDELLYLKAQFAHLAPNKNGLITLDSIRL 475
|
|
| TAIR|locus:2012232 AT1G49580 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1123 (400.4 bits), Expect = 3.1e-138, Sum P(2) = 3.1e-138
Identities = 213/294 (72%), Positives = 249/294 (84%)
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
MTTAIAIEDVRREVKIL+AL+GHKNLVQFYDA+ED+ N+YI MELC+GGELLDRIL+RGG
Sbjct: 189 MTTAIAIEDVRREVKILQALSGHKNLVQFYDAFEDNANVYIAMELCEGGELLDRILARGG 248
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
KYSE DAK V++QIL+VVAFCHFQGVVHRDLKPENFL+TSKEENS LKAIDFGLSD+V+P
Sbjct: 249 KYSENDAKPVIIQILNVVAFCHFQGVVHRDLKPENFLYTSKEENSQLKAIDFGLSDFVRP 308
Query: 309 DERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
DERLNDIVGSAYYVAPEVLHRSY TEAD+WSIGVIAYILLCGSRPFWARTESGIFRAVLK
Sbjct: 309 DERLNDIVGSAYYVAPEVLHRSYTTEADVWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
Query: 369 ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL-ANSHDVKIPSDMIVY 427
ADPSFDE PWP LS +A DFVKRLL KD R+R++A+QAL HPW+ A + D+ IP D++++
Sbjct: 369 ADPSFDEPPWPFLSSDAKDFVKRLLFKDPRRRMSASQALMHPWIRAYNTDMNIPFDILIF 428
Query: 428 KLIKAYIXXXXXXXXXXXXXXXXXXVPQLAYLREQFTLLAPNKNGFISMQNYKM 481
+ +KAY+ ++ YL+ QF+LLAPNK+G I+M +M
Sbjct: 429 RQMKAYLRSSSLRKAALRALSKTLIKDEILYLKTQFSLLAPNKDGLITMDTIRM 482
|
|
| TAIR|locus:2062764 CRK3 "AT2G46700" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1079 (384.9 bits), Expect = 2.1e-135, Sum P(3) = 2.1e-135
Identities = 199/292 (68%), Positives = 239/292 (81%)
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
MTTAIAIEDVRREVK+L++L+GHK L+++YDA ED +N+YIVMELC GGELLDRIL+RGG
Sbjct: 182 MTTAIAIEDVRREVKLLKSLSGHKYLIKYYDACEDANNVYIVMELCDGGELLDRILARGG 241
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
KY E+DAK ++VQIL+VV+FCH QGVVHRDLKPENFLFTS E+S LK IDFGLSD+++P
Sbjct: 242 KYPEDDAKAIVVQILTVVSFCHLQGVVHRDLKPENFLFTSSREDSDLKLIDFGLSDFIRP 301
Query: 309 DERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
DERLNDIVGSAYYVAPEVLHRSY EAD+WSIGVI YILLCGSRPFWARTESGIFR VL+
Sbjct: 302 DERLNDIVGSAYYVAPEVLHRSYSLEADIWSIGVITYILLCGSRPFWARTESGIFRTVLR 361
Query: 369 ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYK 428
+P++D+ PWPS S E DFVKRLLNKDYRKR++A QAL+HPWL + V IP D+++YK
Sbjct: 362 TEPNYDDVPWPSCSSEGKDFVKRLLNKDYRKRMSAVQALTHPWLRDDSRV-IPLDILIYK 420
Query: 429 LIKAYIXXXXXXXXXXXXXXXXXXVPQLAYLREQFTLLAPNKNGFISMQNYK 480
L+KAY+ +L YLR QF LL PNK+G +S++N+K
Sbjct: 421 LVKAYLHATPLRRAALKALAKALTENELVYLRAQFMLLGPNKDGSVSLENFK 472
|
|
| TAIR|locus:2082931 AT3G49370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 975 (348.3 bits), Expect = 8.4e-121, Sum P(2) = 8.4e-121
Identities = 182/291 (62%), Positives = 229/291 (78%)
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
MT+A++IEDVRREVK+L+AL+GH ++V+FYD +ED DN+++VMELC+GGELLD IL+RGG
Sbjct: 181 MTSALSIEDVRREVKLLKALSGHSHMVKFYDVFEDSDNVFVVMELCEGGELLDSILARGG 240
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
+Y E +AK ++VQILS AF H QGVVHRDLKPENFLFTSK E++ LK IDFGLSDY +
Sbjct: 241 RYPEAEAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSKNEDAVLKVIDFGLSDYARF 300
Query: 309 DERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
D+RLND+VGSAYYVAPEVLHRSY TEAD+WSIGVI+YILLCGSRPF+ RTES IFR VL+
Sbjct: 301 DQRLNDVVGSAYYVAPEVLHRSYSTEADIWSIGVISYILLCGSRPFYGRTESAIFRCVLR 360
Query: 369 ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYK 428
A+P+FD+ PWPS+SP A DFVKRLLNKD+RKR+TAAQAL+HPWL + + + D +YK
Sbjct: 361 ANPNFDDLPWPSISPIAKDFVKRLLNKDHRKRMTAAQALAHPWLRDENPGLL-LDFSIYK 419
Query: 429 LIKAYIXXXXXXXXXXXXXXXXXXVPQLAYLREQFTLLAPNKNGFISMQNY 479
L+K+YI +L +L+ QF LL P G + + N+
Sbjct: 420 LVKSYIRASPFRRAALKSLSKAIPEEELVFLKAQFMLLEPEDGG-LHLHNF 469
|
|
| TAIR|locus:2152876 AT5G24430 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 986 (352.1 bits), Expect = 1.4e-120, Sum P(2) = 1.4e-120
Identities = 185/293 (63%), Positives = 234/293 (79%)
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
MT+ ++IEDVRREVK+L+AL+GH+++V+FYD YED DN+++VMELC+GGELLDRIL+RGG
Sbjct: 182 MTSTLSIEDVRREVKLLKALSGHRHMVKFYDVYEDADNVFVVMELCEGGELLDRILARGG 241
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
+Y E DAK ++VQILS AF H QGVVHRDLKPENFLFTS+ E++ LK IDFGLSD+++
Sbjct: 242 RYPEVDAKRILVQILSATAFFHLQGVVHRDLKPENFLFTSRNEDAILKVIDFGLSDFIRY 301
Query: 309 DERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
D+RLND+VGSAYYVAPEVLHRSY TEADMWSIGVI+YILLCGSRPF+ RTES IFR VL+
Sbjct: 302 DQRLNDVVGSAYYVAPEVLHRSYSTEADMWSIGVISYILLCGSRPFYGRTESAIFRCVLR 361
Query: 369 ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYK 428
A+P+F++ PWPS+SP A DFVKRLLNKD+RKR+TAAQAL+HPWL + + + D VYK
Sbjct: 362 ANPNFEDMPWPSISPTAKDFVKRLLNKDHRKRMTAAQALAHPWLRDENPGLL-LDFSVYK 420
Query: 429 LIKAYIXXXXXXXXXXXXXXXXXXVPQLAYLREQFTLLAPNKNGFISMQNYKM 481
L+K+YI +L +L+ QF LL P K+G +S+ + M
Sbjct: 421 LVKSYIRASPFRRSALKALSKAIPDEELVFLKAQFMLLDP-KDGGLSLNCFTM 472
|
|
| TAIR|locus:2827826 CPK16 "AT2G17890" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 862 (308.5 bits), Expect = 1.4e-95, Sum P(2) = 1.4e-95
Identities = 167/294 (56%), Positives = 215/294 (73%)
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-G 247
MT IA+EDV+REVKIL+ALTGH+N+V+FY+A+ED +++YIVMELC+GGELLDRIL+R
Sbjct: 144 MTIPIAVEDVKREVKILQALTGHENVVRFYNAFEDKNSVYIVMELCEGGELLDRILARKD 203
Query: 248 GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK 307
+YSE DA +V+ Q+L V A CH +G+VHRD+KPENFLF S EE+S LKA DFGLSD++K
Sbjct: 204 SRYSERDAAVVVRQMLKVAAECHLRGLVHRDMKPENFLFKSTEEDSPLKATDFGLSDFIK 263
Query: 308 PDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVL 367
P ++ +DIVGSAYYVAPEVL R G E+D+WSIGVI+YILLCG RPFW +TE GIF+ VL
Sbjct: 264 PGKKFHDIVGSAYYVAPEVLKRRSGPESDVWSIGVISYILLCGRRPFWDKTEDGIFKEVL 323
Query: 368 KADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDV-KIPSDMIV 426
K P F PWP++S A DFVK+LL KD R RLTAAQALSHPW+ D +IP D+ V
Sbjct: 324 KNKPDFRRKPWPTISNSAKDFVKKLLVKDPRARLTAAQALSHPWVREGGDASEIPIDISV 383
Query: 427 YKLIKAYIXXXXXXXXXXXXXXXXXXVPQLAYLREQFTLLAPNKNGFISMQNYK 480
++ ++ +LA LR+QF + +KNG IS++ +
Sbjct: 384 LNNMRQFVKFSRLKQFALRALATTLDEEELADLRDQFDAIDVDKNGVISLEEMR 437
|
|
| TAIR|locus:2156947 CPK28 "calcium-dependent protein kinase 28" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 829 (296.9 bits), Expect = 8.9e-92, Sum P(2) = 8.9e-92
Identities = 165/321 (51%), Positives = 218/321 (67%)
Query: 162 GVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY 221
G ++ +H P + LD+ M IA+EDV+REV+IL AL+GH+N+VQF++A+
Sbjct: 74 GYTYVAIHRPNGDRVAVKRLDKSK---MVLPIAVEDVKREVQILIALSGHENVVQFHNAF 130
Query: 222 EDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280
EDDD +YIVMELC+GGELLDRILS+ G +YSE+DA +V+ Q+L V CH G+VHRD+K
Sbjct: 131 EDDDYVYIVMELCEGGELLDRILSKKGNRYSEKDAAVVVRQMLKVAGECHLHGLVHRDMK 190
Query: 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSI 340
PENFLF S + +S LKA DFGLSD++KP +R +DIVGSAYYVAPEVL R G E+D+WSI
Sbjct: 191 PENFLFKSAQLDSPLKATDFGLSDFIKPGKRFHDIVGSAYYVAPEVLKRRSGPESDVWSI 250
Query: 341 GVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKR 400
GVI YILLCG RPFW RTE GIF+ VL+ P F PW ++S A DFVK+LL KD R R
Sbjct: 251 GVITYILLCGRRPFWDRTEDGIFKEVLRNKPDFSRKPWATISDSAKDFVKKLLVKDPRAR 310
Query: 401 LTAAQALSHPWLANSHDVK-IPSDMIVYKLIKAYIXXXXXXXXXXXXXXXXXXVPQLAYL 459
LTAAQALSH W+ + IP D+ V ++ ++ +++ L
Sbjct: 311 LTAAQALSHAWVREGGNATDIPVDISVLNNLRQFVRYSRLKQFALRALASTLDEAEISDL 370
Query: 460 REQFTLLAPNKNGFISMQNYK 480
R+QF + +KNG IS++ +
Sbjct: 371 RDQFDAIDVDKNGVISLEEMR 391
|
|
| TAIR|locus:2054386 CPK14 "calcium-dependent protein kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 701 (251.8 bits), Expect = 3.0e-77, Sum P(3) = 3.0e-77
Identities = 137/289 (47%), Positives = 187/289 (64%)
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+ T+I IEDV+REV+I+R + H N+V + YEDD +++VMELC+GGEL DRI++RG
Sbjct: 90 LKTSIDIEDVKREVEIMRQMPEHPNIVTLKETYEDDKAVHLVMELCEGGELFDRIVARG- 148
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
Y+E A V+ I+ VV CH GV+HRDLKPENFLF +K+E +SLKAIDFGLS + KP
Sbjct: 149 HYTERAAASVIKTIIEVVQMCHKHGVMHRDLKPENFLFANKKETASLKAIDFGLSVFFKP 208
Query: 309 DERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
ER N+IVGS YY+APEVL RSYG E D+WS GVI YILLCG PFWA TE G+ +A+LK
Sbjct: 209 GERFNEIVGSPYYMAPEVLRRSYGQEIDIWSAGVILYILLCGVPPFWAETEHGVAKAILK 268
Query: 369 ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVK-IPSDMIVY 427
+ F PWP +S A D +K++L+ D R+RLTA Q L HPW+ N + + V
Sbjct: 269 SVIDFKRDPWPKVSDNAKDLIKKMLHPDPRRRLTAQQVLDHPWIQNGKNASNVSLGETVR 328
Query: 428 KLIKAYIXXXXXXXXXXXXXXXXXXVPQLAYLREQFTLLAPNKNGFISM 476
+K + V + + ++E+F ++ + G I++
Sbjct: 329 ARLKQFSVMNKLKKRALRVIAEHLSVEETSCIKERFQVMDTSNRGKITI 377
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P53681 | CRK_DAUCA | 2, ., 7, ., 1, 1, ., 1 | 0.7014 | 0.8921 | 0.7142 | N/A | no |
| Q9LET1 | CAMK7_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7654 | 0.9294 | 0.7764 | yes | no |
| Q10KY3 | CAMK1_ORYSJ | 2, ., 7, ., 1, 1, ., 1, 7 | 0.7410 | 0.8692 | 0.6983 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.946 |
| 3rd Layer | 2.7.11 | 0.963 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 482 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-95 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-83 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-57 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-54 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-53 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 4e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-50 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-49 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 7e-48 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-47 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-46 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-46 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-46 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-46 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-44 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-41 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-41 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-40 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-39 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-38 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-38 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-37 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-37 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-36 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-36 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-36 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-35 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-35 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-35 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-34 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-34 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-34 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-33 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-32 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-32 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 6e-32 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-32 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-31 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-31 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-31 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-31 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-30 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-29 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-29 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-29 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-29 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-29 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-29 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-28 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-28 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-28 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-28 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 6e-28 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-27 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-27 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-27 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-27 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 9e-27 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-26 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-26 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-26 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-26 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-26 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-26 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-25 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-25 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-25 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-25 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-25 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-25 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-25 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-25 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 8e-25 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-24 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-24 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-24 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-24 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-24 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-24 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-24 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-24 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-24 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 5e-24 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-24 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-23 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-23 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-23 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-23 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-23 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-22 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-22 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-22 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-22 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-22 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-22 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 3e-22 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-22 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-22 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-22 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-22 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 5e-22 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-22 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-22 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-22 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-22 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 9e-22 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-21 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-21 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-21 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-21 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-21 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-20 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-20 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-20 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-20 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 7e-20 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 8e-20 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 9e-20 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-20 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-19 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-19 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-19 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-19 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-19 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-19 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-19 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-19 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 6e-19 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 6e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-18 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-18 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 3e-18 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-18 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-17 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-17 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 5e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-17 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 6e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 6e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 7e-17 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-17 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-17 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-16 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-16 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-16 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-16 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 9e-16 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-15 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-14 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-14 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-14 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-14 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-14 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 7e-14 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-13 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 9e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 4e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 7e-12 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 8e-12 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-10 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-10 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-10 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 5e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 7e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-10 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-09 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-09 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-09 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-09 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-09 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-09 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-08 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 1e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-07 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-07 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-07 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 9e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 2e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-05 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 4e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-05 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 6e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-04 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 6e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 6e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-04 | |
| COG0661 | 517 | COG0661, AarF, Predicted unusual protein kinase [G | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.002 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 0.003 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 287 bits (737), Expect = 4e-95
Identities = 117/292 (40%), Positives = 164/292 (56%), Gaps = 40/292 (13%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE+ E++G G FG A+ KK G+ VA+KVI K K
Sbjct: 1 YEILEKLGEGSFGKVYLARDKK---TGKLVAIKVIKK------------KKIKKD----- 40
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
E + RE+KIL+ L H N+V+ YD +ED+D +Y+VME C+GG+L D
Sbjct: 41 ------------RERILREIKILKKL-KHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDL 87
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ R G+ SE++A+ + QILS + + H +G+VHRDLKPEN L E+ +K DFGL
Sbjct: 88 LKKR-GRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLD---EDGHVKLADFGL 143
Query: 303 SDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTE-S 360
+ + P E+L VG+ Y+APEVL + YG D+WS+GVI Y LL G PF +
Sbjct: 144 ARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLL 203
Query: 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+F+ + K P F P +SPEA D +++LL KD KRLTA +AL HP+
Sbjct: 204 ELFKKIGKPKPPFPP-PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 1e-83
Identities = 119/296 (40%), Positives = 159/296 (53%), Gaps = 42/296 (14%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YEL ++G G FG AK K G+ VAVK++ K + E +
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGT---GKIVAVKILKK------------RSEKSKKDQTA 45
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
RRE++ILR L H N+V+ DA+ED D++Y+VME C+GG+L D
Sbjct: 46 ----------------RREIRILRRL-SHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFD- 87
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
LSRGG SE++AK + +QIL + + H G++HRDLKPEN L +EN +K DFGL
Sbjct: 88 YLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILL---DENGVVKIADFGL 144
Query: 303 S-DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTE 359
+ +K L VG+ +Y+APEVL YG + D+WS+GVI Y LL G PF
Sbjct: 145 AKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENI 204
Query: 360 SG---IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+ R +L FDE W S S EA D +K+ LNKD KR TA + L HPW
Sbjct: 205 LDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 9e-57
Identities = 91/285 (31%), Positives = 139/285 (48%), Gaps = 73/285 (25%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G G FG A+ KK G+ VA+K+I K
Sbjct: 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKK----------------------------- 28
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
++ +E++ RE++IL+ L H N+V+ Y +ED++++Y+VME C+GG L D + G
Sbjct: 29 EDSSSLLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEG 87
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
K SE++ +++QIL + + H G++HRDLKPEN L S +N +K DFGLS +
Sbjct: 88 KLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDS--DNGKVKLADFGLSKLLTS 145
Query: 309 DER-LNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRA 365
D+ L IVG+ Y+APEVL Y ++D+WS+GVI Y L
Sbjct: 146 DKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------ 187
Query: 366 VLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
PE D ++++L KD KR +A + L H
Sbjct: 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 1e-54
Identities = 80/223 (35%), Positives = 119/223 (53%), Gaps = 14/223 (6%)
Query: 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEE 253
+E E IL + H +V+ + A++ ++ +Y+V+E GGEL LS+ G++SEE
Sbjct: 36 EVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGELFSH-LSKEGRFSEE 93
Query: 254 DAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVKPDERL 312
A+ +I+ + + H G+++RDLKPEN L + +K DFGL+ + R
Sbjct: 94 RARFYAAEIVLALEYLHSLGIIYRDLKPENILLD---ADGHIKLTDFGLAKELSSEGSRT 150
Query: 313 NDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 371
N G+ Y+APEVL YG D WS+GV+ Y +L G PF+A I+ +LK
Sbjct: 151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPL 210
Query: 372 SFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA---LSHPW 411
F E LSPEA D + LL KD KRL + A +HP+
Sbjct: 211 RFPE----FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 6e-53
Identities = 93/293 (31%), Positives = 145/293 (49%), Gaps = 43/293 (14%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+E+ E++G+G FG A+ K+ G++VA+KVI
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIK-------------------LESK 38
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
++ E + E++IL+ H N+V++Y +Y D ++IVME C GG L D
Sbjct: 39 EKK-----------EKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVMEFCSGGSLKD 86
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ S +E V ++L + + H G++HRD+K N L TS E +K IDFG
Sbjct: 87 LLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE---VKLIDFG 143
Query: 302 LSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTES 360
LS + + N +VG+ Y++APEV++ Y +AD+WS+G+ A L G P+ +E
Sbjct: 144 LSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY---SEL 200
Query: 361 GIFRAVLK-ADPSFDEAPWPSL-SPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
+A+ K A P S E DF+K+ L K+ KR TA Q L HP+
Sbjct: 201 PPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 4e-52
Identities = 83/295 (28%), Positives = 134/295 (45%), Gaps = 45/295 (15%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
YE+ +++G+G FG + K G+ +K I
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEID----------------------- 34
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
L + ED EVKIL+ L H N++++Y+++E+ + IVME GG+L
Sbjct: 35 -----LSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVMEYADGGDLSQ 88
Query: 242 RILSR---GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
+I + G + EE VQ+ + + H + ++HRD+KP+N TS N +K
Sbjct: 89 KIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTS---NGLVKLG 145
Query: 299 DFGLSD-YVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWA 356
DFG+S + +VG+ YY++PE+ ++ Y ++D+WS+G + Y L PF
Sbjct: 146 DFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205
Query: 357 RTESGIFRAVLKADPSFDEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
+ +LK P PS S E + V LL KD +R + AQ L P
Sbjct: 206 ENLLELALKILKGQY----PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 171 bits (435), Expect = 5e-50
Identities = 90/300 (30%), Positives = 138/300 (46%), Gaps = 51/300 (17%)
Query: 123 YELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
+ GE +GRG FG Y G+ +AVK + ++ E
Sbjct: 2 WTRGELLGRGSFGSVYLA-----LDKDTGELMAVKSV---------ELSGDSEEE----- 42
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY--EDDDNIYIVMELCKGGE 238
+E + RE++IL +L H N+V++Y + E+ + + I +E GG
Sbjct: 43 --------------LEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGS 87
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
L +L + GK E + QIL +A+ H G+VHRD+K N L S +K
Sbjct: 88 LSS-LLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV---VKLA 143
Query: 299 DFGLSDYVK---PDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPF 354
DFG + + E + G+ Y++APEV+ YG AD+WS+G + G P
Sbjct: 144 DFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP- 202
Query: 355 WARTESGIFRAVLKADPSFDEAPW-PS-LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
W+ + + A L S E P P LS EA DF+++ L +D +KR TA + L HP+L
Sbjct: 203 WSELGNPM--AALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 6e-49
Identities = 86/315 (27%), Positives = 142/315 (45%), Gaps = 64/315 (20%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
++ G+ +G G F AK K+ ++ A+K++ K L E
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKET---NKEYAIKILDK----RQLI-----KEKKV----- 45
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ V+ E ++L L GH +++ Y ++D++N+Y V+E GELL
Sbjct: 46 -------------KYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQY 92
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG- 301
I G E+ + +IL + + H +G++HRDLKPEN L ++ +K DFG
Sbjct: 93 IRKYGSL-DEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLD---KDMHIKITDFGT 148
Query: 302 ---LSDYVKPDE-----------------RLNDIVGSAYYVAPEVL-HRSYGTEADMWSI 340
L P+ R VG+A YV+PE+L + G +D+W++
Sbjct: 149 AKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWAL 208
Query: 341 GVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKR 400
G I Y +L G PF E F+ +LK + SF P+ P+A D +++LL D + R
Sbjct: 209 GCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDR 264
Query: 401 LTA----AQALSHPW 411
L + +HP+
Sbjct: 265 LGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 7e-48
Identities = 90/288 (31%), Positives = 127/288 (44%), Gaps = 52/288 (18%)
Query: 142 AKKGSLKGQDVAVKVIPK--MIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199
AKK S G A+KVI K MI QV E IL + +
Sbjct: 12 AKKKST-GDIYAIKVIKKADMIRKN--QVDQVLTER---DILSQAQSPY----------- 54
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM 259
+V+ Y +++ N+Y+VME GG+L +L G E+ A+I +
Sbjct: 55 --------------VVKLYYSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLDEDVARIYI 99
Query: 260 VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY---------VKPDE 310
+I+ + + H G++HRDLKP+N L S N LK DFGLS ++
Sbjct: 100 AEIVLALEYLHSNGIIHRDLKPDNILIDS---NGHLKLTDFGLSKVGLVRRQINLNDDEK 156
Query: 311 RLNDIVGSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKA 369
IVG+ Y+APEV L + + D WS+G I Y L G PF T IF+ +L
Sbjct: 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG 216
Query: 370 DPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA---LSHPWLAN 414
+ E +S EAID + +LL D KRL A +HP+
Sbjct: 217 KIEWPED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 162 bits (413), Expect = 7e-47
Identities = 88/298 (29%), Positives = 141/298 (47%), Gaps = 47/298 (15%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
H+EL +G+G FG C + + + A+K + K Q K
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNK-------QKCVEKGS------- 43
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ +V E +IL+ L H LV + +++D++N+Y+V++L GG+L
Sbjct: 44 -------------VRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVVDLLLGGDL-- 87
Query: 242 RI-LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
R LS+ K+SEE K + +I+ + + H +G++HRD+KP+N L +E + DF
Sbjct: 88 RYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL---DEQGHVHITDF 144
Query: 301 GLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWART- 358
++ V PD G+ Y+APEVL + Y D WS+GV AY L G RP+ +
Sbjct: 145 NIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204
Query: 359 --ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL--TAAQALSHPWL 412
I AD + + S EAID + +LL +D +KRL +HP+
Sbjct: 205 TIRDQIRAKQETADVLY----PATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 1e-46
Identities = 89/295 (30%), Positives = 147/295 (49%), Gaps = 45/295 (15%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+Y+LG+ +GRG FG + G VA+K I I
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLE------------------KIK 39
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+E A++ + +E+ +L+ L H N+V++ + E D++YI++E + G L
Sbjct: 40 EE----------ALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIILEYAENGSLR- 87
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+I+ + G + E + + Q+L +A+ H QGV+HRD+K N L T+K+ +K DFG
Sbjct: 88 QIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANIL-TTKDGV--VKLADFG 144
Query: 302 LSDYV-KPDERLNDIVGSAYYVAPEVLHRSYGTEA-DMWSIGVIAYILLCGSRPFWARTE 359
++ + + +VG+ Y++APEV+ S + A D+WS+G LL G+ P++
Sbjct: 145 VATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP 204
Query: 360 -SGIFRAVLKADPSFDEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+ +FR V D P P +SPE DF+ + KD R TA Q L HPW+
Sbjct: 205 MAALFRIV-----QDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 166 bits (419), Expect = 1e-46
Identities = 94/342 (27%), Positives = 154/342 (45%), Gaps = 57/342 (16%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y + ++G G FG A+ +K VA+KV+ K
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRK------LVALKVLAKK--------------------- 33
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ + +E RE++IL +L N+V+ YD ++D+ ++Y+VME GG L D
Sbjct: 34 ------LESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLED 87
Query: 242 RI--LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
+ + R G SE +A ++ QILS + + H +G++HRD+KPEN L + +K ID
Sbjct: 88 LLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR--DGRVVKLID 145
Query: 300 FGLS-------DYVKPDERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILL 348
FGL+ + VG+ Y+APEVL + +D+WS+G+ Y LL
Sbjct: 146 FGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELL 205
Query: 349 CGSRPF----WARTESGIFRAVLKADPSFDEAPW-----PSLSPEAIDFVKRLLNKDYRK 399
G PF + S + +L+ +P +S A D +K+LL KD +
Sbjct: 206 TGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKN 265
Query: 400 RLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYISSSSLRK 441
RL+++ LSH LA+ + ++ A + S
Sbjct: 266 RLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAPLRLSLPPS 307
|
Length = 384 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-46
Identities = 99/326 (30%), Positives = 148/326 (45%), Gaps = 79/326 (24%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
Y++ +++G G FG A+ K+ G+ VA+K KM +F +
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIK---KM--------------KKKFYSWE 40
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
E L REVK LR L H N+V+ + + ++D +Y V E +G L
Sbjct: 41 ECMNL------------REVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQL 87
Query: 243 ILSRGGKY-SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ R GK SE + ++ QIL +A H G HRDLKPEN L + E +K DFG
Sbjct: 88 MKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFG 144
Query: 302 LSDYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIA---YILLCGSRP-FW 355
L+ ++ D V + +Y APE+L SY + D+W++G I Y L RP F
Sbjct: 145 LAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTL----RPLFP 200
Query: 356 ARTESG-IFR--AVLKADPSFDEAPW--------------------------PSLSPEAI 386
+E +++ +VL + + W P+ SPEAI
Sbjct: 201 GSSEIDQLYKICSVLG---TPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAI 257
Query: 387 DFVKRLLNKDYRKRLTAAQALSHPWL 412
D +K +L D +KR TA+QAL HP+
Sbjct: 258 DLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 6e-46
Identities = 109/347 (31%), Positives = 158/347 (45%), Gaps = 82/347 (23%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
YEL + +G G +G CSA K+ G+ VA+K I V + K IL
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISN---VFDDLIDA-KR------IL 47
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD-----AYEDDDNIYIVMELCKG 236
RE+K+LR L H+N++ D + ED +++YIV EL
Sbjct: 48 ------------------REIKLLRHL-RHENIIGLLDILRPPSPEDFNDVYIVTELM-- 86
Query: 237 GEL-LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
E L +++ +++ + + QIL + + H V+HRDLKP N L S N L
Sbjct: 87 -ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNS---NCDL 142
Query: 296 KAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLC 349
K DFGL+ V PDE L + V + +Y APE+L Y D+WS+G I LL
Sbjct: 143 KICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELL- 201
Query: 350 GSRPFWA-----------------RTESGI-------FRAVLKADPSFDEAPW----PSL 381
+P + +E + R LK+ P + P P
Sbjct: 202 TRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGA 261
Query: 382 SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYK 428
SPEAID ++++L D +KR+TA +AL+HP+LA HD P D V K
Sbjct: 262 SPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD---PEDEPVAK 305
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 2e-44
Identities = 94/319 (29%), Positives = 146/319 (45%), Gaps = 58/319 (18%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+E + +G G FG + K G+ A+K++ K V QV
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKAKIVKLKQV-------------- 45
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
E V E +IL+++ H LV Y +++DD N+Y+VME GGEL
Sbjct: 46 -------------EHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSH 91
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
L + G++ E A+ Q++ + + H +V+RDLKPEN L S + +K DFG
Sbjct: 92 -LRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDS---DGYIKITDFGF 147
Query: 303 SDYVKPDERLNDIVGSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCGSRPFWARTESG 361
+ VK R + G+ Y+APE+ L + YG D W++G++ Y +L G PF+
Sbjct: 148 AKRVK--GRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ 205
Query: 362 IFRAVLKAD---PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLA 413
I+ +L+ PSF SP+A D ++ LL D KRL +HPW A
Sbjct: 206 IYEKILEGKVRFPSF-------FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258
Query: 414 NSHDVKIPSDMIVYKLIKA 432
I ++ + I+A
Sbjct: 259 G-----IDWIALLQRKIEA 272
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 75/234 (32%), Positives = 119/234 (50%), Gaps = 26/234 (11%)
Query: 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEE 253
I+++ E+K+L L H NLV++Y + +YI ME C GG L + L G+
Sbjct: 42 TIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFMEYCSGGTLEE--LLEHGRI--L 96
Query: 254 DAKIVMV---QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD- 309
D ++ V Q+L +A+ H G+VHRD+KP N N +K DFG + +K +
Sbjct: 97 DEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDH---NGVIKLGDFGCAVKLKNNT 153
Query: 310 ----ERLNDIVGSAYYVAPEVLHRS----YGTEADMWSIGVIAYILLCGSRPFWARTESG 361
E + + G+ Y+APEV+ +G AD+WS+G + + G RP W+ ++
Sbjct: 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP-WSELDNE 212
Query: 362 ---IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+F P ++ LSPE DF+ R L D +KR TA++ L HP++
Sbjct: 213 FQIMFHVGAGHKPPIPDS--LQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 3e-41
Identities = 91/321 (28%), Positives = 144/321 (44%), Gaps = 70/321 (21%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE E++G G +G A+ KK G+ VA+K I ++ +E
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKI-RLD-----------NEEEGIPS-- 43
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL-LD 241
TA+ RE+ +L+ L H N+V+ D + +Y+V E C ++ L
Sbjct: 44 --------TAL------REISLLKELK-HPNIVKLLDVIHTERKLYLVFEYC---DMDLK 85
Query: 242 RIL-SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
+ L R G S K +M Q+L +A+CH ++HRDLKP+N L + LK DF
Sbjct: 86 KYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINR---DGVLKLADF 142
Query: 301 GLS-DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWAR 357
GL+ + P V + +Y APE+L + Y T D+WS+G I ++ G F
Sbjct: 143 GLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202
Query: 358 TESG----IFRAVL-----KADPSFDEAPW-----------------PSLSPEAIDFVKR 391
+E IF+ +L ++ P + P P L PE ID + +
Sbjct: 203 SEIDQLFKIFQ-ILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSK 261
Query: 392 LLNKDYRKRLTAAQALSHPWL 412
+L + KR++A +AL HP+
Sbjct: 262 MLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 145 bits (369), Expect = 2e-40
Identities = 70/228 (30%), Positives = 115/228 (50%), Gaps = 17/228 (7%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
E + E +IL H +V+ Y ++D IY++ME C GGEL IL G + E A
Sbjct: 38 EHIFSEKEIL-EECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWT-ILRDRGLFDEYTA 95
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDI 315
+ + ++ + H +G+++RDLKPEN L + N +K +DFG + +K ++
Sbjct: 96 RFYIACVVLAFEYLHNRGIIYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTF 152
Query: 316 VGSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCGSRPFWARTES--GIFRAVLKADPS 372
G+ YVAPE+ L++ Y D WS+G++ Y LL G PF E I+ +LK +
Sbjct: 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN-- 210
Query: 373 FDEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQA-----LSHPWLAN 414
+ +P+ + A D +K+LL ++ +RL + H W
Sbjct: 211 -GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNG 257
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 2e-39
Identities = 91/320 (28%), Positives = 137/320 (42%), Gaps = 66/320 (20%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
Y++ +G G G AK ++ G+ VA+K +V + E
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRE---TGETVALK-----------KVALRRLEG------- 40
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
I RE+K L+A H +V+ D + +VME +L +
Sbjct: 41 ---------GIP-NQALREIKALQAC-QHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEV 88
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ E K M +L VA+ H G++HRDLKP N L ++ LK DFGL
Sbjct: 89 LRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG---VLKIADFGL 145
Query: 303 SDYVKPDERL--NDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCGSRPFWART 358
+ +E + V + +Y APE+L+ R Y D+W++G I LL GS F
Sbjct: 146 ARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205
Query: 359 E----SGIFRAV----------LKADP-----SFDEA---PW----PSLSPEAIDFVKRL 392
+ + +FR + L + P +F E+ P P SPEA+D +K L
Sbjct: 206 DIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGL 265
Query: 393 LNKDYRKRLTAAQALSHPWL 412
L D KRL+AA+AL HP+
Sbjct: 266 LVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 1e-38
Identities = 75/222 (33%), Positives = 119/222 (53%), Gaps = 11/222 (4%)
Query: 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEE 253
A++ + +E+ +L L H N+VQ+ ++DN+YI +EL GG L ++L + G + E
Sbjct: 45 AVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYIFLELVPGGSLA-KLLKKYGSFPEP 102
Query: 254 DAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN 313
++ QIL + + H + VHRD+K N L + N +K DFG++ V
Sbjct: 103 VIRLYTRQILLGLEYLHDRNTVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAK 159
Query: 314 DIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 371
GS Y++APEV+ + YG AD+WS+G + + +P W++ E AV K
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTV-LEMATGKPPWSQLEG--VAAVFKIGR 216
Query: 372 SFDEAPWP-SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
S + P P LS EA DF+ + L +D R TAA+ L HP++
Sbjct: 217 SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 6e-38
Identities = 81/299 (27%), Positives = 135/299 (45%), Gaps = 47/299 (15%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y+ E++G G G A + G++VA+K + + E
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMR---------LRKQNKEL------ 61
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ E+ I++ H N+V +YD+Y D +++VME GG L D
Sbjct: 62 ----------------IINEILIMKDCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTD 104
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
I + +E V ++L + + H Q V+HRD+K +N L + + S+K DFG
Sbjct: 105 IITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK---DGSVKLADFG 161
Query: 302 LSDYVKPD-ERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTE 359
+ + + + N +VG+ Y++APEV+ R YG + D+WS+G++ + G P+ E
Sbjct: 162 FAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL--RE 219
Query: 360 SG---IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415
+F K P SPE DF+ + L KD KR +A + L HP+L +
Sbjct: 220 PPLRALFLITTKGIPPLKNP--EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 1e-37
Identities = 84/301 (27%), Positives = 134/301 (44%), Gaps = 43/301 (14%)
Query: 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
+ E + +G+G G + K G+ A+K I H E + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKP---TGKIYALKKI-----------HVDGDEEFRKQL 46
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
L RE+K LR+ +V+ Y A+ + I IV+E GG L
Sbjct: 47 L------------------RELKTLRS-CESPYVVKCYGAFYKEGEISIVLEYMDGGSL- 86
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVHRDLKPENFLFTSKEENSSLKAID 299
+L + GK E + QIL + + H + ++HRD+KP N L SK E +K D
Sbjct: 87 ADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE---VKIAD 143
Query: 300 FGLSDYVKP-DERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWAR 357
FG+S ++ ++ N VG+ Y++PE + SY AD+WS+G+ G PF
Sbjct: 144 FGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203
Query: 358 TESGIFRAVLKADPSFDEAPWPS--LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415
+ F +++A P+ SPE DF+ L KD +KR +AA+ L HP++ +
Sbjct: 204 GQPSFF-ELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262
Query: 416 H 416
Sbjct: 263 D 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 5e-37
Identities = 90/312 (28%), Positives = 145/312 (46%), Gaps = 66/312 (21%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+EL E +G G +G A+ KK GQ VA+K++ I D
Sbjct: 8 FELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMD--------------------IIED 44
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY------EDDDNIYIVMELCKG 236
E E+++ E ILR + H N+ FY A+ +DD +++VMELC G
Sbjct: 45 E-----------EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGG 93
Query: 237 G---ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
G +L+ + +G + EE ++ + L +A+ H V+HRD+K +N L T +N+
Sbjct: 94 GSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNA 150
Query: 294 SLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYI 346
+K +DFG+S + R N +G+ Y++APEV+ SY +D+WS+G+ A
Sbjct: 151 EVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIE 210
Query: 347 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEA------IDFVKRLLNKDYRKR 400
L G P + RA+ K + P P+L DF+ L K+Y +R
Sbjct: 211 LADGKPPL---CDMHPMRALFKIPRN----PPPTLKSPENWSKKFNDFISECLIKNYEQR 263
Query: 401 LTAAQALSHPWL 412
+ L HP++
Sbjct: 264 PFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 1e-36
Identities = 78/247 (31%), Positives = 115/247 (46%), Gaps = 42/247 (17%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGG-ELL--DRILSRGGKYSEEDAK 256
RE+K+L+ L H N++ D + NI +V E + E + D+ + + D K
Sbjct: 51 REIKLLQELK-HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV----LTPADIK 105
Query: 257 IVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVKPDERLNDI 315
M+ L + + H ++HRDLKP N L S LK DFGL+ + P+ ++
Sbjct: 106 SYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV---LKLADFGLARSFGSPNRKMTHQ 162
Query: 316 VGSAYYVAPEVLH--RSYGTEADMWSIGVI-AYILLCGSRPFWARTE-----SGIFRA-- 365
V + +Y APE+L R YG DMWS+G I A +LL PF IF A
Sbjct: 163 VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL--RVPFLPGDSDIDQLGKIFEALG 220
Query: 366 --------VLKADPS---FDEAPWPSL-------SPEAIDFVKRLLNKDYRKRLTAAQAL 407
+ + P F P L S +A+D ++RLL + KR+TA QAL
Sbjct: 221 TPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280
Query: 408 SHPWLAN 414
HP+ +N
Sbjct: 281 EHPYFSN 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 3e-36
Identities = 79/256 (30%), Positives = 122/256 (47%), Gaps = 47/256 (18%)
Query: 196 EDVR----REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGG--ELLDRILSRGGK 249
EDV+ REVK+LR L H+N+V +A+ +Y+V E + ELL+ S GG
Sbjct: 41 EDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGG- 96
Query: 250 YSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV--K 307
+ + + Q+L +A+CH ++HRD+KPEN L + E+ LK DFG + + +
Sbjct: 97 LPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRAR 153
Query: 308 PDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTES----- 360
P L D V + +Y APE+L +YG D+W+IG I LL G P +
Sbjct: 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG-EPLFPGDSDIDQLY 212
Query: 361 GIFRA----------VLKADPSFDEAPWPS--------------LSPEAIDFVKRLLNKD 396
I + + ++P F +P +S A+DF+K L D
Sbjct: 213 LIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMD 272
Query: 397 YRKRLTAAQALSHPWL 412
++RLT + L HP+
Sbjct: 273 PKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (338), Expect = 7e-36
Identities = 92/320 (28%), Positives = 137/320 (42%), Gaps = 67/320 (20%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
Y+ ++G G +G A+ K L G+ VA+K I + E+ +
Sbjct: 1 YQKLGKIGEGTYGVVYKARDK---LTGEIVAIKKIK------------LRFES------E 39
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
TA+ RE+K+L+ L H N+++ D + ++Y+V E +L
Sbjct: 40 GIPK----TAL------REIKLLKELN-HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKL 87
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
I R E K + Q+L +AFCH G++HRDLKPEN L LK DFGL
Sbjct: 88 IKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN---TEGVLKLADFGL 144
Query: 303 SDYVKPDER-LNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFWARTE 359
+ R V + +Y APE+L Y T D+WS+G I LL RP +
Sbjct: 145 ARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSR-RPLFPGKS 203
Query: 360 -----SGIF------------------RAVLKADPSFDEAPW----PSLSPEAIDFVKRL 392
IF R + P P P+ SP+A+D + ++
Sbjct: 204 EIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQM 263
Query: 393 LNKDYRKRLTAAQALSHPWL 412
L+ D KR+TA QAL+HP+
Sbjct: 264 LHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 91/328 (27%), Positives = 134/328 (40%), Gaps = 81/328 (24%)
Query: 123 YELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
YE ++G G +G Y KA+ G+ VA+K K+ ++E F I
Sbjct: 1 YEKIAQIGEGTYGQVY----KARNKK-TGELVALK---KIR---------MENEKEGFPI 43
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDD--NIYIVMELC---- 234
TAI RE+K+L+ L H N+V+ + +IY+V E
Sbjct: 44 ----------TAI------REIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMVFEYMDHDL 86
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
G LLD S K++E K M Q+L + + H G++HRD+K N L +
Sbjct: 87 TG--LLD---SPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--- 138
Query: 295 LKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCG 350
LK DFGL+ + V + +Y PE+L YG E DMWS+G I L G
Sbjct: 139 LKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLG 198
Query: 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSL---------------------------SP 383
F TE + + S + WP + P
Sbjct: 199 KPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDP 258
Query: 384 EAIDFVKRLLNKDYRKRLTAAQALSHPW 411
A+D + +LL D +KR++A QAL H +
Sbjct: 259 SALDLLDKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 7e-35
Identities = 89/301 (29%), Positives = 137/301 (45%), Gaps = 44/301 (14%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+++ +VG+G +G AK KK + G+ VA+K + K + + H
Sbjct: 2 DFQILTQVGQGGYGQVFLAK-KKDT--GEIVALKRMKKSL------LFKLNEVRH----- 47
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
V E IL T + LV+ A++DD+ +Y+ ME GG+
Sbjct: 48 ----------------VLTERDIL-TTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF-R 89
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+L+ G SE+ A+ M ++ V H G +HRDLKPENFL + +K DFG
Sbjct: 90 TLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS---GHIKLTDFG 146
Query: 302 LSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTES 360
LS + N +VGS Y+APEVL + Y D WS+G + Y LCG PF T +
Sbjct: 147 LSKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN 204
Query: 361 GIFRAVLK-----ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415
+ + P +D+ P +LS EA D + +L+N R+ + +HP+
Sbjct: 205 ETWENLKYWKETLQRPVYDD-PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263
Query: 416 H 416
Sbjct: 264 D 264
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 7e-35
Identities = 81/294 (27%), Positives = 127/294 (43%), Gaps = 45/294 (15%)
Query: 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCC 186
+ + +G FG AK + G A+KV+ K
Sbjct: 2 KPISKGAFGSVYLAKKR---STGDYFAIKVLKKSD------------------------- 33
Query: 187 LFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR 246
M + +V+ E I+ + + Y +++ D +Y+VME GG+ I +
Sbjct: 34 --MIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL 91
Query: 247 GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSD-- 304
GG E+ AK + +++ V H +G++HRD+KPEN L ++ LK DFGLS
Sbjct: 92 GG-LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI---DQTGHLKLTDFGLSRNG 147
Query: 305 YVKPDERLNDIVGSAYYVAPEVLHRSYGTEA-DMWSIGVIAYILLCGSRPFWARTESGIF 363
VG+ Y+APE + + D WS+G + + L G PF A T +F
Sbjct: 148 LENKK-----FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF 202
Query: 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA---AQALSHPWLAN 414
+L ++ E SPEA+D + RLL D KRL A + SHP+ +
Sbjct: 203 DNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKS 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (330), Expect = 1e-34
Identities = 88/325 (27%), Positives = 143/325 (44%), Gaps = 69/325 (21%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ L E +G+G FG A K+ Q VA+KVI L+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVID----------------------LE 37
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
E IED+++E++ L + ++Y ++ ++I+ME C GG LD
Sbjct: 38 E-------AEDEIEDIQQEIQFLSQCRS-PYITKYYGSFLKGSKLWIIMEYCGGGSCLD- 88
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG- 301
L + GK E ++ ++L + + H +G +HRD+K N L + E +K DFG
Sbjct: 89 -LLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGV 144
Query: 302 ---LSDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWAR 357
L+ + + N VG+ +++APEV+ +S Y +AD+WS+G+ A L G P
Sbjct: 145 SGQLTSTMS---KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPL--- 198
Query: 358 TESGI--FRAVL---KADPSFDEAPWPSL-----SPEAIDFVKRLLNKDYRKRLTAAQAL 407
S + R + K +P PSL S DFV LNKD ++R +A + L
Sbjct: 199 --SDLHPMRVLFLIPKNNP-------PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELL 249
Query: 408 SHPWLAN-SHDVKIPSDMIVYKLIK 431
H ++ + + K K
Sbjct: 250 KHKFIKKAKKTSYLTLLIERIKKWK 274
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 87/321 (27%), Positives = 140/321 (43%), Gaps = 68/321 (21%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+E+ + +GRG FG + K GQ A+KV+ K + Q+ + E
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSDMIKRNQIAHVRAER------- 52
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ A + +V+ Y +++D++++Y+VME GG+L+
Sbjct: 53 ----DILADADS-----------------PWIVKLYYSFQDEEHLYLVMEYMPGGDLM-N 90
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+L R + EE A+ + +++ + H G +HRD+KP+N L + +K DFGL
Sbjct: 91 LLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDAD---GHIKLADFGL 147
Query: 303 S--------DYVKPDERLND----------------------IVGSAYYVAPEVLHR-SY 331
++ N VG+ Y+APEVL Y
Sbjct: 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY 207
Query: 332 GTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKR 391
G E D WS+GVI Y +L G PF++ T + ++ S P P +SPEAID + R
Sbjct: 208 GLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICR 267
Query: 392 LLNKDYRKRLTAA-QALSHPW 411
LL D RL + + SHP+
Sbjct: 268 LL-CDPEDRLGSFEEIKSHPF 287
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 74/227 (32%), Positives = 124/227 (54%), Gaps = 9/227 (3%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMV 260
EV I+R H N+V+ Y +Y D +++VME +GG L D I++ + +EE V +
Sbjct: 66 EVVIMRDYQ-HPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIATVCL 122
Query: 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSA 319
+L ++F H QGV+HRD+K ++ L TS + +K DFG V + R +VG+
Sbjct: 123 AVLKALSFLHAQGVIHRDIKSDSILLTS---DGRVKLSDFGFCAQVSKEVPRRKSLVGTP 179
Query: 320 YYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 378
Y++APEV+ R YGTE D+WS+G++ ++ G P++ + + P +
Sbjct: 180 YWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNL- 238
Query: 379 PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMI 425
+SP F+ R+L +D +R TAA+ L+HP+LA + ++
Sbjct: 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVPLM 285
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-33
Identities = 84/301 (27%), Positives = 129/301 (42%), Gaps = 55/301 (18%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
YEL + +G G +G A+ G+ VA+KVI
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIK----------------------- 37
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ E +++E+ +L+ H N+V ++ +Y D ++IVME C GG L D
Sbjct: 38 -------LEPGDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQD 89
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
G SE V + L +A+ H G +HRD+K N L T E+ +K DFG
Sbjct: 90 IYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT---EDGDVKLADFG 146
Query: 302 LSDYVKPD-ERLNDIVGSAYYVAPEVL----HRSYGTEADMWSIGVIAYILLCGSRPFWA 356
+S + + +G+ Y++APEV Y + D+W++G+ A L P +
Sbjct: 147 VSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF- 205
Query: 357 RTESGIFRAVLKADPSFDEAP-------WPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
+ RA+ S P W SP DF+K+ L KD +KR TA + L H
Sbjct: 206 --DLHPMRALFLISKSNFPPPKLKDKEKW---SPVFHDFIKKCLTKDPKKRPTATKLLQH 260
Query: 410 P 410
P
Sbjct: 261 P 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 100/325 (30%), Positives = 150/325 (46%), Gaps = 73/325 (22%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
VG G FG CSA+ + L GQ+VA+K I K P F
Sbjct: 18 VGMGAFGLVCSARDQ---LTGQNVAIKKIMK-----------P----------------F 47
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAY-EDDDNIYIVMELCKGGELLDRILSRG 247
T +A + RE+K+L+ L H+N++ D + ++IY V EL G L R+L+
Sbjct: 48 STPVLA-KRTYRELKLLKHLR-HENIISLSDIFISPLEDIYFVTELL--GTDLHRLLT-S 102
Query: 248 GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK 307
++ + + QIL + + H GVVHRDLKP N L EN LK DFGL+
Sbjct: 103 RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARI-- 157
Query: 308 PDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRA 365
D ++ V + YY APE++ + Y E D+WS G I +L G F + F
Sbjct: 158 QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI 217
Query: 366 VL-----------------------KADPSFDEAP----WPSLSPEAIDFVKRLLNKDYR 398
+ ++ P + P + + P AID ++++L D +
Sbjct: 218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQ 277
Query: 399 KRLTAAQALSHPWLANSHDVKIPSD 423
KR++AA+AL+HP+LA HD P+D
Sbjct: 278 KRISAAEALAHPYLAPYHD---PTD 299
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 70/229 (30%), Positives = 119/229 (51%), Gaps = 20/229 (8%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
E R E ++L A+ LV + A++ D ++++++ GGEL + R ++E +
Sbjct: 49 EHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEV 107
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLN 313
++ + +I+ + H G+++RD+K EN L + + DFGLS +E R
Sbjct: 108 RVYIAEIVLALDHLHQLGIIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAY 164
Query: 314 DIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCGSRPFWA----RTESGIFRAV 366
G+ Y+APEV+ + D WS+GV+ + LL G+ PF ++S I R +
Sbjct: 165 SFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI 224
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA---LSHPWL 412
LK+ P F ++S EA DF+++LL KD +KRL A A +HP+
Sbjct: 225 LKSKPPFP----KTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-32
Identities = 83/232 (35%), Positives = 118/232 (50%), Gaps = 39/232 (16%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDN--IYIVMELCKGGEL--LDRILSRGGKYSEEDAK 256
EV ILR L H N+V++YD D N +YIVME C+GG+L L + + KY EE+
Sbjct: 49 EVNILRELK-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107
Query: 257 I-VMVQILSVVAFCHFQG-----VVHRDLKPEN-FLFTSKEENSSLKAIDFGLSDYVKPD 309
++ Q+L + CH + V+HRDLKP N FL + N+++K DFGL+ + D
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL----DANNNVKLGDFGLAKILGHD 163
Query: 310 ERL-NDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWART--------E 359
VG+ YY++PE L H SY ++D+WS+G + Y L S PF AR +
Sbjct: 164 SSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK 223
Query: 360 SGIFRAVLKADPSFDEAPWPSL-SPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
G FR P S E + +K +LN D KR + + L P
Sbjct: 224 EGKFR------------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 80/301 (26%), Positives = 138/301 (45%), Gaps = 60/301 (19%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+++ E++G G +G A K+ GQ VA+KV+P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKET---GQVVAIKVVP------------------------ 37
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ + +++ +E+ IL+ +V++Y +Y + +++IVME C G + D
Sbjct: 38 ------VEEDL--QEIIKEISILKQ-CDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDI 88
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ +EE+ ++ Q L + + H +HRD+K N L + + K DFG+
Sbjct: 89 MKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ---AKLADFGV 145
Query: 303 SDYVKPDERLND-------IVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRP- 353
S +L D ++G+ +++APEV+ Y +AD+WS+G+ A I + +P
Sbjct: 146 S------GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITA-IEMAEGKPP 198
Query: 354 -FWARTESGIFRAVLKADPSF-DEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
IF K P+ D W SPE DFVK+ L KD +R +A Q L HP+
Sbjct: 199 YSDIHPMRAIFMIPNKPPPTLSDPEKW---SPEFNDFVKKCLVKDPEERPSAIQLLQHPF 255
Query: 412 L 412
+
Sbjct: 256 I 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 6e-32
Identities = 92/341 (26%), Positives = 154/341 (45%), Gaps = 77/341 (22%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
YEL +E+G+G +G CSA+ + + + VA+K I +F IL
Sbjct: 1 RYELIKELGQGAYGIVCSAR-NAETSEEETVAIKKITN----VF-----------SKKIL 44
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA----YEDDDNIYIVMELCKGG 237
+ RE+K+LR GHKN+ YD + + +Y+ EL +
Sbjct: 45 AKRAL-------------RELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEAD 91
Query: 238 ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKA 297
L +I+ G ++ + + QIL + + H V+HRDLKP N L + + LK
Sbjct: 92 --LHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKI 146
Query: 298 IDFGLS-----DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCG 350
DFGL+ + + + + V + +Y APE++ +SY D+WS+G I LL G
Sbjct: 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-G 205
Query: 351 SRPFW------------------------ARTESGIFRAVLKADPSFDEAPWPSL----S 382
+P + +R S + +++ P+ + P+ S+ +
Sbjct: 206 RKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNAN 265
Query: 383 PEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSD 423
P A+D +++LL D KR++ +AL HP+LA HD P D
Sbjct: 266 PLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD---PDD 303
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 75/240 (31%), Positives = 120/240 (50%), Gaps = 16/240 (6%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
+ED E+ IL + H N+V Y+AY ++ ++I++E C GG L +L +E
Sbjct: 46 LEDFMVEIDIL-SECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQ 104
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLN 313
+ V Q+L + F H V+HRDLK N L T + +K DFG+S K ++ +
Sbjct: 105 IRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTL---DGDVKLADFGVSAKNKSTLQKRD 161
Query: 314 DIVGSAYYVAPEVL------HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVL 367
+G+ Y++APEV+ Y +AD+WS+G+ L P + +L
Sbjct: 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKIL 221
Query: 368 KADPSFDEAP--WPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMI 425
K++P + P W S DF+K L KD R TAA+ L HP++++ D K D++
Sbjct: 222 KSEPPTLDQPSKW---SSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSDNKAIKDLL 278
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 93/327 (28%), Positives = 136/327 (41%), Gaps = 77/327 (23%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH--QFTI 180
YE E+G G +G A+ G+ VA+K +V P E T+
Sbjct: 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALK-----------KVRVPLSEEGIPLSTL 46
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALT--GHKNLVQFYD--AYEDDDN---IYIVMEL 233
RE+ +L+ L H N+V+ D D + +V E
Sbjct: 47 -------------------REIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEH 87
Query: 234 CKGGELLDRILSRGGK--YSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEE 291
+ L LS+ K E K +M Q+L V F H +VHRDLKP+N L TS +
Sbjct: 88 VD--QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ 145
Query: 292 NSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCG 350
+K DFGL+ + L +V + +Y APEVL +S Y T DMWS+G I L
Sbjct: 146 ---VKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELF-R 201
Query: 351 SRP-FWARTESG----IFR-------------AVLKADPSFD-------EAPWPSLSPEA 385
RP F +E+ IF L SF ++ P + E
Sbjct: 202 RRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS-SFPSYTPRSFKSFVPEICEEG 260
Query: 386 IDFVKRLLNKDYRKRLTAAQALSHPWL 412
+D +K++L + KR++A +AL HP+
Sbjct: 261 LDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 96/335 (28%), Positives = 141/335 (42%), Gaps = 77/335 (22%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
Y+ E +G G +G CSA + G+ VA+K IP H F +
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIP-----------------HAFDVP- 45
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY----EDDDNIYIVMELCKGGE 238
T A + RE+KILR H N++ D D ++Y+VM+L +
Sbjct: 46 -------TLA---KRTLRELKILRHFK-HDNIIAIRDILRPPGADFKDVYVVMDLMESD- 93
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
L I+ +EE + + Q+L + + H V+HRDLKP N L E+ L+
Sbjct: 94 -LHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVN---EDCELRIG 149
Query: 299 DFGLSDYV--KPDER---LNDIVGSAYYVAPE---VLHRSYGTEADMWSIG--------- 341
DFG++ + P E + + V + +Y APE L Y T DMWS+G
Sbjct: 150 DFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPE-YTTAIDMWSVGCIFAEMLGR 208
Query: 342 --------------VIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW----PSLSP 383
+I +L S R S R ++ P PW P SP
Sbjct: 209 RQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASP 268
Query: 384 EAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDV 418
EA+D + ++L D +R+T QAL HP+LA HD
Sbjct: 269 EALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 70/248 (28%), Positives = 135/248 (54%), Gaps = 23/248 (9%)
Query: 195 IEDVRREVKILRAL--TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSE 252
+ D++REV +L L + N+ ++Y +Y ++I+ME +GG + R L + G +E
Sbjct: 43 VSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV--RTLMKAGPIAE 100
Query: 253 EDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVKPDER 311
+ +++ ++L + + H GV+HRD+K N L T+ ++K DFG++ + +
Sbjct: 101 KYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN---TGNVKLCDFGVAALLNQNSSK 157
Query: 312 LNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVL-- 367
+ VG+ Y++APEV+ + Y T+AD+WS+G+ Y + G+ P+ ++ FRA++
Sbjct: 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPY---SDVDAFRAMMLI 214
Query: 368 --KADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMI 425
P ++ + S +FV L+++ ++RL+A + L W+ +H K P I
Sbjct: 215 PKSKPPRLEDNGY---SKLLREFVAACLDEEPKERLSAEELLKSKWI-KAHS-KTPV-SI 268
Query: 426 VYKLIKAY 433
+ +LI Y
Sbjct: 269 LKELISRY 276
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 84/294 (28%), Positives = 136/294 (46%), Gaps = 47/294 (15%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G+G FG A+ K + AVKV+ K + + V C
Sbjct: 3 LGKGSFGKVLLAELKG---TDELYAVKVLKKDVILQDDDVECT----------------- 42
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
MT E ++L H L Q + ++ D ++ VME GG+L+ I R G
Sbjct: 43 MT----------EKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSG 91
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVK 307
++ E A+ +I+ + F H +G+++RDLK +N L S+ +K DFG+ + +
Sbjct: 92 RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE---GHIKIADFGMCKEGIL 148
Query: 308 PDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366
+ G+ Y+APE+L ++ YG D W++GV+ Y +L G PF E +F+++
Sbjct: 149 GGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSI 208
Query: 367 LKADPSFDEAPWP-SLSPEAIDFVKRLLNKDYRKRL----TAAQAL-SHPWLAN 414
L+ DE +P LS EA +K L K+ KRL T Q + HP+
Sbjct: 209 LE-----DEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE 257
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 93/339 (27%), Positives = 150/339 (44%), Gaps = 80/339 (23%)
Query: 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
Y+ VG G +G CSA K G+ VA+K K+ + F
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKT---GRKVAIK---KL--------------SRPFQ- 53
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY------EDDDNIYIVMELC 234
+AI + RE+++L+ + H+N++ D + ED ++Y+V L
Sbjct: 54 ----------SAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHLM 102
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
G L+ I+ + K S++ + ++ QIL + + H G++HRDLKP N E+
Sbjct: 103 --GADLNNIV-KCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVN---EDCE 156
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCG-- 350
LK +DFGL+ D+ + V + +Y APE++ Y D+WS+G I LL G
Sbjct: 157 LKILDFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214
Query: 351 ---------------------SRPFWARTESGIFRAVLKADP-----SFDEAPWPSLSPE 384
+ S R +++ P F E + +P
Sbjct: 215 LFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEV-FSGANPL 273
Query: 385 AIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSD 423
AID ++++L D KR+TAA+AL+HP+LA HD P D
Sbjct: 274 AIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD---PED 309
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 3e-30
Identities = 68/219 (31%), Positives = 117/219 (53%), Gaps = 10/219 (4%)
Query: 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGK-YSEEDA 255
D E+ IL +L H N++ +Y+ + DD+ + I ME GG L D+I+ + G+ + EE
Sbjct: 45 DALNEIVIL-SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMV 103
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLND- 314
+ QI+S V++ H G++HRD+K N T + +K DFG+S + + + +
Sbjct: 104 LWYLFQIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYSMAET 160
Query: 315 IVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 373
+VG+ YY++PE+ Y ++D+W++G + Y LL R F A + +++ + +
Sbjct: 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP 220
Query: 374 DEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+ + S E I V LL +D KR TA + L P L
Sbjct: 221 VVSVY---SSELISLVHSLLQQDPEKRPTADEVLDQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-29
Identities = 70/227 (30%), Positives = 109/227 (48%), Gaps = 28/227 (12%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED--AKI 257
RE+ IL +V FY A+ ++ +I I ME GG L D+IL E KI
Sbjct: 48 RELDILHKCN-SPYIVGFYGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKI 105
Query: 258 VMVQILSVVAFCHFQ-GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIV 316
V +L + + H + ++HRD+KP N L S+ + +K DFG+S + + V
Sbjct: 106 A-VAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLV-NSLAKTFV 160
Query: 317 GSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPF--WARTESGIF---RAVLKAD 370
G++ Y+APE + Y ++D+WS+G+ L G P+ GIF + ++
Sbjct: 161 GTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP 220
Query: 371 PSFDEAPWPSL-----SPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
P P L SP+ DFV L KD R+R + + L HP++
Sbjct: 221 P-------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 76/253 (30%), Positives = 116/253 (45%), Gaps = 42/253 (16%)
Query: 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKY-SEEDAK 256
V E +IL L H L Y +++ + + +VM+ C GGEL + + GK SEE A+
Sbjct: 48 VLTEQEILATLD-HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVAR 106
Query: 257 IVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS------------- 303
++L + + H G+V+RDLKPEN L E+ + DF LS
Sbjct: 107 FYAAEVLLALEYLHLLGIVYRDLKPENILLH---ESGHIMLSDFDLSKQSDVEPPPVSKA 163
Query: 304 ---------------DYVK--PDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAY 345
+ P R N VG+ Y+APEV+ +G+ D W++G++ Y
Sbjct: 164 LRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLY 223
Query: 346 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL---- 401
+L G+ PF F +LK + +F P +S A D +++LL KD KRL
Sbjct: 224 EMLYGTTPFKGSNRDETFSNILKKEVTF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKR 281
Query: 402 TAAQALSHPWLAN 414
AA+ HP+
Sbjct: 282 GAAEIKQHPFFRG 294
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-29
Identities = 79/297 (26%), Positives = 138/297 (46%), Gaps = 42/297 (14%)
Query: 126 GEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
GE +G+G +G Y G + +AVK QV P + +
Sbjct: 6 GELIGKGTYGRVYLA-LNVTTGEM----MAVK-----------QVELPATIAGR----HD 45
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
M A+ R E++ L+ L H N+VQ+ ++ + I +E GG +
Sbjct: 46 SRQKDMVKAL-----RSEIETLKDLD-HLNIVQYLGFETTEEYLSIFLEYVPGGSI-GSC 98
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL- 302
L G++ E+ + Q+L +A+ H +G++HRDLK +N L + + K DFG+
Sbjct: 99 LRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV---DADGICKISDFGIS 155
Query: 303 --SDYVKPDERLNDIVGSAYYVAPEVLH---RSYGTEADMWSIGVIAYILLCGSRPFWAR 357
SD + +++ + GS +++APEV+H + Y + D+WS+G + + G RP W+
Sbjct: 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP-WSD 214
Query: 358 TES--GIFR-AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
E+ +F+ ++ P +LSP A+DF+ + R TA + L HP+
Sbjct: 215 EEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 4e-29
Identities = 69/246 (28%), Positives = 105/246 (42%), Gaps = 56/246 (22%)
Query: 124 ELGEEVGRGHFGYTCSAKAK-KGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
LG+++G G FG K K KG K +VAVK + K +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL--------------KED-------- 39
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ IE+ RE +I+R L H N+V+ +++ +YIVME +GG+LL
Sbjct: 40 -------ASEQQIEEFLREARIMRKL-DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSY 91
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ K S D +QI + + + +HRDL N L EN +K DFGL
Sbjct: 92 LRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGL 148
Query: 303 SDYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILLC 349
S + D+ YY APE L + +++D+WS GV+ + I
Sbjct: 149 SRDLYDDD---------YYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTL 199
Query: 350 GSRPFW 355
G +P+
Sbjct: 200 GEQPYP 205
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 49/301 (16%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
YEL E +G G +A + VA+K I L
Sbjct: 2 DYELIEVIGVGATAVVYAAICLP---NNEKVAIKRID----------------------L 36
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
++ +++++R+EV+ + + H N+V++Y ++ D +++VM GG LLD
Sbjct: 37 EKC-------QTSVDELRKEVQAM-SQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLD 88
Query: 242 ---RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
RGG E V+ ++L + + H G +HRD+K N L E+ S+K
Sbjct: 89 IMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL---GEDGSVKIA 144
Query: 299 DFGLSDYVKPD-----ERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCGS 351
DFG+S + + VG+ ++APEV+ Y +AD+WS G+ A L G+
Sbjct: 145 DFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
Query: 352 RPFWARTESGIFRAVLKADPSF--DEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
P+ + L+ DP A + S + L KD KR TA + L H
Sbjct: 205 APYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264
Query: 410 P 410
Sbjct: 265 K 265
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 5e-29
Identities = 74/238 (31%), Positives = 133/238 (55%), Gaps = 30/238 (12%)
Query: 192 AIAIEDVRR---------EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
A+ + D+R+ EV I+R H+N+V+ Y +Y + ++++ME +GG L D
Sbjct: 50 AVKMMDLRKQQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWVLMEFLQGGALTD- 107
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
I+S+ + +EE V +L + + H QGV+HRD+K ++ L T + +K DFG
Sbjct: 108 IVSQT-RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTL---DGRVKLSDFGF 163
Query: 303 SDYVKPD-ERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTES 360
+ D + +VG+ Y++APEV+ R+ YGTE D+WS+G++ ++ G P+++ +
Sbjct: 164 CAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP- 222
Query: 361 GIFRAVLKADPSFDEAPWPSL------SPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
++A ++P P L SP DF++R+L ++ ++R TA + L HP+L
Sbjct: 223 ------VQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 6e-29
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 10/220 (4%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS-RGGKYSEED 254
E+ E ++L L ++++Y+++ D + IVME + G+L + RG E+
Sbjct: 44 EEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQ 102
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL-N 313
+QIL +A H + ++HRD+K N LF +N +K D G++ + + N
Sbjct: 103 VWRFFIQILLGLAHLHSKKILHRDIKSLN-LFLDAYDN--VKIGDLGVAKLLSDNTNFAN 159
Query: 314 DIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 372
IVG+ YY++PE+ + Y ++D+W++GV+ Y G PF A + + +++
Sbjct: 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRG--V 217
Query: 373 FDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
F S + + + L KDYR+R Q L +P L
Sbjct: 218 FPPVSQM-YSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 1e-28
Identities = 80/270 (29%), Positives = 120/270 (44%), Gaps = 54/270 (20%)
Query: 200 REVKILRALTGHKNLVQFYDAY--EDDDNIYIVMELCKGGELLDRILS---RGGKYSEED 254
RE+ L+ L H N+V+ + E+D +IY+V E ++ L R +
Sbjct: 55 REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY------METDLHAVIRANILEDVH 108
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS------DYVKP 308
+ +M Q+L + + H V+HRDLKP N L S +K DFGL+ +
Sbjct: 109 KRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSD---CRVKLADFGLARSLSELEENPE 165
Query: 309 DERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWART-------- 358
+ L D V + +Y APE+L Y DMWS+G I +L G +P + T
Sbjct: 166 NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTSTLNQLEK 224
Query: 359 ----------------ESGIFRAVLKADPSFDEAP----WPSLSPEAIDFVKRLLNKDYR 398
+S +L + PS P P S +A+D +K+LL +
Sbjct: 225 IIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPN 284
Query: 399 KRLTAAQALSHPWLANSHDVKIPSDMIVYK 428
KRLTA +AL HP++A H+ PSD V
Sbjct: 285 KRLTAEEALEHPYVAQFHN---PSDEPVLP 311
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 95/344 (27%), Positives = 146/344 (42%), Gaps = 88/344 (25%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y+ +G G +G CSA K G VA+K I HQ
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHK---PTGVKVAIKKISPF--------------EHQT--- 45
Query: 182 DEYCCLFMTTAIAIEDVR--REVKILRALTGHKNLVQFYD-----AYEDDDNIYIVMELC 234
+C R RE+KILR H+N++ D ++E +++YIV EL
Sbjct: 46 --FC------------QRTLREIKILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELM 90
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
+ L +++ + S + + + QIL + + H V+HRDLKP N L + N
Sbjct: 91 ETD--LYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---NCD 144
Query: 295 LKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVI-AYIL 347
LK DFGL+ P+ L + V + +Y APE++ + Y D+WS+G I A +L
Sbjct: 145 LKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML 204
Query: 348 LCGSRPFW------------------------ARTESGIFRAVLKADPSFDEAPWPSL-- 381
RP + S R +K+ P + PW L
Sbjct: 205 SN--RPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFP 262
Query: 382 --SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSD 423
P+A+D + ++L + KR+T +AL+HP+L HD PSD
Sbjct: 263 NADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD---PSD 303
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 72/252 (28%), Positives = 114/252 (45%), Gaps = 41/252 (16%)
Query: 190 TTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-- 247
+TAI RE+ +++ L H+N+V+ +D ++ + +V E +L + + G
Sbjct: 43 STAI------REISLMKELK-HENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVR 94
Query: 248 GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYV 306
G K Q+L +AFCH V+HRDLKP+N L + E LK DFGL+ +
Sbjct: 95 GALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE---LKLADFGLARAFG 151
Query: 307 KPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364
P ++ V + +Y AP+VL R+Y T D+WS+G I ++ G F
Sbjct: 152 IPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211
Query: 365 AVLKADPSFDEAPWPSLS-------------------------PEAIDFVKRLLNKDYRK 399
+ + + E+ WP +S P ID + RLL +
Sbjct: 212 KIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPEL 271
Query: 400 RLTAAQALSHPW 411
R++A AL HPW
Sbjct: 272 RISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 82/276 (29%), Positives = 130/276 (47%), Gaps = 42/276 (15%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G+G FG A+ K+ G+ AVKV+ K + + V C
Sbjct: 3 LGKGSFGKVMLARLKE---SGRLYAVKVLKKDVILQDDDVECT----------------- 42
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
MT E +IL H L Q Y ++ D ++ VME GG+L+ I +
Sbjct: 43 MT----------EKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHI-QKSR 91
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVK 307
++ E A+ +I S + F H +G+++RDLK +N L + K DFG+ + +
Sbjct: 92 RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIF 148
Query: 308 PDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366
+ + G+ Y+APE+L YG D W++GV+ Y +LCG PF A E +F A+
Sbjct: 149 NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 208
Query: 367 LKADPSFDEAPWPS-LSPEAIDFVKRLLNKDYRKRL 401
L DE +P+ LS +A+D +K + K+ RL
Sbjct: 209 LN-----DEVVYPTWLSQDAVDILKAFMTKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-28
Identities = 70/247 (28%), Positives = 118/247 (47%), Gaps = 37/247 (14%)
Query: 200 REVKILRALTGHKNLVQFYDAY--EDDDNIYIVMELCKGGEL---LDRILSRGGKYSEED 254
RE++I ++ +V++Y A+ E +I I ME C+GG L ++ RGG+ E+
Sbjct: 48 RELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKV 106
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLND 314
+ +L +++ H + ++HRD+KP N L T K + +K DFG+S E +N
Sbjct: 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ---VKLCDFGVS-----GELVNS 158
Query: 315 I----VGSAYYVAPE-VLHRSYGTEADMWSIGVIAYILLCGSRPFWARTE---------- 359
+ G+++Y+APE + + Y +D+WS+G+ + PF E
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218
Query: 360 --SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
+ LK +P + W S E DF+K+ L KD +R T L HPW+
Sbjct: 219 YIVNMPNPELKDEPG-NGIKW---SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ-- 272
Query: 418 VKIPSDM 424
+K +M
Sbjct: 273 MKKKVNM 279
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 77/295 (26%), Positives = 128/295 (43%), Gaps = 47/295 (15%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
E + VG G FG + + A+KV+ + VI L K E H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRIS---EHYYALKVM-AIPEVIRL-----KQEQH------ 47
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
V E ++L+ ++ H +++ + D +Y++ME GGEL
Sbjct: 48 ---------------VHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSY 91
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ + G ++S +I+ + + H + +V+RDLKPEN L KE +K DFG
Sbjct: 92 LRNSG-RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL-DKE--GHIKLTDFGF 147
Query: 303 SDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESG 361
+ ++ +R + G+ Y+APEV+ + D W++G++ Y +L G PF+ G
Sbjct: 148 AKKLR--DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205
Query: 362 IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPW 411
I+ +L F L A D +K+LL D +RL A +H W
Sbjct: 206 IYEKILAGKLEFPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRW 256
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 9e-28
Identities = 91/299 (30%), Positives = 134/299 (44%), Gaps = 50/299 (16%)
Query: 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYC 185
GE +G+G +G +G L +AVK QV ++ EY
Sbjct: 5 GEVLGKGAYGTVYCGLTNQGQL----IAVK-----------QVEL--DTSNVLAAEKEY- 46
Query: 186 CLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS 245
E ++ EV +L++L H N+VQ+ DD+ I I ME GG + IL+
Sbjct: 47 ----------EKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTISIFMEFVPGGSI-SSILN 94
Query: 246 RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG---- 301
R G E QIL VA+ H VVHRD+K N + N +K IDFG
Sbjct: 95 RFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP---NGIIKLIDFGCARR 151
Query: 302 ---LSDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWAR 357
+ + L + G+ Y++APEV++ S YG ++D+WSIG + + G +P A
Sbjct: 152 LAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATG-KPPLAS 210
Query: 358 TE--SGIFR--AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+ + +F A P + S S AIDFV L +D +R +A Q L H +L
Sbjct: 211 MDRLAAMFYIGAHRGLMPRLPD----SFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 68/247 (27%), Positives = 102/247 (41%), Gaps = 57/247 (23%)
Query: 124 ELGEEVGRGHFGYTCSAKAK-KGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
LG+++G G FG K KG K +VAVK + K +
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL--------------KED-------- 39
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ IE+ RE +I+R L H N+V+ +++ + IVME GG+LLD
Sbjct: 40 -------ASEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDY 91
Query: 243 ILSRGGKY-SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ K S D +QI + + + +HRDL N L EN +K DFG
Sbjct: 92 LRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFG 148
Query: 302 LSDYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILL 348
LS + D+ YY APE L + +++D+WS GV+ + I
Sbjct: 149 LSRDLYDDD---------YYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT 199
Query: 349 CGSRPFW 355
G P+
Sbjct: 200 LGEEPYP 206
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 75/223 (33%), Positives = 119/223 (53%), Gaps = 21/223 (9%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMV 260
EV I+R H+N+V+ Y++Y D +++VME +GG L D + + +EE V +
Sbjct: 67 EVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIAAVCL 123
Query: 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV-KPDERLNDIVGSA 319
+L ++ H QGV+HRD+K ++ L T + +K DFG V K R +VG+
Sbjct: 124 AVLKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTP 180
Query: 320 YYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 378
Y++APE++ R YG E D+WS+G++ ++ G P++ LKA +
Sbjct: 181 YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP-------LKAMKMIRDNLP 233
Query: 379 PSL------SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415
P L SP F+ RLL +D +R TAA+ L HP+LA +
Sbjct: 234 PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 72/227 (31%), Positives = 124/227 (54%), Gaps = 18/227 (7%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
++ + RE+ +L+ L H+N+VQ+ + D D++ I +E GG + +L+ G + E
Sbjct: 50 LDALAREIALLKELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSV-AALLNNYGAFEETL 107
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD----- 309
+ + QIL + + H +G++HRD+K N L +K +K DFG+S ++ +
Sbjct: 108 VRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNK---GGIKISDFGISKKLEANSLSTK 164
Query: 310 --ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE-SGIFRA 365
+ GS +++APEV+ + SY +AD+WS+G + +L G PF T+ IF+
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI 224
Query: 366 VLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
A P ++S EAIDF+++ D+ KR TAA+ L HP+L
Sbjct: 225 GENASPEIPS----NISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 72/220 (32%), Positives = 112/220 (50%), Gaps = 16/220 (7%)
Query: 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIV 258
+ E IL A+ H +V A++ +Y+++E GGEL L R G + E+ A
Sbjct: 48 KAERNILEAVK-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMH-LEREGIFMEDTACFY 105
Query: 259 MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPDERLNDIVG 317
+ +I + H QG+++RDLKPEN L ++ +K DFGL + + + G
Sbjct: 106 LSEISLALEHLHQQGIIYRDLKPENILLDAQ---GHVKLTDFGLCKESIHEGTVTHTFCG 162
Query: 318 SAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 376
+ Y+APE+L RS +G D WS+G + Y +L G+ PF A +LK +
Sbjct: 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP-- 220
Query: 377 PWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPW 411
P L+PEA D +K+LL ++ RL AA+ SHP+
Sbjct: 221 --PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPF 258
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 6e-27
Identities = 80/287 (27%), Positives = 131/287 (45%), Gaps = 42/287 (14%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
S ++ +E+GE +G G FG AK K G+ A+K + K + QV +H
Sbjct: 13 SSWKLSDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQV---QHVA 66
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCK 235
+ +IL E H +V +++D++ +Y ++E
Sbjct: 67 QEKSILMELS-------------------------HPFIVNMMCSFQDENRVYFLLEFVV 101
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
GGEL L + G++ + AK +++ + H + +++RDLKPEN L +K +
Sbjct: 102 GGELFTH-LRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNK---GHV 157
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPF 354
K DFG + V +R + G+ Y+APEV+ + +G D W++GV+ Y + G PF
Sbjct: 158 KVTDFGFAKKVP--DRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
Query: 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL 401
+ T I+ +L F W A D VK LL D+ KRL
Sbjct: 216 FDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGLLQTDHTKRL 258
|
Length = 329 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 69/230 (30%), Positives = 116/230 (50%), Gaps = 42/230 (18%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-------GKYSEE 253
E+++L+ L H+ +VQ+Y DD+ + I ME GG + D++ + G KY+
Sbjct: 54 EIQLLKNLQ-HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR- 111
Query: 254 DAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN 313
QIL V + H +VHRD+K N L ++ ++K DFG S +RL
Sbjct: 112 -------QILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGAS------KRLQ 155
Query: 314 DI----------VGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTE--S 360
I G+ Y+++PEV+ YG +AD+WS+G +L +P WA E +
Sbjct: 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT-EKPPWAEFEAMA 214
Query: 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
IF+ + P+ + P +SP+A +F++R ++ +KR +A + L H
Sbjct: 215 AIFK--IATQPTNPQLP-SHVSPDARNFLRRTFVENAKKRPSAEELLRHF 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 80/289 (27%), Positives = 111/289 (38%), Gaps = 82/289 (28%)
Query: 124 ELGEEVGRGHFGYTCSAKAK-KGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
ELG+++G G FG K G VAVK L
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKT------------------------LK 37
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
E + E+ E I++ L H N+V+ + +YIV E GG+LLD
Sbjct: 38 EG-----ASEEEREEFLEEASIMKKL-SHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDF 91
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ G K + +D + +QI + + + VHRDL N L T EN +K DFGL
Sbjct: 92 LRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVT---ENLVVKISDFGL 148
Query: 303 SDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIGVIAYILLC 349
S + D+ YY APE L + +++D+WS GV LL
Sbjct: 149 SRDIYEDD---------YYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGV----LL- 194
Query: 350 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYR 398
W E IF + E P+P +S E V LL YR
Sbjct: 195 -----W---E--IF--------TLGEQPYPGMSNEE---VLELLEDGYR 222
|
Length = 258 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 78/289 (26%), Positives = 131/289 (45%), Gaps = 59/289 (20%)
Query: 178 FTILDEYCC-------LFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDD------ 224
F+ +D C + +T +++ RE+KI+R L H N+V+ Y+
Sbjct: 22 FSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTE 80
Query: 225 --------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276
+++YIV E + L +L +G SEE A++ M Q+L + + H V+H
Sbjct: 81 DVGSLTELNSVYIVQEYMETD--LANVLEQG-PLSEEHARLFMYQLLRGLKYIHSANVLH 137
Query: 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVL--HRS 330
RDLKP N + E+ LK DFGL+ V P L++ + + +Y +P +L +
Sbjct: 138 RDLKPANVFINT--EDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNN 195
Query: 331 YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP------------- 377
Y DMW+ G I +L G F E + +L++ P E
Sbjct: 196 YTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVR 255
Query: 378 -------------WPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413
P ++PEA+DF++++L + RLTA +AL HP+++
Sbjct: 256 NDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-26
Identities = 89/311 (28%), Positives = 142/311 (45%), Gaps = 65/311 (20%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+E+ E +G+G +G KK G AVK++ P H+ +D
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILD------------PIHD------ID 58
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY-----EDDDNIYIVMELCKGG 237
E ++ E IL+AL+ H N+V+FY Y ++ D +++V+ELC GG
Sbjct: 59 E-------------EIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGG 105
Query: 238 ELLDRI---LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
+ D + L RG + E ++ + L + H +HRD+K N L T++
Sbjct: 106 SVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTE---GG 162
Query: 295 LKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEV------LHRSYGTEADMWSIGVIAYIL 347
+K +DFG+S + R N VG+ +++APEV L +Y D+WS+G+ A L
Sbjct: 163 VKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
Query: 348 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL------SPEAIDFVKRLLNKDYRKRL 401
G P + RA+ K P P+L S E DF+++ L KDY KR
Sbjct: 223 GDGDPPL---ADLHPMRALFK----IPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP 275
Query: 402 TAAQALSHPWL 412
T + L H ++
Sbjct: 276 TVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 73/230 (31%), Positives = 115/230 (50%), Gaps = 17/230 (7%)
Query: 193 IAIEDVRREVKILRAL--TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKY 250
IA ++V + R L T H L +++ D + VME GGEL LSR +
Sbjct: 34 IAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVF 92
Query: 251 SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPD 309
SE+ A+ +I+S + + H VV+RDLK EN + +++ +K DFGL + +
Sbjct: 93 SEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGLCKEGISDG 149
Query: 310 ERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
+ G+ Y+APEVL + YG D W +GV+ Y ++CG PF+ + +F +L
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM 209
Query: 369 ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLA 413
+ F +LSPEA + LL KD ++RL A + + H + A
Sbjct: 210 EEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 74/231 (32%), Positives = 114/231 (49%), Gaps = 17/231 (7%)
Query: 193 IAIEDVRREVKILRAL--TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKY 250
IA ++V V R L T H L A++ D + VME GGEL LSR +
Sbjct: 34 IAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRERVF 92
Query: 251 SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE 310
+EE A+ +I+S + + H + VV+RD+K EN + +++ +K DFGL D
Sbjct: 93 TEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGLCKEGISDG 149
Query: 311 -RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
+ G+ Y+APEVL YG D W +GV+ Y ++CG PF+ + +F +L
Sbjct: 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 209
Query: 369 ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLAN 414
+ F +LSPEA + LL KD ++RL A + + H + +
Sbjct: 210 EEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 256
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 77/292 (26%), Positives = 126/292 (43%), Gaps = 43/292 (14%)
Query: 123 YELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
YE VGRG FG + C + + VI K I V Q T
Sbjct: 2 YEKIRVVGRGAFGIVHLC---------RRKADQKLVIIKQIPV------------EQMTK 40
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
+ + E ++L+ L+ H N++++Y+ + +D + IVME GG L
Sbjct: 41 DER------------LAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVMEYAPGGTLA 87
Query: 241 DRILSRGGKYSEEDAKI-VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
+ I R +ED + VQIL + H + ++HRDLK +N L + +K D
Sbjct: 88 EYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHK--MVVKIGD 145
Query: 300 FGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWART 358
FG+S + + +VG+ Y++PE+ + Y ++D+W++G + Y L R F A
Sbjct: 146 FGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205
Query: 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
+ VLK SP+ + +LN D KR +Q ++ P
Sbjct: 206 LPAL---VLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 77/249 (30%), Positives = 114/249 (45%), Gaps = 46/249 (18%)
Query: 200 REVKILRALTGHKNLVQFYDAY--EDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKI 257
RE+ IL L H N+V + + D IY+VME +L + + + + + K
Sbjct: 53 REINILLKL-QHPNIVTVKEVVVGSNLDKIYMVME-YVEHDLKSLMETMKQPFLQSEVKC 110
Query: 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVKPDERLNDIV 316
+M+Q+LS VA H ++HRDLK N L ++ LK DFGL+ +Y P + +V
Sbjct: 111 LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI---LKICDFGLAREYGSPLKPYTQLV 167
Query: 317 GSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKAD 370
+ +Y APE+L + Y T DMWS+G I LL F ++E + IF+ +
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL--GT 225
Query: 371 PSFDEAPWP----------------------------SLSPEAIDFVKRLLNKDYRKRLT 402
P+ E WP SLS D + RLL D KR++
Sbjct: 226 PT--EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS 283
Query: 403 AAQALSHPW 411
A AL HP+
Sbjct: 284 AEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 84/308 (27%), Positives = 143/308 (46%), Gaps = 50/308 (16%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
++EL + +G G +G + G G+ A+KV+ K TI+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKA------------------TIV 42
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ A E R E ++L + LV + A++ D ++++++ GGEL
Sbjct: 43 QK--------AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFT 94
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ R ++ E++ +I +I+ + H G+++RD+K EN L S N + DFG
Sbjct: 95 HLSQRE-RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDS---NGHVVLTDFG 150
Query: 302 LSDYVKPD--ERLNDIVGSAYYVAPEVLH---RSYGTEADMWSIGVIAYILLCGSRPFWA 356
LS D ER G+ Y+AP+++ + D WS+GV+ Y LL G+ PF
Sbjct: 151 LSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210
Query: 357 ----RTESGIFRAVLKADPSFDEAPWPS-LSPEAIDFVKRLLNKDYRKRL-----TAAQA 406
+++ I R +LK++P P+P +S A D ++RLL KD +KRL A +
Sbjct: 211 DGEKNSQAEISRRILKSEP-----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEI 265
Query: 407 LSHPWLAN 414
HP+
Sbjct: 266 KKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-26
Identities = 69/217 (31%), Positives = 114/217 (52%), Gaps = 15/217 (6%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMV 260
E+ ++R H N+V + D+Y D +++VME GG L D + + ++ +I V
Sbjct: 66 EILVMRENK-HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT----ETCMDEGQIAAV 120
Query: 261 --QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER-LNDIVG 317
+ L + F H V+HRD+K +N L + S+K DFG + P++ + +VG
Sbjct: 121 CRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRSTMVG 177
Query: 318 SAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA 376
+ Y++APEV+ R +YG + D+WS+G++A ++ G P+ E+ + L A E
Sbjct: 178 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPEL 235
Query: 377 PWP-SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
P LS DF+ R L D KR +A + L HP+L
Sbjct: 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 7e-26
Identities = 71/249 (28%), Positives = 121/249 (48%), Gaps = 12/249 (4%)
Query: 172 KHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVM 231
K +N + +L + + +ED E+ IL A H N+V+ DA+ ++N++I++
Sbjct: 23 KAQNKETGVLAAAKVIDTKSEEELEDYMVEIDIL-ASCDHPNIVKLLDAFYYENNLWILI 81
Query: 232 ELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEE 291
E C GG + +L +E ++V Q L + + H ++HRDLK N LFT
Sbjct: 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTL--- 138
Query: 292 NSSLKAIDFGLS-DYVKPDERLNDIVGSAYYVAPEVL------HRSYGTEADMWSIGVIA 344
+ +K DFG+S + +R + +G+ Y++APEV+ R Y +AD+WS+G+
Sbjct: 139 DGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 198
Query: 345 YILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA 404
+ P + + K++P P S E DF+K+ L K+ R T
Sbjct: 199 IEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQP-SRWSSEFKDFLKKCLEKNVDARWTTT 257
Query: 405 QALSHPWLA 413
Q L HP++
Sbjct: 258 QLLQHPFVT 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 69/248 (27%), Positives = 110/248 (44%), Gaps = 53/248 (21%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273
+V+ Y +++D DN+Y VM+ GG+++ +L R G + E+ A+ + ++ + H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRLGIFEEDLARFYIAELTCAIESVHKMG 121
Query: 274 VVHRDLKPENFLFTSKEENSSLKAIDFGL--------------------SDYVKPDERLN 313
+HRD+KP+N L + + +K DFGL D ++P E +
Sbjct: 122 FIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWS 178
Query: 314 DI------------------------VGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILL 348
+I VG+ Y+APEVL R+ Y D WS+GVI Y +L
Sbjct: 179 EIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238
Query: 349 CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL---TAAQ 405
G PF A T + V+ + + LS EA D + RL RL A +
Sbjct: 239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297
Query: 406 ALSHPWLA 413
+HP+
Sbjct: 298 IKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 68/232 (29%), Positives = 118/232 (50%), Gaps = 21/232 (9%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAY------EDDDNIYIVMELCKGGELLDRILSRGGK 249
E+++ E+ +L+ + H+N+ +Y A+ DD +++VME C G + D + + G
Sbjct: 57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGN 116
Query: 250 YSEED-AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV-K 307
+ED + +IL +A H V+HRD+K +N L T EN+ +K +DFG+S + +
Sbjct: 117 ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDR 173
Query: 308 PDERLNDIVGSAYYVAPEVL------HRSYGTEADMWSIGVIAYILLCGSRPFW-ARTES 360
R N +G+ Y++APEV+ +Y +D+WS+G+ A + G+ P
Sbjct: 174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMR 233
Query: 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+F P W S + IDF++ L K+Y R + Q L HP++
Sbjct: 234 ALFLIPRNPPPKLKSKKW---SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 67/239 (28%), Positives = 118/239 (49%), Gaps = 30/239 (12%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
Y + E +G G FG C K +K + +A+K I VH P
Sbjct: 2 YAVLEHLGSGAFG--CVYKVRKKNNGQNLLALKEI---------NVHNP----------- 39
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG---GEL 239
+ +I D+ EV I++ H N+V++Y + ++D +YIVM+L +G GE
Sbjct: 40 AFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEH 99
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG-VVHRDLKPENFLFTSKEENSSLKAI 298
+ + + +++EE + VQ++ + + H + +VHRDL P N + E+ +
Sbjct: 100 FNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG---EDDKVTIT 156
Query: 299 DFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWA 356
DFGL+ +P+ +L +VG+ Y PE++ + YG +AD+W+ G I Y + PF++
Sbjct: 157 DFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 19/223 (8%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMV 260
E +IL H L + ++ D ++ VME GG+L+ +I R K+ E ++
Sbjct: 45 EKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQI-QRSRKFDEPRSRFYAA 103
Query: 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPDERLNDIVGSA 319
++ + F H GV++RDLK +N L + K DFG+ + + G+
Sbjct: 104 EVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160
Query: 320 YYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 378
Y+APE+L YG D W++GV+ Y ++ G PF A E +F ++L D+ +
Sbjct: 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH-----DDVLY 215
Query: 379 PS-LSPEAIDFVKRLLNKDYRKRL--TAAQA-----LSHPWLA 413
P LS EA+ +K + K+ KRL A+Q HP+
Sbjct: 216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFK 258
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-25
Identities = 80/302 (26%), Positives = 136/302 (45%), Gaps = 47/302 (15%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+EL + +G G +G + G G+ A+KV+ K
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQK----------------------- 38
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ A +E R E +L + LV + A++ + ++++++ GGE+
Sbjct: 39 ---AALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTH 95
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ R +SE++ + +I+ + H G+V+RD+K EN L S+ + DFGL
Sbjct: 96 LYQRD-NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE---GHVVLTDFGL 151
Query: 303 SD--YVKPDERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCGSRPFWAR- 357
S + ER G+ Y+APE++ +G D WS+G++ + LL G+ PF
Sbjct: 152 SKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211
Query: 358 ---TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA-----QALSH 409
T+S + R +LK DP F + PEA D + +LL KD +KRL A + H
Sbjct: 212 ERNTQSEVSRRILKCDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267
Query: 410 PW 411
P+
Sbjct: 268 PF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 60/264 (22%), Positives = 106/264 (40%), Gaps = 64/264 (24%)
Query: 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCC 186
+++G G FG K K K +VAVK + E+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL---------------KEDA---------- 35
Query: 187 LFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR 246
+ +D +E ++++ L GH N+V+ +++ +Y+V+E +GG+LLD +
Sbjct: 36 ----SEEERKDFLKEARVMKKL-GHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKS 90
Query: 247 GGKYSEEDAKIV--------MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
+ + + +QI + + + VHRDL N L E+ +K
Sbjct: 91 RPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG---EDLVVKIS 147
Query: 299 DFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIGVIAY 345
DFGLS V D+ YY APE L + +++D+WS GV+ +
Sbjct: 148 DFGLSRDVYDDD---------YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLW 198
Query: 346 -ILLCGSRPFWARTESGIFRAVLK 368
I G+ P+ + + + K
Sbjct: 199 EIFTLGATPYPGLSNEEVLEYLRK 222
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 71/222 (31%), Positives = 119/222 (53%), Gaps = 15/222 (6%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
E + E+ +++ L + N+V F D++ D +++VME GG L D + + ++A
Sbjct: 61 ELIINEILVMKELK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVT----ETCMDEA 115
Query: 256 KIVMV--QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RL 312
+I V + L + F H V+HRD+K +N L S+K DFG + P++ +
Sbjct: 116 QIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMD---GSVKLTDFGFCAQITPEQSKR 172
Query: 313 NDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 371
+ +VG+ Y++APEV+ R +YG + D+WS+G++A ++ G P+ E+ + L A
Sbjct: 173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATN 230
Query: 372 SFDEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
E P LSP DF+ R L D KR +A + L HP+L
Sbjct: 231 GTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-25
Identities = 68/215 (31%), Positives = 116/215 (53%), Gaps = 11/215 (5%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMV 260
EV I+R H+N+V Y++Y D +++VME +GG L D + + +EE V +
Sbjct: 69 EVVIMRDYH-HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT--RMNEEQIATVCL 125
Query: 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV-KPDERLNDIVGSA 319
+L +++ H QGV+HRD+K ++ L TS + +K DFG V K + +VG+
Sbjct: 126 SVLRALSYLHNQGVIHRDIKSDSILLTS---DGRIKLSDFGFCAQVSKEVPKRKSLVGTP 182
Query: 320 YYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKA-DPSFDEAP 377
Y++APEV+ R YGTE D+WS+G++ ++ G P++ R + P ++
Sbjct: 183 YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDS- 241
Query: 378 WPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+S F+ +L ++ +R TA + L HP+L
Sbjct: 242 -HKVSSVLRGFLDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-25
Identities = 74/219 (33%), Positives = 112/219 (51%), Gaps = 12/219 (5%)
Query: 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEE 253
A+ED R+E +L A H N+V F +++E D ++YIVME C GG+L+ +I + GK E
Sbjct: 41 AVEDSRKEA-VLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPE 99
Query: 254 DAKIV-MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV-KPDER 311
D + VQ+ V H + V+HRD+K +N T +N +K DFG + + P
Sbjct: 100 DTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAY 156
Query: 312 LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 370
VG+ YYV PE+ Y ++D+WS+G I Y L PF A + + V +
Sbjct: 157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS 216
Query: 371 PSFDEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQALS 408
P PS S E +K++ ++ R R +A LS
Sbjct: 217 YK----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILS 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 59/190 (31%), Positives = 99/190 (52%), Gaps = 10/190 (5%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273
L Q + ++ D +Y VME GG+L+ I + GK+ E A +I + F H +G
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGKFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 274 VVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPDERLNDIVGSAYYVAPE-VLHRSY 331
+++RDLK +N + + +K DFG+ + + + G+ Y+APE + ++ Y
Sbjct: 122 IIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY 178
Query: 332 GTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKR 391
G D W+ GV+ Y +L G PF E +F+++++ + S+ + SLS EA+ K
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKG 234
Query: 392 LLNKDYRKRL 401
LL K KRL
Sbjct: 235 LLTKHPAKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 75/241 (31%), Positives = 108/241 (44%), Gaps = 34/241 (14%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM 259
RE+ +L+ L HKN+V+ YD D + +V E C +L S G E K M
Sbjct: 48 REICLLKELK-HKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFM 105
Query: 260 VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVKPDERLNDIVGS 318
Q+L +AFCH V+HRDLKP+N L +N LK DFGL+ + P + V +
Sbjct: 106 FQLLKGLAFCHSHNVLHRDLKPQNLLIN---KNGELKLADFGLARAFGIPVRCYSAEVVT 162
Query: 319 AYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTE-----SGIFRAV----- 366
+Y P+VL + Y T DMWS G I L RP + + IFR +
Sbjct: 163 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 222
Query: 367 -----------LKADPSFD-----EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
K P + P L+ D ++ LL + +R++A +AL HP
Sbjct: 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282
Query: 411 W 411
+
Sbjct: 283 Y 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 68/243 (27%), Positives = 111/243 (45%), Gaps = 37/243 (15%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM 259
RE+++L+ L H NLV + + +++V E C +L+ + E K ++
Sbjct: 49 REIRMLKQLK-HPNLVNLIEVFRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKII 106
Query: 260 VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGS 318
Q L V FCH +HRD+KPEN L T + +K DFG + + P + D V +
Sbjct: 107 WQTLQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYVAT 163
Query: 319 AYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWA------------RT------ 358
+Y APE+L YG D+W+IG + LL G +P W +T
Sbjct: 164 RWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG-QPLWPGKSDVDQLYLIRKTLGDLIP 222
Query: 359 -------ESGIFRAVLKADPSFD---EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
+ F+ + +P E+ +P++S A+ F+K L D +RL+ + L
Sbjct: 223 RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282
Query: 409 HPW 411
HP+
Sbjct: 283 HPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 69/218 (31%), Positives = 111/218 (50%), Gaps = 19/218 (8%)
Query: 220 AYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279
+++ D ++Y+V + GGEL L + G++SE+ AK + +++ + H +V+RDL
Sbjct: 64 SFQTDSDLYLVTDYMSGGELFWH-LQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDL 122
Query: 280 KPENFLFTSKEENSSLKAIDFGLSDY-VKPDERLNDIVGSAYYVAPEVL--HRSYGTEAD 336
KPEN L + + DFGLS + ++ N G+ Y+APEVL + Y D
Sbjct: 123 KPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVD 179
Query: 337 MWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKD 396
WS+GV+ + + CG PF+A ++R + F P LS E FVK LLN++
Sbjct: 180 FWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF---PKNVLSDEGRQFVKGLLNRN 236
Query: 397 YRKRL----TAAQALSHPWLANSHDVKIPSDMIVYKLI 430
+ RL A + HP+ A+ I D++ K I
Sbjct: 237 PQHRLGAHRDAVELKEHPFFAD-----IDWDLLSKKQI 269
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 65/232 (28%), Positives = 119/232 (51%), Gaps = 21/232 (9%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYED------DDNIYIVMELCKGGELLDRIL-SRGG 248
E++++E+ +L+ + H+N+ +Y A+ DD +++VME C G + D I ++G
Sbjct: 47 EEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN 106
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV-K 307
EE + +IL ++ H V+HRD+K +N L T EN+ +K +DFG+S + +
Sbjct: 107 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDR 163
Query: 308 PDERLNDIVGSAYYVAPEVL------HRSYGTEADMWSIGVIAYILLCGSRPFW-ARTES 360
R N +G+ Y++APEV+ +Y ++D+WS+G+ A + G+ P
Sbjct: 164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 223
Query: 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+F P W S + F++ L K++ +R T Q + HP++
Sbjct: 224 ALFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 79/282 (28%), Positives = 128/282 (45%), Gaps = 47/282 (16%)
Query: 130 GRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL-DEYCCLF 188
GRGHFG A+ KK G+ A+K + K I DE
Sbjct: 8 GRGHFGKVLLAEYKK---TGELYAIKALKK-----------------GDIIARDE----- 42
Query: 189 MTTAIAIEDVRREVKILRAL--TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR 246
+E + E +I H LV + ++ +D++ VME GG+L+ I +
Sbjct: 43 ------VESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT- 95
Query: 247 GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDY 305
+SE A ++ + + H +V+RDLK +N L ++ +K DFGL +
Sbjct: 96 -DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTE---GFVKIADFGLCKEG 151
Query: 306 VKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364
+ +R + G+ ++APEVL SY D W +GV+ Y +L G PF E +F
Sbjct: 152 MGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211
Query: 365 AVLKADPSFDEAPWP-SLSPEAIDFVKRLLNKDYRKRLTAAQ 405
+++ DE +P LS EAI ++RLL ++ +RL + +
Sbjct: 212 SIVN-----DEVRYPRFLSREAISIMRRLLRRNPERRLGSGE 248
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 67/209 (32%), Positives = 111/209 (53%), Gaps = 17/209 (8%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMV 260
E IL A H +V+ + A++ + +Y++++ +GG+L R LS+ ++EED K +
Sbjct: 48 ERDIL-AEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLA 105
Query: 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVKPDERLNDIVGSA 319
++ + H G+++RDLKPEN L +E +K DFGLS + + +++ G+
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162
Query: 320 YYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD---PSFDE 375
Y+APEV++R + AD WS GV+ + +L GS PF + +LKA P F
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQF-- 220
Query: 376 APWPSLSPEAIDFVKRLLNKDYRKRLTAA 404
LSPEA ++ L ++ RL A
Sbjct: 221 -----LSPEAQSLLRALFKRNPANRLGAG 244
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-24
Identities = 66/232 (28%), Positives = 114/232 (49%), Gaps = 12/232 (5%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
+ED E++IL A H +V+ A+ D ++I++E C GG + +L +E
Sbjct: 53 LEDYMVEIEIL-ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ 111
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVKPDERLN 313
+++ Q+L + + H ++HRDLK N L T + +K DFG+S VK +R +
Sbjct: 112 IQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT---LDGDIKLADFGVSAKNVKTLQRRD 168
Query: 314 DIVGSAYYVAPEVL------HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVL 367
+G+ Y++APEV+ Y +AD+WS+G+ + P + +
Sbjct: 169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 228
Query: 368 KADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVK 419
K++P P S E DF+K L+K R +AAQ L HP++++ +
Sbjct: 229 KSEPPTLSQP-SKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 68/212 (32%), Positives = 107/212 (50%), Gaps = 16/212 (7%)
Query: 211 HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCH 270
H L +++ D + VME GGEL LSR +SE+ A+ +I+S + + H
Sbjct: 54 HPFLTALKYSFQTHDRLCFVMEYANGGELFFH-LSRERVFSEDRARFYGAEIVSALDYLH 112
Query: 271 FQ-GVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPDERLNDIVGSAYYVAPEVLH 328
+ VV+RDLK EN + +++ +K DFGL + +K + G+ Y+APEVL
Sbjct: 113 SEKNVVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLE 169
Query: 329 -RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAID 387
YG D W +GV+ Y ++CG PF+ + +F +L + F +LSPEA
Sbjct: 170 DNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKS 225
Query: 388 FVKRLLNKDYRKRL-----TAAQALSHPWLAN 414
+ LL KD ++RL A + + H + A
Sbjct: 226 LLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAG 257
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 68/217 (31%), Positives = 105/217 (48%), Gaps = 34/217 (15%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGE---LLDRILSRGGKYSEEDAKIVMVQILSVVAFCH 270
+V + ++E ++ +VME +GG+ LL I G + A++ + + + + H
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLH 118
Query: 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSD-------------YVKPDERL---ND 314
G+VHRDLKP+N L TS +K DFGLS +++ D R
Sbjct: 119 NYGIVHRDLKPDNLLITSM---GHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 315 IVGSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD--- 370
+ G+ Y+APEV L + YG D W++G+I Y L G PF+ T +F V+ D
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEW 235
Query: 371 PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407
P DEA L +A D + RLL ++ +RL A
Sbjct: 236 PEGDEA----LPADAQDLISRLLRQNPLERLGTGGAF 268
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-24
Identities = 61/203 (30%), Positives = 106/203 (52%), Gaps = 10/203 (4%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMV 260
E ++L H L + ++ ++++ VME GG+L+ I S G ++ E A+
Sbjct: 45 ERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSG-RFDEARARFYAA 103
Query: 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPDERLNDIVGSA 319
+I+ + F H +G+++RDLK +N L +++ +K DFG+ + + + + + G+
Sbjct: 104 EIICGLQFLHKKGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTP 160
Query: 320 YYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 378
Y+APE+L + Y D WS GV+ Y +L G PF E +F ++L P F W
Sbjct: 161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--W 218
Query: 379 PSLSPEAIDFVKRLLNKDYRKRL 401
+S EA D + +L +D KRL
Sbjct: 219 --ISKEAKDCLSKLFERDPTKRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 78/264 (29%), Positives = 121/264 (45%), Gaps = 51/264 (19%)
Query: 190 TTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGK 249
+TAI RE+ +L+ + H N+V+ D + +Y+V E LD L +
Sbjct: 46 STAI------REISLLKEMQ-HGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMD 92
Query: 250 YSEEDA------KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
S + A K + QIL +A+CH V+HRDLKP+N L + ++LK DFGL+
Sbjct: 93 SSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR--TNALKLADFGLA 150
Query: 304 D-YVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRP-FWARTE 359
+ P V + +Y APE+L R Y T D+WS+G I + + +P F +E
Sbjct: 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCI-FAEMVNQKPLFPGDSE 209
Query: 360 ----SGIFRAV----------LKADPSFDEA--PW---------PSLSPEAIDFVKRLLN 394
IFR + + + P + A W P+L P +D + ++L
Sbjct: 210 IDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLR 269
Query: 395 KDYRKRLTAAQALSHPWLANSHDV 418
D KR+TA AL H + + D
Sbjct: 270 LDPSKRITARAALEHEYFKDLGDA 293
|
Length = 294 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 6e-24
Identities = 77/258 (29%), Positives = 115/258 (44%), Gaps = 52/258 (20%)
Query: 190 TTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGK 249
+TAI RE+ +L+ L H N+V+ D ++ +Y+V E LD L +
Sbjct: 43 STAI------REISLLKELN-HPNIVRLLDVVHSENKLYLVFEF------LDLDLKKYMD 89
Query: 250 YSEEDA------KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
S K + Q+L +A+CH V+HRDLKP+N L + +LK DFGL+
Sbjct: 90 SSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI---DREGALKLADFGLA 146
Query: 304 DYVK-PDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRP-FWARTE 359
P V + +Y APE+L R Y T D+WSIG I + + RP F +E
Sbjct: 147 RAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCI-FAEMVNRRPLFPGDSE 205
Query: 360 SG----IFRAVLKAD--------------PSF-------DEAPWPSLSPEAIDFVKRLLN 394
IFR + D P+F P+L + +D + ++L
Sbjct: 206 IDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLV 265
Query: 395 KDYRKRLTAAQALSHPWL 412
D KR++A AL HP+
Sbjct: 266 YDPAKRISAKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-23
Identities = 65/208 (31%), Positives = 108/208 (51%), Gaps = 15/208 (7%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQ 272
+ Q A++D DN+Y+VME GG+LL +L+R ++ E+ A+ + +++ + H
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121
Query: 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDI--VGSAYYVAPEVLHR- 329
G VHRD+KPEN L + +K DFG + + ++ +N VG+ Y+APEVL
Sbjct: 122 GYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM 178
Query: 330 ------SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSP 383
+YG E D WS+GVIAY ++ G PF T + + ++ P +S
Sbjct: 179 NGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSS 238
Query: 384 EAIDFVKRLLNKDYRKRLTAAQALSHPW 411
+ +D ++ LL ++RL HP+
Sbjct: 239 DFLDLIQSLLCGQ-KERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 91/331 (27%), Positives = 143/331 (43%), Gaps = 84/331 (25%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+GRG +G CSAK S + VA+K I +N
Sbjct: 13 IGRGAYGIVCSAK---NSETNEKVAIKKIANAF------------DNR------------ 45
Query: 189 MTTAIAIEDVR--REVKILRALTGHKNLVQFYD--------AYEDDDNIYIVMELCKGGE 238
I+ R RE+K+LR L H+N++ D A+ D +YIV EL
Sbjct: 46 ------IDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREAFND---VYIVYELMDTD- 94
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
L +I+ S++ + + Q+L + + H V+HRDLKP N L + N LK
Sbjct: 95 -LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKIC 150
Query: 299 DFGLSDYV-KPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFW 355
DFGL+ + + + + V + +Y APE+L Y T D+WS+G I LL G +P +
Sbjct: 151 DFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLF 209
Query: 356 ARTE------------------------SGIFRAVLKADPSFDEAP----WPSLSPEAID 387
+ + R +++ P +P +P AID
Sbjct: 210 PGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAID 269
Query: 388 FVKRLLNKDYRKRLTAAQALSHPWLANSHDV 418
++++L D KR+T +AL+HP+LA+ HD
Sbjct: 270 LLEKMLVFDPSKRITVEEALAHPYLASLHDP 300
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 96/358 (26%), Positives = 143/358 (39%), Gaps = 110/358 (30%)
Query: 114 GFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKH 173
G SK YE+ ++G G FG A+ K G+ VA+K I +H +
Sbjct: 3 GCSKL--RDYEILGKLGEGTFGEVYKARQIK---TGRVVALKKI---------LMH---N 45
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD-AYEDDDNI----- 227
E F I TA+ RE+KIL+ L H N+V D A E D
Sbjct: 46 EKDGFPI----------TAL------REIKILKKLK-HPNVVPLIDMAVERPDKSKRKRG 88
Query: 228 -------YIVMELCKGGELLD--RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278
Y+ +L LL+ + K +E K M+Q+L + + H ++HRD
Sbjct: 89 SVYMVTPYMDHDLSG---LLENPSV-----KLTESQIKCYMLQLLEGINYLHENHILHRD 140
Query: 279 LKPENFLFTSKEENSSLKAIDFGLS---DYVKP---------DERLNDIVGSAYYVAPEV 326
+K N L ++ LK DFGL+ D P + ++V + +Y PE+
Sbjct: 141 IKAANILIDNQ---GILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPEL 197
Query: 327 L--HRSYGTEADMWSIGVIAYILLCGSRP-FWARTE----SGIFRAVLKADPSFDEAPWP 379
L R Y T D+W IG + + RP +++ IF+ P+ E WP
Sbjct: 198 LLGERRYTTAVDIWGIGCVFAEMFTR-RPILQGKSDIDQLHLIFKLC--GTPT--EETWP 252
Query: 380 --------------------------SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
L PE +D + +LL+ D KRLTA+ AL HP+
Sbjct: 253 GWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 4e-23
Identities = 58/220 (26%), Positives = 116/220 (52%), Gaps = 10/220 (4%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS-RGGKYSEED 254
E+ R+EV +L + H N+VQ+ +++E++ N+YIVM+ C+GG+L +I + RG + E+
Sbjct: 44 EESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ 102
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL-N 313
VQI + H + ++HRD+K +N T ++ ++K DFG++ + L
Sbjct: 103 ILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELAR 159
Query: 314 DIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 372
+G+ YY++PE+ +R Y ++D+W++G + Y + F A + +++ S
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRG--S 217
Query: 373 FDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+ S + + V +L ++ R R + L ++
Sbjct: 218 YPPVS-SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 6e-23
Identities = 88/336 (26%), Positives = 134/336 (39%), Gaps = 76/336 (22%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
K+ V +++ ++G G +G A+ K G+ VA+K + +E
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDK---DTGELVALKKVRL------------DNEKE 47
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDD----------N 226
F I TAI RE+KILR L H+N+V + D
Sbjct: 48 GFPI----------TAI------REIKILRQLN-HRNIVNLKEIVTDKQDALDFKKDKGA 90
Query: 227 IYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286
Y+V E +L+ + S +SE+ K M Q+L + +CH + +HRD+K N L
Sbjct: 91 FYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL 149
Query: 287 TSKEENSSLKAIDFGLSD-YVKPDERL-NDIVGSAYYVAPEVL--HRSYGTEADMWSIGV 342
+K + +K DFGL+ Y + R + V + +Y PE+L YG D+WS G
Sbjct: 150 NNKGQ---IKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGC 206
Query: 343 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS---------------------- 380
I L F A E + + S A WP
Sbjct: 207 ILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE 266
Query: 381 ----LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+ A+D + +L D KR TA +AL+ PWL
Sbjct: 267 EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 9e-23
Identities = 67/226 (29%), Positives = 109/226 (48%), Gaps = 17/226 (7%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
++ V E KIL + H V Y +++D+ +Y+V+E GGE L R ++ +
Sbjct: 75 VDHVFSERKILNYIN-HPFCVNLYGSFKDESYLYLVLEFVIGGEFFT-FLRRNKRFPNDV 132
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLND 314
QI+ + + +V+RDLKPEN L +++ +K DFG + V D R
Sbjct: 133 GCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL---DKDGFIKMTDFGFAKVV--DTRTYT 187
Query: 315 IVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 373
+ G+ Y+APE+L + +G AD W++G+ Y +L G PF+A I++ +L+ F
Sbjct: 188 LCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYF 247
Query: 374 DEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLAN 414
+ L +K+LL+ D KR A HPW N
Sbjct: 248 PKF----LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289
|
Length = 340 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-22
Identities = 70/261 (26%), Positives = 112/261 (42%), Gaps = 55/261 (21%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM 259
RE+KI+ + H+N++ D Y + D I +VM++ L +++ R + +E K ++
Sbjct: 69 RELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCIL 125
Query: 260 VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS---------------D 304
+QIL+ + H +HRDL P N SK K DFGL+ +
Sbjct: 126 LQILNGLNVLHKWYFMHRDLSPANIFINSKGI---CKIADFGLARRYGYPPYSDTLSKDE 182
Query: 305 YVKPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFWARTE--- 359
++ E + V + +Y APE+L + Y DMWS+G I LL G F E
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQ 242
Query: 360 -SGIFRAVLKADPSFDEAPWPSL------------------------SPEAIDFVKRLLN 394
IF L P+ E WP S +AID ++ LL
Sbjct: 243 LGRIFE--LLGTPN--EDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK 298
Query: 395 KDYRKRLTAAQALSHPWLANS 415
+ +R++A +AL H + +
Sbjct: 299 LNPLERISAKEALKHEYFKSD 319
|
Length = 335 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 97.5 bits (242), Expect = 1e-22
Identities = 68/220 (30%), Positives = 113/220 (51%), Gaps = 11/220 (5%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
E + E+ ++R + N+V + D+Y D +++VME GG L D + E
Sbjct: 62 ELIINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQI 118
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLND 314
V + L + F H V+HRD+K +N L + S+K DFG + P++ + +
Sbjct: 119 AAVCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRST 175
Query: 315 IVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 373
+VG+ Y++APEV+ R +YG + D+WS+G++A ++ G P+ E+ + L A
Sbjct: 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGT 233
Query: 374 DEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
E P LS DF+ R L+ D KR +A + L H +L
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-22
Identities = 68/220 (30%), Positives = 113/220 (51%), Gaps = 11/220 (5%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
E + E+ ++R + N+V + D+Y D +++VME GG L D + E
Sbjct: 61 ELIINEILVMRE-NKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQI 117
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLND 314
V + L + F H V+HRD+K +N L + S+K DFG + P++ + +
Sbjct: 118 AAVCRECLQALDFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFGFCAQITPEQSKRST 174
Query: 315 IVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 373
+VG+ Y++APEV+ R +YG + D+WS+G++A ++ G P+ E+ + L A
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGT 232
Query: 374 DEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
E P LS DF+ R L D +R +A + L HP+L
Sbjct: 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-22
Identities = 65/203 (32%), Positives = 102/203 (50%), Gaps = 11/203 (5%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMV 260
E ++L+ T H L +++ D + VME GGEL LSR +SE+ +
Sbjct: 45 ESRVLKN-TRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFH-LSRERVFSEDRTRFYGA 102
Query: 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPDERLNDIVGSA 319
+I+S + + H +V+RDLK EN + +++ +K DFGL + + + G+
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTP 159
Query: 320 YYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW 378
Y+APEVL YG D W +GV+ Y ++CG PF+ + +F +L D F
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR--- 216
Query: 379 PSLSPEAIDFVKRLLNKDYRKRL 401
+LS +A + LL KD KRL
Sbjct: 217 -TLSADAKSLLSGLLIKDPNKRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 2e-22
Identities = 72/298 (24%), Positives = 135/298 (45%), Gaps = 53/298 (17%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+++ +++G+G F A L G+ VA+K + I +
Sbjct: 4 FKIEKKIGKGQFSVVYKAICL---LDGRVVALKKV---------------------QIFE 39
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
M A A +D +E+ +L+ L H N++++ ++ +++ + IV+EL G+L
Sbjct: 40 ------MMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIVLELADAGDL--- 89
Query: 243 ILSRGGKYSEEDAKIV--------MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
SR K+ ++ +++ VQ+ S + H + ++HRD+KP N T+
Sbjct: 90 --SRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA---TGV 144
Query: 295 LKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSR 352
+K D GL + + +VG+ YY++PE +H + Y ++D+WS+G + Y +
Sbjct: 145 VKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 204
Query: 353 PFWARTESGIFRAVLKADPSFDEAPWPS--LSPEAIDFVKRLLNKDYRKRLTAAQALS 408
PF+ + ++ K D P P+ S E D V R +N D KR + L
Sbjct: 205 PFYGDKMN--LYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 75/243 (30%), Positives = 117/243 (48%), Gaps = 33/243 (13%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDN--IYIVMELCKGGEL---LDRILSRGGKYSEEDA 255
EV ++R L HKN+V++ D + + N +YI+ME C G+L + + GK E
Sbjct: 62 EVNVMRELK-HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAI 120
Query: 256 KIVMVQILSVVAFCHF-------QGVVHRDLKPENFLF----------TSKEENSSLKAI 298
+ Q+L +A+CH + V+HRDLKP+N T++ N + + I
Sbjct: 121 VDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180
Query: 299 ----DFGLSDYVKPDERLNDIVGSAYYVAPEVL---HRSYGTEADMWSIGVIAYILLCGS 351
DFGLS + + + VG+ YY +PE+L +SY ++DMW++G I Y L G
Sbjct: 181 AKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
Query: 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
PF + LK P + P S E +K LLN ++R +A Q L +
Sbjct: 241 TPFHKANNFSQLISELKRGP---DLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQI 297
Query: 412 LAN 414
+ N
Sbjct: 298 IKN 300
|
Length = 1021 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-22
Identities = 84/321 (26%), Positives = 132/321 (41%), Gaps = 70/321 (21%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE VG G +G K K+ GQ VA+K FL+ K
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKE---TGQIVAIK--------KFLESEDDK---------- 41
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
M IA+ RE+++L+ L H+NLV + + +Y+V E +LD
Sbjct: 42 ------MVKKIAM----REIRMLKQLR-HENLVNLIEVFRRKKRLYLVFEFVDH-TVLDD 89
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ E + + QIL + FCH ++HRD+KPEN L + ++ +K DFG
Sbjct: 90 LEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGF 146
Query: 303 SDYVK-PDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTE 359
+ + P E D V + +Y APE+L YG D+W++G + +L G F +
Sbjct: 147 ARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF--PGD 204
Query: 360 SGI----------------FRAVLKADPSFD-------------EAPWPSLSPEAIDFVK 390
S I + + + +P F E +P LS +D K
Sbjct: 205 SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAK 264
Query: 391 RLLNKDYRKRLTAAQALSHPW 411
+ L D R +++Q L H +
Sbjct: 265 QCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 85/325 (26%), Positives = 141/325 (43%), Gaps = 76/325 (23%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
VG G +G CSA K+ G+ VA+K ++ P
Sbjct: 23 VGSGAYGSVCSAIDKR---TGEKVAIK-----------KLSRP----------------- 51
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYD------AYEDDDNIYIVMELCKGGELLDR 242
+ I + RE+ +L+ + H+N++ D + ++ + Y+VM + L +
Sbjct: 52 FQSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQK 108
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
I G SE+ + ++ Q+L + + H G++HRDLKP N + E+ LK +DFGL
Sbjct: 109 I--MGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGL 163
Query: 303 SDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWARTES 360
+ + D + V + +Y APEV+ Y D+WS+G I +L G F +
Sbjct: 164 ARHA--DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL 221
Query: 361 GIFRAVLKAD----PSF-----DEAP------------------WPSLSPEAIDFVKRLL 393
+LK P F D+A +P SP+A+D ++++L
Sbjct: 222 DQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKML 281
Query: 394 NKDYRKRLTAAQALSHPWLANSHDV 418
D KRLTA +AL HP+ + D
Sbjct: 282 ELDVDKRLTATEALEHPYFDSFRDA 306
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 91/351 (25%), Positives = 138/351 (39%), Gaps = 96/351 (27%)
Query: 112 NFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCP 171
F F + V+ YE ++G+G FG A+ KK Q VA+K + M
Sbjct: 4 EFPFCDE-VSKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKV-LM----------- 47
Query: 172 KHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD-------AYEDD 224
++E F I TA+ RE+KIL+ L H+N+V + Y
Sbjct: 48 ENEKEGFPI----------TAL------REIKILQLLK-HENVVNLIEICRTKATPYNRY 90
Query: 225 D-NIYIVMELCKGGELLDRILSRGG-KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282
+ Y+V E C+ L +LS K++ + K VM +L+ + + H ++HRD+K
Sbjct: 91 KGSFYLVFEFCEHD--LAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAA 148
Query: 283 NFLFTSKEENSSLKAIDFGLS-DYVKPDE----RLNDIVGSAYYVAPEVL--HRSYGTEA 335
N L T ++ LK DFGL+ + R + V + +Y PE+L R YG
Sbjct: 149 NILIT---KDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPI 205
Query: 336 DMWSIGVIAYILLCGSRPFWAR-------TESGIFRAVLKADPSFDEAPWPSL------- 381
DMW G C W R TE + + S WP +
Sbjct: 206 DMWGAG-------CIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFK 258
Query: 382 ---------------------SPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
P A+D + +LL D KR+ A AL+H +
Sbjct: 259 KMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 3e-22
Identities = 72/258 (27%), Positives = 112/258 (43%), Gaps = 40/258 (15%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKG--GELLDRILSRGGKYSEEDA 255
RE+ +L L H N+V+ + D+I++VME C+ LLD + + +SE
Sbjct: 55 REITLLLNLR-HPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT---PFSESQV 110
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVKPDERLND 314
K +M+Q+L + + H ++HRDLK N L T K LK DFGL+ Y P + +
Sbjct: 111 KCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC---LKIADFGLARTYGLPAKPMTP 167
Query: 315 IVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTE------------- 359
V + +Y APE+L +Y T DMW++G I LL ++E
Sbjct: 168 KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGT 227
Query: 360 ------------SGIFRAVLKADP-SFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA 406
+ + L P + + +P LS + + LL D +KR TA +A
Sbjct: 228 PNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA 287
Query: 407 LSHPWLANSHDVKIPSDM 424
L + P M
Sbjct: 288 LESSYFKEKPLPCEPEMM 305
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 3e-22
Identities = 68/238 (28%), Positives = 113/238 (47%), Gaps = 31/238 (13%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDN-----IYIVMELCKGG---ELLDRILSRG 247
E++ E IL++L H N+V+FY + D +++V+ELC GG EL+ +L G
Sbjct: 63 EEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICG 122
Query: 248 GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK 307
+ E ++ L + H ++HRD+K N L T++ +K +DFG+S +
Sbjct: 123 QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTE---GGVKLVDFGVSAQLT 179
Query: 308 PDE-RLNDIVGSAYYVAPEVL------HRSYGTEADMWSIGVIAYILLCGSRPFWARTES 360
R N VG+ +++APEV+ SY D+WS+G+ A L G P + +
Sbjct: 180 STRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF---DM 236
Query: 361 GIFRAVLKADPSFDEAPWPSL-SPEAI-----DFVKRLLNKDYRKRLTAAQALSHPWL 412
+ + K P P+L PE F+ + L KD+ R + L HP++
Sbjct: 237 HPVKTLFK----IPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFI 290
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-22
Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 40/275 (14%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G+G FG A+ K Q A+K + K + ++ V C T++
Sbjct: 3 LGKGSFGKVFLAELKG---TNQFFAIKALKKDVVLMDDDVEC--------TMV------- 44
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
E ++L H L Y ++ +N++ VME GG+L+ I S
Sbjct: 45 ------------EKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQS-CH 91
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVK 307
K+ A +I+ + F H +G+V+RDLK +N L + + +K DFG+ + +
Sbjct: 92 KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENML 148
Query: 308 PDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366
D + G+ Y+APE+L + Y T D WS GV+ Y +L G PF E +F+++
Sbjct: 149 GDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL 401
+P + W L+ EA D + +L ++ +RL
Sbjct: 209 RMDNPCYPR--W--LTREAKDILVKLFVREPERRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-22
Identities = 81/324 (25%), Positives = 145/324 (44%), Gaps = 75/324 (23%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
VG G +G C+A K L+ VAVK + + I +H +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLR---VAVKKLSRPFQSI---IHAKR---------------- 62
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAY------EDDDNIYIVMELCKGGELLDR 242
RE+++L+ + H+N++ D + E+ +++Y+V L G L+
Sbjct: 63 ---------TYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNN 110
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
I+ + K +++ + ++ QIL + + H ++HRDLKP N + E+ LK +DFGL
Sbjct: 111 IV-KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKILDFGL 166
Query: 303 SDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPF------ 354
+ + D+ + V + +Y APE++ Y D+WS+G I LL G F
Sbjct: 167 ARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224
Query: 355 -----------------WARTESGIFRAVLKADPSFDEAPWPSL----SPEAIDFVKRLL 393
+ S R +++ + + ++ +P A+D ++++L
Sbjct: 225 DQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKML 284
Query: 394 NKDYRKRLTAAQALSHPWLANSHD 417
D KR+TAAQAL+H + A HD
Sbjct: 285 VLDSDKRITAAQALAHAYFAQYHD 308
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 4e-22
Identities = 73/247 (29%), Positives = 112/247 (45%), Gaps = 54/247 (21%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
+ V+ E IL A ++ +V+ Y +++D DN+Y VM+ GG+++ +L R G + E+
Sbjct: 45 VAHVKAERDIL-AEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMGIFPEDL 102
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL------------ 302
A+ + ++ V H G +HRD+KP+N L + + +K DFGL
Sbjct: 103 ARFYIAELTCAVESVHKMGFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 303 --------------------------SDYVKPDER----------LNDIVGSAYYVAPEV 326
D +KP ER + +VG+ Y+APEV
Sbjct: 160 YQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV 219
Query: 327 LHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEA 385
L R+ Y D WS+GVI Y +L G PF A+T V+ S P LSPEA
Sbjct: 220 LLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEA 279
Query: 386 IDFVKRL 392
D + +L
Sbjct: 280 SDLIIKL 286
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 62/200 (31%), Positives = 97/200 (48%), Gaps = 19/200 (9%)
Query: 206 RALTGHKN---LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQI 262
R + H N +VQ + A++DD +Y+VME GG+L++ L E+ A+ ++
Sbjct: 94 RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN--LMSNYDIPEKWARFYTAEV 151
Query: 263 LSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGS 318
+ + H G +HRD+KP+N L + LK DFG +K D R + VG+
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTC--MKMDANGMVRCDTAVGT 206
Query: 319 AYYVAPEVL-----HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 373
Y++PEVL YG E D WS+GV Y +L G PF+A + G + ++ S
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL 266
Query: 374 DEAPWPSLSPEAIDFVKRLL 393
+S +A D + L
Sbjct: 267 TFPDDIEISKQAKDLICAFL 286
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 5e-22
Identities = 72/236 (30%), Positives = 118/236 (50%), Gaps = 34/236 (14%)
Query: 196 EDVR----REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYS 251
+ VR RE++ILR + H N+V+ +D ++ + I +++E GG L ++ +
Sbjct: 113 DTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA 171
Query: 252 EEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV-KPDE 310
+ V QILS +A+ H + +VHRD+KP N L S + ++K DFG+S + + +
Sbjct: 172 D-----VARQILSGIAYLHRRHIVHRDIKPSNLLINSAK---NVKIADFGVSRILAQTMD 223
Query: 311 RLNDIVGSAYYVAPEVL-----HRSY-GTEADMWSIGVIAYILLCGSRPF-------WAR 357
N VG+ Y++PE + H +Y G D+WS+GV G PF WA
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA- 282
Query: 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413
+ A+ + P EAP + S E F+ L ++ KR +A Q L HP++
Sbjct: 283 ---SLMCAICMSQPP--EAP-ATASREFRHFISCCLQREPAKRWSAMQLLQHPFIL 332
|
Length = 353 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 5e-22
Identities = 75/259 (28%), Positives = 120/259 (46%), Gaps = 53/259 (20%)
Query: 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKI 257
VR E IL A + +V+ Y +++D++ +Y++ME GG+++ +L + ++EE+ +
Sbjct: 48 VRAERDIL-AEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMT-LLMKKDTFTEEETRF 105
Query: 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK---------- 307
+ + + + H G +HRD+KP+N L +K +K DFGL +K
Sbjct: 106 YIAETILAIDSIHKLGYIHRDIKPDNLLLDAK---GHIKLSDFGLCTGLKKSHRTEFYRI 162
Query: 308 -----PDERLNDI------------------------VGSAYYVAPEVLHRS-YGTEADM 337
P L+ I VG+ Y+APEV ++ Y E D
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222
Query: 338 WSIGVIAYILLCGSRPFWARTESGIFRAVL--KADPSF-DEAPWPSLSPEAIDFVKRLL- 393
WS+GVI Y +L G PF + +R ++ K F DE P LSPEA D +KRL
Sbjct: 223 WSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVP---LSPEAKDLIKRLCC 279
Query: 394 NKDYR-KRLTAAQALSHPW 411
+ R + SHP+
Sbjct: 280 EAERRLGNNGVNEIKSHPF 298
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 5e-22
Identities = 64/213 (30%), Positives = 101/213 (47%), Gaps = 10/213 (4%)
Query: 220 AYEDDDNIYIVMELCKGGELLDRILSRGGK-YSEEDAKIVMVQILSVVAFCHFQGVVHRD 278
AYE D + +V+ + GG+L I + G + EE A +IL + H + V+RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRD 127
Query: 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADM 337
LKPEN L ++ ++ D GL+ + E + VG+ Y+APEVL ++ Y D
Sbjct: 128 LKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDY 184
Query: 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDY 397
W +G + Y ++ G PF R E V + +E S EA K LL KD
Sbjct: 185 WGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDP 244
Query: 398 RKRL-----TAAQALSHPWLANSHDVKIPSDMI 425
++RL A + HP+ N + ++ + M+
Sbjct: 245 KQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGML 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 6e-22
Identities = 85/315 (26%), Positives = 132/315 (41%), Gaps = 67/315 (21%)
Query: 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCC 186
E++G G +G A+ K G+ VA+K I LD
Sbjct: 6 EKIGEGTYGVVYKARNKL---TGEVVALKKIR----------------------LDTETE 40
Query: 187 LFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRIL-- 244
+TAI RE+ +L+ L H N+V+ D ++ +Y+V E + L + +
Sbjct: 41 GVPSTAI------REISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLH--QDLKKFMDA 91
Query: 245 SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSD 304
S K + Q+L +AFCH V+HRDLKP+N L ++K DFGL+
Sbjct: 92 SPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLAR 148
Query: 305 -YVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTESG 361
+ P V + +Y APE+L + Y T D+WS+G I ++ F +E
Sbjct: 149 AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID 208
Query: 362 ----IFRAVLKAD----PSFDEAP--------W---------PSLSPEAIDFVKRLLNKD 396
IFR + D P P W P L + D + ++L+ D
Sbjct: 209 QLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYD 268
Query: 397 YRKRLTAAQALSHPW 411
KR++A AL+HP+
Sbjct: 269 PNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 7e-22
Identities = 86/334 (25%), Positives = 150/334 (44%), Gaps = 75/334 (22%)
Query: 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
Y ++VG G +G CSA ++ G VA+K +++ P
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRR---TGAKVAIK-----------KLYRPFQSE----- 55
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNI------YIVMELC 234
LF A RE+++L+ + H+N++ D + D ++ Y+VM
Sbjct: 56 ------LFAKRAY------RELRLLKHMK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM 102
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
G L +++ + K SE+ + ++ Q+L + + H G++HRDLKP N + E+
Sbjct: 103 --GTDLGKLM-KHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL---AVNEDCE 156
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCG-- 350
LK +DFGL+ D + V + +Y APEV+ Y D+WS+G I +L G
Sbjct: 157 LKILDFGLARQT--DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
Query: 351 ---------------------SRPFWARTESGIFRAVLKADPSFDEAPWPSL----SPEA 385
S+ F + +S + +K P F + + SL +P A
Sbjct: 215 LFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLA 274
Query: 386 IDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVK 419
++ ++++L D R+TAA+AL+HP+ HD +
Sbjct: 275 VNVLEKMLVLDAESRITAAEALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 8e-22
Identities = 66/221 (29%), Positives = 111/221 (50%), Gaps = 21/221 (9%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKI 257
E ++L L H +V+F+ ++ + D I+ E C+G +L ++ G SE
Sbjct: 52 EAQLLSKLD-HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCE 110
Query: 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL-NDIV 316
+Q+L V + H + ++HRDLK +N +N+ LK DFG+S + L
Sbjct: 111 WFIQLLLGVHYMHQRRILHRDLKAKNIFL----KNNLLKIGDFGVSRLLMGSCDLATTFT 166
Query: 317 GSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 375
G+ YY++PE L H+ Y +++D+WS+G I Y + C + F VL+ E
Sbjct: 167 GTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG---QNFLSVVLR----IVE 219
Query: 376 APWPSL----SPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
P PSL S + ++ +LNKD R +AA+ L +P++
Sbjct: 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 9e-22
Identities = 56/183 (30%), Positives = 96/183 (52%), Gaps = 12/183 (6%)
Query: 220 AYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279
A++D++N+Y+VM+ GG+LL + + E+ A+ + +++ + H G VHRD+
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDI 128
Query: 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR------SY 331
KP+N L ++N ++ DFG + D + N VG+ Y++PE+L Y
Sbjct: 129 KPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRY 185
Query: 332 GTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW-PSLSPEAIDFVK 390
G E D WS+GV Y +L G PF+A + + ++ F P +S EA D ++
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIR 245
Query: 391 RLL 393
RL+
Sbjct: 246 RLI 248
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 72/250 (28%), Positives = 110/250 (44%), Gaps = 43/250 (17%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDN-----IYIVMELCKGGELLDRILSRGGKYS--- 251
RE+ +L+ L+ +V+ D ++ +Y+V E +L + S G
Sbjct: 49 REISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPL 107
Query: 252 -EEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVKPD 309
+ K M Q+L VA CH GV+HRDLKP+N L ++ LK D GL + P
Sbjct: 108 PAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV--DKQKGLLKIADLGLGRAFSIPV 165
Query: 310 ERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTES----GIF 363
+ + + +Y APEVL Y T D+WS+G I + F +E IF
Sbjct: 166 KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225
Query: 364 RAVLKADPSFDEAP-------W---------------PSLSPEAIDFVKRLLNKDYRKRL 401
+ L P+ P W P LSPE +D ++++L D KR+
Sbjct: 226 K--LLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI 283
Query: 402 TAAQALSHPW 411
+A AL+HP+
Sbjct: 284 SAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-21
Identities = 59/194 (30%), Positives = 101/194 (52%), Gaps = 10/194 (5%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273
L Q + ++ D +Y VME GG+L+ I + GK+ E A +I + F H +G
Sbjct: 63 LTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 274 VVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPDERLNDIVGSAYYVAPEVL-HRSY 331
+++RDLK +N + S+ +K DFG+ +++ G+ Y+APE++ ++ Y
Sbjct: 122 IIYRDLKLDNVMLDSE---GHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY 178
Query: 332 GTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKR 391
G D W+ GV+ Y +L G PF E +F+++++ + S+ + SLS EA+ K
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK----SLSKEAVSICKG 234
Query: 392 LLNKDYRKRLTAAQ 405
L+ K KRL
Sbjct: 235 LMTKHPSKRLGCGP 248
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 62/219 (28%), Positives = 109/219 (49%), Gaps = 12/219 (5%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGK---YSE 252
ED E++IL ++ H N++ + +A+ D + + IVME G+L I R K E
Sbjct: 44 EDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE 102
Query: 253 EDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL 312
++ + +Q+L + H Q ++HRDLK N L + N +K D G+S +K
Sbjct: 103 QEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA---NDLVKIGDLGISKVLK-KNMA 158
Query: 313 NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 371
+G+ +Y+APEV R Y ++D+WS+G + Y + + PF AR+ + V +
Sbjct: 159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG-- 216
Query: 372 SFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
+ P P S + +F++ +L + R + L+ P
Sbjct: 217 KYPPIP-PIYSQDLQNFIRSMLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 3e-21
Identities = 72/244 (29%), Positives = 109/244 (44%), Gaps = 38/244 (15%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM 259
REV +L+ L H N+V +D + + +V E +L + + G S + KI M
Sbjct: 52 REVSLLKNLK-HANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM 109
Query: 260 VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGS 318
Q+L +++CH + ++HRDLKP+N L K E LK DFGL+ P + ++ V +
Sbjct: 110 FQLLRGLSYCHKRKILHRDLKPQNLLINEKGE---LKLADFGLARAKSVPTKTYSNEVVT 166
Query: 319 AYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFWARTESG----IFRAVLKADPS 372
+Y P+VL S Y T DMW +G I Y + G F T IFR L P+
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR--LLGTPT 224
Query: 373 FDEAPW------------------------PSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
+ P P L + ID + LL + + R++A AL
Sbjct: 225 EETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284
Query: 409 HPWL 412
H +
Sbjct: 285 HSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 78/258 (30%), Positives = 124/258 (48%), Gaps = 51/258 (19%)
Query: 190 TTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMEL--CKGGELLDRILSRG 247
+TAI RE+ +L+ L H N+V D + +Y++ E + LD +
Sbjct: 44 STAI------REISLLKELQ-HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PK 94
Query: 248 GKYSE-EDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV 306
G+Y + E K + QIL + FCH + V+HRDLKP+N L +K +K DFGL+
Sbjct: 95 GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNK---GVIKLADFGLARAF 151
Query: 307 KPDERL--NDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRP-FWARTESG 361
R+ +++V + +Y APEVL S Y T D+WSIG I + + +P F +E
Sbjct: 152 GIPVRVYTHEVV-TLWYRAPEVLLGSPRYSTPVDIWSIGTI-FAEMATKKPLFHGDSEID 209
Query: 362 ----IFRAVLKADPSFDEAP--------------W---------PSLSPEAIDFVKRLLN 394
IFR + P+ D P W +L + +D ++++L
Sbjct: 210 QLFRIFRIL--GTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLI 267
Query: 395 KDYRKRLTAAQALSHPWL 412
D KR++A +AL+HP+
Sbjct: 268 YDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 78/277 (28%), Positives = 123/277 (44%), Gaps = 40/277 (14%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G+G FG AK K G AVKV+ K + K +NH
Sbjct: 3 IGKGSFGKVLLAKRKS---DGSFYAVKVLQKKT------ILKKKEQNH------------ 41
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+ E +L H LV + +++ + +Y V++ GGEL L R
Sbjct: 42 ---------IMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFH-LQRER 91
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVK 307
+ E A+ ++ S + + H +++RDLKPEN L S+ + DFGL + V+
Sbjct: 92 CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFGLCKEGVE 148
Query: 308 PDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366
P+E + G+ Y+APEVL + Y D W +G + Y +L G PF++R S ++ +
Sbjct: 149 PEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNI 208
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA 403
L + A D + LL+KD R+RL A
Sbjct: 209 LHKPLQLP----GGKTVAACDLLVGLLHKDQRRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 3e-21
Identities = 65/220 (29%), Positives = 110/220 (50%), Gaps = 9/220 (4%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI-LSRGGKYSEED 254
E ++EV IL A H N+V F+ +++++ ++IVME C GG+L+ RI RG +SE+
Sbjct: 44 EASKKEV-ILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ 102
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL-N 313
VQI + H + ++HRD+K +N + + L DFG++ + L
Sbjct: 103 ILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLG--DFGIARQLNDSMELAY 160
Query: 314 DIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 372
VG+ YY++PE+ +R Y + D+WS+G + Y L PF + + + VLK
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF---EGNNLHQLVLKICQG 217
Query: 373 FDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+ P+ S + + +L R R + L P+L
Sbjct: 218 YFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 6e-21
Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 11/223 (4%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
+E +R+E++++ L H ++++ A +D + + +E GG + +LS+ G + E
Sbjct: 47 VEALRKEIRLMARLN-HPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYGAFKEAV 104
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-----SDYVKPD 309
Q+L +++ H ++HRD+K N L S + L+ DFG +
Sbjct: 105 IINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAG 162
Query: 310 ERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
E ++G+ ++APEVL YG D+WS+G + + P+ A S + K
Sbjct: 163 EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222
Query: 369 ADPSFDEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
+ P LSP D R L R + + L HP
Sbjct: 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 6e-21
Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 10/208 (4%)
Query: 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKI 257
+ E +L H LV + +++ D +Y V++ GGEL L R + E A+
Sbjct: 42 IMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYH-LQRERCFLEPRARF 100
Query: 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPDERLNDIV 316
+I S + + H +V+RDLKPEN L S+ + DFGL + ++ + +
Sbjct: 101 YAAEIASALGYLHSLNIVYRDLKPENILLDSQ---GHIVLTDFGLCKENIEHNGTTSTFC 157
Query: 317 GSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 375
G+ Y+APEVLH+ Y D W +G + Y +L G PF++R + ++ +L
Sbjct: 158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK- 216
Query: 376 APWPSLSPEAIDFVKRLLNKDYRKRLTA 403
P+++ A ++ LL KD KRL A
Sbjct: 217 ---PNITNSARHLLEGLLQKDRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 8e-21
Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 11/220 (5%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
IED+++E+ +L + + ++Y +Y D ++I+ME GG LD L G E
Sbjct: 46 IEDIQQEITVL-SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD--LLEPGPLDETQ 102
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLN 313
++ +IL + + H + +HRD+K N L + E+ +K DFG++ + + + N
Sbjct: 103 IATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRN 159
Query: 314 DIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 372
VG+ +++APEV+ +S Y ++AD+WS+G+ A L G P + + K +P
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP 219
Query: 373 FDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
E + S +FV+ LNK+ R TA + L H ++
Sbjct: 220 TLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 1e-20
Identities = 77/262 (29%), Positives = 117/262 (44%), Gaps = 59/262 (22%)
Query: 191 TAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---- 246
TAI RE +L+ L H N+V +D + +V E LD L +
Sbjct: 49 TAI------REASLLKDLK-HANIVTLHDIIHTKKTLTLVFEY------LDTDLKQYMDD 95
Query: 247 -GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305
GG S + ++ + Q+L +A+CH + V+HRDLKP+N L + + E LK DFGL+
Sbjct: 96 CGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLAR- 151
Query: 306 VK--PDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFWARTESG 361
K P + ++ V + +Y P+VL S Y T DMW +G I Y + G F T+
Sbjct: 152 AKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211
Query: 362 -----IFRAVLKADPSFDEAP------------------------WPSLS--PEAIDFVK 390
IFR VL P+ + P P L P +
Sbjct: 212 DQLHKIFR-VL-GTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELAL 269
Query: 391 RLLNKDYRKRLTAAQALSHPWL 412
+ L + +KR++AA+A+ HP+
Sbjct: 270 KFLQYEPKKRISAAEAMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 64/237 (27%), Positives = 114/237 (48%), Gaps = 25/237 (10%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
I+ V+ E + + H LV + ++ + ++ V+E GG+L+ + R K EE
Sbjct: 39 IDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQRKLPEEH 97
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPDERLN 313
A+ +I + + H +G+++RDLK +N L S+ +K D+G+ + ++P + +
Sbjct: 98 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE---GHIKLTDYGMCKEGLRPGDTTS 154
Query: 314 DIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPF---------WARTESGIF 363
G+ Y+APE+L YG D W++GV+ + ++ G PF TE +F
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF 214
Query: 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA------AQALSHPWLAN 414
+ +L+ SLS +A +K LNKD ++RL A HP+ N
Sbjct: 215 QVILEKQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 1e-20
Identities = 67/224 (29%), Positives = 116/224 (51%), Gaps = 19/224 (8%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
IED+++E+ +L + + ++Y +Y ++I+ME GG LD L R G + E
Sbjct: 46 IEDIQQEITVL-SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD--LLRAGPFDEFQ 102
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLN 313
++ +IL + + H + +HRD+K N L + E +K DFG++ + + + N
Sbjct: 103 IATMLKEILKGLDYLHSEKKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN 159
Query: 314 DIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 372
VG+ +++APEV+ +S Y ++AD+WS+G+ A L G P ++ R VL P
Sbjct: 160 TFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP---NSDMHPMR-VLFLIPK 215
Query: 373 FDEAPWPSLSPEAI----DFVKRLLNKDYRKRLTAAQALSHPWL 412
P+L+ E +F+ LNKD R TA + L H ++
Sbjct: 216 N---NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 2e-20
Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 24/214 (11%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED----AKIVMVQILSVVAFC 269
+V FY A+ + +Y+ ME G L D++ + G +I + +
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119
Query: 270 HFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVKPDERLNDIVGSAYYVAPEVLH 328
++HRD+KP N L N +K DFG+S + V + N +G Y+APE +
Sbjct: 120 EEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLVASLAKTN--IGCQSYMAPERIK 174
Query: 329 R-------SYGTEADMWSIGVIAYILLCGSRPFWARTESGIF---RAVLKADPSFDEAPW 378
+Y ++D+WS+G+ + G P+ T + IF A++ DP P
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPP--TLP- 231
Query: 379 PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
S +A DFV + LNK +R T AQ L HPWL
Sbjct: 232 SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-20
Identities = 74/249 (29%), Positives = 114/249 (45%), Gaps = 48/249 (19%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-----GGKYSEED 254
REV +L+ L H N+V +D D ++ +V E LD+ L + G S +
Sbjct: 53 REVSLLKDLK-HANIVTLHDIVHTDKSLTLVFEY------LDKDLKQYMDDCGNIMSMHN 105
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLN 313
KI + QIL +A+CH + V+HRDLKP+N L + E LK DFGL+ P + +
Sbjct: 106 VKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYS 162
Query: 314 DIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFWARTESG----IFRAVL 367
+ V + +Y P+VL S Y T+ DMW +G I + + G F T IFR L
Sbjct: 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR--L 220
Query: 368 KADPSFDEAPW------------------------PSLSPEAIDFVKRLLNKDYRKRLTA 403
P+ + P P L E I+ + + L + +KR++A
Sbjct: 221 LGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISA 280
Query: 404 AQALSHPWL 412
+A+ H +
Sbjct: 281 EEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 2e-20
Identities = 65/220 (29%), Positives = 112/220 (50%), Gaps = 11/220 (5%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
IED+++E+ +L + + ++Y +Y ++I+ME GG LD L + G E
Sbjct: 46 IEDIQQEITVL-SQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD--LLKPGPLEETY 102
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLN 313
++ +IL + + H + +HRD+K N L + E +K DFG++ + + + N
Sbjct: 103 IATILREILKGLDYLHSERKIHRDIKAANVLLS---EQGDVKLADFGVAGQLTDTQIKRN 159
Query: 314 DIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS 372
VG+ +++APEV+ +S Y +AD+WS+G+ A L G P + + K P
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP 219
Query: 373 FDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
E + S +FV+ LNKD R R TA + L H ++
Sbjct: 220 TLEGQY---SKPFKEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 59/195 (30%), Positives = 103/195 (52%), Gaps = 20/195 (10%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273
L Q + ++ D +Y VME GG+L+ +I + G++ E A +I + F H +G
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQI-QQVGRFKEPHAVFYAAEIAIGLFFLHSKG 121
Query: 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIV------GSAYYVAPEVL 327
+++RDLK +N + S+ +K DFG+ E + D V G+ Y+APE++
Sbjct: 122 IIYRDLKLDNVMLDSE---GHIKIADFGMCK-----ENMWDGVTTKTFCGTPDYIAPEII 173
Query: 328 -HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAI 386
++ YG D W+ GV+ Y +L G PF E +F+++++ + ++ + S+S EA+
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK----SMSKEAV 229
Query: 387 DFVKRLLNKDYRKRL 401
K L+ K KRL
Sbjct: 230 AICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 6e-20
Identities = 55/163 (33%), Positives = 89/163 (54%), Gaps = 16/163 (9%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273
+VQ + A++DD +Y+VME GG+L++ L E+ AK +++ + H G
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVN--LMSNYDVPEKWAKFYTAEVVLALDAIHSMG 162
Query: 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLHR 329
++HRD+KP+N L +++ LK DFG +K DE R + VG+ Y++PEVL
Sbjct: 163 LIHRDVKPDNMLL---DKHGHLKLADFGTC--MKMDETGMVRCDTAVGTPDYISPEVLKS 217
Query: 330 S-----YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVL 367
YG E D WS+GV + +L G PF+A + G + ++
Sbjct: 218 QGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 7e-20
Identities = 67/253 (26%), Positives = 124/253 (49%), Gaps = 44/253 (17%)
Query: 200 REVKILRALTGHKNLVQFYDAY------EDDDNIYIVMELCKGGELLDRILSRGGKYSEE 253
RE+++L+ + H+N++ D + E+ + +Y+V L G L+ I+ + K S+E
Sbjct: 63 RELRLLKHMK-HENVIGLLDVFTPATSIENFNEVYLVTNLM--GADLNNIV-KCQKLSDE 118
Query: 254 DAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN 313
+ ++ Q+L + + H G++HRDLKP N + E+ L+ +DFGL+ + D+ +
Sbjct: 119 HVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRILDFGLAR--QADDEMT 173
Query: 314 DIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCG--------------------- 350
V + +Y APE++ Y D+WS+G I LL G
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG 233
Query: 351 --SRPFWARTESGIFRAVLKADPSFDEAPWPSL----SPEAIDFVKRLLNKDYRKRLTAA 404
S + S R +++ P + + +P AID ++++L D KR++A+
Sbjct: 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISAS 293
Query: 405 QALSHPWLANSHD 417
+AL+HP+ + HD
Sbjct: 294 EALAHPYFSQYHD 306
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 8e-20
Identities = 70/217 (32%), Positives = 107/217 (49%), Gaps = 16/217 (7%)
Query: 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGK---YSEEDA 255
R E+ L A H +V+ +D ++ DD + ++ME GG+L +I R + + E +
Sbjct: 113 RSELHCLAACD-HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEV 171
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPEN-FLFTSKEENSSLKAIDFGLSDYVKPDERLN- 313
++ QI+ + H + ++HRDLK N FL + +K DFG S L+
Sbjct: 172 GLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT----GIIKLGDFGFSKQYSDSVSLDV 227
Query: 314 --DIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 370
G+ YY+APE+ R Y +ADMWS+GVI Y LL RPF ++ I + VL
Sbjct: 228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGK 287
Query: 371 PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407
+D P P +S + LL+K+ R T Q L
Sbjct: 288 --YDPFPCP-VSSGMKALLDPLLSKNPALRPTTQQLL 321
|
Length = 478 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 9e-20
Identities = 78/258 (30%), Positives = 117/258 (45%), Gaps = 45/258 (17%)
Query: 193 IAIEDVRREVKILRALTGHKNLVQFYDAYEDDD-----NIYIVMELCKGGELLDRILSRG 247
++ + V RE+K+L H N++ D + IY+V EL + L +I+
Sbjct: 41 VSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEIYVVTELMQSD--LHKIIVSP 97
Query: 248 GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK 307
S + K+ + QIL + + H G++HRD+KP N L S N LK DFGL+ +
Sbjct: 98 QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNS---NCVLKICDFGLARVEE 154
Query: 308 PDERLNDI--VGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWART----- 358
PDE + V + YY APE+L R Y + D+WS+G I LL F A++
Sbjct: 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214
Query: 359 ----------------------ESGIFRAVLKADPSFDEAPWPS--LSPEAIDFVKRLLN 394
+ I R K PS S + EA+ + R+L
Sbjct: 215 DLITDLLGTPSLEAMRSACEGARAHILRGPHKP-PSLPVLYTLSSQATHEAVHLLCRMLV 273
Query: 395 KDYRKRLTAAQALSHPWL 412
D KR++AA AL+HP+L
Sbjct: 274 FDPDKRISAADALAHPYL 291
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 9e-20
Identities = 66/247 (26%), Positives = 111/247 (44%), Gaps = 44/247 (17%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-----GGKYSEED 254
REV +L+ L H N+V +D + ++ +V E LD+ L + G + +
Sbjct: 53 REVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEY------LDKDLKQYLDDCGNSINMHN 105
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLN 313
K+ + Q+L + +CH + V+HRDLKP+N L + E LK DFGL+ P + +
Sbjct: 106 VKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSIPTKTYS 162
Query: 314 DIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 371
+ V + +Y P++L S Y T+ DMW +G I Y + G F T + +
Sbjct: 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILG 222
Query: 372 SFDEAPWPS--------------------------LSPEAIDFVKRLLNKDYRKRLTAAQ 405
+ E WP L + + + +LL + RKR++A +
Sbjct: 223 TPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE 282
Query: 406 ALSHPWL 412
A+ HP+
Sbjct: 283 AMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 60/185 (32%), Positives = 94/185 (50%), Gaps = 7/185 (3%)
Query: 220 AYEDDDNIYIVMELCKGGELLDRILSRGGK-YSEEDAKIVMVQILSVVAFCHFQGVVHRD 278
A+E D++ +VM L GG+L I + G + E A QI+ + H + +V+RD
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120
Query: 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADM 337
LKPEN L +++ +++ D GL+ +K +++ G+ Y+APEVL Y D
Sbjct: 121 LKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDW 177
Query: 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP-SLSPEAIDFVKRLLNKD 396
+++G Y ++ G PF R E + + LK +P SPEA D + LL KD
Sbjct: 178 FALGCTLYEMIAGRSPFRQRKEK-VEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236
Query: 397 YRKRL 401
KRL
Sbjct: 237 PEKRL 241
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 77/277 (27%), Positives = 126/277 (45%), Gaps = 40/277 (14%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G+G FG AK K G+ AVKV+ K + + Q I+ E L
Sbjct: 3 IGKGSFGKVLLAKHK---ADGKFYAVKVLQKKAIL---------KKKEQKHIMAERNVL- 49
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+++V+ H LV + +++ D +Y V++ GGEL L R
Sbjct: 50 ------LKNVK-----------HPFLVGLHYSFQTADKLYFVLDYVNGGELFFH-LQRER 91
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVK 307
+ E A+ +I S + + H +++RDLKPEN L S+ + DFGL + ++
Sbjct: 92 SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ---GHVVLTDFGLCKEGIE 148
Query: 308 PDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366
+ + G+ Y+APEVL + Y D W +G + Y +L G PF++R + ++ +
Sbjct: 149 HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNI 208
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA 403
L P++S A ++ LL KD KRL A
Sbjct: 209 LNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 58/216 (26%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
I+ V+ E + + + LV + ++ +++V+E GG+L+ + R K EE
Sbjct: 39 IDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFH-MQRQRKLPEEH 97
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPDERLN 313
A+ +I + F H +G+++RDLK +N L + + +K D+G+ + + P + +
Sbjct: 98 ARFYAAEICIALNFLHERGIIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTS 154
Query: 314 DIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPF-------WARTESGIFRA 365
G+ Y+APE+L YG D W++GV+ + ++ G PF TE +F+
Sbjct: 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
Query: 366 VLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL 401
+L+ LS +A +K LNKD ++RL
Sbjct: 215 ILEKPIRIPR----FLSVKASHVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-19
Identities = 66/204 (32%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 220 AYEDDDN------IYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCH 270
A +D N I +V++ G+L I SR + E +A ++ +Q+L V H
Sbjct: 101 AKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVH 160
Query: 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK---PDERLNDIVGSAYYVAPEVL 327
+ ++HRD+K N L S N +K DFG S D+ G+ YYVAPE+
Sbjct: 161 SKHMIHRDIKSANILLCS---NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIW 217
Query: 328 HRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAI 386
R Y +ADM+S+GV+ Y LL RPF + L +D P PS+SPE
Sbjct: 218 RRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG--RYDPLP-PSISPEMQ 274
Query: 387 DFVKRLLNKDYRKRLTAAQALSHP 410
+ V LL+ D ++R ++++ L+ P
Sbjct: 275 EIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 1e-19
Identities = 66/214 (30%), Positives = 101/214 (47%), Gaps = 21/214 (9%)
Query: 211 HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMV--QILSVVAF 268
H+N+VQ+ + ++ I ME GG L + S+ G + + I+ QIL + +
Sbjct: 64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKY 123
Query: 269 CHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIV----GSAYYVAP 324
H +VHRD+K +N L + + +K DFG S K +N G+ Y+AP
Sbjct: 124 LHDNQIVHRDIKGDNVLVNTY--SGVVKISDFGTS---KRLAGINPCTETFTGTLQYMAP 178
Query: 325 EVLH---RSYGTEADMWSIGVIAYILLCGSRPFW--ARTESGIFR-AVLKADPSFDEAPW 378
EV+ R YG AD+WS+G + G PF ++ +F+ + K P E
Sbjct: 179 EVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPE--- 235
Query: 379 PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
SLS EA +F+ R D KR +A L P+L
Sbjct: 236 -SLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-19
Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 13/200 (6%)
Query: 220 AYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279
+++ + +Y+V+ GGEL L R G++ A+ ++L + H V++RDL
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHH-LQREGRFDLSRARFYTAELLCALENLHKFNVIYRDL 119
Query: 280 KPENFLFTSKEENSSLKAIDFGLSDY-VKPDERLNDIVGSAYYVAPEVLH-RSYGTEADM 337
KPEN L + + DFGL +K D++ N G+ Y+APE+L Y D
Sbjct: 120 KPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDW 176
Query: 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDY 397
W++GV+ Y +L G PF+ + ++R +L+ F + +A D + LL++D
Sbjct: 177 WTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD----GFDRDAKDLLIGLLSRDP 232
Query: 398 RKRL---TAAQALSHPWLAN 414
+RL A + +HP+ +
Sbjct: 233 TRRLGYNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 2e-19
Identities = 54/174 (31%), Positives = 90/174 (51%), Gaps = 12/174 (6%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMV 260
E + + A +VQ + A++DD +Y+VME GG+L++ L E+ A+
Sbjct: 92 EERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN--LMSNYDVPEKWARFYTA 149
Query: 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGS 318
+++ + H G +HRD+KP+N L +++ LK DFG + + R + VG+
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 206
Query: 319 AYYVAPEVLHRS-----YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVL 367
Y++PEVL YG E D WS+GV Y +L G PF+A + G + ++
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 54/190 (28%), Positives = 97/190 (51%), Gaps = 10/190 (5%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273
L Y ++ ++++ VME GG+L+ I +G ++ A +I+ + F H +G
Sbjct: 58 LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSKG 116
Query: 274 VVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPDERLNDIVGSAYYVAPEVLH-RSY 331
+++RDLK +N + + + +K DFG+ + V D R + G+ Y+APE+L Y
Sbjct: 117 IIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY 173
Query: 332 GTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKR 391
D WS GV+ Y +L G PF E +F ++ P + W ++ E+ D +++
Sbjct: 174 TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--W--ITKESKDILEK 229
Query: 392 LLNKDYRKRL 401
L +D +RL
Sbjct: 230 LFERDPTRRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 2e-19
Identities = 77/277 (27%), Positives = 120/277 (43%), Gaps = 40/277 (14%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G+G FG AK K L G+ AVKV+ K I V K + H
Sbjct: 3 IGKGSFGKVLLAKRK---LDGKCYAVKVLQKKI------VLNRKEQKH------------ 41
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+ E +L H LV + +++ + +Y V++ GGEL L R
Sbjct: 42 ---------IMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFH-LQRER 91
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVK 307
+ E A+ +I S + + H +V+RDLKPEN L S+ + DFGL + +
Sbjct: 92 SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ---GHVVLTDFGLCKEGIA 148
Query: 308 PDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366
+ G+ Y+APEV+ + Y D W +G + Y +L G PF+ R + ++ +
Sbjct: 149 QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI 208
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA 403
L P S A ++ LL KD ++RL A
Sbjct: 209 LHKPLVLR----PGASLTAWSILEELLEKDRQRRLGA 241
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-19
Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 14/219 (6%)
Query: 199 RREVKILRALTGHKNLVQFYDAYE-DDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKI 257
RRE + L H N+V D+ E ++ V E G L + L+ G +
Sbjct: 26 RRETALCARLY-HPNIVALLDSGEAPPGLLFAVFEYVPGRTLREV-LAADGALPAGETGR 83
Query: 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG----LSDYVKPDE--- 310
+M+Q+L +A H QG+VHRDLKP+N + + K +DFG L D
Sbjct: 84 LMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATL 143
Query: 311 -RLNDIVGSAYYVAPEVLHRSYGT-EADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK 368
R +++G+ Y APE L T +D+++ G+I L G R + + I L
Sbjct: 144 TRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEILYQQLS 203
Query: 369 ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407
PW + P +++ LNKD R+R +A AL
Sbjct: 204 PVD-VSLPPWIAGHPLG-QVLRKALNKDPRQRAASAPAL 240
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-19
Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 59/281 (20%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
+ V+ E IL A ++ +V+ Y +++D DN+Y VM+ GG+++ +L R + E
Sbjct: 45 VAHVKAERDIL-AEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMS-LLIRMEVFPEVL 102
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL------------ 302
A+ + ++ + H G +HRD+KP+N L + + +K DFGL
Sbjct: 103 ARFYIAELTLAIESVHKMGFIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKY 159
Query: 303 --------SDYVKPDERLNDI----------------------------VGSAYYVAPEV 326
D ++P + +D+ VG+ Y+APEV
Sbjct: 160 YQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219
Query: 327 LHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEA 385
L R Y D WS+GVI + +L G PF A T + V+ + + P LSPEA
Sbjct: 220 LLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEA 279
Query: 386 IDFVKRLL--NKDYRKRLTAAQALSHPWLANSHDVKIPSDM 424
+D + +L ++ R A +HP+ +V SD+
Sbjct: 280 VDLITKLCCSAEERLGRNGADDIKAHPFF---SEVDFSSDI 317
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 34/219 (15%)
Query: 212 KNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED--AKIVMVQILSVVAFC 269
+V+ Y + D +++I MEL LD++L R ED K+ +++V
Sbjct: 74 PYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMT----VAIVKAL 127
Query: 270 HF----QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPE 325
H+ GV+HRD+KP N L + + ++K DFG+S + + G A Y+APE
Sbjct: 128 HYLKEKHGVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPE 184
Query: 326 VL-----HRSYGTEADMWSIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDEAPWP 379
+ + Y AD+WS+G+ L G P+ +TE + +L+ +P P
Sbjct: 185 RIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-------P 237
Query: 380 SL------SPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
SL SP+ FV L KD+RKR + L HP++
Sbjct: 238 SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 59/219 (26%), Positives = 115/219 (52%), Gaps = 15/219 (6%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDN-IYIVMELCKGGELLDRILSRGGKYSEEDAKIV 258
+E ++L L H N+V + +++E +D +YIVM C+GG+L ++ + GK E+ +
Sbjct: 48 QEAQLLSQLK-HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVE 106
Query: 259 -MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIV 316
VQI + + H + ++HRDLK +N T + +K D G++ ++ + + ++
Sbjct: 107 WFVQIAMALQYLHEKHILHRDLKTQNVFLT---RTNIIKVGDLGIARVLENQCDMASTLI 163
Query: 317 GSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFD 374
G+ YY++PE+ ++ Y ++D+W++G Y + F A+ S ++R + P
Sbjct: 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP--- 220
Query: 375 EAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
P P SPE + + +L+K KR + L P++
Sbjct: 221 --PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 4e-19
Identities = 66/249 (26%), Positives = 106/249 (42%), Gaps = 47/249 (18%)
Query: 125 LGEEVGRGHFGYTCSAKAKKGSLKGQ-DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
+E+G G FG G +G+ DVA+K+I E
Sbjct: 8 FLKELGSGQFG-----VVHLGKWRGKIDVAIKMI---------------REG-------- 39
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
A++ +D E K++ L+ H NLVQ Y I+IV E G LL+ +
Sbjct: 40 --------AMSEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYL 90
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
R GK E + + + + G +HRDL N L E++ +K DFGL+
Sbjct: 91 RERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLA 147
Query: 304 DYVKPDERLNDIVGSAYYV---APEVLHRS-YGTEADMWSIGVIAY-ILLCGSRPFWART 358
YV D+ + G+ + V PEV S + +++D+WS GV+ + + G P+ +
Sbjct: 148 RYVLDDQYTSS-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS 206
Query: 359 ESGIFRAVL 367
S + +V
Sbjct: 207 NSEVVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 86.7 bits (214), Expect = 4e-19
Identities = 63/219 (28%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 201 EVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIV 258
E+++L+ L H+ +VQ+Y D + + I ME GG + D++ + G +E +
Sbjct: 54 EIQLLKNLQ-HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA-LTESVTRKY 111
Query: 259 MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK----PDERLND 314
QIL +++ H +VHRD+K N L ++ ++K DFG S ++ +
Sbjct: 112 TRQILEGMSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTGIRS 168
Query: 315 IVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 373
+ G+ Y+++PEV+ YG +AD+WS+G +L +P WA E+ A+ K
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLT-EKPPWAEYEA--MAAIFKIATQP 225
Query: 374 DEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
PS +S A DF+ + + R R +A + L HP+
Sbjct: 226 TNPQLPSHISEHARDFLGCIF-VEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 70/229 (30%), Positives = 106/229 (46%), Gaps = 26/229 (11%)
Query: 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAK 256
V ++ I+ H N+V ++ +Y D ++I ME C GG L D I G SE
Sbjct: 51 AVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGPLSESQIA 109
Query: 257 IVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDI 315
V + L + + H +G +HRD+K N L T +N +K DFG+S + +
Sbjct: 110 YVSRETLQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSF 166
Query: 316 VGSAYYVAPEV--LHRS--YGTEADMWSIGVIAYIL---------LCGSRPFWARTESGI 362
+G+ Y++APEV + R Y D+W++G+ A L L R + T+S
Sbjct: 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNF 226
Query: 363 FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
LK D+ W S FVK L K+ +KR TA + L HP+
Sbjct: 227 QPPKLK-----DKMKW---SNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 54/198 (27%), Positives = 102/198 (51%), Gaps = 13/198 (6%)
Query: 211 HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCH 270
++ + + A++D++N+Y+VM+ GG+LL + + E+ A+ + +++ + H
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119
Query: 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLND--IVGSAYYVAPEVLH 328
VHRD+KP+N L + N ++ DFG + D + VG+ Y++PE+L
Sbjct: 120 QLHYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176
Query: 329 R------SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD-EAPWPSL 381
YG E D WS+GV Y +L G PF+A + + ++ F A +
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDV 236
Query: 382 SPEAIDFVKRLL-NKDYR 398
S +A D ++RL+ ++++R
Sbjct: 237 SEDAKDLIRRLICSREHR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 6e-19
Identities = 55/192 (28%), Positives = 97/192 (50%), Gaps = 18/192 (9%)
Query: 220 AYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279
A++D++ +Y+VM+ GG+LL + + E+ A+ + +++ + H VHRD+
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDI 128
Query: 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLND--IVGSAYYVAPEVLHR------SY 331
KP+N L + N ++ DFG + D + VG+ Y++PE+L Y
Sbjct: 129 KPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY 185
Query: 332 GTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS----LSPEAID 387
G E D WS+GV Y +L G PF+A + + ++ + F +PS +S EA D
Sbjct: 186 GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSHITDVSEEAKD 242
Query: 388 FVKRLLNKDYRK 399
++RL+ R+
Sbjct: 243 LIQRLICSRERR 254
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 8e-19
Identities = 65/238 (27%), Positives = 108/238 (45%), Gaps = 22/238 (9%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG--GELLDRILSRGGKYSEE 253
+D+ +EV+ L+ L H N +++ Y + ++VME C G ++L+ + + E
Sbjct: 60 QDIIKEVRFLQQLR-HPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVE 116
Query: 254 DAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN 313
A I L +A+ H +HRD+K N L T E ++K DFG + V P N
Sbjct: 117 IAAICH-GALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSP---AN 169
Query: 314 DIVGSAYYVAPEVL----HRSYGTEADMWSIGVIAYILLCGSRP--FWARTESGIFRAVL 367
VG+ Y++APEV+ Y + D+WS+G I I L +P F S ++
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQ 228
Query: 368 KADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMI 425
P+ W S +FV L K + R ++ + L H ++ + D+I
Sbjct: 229 NDSPTLSSNDW---SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERPPTVIIDLI 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-18
Identities = 65/218 (29%), Positives = 112/218 (51%), Gaps = 19/218 (8%)
Query: 201 EVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIV 258
E+++L+ L H+ +VQ+Y D + + I ME GG + D++ S G +E +
Sbjct: 54 EIQLLKNLL-HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA-LTENVTRKY 111
Query: 259 MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK----PDERLND 314
QIL V++ H +VHRD+K N L ++ ++K DFG S ++ +
Sbjct: 112 TRQILEGVSYLHSNMIVHRDIKGANIL---RDSVGNVKLGDFGASKRLQTICLSGTGMKS 168
Query: 315 IVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADP 371
+ G+ Y+++PEV+ YG +AD+WS+G +L +P WA E + IF+ + P
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLT-EKPPWAEFEAMAAIFK--IATQP 225
Query: 372 SFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
+ P P +S DF+KR+ + + R +A + L H
Sbjct: 226 TNPVLP-PHVSDHCRDFLKRIF-VEAKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-18
Identities = 65/251 (25%), Positives = 107/251 (42%), Gaps = 55/251 (21%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273
+V Y +++D +Y++ME GG+L+ +L + +SE+ + M + + + H G
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMT-MLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121
Query: 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSD----------YVKPDER------------ 311
+HRD+KP+N L + +K DFGLS Y K +
Sbjct: 122 FIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178
Query: 312 --LNDI------------------------VGSAYYVAPEV-LHRSYGTEADMWSIGVIA 344
++ I VG+ Y+APE+ L + YG E D WS+G I
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238
Query: 345 YILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLL-NKDYR-KRLT 402
+ L G PF + +R ++ + LS EA D ++RL+ N + R R
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLITNAENRLGRGG 298
Query: 403 AAQALSHPWLA 413
A + SHP+
Sbjct: 299 AHEIKSHPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 90/348 (25%), Positives = 144/348 (41%), Gaps = 79/348 (22%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
Y++ E +G+G +G CSA + G+ VA+K I +F +H + IL
Sbjct: 2 YKIQEVIGKGSYGVVCSAI---DTHTGEKVAIKKIND----VF------EHVSDATRIL- 47
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD-----AYEDDDNIYIVMELCKGG 237
RE+K+LR L H ++V+ + + +IY+V EL +
Sbjct: 48 -----------------REIKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFELMESD 89
Query: 238 ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKA 297
L +++ + E + + Q+L + + H V HRDLKP+N L + + LK
Sbjct: 90 --LHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANA---DCKLKI 144
Query: 298 IDFGLSDYVKPDER----LNDIVGSAYYVAPEV---LHRSYGTEADMWSIGVIAYILLCG 350
DFGL+ D D V + +Y APE+ Y D+WSIG I +L G
Sbjct: 145 CDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG 204
Query: 351 SRPFW------------------------ARTESGIFRAVL----KADPSFDEAPWPSLS 382
+P + +R + R L K P +P+
Sbjct: 205 -KPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNAD 263
Query: 383 PEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDV-KIPSDMIVYKL 429
P A+ ++RLL D + R TA +AL+ P+ V + PS + KL
Sbjct: 264 PLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVEREPSAQPITKL 311
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 18/217 (8%)
Query: 220 AYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278
AYE D + +V+ L GG+L I + G + EE A +I + H + +V+RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRD 127
Query: 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADM 337
LKPEN L ++ ++ D GL+ + E + VG+ Y+APEV+ + Y D
Sbjct: 128 LKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDW 184
Query: 338 WSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLL 393
W +G + Y ++ G PF R E + R V + + E S A ++LL
Sbjct: 185 WGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE----KFSEAARSICRQLL 240
Query: 394 NKDYRKRL-----TAAQALSHPWLANSHDVKIPSDMI 425
KD RL A + +HP+ ++ ++ + M+
Sbjct: 241 TKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGML 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 87/344 (25%), Positives = 135/344 (39%), Gaps = 85/344 (24%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE+ +GRG +G AK K G G++ A+K K + Q+T +
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGK-DGKEYAIKKF--------------KGDKEQYTGIS 46
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN--IYIVMELCKGGELL 240
+A RE+ +LR L H+N+V + + + + +Y++ + + +L
Sbjct: 47 -------QSAC------REIALLRELK-HENVVSLVEVFLEHADKSVYLLFDYAEH-DLW 91
Query: 241 DRI----LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSK-EENSSL 295
I ++ K ++ QIL+ V + H V+HRDLKP N L + E +
Sbjct: 92 QIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVV 151
Query: 296 KAIDFGLSDYV----KPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLC 349
K D GL+ KP L+ +V + +Y APE+L R Y D+W+IG I LL
Sbjct: 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
Query: 350 GSRPFWARTES-------------GIFR-------------------AVLKADPSFDEAP 377
F R IF L D P
Sbjct: 212 LEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYP 271
Query: 378 WPSL----------SPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
SL + D +++LL D KR+TA +AL HP+
Sbjct: 272 SNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 9e-18
Identities = 67/264 (25%), Positives = 108/264 (40%), Gaps = 66/264 (25%)
Query: 200 REVKILRALTGHK----NLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
RE+K+L H+ +V FY A+ D I I ME GG LD++L + G+ E
Sbjct: 48 RELKVL-----HECNSPYIVGFYGAFYSDGEISICMEHMDGGS-LDQVLKKAGRIPE--- 98
Query: 256 KIVMVQILSVVAFCHFQG---------VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV 306
IL ++ +G ++HRD+KP N L S+ E +K DFG+S +
Sbjct: 99 -----NILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQL 150
Query: 307 KPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESG---I 362
D N VG+ Y++PE L + Y ++D+WS+G+ + G P +
Sbjct: 151 I-DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209
Query: 363 FRAVLKADPSFD--------------------------EAPWPSL-----SPEAIDFVKR 391
F + + + P P L S E DFV +
Sbjct: 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK 269
Query: 392 LLNKDYRKRLTAAQALSHPWLANS 415
L K+ ++R + HP++ +
Sbjct: 270 CLKKNPKERADLKELTKHPFIKRA 293
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 1e-17
Identities = 60/218 (27%), Positives = 109/218 (50%), Gaps = 19/218 (8%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
I+ V+ E + + H LV + ++ + ++ V+E GG+L+ + R K EE
Sbjct: 39 IDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFH-MQRQRKLPEEH 97
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL-SDYVKPDERLN 313
A+ +I + F H +G+++RDLK +N L ++ +K D+G+ + ++P + +
Sbjct: 98 ARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE---GHIKLTDYGMCKEGIRPGDTTS 154
Query: 314 DIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPF---------WARTESGIF 363
G+ Y+APE+L YG D W++GV+ + ++ G PF TE +F
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF 214
Query: 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL 401
+ +L+ SLS +A +K LNKD ++RL
Sbjct: 215 QVILEKQIRIPR----SLSVKASSVLKGFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 1e-17
Identities = 58/188 (30%), Positives = 98/188 (52%), Gaps = 16/188 (8%)
Query: 220 AYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279
A+ D + +++L GG+L LS+ G +SE + + +I+ + H + VV+RDL
Sbjct: 65 AFHTPDKLSFILDLMNGGDL-HYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDL 123
Query: 280 KPENFLFTSKEENSSLKAIDFGLS-DYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEAD 336
KP N L +E+ ++ D GL+ D+ K ++ + VG+ Y+APEVL + +Y + AD
Sbjct: 124 KPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGVAYDSSAD 178
Query: 337 MWSIGVIAYILLCGSRPF---WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLL 393
+S+G + + LL G PF + + I R L + S SPE ++ LL
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD----SFSPELRSLLEGLL 234
Query: 394 NKDYRKRL 401
+D +RL
Sbjct: 235 QRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 52/178 (29%), Positives = 94/178 (52%), Gaps = 19/178 (10%)
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
M A A +D +E+ +L+ L H N++++ D++ +D+ + IV+EL G+L I
Sbjct: 40 MMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIVLELADAGDLSQMI----- 93
Query: 249 KYSEEDAKIV--------MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
KY ++ +++ VQ+ S V H + V+HRD+KP N T+ +K D
Sbjct: 94 KYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV---VKLGDL 150
Query: 301 GLSDYVKPDER-LNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWA 356
GL + + +VG+ YY++PE +H + Y ++D+WS+G + Y + PF+
Sbjct: 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 27/226 (11%)
Query: 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKI 257
+++E+ +++ H N+V ++ +Y + ++I ME C GG L D I G SE
Sbjct: 53 IQQEIFMVKECK-HCNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGPLSELQIAY 110
Query: 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIV 316
V + L +A+ H +G +HRD+K N L T +N +K DFG++ + + +
Sbjct: 111 VCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFI 167
Query: 317 GSAYYVAPEVL----HRSYGTEADMWSIGVIAYIL---------LCGSRPFWARTESGIF 363
G+ Y++APEV + Y D+W++G+ A L L R + ++S
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ 227
Query: 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
LK D+ W S +FVK L K+ +KR TA + L+H
Sbjct: 228 PPKLK-----DKTKW---SSTFHNFVKISLTKNPKKRPTAERLLTH 265
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 5e-17
Identities = 70/243 (28%), Positives = 106/243 (43%), Gaps = 38/243 (15%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDN--IYIVMELCKGGELLDRILSRGGKYSEEDAKI 257
RE++ LR L+ H N+++ + D + +V EL L + I R E+ K
Sbjct: 46 REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKS 104
Query: 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG--LSDYVKPDERLNDI 315
M Q+L + H G+ HRD+KPEN L LK DFG Y KP +
Sbjct: 105 YMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI----LKLADFGSCRGIYSKPP--YTEY 158
Query: 316 VGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFWARTE----SGI------- 362
+ + +Y APE L YG + D+W++G + + +L F E + I
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTP 218
Query: 363 -------FRAVLKADPSF-----DEAPW--PSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
FR + +F P+ S E +D +K+LL D +R+TA QAL
Sbjct: 219 DAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278
Query: 409 HPW 411
HP+
Sbjct: 279 HPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 5e-17
Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 10/198 (5%)
Query: 220 AYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278
AYE D + +V+ L GG+L I G + E A +I + H + +V+RD
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRD 127
Query: 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADM 337
LKPEN L +++ ++ D GL+ +V + + VG+ Y+APEV+ + Y D
Sbjct: 128 LKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDW 184
Query: 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDY 397
W++G + Y ++ G PF R + V + E SP+A K LL KD
Sbjct: 185 WALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDP 244
Query: 398 RKRL-----TAAQALSHP 410
++RL A + HP
Sbjct: 245 KERLGCQGGGAREVKEHP 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 6e-17
Identities = 67/258 (25%), Positives = 109/258 (42%), Gaps = 46/258 (17%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
+ +R E IL G + FY +++D N+Y++ME GG+++ +L + SEE
Sbjct: 45 VAHIRAERDILVEADGAWVVKMFY-SFQDKRNLYLIMEFLPGGDMMT-LLMKKDTLSEEA 102
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN- 313
+ + + + + H G +HRD+KP+N L +K +K DFGL +K R
Sbjct: 103 TQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAK---GHVKLSDFGLCTGLKKAHRTEF 159
Query: 314 -----------------------------------DIVGSAYYVAPEVLHRS-YGTEADM 337
VG+ Y+APEV ++ Y D
Sbjct: 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDW 219
Query: 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDY 397
WS+GVI Y +L G PF + T +R V+ + P +S +A D + R D
Sbjct: 220 WSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DS 278
Query: 398 RKRLTAA---QALSHPWL 412
R+ + + SHP+
Sbjct: 279 ENRIGSNGVEEIKSHPFF 296
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 6e-17
Identities = 62/224 (27%), Positives = 110/224 (49%), Gaps = 23/224 (10%)
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+ A A D +E+ +L+ L H N++++Y ++ +D+ + IV+EL G+L SR
Sbjct: 40 LMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDL-----SRMI 93
Query: 249 KYSEEDAKIV--------MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
K+ ++ +++ VQ+ S + H + V+HRD+KP N T+ +K D
Sbjct: 94 KHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---TGVVKLGDL 150
Query: 301 GLSDYVKPDER-LNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWART 358
GL + + +VG+ YY++PE +H + Y ++D+WS+G + Y + PF+
Sbjct: 151 GLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210
Query: 359 ESGIFRAVLKADPSFDEAPWPS--LSPEAIDFVKRLLNKDYRKR 400
+ ++ K D P PS S E V +N D KR
Sbjct: 211 MN--LYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 6e-17
Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 37/240 (15%)
Query: 194 AIEDVRREVKILRALTGHKN-----LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
A VR++ ILR L +V FY A+ +++NI + ME G L DRI +GG
Sbjct: 42 AKSSVRKQ--ILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGG 98
Query: 249 KYSEEDAKIVMVQILSVVAFCHF-QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK 307
E + V ++ + + + ++HRD+KP N L S+ + +K DFG+S
Sbjct: 99 PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVS---- 151
Query: 308 PDERLNDI----VGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTES-- 360
E +N I VG++ Y++PE + Y ++D+WS+G+ L G PF
Sbjct: 152 -GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210
Query: 361 ------GIF----RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
GI + V + P + +P + DFV L KD +R T Q + P
Sbjct: 211 GQDDPMGILDLLQQIVQEPPPRLPSSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMP 267
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 7e-17
Identities = 80/300 (26%), Positives = 137/300 (45%), Gaps = 51/300 (17%)
Query: 122 HYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
++ LG+ +GRG FG Y C + G+++AVK +P
Sbjct: 3 NWRLGKLLGRGAFGEVYLCY-----DADTGRELAVKQVP--------------------- 36
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGG 237
D T+ + + E+++L+ L H +VQ+Y D + + I +E GG
Sbjct: 37 -FDPDS---QETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKKLSIFVEYMPGG 91
Query: 238 ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKA 297
+ D+ L G +E + QIL V++ H +VHRD+K N L ++ ++K
Sbjct: 92 SIKDQ-LKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANIL---RDSAGNVKL 147
Query: 298 IDFGLSDYVK----PDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSR 352
DFG S ++ + + G+ Y+++PEV+ YG +AD+WS+ +L +
Sbjct: 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT-EK 206
Query: 353 PFWARTE--SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
P WA E + IF+ + P+ P +S DF+K++ ++ R R TA L HP
Sbjct: 207 PPWAEYEAMAAIFK--IATQPTKPMLP-DGVSDACRDFLKQIFVEEKR-RPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 8e-17
Identities = 59/227 (25%), Positives = 85/227 (37%), Gaps = 48/227 (21%)
Query: 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
+LG +G+G FG G +GQ VAVK + F
Sbjct: 6 KELKLGATIGKGEFG-----DVMLGDYRGQKVAVKCLKDDSTAA-----------QAF-- 47
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
L E MTT LR H NLVQ + +YIV E G L+
Sbjct: 48 LAE--ASVMTT-------------LR----HPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88
Query: 241 DRILSRGGKYSE-EDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
D + SRG + + + + + VHRDL N L + E+ K D
Sbjct: 89 DYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSD 145
Query: 300 FGLSDYVKPDERLNDIVGS--AYYVAPEVL-HRSYGTEADMWSIGVI 343
FGL+ + G + APE L + + T++D+WS G++
Sbjct: 146 FGLAK----EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGIL 188
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 8e-17
Identities = 64/246 (26%), Positives = 110/246 (44%), Gaps = 36/246 (14%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
E RE+K+LR L +N+V+ +A+ +Y+V E + +L+ + E
Sbjct: 45 ETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKV 102
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP--DERLN 313
+ + Q++ + +CH +VHRD+KPEN L + N LK DFG + + +
Sbjct: 103 RSYIYQLIKAIHWCHKNDIVHRDIKPENLLISH---NDVLKLCDFGFARNLSEGSNANYT 159
Query: 314 DIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK---- 368
+ V + +Y +PE+L + YG DMWS+G I L G F +E + K
Sbjct: 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP 219
Query: 369 ----------ADPSFDEAPWPSLS-PEA-------------IDFVKRLLNKDYRKRLTAA 404
++P F +P+++ P++ +D +K LL + R
Sbjct: 220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTE 279
Query: 405 QALSHP 410
Q L+HP
Sbjct: 280 QCLNHP 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 9e-17
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 41/216 (18%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273
+V+ + +++D N+Y++ME GG+++ +L + +EE+ + + + + + H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMT-LLMKKDTLTEEETQFYIAETVLAIDSIHQLG 121
Query: 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER------LN-------------- 313
+HRD+KP+N L SK +K DFGL +K R LN
Sbjct: 122 FIHRDIKPDNLLLDSK---GHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178
Query: 314 ----------------DIVGSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCGSRPFWA 356
VG+ Y+APEV + Y D WS+GVI Y +L G PF +
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS 238
Query: 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRL 392
T ++ V+ + P +S +A D + R
Sbjct: 239 ETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRF 274
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 57/213 (26%), Positives = 98/213 (46%), Gaps = 10/213 (4%)
Query: 220 AYEDDDNIYIVMELCKGGELLDRILSRGGK-YSEEDAKIVMVQILSVVAFCHFQGVVHRD 278
AYE D + +V+ + GG+L I + G + E+ A ++ + + +V+RD
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRD 127
Query: 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADM 337
LKPEN L ++ ++ D GL+ + E + VG+ Y+APEV+ + Y D
Sbjct: 128 LKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDW 184
Query: 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDY 397
W +G + Y ++ G PF R E V + E S +A + LL K+
Sbjct: 185 WGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNP 244
Query: 398 RKRL-----TAAQALSHPWLANSHDVKIPSDMI 425
++RL AA HP N + ++ ++M+
Sbjct: 245 KERLGCRGNGAAGVKQHPIFKNINFKRLEANML 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 18/222 (8%)
Query: 213 NLVQFYDAYEDDDNIYIVMELCKGG--ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCH 270
V FY A + +++I ME+ + ++ +G E+ + V I+ + + H
Sbjct: 61 YTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLH 120
Query: 271 FQ-GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-- 327
+ V+HRD+KP N L N +K DFG+S Y+ G Y+APE +
Sbjct: 121 SKLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINP 177
Query: 328 ---HRSYGTEADMWSIGVIAYILLCGSRPF--WARTESGIFRAVLKADPSFDEAPWPSLS 382
+ Y ++D+WS+G+ L G P+ W +T + V++ +PS + P S
Sbjct: 178 ELNQKGYDVKSDVWSLGITMIELATGRFPYDSW-KTPFQQLKQVVE-EPS-PQLPAEKFS 234
Query: 383 PEAIDFVKRLLNKDYRKRLTAAQALSHPW--LANSHDVKIPS 422
PE DFV + L K+Y++R + L HP+ L S + + S
Sbjct: 235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSKNTDVAS 276
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 10/207 (4%)
Query: 211 HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSE-EDAKIVMVQILSVVAFC 269
+ N ++ Y + ++M+ K G+L D +L + GK SE E KI+ Q++ +
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD-LLKKEGKLSEAEVKKIIR-QLVEALNDL 125
Query: 270 HFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPE-VLH 328
H ++H D+K EN L+ ++ + D+GL + D G+ Y +PE +
Sbjct: 126 HKHNIIHNDIKLENVLYDRAKDR--IYLCDYGLCKIIG-TPSCYD--GTLDYFSPEKIKG 180
Query: 329 RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDF 388
+Y D W++GV+ Y LL G PF + + L ++S A DF
Sbjct: 181 HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNANDF 240
Query: 389 VKRLLNKDYRKRLTA-AQALSHPWLAN 414
V+ +L + RLT + + HP+L
Sbjct: 241 VQSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 18/236 (7%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
+D+ +EVK L+ L H N +++ Y + ++VME C G D + E +
Sbjct: 66 QDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEI 123
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDI 315
+ L +A+ H ++HRD+K N L T E +K DFG + P N
Sbjct: 124 AAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSP---ANSF 177
Query: 316 VGSAYYVAPEVL----HRSYGTEADMWSIGVIAYILLCGSRP--FWARTESGIFRAVLKA 369
VG+ Y++APEV+ Y + D+WS+G I I L +P F S ++
Sbjct: 178 VGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQND 236
Query: 370 DPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMI 425
P+ W + FV L K ++R +A+ L H ++ ++ D+I
Sbjct: 237 SPTLQSNEW---TDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDRPARVLIDLI 289
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 4e-16
Identities = 73/250 (29%), Positives = 105/250 (42%), Gaps = 46/250 (18%)
Query: 200 REVKILRALTG--HKNLVQFYDA-----YEDDDNIYIVMELCKGG--ELLDRILSRGGKY 250
REV +L+ L H N+V+ D + + + +V E LD++ G
Sbjct: 48 REVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG--L 105
Query: 251 SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE 310
E K +M Q L + F H +VHRDLKPEN L TS +K DFGL+
Sbjct: 106 PAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG---GQVKLADFGLARIYSCQM 162
Query: 311 RLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVI------AYILLCGSRPFWARTESGIF 363
L +V + +Y APEVL +S Y T DMWS+G I L CG+ A IF
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE--ADQLGKIF 220
Query: 364 RAVLKADPSFDEAP---------WPSLSPEAI------------DFVKRLLNKDYRKRLT 402
+ P D+ P + P + + +L + KR++
Sbjct: 221 DLI--GLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS 278
Query: 403 AAQALSHPWL 412
A +AL HP+
Sbjct: 279 AFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 4e-16
Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 21/181 (11%)
Query: 190 TTAIAI----------EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
TT +A+ +D E +I++ L H L+Q Y ++ IYIV EL K G L
Sbjct: 30 TTPVAVKTLKPGTMDPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYIVTELMKYGSL 88
Query: 240 LDRILSRGGKYSEEDAKIVM-VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
L+ + G+ + I M Q+ S +A+ Q +HRDL N L EN+ K
Sbjct: 89 LEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVA 145
Query: 299 DFGLSDYVKPDERLNDIVGSAY---YVAPE-VLHRSYGTEADMWSIGVIAY-ILLCGSRP 353
DFGL+ +K D G+ + + APE L+ + ++D+WS G++ I+ G P
Sbjct: 146 DFGLARVIKEDI-YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
Query: 354 F 354
+
Sbjct: 205 Y 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 9e-16
Identities = 59/188 (31%), Positives = 100/188 (53%), Gaps = 16/188 (8%)
Query: 220 AYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279
A+ D + +++L GG+L LS+ G +SE++ + +I+ + H + VV+RDL
Sbjct: 65 AFHTPDKLCFILDLMNGGDL-HYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDL 123
Query: 280 KPENFLFTSKEENSSLKAIDFGLS-DYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEAD 336
KP N L +E+ ++ D GL+ D+ K ++ + VG+ Y+APEVL + +Y + AD
Sbjct: 124 KPANILL---DEHGHVRISDLGLACDFSK--KKPHASVGTHGYMAPEVLQKGTAYDSSAD 178
Query: 337 MWSIGVIAYILLCGSRPFW---ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLL 393
+S+G + + LL G PF + + I R L + + S SPE ++ LL
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPD----SFSPELKSLLEGLL 234
Query: 394 NKDYRKRL 401
+D KRL
Sbjct: 235 QRDVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-15
Identities = 52/174 (29%), Positives = 90/174 (51%), Gaps = 10/174 (5%)
Query: 192 AIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYS 251
A++ ED E +++ L+ H LVQ Y + I +V E + G L D + ++ GK+S
Sbjct: 40 AMSEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFS 98
Query: 252 EEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER 311
+E + + + +A+ V+HRDL N L EN +K DFG++ +V D++
Sbjct: 99 QETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVL-DDQ 154
Query: 312 LNDIVGSAYYV---APEVLHRS-YGTEADMWSIGVIAYILLC-GSRPFWARTES 360
G+ + V +PEV S Y +++D+WS GV+ + + G P+ R+ S
Sbjct: 155 YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS 208
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 69/263 (26%), Positives = 116/263 (44%), Gaps = 53/263 (20%)
Query: 200 REVKILRALTGHKNLVQFYDAY------EDDDNIYIVMELCKGGELLDRILSRGGKYSEE 253
RE+ +L+ + HKN++ + + E+ ++Y+VMEL L +++ + E
Sbjct: 69 RELVLLKCVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHM--ELDHE 123
Query: 254 DAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN 313
++ Q+L + H G++HRDLKP N + S + +LK +DFGL+ + +
Sbjct: 124 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTACTNFMMT 180
Query: 314 DIVGSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCGSRPF--------WAR------T 358
V + YY APEV L Y D+WS+G I L+ GS F W + T
Sbjct: 181 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGT 240
Query: 359 ESGIFRAVLKAD--------PSFDEAPWPSLSP----------------EAIDFVKRLLN 394
S F L+ P + + L P +A D + ++L
Sbjct: 241 PSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLV 300
Query: 395 KDYRKRLTAAQALSHPWLANSHD 417
D KR++ +AL HP++ +D
Sbjct: 301 IDPDKRISVDEALRHPYITVWYD 323
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 5e-15
Identities = 60/248 (24%), Positives = 108/248 (43%), Gaps = 42/248 (16%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ L ++G G+FG K ++ VA+K++ K ++
Sbjct: 8 FTLERKLGSGYFGEVWEGLWK-NRVR---VAIKIL--------------KSDD------- 42
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ +D ++EV+ L+ L HK+L+ + + +YI+ EL + G LL
Sbjct: 43 ---------LLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92
Query: 243 ILSRGGKYSEEDAKIVMV-QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ S G+ + I M Q+ +A+ Q +HRDL N L E+ K DFG
Sbjct: 93 LRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFG 149
Query: 302 LSDYVKPDERLNDIVGSAY-YVAPEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPFWART 358
L+ +K D L+ Y + APE H ++ T++D+WS G++ Y + G P+
Sbjct: 150 LARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209
Query: 359 ESGIFRAV 366
++ +
Sbjct: 210 NHEVYDQI 217
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 64/249 (25%), Positives = 107/249 (42%), Gaps = 45/249 (18%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM 259
RE +L+ L H N+V +D + + V E +L ++ G + ++ M
Sbjct: 52 REASLLKGLK-HANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFM 109
Query: 260 VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGS 318
Q+L +A+ H Q ++HRDLKP+N L + E LK DFGL+ P + + V +
Sbjct: 110 FQLLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVVT 166
Query: 319 AYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK-----ADP 371
+Y P+VL + Y + D+W G I +I + +P + S +F + K P
Sbjct: 167 LWYRPPDVLLGATDYSSALDIWGAGCI-FIEMLQGQPAFPGV-SDVFEQLEKIWTVLGVP 224
Query: 372 SFDEAPWPSLS----------------------------PEAIDFVKRLLNKDYRKRLTA 403
+ E WP +S P+A D ++L + R++A
Sbjct: 225 T--EDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA 282
Query: 404 AQALSHPWL 412
AL HP+
Sbjct: 283 QDALLHPYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 1e-14
Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 10/155 (6%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
E +E +I++ L H LVQ Y +++ IYIV E G LLD + S GK
Sbjct: 46 EAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQ 104
Query: 256 KIVM-VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLND 314
+ M QI +A+ + +HRDL N L EN K DFGL+ ++ DE
Sbjct: 105 LVDMAAQIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDE-YTA 160
Query: 315 IVGSAY---YVAPE-VLHRSYGTEADMWSIGVIAY 345
G+ + + APE + + ++D+WS G++
Sbjct: 161 REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLT 195
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 2e-14
Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 18/236 (7%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
+D+ +EV+ L+ L H N +Q+ Y + ++VME C G D + E +
Sbjct: 60 QDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEI 117
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDI 315
V L +A+ H ++HRD+K N L + E +K DFG + + P N
Sbjct: 118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAP---ANXF 171
Query: 316 VGSAYYVAPEVL----HRSYGTEADMWSIGVIAYILLCGSRP--FWARTESGIFRAVLKA 369
VG+ Y++APEV+ Y + D+WS+G+ I L +P F S ++
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITC-IELAERKPPLFNMNAMSALYHIAQNE 230
Query: 370 DPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMI 425
P+ W S +FV L K + R T+ L H ++ + D+I
Sbjct: 231 SPALQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 18/236 (7%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
+D+ +EVK L+ + H N +++ Y + ++VME C G D + E +
Sbjct: 70 QDIIKEVKFLQRIK-HPNSIEYKGCYLREHTAWLVMEYCLGSAS-DLLEVHKKPLQEVEI 127
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDI 315
+ L +A+ H ++HRD+K N L T E +K DFG + P N
Sbjct: 128 AAITHGALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASP---ANSF 181
Query: 316 VGSAYYVAPEVL----HRSYGTEADMWSIGVIAYILLCGSRP--FWARTESGIFRAVLKA 369
VG+ Y++APEV+ Y + D+WS+G I I L +P F S ++
Sbjct: 182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNE 240
Query: 370 DPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMI 425
P+ W S +FV L K + R T+ + L H ++ + D+I
Sbjct: 241 SPTLQSNEW---SDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLIDLI 293
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 54/183 (29%), Positives = 92/183 (50%), Gaps = 11/183 (6%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM 259
RE+++L +V FY A+ D I I ME GG L D++L + G+ E+ V
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVS 109
Query: 260 VQILSVVAFCHFQ-GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGS 318
+ ++ + + + ++HRD+KP N L S+ E +K DFG+S + D N VG+
Sbjct: 110 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGT 165
Query: 319 AYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFW---ARTESGIFRAVLKADPSFD 374
Y++PE L + Y ++D+WS+G+ + G P A+ +F ++ DP+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225
Query: 375 EAP 377
E
Sbjct: 226 ETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 3e-14
Identities = 66/261 (25%), Positives = 112/261 (42%), Gaps = 58/261 (22%)
Query: 200 REVKILRALTGHKNLVQFYDAY------EDDDNIYIVMELCKGG--ELLDRILSRGGKYS 251
RE+ +++ L HKN++ + + E+ ++Y+VMEL +++ L
Sbjct: 64 RELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLD------ 116
Query: 252 EEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER 311
E ++ Q+L + H G++HRDLKP N + S + +LK +DFGL+
Sbjct: 117 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFM 173
Query: 312 LNDIVGSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCGSRPF--------WAR----- 357
+ V + YY APEV L Y D+WS+G I ++ G+ F W +
Sbjct: 174 MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQL 233
Query: 358 -TESGIF--------RAVLKADPSFDEAPWPSLSPE-----------------AIDFVKR 391
T S F R ++ P + + L P+ A D + +
Sbjct: 234 GTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSK 293
Query: 392 LLNKDYRKRLTAAQALSHPWL 412
+L D KR++ AL HP++
Sbjct: 294 MLVIDPEKRISVDDALQHPYI 314
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-14
Identities = 55/154 (35%), Positives = 77/154 (50%), Gaps = 15/154 (9%)
Query: 200 REVKILRALTG--HKNLVQFYDA-----YEDDDNIYIVMELCKGG--ELLDRILSRGGKY 250
REV +LR L H N+V+ +D + + + +V E LD++ G
Sbjct: 50 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG--V 107
Query: 251 SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE 310
E K +M Q+L + F H VVHRDLKP+N L TS + +K DFGL+
Sbjct: 108 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTS---SGQIKLADFGLARIYSFQM 164
Query: 311 RLNDIVGSAYYVAPEV-LHRSYGTEADMWSIGVI 343
L +V + +Y APEV L SY T D+WS+G I
Sbjct: 165 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCI 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 6e-14
Identities = 52/184 (28%), Positives = 88/184 (47%), Gaps = 10/184 (5%)
Query: 192 AIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYS 251
A++ ED E K++ L+ H LVQ Y +YIV E + G LL+ + R GK S
Sbjct: 40 AMSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLS 98
Query: 252 EEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER 311
++ + + + + +HRDL N L +S +K DFG++ YV DE
Sbjct: 99 KDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSST---GVVKVSDFGMTRYVLDDEY 155
Query: 312 LNDIVGSAYYV---APEVLHRS-YGTEADMWSIGVIAY-ILLCGSRPFWARTESGIFRAV 366
+ G+ + V PEV + S Y +++D+WS GV+ + + G PF ++ + +
Sbjct: 156 TSS-SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214
Query: 367 LKAD 370
+
Sbjct: 215 SRGF 218
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 64/263 (24%), Positives = 113/263 (42%), Gaps = 53/263 (20%)
Query: 200 REVKILRALTGHKNLVQFYDAY------EDDDNIYIVMELCKGGELLDRILSRGGKYSEE 253
RE+ +++ + HKN++ + + E+ ++YIVMEL L +++ + E
Sbjct: 72 RELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM--ELDHE 126
Query: 254 DAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN 313
++ Q+L + H G++HRDLKP N + S + +LK +DFGL+ +
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMT 183
Query: 314 DIVGSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCGSRPF--------WARTESGI-- 362
V + YY APEV L Y D+WS+G I ++ G F W + +
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGT 243
Query: 363 ------------FRAVLKADPSFDEAPWPSLSP----------------EAIDFVKRLLN 394
R ++ P + + L P +A D + ++L
Sbjct: 244 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLV 303
Query: 395 KDYRKRLTAAQALSHPWLANSHD 417
D KR++ +AL HP++ +D
Sbjct: 304 IDASKRISVDEALQHPYINVWYD 326
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 7e-14
Identities = 69/299 (23%), Positives = 133/299 (44%), Gaps = 61/299 (20%)
Query: 175 NHQFTILDEYCCLFMTTAIAIEDV-------RREVKILRALTGHKNLVQFYDAY------ 221
N F ++ E C+ + +AI+ V RE+ I++ L H N++ D Y
Sbjct: 76 NGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN-HINIIFLKDYYYTECFK 134
Query: 222 EDDDNIY--IVMELCKGGELLDRILSRGGKYSEED--------AKIVMVQILSVVAFCHF 271
+++ NI+ +VME + + + + K+ + K+ Q+ +A+ H
Sbjct: 135 KNEKNIFLNVVMEF------IPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS 188
Query: 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL--HR 329
+ + HRDLKP+N L +LK DFG + + +R + S +Y APE++
Sbjct: 189 KFICHRDLKPQNLLIDPN--THTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGAT 246
Query: 330 SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKA------------DPSFDEAP 377
+Y T D+WS+G I ++ G F ++ +++ +P++ +
Sbjct: 247 NYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIK 306
Query: 378 WPSLSP-------------EAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD--VKIP 421
+P + P +AI+F+ + L + KRL +AL+ P+ + D +K+P
Sbjct: 307 FPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLP 365
|
Length = 440 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 7e-14
Identities = 66/235 (28%), Positives = 103/235 (43%), Gaps = 49/235 (20%)
Query: 127 EEVGRGHFGYTCSAKAKKGSLKGQ-DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYC 185
+E+G G FG K G +GQ DVA+K+I +
Sbjct: 10 KELGTGQFGVV-----KYGKWRGQYDVAIKMIKE-------------------------- 38
Query: 186 CLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS 245
+++ ++ E K++ L+ H+ LVQ Y IYIV E G LL+ L
Sbjct: 39 -----GSMSEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN-YLR 91
Query: 246 RGGKYSEEDAKIVMVQ-ILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSD 304
GK + + M + + +A+ + +HRDL N L +K DFGLS
Sbjct: 92 EHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD---QGCVKVSDFGLSR 148
Query: 305 YVKPDERLNDIVGSAYYV---APEVLHRS-YGTEADMWSIGVIAY-ILLCGSRPF 354
YV DE + VGS + V PEVL S + +++D+W+ GV+ + + G P+
Sbjct: 149 YVLDDEYTSS-VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 8e-14
Identities = 61/190 (32%), Positives = 94/190 (49%), Gaps = 16/190 (8%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM 259
RE+++L +V FY A+ D I I ME GG L D++L + EE V
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVS 109
Query: 260 VQILSVVAFCHFQ-GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGS 318
+ +L +A+ + ++HRD+KP N L S+ E +K DFG+S + D N VG+
Sbjct: 110 IAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGT 165
Query: 319 AYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFW---ARTESGIF-RAVLKADPSF 373
Y++PE L + Y ++D+WS+G+ L G P A+ IF R V+
Sbjct: 166 RSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDG---- 221
Query: 374 DEAPWPSLSP 383
+E S+SP
Sbjct: 222 EEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 1e-13
Identities = 83/324 (25%), Positives = 132/324 (40%), Gaps = 69/324 (21%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE E++G G + K+K + G+ VA+KVI + E FT +
Sbjct: 7 YEKLEKLGEGSYATVYKGKSK---VNGKLVALKVI-----------RLQEEEGTPFTAI- 51
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
RE +L+ L H N+V +D + + +V E +L
Sbjct: 52 -----------------REASLLKGLK-HANIVLLHDIIHTKETLTLVFEYVHT-DLCQY 92
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ G E+ K+ + Q+L +++ H + ++HRDLKP+N L + E LK DFGL
Sbjct: 93 MDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE---LKLADFGL 149
Query: 303 SDYVK-PDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCG--SRPFWAR 357
+ P ++ V + +Y P+VL S Y T DMW +G I ++ G + P
Sbjct: 150 ARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD 209
Query: 358 TESGIFRAVLK-ADPSFDEAP----WPSLSPE----------------------AIDFVK 390
+ + R L P+ D P P PE A D
Sbjct: 210 IQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLAS 269
Query: 391 RLLNKDYRKRLTAAQALSHPWLAN 414
+LL + RL+A ALSH + ++
Sbjct: 270 KLLQCFPKNRLSAQAALSHEYFSD 293
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 64/263 (24%), Positives = 114/263 (43%), Gaps = 53/263 (20%)
Query: 200 REVKILRALTGHKNLVQFYDAY------EDDDNIYIVMELCKGGELLDRILSRGGKYSEE 253
RE+ +++ + HKN++ + + E+ ++Y+VMEL L +++ + E
Sbjct: 65 RELVLMKCVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQM--ELDHE 119
Query: 254 DAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN 313
++ Q+L + H G++HRDLKP N + S + +LK +DFGL+ +
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTLKILDFGLARTAGTSFMMT 176
Query: 314 DIVGSAYYVAPEV-LHRSYGTEADMWSIGVIA------YILLCGSR-------------- 352
V + YY APEV L Y D+WS+G I IL G
Sbjct: 177 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 236
Query: 353 --PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAI----------------DFVKRLLN 394
P + + R ++ P + +P L P+++ D + ++L
Sbjct: 237 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLV 296
Query: 395 KDYRKRLTAAQALSHPWLANSHD 417
D KR++ +AL HP++ +D
Sbjct: 297 IDPAKRISVDEALQHPYINVWYD 319
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 2e-13
Identities = 70/298 (23%), Positives = 111/298 (37%), Gaps = 92/298 (30%)
Query: 125 LGEEVGRGHFGYTCSAKAKKGSLKGQD--VAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
L E+G G FG + + VAVK + +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET---------------------- 46
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ A +D RE ++L H+N+V+FY + D +V E + G+L
Sbjct: 47 -------ASNDARKDFEREAELLTNF-QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKF 98
Query: 243 ILSRG-------------GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSK 289
+ S G G+ + + VQI S + + Q VHRDL N L
Sbjct: 99 LRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG-- 156
Query: 290 EENSSLKAIDFGLS------DYVKPDERLNDIVGSAY----YVAPE-VLHRSYGTEADMW 338
+ +K DFG+S DY + + G ++ PE +++R + TE+D+W
Sbjct: 157 -YDLVVKIGDFGMSRDVYTTDYYR-------VGGHTMLPIRWMPPESIMYRKFTTESDVW 208
Query: 339 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS-PEAIDFVK--RLL 393
S GV+ W IF ++ + PW LS E I+ + RLL
Sbjct: 209 SFGVV----------LWE-----IF--------TYGKQPWYGLSNEEVIECITQGRLL 243
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 78/291 (26%), Positives = 119/291 (40%), Gaps = 44/291 (15%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
G+ +G G FG A A L D +KV KM+ K H E
Sbjct: 38 SFGKTLGAGAFGKVVEATAY--GLSKSDAVMKVAVKML----------KPTAH----SSE 81
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
E + E+KI+ L H+N+V A I ++ E C G+LL+ +
Sbjct: 82 R-----------EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL 130
Query: 244 LSRGGKYSE-EDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ + ED Q+ +AF + +HRDL N L T +K DFGL
Sbjct: 131 RRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVKICDFGL 187
Query: 303 SDYVKPDERLNDIV-GSAY----YVAPE-VLHRSYGTEADMWSIGVIAY-ILLCGSRPFW 355
+ + D N +V G+A ++APE + + Y E+D+WS G++ + I GS P+
Sbjct: 188 ARDIMNDS--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP 245
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAI-DFVKRLLNKDYRKRLTAAQ 405
F ++K + P +P I D +K + D KR T Q
Sbjct: 246 GMPVDSKFYKLIKEGYRMAQ---PEHAPAEIYDIMKTCWDADPLKRPTFKQ 293
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 9e-13
Identities = 52/203 (25%), Positives = 91/203 (44%), Gaps = 12/203 (5%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKI-VMVQILSVVAFCHFQ 272
+V A+E ++ +VM L GG+L I + G + E + I QI + H
Sbjct: 55 IVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM 114
Query: 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSY 331
+V+RD+KPEN L ++ + + D GL+ +K + + G+ Y+APE+L Y
Sbjct: 115 DIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171
Query: 332 GTEADMWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFDEAPWPSLSPEAID 387
D +++G Y ++ G PF E + R L+ + F+ + + E+ D
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQ---NFTEESKD 228
Query: 388 FVKRLLNKDYRKRLTAAQALSHP 410
+ L K RL + + P
Sbjct: 229 ICRLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 4e-12
Identities = 62/236 (26%), Positives = 108/236 (45%), Gaps = 16/236 (6%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKI 257
E +IL A + +V A++ ++ +VM + GG+L I + + E A
Sbjct: 43 EKRIL-AKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACF 101
Query: 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP-DERLNDIV 316
QI+S + H + +++RDLKPEN L + + +++ D GL+ +K +
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 317 GSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE 375
G+ ++APE+L Y D +++GV Y ++ PF AR E + LK D
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEK-VENKELKQRILNDS 217
Query: 376 APWP-SLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANSHDVKIPSDMI 425
+P SP + F + LL KD KRL +HP + + ++ + M+
Sbjct: 218 VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGML 273
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 4e-12
Identities = 65/243 (26%), Positives = 104/243 (42%), Gaps = 46/243 (18%)
Query: 115 FSKQFVAHYELGEEVGRGHFGYT--CSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPK 172
F K+F+ ++G GHFG C + G G+ VAVK + G
Sbjct: 1 FEKRFLKRIR---DLGEGHFGKVELCRYDPE-GDNTGEQVAVKSLKPESG---------- 46
Query: 173 HENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDD--DNIYIV 230
NH I D+++E++ILR L H+N+V++ +D + I ++
Sbjct: 47 -GNH------------------IADLKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLI 86
Query: 231 MELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKE 290
ME G L + + K + + VQI + + + VHRDL N L E
Sbjct: 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---E 143
Query: 291 ENSSLKAIDFGLSDYVKPDERL----NDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY 345
+K DFGL+ ++ D+ +D+ ++ APE L + +D+WS GV Y
Sbjct: 144 SEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203
Query: 346 ILL 348
LL
Sbjct: 204 ELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 7e-12
Identities = 54/215 (25%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273
++ FY A+ ++ I I E GG L K E + V ++ + +
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSL-----DVYRKIPEHVLGRIAVAVVKGLTYLWSLK 115
Query: 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDI----VGSAYYVAPE-VLH 328
++HRD+KP N L ++ +K DFG+S + +N I VG+ Y+APE +
Sbjct: 116 ILHRDVKPSNMLVNTR---GQVKLCDFGVST-----QLVNSIAKTYVGTNAYMAPERISG 167
Query: 329 RSYGTEADMWSIGVIAYILLCGSRPF-WARTESGIFRAVLKADPSFDEAPWPSL-----S 382
YG +D+WS+G+ L G P+ + G + DE P P L S
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP-PVLPVGQFS 226
Query: 383 PEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
+ + F+ + + K ++R + HP++ +D
Sbjct: 227 EKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 58/238 (24%), Positives = 93/238 (39%), Gaps = 47/238 (19%)
Query: 128 EVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYC 185
++G GHFG C + G+ VAVK L E H+
Sbjct: 11 QLGEGHFGKVELCRYDPLGDN-TGEQVAVKS---------LNHSGE--EQHR-------- 50
Query: 186 CLFMTTAIAIEDVRREVKILRALTGHKNLVQF-YDAYEDDDNIY-IVMELCKGGELLDRI 243
D RE++ILR L H+N+V++ + ++ME G L R
Sbjct: 51 ----------SDFEREIEILRTLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSL--RD 97
Query: 244 LSRGGKYSEEDAKIVM--VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ + ++++ QI + + Q +HRDL N L E +K DFG
Sbjct: 98 YLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV---ESEDLVKISDFG 154
Query: 302 LSDYVKPDE---RLNDIVGS-AYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPF 354
L+ + D+ + + S ++ APE L + + +D+WS GV Y L P
Sbjct: 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 4e-11
Identities = 52/216 (24%), Positives = 87/216 (40%), Gaps = 47/216 (21%)
Query: 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI---------L 244
++D +E I+ +L H+NL++ Y + +V EL G LLDR+ +
Sbjct: 39 IMDDFLKEAAIMHSLD-HENLIRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLI 96
Query: 245 SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSD 304
S Y+ VQI + + + + +HRDL N L S ++ +K DFGL
Sbjct: 97 STLCDYA--------VQIANGMRYLESKRFIHRDLAARNILLASDDK---VKIGDFGLMR 145
Query: 305 YVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIGVIAYILLC-G 350
+ +YV APE L R++ +D+W GV + + G
Sbjct: 146 ALP--------QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYG 197
Query: 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAI 386
P+ + S I + + D + P P+ I
Sbjct: 198 EEPWAGLSGSQILKKI---DKEGERLERPEACPQDI 230
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 11/181 (6%)
Query: 192 AIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS-RGGKY 250
++++ E +++ L H LV+ Y ++ IYI+ E G LLD + S GGK
Sbjct: 42 TMSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKV 100
Query: 251 SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE 310
QI +A+ + +HRDL+ N L + E+ K DFGL+ ++ +E
Sbjct: 101 LLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNE 157
Query: 311 RLNDIVGSAY---YVAPEVLHR-SYGTEADMWSIGVIAY-ILLCGSRPFWARTESGIFRA 365
G+ + + APE ++ S+ ++D+WS G++ Y I+ G P+ + S + A
Sbjct: 158 -YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA 216
Query: 366 V 366
+
Sbjct: 217 L 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 7e-11
Identities = 45/150 (30%), Positives = 80/150 (53%), Gaps = 12/150 (8%)
Query: 211 HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM--VQILSVVAF 268
H ++V+ ++ ++IVMEL GEL R + KYS + A +++ Q+ + +A+
Sbjct: 66 HPHIVKLIGVITENP-VWIVMELAPLGEL--RSYLQVNKYSLDLASLILYSYQLSTALAY 122
Query: 269 CHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGS--AYYVAPEV 326
+ VHRD+ N L +S + +K DFGLS Y++ + G ++APE
Sbjct: 123 LESKRFVHRDIAARNVLVSSPD---CVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPES 179
Query: 327 LH-RSYGTEADMWSIGVIAY-ILLCGSRPF 354
++ R + + +D+W GV + IL+ G +PF
Sbjct: 180 INFRRFTSASDVWMFGVCMWEILMLGVKPF 209
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 24/212 (11%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM 259
+E +IL+ + H N+V+ IYIVMEL +GG+ L + + G + ++ ++
Sbjct: 42 QEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMV 100
Query: 260 VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSA 319
+ + + + +HRDL N L T E + LK DFG+S E + + S
Sbjct: 101 ENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMS-----REEEDGVYAST 152
Query: 320 --------YYVAPEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKA 369
+ APE L + Y +E+D+WS G++ + G+ P+ + A+ +
Sbjct: 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212
Query: 370 DPSFDEAPWPSLSPEAI-DFVKRLLNKDYRKR 400
P P L P+A+ ++R D +R
Sbjct: 213 ----VRLPCPELCPDAVYRLMERCWEYDPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 51/185 (27%), Positives = 88/185 (47%), Gaps = 33/185 (17%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---GGKYS 251
+ D+ E+++++ + HKN++ A D +Y+++E G L + + +R G +YS
Sbjct: 64 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 123
Query: 252 EEDAKI------------VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
+ A++ Q+ + + Q +HRDL N L T EN+ +K D
Sbjct: 124 YDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIAD 180
Query: 300 FGLS------DYVK--PDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY-ILLC 349
FGL+ DY K + RL ++APE L R Y ++D+WS GV+ + I
Sbjct: 181 FGLARDVNNIDYYKKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTL 235
Query: 350 GSRPF 354
G P+
Sbjct: 236 GGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 2e-10
Identities = 50/167 (29%), Positives = 80/167 (47%), Gaps = 25/167 (14%)
Query: 211 HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIV----MVQI-LSV 265
H N+V+ ++ YI+MEL +GG+LL + R + ++ ++ I L V
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL--RDARVERFGPPLLTLKELLDICLDV 115
Query: 266 VAFCHF---QGVVHRDLKPENFLFTSKEENSS--LKAIDFGL------SDYV-KPDERLN 313
C + +HRDL N L + K ++ +K DFGL SDY K E L
Sbjct: 116 AKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 314 DIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAY-ILLCGSRPFWART 358
+ ++APE L + T++D+WS GV+ + IL G +P+ A
Sbjct: 176 PV----RWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 190 TTAIAIEDVR----------REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
TT +AI+ ++ +E ++++ L H+ LVQ Y A ++ IYIV E G L
Sbjct: 30 TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLY-AVVSEEPIYIVTEYMSKGSL 87
Query: 240 LDRILSRGGKYSEEDAKIVMV-QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
LD + GKY + M QI S +A+ VHRDL+ N L EN K
Sbjct: 88 LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVA 144
Query: 299 DFGLSDYVKPDERLNDIVGSAY---YVAPE-VLHRSYGTEADMWSIGVIAYILLCGSR-P 353
DFGL+ ++ D G+ + + APE L+ + ++D+WS G++ L R P
Sbjct: 145 DFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 203
Query: 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAI 386
+ + R VL P P PE++
Sbjct: 204 Y----PGMVNREVLDQVERGYRMPCPPECPESL 232
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 27/230 (11%)
Query: 190 TTAIAIEDVR----------REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
TT +AI+ ++ +E +I++ L H LV Y A ++ IYIV E G L
Sbjct: 30 TTKVAIKTLKPGTMMPEAFLQEAQIMKKLR-HDKLVPLY-AVVSEEPIYIVTEFMGKGSL 87
Query: 240 LDRILSRGGKYSEEDAKIVMV-QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
LD + GKY + + M QI +A+ +HRDL+ N L +N K
Sbjct: 88 LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIA 144
Query: 299 DFGLSDYVKPDERLNDIVGSAY---YVAPE-VLHRSYGTEADMWSIGVIAYILLCGSR-P 353
DFGL+ ++ D G+ + + APE L+ + ++D+WS G++ L+ R P
Sbjct: 145 DFGLARLIE-DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
Query: 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAI-DFVKRLLNKDYRKRLT 402
+ + R VL+ P P PE++ + +K KD +R T
Sbjct: 204 Y----PGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPT 249
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 3e-10
Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 39/202 (19%)
Query: 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL--------LDRILS 245
A +D RE ++L L H+++V+FY + D + +V E K G+L D +L
Sbjct: 50 ARKDFHREAELLTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLM 108
Query: 246 RGGKYSEEDAKIVMVQILSVVA----FCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
G E + M+ I +A + Q VHRDL N L EN +K DFG
Sbjct: 109 AEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFG 165
Query: 302 LSDYVKPDERLNDIVGSAYY------------VAPE-VLHRSYGTEADMWSIGVIAY-IL 347
+S D+ + YY + PE +++R + TE+D+WS+GV+ + I
Sbjct: 166 MS---------RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIF 216
Query: 348 LCGSRPFWARTESGIFRAVLKA 369
G +P++ + + + + +
Sbjct: 217 TYGKQPWYQLSNNEVIECITQG 238
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 53/205 (25%), Positives = 94/205 (45%), Gaps = 42/205 (20%)
Query: 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG------ 247
A +D +RE ++L L H+++V+FY D D + +V E K G+L + + G
Sbjct: 50 ARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMIL 108
Query: 248 --GKYSEEDAKI-------VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
G+ + ++ + QI S + + Q VHRDL N L + N +K
Sbjct: 109 VDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA---NLLVKIG 165
Query: 299 DFGLSDYVKPDERLNDIVGSAYY------------VAPE-VLHRSYGTEADMWSIGVIAY 345
DFG+S D+ + YY + PE +++R + TE+D+WS GVI +
Sbjct: 166 DFGMS---------RDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILW 216
Query: 346 -ILLCGSRPFWARTESGIFRAVLKA 369
I G +P++ + + + + +
Sbjct: 217 EIFTYGKQPWFQLSNTEVIECITQG 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 5e-10
Identities = 68/245 (27%), Positives = 101/245 (41%), Gaps = 49/245 (20%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYS-----EED 254
RE KI L H +V Y D D +Y M +G L + S K S E
Sbjct: 51 REAKIAADLI-HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEK 109
Query: 255 AKI-----VMVQILSVVAFCHFQGVVHRDLKPENFLF--------------TSKE-ENSS 294
+ + +I + + + H +GV+HRDLKP+N L K+ E
Sbjct: 110 TSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED 169
Query: 295 LKAIDFGL-----SDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEA----DMWSIGVIAY 345
L ID S P + IVG+ Y+APE R G A D++++GVI Y
Sbjct: 170 LLDIDVDERNICYSSMTIPGK----IVGTPDYMAPE---RLLGVPASESTDIYALGVILY 222
Query: 346 ILLCGSRPFWARTESG---IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT 402
+L S P+ R + G +R V+ P + AP+ + P + L D +R +
Sbjct: 223 QMLTLSFPY--RRKKGRKISYRDVI-LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYS 278
Query: 403 AAQAL 407
+ Q L
Sbjct: 279 SVQEL 283
|
Length = 932 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 63/217 (29%), Positives = 98/217 (45%), Gaps = 31/217 (14%)
Query: 213 NLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM-VQILSVVAFCHF 271
+V+FY A + + +I MEL +D L + KY E K V+ +IL +A
Sbjct: 64 YIVKFYGALFREGDCWICMEL------MDISLDKFYKYVYEVLKSVIPEEILGKIAVATV 117
Query: 272 QG---------VVHRDLKPENFLFTSKEENSSLKAIDFGLSDY-VKPDERLNDIVGSAYY 321
+ ++HRD+KP N L + N ++K DFG+S V + D G Y
Sbjct: 118 KALNYLKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRD-AGCRPY 173
Query: 322 VAPEVLHRS----YGTEADMWSIGVIAYILLCGSRPFWARTESGIF---RAVLKAD-PSF 373
+APE + S Y +D+WS+G+ Y + G P+ + +F V+K D P
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLTQVVKGDPPIL 231
Query: 374 DEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
+ SP ++F+ L KD KR + L HP
Sbjct: 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 7e-10
Identities = 57/198 (28%), Positives = 89/198 (44%), Gaps = 57/198 (28%)
Query: 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEE 253
A +D +RE ++L L H+++V+FY + + +V E + G+L +R L G
Sbjct: 50 ARQDFQREAELLTVLQ-HQHIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGP---- 103
Query: 254 DAKIV---------------MVQILSVVAF-------CHFQGVVHRDLKPENFLFTSKEE 291
DAKI+ M+ I S +A HF VHRDL N L +
Sbjct: 104 DAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHF---VHRDLATRNCLVG---Q 157
Query: 292 NSSLKAIDFGLSDYVKPDERLNDIVGSAYY------------VAPE-VLHRSYGTEADMW 338
+K DFG+S DI + YY + PE +L+R + TE+D+W
Sbjct: 158 GLVVKIGDFGMS---------RDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIW 208
Query: 339 SIGVIAY-ILLCGSRPFW 355
S GV+ + I G +P++
Sbjct: 209 SFGVVLWEIFTYGKQPWY 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 9e-10
Identities = 72/287 (25%), Positives = 113/287 (39%), Gaps = 84/287 (29%)
Query: 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
+ LGE +G G FG +G GQ VAVK I C
Sbjct: 5 LQKLTLGEIIGEGEFG-----AVLQGEYTGQKVAVKNI-----------KC--------- 39
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
D F+ + + HKNLV+ + +YIVMEL G L
Sbjct: 40 --DVTAQAFLEETAVMTKLH-----------HKNLVRLLGVILHN-GLYIVMELMSKGNL 85
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSV-------VAFCHFQGVVHRDLKPENFLFTSKEEN 292
++ + +RG A + ++Q+L + + + +VHRDL N L + E+
Sbjct: 86 VNFLRTRG------RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVS---ED 136
Query: 293 SSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGS 351
K DFGL+ V +++ + APE L H+ + +++D+WS GV+
Sbjct: 137 GVAKVSDFGLAR-VGS-MGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVL-------- 186
Query: 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYR 398
W +F S+ AP+P +S + VK + K YR
Sbjct: 187 --LWE-----VF--------SYGRAPYPKMS---LKEVKECVEKGYR 215
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 57/225 (25%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
+L + +G+G FG G +G VAVK C K+ D
Sbjct: 9 KLLQTIGKGEFG-----DVMLGDYRGNKVAVK--------------CIKN--------DA 41
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA-YEDDDNIYIVMELCKGGELLDR 242
F+ A + +R H NLVQ E+ +YIV E G L+D
Sbjct: 42 TAQAFLAEASVMTQLR-----------HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 90
Query: 243 ILSRGGKYSEEDAKI-VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ SRG D + + + + + VHRDL N L + E+N + K DFG
Sbjct: 91 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS--EDNVA-KVSDFG 147
Query: 302 LSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY 345
L+ + + + APE L + + T++D+WS G++ +
Sbjct: 148 LTKEASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLW 190
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 63/241 (26%), Positives = 99/241 (41%), Gaps = 58/241 (24%)
Query: 127 EEVGRGHFGYTCSAKAKKGSLKGQ-DVAVKV----IPKMIGVIFLQVHCPKHENHQFTIL 181
E++G+G+FG KG LKG +VAVK +P + FLQ + IL
Sbjct: 1 EKIGKGNFG-----DVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQ---------EAEIL 46
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+Y H N+V+ IYIVMEL GG LL
Sbjct: 47 KQY-------------------------DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ + + + + + + + + + + +HRDL N L EN+ LK DFG
Sbjct: 82 FLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVG---ENNVLKISDFG 138
Query: 302 LSDYVKPDERLNDIVGSAY------YVAPEVLHRS-YGTEADMWSIGVIAY-ILLCGSRP 353
+S + +E V + APE L+ Y +E+D+WS G++ + G P
Sbjct: 139 MS---REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP 195
Query: 354 F 354
+
Sbjct: 196 Y 196
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 1e-09
Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 15/171 (8%)
Query: 192 AIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYS 251
+ +E+ +E +++ + H NLVQ + YI+ E G LLD + R
Sbjct: 43 TMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL--RECNRQ 99
Query: 252 EEDAKIVM---VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
E +A +++ QI S + + + +HRDL N L EN +K DFGLS +
Sbjct: 100 EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMT- 155
Query: 309 DERLNDIVGSAY---YVAPEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPF 354
+ G+ + + APE L + + ++D+W+ GV+ + I G P+
Sbjct: 156 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 206
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 45/179 (25%), Positives = 86/179 (48%), Gaps = 17/179 (9%)
Query: 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM 259
RE+ IL+ ++ H+ ++ AY + +VM K L + R G E A +
Sbjct: 135 REIDILKTIS-HRAIINLIHAYRWKSTVCMVMPKYKCD--LFTYVDRSGPLPLEQAITIQ 191
Query: 260 VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLND----- 314
++L +A+ H +G++HRD+K EN +F + EN+ L DFG + K D +
Sbjct: 192 RRLLEALAYLHGRGIIHRDVKTEN-IFLDEPENAVLG--DFGAA--CKLDAHPDTPQCYG 246
Query: 315 IVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWAR---TESGIFRAVLKA 369
G+ +PE+L Y + D+WS G++ + + + + + + S R++++
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305
|
Length = 392 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 44/150 (29%), Positives = 70/150 (46%), Gaps = 11/150 (7%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMV 260
E +IL+ H N+V+ IYIVMEL GG+ L + + + + +
Sbjct: 42 EARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL 100
Query: 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS----DYVKPDERLNDIV 316
+ +A+ + +HRDL N L EN+ LK DFG+S D + L I
Sbjct: 101 DAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGIYSSSGLKQI- 156
Query: 317 GSAYYVAPEVL-HRSYGTEADMWSIGVIAY 345
+ APE L + Y +E+D+WS G++ +
Sbjct: 157 -PIKWTAPEALNYGRYSSESDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 3e-09
Identities = 66/253 (26%), Positives = 105/253 (41%), Gaps = 51/253 (20%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE G +VGRG +G+ AK K G +D A+K I
Sbjct: 4 YE-GCKVGRGTYGHVYKAKRKDGK-DDRDYALKQIEG----------------------- 38
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY--EDDDNIYIVMELCKGGELL 240
T I++ R E+ +LR L H N++ + D ++++ + +
Sbjct: 39 --------TGISMSACR-EIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWH 88
Query: 241 DRILSRGGKYSEEDAKI-------VMVQILSVVAFCHFQGVVHRDLKPENFLFTSK-EEN 292
R K +++ ++ ++ QIL + + H V+HRDLKP N L + E
Sbjct: 89 IIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPER 148
Query: 293 SSLKAIDFGLSDY----VKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYI 346
+K D G + +KP L+ +V + +Y APE+L R Y D+W+IG I
Sbjct: 149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAE 208
Query: 347 LLCGSRPFWARTE 359
LL F R E
Sbjct: 209 LLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 4e-09
Identities = 55/229 (24%), Positives = 89/229 (38%), Gaps = 56/229 (24%)
Query: 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCC 186
+E+G G+FG S K +VAVK + + H E
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTL---------------KQEHIAAGKKE--- 42
Query: 187 LFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR 246
F+ RE ++ L H +V+ + + + +VMEL G LL + R
Sbjct: 43 -FL----------REASVMAQLD-HPCIVRLIGVCKGE-PLMLVMELAPLGPLLKYLKKR 89
Query: 247 GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV 306
+ D K + Q+ +A+ + VHRDL N L ++ + K DFG+S +
Sbjct: 90 R-EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ---AKISDFGMSRAL 145
Query: 307 KPDERLNDIVGSAYY------------VAPEVLH-RSYGTEADMWSIGV 342
GS YY APE ++ + +++D+WS GV
Sbjct: 146 GA--------GSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGV 186
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 62/256 (24%), Positives = 107/256 (41%), Gaps = 60/256 (23%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
LG+ +G G FG A+A L + V KM L+ + +
Sbjct: 15 TLGKPLGEGAFGQVVKAEAV--GLDNPNETSTVAVKM-----LKDDATEKD--------- 58
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
+ D+ E+++++ + HKN++ + +Y+V+E G L D +
Sbjct: 59 -----------LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL 107
Query: 244 LSR--GGKYSEEDAKIVMVQILS---VVAFCH----------FQGVVHRDLKPENFLFTS 288
+R G+Y+ D + L+ +V+F + + +HRDL N L T
Sbjct: 108 RARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT- 166
Query: 289 KEENSSLKAIDFGLS------DYVKP--DERLNDIVGSAYYVAPEVL-HRSYGTEADMWS 339
E+ +K DFGL+ DY + + RL ++APE L R Y ++D+WS
Sbjct: 167 --EDHVMKIADFGLARDIHHIDYYRKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWS 219
Query: 340 IGVIAY-ILLCGSRPF 354
GV+ + I G P+
Sbjct: 220 FGVLLWEIFTLGGSPY 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 50/185 (27%), Positives = 86/185 (46%), Gaps = 33/185 (17%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---GGKYS 251
+ D+ E+++++ + HKN++ A D +Y+++E G L + + +R G YS
Sbjct: 61 LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYS 120
Query: 252 EEDAKI------------VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
+ K+ Q+ + + Q +HRDL N L T E++ +K D
Sbjct: 121 FDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT---EDNVMKIAD 177
Query: 300 FGLS------DYVKP--DERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY-ILLC 349
FGL+ DY K + RL ++APE L R Y ++D+WS GV+ + I
Sbjct: 178 FGLARDVHNIDYYKKTTNGRL-----PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTL 232
Query: 350 GSRPF 354
G P+
Sbjct: 233 GGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 60/254 (23%), Positives = 98/254 (38%), Gaps = 56/254 (22%)
Query: 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCC 186
+ +G G FG C + K K DVA+K L+ + F
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT---------LKAGSSDKQRLDFL------- 53
Query: 187 LFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR 246
E I+ H N+++ + I+ E + G L D+ L
Sbjct: 54 -------------TEASIMGQFD-HPNIIRLEGVVTKSRPVMIITEYMENGSL-DKFLR- 97
Query: 247 GGKYSEEDAKIVMVQIL-------SVVAFCHFQGVVHRDLKPENFLFTSKEENSSL--KA 297
E D K + Q++ S + + VHRDL N L NS+L K
Sbjct: 98 -----ENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV-----NSNLVCKV 147
Query: 298 IDFGLSDYVKPDERLNDIVG---SAYYVAPEVL-HRSYGTEADMWSIGVIAY-ILLCGSR 352
DFGLS ++ E G + APE + +R + + +D+WS G++ + ++ G R
Sbjct: 148 SDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER 207
Query: 353 PFWARTESGIFRAV 366
P+W + + +AV
Sbjct: 208 PYWDMSNQDVIKAV 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 51/186 (27%), Positives = 87/186 (46%), Gaps = 35/186 (18%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---GGKYS 251
+ D+ E+++++ + HKN++ A D +Y+++E G L + + +R G +Y
Sbjct: 67 LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYC 126
Query: 252 EEDAKIVMVQILSV--VAFCHFQ-----------GVVHRDLKPENFLFTSKEENSSLKAI 298
+ V + LS + C +Q +HRDL N L T E++ +K
Sbjct: 127 YNPTQ-VPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIA 182
Query: 299 DFGLS------DYVKP--DERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY-ILL 348
DFGL+ DY K + RL ++APE L R Y ++D+WS GV+ + I
Sbjct: 183 DFGLARDIHHIDYYKKTTNGRL-----PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
Query: 349 CGSRPF 354
G P+
Sbjct: 238 LGGSPY 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 1e-08
Identities = 49/176 (27%), Positives = 79/176 (44%), Gaps = 17/176 (9%)
Query: 200 REVKILRALTGHKNLVQFYDAY--EDDDNIYIVMELCKGGELLDRILSRGGKYSEED--- 254
RE+ +LR L H N++ + D ++++ + + R K +++
Sbjct: 47 REIALLRELK-HPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQL 105
Query: 255 ----AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSK-EENSSLKAIDFGLSDY---- 305
K ++ QIL + + H V+HRDLKP N L + E +K D G +
Sbjct: 106 PRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP 165
Query: 306 VKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTE 359
+KP L+ +V + +Y APE+L R Y D+W+IG I LL F R E
Sbjct: 166 LKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 59/244 (24%), Positives = 99/244 (40%), Gaps = 50/244 (20%)
Query: 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHC-PKH 173
F K+++ + +G GHFG K SL D A +M+ V L+ C ++
Sbjct: 1 FHKRYL---KKIRVLGEGHFG--------KVSLYCYDPANDGTGEMVAVKTLKRECGQQN 49
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED--DDNIYIVM 231
++E+ IL+ L H+N+V++ + + ++M
Sbjct: 50 T---------------------SGWKKEINILKTLY-HENIVKYKGCCSEQGGKGLQLIM 87
Query: 232 ELCKGGELLDRILSRGGKYSEEDAKIVMV--QILSVVAFCHFQGVVHRDLKPENFLFTSK 289
E G L D + K+ A++++ QI +A+ H Q +HRDL N L
Sbjct: 88 EYVPLGSLRDYL----PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL--- 140
Query: 290 EENSSLKAIDFGLSDYVKPDERL----NDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIA 344
+ + +K DFGL+ V D ++ A E L + +D+WS GV
Sbjct: 141 DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTL 200
Query: 345 YILL 348
Y LL
Sbjct: 201 YELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 41/132 (31%), Positives = 69/132 (52%), Gaps = 8/132 (6%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
+ V+ E L AL+ +V Y + + +N+Y+VME GG++ +L G + EE
Sbjct: 48 VHQVQAERDAL-ALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDV-KSLLHIYGYFDEEM 105
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN- 313
A + ++ + + H G++HRDLKP+N L +++ +K DFGLS V + LN
Sbjct: 106 AVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE---GHIKLTDFGLSK-VTLNRELNM 161
Query: 314 -DIVGSAYYVAP 324
DI+ + P
Sbjct: 162 MDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 4/104 (3%)
Query: 246 RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305
R + A I+ QIL + + H Q ++HRD+K EN + + D G + +
Sbjct: 150 RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQF 206
Query: 306 VKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILL 348
+ G+ APEVL R Y ++AD+WS G++ + +L
Sbjct: 207 PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 59/257 (22%), Positives = 97/257 (37%), Gaps = 65/257 (25%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G G FG CS + K + VA+K L+ + + F
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKT---------LKAGYTEKQRRDFL--------- 53
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
E I+ H N++ + IV E + G L D L +
Sbjct: 54 -----------SEASIMGQFD-HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRK-- 98
Query: 249 KYSEEDAKIVMVQ-------ILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
D + ++Q I S + + G VHRDL N L S N K DFG
Sbjct: 99 ----HDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNS---NLVCKVSDFG 151
Query: 302 LSDYVKPDERLNDIVGSAY----------YVAPEVL-HRSYGTEADMWSIGVIAY-ILLC 349
LS ++ D +AY + APE + +R + + +D+WS G++ + ++
Sbjct: 152 LSRVLEDDPE------AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSY 205
Query: 350 GSRPFWARTESGIFRAV 366
G RP+W + + +A+
Sbjct: 206 GERPYWEMSNQDVIKAI 222
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 16/172 (9%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVM- 259
E +++ L H LV+ Y A + IYI+ E + G L+D + + G + I M
Sbjct: 51 EANLMKQLQ-HPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA 108
Query: 260 VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSA 319
QI +AF + +HRDL+ N L + E K DFGL+ ++ +E G+
Sbjct: 109 AQIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAR-EGAK 164
Query: 320 Y---YVAPEVLHRSYGT---EADMWSIGV-IAYILLCGSRPFWARTESGIFR 364
+ + APE + +YGT ++D+WS G+ + I+ G P+ T + +
Sbjct: 165 FPIKWTAPEAI--NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQ 214
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 30/210 (14%)
Query: 213 NLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272
N+V + +D++++V++ +GG+L I EE K +++ + H +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL-NIPEECVKRWAAEMVVALDALHRE 104
Query: 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYG 332
G+V RDL P N L ++ ++ F V+ + V Y APEV S
Sbjct: 105 GIVCRDLNPNNILL---DDRGHIQLTYFSRWSEVED-SCDGEAV-ENMYCAPEVGGISEE 159
Query: 333 TEA-DMWSIGVIAYILLCG-----SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAI 386
TEA D WS+G I + LL G P SGI P + +S EA
Sbjct: 160 TEACDWWSLGAILFELLTGKTLVECHP------SGINTHTTLNIPEW-------VSEEAR 206
Query: 387 DFVKRLLNKDYRKRLTAAQA-----LSHPW 411
+++LL + +RL A A SHP+
Sbjct: 207 SLLQQLLQFNPTERLGAGVAGVEDIKSHPF 236
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 46/162 (28%), Positives = 76/162 (46%), Gaps = 11/162 (6%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
E E +I++ L H LVQ Y A ++ IYIV E G LLD + G+ +
Sbjct: 46 ESFLEEAQIMKKLR-HDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPN 103
Query: 256 KIVMV-QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLND 314
+ M Q+ + +A+ +HRDL+ N L + K DFGL+ ++ D
Sbjct: 104 LVDMAAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIE-DNEYTA 159
Query: 315 IVGSAY---YVAPE-VLHRSYGTEADMWSIGVIAYILLCGSR 352
G+ + + APE L+ + ++D+WS G++ L+ R
Sbjct: 160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 59/241 (24%), Positives = 99/241 (41%), Gaps = 49/241 (20%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQD--VAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCC 186
+GRG FG AKAK +G + V VK + K DE
Sbjct: 13 LGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK--------------------TKDENLQ 52
Query: 187 LFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRIL-S 245
+ RRE+ + R L+ HKN+V+ + + Y+++E G+L + +
Sbjct: 53 S---------EFRRELDMFRKLS-HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRAT 102
Query: 246 RGGKYSEEDAKIVMVQILSVVAFCHFQGV--------VHRDLKPENFLFTSKEENSSLKA 297
+ + + Q +++ G+ VHRDL N L +S+ E +K
Sbjct: 103 KSKDEKLKPPPLSTKQKVALCT-QIALGMDHLSNARFVHRDLAARNCLVSSQRE---VKV 158
Query: 298 IDFGLSDYVKPDE--RLNDIVGSAYYVAPE-VLHRSYGTEADMWSIGVIAY-ILLCGSRP 353
LS V E +L + + ++APE V + T++D+WS GV+ + + G P
Sbjct: 159 SLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELP 218
Query: 354 F 354
F
Sbjct: 219 F 219
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 66/217 (30%)
Query: 249 KYSEEDAKIV---MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-- 303
K E + KI+ M QIL + H G+VHRD+KP+N +F+ E + S K ID G +
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAAD 305
Query: 304 -----DYVKPDERLNDIVGSAYYVAPEVLHRSYGT-EA---------------------- 335
+Y+ P E L D Y APE S T A
Sbjct: 306 LRVGINYI-PKEFLLD----PRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRF 360
Query: 336 DMWSIGVIAYILLCGSRPFWARTESGI--FRAVLKADPSFDEAPWPSLSP---------- 383
D++S G+I ++ + R++S + F LK +D W L
Sbjct: 361 DIYSAGLI-FLQMAFPN---LRSDSNLIQFNRQLK-RNDYDLVAWRKLVEPRASPDLRRG 415
Query: 384 -EAID--------FVKRLLNKDYRKRLTAAQALSHPW 411
E +D +K ++ R+R++A AL+HP+
Sbjct: 416 FEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPY 452
|
Length = 566 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 33/131 (25%), Positives = 62/131 (47%), Gaps = 8/131 (6%)
Query: 229 IVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTS 288
+V +L G LLD + + VQI + + +VHR+L N L S
Sbjct: 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKS 144
Query: 289 KEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIA 344
+S ++ DFG++D + PD++ ++ ++A E + Y ++D+WS GV
Sbjct: 145 ---DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTV 201
Query: 345 YILLC-GSRPF 354
+ ++ G+ P+
Sbjct: 202 WEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 30/112 (26%), Positives = 47/112 (41%), Gaps = 15/112 (13%)
Query: 196 EDVRREVKILRALTGHKNLV-QFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
D REV IL+ L V + + E D Y++ME +G L + SEE+
Sbjct: 36 ADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL--------DEVSEEE 87
Query: 255 AKIVMVQILSVVAFCH---FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
+ + Q+ ++A H + H DL P N L + L ID+ +
Sbjct: 88 KEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD---DGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 61/255 (23%), Positives = 103/255 (40%), Gaps = 58/255 (22%)
Query: 125 LGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEY 184
LG+ +G G FG A+A D V V KM+ +N
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKML-----------KDN--------- 55
Query: 185 CCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRIL 244
T + D+ E+++++ + HKN++ + +Y+++E G L + +
Sbjct: 56 -----ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLR 110
Query: 245 SR----------GGKYSEE-----DAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSK 289
+R K EE D Q+ + + + +HRDL N L T
Sbjct: 111 ARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT-- 168
Query: 290 EENSSLKAIDFGLS------DYVK--PDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSI 340
E++ +K DFGL+ DY K + RL ++APE L R Y ++D+WS
Sbjct: 169 -EDNVMKIADFGLARGVHDIDYYKKTSNGRL-----PVKWMAPEALFDRVYTHQSDVWSF 222
Query: 341 GVIAY-ILLCGSRPF 354
G++ + I G P+
Sbjct: 223 GILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 67/254 (26%), Positives = 98/254 (38%), Gaps = 64/254 (25%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G G+FG A+ KK L+ D A+K + + ++H+
Sbjct: 15 IGEGNFGQVLKARIKKDGLR-MDAAIKRMKEY----------ASKDDHR----------- 52
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
D E+++L L H N++ A E +Y+ +E G LLD + R
Sbjct: 53 --------DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL--RKS 102
Query: 249 KYSEEDAKIVMVQ----ILSVVAFCHFQG-------------VVHRDLKPENFLFTSKEE 291
+ E D + LS HF +HRDL N L E
Sbjct: 103 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---E 159
Query: 292 NSSLKAIDFGLSD----YVKPDE-RLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAY 345
N K DFGLS YVK RL ++A E L+ S Y T +D+WS GV+ +
Sbjct: 160 NYVAKIADFGLSRGQEVYVKKTMGRL-----PVRWMAIESLNYSVYTTNSDVWSYGVLLW 214
Query: 346 -ILLCGSRPFWART 358
I+ G P+ T
Sbjct: 215 EIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 3e-07
Identities = 50/175 (28%), Positives = 76/175 (43%), Gaps = 31/175 (17%)
Query: 190 TTAIAIEDVRREVKILRALTGHKNLVQF----YDAYEDDDNIYIVMELCKGGELLDRILS 245
+TA + D RE++IL++L H N+V++ Y A N+ +VME G L D +
Sbjct: 44 STAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQK 100
Query: 246 RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305
+ + QI + + + VHRDL N L E + +K DFGL+
Sbjct: 101 HRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV---ESENRVKIGDFGLTKV 157
Query: 306 VKPDERLNDIVGSAYYV------------APEVLHRS-YGTEADMWSIGVIAYIL 347
+ D+ YY APE L S + +D+WS GV+ Y L
Sbjct: 158 LPQDKE--------YYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 48/181 (26%), Positives = 85/181 (46%), Gaps = 12/181 (6%)
Query: 192 AIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYS 251
++++E E +++ L H LV+ + A + IYI+ E G LLD + S G
Sbjct: 42 SMSVEAFLAEANVMKTLQ-HDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQ 99
Query: 252 EEDAKI-VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE 310
I QI +AF + +HRDL+ N L ++ K DFGL+ ++ +E
Sbjct: 100 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNE 156
Query: 311 RLNDIVGSAY---YVAPEVL-HRSYGTEADMWSIGV-IAYILLCGSRPFWARTESGIFRA 365
G+ + + APE + S+ ++D+WS G+ + I+ G P+ + + RA
Sbjct: 157 YTAR-EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 215
Query: 366 V 366
+
Sbjct: 216 L 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 33/101 (32%), Positives = 49/101 (48%), Gaps = 10/101 (9%)
Query: 315 IVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSF 373
I+G+ Y+APE+L + +G D W++GV + L G PF T +F+ +L D
Sbjct: 540 ILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRD--- 596
Query: 374 DEAPWP----SLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
PWP LS A + ++ LL D KR + HP
Sbjct: 597 --IPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 65/252 (25%), Positives = 103/252 (40%), Gaps = 60/252 (23%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G G+FG A KK LK + A+K++ + +H+
Sbjct: 10 IGEGNFGQVIRAMIKKDGLK-MNAAIKMLKEF----------ASENDHR----------- 47
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD-----RI 243
D E+++L L H N++ A E+ +YI +E G LLD R+
Sbjct: 48 --------DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRV 99
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFC-------HF---QGVVHRDLKPENFLFTSKEENS 293
L +++E + ++ F + + +HRDL N L EN
Sbjct: 100 LETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENL 156
Query: 294 SLKAIDFGLSD----YVKPDE-RLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAY-I 346
+ K DFGLS YVK RL ++A E L+ S Y T++D+WS GV+ + I
Sbjct: 157 ASKIADFGLSRGEEVYVKKTMGRL-----PVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211
Query: 347 LLCGSRPFWART 358
+ G P+ T
Sbjct: 212 VSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 65/252 (25%), Positives = 102/252 (40%), Gaps = 60/252 (23%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G G+FG A+ KK L+ D A+K + + ++H+
Sbjct: 3 IGEGNFGQVLKARIKKDGLR-MDAAIKRMKEY----------ASKDDHR----------- 40
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD-----RI 243
D E+++L L H N++ A E +Y+ +E G LLD R+
Sbjct: 41 --------DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRV 92
Query: 244 LSRGGKYSEEDAKIVMV---QILSVVA-------FCHFQGVVHRDLKPENFLFTSKEENS 293
L ++ ++ + Q+L A + + +HRDL N L EN
Sbjct: 93 LETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENY 149
Query: 294 SLKAIDFGLSD----YVKPDE-RLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAY-I 346
K DFGLS YVK RL ++A E L+ S Y T +D+WS GV+ + I
Sbjct: 150 VAKIADFGLSRGQEVYVKKTMGRL-----PVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204
Query: 347 LLCGSRPFWART 358
+ G P+ T
Sbjct: 205 VSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 43/170 (25%), Positives = 81/170 (47%), Gaps = 10/170 (5%)
Query: 190 TTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGK 249
T+ A +++ E ++ A H ++V+ + ++ +L G LLD + +
Sbjct: 48 TSPKANKEILDEAYVM-ASVDHPHVVRLL-GICLSSQVQLITQLMPLGCLLDYVRNHKDN 105
Query: 250 YSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD 309
+ VQI +++ + +VHRDL N L + + +K DFGL+ + D
Sbjct: 106 IGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLDVD 162
Query: 310 ERLNDIVGSAY---YVAPE-VLHRSYGTEADMWSIGVIAYILLC-GSRPF 354
E+ G ++A E +LHR Y ++D+WS GV + L+ G++P+
Sbjct: 163 EKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 6e-07
Identities = 45/182 (24%), Positives = 79/182 (43%), Gaps = 13/182 (7%)
Query: 211 HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCH 270
H N+++ I+ E + G L + G++S ++ I + + +
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAY---YVAPEV 326
VHRDL N L S N K DFGLS ++ D E G + APE
Sbjct: 125 DMNYVHRDLAARNILVNS---NLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEA 181
Query: 327 L-HRSYGTEADMWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPE 384
+ +R + + +D+WS G++ + ++ G RP+W + + +A+ + F P P P
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI---NDGF-RLPAPMDCPS 237
Query: 385 AI 386
A+
Sbjct: 238 AV 239
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 9e-07
Identities = 37/133 (27%), Positives = 62/133 (46%), Gaps = 8/133 (6%)
Query: 227 IYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286
+ +V +L G LLD + + +D VQI +++ +VHRDL N L
Sbjct: 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV 142
Query: 287 TSKEENSSLKAIDFGLSDYVKPDERLNDIVGS----AYYVAPEVLHRSYGTEADMWSIGV 342
S + +K DFGL+ + DE G + +LHR + ++D+WS GV
Sbjct: 143 KSP---NHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGV 199
Query: 343 IAYILLC-GSRPF 354
+ L+ G++P+
Sbjct: 200 TVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-06
Identities = 52/254 (20%), Positives = 97/254 (38%), Gaps = 63/254 (24%)
Query: 124 ELGEEVGRGHFGYT---CSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
L E+G+G FG + KG + + VA+K + + E +F
Sbjct: 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETR-VAIKT---------VNENASMRERIEFLN 58
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
E +++ H ++V+ +VMEL G+L
Sbjct: 59 --------------------EASVMKEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDLK 97
Query: 241 DRILSRGGKYSEEDAKIVMV-----------QILSVVAFCHFQGVVHRDLKPENFLFTSK 289
+ SR + E+ + +I +A+ + VHRDL N +
Sbjct: 98 SYLRSR--RPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA-- 153
Query: 290 EENSSLKAIDFGL------SDYVKPD-ERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIG 341
E+ ++K DFG+ +DY + + L + ++APE L + T++D+WS G
Sbjct: 154 -EDLTVKIGDFGMTRDIYETDYYRKGGKGLLPV----RWMAPESLKDGVFTTKSDVWSFG 208
Query: 342 VIAY-ILLCGSRPF 354
V+ + + +P+
Sbjct: 209 VVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 53/256 (20%), Positives = 100/256 (39%), Gaps = 43/256 (16%)
Query: 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
V+ ++ E +G G FG C + K + VA+K L+ + + F
Sbjct: 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKT---------LKSGYTEKQRRDFL 53
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
E I+ H N++ + I+ E + G L
Sbjct: 54 --------------------SEASIMGQFD-HPNIIHLEGVVTKSRPVMIITEFMENGAL 92
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
+ G+++ ++ I + + + VHRDL N L S N K D
Sbjct: 93 DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNS---NLVCKVSD 149
Query: 300 FGLSDYVKPDERLNDIVGSAY-------YVAPE-VLHRSYGTEADMWSIGVIAY-ILLCG 350
FGLS +++ D+ + S+ + APE + +R + + +D+WS G++ + ++ G
Sbjct: 150 FGLSRFLE-DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG 208
Query: 351 SRPFWARTESGIFRAV 366
RP+W + + A+
Sbjct: 209 ERPYWDMSNQDVINAI 224
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 18/112 (16%)
Query: 253 EDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-------DY 305
ED Q+ + F + +HRDL N L + EN+ +K DFGL+ DY
Sbjct: 179 EDLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDY 235
Query: 306 V-KPDERLNDIVGSAYYVAPE-VLHRSYGTEADMWSIGVIAY-ILLCGSRPF 354
V K D RL ++APE + R Y ++D+WS GV+ + I G+ P+
Sbjct: 236 VRKGDARL-----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 282
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 4e-06
Identities = 33/100 (33%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 260 VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSA 319
VQI + + + +VHRDL N L + + +K DFGL+ + DE+ G
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHAEGGK 172
Query: 320 Y---YVAPE-VLHRSYGTEADMWSIGVIAYILLC-GSRPF 354
++A E +LHR Y ++D+WS GV + L+ GS+P+
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 6e-06
Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 31/169 (18%)
Query: 211 HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQIL----SVV 266
H+N+V+ + +I++EL GG+L L E + + M +L V
Sbjct: 68 HQNIVRLIGVSFERLPRFILLELMAGGDLKS-FLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 267 AFCHF---QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYY-- 321
C + +HRD+ N L T K K DFG++ DI ++YY
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA---------RDIYRASYYRK 177
Query: 322 ----------VAPEV-LHRSYGTEADMWSIGVIAY-ILLCGSRPFWART 358
+ PE L + ++ D+WS GV+ + I G P+ RT
Sbjct: 178 GGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 9e-06
Identities = 56/224 (25%), Positives = 91/224 (40%), Gaps = 37/224 (16%)
Query: 211 HKNLVQFYDAYEDDDNIYIVMELCKGG----ELLDRILSRGGKYSEEDAKIVMV------ 260
+KNL+ + D N Y+ M+ + R R G Y ++D ++
Sbjct: 151 YKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELA 210
Query: 261 -----------QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD 309
Q+ ++F + +HRDL N L T K DFGL+ ++ D
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRND 267
Query: 310 ERLNDIV-GSAY----YVAPE-VLHRSYGTEADMWSIGVIAY-ILLCGSRPFWARTESGI 362
N +V G+A ++APE + + Y E+D+WS G++ + I GS P+
Sbjct: 268 S--NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK 325
Query: 363 FRAVLKADPSFDEAPWPSLSP-EAIDFVKRLLNKDYRKRLTAAQ 405
F ++K P +P E D +K + D KR T Q
Sbjct: 326 FYKMIKEGYRMLS---PECAPSEMYDIMKSCWDADPLKRPTFKQ 366
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 18/90 (20%)
Query: 275 VHRDLKPENFLFTSKEENSSLKAIDFGLS-------DYV-KPDERLNDIVGSAYYVAPE- 325
+HRDL N L + EN+ +K DFGL+ DYV K D RL ++APE
Sbjct: 195 IHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL-----PLKWMAPES 246
Query: 326 VLHRSYGTEADMWSIGVIAY-ILLCGSRPF 354
+ + Y T++D+WS GV+ + I G+ P+
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPY 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 1e-05
Identities = 33/105 (31%), Positives = 51/105 (48%), Gaps = 12/105 (11%)
Query: 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS------DYVKPDERLND 314
Q+ + +A+ + VHRDL N L EN +K DFGLS DY K E ND
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVG---ENMVVKIADFGLSRNIYSADYYKASE--ND 192
Query: 315 IVGSAYYVAPEVLHRSYGTEADMWSIGVIAY-ILLCGSRPFWART 358
+ + + + Y TE+D+W+ GV+ + I G +P++
Sbjct: 193 AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 52/258 (20%), Positives = 100/258 (38%), Gaps = 54/258 (20%)
Query: 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGG---ELLDRILSRGGKYSEEDAKI 257
E+ R L H N++ + ++ D +Y+V L G +LL G E
Sbjct: 49 EIITSRQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG--LPELAIAF 105
Query: 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS---DYVKPDERLND 314
++ +L+ + + H +G +HR +K + L + K + GL +K +R
Sbjct: 106 ILKDVLNALDYIHSKGFIHRSVKASHILLS-----GDGKVVLSGLRYSVSMIKHGKRQRV 160
Query: 315 IVGSA-------YYVAPEVLHRS---YGTEADMWSIGVIAYILLCGSRPFWA-------- 356
+ +++PEVL ++ Y ++D++S+G+ A L G PF
Sbjct: 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLL 220
Query: 357 ------------RTESGIFRAVLKADPSFDEAPWP----------SLSPEAIDFVKRLLN 394
++ ++ + S +E P + S FV+ L
Sbjct: 221 EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQ 280
Query: 395 KDYRKRLTAAQALSHPWL 412
+D R +A+Q L+H +
Sbjct: 281 RDPESRPSASQLLNHSFF 298
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 44/173 (25%), Positives = 59/173 (34%), Gaps = 39/173 (22%)
Query: 140 AKAKKGSLKGQDVAVKV-IPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198
A G VK IPK +H LDE + E
Sbjct: 10 AIIYLTDFLGLPAVVKERIPKRY----------RHPE-----LDE--------KLRRERT 46
Query: 199 RREVKILRALTGHKNLVQFYDAYE-DDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKI 257
RRE +IL + V Y+ D DN IVME +G L D + E
Sbjct: 47 RREARILAKA--REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEARPDLLRE---- 100
Query: 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE 310
+ +V H G+VH DL N + + + IDFGL ++ E
Sbjct: 101 ----VGRLVGKLHKAGIVHGDLTTSNIILSG----GRIYFIDFGLGEFSDEVE 145
|
Length = 204 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 2e-05
Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 25/175 (14%)
Query: 202 VKILRALTGHKNLVQFYD-----AYEDDDNIYIVMELCKGG--ELLDRILSRGG--KYSE 252
+KIL TG K V+F D A D ++ ++ +C +L+ +++ G Y
Sbjct: 41 IKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVH 100
Query: 253 ED-----AKIVM---VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSD 304
E +++++ VQI + + + +VHRDL N L S + +K DFGL+
Sbjct: 101 EHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSP---NHVKITDFGLAR 157
Query: 305 YVKPDERLNDIVGSAY---YVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354
++ DE+ + G ++A E +H R + ++D+WS GV + L+ G +P+
Sbjct: 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPY 212
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 3e-05
Identities = 61/259 (23%), Positives = 100/259 (38%), Gaps = 61/259 (23%)
Query: 125 LGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEY 184
LG+ +G G FG A A + LKG+ V KM+ EN
Sbjct: 4 LGKTLGEGEFGKVVKATAFR--LKGRAGYTTVAVKML-----------KEN--------- 41
Query: 185 CCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL----- 239
++ + D+ E +L+ + H ++++ Y A D + +++E K G L
Sbjct: 42 -----ASSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLR 95
Query: 240 LDRILSRGGKYS-------------EEDAKIVMV-----QILSVVAFCHFQGVVHRDLKP 281
R + S E + + QI + + +VHRDL
Sbjct: 96 ESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155
Query: 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVL-HRSYGTEAD 336
N L E +K DFGLS V ++ R + ++A E L Y T++D
Sbjct: 156 RNVLVA---EGRKMKISDFGLSRDVYEEDSYVKRSKGRI-PVKWMAIESLFDHIYTTQSD 211
Query: 337 MWSIGVIAY-ILLCGSRPF 354
+WS GV+ + I+ G P+
Sbjct: 212 VWSFGVLLWEIVTLGGNPY 230
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 51/186 (27%), Positives = 77/186 (41%), Gaps = 38/186 (20%)
Query: 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL---------LDRIL 244
A ED +EVKIL L+ N+ + D + ++ME + G+L L
Sbjct: 62 AREDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL 120
Query: 245 SRGGKYSEEDAKIVM-VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
+ K + M QI S + + VHRDL N L N ++K DFG+S
Sbjct: 121 ACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK---NYTIKIADFGMS 177
Query: 304 ------DYVKPDERLNDIVGSAYYVAP-------EVLHRSYGTEADMWSIGVIAY-IL-L 348
DY + + G A P VL + T++D+W+ GV + IL L
Sbjct: 178 RNLYSSDYYR-------VQGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTL 228
Query: 349 CGSRPF 354
C +P+
Sbjct: 229 CREQPY 234
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 3e-05
Identities = 36/112 (32%), Positives = 55/112 (49%), Gaps = 18/112 (16%)
Query: 253 EDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-------DY 305
ED Q+ + F + +HRDL N L + EN+ +K DFGL+ DY
Sbjct: 174 EDLICYSFQVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDY 230
Query: 306 V-KPDERLNDIVGSAYYVAPE-VLHRSYGTEADMWSIGVIAY-ILLCGSRPF 354
V K RL ++APE + + Y T++D+WS GV+ + I G+ P+
Sbjct: 231 VRKGSARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPY 277
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 35/115 (30%), Positives = 44/115 (38%), Gaps = 19/115 (16%)
Query: 199 RREVKILRALTGHKNLVQ---FYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
R E ++L K V YD D DN IVME +G L D I + E
Sbjct: 45 RNEARLLSRA--RKAGVNTPVVYDV--DPDNKTIVMEYIEGKPLKDVIEEGNDELLREIG 100
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE 310
++V H G+VH DL N + + L IDFGL Y E
Sbjct: 101 RLV--------GKLHKAGIVHGDLTTSNIIVR----DDKLYLIDFGLGKYSDEIE 143
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 5e-05
Identities = 60/245 (24%), Positives = 104/245 (42%), Gaps = 65/245 (26%)
Query: 128 EVGRGHFGYTCSAKAKKGSLKGQ----DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
E+G G+FG C KKG K + DVA+KV+ K+EN + ++ DE
Sbjct: 2 ELGSGNFG--C---VKKGVYKMRKKQIDVAIKVL--------------KNENEK-SVRDE 41
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
+ RE +I+ L + +V+ E + + +VME+ GG L +
Sbjct: 42 --------------MMREAEIMHQLD-NPYIVRMIGVCEAE-ALMLVMEMASGGPLNKFL 85
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
+ + + + +M Q+ + + + VHRDL N L ++ K DFGLS
Sbjct: 86 SGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH---YAKISDFGLS 142
Query: 304 DYVKPDERLNDIVGSAYY------------VAPEVLH-RSYGTEADMWSIGVIAYILLC- 349
+ D+ +YY APE ++ R + + +D+WS G+ +
Sbjct: 143 KALGADD--------SYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSY 194
Query: 350 GSRPF 354
G +P+
Sbjct: 195 GQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 5e-05
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 7/89 (7%)
Query: 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN---DIVG 317
Q+LS + + H +G++HRD+K EN + + E+ L DFG + + + I G
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTEN-VLVNGPEDICLG--DFGAACFARGSWSTPFHYGIAG 324
Query: 318 SAYYVAPEVLH-RSYGTEADMWSIGVIAY 345
+ APEVL Y D+WS G++ +
Sbjct: 325 TVDTNAPEVLAGDPYTPSVDIWSAGLVIF 353
|
Length = 461 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 6e-05
Identities = 31/116 (26%), Positives = 49/116 (42%), Gaps = 18/116 (15%)
Query: 199 RREVKILRALTGHKNLVQFYDAYEDD-DNIYIVMELCKG---GELLDRILSRGGKYSEED 254
RRE +I+ K V Y D +N IVME +G +L++ + S E
Sbjct: 47 RREARIMSRA--RKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGMEELELSREI 104
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE 310
++V H G++H DL N + + + IDFGL+++ K E
Sbjct: 105 GRLV--------GKLHSAGIIHGDLTTSNMILS----GGKIYLIDFGLAEFSKDLE 148
|
Length = 211 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 6e-05
Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 34/188 (18%)
Query: 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL--------LDRILS 245
A D +EVKIL L N+++ D+D + ++ E + G+L LD
Sbjct: 62 ARNDFLKEVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEE 120
Query: 246 RGGKYSEEDAKI----------VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
G + V +QI S + + VHRDL N L EN ++
Sbjct: 121 NGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVG---ENLTI 177
Query: 296 KAIDFGLS------DYVKPDERLNDIVGSAYYVAPE-VLHRSYGTEADMWSIGVIAY--I 346
K DFG+S DY + R V ++A E +L + T +D+W+ GV + +
Sbjct: 178 KIADFGMSRNLYAGDYYRIQGR---AVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
Query: 347 LLCGSRPF 354
+LC +P+
Sbjct: 235 MLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 3e-04
Identities = 52/223 (23%), Positives = 96/223 (43%), Gaps = 40/223 (17%)
Query: 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCL 187
E+G G+FG KKG K + V K++ K++N+ + DE
Sbjct: 2 ELGSGNFG-----TVKKGMYKMKKSEKTVAVKIL----------KNDNNDPALKDE---- 42
Query: 188 FMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG 247
+ RE +++ L + +V+ E + + +VMEL + G L ++ L +
Sbjct: 43 ----------LLREANVMQQLD-NPYIVRMIGICEAE-SWMLVMELAELGPL-NKFLQKN 89
Query: 248 GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK 307
+E++ ++ Q+ + + VHRDL N L ++ K DFGLS +
Sbjct: 90 KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH---YAKISDFGLSKALG 146
Query: 308 PDERLNDIVGSAYY----VAPEVL-HRSYGTEADMWSIGVIAY 345
DE + APE + + + +++D+WS GV+ +
Sbjct: 147 ADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 57/232 (24%), Positives = 88/232 (37%), Gaps = 66/232 (28%)
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVHRDLKPENFLFTSKEENSSLKA 297
LLD I+ G A+I+ Q + + H + ++H DLKPEN L + +
Sbjct: 218 LLDWIMKHGPFSHRHLAQIIF-QTGVALDYFHTELHLMHTDLKPENILMETSD-----TV 271
Query: 298 IDFGLSDYVKPDE---RLND-------------IVGSAYYVAPEV---LHRSYGTEADMW 338
+D + + PD R+ D IV + +Y +PEV L Y T DMW
Sbjct: 272 VDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYST--DMW 329
Query: 339 SIGVIAYILLCGSRPF----------------------WAR---TESG--IFRAVLKADP 371
S+G I Y L G + WA TE ++ + + P
Sbjct: 330 SMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRP 389
Query: 372 SFDEAPWPSLS-----------PEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
D ++ D + LL+ D +KRL A Q +HP++
Sbjct: 390 CTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYV 441
|
Length = 467 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 5e-04
Identities = 46/208 (22%), Positives = 81/208 (38%), Gaps = 54/208 (25%)
Query: 189 MTTAIAI------------EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG 236
T++AI ++ R+E + L + H N+V + ++ E
Sbjct: 34 SATSVAIKTLKENAEPKVQQEFRQEAE-LMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAH 92
Query: 237 GELLDRILSR----GGKYSEEDAKI-----------VMVQILSVVAFCHFQGVVHRDLKP 281
G+L + ++ D + + +QI + + + VHRDL
Sbjct: 93 GDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAA 152
Query: 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYY------------VAPE-VLH 328
N L E ++K DFGLS DI + YY + PE +L+
Sbjct: 153 RNCLVG---EGLTVKISDFGLS---------RDIYSADYYRVQSKSLLPVRWMPPEAILY 200
Query: 329 RSYGTEADMWSIGVIAY-ILLCGSRPFW 355
+ TE+D+WS GV+ + I G +P++
Sbjct: 201 GKFTTESDIWSFGVVLWEIFSYGLQPYY 228
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 6e-04
Identities = 44/198 (22%), Positives = 85/198 (42%), Gaps = 35/198 (17%)
Query: 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-----GKYS 251
+ ++E ++ L H N+V + + ++ E G+L + ++ R G S
Sbjct: 53 EFQQEASLMAELH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSS 111
Query: 252 EEDAKI-----------VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
+ED + + +QI + + + VH+DL N L E +K D
Sbjct: 112 DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDL 168
Query: 301 GLS------DY--VKPDERLNDIVGSAYYVAPE-VLHRSYGTEADMWSIGVIAY-ILLCG 350
GLS DY V+P L ++ PE +++ + +++D+WS GV+ + I G
Sbjct: 169 GLSREIYSADYYRVQPKSLL-----PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFG 223
Query: 351 SRPFWARTESGIFRAVLK 368
+P++ + + V K
Sbjct: 224 LQPYYGFSNQEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 29/89 (32%), Positives = 45/89 (50%), Gaps = 6/89 (6%)
Query: 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG-LSDYVKPDE-RLNDI 315
+M Q+L V + H + ++HRD+K EN +F + + L DFG + K E
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLEN-IFLNCDGKIVLG--DFGTAMPFEKEREAFDYGW 328
Query: 316 VGSAYYVAPEVLHR-SYGTEADMWSIGVI 343
VG+ +PE+L Y D+WS G+I
Sbjct: 329 VGTVATNSPEILAGDGYCEITDIWSCGLI 357
|
Length = 501 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 22/46 (47%), Positives = 29/46 (63%), Gaps = 3/46 (6%)
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
K VM Q+L+ + H G+VHRD+KPEN L T + +K IDFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV---DGQVKIIDFG 354
|
Length = 507 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 48/224 (21%), Positives = 91/224 (40%), Gaps = 33/224 (14%)
Query: 193 IAIEDVRREVKILRALTGHKNLVQ----FYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+ I+ E+K LR + + N+++ D +D + +++E C G L R
Sbjct: 60 VLIDITENEIKNLRRIDSN-NILKIYGFIIDIVDDLPRLSLILEYCTRGYL------REV 112
Query: 249 KYSEED------AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
E+D + + + + +++L +FL T EN LK I GL
Sbjct: 113 LDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT---ENYKLKIICHGL 169
Query: 303 SD--YVKPDERLNDIVGSAYYVAPEVLH---RSYGTEADMWSIGVIAYILLCGSRPFWAR 357
P + +N +V Y + ++L+ Y + D++S+GV+ + + G PF
Sbjct: 170 EKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL 225
Query: 358 TESGIFRAVLKADPSFDEAPWPSLSPEAID-FVKRLLNKDYRKR 400
T I+ ++ + + P P I V+ + D KR
Sbjct: 226 TTKEIYDLIINKN---NSLKLPLDCPLEIKCIVEACTSHDSIKR 266
|
Length = 283 |
| >gnl|CDD|223733 COG0661, AarF, Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 39/199 (19%), Positives = 66/199 (33%), Gaps = 57/199 (28%)
Query: 148 KGQDVAVKVI-PKMIGVIFL------------QVHCPKHENHQFT-ILDEYCCLFMTTAI 193
G++VAVKV P + I + P ++DE+ +
Sbjct: 148 SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE-----KRL 202
Query: 194 AIE-DVRREVKILRALTGHKNLVQFYDAYEDDDNIYI-------------VMELCKGGEL 239
E D RRE N +F + ++DD ++Y+ ME G ++
Sbjct: 203 REELDYRREAA---------NAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKI 253
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-----GVVHRDLKPENFLFTSKEENSS 294
D + A I ++ ++ + G H D P N L S
Sbjct: 254 SDIAAL-------KSAGIDRKELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGR--- 303
Query: 295 LKAIDFGLSDYVKPDERLN 313
+ +DFG+ + P R
Sbjct: 304 IVLLDFGIVGRLDPKFRRY 322
|
Length = 517 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 12/101 (11%)
Query: 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIV-GSA 319
Q+ + + F + VHRDL N L E +K DFGL+ + D N I GS
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDS--NYISKGST 301
Query: 320 Y----YVAPE-VLHRSYGTEADMWSIGVIAY-ILLCGSRPF 354
+ ++APE + + Y T +D+WS G++ + I G P+
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.002
Identities = 48/210 (22%), Positives = 85/210 (40%), Gaps = 30/210 (14%)
Query: 162 GVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR-----EVKILRALTGHKNLVQ 216
G L+ P E F +D C + I+ +R E ILRA+ H +++Q
Sbjct: 93 GFSILETFTPGAEGFAFACIDNKTC----EHVVIKAGQRGGTATEAHILRAIN-HPSIIQ 147
Query: 217 FYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276
+ + +++ K L L+ + D + +L + + H ++H
Sbjct: 148 LKGTFTYNKFTCLILPRYKTD--LYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIH 205
Query: 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYY--------VAPEVLH 328
RD+K EN +F + + L DFG + + DI + YY APE+L
Sbjct: 206 RDIKAEN-IFINHPGDVCLG--DFGAACFPV------DINANKYYGWAGTIATNAPELLA 256
Query: 329 RS-YGTEADMWSIGVIAYILLCGSRPFWAR 357
R YG D+WS G++ + + + +
Sbjct: 257 RDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286
|
Length = 391 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.003
Identities = 34/113 (30%), Positives = 52/113 (46%), Gaps = 14/113 (12%)
Query: 259 MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS------DYVKPDERL 312
M I S + + + +HRDL N + EN ++ DFGLS DY + R+
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLN---ENMNVCVADFGLSKKIYNGDYYR-QGRI 173
Query: 313 NDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPFWARTESGIF 363
+ ++A E L R Y T++D+WS GV + I G P+ S I+
Sbjct: 174 AKM--PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.004
Identities = 40/182 (21%), Positives = 80/182 (43%), Gaps = 30/182 (16%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKY---SE 252
E+ + E ++R+ H N+V + + ++ C +L + ++ R S
Sbjct: 53 EEFKHEA-MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGST 111
Query: 253 EDAKIV------------MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
+D K V + QI + + F VVH+DL N L K ++K D
Sbjct: 112 DDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK---LNVKISDL 168
Query: 301 GL------SDYVKPDERLNDIVGSAYYVAPE-VLHRSYGTEADMWSIGVIAY-ILLCGSR 352
GL +DY K + + + +++PE +++ + ++D+WS GV+ + + G +
Sbjct: 169 GLFREVYAADYYK---LMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQ 225
Query: 353 PF 354
P+
Sbjct: 226 PY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 482 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.91 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.9 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.83 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.78 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.74 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.56 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.46 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.34 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.33 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.2 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.15 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.12 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.06 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.01 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.0 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.92 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.85 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.82 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.68 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.61 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.59 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.54 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.53 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.37 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.37 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.33 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.32 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.27 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.25 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.14 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.92 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.87 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.81 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.7 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.64 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.62 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.6 | |
| PF00036 | 29 | EF-hand_1: EF hand; InterPro: IPR018248 Many calci | 97.54 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.54 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.51 | |
| PF13202 | 25 | EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ | 97.48 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.44 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.29 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.28 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.19 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.14 | |
| PLN02236 | 344 | choline kinase | 97.06 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.0 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.92 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.89 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 96.81 | |
| PF13405 | 31 | EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J | 96.77 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.65 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.04 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.02 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.89 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.88 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.72 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.69 | |
| PF13499 | 66 | EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A | 95.56 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.52 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.32 | |
| PF13833 | 54 | EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A | 95.25 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-64 Score=485.90 Aligned_cols=274 Identities=34% Similarity=0.637 Sum_probs=245.6
Q ss_pred ccccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHH
Q 011582 114 GFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAI 193 (482)
Q Consensus 114 ~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (482)
...+.+.+.|.+.+.||+|+||.|-+|..++ +|+.||||++++.... .|.. ...
T Consensus 165 ~~pks~~d~yii~~~LGsGafg~Vkla~e~~---tgk~vAiKIi~krk~~-----~~s~------------------~~~ 218 (475)
T KOG0615|consen 165 VPPKSFNDYYIISKTLGSGAFGLVKLAYEKK---TGKQVAIKIINKRKST-----GCSR------------------AIA 218 (475)
T ss_pred CccchhcceeEeeeeecCCceeEEEEEEEcc---cCcEEEeeeeehhhcc-----cccc------------------ccc
Confidence 3456688899999999999999999999998 9999999999875110 0000 011
Q ss_pred HHHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 194 ~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
....+.+|++||++|. |||||+++++|+..+..||||||++||+|++++... +.+.+...+.+++|++.||.|||++|
T Consensus 219 ~~~~v~~EieILkkL~-HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~n-k~l~ed~~K~~f~Qll~avkYLH~~G 296 (475)
T KOG0615|consen 219 KTRDVQNEIEILKKLS-HPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVAN-KYLREDLGKLLFKQLLTAVKYLHSQG 296 (475)
T ss_pred chhhhHHHHHHHHhcC-CCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhc-cccccchhHHHHHHHHHHHHHHHHcC
Confidence 1234689999999997 999999999999999999999999999999999866 68999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc----cCCCcchhhhhHHHHHHHhh
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR----SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~ellt 349 (482)
|+||||||+|||+..++++..+||+|||+|+.......+.+.||||.|.|||++.. .|..++|+||+||+||.+|+
T Consensus 297 I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs 376 (475)
T KOG0615|consen 297 IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS 376 (475)
T ss_pred cccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec
Confidence 99999999999998877888999999999999988888999999999999999863 24558999999999999999
Q ss_pred CCCCCCCCChHH-HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 350 GSRPFWARTESG-IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 350 g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
|.+||.+..... +.++|..+.+.|....|..+|+++.+||.+||..||++|||++|+|+||||+..
T Consensus 377 G~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~ 443 (475)
T KOG0615|consen 377 GYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA 443 (475)
T ss_pred cCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence 999998877666 899999999999999999999999999999999999999999999999999865
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-61 Score=438.44 Aligned_cols=299 Identities=34% Similarity=0.656 Sum_probs=273.0
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.+.|++-++||+|.|+.|+++.+.. +|+.+|+|+|... ..+..+.++
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~---tg~~fa~kiin~~----------------------------k~~~~~~e~ 56 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTK----------------------------KLSARDFQK 56 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhcc---chHHHHHHHhhhh----------------------------hhccccHHH
Confidence 466789999999999999999999887 8999999998643 122336788
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.|.+.|+ |||||+|.+.+.+++..|||+|++.|++|..-|..+ ..++|..+-.+++||+++|.|+|.+|||||
T Consensus 57 l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal~yCH~n~IvHR 134 (355)
T KOG0033|consen 57 LEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEALAYCHSNGIVHR 134 (355)
T ss_pred HHHHHHHHHhcC-CCcEeehhhhhcccceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHhcCceec
Confidence 999999999997 999999999999999999999999999999888877 678999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|+||+|+|+.+++...-+||+|||+|..+..+......+|||.|||||++.+ .|+..+|||+.|||||.||.|.+||++
T Consensus 135 DvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~ 214 (355)
T KOG0033|consen 135 DLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 214 (355)
T ss_pred cCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCC
Confidence 9999999999988889999999999999987778889999999999999975 699999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCC-CCccHHHHHHHHHHhc
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVK-IPSDMIVYKLIKAYIS 435 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~-~~~~~~~~~~~~~~~~ 435 (482)
.+...+++.|+.+.+.++.+.|+.+++++++||++||..||.+|+|+.|+|+|||+.+..... ......+.+.+++|..
T Consensus 215 ~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNa 294 (355)
T KOG0033|consen 215 EDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNA 294 (355)
T ss_pred ccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhH
Confidence 999999999999999999999999999999999999999999999999999999998764321 2233457789999999
Q ss_pred cchHHHHHHHhhhh
Q 011582 436 SSSLRKAALGALAK 449 (482)
Q Consensus 436 ~~~l~~~~~~~~~~ 449 (482)
+++|+-++|..+..
T Consensus 295 rRKLKgavLtav~s 308 (355)
T KOG0033|consen 295 RRKLKGAILTTVIA 308 (355)
T ss_pred HHHHHHHHHHHHHh
Confidence 99999999988853
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-59 Score=472.02 Aligned_cols=255 Identities=36% Similarity=0.644 Sum_probs=237.5
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|+.++.||+|||+.||.+++.. +|+.||+|++.|. ........+.+.+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~---tge~~A~KvVpk~---------------------------~l~k~~~reKv~~ 67 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLD---TGEVVAVKVVPKK---------------------------LLKKPKQREKVLN 67 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcC---CCcEEEEEEeehH---------------------------HhcCcchHHHHHH
Confidence 579999999999999999999976 8999999999885 2344556788999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
||+|++.|. |||||+++++|++.++.|||.|+|..++|.+++. +.+.++|.+++.+++||+.||.|||+++|||||||
T Consensus 68 EIeIHr~L~-HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLK 145 (592)
T KOG0575|consen 68 EIEIHRSLK-HPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLK 145 (592)
T ss_pred HHHHHHhcC-CCcEEeeeeEeecCCceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccc
Confidence 999999997 9999999999999999999999999999998765 66899999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
..|||| +++.+|||+|||||..+..+ +...+.||||.|.|||++.+ .++..+||||+||+||-||+|++||...+
T Consensus 146 LGNlfL---~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~ 222 (592)
T KOG0575|consen 146 LGNLFL---NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT 222 (592)
T ss_pred hhheee---cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch
Confidence 999999 78889999999999998754 77889999999999999975 59999999999999999999999999999
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
..+++..|....+.++. .+|.++++||.+||+.||.+|||++++|.|+||..
T Consensus 223 vkety~~Ik~~~Y~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 223 VKETYNKIKLNEYSMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred HHHHHHHHHhcCccccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 99999999999998886 49999999999999999999999999999999954
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-57 Score=459.31 Aligned_cols=321 Identities=52% Similarity=0.877 Sum_probs=289.0
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
...+...|+++++||+|.||.||+|+.+. +|+.+|+|++.|. ........
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~---tg~~~A~K~i~k~---------------------------~~~~~~~~ 79 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKS---TGKEVACKVIPKR---------------------------KLRGKEDR 79 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecC---CCceeEEEEeehh---------------------------hccccccH
Confidence 34566789999999999999999999987 7999999999885 12233356
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
+.+.+|+.+|+++..|||||.++++|++...+|+|||+|.||+|+++|... .++|.++..++.|++.++.|||+.||+
T Consensus 80 ~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvv 157 (382)
T KOG0032|consen 80 EDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVV 157 (382)
T ss_pred HHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCce
Confidence 789999999999988999999999999999999999999999999999877 499999999999999999999999999
Q ss_pred ccCCCCCceEEecCCC-CCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCC
Q 011582 276 HRDLKPENFLFTSKEE-NSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 276 HrDlkp~NIll~~~~~-~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~p 353 (482)
||||||+|+|+...+. ++.+|++|||++............+||+.|+|||++. ..|+..+||||+||++|.|++|.+|
T Consensus 158 HrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~P 237 (382)
T KOG0032|consen 158 HRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPP 237 (382)
T ss_pred eccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCC
Confidence 9999999999986544 4689999999999988877889999999999999998 6899999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC-CCCCCccHHHHHHHHH
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH-DVKIPSDMIVYKLIKA 432 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~-~~~~~~~~~~~~~~~~ 432 (482)
|++.+..+...+|..+.+.|....|+.+|..+++||++||..||.+|+|+.++|+|||+.... ....+....+....++
T Consensus 238 F~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~~~~~~~~~~~~~~ 317 (382)
T KOG0032|consen 238 FWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATNIPLDISVLSRSKQ 317 (382)
T ss_pred CcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcccccccccchhhhhHHH
Confidence 999999999999999999999999999999999999999999999999999999999999863 3334445556666778
Q ss_pred HhccchHHHHHHHhhhhcCCHHHHHHHHHHHhhhCCCCC
Q 011582 433 YISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKN 471 (482)
Q Consensus 433 ~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~f~~~d~n~d 471 (482)
+...+.+++..+...+..++ +..++.+|..+|.+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 353 (382)
T KOG0032|consen 318 FLSMSKLKKLALRVLAESLS---ISGLKEMFKLMDTDNN 353 (382)
T ss_pred HHHHHHHHHHHHHHHhhhhh---HHHHHHHHHhhccccc
Confidence 88888888888888877776 7778889999999877
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-56 Score=430.83 Aligned_cols=264 Identities=37% Similarity=0.653 Sum_probs=237.5
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
...+|.+.++||+|+||+||+|++++ +|..||||.|.+. .......+.+
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~---~~~~VAIK~i~~~----------------------------~l~~k~~e~L 56 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKK---SGTEVAIKCIAKK----------------------------KLNKKLVELL 56 (429)
T ss_pred ccccceehhhccCcceEEEEEeEecc---CCceEEeeeehhh----------------------------ccCHHHHHHH
Confidence 45789999999999999999999998 7899999999764 1245567788
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
..||.+|+.|+ |||||++++++++++.+|||||||+||+|.++|..+ +.++|..++.++.||+.||++||+++|||||
T Consensus 57 ~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRD 134 (429)
T KOG0595|consen 57 LSEIKILKELK-HPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQFLHENNIIHRD 134 (429)
T ss_pred HHHHHHHHhcC-CcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 99999999997 999999999999999999999999999999999766 6899999999999999999999999999999
Q ss_pred CCCCceEEecCCCC---CcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 279 LKPENFLFTSKEEN---SSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~---~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf 354 (482)
|||+||||+....+ ..+||+|||+|+.+.++....+.||++.|||||++. .+|+.|+|+||+|+|+|+|++|+.||
T Consensus 135 LKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf 214 (429)
T KOG0595|consen 135 LKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPF 214 (429)
T ss_pred CCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCc
Confidence 99999999864223 679999999999999888889999999999999995 78999999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
...+..+++..+..+....+... ..++....+|+..+|..++.+|.+..+-+.|+++....
T Consensus 215 ~a~t~~eL~~~~~k~~~~~~~~~-~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 215 DAETPKELLLYIKKGNEIVPVLP-AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred cccCHHHHHHHHhccccccCchh-hhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 99999999998877665443322 34677888999999999999999999999999998754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-56 Score=427.74 Aligned_cols=259 Identities=30% Similarity=0.602 Sum_probs=232.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||+||.++.+. +|+.||+|+++|.. .......+...
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~d---t~kiYAmKvl~K~~---------------------------iv~~~e~~~~~ 73 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKD---TGKIYAMKVLKKKK---------------------------IVEKKEVRHTK 73 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcc---cCceeehhhhhhhH---------------------------hhhhhhHHHHH
Confidence 4689999999999999999999886 89999999998862 22334567889
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|..||.++. ||.||.++..|++.+.+|||+||+.||+|+.+|.+ .+.|+|..++.++..|+.||.|||++|||||||
T Consensus 74 ~Er~IL~~v~-hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDl 151 (357)
T KOG0598|consen 74 AERNILSKIK-HPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDL 151 (357)
T ss_pred HHHHHHHhCC-CCcEeeeEEecccCCeEEEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 9999999997 99999999999999999999999999999998854 479999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEeccccccc-CCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYV-KPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||| |.+|+++|+|||+++.. ..+....++|||+.|||||++.+ .|+..+|.|||||++|+|++|.+||.+.
T Consensus 152 KPENILL---d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~ 228 (357)
T KOG0598|consen 152 KPENILL---DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE 228 (357)
T ss_pred CHHHeee---cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc
Confidence 9999999 78999999999999854 44456677899999999998865 6999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC----CHHHHhcCcccccCC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL----TAAQALSHPWLANSH 416 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~----s~~e~L~hp~~~~~~ 416 (482)
+...++++|..+....... -++.++++||+++|+.||++|. ++.++-+||||...+
T Consensus 229 ~~~~~~~~I~~~k~~~~p~---~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 229 DVKKMYDKILKGKLPLPPG---YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred cHHHHHHHHhcCcCCCCCc---cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 9999999999988433322 2899999999999999999995 799999999998765
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-55 Score=421.40 Aligned_cols=258 Identities=29% Similarity=0.466 Sum_probs=227.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++.+.++.||+|..|+||+|+++. +++.+|+|+|.-. ......+++.
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~---t~~i~AlK~I~~~-----------------------------~~~~~~~Qi~ 125 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKP---TGKIYALKVILLN-----------------------------IDPALQKQIL 125 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcC---CCeEEEEEeeccc-----------------------------CCHHHHHHHH
Confidence 4567788899999999999999997 8999999999432 4566778999
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCC-eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDD-NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHr 277 (482)
+|+++++.+. |||||.+|+.|..++ .++|+||||+||+|.+.+... ++++|.....++.+|++||.|||+ ++||||
T Consensus 126 rEl~il~~~~-spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~-g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHR 203 (364)
T KOG0581|consen 126 RELEILRSCQ-SPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV-GRIPEPVLGKIARAVLRGLSYLHEERKIIHR 203 (364)
T ss_pred HHHHHHhhCC-CCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhccCeeec
Confidence 9999999995 999999999999999 499999999999998876544 789999999999999999999996 999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||||+|||+ +..+.|||||||.+..+... ...+++||..|||||.+.+ .|+.++||||||+.++|+.+|+.||..
T Consensus 204 DIKPsNlLv---NskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~ 279 (364)
T KOG0581|consen 204 DIKPSNLLV---NSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPP 279 (364)
T ss_pred cCCHHHeee---ccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCC
Confidence 999999999 56788999999999887654 6688999999999999987 599999999999999999999999977
Q ss_pred C-----ChHHHHHHHHhcCCC-CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCC
Q 011582 357 R-----TESGIFRAVLKADPS-FDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDV 418 (482)
Q Consensus 357 ~-----~~~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 418 (482)
. ..-+++..|..+.+. .+.. .+|+++++||..||++||.+|+++.|+|+|||+++....
T Consensus 280 ~~~~~~~~~~Ll~~Iv~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 280 PNPPYLDIFELLCAIVDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred cCCCCCCHHHHHHHHhcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 5 556777788775432 2222 489999999999999999999999999999999976543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-55 Score=444.96 Aligned_cols=258 Identities=34% Similarity=0.632 Sum_probs=237.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+-|++++.||.|+-|.|.+|++.. +|+.+|||+|.+.. .........+.
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~---TGqlaaiKii~k~~---------------------------~~s~s~~~~Ie 60 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAE---TGQLAAIKIIPKRS---------------------------ELSSSQPAGIE 60 (786)
T ss_pred ccceeccccccCCCCceehhhhccc---ccceeEEEeecccc---------------------------ccccccccchh
Confidence 4569999999999999999999987 99999999998741 13334456789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+||.||+.|. |||++++|++|++..++|+|.||++||.|++++..+ ++|++.+++++++||+.|+.|||..+|+||||
T Consensus 61 rEIviMkLi~-HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~k-G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDL 138 (786)
T KOG0588|consen 61 REIVIMKLIE-HPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRK-GPLPEREAAHFFRQILDGVSYCHAFNICHRDL 138 (786)
T ss_pred hhhHHHHHhc-CCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHhhhcceeccC
Confidence 9999999997 999999999999999999999999999999999877 68999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccccc-C-CCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-Y-GTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|+|| |..+++||+|||+|..-.++..+.+.||+|.|.|||++.+. | +.++||||+|||||.||||++||+++
T Consensus 139 KpENlLL---d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd 215 (786)
T KOG0588|consen 139 KPENLLL---DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD 215 (786)
T ss_pred Cchhhhh---hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc
Confidence 9999999 66667999999999988888889999999999999999864 4 68999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
+...++.++..+.+..+. .+|+++++||.+||++||.+|+|.+|+++|||+.+..
T Consensus 216 Nir~LLlKV~~G~f~MPs----~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 216 NIRVLLLKVQRGVFEMPS----NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred cHHHHHHHHHcCcccCCC----cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 999999999999887774 5999999999999999999999999999999998765
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-55 Score=405.93 Aligned_cols=256 Identities=31% Similarity=0.632 Sum_probs=234.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||.|+||.|.+++.+. +|..+|+|++++.. .......+...
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~---~g~yYAmKvL~k~~---------------------------vVklKQveH~~ 92 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKH---SGNYYAMKVLDKQK---------------------------VVKLKQVEHTH 92 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEcc---CCceeehhhcCHHH---------------------------HHHHHHHHHHh
Confidence 4689999999999999999999987 79999999998752 23334557788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|..+|+.+. ||+++++++.|.+.+.+||||||.+||.|+.++.+. ++|++..++.++.||+.||+|||+++|++|||
T Consensus 93 nEk~vL~~v~-~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~-~rF~e~~arFYAAeivlAleylH~~~iiYRDL 170 (355)
T KOG0616|consen 93 NEKRVLKAVS-HPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKS-GRFSEPHARFYAAEIVLALEYLHSLDIIYRDL 170 (355)
T ss_pred hHHHHHhhcc-CceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhc-CCCCchhHHHHHHHHHHHHHHHHhcCeeeccC
Confidence 9999999997 999999999999999999999999999999988654 78999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
||+|||+ |.+|.+||+|||+|+.+.. ...+.||||.|+|||++. +.|+.++|.|||||++|||++|.+||...+
T Consensus 171 KPENiLl---D~~G~iKitDFGFAK~v~~--rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~ 245 (355)
T KOG0616|consen 171 KPENLLL---DQNGHIKITDFGFAKRVSG--RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDN 245 (355)
T ss_pred ChHHeee---ccCCcEEEEeccceEEecC--cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCC
Confidence 9999999 7899999999999998764 377899999999999886 579999999999999999999999999999
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccCC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANSH 416 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~~ 416 (482)
...++++|++++..|+.- +++++++||+++|++|-.+|. ...++.+||||+.-.
T Consensus 246 ~~~iY~KI~~~~v~fP~~----fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 246 PIQIYEKILEGKVKFPSY----FSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred hHHHHHHHHhCcccCCcc----cCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 999999999999998864 899999999999999999993 678999999998643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-55 Score=435.41 Aligned_cols=259 Identities=33% Similarity=0.650 Sum_probs=234.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
..+|.+++.||.|+|++|++|+++. +++.||||++.|.. ...+.....+.
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~---t~keYAiKVl~K~~---------------------------Iike~KvkYV~ 121 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKA---TGKEYAIKVLDKRY---------------------------IIKEKKVKYVT 121 (604)
T ss_pred hhhcchhheeccccceeEEEeeecC---CCceeeHhhhhHHH---------------------------HHhhcccchhh
Confidence 4689999999999999999999998 89999999998752 22333345677
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|-.+|.+|.+||.|++|+-.|+|+..+|+|+||+++|+|+++|.+. +.|++..++.++.||+.||+|||++|||||||
T Consensus 122 ~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAleylH~~GIIHRDl 200 (604)
T KOG0592|consen 122 REKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDALEYLHSNGIIHRDL 200 (604)
T ss_pred HHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHHHHHHhcCceeccC
Confidence 88899999988999999999999999999999999999999999766 78999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCc--------------ccccccCccccCcccccc-cCCCcchhhhhHHHH
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDER--------------LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIA 344 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--------------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil 344 (482)
||+|||| +.++++||.|||.|+.+.+... ..+++||-.|.+||++.. ..+..+|+|+|||||
T Consensus 201 KPENILL---d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCil 277 (604)
T KOG0592|consen 201 KPENILL---DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCIL 277 (604)
T ss_pred ChhheeE---cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHH
Confidence 9999999 8899999999999987654221 145899999999999975 578899999999999
Q ss_pred HHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 345 YILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 345 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|.|+.|.+||.+.++--++++|+...+.|+. ++++.+++||+++|..||.+|+|++++.+||||.+-.
T Consensus 278 yQmlaG~PPFra~NeyliFqkI~~l~y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd 345 (604)
T KOG0592|consen 278 YQMLAGQPPFRAANEYLIFQKIQALDYEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD 345 (604)
T ss_pred HHHhcCCCCCccccHHHHHHHHHHhcccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence 9999999999999999999999999998875 4889999999999999999999999999999998654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-54 Score=434.04 Aligned_cols=261 Identities=40% Similarity=0.725 Sum_probs=233.5
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...+.|++++.||+|+||.|++|.+.. +|..||||++.+.... ... ....+.
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~---t~~~vAiKii~~~~~~------------------------~~~-~~~~~~ 65 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRL---TGEKVAIKIIDRKKVS------------------------SKS-QKLDEL 65 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeecc---CCCeEEEEEechhccc------------------------ccc-cccchh
Confidence 345789999999999999999999987 8899999988663100 001 123456
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+..||||+++++++.....+|+|||||.||+|++++.+ .+++.|.+++.+++|++.|++|||++||+||
T Consensus 66 i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HR 144 (370)
T KOG0583|consen 66 IKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHR 144 (370)
T ss_pred hHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeC
Confidence 679999999997799999999999999999999999999999999988 6899999999999999999999999999999
Q ss_pred CCCCCceEEecCCCC-CcEEEEeccccccc-CCCCcccccccCccccCcccccc-c-C-CCcchhhhhHHHHHHHhhCCC
Q 011582 278 DLKPENFLFTSKEEN-SSLKAIDFGLSDYV-KPDERLNDIVGSAYYVAPEVLHR-S-Y-GTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 278 Dlkp~NIll~~~~~~-~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~~DiwSlGvil~elltg~~ 352 (482)
||||+|||+ +.+ +++||+|||++... ..+....+.|||+.|+|||++.+ . | +.++||||+||+||.|++|..
T Consensus 145 DLK~ENill---d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~ 221 (370)
T KOG0583|consen 145 DLKPENILL---DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRL 221 (370)
T ss_pred CCCHHHEEe---cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCC
Confidence 999999999 455 89999999999988 56778899999999999999975 3 6 478999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCC-CHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSL-SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
||...+...++..|..+...++.. + |+++++||++||..||.+|+++.+++.||||+.
T Consensus 222 PF~d~~~~~l~~ki~~~~~~~p~~----~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 222 PFDDSNVPNLYRKIRKGEFKIPSY----LLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CCCCccHHHHHHHHhcCCccCCCC----cCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999999999988777653 5 999999999999999999999999999999997
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-55 Score=404.12 Aligned_cols=270 Identities=36% Similarity=0.654 Sum_probs=245.1
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.+.+.+.|+-.+.||+|..+.|.++.++. +|..+|+|+|.... .....+ ......
T Consensus 12 a~~fy~~y~pkeilgrgvss~vrRci~k~---t~~e~a~kii~~~a-------t~~~~e---------------~~~~~~ 66 (411)
T KOG0599|consen 12 AKGFYAKYEPKEILGRGVSSVVRRCIHKE---TGKEFAVKIIDVTA-------TTESGE---------------TPYEMR 66 (411)
T ss_pred HhhHHhhcChHHHhcccchhhhhhhhhcc---cccceeEEEEEecc-------cccCCc---------------cHHHHH
Confidence 34567789999999999999999999988 89999999996531 001111 122345
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
+...+|+.||+++.+||+|+.+.++|+.+..+++|+|.|+.|.|+|++.+. -.++|...+.||+|+++|++|||.++||
T Consensus 67 EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~-VtlSEK~tR~iMrqlfegVeylHa~~IV 145 (411)
T KOG0599|consen 67 EATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSK-VTLSEKETRRIMRQLFEGVEYLHARNIV 145 (411)
T ss_pred HHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhh-eeecHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 677899999999999999999999999999999999999999999998655 6899999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-------ccCCCcchhhhhHHHHHHHh
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-------RSYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlGvil~ell 348 (482)
||||||+|||+ +++.++||+|||+|..+..+.++...||||+|+|||.+. ..|+..+|+|++|||||-||
T Consensus 146 HRDLKpENILl---ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLL 222 (411)
T KOG0599|consen 146 HRDLKPENILL---DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLL 222 (411)
T ss_pred hcccChhheee---ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHH
Confidence 99999999999 788999999999999999999999999999999999873 25899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 349 CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 349 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
.|.+|||.+...-+++.|+.+++.|..+.|.++|.+.++||++||++||.+|+|++|+|.||||..
T Consensus 223 aGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 223 AGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred cCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence 999999999999999999999999999999999999999999999999999999999999999954
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-54 Score=424.99 Aligned_cols=263 Identities=35% Similarity=0.519 Sum_probs=233.7
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|.++++||.|+||.||+|+.+. +|..||||.++++. ... ..--
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~---~~~~VAIK~MK~Kf----------------------------~s~-ee~~ 54 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKE---TGELVAIKKMKKKF----------------------------YSW-EECM 54 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecC---CCceeeHHHHHhhh----------------------------ccH-HHHH
Confidence 456789999999999999999999987 89999999997741 111 1112
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCC-eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDD-NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
-.||++.|++|..|||||+|.+++.+.+ .+|+|||||+. +|++.+..++..|++..++.|+.||++||+|+|.+|+.|
T Consensus 55 nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFH 133 (538)
T KOG0661|consen 55 NLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFH 133 (538)
T ss_pred HHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCccc
Confidence 3689999999977999999999999888 99999999965 899999999899999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc--ccCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~elltg~~pf 354 (482)
||+||+|||+. ....+||+|||+|+-+......+.++.|.||+|||++. +.|+.++||||+|||++|+.+-++.|
T Consensus 134 RDlKPENiLi~---~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF 210 (538)
T KOG0661|consen 134 RDLKPENILIS---GNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF 210 (538)
T ss_pred ccCChhheEec---ccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence 99999999994 46689999999999999888999999999999999885 46999999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCC--------------------------CCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPW--------------------------PSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~--------------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.|.++.+.+-+|+..........| +..++++.+||.+||.+||.+||||.|+|+
T Consensus 211 PG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 211 PGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred CCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 999999999988886655544443 346899999999999999999999999999
Q ss_pred CcccccCC
Q 011582 409 HPWLANSH 416 (482)
Q Consensus 409 hp~~~~~~ 416 (482)
||||+...
T Consensus 291 ~pffq~~~ 298 (538)
T KOG0661|consen 291 HPFFQVGR 298 (538)
T ss_pred Cccccccc
Confidence 99998543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-53 Score=422.84 Aligned_cols=264 Identities=31% Similarity=0.549 Sum_probs=231.6
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
+.-.++|+++..||+|+||.||+|+.+. +|..+|+|+++|.. +......+
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~---Tg~iyAmK~LkKS~---------------------------M~~~~Qv~ 186 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKD---TGEIYAMKILKKSE---------------------------MLKKNQVE 186 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEcc---CCcEEeeecccHHH---------------------------HHhhhhHH
Confidence 4467899999999999999999999887 99999999999862 23444567
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.++.|-.+|... ++|+||+||..|++.+++||||||++||++...|... +.|++..++.++.+++.|++.||+.|+||
T Consensus 187 hV~aERdiL~~~-ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~-~~L~e~~arfYiaE~vlAI~~iH~~gyIH 264 (550)
T KOG0605|consen 187 HVRAERDILAEV-DSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRK-DTLTEDWARFYIAETVLAIESIHQLGYIH 264 (550)
T ss_pred HHHHHHHHhhhc-CCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhc-CcCchHHHHHHHHHHHHHHHHHHHcCccc
Confidence 788999999885 5999999999999999999999999999999987655 78999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCC----------------------CC-c----------------------
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKP----------------------DE-R---------------------- 311 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~----------------------~~-~---------------------- 311 (482)
|||||+|+|| |..|++||+||||+.-+.. .. .
T Consensus 265 RDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nr 341 (550)
T KOG0605|consen 265 RDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNR 341 (550)
T ss_pred ccCChhheee---cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhh
Confidence 9999999999 8899999999999853211 00 0
Q ss_pred ---ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHH
Q 011582 312 ---LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAID 387 (482)
Q Consensus 312 ---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 387 (482)
....+|||.|||||++.+ .|+..+|+||||||+||||.|.+||.+.+..+++++|++-...+..+.-..++++++|
T Consensus 342 r~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~D 421 (550)
T KOG0605|consen 342 RQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKD 421 (550)
T ss_pred hhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHH
Confidence 013589999999999875 5999999999999999999999999999999999999998755444444568999999
Q ss_pred HHHHhchhccccCCC---HHHHhcCcccccCC
Q 011582 388 FVKRLLNKDYRKRLT---AAQALSHPWLANSH 416 (482)
Q Consensus 388 li~~~L~~dP~~R~s---~~e~L~hp~~~~~~ 416 (482)
||.+||. ||.+|.. ++|+..||||++-.
T Consensus 422 LI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~ 452 (550)
T KOG0605|consen 422 LITRLLC-DPENRLGSKGAEEIKKHPFFKGVD 452 (550)
T ss_pred HHHHHhc-CHHHhcCcccHHHHhcCCccccCC
Confidence 9999999 9999985 99999999998754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-53 Score=430.09 Aligned_cols=259 Identities=30% Similarity=0.527 Sum_probs=234.7
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
-.++|.++++||+|+||+|++|..+. +++.||||+++|.+. ......+..
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~---~~e~yAIK~LKK~~I---------------------------l~~d~Ve~~ 415 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKG---TNEYYAIKVLKKGDI---------------------------LQRDEVESL 415 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcC---CCcEEEEEEeeccce---------------------------eccccHHHH
Confidence 35789999999999999999999987 899999999998732 344456778
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
..|-.|+.....||.+++|+.+|+..+++|+||||+.||++..++ +...|++..++.|+..|+.||.|||++||||||
T Consensus 416 ~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~--~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRD 493 (694)
T KOG0694|consen 416 MCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHI--HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRD 493 (694)
T ss_pred HHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEE--ecccccHHHHHHHHHHHHHHHHHHHhcCceeee
Confidence 889999988878999999999999999999999999999955432 346899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||.+|||| |..|++||+|||+++..- .+..+.++||||.|||||++.+ .|+..+|.|||||+|||||.|..||.+
T Consensus 494 lKLdNiLL---D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~g 570 (694)
T KOG0694|consen 494 LKLDNLLL---DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPG 570 (694)
T ss_pred cchhheEE---cccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999 789999999999998654 5667889999999999999985 699999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANSH 416 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~~ 416 (482)
+++++++..|+..++.++.. +|.++.+++++||++||++|.. ++++..||||+...
T Consensus 571 ddEee~FdsI~~d~~~yP~~----ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 571 DDEEEVFDSIVNDEVRYPRF----LSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred CCHHHHHHHHhcCCCCCCCc----ccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 99999999999999888754 8999999999999999999995 58899999999765
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-54 Score=399.80 Aligned_cols=259 Identities=29% Similarity=0.530 Sum_probs=226.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
+.|+.+.++|+|+||+||+|+++. +|+.||||.+..+ ..++...+-..|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~---TgqIVAIKkF~Es----------------------------edd~~VkKIAlR 50 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKD---TGQIVAIKKFVES----------------------------EDDPVVKKIALR 50 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCC---cccEEEEEeeccC----------------------------CccHHHHHHHHH
Confidence 468899999999999999999988 9999999998543 123455667789
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
||++|++|+ |+|+|.|+++|.....++||+|||+. ++++.+......+++..++.++.|++.|+.|+|++++||||||
T Consensus 51 EIrmLKqLk-H~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIK 128 (396)
T KOG0593|consen 51 EIRMLKQLK-HENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIK 128 (396)
T ss_pred HHHHHHhcc-cchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCC
Confidence 999999998 99999999999999999999999977 5666676666789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|+|||+ ..++.+||||||+|+.+. ++...+.++.|.||+|||.+-+ +|+..+||||+||++.||++|.+.|.+.
T Consensus 129 PENILi---t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~ 205 (396)
T KOG0593|consen 129 PENILI---TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGR 205 (396)
T ss_pred hhheEE---ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCc
Confidence 999999 678899999999999887 6777889999999999998865 6999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCC-------------------C--------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCc
Q 011582 358 TESGIFRAVLKADPSFD-------------------E--------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~-------------------~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 410 (482)
++-+.+-.|...-..+. . ..+++++..+.+|+++||..||.+|++.+|+|+|+
T Consensus 206 SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 206 SDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred chHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 98877666654322111 1 12456788999999999999999999999999999
Q ss_pred ccccC
Q 011582 411 WLANS 415 (482)
Q Consensus 411 ~~~~~ 415 (482)
||...
T Consensus 286 yFd~~ 290 (396)
T KOG0593|consen 286 YFDGF 290 (396)
T ss_pred HHHHH
Confidence 99543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-53 Score=416.85 Aligned_cols=265 Identities=32% Similarity=0.508 Sum_probs=234.6
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.....+.|+.+++||+|.||.||+|++.. +|+.||+|.+.... ......
T Consensus 112 ~~r~~~~feki~kIGeGTyg~VYkAr~~~---tgkivALKKvr~d~----------------------------~~~~~~ 160 (560)
T KOG0600|consen 112 GPRRADSFEKIEKIGEGTYGQVYKARDLE---TGKIVALKKVRFDN----------------------------EKEGFP 160 (560)
T ss_pred cccchHHHHHHHHhcCcchhheeEeeecc---cCcEEEEEEeeccc----------------------------CCCcch
Confidence 34556889999999999999999999987 89999999986531 122234
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
.-..|||.||++|. ||||++|.+...+. +.+|||+|||+. +|.-++...+-+|++.+++.||+||+.||+|||++|
T Consensus 161 ~t~~REI~ILr~l~-HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g 238 (560)
T KOG0600|consen 161 ITAIREIKILRRLD-HPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG 238 (560)
T ss_pred HHHHHHHHHHHhcC-CCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC
Confidence 45789999999996 99999999998876 789999999976 888887776779999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhh
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ellt 349 (482)
|+|||||.+|||| |+++.+||+|||||+++.... .++..+.|.||+|||.+.| .|+.++|+||+||||.||++
T Consensus 239 vlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~ 315 (560)
T KOG0600|consen 239 VLHRDIKGSNILI---DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFL 315 (560)
T ss_pred eeeccccccceEE---cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHc
Confidence 9999999999999 789999999999999876554 5778899999999999876 59999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCCCCC-------------------------CCCHHHHHHHHHhchhccccCCCHH
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFDEAPWP-------------------------SLSPEAIDFVKRLLNKDYRKRLTAA 404 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~-------------------------~~s~~~~~li~~~L~~dP~~R~s~~ 404 (482)
|++.|.+.++-+.+..|.+......+..|+ .++..+.+|+..||..||.+|.||.
T Consensus 316 gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~ 395 (560)
T KOG0600|consen 316 GKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTAS 395 (560)
T ss_pred CCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHH
Confidence 999999999999999999877766666664 3578899999999999999999999
Q ss_pred HHhcCcccccCC
Q 011582 405 QALSHPWLANSH 416 (482)
Q Consensus 405 e~L~hp~~~~~~ 416 (482)
++|+|+||....
T Consensus 396 ~aL~seyF~t~p 407 (560)
T KOG0600|consen 396 SALQSEYFTTEP 407 (560)
T ss_pred HHhcCcccccCC
Confidence 999999996543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-52 Score=382.13 Aligned_cols=260 Identities=31% Similarity=0.523 Sum_probs=231.3
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|...+.||+|.||.||+|++.. +|+.||||.|+... ...-......|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~---t~~~VAIKKIkl~~----------------------------~kdGi~~talR 50 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTE---TGKRVAIKKIKLGN----------------------------AKDGINRTALR 50 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecC---CCcEEEEEEeeccc----------------------------cccCccHHHHH
Confidence 478899999999999999999988 89999999997531 11112345789
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
||+.|+.++ |+||+.|+++|...+.+.||+||++. +|...|.++...|+..+++.|+.++++||+|||++.|+|||||
T Consensus 51 EIK~Lqel~-h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlK 128 (318)
T KOG0659|consen 51 EIKLLQELK-HPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLK 128 (318)
T ss_pred HHHHHHHcc-CcchhhhhhhccCCCceEEEEEeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCC
Confidence 999999997 99999999999999999999999975 8999998888889999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc-ccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER-LNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|+|+|+ +.++.+||+|||+|+.+..... ....+.|.+|+|||.+.| .|+..+||||.|||+.||+.|.+-|.+.
T Consensus 129 PnNLLi---s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~ 205 (318)
T KOG0659|consen 129 PNNLLI---SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGD 205 (318)
T ss_pred ccceEE---cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCC
Confidence 999999 6788999999999998865433 334488999999998865 6999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCC------------------------CCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 358 TESGIFRAVLKADPSFDEAPWPS------------------------LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~------------------------~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
++-+.+..|...-.......|++ .+.++.||+.+||..||.+|+|+.|+|+|+||.
T Consensus 206 sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~ 285 (318)
T KOG0659|consen 206 SDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK 285 (318)
T ss_pred chHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence 99999999999877777777764 357889999999999999999999999999999
Q ss_pred cCC
Q 011582 414 NSH 416 (482)
Q Consensus 414 ~~~ 416 (482)
+..
T Consensus 286 ~~P 288 (318)
T KOG0659|consen 286 SLP 288 (318)
T ss_pred cCC
Confidence 754
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-52 Score=389.31 Aligned_cols=262 Identities=36% Similarity=0.645 Sum_probs=238.9
Q ss_pred ccccceEecc-eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 118 QFVAHYELGE-EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 118 ~~~~~y~~~~-~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
.++++|.+.. +||-|-.|.|..+.++. +|+.+|+|++... .
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~---T~ekfALKvL~Ds-----------------------------------~ 99 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKR---TQEKFALKVLLDS-----------------------------------P 99 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEecc---chhhhHHHHHhcC-----------------------------------H
Confidence 4567888876 59999999999999988 8999999998543 4
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
..++|+++.-...+|||||.++++|+. ...+.+|||.++||+|+.+|.+++ ..|+|.++..|++||+.|+.|||+
T Consensus 100 KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~ 179 (400)
T KOG0604|consen 100 KARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS 179 (400)
T ss_pred HHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh
Confidence 678999999888899999999999864 467899999999999999998774 469999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhC
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg 350 (482)
.+|.||||||+|+|.+....+..+||+|||+|+.-.....+.+.|.||.|.|||++. ..|+..+|+||+||++|.||||
T Consensus 180 ~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCG 259 (400)
T KOG0604|consen 180 MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259 (400)
T ss_pred cchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcC
Confidence 999999999999999988899999999999999877677888999999999999996 4699999999999999999999
Q ss_pred CCCCCCCCh----HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 351 SRPFWARTE----SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 351 ~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.+||+.... ..+..+|..+.+.|+.+.|..+|++++++|+.||..+|.+|.|++++++|||+.....
T Consensus 260 yPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 260 YPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred CCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 999987543 4678899999999999999999999999999999999999999999999999998653
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=378.50 Aligned_cols=259 Identities=31% Similarity=0.593 Sum_probs=235.2
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++++.||+|.||.||+|+.++ ++-.||+|++.|.. .........
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekk---s~~IvalKVlfKsq---------------------------i~~~~v~~q 68 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKK---SLFIVALKVLFKSQ---------------------------ILKTQVEHQ 68 (281)
T ss_pred cchhhccccccccCCccccEeEeeecc---CCcEEEEeeeeHHH---------------------------HHHhcchhh
Confidence 345789999999999999999999998 88999999998752 123334568
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS-RGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+++|++|-..|+ ||||+++|++|.+....||++||..+|+|+..+.. +..++++..++.++.|++.||.|+|.++|||
T Consensus 69 lrREiEIqs~L~-hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIh 147 (281)
T KOG0580|consen 69 LRREIEIQSHLR-HPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIH 147 (281)
T ss_pred hhheeEeecccC-CccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCccc
Confidence 899999999997 99999999999999999999999999999998874 3467999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||||+|+|+ +..+.+||+|||.+.... .....+.|||..|.+||+..+ .++..+|+|++|+++||++.|.+||.
T Consensus 148 RdiKpenlLl---g~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFe 223 (281)
T KOG0580|consen 148 RDIKPENLLL---GSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFE 223 (281)
T ss_pred CCCCHHHhcc---CCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchh
Confidence 9999999999 556779999999998755 666788999999999999976 59999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
..+..+.++.|.+.+..++ ..++.++.|||.+||.++|.+|++..|++.|||+...
T Consensus 224 s~~~~etYkrI~k~~~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 224 SQSHSETYKRIRKVDLKFP----STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred hhhhHHHHHHHHHccccCC----cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 9999999999999998887 3599999999999999999999999999999999753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-52 Score=404.66 Aligned_cols=274 Identities=32% Similarity=0.614 Sum_probs=229.3
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
....+.|+++++||+|.||+|-+|++.. +|+.||||++.|..... +.-++... ...-.-++
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~---~~~l~AiKil~K~~~~~--~~~~~~~~--------------a~~~~~~e 153 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEV---DGKLYAIKILPKKELRR--QYGFPRQP--------------AMKLMPIE 153 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecC---CCcEEEEEeechhhhhh--hccccccc--------------ccccCcHH
Confidence 3457899999999999999999999876 89999999998852210 00011000 01112346
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGK-YSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
.+++||.||++|. |||||+|+++..+. +.+|||+|||..|.+... ...+. +++.+++.|++.++.||+|||.+|
T Consensus 154 kv~~EIailKkl~-H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~--p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg 230 (576)
T KOG0585|consen 154 KVRREIAILKKLH-HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC--PPDKPELSEQQARKYLRDVVLGLEYLHYQG 230 (576)
T ss_pred HHHHHHHHHHhcC-CcCeeEEEEeecCcccCceEEEEEeccCCccccC--CCCcccccHHHHHHHHHHHHHHHHHHHhcC
Confidence 8999999999997 99999999998764 689999999999986542 22344 999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCC------CCcccccccCccccCcccccc---c--CCCcchhhhhHH
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP------DERLNDIVGSAYYVAPEVLHR---S--YGTEADMWSIGV 342 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~------~~~~~~~~gt~~y~aPE~~~~---~--~~~~~DiwSlGv 342 (482)
||||||||+|+|| +.++.+||+|||.+..+.. +..+...+|||.|||||.+.+ . .+.+.||||+||
T Consensus 231 iiHRDIKPsNLLl---~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV 307 (576)
T KOG0585|consen 231 IIHRDIKPSNLLL---SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV 307 (576)
T ss_pred eeccccchhheEE---cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence 9999999999999 5679999999999886622 233456899999999998764 1 356889999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 343 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 343 il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
+||+|+.|+.||.+....+++.+|.+....|+.. +.+.+++++||.+||++||.+|+++.++..|||+....+
T Consensus 308 TLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 308 TLYCLLFGQLPFFDDFELELFDKIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred hHHHhhhccCCcccchHHHHHHHHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 9999999999999999999999999998888765 468999999999999999999999999999999987644
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-51 Score=387.72 Aligned_cols=264 Identities=31% Similarity=0.462 Sum_probs=230.5
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...+.|+.++.|++|+||.||+|++++ +++.||+|+++-. .+...+.+ .
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~---t~eIVALKr~kme------------kek~GFPI----------------t 121 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKK---TDEIVALKRLKME------------KEKEGFPI----------------T 121 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCC---cceeEEeeecccc------------cccCCCcc----------------h
Confidence 345789999999999999999999998 8999999998642 13333322 3
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
..|||.+|.+++ |||||.+-++... -+.+|||||||+. +|...+.....+|...+++.++.|+++||+|||.+.|+
T Consensus 122 sLREIniLl~~~-H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wil 199 (419)
T KOG0663|consen 122 SLREINILLKAR-HPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWIL 199 (419)
T ss_pred hHHHHHHHHhcC-CCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeE
Confidence 579999999997 9999999998764 4679999999976 88888877778999999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~ 352 (482)
|||||++|+|+ .+.|.+||+|||+|+.+... ..++..+.|.+|+|||.+.+ .|++.+||||+|||+.||+++++
T Consensus 200 HRDLK~SNLLm---~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kP 276 (419)
T KOG0663|consen 200 HRDLKTSNLLL---SHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKP 276 (419)
T ss_pred ecccchhheee---ccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCC
Confidence 99999999999 67889999999999987654 44677889999999999875 59999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCC----------------------------CCHHHHHHHHHhchhccccCCCHH
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPS----------------------------LSPEAIDFVKRLLNKDYRKRLTAA 404 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~----------------------------~s~~~~~li~~~L~~dP~~R~s~~ 404 (482)
.|.+..+.+.+..|........+..|++ +++...+|+..+|..||.+|.||+
T Consensus 277 lf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~ 356 (419)
T KOG0663|consen 277 LFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAE 356 (419)
T ss_pred CCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHH
Confidence 9999999999999988766666666643 357888999999999999999999
Q ss_pred HHhcCcccccCCC
Q 011582 405 QALSHPWLANSHD 417 (482)
Q Consensus 405 e~L~hp~~~~~~~ 417 (482)
|+|+|.||.+...
T Consensus 357 ~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 357 DGLKHEYFRETPL 369 (419)
T ss_pred HhhcccccccCCC
Confidence 9999999998543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-52 Score=412.24 Aligned_cols=254 Identities=32% Similarity=0.611 Sum_probs=231.3
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|.+.+.||+|+||.||+|+.|. +++.||+|++.|. -........+.+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~---t~~~vAik~i~K~----------------------------gr~~k~l~~l~~ 50 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKY---TIQVVAIKFIDKS----------------------------GRNEKELKNLRQ 50 (808)
T ss_pred cchhHHHHhcCCccceeeeccccc---ceeEEEEEEehhc----------------------------CCchHHHHHHHH
Confidence 578999999999999999999987 8999999999874 133456788999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|++|++.|+ |||||.+++.|+...++++|+|||.| +|..++ ..++.++|+.++.++.+++.||.|||+++|+|||+|
T Consensus 51 ev~i~r~lk-Hpniv~m~esfEt~~~~~vVte~a~g-~L~~il-~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~k 127 (808)
T KOG0597|consen 51 EVRILRSLK-HPNIVEMLESFETSAHLWVVTEYAVG-DLFTIL-EQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMK 127 (808)
T ss_pred HHHHHHhcC-CcchhhHHHhhcccceEEEEehhhhh-hHHHHH-HhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCC
Confidence 999999997 99999999999999999999999987 998876 455899999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|.|||+ +.++.+|+||||+|+.+..+. ..+.+.|||.|||||.+.+ .|+..+|+||+|||+|||.+|++||....
T Consensus 128 PqniLl---~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 128 PQNILL---EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred cceeee---cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence 999999 789999999999999887654 3566789999999998875 69999999999999999999999999999
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
..++.+.|......++. ..|.++++|++.+|.+||.+|+++.++|.|||+++.
T Consensus 205 i~~Lv~~I~~d~v~~p~----~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 205 ITQLVKSILKDPVKPPS----TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred HHHHHHHHhcCCCCCcc----cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 99999999988766554 589999999999999999999999999999999864
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-52 Score=397.73 Aligned_cols=257 Identities=35% Similarity=0.623 Sum_probs=238.3
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
....+|++.+.||+|.||.|-+|+... .|+.||||.|+|. +..+.+++-.
T Consensus 50 nlkHRyE~~etLGkGTYGKVk~A~e~~---sgR~VAiKsIrKd---------------------------kIkdeqDlvh 99 (668)
T KOG0611|consen 50 NLKHRYEITETLGKGTYGKVKLAYEHK---SGREVAIKSIRKD---------------------------KIKDEQDLVH 99 (668)
T ss_pred chhhHHHHHHHhcCCcccceeehhhcc---CCcEeehhhhhhh---------------------------hcccHHHHHH
Confidence 456789999999999999999999876 8999999999886 4567778889
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+++||+||..|. ||||+.+|++|+..+.+.|||||..+|+|+|++..+ +.|+|.+++.+++||.+|+.|+|.++++||
T Consensus 100 IRREIeIMSsLN-HPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhYCHknrVvHR 177 (668)
T KOG0611|consen 100 IRREIEIMSSLN-HPHIIQIYEVFENKDKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHYCHKNRVVHR 177 (668)
T ss_pred HHHHHHHHhhcC-CCceeehhhhhcCCceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHHHhhccceec
Confidence 999999999996 999999999999999999999999999999999665 789999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccccc--CCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||.+|||+ |.++++||+|||++..+.....+.++||+|.|.+||++++. -++.+|-|||||+||-|+.|..||+
T Consensus 178 DLKLENILL---D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD 254 (668)
T KOG0611|consen 178 DLKLENILL---DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD 254 (668)
T ss_pred ccchhheee---cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC
Confidence 999999999 78999999999999999888899999999999999999874 4789999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
+.+...++++|..+.+.-+. -+.++.-||+.||.+||++|.|++++-.|.|++-
T Consensus 255 G~Dhk~lvrQIs~GaYrEP~-----~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 255 GRDHKRLVRQISRGAYREPE-----TPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred CchHHHHHHHhhcccccCCC-----CCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 99999999999988765443 4678999999999999999999999999999973
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-51 Score=402.64 Aligned_cols=261 Identities=33% Similarity=0.635 Sum_probs=240.9
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.+-|.+.+.||+|.|++|-+|++.- +|..||||+|.|. ..+......
T Consensus 15 kIAGLYDLekTlG~GHFAVVKLArHVF---TGekVAVKviDKT----------------------------KlD~~st~h 63 (864)
T KOG4717|consen 15 KIAGLYDLEKTLGRGHFAVVKLARHVF---TGEKVAVKVIDKT----------------------------KLDTLSTGH 63 (864)
T ss_pred ceeeeehhhhhhcCCceehhhhhhhhc---ccceeEEEEeccc----------------------------ccchhhhhH
Confidence 456679999999999999999998765 9999999999875 134455678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+..|+.++ |||||+||++......+|||+|+-++|+|+++|.++...+.|..++.+++||+.|+.|+|+..+|||
T Consensus 64 lfqEVRCMKLVQ-HpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHR 142 (864)
T KOG4717|consen 64 LFQEVRCMKLVQ-HPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHR 142 (864)
T ss_pred HHHHHHHHHHhc-CcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcc
Confidence 899999999886 9999999999999999999999999999999999998999999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccccc-CC-CcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-YG-TEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~-~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+||.+. ..-|.+||.|||++..+.++..+.+.||+..|.|||++.+. |+ +++||||||||||.|+||++||.
T Consensus 143 DLKPENVVFF--EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFq 220 (864)
T KOG4717|consen 143 DLKPENVVFF--EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQ 220 (864)
T ss_pred cCCcceeEEe--eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccc
Confidence 9999999997 46788999999999999999999999999999999998864 65 57999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..++.+.+..|+..++..+.. +|.++++||..||..||++|.+.+++..|+|++...
T Consensus 221 eANDSETLTmImDCKYtvPsh----vS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D 277 (864)
T KOG4717|consen 221 EANDSETLTMIMDCKYTVPSH----VSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD 277 (864)
T ss_pred cccchhhhhhhhcccccCchh----hhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence 999999999999998877654 899999999999999999999999999999998654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-50 Score=404.00 Aligned_cols=258 Identities=29% Similarity=0.522 Sum_probs=223.9
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.-...|....+||+|+.|.||.|.... +++.||||.+... .....+.
T Consensus 270 dP~~~y~~~~kigqgaSG~vy~A~~~~---~~~~VaiK~m~l~------------------------------~Q~~keL 316 (550)
T KOG0578|consen 270 DPRSKYTDFKKIGQGATGGVYVARKIS---TKQEVAIKRMDLR------------------------------KQPKKEL 316 (550)
T ss_pred Chhhhhcchhhhccccccceeeeeecc---CCceEEEEEEEec------------------------------cCCchhh
Confidence 345678889999999999999999987 8999999998653 3344567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+|+.++ |+|||++++.|...+.+|+||||++||+|.|.+.. ..++|.+++.|+++++.||+|||.+||+||
T Consensus 317 ilnEi~Vm~~~~-H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHr 393 (550)
T KOG0578|consen 317 LLNEILVMRDLH-HPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHR 393 (550)
T ss_pred hHHHHHHHHhcc-chHHHHHHHHhcccceeEEEEeecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeee
Confidence 899999999997 99999999999999999999999999999997744 469999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||.+|||+ +.++.+||+|||++..+.... ...+.+|||+|||||++.+ .|++|+||||||++++||+-|++||.
T Consensus 394 DIKSDnILL---~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYl 470 (550)
T KOG0578|consen 394 DIKSDNILL---TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYL 470 (550)
T ss_pred ccccceeEe---ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCcc
Confidence 999999999 567789999999999887654 6678899999999999875 69999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
..+.-.-+..|.... ......+..+|+++++|+.+||+.|+.+|++|.++|+||||+..
T Consensus 471 nE~PlrAlyLIa~ng-~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 471 NENPLRALYLIATNG-TPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred CCChHHHHHHHhhcC-CCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 765544444443322 22333456799999999999999999999999999999999543
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-51 Score=388.92 Aligned_cols=264 Identities=34% Similarity=0.590 Sum_probs=224.7
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+..+|...+.||+|+||.|+.|.++. +|..||||.+... +......++
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~---t~~~VAIKKi~~~----------------------------F~~~~~akR 67 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKR---TGEKVAIKKILNP----------------------------FENQIDAKR 67 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcC---CCCEeehhhhhhh----------------------------hhchHHHHH
Confidence 344567778899999999999999998 8999999998642 355667788
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEe-----CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYED-----DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
..+|+++|+.++ |+||+.+++++.. -+.+|+|+|+| +.+|...| +.+..|++..+..++.||++||+|+|+.
T Consensus 68 tlRElklLr~~~-HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~ii-k~~~~L~d~H~q~f~YQiLrgLKyiHSA 144 (359)
T KOG0660|consen 68 TLRELKLLRHLR-HENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQII-KSQQDLTDDHAQYFLYQILRGLKYIHSA 144 (359)
T ss_pred HHHHHHHHHHhc-CCCcceEEeecccccccccceeEEehhHH-hhHHHHHH-HcCccccHHHHHHHHHHHHHhcchhhcc
Confidence 999999999998 9999999999865 46799999999 44776655 5545699999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCC---CCcccccccCccccCccccc--ccCCCcchhhhhHHHHHHH
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP---DERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el 347 (482)
||+||||||.|+|+ +.+..+||||||+|+.... ...++..+.|.+|+|||++. ..|+...||||+|||+.||
T Consensus 145 nViHRDLKPsNll~---n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEm 221 (359)
T KOG0660|consen 145 NVIHRDLKPSNLLL---NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEM 221 (359)
T ss_pred cccccccchhheee---ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHH
Confidence 99999999999999 5667799999999998864 45668889999999999874 4699999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHhcCCCCC-----------------------CC----CCCCCCHHHHHHHHHhchhccccC
Q 011582 348 LCGSRPFWARTESGIFRAVLKADPSFD-----------------------EA----PWPSLSPEAIDFVKRLLNKDYRKR 400 (482)
Q Consensus 348 ltg~~pf~~~~~~~~~~~i~~~~~~~~-----------------------~~----~~~~~s~~~~~li~~~L~~dP~~R 400 (482)
++|++.|.+.+.-..+..|+...+..+ .. .+++.++++.+|+.+||..||.+|
T Consensus 222 L~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kR 301 (359)
T KOG0660|consen 222 LTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKR 301 (359)
T ss_pred HcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCcccc
Confidence 999999999887766666655333222 11 246789999999999999999999
Q ss_pred CCHHHHhcCcccccCCCC
Q 011582 401 LTAAQALSHPWLANSHDV 418 (482)
Q Consensus 401 ~s~~e~L~hp~~~~~~~~ 418 (482)
+|++|+|.||||....+.
T Consensus 302 ita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 302 ITAEEALAHPYLAPYHDP 319 (359)
T ss_pred CCHHHHhcChhhhhhcCC
Confidence 999999999999987653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=385.43 Aligned_cols=247 Identities=29% Similarity=0.544 Sum_probs=216.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
..+|++.++||+|+||.||+|.+.. +|..||.|.+.- ...+....+...
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~---~g~l~a~K~i~f----------------------------~~md~k~rq~~v 66 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLL---DGKLVALKKIQF----------------------------GMMDAKARQDCV 66 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeecc---Ccchhhhhhcch----------------------------hhccHHHHHHHH
Confidence 4689999999999999999999987 899999998852 124566778899
Q ss_pred HHHHHHHhhcCCCCcceeeE-EEEeCCe-EEEEEecCCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHH--C
Q 011582 200 REVKILRALTGHKNLVQFYD-AYEDDDN-IYIVMELCKGGELLDRIL---SRGGKYSEEDAKIVMVQILSVVAFCHF--Q 272 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~-~~~~~~~-~~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~yLH~--~ 272 (482)
.|+.+|++|+ |||||++++ .|.+++. ++||||||.+|+|...|. +....++|..+|.++.|++.||..+|+ .
T Consensus 67 ~Ei~lLkQL~-HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~ 145 (375)
T KOG0591|consen 67 KEISLLKQLN-HPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIP 145 (375)
T ss_pred HHHHHHHhcC-CchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccc
Confidence 9999999997 999999998 4555555 999999999999988775 345679999999999999999999999 4
Q ss_pred C--CcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc-ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHh
Q 011582 273 G--VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER-LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 273 ~--ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ell 348 (482)
. |+||||||.||++ +.++.+||+|||+++.+..... ..+.+|||.||+||.+++ .|+.|+||||+||++|||+
T Consensus 146 r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMc 222 (375)
T KOG0591|consen 146 RGTVMHRDIKPANIFL---TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMC 222 (375)
T ss_pred ccceeeccCcchheEE---cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHH
Confidence 4 9999999999999 6788999999999999876543 467899999999999875 6999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH
Q 011582 349 CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA 403 (482)
Q Consensus 349 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~ 403 (482)
.-++||.+++-.++.++|..++.. .-+-..+|.++..||..|+.+||+.||+.
T Consensus 223 aL~~PF~g~n~~~L~~KI~qgd~~--~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 223 ALQSPFYGDNLLSLCKKIEQGDYP--PLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred hcCCCcccccHHHHHHHHHcCCCC--CCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 999999999999999999988643 11113589999999999999999999986
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=393.63 Aligned_cols=258 Identities=34% Similarity=0.536 Sum_probs=214.6
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|..++.||+|+||.||++..++ +|..+|||.+... .....+.+.+
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~---~g~~~AvK~v~~~------------------------------~~~~~~~l~~ 63 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKK---TGELMAVKSVELE------------------------------DSPTSESLER 63 (313)
T ss_pred chhhhhccccCccceEEEEEEecC---CCcceeeeeeecc------------------------------cchhHHHHHH
Confidence 468888999999999999999987 6999999988542 1111577899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCC--eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDD--NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
|+.+|++|+ |||||+++|...... .++++|||+++|+|.+++...++.|++..++.+.+||++||.|||++||||||
T Consensus 64 Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~D 142 (313)
T KOG0198|consen 64 EIRILSRLN-HPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCD 142 (313)
T ss_pred HHHHHHhCC-CCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccC
Confidence 999999998 999999999855444 69999999999999999987665899999999999999999999999999999
Q ss_pred CCCCceEEecCCC-CCcEEEEecccccccCC----CCcccccccCccccCcccccccC--CCcchhhhhHHHHHHHhhCC
Q 011582 279 LKPENFLFTSKEE-NSSLKAIDFGLSDYVKP----DERLNDIVGSAYYVAPEVLHRSY--GTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 279 lkp~NIll~~~~~-~~~~kl~DfGla~~~~~----~~~~~~~~gt~~y~aPE~~~~~~--~~~~DiwSlGvil~elltg~ 351 (482)
|||+|||+ +. ++.+||+|||++..... ........||+.|||||++...+ ..++|||||||++.||+||+
T Consensus 143 iK~~NiLl---~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~ 219 (313)
T KOG0198|consen 143 IKPANILL---DPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGK 219 (313)
T ss_pred cccceEEE---eCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCC
Confidence 99999999 45 68899999999987663 12244578999999999998443 34999999999999999999
Q ss_pred CCCCCC-ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 352 RPFWAR-TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 352 ~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.||... ...+.+-.+...... + .....+|+++++||.+||..||.+||||+++|+|||+.....
T Consensus 220 ~PW~~~~~~~~~~~~ig~~~~~-P-~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 220 PPWSEFFEEAEALLLIGREDSL-P-EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CcchhhcchHHHHHHHhccCCC-C-CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999873 333333444433311 1 222459999999999999999999999999999999987543
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-51 Score=382.01 Aligned_cols=265 Identities=37% Similarity=0.645 Sum_probs=233.8
Q ss_pred ccccceEecc-eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 118 QFVAHYELGE-EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 118 ~~~~~y~~~~-~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
.|.+-|++.. .||+|+||.|-.++... +|.+||||+|.|. ......
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~---t~~EYAVKiidKq------------------------------~gHsR~ 120 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQ---TGKEYAVKIIDKQ------------------------------PGHSRS 120 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeec---cchhhhhhhhhcC------------------------------CchHHH
Confidence 4556677754 58999999999998877 8999999999773 233457
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
++.+|++++..+++|+||++|+++|+++..+|||||-|.||.|+.+|.++ ..|+|.++.++.+.|+.||.|||.+||.|
T Consensus 121 RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aLdFlH~kgIAH 199 (463)
T KOG0607|consen 121 RVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASALDFLHTKGIAH 199 (463)
T ss_pred HHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHHHHHhhcCccc
Confidence 88999999999999999999999999999999999999999999999876 68999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCC--------CcccccccCccccCccccc---c---cCCCcchhhhhHH
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD--------ERLNDIVGSAYYVAPEVLH---R---SYGTEADMWSIGV 342 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~--------~~~~~~~gt~~y~aPE~~~---~---~~~~~~DiwSlGv 342 (482)
|||||+|||....+.-.-+|||||.+..-.... ..+.+.+|+..|||||+.. + .|+.++|.|||||
T Consensus 200 RDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGv 279 (463)
T KOG0607|consen 200 RDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGV 279 (463)
T ss_pred ccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHH
Confidence 999999999986666667999999887543322 2345678999999999763 2 4999999999999
Q ss_pred HHHHHhhCCCCCCCCC---------------hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHh
Q 011582 343 IAYILLCGSRPFWART---------------ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407 (482)
Q Consensus 343 il~elltg~~pf~~~~---------------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L 407 (482)
|+|.||+|.+||.+.. ...++..|..+.+.|++..|..+|.++++||+.+|..|+.+|.++.+++
T Consensus 280 IlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vl 359 (463)
T KOG0607|consen 280 ILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVL 359 (463)
T ss_pred HHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhcc
Confidence 9999999999996543 3568999999999999999999999999999999999999999999999
Q ss_pred cCcccccCC
Q 011582 408 SHPWLANSH 416 (482)
Q Consensus 408 ~hp~~~~~~ 416 (482)
+|||++.-.
T Consensus 360 nhPw~~~~~ 368 (463)
T KOG0607|consen 360 NHPWVQRCA 368 (463)
T ss_pred CCccccccc
Confidence 999998643
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=385.83 Aligned_cols=262 Identities=29% Similarity=0.486 Sum_probs=225.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++..+||.|.-++||+|+... ++..||||++.-. ......+.++
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p---~~e~VAIK~inLE-----------------------------kc~~~ld~l~ 72 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIP---TNEVVAIKIINLE-----------------------------KCNNDLDALR 72 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecc---cCCEEEEEEeehh-----------------------------hhhhhHHHHH
Confidence 4689999999999999999999987 7899999999642 2233478899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+..|+.+. ||||++++..|..+.++|+||.||.+|++++.+... ...++|..++.|++++++||.|||.+|.||||
T Consensus 73 kE~~~msl~~-HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRd 151 (516)
T KOG0582|consen 73 KEVQTMSLID-HPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRD 151 (516)
T ss_pred HHHHHhhhcC-CCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecc
Confidence 9999999996 999999999999999999999999999999988653 34699999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC-----cccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhhC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~elltg 350 (482)
||+.|||| +.+|.|||+|||.+..+.... ...+.+||++|||||++.. .|+.|+||||||++..||.+|
T Consensus 152 vKAgnILi---~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G 228 (516)
T KOG0582|consen 152 VKAGNILI---DSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHG 228 (516)
T ss_pred cccccEEE---cCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcC
Confidence 99999999 788999999999876553322 1256799999999999643 599999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCC------CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 351 SRPFWARTESGIFRAVLKADPS------FDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
..||......+++-.-+++.+. ++.+....++..++.+|..||+.||++|||++++|+|+||+....
T Consensus 229 ~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 229 HAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred CCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 9999887776665555555442 333444567889999999999999999999999999999987643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=395.46 Aligned_cols=256 Identities=30% Similarity=0.576 Sum_probs=224.3
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|+++. +|+.||||++.+.. .......+.+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~ 65 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKRE---------------------------ILKMKQVQHV 65 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------HhhhhhHHHH
Confidence 35789999999999999999999876 79999999997530 1122345678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+++.+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+|||
T Consensus 66 ~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~d 143 (329)
T PTZ00263 66 AQEKSILMELS-HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKA-GRFPNDVAKFYHAELVLAFEYLHSKDIIYRD 143 (329)
T ss_pred HHHHHHHHhCC-CCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 89999999996 999999999999999999999999999999988654 6799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|||+|||+ +.++.+||+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 144 lkp~NIll---~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 218 (329)
T PTZ00263 144 LKPENLLL---DNKGHVKVTDFGFAKKVPDR--TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD 218 (329)
T ss_pred CCHHHEEE---CCCCCEEEeeccCceEcCCC--cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence 99999999 67788999999999876432 335689999999998865 5899999999999999999999999998
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
+....+..+......++. .++.++++||++||+.||.+|++ ++++++||||.+.
T Consensus 219 ~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 219 TPFRIYEKILAGRLKFPN----WFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred CHHHHHHHHhcCCcCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 888888888877654432 37899999999999999999997 7999999999864
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-49 Score=389.59 Aligned_cols=254 Identities=27% Similarity=0.514 Sum_probs=222.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.++. +|+.||||++.... .......+.+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~ 50 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRI---SEHYYALKVMAIPE---------------------------VIRLKQEQHVHN 50 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcC---CCCEEEEEEEEHHH---------------------------HhhhHHHHHHHH
Confidence 469999999999999999999876 79999999986530 112234567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++.+++.+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+|||||
T Consensus 51 E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 128 (291)
T cd05612 51 EKRVLKEVS-HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128 (291)
T ss_pred HHHHHHhCC-CCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 999999997 999999999999999999999999999999988654 679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
|+|||+ +.++.+||+|||++...... ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.
T Consensus 129 p~NIli---~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 129 PENILL---DKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred HHHeEE---CCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999 56778999999999876432 334679999999998865 589999999999999999999999999998
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
.+....+......++. .+++.+++||++||+.||.+|++ ++++++||||...
T Consensus 204 ~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 260 (291)
T cd05612 204 FGIYEKILAGKLEFPR----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSV 260 (291)
T ss_pred HHHHHHHHhCCcCCCc----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCC
Confidence 8888888887665543 37899999999999999999995 9999999999754
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=393.62 Aligned_cols=250 Identities=30% Similarity=0.565 Sum_probs=218.1
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|+++. +|+.||||++++.. .........+.+|+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~e~~~l~ 50 (323)
T cd05571 1 KLLGKGTFGKVILVREKA---TGKYYAMKILKKEV---------------------------IIAKDEVAHTLTESRVLQ 50 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhhHHHHHHHHHHHHHH
Confidence 369999999999999876 79999999997531 122334566789999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
++. ||||+++++++...+.+|+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 51 ~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll 128 (323)
T cd05571 51 NTR-HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML 128 (323)
T ss_pred hCC-CCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE
Confidence 996 999999999999999999999999999999888654 679999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
+.++.+||+|||+++... ........+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+......
T Consensus 129 ---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~ 205 (323)
T cd05571 129 ---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205 (323)
T ss_pred ---CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH
Confidence 567889999999987542 2233456789999999999864 58999999999999999999999999988888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
.+......++ ..+++++.+||++||+.||++|| ++.++++||||...
T Consensus 206 ~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 206 LILMEEIRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred HHHcCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 8877765554 34899999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-49 Score=398.84 Aligned_cols=260 Identities=26% Similarity=0.493 Sum_probs=220.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|+++. +|+.||||++.+. ..........+.+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~---~~~~~aiK~~~~~---------------------------~~~~~~~~~~~~~ 50 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKD---TGHVYAMKILRKA---------------------------DMLEKEQVGHIRA 50 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEEHH---------------------------HHHHhhHHHHHHH
Confidence 479999999999999999999876 7999999999763 1122334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.++..+. |+||+++++++.+.+.+|||||||+||+|.+++... +.+++..++.++.|++.||.|||++||+|||||
T Consensus 51 E~~il~~~~-~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlK 128 (363)
T cd05628 51 ERDILVEAD-SLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK-DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIK 128 (363)
T ss_pred HHHHHHhCC-CCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCC
Confidence 999999996 999999999999999999999999999999988654 689999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC------------------------------------cccccccCccccCc
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE------------------------------------RLNDIVGSAYYVAP 324 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~------------------------------------~~~~~~gt~~y~aP 324 (482)
|+|||+ +.++.+||+|||+++.+.... .....+||+.|+||
T Consensus 129 p~NILi---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aP 205 (363)
T cd05628 129 PDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAP 205 (363)
T ss_pred HHHeEE---CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCH
Confidence 999999 567889999999987543211 01245899999999
Q ss_pred ccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhcccc---C
Q 011582 325 EVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRK---R 400 (482)
Q Consensus 325 E~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~---R 400 (482)
|++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.........+....+++++++||.+|+. +|.+ |
T Consensus 206 E~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r 284 (363)
T cd05628 206 EVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA 284 (363)
T ss_pred HHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCC
Confidence 99864 58999999999999999999999999998888888888754333333334589999999999885 5554 5
Q ss_pred CCHHHHhcCcccccCC
Q 011582 401 LTAAQALSHPWLANSH 416 (482)
Q Consensus 401 ~s~~e~L~hp~~~~~~ 416 (482)
|+++++++||||+...
T Consensus 285 ~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 285 PGVEEIKTNPFFEGVD 300 (363)
T ss_pred CCHHHHhCCCCCCCCC
Confidence 8999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-49 Score=385.59 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=217.6
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.|++.+.||+|+||.||+|.+.. +|+.||||++.+.. .........+.+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~---------------------------~~~~~~~~~~~~E 50 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKR---------------------------IKKRKGEAMALNE 50 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEec---CCceEEEEEeeHhh---------------------------hhhhhhHHHHHHH
Confidence 37889999999999999999987 79999999986531 1112233567899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
+.+++.+. |+||+++++++.+++.+++|||||++|+|.+++... ...+++..+..++.|++.||.|||++||+|||||
T Consensus 51 ~~il~~l~-~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dik 129 (285)
T cd05631 51 KRILEKVN-SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLK 129 (285)
T ss_pred HHHHHhcC-CCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC
Confidence 99999996 999999999999999999999999999998877643 3468999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
|+|||+ +.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....
T Consensus 130 p~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 130 PENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred HHHEEE---CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 999999 5677899999999987655545556789999999998864 699999999999999999999999987665
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccCC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANSH 416 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~~ 416 (482)
......+..............+++++.+||++||+.||.+|++ ++++++||||....
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~ 268 (285)
T cd05631 207 RVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN 268 (285)
T ss_pred chhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence 4333333222222222233458999999999999999999997 99999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=382.26 Aligned_cols=262 Identities=31% Similarity=0.538 Sum_probs=232.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|.-|+||+|+.+. ++..+|+|++.|.. ........++.
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~---t~~~fAmKVmdK~~---------------------------l~~rkKl~Ra~ 125 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRG---TNCLFAMKVMDKES---------------------------LASRKKLKRAQ 125 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecC---CCceEEEEEecHHH---------------------------HhhhhHHHHHH
Confidence 3679999999999999999999987 77999999998752 23344556778
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.|-+||+.+. ||.++.||..|+.+...|+|||||+||+|.....++ ++.|++..++.++..|+.||+|||-.|||+||
T Consensus 126 tE~eIL~~lD-HPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRD 204 (459)
T KOG0610|consen 126 TEREILSLLD-HPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRD 204 (459)
T ss_pred HHHHHHHhcC-CCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeecc
Confidence 8999999995 999999999999999999999999999998877654 56799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCC-----------------------------------C--------------
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKP-----------------------------------D-------------- 309 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~-----------------------------------~-------------- 309 (482)
|||+|||| .++|+|.|+||.|+..... .
T Consensus 205 LKPENILv---redGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p 281 (459)
T KOG0610|consen 205 LKPENILV---REDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLP 281 (459)
T ss_pred CCcceeEE---ecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccch
Confidence 99999999 7899999999998642210 0
Q ss_pred --------CcccccccCccccCccccccc-CCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC
Q 011582 310 --------ERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS 380 (482)
Q Consensus 310 --------~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 380 (482)
.....++||-.|+|||++.+. .+.++|+|+|||++||||.|..||.+.+..+.+.+|+.....|+... .
T Consensus 282 ~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~ 359 (459)
T KOG0610|consen 282 ELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--E 359 (459)
T ss_pred hhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--c
Confidence 012246899999999999974 89999999999999999999999999999999999999999998764 6
Q ss_pred CCHHHHHHHHHhchhccccCCC----HHHHhcCcccccCCC
Q 011582 381 LSPEAIDFVKRLLNKDYRKRLT----AAQALSHPWLANSHD 417 (482)
Q Consensus 381 ~s~~~~~li~~~L~~dP~~R~s----~~e~L~hp~~~~~~~ 417 (482)
++..++|||+++|.+||.+|.. |.|+-.||||++-++
T Consensus 360 vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred chhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 8999999999999999999998 999999999998664
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=396.86 Aligned_cols=259 Identities=30% Similarity=0.553 Sum_probs=221.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|++.. +|+.||||++.+. ..........+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~---------------------------~~~~~~~~~~~~~ 50 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKD---TGHIYAMKKLRKS---------------------------EMLEKEQVAHVRA 50 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECC---CCCEEEEEEEEHH---------------------------HhhhhhHHHHHHH
Confidence 479999999999999999999987 7999999999753 1112334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|+.+. ||||+++++++.+++.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+|||||
T Consensus 51 E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlk 128 (364)
T cd05599 51 ERDILAEAD-NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYIAETILAIDSIHKLGYIHRDIK 128 (364)
T ss_pred HHHHHHhCC-CCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCC
Confidence 999999996 999999999999999999999999999999988654 579999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC---------------------------------------cccccccCccc
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE---------------------------------------RLNDIVGSAYY 321 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~---------------------------------------~~~~~~gt~~y 321 (482)
|+|||+ +.++.+||+|||++..+.... .....+||+.|
T Consensus 129 p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y 205 (364)
T cd05599 129 PDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDY 205 (364)
T ss_pred HHHeEE---CCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccc
Confidence 999999 678889999999987543211 01134799999
Q ss_pred cCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccC
Q 011582 322 VAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKR 400 (482)
Q Consensus 322 ~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 400 (482)
+|||++.+ .++.++|||||||++|+|++|..||.+.+..+....+......+..+....+++++++||.+||. +|.+|
T Consensus 206 ~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R 284 (364)
T cd05599 206 IAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERR 284 (364)
T ss_pred cCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhc
Confidence 99998864 68999999999999999999999999988888888887655444433334689999999999996 99999
Q ss_pred CC---HHHHhcCcccccC
Q 011582 401 LT---AAQALSHPWLANS 415 (482)
Q Consensus 401 ~s---~~e~L~hp~~~~~ 415 (482)
++ ++++|.||||...
T Consensus 285 ~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 285 LGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCCHHHHhcCCCcCCC
Confidence 98 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=384.26 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=214.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||.|+||.||+|+++. +|..||+|+++... .......+.
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-----------------------------~~~~~~~~~ 51 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKL---TENLVALKEIRLEH-----------------------------EEGAPCTAI 51 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECC---CCCEEEEEEecccc-----------------------------cCCcchhHH
Confidence 3579999999999999999999876 78999999986420 111124567
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. ||||+++++++.+++..|+||||+++ +|.+++...+..+++..+..++.||+.||.|||++||+||||
T Consensus 52 ~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dl 129 (288)
T cd07871 52 REVSLLKNLK-HANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDL 129 (288)
T ss_pred HHHHHHHhCC-CCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 8999999996 99999999999999999999999975 899888766667899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||+|||+ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+
T Consensus 130 kp~Nil~---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~ 206 (288)
T cd07871 130 KPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206 (288)
T ss_pred CHHHEEE---CCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999 56778999999999765332 23345678999999998754 589999999999999999999999998
Q ss_pred CChHHHHHHHHhcCCCCCCC--------------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHhcCc
Q 011582 357 RTESGIFRAVLKADPSFDEA--------------------------PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 410 (482)
.+..+.+..+.......... ..+.+++++++||++||+.||.+|+|++|+|+||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp 286 (288)
T cd07871 207 STVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHS 286 (288)
T ss_pred CCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCC
Confidence 88777666554432211111 1235688999999999999999999999999999
Q ss_pred cc
Q 011582 411 WL 412 (482)
Q Consensus 411 ~~ 412 (482)
||
T Consensus 287 ~f 288 (288)
T cd07871 287 YF 288 (288)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=389.87 Aligned_cols=258 Identities=32% Similarity=0.544 Sum_probs=223.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|++.. +|+.||||++++.. .........+.+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~---------------------------~~~~~~~~~~~~ 50 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKD---TGEIVALKRMKKSL---------------------------LFKLNEVRHVLT 50 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------HhhhhHHHHHHH
Confidence 369999999999999999999876 78999999997631 112234567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++.+.+..|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+|||||
T Consensus 51 e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 128 (333)
T cd05600 51 ERDILTTTK-SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL-GVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128 (333)
T ss_pred HHHHHHhCC-CCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 999999997 999999999999999999999999999999988544 679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
|+|||+ +.++.+||+|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+.
T Consensus 129 p~Nil~---~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 129 PENFLI---DASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred HHHEEE---CCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 999999 5678899999999986543 3455689999999998864 689999999999999999999999999888
Q ss_pred HHHHHHHHhcCCCCCCCCCC----CCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 360 SGIFRAVLKADPSFDEAPWP----SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~----~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.+.+..+......+..+.+. .+++++.+||.+||..+|.+|++++++++||||...
T Consensus 204 ~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 204 NETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 88887777654333333222 579999999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=396.29 Aligned_cols=259 Identities=29% Similarity=0.496 Sum_probs=217.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.|++++.||+|+||.||+|++.. +|+.||||++.+. ..........+.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~---~~~~~aiK~i~~~---------------------------~~~~~~~~~~~~~E 51 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVD---THALYAMKTLRKK---------------------------DVLNRNQVAHVKAE 51 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHH---------------------------HhhhhHHHHHHHHH
Confidence 68999999999999999999877 7999999999753 11223445678999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+. ||||+++++++.+.+.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 52 ~~il~~l~-h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp 129 (381)
T cd05626 52 RDILAEAD-NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKP 129 (381)
T ss_pred HHHHHhcC-CCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcH
Confidence 99999996 999999999999999999999999999999987654 5799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCC------------------------------------------------ccc
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDE------------------------------------------------RLN 313 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~------------------------------------------------~~~ 313 (482)
+|||+ +.++.+||+|||++..+.... ...
T Consensus 130 ~Nili---~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (381)
T cd05626 130 DNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206 (381)
T ss_pred HHEEE---CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccc
Confidence 99999 567889999999975331000 012
Q ss_pred ccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 011582 314 DIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRL 392 (482)
Q Consensus 314 ~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 392 (482)
..+||+.|+|||++.+ .++.++|||||||++|||++|..||...+..+....+.........+.+..+++++++||.+|
T Consensus 207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~l 286 (381)
T cd05626 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKL 286 (381)
T ss_pred cccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHH
Confidence 4579999999998864 589999999999999999999999998887777777765444444444556899999999997
Q ss_pred chh--ccccCCCHHHHhcCcccccC
Q 011582 393 LNK--DYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 393 L~~--dP~~R~s~~e~L~hp~~~~~ 415 (482)
|.. ++..|++++++++||||...
T Consensus 287 l~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 287 CCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred ccCcccccCCCCHHHHhcCcccCCC
Confidence 654 45559999999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-48 Score=390.71 Aligned_cols=256 Identities=28% Similarity=0.403 Sum_probs=209.2
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|++.. +|+.||||++... ........+.
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----------------------------~~~~~~~~~~ 120 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRP---TGRLYALKVIYGN-----------------------------HEDTVRRQIC 120 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECC---CCCEEEEEEEecC-----------------------------CcHHHHHHHH
Confidence 4678899999999999999999876 7899999998542 1233456788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. |+||+++++++.+.+.+|+|||||++++|.+. ....+..+..++.||+.||.|||++||+||||
T Consensus 121 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 194 (353)
T PLN00034 121 REIEILRDVN-HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDI 194 (353)
T ss_pred HHHHHHHhCC-CCCcceeeeEeccCCeEEEEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCC
Confidence 9999999997 99999999999999999999999999987642 34678888999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc------cCCCcchhhhhHHHHHHHhhCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR------SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlGvil~elltg~~ 352 (482)
||+|||+ +.++.+||+|||++....... .....+||..|+|||++.. .++.++|||||||++|+|++|+.
T Consensus 195 kp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~ 271 (353)
T PLN00034 195 KPSNLLI---NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRF 271 (353)
T ss_pred CHHHEEE---cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCC
Confidence 9999999 567889999999998764332 2345689999999998742 24568999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
||......+....+..............++.++++||.+||..||.+||++.|+|+||||....
T Consensus 272 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 272 PFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 9975443332222222111112222346899999999999999999999999999999998764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=390.95 Aligned_cols=257 Identities=29% Similarity=0.530 Sum_probs=223.3
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|.++.. .+..||+|++.+.. .......+.+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~--~~~~vavK~~~~~~---------------------------~~~~~~~~~~ 78 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNE--DFPPVAIKRFEKSK---------------------------IIKQKQVDHV 78 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECC--CCeEEEEEEEEHHH---------------------------hhhhhhHHHH
Confidence 346899999999999999999987651 34689999986531 1122345678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+|||
T Consensus 79 ~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrD 156 (340)
T PTZ00426 79 FSERKILNYIN-HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN-KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRD 156 (340)
T ss_pred HHHHHHHHhCC-CCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccC
Confidence 89999999996 999999999999999999999999999999988654 6799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|||+|||+ +.++.+||+|||++..... .....+||+.|||||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 157 Lkp~NILl---~~~~~ikL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 231 (340)
T PTZ00426 157 LKPENLLL---DKDGFIKMTDFGFAKVVDT--RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN 231 (340)
T ss_pred CCHHHEEE---CCCCCEEEecCCCCeecCC--CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC
Confidence 99999999 6678899999999987643 2345689999999999865 5899999999999999999999999998
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
+...+...+......++. .+++++.++|++||+.||.+|+ +++++++||||.+.
T Consensus 232 ~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 232 EPLLIYQKILEGIIYFPK----FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred CHHHHHHHHhcCCCCCCC----CCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 888888888877655543 4789999999999999999996 89999999999864
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=396.51 Aligned_cols=259 Identities=27% Similarity=0.491 Sum_probs=217.8
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|.+++.||+|+||.||+|+++. +|+.||||++.+. ........+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~---------------------------~~~~~~~~~~~~~ 50 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKD---TGKIYAMKTLLKS---------------------------EMFKKDQLAHVKA 50 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECC---CCCEEEEEEEEHH---------------------------HHHHhHHHHHHHH
Confidence 369999999999999999999887 7999999998653 1112334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++.+.+.+|+|||||+||+|.+++... +.+++..++.++.|++.||.|||++||+|||||
T Consensus 51 E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlk 128 (377)
T cd05629 51 ERDVLAESD-SPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY-DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIK 128 (377)
T ss_pred HHHHHHhCC-CCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 999999996 999999999999999999999999999999988654 679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC------------------------------------------------cc
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE------------------------------------------------RL 312 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~------------------------------------------------~~ 312 (482)
|+|||+ +.++.+||+|||+++.+.... ..
T Consensus 129 p~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (377)
T cd05629 129 PDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMA 205 (377)
T ss_pred HHHEEE---CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccc
Confidence 999999 567889999999986321100 00
Q ss_pred cccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHH
Q 011582 313 NDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKR 391 (482)
Q Consensus 313 ~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 391 (482)
...+||+.|+|||++.+ .++.++|||||||++|||++|..||.+....+.+..+.........+....++.++++||.+
T Consensus 206 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~ 285 (377)
T cd05629 206 YSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRR 285 (377)
T ss_pred cccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHH
Confidence 12579999999998864 59999999999999999999999999888888888777644333333334589999999999
Q ss_pred hchhccccC---CCHHHHhcCcccccC
Q 011582 392 LLNKDYRKR---LTAAQALSHPWLANS 415 (482)
Q Consensus 392 ~L~~dP~~R---~s~~e~L~hp~~~~~ 415 (482)
||. +|.+| +++.+++.||||...
T Consensus 286 lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 286 LIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred Hhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 997 77775 599999999999854
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=395.64 Aligned_cols=258 Identities=31% Similarity=0.530 Sum_probs=220.2
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++++.||+|+||.||+|++.. +++.||||++.+. ..........+.+|
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~---~~~~~aiK~i~~~---------------------------~~~~~~~~~~~~~E 51 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVD---TKALYAMKTLRKK---------------------------DVLLRNQVAHVKAE 51 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECC---CCCEEEEEEEeHH---------------------------HhhhHHHHHHHHHH
Confidence 68999999999999999999876 7899999998653 11223345678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+. ||||+++++++.+++.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||||
T Consensus 52 ~~il~~~~-h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp 129 (382)
T cd05625 52 RDILAEAD-NEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKP 129 (382)
T ss_pred HHHHHhCC-CCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 99999996 999999999999999999999999999999988654 5799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCC------------------------------------------------Cccc
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPD------------------------------------------------ERLN 313 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~------------------------------------------------~~~~ 313 (482)
+|||+ +.++.+||+|||++..+... ....
T Consensus 130 ~NILl---~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (382)
T cd05625 130 DNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAH 206 (382)
T ss_pred HHEEE---CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccc
Confidence 99999 67788999999997532100 0012
Q ss_pred ccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 011582 314 DIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRL 392 (482)
Q Consensus 314 ~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 392 (482)
..+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+.+..+....+.........+.+..+++++.++|.+|
T Consensus 207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l 286 (382)
T cd05625 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL 286 (382)
T ss_pred ccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHH
Confidence 3579999999998864 699999999999999999999999999888777777776555444455567899999999998
Q ss_pred chhccccCCC---HHHHhcCcccccC
Q 011582 393 LNKDYRKRLT---AAQALSHPWLANS 415 (482)
Q Consensus 393 L~~dP~~R~s---~~e~L~hp~~~~~ 415 (482)
+ .+|.+|++ ++++++||||...
T Consensus 287 ~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 287 C-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred c-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 7 59999997 9999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-48 Score=394.38 Aligned_cols=261 Identities=28% Similarity=0.483 Sum_probs=224.6
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|+++. +|+.||||++++.. .........+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~ 90 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKS---SKQVYAMKLLSKFE---------------------------MIKRSDSAFF 90 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhhhhHHHH
Confidence 35689999999999999999999886 79999999997530 1122334567
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+++.+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+|||
T Consensus 91 ~~e~~il~~~~-h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrD 167 (370)
T cd05596 91 WEERDIMAHAN-SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRD 167 (370)
T ss_pred HHHHHHHHhCC-CCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 88999999996 99999999999999999999999999999998754 3689999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc-----cCCCcchhhhhHHHHHHHhhCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR-----SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlGvil~elltg~ 351 (482)
|||+|||+ +.++.+||+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus 168 Lkp~NILl---~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~ 244 (370)
T cd05596 168 VKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 244 (370)
T ss_pred CCHHHEEE---cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCC
Confidence 99999999 678899999999998764332 2245679999999998753 3789999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhcccc--CCCHHHHhcCcccccC
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRK--RLTAAQALSHPWLANS 415 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~ 415 (482)
.||.+.+....+..+.........+....+|.++++||++||+.+|.+ |++++++++||||++.
T Consensus 245 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 245 TPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred CCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 999999988888888876544444444568999999999999999988 9999999999999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=384.67 Aligned_cols=248 Identities=26% Similarity=0.528 Sum_probs=216.3
Q ss_pred eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhh
Q 011582 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL 208 (482)
Q Consensus 129 LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l 208 (482)
||+|+||.||+|++.. +|+.||+|++.+. ..........+.+|+.+++++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~aiK~i~~~---------------------------~~~~~~~~~~~~~E~~~l~~l 50 (312)
T cd05585 1 IGKGSFGKVMQVRKRD---TQRIYALKTIRKA---------------------------HIVSRSEVTHTLAERTVLAQV 50 (312)
T ss_pred CCcCCCeEEEEEEECC---CCCEEEEEEEEHH---------------------------HhhhhhHHHHHHHHHHHHHhC
Confidence 7999999999999876 7899999998753 112233456788999999999
Q ss_pred cCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 011582 209 TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTS 288 (482)
Q Consensus 209 ~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~ 288 (482)
. ||||+++++++.+.+..|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 51 ~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili-- 126 (312)
T cd05585 51 N-CPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL-- 126 (312)
T ss_pred C-CCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE--
Confidence 6 999999999999999999999999999999988654 679999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHH
Q 011582 289 KEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366 (482)
Q Consensus 289 ~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i 366 (482)
+.++.+||+|||+++.... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus 127 -~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~ 205 (312)
T cd05585 127 -DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI 205 (312)
T ss_pred -CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHH
Confidence 6678899999999976432 233445689999999998865 5899999999999999999999999998888888888
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC---CHHHHhcCcccccC
Q 011582 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL---TAAQALSHPWLANS 415 (482)
Q Consensus 367 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~L~hp~~~~~ 415 (482)
......++ ..+++++.+||.+||..||.+|+ ++.++|+||||...
T Consensus 206 ~~~~~~~~----~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 206 LQEPLRFP----DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred HcCCCCCC----CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 87665544 34899999999999999999997 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=395.97 Aligned_cols=259 Identities=29% Similarity=0.505 Sum_probs=219.8
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||.||+|++.. +|+.||||++.+.. .........+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~---~~~~~avK~~~~~~---------------------------~~~~~~~~~~~~ 50 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVD---TNALYAMKTLRKAD---------------------------VLMRNQAAHVKA 50 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEcHHH---------------------------HHhhhhHHHHHH
Confidence 369999999999999999999886 79999999986530 111223466889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|+.+. |+||+++++.+.+++.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+|||||
T Consensus 51 E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlk 128 (376)
T cd05598 51 ERDILAEAD-NEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIK 128 (376)
T ss_pred HHHHHHhCC-CCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCC
Confidence 999999996 999999999999999999999999999999988654 679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC--------------------------------------------Ccccccc
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD--------------------------------------------ERLNDIV 316 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~--------------------------------------------~~~~~~~ 316 (482)
|+|||+ +.++.+||+|||+|..+... ......+
T Consensus 129 p~Nill---~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (376)
T cd05598 129 PDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLV 205 (376)
T ss_pred HHHEEE---CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccC
Confidence 999999 66788999999997532100 0012357
Q ss_pred cCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchh
Q 011582 317 GSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNK 395 (482)
Q Consensus 317 gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 395 (482)
||+.|||||++.+ .++.++|||||||++|+|++|+.||.+....+....+...........+..+++++.+||.+|+ .
T Consensus 206 gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~ 284 (376)
T cd05598 206 GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-C 284 (376)
T ss_pred CCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-c
Confidence 9999999999865 5899999999999999999999999998887777777665544444445678999999999987 5
Q ss_pred ccccCC---CHHHHhcCcccccC
Q 011582 396 DYRKRL---TAAQALSHPWLANS 415 (482)
Q Consensus 396 dP~~R~---s~~e~L~hp~~~~~ 415 (482)
+|.+|+ ++.++++||||...
T Consensus 285 ~p~~R~~~~t~~ell~h~~~~~~ 307 (376)
T cd05598 285 GAEDRLGKNGADEIKAHPFFKGI 307 (376)
T ss_pred CHhhcCCCCCHHHHhCCCCcCCC
Confidence 999999 99999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-48 Score=382.27 Aligned_cols=259 Identities=28% Similarity=0.434 Sum_probs=210.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|+++. +|+.||||++.... .......+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~-----------------------------~~~~~~~~~ 51 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKV---NGKLVALKVIRLQE-----------------------------EEGTPFTAI 51 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECC---CCCEEEEEEecccc-----------------------------ccccchhHH
Confidence 4689999999999999999999876 78999999986430 111123567
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. ||||+++++++.+++..|+||||+. ++|.+++....+.+++..++.++.||+.||.|||++||+||||
T Consensus 52 ~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dl 129 (303)
T cd07869 52 REASLLKGLK-HANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDL 129 (303)
T ss_pred HHHHHHhhCC-CCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 8999999996 9999999999999999999999995 5888888776678999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||+|||+ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||+||++|+|++|..||.+
T Consensus 130 kp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 130 KPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred CHHHEEE---CCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999 56788999999998754322 23345678999999998754 488999999999999999999999987
Q ss_pred CCh-HHHHHHHHhcCCCCCCCC--------------------------C--CCCCHHHHHHHHHhchhccccCCCHHHHh
Q 011582 357 RTE-SGIFRAVLKADPSFDEAP--------------------------W--PSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407 (482)
Q Consensus 357 ~~~-~~~~~~i~~~~~~~~~~~--------------------------~--~~~s~~~~~li~~~L~~dP~~R~s~~e~L 407 (482)
... .+.+..+........... | ..+++++.+||.+||+.||++|||+.++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l 286 (303)
T cd07869 207 MKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286 (303)
T ss_pred CccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHh
Confidence 543 233333322111100000 1 12457899999999999999999999999
Q ss_pred cCcccccC
Q 011582 408 SHPWLANS 415 (482)
Q Consensus 408 ~hp~~~~~ 415 (482)
+||||++.
T Consensus 287 ~h~~f~~~ 294 (303)
T cd07869 287 SHEYFSDL 294 (303)
T ss_pred cCcccccC
Confidence 99999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=372.01 Aligned_cols=261 Identities=31% Similarity=0.507 Sum_probs=225.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
...|..+++||+|+||+||+|+.+. +|+.||+|.++-... .+-.-....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~---~g~~VALKkirl~~~----------------------------~EG~P~tai 58 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKR---TGKFVALKKIRLEFE----------------------------EEGVPSTAI 58 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEec---CCCEEEEEEEecccc----------------------------ccCCCchhh
Confidence 4568888999999999999999998 899999999965310 000113457
Q ss_pred HHHHHHHhhcCCCC-cceeeEEEEeCC------eEEEEEecCCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHH
Q 011582 200 REVKILRALTGHKN-LVQFYDAYEDDD------NIYIVMELCKGGELLDRILSRG---GKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 200 ~Ei~~l~~l~~hpn-iv~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~yL 269 (482)
+|+.+|+.|+ |+| |++|++++...+ .+++|+||++. +|..++.... ..++...++.++.||+.||.||
T Consensus 59 REisllk~L~-~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~ 136 (323)
T KOG0594|consen 59 REISLLKRLS-HANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFL 136 (323)
T ss_pred HHHHHHHHhC-CCcceEEEEeeeeecccccccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 9999999997 999 999999998877 89999999965 8998887655 3688899999999999999999
Q ss_pred HHCCCcccCCCCCceEEecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHH
Q 011582 270 HFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYI 346 (482)
Q Consensus 270 H~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~e 346 (482)
|++||+||||||+|||+ +..+.+||+|||+|+... +....+..++|.+|+|||++.+ .|+..+||||+|||++|
T Consensus 137 H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaE 213 (323)
T KOG0594|consen 137 HSHGILHRDLKPQNLLI---SSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAE 213 (323)
T ss_pred HhCCeecccCCcceEEE---CCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHH
Confidence 99999999999999999 568899999999999776 3445777899999999999875 49999999999999999
Q ss_pred HhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC--------------------------CHHHHHHHHHhchhccccC
Q 011582 347 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL--------------------------SPEAIDFVKRLLNKDYRKR 400 (482)
Q Consensus 347 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~--------------------------s~~~~~li~~~L~~dP~~R 400 (482)
|++++..|.+..+.+.+..|...........|+.+ +++..+++.+||+.+|.+|
T Consensus 214 m~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R 293 (323)
T KOG0594|consen 214 MFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKR 293 (323)
T ss_pred HHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccC
Confidence 99999999999999999999887666666666432 3588999999999999999
Q ss_pred CCHHHHhcCcccccCC
Q 011582 401 LTAAQALSHPWLANSH 416 (482)
Q Consensus 401 ~s~~e~L~hp~~~~~~ 416 (482)
.|++.+|.||||....
T Consensus 294 ~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 294 ISAKGALTHPYFSELP 309 (323)
T ss_pred cCHHHHhcChhhcccc
Confidence 9999999999998764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=387.84 Aligned_cols=260 Identities=30% Similarity=0.556 Sum_probs=217.5
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++++.||+|+||.||+|+...+..+|+.||+|++.+.. ........+.+.+|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--------------------------~~~~~~~~~~~~~e 54 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAA--------------------------LVQKAKTVEHTRTE 54 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHH--------------------------HhhhhhHHHHHHHH
Confidence 4899999999999999999886555578999999997531 00122334677899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+.+|+||+++++++.+++.+|+|||||++|+|.+++..+ ..+++..++.++.||+.||.|||++||+||||||
T Consensus 55 ~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp 133 (332)
T cd05614 55 RNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQR-DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKL 133 (332)
T ss_pred HHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCH
Confidence 999999977999999999999999999999999999999988654 5799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
+|||+ +.++.+||+|||+++...... .....+||+.|||||++.+ .++.++|||||||++|+|++|..||...
T Consensus 134 ~Nili---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 134 ENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred HHeEE---CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 99999 567789999999998653322 2345689999999999864 4788999999999999999999999643
Q ss_pred C----hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 358 T----ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 358 ~----~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
. ...+...+......++ ..+++++.+||.+||+.||++|+ +++++++||||+..
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 211 GERNTQSEVSRRILKCDPPFP----SFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 2 3344444554443332 35899999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-48 Score=391.45 Aligned_cols=259 Identities=35% Similarity=0.623 Sum_probs=224.3
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|.+.+.||+|+||.||+|++.. +|+.||||++.+.. .........+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~ 50 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKD---TGQVYAMKVLRKSD---------------------------MIKRNQIAHVRA 50 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECC---CCCEEEEEEEEHHH---------------------------HhhccHHHHHHH
Confidence 479999999999999999999886 79999999997631 112234567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.++..+. ||||+++++++.+++.+|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+|||||
T Consensus 51 e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlk 128 (350)
T cd05573 51 ERDILADAD-SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIK 128 (350)
T ss_pred HHHHHHhcC-CCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCC
Confidence 999999997 999999999999999999999999999999988765 689999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC------------------------------cccccccCccccCcccccc-
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE------------------------------RLNDIVGSAYYVAPEVLHR- 329 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~- 329 (482)
|+|||+ +.++.+||+|||++....... ......||+.|+|||++.+
T Consensus 129 p~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 205 (350)
T cd05573 129 PDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT 205 (350)
T ss_pred HHHeEE---CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC
Confidence 999999 677889999999998664433 2334679999999998865
Q ss_pred cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-HHHHhc
Q 011582 330 SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-AAQALS 408 (482)
Q Consensus 330 ~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-~~e~L~ 408 (482)
.++.++|||||||++|+|++|+.||...+..+....+......+..+....+++++.+||.+||. ||.+|++ ++++|+
T Consensus 206 ~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 206 PYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 58999999999999999999999999988888888887743333333344589999999999997 9999999 999999
Q ss_pred CcccccC
Q 011582 409 HPWLANS 415 (482)
Q Consensus 409 hp~~~~~ 415 (482)
||||...
T Consensus 285 hp~~~~~ 291 (350)
T cd05573 285 HPFFKGI 291 (350)
T ss_pred CCCcCCC
Confidence 9999864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-48 Score=386.15 Aligned_cols=250 Identities=29% Similarity=0.551 Sum_probs=216.9
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|++.. +|+.||||++.+.. .........+.+|+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~---------------------------~~~~~~~~~~~~E~~~l~ 50 (328)
T cd05593 1 KLLGKGTFGKVILVREKA---SGKYYAMKILKKEV---------------------------IIAKDEVAHTLTESRVLK 50 (328)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhhhHHHHHHHHHHHHH
Confidence 369999999999999876 79999999997631 122334567889999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+. ||||+++++++.+.+.+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 51 ~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll 128 (328)
T cd05593 51 NTR-HPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRE-RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML 128 (328)
T ss_pred hCC-CCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE
Confidence 996 999999999999999999999999999998887544 679999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
+.++.+||+|||+++.... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+...
T Consensus 129 ---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~ 205 (328)
T cd05593 129 ---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE 205 (328)
T ss_pred ---CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH
Confidence 5678899999999876432 233445689999999999864 68999999999999999999999999888888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
.+......++. .+++++.+||++||..||.+|+ ++.++++||||...
T Consensus 206 ~~~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 206 LILMEDIKFPR----TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred HhccCCccCCC----CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 77766555443 4899999999999999999997 89999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-48 Score=387.80 Aligned_cols=260 Identities=30% Similarity=0.526 Sum_probs=223.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|.+.+.||+|+||.||+|+++. +|+.||||++++. ..........+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~---------------------------~~~~~~~~~~~~~ 50 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKA---TGDIYAMKVMKKS---------------------------VLLAQETVSFFEE 50 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECC---CCCEEEEEEEEHH---------------------------HhhhhhHHHHHHH
Confidence 369999999999999999999886 7999999999763 1122334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. |+||+++++++.+.+.+|+||||+++|+|.+++......+++..+..++.||+.||.|||++||+|||||
T Consensus 51 e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlk 129 (330)
T cd05601 51 ERDILSISN-SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIK 129 (330)
T ss_pred HHHHHHhCC-CCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCc
Confidence 999999886 9999999999999999999999999999999887765789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-------ccCCCcchhhhhHHHHHHHhhCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-------RSYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlGvil~elltg~ 351 (482)
|+|||+ +.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++|.
T Consensus 130 p~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~ 206 (330)
T cd05601 130 PENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206 (330)
T ss_pred hHheEE---CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCC
Confidence 999999 6778899999999987654332 23357999999999874 34788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.||...+....+..++........+..+.+++++.+||.+||. ||.+||+++++++||||...
T Consensus 207 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 207 SPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred CCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 9999888888888887654333333334689999999999998 99999999999999999864
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-48 Score=384.69 Aligned_cols=250 Identities=30% Similarity=0.570 Sum_probs=217.0
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|++.. +|..||+|++.+.. .........+.+|+.+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~---------------------------~~~~~~~~~~~~E~~~l~ 50 (323)
T cd05595 1 KLLGKGTFGKVILVREKA---TGRYYAMKILRKEV---------------------------IIAKDEVAHTVTESRVLQ 50 (323)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhhHHHHHHHHHHHHHH
Confidence 369999999999999876 79999999997531 112234566788999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+. ||||+++++++...+.+|+||||+++|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 51 ~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll 128 (323)
T cd05595 51 NTR-HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML 128 (323)
T ss_pred hCC-CCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE
Confidence 996 999999999999999999999999999998877544 679999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCC-CCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
+.++.+||+|||++..... .......+||+.|+|||++. +.++.++|||||||++|+|++|+.||...+......
T Consensus 129 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~ 205 (323)
T cd05595 129 ---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 205 (323)
T ss_pred ---cCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 5678899999999876432 23344568999999999886 468999999999999999999999999988888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
.+......++. .+++++.+||.+||..||.+|+ ++.++++|+||.+.
T Consensus 206 ~~~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 206 LILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred HHhcCCCCCCC----CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 88776655543 4899999999999999999998 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=391.33 Aligned_cols=261 Identities=28% Similarity=0.481 Sum_probs=222.4
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|+++. +++.||+|++.+. ..........+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~~~~~---------------------------~~~~~~~~~~~ 90 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKS---SQKVYAMKLLSKF---------------------------EMIKRSDSAFF 90 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHH---------------------------HhhhhhhHHHH
Confidence 34689999999999999999999876 7899999999753 11222334567
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+++.+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+|||
T Consensus 91 ~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrD 167 (370)
T cd05621 91 WEERDIMAFAN-SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRD 167 (370)
T ss_pred HHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecC
Confidence 89999999996 99999999999999999999999999999998754 3689999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc-----cCCCcchhhhhHHHHHHHhhCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR-----SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlGvil~elltg~ 351 (482)
|||+|||+ +.++.+||+|||++....... .....+||+.|||||++.+ .++.++||||+||++|+|++|.
T Consensus 168 LKp~NILl---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~ 244 (370)
T cd05621 168 VKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGD 244 (370)
T ss_pred CCHHHEEE---CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCC
Confidence 99999999 667889999999998764332 2345689999999998853 2788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhcccc--CCCHHHHhcCcccccC
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRK--RLTAAQALSHPWLANS 415 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~ 415 (482)
.||.+.+....+..+......+..+....++..++++|.+||..++.+ |++++++++||||+..
T Consensus 245 ~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 245 TPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred CCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999888888888876544433333468999999999999865544 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-48 Score=384.50 Aligned_cols=251 Identities=31% Similarity=0.572 Sum_probs=217.2
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|+++. +|+.||||++.+.. .......+.+.+|+.++.
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~e~~~l~ 50 (320)
T cd05590 1 RVLGKGSFGKVMLARLKE---SGRLYAVKVLKKDV---------------------------ILQDDDVECTMTEKRILS 50 (320)
T ss_pred CeeeeCCCeEEEEEEEcC---CCCEEEEEEEEHHH---------------------------HhhccHHHHHHHHHHHHH
Confidence 369999999999999876 78999999997531 112234466778999998
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+.+||||+++++++.+.+.+|+|||||+||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 51 ~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~-~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli 129 (320)
T cd05590 51 LARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL 129 (320)
T ss_pred hccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE
Confidence 8767999999999999999999999999999999887554 679999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
+.++.+||+|||++..... .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+..+++.
T Consensus 130 ---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~ 206 (320)
T cd05590 130 ---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE 206 (320)
T ss_pred ---CCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 6678899999999876432 233455689999999998874 58999999999999999999999999999999988
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH------HHHhcCcccccC
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA------AQALSHPWLANS 415 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~------~e~L~hp~~~~~ 415 (482)
.+......++. .+++++.+||++||+.||.+|+++ ++++.||||...
T Consensus 207 ~i~~~~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 207 AILNDEVVYPT----WLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred HHhcCCCCCCC----CCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence 88876654432 389999999999999999999998 999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=382.79 Aligned_cols=256 Identities=28% Similarity=0.492 Sum_probs=220.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|+++. +++.||||++.+.. .......+.+..|
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~---------------------------~~~~~~~~~~~~e 50 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDV---------------------------IIQDDDVECTMVE 50 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhhhHHHHHHHH
Confidence 58999999999999999999876 78899999997631 1123345677889
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.++..+..|++|+++++++.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||
T Consensus 51 ~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp 129 (324)
T cd05587 51 KRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL 129 (324)
T ss_pred HHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH
Confidence 999999974567899999999999999999999999999887554 6799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
+|||+ +.++.+||+|||++.... ........+||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+.
T Consensus 130 ~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (324)
T cd05587 130 DNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206 (324)
T ss_pred HHeEE---cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 99999 567789999999987532 2233445689999999998875 589999999999999999999999999998
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH-----HHHhcCcccccC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA-----AQALSHPWLANS 415 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~e~L~hp~~~~~ 415 (482)
.+.+..+......++. .+++++.++|++||..||.+|+++ +++++||||...
T Consensus 207 ~~~~~~i~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 207 DELFQSIMEHNVSYPK----SLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred HHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 8888888876655443 489999999999999999999986 899999999864
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=382.59 Aligned_cols=251 Identities=28% Similarity=0.508 Sum_probs=217.7
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|+++. +|+.||||++.+.. .......+.+..|+.++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~e~~il~ 50 (321)
T cd05591 1 KVLGKGSFGKVMLAELKG---TDEVYAIKVLKKDV---------------------------ILQDDDVDCTMTEKRILA 50 (321)
T ss_pred CccccCCCeEEEEEEECC---CCCEEEEEEEeHHH---------------------------hhhhhHHHHHHHHHHHHH
Confidence 369999999999999876 78999999997631 122334566778999998
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+.+||||+++++++.+.+.+|+||||+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 51 ~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill 129 (321)
T cd05591 51 LAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS-RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129 (321)
T ss_pred hccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE
Confidence 7767999999999999999999999999999999887654 679999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
+.++.+||+|||++..... .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+.+.
T Consensus 130 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~ 206 (321)
T cd05591 130 ---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFE 206 (321)
T ss_pred ---CCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHH
Confidence 6678899999999876432 233445679999999998865 68999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-------CHHHHhcCcccccC
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-------TAAQALSHPWLANS 415 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-------s~~e~L~hp~~~~~ 415 (482)
.+......++. .++.++.+||.+||+.||.+|+ +++++++||||...
T Consensus 207 ~i~~~~~~~p~----~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 207 SILHDDVLYPV----WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred HHHcCCCCCCC----CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 88887655442 3789999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=381.40 Aligned_cols=256 Identities=27% Similarity=0.478 Sum_probs=221.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|++.. +++.||||++.+.. .......+.+..|
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~e 50 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDV---------------------------VIQDDDVECTMVE 50 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhhhHHHHHHHH
Confidence 58899999999999999999876 78999999997631 1122334566778
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
..++..+..|++|+++++++.+.+.+|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||
T Consensus 51 ~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp 129 (323)
T cd05616 51 KRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKL 129 (323)
T ss_pred HHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCH
Confidence 888888866899999999999999999999999999999887654 6799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
+|||+ +.++.+||+|||++..... .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.+.
T Consensus 130 ~Nill---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~ 206 (323)
T cd05616 130 DNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206 (323)
T ss_pred HHeEE---CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH
Confidence 99999 6778899999999975432 233445789999999998864 699999999999999999999999999998
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
.++...+......++. .+++++.+||.+||+.||.+|++ ..++++||||...
T Consensus 207 ~~~~~~i~~~~~~~p~----~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~ 263 (323)
T cd05616 207 DELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 263 (323)
T ss_pred HHHHHHHHhCCCCCCC----cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence 8998888887665543 48999999999999999999998 4899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=382.65 Aligned_cols=248 Identities=29% Similarity=0.431 Sum_probs=212.8
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCce-EEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQD-VAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~-vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
...+.+.||+|+||+||+|.. .|+. ||||++.... ......+.|.+
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~-----~g~~~vavK~~~~~~----------------------------~~~~~~~~f~~ 88 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKW-----RGTDVVAVKIISDPD----------------------------FDDESRKAFRR 88 (362)
T ss_pred HhhhhhhcccCCceeEEEEEe-----CCceeEEEEEecchh----------------------------cChHHHHHHHH
Confidence 345566699999999999886 4677 9999997631 11222779999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCC-eEEEEEecCCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC-Cccc
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDD-NIYIVMELCKGGELLDRILS-RGGKYSEEDAKIVMVQILSVVAFCHFQG-VVHR 277 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~-ivHr 277 (482)
|+.+|.+++ |||||+++|++.+.. .++|||||+++|+|.+++.. +...++...+..++.||++||.|||+++ ||||
T Consensus 89 E~~il~~l~-HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHr 167 (362)
T KOG0192|consen 89 EASLLSRLR-HPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHR 167 (362)
T ss_pred HHHHHHhCC-CCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeec
Confidence 999999997 999999999999988 79999999999999999987 4688999999999999999999999999 9999
Q ss_pred CCCCCceEEecCCCCC-cEEEEecccccccCCC-CcccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhhCCC
Q 011582 278 DLKPENFLFTSKEENS-SLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~-~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~elltg~~ 352 (482)
||||+|||+ +.+. ++||+|||+++..... ...+...||+.|||||++.+ .|+.|+|||||||+||||+||+.
T Consensus 168 DLK~~NiLv---~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~ 244 (362)
T KOG0192|consen 168 DLKSDNILV---DLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEI 244 (362)
T ss_pred ccChhhEEE---cCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCC
Confidence 999999999 5665 9999999999876654 34455799999999999984 39999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||.+.........+.........+ ...++.+..|+.+|+..||.+||+..+++.
T Consensus 245 Pf~~~~~~~~~~~v~~~~~Rp~~p--~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 245 PFEDLAPVQVASAVVVGGLRPPIP--KECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCCCCHHHHHHHHHhcCCCCCCC--ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 999988877766666554443322 228999999999999999999999999875
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=388.98 Aligned_cols=259 Identities=29% Similarity=0.520 Sum_probs=219.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|+++. +|+.||||++++. ..........+.+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~---------------------------~~~~~~~~~~~~~ 50 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKD---TGHIYAMKILRKA---------------------------DMLEKEQVAHIRA 50 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHH---------------------------HHhhhhhHHHHHH
Confidence 468999999999999999999987 7999999999753 1122334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.++..+. ||||+++++++.+.+.+|+|||||+||+|.+++.+. ..+++..++.++.|++.||.|||++||+|||||
T Consensus 51 e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLk 128 (360)
T cd05627 51 ERDILVEAD-GAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK-DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIK 128 (360)
T ss_pred HHHHHHhCC-CCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCC
Confidence 999999996 999999999999999999999999999999988654 679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC------------------------------------cccccccCccccCc
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE------------------------------------RLNDIVGSAYYVAP 324 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~------------------------------------~~~~~~gt~~y~aP 324 (482)
|+|||+ +.++.+||+|||++....... .....+||+.|+||
T Consensus 129 p~NIli---~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 205 (360)
T cd05627 129 PDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAP 205 (360)
T ss_pred HHHEEE---CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCH
Confidence 999999 667889999999987542210 01245799999999
Q ss_pred ccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC--
Q 011582 325 EVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-- 401 (482)
Q Consensus 325 E~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-- 401 (482)
|++.+ .++.++|||||||++|+|++|+.||.+.+..+.+..+.........+....+++++++||.+|+ .||.+|+
T Consensus 206 E~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~ 284 (360)
T cd05627 206 EVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGS 284 (360)
T ss_pred HHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCC
Confidence 98864 5999999999999999999999999999888888888764433332333348999999999987 4999998
Q ss_pred -CHHHHhcCcccccC
Q 011582 402 -TAAQALSHPWLANS 415 (482)
Q Consensus 402 -s~~e~L~hp~~~~~ 415 (482)
+++++++||||...
T Consensus 285 ~~~~ei~~hp~f~~~ 299 (360)
T cd05627 285 NGVEEIKSHPFFEGV 299 (360)
T ss_pred CCHHHHhcCCCCCCC
Confidence 58999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=383.49 Aligned_cols=250 Identities=30% Similarity=0.570 Sum_probs=216.4
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|++.. +|+.||+|++.+.. .........+.+|+.+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~a~K~~~~~~---------------------------~~~~~~~~~~~~e~~~l~ 50 (325)
T cd05594 1 KLLGKGTFGKVILVKEKA---TGRYYAMKILKKEV---------------------------IVAKDEVAHTLTENRVLQ 50 (325)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhhhHHHHHHHHHHHHH
Confidence 369999999999999876 79999999997631 112234466788999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCceE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHRDLKPENFL 285 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDlkp~NIl 285 (482)
.+. ||||+++++++.+.+.+|+||||++||+|..++... ..+++..+..++.||+.||.|||+ +||+||||||+|||
T Consensus 51 ~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIl 128 (325)
T cd05594 51 NSR-HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 128 (325)
T ss_pred hCC-CCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEE
Confidence 996 999999999999999999999999999998877544 679999999999999999999998 79999999999999
Q ss_pred EecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHH
Q 011582 286 FTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIF 363 (482)
Q Consensus 286 l~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~ 363 (482)
+ +.++.+||+|||++.... ........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.....
T Consensus 129 l---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~ 205 (325)
T cd05594 129 L---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF 205 (325)
T ss_pred E---CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH
Confidence 9 667889999999987543 2333445679999999998864 6899999999999999999999999998888888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 364 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
..+......++. .+++++.+||.+||+.||.+|+ ++.++++||||.+.
T Consensus 206 ~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 206 ELILMEEIRFPR----TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred HHHhcCCCCCCC----CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 888776655543 4899999999999999999997 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=382.31 Aligned_cols=251 Identities=29% Similarity=0.527 Sum_probs=211.2
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|+++. +|+.||||++++. ..........+.+|+.++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~i~~~---------------------------~~~~~~~~~~~~~e~~il~ 50 (329)
T cd05588 1 RVIGRGSYAKVLLVELKK---TRRIYAMKVIKKE---------------------------LVNDDEDIDWVQTEKHVFE 50 (329)
T ss_pred CeEeeCCCeEEEEEEECC---CCCEEEEEEEEHH---------------------------HhhhhhHHHHHHHHHHHHH
Confidence 469999999999999887 7999999999763 1122344567889999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+.+||||+++++++.+.+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 51 ~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili 129 (329)
T cd05588 51 TASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL 129 (329)
T ss_pred hccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence 9977999999999999999999999999999998887544 689999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEeccccccc-CCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC-------
Q 011582 287 TSKEENSSLKAIDFGLSDYV-KPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR------- 357 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~------- 357 (482)
+.++.+||+|||++... .........+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 130 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~ 206 (329)
T cd05588 130 ---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD 206 (329)
T ss_pred ---CCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc
Confidence 56788999999998753 22334456789999999998875 5899999999999999999999999532
Q ss_pred --ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC------HHHHhcCcccccC
Q 011582 358 --TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT------AAQALSHPWLANS 415 (482)
Q Consensus 358 --~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s------~~e~L~hp~~~~~ 415 (482)
......+.+......++ ..++.++.++|++||+.||.+|++ ++++++||||...
T Consensus 207 ~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 207 QNTEDYLFQVILEKQIRIP----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred ccchHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 12234455555544433 248999999999999999999997 7999999999753
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=373.73 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=211.0
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|+++. +++.||||++.... ......+.+.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~~----------------------------~~~~~~~~~~~ 49 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKE---TKEIVAIKKFKDSE----------------------------ENEEVKETTLR 49 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECC---CCcEEEEEEEeccc----------------------------ccccchhhHHH
Confidence 479999999999999999999876 78999999986531 11223456789
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++..++..|+||||++++.+ +.+......+++..++.++.||+.||.|||+.||+|||||
T Consensus 50 E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~l-~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlk 127 (287)
T cd07848 50 ELKMLRTLK-QENIVELKEAFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127 (287)
T ss_pred HHHHHHhCC-CccccchhhhEecCCEEEEEEecCCCCHH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 999999996 99999999999999999999999988655 4454555679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|+||++ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.
T Consensus 128 p~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 128 PENLLI---SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred HHHEEE---cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 999999 567789999999998764322 2344679999999998864 5899999999999999999999999887
Q ss_pred ChHHHHHHHHhcCCCCC--------------C--------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 358 TESGIFRAVLKADPSFD--------------E--------------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~--------------~--------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
+..+....+.......+ . ..+..+|.++.+||++||+.||++|||++++|+|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 205 SEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred CHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 66554444333211100 0 0112378899999999999999999999999999
Q ss_pred ccc
Q 011582 410 PWL 412 (482)
Q Consensus 410 p~~ 412 (482)
|||
T Consensus 285 p~f 287 (287)
T cd07848 285 PAF 287 (287)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=385.24 Aligned_cols=255 Identities=29% Similarity=0.532 Sum_probs=220.7
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
..|...+.||+|+||.||+|.+.. +++.||+|++.-. ......+++.+
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~---t~k~vAiKii~Le-----------------------------~~~deIediqq 60 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNK---TKKVVAIKIIDLE-----------------------------EAEDEIEDIQQ 60 (467)
T ss_pred cccccchhccccccceeeeeeecc---ccceEEEEEechh-----------------------------hcchhhHHHHH
Confidence 357777899999999999999988 8999999999643 34456788999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|..+. ++||.++|+.|..+..++++||||.||++.+.+ +.+..+.+..+..++++++.||.|||.++.+|||||
T Consensus 61 ei~~Ls~~~-~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL-~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIK 138 (467)
T KOG0201|consen 61 EISVLSQCD-SPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLL-KSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIK 138 (467)
T ss_pred HHHHHHhcC-cchHHhhhhheeecccHHHHHHHhcCcchhhhh-ccCCCCccceeeeehHHHHHHhhhhhhcceeccccc
Confidence 999999997 999999999999999999999999999999976 455566999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
+.|||+. .++.+||+|||.+..+.... ...+++|||.|||||++.+ .|+.|+||||||++.+||++|.+||....
T Consensus 139 aanil~s---~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~h 215 (467)
T KOG0201|consen 139 AANILLS---ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLH 215 (467)
T ss_pred ccceeEe---ccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccC
Confidence 9999994 56889999999998876543 3378999999999999986 69999999999999999999999998776
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
....+..|-+..+.... ..+|+.+++||..||++||+.||+|.++|+|+|++..
T Consensus 216 PmrvlflIpk~~PP~L~---~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 216 PMRVLFLIPKSAPPRLD---GDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred cceEEEeccCCCCCccc---cccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 64433333333322211 2589999999999999999999999999999999873
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=379.57 Aligned_cols=254 Identities=31% Similarity=0.551 Sum_probs=217.8
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|+...+..+|+.||||++.+.. ..........+.+|+.+|+
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~--------------------------~~~~~~~~~~~~~E~~il~ 55 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKAT--------------------------IVRNQKDTAHTKAERNILE 55 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHH--------------------------HHhhhhhHHHHHHHHHHHH
Confidence 57999999999999886555578999999997531 0012223456789999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+. ||||+++++++.+++.+|+||||++|++|.+++... +.+.+..+..++.||+.||.|||++||+||||||+|||+
T Consensus 56 ~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~ 133 (323)
T cd05584 56 AVK-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE-GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133 (323)
T ss_pred hCC-CCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 997 999999999999999999999999999999988554 678999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
+.++.+||+|||+++.... .......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+....+.
T Consensus 134 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~ 210 (323)
T cd05584 134 ---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID 210 (323)
T ss_pred ---CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 6678899999999875432 233345689999999998865 58899999999999999999999999988888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
.+......++ +.+++++.+||++||+.||.+|+ +++++++||||...
T Consensus 211 ~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 211 KILKGKLNLP----PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred HHHcCCCCCC----CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 8877665443 34899999999999999999999 89999999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-47 Score=379.17 Aligned_cols=251 Identities=27% Similarity=0.530 Sum_probs=214.5
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|+++. +|..||||++++.. .........+..|..++.
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~---------------------------~~~~~~~~~~~~e~~~l~ 50 (316)
T cd05620 1 KVLGKGSFGKVLLAELKG---KGEYFAVKALKKDV---------------------------VLIDDDVECTMVEKRVLA 50 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhcchHHHHHHHHHHHH
Confidence 469999999999999886 79999999997631 011223456677888887
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+.+||||+++++++.+.+.+|+|||||.||+|.+++... ..+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 51 ~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~ 129 (316)
T cd05620 51 LAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK-GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML 129 (316)
T ss_pred hccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence 7656999999999999999999999999999999887654 679999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
+.++.+||+|||+++.... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..++..
T Consensus 130 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~ 206 (316)
T cd05620 130 ---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFE 206 (316)
T ss_pred ---CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 5677899999999875322 233455789999999999874 68999999999999999999999999998888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH-HHHhcCcccccC
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA-AQALSHPWLANS 415 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-~e~L~hp~~~~~ 415 (482)
.+......++. .++.++++||++||+.||.+|+++ +++++||||...
T Consensus 207 ~~~~~~~~~~~----~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 207 SIRVDTPHYPR----WITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred HHHhCCCCCCC----CCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 88766554432 388999999999999999999998 589999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=379.62 Aligned_cols=253 Identities=30% Similarity=0.521 Sum_probs=216.9
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|++.+.||+|+||.||+|.+.. +|+.||||++++.. .......+.+.+|+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~l~~e~ 50 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKK---TGELYAIKALKKGD---------------------------IIARDEVESLMCEK 50 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhhhHHHHHHHHH
Confidence 7889999999999999999876 79999999997531 11222345677777
Q ss_pred HHHH---hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 203 KILR---ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 203 ~~l~---~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
.++. .+. ||||+++++++.+.+..|+||||++|++|..++.. ..+++..+..++.||+.||.|||++||+||||
T Consensus 51 ~~~~~~~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdl 127 (324)
T cd05589 51 RIFETANSER-HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLGLQYLHENKIVYRDL 127 (324)
T ss_pred HHHHhccccC-CCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCC
Confidence 6654 454 99999999999999999999999999999887643 57999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||+ +.++.+||+|||++..... .......+||+.|||||++.+ .++.++|||||||++|+|++|+.||.+.
T Consensus 128 kp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~ 204 (324)
T cd05589 128 KLDNLLL---DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD 204 (324)
T ss_pred CHHHeEE---CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC
Confidence 9999999 6678899999999875432 233456789999999998864 5899999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
+..+....+......++. .+++++.+||.+||+.||.+|| ++.++++||||.+.
T Consensus 205 ~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 205 DEEEVFDSIVNDEVRYPR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred CHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 988888888877665443 4899999999999999999999 79999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=385.85 Aligned_cols=260 Identities=28% Similarity=0.483 Sum_probs=222.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|+++. +++.||+|++.+.. .........+.
T Consensus 42 ~~~y~i~~~lG~G~fg~Vy~~~~~~---~~~~~aiK~i~~~~---------------------------~~~~~~~~~~~ 91 (371)
T cd05622 42 AEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFE---------------------------MIKRSDSAFFW 91 (371)
T ss_pred hhhcEEEEEEeecCCeEEEEEEECC---CCcEEEEEEEEHHH---------------------------hhhhHHHHHHH
Confidence 4789999999999999999999887 79999999986530 11223345678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. ||||+++++++.+++.+|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||
T Consensus 92 ~e~~i~~~~~-hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDL 168 (371)
T cd05622 92 EERDIMAFAN-SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDV 168 (371)
T ss_pred HHHHHHHhCC-CCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCC
Confidence 8999999996 99999999999999999999999999999998754 36899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc-----cCCCcchhhhhHHHHHHHhhCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR-----SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlGvil~elltg~~ 352 (482)
||+|||+ +.++.+||+|||++....... .....+||+.|||||++.+ .++.++|||||||++|+|++|..
T Consensus 169 kp~NIll---~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 245 (371)
T cd05622 169 KPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245 (371)
T ss_pred CHHHEEE---CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCC
Confidence 9999999 567889999999998764332 2345679999999998853 27899999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhcccc--CCCHHHHhcCcccccC
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRK--RLTAAQALSHPWLANS 415 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~ 415 (482)
||.+.+....+..|......+..+....++.++++||.+||..++.+ |++++++++|+||++.
T Consensus 246 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 246 PFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred CCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 99999988888888876544444445579999999999999844443 7899999999999764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=378.68 Aligned_cols=261 Identities=29% Similarity=0.513 Sum_probs=219.7
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|++.. +|+.||||++.+. ........+.+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~---------------------------~~~~~~~~~~~~~ 50 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKN---TGQVYAMKILNKW---------------------------EMLKRAETACFRE 50 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHH---------------------------HHhhhhhHHHHHH
Confidence 479999999999999999999886 7899999998653 0122234566889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. |+||+++++++.+++.+|+||||++||+|.+++......+++..+..++.||+.||.|||++||+|||||
T Consensus 51 e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 129 (331)
T cd05597 51 ERDVLVNGD-RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIK 129 (331)
T ss_pred HHHHHHhCC-CCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCC
Confidence 999999986 9999999999999999999999999999999987656789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc------ccCCCcchhhhhHHHHHHHhhCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~elltg~~ 352 (482)
|+|||+ +.++.+||+|||++........ ....+||+.|||||++. +.++.++|||||||++|+|++|+.
T Consensus 130 p~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~ 206 (331)
T cd05597 130 PDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGET 206 (331)
T ss_pred HHHEEE---CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCC
Confidence 999999 5678899999999876544332 22357999999999885 347889999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHHhchhcccc--CCCHHHHhcCcccccC
Q 011582 353 PFWARTESGIFRAVLKADPSFDE-APWPSLSPEAIDFVKRLLNKDYRK--RLTAAQALSHPWLANS 415 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~ 415 (482)
||.+....+.+..+......+.. ..+..+++++++||++||..++.+ |++++++|+||||...
T Consensus 207 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 207 PFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred CCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 99988888887777765432221 223458999999999999765444 7899999999999764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-47 Score=377.78 Aligned_cols=251 Identities=29% Similarity=0.545 Sum_probs=213.3
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|++.. +++.||||++++.. .......+.+..|..++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~---------------------------~~~~~~~~~~~~e~~~l~ 50 (316)
T cd05592 1 KVLGKGSFGKVMLAELKG---TNEFFAIKALKKDV---------------------------VLEDDDVECTMVERRVLA 50 (316)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhhhhHHHHHHHHHHHH
Confidence 369999999999999876 78999999997631 011223445567777777
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+.+||||+++++++..++.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 51 ~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill 129 (316)
T cd05592 51 LAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS-GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL 129 (316)
T ss_pred hccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE
Confidence 6656999999999999999999999999999999887654 679999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
+.++.+||+|||++..... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++.
T Consensus 130 ---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~ 206 (316)
T cd05592 130 ---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD 206 (316)
T ss_pred ---CCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 5678899999999976432 233455689999999998865 58999999999999999999999999999888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH-HHHhcCcccccC
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA-AQALSHPWLANS 415 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-~e~L~hp~~~~~ 415 (482)
.+......++ ..++.++.+||.+||+.||.+|+++ .++++||||...
T Consensus 207 ~i~~~~~~~~----~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 207 SILNDRPHFP----RWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred HHHcCCCCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 8876654443 2388999999999999999999986 588899999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-47 Score=371.69 Aligned_cols=258 Identities=29% Similarity=0.417 Sum_probs=210.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|++.+.||+|+||.||+|++... .|+.||||+++... ........+.+
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~--~~~~vavK~~~~~~----------------------------~~~~~~~~~~~ 50 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQT----------------------------GEEGMPLSTIR 50 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCC--CCeEEEEEEEeccc----------------------------CCCCchHHHHH
Confidence 3699999999999999999998541 47889999986431 01111234557
Q ss_pred HHHHHHhhc--CCCCcceeeEEEE-----eCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 201 EVKILRALT--GHKNLVQFYDAYE-----DDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 201 Ei~~l~~l~--~hpniv~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
|+.+++.+. +||||+++++++. ....+++||||+. ++|.+++... ...+++..+..++.||+.||.|||++
T Consensus 51 e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~ 129 (290)
T cd07862 51 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 129 (290)
T ss_pred HHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 777777663 4999999999985 3456899999996 5888888653 34589999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~ 351 (482)
||+||||||+|||+ +.++.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|.
T Consensus 130 ~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 206 (290)
T cd07862 130 RVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206 (290)
T ss_pred CeeeCCCCHHHEEE---cCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCC
Confidence 99999999999999 567789999999998766554555678999999999885 46899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCC-----------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEA-----------------------PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~-----------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+||.+.+..+.+..+.......... ..+.+++.+++||.+||+.||++|||+.++|+
T Consensus 207 ~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 207 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred CCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 9999988888777776542211111 12357889999999999999999999999999
Q ss_pred Cccc
Q 011582 409 HPWL 412 (482)
Q Consensus 409 hp~~ 412 (482)
||||
T Consensus 287 hp~f 290 (290)
T cd07862 287 HPYF 290 (290)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=378.38 Aligned_cols=251 Identities=29% Similarity=0.525 Sum_probs=217.2
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|+++. +++.||||++++.. .........+.+|+.++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~e~~il~ 50 (318)
T cd05570 1 KVLGKGSFGKVLLAELKG---TDELYAVKVLKKDV---------------------------ILQDDDVECTMTEKRVLA 50 (318)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------HhhhhHHHHHHHHHHHHH
Confidence 469999999999999876 78999999997641 122334566788999998
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+.+||||+++++++.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 51 ~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill 129 (318)
T cd05570 51 LAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL 129 (318)
T ss_pred hccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE
Confidence 8867999999999999999999999999999999887554 579999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
+.++.+||+|||++..... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+......
T Consensus 130 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~ 206 (318)
T cd05570 130 ---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ 206 (318)
T ss_pred ---CCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH
Confidence 5678899999999875322 233445679999999998864 68999999999999999999999999988888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH-----HHHhcCcccccC
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA-----AQALSHPWLANS 415 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~e~L~hp~~~~~ 415 (482)
.+......++. .+++++.+||++||..||.+||++ .++++||||...
T Consensus 207 ~i~~~~~~~~~----~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 207 SILEDEVRYPR----WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred HHHcCCCCCCC----cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 88776655442 489999999999999999999999 999999999764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-47 Score=370.41 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=217.1
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|.+.. +|+.||||++.+.. .........+.+|
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~---------------------------~~~~~~~~~~~~E 50 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKR---------------------------IKKRKGEAMALNE 50 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcC---CCceEEEEEEehhh---------------------------hhhhhhHHHHHHH
Confidence 48899999999999999999876 78999999986531 1112234567789
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
+.+++.+. ||||+++++++.+++.+|+||||+++|+|.+++... ...+++..+..++.|++.||.|||++||+|||||
T Consensus 51 ~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlk 129 (285)
T cd05605 51 KQILEKVN-SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLK 129 (285)
T ss_pred HHHHHhcC-CCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Confidence 99999996 999999999999999999999999999999887654 3469999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
|+||++ ++++.++|+|||++............+||+.|+|||++. ..++.++||||+||++|+|++|..||.+...
T Consensus 130 p~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 130 PENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred HHHEEE---CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 999999 667889999999998765544445668999999999886 4589999999999999999999999988766
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
......+..............+++.+.+||.+||..||.+|| +++++++||||...
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05605 207 KVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267 (285)
T ss_pred hhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence 444333332221112222345899999999999999999999 99999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=395.83 Aligned_cols=257 Identities=25% Similarity=0.421 Sum_probs=209.6
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
...+|++++.||+|+||.||+|++.. +|+.||||++.+. ....
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~----------------------------------~~~~ 106 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICID---TSEKVAIKKVLQD----------------------------------PQYK 106 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECC---CCCEEEEEEEecC----------------------------------cchH
Confidence 34679999999999999999999876 7899999988542 0123
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC--------CeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD--------DNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVA 267 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~ 267 (482)
.+|+.+|+.+. ||||+++++++... ..+++||||+++ +|.+++.. ....+++..++.++.||+.||.
T Consensus 107 ~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~ 184 (440)
T PTZ00036 107 NRELLIMKNLN-HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184 (440)
T ss_pred HHHHHHHHhcC-CCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Confidence 57999999997 99999999987532 247799999975 67666542 3467999999999999999999
Q ss_pred HHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHH
Q 011582 268 FCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAY 345 (482)
Q Consensus 268 yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ 345 (482)
|||++||+||||||+|||++ ..++.+||+|||+|+.+.........+||+.|+|||++.+ .|+.++|||||||++|
T Consensus 185 yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ 262 (440)
T PTZ00036 185 YIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIA 262 (440)
T ss_pred HHHHCCEecCCcCHHHEEEc--CCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHH
Confidence 99999999999999999994 2334799999999987765555566789999999998754 5899999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHhcCCC-----------------CCCCC-------C-CCCCHHHHHHHHHhchhccccC
Q 011582 346 ILLCGSRPFWARTESGIFRAVLKADPS-----------------FDEAP-------W-PSLSPEAIDFVKRLLNKDYRKR 400 (482)
Q Consensus 346 elltg~~pf~~~~~~~~~~~i~~~~~~-----------------~~~~~-------~-~~~s~~~~~li~~~L~~dP~~R 400 (482)
+|++|.+||.+.+..+.+..+...... ++... + ...++++++||.+||+.||.+|
T Consensus 263 elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R 342 (440)
T PTZ00036 263 EMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKR 342 (440)
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHC
Confidence 999999999988776666665542211 11100 0 1367899999999999999999
Q ss_pred CCHHHHhcCcccccCC
Q 011582 401 LTAAQALSHPWLANSH 416 (482)
Q Consensus 401 ~s~~e~L~hp~~~~~~ 416 (482)
+|+.|+|+||||....
T Consensus 343 ~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 343 LNPIEALADPFFDDLR 358 (440)
T ss_pred cCHHHHhCChhHHhhh
Confidence 9999999999997643
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-47 Score=387.76 Aligned_cols=263 Identities=32% Similarity=0.479 Sum_probs=222.6
Q ss_pred cccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
..+.+..+|++.+.||+|+||.|.+|.+.+ +++.||||+|+.. ...
T Consensus 180 ~~d~i~~rY~V~e~LGkGtFGQVvk~~d~~---T~e~VAIKIiKN~-------------------------------k~f 225 (586)
T KOG0667|consen 180 VNDHIAYRYEVLEVLGKGSFGQVVKAYDHK---TGEIVAIKIIKNK-------------------------------KRF 225 (586)
T ss_pred ecceeEEEEEEEEEecccccceeEEEEecC---CCcEEEEEeeccC-------------------------------hHH
Confidence 345667799999999999999999999988 8999999999753 334
Q ss_pred HHHHHHHHHHHHhhcCC-----CCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHH
Q 011582 195 IEDVRREVKILRALTGH-----KNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~h-----pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~y 268 (482)
..+...||.+|..|+.| -|||+++++|...+++|||+|++. .+|+++|.... ..|+...++.++.||+.||.+
T Consensus 226 ~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~ 304 (586)
T KOG0667|consen 226 LRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLF 304 (586)
T ss_pred HHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence 56778899999999744 489999999999999999999994 59999997653 569999999999999999999
Q ss_pred HHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHH
Q 011582 269 CHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 269 LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el 347 (482)
||+.||||+|||||||||...... .|||+|||+|.+... ...+++-+..|+|||++.| .|+.+.||||||||++||
T Consensus 305 L~~l~IIHcDLKPENILL~~~~r~-~vKVIDFGSSc~~~q--~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL 381 (586)
T KOG0667|consen 305 LHELGIIHCDLKPENILLKDPKRS-RIKVIDFGSSCFESQ--RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAEL 381 (586)
T ss_pred HHhCCeeeccCChhheeeccCCcC-ceeEEecccccccCC--cceeeeeccccccchhhccCCCCCccceeehhhhHHhH
Confidence 999999999999999999864433 899999999988653 3347888999999999876 799999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHhcCCCCCC--------------C-C--------------------------------CC-
Q 011582 348 LCGSRPFWARTESGIFRAVLKADPSFDE--------------A-P--------------------------------WP- 379 (482)
Q Consensus 348 ltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------~-~--------------------------------~~- 379 (482)
++|.+.|.+.++.+.+..|++.....+. . . .+
T Consensus 382 ~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~ 461 (586)
T KOG0667|consen 382 FTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPP 461 (586)
T ss_pred hcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCC
Confidence 9999999999999988888763221110 0 0 00
Q ss_pred -----------CCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 380 -----------SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 380 -----------~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.-...+.+||++||++||.+|+|+.++|+||||...
T Consensus 462 ~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 462 GSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred CCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 012457899999999999999999999999999854
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=377.86 Aligned_cols=251 Identities=28% Similarity=0.525 Sum_probs=210.6
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|+++. +++.||+|++.+. ..........+.+|+.++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~---------------------------~~~~~~~~~~~~~E~~~l~ 50 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKK---TERIYAMKVVKKE---------------------------LVNDDEDIDWVQTEKHVFE 50 (329)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEhh---------------------------HhcchhHHHHHHHHHHHHH
Confidence 469999999999999887 7899999999763 1122344567889999998
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
++.+||||+++++++.+.+.+|+||||+++|+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 51 ~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili 129 (329)
T cd05618 51 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 129 (329)
T ss_pred hcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE
Confidence 8866999999999999999999999999999998877544 679999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC--------
Q 011582 287 TSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA-------- 356 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~-------- 356 (482)
+.++.+||+|||+++... ........+||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 130 ---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~ 206 (329)
T cd05618 130 ---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD 206 (329)
T ss_pred ---CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc
Confidence 667889999999987542 2333455789999999998865 589999999999999999999999952
Q ss_pred -CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC------HHHHhcCcccccC
Q 011582 357 -RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT------AAQALSHPWLANS 415 (482)
Q Consensus 357 -~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s------~~e~L~hp~~~~~ 415 (482)
.....+...+......++ ..++.++.+||++||+.||.+|++ ++++++||||...
T Consensus 207 ~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 207 QNTEDYLFQVILEKQIRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred cccHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 122234455555544443 348899999999999999999998 5899999999764
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=375.43 Aligned_cols=256 Identities=28% Similarity=0.493 Sum_probs=220.7
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|+++. +|+.||||++.+.. .......+.+..|
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~---------------------------~~~~~~~~~~~~e 50 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKG---TDELYAIKILKKDV---------------------------VIQDDDVECTMVE 50 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhhhHHHHHHHH
Confidence 47888999999999999999876 79999999997631 1122344667789
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.++..+.+|++|+++++++.+.+.+|+||||++||+|.+++... +.+++.++..++.||+.||.|||++||+||||||
T Consensus 51 ~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp 129 (323)
T cd05615 51 KRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV-GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKL 129 (323)
T ss_pred HHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 999988876788999999999999999999999999999887544 6799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
+|||+ +.++.+||+|||++...... ......+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+...
T Consensus 130 ~Nill---~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 130 DNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred HHeEE---CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 99999 56788999999998764322 23345679999999998864 589999999999999999999999999988
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
..+...+......++. .++.++.+++.+||+.||.+|++ .+++++||||...
T Consensus 207 ~~~~~~i~~~~~~~p~----~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 207 DELFQSIMEHNVSYPK----SLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred HHHHHHHHhCCCCCCc----cCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 8888888877655443 48899999999999999999997 5899999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=377.94 Aligned_cols=252 Identities=29% Similarity=0.531 Sum_probs=217.6
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||++++..+..+|+.||+|++.+.. ........+.+|+.+|+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~----------------------------~~~~~~~~~~~E~~~l~ 53 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT----------------------------LKVRDRVRTKMERDILA 53 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHH----------------------------hhhhhHHHHHHHHHHHH
Confidence 57999999999999886554579999999997531 11223346678999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
++. ||||+++++++.+++.+|+||||+++|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 54 ~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~ 131 (318)
T cd05582 54 EVN-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 131 (318)
T ss_pred hCC-CCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE
Confidence 996 999999999999999999999999999999988544 579999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
+.++.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+...
T Consensus 132 ---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~ 208 (318)
T cd05582 132 ---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT 208 (318)
T ss_pred ---CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH
Confidence 56778999999999765443 23445689999999999864 58899999999999999999999999988888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
.+......++. .+++++.+||++||+.||.+||+ +++++.||||...
T Consensus 209 ~i~~~~~~~p~----~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 209 MILKAKLGMPQ----FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred HHHcCCCCCCC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 88776655442 48999999999999999999999 7889999999764
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-48 Score=363.45 Aligned_cols=259 Identities=30% Similarity=0.567 Sum_probs=235.2
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
-.++|+++++||+|.||+|.+++.+. +|+.||+|+++|.+. .........
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKa---t~k~YAiKIlkKevi---------------------------iakdEVAHT 215 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKA---TGKLYAIKILKKEVI---------------------------IAKDEVAHT 215 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecc---cCceeehhhhhhhhe---------------------------eehHHhhhh
Confidence 45789999999999999999999988 899999999988632 233445566
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
..|-.+|+..+ ||.+..|.-.|+..+.+|+||||.+||.|+-++. +...|++..++.+-..|+.||.|||+++||+||
T Consensus 216 lTE~RVL~~~~-HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLs-rer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRD 293 (516)
T KOG0690|consen 216 LTENRVLQNCR-HPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLS-RERVFSEDRTRFYGAEIVSALGYLHSRNIVYRD 293 (516)
T ss_pred hhHHHHHHhcc-CcHHHHhhhhhccCceEEEEEEEccCceEeeehh-hhhcccchhhhhhhHHHHHHhhhhhhCCeeeee
Confidence 78999999997 9999999999999999999999999999998874 446899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEeccccccc-CCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYV-KPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||.+|+|+ |.++++||+|||+++-- ..+..++++||||.|+|||++. ..|+.++|.|.+||++|||+||+.||+.
T Consensus 294 lKLENLlL---DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn 370 (516)
T KOG0690|consen 294 LKLENLLL---DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYN 370 (516)
T ss_pred chhhhhee---ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccc
Confidence 99999999 88999999999999753 4456788999999999999997 4699999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANSH 416 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~~ 416 (482)
.+.+.++..|+-....|+.. ++++++.|+..+|.+||.+|. .+.++..|+||....
T Consensus 371 ~dh~kLFeLIl~ed~kFPr~----ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 371 KDHEKLFELILMEDLKFPRT----LSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred cchhHHHHHHHhhhccCCcc----CCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 99999999999999998865 899999999999999999998 689999999998654
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=378.37 Aligned_cols=259 Identities=30% Similarity=0.514 Sum_probs=209.2
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|+++. +|..||||++... .........+.+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~~~~E 49 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTH---TGEKVAIKKINDV----------------------------FEHVSDATRILRE 49 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECC---CCCEEEEEEechh----------------------------hccchhHHHHHHH
Confidence 58999999999999999999876 7999999998642 0112233567899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeC-----CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 202 VKILRALTGHKNLVQFYDAYEDD-----DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+.++++++ ||||+++++++... ..+|+|||||. ++|.+++.. ...+++..+..++.||+.||.|||++||+|
T Consensus 50 ~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 126 (338)
T cd07859 50 IKLLRLLR-HPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFH 126 (338)
T ss_pred HHHHHhCC-CCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 99999997 99999999988643 35899999995 688887754 457999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCC----cccccccCccccCccccc---ccCCCcchhhhhHHHHHHHhh
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLH---RSYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~ellt 349 (482)
|||||+|||+ +.++.+||+|||+++...... .....+||+.|+|||++. ..++.++|||||||++|+|++
T Consensus 127 ~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~t 203 (338)
T cd07859 127 RDLKPKNILA---NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLT 203 (338)
T ss_pred CCCCHHHeEE---CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHc
Confidence 9999999999 677889999999997643221 224567999999999875 368999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhc---------------------------CCCCCCCCCCCCCHHHHHHHHHhchhccccCCC
Q 011582 350 GSRPFWARTESGIFRAVLKA---------------------------DPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT 402 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~---------------------------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s 402 (482)
|+.||.+.+.......+... ........++.+++++.++|.+||+.||++|||
T Consensus 204 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 283 (338)
T cd07859 204 GKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT 283 (338)
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC
Confidence 99999876654332222110 111111224567899999999999999999999
Q ss_pred HHHHhcCcccccCCC
Q 011582 403 AAQALSHPWLANSHD 417 (482)
Q Consensus 403 ~~e~L~hp~~~~~~~ 417 (482)
++++|+||||+....
T Consensus 284 ~~e~l~hp~f~~~~~ 298 (338)
T cd07859 284 AEEALADPYFKGLAK 298 (338)
T ss_pred HHHHhcCchhhhcCc
Confidence 999999999986543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=373.92 Aligned_cols=252 Identities=29% Similarity=0.513 Sum_probs=213.9
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|++.. +++.||||++++.. ............|..++.
T Consensus 1 ~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~---------------------------~~~~~~~~~~~~e~~~l~ 50 (316)
T cd05619 1 KMLGKGSFGKVFLAELKG---TNQFFAIKALKKDV---------------------------VLMDDDVECTMVEKRVLS 50 (316)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhcchHHHHHHHHHHHH
Confidence 469999999999999876 78999999997631 011122345667888887
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+.+||||+++++++.+.+.+|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||+
T Consensus 51 ~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~ 129 (316)
T cd05619 51 LAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC-HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL 129 (316)
T ss_pred hccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE
Confidence 7656999999999999999999999999999999988654 579999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
+.++.+||+|||++..... .......+||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+++.
T Consensus 130 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~ 206 (316)
T cd05619 130 ---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206 (316)
T ss_pred ---CCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 5677899999999875322 233455689999999998864 58999999999999999999999999988888888
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHH-HHhcCcccccCC
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA-QALSHPWLANSH 416 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~-e~L~hp~~~~~~ 416 (482)
.+......++. .++.++++||.+||+.||.+|+++. ++++||||....
T Consensus 207 ~i~~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 207 SIRMDNPCYPR----WLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred HHHhCCCCCCc----cCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 87766544432 3789999999999999999999996 899999998743
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=374.92 Aligned_cols=250 Identities=29% Similarity=0.528 Sum_probs=211.6
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHH-HH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVK-IL 205 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~-~l 205 (482)
+.||+|+||.||+|+++. +|+.||||++.+.. .........+.+|.. ++
T Consensus 1 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~---------------------------~~~~~~~~~~~~e~~~~~ 50 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKA---DGKFYAVKVLQKKA---------------------------ILKKKEQKHIMAERNVLL 50 (323)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------HhhhhHHHHHHHHHHHHH
Confidence 369999999999999987 79999999987531 011122344555555 45
Q ss_pred HhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 011582 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL 285 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIl 285 (482)
+.+. ||||+++++++.+.+.+|+||||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 51 ~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIl 128 (323)
T cd05575 51 KNVK-HPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENIL 128 (323)
T ss_pred hhCC-CCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeE
Confidence 6675 99999999999999999999999999999988755 467999999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHH
Q 011582 286 FTSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIF 363 (482)
Q Consensus 286 l~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~ 363 (482)
+ +.++.+||+|||++..... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..++.
T Consensus 129 l---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~ 205 (323)
T cd05575 129 L---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY 205 (323)
T ss_pred E---CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH
Confidence 9 6678899999999875432 233445689999999998864 5899999999999999999999999998888888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH----HHHhcCcccccC
Q 011582 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA----AQALSHPWLANS 415 (482)
Q Consensus 364 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~----~e~L~hp~~~~~ 415 (482)
..+........ +.+++++.++|++||+.||.+|+++ .++++||||...
T Consensus 206 ~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 206 DNILNKPLRLK----PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred HHHHcCCCCCC----CCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCC
Confidence 88877654433 4589999999999999999999988 699999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-46 Score=372.91 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=215.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|++.. +|..||+|++... ......+.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~-----------------------------~~~~~~~~~~ 51 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKP---SGLIMARKLIHLE-----------------------------IKPAIRNQII 51 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECC---CCcEEEEEEeecc-----------------------------cCHHHHHHHH
Confidence 4689999999999999999999886 7899999998642 1233456789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrD 278 (482)
+|+.+|+++. ||||+++++++.+++..++||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+|||
T Consensus 52 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~d 129 (331)
T cd06649 52 RELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSIAVLRGLAYLREKHQIMHRD 129 (331)
T ss_pred HHHHHHHHCC-CCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCC
Confidence 9999999996 999999999999999999999999999999987554 5799999999999999999999986 599999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|||+|||+ +.++.+||+|||++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 130 lkp~Nil~---~~~~~~kl~Dfg~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 130 VKPSNILV---NSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred CChhhEEE---cCCCcEEEccCcccccccc-cccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999 5677899999999876543 23345679999999998875 5899999999999999999999999776
Q ss_pred ChHHHHHHHHhcCC--------------------------------------------CCCCCCCCCCCHHHHHHHHHhc
Q 011582 358 TESGIFRAVLKADP--------------------------------------------SFDEAPWPSLSPEAIDFVKRLL 393 (482)
Q Consensus 358 ~~~~~~~~i~~~~~--------------------------------------------~~~~~~~~~~s~~~~~li~~~L 393 (482)
...++...+..... ..+......+++++++||.+||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L 285 (331)
T cd06649 206 DAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCL 285 (331)
T ss_pred CHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHc
Confidence 55444322111000 0001111247899999999999
Q ss_pred hhccccCCCHHHHhcCcccccCC
Q 011582 394 NKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 394 ~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..||++|||+.++|+||||+...
T Consensus 286 ~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 286 IKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cCCcccCCCHHHHhcChHHhhcc
Confidence 99999999999999999998653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=374.80 Aligned_cols=261 Identities=27% Similarity=0.487 Sum_probs=220.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+++.+. +++.||+|++.+.. .........+.+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~ 50 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWE---------------------------MLKRAETACFRE 50 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECC---CCCEEEEEEEeHHH---------------------------HHHhhHHHHHHH
Confidence 479999999999999999999876 78899999986520 112233456788
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.++..+. |+||+++++++.+.+.+|+||||+++|+|.+++.+....+++..++.++.||+.||.|||++||+|||||
T Consensus 51 e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlk 129 (332)
T cd05623 51 ERDVLVNGD-NQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIK 129 (332)
T ss_pred HHHHHhhCC-CCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCC
Confidence 999999986 9999999999999999999999999999999987656789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc------ccCCCcchhhhhHHHHHHHhhCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~elltg~~ 352 (482)
|+|||+ +.++.+||+|||++........ ....+||+.|+|||++. +.++.++|||||||++|+|++|+.
T Consensus 130 p~Nili---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~ 206 (332)
T cd05623 130 PDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET 206 (332)
T ss_pred HHHEEE---CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCC
Confidence 999999 5678899999999876533222 23457999999999874 358899999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHHhchhcccc--CCCHHHHhcCcccccC
Q 011582 353 PFWARTESGIFRAVLKADPSFDE-APWPSLSPEAIDFVKRLLNKDYRK--RLTAAQALSHPWLANS 415 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~ 415 (482)
||...+..+.+..+......+.. ..+..+++++++||++||..++.+ |++++++++||||...
T Consensus 207 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~ 272 (332)
T cd05623 207 PFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI 272 (332)
T ss_pred CCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence 99998888888888765543322 223468999999999999765554 6899999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=366.70 Aligned_cols=257 Identities=29% Similarity=0.489 Sum_probs=218.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.-.|.-.+.+|+|+||.||.|+... ++..||||.+-.. .+.-.
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e---~~~~vAIKKv~~d----------------------------------~r~kn 65 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRE---TEEEVAIKKVLQD----------------------------------KRYKN 65 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcC---CCceeEEEEecCC----------------------------------CCcCc
Confidence 3468889999999999999999987 6899999987432 01123
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCC-----eEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDD-----NIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+|+.+|+.+. |||||+|.-+|.... ...+||||++. +|.+.+.. .+.+++...++.+..||++||.|||+
T Consensus 66 rEl~im~~l~-HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~ 143 (364)
T KOG0658|consen 66 RELQIMRKLD-HPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS 143 (364)
T ss_pred HHHHHHHhcC-CcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh
Confidence 7999999886 999999999886432 34699999976 88887763 25789999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhh
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ellt 349 (482)
.||+||||||.|||++ .+.+.+||||||.|+.+..++...++..|..|+|||.+-+ .|+.+.||||.||++.||+-
T Consensus 144 ~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~ 221 (364)
T KOG0658|consen 144 HGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLK 221 (364)
T ss_pred cCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhc
Confidence 9999999999999996 4568999999999999998888889999999999998865 69999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCC--------------------CCC-----CCCCHHHHHHHHHhchhccccCCCHH
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFDE--------------------APW-----PSLSPEAIDFVKRLLNKDYRKRLTAA 404 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~~--------------------~~~-----~~~s~~~~~li~~~L~~dP~~R~s~~ 404 (482)
|++.|.+.+..+.+..|.+.-..... ..| ..+++++.+|+.++|..+|.+|.++.
T Consensus 222 g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~ 301 (364)
T KOG0658|consen 222 GQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSAL 301 (364)
T ss_pred CCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHH
Confidence 99999999888887777663322111 112 34789999999999999999999999
Q ss_pred HHhcCcccccCCC
Q 011582 405 QALSHPWLANSHD 417 (482)
Q Consensus 405 e~L~hp~~~~~~~ 417 (482)
|+|.||||....+
T Consensus 302 ~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 302 EALAHPFFDELRD 314 (364)
T ss_pred HHhcchhhHHhhC
Confidence 9999999987543
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=386.38 Aligned_cols=260 Identities=23% Similarity=0.362 Sum_probs=205.1
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++.. +++.||||++++. .......
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~---~~~~vAvK~i~~~-------------------------------~~~~~~~ 172 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRK---RKEYCAVKIVRNV-------------------------------PKYTRDA 172 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcC---CCeEEEEEEEecc-------------------------------hhhHHHH
Confidence 35789999999999999999999876 7899999998542 1112345
Q ss_pred HHHHHHHHhhc-----CCCCcceeeEEEEeC-CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-
Q 011582 199 RREVKILRALT-----GHKNLVQFYDAYEDD-DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF- 271 (482)
Q Consensus 199 ~~Ei~~l~~l~-----~hpniv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~- 271 (482)
..|+.+++.++ +|.++++++++|..+ +.+|+|||++ |++|.+++.+. +.+++..++.|+.||+.||.|||+
T Consensus 173 ~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~yLH~~ 250 (467)
T PTZ00284 173 KIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKH-GPFSHRHLAQIIFQTGVALDYFHTE 250 (467)
T ss_pred HHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 66777777765 245688999988765 5789999998 77899888654 679999999999999999999998
Q ss_pred CCCcccCCCCCceEEecCCC-------------CCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchh
Q 011582 272 QGVVHRDLKPENFLFTSKEE-------------NSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADM 337 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~-------------~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Di 337 (482)
.|||||||||+|||+...+. ...+||+|||++.... ......+||+.|||||++.+ .|+.++||
T Consensus 251 ~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~Di 328 (467)
T PTZ00284 251 LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDM 328 (467)
T ss_pred CCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHH
Confidence 59999999999999964321 2259999999886432 23456789999999998875 59999999
Q ss_pred hhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCC------------------------------------CC--
Q 011582 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAP------------------------------------WP-- 379 (482)
Q Consensus 338 wSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------------------~~-- 379 (482)
|||||++|||++|+.||.+.+..+.+..+......++... +.
T Consensus 329 wSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (467)
T PTZ00284 329 WSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREV 408 (467)
T ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhh
Confidence 9999999999999999988777665554433222111000 00
Q ss_pred CCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 380 SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 380 ~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..++.+.+||.+||++||.+|||++|+|+||||.+..
T Consensus 409 ~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 445 (467)
T PTZ00284 409 IRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYY 445 (467)
T ss_pred hchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccC
Confidence 0145678999999999999999999999999998754
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=374.72 Aligned_cols=261 Identities=26% Similarity=0.469 Sum_probs=220.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|+++. +++.||||++.+. ..........+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~---------------------------~~~~~~~~~~~~~ 50 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKH---TERIYAMKILNKW---------------------------EMLKRAETACFRE 50 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHH---------------------------HHHhhHHHHHHHH
Confidence 479999999999999999999876 7899999998652 0112233456788
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.++..+. |+||+++++++.+++..|+||||++||+|.+++......+++..+..++.|++.||.|||++||+|||||
T Consensus 51 e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlk 129 (331)
T cd05624 51 ERNVLVNGD-CQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIK 129 (331)
T ss_pred HHHHHHhCC-CCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCc
Confidence 999999886 9999999999999999999999999999999987656789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCcccccc------cCCCcchhhhhHHHHHHHhhCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLHR------SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlGvil~elltg~~ 352 (482)
|+|||+ +.++.+||+|||++........ ....+||+.|+|||++.+ .++.++|||||||++|+|++|+.
T Consensus 130 p~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~ 206 (331)
T cd05624 130 PDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET 206 (331)
T ss_pred hHHEEE---cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCC
Confidence 999999 5677899999999977654332 233579999999998853 57889999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHHhchhcccc--CCCHHHHhcCcccccC
Q 011582 353 PFWARTESGIFRAVLKADPSFDE-APWPSLSPEAIDFVKRLLNKDYRK--RLTAAQALSHPWLANS 415 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~ 415 (482)
||...+..+.+..+......+.. ..+..+++++++||.+||..++++ |++++++++||||...
T Consensus 207 Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 207 PFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred CccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 99988888888887765433321 223568999999999999976654 5799999999999864
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=371.99 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=215.3
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|.+.+.||+|+||.||+|+++. ++..||+|+++... .......+.+
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~-----------------------------~~~~~~~~~~ 53 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKL---TENLVALKEIRLEH-----------------------------EEGAPCTAIR 53 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecC---CCCeEEEEEeeccc-----------------------------cCCcchhHHH
Confidence 679999999999999999999876 78899999986430 1111234678
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.++++++ ||||+++++++..++..|+||||+++ +|.+++...+..+++..+..++.||+.||.|||++||+|||||
T Consensus 54 E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlk 131 (309)
T cd07872 54 EVSLLKDLK-HANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLK 131 (309)
T ss_pred HHHHHHhCC-CCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 999999996 99999999999999999999999975 8888887666678999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|+|||+ +.++.+||+|||++...... .......+|+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.
T Consensus 132 p~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 208 (309)
T cd07872 132 PQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGS 208 (309)
T ss_pred HHHEEE---CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999 56778999999998764332 22334578999999998753 5889999999999999999999999888
Q ss_pred ChHHHHHHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 358 TESGIFRAVLKADPSFDE--------------------------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
+..+....+......... ...+.+++++++||.+||..||.+|+|++|+|.|||
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 209 TVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred ChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 776665555432111100 112357899999999999999999999999999999
Q ss_pred cccCC
Q 011582 412 LANSH 416 (482)
Q Consensus 412 ~~~~~ 416 (482)
|+...
T Consensus 289 ~~~~~ 293 (309)
T cd07872 289 FRSLG 293 (309)
T ss_pred hhhcc
Confidence 98754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=380.09 Aligned_cols=257 Identities=31% Similarity=0.481 Sum_probs=230.7
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|..++.+|+|+||.+++++++. .++.|++|.|.-. ..+....+...
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~---~~~~~vlK~I~l~----------------------------~~t~~~r~~A~ 51 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKS---DDKLYVLKKINLE----------------------------KLTEPERRSAI 51 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhcc---CCceEEEEEEecc----------------------------ccCchhhHHHH
Confidence 4689999999999999999999887 7889999998642 12233345788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCe-EEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDN-IYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+|+.++++++ |||||.+.+.|++++. .+|||+||+||+|.+.|.+.. ..|+|+.+..|+.|++.|+.|||+++|+||
T Consensus 52 ~E~~lis~~~-hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHR 130 (426)
T KOG0589|consen 52 QEMDLLSKLL-HPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHR 130 (426)
T ss_pred HHHHHHHhcc-CCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcc
Confidence 9999999997 9999999999999988 999999999999999998664 679999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||+.||++ ..+..|||+|||+|+.+.... ...+.+||+.||+||++.+ .|+.|+|||||||++|||++-+++|.
T Consensus 131 DlK~~Nifl---tk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~ 207 (426)
T KOG0589|consen 131 DLKCANIFL---TKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFK 207 (426)
T ss_pred cchhhhhhc---cccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccC
Confidence 999999999 466678999999999988776 6788999999999999976 69999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
+.+...++.+|........ -..++.+++.+|+.||..+|..||++.++|.+|.+..
T Consensus 208 a~~m~~Li~ki~~~~~~Pl---p~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 208 ASNMSELILKINRGLYSPL---PSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ccchHHHHHHHhhccCCCC---CccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 9999999999999873322 2458999999999999999999999999999998873
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=378.22 Aligned_cols=250 Identities=30% Similarity=0.548 Sum_probs=212.5
Q ss_pred eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhh
Q 011582 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL 208 (482)
Q Consensus 129 LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l 208 (482)
||+|+||.||+|+++. +|+.||||++.+.. ............|..++..+
T Consensus 1 lG~G~~g~Vy~~~~~~---~~~~~avK~~~~~~---------------------------~~~~~~~~~~~~e~~~l~~~ 50 (330)
T cd05586 1 IGKGTFGQVYQVRKKD---TRRIYAMKVLSKKE---------------------------IVAKKEVAHTIGERNILVRT 50 (330)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEEeHHH---------------------------HhhhhHHHHHHHHHHHHHHh
Confidence 7999999999999876 79999999986531 01122234455677777665
Q ss_pred c--CCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 209 T--GHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 209 ~--~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
. +||||+.+++++.+.+.+|+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 51 ~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili 129 (330)
T cd05586 51 LLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL 129 (330)
T ss_pred ccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE
Confidence 4 699999999999999999999999999999988765 4679999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWARTESGIF 363 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~ 363 (482)
+.++.+||+|||++..... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+
T Consensus 130 ---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~ 206 (330)
T cd05586 130 ---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY 206 (330)
T ss_pred ---CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH
Confidence 5677899999999875432 233456789999999998864 4899999999999999999999999999888888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC----CHHHHhcCcccccC
Q 011582 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL----TAAQALSHPWLANS 415 (482)
Q Consensus 364 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~----s~~e~L~hp~~~~~ 415 (482)
..+......++.. .+++++.+||++||..||.+|| +++++++||||...
T Consensus 207 ~~i~~~~~~~~~~---~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 207 RNIAFGKVRFPKN---VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HHHHcCCCCCCCc---cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 8887776655432 4789999999999999999998 79999999999764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=365.60 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=207.0
Q ss_pred eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhh
Q 011582 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL 208 (482)
Q Consensus 129 LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l 208 (482)
||+|+||+||+|.++. +|+.||||++.+.. .......+.+..|+.+++.+
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~avK~~~~~~---------------------------~~~~~~~~~~~~E~~il~~l 50 (280)
T cd05608 1 LGKGGFGEVSACQMRA---TGKLYACKKLNKKR---------------------------LKKRKGYEGAMVEKRILAKV 50 (280)
T ss_pred CCCCCceeEEEEEEcc---CCcEEEEEeeeHHH---------------------------HhhhHHHHHHHHHHHHHHhC
Confidence 7999999999999876 79999999986531 11223345678899999999
Q ss_pred cCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 011582 209 TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL 285 (482)
Q Consensus 209 ~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIl 285 (482)
. |+||+++++++..++.+|+||||++||+|.+.+.. ....+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 51 ~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 129 (280)
T cd05608 51 H-SRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVL 129 (280)
T ss_pred C-CCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 6 99999999999999999999999999999887743 3356999999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHH
Q 011582 286 FTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIF 363 (482)
Q Consensus 286 l~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~ 363 (482)
+ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.........
T Consensus 130 i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 206 (280)
T cd05608 130 L---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 206 (280)
T ss_pred E---CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH
Confidence 9 567889999999997654432 2345679999999998864 6899999999999999999999999765432222
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 364 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
..+..............+++++.+++.+||+.||.+|+ +++++++||||+..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 207 KELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred HHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 22222111111122245899999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=365.82 Aligned_cols=256 Identities=29% Similarity=0.423 Sum_probs=208.6
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|+++. +|+.||+|.++... ........+.+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~aiK~~~~~~----------------------------~~~~~~~~~~~e 49 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVQT----------------------------NEDGLPLSTVRE 49 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECC---CCcEEEEEEeccCc----------------------------CCCCCchHHHHH
Confidence 58999999999999999999987 79999999986531 001111245567
Q ss_pred HHHHHhhc--CCCCcceeeEEEEe-----CCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 202 VKILRALT--GHKNLVQFYDAYED-----DDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 202 i~~l~~l~--~hpniv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
+.+++.+. +||||+++++++.+ ...+++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++|
T Consensus 50 ~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 128 (288)
T cd07863 50 VALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC 128 (288)
T ss_pred HHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 77777663 49999999999865 3468999999975 8888776542 45899999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCC
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~ 352 (482)
|+||||||+|||+ +.++.+||+|||++.............||..|+|||++. ..++.++||||+||++|+|++|.+
T Consensus 129 ivH~dikp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~ 205 (288)
T cd07863 129 IVHRDLKPENILV---TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 205 (288)
T ss_pred eecCCCCHHHEEE---CCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCc
Confidence 9999999999999 567789999999998765544445667899999999886 468999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCC-----------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 353 PFWARTESGIFRAVLKADPSFDE-----------------------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~-----------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||.+....+.+..+......... ..++.++.++.+||.+||+.||.+|||+.++|.|
T Consensus 206 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 206 LFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred CcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 99888777766666542211100 1124578899999999999999999999999999
Q ss_pred ccc
Q 011582 410 PWL 412 (482)
Q Consensus 410 p~~ 412 (482)
|||
T Consensus 286 p~f 288 (288)
T cd07863 286 PFF 288 (288)
T ss_pred CCC
Confidence 998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=378.82 Aligned_cols=260 Identities=38% Similarity=0.688 Sum_probs=233.5
Q ss_pred cceEe--cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYEL--GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~--~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
.-|.+ .+.||+|-||+||-|++++ +|+.||||+|.|.. +.. .....+
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRk---tGrdVAvKvIdKlr---------------------------Fp~-kqesql 610 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRK---TGRDVAVKVIDKLR---------------------------FPT-KQESQL 610 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecc---cCceeeeeeeeccc---------------------------CCC-chHHHH
Confidence 34554 3579999999999999998 89999999998741 111 123789
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS-RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
++|+.||..+. ||.||.+.-.|+..+..++|||-+. |+.++.|.. ..++|++...+.++.||+.||.|||.+||+|+
T Consensus 611 R~EVaILq~l~-HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHC 688 (888)
T KOG4236|consen 611 RNEVAILQNLH-HPGIVNLECMFETPERVFVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHC 688 (888)
T ss_pred HHHHHHHHhcC-CCCeeEEEEeecCCceEEEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeec
Confidence 99999999997 9999999999999999999999995 577777764 46899999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||||+|||+.+.+..-.+||||||+|+.+.......+++|||.|+|||++. +.|....||||+|||+|.-|+|..||..
T Consensus 689 DLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE 768 (888)
T KOG4236|consen 689 DLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE 768 (888)
T ss_pred cCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC
Confidence 999999999987778899999999999998888788899999999999996 4699999999999999999999999954
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
++++-.+|.+....++..+|..+++++.|||..+|++.-++|.|++..|.|||++++
T Consensus 769 --dEdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 769 --DEDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred --ccchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 456777888999999999999999999999999999999999999999999999876
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=372.92 Aligned_cols=251 Identities=27% Similarity=0.496 Sum_probs=210.6
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|+... +++.||||++++. ........+.+.+|+.++.
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~---------------------------~~~~~~~~~~~~~e~~~~~ 50 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKK---NDQIYAMKVVKKE---------------------------LVHDDEDIDWVQTEKHVFE 50 (327)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHH---------------------------HhhhhhHHHHHHHHHHHHH
Confidence 469999999999999877 7899999999763 1122344567889999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
++.+||||+.+++++.+.+.+|+|||||+||+|..++... +.+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 51 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili 129 (327)
T cd05617 51 QASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL 129 (327)
T ss_pred hhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 9877999999999999999999999999999998877544 579999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC-------
Q 011582 287 TSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR------- 357 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~------- 357 (482)
+.++.+||+|||++.... ........+||+.|+|||++.+ .++.++|||||||++|+|++|..||...
T Consensus 130 ---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~ 206 (327)
T cd05617 130 ---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMN 206 (327)
T ss_pred ---eCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccc
Confidence 567789999999987532 2334456789999999998864 6899999999999999999999999532
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC------HHHHhcCcccccC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT------AAQALSHPWLANS 415 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s------~~e~L~hp~~~~~ 415 (482)
........+......++ ..++.++.++|++||..||.+|++ ++++++||||...
T Consensus 207 ~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 207 TEDYLFQVILEKPIRIP----RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred cHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 22334444544433333 248899999999999999999998 5799999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-46 Score=373.34 Aligned_cols=250 Identities=29% Similarity=0.537 Sum_probs=211.5
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHH-H
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKI-L 205 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~-l 205 (482)
+.||+|+||.||+|+++. +|+.||||++.+.. .........+..|..+ +
T Consensus 1 ~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~e~~~~l 50 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKL---DGKCYAVKVLQKKI---------------------------VLNRKEQKHIMAERNVLL 50 (325)
T ss_pred CceeeCCCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhhhHHHHHHHHHHHHH
Confidence 469999999999999876 79999999997531 1122233455666654 5
Q ss_pred HhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 011582 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL 285 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIl 285 (482)
+.+. ||||+++++++..++.+|+||||++||+|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 51 ~~~~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIl 128 (325)
T cd05604 51 KNVK-HPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENIL 128 (325)
T ss_pred HhCC-CCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE
Confidence 6675 99999999999999999999999999999888754 468999999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHH
Q 011582 286 FTSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIF 363 (482)
Q Consensus 286 l~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~ 363 (482)
+ +.++.+||+|||++..... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+++
T Consensus 129 l---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~ 205 (325)
T cd05604 129 L---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY 205 (325)
T ss_pred E---CCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH
Confidence 9 6678899999999875432 233455689999999998865 5899999999999999999999999999888888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH----HHHhcCcccccC
Q 011582 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA----AQALSHPWLANS 415 (482)
Q Consensus 364 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~----~e~L~hp~~~~~ 415 (482)
..+......+. +.++.++.++|++||+.||.+||++ .++++||||...
T Consensus 206 ~~~~~~~~~~~----~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 206 DNILHKPLVLR----PGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred HHHHcCCccCC----CCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 88877654332 3589999999999999999999977 599999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=379.18 Aligned_cols=252 Identities=19% Similarity=0.341 Sum_probs=205.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
..+|++.+.||+|+||.||+|++.. +++.||+|.... ..+.
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~---~~~~vaiK~~~~------------------------------------~~~~ 131 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNK---TCEHVVIKAGQR------------------------------------GGTA 131 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECC---CCCEEEEechhh------------------------------------hhhH
Confidence 4679999999999999999999987 899999997532 2467
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|++|. ||||++++++|..+...++|||++. ++|..++... ..+++..++.++.||+.||.|||++|||||||
T Consensus 132 ~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDi 208 (391)
T PHA03212 132 TEAHILRAIN-HPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDI 208 (391)
T ss_pred HHHHHHHhCC-CCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 8999999997 9999999999999999999999995 6888887654 57999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC--CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD--ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||+|||+ +.++.+||+|||++...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||..
T Consensus 209 KP~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 209 KAENIFI---NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ChHhEEE---cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 9999999 56778999999999754321 23345689999999998864 699999999999999999999988754
Q ss_pred CC-------hHHHHHHHHhcCCCC----------------------------CCCCC---CCCCHHHHHHHHHhchhccc
Q 011582 357 RT-------ESGIFRAVLKADPSF----------------------------DEAPW---PSLSPEAIDFVKRLLNKDYR 398 (482)
Q Consensus 357 ~~-------~~~~~~~i~~~~~~~----------------------------~~~~~---~~~s~~~~~li~~~L~~dP~ 398 (482)
.. ....+..+....... ....| ..++.++.+||.+||+.||.
T Consensus 286 ~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~ 365 (391)
T PHA03212 286 KDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAH 365 (391)
T ss_pred cccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChh
Confidence 32 111222222111000 01111 13567899999999999999
Q ss_pred cCCCHHHHhcCcccccCC
Q 011582 399 KRLTAAQALSHPWLANSH 416 (482)
Q Consensus 399 ~R~s~~e~L~hp~~~~~~ 416 (482)
+|||++|+|+||||+...
T Consensus 366 ~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 366 HRPSAEALLDFAAFQDIP 383 (391)
T ss_pred hCCCHHHHhcChhhccCC
Confidence 999999999999998753
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-46 Score=376.24 Aligned_cols=259 Identities=27% Similarity=0.480 Sum_probs=210.6
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|++.. +|..||||++.+. .........
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----------------------------~~~~~~~~~ 66 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTV---LGINVAVKKLSRP----------------------------FQNQTHAKR 66 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcC---CCceeEEEEeccc----------------------------ccchhHHHH
Confidence 356889999999999999999999876 7999999998653 122334567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCC------eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDD------NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+.+|+.+++.+. ||||+++++++...+ .+|+||||+++ +|...+. ..+++..+..++.||+.||.|||+
T Consensus 67 ~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~ 141 (359)
T cd07876 67 AYRELVLLKCVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHS 141 (359)
T ss_pred HHHHHHHHHhCC-CCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHh
Confidence 789999999996 999999999986543 57999999976 5666553 358999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhC
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg 350 (482)
+||+||||||+|||+ +.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 142 ~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg 218 (359)
T cd07876 142 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218 (359)
T ss_pred CCcccCCCCHHHEEE---CCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhC
Confidence 999999999999999 5678899999999987655444556789999999998865 689999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcC----------------------CCCCCC----------------CCCCCCHHHHHHHHHh
Q 011582 351 SRPFWARTESGIFRAVLKAD----------------------PSFDEA----------------PWPSLSPEAIDFVKRL 392 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~----------------------~~~~~~----------------~~~~~s~~~~~li~~~ 392 (482)
+.||.+.+....+..+.... ..+... .....++++++||.+|
T Consensus 219 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 298 (359)
T cd07876 219 SVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKM 298 (359)
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHH
Confidence 99998776554433332211 111100 0112467899999999
Q ss_pred chhccccCCCHHHHhcCcccccC
Q 011582 393 LNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 393 L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
|+.||++|||+.|+|+||||...
T Consensus 299 L~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 299 LVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred hccCcccCCCHHHHhcCchhhhh
Confidence 99999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-46 Score=370.30 Aligned_cols=250 Identities=28% Similarity=0.514 Sum_probs=209.9
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHH-HH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVK-IL 205 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~-~l 205 (482)
+.||+|+||.||+|++.. +++.||+|++.+.. .........+.+|.. ++
T Consensus 1 ~~lg~G~fg~V~~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~e~~~~l 50 (325)
T cd05602 1 KVIGKGSFGKVLLARHKA---EEKFYAVKVLQKKA---------------------------ILKKKEEKHIMSERNVLL 50 (325)
T ss_pred CeeeeCCCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------HHhhhHHHHHHHHHHHHH
Confidence 369999999999999876 78899999997531 011122234445544 45
Q ss_pred HhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 011582 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL 285 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIl 285 (482)
+.+. ||||+++++++.+.+.+|+||||++||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 51 ~~~~-h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nil 128 (325)
T cd05602 51 KNVK-HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL 128 (325)
T ss_pred HhCC-CCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence 6675 999999999999999999999999999999887654 67899999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHH
Q 011582 286 FTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIF 363 (482)
Q Consensus 286 l~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~ 363 (482)
+ +.++.+||+|||++.... ........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+
T Consensus 129 i---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 205 (325)
T cd05602 129 L---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY 205 (325)
T ss_pred E---CCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH
Confidence 9 567789999999987543 2333456789999999998865 5899999999999999999999999999888888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHH----HHhcCcccccC
Q 011582 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA----QALSHPWLANS 415 (482)
Q Consensus 364 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~----e~L~hp~~~~~ 415 (482)
..+......+ .+.+++++.++|++||+.||.+|+++. ++++|+||...
T Consensus 206 ~~i~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 206 DNILNKPLQL----KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred HHHHhCCcCC----CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 8887664433 246899999999999999999999876 89999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=361.91 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=213.2
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|.+.. +|+.||||.+.+.. .........+.+|
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~---~~~~~avK~~~~~~---------------------------~~~~~~~~~~~~E 50 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKR---------------------------IKKRKGESMALNE 50 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcC---CCceEEEEEEehhh---------------------------ccchHHHHHHHHH
Confidence 47888999999999999999987 79999999986531 1122234567789
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
+.+++.+. |+||+.+++.+.+.+..|+||||++|++|.+++... ...+++..+..++.|++.||.|||+.||+|||||
T Consensus 51 ~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dik 129 (285)
T cd05630 51 KQILEKVN-SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLK 129 (285)
T ss_pred HHHHHhCC-CCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCC
Confidence 99999996 999999999999999999999999999999887543 2469999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
|+||++ +.++.++|+|||++.............||..|+|||++.+ .++.++||||+||++|+|++|..||.....
T Consensus 130 p~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~ 206 (285)
T cd05630 130 PENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 206 (285)
T ss_pred HHHEEE---CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCc
Confidence 999999 5677899999999987654444455689999999998864 589999999999999999999999986543
Q ss_pred H---HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 360 S---GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 360 ~---~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
. +....+... ........+++++.+||.+||+.||.+|+| ++++++||||+..
T Consensus 207 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05630 207 KIKREEVERLVKE---VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI 267 (285)
T ss_pred cchHHHHHhhhhh---hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence 2 122222211 111223458899999999999999999999 9999999999763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=379.31 Aligned_cols=257 Identities=33% Similarity=0.578 Sum_probs=236.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
...|.+.+.||+|.|+.|.+|++.. +|..||||+|+|.. ......+.+.
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~---t~~~VaiK~idkt~----------------------------ln~~~~~k~~ 103 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHIL---TGTEVAIKIIDKTQ----------------------------LNPSKRQKLG 103 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecC---CCceEEEEEehhcc----------------------------cChHHHHHHH
Confidence 4679999999999999999999987 89999999998851 3344556799
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+++|+.|. |||||+++.+.+....+|+||||+.+|.+++++.+. ++..+..+..++.|+.+|++|||+++||||||
T Consensus 104 rev~imk~l~-HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdL 181 (596)
T KOG0586|consen 104 REVDIMKSLN-HPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDL 181 (596)
T ss_pred HHHHHHHhcC-CcceeeeeeeeeecceeEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHHHhhcceecccc
Confidence 9999999996 999999999999999999999999999999999776 67888999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccccc--CCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|++|||| +.+.++||+|||++.++..+....+.||++.|.|||++.+. -++++|+||+|+++|-|++|.+||++.
T Consensus 182 k~eNilL---~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 182 KAENILL---DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred chhhccc---ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 9999999 78888999999999999988999999999999999999863 578999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
+..++...++.+...++.. ++.+++++|++||..+|.+|++.+++..|.|+....
T Consensus 259 ~lk~Lr~rvl~gk~rIp~~----ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 259 NLKELRPRVLRGKYRIPFY----MSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLL 313 (596)
T ss_pred ccccccchheeeeecccce----eechhHHHHHHhhccCccccCCHHHhhhhcccchhh
Confidence 9999988888888877654 899999999999999999999999999999998654
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=368.39 Aligned_cols=250 Identities=29% Similarity=0.523 Sum_probs=210.0
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHH-HH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVK-IL 205 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~-~l 205 (482)
+.||+|+||.||+|++.. +|+.||+|++.+.. .........+.+|+. ++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~e~~~~l 50 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKS---DGSFYAVKVLQKKT---------------------------ILKKKEQNHIMAERNVLL 50 (321)
T ss_pred CeeeeCCCEEEEEEEECC---CCCEEEEEEEEHHH---------------------------HHHhhHHHHHHHHHHHHH
Confidence 469999999999999876 78999999997531 011222344555654 56
Q ss_pred HhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 011582 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL 285 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIl 285 (482)
+.+. ||||+++++++.+.+..|+|||||+|++|...+.. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 51 ~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIl 128 (321)
T cd05603 51 KNLK-HPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENIL 128 (321)
T ss_pred HhCC-CCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeE
Confidence 7775 99999999999999999999999999999887754 467999999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHH
Q 011582 286 FTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIF 363 (482)
Q Consensus 286 l~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~ 363 (482)
+ +.++.+||+|||++.... ........+||+.|+|||++.+ .++.++|||||||++|+|++|..||...+...+.
T Consensus 129 l---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 205 (321)
T cd05603 129 L---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMY 205 (321)
T ss_pred E---CCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHH
Confidence 9 667889999999987532 2233445689999999998864 5899999999999999999999999998888888
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH----HHHhcCcccccC
Q 011582 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA----AQALSHPWLANS 415 (482)
Q Consensus 364 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~----~e~L~hp~~~~~ 415 (482)
..+......++ +..+.++.++|.+||+.||.+|+++ .++++|+||...
T Consensus 206 ~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~ 257 (321)
T cd05603 206 DNILHKPLQLP----GGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPI 257 (321)
T ss_pred HHHhcCCCCCC----CCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCC
Confidence 88877654433 3478999999999999999999875 599999999753
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=362.50 Aligned_cols=260 Identities=27% Similarity=0.447 Sum_probs=215.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|.+.+.||.|+||.||+|++.. +++.||+|.+... ........+.
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~vaiK~~~~~-----------------------------~~~~~~~~~~ 52 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKL---TDNLVALKEIRLE-----------------------------HEEGAPCTAI 52 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcC---CCcEEEEEEEecc-----------------------------cccCchhHHH
Confidence 4679999999999999999999876 7899999998642 0111123567
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. ||||+++++++.+++..|+||||++ ++|.+++......+++..+..++.||+.||.|||++||+||||
T Consensus 53 ~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dl 130 (301)
T cd07873 53 REVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130 (301)
T ss_pred HHHHHHHhcC-CCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 8999999996 9999999999999999999999997 5898888776677999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||+|||+ +.++.+||+|||++....... ......+++.|+|||++.+ .++.++|||||||++|+|++|+.||..
T Consensus 131 kp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~ 207 (301)
T cd07873 131 KPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207 (301)
T ss_pred CHHHEEE---CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999 567789999999987643322 2334567899999998754 478899999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCC--------------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHhcCc
Q 011582 357 RTESGIFRAVLKADPSFDEA--------------------------PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 410 (482)
.+..+....+.......... ....+++++++||.+||+.||.+|||++++|+||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~ 287 (301)
T cd07873 208 STVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHP 287 (301)
T ss_pred CCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 87766665554422111110 1235788999999999999999999999999999
Q ss_pred ccccCC
Q 011582 411 WLANSH 416 (482)
Q Consensus 411 ~~~~~~ 416 (482)
||+...
T Consensus 288 ~f~~~~ 293 (301)
T cd07873 288 YFHCLG 293 (301)
T ss_pred cccccc
Confidence 998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=357.60 Aligned_cols=260 Identities=29% Similarity=0.452 Sum_probs=218.0
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.|+..+.||.|+||.||+|.+.. +|+.||+|.+.+.. .........+.+|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~E 50 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRA---TGKMYACKRLEKKR---------------------------IKKRKGESMALNE 50 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECC---CCcEEEEEEeehhh---------------------------hhhhhHHHHHHHH
Confidence 37788899999999999999887 79999999986531 1122234557889
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
+.+|+.++ |+||+.+++++.+++..|+||||+++++|.+++... ...+++..+..++.|++.||.|||+.||+|||||
T Consensus 51 ~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dik 129 (285)
T cd05632 51 KQILEKVN-SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLK 129 (285)
T ss_pred HHHHHHcC-CcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCC
Confidence 99999996 999999999999999999999999999998887654 3469999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
|+||++ +.++.+||+|||++.............|+..|+|||++. ..++.++|+|||||++|+|++|..||.+...
T Consensus 130 p~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~ 206 (285)
T cd05632 130 PENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE 206 (285)
T ss_pred HHHEEE---CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999 566789999999997665444445568999999999886 4689999999999999999999999988766
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
......+..............+++++.+|+.+||+.||.+||+ +.++++|+||+..
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 207 KVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 5544444433322222334568999999999999999999999 8999999999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=370.74 Aligned_cols=258 Identities=26% Similarity=0.451 Sum_probs=212.3
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|.+.+.||+|+||.||+|++.. .++.||||++.+. .........+
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~~ 70 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRP----------------------------FQNQTHAKRA 70 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECC---CCcEEEEEEeCcc----------------------------ccCchhHHHH
Confidence 46789999999999999999999876 7899999998652 1122334667
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
.+|+.+++.+. ||||+++++++... ..+|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++
T Consensus 71 ~~E~~~l~~l~-h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~ 145 (364)
T cd07875 71 YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA 145 (364)
T ss_pred HHHHHHHHhcC-CCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhC
Confidence 89999999996 99999999987543 457999999965 6777663 3588999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~ 351 (482)
||+||||||+|||+ +.++.+||+|||+++............||+.|+|||++.+ .++.++|||||||++|+|++|+
T Consensus 146 ~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 222 (364)
T cd07875 146 GIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222 (364)
T ss_pred CeecCCCCHHHEEE---CCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCC
Confidence 99999999999999 5678899999999987655444556789999999998865 5899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCC----------------------CC----------------CCCCCCCHHHHHHHHHhc
Q 011582 352 RPFWARTESGIFRAVLKADPSF----------------------DE----------------APWPSLSPEAIDFVKRLL 393 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~----------------------~~----------------~~~~~~s~~~~~li~~~L 393 (482)
.||.+.+..+.+..+....... .. ......+.++++||.+||
T Consensus 223 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL 302 (364)
T cd07875 223 VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302 (364)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhc
Confidence 9999888777666655421110 00 001123568899999999
Q ss_pred hhccccCCCHHHHhcCcccccC
Q 011582 394 NKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 394 ~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
+.||.+|||+.++|+||||...
T Consensus 303 ~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 303 VIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred CcCcccCCCHHHHhcCcccccc
Confidence 9999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=373.56 Aligned_cols=257 Identities=32% Similarity=0.506 Sum_probs=212.3
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++++.||+|+||.||+|.+.. +|+.||||++.+. .........+.+|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~~~~E 49 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPR---DGKRVALKKMPNV----------------------------FQNLVSCKRVFRE 49 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECC---CCCEEEEEecccc----------------------------ccchHHHHHHHHH
Confidence 47889999999999999999876 7999999998542 1122344678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCC-----eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDD-----NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+.+++.++ |+||+++++++...+ ..|+||||+. ++|.+.+.. ...+++..+..++.||+.||.|||++||+|
T Consensus 50 ~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH 126 (372)
T cd07853 50 LKMLCFFK-HDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILH 126 (372)
T ss_pred HHHHHhCC-CCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeC
Confidence 99999997 999999999998876 8999999996 578887654 467999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~ 352 (482)
|||||+|||+ +.++.+||+|||+++...... ......+|+.|+|||++.+ .++.++||||+||++|+|++|+.
T Consensus 127 ~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 203 (372)
T cd07853 127 RDIKPGNLLV---NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203 (372)
T ss_pred CCCChHHEEE---CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCC
Confidence 9999999999 667889999999998654322 2344578999999998865 48899999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCC-----------------------CCCC-----CCCCCCCHHHHHHHHHhchhccccCCCHH
Q 011582 353 PFWARTESGIFRAVLKADP-----------------------SFDE-----APWPSLSPEAIDFVKRLLNKDYRKRLTAA 404 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~-----------------------~~~~-----~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 404 (482)
||.+.+..+.+..+..... ..+. ......++++.+||.+||+.||.+|||+.
T Consensus 204 pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~ 283 (372)
T cd07853 204 LFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAA 283 (372)
T ss_pred CCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHH
Confidence 9988877666555543211 0000 11234688999999999999999999999
Q ss_pred HHhcCcccccC
Q 011582 405 QALSHPWLANS 415 (482)
Q Consensus 405 e~L~hp~~~~~ 415 (482)
++|+||||.+.
T Consensus 284 e~l~hp~~~~~ 294 (372)
T cd07853 284 DALAHPYLDEG 294 (372)
T ss_pred HHhcCHhhCCC
Confidence 99999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-47 Score=402.02 Aligned_cols=264 Identities=29% Similarity=0.467 Sum_probs=230.1
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.-.++|+++++||+|+||.|.+++++. +++.||+|+++|- .+.......-
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~---t~~VYAMK~lnK~---------------------------eMlKr~~tA~ 121 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKS---TEKVYAMKILNKW---------------------------EMLKRAETAC 121 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeec---cccchhHHHhhHH---------------------------HHhhchhHHH
Confidence 345799999999999999999999988 8999999999873 1122334466
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
|..|-.+|..- +.+-|++++-.|+++.++|+||||++||+|...+.+.. ++++..++.|+..|+.||.-||+.|+|||
T Consensus 122 F~EERDimv~~-ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHR 199 (1317)
T KOG0612|consen 122 FREERDIMVFG-NSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHR 199 (1317)
T ss_pred HHHHhHHHHcC-CcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceec
Confidence 88888898766 48999999999999999999999999999999886654 89999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc------ccCCCcchhhhhHHHHHHHhh
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~ellt 349 (482)
||||+|||| |..|++||+|||.+..+..+.. ....+|||.|.+||++. +.|+..+|.||+||++|||++
T Consensus 200 DiKPDNvLl---d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMly 276 (1317)
T KOG0612|consen 200 DIKPDNVLL---DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLY 276 (1317)
T ss_pred cCCcceeEe---cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHc
Confidence 999999999 7899999999999988875543 45678999999999984 459999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC---HHHHhcCcccccCCC
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT---AAQALSHPWLANSHD 417 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~L~hp~~~~~~~ 417 (482)
|..||+..+.-+.+.+|++-.-.+..+.-..+|+++++||.++|. +|..|.. ++++-+||||.+..+
T Consensus 277 G~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 277 GETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred CCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 999999999999999999874433333334599999999999994 7889998 999999999987643
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=369.92 Aligned_cols=259 Identities=25% Similarity=0.448 Sum_probs=211.0
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++.+.||+|+||.||+|.+.. +++.||||++.+. .........+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~~ 63 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRP----------------------------FQNQTHAKRA 63 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecC---CCceEEEEEeCCc----------------------------ccChHHHHHH
Confidence 46789999999999999999999876 7899999998652 1223345677
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
.+|+.+++.+. ||||+++++++... ...|+||||+++ +|.+.+. ..+++..+..++.|++.||.|||++
T Consensus 64 ~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~ 138 (355)
T cd07874 64 YRELVLMKCVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSA 138 (355)
T ss_pred HHHHHHHHHhC-CCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhC
Confidence 89999999996 99999999998654 357999999976 6666653 3589999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~ 351 (482)
||+||||||+|||+ +.++.+||+|||+++............||+.|+|||++.+ .++.++|||||||++|+|++|+
T Consensus 139 givHrDikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 215 (355)
T cd07874 139 GIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215 (355)
T ss_pred CcccCCCChHHEEE---CCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999 5678899999999987655545566789999999998865 5899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCC----------------------CCC----------------CCCCCCCCHHHHHHHHHhc
Q 011582 352 RPFWARTESGIFRAVLKADP----------------------SFD----------------EAPWPSLSPEAIDFVKRLL 393 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~----------------------~~~----------------~~~~~~~s~~~~~li~~~L 393 (482)
.||.+....+.+..+..... .+. .......+.++++||.+||
T Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL 295 (355)
T cd07874 216 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295 (355)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHh
Confidence 99988776554443332110 000 0011224678899999999
Q ss_pred hhccccCCCHHHHhcCcccccCC
Q 011582 394 NKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 394 ~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..||.+|||+.|+|+||||....
T Consensus 296 ~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 296 VIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred cCCchhcCCHHHHhcCcchhccc
Confidence 99999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=357.32 Aligned_cols=250 Identities=26% Similarity=0.427 Sum_probs=206.6
Q ss_pred eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhh
Q 011582 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL 208 (482)
Q Consensus 129 LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l 208 (482)
||+|+||.||+|+.+. +|+.||+|++.+.. .........+..|+.+++++
T Consensus 1 lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~~---------------------------~~~~~~~~~~~~E~~il~~l 50 (277)
T cd05607 1 LGKGGFGEVCAVQVKN---TGKMYACKKLDKKR---------------------------LKKKSGEKMALLEKEILEKV 50 (277)
T ss_pred CCCCCceEEEEEEEcc---CCcEEEEEEEcHHH---------------------------hhcchhhHHHHHHHHHHHhc
Confidence 7999999999999887 79999999986531 01112234456799999999
Q ss_pred cCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 011582 209 TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFT 287 (482)
Q Consensus 209 ~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~ 287 (482)
. ||||++++++++++..+|+||||++|++|.+++.... ..+++..+..++.|++.||.|||+.||+||||||+|||+
T Consensus 51 ~-hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili- 128 (277)
T cd05607 51 N-SPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL- 128 (277)
T ss_pred C-CCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE-
Confidence 6 9999999999999999999999999999988876543 358999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh----HHH
Q 011582 288 SKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE----SGI 362 (482)
Q Consensus 288 ~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~----~~~ 362 (482)
+.++.++|+|||++.............||..|+|||++.+ .++.++||||+||++|+|++|..||..... .++
T Consensus 129 --~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~ 206 (277)
T cd05607 129 --DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL 206 (277)
T ss_pred --cCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH
Confidence 5677899999999987665444455679999999998864 589999999999999999999999976533 233
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH----HHHhcCcccccC
Q 011582 363 FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA----AQALSHPWLANS 415 (482)
Q Consensus 363 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~----~e~L~hp~~~~~ 415 (482)
...+......+ ....+++++.+||++||+.||.+||++ ++++.||||+..
T Consensus 207 ~~~~~~~~~~~---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~ 260 (277)
T cd05607 207 KRRTLEDEVKF---EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI 260 (277)
T ss_pred HHHhhcccccc---ccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence 33333333222 223589999999999999999999999 778899999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=382.37 Aligned_cols=255 Identities=28% Similarity=0.407 Sum_probs=218.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
..|.+.+.||+|+||.||+|..... .+..||+|.+.. ........+.+
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~--~~~~vv~K~~~~------------------------------~~~~~~~~~~~ 114 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSD--PKEKVVAKFVML------------------------------NDERQAAYARS 114 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCC--CCeEEEEEEccc------------------------------CCHHHHHHHHH
Confidence 4599999999999999999987651 267899997633 12233456788
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
|+.+|+.+. ||||+++++++..++.+||||||++||+|.+++.. ....+++..+..++.||+.||.|||++||+||
T Consensus 115 E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHr 193 (478)
T PTZ00267 115 ELHCLAACD-HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHR 193 (478)
T ss_pred HHHHHHhCC-CCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEEC
Confidence 999999996 99999999999999999999999999999987754 23568999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~p 353 (482)
||||+|||+ +.++.+||+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.|
T Consensus 194 Dlkp~NIll---~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~P 270 (478)
T PTZ00267 194 DLKSANIFL---MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRP 270 (478)
T ss_pred CcCHHhEEE---CCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCC
Confidence 999999999 567889999999998764332 2345679999999998864 589999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
|.+.+..+++..+....... ....+++++.+||.+||..||.+||+++++|.|+|++.
T Consensus 271 f~~~~~~~~~~~~~~~~~~~---~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 271 FKGPSQREIMQQVLYGKYDP---FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred CCCCCHHHHHHHHHhCCCCC---CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99988888888887765431 12358899999999999999999999999999999974
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=373.65 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=205.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
...|.+.+.||+|+||.||+|++.. .++.||||.... ..+.
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~---~~~~vavK~~~~------------------------------------~~~~ 208 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPD---YPQRVVVKAGWY------------------------------------ASSV 208 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECC---CCCEEEEecccc------------------------------------cCHH
Confidence 3479999999999999999999876 789999996421 2356
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|++|. |+|||++++++..++..++|||++. ++|.+++......+++..++.++.||+.||.|||++|||||||
T Consensus 209 ~E~~iL~~L~-HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDL 286 (461)
T PHA03211 209 HEARLLRRLS-HPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDI 286 (461)
T ss_pred HHHHHHHHCC-CCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcC
Confidence 8999999997 9999999999999999999999995 6899888766667999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||+|||+ +.++.+||+|||+++...... .....+||+.|+|||++.+ .++.++|||||||+||||++|..++.
T Consensus 287 KP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 287 KTENVLV---NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred CHHHEEE---CCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 9999999 567789999999998654322 1234679999999998865 58999999999999999999887653
Q ss_pred CCC--------hHHHHHHHHhcCCC---------------------------CCCCCCC---CCCHHHHHHHHHhchhcc
Q 011582 356 ART--------ESGIFRAVLKADPS---------------------------FDEAPWP---SLSPEAIDFVKRLLNKDY 397 (482)
Q Consensus 356 ~~~--------~~~~~~~i~~~~~~---------------------------~~~~~~~---~~s~~~~~li~~~L~~dP 397 (482)
... ...+.+.+...... +....|. .++.++.+||.+||+.||
T Consensus 364 ~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP 443 (461)
T PHA03211 364 SASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDG 443 (461)
T ss_pred cCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccCh
Confidence 321 22333333322211 1111122 456789999999999999
Q ss_pred ccCCCHHHHhcCccccc
Q 011582 398 RKRLTAAQALSHPWLAN 414 (482)
Q Consensus 398 ~~R~s~~e~L~hp~~~~ 414 (482)
.+|||+.|+|+||||+.
T Consensus 444 ~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 444 ARRPSAAELLRLPLFQS 460 (461)
T ss_pred hhCcCHHHHhhCcccCC
Confidence 99999999999999975
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=377.66 Aligned_cols=257 Identities=31% Similarity=0.512 Sum_probs=226.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
+.|+|+..||-|+||.||+|..+. ++-.-|.|+|.. .+.+.++.+.-
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nke---t~~lAAaKvIet------------------------------kseEELEDylV 78 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKE---TKLLAAAKVIET------------------------------KSEEELEDYLV 78 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhccc---chhhhhhhhhcc------------------------------cchhHHhhhhh
Confidence 568999999999999999999886 777888998843 45677889999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
||.||..+. ||+||+|++.|..++.++|..|||.||-....+...+..|++.++..+++|++.||.|||+++|||||||
T Consensus 79 EIeILa~Cd-HP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLK 157 (1187)
T KOG0579|consen 79 EIEILAECD-HPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLK 157 (1187)
T ss_pred hhhhhhcCC-ChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhcc
Confidence 999999996 9999999999999999999999999999888888888899999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccC-CCCcccccccCccccCccccc------ccCCCcchhhhhHHHHHHHhhCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~elltg~~p 353 (482)
..|||++ .+|.++|+|||.+.... .-....+++|||+|||||++. ..|+.++||||||++|.||..+.+|
T Consensus 158 AGNiL~T---ldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPP 234 (1187)
T KOG0579|consen 158 AGNILLT---LDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPP 234 (1187)
T ss_pred ccceEEE---ecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCC
Confidence 9999994 67779999999876433 234556789999999999763 4699999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
...-+..-++-+|.+..+.... ....++..+.||+++||.+||..||++.++|+||||.+.
T Consensus 235 HhelnpMRVllKiaKSePPTLl-qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~ 295 (1187)
T KOG0579|consen 235 HHELNPMRVLLKIAKSEPPTLL-QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA 295 (1187)
T ss_pred ccccchHHHHHHHhhcCCCccc-CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence 9888888888788776653222 224578999999999999999999999999999999865
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=367.89 Aligned_cols=251 Identities=21% Similarity=0.321 Sum_probs=203.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
..+|++++.||+|+||.||+|++.. ++..||+|+..+. ...
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~valK~~~~~------------------------------------~~~ 105 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPG---QPDPVVLKIGQKG------------------------------------TTL 105 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECC---CCceEEEEeCCcc------------------------------------ccH
Confidence 3579999999999999999999876 7889999985432 234
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
.|+.+++++. ||||+++++++.+.+..++||||+. ++|.+++......+++..+..++.||+.||.|||++|||||||
T Consensus 106 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 183 (357)
T PHA03209 106 IEAMLLQNVN-HPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDV 183 (357)
T ss_pred HHHHHHHhCC-CCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 6899999997 9999999999999999999999995 5889988777778999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC-
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR- 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~- 357 (482)
||+|||+ +.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|||+++..++...
T Consensus 184 kp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~ 260 (357)
T PHA03209 184 KTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDP 260 (357)
T ss_pred CHHHEEE---CCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCC
Confidence 9999999 5677899999999986544444456789999999998864 6899999999999999999865554322
Q ss_pred Ch---------HHHHHHHHhcCC----CCCC--------------------------CCCCCCCHHHHHHHHHhchhccc
Q 011582 358 TE---------SGIFRAVLKADP----SFDE--------------------------APWPSLSPEAIDFVKRLLNKDYR 398 (482)
Q Consensus 358 ~~---------~~~~~~i~~~~~----~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~ 398 (482)
.. ...+..+..... .++. .....++.++.+||.+||+.||.
T Consensus 261 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 340 (357)
T PHA03209 261 PSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAA 340 (357)
T ss_pred CCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcc
Confidence 11 111112111110 0110 00124677888999999999999
Q ss_pred cCCCHHHHhcCccccc
Q 011582 399 KRLTAAQALSHPWLAN 414 (482)
Q Consensus 399 ~R~s~~e~L~hp~~~~ 414 (482)
+|||+.|+|+||||++
T Consensus 341 ~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 341 MRPSAEEILNYPMFAQ 356 (357)
T ss_pred cCcCHHHHhcCchhcc
Confidence 9999999999999975
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=363.89 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=212.2
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|.+.. +|..+|+|++... ........+.
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~~a~k~~~~~-----------------------------~~~~~~~~~~ 51 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKP---SGLIMARKLIHLE-----------------------------IKPAIRNQII 51 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECC---CCcEEEEEEeecc-----------------------------cCHHHHHHHH
Confidence 4689999999999999999999876 7899999988642 1233456789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHrD 278 (482)
+|+.+++.+. ||||++++++|.+++.+|+||||+++++|.+++... +.+++..+..++.|++.||.|||+. +|+|||
T Consensus 52 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~d 129 (333)
T cd06650 52 RELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHRD 129 (333)
T ss_pred HHHHHHHHCC-CCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecC
Confidence 9999999996 999999999999999999999999999999988654 5799999999999999999999985 799999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|||+|||+ +.++.+||+|||++..... .......||..|+|||++.+ .++.++|||||||++|+|++|+.||...
T Consensus 130 lkp~Nili---~~~~~~kL~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 130 VKPSNILV---NSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred CChhhEEE---cCCCCEEEeeCCcchhhhh-hccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 99999999 5677899999999876532 22345679999999999875 5899999999999999999999999765
Q ss_pred ChHHHHHHHH--------------------------------------------hcCCCCCCCCCCCCCHHHHHHHHHhc
Q 011582 358 TESGIFRAVL--------------------------------------------KADPSFDEAPWPSLSPEAIDFVKRLL 393 (482)
Q Consensus 358 ~~~~~~~~i~--------------------------------------------~~~~~~~~~~~~~~s~~~~~li~~~L 393 (482)
....+...+. .... +......++.++++||.+||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L 283 (333)
T cd06650 206 DAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCL 283 (333)
T ss_pred chhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhc
Confidence 5433321110 0000 00001136789999999999
Q ss_pred hhccccCCCHHHHhcCcccccCC
Q 011582 394 NKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 394 ~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
+.||.+|||++++|.||||+...
T Consensus 284 ~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 284 IKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred cCCcccCcCHHHHhhCHHHhcCc
Confidence 99999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=354.81 Aligned_cols=254 Identities=42% Similarity=0.696 Sum_probs=211.5
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|++++.||+|+||+||+|++.. +++.||+|++.... ..........+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~---~~~~~~~K~~~~~~----------------------------~~~~~~~~~~~e~ 49 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKK---NGQKVAVKIIDKSE----------------------------IEEEEREENIREI 49 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETT---TTEEEEEEEEESTT----------------------------HHHHHHHHHHHHH
T ss_pred CEEeEEEEeCCCEEEEEEEECC---CCeEEEEEEecccc----------------------------ccccccchhhhhh
Confidence 8899999999999999999987 78899999997641 1222233445699
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~ 282 (482)
.+++++. ||||+++++++.+....++||||+++++|.+++. ....+++..+..++.||+.||.+||++||+||||||+
T Consensus 50 ~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~ 127 (260)
T PF00069_consen 50 KILRRLR-HPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPE 127 (260)
T ss_dssp HHHHHHT-BTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGG
T ss_pred hcccccc-cccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence 9999996 9999999999999999999999999999999886 3468999999999999999999999999999999999
Q ss_pred ceEEecCCCCCcEEEEeccccccc-CCCCcccccccCccccCccccc--ccCCCcchhhhhHHHHHHHhhCCCCCCCCC-
Q 011582 283 NFLFTSKEENSSLKAIDFGLSDYV-KPDERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCGSRPFWART- 358 (482)
Q Consensus 283 NIll~~~~~~~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~- 358 (482)
||++ +.++.++|+|||++... ..........+|..|+|||++. ..++.++||||||+++|+|++|..||....
T Consensus 128 NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~ 204 (260)
T PF00069_consen 128 NILL---DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNS 204 (260)
T ss_dssp GEEE---STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSH
T ss_pred cccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999 67888999999999763 3334556678999999999987 468999999999999999999999998873
Q ss_pred --hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 359 --ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 359 --~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
...................+...++++.++|.+||+.||++||++.++++||||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 205 DDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred hhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 333343333322211111112234899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=362.85 Aligned_cols=252 Identities=28% Similarity=0.442 Sum_probs=195.1
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
+++||+|+||.||+|+++.+ .+++.||+|.+.... ....+.+|+.+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~-~~~~~~aiK~~~~~~--------------------------------~~~~~~~E~~~l 52 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDG-KDDRDYALKQIEGTG--------------------------------ISMSACREIALL 52 (317)
T ss_pred ccccccCCCeEEEEEEEccC-CCCceEEEEEECCCC--------------------------------CcHHHHHHHHHH
Confidence 45799999999999997532 257889999985420 113467899999
Q ss_pred HhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 206 RALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSR--------GGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
+++. ||||+++++++.+ +..+|+||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+
T Consensus 53 ~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~iv 130 (317)
T cd07868 53 RELK-HPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVL 130 (317)
T ss_pred HhcC-CCCCcceeeeEecCCCcEEEEEEeccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 9996 9999999999864 4678999999954 788776432 13589999999999999999999999999
Q ss_pred ccCCCCCceEEecC-CCCCcEEEEecccccccCCCC----cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHh
Q 011582 276 HRDLKPENFLFTSK-EENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 276 HrDlkp~NIll~~~-~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ell 348 (482)
||||||+|||+... +..+.+||+|||+++...... .....+||+.|+|||++.+ .++.++||||+||++|+|+
T Consensus 131 HrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~ 210 (317)
T cd07868 131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (317)
T ss_pred cCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHH
Confidence 99999999999643 355789999999998764321 2345688999999998864 4899999999999999999
Q ss_pred hCCCCCCCCChH---------HHHHHHHhcCCCCCC----------------------------------CCCCCCCHHH
Q 011582 349 CGSRPFWARTES---------GIFRAVLKADPSFDE----------------------------------APWPSLSPEA 385 (482)
Q Consensus 349 tg~~pf~~~~~~---------~~~~~i~~~~~~~~~----------------------------------~~~~~~s~~~ 385 (482)
+|++||...... ..+..+......... ......+.++
T Consensus 211 ~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (317)
T cd07868 211 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 290 (317)
T ss_pred hCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHH
Confidence 999999654321 222222221100000 0011235678
Q ss_pred HHHHHHhchhccccCCCHHHHhcCccc
Q 011582 386 IDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 386 ~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.+||.+||+.||.+|+|++|+|+||||
T Consensus 291 ~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 291 FHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=380.78 Aligned_cols=260 Identities=29% Similarity=0.440 Sum_probs=220.9
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|.+.+.||+|+||.||+|++.. +|+.||||++... .........
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~i~~~----------------------------~~~~~~~~~ 77 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVS---DGEPFAVKVVDME----------------------------GMSEADKNR 77 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcC---CCCEEEEEEEecc----------------------------cCCHHHHHH
Confidence 345689999999999999999999876 7999999998653 123344567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCC--------eEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDD--------NIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVV 266 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L 266 (482)
+.+|+.++..+. |+||+++++.+...+ .+++||||+++|+|.+++..+ ...+++..+..++.|++.||
T Consensus 78 ~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL 156 (496)
T PTZ00283 78 AQAEVCCLLNCD-FFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156 (496)
T ss_pred HHHHHHHHhcCC-CCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHH
Confidence 889999999996 999999988775432 378999999999999988653 35689999999999999999
Q ss_pred HHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCC---CcccccccCccccCcccccc-cCCCcchhhhhHH
Q 011582 267 AFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD---ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGV 342 (482)
Q Consensus 267 ~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGv 342 (482)
.|||++||+||||||+|||+ +.++.+||+|||+++..... ......+||+.|+|||++.+ .|+.++|||||||
T Consensus 157 ~~lH~~~IiHrDLKP~NILl---~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGv 233 (496)
T PTZ00283 157 HHVHSKHMIHRDIKSANILL---CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGV 233 (496)
T ss_pred HHHHhCCEecCCCCHHHEEE---eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHH
Confidence 99999999999999999999 56778999999999765432 22345689999999999875 5999999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 343 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 343 il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
++|+|++|+.||.+.+..+++..+....... ..+.+++++.+||.+||..||.+||++.++|+|||++..
T Consensus 234 ilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 234 LLYELLTLKRPFDGENMEEVMHKTLAGRYDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred HHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 9999999999999988888888877654432 224589999999999999999999999999999998753
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=367.71 Aligned_cols=259 Identities=29% Similarity=0.556 Sum_probs=211.4
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|.+++.||+|+||.||+|.+.. +++.||||++.+.. ........+
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~----------------------------~~~~~~~~~ 61 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTR---LRQKVAVKKLSRPF----------------------------QSLIHARRT 61 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECC---CCCEEEEEEeCchh----------------------------hhhHHHHHH
Confidence 45789999999999999999999876 78999999986520 112234567
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
.+|+.+|+.+. ||||+++++++... ..+|++||++ +++|.+++. ...+++..+..++.||+.||.|||++
T Consensus 62 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~ 137 (343)
T cd07878 62 YRELRLLKHMK-HENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSA 137 (343)
T ss_pred HHHHHHHHhcC-CCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 78999999997 99999999988643 4579999998 778877653 35799999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg 350 (482)
||+||||||+|||+ +.++.+||+|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 138 ~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g 212 (343)
T cd07878 138 GIIHRDLKPSNVAV---NEDCELRILDFGLARQADD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212 (343)
T ss_pred CeecccCChhhEEE---CCCCCEEEcCCccceecCC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHC
Confidence 99999999999999 5678899999999987543 3345689999999998864 589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCC-----------------------CCC----CCCCCCCHHHHHHHHHhchhccccCCCH
Q 011582 351 SRPFWARTESGIFRAVLKADPS-----------------------FDE----APWPSLSPEAIDFVKRLLNKDYRKRLTA 403 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~-----------------------~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~ 403 (482)
+.||.+.+..+.+..+...... .+. ..+...++.+.+||.+||..||.+|||+
T Consensus 213 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~ 292 (343)
T cd07878 213 KALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA 292 (343)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCH
Confidence 9999887665555544332111 010 0123467789999999999999999999
Q ss_pred HHHhcCcccccCCC
Q 011582 404 AQALSHPWLANSHD 417 (482)
Q Consensus 404 ~e~L~hp~~~~~~~ 417 (482)
.++|+||||.....
T Consensus 293 ~ell~hp~~~~~~~ 306 (343)
T cd07878 293 SEALAHPYFSQYHD 306 (343)
T ss_pred HHHhcCcchhccCC
Confidence 99999999987543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=363.88 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=203.0
Q ss_pred ccceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++++.||+|+||.||+|.+.. ...++..||||++... ........
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~ 56 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEG-----------------------------ATASEHKA 56 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccc-----------------------------cchHHHHH
Confidence 3689999999999999999998632 1124678999998542 12233467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeC-CeEEEEEecCCCCChHHHHHhcC-----------------------------
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDD-DNIYIVMELCKGGELLDRILSRG----------------------------- 247 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~----------------------------- 247 (482)
+.+|+.++..+.+||||+++++++... +.+|+|||||++|+|.+++....
T Consensus 57 ~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 136 (338)
T cd05102 57 LMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRR 136 (338)
T ss_pred HHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccc
Confidence 889999999995599999999988764 46899999999999999886431
Q ss_pred --------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcE
Q 011582 248 --------------------------------GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295 (482)
Q Consensus 248 --------------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~ 295 (482)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~~~~~~ 213 (338)
T cd05102 137 IEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVV 213 (338)
T ss_pred cccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---cCCCcE
Confidence 247888999999999999999999999999999999999 567789
Q ss_pred EEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcC
Q 011582 296 KAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWARTESGIFRAVLKAD 370 (482)
Q Consensus 296 kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~ 370 (482)
||+|||+++....... .....+++.|+|||++. ..++.++|||||||++|||++ |..||.+....+.+.......
T Consensus 214 kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 293 (338)
T cd05102 214 KICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG 293 (338)
T ss_pred EEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC
Confidence 9999999986533221 22345678899999876 468999999999999999997 999998765444333333322
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 371 PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 371 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.... ....+++++.+||.+||..||.+|||+.++++
T Consensus 294 ~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 294 TRMR--APENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred CCCC--CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2211 12357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=392.90 Aligned_cols=267 Identities=31% Similarity=0.508 Sum_probs=219.7
Q ss_pred ccccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHH
Q 011582 114 GFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAI 193 (482)
Q Consensus 114 ~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (482)
.....+.++|++++.||+|+||.||+|.+.. ++..||+|++... .....
T Consensus 6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~---tg~~vAlKvIk~~----------------------------~l~e~ 54 (1021)
T PTZ00266 6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKR---TQEFFCWKAISYR----------------------------GLKER 54 (1021)
T ss_pred cCCccccCCEEEEEEEecCCCeEEEEEEECC---CCeEEEEEEEecc----------------------------ccCHH
Confidence 3455667899999999999999999999986 7899999998642 12233
Q ss_pred HHHHHHHHHHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHH
Q 011582 194 AIEDVRREVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 194 ~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~y 268 (482)
....+.+|+.+|+.|. |||||+++++|.+ ...+|||||||++|+|.++|... ...+++..++.|+.||+.||.|
T Consensus 55 ~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaY 133 (1021)
T PTZ00266 55 EKSQLVIEVNVMRELK-HKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAY 133 (1021)
T ss_pred HHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 4567889999999997 9999999998865 45799999999999999988642 3579999999999999999999
Q ss_pred HHHC-------CCcccCCCCCceEEecC--------------CCCCcEEEEecccccccCCCCcccccccCccccCcccc
Q 011582 269 CHFQ-------GVVHRDLKPENFLFTSK--------------EENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL 327 (482)
Q Consensus 269 LH~~-------~ivHrDlkp~NIll~~~--------------~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~ 327 (482)
||+. +||||||||+||||... +....+||+|||++..+.........+||+.|+|||++
T Consensus 134 LHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL 213 (1021)
T PTZ00266 134 CHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELL 213 (1021)
T ss_pred HHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHH
Confidence 9995 49999999999999632 12345899999999876555445567899999999988
Q ss_pred c---ccCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHH
Q 011582 328 H---RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA 404 (482)
Q Consensus 328 ~---~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 404 (482)
. ..++.++||||||||||+|+||..||........+...+...+.+ ....++.++.+||..||..+|.+||++.
T Consensus 214 ~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~ 290 (1021)
T PTZ00266 214 LHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDL---PIKGKSKELNILIKNLLNLSAKERPSAL 290 (1021)
T ss_pred hccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCC---CcCCCCHHHHHHHHHHhcCChhHCcCHH
Confidence 4 348899999999999999999999997665544443333333322 2345789999999999999999999999
Q ss_pred HHhcCcccccC
Q 011582 405 QALSHPWLANS 415 (482)
Q Consensus 405 e~L~hp~~~~~ 415 (482)
++|.|+||...
T Consensus 291 QlL~h~~ik~i 301 (1021)
T PTZ00266 291 QCLGYQIIKNV 301 (1021)
T ss_pred HHhccHHHhhc
Confidence 99999999754
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=367.17 Aligned_cols=299 Identities=25% Similarity=0.403 Sum_probs=239.7
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
...|.-++.||.|+||.||.|++.. +.+.||||.++-. -.-+.+.++++.
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~---n~evVAIKKMsyS---------------------------GKQs~EKWqDIl 74 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYS---------------------------GKQSNEKWQDIL 74 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccC---ccceeeeeecccc---------------------------ccccHHHHHHHH
Confidence 3457888999999999999999988 7899999988532 113455678999
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
.||..|.+|. |||++.+-+||..+...|||||||-| +-.|.+.-..+++-+.+++.|..+.+.||.|||+.+.|||||
T Consensus 75 KEVrFL~~l~-HPntieYkgCyLre~TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDi 152 (948)
T KOG0577|consen 75 KEVRFLRQLR-HPNTIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDI 152 (948)
T ss_pred HHHHHHHhcc-CCCcccccceeeccchHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhc
Confidence 9999999997 99999999999999999999999955 666766555678999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|..|||+ .+.+.|||+|||.|..+.+ .++++|||.|||||++. |.|+-++||||||+++.||.-.++|+.
T Consensus 153 KAGNILL---se~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 153 KAGNILL---SEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred cccceEe---cCCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 9999999 6889999999999987654 46789999999999873 689999999999999999999999988
Q ss_pred CCChHHHHHHHHhcC-CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCCCccHHHHHHHHHHh
Q 011582 356 ARTESGIFRAVLKAD-PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYI 434 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~ 434 (482)
..+-..-+..|.... +.... +.+|..+.+||..||++-|..|||.+++|.|+|+...... ..+.++|..-
T Consensus 227 nMNAMSALYHIAQNesPtLqs---~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp~-----tvi~dLIqRT- 297 (948)
T KOG0577|consen 227 NMNAMSALYHIAQNESPTLQS---NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERPP-----TVIMDLIQRT- 297 (948)
T ss_pred CchHHHHHHHHHhcCCCCCCC---chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCCc-----hHHHHHHHHH-
Confidence 777666666665544 33333 4468999999999999999999999999999999765322 1233333321
Q ss_pred ccchHHHHHHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccc
Q 011582 435 SSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFIS 475 (482)
Q Consensus 435 ~~~~l~~~~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~ 475 (482)
+. +...++.-|+.+++.+...=..|+-|.-.
T Consensus 298 ------Kd----aVrELDNlqYrKMkKilf~e~~ng~~ae~ 328 (948)
T KOG0577|consen 298 ------KD----AVRELDNLQYRKMKKILFQEAPNGPGAEG 328 (948)
T ss_pred ------HH----HHHHhhhhhHHHHHHHHhhccCCCCCCCC
Confidence 11 12233445666666665555556655443
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=350.73 Aligned_cols=254 Identities=32% Similarity=0.646 Sum_probs=221.0
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|.+.+.||+|+||.||+|.+.. +++.||+|++.+. ........+.+.+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~---~~~~~aiK~~~~~---------------------------~~~~~~~~~~~~~ 50 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKG---SGKYYALKILSKA---------------------------KIVKLKQVEHVLN 50 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcC---CCCEEEEEEEEHH---------------------------HhhhhhHHHHHHH
Confidence 469999999999999999999886 7899999998653 1122334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+++++++. ||||+++++++.+.+.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||+
T Consensus 51 e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~ 128 (290)
T cd05580 51 EKRILQSIR-HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLK 128 (290)
T ss_pred HHHHHHhCC-CCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCC
Confidence 999999997 999999999999999999999999999999988655 689999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
|+|||+ +.++.+||+|||++...... .....|++.|+|||.+. ..++.++||||||+++|+|++|..||.....
T Consensus 129 p~nili---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 203 (290)
T cd05580 129 PENLLL---DSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP 203 (290)
T ss_pred HHHEEE---CCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999 56778999999999876543 34557899999999875 4578899999999999999999999988887
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
......+......++. .+++.++++|.+||+.||.+|+ +++++++||||...
T Consensus 204 ~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 260 (290)
T cd05580 204 IQIYEKILEGKVRFPS----FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI 260 (290)
T ss_pred HHHHHHHhcCCccCCc----cCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence 7777777765544432 3689999999999999999999 99999999999764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=353.57 Aligned_cols=261 Identities=29% Similarity=0.490 Sum_probs=232.5
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.-..+|.++.+||+|+||.|.+|..+. +.+.||||+++|.+...+..+.|+..
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkg---tdELyAiKiLkKDViiQdDDvectm~------------------------ 398 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKG---TDELYAIKILKKDVIIQDDDVECTMV------------------------ 398 (683)
T ss_pred eeecccceEEEeccCccceeeeecccC---cchhhhhhhhccceeeecCcccceeh------------------------
Confidence 345789999999999999999999876 78899999999988777777766554
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
|-++|.....-|.+++++.+|+.-+.+|+||||+.||+|..+|.+- ++|.|..+..++..|+-||-|||++|||+|
T Consensus 399 ---EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~-GkFKEp~AvFYAaEiaigLFFLh~kgIiYR 474 (683)
T KOG0696|consen 399 ---EKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GKFKEPVAVFYAAEIAIGLFFLHSKGIIYR 474 (683)
T ss_pred ---hhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHh-cccCCchhhhhhHHHHHHhhhhhcCCeeee
Confidence 4456665555789999999999999999999999999999988665 789999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEeccccccc-CCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYV-KPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||.+|||+ +.++++||+|||+++-- -.+....+.||||.|+|||++. ..|+..+|.||+||+|||||.|++||.
T Consensus 475 DLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFd 551 (683)
T KOG0696|consen 475 DLKLDNVML---DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 551 (683)
T ss_pred eccccceEe---ccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCC
Confidence 999999999 78899999999999743 3345667899999999999875 679999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH-----HHHhcCcccccCC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA-----AQALSHPWLANSH 416 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~e~L~hp~~~~~~ 416 (482)
+.+++++++.|+.....++.. +|.++.++++.+|.+.|.+|... .++-.||||+...
T Consensus 552 GeDE~elF~aI~ehnvsyPKs----lSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 552 GEDEDELFQAIMEHNVSYPKS----LSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred CCCHHHHHHHHHHccCcCccc----ccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 999999999999999888764 89999999999999999999854 6888999998654
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=350.51 Aligned_cols=255 Identities=30% Similarity=0.464 Sum_probs=207.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|++.. +|..||||+++... ........+.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~----------------------------~~~~~~~~~~~e 49 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKK---TGQIVAMKKIRLES----------------------------EEEGVPSTAIRE 49 (285)
T ss_pred CceEeeEecccCceEEEEEEECC---CCcEEEEEEecccc----------------------------ccCCchHHHHHH
Confidence 58899999999999999999876 78999999985420 111223567889
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR--GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+.+++.+. ||||+++++++.+++.+|+||||++ ++|.+++... +..+++..++.++.||+.||.|||++||+||||
T Consensus 50 ~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl 127 (285)
T cd07861 50 ISLLKELQ-HPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDL 127 (285)
T ss_pred HHHHHhcC-CCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCC
Confidence 99999997 9999999999999999999999997 5888877543 257999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||+|||+ +.++.+||+|||++....... ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||.+
T Consensus 128 ~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~ 204 (285)
T cd07861 128 KPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHG 204 (285)
T ss_pred CHHHEEE---cCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9999999 567889999999987654322 2233467899999998754 478899999999999999999999987
Q ss_pred CChHHHHHHHHhcCCCCC-------------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 357 RTESGIFRAVLKADPSFD-------------------------EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
.........+........ ...+..+++++.+||++||+.||.+|||+.++++|||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~ 284 (285)
T cd07861 205 DSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284 (285)
T ss_pred CCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence 765444333322111000 1113457899999999999999999999999999999
Q ss_pred c
Q 011582 412 L 412 (482)
Q Consensus 412 ~ 412 (482)
|
T Consensus 285 ~ 285 (285)
T cd07861 285 F 285 (285)
T ss_pred C
Confidence 7
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=354.09 Aligned_cols=255 Identities=31% Similarity=0.488 Sum_probs=207.8
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|++.. +|+.||+|+++... ........+.+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~---~g~~~~~k~~~~~~----------------------------~~~~~~~~~~~e 49 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDD----------------------------DDEGVPSSALRE 49 (284)
T ss_pred CceeEEEecccCCeEEEEEEECC---CCcEEEEEEeeccc----------------------------ccccCccchhHH
Confidence 58999999999999999999987 79999999986421 111122456789
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+. ||||+++++++.+.+.+|+|+||+++ +|.+++....+.+++..++.++.||+.||.|||++||+||||||
T Consensus 50 i~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~ 127 (284)
T cd07839 50 ICLLKELK-HKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKP 127 (284)
T ss_pred HHHHHhcC-CCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence 99999996 99999999999999999999999974 78888776667899999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCC-CCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPF-WAR 357 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf-~~~ 357 (482)
+||++ +.++.+||+|||++...... .......+++.|+|||++.+ .++.++|||||||++|+|++|..|| .+.
T Consensus 128 ~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~ 204 (284)
T cd07839 128 QNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 204 (284)
T ss_pred HHEEE---cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCC
Confidence 99999 56778999999999865432 22334567899999998764 3789999999999999999998885 444
Q ss_pred ChHHHHHHHHhcCCCCC-------------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 358 TESGIFRAVLKADPSFD-------------------------EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
+..+.+..+........ ....+.+++++.+||.+||..||.+|||++++|.||||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 205 DVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 44444444433211000 01123578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=365.60 Aligned_cols=256 Identities=21% Similarity=0.381 Sum_probs=207.4
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+..+|++++.||+|+||.||+|.... ...+..||||.+.+. ...
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~-~~~~~~v~vK~~~~~-----------------------------------~~~ 133 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHG-DEQRKKVIVKAVTGG-----------------------------------KTP 133 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcC-CccceeEEEEecccc-----------------------------------ccH
Confidence 45689999999999999999997643 225788999987542 234
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+|+++. ||||+++++++...+..|+|||++. ++|.+++ .....+++.++..++.||+.||.|||++||||||
T Consensus 134 ~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l-~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrD 210 (392)
T PHA03207 134 GREIDILKTIS-HRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYV-DRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRD 210 (392)
T ss_pred HHHHHHHHhcC-CCCccceeeeEeeCCEEEEEehhcC-CCHHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 68999999997 9999999999999999999999995 5888887 4457899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf 354 (482)
|||+|||+ +.++.+||+|||++........ .....||+.|+|||++.+ .|+.++|||||||++|+|++|+.||
T Consensus 211 lkp~Nill---~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf 287 (392)
T PHA03207 211 VKTENIFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287 (392)
T ss_pred CCHHHEEE---cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999 6678899999999976543322 234679999999999874 5899999999999999999999999
Q ss_pred CCCCh---HHHHHHHHhcCC----CCCC------------------CC--------CCCCCHHHHHHHHHhchhccccCC
Q 011582 355 WARTE---SGIFRAVLKADP----SFDE------------------AP--------WPSLSPEAIDFVKRLLNKDYRKRL 401 (482)
Q Consensus 355 ~~~~~---~~~~~~i~~~~~----~~~~------------------~~--------~~~~s~~~~~li~~~L~~dP~~R~ 401 (482)
.+... ...+..+..... .++. .. ...++.++.+||++||..||.+||
T Consensus 288 ~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp 367 (392)
T PHA03207 288 FGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP 367 (392)
T ss_pred CCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC
Confidence 76542 222222222110 0000 00 013577899999999999999999
Q ss_pred CHHHHhcCcccccCC
Q 011582 402 TAAQALSHPWLANSH 416 (482)
Q Consensus 402 s~~e~L~hp~~~~~~ 416 (482)
|+.++|.||||.+..
T Consensus 368 sa~e~l~~p~f~~~~ 382 (392)
T PHA03207 368 SAQDILSLPLFTKEP 382 (392)
T ss_pred CHHHHhhCchhhccc
Confidence 999999999998754
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=343.14 Aligned_cols=257 Identities=27% Similarity=0.470 Sum_probs=214.0
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
+.|++.+.||+|+||.||.|.+.. +|+.||+|++..... ..........+.+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~lk~~~~~~~-------------------------~~~~~~~~~~~~~ 53 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVD---TGRELAVKQVPFDPD-------------------------SPETKKEVNALEC 53 (263)
T ss_pred CcccccceecCCCceEEEEEEEcC---CCcEEEEEEEeeccc-------------------------chhhHHHHHHHHH
Confidence 468999999999999999999876 789999999865310 0011223467889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. ||||+++++++.+++..|+||||+++++|.+.+... ..+++..+..++.|++.||.|||+.||+||||+
T Consensus 54 e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~ 131 (263)
T cd06625 54 EIQLLKNLQ-HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSNMIVHRDIK 131 (263)
T ss_pred HHHHHHhCC-CCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 999999996 999999999999999999999999999999987654 579999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|+||++ +.++.++|+|||++........ .....|+..|+|||++.+ .++.++||||||+++|+|++|+.||.
T Consensus 132 p~nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~ 208 (263)
T cd06625 132 GANILR---DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWA 208 (263)
T ss_pred HHHEEE---cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcc
Confidence 999999 5677899999999876543211 134568899999998865 48899999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
..........+....... .....++.++.++|.+||..+|.+|||+.++|+|+||
T Consensus 209 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 209 EFEAMAAIFKIATQPTNP--QLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred ccchHHHHHHHhccCCCC--CCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 766555555544433221 2223588999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=359.38 Aligned_cols=260 Identities=28% Similarity=0.479 Sum_probs=227.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+.|..-++||+||||.||-++.+. +|+.||+|.+.|+. .....+.....
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvra---TGKMYAcKkL~KKR---------------------------iKkr~ge~maL 233 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRA---TGKMYACKKLDKKR---------------------------IKKRKGETMAL 233 (591)
T ss_pred ccceeeeEEEecccccceeEEEEec---chhhHHHHHHHHHH---------------------------HHHhhhhHHhh
Confidence 4678888999999999999999987 89999999987752 12333445678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|-.||.++. .+.||.+--.|+..+.+++||..|+||+|.-+|.+.+ ..|++..+..++.+|+.||++||+.+||+||
T Consensus 234 nEk~iL~kV~-s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRD 312 (591)
T KOG0986|consen 234 NEKQILEKVS-SPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRD 312 (591)
T ss_pred HHHHHHHHhc-cCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeecc
Confidence 8999999997 9999999999999999999999999999988887654 4799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|||+|||+ |+.|+++|+|+|+|..+..+......+||.+|||||++++ .|+...|.|||||++|||+.|+.||...
T Consensus 313 LKPeNILL---Dd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 313 LKPENILL---DDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CChhheee---ccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 99999999 8899999999999999988888888899999999999974 5999999999999999999999999776
Q ss_pred ChH----HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccCCC
Q 011582 358 TES----GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANSHD 417 (482)
Q Consensus 358 ~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~~~ 417 (482)
.+. ++-+.++.....++ ..+|+++++|.+.+|++||.+|. .++++.+||||++.+.
T Consensus 390 KeKvk~eEvdrr~~~~~~ey~----~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw 454 (591)
T KOG0986|consen 390 KEKVKREEVDRRTLEDPEEYS----DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNW 454 (591)
T ss_pred hhhhhHHHHHHHHhcchhhcc----cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCH
Confidence 543 44445555544444 45999999999999999999997 6789999999997653
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=362.46 Aligned_cols=245 Identities=27% Similarity=0.423 Sum_probs=210.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
..+.+++.||+|-||.|++|.... ...||+|.++.. ....+.|.+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~----~~~vavk~ik~~-------------------------------~m~~~~f~~ 250 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNG----STKVAVKTIKEG-------------------------------SMSPEAFLR 250 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcC----CCcccceEEecc-------------------------------ccChhHHHH
Confidence 346678899999999999998752 348999998642 122356789
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS-RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
|+++|++|+ |+|||+++++|..++.+|||||||+.|+|.++|.. .+..+...+...++.|||+|++||+++++|||||
T Consensus 251 Ea~iMk~L~-H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDL 329 (468)
T KOG0197|consen 251 EAQIMKKLR-HEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDL 329 (468)
T ss_pred HHHHHHhCc-ccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhh
Confidence 999999998 99999999999999999999999999999999986 5678999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCccccc--ccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDI--VGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~--~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
-+.|||| +++..+||+|||||+...++...... --...|.|||+++ +.++.|+|||||||+||||+| |+.||.
T Consensus 330 AARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~ 406 (468)
T KOG0197|consen 330 AARNILV---DEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYP 406 (468)
T ss_pred hhhheee---ccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCC
Confidence 9999999 67889999999999965544432221 2235699999987 679999999999999999998 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHh
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L 407 (482)
+.+..+.++.+.++. ..+.+ ..+|+++.+++..|+..+|++|||.+.+.
T Consensus 407 ~msn~ev~~~le~Gy-Rlp~P--~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 407 GMSNEEVLELLERGY-RLPRP--EGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCHHHHHHHHhccC-cCCCC--CCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 999999999888764 33333 46999999999999999999999998654
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=347.84 Aligned_cols=256 Identities=32% Similarity=0.510 Sum_probs=215.7
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||.|+||.||+|.+.. +|..||||++.... ........+.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~vK~~~~~~----------------------------~~~~~~~~~~~e 49 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRE---TGETVALKKVALRR----------------------------LEGGIPNQALRE 49 (286)
T ss_pred CceEEeecccCCCcEEEEEEECC---CCceEEEEEEEccc----------------------------ccchhhHHHHHH
Confidence 58999999999999999999876 78999999986531 112234678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+. ||||+++++++.+...+|+||||+ +++|.+++......+++..++.++.||+.||.|||+.|++|+||||
T Consensus 50 ~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p 127 (286)
T cd07832 50 IKALQACQ-HPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKP 127 (286)
T ss_pred HHHHHhCC-CCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCH
Confidence 99999997 999999999999999999999999 9999998876667799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
+||++ +.++.++|+|||++....... ......|+..|+|||++.+ .++.++||||+||++|+|++|.++|.+.
T Consensus 128 ~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~ 204 (286)
T cd07832 128 ANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGE 204 (286)
T ss_pred HHEEE---cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence 99999 557789999999988765433 2345678999999998753 4789999999999999999999999887
Q ss_pred ChHHHHHHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 358 TESGIFRAVLKADPSFDE--------------------------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
...+.+..+......... ..++.++.++.+||++||..||.+||+++++|.|||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~ 284 (286)
T cd07832 205 NDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284 (286)
T ss_pred CHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence 776666655542211100 112356799999999999999999999999999999
Q ss_pred cc
Q 011582 412 LA 413 (482)
Q Consensus 412 ~~ 413 (482)
|.
T Consensus 285 ~~ 286 (286)
T cd07832 285 FT 286 (286)
T ss_pred cC
Confidence 84
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=348.56 Aligned_cols=261 Identities=26% Similarity=0.419 Sum_probs=214.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.+.. +|..||+|.+... ........+.+
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~-----------------------------~~~~~~~~~~~ 48 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRP---TGVTMAMKEIRLE-----------------------------LDESKFNQIIM 48 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcC---CCcEEEEEEeecc-----------------------------cCHHHHHHHHH
Confidence 368999999999999999999876 7899999988542 22334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR--GGKYSEEDAKIVMVQILSVVAFCHF-QGVVHR 277 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHr 277 (482)
|+.+++++. |+||+++++++...+.+|+||||+++++|..++... ...+++..+..++.|++.||.|||+ .||+||
T Consensus 49 e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~ 127 (286)
T cd06622 49 ELDILHKAV-SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHR 127 (286)
T ss_pred HHHHHHhcC-CCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeC
Confidence 999999996 999999999999999999999999999998877543 2479999999999999999999997 599999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-------cCCCcchhhhhHHHHHHHhhC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-------SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwSlGvil~elltg 350 (482)
||||+||++ +.++.+||+|||++..... .......|++.|+|||.+.+ .++.++|+|||||++|+|++|
T Consensus 128 dl~p~nil~---~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g 203 (286)
T cd06622 128 DVKPTNVLV---NGNGQVKLCDFGVSGNLVA-SLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALG 203 (286)
T ss_pred CCCHHHEEE---CCCCCEEEeecCCcccccC-CccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhC
Confidence 999999999 5577899999999876543 23344578899999998743 257899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCC
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDV 418 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 418 (482)
..||...........+..............+++++.+||.+||..+|.+||+++++++||||......
T Consensus 204 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 204 RYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred CCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 99997765554444333221111222334589999999999999999999999999999999876543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=352.11 Aligned_cols=260 Identities=33% Similarity=0.581 Sum_probs=221.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.+.. +|+.||+|.+.+.. .........+.+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~ 50 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKG---TGKLFALKVLDKKE---------------------------MIKRNKVKRVLT 50 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcC---CCcEEEEEEEeccc---------------------------cchHHHHHHHHH
Confidence 369999999999999999999876 78999999987531 112234567899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
|+.+++.+. |+||+++++++.+.+..|+||||+.|++|.+++... +..+++..+..++.|++.||.|||+.|++||||
T Consensus 51 e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 129 (316)
T cd05574 51 EQEILATLD-HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDL 129 (316)
T ss_pred HHHHHHhCC-CCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 999999997 999999999999999999999999999999987653 357999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC------------------------------cccccccCccccCcccccc
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE------------------------------RLNDIVGSAYYVAPEVLHR 329 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~------------------------------~~~~~~gt~~y~aPE~~~~ 329 (482)
||+||++ +.++.++|+|||++....... ......||..|+|||++.+
T Consensus 130 kp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~ 206 (316)
T cd05574 130 KPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206 (316)
T ss_pred ChHHeEE---cCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC
Confidence 9999999 567789999999987543211 1123468999999998864
Q ss_pred -cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC----HH
Q 011582 330 -SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT----AA 404 (482)
Q Consensus 330 -~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s----~~ 404 (482)
.++.++||||||+++|+|++|..||.+.+....+..+......++.. ..+++++.++|.+||..||.+||+ ++
T Consensus 207 ~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 207 DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred CCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 58889999999999999999999999888888777777655444332 237999999999999999999999 99
Q ss_pred HHhcCcccccCC
Q 011582 405 QALSHPWLANSH 416 (482)
Q Consensus 405 e~L~hp~~~~~~ 416 (482)
++|+||||++..
T Consensus 285 ~ll~~~~~~~~~ 296 (316)
T cd05574 285 EIKQHPFFRGVN 296 (316)
T ss_pred HHHcCchhhcCC
Confidence 999999998754
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=347.64 Aligned_cols=258 Identities=29% Similarity=0.485 Sum_probs=217.7
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
+.|++.++||.|+||.||+|++.. +|+.||+|++... .....+.+.+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~------------------------------~~~~~~~~~~ 58 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKE---TGALAAAKVIETK------------------------------SEEELEDYMV 58 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECC---CCceEEEEEeccC------------------------------CHHHHHHHHH
Confidence 679999999999999999999876 7899999998542 3344677889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. |+||+++++++..++.+|+||||+++++|..++.+....+++..+..++.|++.||.|||++||+|||||
T Consensus 59 e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlk 137 (292)
T cd06644 59 EIEILATCN-HPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLK 137 (292)
T ss_pred HHHHHHhCC-CCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCC
Confidence 999999997 9999999999999999999999999999988877666779999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCccccc------ccCCCcchhhhhHHHHHHHhhCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~elltg~~p 353 (482)
|+||++ +.++.+||+|||++...... .......+++.|+|||++. ..++.++|||||||++|+|++|..|
T Consensus 138 p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p 214 (292)
T cd06644 138 AGNVLL---TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214 (292)
T ss_pred cceEEE---cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCC
Confidence 999999 56778999999998754322 2234456889999999873 2478899999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|...+.......+...... .......++.++.++|.+||..||++||+++++++||||....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 215 HHELNPMRVLLKIAKSEPP-TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred CccccHHHHHHHHhcCCCc-cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 9887766655555443321 1112235789999999999999999999999999999997654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=347.41 Aligned_cols=257 Identities=32% Similarity=0.516 Sum_probs=219.0
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||.|+||.||+|.... ++..||+|++... .....+.+.+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~------------------------------~~~~~~~~~~ 51 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKE---TGLFAAAKIIQIE------------------------------SEEELEDFMV 51 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcC---CCcEEEEEEEeeC------------------------------CHHHHHHHHH
Confidence 579999999999999999999876 7899999998542 2334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. ||||+++++++.+++..|+||||+++++|.+++......+++..+..++.|++.||.|||++||+|||||
T Consensus 52 e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~ 130 (280)
T cd06611 52 EIDILSECK-HPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLK 130 (280)
T ss_pred HHHHHHhCC-CCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 999999997 9999999999999999999999999999999887766789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCccccc------ccCCCcchhhhhHHHHHHHhhCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~elltg~~p 353 (482)
|+||++ +.++.++|+|||++...... .......||+.|+|||.+. ..++.++|+|||||++|+|++|..|
T Consensus 131 p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p 207 (280)
T cd06611 131 AGNILL---TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207 (280)
T ss_pred hhhEEE---CCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999 66788999999998765332 2234457899999999874 2367899999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
|...........+........ .....++.++.++|.+||+.||.+||+++++|+||||.+.
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 208 HHELNPMRVLLKILKSEPPTL-DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred cccCCHHHHHHHHhcCCCCCc-CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 988777666666655432211 1123578999999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=346.46 Aligned_cols=253 Identities=29% Similarity=0.487 Sum_probs=209.2
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|++.+.||+|+||.||+|.+.. +++.||+|++++.. ... ......+|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~----------------------------~~~-~~~~~~~e~ 48 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRK---TGKYYAIKCMKKHF----------------------------KSL-EQVNNLREI 48 (282)
T ss_pred CceEeeccccccceEEEEEEcC---CCcEEEEEEehhcc----------------------------CCc-hhhhHHHHH
Confidence 6788999999999999999876 78999999986531 111 112345789
Q ss_pred HHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
.++.++.+|+||+++++++.+. +.+++||||++ ++|.+.+......+++..+..++.|++.||.|||+.|++|||||
T Consensus 49 ~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~ 127 (282)
T cd07831 49 QALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIK 127 (282)
T ss_pred HHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccC
Confidence 9999997799999999999988 89999999997 48888887665679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc--ccCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+||+++ . +.+||+|||++.............++..|+|||++. +.++.++|||||||++|+|++|..||.+.+
T Consensus 128 p~ni~l~---~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 128 PENILIK---D-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred HHHEEEc---C-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 9999994 4 889999999998775544445567899999999764 347889999999999999999999998887
Q ss_pred hHHHHHHHHhcCCC------------------CCCC-------CCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 359 ESGIFRAVLKADPS------------------FDEA-------PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 359 ~~~~~~~i~~~~~~------------------~~~~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
..+.+..+...... ++.. ..+.++.++.+||.+||..||.+||+++++|.||||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 204 ELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 76655555432111 1100 013578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=332.07 Aligned_cols=259 Identities=26% Similarity=0.438 Sum_probs=222.8
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++.+++..||.|+-|.|++++.+. +|..+|||.+.+. ...+...++..
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs---~~~iiAVK~M~rt-----------------------------~Nkee~kRILm 139 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRS---TGHIIAVKQMRRT-----------------------------GNKEENKRILM 139 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcc---cceEEEEEeeccc-----------------------------CCHHHHHHHHH
Confidence 345667789999999999999987 8999999999764 55667788999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS-RGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHRD 278 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrD 278 (482)
.+.++.+..++|+||+.+|+|..+...++.||.|.. - .+.+.. -.+.++|..+-.+...++.||.||.+ +||+|||
T Consensus 140 Dldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C-~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRD 217 (391)
T KOG0983|consen 140 DLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-C-AEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRD 217 (391)
T ss_pred hhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-H-HHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecc
Confidence 999998887899999999999999999999999843 2 444443 35679999999999999999999987 4899999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~~pf 354 (482)
+||+|||+ |+.|++||||||++.++.+....+...|.+.|||||.+. ..|+.++||||||+.++||.||..||
T Consensus 218 vKPSNILl---De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy 294 (391)
T KOG0983|consen 218 VKPSNILL---DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPY 294 (391)
T ss_pred cCccceEE---ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCC
Confidence 99999999 788999999999999887777777788999999999885 35999999999999999999999999
Q ss_pred CCC-ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 355 WAR-TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 355 ~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.+. .+-+++.+|++..+..- +.-.++|+++.+|+..||++|+.+||...++|+|||+..+..
T Consensus 295 ~~c~tdFe~ltkvln~ePP~L-~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 295 KGCKTDFEVLTKVLNEEPPLL-PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred CCCCccHHHHHHHHhcCCCCC-CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 885 55678888888655222 222359999999999999999999999999999999987643
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=343.90 Aligned_cols=257 Identities=30% Similarity=0.524 Sum_probs=218.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||.|+||.||+|++.. +|+.||+|++... ........+.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~-----------------------------~~~~~~~~~~~ 48 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKR---TNQVVAIKVIDLE-----------------------------EAEDEIEDIQQ 48 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECC---CCeEEEEEEeecc-----------------------------ccchHHHHHHH
Confidence 368899999999999999999876 7899999998642 12233467889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. |+||+++++++.++...|+|+||+++++|.+++... .+++..++.++.|++.||.|||++|++||||+
T Consensus 49 e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~ 125 (274)
T cd06609 49 EIQFLSQCR-SPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIK 125 (274)
T ss_pred HHHHHHHcC-CCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 999999997 999999999999999999999999999999988643 79999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+||++ +.++.++|+|||+++..... .......|+..|+|||.+.+ .++.++|||||||++|+|++|..||...+
T Consensus 126 p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 126 AANILL---SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred HHHEEE---CCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 999999 56788999999999876543 23345678999999998864 58999999999999999999999998776
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.......+....... .....+++++.++|.+||..||++|||++++++||||.+...
T Consensus 203 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 203 PMRVLFLIPKNNPPS--LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred hHHHHHHhhhcCCCC--CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCc
Confidence 666555555443211 111227899999999999999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=341.43 Aligned_cols=256 Identities=30% Similarity=0.497 Sum_probs=216.8
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||.|+||.||+|.... +|..+|+|++... ........+.+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~-----------------------------~~~~~~~~~~~ 48 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLP---NNEKVAIKRIDLE-----------------------------KCQTSVDELRK 48 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcC---CCcEEEEEEeccC-----------------------------CcchHHHHHHH
Confidence 479999999999999999999876 7889999998643 11225578899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR--GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
|+.+++.+. |+||+++++.+..++..|+||||+++++|.+++... ...+++..+..++.|++.||.|||++||+|||
T Consensus 49 e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~ 127 (267)
T cd06610 49 EVQAMSQCN-HPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRD 127 (267)
T ss_pred HHHHHHhcC-CCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 999999996 999999999999999999999999999999988654 24689999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc-----ccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER-----LNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~ 351 (482)
|+|+||++ ++++.++|+|||++........ .....|+..|+|||++.. .++.++|+|||||++|+|++|+
T Consensus 128 l~p~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~ 204 (267)
T cd06610 128 IKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204 (267)
T ss_pred CCHHhEEE---cCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCC
Confidence 99999999 5677899999999876654322 234578999999998764 5889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCC--CCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEA--PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.||...+....+..+.......... .+..+++++.++|.+||..||.+||++++++.||||
T Consensus 205 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 205 APYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred CCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 9998877666666655543221111 124688999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=344.13 Aligned_cols=254 Identities=29% Similarity=0.523 Sum_probs=210.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+.|++.+.||+|+||.||+|.... +++.||+|++... ......+.
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~-------------------------------~~~~~~~~ 50 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVT-------------------------------GDEEEEIK 50 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcC---CCcEEEEEEEEcC-------------------------------CccHHHHH
Confidence 4679999999999999999999876 7899999998542 11235678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
+|+.+++++.+|+||+++++++... ..+|+||||+.+++|.+++... ...+++..+..++.|++.||.|||++
T Consensus 51 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 130 (272)
T cd06637 51 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130 (272)
T ss_pred HHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 9999999986699999999998753 4689999999999999988753 35689999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCccccc------ccCCCcchhhhhHHHHH
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAY 345 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~ 345 (482)
||+||||||+||++ ++++.+||+|||++...... .......|++.|+|||++. ..++.++||||+||++|
T Consensus 131 ~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~ 207 (272)
T cd06637 131 KVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAI 207 (272)
T ss_pred CCccCCCCHHHEEE---CCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHH
Confidence 99999999999999 56778999999999865432 2334567899999999874 24888999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 346 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 346 elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
+|++|..||...........+.... ........++.++.+||.+||..||.+|||+.+++.||||
T Consensus 208 el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 208 EMAEGAPPLCDMHPMRALFLIPRNP--APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHhCCCCccccCHHHHHHHHhcCC--CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 9999999997665544444333322 1222234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=344.93 Aligned_cols=257 Identities=31% Similarity=0.522 Sum_probs=217.1
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.|++.+.||.|+||.||+|.+.. ++..+|+|.+... .....+.+.+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~------------------------------~~~~~~~~~~e 52 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKE---TGVLAAAKVIDTK------------------------------SEEELEDYMVE 52 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECC---CCeEEEEEEeCCC------------------------------CHHHHHHHHHH
Confidence 37888999999999999999876 7889999998542 23345678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+. ||||+++++++..++..|+||||+++++|..++......+++..+..++.|++.||.|||+.||+||||||
T Consensus 53 ~~~l~~l~-h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp 131 (282)
T cd06643 53 IDILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKA 131 (282)
T ss_pred HHHHHHCC-CCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCc
Confidence 99999996 99999999999999999999999999999888766556799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCccccc------ccCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~elltg~~pf 354 (482)
+|||+ +.++.+||+|||++...... .......||..|+|||++. ..++.++||||+||++|+|++|..||
T Consensus 132 ~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~ 208 (282)
T cd06643 132 GNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH 208 (282)
T ss_pred ccEEE---ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCc
Confidence 99999 56778999999998765322 2234457899999999873 24778999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
...+..+....+....... ......++.++.+||.+||..||.+||+++++++||||....
T Consensus 209 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 209 HELNPMRVLLKIAKSEPPT-LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred cccCHHHHHHHHhhcCCCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 8877766666665543221 112235789999999999999999999999999999998753
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=344.40 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=210.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|.+.+.||+|+||.||+|++.. +++.||+|+++.. .......+.
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~------------------------------~~~~~~~~~ 54 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVN---TGELAAIKVIKLE------------------------------PGEDFAVVQ 54 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcC---CCcEEEEEEEecC------------------------------chhHHHHHH
Confidence 3589999999999999999999876 7899999998642 112234678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. ||||+++++++.+.+.+|+||||+++++|.+++... +.+++.++..++.|++.||.|||++||+||||
T Consensus 55 ~e~~~~~~l~-h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 132 (267)
T cd06645 55 QEIIMMKDCK-HSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVT-GPLSESQIAYVSRETLQGLYYLHSKGKMHRDI 132 (267)
T ss_pred HHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 8999999996 999999999999999999999999999999987544 67999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~~pf 354 (482)
||+||++ +.++.+||+|||++...... .......|+..|+|||++. +.++.++|+|||||++|+|++|..||
T Consensus 133 kp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~ 209 (267)
T cd06645 133 KGANILL---TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209 (267)
T ss_pred CHHHEEE---CCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCc
Confidence 9999999 56778999999998765432 2234457999999999873 35889999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCC-CCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 355 WARTESGIFRAVLKADPSFDEA-PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
...........+.......+.. ....++..+.++|.+||..||++||+++++++|||
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 210 FDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred ccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 7665444333333322221111 11247889999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=337.99 Aligned_cols=253 Identities=26% Similarity=0.473 Sum_probs=217.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.+.+.||+|+||.||+|..+. +|+.||+|.+... .........+.+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~----------------------------~~~~~~~~~~~~e 49 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKA---DKRVYAMKQIDLS----------------------------KMNRREREEAIDE 49 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcC---CCcEEEEEEeehh----------------------------hCCHHHHHHHHHH
Confidence 48889999999999999999876 7899999998642 1223445778999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
+.+++.+. ||||+++++++.+.+..|+||||++|++|.+++... ...+++..++.++.|++.||.|||++||+|||||
T Consensus 50 ~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~ 128 (256)
T cd08529 50 ARVLAKLD-SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIK 128 (256)
T ss_pred HHHHHhcC-CCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 99999996 999999999999999999999999999999988764 4679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+||++ +.++.++|+|||++....... ......|++.|+|||++.+ .++.++|+|||||++|+|++|+.||...+
T Consensus 129 ~~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 129 SLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred cceEEE---eCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 999999 566789999999988765432 2334578999999998864 58899999999999999999999998888
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.......+......... ..++.++.++|.+||+.+|++||++.+++.|||+
T Consensus 206 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 206 QGALILKIIRGVFPPVS---QMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHHHcCCCCCCc---cccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 77777777665432111 2578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=350.16 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=211.5
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.+.. +|..||+|.+... ........+.+
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~---~~~~~a~k~~~~~-----------------------------~~~~~~~~~~~ 48 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRP---SGLIMARKLIHLE-----------------------------IKPAIRNQIIR 48 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcC---CCeEEEEEEeccc-----------------------------cCHHHHHHHHH
Confidence 369999999999999999999876 7889999988542 12334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDl 279 (482)
|+++++++. ||||+++++++.+++.+|+||||++|++|.+++... ..+++..+..++.|++.||.|||+ .+++||||
T Consensus 49 E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl 126 (308)
T cd06615 49 ELKVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTYLREKHKIMHRDV 126 (308)
T ss_pred HHHHHHhCC-CCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCC
Confidence 999999996 999999999999999999999999999999988654 679999999999999999999998 58999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
||+|||+ +.++.+||+|||++...... .....+|+..|+|||++.+ .++.++|+|||||++|+|++|..||...+
T Consensus 127 ~p~nil~---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 127 KPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred ChHHEEE---ecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999999 56778999999998765332 2345678999999998865 58899999999999999999999997655
Q ss_pred hHHHHHHHHhcCCCC----------------------------------CCCCCCCCCHHHHHHHHHhchhccccCCCHH
Q 011582 359 ESGIFRAVLKADPSF----------------------------------DEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA 404 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~----------------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 404 (482)
.......+....... +......++.++++||.+||..||++||++.
T Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~ 282 (308)
T cd06615 203 AKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLK 282 (308)
T ss_pred hhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHH
Confidence 433322221110000 0111123688999999999999999999999
Q ss_pred HHhcCcccccC
Q 011582 405 QALSHPWLANS 415 (482)
Q Consensus 405 e~L~hp~~~~~ 415 (482)
++++||||.+.
T Consensus 283 ~ll~~~~~~~~ 293 (308)
T cd06615 283 ELTKHPFIKRA 293 (308)
T ss_pred HHhcChhhhhc
Confidence 99999999764
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=337.65 Aligned_cols=253 Identities=23% Similarity=0.491 Sum_probs=214.3
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.|++.+.||+|+||.||+|.++. +++.||+|.+... .......+.+.+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~----------------------------~~~~~~~~~~~~e 49 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRT---DGKQYVIKKLNLR----------------------------NASRRERKAAEQE 49 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcC---CCcEEEEEEEehh----------------------------hcCHHHHHHHHHH
Confidence 48999999999999999999876 6889999998642 1223345678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEe-CCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 202 VKILRALTGHKNLVQFYDAYED-DDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+.+++++. |+|++++++.+.. +..+|+||||+++++|.+++... ...+++.++..++.|++.||.|||++||+||||
T Consensus 50 ~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di 128 (257)
T cd08223 50 AQLLSQLK-HPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDL 128 (257)
T ss_pred HHHHHhCC-CCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 99999996 9999999998864 45689999999999999988753 356899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+||++ +.++.++|+|||++...... .......|++.|+|||++.+ .++.++||||||+++|+|++|+.||...
T Consensus 129 ~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 129 KTQNVFL---TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred CchhEEE---ecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 9999999 56778999999999876432 22345578999999998764 5889999999999999999999999888
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
+.......+..+... .....+++++.++|.+||+.||.+||++.+++.||||
T Consensus 206 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 206 DMNSLVYRIIEGKLP---PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred CHHHHHHHHHhcCCC---CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 777766666554431 1124588999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=343.98 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=208.7
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|++.. +++.||+|++.+. ........+.+|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~aiK~~~~~-----------------------------~~~~~~~~~~~E 49 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLL---TRRILAVKVIPLD-----------------------------ITVELQKQIMSE 49 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcC---CCcEEEEEEEecC-----------------------------CChHHHHHHHHH
Confidence 68889999999999999999876 7899999998653 123344678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++++. ||||+++++++...+..++||||+++++|..+ ..+++..+..++.|++.||.|||+.||+|+||||
T Consensus 50 ~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 123 (279)
T cd06619 50 LEILYKCD-SPYIIGFYGAFFVENRISICTEFMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKP 123 (279)
T ss_pred HHHHHhCC-CCCeeeEEEEEEECCEEEEEEecCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCH
Confidence 99999996 99999999999999999999999999988543 3578999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh-
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE- 359 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~- 359 (482)
+|||+ +.++.+||+|||++...... .....+||..|+|||++.+ .++.++|+|||||++|+|++|..||.....
T Consensus 124 ~Nill---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~ 199 (279)
T cd06619 124 SNMLV---NTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKN 199 (279)
T ss_pred HHEEE---CCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhccc
Confidence 99999 56788999999999765432 3345689999999998864 589999999999999999999999965321
Q ss_pred ------HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 360 ------SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 360 ------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
......+.... ........+++++.++|.+||+.||.+||+++++++||||+...
T Consensus 200 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 200 QGSLMPLQLLQCIVDED--PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred ccccchHHHHHHHhccC--CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 12222222222 11122345789999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=360.56 Aligned_cols=250 Identities=25% Similarity=0.385 Sum_probs=214.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+...++..||+|.||+||+|.... +||||++... ..+.+..+.|+
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~whG------dVAVK~Lnv~----------------------------~pt~~qlqaFK 436 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWHG------DVAVKLLNVD----------------------------DPTPEQLQAFK 436 (678)
T ss_pred HHHhhccceeccccccceeeccccc------ceEEEEEecC----------------------------CCCHHHHHHHH
Confidence 3556788899999999999999865 6999999653 24556789999
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.++++-+ |.||+-+.|++..++. .||+.+|+|.+|+.+|+-...+|.....+.|++||++|+.|||.++||||||
T Consensus 437 nEVa~lkkTR-H~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDL 514 (678)
T KOG0193|consen 437 NEVAVLKKTR-HENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDL 514 (678)
T ss_pred HHHHHHhhcc-hhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhc
Confidence 9999999998 9999999999998877 9999999999999999877788999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEeccccccc---CCCCcccccccCccccCcccccc----cCCCcchhhhhHHHHHHHhhCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYV---KPDERLNDIVGSAYYVAPEVLHR----SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~---~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~elltg~~ 352 (482)
|..||++ .+++.|||+|||++... ..........|...|||||+++. .|+..+||||||+++|||+||..
T Consensus 515 KSnNIFl---~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~l 591 (678)
T KOG0193|consen 515 KSNNIFL---HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGEL 591 (678)
T ss_pred cccceEE---ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcC
Confidence 9999999 66789999999998643 33445666788999999999862 59999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 353 PFWARTESGIFRAVLKADPSFDE-APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||...+.+.++-.+-.+....+. ....+.+.++++|+..|+.+++++||...++|.
T Consensus 592 Pysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 592 PYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred CcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 99977777776655555322221 122346679999999999999999999999887
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=350.67 Aligned_cols=262 Identities=28% Similarity=0.422 Sum_probs=214.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|.++. +|+.||+|+++... ........+.
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~vaiK~~~~~~----------------------------~~~~~~~~~~ 54 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTT---SGEIVALKKVRMDN----------------------------ERDGIPISSL 54 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECC---CCcEEEEEEEEecc----------------------------CCCCCcchhh
Confidence 4689999999999999999999876 79999999986421 0011112456
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+|+.++++++ |+||+++++++.+. +.+|+||||+.+ +|.+.+......+++.++..++.||+.||.|||+.|++||
T Consensus 55 ~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~ 132 (309)
T cd07845 55 REITLLLNLR-HPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHR 132 (309)
T ss_pred HHHHHHHhCC-CCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 7999999997 99999999998765 578999999965 7888876655779999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf 354 (482)
||||+||++ +.++.+||+|||++...... .......++..|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 133 dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f 209 (309)
T cd07845 133 DLKVSNLLL---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL 209 (309)
T ss_pred CCCHHHEEE---CCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC
Confidence 999999999 56778999999999876543 22333456888999998854 4789999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCC--------------------------CCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAP--------------------------WPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~--------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+.+..+.+..+........... +..+++++.+||.+||..||++|||+.++|.
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 210 PGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred CCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 98888877777665322111110 1236899999999999999999999999999
Q ss_pred CcccccCCC
Q 011582 409 HPWLANSHD 417 (482)
Q Consensus 409 hp~~~~~~~ 417 (482)
||||++..-
T Consensus 290 h~~f~~~~~ 298 (309)
T cd07845 290 SSYFKEKPL 298 (309)
T ss_pred ChhhccCCC
Confidence 999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=345.45 Aligned_cols=256 Identities=28% Similarity=0.510 Sum_probs=210.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|+++. +|+.||+|++.+.. ......+.+.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~----------------------------~~~~~~~~~~~ 49 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRE---TGQIVAIKKFVESE----------------------------DDPVIKKIALR 49 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECC---CCcEEEEEEEeecc----------------------------cCccccHHHHH
Confidence 479999999999999999999876 78999999986430 11112345789
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. |+||+++++++.....+++||||++++.|..++ .....+++..+..++.||+.||.|||++||+|||||
T Consensus 50 e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~ 127 (286)
T cd07847 50 EIRMLKQLK-HPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELE-KNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVK 127 (286)
T ss_pred HHHHHHhCC-CCCEeeeeeEEeeCCEEEEEEeccCccHHHHHH-hCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCC
Confidence 999999997 999999999999999999999999987766554 444679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|+||++ +.++.+||+|||++....... ......++..|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 128 p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~ 204 (286)
T cd07847 128 PENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGK 204 (286)
T ss_pred hhhEEE---cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 999999 567789999999998765433 2334568899999998754 4789999999999999999999999887
Q ss_pred ChHHHHHHHHhcCCC-------------------CCC--------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCc
Q 011582 358 TESGIFRAVLKADPS-------------------FDE--------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~-------------------~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 410 (482)
...+....+...... .+. ..++.++..+.+||.+||+.||++||++.+++.||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~ 284 (286)
T cd07847 205 SDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284 (286)
T ss_pred ChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCC
Confidence 665544443321100 000 01345789999999999999999999999999999
Q ss_pred cc
Q 011582 411 WL 412 (482)
Q Consensus 411 ~~ 412 (482)
||
T Consensus 285 ~f 286 (286)
T cd07847 285 YF 286 (286)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=347.11 Aligned_cols=259 Identities=31% Similarity=0.470 Sum_probs=209.6
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.+.. +|+.||||++.... ........+.+
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~lK~~~~~~----------------------------~~~~~~~~~~~ 49 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKN---TGKLVALKKTRLEM----------------------------DEEGIPPTALR 49 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECC---CCcEEEEEeehhhc----------------------------cccCCchHHHH
Confidence 469999999999999999999876 78999999875421 11112346788
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCe-----EEEEEecCCCCChHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDN-----IYIVMELCKGGELLDRILSR----GGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
|+.+++.+.+||||+++++++...+. .|+||||+++ +|.+++... ...+++..++.++.||+.||.|||+
T Consensus 50 E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~ 128 (295)
T cd07837 50 EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK 128 (295)
T ss_pred HHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 99999999768999999999987766 8999999986 788887653 2358999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHh
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ell 348 (482)
+||+||||||+||+++. .++.+||+|||++...... .......+++.|+|||++.+ .++.++||||||+++|+|+
T Consensus 129 ~~i~H~dl~~~nil~~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 206 (295)
T cd07837 129 HGVMHRDLKPQNLLVDK--QKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206 (295)
T ss_pred CCeeecCCChHHEEEec--CCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHH
Confidence 99999999999999942 2678999999998765322 22233467889999998753 4789999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCC------------------------CCCCCCCHHHHHHHHHhchhccccCCCHH
Q 011582 349 CGSRPFWARTESGIFRAVLKADPSFDE------------------------APWPSLSPEAIDFVKRLLNKDYRKRLTAA 404 (482)
Q Consensus 349 tg~~pf~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 404 (482)
+|..||.+.+..+....+......... ...+.+++++.+||.+||..||.+||++.
T Consensus 207 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~ 286 (295)
T cd07837 207 RKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAK 286 (295)
T ss_pred cCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHH
Confidence 999999887766655555442111111 01245789999999999999999999999
Q ss_pred HHhcCcccc
Q 011582 405 QALSHPWLA 413 (482)
Q Consensus 405 e~L~hp~~~ 413 (482)
++|.||||+
T Consensus 287 eil~~~~~~ 295 (295)
T cd07837 287 AALTHPYFD 295 (295)
T ss_pred HHhcCCCcC
Confidence 999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=353.67 Aligned_cols=256 Identities=21% Similarity=0.310 Sum_probs=204.5
Q ss_pred ecceeecC--CceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 125 LGEEVGRG--HFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 125 ~~~~LG~G--~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
++++||+| +||+||+++.+. +|+.||||++... .......+.+.+|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~~~~e~ 50 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKP---TGEYVTVRRINLE----------------------------ACTNEMVTFLQGEL 50 (327)
T ss_pred hhhhccccccceEEEEEEeecc---cCcEEEEEEechh----------------------------hccHHHHHHHHHHH
Confidence 56789999 788999999987 8999999998642 12233456778899
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
.+++.+. ||||+++++++..++..|+||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||
T Consensus 51 ~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp 129 (327)
T cd08227 51 HVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKA 129 (327)
T ss_pred HHHHhcC-CCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCh
Confidence 9999996 999999999999999999999999999999988653 34599999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCC--------cccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhhC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDE--------RLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~elltg 350 (482)
+|||+ +.++.++++|||.+....... ......++..|+|||++.+ .|+.++|||||||++|+|++|
T Consensus 130 ~Nil~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g 206 (327)
T cd08227 130 SHILI---SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206 (327)
T ss_pred hhEEE---ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHC
Confidence 99999 566789999998654332111 1122356788999999863 489999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCC------------------------------------------CCCCCCCCHHHHHH
Q 011582 351 SRPFWARTESGIFRAVLKADPSFD------------------------------------------EAPWPSLSPEAIDF 388 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~------------------------------------------~~~~~~~s~~~~~l 388 (482)
..||.................... ......+++++.+|
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 286 (327)
T cd08227 207 HVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHF 286 (327)
T ss_pred CCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHH
Confidence 999977655444333332211000 00112357889999
Q ss_pred HHHhchhccccCCCHHHHhcCcccccC
Q 011582 389 VKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 389 i~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
|.+||+.||.+|||++++|+||||+..
T Consensus 287 i~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 287 VEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred HHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 999999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-44 Score=354.31 Aligned_cols=261 Identities=29% Similarity=0.466 Sum_probs=209.0
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..-...|++++.||+||.+.||+|... +.+.||+|.+.. ...+.....
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s----~~~iyalkkv~~----------------------------~~~D~qtl~ 404 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNS----DKQIYALKKVVL----------------------------LEADNQTLD 404 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecC----CCcchhhhHHHH----------------------------hhcCHHHHH
Confidence 344567999999999999999999864 356678776532 224566788
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
-+.+||.+|.+|++|.+||+||+|-..++.+||||||- ..+|...|.++........++.+..|++.|+.++|+.||||
T Consensus 405 gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVH 483 (677)
T KOG0596|consen 405 GYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVH 483 (677)
T ss_pred HHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceee
Confidence 99999999999999999999999999999999999986 44888877766555565689999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc------------cCCCcchhhhhH
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR------------SYGTEADMWSIG 341 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~------------~~~~~~DiwSlG 341 (482)
.||||.|+|+. .|.+||+|||+|..+..+.. ..+.+||+.||+||++.. ..+.++||||||
T Consensus 484 SDLKPANFLlV----kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLG 559 (677)
T KOG0596|consen 484 SDLKPANFLLV----KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLG 559 (677)
T ss_pred cCCCcccEEEE----eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhh
Confidence 99999999994 67899999999998765532 345689999999998731 156789999999
Q ss_pred HHHHHHhhCCCCCCCCC-hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 342 VIAYILLCGSRPFWART-ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 342 vil~elltg~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
||||+|+.|+.||..-. .-.-+..|..-...+..+..+. ..++.++++.||..||++||++.++|+|||++-.
T Consensus 560 CILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 560 CILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-NDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred hHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-chHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 99999999999995432 2233334443332222222111 2349999999999999999999999999999763
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=351.73 Aligned_cols=252 Identities=27% Similarity=0.433 Sum_probs=193.6
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
+.+||+|+||.||+|+.+.+ .++..||+|.+... .....+.+|+.++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~-~~~~~~a~k~~~~~--------------------------------~~~~~~~~E~~~l 52 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDG-KDEKEYALKQIEGT--------------------------------GISMSACREIALL 52 (317)
T ss_pred ceEeccCCCeeEEEEEecCC-CccceEEEEEecCC--------------------------------CCcHHHHHHHHHH
Confidence 35799999999999987542 25688999988542 0123567899999
Q ss_pred HhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 206 RALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSR--------GGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
+.+. ||||+++++++.. +..+|+||||+.+ +|.+.+... ...+++..++.++.||+.||.|||++||+
T Consensus 53 ~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~iv 130 (317)
T cd07867 53 RELK-HPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVL 130 (317)
T ss_pred HhCC-CCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 9997 9999999998854 5678999999965 777776421 23588999999999999999999999999
Q ss_pred ccCCCCCceEEecC-CCCCcEEEEecccccccCCCC----cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHh
Q 011582 276 HRDLKPENFLFTSK-EENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 276 HrDlkp~NIll~~~-~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ell 348 (482)
||||||+|||+..+ +.++.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 131 H~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~ 210 (317)
T cd07867 131 HRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (317)
T ss_pred cCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHH
Confidence 99999999999543 356789999999998764322 2345678999999998864 4899999999999999999
Q ss_pred hCCCCCCCCChH---------HHHHHHHhcCCCCCC----------------------------------CCCCCCCHHH
Q 011582 349 CGSRPFWARTES---------GIFRAVLKADPSFDE----------------------------------APWPSLSPEA 385 (482)
Q Consensus 349 tg~~pf~~~~~~---------~~~~~i~~~~~~~~~----------------------------------~~~~~~s~~~ 385 (482)
||.+||...... .....+......... ......+..+
T Consensus 211 tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (317)
T cd07867 211 TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKV 290 (317)
T ss_pred hCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHH
Confidence 999999654321 111111111000000 0001235678
Q ss_pred HHHHHHhchhccccCCCHHHHhcCccc
Q 011582 386 IDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 386 ~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.+||.+||+.||.+|||++|+|+||||
T Consensus 291 ~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 291 FLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HHHHHHHhccCcccccCHHHHhcCCCC
Confidence 899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=336.30 Aligned_cols=254 Identities=28% Similarity=0.473 Sum_probs=218.2
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|.... +++.+|||++.... ........+.+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~----------------------------~~~~~~~~~~~e 49 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKA---DQKLVIIKQIPVEQ----------------------------MTKDERLAAQNE 49 (256)
T ss_pred CceEEEEecccCceEEEEEEEcC---CCcEEEEEEEeccc----------------------------cccHHHHHHHHH
Confidence 58999999999999999999876 78999999986531 123345778999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
+.+++.+. ||||+++++.+..++..++||||+++++|.+++... +..+++..+..++.|++.||.|||++||+|||||
T Consensus 50 ~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~ 128 (256)
T cd08220 50 CQVLKLLS-HPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLK 128 (256)
T ss_pred HHHHhhCC-CCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 99999996 999999999999999999999999999999998764 3458999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
|+||+++ ..+..+||+|||++.............|+..|+|||.+.+ .++.++||||||+++|+|++|+.||...+.
T Consensus 129 ~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 206 (256)
T cd08220 129 TQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL 206 (256)
T ss_pred HHHEEEc--CCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch
Confidence 9999995 2345689999999987765544455678999999998864 578899999999999999999999988877
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
......+...... .....+++++.++|.+||..||.+|||+.++|.||||
T Consensus 207 ~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 207 PALVLKIMSGTFA---PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHHhcCCC---CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 7777666654322 1123488999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=376.50 Aligned_cols=251 Identities=26% Similarity=0.452 Sum_probs=211.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+++|.+.|.+|||+.||+|.+.. .|..||+|++- ..++..++.+.+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~---~~~~~AlKrm~------------------------------~~de~~L~~v~~ 83 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVK---GGKKYALKRMY------------------------------VNDEEALNAVKR 83 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecC---CCceeeeeeee------------------------------cCCHHHHHHHHH
Confidence 468899999999999999999986 45999999873 246678899999
Q ss_pred HHHHHHhhcCCCCcceeeE-EEEe------CCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 201 EVKILRALTGHKNLVQFYD-AYED------DDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~-~~~~------~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
||.+|++|++|+|||.+++ .... .-+++|.||||.||.|.|++..+ ..+|+|.++.+|+.++++|+.+||..
T Consensus 84 EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~ 163 (738)
T KOG1989|consen 84 EIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL 163 (738)
T ss_pred HHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC
Confidence 9999999999999999999 3221 13578999999999999999754 35699999999999999999999999
Q ss_pred C--CcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcc----------cccccCccccCccccc---c-cCCCcch
Q 011582 273 G--VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL----------NDIVGSAYYVAPEVLH---R-SYGTEAD 336 (482)
Q Consensus 273 ~--ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~----------~~~~gt~~y~aPE~~~---~-~~~~~~D 336 (482)
. |||||||-||||| ..++..||||||.|......... -...-|+.|+|||++. + ..+.|+|
T Consensus 164 ~pPiIHRDLKiENvLl---s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsD 240 (738)
T KOG1989|consen 164 KPPIIHRDLKIENVLL---SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSD 240 (738)
T ss_pred CCccchhhhhhhheEE---cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhH
Confidence 8 9999999999999 67778999999998643221100 0124689999999874 3 5899999
Q ss_pred hhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 337 MWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 337 iwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
||+|||+||-|+....||.+... ..|+++.+.|+.. +.++..+++||+.||+.||.+||++.|++.+-+.-
T Consensus 241 IWALGclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 241 IWALGCLLYKLCYFTTPFEESGK----LAILNGNYSFPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred HHHHHHHHHHHHHhCCCcCcCcc----eeEEeccccCCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 99999999999999999977644 3567777777654 67999999999999999999999999999765543
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=345.48 Aligned_cols=259 Identities=28% Similarity=0.471 Sum_probs=219.3
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.+.. +++.||+|.+.+. ..........+.+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~ik~~~~~---------------------------~~~~~~~~~~~~~ 50 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKE---TRQRFAMKKINKQ---------------------------NLILRNQIQQVFV 50 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECC---CCcEEEEEEeehh---------------------------hhhhHHHHHHHHH
Confidence 368999999999999999999876 7899999998653 1112234567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++.+..++.+|+||||++|++|.+++... +.+++..+..++.|++.||.|||++||+|||||
T Consensus 51 e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 128 (305)
T cd05609 51 ERDILTFAE-NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEYLHNYGIVHRDLK 128 (305)
T ss_pred HHHHHHhCC-CCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 999999996 999999999999999999999999999999988554 679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC----------------cccccccCccccCccccc-ccCCCcchhhhhHHH
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE----------------RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVI 343 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvi 343 (482)
|+||++ +.++.+||+|||+++...... ......|+..|+|||.+. ..++.++|+|||||+
T Consensus 129 p~NIll---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~v 205 (305)
T cd05609 129 PDNLLI---TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGII 205 (305)
T ss_pred hHHEEE---CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHH
Confidence 999999 567889999999986421100 111246788999999875 468999999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC---HHHHhcCcccccC
Q 011582 344 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT---AAQALSHPWLANS 415 (482)
Q Consensus 344 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~L~hp~~~~~ 415 (482)
+|+|++|..||.+....+....+.......+.... .++.++.++|.+||..||.+||+ +.++|+||||...
T Consensus 206 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 206 LYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccc-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 99999999999988888888887776554444332 58999999999999999999998 8999999999764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=341.42 Aligned_cols=254 Identities=28% Similarity=0.455 Sum_probs=208.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|+++. +|+.||+|++... .......+.
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~~aik~~~~~------------------------------~~~~~~~~~ 54 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLH---TGELAAVKIIKLE------------------------------PGDDFSLIQ 54 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECC---CCeEEEEEEEecC------------------------------ccchHHHHH
Confidence 4679999999999999999999876 7899999998542 111234578
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++++. ||||+++++++..++.+|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.||+||||
T Consensus 55 ~e~~~l~~~~-h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 132 (267)
T cd06646 55 QEIFMVKECK-HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVT-GPLSELQIAYVCRETLQGLAYLHSKGKMHRDI 132 (267)
T ss_pred HHHHHHHhcC-CCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 8999999996 999999999999999999999999999999987544 67999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~~pf 354 (482)
||+||++ +.++.+||+|||++....... ......|++.|+|||.+. ..++.++||||+||++|+|++|..||
T Consensus 133 ~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~ 209 (267)
T cd06646 133 KGANILL---TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209 (267)
T ss_pred CHHHEEE---CCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCc
Confidence 9999999 567789999999998664322 234457899999999873 34788999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCC-CCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 355 WARTESGIFRAVLKADPSFDEA-PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
......+....+.......+.. ....++.++.+||++||..||.+||+++++|+|+|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 210 FDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred cccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 6554433322222222211111 11247899999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=338.55 Aligned_cols=253 Identities=31% Similarity=0.511 Sum_probs=211.8
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||.|+||.||+|.+.. +|+.||||++.+.. .........+..|..++.
T Consensus 2 ~~l~~g~~~~v~~a~~~~---~~~~vavK~~~~~~---------------------------~~~~~~~~~~~~e~~~~~ 51 (260)
T cd05611 2 KPISKGAFGSVYLAKKRS---TGDYFAIKVLKKSD---------------------------MIAKNQVTNVKAERAIMM 51 (260)
T ss_pred ccCCcCCCeeEEEEEecC---CCCeEEEEEecchh---------------------------hhHHHHHHHHHHHHHHHh
Confidence 469999999999999876 78999999986531 011222334556666555
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
...+|+||+++++++..++.+|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|+||++
T Consensus 52 ~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~ 130 (260)
T cd05611 52 IQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI 130 (260)
T ss_pred hcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 5546999999999999999999999999999999987544 579999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRA 365 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~ 365 (482)
+.++.+||+|||++..... .....|+..|+|||.+.+ .++.++||||||+++|+|++|..||...+....+..
T Consensus 131 ---~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 204 (260)
T cd05611 131 ---DQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDN 204 (260)
T ss_pred ---CCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 5677899999999876433 234568899999998865 478999999999999999999999998888888888
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC---CHHHHhcCcccccCC
Q 011582 366 VLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL---TAAQALSHPWLANSH 416 (482)
Q Consensus 366 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~L~hp~~~~~~ 416 (482)
+......+.......+++++.++|.+||+.||++|| +++|+|+||||.+..
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 205 ILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred HHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 777666555555556899999999999999999999 558999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=344.98 Aligned_cols=257 Identities=26% Similarity=0.507 Sum_probs=220.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.-|.++++||+|+||.||+|.++. +|+.+|||.+.. ..+++++..
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~E---sG~v~AIK~VPV--------------------------------~sDLQEIIK 77 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRE---SGHVLAIKKVPV--------------------------------DTDLQEIIK 77 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhc---cCcEEEEEecCc--------------------------------cchHHHHHH
Confidence 458889999999999999999998 899999998753 345789999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
||.||+++. .|++|++|+.|.....+|||||||..|++.+.+.-+++.|++.++..+++..+.||+|||...-||||||
T Consensus 78 EISIMQQC~-S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIK 156 (502)
T KOG0574|consen 78 EISIMQQCK-SKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIK 156 (502)
T ss_pred HHHHHHHcC-CchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcc
Confidence 999999996 9999999999999999999999999999999998888999999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
..|||+ +.++..||+|||.|..+.+. ...+++.|||.|||||++.. .|+.++||||||++..||.-|++||.+-.
T Consensus 157 AGNILL---NT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 157 AGNILL---NTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred cccEEE---cccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 999999 56788999999999876543 24567899999999999975 79999999999999999999999996644
Q ss_pred hHHHHHHHHhc-CCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCC
Q 011582 359 ESGIFRAVLKA-DPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDV 418 (482)
Q Consensus 359 ~~~~~~~i~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 418 (482)
....+-.|-.. .+.|..+ ...|.++.|||++||.++|++|-|+.++++|||+++....
T Consensus 234 PMRAIFMIPT~PPPTF~KP--E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 234 PMRAIFMIPTKPPPTFKKP--EEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred ccceeEeccCCCCCCCCCh--HhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 32111111111 1111111 2368999999999999999999999999999999986543
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=334.88 Aligned_cols=253 Identities=30% Similarity=0.503 Sum_probs=219.5
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||.|+||.||.++... +|+.+|+|.+... .........+.+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~~k~~~~~----------------------------~~~~~~~~~~~~e 49 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTE---DDSLVVWKEVNLT----------------------------RLSEKERRDALNE 49 (256)
T ss_pred CceEeeEecccCCceEEEEEEcC---CCcEEEEEEEeec----------------------------ccchhHHHHHHHH
Confidence 58999999999999999999876 7899999998642 1233445678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
+.+++++. |+||+++++++.+.+.+++|||||++++|.+++... ...+++..+..++.|++.||.|||+.|++||||+
T Consensus 50 ~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~ 128 (256)
T cd08221 50 IVILSLLQ-HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIK 128 (256)
T ss_pred HHHHHhCC-CCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Confidence 99999996 999999999999999999999999999999988764 4568999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+||++ +.++.+||+|||++....... ......|++.|+|||.+.+ .++.++||||||+++|+|++|..||....
T Consensus 129 p~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 129 TLNIFL---TKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred hHhEEE---eCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 999999 567789999999998764433 3345678999999998864 58889999999999999999999999888
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
..+....+........ ...++.++.++|.+||..+|.+||++.++|+|+|+
T Consensus 206 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 206 PLNLVVKIVQGNYTPV---VSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHHHcCCCCCC---ccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 8888888776544322 14578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=309.62 Aligned_cols=259 Identities=30% Similarity=0.497 Sum_probs=224.4
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.-.++||+|.||+||+|+.+. +++.||+|.++-.. .++-.-....+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~---t~eivalkrvrldd----------------------------ddegvpssalre 51 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRE---THEIVALKRVRLDD----------------------------DDEGVPSSALRE 51 (292)
T ss_pred chHHHHhhcCCcceeeEecccCC---ccceEEEEEEeccC----------------------------CCCCCcHHHHHH
Confidence 57778899999999999999887 89999999986431 111112456899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
|-+|+.|+ |.|||+++++...+..+.+|+|||.. +|..++..-++.++.+.++.++.|+++||.|+|++++.||||||
T Consensus 52 icllkelk-hknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkp 129 (292)
T KOG0662|consen 52 ICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKP 129 (292)
T ss_pred HHHHHHhh-hcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCc
Confidence 99999998 99999999999999999999999965 78888888889999999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhh-CCCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLC-GSRPFWAR 357 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ellt-g~~pf~~~ 357 (482)
.|+|+ +.++.+||+|||+++.+.-.- -....+.|.+|++|.++-+ -|++..|+||.|||+.|+.. |++.|.+.
T Consensus 130 qnlli---n~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~ 206 (292)
T KOG0662|consen 130 QNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 206 (292)
T ss_pred ceEEe---ccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence 99999 678899999999999775432 2344577999999999875 49999999999999999975 78889999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCC-------------------------CHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSL-------------------------SPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~-------------------------s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
+..+.+..|........++.|+.+ +..-++|++++|..+|.+|++++++|+||||
T Consensus 207 dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf 286 (292)
T KOG0662|consen 207 DVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF 286 (292)
T ss_pred cHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence 999999999988777777777643 3456799999999999999999999999999
Q ss_pred ccCC
Q 011582 413 ANSH 416 (482)
Q Consensus 413 ~~~~ 416 (482)
....
T Consensus 287 ~d~s 290 (292)
T KOG0662|consen 287 SDFS 290 (292)
T ss_pred cccC
Confidence 8653
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=343.80 Aligned_cols=256 Identities=29% Similarity=0.482 Sum_probs=205.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|.++. +|+.||||.+.... .......+.
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~-----------------------------~~~~~~~~~ 51 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKL---TGQLVALKEIRLEH-----------------------------EEGAPFTAI 51 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcC---CCcEEEEEEEeccc-----------------------------ccCCchhHH
Confidence 4689999999999999999999876 78999999986430 001112456
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. |+||+++++++.+++..|+||||+.+ +|.+++......+++..++.++.|++.||.|||++||+||||
T Consensus 52 ~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl 129 (291)
T cd07844 52 REASLLKDLK-HANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDL 129 (291)
T ss_pred HHHHHHhhCC-CcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccC
Confidence 8999999996 99999999999999999999999975 899988766667899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||+||++ +.++.+||+|||+++...... ......++..|+|||++.+ .++.++||||+||++|+|++|..||.+
T Consensus 130 ~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~ 206 (291)
T cd07844 130 KPQNLLI---SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPG 206 (291)
T ss_pred CHHHEEE---cCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999 567789999999987543221 2223457889999998754 488999999999999999999999976
Q ss_pred CC-hHHHHHHHHhcCCCCCC--------------------------CCCCCCC--HHHHHHHHHhchhccccCCCHHHHh
Q 011582 357 RT-ESGIFRAVLKADPSFDE--------------------------APWPSLS--PEAIDFVKRLLNKDYRKRLTAAQAL 407 (482)
Q Consensus 357 ~~-~~~~~~~i~~~~~~~~~--------------------------~~~~~~s--~~~~~li~~~L~~dP~~R~s~~e~L 407 (482)
.. ..+.+..+......... ..+..++ .++.++|.+||+.||++|||+.++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l 286 (291)
T cd07844 207 STDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAM 286 (291)
T ss_pred CccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHh
Confidence 65 23333322221100000 0112344 8899999999999999999999999
Q ss_pred cCccc
Q 011582 408 SHPWL 412 (482)
Q Consensus 408 ~hp~~ 412 (482)
.||||
T Consensus 287 ~~~~f 291 (291)
T cd07844 287 KHPYF 291 (291)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=336.21 Aligned_cols=254 Identities=31% Similarity=0.515 Sum_probs=215.0
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||.|+||.||+|.... +++.+|+|++... .....+.+.+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~------------------------------~~~~~~~~~~ 49 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIA---TGELVAIKVIKLE------------------------------PGDDFEIIQQ 49 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecC---CCCEEEEEEEEcC------------------------------chhhHHHHHH
Confidence 579999999999999999999876 6889999998642 1224578899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. ||||+++++++.+.+.+|++|||+++++|.+++......+++..+..++.|++.||.|||++||+|||||
T Consensus 50 e~~~l~~~~-h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~ 128 (262)
T cd06613 50 EISMLKECR-HPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIK 128 (262)
T ss_pred HHHHHHhCC-CCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCC
Confidence 999999996 9999999999999999999999999999999887655789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc----cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR----SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|+||++ +.++.+||+|||++....... ......++..|+|||.+.+ .++.++|+|||||++|+|++|..||.
T Consensus 129 p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~ 205 (262)
T cd06613 129 GANILL---TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMF 205 (262)
T ss_pred hhhEEE---CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCC
Confidence 999999 567789999999987654332 3345678999999998753 58889999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 356 ARTESGIFRAVLKADPSFDE-APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
..........+......... .....++.++.+||.+||..||.+|||+.+++.|+|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 206 DLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred CCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 87766555555444222111 112346789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=341.83 Aligned_cols=257 Identities=27% Similarity=0.435 Sum_probs=206.5
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|+++. +|+.||+|++++. ........+..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~-----------------------------~~~~~~~~~~~ 48 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVP---TGTIMAVKRIRAT-----------------------------VNSQEQKRLLM 48 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcC---CCcEEEEEEEecC-----------------------------CCcHHHHHHHH
Confidence 468999999999999999999886 7999999998653 11112334556
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcc
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVH 276 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivH 276 (482)
|+.++.+..+||||+++++++..++..|+||||++ |+|.+++.. ....+++..++.++.||+.||.|||++ +++|
T Consensus 49 e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h 127 (283)
T cd06617 49 DLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIH 127 (283)
T ss_pred HHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeec
Confidence 77765455469999999999999999999999996 577776643 235689999999999999999999998 9999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-----cCCCcchhhhhHHHHHHHhhCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-----SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlGvil~elltg~ 351 (482)
|||||+|||+ +.++.+||+|||++.............|+..|+|||.+.+ .++.++|+|||||++|+|++|+
T Consensus 128 ~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (283)
T cd06617 128 RDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGR 204 (283)
T ss_pred CCCCHHHEEE---CCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCC
Confidence 9999999999 6678899999999987654333344578999999998743 4788999999999999999999
Q ss_pred CCCCCCC-hHHHHHHHHhcC-CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 352 RPFWART-ESGIFRAVLKAD-PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 352 ~pf~~~~-~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.||.... ..+....+.... ..++ ...+|.++.++|.+||..+|.+||++.++++||||....
T Consensus 205 ~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 205 FPYDSWKTPFQQLKQVVEEPSPQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred CCCCccccCHHHHHHHHhcCCCCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 9996532 223333333321 2221 234789999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=358.74 Aligned_cols=255 Identities=24% Similarity=0.346 Sum_probs=206.2
Q ss_pred ccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++++.||+|+||.||+|++... ..++..||||+++.. ......+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~ 87 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS-----------------------------AHTDEREA 87 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCC-----------------------------CCHHHHHH
Confidence 35799999999999999999987541 124568999998643 12233567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC------------------------------
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG------------------------------ 247 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------ 247 (482)
+.+|+.+++.+.+|+||+++++++.+.+..|+|||||++|+|.+++....
T Consensus 88 ~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (374)
T cd05106 88 LMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYI 167 (374)
T ss_pred HHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccc
Confidence 88999999999559999999999999999999999999999999885421
Q ss_pred ---------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 011582 248 ---------------------------------------GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTS 288 (482)
Q Consensus 248 ---------------------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~ 288 (482)
..+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~-- 245 (374)
T cd05106 168 RSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL-- 245 (374)
T ss_pred cccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE--
Confidence 247888999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCCChHHHH
Q 011582 289 KEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWARTESGIF 363 (482)
Q Consensus 289 ~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~ 363 (482)
++++.+||+|||+++....... .....++..|||||++. +.++.++|||||||++|+|++ |+.||........+
T Consensus 246 -~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~ 324 (374)
T cd05106 246 -TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF 324 (374)
T ss_pred -eCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH
Confidence 5677899999999976543321 11233567899999875 569999999999999999997 99999877655554
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 364 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
..+.......... ..+++++.++|.+||+.||.+|||+.++++
T Consensus 325 ~~~~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 325 YKMVKRGYQMSRP--DFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHcccCccCC--CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 4544443322222 236899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=344.01 Aligned_cols=257 Identities=28% Similarity=0.493 Sum_probs=214.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
..+|++.+.||+|+||.||+|++.. +|+.||+|.+... .....+.+.
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~v~ik~~~~~------------------------------~~~~~~~~~ 65 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQ------------------------------QQPKKELII 65 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECC---CCcEEEEEEEecC------------------------------CcchHHHHH
Confidence 4689999999999999999999876 7899999998653 112246688
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. |+||+++++++......|+||||++|++|.+++.. ..+++.++..++.|++.||.|||+.||+||||
T Consensus 66 ~e~~~l~~~~-h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dL 142 (296)
T cd06654 66 NEILVMRENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142 (296)
T ss_pred HHHHHHHhCC-CCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 9999999996 99999999999999999999999999999998753 46899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||+ +.++.+||+|||++....... ......|++.|+|||.+.+ .++.++|||||||++|+|++|+.||...
T Consensus 143 kp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~ 219 (296)
T cd06654 143 KSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (296)
T ss_pred CHHHEEE---cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999 567789999999987654332 2234578999999998864 5889999999999999999999999877
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
........+.... .........++..+.++|.+||..||.+||++.++++||||....
T Consensus 220 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 220 NPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred CHHHhHHHHhcCC-CCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 6644443333222 111112245889999999999999999999999999999998653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=342.80 Aligned_cols=241 Identities=19% Similarity=0.243 Sum_probs=204.8
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
..||+|++|.||+|.. +|+.||||++++. ........+.+.+|+.+|+
T Consensus 26 ~~i~~g~~~~v~~~~~-----~~~~vavK~~~~~---------------------------~~~~~~~~~~~~~E~~~l~ 73 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-----NNKEVIIRTFKKF---------------------------HKGHKVLIDITENEIKNLR 73 (283)
T ss_pred eEEeeCCceEEEEEEE-----CCEEEEEEecccc---------------------------ccccHHHHHHHHHHHHHHH
Confidence 4699999999999986 5889999998653 1122233567889999999
Q ss_pred hhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCC
Q 011582 207 ALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHRDLKP 281 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDlkp 281 (482)
++. ||||+++++++.+ ...+++|||||+||+|.+++.+. ..+++.....++.|++.||.|||+ .+++||||||
T Consensus 74 ~l~-h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp 151 (283)
T PHA02988 74 RID-SNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTS 151 (283)
T ss_pred hcC-CCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCCh
Confidence 997 9999999999877 45789999999999999988654 679999999999999999999998 4999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc---ccCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH---RSYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
+|||+ +.++.+||+|||+++..... .....||..|+|||++. +.++.++|||||||++|||++|+.||.+.+
T Consensus 152 ~nill---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 152 VSFLV---TENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred hhEEE---CCCCcEEEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 99999 66788999999999865432 23457899999999986 368999999999999999999999999888
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
..++...+......+..+ ...++++++||.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~i~~~~~~~~~~--~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 227 TKEIYDLIINKNNSLKLP--LDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHHHhcCCCCCCC--CcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 888888876655443322 257899999999999999999999999975
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=339.60 Aligned_cols=252 Identities=33% Similarity=0.606 Sum_probs=214.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||.|+||.||+|.+.. +|+.||+|++.+. ........+.+.+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~---------------------------~~~~~~~~~~~~~e 50 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRD---TKKMFAMKYMNKQ---------------------------KCVEKGSVRNVLNE 50 (258)
T ss_pred CceEEEEeccCCCceEEEEEEcc---CCcEEEEEEEehh---------------------------hhcchhHHHHHHHH
Confidence 48999999999999999999876 7899999999753 11222346789999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++++. ||||+++++++.+.+..|+||||+.|++|.+++... ..+++..+..++.|+++||.|||++|++|+||+|
T Consensus 51 ~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~ 128 (258)
T cd05578 51 RRILQELN-HPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKP 128 (258)
T ss_pred HHHHHhCC-CCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 99999996 999999999999999999999999999999988655 6899999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh-
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE- 359 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~- 359 (482)
+||++ +.++.++|+|||++.............|+..|+|||++.+ .++.++|+||||+++|+|++|..||.....
T Consensus 129 ~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~ 205 (258)
T cd05578 129 DNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT 205 (258)
T ss_pred HHeEE---cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc
Confidence 99999 5677899999999987655444455678999999998864 579999999999999999999999987763
Q ss_pred --HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH--HHHhcCccc
Q 011582 360 --SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA--AQALSHPWL 412 (482)
Q Consensus 360 --~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~--~e~L~hp~~ 412 (482)
..+..........+ ...++.++.++|.+||..||.+|+++ .++++||||
T Consensus 206 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 206 IRDQIRAKQETADVLY----PATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHHhccccccC----cccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 33333322222222 23578999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=344.97 Aligned_cols=264 Identities=30% Similarity=0.462 Sum_probs=215.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|.+.. +|+.||||.+..... ..........+.+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~---~~~~v~iK~~~~~~~-------------------------~~~~~~~~~~~~~e 52 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKE---TGRIVAIKKIKLGER-------------------------KEAKDGINFTALRE 52 (298)
T ss_pred CceeeeeeeeccccEEEEEEECC---CCcEEEEEEEecccc-------------------------ccccchhhHHHHHH
Confidence 48899999999999999999876 689999999875310 00012234567789
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+. |+||+++++++.+.+..|+||||+ +++|.+++......+++..+..++.||++||.|||++||+||||||
T Consensus 53 ~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p 130 (298)
T cd07841 53 IKLLQELK-HPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKP 130 (298)
T ss_pred HHHHhhcC-CCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCh
Confidence 99999997 999999999999999999999999 8899998865444799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
+||++ +.++.++|+|||++...... .......+++.|+|||.+.+ .++.++|||||||++|+|++|.++|.+..
T Consensus 131 ~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~ 207 (298)
T cd07841 131 NNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS 207 (298)
T ss_pred hhEEE---cCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc
Confidence 99999 56778999999999876543 22334467889999998753 57899999999999999999988888877
Q ss_pred hHHHHHHHHhcCCCCCC------------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 359 ESGIFRAVLKADPSFDE------------------------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
..+.+..+......... ..+..++.++.+||.+||..||++|||+.++|.|+||.+
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~ 287 (298)
T cd07841 208 DIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN 287 (298)
T ss_pred cHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence 76666555443211111 112346789999999999999999999999999999998
Q ss_pred CCCC
Q 011582 415 SHDV 418 (482)
Q Consensus 415 ~~~~ 418 (482)
....
T Consensus 288 ~~~~ 291 (298)
T cd07841 288 DPAP 291 (298)
T ss_pred CCCC
Confidence 6543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=343.37 Aligned_cols=256 Identities=30% Similarity=0.524 Sum_probs=216.6
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|.+.+.||.|+||.||+|++.. +|+.||+|.+... .....+.+.+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~------------------------------~~~~~~~~~~ 65 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVA---TGQEVAIKQINLQ------------------------------KQPKKELIIN 65 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcC---CCcEEEEEEEecc------------------------------cCchHHHHHH
Confidence 579999999999999999999876 7999999988542 1122456789
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++...+.+|+||||+++++|.+++.. ..+++.++..++.|++.||.|||++|++|||||
T Consensus 66 e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~ 142 (296)
T cd06655 66 EILVMKELK-NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIK 142 (296)
T ss_pred HHHHHHhcC-CCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 999999996 99999999999999999999999999999987754 368999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc-ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER-LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+||++ +.++.+||+|||++........ .....|+..|+|||.+.+ .++.++|||||||++|+|++|..||....
T Consensus 143 p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 143 SDNVLL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred HHHEEE---CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999 5677899999999876544322 234578999999998864 58899999999999999999999998877
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.......+...... .......+++.+.+||.+||..||.+||++.+++.||||+...
T Consensus 220 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 220 PLRALYLIATNGTP-ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHHHHHHhcCCc-ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 66555555443221 1122345899999999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=339.12 Aligned_cols=252 Identities=18% Similarity=0.282 Sum_probs=210.5
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|++.+.||+|+||.||+|..+.....+..||+|.++.. ........+.+
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~-----------------------------~~~~~~~~~~~ 55 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG-----------------------------CSDKQRRGFLA 55 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCC-----------------------------CCHHHHHHHHH
Confidence 5799999999999999999987654346789999998642 12233467889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. ||||+++++++...+..++||||+++|+|.+++......+++..+..++.||+.||.|||++|++|||||
T Consensus 56 e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dik 134 (266)
T cd05064 56 EALTLGQFD-HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLA 134 (266)
T ss_pred HHHHHhcCC-CCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence 999999996 9999999999999999999999999999999887666689999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCccc--ccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLN--DIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
|+|||+ +.++.+|++|||.+.......... ...++..|+|||.+. +.++.++|||||||++|++++ |..||..
T Consensus 135 p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~ 211 (266)
T cd05064 135 AHKVLV---NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred HhhEEE---cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 999999 567789999999876543222111 234567899999875 568999999999999999775 9999998
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
....+....+..... . .....++..+.+++.+||..+|.+||+++++++
T Consensus 212 ~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 212 MSGQDVIKAVEDGFR-L--PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCHHHHHHHHHCCCC-C--CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 888877777654422 2 223468899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=364.73 Aligned_cols=250 Identities=28% Similarity=0.467 Sum_probs=213.3
Q ss_pred eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
+||+|.||+||.|+++. +...+|||.|... .....+.+..||.+.+.
T Consensus 582 VLGKGTYG~VYA~RD~~---tqvrIaIKEIpek------------------------------dsr~~QPLhEEIaLH~~ 628 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMD---TQVRIAIKEIPEK------------------------------DSREVQPLHEEIALHST 628 (1226)
T ss_pred EeecCceeEEEeecccc---ceeEEEeeecccc------------------------------cchhhccHHHHHHHHHH
Confidence 49999999999999987 7888999998642 33445788999999999
Q ss_pred hcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 011582 208 LTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKY--SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL 285 (482)
Q Consensus 208 l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIl 285 (482)
|+ |.|||+++|.+.+++.+-|.||-++||+|.+.+..+=+++ .|..+..+-+||++||.|||++.|||||||-+|||
T Consensus 629 Lr-HkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVL 707 (1226)
T KOG4279|consen 629 LR-HKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVL 707 (1226)
T ss_pred Hh-hHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEE
Confidence 98 9999999999999999999999999999999988776777 88999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEEecccccccCC-CCcccccccCccccCccccc---ccCCCcchhhhhHHHHHHHhhCCCCCCCCCh--
Q 011582 286 FTSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLH---RSYGTEADMWSIGVIAYILLCGSRPFWARTE-- 359 (482)
Q Consensus 286 l~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~elltg~~pf~~~~~-- 359 (482)
++ .-.|.+||+|||-++.+.. +.-..++.||..|||||++. +.|+.++|||||||++.||.||++||..-..
T Consensus 708 vN--TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq 785 (1226)
T KOG4279|consen 708 VN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ 785 (1226)
T ss_pred Ee--eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh
Confidence 97 5678899999999877643 34456789999999999996 3599999999999999999999999965432
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..+++ -+.+....+....+|.+++.||.+|+.+||.+||+|.++|.+||++..+
T Consensus 786 AAMFk---VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~ 839 (1226)
T KOG4279|consen 786 AAMFK---VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNN 839 (1226)
T ss_pred Hhhhh---hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCC
Confidence 22222 1222222222245899999999999999999999999999999998763
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-43 Score=341.07 Aligned_cols=254 Identities=30% Similarity=0.557 Sum_probs=209.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+.|++.+.||.|+||.||+|++.. +++.||+|++... ......+.
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~a~K~~~~~-------------------------------~~~~~~~~ 60 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVK---TGQLAAIKVMDVT-------------------------------EDEEEEIK 60 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcC---CCcEEEEEEEecC-------------------------------hHHHHHHH
Confidence 4679999999999999999999876 7899999997542 12335678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEe------CCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 200 REVKILRALTGHKNLVQFYDAYED------DDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
+|+.+++++.+|+||+++++++.. .+.+|+||||+++|+|.+++... ...+++..+..++.||+.||.|||+.
T Consensus 61 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~ 140 (282)
T cd06636 61 LEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140 (282)
T ss_pred HHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 899999999779999999999853 46789999999999999988653 35689999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCccccc------ccCCCcchhhhhHHHHH
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAY 345 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~ 345 (482)
||+||||||+||++ +.++.++|+|||++...... .......|++.|+|||.+. ..++.++|||||||++|
T Consensus 141 ~ivH~dl~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~ 217 (282)
T cd06636 141 KVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAI 217 (282)
T ss_pred CcccCCCCHHHEEE---CCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHH
Confidence 99999999999999 56778999999998765422 2234567899999999874 24788999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 346 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 346 elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
+|++|..||...........+..... .......++.++.+||.+||..||.+||++.++|+||||
T Consensus 218 el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 218 EMAEGAPPLCDMHPMRALFLIPRNPP--PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHhCCCCccccCHHhhhhhHhhCCC--CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 99999999977655444443333221 112223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=357.03 Aligned_cols=256 Identities=25% Similarity=0.346 Sum_probs=205.2
Q ss_pred ccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++++.||+|+||.||+|+.... ..++..||||+++.. ......+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~-----------------------------~~~~~~~~ 84 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPS-----------------------------AHLTEREA 84 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCC-----------------------------cCcHHHHH
Confidence 35799999999999999999986431 125678999998542 11223467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC------------------------------
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG------------------------------ 247 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------ 247 (482)
+.+|+.+|+.+.+||||+++++++.+.+..|+|||||+||+|.+++....
T Consensus 85 ~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (375)
T cd05104 85 LMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDS 164 (375)
T ss_pred HHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchh
Confidence 88999999999559999999999999999999999999999999886432
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 011582 248 --------------------------------------------GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPEN 283 (482)
Q Consensus 248 --------------------------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~N 283 (482)
..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 165 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 244 (375)
T cd05104 165 LNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARN 244 (375)
T ss_pred hhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhh
Confidence 247888999999999999999999999999999999
Q ss_pred eEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCCCCCC
Q 011582 284 FLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPFWART 358 (482)
Q Consensus 284 Ill~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf~~~~ 358 (482)
||+ +.+..+||+|||+++....... .....++..|+|||++.+ .++.++|||||||++|+|++ |..||....
T Consensus 245 ill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 245 ILL---THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred EEE---ECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999 4577899999999986643322 122345678999998864 68999999999999999998 899998765
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
....+..+......... ....+.++.+||.+||+.||++||++.++++.
T Consensus 322 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 322 VDSKFYKMIKEGYRMLS--PECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred chHHHHHHHHhCccCCC--CCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 54444444433322221 23468899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=335.08 Aligned_cols=252 Identities=30% Similarity=0.543 Sum_probs=213.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||.|+||.||+|+... +++.||+|.+... ...+.+.+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~~k~~~~~--------------------------------~~~~~~~~ 47 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKE---TGQVVAIKVVPVE--------------------------------EDLQEIIK 47 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcC---CCcEEEEEEeecH--------------------------------HHHHHHHH
Confidence 579999999999999999999876 6889999998542 11568899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. |+||+++++++.+...+|+++||+++++|.+++......+++..+..++.|++.||.|||+.||+||||+
T Consensus 48 e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~ 126 (256)
T cd06612 48 EISILKQCD-SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIK 126 (256)
T ss_pred HHHHHHhCC-CCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 999999995 9999999999999999999999999999999887666789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+||++ +.++.+||+|||++....... ......|+..|+|||++.+ .++.++|||||||++|+|++|+.||....
T Consensus 127 ~~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 127 AGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred cceEEE---CCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 999999 567789999999998765433 2334568899999998865 58899999999999999999999998766
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.......+....... ......++.++.++|.+||+.||.+|||+.++|.||||
T Consensus 204 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 204 PMRAIFMIPNKPPPT-LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hhhhhhhhccCCCCC-CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 554444333321111 11123478899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=340.84 Aligned_cols=254 Identities=30% Similarity=0.476 Sum_probs=208.8
Q ss_pred eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhh
Q 011582 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL 208 (482)
Q Consensus 129 LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l 208 (482)
||+|+||.||+|.+.. +|+.||+|++.+.. .........+.+|+.+++.+
T Consensus 1 lg~g~~g~vy~~~~~~---~~~~~~ik~~~~~~---------------------------~~~~~~~~~~~~e~~~l~~l 50 (277)
T cd05577 1 LGKGGFGEVCACQVKA---TGKMYACKKLDKKR---------------------------LKKRKGEQMALNEKKILEKV 50 (277)
T ss_pred CCCCCceeEEEEEEcC---CCcEEEEEEEehhh---------------------------hhhhhhhHHHHHHHHHHHhC
Confidence 6999999999998876 79999999986531 11122345667899999999
Q ss_pred cCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 011582 209 TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFT 287 (482)
Q Consensus 209 ~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~ 287 (482)
+ ||||+++++++...+.+|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||+|+||++
T Consensus 51 ~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~- 128 (277)
T cd05577 51 S-SRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL- 128 (277)
T ss_pred C-CCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE-
Confidence 7 9999999999999999999999999999999887653 369999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHH
Q 011582 288 SKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366 (482)
Q Consensus 288 ~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i 366 (482)
+.++.+||+|||++.............++..|+|||++.+ .++.++|||||||++|+|++|+.||...........+
T Consensus 129 --~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 206 (277)
T cd05577 129 --DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEEL 206 (277)
T ss_pred --CCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHH
Confidence 5677899999999987654444455678899999998764 5889999999999999999999999776542222222
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccCC
Q 011582 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANSH 416 (482)
Q Consensus 367 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~~ 416 (482)
..............+++++.++|.+||+.||.+|| ++.+++.||||....
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~ 261 (277)
T cd05577 207 KRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLN 261 (277)
T ss_pred HhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCC
Confidence 22222222233345799999999999999999999 999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=344.61 Aligned_cols=257 Identities=30% Similarity=0.475 Sum_probs=206.4
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|+... +|+.||||++.... ........+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~aik~~~~~~----------------------------~~~~~~~~~~ 59 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKK---TKQIVALKKVLMEN----------------------------EKEGFPITAL 59 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECC---CCcEEEEEEEeccC----------------------------CcCCchhHHH
Confidence 4679999999999999999999876 79999999985420 0111123456
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCC--------eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDD--------NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~--------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+|+.+++++. ||||+++++++...+ ..++||||+.+ +|.+.+......+++.+++.++.||+.||.|||+
T Consensus 60 ~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~ 137 (310)
T cd07865 60 REIKILQLLK-HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR 137 (310)
T ss_pred HHHHHHHhCC-CCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 8999999996 999999999987654 45999999964 8888877665679999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC-----cccccccCccccCcccccc--cCCCcchhhhhHHHH
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIA 344 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil 344 (482)
+|++||||||+||++ +.++.+||+|||++....... ......++..|+|||.+.+ .++.++||||||+++
T Consensus 138 ~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l 214 (310)
T cd07865 138 NKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIM 214 (310)
T ss_pred CCeeccCCCHHHEEE---CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHH
Confidence 999999999999999 667889999999997654322 1234567889999998754 378899999999999
Q ss_pred HHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCC----------------------------CCCHHHHHHHHHhchhc
Q 011582 345 YILLCGSRPFWARTESGIFRAVLKADPSFDEAPWP----------------------------SLSPEAIDFVKRLLNKD 396 (482)
Q Consensus 345 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----------------------------~~s~~~~~li~~~L~~d 396 (482)
|+|++|..||.+.+.......+......++...++ ..+..+.+||.+||..|
T Consensus 215 ~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~ 294 (310)
T cd07865 215 AEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLD 294 (310)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCC
Confidence 99999999998877655544444322221111111 13577889999999999
Q ss_pred cccCCCHHHHhcCccc
Q 011582 397 YRKRLTAAQALSHPWL 412 (482)
Q Consensus 397 P~~R~s~~e~L~hp~~ 412 (482)
|.+|||++++|+||||
T Consensus 295 P~~R~t~~e~l~h~~f 310 (310)
T cd07865 295 PAKRIDADTALNHDFF 310 (310)
T ss_pred hhhccCHHHHhcCCCC
Confidence 9999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=333.35 Aligned_cols=253 Identities=25% Similarity=0.510 Sum_probs=216.8
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||++.... +|+.||+|.+... .........+.+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~---~~~~~~ik~~~~~----------------------------~~~~~~~~~~~~e 49 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKE---DGKQYVIKEINIS----------------------------KMSPKEREESRKE 49 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcC---CCCEEEEEEEEhH----------------------------hCChHHHHHHHHH
Confidence 58999999999999999999876 7899999998642 0122344678999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
+.+++++. ||||+++++++.+.+..|+||||+.+++|.+++... ...+++..+..++.|++.||.|||++|++|+||+
T Consensus 50 ~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~ 128 (256)
T cd08218 50 VAVLSNMK-HPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIK 128 (256)
T ss_pred HHHHHhCC-CCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 99999997 999999999999999999999999999999988654 3468999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc-ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER-LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+|||+ +.++.++|+|||++........ .....|++.|+|||++.+ .++.++|+|||||++|+|++|..||....
T Consensus 129 ~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 129 SQNIFL---TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred HHHEEE---cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 999999 5677899999999976644322 234568899999998764 57889999999999999999999999888
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
..+....+..+..... ...++.++.++|.+||+.+|.+||++.++|.||||
T Consensus 206 ~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 206 MKNLVLKIIRGSYPPV---SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHHhcCCCCCC---cccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 8888777766543211 23578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=339.41 Aligned_cols=251 Identities=24% Similarity=0.404 Sum_probs=201.2
Q ss_pred cccceEeccee--ecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 119 FVAHYELGEEV--GRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 119 ~~~~y~~~~~L--G~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
+.+.|++.+.+ |.|+||.||+++.+. +|..+|+|++.+.. . .
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~k~~~~~~----------------------------~-----~ 55 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKP---TQKLFVQKIIKAKN----------------------------F-----N 55 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcC---CCcEEEEEEEehhh----------------------------c-----c
Confidence 34677777776 999999999999877 78999999986530 0 0
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
..|+.+...+.+||||+++++++...+.+|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|
T Consensus 56 --~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 132 (267)
T PHA03390 56 --AIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIH 132 (267)
T ss_pred --hhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 012333333346999999999999999999999999999999988654 48999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCC-cEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 277 RDLKPENFLFTSKEENS-SLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~-~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf 354 (482)
|||||+||++. .++ .++|+|||++...... ....|+..|+|||++.+ .++.++||||+||++|+|++|..||
T Consensus 133 ~dl~p~nil~~---~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~ 206 (267)
T PHA03390 133 NDIKLENVLYD---RAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206 (267)
T ss_pred CCCCHHHEEEe---CCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 99999999995 444 7999999998765432 23468999999998864 6899999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-HHHHhcCccccc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-AAQALSHPWLAN 414 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-~~e~L~hp~~~~ 414 (482)
.......+...............++.+++.+.+||.+||+.||.+|++ ++++|+||||.+
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 207 KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred CCCCcchhhHHHHHHhhcccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 865443321111111112222334568999999999999999999996 699999999964
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=340.72 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=204.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|.+.+.||+|+||.||+|.+.. +|..||+|++.... .......+.
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~~-----------------------------~~~~~~~~~ 51 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRI---NGQLVALKVISMKT-----------------------------EEGVPFTAI 51 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcC---CCcEEEEEEecccC-----------------------------cCCCcHHHH
Confidence 3689999999999999999999876 78999999986430 111123567
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. |+||+++++++.+++..|+||||+. ++|.+++......+++..+..++.|++.||.|||++||+||||
T Consensus 52 ~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl 129 (291)
T cd07870 52 REASLLKGLK-HANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDL 129 (291)
T ss_pred HHHHHHHhcC-CCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 8999999996 9999999999999999999999995 6788877665567899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||+|||+ +.++.+||+|||+++..... .......+++.|+|||.+.+ .++.++|||||||++|+|++|..||.+
T Consensus 130 kp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~ 206 (291)
T cd07870 130 KPQNLLI---SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206 (291)
T ss_pred ChHHEEE---cCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999 56778999999998764322 22344567899999998864 478899999999999999999999976
Q ss_pred CChH-HHHHHHHhcCC--------------CCCCC------------CCC--CCCHHHHHHHHHhchhccccCCCHHHHh
Q 011582 357 RTES-GIFRAVLKADP--------------SFDEA------------PWP--SLSPEAIDFVKRLLNKDYRKRLTAAQAL 407 (482)
Q Consensus 357 ~~~~-~~~~~i~~~~~--------------~~~~~------------~~~--~~s~~~~~li~~~L~~dP~~R~s~~e~L 407 (482)
.... +.+..+..... .+... .|. ..++++.++|.+||..||.+|||+.++|
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 207 VSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred chhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 5432 22222221100 00000 011 1357899999999999999999999999
Q ss_pred cCccc
Q 011582 408 SHPWL 412 (482)
Q Consensus 408 ~hp~~ 412 (482)
.||||
T Consensus 287 ~h~~~ 291 (291)
T cd07870 287 LHPYF 291 (291)
T ss_pred cCCCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=338.57 Aligned_cols=257 Identities=27% Similarity=0.499 Sum_probs=211.5
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|.+.+.||+|+||.||+|..+. +|+.+|+|++... ......+
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~---~~~~~aik~~~~~-------------------------------~~~~~~~ 65 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKK---DGSLAAVKILDPI-------------------------------SDVDEEI 65 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEeccc-------------------------------ccHHHHH
Confidence 46789999999999999999999876 7899999998542 1123467
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC-----CeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD-----DNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH 270 (482)
.+|+.+++++.+||||+++++++... +.+|+||||++|++|.+++.. .+..+++..++.++.|++.||.|||
T Consensus 66 ~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH 145 (291)
T cd06639 66 EAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLH 145 (291)
T ss_pred HHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 78999999996699999999998754 468999999999999987753 3467899999999999999999999
Q ss_pred HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc------cCCCcchhhhhHHH
Q 011582 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR------SYGTEADMWSIGVI 343 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlGvi 343 (482)
+.||+||||||+||++ +.++.+||+|||++....... ......|+..|+|||++.. .++.++|||||||+
T Consensus 146 ~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi 222 (291)
T cd06639 146 NNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGIT 222 (291)
T ss_pred hCCeeccCCCHHHEEE---cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHH
Confidence 9999999999999999 567789999999988654322 2234578999999998742 26889999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 344 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 344 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
+|+|++|+.||...........+........ .....++.++.+||.+||+.||.+||++.++|+||||+
T Consensus 223 ~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 223 AIELGDGDPPLFDMHPVKTLFKIPRNPPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 9999999999987766555555544322111 11134678899999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=343.05 Aligned_cols=255 Identities=23% Similarity=0.302 Sum_probs=204.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCC-------------CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhh
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGS-------------LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCC 186 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~-------------~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (482)
.++|++.++||+|+||.||+|.+.... .++..||||++...
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~-------------------------- 57 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPD-------------------------- 57 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCC--------------------------
Confidence 368999999999999999999864311 13457999998642
Q ss_pred hccccHHHHHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC------------------C
Q 011582 187 LFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG------------------G 248 (482)
Q Consensus 187 ~~~~~~~~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------~ 248 (482)
........+.+|+.++.++. ||||+++++++.+.+..++||||+++|+|.+++.... .
T Consensus 58 ---~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~ 133 (304)
T cd05096 58 ---ANKNARNDFLKEVKILSRLK-DPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLP 133 (304)
T ss_pred ---CCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccc
Confidence 22334567899999999996 9999999999999999999999999999999885431 2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcc
Q 011582 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPE 325 (482)
Q Consensus 249 ~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE 325 (482)
.+++..+..++.||+.||.|||+.||+||||||+|||+ +.++.+||+|||+++....... .....++..|||||
T Consensus 134 ~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE 210 (304)
T cd05096 134 AISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE 210 (304)
T ss_pred cccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHH
Confidence 46788899999999999999999999999999999999 5678899999999986543321 22345678999999
Q ss_pred ccc-ccCCCcchhhhhHHHHHHHhh--CCCCCCCCChHHHHHHHHhcC----CCCCCCCCCCCCHHHHHHHHHhchhccc
Q 011582 326 VLH-RSYGTEADMWSIGVIAYILLC--GSRPFWARTESGIFRAVLKAD----PSFDEAPWPSLSPEAIDFVKRLLNKDYR 398 (482)
Q Consensus 326 ~~~-~~~~~~~DiwSlGvil~ellt--g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~ 398 (482)
++. +.++.++|||||||++|+|++ +..||......+.+..+.... ........+.+++.+.+||.+||..||.
T Consensus 211 ~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~ 290 (304)
T cd05096 211 CILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCR 290 (304)
T ss_pred HHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCch
Confidence 875 569999999999999999986 677888777666655443211 1111111235789999999999999999
Q ss_pred cCCCHHHHh
Q 011582 399 KRLTAAQAL 407 (482)
Q Consensus 399 ~R~s~~e~L 407 (482)
+|||+.++.
T Consensus 291 ~RPs~~~i~ 299 (304)
T cd05096 291 ERPSFSDIH 299 (304)
T ss_pred hCcCHHHHH
Confidence 999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=341.67 Aligned_cols=255 Identities=29% Similarity=0.469 Sum_probs=209.0
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||.|+||.||+|++.. +|+.||||.+.... ........+.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~----------------------------~~~~~~~~~~~E 49 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDT----------------------------ETEGVPSTAIRE 49 (284)
T ss_pred CceeeeeecCCCceEEEEEEECC---CCCEEEEEEccccc----------------------------cccccchHHHHH
Confidence 48899999999999999999876 78999999886421 111223568899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
+.+++++. ||||+++++++.+.+..++||||+. ++|..++... ...+++..+..++.|++.||.|||+.|++||||+
T Consensus 50 ~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~ 127 (284)
T cd07860 50 ISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLK 127 (284)
T ss_pred HHHHHhcC-CCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 99999996 9999999999999999999999996 5788877643 3578999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|+||++ +.++.+||+|||++....... ......+++.|+|||++.+ .++.++|||||||++|+|+||+.||...
T Consensus 128 p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 128 PQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred HHHEEE---CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999999 567789999999987654322 2233467889999998764 3688999999999999999999999887
Q ss_pred ChHHHHHHHHhcCCCCCC-------------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 358 TESGIFRAVLKADPSFDE-------------------------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
+.......+......... ...+.++++++++|.+||+.||.+|||++++|+||||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 205 SEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 765554444332111110 0123478999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=335.17 Aligned_cols=259 Identities=29% Similarity=0.492 Sum_probs=212.0
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.+++.||.|+||.||+|.+.. +++.||+|.+..... .... ........+.+.+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~---~~~~~~~k~~~~~~~--------~~~~-------------~~~~~~~~~~~~~e 56 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNAS---SGELMAVKQVELPSV--------SASS-------------KDRKRSMLDALARE 56 (267)
T ss_pred CccccceeecCCCeEEEEEEecC---CCcEEEEEEecCCCc--------ccch-------------hHHHHHHHHHHHHH
Confidence 47888999999999999999876 688999998865310 0000 00122344678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++++. ||||+++++++.+.+..++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||+|
T Consensus 57 ~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p 134 (267)
T cd06628 57 IALLKELQ-HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKG 134 (267)
T ss_pred HHHHHhcC-CCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCH
Confidence 99999996 999999999999999999999999999999988554 6789999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCC-------cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDE-------RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~p 353 (482)
+||++ +.++.+||+|||+++...... ......|+..|+|||.+.+ .++.++|+|||||++|+|++|..|
T Consensus 135 ~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p 211 (267)
T cd06628 135 ANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211 (267)
T ss_pred HHEEE---cCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCC
Confidence 99999 567889999999988764221 1123468899999998864 588899999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
|...+....+..+..... ......++.++.++|++||+.||.+||++.++++||||
T Consensus 212 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 212 FPDCTQLQAIFKIGENAS---PEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CCCccHHHHHHHHhccCC---CcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 987766555444443211 11223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=337.07 Aligned_cols=255 Identities=31% Similarity=0.561 Sum_probs=211.2
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|.++. +++.||+|++... ....+.+.
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~-------------------------------~~~~~~~~ 50 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKK---TGQLVAIKIMDII-------------------------------EDEEEEIK 50 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECC---CCcEEEEEEEecC-------------------------------chhHHHHH
Confidence 4789999999999999999999876 6889999998643 11245788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCC------eEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDD------NIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH 270 (482)
+|+.+++++.+|+||+++++++.+.. .+|+||||+++++|.+++... +..+++..++.++.|++.||.|||
T Consensus 51 ~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH 130 (275)
T cd06608 51 EEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLH 130 (275)
T ss_pred HHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 99999999966999999999997654 489999999999998887542 467999999999999999999999
Q ss_pred HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc------cCCCcchhhhhHHH
Q 011582 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR------SYGTEADMWSIGVI 343 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~------~~~~~~DiwSlGvi 343 (482)
+.|++||||+|+||++ +.++.+||+|||++...... .......|+..|+|||++.. .++.++|||||||+
T Consensus 131 ~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~i 207 (275)
T cd06608 131 ENKVIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGIT 207 (275)
T ss_pred cCCcccCCCCHHHEEE---ccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHH
Confidence 9999999999999999 56778999999998765432 22344678999999998742 37789999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 344 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 344 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
+|+|++|..||...........+........ .....++.++++||.+||..||.+|||+.+++.|||+
T Consensus 208 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 208 AIELADGKPPLCDMHPMRALFKIPRNPPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHHHHhCCCCccccchHHHHHHhhccCCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 9999999999987665555555544322111 1112367899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=339.62 Aligned_cols=257 Identities=30% Similarity=0.542 Sum_probs=208.2
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++.+.||+|+||.||+|++.. +|+.+|+|++... ......
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~-------------------------------~~~~~~ 60 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKK---NGSKAAVKILDPI-------------------------------HDIDEE 60 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECC---CCceeEEEeeccc-------------------------------cchHHH
Confidence 356789999999999999999999876 7899999987532 111246
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEE-----eCCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYE-----DDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yL 269 (482)
+.+|+.+++.+.+||||+++++++. .++.+|+||||++|++|.+.+.. ....+++..+..++.|++.||.||
T Consensus 61 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 140 (286)
T cd06638 61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHL 140 (286)
T ss_pred HHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHH
Confidence 7789999999966999999999874 44679999999999999887653 345789999999999999999999
Q ss_pred HHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCccccc------ccCCCcchhhhhHH
Q 011582 270 HFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGV 342 (482)
Q Consensus 270 H~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGv 342 (482)
|+++|+||||||+||++ +.++.+||+|||++....... ......|++.|+|||++. ..++.++||||+||
T Consensus 141 H~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv 217 (286)
T cd06638 141 HVNKTIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGI 217 (286)
T ss_pred HhCCccccCCCHHhEEE---CCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHH
Confidence 99999999999999999 566779999999988654322 233457999999999874 34788999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 343 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 343 il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
++|+|++|+.||........+..+...... .......++.++.+||.+||+.||.+|||+.++|+|+||
T Consensus 218 i~~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 218 TAIELGDGDPPLADLHPMRALFKIPRNPPP-TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHHhcCCCCCCCCchhHHHhhccccCCC-cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 999999999999876654443333222111 111112357899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=334.91 Aligned_cols=257 Identities=31% Similarity=0.473 Sum_probs=211.2
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++++.||.|+||.||+|... +|+.+|||.+...... ..........+.+|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~----~~~~~avk~~~~~~~~------------------------~~~~~~~~~~~~~e 52 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN----QGQLIAVKQVELDTSN------------------------VLAAEKEYEKLQEE 52 (265)
T ss_pred CccccceEeccCCeEEEEEEEc----CCCeEEEEEeecCccc------------------------hhhHHHHHHHHHHH
Confidence 4788999999999999999763 6889999988642100 00122334678999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+. |+||+++++++.+.+..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.||+|+||+|
T Consensus 53 ~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p 130 (265)
T cd06631 53 VDLLKSLK-HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKG 130 (265)
T ss_pred HHHHHhcC-CCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCH
Confidence 99999996 999999999999999999999999999999988654 5789999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCC-------CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKP-------DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~-------~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~p 353 (482)
+||++ +.++.++|+|||++..... ........|+..|+|||++.+ .++.++|||||||++|+|++|..|
T Consensus 131 ~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p 207 (265)
T cd06631 131 NNVML---MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207 (265)
T ss_pred HhEEE---CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCc
Confidence 99999 5678899999999876421 112234578999999999875 588999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
|...........+.......+ .....++.++.++|.+||..+|.+||++.++|.||||
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 208 LASMDRLAAMFYIGAHRGLMP-RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred cccCChHHHHHHhhhccCCCC-CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 987665554444443322222 1224589999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=338.22 Aligned_cols=256 Identities=28% Similarity=0.460 Sum_probs=213.6
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.++. +++.||+|++.+. ........+.+
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~ik~~~~~-----------------------------~~~~~~~~~~~ 48 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRP---TGKIMAVKTIRLE-----------------------------INEAIQKQILR 48 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcC---CCcEEEEEEEecc-----------------------------cChHHHHHHHH
Confidence 368889999999999999999976 7899999998653 12244567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDl 279 (482)
|+.+++.+. ||||+++++++...+.+++||||+++++|.+++......+++..+..++.|++.||.|||+ .|++||||
T Consensus 49 e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl 127 (265)
T cd06605 49 ELDILHKCN-SPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDV 127 (265)
T ss_pred HHHHHHHCC-CCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCC
Confidence 999999997 9999999999999999999999999999999886655789999999999999999999999 99999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
||+||++ +.++.++|+|||++........ ....|+..|+|||.+.+ .++.++||||||+++|+|++|..||....
T Consensus 128 ~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 203 (265)
T cd06605 128 KPSNILV---NSRGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPEN 203 (265)
T ss_pred CHHHEEE---CCCCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccc
Confidence 9999999 5677899999999876543222 22678999999998864 58899999999999999999999996542
Q ss_pred -----hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 359 -----ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 359 -----~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
..+..+.+..... +......+++++.++|.+||..||.+|||+.+++.||||+..
T Consensus 204 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 204 DPPDGIFELLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred cccccHHHHHHHHhcCCC--CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 2233333333221 111111278999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=339.89 Aligned_cols=254 Identities=28% Similarity=0.510 Sum_probs=210.1
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||.|++|.||+|++.. +|..||||++.... .......+.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~-----------------------------~~~~~~~~~~E 48 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRT---TGEIVALKEIHLDA-----------------------------EEGTPSTAIRE 48 (284)
T ss_pred CceEeeeeccCCceEEEEEEECC---CCeEEEEEEecccc-----------------------------cccchHHHHHH
Confidence 58999999999999999999876 79999999986531 11123456789
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG--GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+.+++.+. |+||+++++++.+.+..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.|++||||
T Consensus 49 ~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl 126 (284)
T cd07836 49 ISLMKELK-HENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDL 126 (284)
T ss_pred HHHHHhhc-CCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence 99999996 99999999999999999999999985 8888876543 46899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||+||++ +.++.++|+|||++....... ......+|..|++||++.+ .++.++|||||||++|+|++|..||.+
T Consensus 127 ~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 203 (284)
T cd07836 127 KPQNLLI---NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPG 203 (284)
T ss_pred CHHHEEE---CCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999 567789999999997654322 2234567899999998754 478899999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCC-------------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 357 RTESGIFRAVLKADPSFDEA-------------------------PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
.+..+....+.......... ..+.++.++.++|.+||+.||.+||++.++++|||
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~ 283 (284)
T cd07836 204 TNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283 (284)
T ss_pred CCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence 87776666554432111100 01246788999999999999999999999999999
Q ss_pred c
Q 011582 412 L 412 (482)
Q Consensus 412 ~ 412 (482)
|
T Consensus 284 f 284 (284)
T cd07836 284 F 284 (284)
T ss_pred C
Confidence 8
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=343.72 Aligned_cols=256 Identities=32% Similarity=0.465 Sum_probs=211.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||.|+||.||+|.+.. +|+.||+|.++... ........+.+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~----------------------------~~~~~~~~~~~ 53 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKK---TGEIVALKKLKMEK----------------------------EKEGFPITSLR 53 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECC---CCcEEEEEEEeecc----------------------------ccccchhhHHH
Confidence 579999999999999999999876 78999999986431 11112235678
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
|+.+++++. ||||+++++++... +..|+||||+.+ +|.+.+......+++..++.++.||+.||.|||++||+|||
T Consensus 54 e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~d 131 (293)
T cd07843 54 EINILLKLQ-HPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRD 131 (293)
T ss_pred HHHHHHhcC-CCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 999999997 99999999999887 899999999975 88888766556799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||+|||+ +.++.+||+|||++...... .......+++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.
T Consensus 132 l~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~ 208 (293)
T cd07843 132 LKTSNLLL---NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP 208 (293)
T ss_pred CCHHHEEE---CCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999 56788999999999876543 23344567899999998864 36889999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCC--------------------------CCCCCC--CCHHHHHHHHHhchhccccCCCHHHHh
Q 011582 356 ARTESGIFRAVLKADPSFD--------------------------EAPWPS--LSPEAIDFVKRLLNKDYRKRLTAAQAL 407 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~--~s~~~~~li~~~L~~dP~~R~s~~e~L 407 (482)
.....+....+........ ...++. +++.+.++|++||+.||++|||+.|+|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 209 GKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred CCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 8877666655543211000 011222 488999999999999999999999999
Q ss_pred cCccc
Q 011582 408 SHPWL 412 (482)
Q Consensus 408 ~hp~~ 412 (482)
.||||
T Consensus 289 ~~~~f 293 (293)
T cd07843 289 KHPYF 293 (293)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=351.96 Aligned_cols=258 Identities=26% Similarity=0.467 Sum_probs=210.1
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++.+.||+|+||.||+|.+.. +|+.||||++.+. .........+
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~~ 62 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTV---TGQNVAIKKLSRP----------------------------FQNVTHAKRA 62 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECC---CCCEEEEEecCcc----------------------------ccChhHHHHH
Confidence 46789999999999999999999876 7999999998642 1122334567
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
.+|+.+++++. |+||++++++|... ...|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++
T Consensus 63 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~~ 137 (353)
T cd07850 63 YRELVLMKLVN-HKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM---DLDHERMSYLLYQMLCGIKHLHSA 137 (353)
T ss_pred HHHHHHHHhcC-CCCCcceeeeeccCCCccccCcEEEEEeccCC-CHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC
Confidence 78999999996 99999999998644 357999999965 78887643 389999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~ 351 (482)
||+||||||+||++ +.++.+||+|||++.............||..|+|||.+.+ .++.++|||||||++|+|++|+
T Consensus 138 gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~ 214 (353)
T cd07850 138 GIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214 (353)
T ss_pred CeeeCCCCHHHEEE---CCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCC
Confidence 99999999999999 5678899999999987655444455678999999998764 6899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCC-------------------------------CCCC--------CCCCCHHHHHHHHHh
Q 011582 352 RPFWARTESGIFRAVLKADPSF-------------------------------DEAP--------WPSLSPEAIDFVKRL 392 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~-------------------------------~~~~--------~~~~s~~~~~li~~~ 392 (482)
.||...+....+..+....... +... ....++++.+||.+|
T Consensus 215 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 294 (353)
T cd07850 215 VLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKM 294 (353)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHH
Confidence 9998777655555443311110 0000 113466789999999
Q ss_pred chhccccCCCHHHHhcCcccccC
Q 011582 393 LNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 393 L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
|+.||++|||+.++|.||||...
T Consensus 295 L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 295 LVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred cCCChhhCcCHHHHhcChhHhhc
Confidence 99999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-44 Score=360.84 Aligned_cols=255 Identities=24% Similarity=0.445 Sum_probs=219.3
Q ss_pred EecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHH
Q 011582 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVK 203 (482)
Q Consensus 124 ~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~ 203 (482)
++..+||+|+|-+||+|.+.. +|..||---++.. + ........++|..|+.
T Consensus 43 k~~evLGrGafKtVYka~De~---~giEVAWnqvk~~----------------------d----~~q~~~~leR~~~Ev~ 93 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEE---EGIEVAWNQVKIR----------------------D----VTQSPEELERLYSEVH 93 (632)
T ss_pred ehhhhcccccceeeeeccccc---cchhhHHHHHhHH----------------------H----hhcChHHHHHHHHHHH
Confidence 345579999999999999966 7888885544321 0 2355677899999999
Q ss_pred HHHhhcCCCCcceeeEEEEeCCe--EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--CcccCC
Q 011582 204 ILRALTGHKNLVQFYDAYEDDDN--IYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG--VVHRDL 279 (482)
Q Consensus 204 ~l~~l~~hpniv~l~~~~~~~~~--~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivHrDl 279 (482)
+|+.|+ ||||+++|++|.+... +.+|+|++..|+|..|+.+. ++.+...++.|++||++||.|||++. ||||||
T Consensus 94 lLKsL~-H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDL 171 (632)
T KOG0584|consen 94 LLKSLK-HPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDL 171 (632)
T ss_pred HHccCC-CCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhhhhcCCCCcccccc
Confidence 999997 9999999999998765 88999999999999988654 78999999999999999999999986 999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCC-CC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWA-RT 358 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~-~~ 358 (482)
|.+||+|+ +..|.|||+|+|||+...... ...++|||.|||||++...|+..+||||||++++||+|+..||.. .+
T Consensus 172 KCDNIFin--G~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n 248 (632)
T KOG0584|consen 172 KCDNIFVN--GNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTN 248 (632)
T ss_pred ccceEEEc--CCcCceeecchhHHHHhhccc-cceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCC
Confidence 99999997 677899999999999876544 344899999999999999999999999999999999999999965 56
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
..++++++..+...-.... -=.+++++||.+||.. ...|+|+.|+|+||||...
T Consensus 249 ~AQIYKKV~SGiKP~sl~k--V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 249 PAQIYKKVTSGIKPAALSK--VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHHHHHHHcCCCHHHhhc--cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 7788999988764322221 1368999999999999 9999999999999999976
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=333.78 Aligned_cols=250 Identities=30% Similarity=0.572 Sum_probs=211.9
Q ss_pred eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhh
Q 011582 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL 208 (482)
Q Consensus 129 LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l 208 (482)
||.|+||.||+|++.. +++.||+|++.+. ........+.+.+|+.+++.+
T Consensus 1 lg~g~~~~v~~~~~~~---~~~~~~iK~~~~~---------------------------~~~~~~~~~~~~~e~~~l~~l 50 (262)
T cd05572 1 LGVGGFGRVELVKVKS---KNRTFALKCVKKR---------------------------HIVETGQQEHIFSEKEILEEC 50 (262)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEEehh---------------------------cchhhhHHHHHHHHHHHHHhC
Confidence 6999999999999876 7899999998753 112223456789999999999
Q ss_pred cCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 011582 209 TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTS 288 (482)
Q Consensus 209 ~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~ 288 (482)
. ||||+++++++.+++.+|+||||+++++|.+++.+. ..+++..+..++.||+.||.|||++|++|+||+|+||++
T Consensus 51 ~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv-- 126 (262)
T cd05572 51 N-HPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL-- 126 (262)
T ss_pred C-CCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE--
Confidence 6 999999999999999999999999999999988654 568999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC--hHHHHHH
Q 011582 289 KEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART--ESGIFRA 365 (482)
Q Consensus 289 ~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~--~~~~~~~ 365 (482)
+.++.++|+|||++.............|+..|++||.+.+ .++.++|+||+|+++|+|++|..||.... ..+....
T Consensus 127 -~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 205 (262)
T cd05572 127 -DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND 205 (262)
T ss_pred -cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH
Confidence 5677899999999987755433445678999999998764 58999999999999999999999998776 5566666
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 366 VLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 366 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
+.........+ ...++++.++|.+||..||.+|++ ++|+++||||+..
T Consensus 206 ~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 206 ILKGNGKLEFP--NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred HhccCCCCCCC--cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 66322222211 235899999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=341.20 Aligned_cols=256 Identities=29% Similarity=0.497 Sum_probs=210.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.+.. +|+.||+|++.+.. ......+.+.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~iK~~~~~~----------------------------~~~~~~~~~~~ 49 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKE---TGQIVAIKKFLESE----------------------------DDKMVKKIAMR 49 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECC---CCCEEEEEeHhhcc----------------------------CcchhhHHHHH
Confidence 469999999999999999999876 68999999976531 11123456789
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++.+++..|+||||+++++|.++. .....+++..+..++.||+.||.|||+.||+||||+
T Consensus 50 e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~ 127 (286)
T cd07846 50 EIRMLKQLR-HENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLE-KYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIK 127 (286)
T ss_pred HHHHHHhcC-CcchhhHHHhcccCCeEEEEEecCCccHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence 999999996 999999999999999999999999988777654 344569999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|+||++ +.++.++|+|||++...... .......++..|+|||++.+ .++.++|||||||++|+|++|.+||...
T Consensus 128 p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 128 PENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred HHHEEE---CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 999999 56788999999998875433 22344568999999998764 4788999999999999999999999877
Q ss_pred ChHHHHHHHHhcCCCCC-------------------C--------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCc
Q 011582 358 TESGIFRAVLKADPSFD-------------------E--------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~-------------------~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 410 (482)
...+....+......+. . ..++.++..+.+|+.+||..+|.+||++.++|.||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~ 284 (286)
T cd07846 205 SDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHE 284 (286)
T ss_pred chHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCC
Confidence 66555444443211110 0 11346789999999999999999999999999999
Q ss_pred cc
Q 011582 411 WL 412 (482)
Q Consensus 411 ~~ 412 (482)
||
T Consensus 285 ~~ 286 (286)
T cd07846 285 FF 286 (286)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=340.21 Aligned_cols=260 Identities=28% Similarity=0.454 Sum_probs=211.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.++. +|+.||+|.+.... ........+.+
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~----------------------------~~~~~~~~~~~ 50 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRV---TNETIALKKIRLEQ----------------------------EDEGVPSTAIR 50 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecC---CCcEEEEEehhhcc----------------------------ccccchHHHHH
Confidence 579999999999999999999876 78999999885420 11122356788
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
|+.+++.+. ||||+++++++.+.+..|+||||++ ++|.+++.... ..+++..+..++.||+.||.|||++||+||||
T Consensus 51 e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl 128 (294)
T PLN00009 51 EISLLKEMQ-HGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDL 128 (294)
T ss_pred HHHHHHhcc-CCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCC
Confidence 999999996 9999999999999999999999996 47888775543 33688999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
+|+||+++. .+..+||+|||++...... .......+++.|+|||++.+ .++.++||||+||++|+|++|..||..
T Consensus 129 ~p~nill~~--~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~ 206 (294)
T PLN00009 129 KPQNLLIDR--RTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPG 206 (294)
T ss_pred CcceEEEEC--CCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999952 3457999999999765432 22234567899999998754 478899999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCC-------------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 357 RTESGIFRAVLKADPSFDEA-------------------------PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
....+.+.++.......... ..+.+++++.++|.+||+.||.+||++.++|.|||
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~ 286 (294)
T PLN00009 207 DSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286 (294)
T ss_pred CCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 77666655554321111111 12457899999999999999999999999999999
Q ss_pred cccC
Q 011582 412 LANS 415 (482)
Q Consensus 412 ~~~~ 415 (482)
|.+.
T Consensus 287 ~~~~ 290 (294)
T PLN00009 287 FKDL 290 (294)
T ss_pred HhHH
Confidence 9864
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-43 Score=343.15 Aligned_cols=260 Identities=25% Similarity=0.392 Sum_probs=208.8
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|...+.||+|+||.||++.+.. +|+.||||.+.+. ........+.+
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~aiK~~~~~-----------------------------~~~~~~~~~~~ 51 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKP---SGTIMAVKRIRST-----------------------------VDEKEQKRLLM 51 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECC---CCCEEEEEEehhc-----------------------------cChHHHHHHHH
Confidence 467778899999999999999876 7899999998653 11234567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHH---Hh-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCc
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI---LS-RGGKYSEEDAKIVMVQILSVVAFCHFQ-GVV 275 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l---~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iv 275 (482)
|+.++.++.+|+||+++++++..++..+++|||+.+ +|.+.. .. ....+++..+..++.|++.||.|||+. ||+
T Consensus 52 e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~ 130 (288)
T cd06616 52 DLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKII 130 (288)
T ss_pred HHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCee
Confidence 999999997799999999999999999999999864 544432 22 236799999999999999999999985 999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc----cCCCcchhhhhHHHHHHHhhCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR----SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~elltg~ 351 (482)
||||||+||++ +.++.+||+|||++.............|+..|+|||++.+ .++.++||||+||++|+|++|+
T Consensus 131 H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~ 207 (288)
T cd06616 131 HRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207 (288)
T ss_pred ccCCCHHHEEE---ccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCC
Confidence 99999999999 5677899999999987654443445578999999998864 4889999999999999999999
Q ss_pred CCCCCCCh-HHHHHHHHhcC-CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 352 RPFWARTE-SGIFRAVLKAD-PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 352 ~pf~~~~~-~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.||..... .+....+.... .......+..++.++.+||.+||+.||.+|||+++++.||||+...
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 208 FPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred CCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 99976542 12222222221 1222222345899999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=341.21 Aligned_cols=259 Identities=29% Similarity=0.484 Sum_probs=214.8
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
...+|.+.+.||+|+||.||+|++.. +|+.||+|.+... .....+.+
T Consensus 17 ~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~------------------------------~~~~~~~~ 63 (297)
T cd06656 17 PKKKYTRFEKIGQGASGTVYTAIDIA---TGQEVAIKQMNLQ------------------------------QQPKKELI 63 (297)
T ss_pred hhhhceeeeeeccCCCeEEEEEEECC---CCCEEEEEEEecC------------------------------ccchHHHH
Confidence 34789999999999999999999876 7999999998542 11223567
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. |+||+++++++...+..|+||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.||+|||
T Consensus 64 ~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~d 140 (297)
T cd06656 64 INEILVMRENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRD 140 (297)
T ss_pred HHHHHHHHhCC-CCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 89999999996 99999999999999999999999999999998754 4689999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc-ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER-LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||+|||+ +.++.++|+|||++........ .....|++.|+|||.+.+ .++.++|+|||||++|+|++|..||..
T Consensus 141 L~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~ 217 (297)
T cd06656 141 IKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN 217 (297)
T ss_pred CCHHHEEE---CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999 5678899999999876543322 234578999999998864 588999999999999999999999977
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.+.......+.... .........++..+.+||.+||..||.+||+++++|+||||.....
T Consensus 218 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 218 ENPLRALYLIATNG-TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred CCcchheeeeccCC-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 65543332222221 1111122357899999999999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=337.37 Aligned_cols=256 Identities=27% Similarity=0.517 Sum_probs=213.3
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.|++.+.||+|+||.||+|.+.. +|+.||+|++... ........+.+|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~---~~~~~~iK~~~~~-----------------------------~~~~~~~~~~~e 49 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVP---TGRVVALKIINLD-----------------------------TPDDDVSDIQRE 49 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcC---CCcEEEEEEecCC-----------------------------CCchhHHHHHHH
Confidence 47888999999999999999876 7899999998643 122334678899
Q ss_pred HHHHHhhc--CCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 202 VKILRALT--GHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 202 i~~l~~l~--~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+.+++.+. +|||++++++++.++...|+||||++|++|.+++.. ..+++..+..++.|++.||.|||+.||+||||
T Consensus 50 ~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl 127 (277)
T cd06917 50 VALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDI 127 (277)
T ss_pred HHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 99999985 599999999999999999999999999999987743 47999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
+|+||++ +.++.++|+|||++....... ......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||..
T Consensus 128 ~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 204 (277)
T cd06917 128 KAANILV---TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSD 204 (277)
T ss_pred CHHHEEE---cCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999 557789999999998765432 2334578999999998764 478899999999999999999999987
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.........+... ..+......++.++.+++.+||+.||.+||++.+++.|+||++..
T Consensus 205 ~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 205 VDAFRAMMLIPKS--KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CChhhhhhccccC--CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 6655444333222 111222223789999999999999999999999999999998754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=337.60 Aligned_cols=255 Identities=27% Similarity=0.482 Sum_probs=215.3
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
..|+..+.||.|+||.||+|.+.. ++..||+|++... ........+.+
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~vaiK~~~~~-----------------------------~~~~~~~~~~~ 51 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNR---TQQVVAIKIIDLE-----------------------------EAEDEIEDIQQ 51 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEcc---CCEEEEEEEEecc-----------------------------ccHHHHHHHHH
Confidence 458888999999999999999876 7889999998643 12334578899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. |+||+++++++.+++..|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+
T Consensus 52 e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~ 128 (277)
T cd06640 52 EITVLSQCD-SPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128 (277)
T ss_pred HHHHHHhCC-CCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCC
Confidence 999999996 99999999999999999999999999999998753 478999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+||++ +.++.++|+|||++....... ......++..|+|||++.+ .++.++|+|||||++|+|++|..||....
T Consensus 129 p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 129 AANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred hhhEEE---cCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999999 567789999999997654332 2233568889999998864 58899999999999999999999998776
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.......+.... .......++.++.++|.+||..+|.+||++++++.|+||.+..
T Consensus 206 ~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06640 206 PMRVLFLIPKNN---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA 260 (277)
T ss_pred hHhHhhhhhcCC---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence 655554443322 1222335788999999999999999999999999999998754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=331.87 Aligned_cols=253 Identities=34% Similarity=0.527 Sum_probs=215.6
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||.|+||.||+|.+.. +|..||+|++... .......+.+.+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~----------------------------~~~~~~~~~~~~e 49 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKS---DGKILVWKEIDYG----------------------------NMTEKEKQQLVSE 49 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecC---CCCEEEEEEEecc----------------------------cCCHHHHHHHHHH
Confidence 58899999999999999999876 7899999998653 1233445678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----H
Q 011582 202 VKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCH-----F 271 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH-----~ 271 (482)
+.+++.+. |+||+++++++.. ....|++|||+++++|.+++... ...+++..++.++.||+.||.||| +
T Consensus 50 ~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~ 128 (265)
T cd08217 50 VNILRELK-HPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPG 128 (265)
T ss_pred HHHHHhcC-CCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc
Confidence 99999997 9999999998764 45689999999999999988653 467999999999999999999999 8
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc-ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER-LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt 349 (482)
.+|+||||||+||++ +.++.+||+|||++........ .....|++.|+|||++.+ .++.++|+||||+++|+|++
T Consensus 129 ~~i~h~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~ 205 (265)
T cd08217 129 NTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA 205 (265)
T ss_pred CcceecCCCHHHEEE---ecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHH
Confidence 999999999999999 5678899999999987654433 345678999999998864 58889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
|..||...+...+...+....... .-..++.++.+++.+||..+|.+||++.++|+|||+
T Consensus 206 g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 206 LSPPFTARNQLQLASKIKEGKFRR---IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CCCcccCcCHHHHHHHHhcCCCCC---CccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999888777776666554321 123578999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=365.68 Aligned_cols=280 Identities=19% Similarity=0.273 Sum_probs=202.7
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
...+.++|++++.||+|+||.||+|..+.. .+..+++|.+...... .......+.. .........
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~--~~~~~~~~~~~~~~~~---------~~~~~~~~~k----~~~~~~~~~ 207 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRAS--TEEAEARRGVNSTNQG---------KPKCERLIAK----RVKAGSRAA 207 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEecc--chhhhhhhcccccccc---------chhhhhhHhH----HhhcchHHH
Confidence 345678999999999999999999987642 3344444432211000 0000000000 011223345
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG----GKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
..+.+|+.+|+++. ||||+++++++.+.+..|+|+|++. ++|++++.... .......+..++.||+.||.|||+
T Consensus 208 ~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~ 285 (501)
T PHA03210 208 IQLENEILALGRLN-HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD 285 (501)
T ss_pred HHHHHHHHHHHhCC-CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence 67899999999996 9999999999999999999999995 57888775431 234567788999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHh
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ell 348 (482)
+|||||||||+|||+ +.++.+||+|||++..+.... .....+||+.|+|||++.+ .|+.++|||||||++|||+
T Consensus 286 ~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 362 (501)
T PHA03210 286 KKLIHRDIKLENIFL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362 (501)
T ss_pred CCeecCCCCHHHEEE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999 567889999999998765432 2234689999999999865 5999999999999999999
Q ss_pred hCCCCCCCCC---hHHHHHHHHhcCC----CCCCC------------------------CCCCCCHHHHHHHHHhchhcc
Q 011582 349 CGSRPFWART---ESGIFRAVLKADP----SFDEA------------------------PWPSLSPEAIDFVKRLLNKDY 397 (482)
Q Consensus 349 tg~~pf~~~~---~~~~~~~i~~~~~----~~~~~------------------------~~~~~s~~~~~li~~~L~~dP 397 (482)
+|..++.... ....+..+..... .++.. ....++.++.++|.+||+.||
T Consensus 363 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP 442 (501)
T PHA03210 363 SHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDW 442 (501)
T ss_pred HCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCc
Confidence 9986554322 2222222222110 01000 001356788899999999999
Q ss_pred ccCCCHHHHhcCcccccC
Q 011582 398 RKRLTAAQALSHPWLANS 415 (482)
Q Consensus 398 ~~R~s~~e~L~hp~~~~~ 415 (482)
.+|||+.|+|.||||...
T Consensus 443 ~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 443 HLRPGAAELLALPLFSAE 460 (501)
T ss_pred ccCcCHHHHhhChhhhcC
Confidence 999999999999999764
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=337.60 Aligned_cols=253 Identities=26% Similarity=0.413 Sum_probs=198.6
Q ss_pred eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
.||+|+||.||+|.+.. +|+.||+|++.+.. ...........+|..+++.
T Consensus 1 ~lg~G~~g~Vy~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~~~~~~~~~ 50 (279)
T cd05633 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKR---------------------------IKMKQGETLALNERIMLSL 50 (279)
T ss_pred CcccCCCeEEEEEEECC---CCcEEEEEEEEccc---------------------------cccchHHHHHHHHHHHHHH
Confidence 38999999999999876 78999999986531 0111112233445444433
Q ss_pred h--cCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 011582 208 L--TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL 285 (482)
Q Consensus 208 l--~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIl 285 (482)
+ .+||||+.+++++..++..|+||||++|++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||
T Consensus 51 ~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil 129 (279)
T cd05633 51 VSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQH-GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANIL 129 (279)
T ss_pred HhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEE
Confidence 3 24999999999999999999999999999998887654 57999999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-c-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHH
Q 011582 286 FTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-R-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIF 363 (482)
Q Consensus 286 l~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~ 363 (482)
+ +.++.++|+|||++...... ......||..|+|||.+. + .++.++||||+||++|+|++|..||........
T Consensus 130 ~---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~- 204 (279)
T cd05633 130 L---DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK- 204 (279)
T ss_pred E---CCCCCEEEccCCcceecccc-CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-
Confidence 9 56778999999998765432 223457999999999875 3 488999999999999999999999975432111
Q ss_pred HHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccCC
Q 011582 364 RAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANSH 416 (482)
Q Consensus 364 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~~ 416 (482)
..+..............+++++.++|++||..||.+|+ +++++++||||+...
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 205 HEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred HHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 11111111122223345899999999999999999999 699999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=330.58 Aligned_cols=249 Identities=31% Similarity=0.504 Sum_probs=213.1
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||.|+||.||++.+.. +|+.||+|.++.. ......+.+.+|
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~-----------------------------~~~~~~~~~~~e 48 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVN---SDQKYAMKEIRLP-----------------------------KSSSAVEDSRKE 48 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcC---CCceEEEEEEEcC-----------------------------cchHHHHHHHHH
Confidence 58899999999999999999876 7899999998642 122345678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
+.+++.+. |+||+++++++.+++.+|+||||+++++|.+++... +..+++..+..++.|++.||.|||++||+|+|||
T Consensus 49 ~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~ 127 (255)
T cd08219 49 AVLLAKMK-HPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIK 127 (255)
T ss_pred HHHHHhCC-CCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence 99999996 999999999999999999999999999999988653 4568999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+||++ +.++.++|+|||++....... ......|++.|+|||++.+ .++.++|+||||+++|+|++|..||...+
T Consensus 128 p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 128 SKNIFL---TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred cceEEE---CCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 999999 567789999999997664332 2334678999999998864 58899999999999999999999999888
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.......+........ ...++.++.+||.+||+.||.+||++.+++.-
T Consensus 205 ~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 205 WKNLILKVCQGSYKPL---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred HHHHHHHHhcCCCCCC---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 7777777665543321 23478999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=335.02 Aligned_cols=261 Identities=24% Similarity=0.408 Sum_probs=209.5
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|+.++.||+|+||.||+|.+.. +|+.||+|++..... . ........+.+.+|
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~---~~~~~alk~~~~~~~-----------~-------------~~~~~~~~~~~~~e 53 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVK---TGTLMAVKQVTYVRN-----------T-------------SSEQEEVVEALRKE 53 (268)
T ss_pred CccccceecCcCceEEEEEEEcC---CCcEEEEEEeecccC-----------C-------------chhHHHHHHHHHHH
Confidence 47888999999999999999876 799999999865310 0 00112345788999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.++++++ |+||+++++++.+.+.+++||||++|++|.+++... +.+++..+..++.||+.||.|||++|++||||+|
T Consensus 54 ~~~l~~l~-h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~ 131 (268)
T cd06630 54 IRLMARLN-HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKG 131 (268)
T ss_pred HHHHHHcC-CCceehhhceeccCCeEEEEEeccCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 99999997 999999999999999999999999999999987544 5799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCC-----cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
+||+++. .+..+||+|||++....... ......||..|+|||.+.+ .++.++||||+|+++|+|++|..||.
T Consensus 132 ~nil~~~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 209 (268)
T cd06630 132 ANLLIDS--TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWN 209 (268)
T ss_pred HHEEEcC--CCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 9999942 23469999999987664321 1223568899999998864 58899999999999999999999997
Q ss_pred CCChHHHHHHHHhcCC-CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 356 ARTESGIFRAVLKADP-SFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
..........+..... .........+++++.++|.+||..+|.+||++.++++||||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 210 AEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 5543332222222111 111122235789999999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=332.85 Aligned_cols=256 Identities=25% Similarity=0.440 Sum_probs=207.6
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.+.+.||+|+||.||+|.+.. +|..||+|++..... ..........+.+|
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~---~~~~~~~k~~~~~~~-------------------------~~~~~~~~~~~~~e 54 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVD---TGRELAAKQVQFDPE-------------------------SPETSKEVSALECE 54 (266)
T ss_pred CccccceecCCCCEEEEEEEEcC---CCcEEEEEEeecCcC-------------------------CchhHHHHHHHHHH
Confidence 68899999999999999999876 789999999864310 00122345678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 202 VKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+.+++.++ ||||+++++++.+ ...++++|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||
T Consensus 55 ~~~l~~l~-h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l 132 (266)
T cd06651 55 IQLLKNLQ-HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYLHSNMIVHRDI 132 (266)
T ss_pred HHHHHHcC-CCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCC
Confidence 99999997 9999999999876 46789999999999999988654 56899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC----CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD----ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf 354 (482)
||+||++ +.++.+||+|||++...... .......++..|+|||.+.+ .++.++||||+||++|+|++|+.||
T Consensus 133 ~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf 209 (266)
T cd06651 133 KGANILR---DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209 (266)
T ss_pred CHHHEEE---CCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCc
Confidence 9999999 56778999999998765321 12233568899999998865 5889999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
...........+....... ..-..+++.++++| +||..+|++||+++++++||||+
T Consensus 210 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 210 AEYEAMAAIFKIATQPTNP--QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred cccchHHHHHHHhcCCCCC--CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 8766555444443322111 11124688899999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=347.99 Aligned_cols=260 Identities=31% Similarity=0.550 Sum_probs=208.5
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++.+.||+|+||.||+|++.. +|+.||||+++.. ........+
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~---~~~~vaiK~~~~~-----------------------------~~~~~~~~~ 50 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKP---TGVKVAIKKISPF-----------------------------EHQTFCQRT 50 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcC---CCCeEEEEEeccc-----------------------------ccchhHHHH
Confidence 45789999999999999999999876 7999999998532 112234567
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC-----CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD-----DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
.+|+.++++++ |+||+++++++... ...|+||||+.+ +|...+.. ..+++..++.++.|++.||.|||++|
T Consensus 51 ~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~LH~~~ 126 (336)
T cd07849 51 LREIKILRRFK-HENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKT--QHLSNDHIQYFLYQILRGLKYIHSAN 126 (336)
T ss_pred HHHHHHHHhCC-CCCcCchhheeecccccccceEEEEehhccc-CHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 78999999997 99999999987654 358999999965 78776633 57999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCC----cccccccCccccCccccc--ccCCCcchhhhhHHHHHHH
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el 347 (482)
|+||||||+|||+ +.++.+||+|||++....... ......||+.|+|||.+. ..++.++||||+||++|+|
T Consensus 127 ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el 203 (336)
T cd07849 127 VLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEM 203 (336)
T ss_pred eeccCCCHHHEEE---CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999 567889999999987654322 123457899999999864 3588999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHhcCCC-----------------------CCCC----CCCCCCHHHHHHHHHhchhccccC
Q 011582 348 LCGSRPFWARTESGIFRAVLKADPS-----------------------FDEA----PWPSLSPEAIDFVKRLLNKDYRKR 400 (482)
Q Consensus 348 ltg~~pf~~~~~~~~~~~i~~~~~~-----------------------~~~~----~~~~~s~~~~~li~~~L~~dP~~R 400 (482)
++|+.||.+.+....+..+...... .... ..+.+++++.+||.+||+.||.+|
T Consensus 204 ~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 283 (336)
T cd07849 204 LSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKR 283 (336)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhC
Confidence 9999999876554433332211100 0000 123568899999999999999999
Q ss_pred CCHHHHhcCcccccCCC
Q 011582 401 LTAAQALSHPWLANSHD 417 (482)
Q Consensus 401 ~s~~e~L~hp~~~~~~~ 417 (482)
||+.++++||||+....
T Consensus 284 pt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 284 ITVEEALAHPYLEQYHD 300 (336)
T ss_pred cCHHHHhcCccccccCC
Confidence 99999999999987653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=332.16 Aligned_cols=269 Identities=28% Similarity=0.455 Sum_probs=216.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCC-CCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSL-KGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~-~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
...|+++..||+|.||.||+|..+.... ....+|+|.++... ...-.-...
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~k----------------------------d~tGiS~SA 74 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEK----------------------------DGTGISMSA 74 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccC----------------------------CCCCcCHHH
Confidence 3579999999999999999997665321 13479999885420 000112356
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEe-CCeEEEEEecCCCCChHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYED-DDNIYIVMELCKGGELLDRILSR----GGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
.+|+.+++.|+ |||++.|..+|.. +..++|++||.+. +|++.|... ...++...++.|+.||+.|+.|||++-
T Consensus 75 cREiaL~REl~-h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW 152 (438)
T KOG0666|consen 75 CREIALLRELK-HPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW 152 (438)
T ss_pred HHHHHHHHHhc-CCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh
Confidence 79999999998 9999999999887 8899999999976 888888643 356899999999999999999999999
Q ss_pred CcccCCCCCceEEecC-CCCCcEEEEecccccccCCC----CcccccccCccccCcccccc--cCCCcchhhhhHHHHHH
Q 011582 274 VVHRDLKPENFLFTSK-EENSSLKAIDFGLSDYVKPD----ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYI 346 (482)
Q Consensus 274 ivHrDlkp~NIll~~~-~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~e 346 (482)
|+||||||.|||+..+ .+.|.|||+|||+++.+... -....++.|.+|+|||.+.+ .|+.+.|||++|||+.|
T Consensus 153 vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaE 232 (438)
T KOG0666|consen 153 VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAE 232 (438)
T ss_pred eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHH
Confidence 9999999999999643 34589999999999987543 13456788999999998875 59999999999999999
Q ss_pred HhhCCCCCCCCCh---------HHHHHHHHhcCCCCCCCCCCCC---------------------------------CHH
Q 011582 347 LLCGSRPFWARTE---------SGIFRAVLKADPSFDEAPWPSL---------------------------------SPE 384 (482)
Q Consensus 347 lltg~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~~---------------------------------s~~ 384 (482)
|+|-++.|.+... .+.+..|++.........|+.+ ++.
T Consensus 233 lLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~ 312 (438)
T KOG0666|consen 233 LLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPS 312 (438)
T ss_pred HHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCch
Confidence 9999999965432 3456677776655555555422 456
Q ss_pred HHHHHHHhchhccccCCCHHHHhcCcccccCCCC
Q 011582 385 AIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDV 418 (482)
Q Consensus 385 ~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~ 418 (482)
+.+|+.+||+.||.+|+|++++|+|+||....-.
T Consensus 313 a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp 346 (438)
T KOG0666|consen 313 ALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP 346 (438)
T ss_pred HHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence 8899999999999999999999999999987543
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=337.26 Aligned_cols=261 Identities=31% Similarity=0.540 Sum_probs=215.2
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||.|+||.||+|+...+..+|..||+|++.+.. ........+.+.+|
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~--------------------------~~~~~~~~~~~~~e 54 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKAT--------------------------IVQKAKTTEHTRTE 54 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhh--------------------------hhhcchHHHHHHHH
Confidence 4889999999999999999987555578999999986531 00122334677899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+.+|+||+.++++++.++.+|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||+|
T Consensus 55 ~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p 133 (290)
T cd05613 55 RQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKL 133 (290)
T ss_pred HHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence 999999977999999999999999999999999999999988654 5799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
+|||+ +.++.+||+|||++....... ......|+..|+|||.+.. .++.++||||||+++|+|++|..||..
T Consensus 134 ~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 134 ENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred HHeEE---CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 99999 567889999999998754432 2234678999999998753 478899999999999999999999965
Q ss_pred CCh----HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccCC
Q 011582 357 RTE----SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANSH 416 (482)
Q Consensus 357 ~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~~ 416 (482)
... .++...+......++ ..+++.+.+++++||..||.+|+ ++++++.||||....
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 211 DGEKNSQAEISRRILKSEPPYP----QEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCccccHHHHHHHhhccCCCCC----ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 432 333444443333222 34789999999999999999997 899999999998754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=336.92 Aligned_cols=253 Identities=19% Similarity=0.328 Sum_probs=211.9
Q ss_pred cceEecceeecCCceEEEEEEEecCC--CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGS--LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~--~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
++|++.+.||+|+||.||+|...... ..+..||+|.+... ........+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~-----------------------------~~~~~~~~~ 55 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKEN-----------------------------AEPKVQQEF 55 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccC-----------------------------CCHHHHHHH
Confidence 57999999999999999999876521 13467999987542 223345678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMVQIL 263 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~ 263 (482)
.+|+.+++.+. ||||+++++++.+.+..|++|||+++++|.+++.... ..+++..+..++.|++
T Consensus 56 ~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~ 134 (283)
T cd05048 56 RQEAELMSDLQ-HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIA 134 (283)
T ss_pred HHHHHHHHhcC-CcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHH
Confidence 99999999996 9999999999999999999999999999999886531 4588899999999999
Q ss_pred HHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchhhh
Q 011582 264 SVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADMWS 339 (482)
Q Consensus 264 ~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwS 339 (482)
.||.|||++|++||||||+||++ ++++.+||+|||++....... ......+++.|+|||.+. +.++.++||||
T Consensus 135 ~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~s 211 (283)
T cd05048 135 AGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWS 211 (283)
T ss_pred HHHHHHHhCCeeccccccceEEE---cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHH
Confidence 99999999999999999999999 567789999999997654322 223446788999999875 56899999999
Q ss_pred hHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 340 IGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 340 lGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|||++|||++ |..||.+....++...+....... ....+++++.+|+.+||+.||.+||++.+++++
T Consensus 212 lG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 212 FGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999998 999999988888877776554322 124589999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.18 Aligned_cols=254 Identities=32% Similarity=0.547 Sum_probs=211.6
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.+.+.||+|+||.||+|.... +++.||+|+++... ......+.+.+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~---~~~~~~ik~~~~~~----------------------------~~~~~~~~~~~e 49 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLD---TGELMAVKEIRIQD----------------------------NDPKTIKEIADE 49 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECC---CCcEEEEEEEECcc----------------------------cchHHHHHHHHH
Confidence 58899999999999999999876 78999999986531 113456789999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+. |+||+++++++.+.+.+++|+||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||+|
T Consensus 50 ~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~ 127 (264)
T cd06626 50 MKVLELLK-HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHG-RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKP 127 (264)
T ss_pred HHHHHhCC-CCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhc-CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 99999996 999999999999999999999999999999987654 5689999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCc-----ccccccCccccCcccccc-c---CCCcchhhhhHHHHHHHhhCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDER-----LNDIVGSAYYVAPEVLHR-S---YGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~-~---~~~~~DiwSlGvil~elltg~~ 352 (482)
+||++ +.++.+||+|||++........ .....++..|+|||++.+ . ++.++||||||+++|+|++|..
T Consensus 128 ~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~ 204 (264)
T cd06626 128 ANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204 (264)
T ss_pred HHEEE---CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCC
Confidence 99999 5678899999999887643322 223568899999998864 2 7889999999999999999999
Q ss_pred CCCCCChH-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 353 PFWARTES-GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 353 pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
||...... .....+.. ......+.+..+++.+.+||.+||+.+|.+||++.+++.|||+
T Consensus 205 pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 205 PWSELDNEFQIMFHVGA-GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CccCCcchHHHHHHHhc-CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99765333 22222332 2222223344568999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=338.86 Aligned_cols=258 Identities=25% Similarity=0.406 Sum_probs=215.0
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
....|.+.+.||+|+||.||+|+... +|+.||+|++... ..........+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~---~~~~v~iK~~~~~---------------------------~~~~~~~~~~~ 62 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYS---------------------------GKQSNEKWQDI 62 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcC---CCcEEEEEEEecc---------------------------ccCcHHHHHHH
Confidence 34679999999999999999999876 7899999998642 01223345678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+++..|+||||+. |+|.+.+......+++..+..++.|++.||.|||+.||+|||
T Consensus 63 ~~Ei~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~d 140 (307)
T cd06607 63 IKEVRFLQQLR-HPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD 140 (307)
T ss_pred HHHHHHHHhCC-CCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence 89999999996 9999999999999999999999997 477777765556799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~~pf 354 (482)
|+|+||++ +.++.+||+|||++...... ....|++.|+|||++. +.++.++||||||+++|+|++|..||
T Consensus 141 l~p~nIl~---~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~ 214 (307)
T cd06607 141 IKAGNILL---TEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214 (307)
T ss_pred CCcccEEE---CCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCC
Confidence 99999999 56788999999998765432 3457889999999873 45889999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
...+.......+..... +......++.++.++|.+||..||.+||++.+++.||||....
T Consensus 215 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 215 FNMNAMSALYHIAQNDS--PTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred CCccHHHHHHHHhcCCC--CCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 88776655554443321 1111224688999999999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=357.07 Aligned_cols=245 Identities=37% Similarity=0.570 Sum_probs=212.6
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.+.|++...+|.|+|+.|-.+.+.. +++..+||++.+. ..+.
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~---t~~~~~vkii~~~----------------------------------~~~~ 362 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSP---TDQEPAVKIISKR----------------------------------ADDN 362 (612)
T ss_pred cchhhccccccCCCCccceeeeeccc---cccchhheecccc----------------------------------cccc
Confidence 56789999999999999999999887 8999999999763 1223
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.++....+||||+++.+++.+..+.|+|||++.|+.|++.+... ..+. .++..|+++|+.|+.|||++||||||
T Consensus 363 ~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~-~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRD 440 (612)
T KOG0603|consen 363 QDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSK-PEFC-SEASQWAAELVSAVDYLHEQGVVHRD 440 (612)
T ss_pred ccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhc-chhH-HHHHHHHHHHHHHHHHHHhcCeeecC
Confidence 467888888888999999999999999999999999999999988755 2333 78888999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|||+|||+. +..++++|+|||.++..... ..+.+-|..|.|||++.. .|+.++|+||||++||+||+|+.||...
T Consensus 441 Lkp~NIL~~--~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~ 516 (612)
T KOG0603|consen 441 LKPGNILLD--GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH 516 (612)
T ss_pred CChhheeec--CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC
Confidence 999999995 46778999999999877644 455677899999999875 5999999999999999999999999877
Q ss_pred ChH-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 358 TES-GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 358 ~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
... ++...|...... ..+|.++++||++||++||.+|+++.+++.||||
T Consensus 517 P~~~ei~~~i~~~~~s------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 517 PAGIEIHTRIQMPKFS------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred CchHHHHHhhcCCccc------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 665 555555544332 3499999999999999999999999999999999
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=337.00 Aligned_cols=256 Identities=32% Similarity=0.550 Sum_probs=210.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.+.. +++.||||+++... ........+.+
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~---~~~~v~vK~~~~~~----------------------------~~~~~~~~~~~ 49 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKA---TGEIVAIKKFKESE----------------------------DDEDVKKTALR 49 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCC---CCcEEEEehhhhhc----------------------------ccccchhHHHH
Confidence 379999999999999999999876 68999999886431 12233467889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. |+||+++++++.+++..|+||||++++.+. .+......+++..+..++.||+.||.|||++|++||||+
T Consensus 50 e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~-~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~ 127 (288)
T cd07833 50 EVKVLRQLR-HENIVNLKEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIK 127 (288)
T ss_pred HHHHHHhcC-CCCeeehhheEEECCEEEEEEecCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 999999997 999999999999999999999999875554 444555679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|+||++ ++++.+||+|||++....... ......++..|+|||++.+ .++.++||||||+++|+|++|..||.+
T Consensus 128 ~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 128 PENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred HHHeEE---CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999 568889999999998765443 3345678999999998753 578899999999999999999999987
Q ss_pred CChHHHHHHHHhcCCCCC-------------------CC--------CCC-CCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 357 RTESGIFRAVLKADPSFD-------------------EA--------PWP-SLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~-------------------~~--------~~~-~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
....+....+........ .. .++ .++.++.+||++||..+|++||++++++.
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 205 DSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred CCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 766554443332111000 00 011 24899999999999999999999999999
Q ss_pred Cccc
Q 011582 409 HPWL 412 (482)
Q Consensus 409 hp~~ 412 (482)
||||
T Consensus 285 ~~~f 288 (288)
T cd07833 285 HPYF 288 (288)
T ss_pred CCCC
Confidence 9997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=336.16 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=213.1
Q ss_pred ccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|.+.+.||+|+||.||+|.+... ..++..||||+++.. ......+.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~-----------------------------~~~~~~~~ 54 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKET-----------------------------ASNDARKD 54 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeeccc-----------------------------CCHHHHHH
Confidence 35789999999999999999988643 124688999998653 22334578
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-------------CCCCHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-------------GKYSEEDAKIVMVQILS 264 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~l~~~~~~~i~~qi~~ 264 (482)
+.+|+++++.+. |+||+++++++...+..++||||+++++|.+++...+ ..+++..+..++.|++.
T Consensus 55 ~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~ 133 (280)
T cd05049 55 FEREAELLTNFQ-HENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIAS 133 (280)
T ss_pred HHHHHHHHHhcC-CCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHH
Confidence 899999999996 9999999999999999999999999999999986542 34789999999999999
Q ss_pred HHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchhhhh
Q 011582 265 VVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADMWSI 340 (482)
Q Consensus 265 ~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSl 340 (482)
||.|||++|++||||||+||++ +.++.+||+|||++....... ......+++.|+|||++. +.++.++|||||
T Consensus 134 ~l~~lH~~~i~h~dlkp~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05049 134 GMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 210 (280)
T ss_pred HHHHHhhCCeeccccccceEEE---cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHH
Confidence 9999999999999999999999 567889999999997653322 122345678899999886 468999999999
Q ss_pred HHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 341 GVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 341 Gvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||++|+|++ |..||.+....+....+........ ...++.++.++|.+||..||.+||++.|+++
T Consensus 211 G~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 211 GVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999998 9999998888888887775543322 2358899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=328.43 Aligned_cols=256 Identities=30% Similarity=0.484 Sum_probs=214.2
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|+..+.||+|+||.||+|.... +|..||+|.+..... ........+.+.+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~---~~~~~~ik~~~~~~~-------------------------~~~~~~~~~~~~~e 52 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLD---DGDFFAVKEVSLADD-------------------------GQTGQEAVKQLEQE 52 (258)
T ss_pred CccccceeeecCCceEEEEEEcC---CCcEEEEEEEEEccc-------------------------cccchHHHHHHHHH
Confidence 47788899999999999999876 789999999865310 01123445778999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+. |+||+++++++.+.+.+|+||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+|+||+|
T Consensus 53 ~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~ 130 (258)
T cd06632 53 IALLSKLQ-HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKG 130 (258)
T ss_pred HHHHHhcC-CCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 99999996 999999999999999999999999999999987654 5689999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-c-CCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-S-YGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
+||++ +.++.+||+|||++.............|+..|+|||.+.. . ++.++|+|||||++|+|++|..||.....
T Consensus 131 ~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~ 207 (258)
T cd06632 131 ANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG 207 (258)
T ss_pred HHEEE---CCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH
Confidence 99999 5677899999999887654444456678999999998753 4 88999999999999999999999977665
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
......+..... . ......+++++.++|.+||..+|.+||++.++|.|||+
T Consensus 208 ~~~~~~~~~~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 208 VAAVFKIGRSKE-L-PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HHHHHHHHhccc-C-CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 554444443221 1 12234578999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=340.79 Aligned_cols=258 Identities=30% Similarity=0.536 Sum_probs=215.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+.|.....||.|+||.||++.+.. ++..||||.+... .....+.+.
T Consensus 21 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~vaiK~~~~~------------------------------~~~~~~~~~ 67 (292)
T cd06658 21 REYLDSFIKIGEGSTGIVCIATEKH---TGKQVAVKKMDLR------------------------------KQQRRELLF 67 (292)
T ss_pred HHHHhhhhcccCCCCeEEEEEEECC---CCCEEEEEEEecc------------------------------hHHHHHHHH
Confidence 3456666789999999999999876 7899999998542 223456788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. |+||+++++.+...+..|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||
T Consensus 68 ~e~~~l~~l~-h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dl 144 (292)
T cd06658 68 NEVVIMRDYH-HENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDI 144 (292)
T ss_pred HHHHHHHhCC-CCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCC
Confidence 9999999996 99999999999999999999999999999887643 46899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+||++ +.++.++|+|||++...... .......|+..|+|||.+.+ .++.++|||||||++|+|++|..||...
T Consensus 145 kp~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 221 (292)
T cd06658 145 KSDSILL---TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNE 221 (292)
T ss_pred CHHHEEE---cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999 56778999999998765322 22344678999999998864 5889999999999999999999999887
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.....+..+........ .....++..+.++|.+||..||.+|||++++|+||||.....
T Consensus 222 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 222 PPLQAMRRIRDNLPPRV-KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGP 280 (292)
T ss_pred CHHHHHHHHHhcCCCcc-ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCC
Confidence 76666555544322111 112347899999999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.04 Aligned_cols=257 Identities=27% Similarity=0.465 Sum_probs=209.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|++++.||+|+||.||+|.+.. +|..||||.+..... ........+.+.+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~---~~~~v~ik~~~~~~~-------------------------~~~~~~~~~~~~~ 53 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDAD---TGRELAVKQVQFDPE-------------------------SPETSKEVNALEC 53 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcC---CCcEEEEEEeecCcC-------------------------CcccHHHHHHHHH
Confidence 469999999999999999999876 799999998753200 0112234568899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
|+.+++++. ||||+++++++.+. ..+++||||++|++|.+++... ..+++..+..++.|++.||.|||++||+|+|
T Consensus 54 E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~d 131 (265)
T cd06652 54 EIQLLKNLL-HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYLHSNMIVHRD 131 (265)
T ss_pred HHHHHHhcC-CCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 999999996 99999999998764 5688999999999999987654 5689999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCC----CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPD----ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~p 353 (482)
|||+||++ +.++.++|+|||++...... .......|+..|+|||.+.+ .++.++|||||||++|+|++|+.|
T Consensus 132 l~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p 208 (265)
T cd06652 132 IKGANILR---DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208 (265)
T ss_pred CCHHHEEe---cCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCC
Confidence 99999999 56778999999998765321 12334568999999998754 588999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
|...........+...... ......++..+.++|.+|+. +|.+||++++++.|||+.
T Consensus 209 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 209 WAEFEAMAAIFKIATQPTN--PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CCccchHHHHHHHhcCCCC--CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9876555554444332211 11223578899999999994 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=332.07 Aligned_cols=263 Identities=27% Similarity=0.485 Sum_probs=212.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.+.+.||.|+||.||+|.... +|+.||||.+...... .... ........+.+.+|
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~---~~~~~a~K~~~~~~~~---------~~~~-----------~~~~~~~~~~~~~e 58 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVT---TGEMMAVKQVELPATI---------AGRH-----------DSRQKDMVKALRSE 58 (272)
T ss_pred ceeecceecccCceEEEEEeecC---CCceeeeeeeechhhh---------hccc-----------chHHHHHHHHHHHH
Confidence 58899999999999999999876 7899999988542000 0000 00112234678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+. |+||+++++++...+..++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||+|
T Consensus 59 ~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~ 136 (272)
T cd06629 59 IETLKDLD-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKA 136 (272)
T ss_pred HHHHHhcC-CCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCCh
Confidence 99999996 999999999999999999999999999999988655 6799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCC---CcccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPD---ERLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
+||++ +.++.++|+|||++...... .......|+..|+|||.+.. .++.++|+||||+++|+|++|..||.
T Consensus 137 ~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 137 DNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred hhEEE---cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 99999 56788999999998765321 11234568899999998753 37899999999999999999999997
Q ss_pred CCChHHHHHHHHhc--CCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 356 ARTESGIFRAVLKA--DPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 356 ~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.....+....+... ...++......++.++.++|.+||..||.+||+++++|.||||
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 214 DEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 65554444433322 2233334445689999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=329.95 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=208.0
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|..+ .+..+|+|.+.+. ......+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~----~~~~~a~K~~~~~-------------------------------~~~~~~~~~ 48 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR----AQIKVAIKAINEG-------------------------------AMSEEDFIE 48 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec----cCceEEEEecccC-------------------------------CccHHHHHH
Confidence 46899999999999999999875 4568999987542 111356889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. ||||+++++++.+.+..++||||+++|+|.+++....+.+++..+..++.|++.||.|||++||+|||||
T Consensus 49 e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 127 (256)
T cd05114 49 EAKVMMKLS-HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLA 127 (256)
T ss_pred HHHHHHHCC-CCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccC
Confidence 999999997 9999999999999999999999999999999887655679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcc--cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERL--NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
|+||++ +.++.+||+|||+++........ ....++..|+|||++. ..++.++||||||+++|+|++ |+.||..
T Consensus 128 p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~ 204 (256)
T cd05114 128 ARNCLV---SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEK 204 (256)
T ss_pred cceEEE---cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCC
Confidence 999999 56778999999998865432221 2234567899999886 468999999999999999999 9999998
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+..+....+......... ...+.++.+++.+||..||.+||+++++++
T Consensus 205 ~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 205 KSNYEVVEMISRGFRLYRP---KLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCHHHHHHHHHCCCCCCCC---CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 8888888887765432211 236789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=330.50 Aligned_cols=253 Identities=23% Similarity=0.380 Sum_probs=212.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|..+....+...||||+++.. ........+.+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~-----------------------------~~~~~~~~~~~ 54 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAG-----------------------------SSDKQRLDFLT 54 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCC-----------------------------CChHHHHHHHH
Confidence 5799999999999999999998753224568999988643 22334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++...+..++||||+++++|.+++....+.+++..+..++.|++.||.|||++||+|||||
T Consensus 55 e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~ 133 (266)
T cd05033 55 EASIMGQFD-HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLA 133 (266)
T ss_pred HHHHHHhCC-CCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 999999996 9999999999999999999999999999999987766789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-Ccc--cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERL--NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
|+|||+ +.++.++|+|||++...... ... ....++..|+|||.+. ..++.++||||||+++|+|++ |..||.
T Consensus 134 p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~ 210 (266)
T cd05033 134 ARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYW 210 (266)
T ss_pred cceEEE---cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCC
Confidence 999999 56778999999999876421 111 1234567899999886 468999999999999999998 999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.....+....+..... .+ ....+++.+.+|+.+||+.+|++||++.+++++
T Consensus 211 ~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 211 DMSNQDVIKAVEDGYR-LP--PPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCHHHHHHHHHcCCC-CC--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8887777777665422 11 123578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=328.90 Aligned_cols=255 Identities=30% Similarity=0.478 Sum_probs=216.7
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||.|+||.||+|++.. +|+.||||++... ........+.+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~vk~~~~~-----------------------------~~~~~~~~~~~ 48 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKP---TGKIYALKKIHVD-----------------------------GDEEFRKQLLR 48 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcC---CCcEEEEEEeccC-----------------------------cchHHHHHHHH
Confidence 368999999999999999999986 7999999998653 11134578899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDl 279 (482)
|+.++..++ |+||+++++++...+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+ .|++||||
T Consensus 49 e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l 126 (264)
T cd06623 49 ELKTLRSCE-SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDI 126 (264)
T ss_pred HHHHHHhcC-CCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCC
Confidence 999999997 999999999999999999999999999999988654 679999999999999999999999 99999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcc-cccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERL-NDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~-~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
+|+||++ +.++.++|+|||++......... ....++..|+|||.+.+ .++.++|+||||+++|+|++|..||...
T Consensus 127 ~~~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 203 (264)
T cd06623 127 KPSNLLI---NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPP 203 (264)
T ss_pred CHHHEEE---CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9999999 56788999999999876543332 25678899999998864 5888999999999999999999999776
Q ss_pred ---ChHHHHHHHHhcCCCCCCCCCCC-CCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 358 ---TESGIFRAVLKADPSFDEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 358 ---~~~~~~~~i~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
...+....+...... ..... ++..+.++|.+||..+|++||++.++++||||+..
T Consensus 204 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 204 GQPSFFELMQAICDGPPP---SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred cccCHHHHHHHHhcCCCC---CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 344555555433221 11123 78999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=336.47 Aligned_cols=260 Identities=26% Similarity=0.425 Sum_probs=211.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|.+.. +|+.||||++++. ........+.
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~avK~~~~~-----------------------------~~~~~~~~~~ 61 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKK---TGHVMAVKQMRRT-----------------------------GNKEENKRIL 61 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECC---CCeEEEEEEEecc-----------------------------CChHHHHHHH
Confidence 4679999999999999999999876 6899999998653 1122345667
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrD 278 (482)
.|+.++.++.+|+||+++++++.++...|+||||+. ++|.+.+......+++..+..++.|++.||.|||+ .||+|||
T Consensus 62 ~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~d 140 (296)
T cd06618 62 MDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRD 140 (296)
T ss_pred HHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCC
Confidence 788877777679999999999999999999999985 46777665555689999999999999999999997 5999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-----cCCCcchhhhhHHHHHHHhhCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-----SYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlGvil~elltg~~p 353 (482)
|+|+||++ +.++.+||+|||++.............++..|+|||.+.+ .++.++||||||+++|+|++|+.|
T Consensus 141 l~p~nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 217 (296)
T cd06618 141 VKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217 (296)
T ss_pred CcHHHEEE---cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCC
Confidence 99999999 5678899999999987654444444568889999998853 378899999999999999999999
Q ss_pred CCCCCh-HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 354 FWARTE-SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 354 f~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|..... .+....+....... ......++.++.+||.+||..||.+||++++++.||||....
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 218 YKNCKTEFEVLTKILQEEPPS-LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CCcchhHHHHHHHHhcCCCCC-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 976432 34444444433211 111224789999999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=329.96 Aligned_cols=249 Identities=29% Similarity=0.437 Sum_probs=202.4
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
...||+|+||.||+|++.. ++..||+|.+... .....+.+.+|+.++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~---~~~~v~~k~~~~~------------------------------~~~~~~~~~~e~~~l 59 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLS---TQVRIAIKEIPER------------------------------DSRYVQPLHEEIALH 59 (268)
T ss_pred eEEEecCCceEEEEeEecC---CCcEEEEEEecCC------------------------------CHHHHHHHHHHHHHH
Confidence 3479999999999999876 7889999988542 233456789999999
Q ss_pred HhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 011582 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKY--SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPEN 283 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l--~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~N 283 (482)
+.++ |+||+++++++..++..++||||+++++|.+++......+ ++..+..++.||+.||.|||++||+||||||+|
T Consensus 60 ~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~n 138 (268)
T cd06624 60 SYLK-HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDN 138 (268)
T ss_pred HhcC-CCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHH
Confidence 9997 9999999999999999999999999999999887654556 889999999999999999999999999999999
Q ss_pred eEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 284 FLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 284 Ill~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
|+++ ..++.++|+|||++....... ......|++.|+|||++.+ .++.++||||+|+++|+|++|..||.....
T Consensus 139 il~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~ 216 (268)
T cd06624 139 VLVN--TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE 216 (268)
T ss_pred EEEc--CCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence 9994 235689999999987654322 2334568999999998753 378999999999999999999999975433
Q ss_pred HHH-HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 360 SGI-FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 360 ~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
... ...+.... ........+++++.+|+.+||+.+|.+|||+.+++.||||
T Consensus 217 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 217 PQAAMFKVGMFK--IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred hhhhHhhhhhhc--cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 221 11111111 1111223578999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=334.04 Aligned_cols=254 Identities=32% Similarity=0.507 Sum_probs=212.3
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|++.+.||.|+||.||+|+... +|+.||+|++.... ........+.+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~~K~~~~~~----------------------------~~~~~~~~~~~e~ 49 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKK---TGELVALKKIRMEN----------------------------EKEGFPITAIREI 49 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECC---CCeEEEEEEEeccc----------------------------ccccchHHHHHHH
Confidence 6788999999999999999876 68999999997531 1122335678999
Q ss_pred HHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
.+++.+. |+|++++++++.+. +..++||||+++ +|.+++......+++..+..++.||+.||.|||+.|++|+|||
T Consensus 50 ~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~ 127 (287)
T cd07840 50 KLLQKLR-HPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIK 127 (287)
T ss_pred HHHHhcc-CCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCc
Confidence 9999997 99999999999988 899999999975 8888876655689999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|+||++ ++++.+||+|||++....... ......++..|+|||.+.+ .++.++||||||+++|+|++|+.||..
T Consensus 128 p~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~ 204 (287)
T cd07840 128 GSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204 (287)
T ss_pred HHHeEE---cCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999 567889999999998765433 2334567889999997753 478999999999999999999999998
Q ss_pred CChHHHHHHHHhcCCCCCCCCC--------------------------CC-CCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 357 RTESGIFRAVLKADPSFDEAPW--------------------------PS-LSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~--------------------------~~-~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.+.......+...........| .. +++++.++|++||..||.+||++.+++.|
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 205 STELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred CChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 8877766666553322221111 12 28899999999999999999999999999
Q ss_pred ccc
Q 011582 410 PWL 412 (482)
Q Consensus 410 p~~ 412 (482)
|||
T Consensus 285 ~~~ 287 (287)
T cd07840 285 EYF 287 (287)
T ss_pred cCC
Confidence 997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=334.87 Aligned_cols=254 Identities=30% Similarity=0.476 Sum_probs=207.7
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|++.+.||.|++|.||+|.+.. +|..||+|++.... ........+.+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~---~~~~~~ik~~~~~~----------------------------~~~~~~~~~~~E~ 49 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKL---TGEIVALKKIRLET----------------------------EDEGVPSTAIREI 49 (283)
T ss_pred CchheEecCCCCeEEEEEEEcC---CCCEEEEEEeeccc----------------------------ccccchhHHHHHH
Confidence 6778899999999999999876 79999999986431 1112234677899
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
.+++.+. ||||+++++++.+++..|+||||++ ++|.+++.... ..+++..+..++.|++.||.|||++|++||||+|
T Consensus 50 ~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p 127 (283)
T cd07835 50 SLLKELN-HPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKP 127 (283)
T ss_pred HHHHhcC-CCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCH
Confidence 9999997 9999999999999999999999995 58888876543 3689999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
+||++ +.++.++|+|||++....... ......++..|+|||++.+ .++.++||||||+++|+|++|..||...+
T Consensus 128 ~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 128 QNLLI---DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred HHEEE---cCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999 557889999999997654322 2233467899999998754 47889999999999999999999998777
Q ss_pred hHHHHHHHHhcCCCCC-------------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 359 ESGIFRAVLKADPSFD-------------------------EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~-------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.......+........ ....+.++.++.++|.+||+.||.+|||+++++.||||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 205 EIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 6555444433211100 11134578999999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=329.68 Aligned_cols=252 Identities=26% Similarity=0.478 Sum_probs=208.3
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|+.+. +|+.||||.+... ..........+.+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~---------------------------~~~~~~~~~~~~~ 51 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLL---DRKPVALKKVQIF---------------------------EMMDAKARQDCVK 51 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeC---CCCEEEEEEeecc---------------------------ccCCHHHHHHHHH
Confidence 579999999999999999999887 7899999987642 1123344567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
|+.+++.+. ||||+++++++.+.+..++||||+++++|.+++.. ....+++..+..++.|++.||.|||++|++||
T Consensus 52 e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~ 130 (267)
T cd08228 52 EIDLLKQLN-HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHR 130 (267)
T ss_pred HHHHHHhCC-CcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCC
Confidence 999999996 99999999999999999999999999999887753 23458999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+||++ +.++.++|+|||++....... ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||.
T Consensus 131 dl~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~ 207 (267)
T cd08228 131 DIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCCHHHEEE---cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence 999999999 567789999999988765432 2234578899999998864 58899999999999999999999996
Q ss_pred CCCh--HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 356 ARTE--SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 356 ~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.... ......+.... ++......++.++.++|.+||..+|.+||++.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 208 GDKMNLFSLCQKIEQCD--YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred cccccHHHHHHHHhcCC--CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 6532 34444433322 222223357889999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=333.01 Aligned_cols=249 Identities=27% Similarity=0.421 Sum_probs=199.0
Q ss_pred eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHH---
Q 011582 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKI--- 204 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~--- 204 (482)
.||+|+||.||+|.+.. +|+.||+|++.+... ........+..|..+
T Consensus 1 ~ig~g~~g~Vy~~~~~~---~~~~vaiK~~~~~~~---------------------------~~~~~~~~~~~~~~~~~~ 50 (278)
T cd05606 1 IIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRI---------------------------KMKQGETLALNERIMLSL 50 (278)
T ss_pred CcccCCCeEEEEEEEec---CCCEEEEEEeecccc---------------------------ccchhHHHHHHHHHHHHH
Confidence 38999999999999876 789999999875310 001111223334333
Q ss_pred HHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 011582 205 LRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENF 284 (482)
Q Consensus 205 l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NI 284 (482)
++.. +||||+.+++++.+.+.+|+||||+.|++|.+++.. .+.+++..+..++.|++.||.|||+.+|+||||||+||
T Consensus 51 ~~~~-~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~ni 128 (278)
T cd05606 51 VSTG-DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANI 128 (278)
T ss_pred HHhC-CCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHE
Confidence 3334 499999999999999999999999999999887754 46799999999999999999999999999999999999
Q ss_pred EEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCC---Ch
Q 011582 285 LFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWAR---TE 359 (482)
Q Consensus 285 ll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~---~~ 359 (482)
++ +.++.+||+|||++...... .....+|+..|+|||++.+ .++.++||||+||++|+|++|..||... ..
T Consensus 129 li---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~ 204 (278)
T cd05606 129 LL---DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204 (278)
T ss_pred EE---CCCCCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch
Confidence 99 56778999999998765432 2234579999999999863 4899999999999999999999999766 33
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccCC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANSH 416 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~~ 416 (482)
......+...... ....++.++.++|.+||..||.+|+ ++.++++||||+...
T Consensus 205 ~~~~~~~~~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 205 HEIDRMTLTMAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred HHHHHHhhccCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCC
Confidence 3333333322222 2234789999999999999999999 999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=335.14 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=212.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.... +|+.||+|++... ........+.+
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~---~~~~~a~k~~~~~-----------------------------~~~~~~~~~~~ 52 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIP---TGTVMAKKVVHIG-----------------------------AKSSVRKQILR 52 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcC---CCcEEEEEEEEec-----------------------------CcchHHHHHHH
Confidence 579999999999999999999876 7899999988542 12334567899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDl 279 (482)
|+.+++.+. ||||+++++++...+.+|+||||+++++|.+++.. .+.+++..+..++.|++.||.|||+ .|++||||
T Consensus 53 E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl 130 (284)
T cd06620 53 ELQIMHECR-SPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDI 130 (284)
T ss_pred HHHHHHHcC-CCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCC
Confidence 999999996 99999999999999999999999999999887754 3679999999999999999999997 58999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
||+||++ ++++.++|+|||++..... ......+|+..|+|||++. +.++.++|||||||++|+|++|..||....
T Consensus 131 ~p~nil~---~~~~~~~l~d~gl~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~ 206 (284)
T cd06620 131 KPSNILV---NSRGQIKLCDFGVSGELIN-SIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSN 206 (284)
T ss_pred CHHHEEE---CCCCcEEEccCCcccchhh-hccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999 5677899999999875432 2233567899999999875 568899999999999999999999997654
Q ss_pred hH-----------HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 359 ES-----------GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 359 ~~-----------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.. +....+..... .......++.++.+||.+||..||.+|||+.++++|+||....
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 207 IDDDGQDDPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred hhhhhhhhhhHHHHHHHHHhhccC--CCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 42 22333332221 1111223788999999999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=332.23 Aligned_cols=257 Identities=32% Similarity=0.579 Sum_probs=216.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
..|...+.||+|+||.||++.+.. +++.||+|++... .....+.+.+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~iK~~~~~------------------------------~~~~~~~~~~ 65 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKS---TGRQVAVKKMDLR------------------------------KQQRRELLFN 65 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECC---CCCEEEEEEEecc------------------------------chhHHHHHHH
Confidence 456666789999999999999876 7889999987532 2223456889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++...+..++|+||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||+
T Consensus 66 e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~ 142 (285)
T cd06648 66 EVVIMRDYQ-HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIK 142 (285)
T ss_pred HHHHHHHcC-CCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 999999996 99999999999999999999999999999998765 579999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+||++ +.++.++|+|||++....... ......|++.|+|||.+.+ .++.++|||||||++|+|++|..||...+
T Consensus 143 p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 143 SDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred hhhEEE---cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 999999 567889999999887654322 2234568999999998864 58899999999999999999999998877
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
..+....+......... ....++..+.+||.+||+.+|.+||++.++++||||.+...
T Consensus 220 ~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 220 PLQAMKRIRDNLPPKLK-NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HHHHHHHHHhcCCCCCc-ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCC
Confidence 77777666655322211 12347899999999999999999999999999999987653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=327.99 Aligned_cols=254 Identities=27% Similarity=0.500 Sum_probs=213.2
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.+.+.||+|+||.||+|..+. +|..||+|.+.... ......+.+.+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~----------------------------~~~~~~~~~~~E 49 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKS---DSEHCVIKEIDLTK----------------------------MPVKEKEASKKE 49 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcC---CCceEEEEEeeHhh----------------------------ccchhhHHHHHH
Confidence 58899999999999999999977 78999999986420 111234567899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
+.+++.++ |+||+++++++.+.+..|+|+||+++++|.+++.... ..+++..+..++.|++.||.|||+.+++|+|||
T Consensus 50 ~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~ 128 (257)
T cd08225 50 VILLAKMK-HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIK 128 (257)
T ss_pred HHHHHhCC-CCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Confidence 99999997 9999999999999999999999999999999886543 358999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+||+++. ++..+||+|||.+....... ......|++.|+|||++. ..++.++|+|||||++++|++|..||...+
T Consensus 129 ~~nil~~~--~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 129 SQNIFLSK--NGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred HHHEEEcC--CCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999952 23457999999987765432 223356899999999875 458899999999999999999999998877
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
..+....+...... ...+.++.++.++|.+||..+|++|||+.++++||||
T Consensus 207 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 207 LHQLVLKICQGYFA---PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHHhcccCC---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 76666665544322 1224578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=337.89 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=205.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCce--EEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQD--VAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~--vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++.+.||+|+||.||+|.+.. +|.. +|+|.+... ........
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~---~~~~~~~~ik~~~~~-----------------------------~~~~~~~~ 53 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY-----------------------------ASKDDHRD 53 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEcc---CCceeeEEEEEeccc-----------------------------CCHHHHHH
Confidence 4689999999999999999999865 5554 577765431 23344567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMVQI 262 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi 262 (482)
+.+|+.++.++.+|+||+++++++.+++.+|+||||+++++|.+++...+ ..+++..+..++.||
T Consensus 54 ~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 133 (303)
T cd05088 54 FAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133 (303)
T ss_pred HHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHH
Confidence 88999999999559999999999999999999999999999999886432 358899999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhH
Q 011582 263 LSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIG 341 (482)
Q Consensus 263 ~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlG 341 (482)
+.||.|||++||+||||||+|||+ +.++.+||+|||++.............++..|+|||.+.+ .++.++||||||
T Consensus 134 ~~al~~LH~~gi~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 210 (303)
T cd05088 134 ARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYG 210 (303)
T ss_pred HHHHHHHHhCCccccccchheEEe---cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhh
Confidence 999999999999999999999999 5677899999999864322111122234678999998764 588999999999
Q ss_pred HHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 342 VIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 342 vil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|++|+|+| |..||...+..+....+.... .......+++++.+||.+||+.+|++||+++++|.+
T Consensus 211 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 211 VLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred hHHHHHHhcCCCCcccCChHHHHHHHhcCC---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999998 999998887777666554321 111223478999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=338.93 Aligned_cols=255 Identities=31% Similarity=0.587 Sum_probs=213.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.|+....||+|+||.||+|.+.. +|+.||+|++... .....+.+.+|
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~---~~~~v~iK~~~~~------------------------------~~~~~~~~~~e 68 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKH---SGRQVAVKMMDLR------------------------------KQQRRELLFNE 68 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcC---CCCEEEEEEEEec------------------------------ccchHHHHHHH
Confidence 45556679999999999999876 7899999998542 11223567899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+. ||||+++++++..++..|+||||+++++|..++.. ..+++..++.++.|++.||.|||++||+||||||
T Consensus 69 ~~~l~~l~-hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p 145 (297)
T cd06659 69 VVIMRDYQ-HQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145 (297)
T ss_pred HHHHHhCC-CCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 99999996 99999999999999999999999999999886643 4689999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
+||++ +.++.+||+|||++....... ......|+..|+|||++.+ .++.++|||||||++|+|++|+.||.....
T Consensus 146 ~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 222 (297)
T cd06659 146 DSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP 222 (297)
T ss_pred HHeEE---ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999 677889999999987654322 2344678999999998864 589999999999999999999999988776
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.+....+...... ....+..++.++.++|.+||+.+|.+||+++++++||||.+..
T Consensus 223 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 223 VQAMKRLRDSPPP-KLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHHHHhccCCC-CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 6666655443222 2223456889999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=333.75 Aligned_cols=254 Identities=33% Similarity=0.664 Sum_probs=218.0
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|.+.+.||+|+||.||+|+... +|+.||+|++.+. ..........+.+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~---~~~~~~ik~~~~~---------------------------~~~~~~~~~~~~~ 50 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKE---TNKEYAIKILDKR---------------------------QLIKEKKVKYVKI 50 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcC---CCCEEEEEEechH---------------------------hccchHHHHHHHH
Confidence 379999999999999999999876 7999999998653 1122334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++.+|+||+++++++.+++..++||||+++++|.+++.+. +.+++..+..++.|++.||.|||+.|++|+||+
T Consensus 51 e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~ 129 (280)
T cd05581 51 EKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLK 129 (280)
T ss_pred HHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 9999999966999999999999999999999999999999988654 579999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC---------------------cccccccCccccCcccccc-cCCCcchhh
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE---------------------RLNDIVGSAYYVAPEVLHR-SYGTEADMW 338 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~---------------------~~~~~~gt~~y~aPE~~~~-~~~~~~Diw 338 (482)
|+||++ +.++.++|+|||++....... ......|+..|+|||++.. .++.++|||
T Consensus 130 ~~ni~i---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~ 206 (280)
T cd05581 130 PENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLW 206 (280)
T ss_pred HHHeEE---CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHH
Confidence 999999 567789999999987654322 1223467899999998764 588899999
Q ss_pred hhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH----HHHhcCccc
Q 011582 339 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA----AQALSHPWL 412 (482)
Q Consensus 339 SlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~----~e~L~hp~~ 412 (482)
|||++++++++|..||........+..+......++ ..+++.+.+||.+||+.||.+||++ +++|+||||
T Consensus 207 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 207 ALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 999999999999999998887777777765544443 3478999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=331.42 Aligned_cols=260 Identities=26% Similarity=0.461 Sum_probs=209.6
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|+..+.||.|++|.||+|.+.. +++.||+|++... ........+.+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~---~~~~~~~k~~~~~-----------------------------~~~~~~~~~~~ 48 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKN---TGMIFALKTITTD-----------------------------PNPDLQKQILR 48 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECC---CCeEEEEEEEecC-----------------------------CchHHHHHHHH
Confidence 468999999999999999999976 7899999998653 12234567899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
|+++++.+. ||||++++++|.+. +.+|+||||++|++|.+++.. ....+++..+..++.||+.||.|||+.|++
T Consensus 49 e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~ 127 (287)
T cd06621 49 ELEINKSCK-SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKII 127 (287)
T ss_pred HHHHHHhCC-CCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999996 99999999998653 478999999999999887643 345689999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf 354 (482)
|+||+|+||++ +.++.++|+|||++....... .....++..|+|||.+. ..++.++|||||||++|+|++|..||
T Consensus 128 H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~ 203 (287)
T cd06621 128 HRDIKPSNILL---TRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203 (287)
T ss_pred cCCCCHHHEEE---ecCCeEEEeeccccccccccc-cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999 556789999999987654322 23456788999999876 46899999999999999999999999
Q ss_pred CCCC-----hHHHHHHHHhcCC-CCCCCCC--CCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 355 WART-----ESGIFRAVLKADP-SFDEAPW--PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 355 ~~~~-----~~~~~~~i~~~~~-~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.... ..+....+..... ....... ..+++++.+||.+||..||.+|||+.|++.||||.+...
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 204 PPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred CcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 7652 2333333333211 1111111 135688999999999999999999999999999966543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=344.04 Aligned_cols=261 Identities=32% Similarity=0.521 Sum_probs=210.5
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+..+|.+.+.||+|+||.||+|++.. +|+.||||.+.... ........+
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~---~~~~vaiK~~~~~~----------------------------~~~~~~~~~ 51 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSE---TNEKVAIKKIANAF----------------------------DNRIDAKRT 51 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecC---CCCeEEEEEecccc----------------------------cccchhHHH
Confidence 34689999999999999999999876 79999999986420 112223456
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC-----CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD-----DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
.+|+.+++.+. |+||+++++++... ...|+||||+. ++|.+++.. .+.+++..+..++.|++.||.|||++|
T Consensus 52 ~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ 128 (337)
T cd07858 52 LREIKLLRHLD-HENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSAN 128 (337)
T ss_pred HHHHHHHHhcC-CCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 78999999996 99999999988654 35899999995 588887754 467999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCccccc--ccCCCcchhhhhHHHHHHHhhC
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~elltg 350 (482)
++||||||+||++ +.++.+||+|||++...... .......|+..|+|||.+. ..++.++|||||||++|+|++|
T Consensus 129 i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 205 (337)
T cd07858 129 VLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR 205 (337)
T ss_pred EecCCCCHHHEEE---cCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcC
Confidence 9999999999999 56778999999999876443 2334557899999999875 3588999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCC-----------------------CCC----CCCCCCCCHHHHHHHHHhchhccccCCCH
Q 011582 351 SRPFWARTESGIFRAVLKADP-----------------------SFD----EAPWPSLSPEAIDFVKRLLNKDYRKRLTA 403 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~-----------------------~~~----~~~~~~~s~~~~~li~~~L~~dP~~R~s~ 403 (482)
+.||.+.+.......+..... ... ...++.+++++.+||++||+.||.+|||+
T Consensus 206 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~ 285 (337)
T cd07858 206 KPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITV 285 (337)
T ss_pred CCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCH
Confidence 999987654443333322110 000 01234689999999999999999999999
Q ss_pred HHHhcCcccccCC
Q 011582 404 AQALSHPWLANSH 416 (482)
Q Consensus 404 ~e~L~hp~~~~~~ 416 (482)
+++|+||||....
T Consensus 286 ~ell~h~~~~~~~ 298 (337)
T cd07858 286 EEALAHPYLASLH 298 (337)
T ss_pred HHHHcCcchhhhc
Confidence 9999999998654
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=334.99 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=205.6
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCC--ceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKG--QDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g--~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
++|++.+.||+|+||.||+|+.+. +| ..+|+|.++.. ......+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~~~ik~~~~~-----------------------------~~~~~~~~~ 49 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKK---DGLKMNAAIKMLKEF-----------------------------ASENDHRDF 49 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecC---CCCcceeEEEEcccc-----------------------------CCHHHHHHH
Confidence 579999999999999999998875 34 34788877531 223345678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMVQIL 263 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~ 263 (482)
.+|+.++.++.+||||+++++++.+.+.+|+||||+++++|.+++.... ..+++..+..++.|++
T Consensus 50 ~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 129 (297)
T cd05089 50 AGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129 (297)
T ss_pred HHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHH
Confidence 9999999999669999999999999999999999999999999886532 3588999999999999
Q ss_pred HHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHH
Q 011582 264 SVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGV 342 (482)
Q Consensus 264 ~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGv 342 (482)
.||.|||++||+||||||+|||+ +.++.+||+|||++..............+..|+|||++.+ .++.++|||||||
T Consensus 130 ~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~ 206 (297)
T cd05089 130 TGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGV 206 (297)
T ss_pred HHHHHHHHCCcccCcCCcceEEE---CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHH
Confidence 99999999999999999999999 5677899999999864322111112233567999998764 5899999999999
Q ss_pred HHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 343 IAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 343 il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
++|+|++ |..||......+....+..... . .....++.++.+||.+||..+|.+||+++++++.
T Consensus 207 il~el~t~g~~pf~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 207 LLWEIVSLGGTPYCGMTCAELYEKLPQGYR-M--EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHhcCCC-C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999997 9999998888877777655421 1 1223588999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=346.86 Aligned_cols=254 Identities=24% Similarity=0.347 Sum_probs=202.1
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
...+++|.-.+.||+|+||.||+|... +|..||||++... .... ..
T Consensus 71 ~~AT~~Fs~~~~ig~Ggfg~VYkG~l~----~~~~vAVK~~~~~-----------------------------~~~~-~~ 116 (361)
T KOG1187|consen 71 RKATNNFSESNLIGEGGFGTVYKGVLS----DGTVVAVKRLSSN-----------------------------SGQG-ER 116 (361)
T ss_pred HHHHhCCchhcceecCCCeEEEEEEEC----CCCEEEEEEecCC-----------------------------CCcc-hh
Confidence 456678888899999999999999986 4689999987542 1111 35
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCC-eEEEEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC-
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDD-NIYIVMELCKGGELLDRILSRGG-KYSEEDAKIVMVQILSVVAFCHFQG- 273 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~- 273 (482)
+|.+|+.++.+++ |||+|+|+|||.+.+ ..+||+||+++|+|.+++..... .++|....+|+.+++.||.|||...
T Consensus 117 eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~ 195 (361)
T KOG1187|consen 117 EFLNEVEILSRLR-HPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCP 195 (361)
T ss_pred HHHHHHHHHhcCC-CcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCC
Confidence 5999999999998 999999999999999 59999999999999999987765 8999999999999999999999964
Q ss_pred --CcccCCCCCceEEecCCCCCcEEEEecccccccCC-CCccccc-ccCccccCccccc-ccCCCcchhhhhHHHHHHHh
Q 011582 274 --VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP-DERLNDI-VGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 274 --ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~-~~~~~~~-~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ell 348 (482)
|||||||++|||| |++.+.||+|||+|+.... .....+. .||.+|+|||++. +..+.|+|||||||+|.||+
T Consensus 196 ~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEli 272 (361)
T KOG1187|consen 196 PPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELI 272 (361)
T ss_pred CCEecCCCCHHHeeE---CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHH
Confidence 9999999999999 7899999999999976554 3333333 8999999999886 67999999999999999999
Q ss_pred hCCCCCCCCC---h---HHHHHHHHhcC--CCCCCCCC--CCCC--HH---HHHHHHHhchhccccCCCHHHHhc
Q 011582 349 CGSRPFWART---E---SGIFRAVLKAD--PSFDEAPW--PSLS--PE---AIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 349 tg~~pf~~~~---~---~~~~~~i~~~~--~~~~~~~~--~~~s--~~---~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||+.+..... . .+......... ..+.++.. ...+ .+ +..+..+|++.+|..||++.+++.
T Consensus 273 tgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 273 TGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred hCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 9998876432 1 11111222211 11111111 1233 22 457788999999999999998643
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=338.99 Aligned_cols=252 Identities=20% Similarity=0.284 Sum_probs=206.1
Q ss_pred cceEecceeecCCceEEEEEEEecC-CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKG-SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~-~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+|++.+.||+|+||.||+|++... ...+..||||++... ......+.+.
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-----------------------------~~~~~~~~~~ 57 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-----------------------------TSPKANKEIL 57 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-----------------------------CCHHHHHHHH
Confidence 5799999999999999999987641 112335899987532 2234456788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. ||||+++++++... ..++|+||+++|+|.+++......+++..+..++.||+.||.|||++||+||||
T Consensus 58 ~e~~~l~~l~-h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dl 135 (316)
T cd05108 58 DEAYVMASVD-NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDL 135 (316)
T ss_pred HHHHHHHhCC-CCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeecccc
Confidence 9999999996 99999999998764 578999999999999999876667999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcc---cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERL---NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
||+|||+ +.++.+||+|||+++........ ....++..|+|||++. ..++.++|||||||++|||++ |..||
T Consensus 136 kp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~ 212 (316)
T cd05108 136 AARNVLV---KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 212 (316)
T ss_pred chhheEe---cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCC
Confidence 9999999 56778999999999876543322 2233467899999876 468999999999999999997 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.+....++.. +.......+.. +.++.++.+++.+||..||.+||++.+++.+
T Consensus 213 ~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 213 DGIPASEISS-ILEKGERLPQP--PICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCHHHHHH-HHhCCCCCCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8877666544 44433333322 3478899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=330.04 Aligned_cols=254 Identities=28% Similarity=0.496 Sum_probs=213.6
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
+-|++.+.||+|+||.||+|.+.. +|..||||++... ........+.+
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~---~~~~~aiK~~~~~-----------------------------~~~~~~~~~~~ 51 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLE-----------------------------EAEDEIEDIQQ 51 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECC---CCcEEEEEEeccc-----------------------------cchHHHHHHHH
Confidence 347888999999999999998876 7899999987542 12233467889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. ||||+++++++.+++..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+|||
T Consensus 52 e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~ 128 (277)
T cd06641 52 EITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIK 128 (277)
T ss_pred HHHHHHhcC-CCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCC
Confidence 999999996 99999999999999999999999999999988743 468999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+||++ +.++.++|+|||++....... ......|+..|+|||.+.. .++.++|+|||||++|+|++|..||....
T Consensus 129 p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 129 AANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred HHhEEE---CCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 999999 567789999999987654322 2234568899999998864 57889999999999999999999998777
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.......+...... .....++.++.++|.+||..+|.+||++.++++||||.+.
T Consensus 206 ~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~ 259 (277)
T cd06641 206 PMKVLFLIPKNNPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259 (277)
T ss_pred hHHHHHHHhcCCCC---CCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence 66655555433221 1123478999999999999999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=336.64 Aligned_cols=259 Identities=29% Similarity=0.470 Sum_probs=211.7
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++.+.||+|+||.||+|..+. +|+.||||+++... ........
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~~----------------------------~~~~~~~~ 52 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKD---TGELVALKKVRLDN----------------------------EKEGFPIT 52 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECC---CCcEEEEEEEeecc----------------------------cccCchHH
Confidence 456789999999999999999999976 78999999986531 11112245
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCC----------eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDD----------NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVA 267 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~----------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~ 267 (482)
+.+|+.+++.++ ||||+++++++.+.. .+|+||||+++ +|...+......+++..+..++.|++.||.
T Consensus 53 ~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~ 130 (302)
T cd07864 53 AIREIKILRQLN-HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLN 130 (302)
T ss_pred HHHHHHHHHhCC-CCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 678999999996 999999999987655 89999999976 777777665567999999999999999999
Q ss_pred HHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc--cCCCcchhhhhHHH
Q 011582 268 FCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVI 343 (482)
Q Consensus 268 yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvi 343 (482)
|||+.||+||||||+||++ ++++.+||+|||++....... ......++..|+|||.+.+ .++.++|||||||+
T Consensus 131 ~LH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~ 207 (302)
T cd07864 131 YCHKKNFLHRDIKCSNILL---NNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCI 207 (302)
T ss_pred HHHhCCeecCCCCHHHEEE---CCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHH
Confidence 9999999999999999999 667889999999998764332 2233456888999998753 47889999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhchhcc
Q 011582 344 AYILLCGSRPFWARTESGIFRAVLKADPSFDE--------------------------APWPSLSPEAIDFVKRLLNKDY 397 (482)
Q Consensus 344 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP 397 (482)
+|+|++|+.||......+.+..+......... ..+..++..+.++|.+||..||
T Consensus 208 ~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 287 (302)
T cd07864 208 LGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDP 287 (302)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCCh
Confidence 99999999999877766665555443211110 1133578999999999999999
Q ss_pred ccCCCHHHHhcCccc
Q 011582 398 RKRLTAAQALSHPWL 412 (482)
Q Consensus 398 ~~R~s~~e~L~hp~~ 412 (482)
.+||++.+++.||||
T Consensus 288 ~~Rp~~~~il~~~~~ 302 (302)
T cd07864 288 SKRCTAEEALNSPWL 302 (302)
T ss_pred hhCCCHHHHhcCCCC
Confidence 999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=326.05 Aligned_cols=243 Identities=23% Similarity=0.365 Sum_probs=201.4
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|+++. +|+.||+|.+.+. ........+.+|+.+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~---~~~~~a~k~~~~~-----------------------------~~~~~~~~~~~e~~~l~ 48 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRA---DNTPVAVKSCRET-----------------------------LPPDLKAKFLQEARILK 48 (252)
T ss_pred CccCcccCccEEEEEEec---CCceEEEEecCcc-----------------------------CCHHHHHHHHHHHHHHH
Confidence 369999999999999976 7899999987542 22344567899999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+. ||||+++++++...+..|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||||+|||+
T Consensus 49 ~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~ 127 (252)
T cd05084 49 QYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV 127 (252)
T ss_pred hCC-CCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE
Confidence 996 9999999999999999999999999999999887666679999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCCCCcc---cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCCChHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKPDERL---NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWARTESG 361 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~ 361 (482)
+.++.+||+|||++......... ....++..|+|||.+. +.++.++|||||||++|+|++ |..||.......
T Consensus 128 ---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~ 204 (252)
T cd05084 128 ---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ 204 (252)
T ss_pred ---cCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH
Confidence 56778999999998765432111 1112345799999886 468999999999999999997 999998777666
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 362 IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 362 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
....+..... . .....++..+.+||.+||+.||.+|||+.+++.
T Consensus 205 ~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 205 TREAIEQGVR-L--PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHcCCC-C--CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6555544321 1 222357899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=336.77 Aligned_cols=254 Identities=28% Similarity=0.483 Sum_probs=212.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
+.|.+.+.||+|+||.||+|.+.. +|..||+|++... ......+.+.+
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~---~~~~vaiK~~~~~-----------------------------~~~~~~~~~~~ 51 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNR---TKEVVAIKIIDLE-----------------------------EAEDEIEDIQQ 51 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcC---CCeEEEEEEeccc-----------------------------cchHHHHHHHH
Confidence 457788899999999999999876 7889999998642 12234567899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. ||||+++++++..++..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+
T Consensus 52 e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~ 128 (277)
T cd06642 52 EITVLSQCD-SPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIK 128 (277)
T ss_pred HHHHHHcCC-CCccHhhhcccccCCceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCC
Confidence 999999996 99999999999999999999999999999987743 578999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+||++ +.++.++|+|||++....... ......|+..|+|||.+.+ .++.++|||||||++|+|++|..||....
T Consensus 129 p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 129 AANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred hheEEE---eCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 999999 567789999999997664332 2233468899999998865 58889999999999999999999997665
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.......+...... ..-..++.++.++|.+||..+|.+||++.++++||||...
T Consensus 206 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 206 PMRVLFLIPKNSPP---TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred hhhHHhhhhcCCCC---CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence 55544443332211 1112478899999999999999999999999999999764
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=348.50 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=204.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCC--CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGS--LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~--~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|.+++.||+|+||.||+|++.... ..+..||||++... ......+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-----------------------------~~~~~~~~ 86 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT-----------------------------ARSSEKQA 86 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC-----------------------------CChHHHHH
Confidence 458999999999999999999875321 13457999998642 12233467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC------------------------------
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG------------------------------ 247 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------ 247 (482)
+.+|+.+|+++..||||+++++++.+.+..|||||||++|+|.+++....
T Consensus 87 ~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (400)
T cd05105 87 LMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSY 166 (400)
T ss_pred HHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccch
Confidence 89999999999669999999999999999999999999999998876421
Q ss_pred -----------------------------------------------------------------CCCCHHHHHHHHHHH
Q 011582 248 -----------------------------------------------------------------GKYSEEDAKIVMVQI 262 (482)
Q Consensus 248 -----------------------------------------------------------------~~l~~~~~~~i~~qi 262 (482)
..+++..+..++.||
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi 246 (400)
T cd05105 167 VILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQV 246 (400)
T ss_pred hhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHH
Confidence 247888899999999
Q ss_pred HHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhh
Q 011582 263 LSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMW 338 (482)
Q Consensus 263 ~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Diw 338 (482)
+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... .....++..|+|||.+. ..++.++|||
T Consensus 247 ~~aL~~LH~~~ivH~dikp~Nill---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 323 (400)
T cd05105 247 ARGMEFLASKNCVHRDLAARNVLL---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVW 323 (400)
T ss_pred HHHHHHHHhCCeeCCCCChHhEEE---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHH
Confidence 999999999999999999999999 5677899999999986543221 22345678899999876 4689999999
Q ss_pred hhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 339 SIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 339 SlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||||++|+|++ |..||........+........... ....++.++.++|.+||..||++||++.++.+
T Consensus 324 SlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 99999999997 9999987654444333333332222 22458899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.81 Aligned_cols=255 Identities=27% Similarity=0.388 Sum_probs=203.6
Q ss_pred cceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
++|++.+.||+|+||.||+|+... ...+++.||+|++... ........+
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~-----------------------------~~~~~~~~~ 57 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEG-----------------------------ATASEYKAL 57 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCC-----------------------------CCHHHHHHH
Confidence 589999999999999999997643 1125688999988542 122334567
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEe-CCeEEEEEecCCCCChHHHHHhcC------------------------------
Q 011582 199 RREVKILRALTGHKNLVQFYDAYED-DDNIYIVMELCKGGELLDRILSRG------------------------------ 247 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~------------------------------ 247 (482)
.+|+.++.++.+|+||+++++++.. +..++++|||+++++|.+++....
T Consensus 58 ~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (337)
T cd05054 58 MTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVS 137 (337)
T ss_pred HHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCC
Confidence 8899999999669999999998765 467899999999999999885421
Q ss_pred ------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEE
Q 011582 248 ------------------------------GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKA 297 (482)
Q Consensus 248 ------------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl 297 (482)
..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~~~~~vkL 214 (337)
T cd05054 138 SSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---SENNVVKI 214 (337)
T ss_pred ccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---eCCCcEEE
Confidence 267899999999999999999999999999999999999 45778999
Q ss_pred EecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCC
Q 011582 298 IDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPS 372 (482)
Q Consensus 298 ~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~ 372 (482)
+|||++..+..... .....++..|+|||++. ..++.++|||||||++|+|++ |..||.+....+.+.........
T Consensus 215 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 294 (337)
T cd05054 215 CDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTR 294 (337)
T ss_pred eccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCC
Confidence 99999987643221 22345677899999775 569999999999999999998 99999876544444444333222
Q ss_pred CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 373 FDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 373 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
... ....++++.+++.+||+.+|.+||++.++++|
T Consensus 295 ~~~--~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 295 MRA--PEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred CCC--CccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 211 13478999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=330.42 Aligned_cols=255 Identities=18% Similarity=0.278 Sum_probs=208.2
Q ss_pred cccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..++|++.+.||+|+||.||+|.+... ...+..||||++... .......
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-----------------------------~~~~~~~ 54 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA-----------------------------ASMRERI 54 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc-----------------------------CCHHHHH
Confidence 356899999999999999999987531 124678999987542 1122345
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------GKYSEEDAKIVMVQILSVVA 267 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~ 267 (482)
.+.+|+.+++.+. ||||+++++++.+.+..++||||+++++|.+++.... ..+++..+..++.|++.||.
T Consensus 55 ~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 133 (277)
T cd05062 55 EFLNEASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133 (277)
T ss_pred HHHHHHHHHHhCC-CCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHH
Confidence 6889999999996 9999999999999999999999999999999886532 23577889999999999999
Q ss_pred HHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHH
Q 011582 268 FCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVI 343 (482)
Q Consensus 268 yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvi 343 (482)
|||+.|++||||||+||++ +.++.+||+|||++........ .....++..|||||++. +.++.++|||||||+
T Consensus 134 ~lH~~~~vH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~ 210 (277)
T cd05062 134 YLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 210 (277)
T ss_pred HHHHCCcccCCcchheEEE---cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHH
Confidence 9999999999999999999 5678899999999876543221 12234578899999886 468999999999999
Q ss_pred HHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 344 AYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 344 l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
+|+|++ |..||.+.+..+....+........ ...++..+.++|.+||+.||++|||+.+++++
T Consensus 211 l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 211 LWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999 7899988887777776665443211 13478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=323.68 Aligned_cols=253 Identities=30% Similarity=0.534 Sum_probs=218.2
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.+.+.||+|+||.||+|.+.. ++..||+|++... .........+.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~----------------------------~~~~~~~~~~~~e 49 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKS---DGKLYVLKEIDLS----------------------------NMSEKEREDALNE 49 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcC---CCcEEEEEEeecc----------------------------cCChHHHHHHHHH
Confidence 58899999999999999999876 7899999998643 1223455678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+++++.++ |+|++++++.+...+..++||||+++++|.+++... +..+++..+..++.|++.||.|||++|++|+|
T Consensus 50 ~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~d 128 (258)
T cd08215 50 VKILKKLN-HPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRD 128 (258)
T ss_pred HHHHHhcC-CCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEeccc
Confidence 99999997 999999999999999999999999999999988765 37899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|+|+||++ +.++.++|+|||++....... ......|++.|+|||.+.+ .++.++|+||+|+++++|++|..||..
T Consensus 129 l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 205 (258)
T cd08215 129 IKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEG 205 (258)
T ss_pred CChHHeEE---cCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCC
Confidence 99999999 567789999999998765433 2344578999999998754 588999999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
....++...+........ ...++.++.++|.+||..+|.+||++.++|+||||
T Consensus 206 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 206 ENLLELALKILKGQYPPI---PSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CcHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 877777776665442211 12578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=331.96 Aligned_cols=251 Identities=25% Similarity=0.388 Sum_probs=209.9
Q ss_pred cceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
.+|.+.+.||+|+||.||++.+... ..++..+|+|.+.+. .......+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~------------------------------~~~~~~~~ 54 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA------------------------------SDNARKDF 54 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc------------------------------CHHHHHHH
Confidence 5799999999999999999986432 124567999987542 23445678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC------------CCCCHHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG------------GKYSEEDAKIVMVQILSVV 266 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~qi~~~L 266 (482)
.+|+.+++++. ||||+++++++...+.+++||||+++++|.+++.... ..+++..+..++.|++.||
T Consensus 55 ~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL 133 (288)
T cd05093 55 HREAELLTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGM 133 (288)
T ss_pred HHHHHHHHhCC-CCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHH
Confidence 99999999996 9999999999999999999999999999999886442 2489999999999999999
Q ss_pred HHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHH
Q 011582 267 AFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGV 342 (482)
Q Consensus 267 ~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGv 342 (482)
.|||++|++||||||+|||+ +.++.+||+|||++........ .....++..|+|||.+. ..++.++|||||||
T Consensus 134 ~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~ 210 (288)
T cd05093 134 VYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210 (288)
T ss_pred HHHHhCCeeecccCcceEEE---ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHH
Confidence 99999999999999999999 5678899999999986543221 22344578899999886 45899999999999
Q ss_pred HHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 343 IAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 343 il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
++|+|++ |..||......+....+........ ...++.++.+|+.+||+.||.+|||+.+++.
T Consensus 211 il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 211 VLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999998 9999988888888888776543211 1347899999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=343.84 Aligned_cols=261 Identities=33% Similarity=0.563 Sum_probs=210.4
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||.|+||.||+|.++. +|..||+|++.+.. ........+.
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~valK~~~~~~----------------------------~~~~~~~~~~ 52 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTR---SGKKVAIKKIPHAF----------------------------DVPTLAKRTL 52 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcC---CCCEEEEEEecccc----------------------------ccccchHHHH
Confidence 4689999999999999999999887 79999999986530 1122345677
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 200 REVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
+|+.+|+++. ||||+++++++.. ...+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+
T Consensus 53 ~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~iv 129 (334)
T cd07855 53 RELKILRHFK-HDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVI 129 (334)
T ss_pred HHHHHHHhcC-CCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 8999999997 9999999998763 457899999995 588887644 45699999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCC-----cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHh
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ell 348 (482)
||||||+||++ +.++.+||+|||++....... ......|+..|+|||++.+ .++.++|||||||++|+|+
T Consensus 130 H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~ 206 (334)
T cd07855 130 HRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206 (334)
T ss_pred cCCCCHHHEEE---cCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHH
Confidence 99999999999 567889999999987654322 1234578999999998753 5889999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhcC-----------------------CCCCCC----CCCCCCHHHHHHHHHhchhccccCC
Q 011582 349 CGSRPFWARTESGIFRAVLKAD-----------------------PSFDEA----PWPSLSPEAIDFVKRLLNKDYRKRL 401 (482)
Q Consensus 349 tg~~pf~~~~~~~~~~~i~~~~-----------------------~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~ 401 (482)
+|+.||.+.+....+..+.... ...... .++.+++++.++|++||+.||.+||
T Consensus 207 ~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 286 (334)
T cd07855 207 GRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI 286 (334)
T ss_pred cCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc
Confidence 9999998766544333322211 111111 1245789999999999999999999
Q ss_pred CHHHHhcCcccccCCC
Q 011582 402 TAAQALSHPWLANSHD 417 (482)
Q Consensus 402 s~~e~L~hp~~~~~~~ 417 (482)
++++++.||||.+...
T Consensus 287 t~~~~l~~~~~~~~~~ 302 (334)
T cd07855 287 TVEQALQHPFLAQYHD 302 (334)
T ss_pred CHHHHHhChhhhhccC
Confidence 9999999999986553
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=330.12 Aligned_cols=255 Identities=30% Similarity=0.458 Sum_probs=209.4
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|++.+.||+|+||.||+|+.+. +|+.||+|++.... ........+.+|+
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~---~~~~~aiK~~~~~~----------------------------~~~~~~~~~~~e~ 49 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLN---TGRFVALKKVRVPL----------------------------SEEGIPLSTLREI 49 (287)
T ss_pred CeEEEEecccCceEEEEEEECC---CCCEEEEEEecccc----------------------------ccchhhhhHHHHH
Confidence 6788999999999999999876 68999999986431 1111224566788
Q ss_pred HHHHhhc--CCCCcceeeEEEEeCCe-----EEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011582 203 KILRALT--GHKNLVQFYDAYEDDDN-----IYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGV 274 (482)
Q Consensus 203 ~~l~~l~--~hpniv~l~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~i 274 (482)
.+++++. +|+||+++++++.+.+. ++++|||+.+ +|.+++.... ..+++..+..++.|++.||.|||+.|+
T Consensus 50 ~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i 128 (287)
T cd07838 50 ALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRI 128 (287)
T ss_pred HHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 8887764 49999999999998877 9999999975 7888776533 369999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCC
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~p 353 (482)
+|+||+|+||++ +.++.+||+|||++.............++..|+|||++.+ .++.++|+|||||++|+|++|.+|
T Consensus 129 ~h~~l~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~ 205 (287)
T cd07838 129 VHRDLKPQNILV---TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPL 205 (287)
T ss_pred eeccCChhhEEE---ccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCc
Confidence 999999999999 5668899999999987655544455668999999998864 588999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCC-----------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCc
Q 011582 354 FWARTESGIFRAVLKADPSFD-----------------------EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 410 (482)
|.+....+.+..+........ ....+.+++++.++|.+||+.||.+||++++++.||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~ 285 (287)
T cd07838 206 FRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP 285 (287)
T ss_pred ccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence 998888777776654321100 001124578889999999999999999999999999
Q ss_pred cc
Q 011582 411 WL 412 (482)
Q Consensus 411 ~~ 412 (482)
||
T Consensus 286 ~~ 287 (287)
T cd07838 286 YF 287 (287)
T ss_pred CC
Confidence 97
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=327.65 Aligned_cols=250 Identities=34% Similarity=0.575 Sum_probs=213.3
Q ss_pred eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhh
Q 011582 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL 208 (482)
Q Consensus 129 LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l 208 (482)
||.|+||.||+|++.. +|+.||+|++.+.. .......+.+.+|+.+++++
T Consensus 1 lg~g~~~~vy~~~~~~---~~~~~~~k~~~~~~---------------------------~~~~~~~~~~~~e~~~l~~~ 50 (265)
T cd05579 1 ISKGAYGRVFLAKKKS---TGDIYAIKVIKKAD---------------------------MIRKNQVDQVLTERDILSQA 50 (265)
T ss_pred CCCCCceEEEEEEECC---CCCEEEEEEecchh---------------------------hhhhhHHHHHHHHHHHHHhC
Confidence 6899999999999876 69999999986531 12234567889999999999
Q ss_pred cCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 011582 209 TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTS 288 (482)
Q Consensus 209 ~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~ 288 (482)
. ||||+++++.+..++..|+||||+++++|.+++... +.+++..+..++.||+.||.|||++|++||||+|+||++
T Consensus 51 ~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~-- 126 (265)
T cd05579 51 Q-SPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI-- 126 (265)
T ss_pred C-CcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE--
Confidence 7 999999999999999999999999999999988654 479999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecccccccCCCC---------cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 289 KEENSSLKAIDFGLSDYVKPDE---------RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 289 ~~~~~~~kl~DfGla~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
+.++.++|+|||++....... ......++..|+|||.+.+ .++.++||||||+++|+|++|..||....
T Consensus 127 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 127 -DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred -cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 567789999999987643321 2234568899999998754 58889999999999999999999999888
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH---HHHhcCcccccC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA---AQALSHPWLANS 415 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~---~e~L~hp~~~~~ 415 (482)
..+....+......++.. ..++.++.++|.+||+.+|.+|||+ .++|+||||++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~ 263 (265)
T cd05579 206 PEEIFQNILNGKIEWPED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI 263 (265)
T ss_pred HHHHHHHHhcCCcCCCcc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence 888887777655443322 2358999999999999999999999 999999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=337.12 Aligned_cols=257 Identities=29% Similarity=0.455 Sum_probs=207.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|.+.+.||+|+||.||+|+++. +|+.||||++.... ........+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~~----------------------------~~~~~~~~~~ 55 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIK---TGRVVALKKILMHN----------------------------EKDGFPITAL 55 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEEecc----------------------------CCCCcchhHH
Confidence 5789999999999999999999876 78999999986531 0111123467
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeC--------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDD--------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+|+.+++.+. ||||+++++++.+. ..+|+||||+.+ +|...+......+++..+..++.|+++||.|||+
T Consensus 56 ~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~ 133 (311)
T cd07866 56 REIKILKKLK-HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHE 133 (311)
T ss_pred HHHHHHHhcC-CCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 8999999996 99999999987543 357999999965 7777776656689999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc------------ccccccCccccCcccccc--cCCCcchh
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER------------LNDIVGSAYYVAPEVLHR--SYGTEADM 337 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~------------~~~~~gt~~y~aPE~~~~--~~~~~~Di 337 (482)
+||+||||||+||++ +.++.+||+|||++........ .....|++.|+|||.+.+ .++.++||
T Consensus 134 ~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv 210 (311)
T cd07866 134 NHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDI 210 (311)
T ss_pred CCeecCCCCHHHEEE---CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHh
Confidence 999999999999999 6678899999999976543211 123467889999998753 48899999
Q ss_pred hhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCC--------------------------CCCCCCHHHHHHHHH
Q 011582 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA--------------------------PWPSLSPEAIDFVKR 391 (482)
Q Consensus 338 wSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~--------------------------~~~~~s~~~~~li~~ 391 (482)
|||||++|+|++|++||.+.+.......+.......... .+..+++++.+||.+
T Consensus 211 ~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 290 (311)
T cd07866 211 WGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSK 290 (311)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHH
Confidence 999999999999999998888776666554422111110 123456789999999
Q ss_pred hchhccccCCCHHHHhcCccc
Q 011582 392 LLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 392 ~L~~dP~~R~s~~e~L~hp~~ 412 (482)
||..||.+|||+.+++.||||
T Consensus 291 ~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 291 LLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HcccCcccCcCHHHHhcCCCC
Confidence 999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=367.24 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=205.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.++||+|+||.||+|++.. +|+.||||++.+.. .......+++.+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~---tg~~VAIK~I~~~l---------------------------~~~e~~~~rflr 51 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPV---CSRRVALKKIREDL---------------------------SENPLLKKRFLR 51 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECC---CCcEEEEEEECccc---------------------------ccCHHHHHHHHH
Confidence 589999999999999999999876 79999999986531 122334567899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHH
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR----------GGKYSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----------~~~l~~~~~~~i~~qi~~~L~yLH 270 (482)
|+.+++.+. ||||+++++++.+.+..|+||||++||+|.+++... ...++...+..++.||+.||.|||
T Consensus 52 Ei~ILs~L~-HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH 130 (932)
T PRK13184 52 EAKIAADLI-HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH 130 (932)
T ss_pred HHHHHHhCC-CcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH
Confidence 999999997 999999999999999999999999999999987532 124566788899999999999999
Q ss_pred HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC-------------------cccccccCccccCcccccc-c
Q 011582 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-------------------RLNDIVGSAYYVAPEVLHR-S 330 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-------------------~~~~~~gt~~y~aPE~~~~-~ 330 (482)
++||+||||||+|||+ +.++.+||+|||++....... .....+||+.|||||++.+ .
T Consensus 131 s~GIIHRDLKPeNILL---d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~ 207 (932)
T PRK13184 131 SKGVLHRDLKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP 207 (932)
T ss_pred HCCccccCCchheEEE---cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC
Confidence 9999999999999999 667789999999998652110 1123579999999998864 5
Q ss_pred CCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 331 YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 331 ~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
++.++|||||||++|+|+||..||.......+........+ .....+..+++.+.+++.+||..||++|++..+.|.+
T Consensus 208 ~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P-~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 208 ASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSP-IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccCh-hhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 89999999999999999999999987655443322111111 1112245689999999999999999999887776654
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=328.44 Aligned_cols=252 Identities=26% Similarity=0.492 Sum_probs=208.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|+... +|..||||.+.+. ..........+.+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~---~~~~~~vK~~~~~---------------------------~~~~~~~~~~~~~ 51 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLL---DGVPVALKKVQIF---------------------------DLMDAKARADCIK 51 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecC---CCceEEEEeeeeh---------------------------hhhhHHHHHHHHH
Confidence 578999999999999999999876 7899999988652 1122334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
|+.+++.+. |+||+++++++.+++..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++|++|+
T Consensus 52 e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~ 130 (267)
T cd08229 52 EIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHR 130 (267)
T ss_pred HHHHHHHcc-CCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecC
Confidence 999999996 99999999999999999999999999999987753 23568999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+||++ +.++.++|+|||++....... ......|+..|+|||++.+ .++.++|+||||+++|+|++|..||.
T Consensus 131 dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 207 (267)
T cd08229 131 DIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CCCHHHEEE---cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcc
Confidence 999999999 567789999999987764332 2334578999999998864 58889999999999999999999997
Q ss_pred CCCh--HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 356 ARTE--SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 356 ~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+... ......+... .++...+..+++++.++|.+||..||.+|||+.++++
T Consensus 208 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 208 GDKMNLYSLCKKIEQC--DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred cccchHHHHhhhhhcC--CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 6543 2333333332 2222333458899999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=348.31 Aligned_cols=238 Identities=25% Similarity=0.359 Sum_probs=203.6
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
++-||.|+.|.||+++. .++.||||.++. .-..+|+-|
T Consensus 129 LeWlGSGaQGAVF~Grl-----~netVAVKKV~e-------------------------------------lkETdIKHL 166 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRL-----HNETVAVKKVRE-------------------------------------LKETDIKHL 166 (904)
T ss_pred hhhhccCcccceeeeec-----cCceehhHHHhh-------------------------------------hhhhhHHHH
Confidence 45599999999999987 478999998632 234688999
Q ss_pred HhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 011582 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL 285 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIl 285 (482)
++|+ ||||+.+.|+|.....+|||||||..|.|...|.. +..++......|..+|+.|+.|||.+.|||||||.-|||
T Consensus 167 RkLk-H~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiL 244 (904)
T KOG4721|consen 167 RKLK-HPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNIL 244 (904)
T ss_pred Hhcc-CcceeeEeeeecCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceE
Confidence 9997 99999999999999999999999999999997754 468999999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 286 FTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 286 l~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
|+ .+..|||+|||-++-.........++||..|||||+++. ..+.|+|||||||+|||||||..||.+-+...++-
T Consensus 245 Is---~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw 321 (904)
T KOG4721|consen 245 IS---YDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW 321 (904)
T ss_pred ee---ccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEE
Confidence 95 455699999999988776666778999999999999975 58999999999999999999999997766655544
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.+-......+ .-...++.++=||++|+.-.|..||+..++|.|-=+
T Consensus 322 GVGsNsL~Lp--vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI 367 (904)
T KOG4721|consen 322 GVGSNSLHLP--VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI 367 (904)
T ss_pred eccCCccccc--CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence 3333322222 224578899999999999999999999999998544
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=329.76 Aligned_cols=260 Identities=20% Similarity=0.300 Sum_probs=210.7
Q ss_pred ccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++.+.||+|+||.||+|..+.. ...+..||+|.+... ........
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~ 55 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNES-----------------------------ASLRERIE 55 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCc-----------------------------CCHHHHHH
Confidence 46899999999999999999976531 113568999987542 11223346
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------GKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~y 268 (482)
+.+|+.+++.+. ||||+++++++.+.+..|+||||+++|+|.+++.... ..++...+..++.|++.||.|
T Consensus 56 ~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 134 (288)
T cd05061 56 FLNEASVMKGFT-CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 134 (288)
T ss_pred HHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 788999999996 9999999999999999999999999999999986532 235677889999999999999
Q ss_pred HHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHHH
Q 011582 269 CHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIA 344 (482)
Q Consensus 269 LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil 344 (482)
||++||+||||||+|||+ +.++.+||+|||+++....... .....++..|+|||.+. +.++.++|||||||++
T Consensus 135 lH~~~i~H~dikp~nili---~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l 211 (288)
T cd05061 135 LNAKKFVHRDLAARNCMV---AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211 (288)
T ss_pred HHhCCCcCCCCChheEEE---cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence 999999999999999999 5677899999999876533221 12234567899999876 4689999999999999
Q ss_pred HHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc------CcccccC
Q 011582 345 YILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS------HPWLANS 415 (482)
Q Consensus 345 ~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~------hp~~~~~ 415 (482)
|+|++ |..||.+....+....+........ ...+++++.++|.+||+.||++|||+.++++ ||||...
T Consensus 212 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~ 286 (288)
T cd05061 212 WEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEV 286 (288)
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCC
Confidence 99998 7899988887777776655432111 1246899999999999999999999999987 8988753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=331.31 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=217.2
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
....|...+.||+|+||.||+|++.. +|..||+|++.+. ..........+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~---~~~~valK~~~~~---------------------------~~~~~~~~~~~ 72 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVR---TNEVVAIKKMSYS---------------------------GKQSNEKWQDI 72 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcC---CCcEEEEEEEecC---------------------------CCCchHHHHHH
Confidence 34558889999999999999999876 7899999998653 11223345678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. |||++++++++.+++..|+||||+.| +|.+.+......+++.++..++.|++.||.|||++||+|||
T Consensus 73 ~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~d 150 (317)
T cd06635 73 IKEVKFLQRIK-HPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150 (317)
T ss_pred HHHHHHHHhCC-CCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 89999999996 99999999999999999999999975 78887766667799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~~pf 354 (482)
|+|+||++ +.++.+||+|||++..... .....|++.|+|||.+. +.++.++|||||||++|+|++|..||
T Consensus 151 L~p~Nil~---~~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~ 224 (317)
T cd06635 151 IKAGNILL---TEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224 (317)
T ss_pred CCcccEEE---CCCCCEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 99999999 5677899999999875432 23457889999999863 45889999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
...........+....... .....+++.+.+||.+||+.+|.+||++.++++|+|+.....
T Consensus 225 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 225 FNMNAMSALYHIAQNESPT--LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred CCccHHHHHHHHHhccCCC--CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 8877766666665543321 122357889999999999999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=340.36 Aligned_cols=259 Identities=29% Similarity=0.550 Sum_probs=213.0
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|.+.+.||+|+||.||+|.+.. +|..||||++.+. .........
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----------------------------~~~~~~~~~ 60 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRR---TGAKVAIKKLYRP----------------------------FQSELFAKR 60 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECC---CCcEEEEEEeccc----------------------------ccchHHHHH
Confidence 356789999999999999999999876 7999999998542 012233456
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCC------eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDD------NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+.+|+.+|+.+. ||||+++++++..+. .+++||||+ +++|.+++.. ..+++..+..++.||+.||.|||+
T Consensus 61 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~ 136 (343)
T cd07880 61 AYRELRLLKHMK-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHA 136 (343)
T ss_pred HHHHHHHHHhcC-CCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 889999999996 999999999987654 469999999 7788876643 579999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhh
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ellt 349 (482)
.||+||||||+||++ +.++.+||+|||++..... ......+++.|+|||.+.+ .++.++|+|||||++|+|++
T Consensus 137 ~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~ 211 (343)
T cd07880 137 AGIIHRDLKPGNLAV---NEDCELKILDFGLARQTDS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLT 211 (343)
T ss_pred CCeecCCCCHHHEEE---cCCCCEEEeeccccccccc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999999 5677899999999986543 2334577899999998764 48889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCC---------------------------CCCCCCCCHHHHHHHHHhchhccccCCC
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFD---------------------------EAPWPSLSPEAIDFVKRLLNKDYRKRLT 402 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s 402 (482)
|..||.+.+.......++......+ ...++.+++++.++|.+||..||.+|||
T Consensus 212 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t 291 (343)
T cd07880 212 GKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT 291 (343)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC
Confidence 9999988776555555444221110 0123467889999999999999999999
Q ss_pred HHHHhcCcccccCC
Q 011582 403 AAQALSHPWLANSH 416 (482)
Q Consensus 403 ~~e~L~hp~~~~~~ 416 (482)
+.+++.||||+...
T Consensus 292 ~~~~l~~~~~~~~~ 305 (343)
T cd07880 292 AAEALAHPYFEEFH 305 (343)
T ss_pred HHHHhcCccHhhhc
Confidence 99999999998754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=348.74 Aligned_cols=263 Identities=26% Similarity=0.490 Sum_probs=234.6
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
....+.+++..||.||||.|-++..+. ....+|+|+++|. ........+.
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~---~~~~fAlKilkK~---------------------------hIVdtkQqeH 466 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNS---QKATFALKILKKK---------------------------HIVDTKQQEH 466 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecc---cchHHHHHHHhHh---------------------------hccchhHHHH
Confidence 344667788889999999999998864 3335999999875 1234445678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+..|-.||..++ .|.||+||-.|.+....||.||-|-||.|...+.++ +.|++..++.++..+++|++|||++|||+|
T Consensus 467 v~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdR-g~Fdd~tarF~~acv~EAfeYLH~k~iIYR 544 (732)
T KOG0614|consen 467 VFSERNIMMECR-SDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDR-GSFDDYTARFYVACVLEAFEYLHRKGIIYR 544 (732)
T ss_pred HHhHHHHHHhcC-chHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhc-CCcccchhhhhHHHHHHHHHHHHhcCceec
Confidence 889999999997 999999999999999999999999999999977655 789999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccc-cccCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||||+|+|+ +.++.+||.|||+|+.+..+.++.++||||.|.|||++ ++..+.++|.||||+++||||+|.+||.+
T Consensus 545 DLKPENllL---d~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~ 621 (732)
T KOG0614|consen 545 DLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSG 621 (732)
T ss_pred cCChhheee---ccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999 78999999999999999999999999999999999976 56799999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccCCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANSHD 417 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~~~ 417 (482)
.+...++..|+++.-.+..+ ..++..+.+||+++-.-+|.+|.. +.++-+|.||.+...
T Consensus 622 ~dpmktYn~ILkGid~i~~P--r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdw 685 (732)
T KOG0614|consen 622 VDPMKTYNLILKGIDKIEFP--RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDW 685 (732)
T ss_pred CchHHHHHHHHhhhhhhhcc--cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCCh
Confidence 99999999999986544333 358999999999999999999986 899999999988764
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=319.59 Aligned_cols=251 Identities=34% Similarity=0.601 Sum_probs=212.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.+.+.||+|+||.||+|.+.. +|+.|++|++... .......+.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~~k~~~~~------------------------------~~~~~~~~~~e 47 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKR---TGKEVAIKVIKLE------------------------------SKEKKEKIINE 47 (253)
T ss_pred CceeeeeeccCCceEEEEEEECC---CCcEEEEEEeccc------------------------------chhHHHHHHHH
Confidence 48889999999999999999876 7899999998653 11345688999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.+. |+||+++++++...+..++++||+++++|.+++......+++..+..++.|++.||.|||++|++||||+|
T Consensus 48 ~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p 126 (253)
T cd05122 48 IQILKKCK-HPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKA 126 (253)
T ss_pred HHHHHhCC-CCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCH
Confidence 99999997 99999999999999999999999999999998876556899999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChH
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTES 360 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~ 360 (482)
+||++ ++++.++|+|||++.............|+..|+|||.+.+ .++.++||||||+++|+|++|..||...+..
T Consensus 127 ~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 203 (253)
T cd05122 127 ANILL---TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM 203 (253)
T ss_pred HHEEE---ccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH
Confidence 99999 5677899999999987655433455678999999998864 4788999999999999999999999877554
Q ss_pred HHHHHHHhcCCCCCCCCC-CCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 361 GIFRAVLKADPSFDEAPW-PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 361 ~~~~~i~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
.....+..... ..... ..++.++.++|.+||+.||.+|||+.++|.|||
T Consensus 204 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 204 KALFKIATNGP--PGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHHhcCC--CCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 44444433221 11111 124899999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=332.81 Aligned_cols=266 Identities=29% Similarity=0.487 Sum_probs=216.3
Q ss_pred cccccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccH
Q 011582 113 FGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTA 192 (482)
Q Consensus 113 ~~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (482)
+...+.+..+|.+...+|+|.||.|..+.+.. ++..||||+++.. .
T Consensus 81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~---~~~~vAlKIik~V-------------------------------~ 126 (415)
T KOG0671|consen 81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRE---TKEHVALKIIKNV-------------------------------D 126 (415)
T ss_pred EEeccccccceehhhhhcCCcccceEEEeecC---CCceehHHHHHHH-------------------------------H
Confidence 55667789999999999999999999999987 6899999998531 2
Q ss_pred HHHHHHHHHHHHHHhhcCC-C----CcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHH
Q 011582 193 IAIEDVRREVKILRALTGH-K----NLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVV 266 (482)
Q Consensus 193 ~~~~~~~~Ei~~l~~l~~h-p----niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L 266 (482)
...+..+-|+++|.++..+ | -+|.+.++|...++.|||+|.+ |-|+++++.+.+ .+|+...++.+..|+++++
T Consensus 127 kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv 205 (415)
T KOG0671|consen 127 KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESV 205 (415)
T ss_pred HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHH
Confidence 3345667899999999533 2 3788889999999999999999 669999997643 5699999999999999999
Q ss_pred HHHHHCCCcccCCCCCceEEecCC-----------------CCCcEEEEecccccccCCCCcccccccCccccCcccccc
Q 011582 267 AFCHFQGVVHRDLKPENFLFTSKE-----------------ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR 329 (482)
Q Consensus 267 ~yLH~~~ivHrDlkp~NIll~~~~-----------------~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~ 329 (482)
+|||+.+++|.||||+|||+.+.+ .+..|+|+|||.|++.... -..++.|..|+|||++.+
T Consensus 206 ~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~--hs~iVsTRHYRAPEViLg 283 (415)
T KOG0671|consen 206 AFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH--HSTIVSTRHYRAPEVILG 283 (415)
T ss_pred HHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC--cceeeeccccCCchheec
Confidence 999999999999999999996422 2456999999999875433 367889999999999987
Q ss_pred -cCCCcchhhhhHHHHHHHhhCCCCCCCCChHH---HHHHHHhcCCCC-------------CCCCCCCC-----------
Q 011582 330 -SYGTEADMWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPSF-------------DEAPWPSL----------- 381 (482)
Q Consensus 330 -~~~~~~DiwSlGvil~elltg~~pf~~~~~~~---~~~~i~~~~~~~-------------~~~~~~~~----------- 381 (482)
.++..+||||+||||+|+.||...|......+ +++.|+...+.. ....|++.
T Consensus 284 LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~ 363 (415)
T KOG0671|consen 284 LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFE 363 (415)
T ss_pred cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhc
Confidence 69999999999999999999999998887666 344443311100 00112211
Q ss_pred ---------------CHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 382 ---------------SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 382 ---------------s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
..++.|||++||.+||.+|+|+.|+|.||||...
T Consensus 364 ~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 364 PCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred CCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence 2457899999999999999999999999999754
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=328.56 Aligned_cols=257 Identities=20% Similarity=0.298 Sum_probs=209.7
Q ss_pred ccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|.+.+.||+|+||.||+|.+... ...+..||+|.+... ........
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~-----------------------------~~~~~~~~ 55 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES-----------------------------CSEQDESD 55 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC-----------------------------CCHHHHHH
Confidence 46799999999999999999998641 114678999987532 22333467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG------GKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+.+|+.+++.+. |+||+++++++.+.+..++||||++|++|.+++.... ..+++..+..++.||+.||.|||+
T Consensus 56 ~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 134 (277)
T cd05036 56 FLMEALIMSKFN-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE 134 (277)
T ss_pred HHHHHHHHHhCC-CCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 889999999996 9999999999999999999999999999999886543 258999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHHHHHH
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el 347 (482)
+|++||||||+|||++.++....+||+|||+++....... ......+..|+|||++. +.++.++|||||||++|+|
T Consensus 135 ~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el 214 (277)
T cd05036 135 NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214 (277)
T ss_pred CCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHH
Confidence 9999999999999997544456799999999987632221 11223356899999876 4699999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 348 LC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 348 lt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
++ |..||.+.+..+....+..... .. ....++.++.+++.+||..+|++||++.++|+|
T Consensus 215 ~~~g~~pf~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 215 FSLGYMPYPGRTNQEVMEFVTGGGR-LD--PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HcCCCCCCCCCCHHHHHHHHHcCCc-CC--CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 97 9999998887777666554322 11 123578999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=325.95 Aligned_cols=247 Identities=26% Similarity=0.399 Sum_probs=207.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|... .+..||||.+... ....+.+.+
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~----~~~~~aik~~~~~-------------------------------~~~~~~~~~ 48 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEG-------------------------------SMSEDEFIE 48 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec----CCCcEEEEEcCCC-------------------------------cccHHHHHH
Confidence 57999999999999999999764 3456999987542 011356889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. ||||+++++++.+.+..|+||||+.+|+|.+++......+++..++.++.||+.||.|||+.|++|+|||
T Consensus 49 e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 127 (256)
T cd05113 49 EAKVMMKLS-HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLA 127 (256)
T ss_pred HHHHHhcCC-CCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC
Confidence 999999996 9999999999999999999999999999999887655579999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcc--cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERL--NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
|+||++ +.++.+||+|||+++........ ....++..|+|||.+. ..++.++|||||||++|+|++ |..||..
T Consensus 128 p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~ 204 (256)
T cd05113 128 ARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER 204 (256)
T ss_pred cceEEE---cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCc
Confidence 999999 56778999999998765433221 1234567899999886 468999999999999999998 9999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.+..+....+......... ...+..+.+++.+||..||.+||++.+++.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 205 FNNSETVEKVSQGLRLYRP---HLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCHHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 8877777777665433222 2368999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=330.09 Aligned_cols=254 Identities=34% Similarity=0.532 Sum_probs=210.0
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|.+.+.||+|+||.||+|+... +++.||||++.+.. .........+|+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~---~~~~~~ik~~~~~~-----------------------------~~~~~~~~~~e~ 48 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKE---TGELVAIKKMKKKF-----------------------------YSWEECMNLREV 48 (283)
T ss_pred CeeheeeccCCceEEEEEEECC---CCcEEEEEEehhhc-----------------------------cchhHHHHHHHH
Confidence 6788999999999999999876 68899999986531 111123345789
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
..++++.+|+||+++++++.+++..|+||||+ +|+|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|
T Consensus 49 ~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~ 127 (283)
T cd07830 49 KSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKP 127 (283)
T ss_pred HHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCh
Confidence 99999966999999999999999999999999 779998886653 4789999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
+||++ +.++.++|+|||++.............|+..|+|||++.+ .++.++|+||||+++++|++|+.||.....
T Consensus 128 ~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~ 204 (283)
T cd07830 128 ENLLV---SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSE 204 (283)
T ss_pred hhEEE---cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCCh
Confidence 99999 5678899999999987665444556678999999998743 478999999999999999999999988776
Q ss_pred HHHHHHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 360 SGIFRAVLKADPSFDE--------------------------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.+....+......... ...+..+.++.+||++||..||.+|||++|++.||||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 205 IDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred HHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 6655544432111110 0112346889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=334.13 Aligned_cols=257 Identities=29% Similarity=0.503 Sum_probs=213.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||++.... ++..||+|.+... .....+.+.
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~------------------------------~~~~~~~~~ 64 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVA---TGQEVAIKQMNLQ------------------------------QQPKKELII 64 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcC---CCCEEEEEEeccc------------------------------cchHHHHHH
Confidence 4789999999999999999998765 6889999997532 122346788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. ||||+++++++...+..|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||
T Consensus 65 ~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL 141 (293)
T cd06647 65 NEILVMRENK-HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 141 (293)
T ss_pred HHHHHHhhcC-CCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccC
Confidence 9999999997 99999999999999999999999999999998754 36899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+||++ +.++.+||+|||++....... ......|++.|+|||.+. +.++.++|+|||||++|++++|+.||...
T Consensus 142 ~p~Nili---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~ 218 (293)
T cd06647 142 KSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNE 218 (293)
T ss_pred CHHHEEE---cCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999 567789999999987654332 233457889999999875 45889999999999999999999999876
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
+.......+.... ......+..++..+.++|.+||..+|.+||++.+++.|+||+...
T Consensus 219 ~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 219 NPLRALYLIATNG-TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred ChhhheeehhcCC-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 6544433332221 111122345788999999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=338.52 Aligned_cols=276 Identities=26% Similarity=0.385 Sum_probs=214.6
Q ss_pred ccccceEe-cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 118 QFVAHYEL-GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 118 ~~~~~y~~-~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
.+.++|.. .+.||.|+||.||+|+++. +|+.||||++...... ......... ........
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~---~~~~vaiK~~~~~~~~--------~~~~~~~~~--------~~~~~~~~ 65 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTL---TGKIVAIKKVKIIEIS--------NDVTKDRQL--------VGMCGIHF 65 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECC---CCCeEEEEEeeccccc--------cccccchhh--------hcccccch
Confidence 34567765 5679999999999999876 7999999998653110 000000000 00011123
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+.+++.+. |+||+++++++..++..|+||||+. |+|.+++.. ...+++..+..++.|++.||.|||+.||+|
T Consensus 66 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H 142 (335)
T PTZ00024 66 TTLRELKIMNEIK-HENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMH 142 (335)
T ss_pred hHHHHHHHHHhCC-CcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 5779999999997 9999999999999999999999997 588888754 467999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCC---------------CCcccccccCccccCcccccc--cCCCcchhhh
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKP---------------DERLNDIVGSAYYVAPEVLHR--SYGTEADMWS 339 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~---------------~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwS 339 (482)
|||+|+||++ +.++.+||+|||++..... ........++..|+|||.+.+ .++.++||||
T Consensus 143 ~dl~~~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~s 219 (335)
T PTZ00024 143 RDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWS 219 (335)
T ss_pred ccccHHHeEE---CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHH
Confidence 9999999999 5677899999999876541 111223457889999998864 3789999999
Q ss_pred hHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCC------------------------CCCCCCHHHHHHHHHhchh
Q 011582 340 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA------------------------PWPSLSPEAIDFVKRLLNK 395 (482)
Q Consensus 340 lGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------------------------~~~~~s~~~~~li~~~L~~ 395 (482)
|||++|+|++|..||.+.+..+.+..+.......... .....+.++.++|.+||+.
T Consensus 220 lG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 299 (335)
T PTZ00024 220 VGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKL 299 (335)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCC
Confidence 9999999999999999888777666665432211111 1134578899999999999
Q ss_pred ccccCCCHHHHhcCcccccCCCC
Q 011582 396 DYRKRLTAAQALSHPWLANSHDV 418 (482)
Q Consensus 396 dP~~R~s~~e~L~hp~~~~~~~~ 418 (482)
+|.+||+++++|.||||+.....
T Consensus 300 ~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 300 NPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred CchhccCHHHHhcCcccCCCCCC
Confidence 99999999999999999876543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=325.22 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=208.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.++||+|+||.||+|... .+..||+|.+... ....+.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~----~~~~v~iK~~~~~-------------------------------~~~~~~~~ 49 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYN----NSTKVAVKTLKPG-------------------------------TMSVQAFL 49 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEec----CCceEEEEEccCC-------------------------------chhHHHHH
Confidence 367999999999999999999865 4678999987532 11246788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+++.+. |+||+++++++.+.+..|+||||+++++|.+++... ...+++..+..++.|++.||.|||++|++|||
T Consensus 50 ~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~d 128 (261)
T cd05072 50 EEANLMKTLQ-HDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128 (261)
T ss_pred HHHHHHHhCC-CCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 9999999996 999999999999999999999999999999988653 45789999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|||+||++ +.++.+||+|||++........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||
T Consensus 129 l~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~ 205 (261)
T cd05072 129 LRAANVLV---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPY 205 (261)
T ss_pred cchhhEEe---cCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCC
Confidence 99999999 5677899999999987643321 12334567899999876 468899999999999999998 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
...........+..... .+....++.++.++|.+||..+|++||+++++++
T Consensus 206 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 206 PGMSNSDVMSALQRGYR---MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 88887777777665422 2233468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=325.90 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=209.8
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|++.+.||+|+||.||+|+++.....+..+|+|.++.. ........+.+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~-----------------------------~~~~~~~~~~~ 54 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAG-----------------------------YTEKQRRDFLS 54 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCC-----------------------------CCHHHHHHHHH
Confidence 5799999999999999999998653223457999988542 12234567899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. ||||+++++++.+++..|+||||+++++|.+++......+++.++..++.|++.||.|||++|++|||||
T Consensus 55 e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlk 133 (267)
T cd05066 55 EASIMGQFD-HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLA 133 (267)
T ss_pred HHHHHHhCC-CCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhc
Confidence 999999996 9999999999999999999999999999999987766779999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|+|||+ +.++.++|+|||++........ .....++..|+|||.+. +.++.++|+|||||++|++++ |..||
T Consensus 134 p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~ 210 (267)
T cd05066 134 ARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 210 (267)
T ss_pred hhcEEE---CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCc
Confidence 999999 5677899999999987643321 11122356899999886 468999999999999999886 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
......+....+.... ..+ ....+++.+.+++.+||+.+|.+||++.++++
T Consensus 211 ~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 211 WEMSNQDVIKAIEEGY-RLP--APMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ccCCHHHHHHHHhCCC-cCC--CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 8887777777665542 222 22457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=340.74 Aligned_cols=259 Identities=32% Similarity=0.513 Sum_probs=208.8
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+..+|.+.+.||.|+||.||+|+++. +|..||+|.+... .....+.+
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~---~~~~v~iK~i~~~------------------------------~~~~~~~~ 49 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSD---CDKRVAVKKIVLT------------------------------DPQSVKHA 49 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECC---CCcEEEEEEEecC------------------------------CCchHHHH
Confidence 35789999999999999999999876 7999999998542 11234668
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC--------------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD--------------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILS 264 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~--------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~ 264 (482)
.+|+.++++++ ||||+++++++... ...|+||||++ ++|.+.+.. ..+++..++.++.||+.
T Consensus 50 ~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~l~~~~~~~~~~qi~~ 125 (342)
T cd07854 50 LREIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ--GPLSEEHARLFMYQLLR 125 (342)
T ss_pred HHHHHHHHhcC-CCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHHc--CCCCHHHHHHHHHHHHH
Confidence 89999999996 99999999876654 36899999997 488876642 47999999999999999
Q ss_pred HHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC----cccccccCccccCcccccc--cCCCcchhh
Q 011582 265 VVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLHR--SYGTEADMW 338 (482)
Q Consensus 265 ~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~Diw 338 (482)
||.|||+.||+||||||+||+++ ..+..+||+|||++....... ......|+..|+|||.+.+ .++.++|||
T Consensus 126 aL~~LH~~givH~dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw 203 (342)
T cd07854 126 GLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 203 (342)
T ss_pred HHHHHHhCCcccCCCCHHHEEEc--CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHH
Confidence 99999999999999999999995 245679999999997653321 1223467899999997643 488899999
Q ss_pred hhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCC----------------------C----CCCCCCCHHHHHHHHHh
Q 011582 339 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFD----------------------E----APWPSLSPEAIDFVKRL 392 (482)
Q Consensus 339 SlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~----------------------~----~~~~~~s~~~~~li~~~ 392 (482)
||||++|+|++|+.||.+.+..+....+....+... . ...+.++.++.+||.+|
T Consensus 204 SlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 283 (342)
T cd07854 204 AAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQI 283 (342)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHH
Confidence 999999999999999988776665555443221100 0 01235789999999999
Q ss_pred chhccccCCCHHHHhcCcccccCC
Q 011582 393 LNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 393 L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|+.||.+|||+.++|.||||+...
T Consensus 284 L~~dP~~R~t~~ell~h~~~~~~~ 307 (342)
T cd07854 284 LTFNPMDRLTAEEALMHPYMSCYS 307 (342)
T ss_pred hCCCchhccCHHHHhCCCcccccc
Confidence 999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=331.09 Aligned_cols=261 Identities=31% Similarity=0.545 Sum_probs=212.3
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|+......++..||||++.+.. ..........+.+|
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~--------------------------~~~~~~~~~~~~~E 54 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKAT--------------------------IVQKAKTAEHTRTE 54 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHH--------------------------HHhhhhHHHHHHHH
Confidence 4889999999999999999876544468899999986531 01122344577899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.++.++.+||||+++++++..+...|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||
T Consensus 55 ~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p 133 (288)
T cd05583 55 RQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKL 133 (288)
T ss_pred HHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 999999977999999999999999999999999999999988654 5799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccccc---CCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLHRS---YGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~~---~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
+||++ +.++.++|+|||++........ .....|+..|+|||.+.+. .+.++||||||+++|+|++|..||..
T Consensus 134 ~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 134 ENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred HHeEE---CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 99999 5677899999999876543322 2235689999999987542 68899999999999999999999964
Q ss_pred CC----hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC---HHHHhcCcccccCC
Q 011582 357 RT----ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT---AAQALSHPWLANSH 416 (482)
Q Consensus 357 ~~----~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s---~~e~L~hp~~~~~~ 416 (482)
.. ..++...+....... ...++.++.++|.+||+.||++||| +.++|+||||+...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 211 DGEQNSQSEISRRILKSKPPF----PKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred CcccchHHHHHHHHHccCCCC----CcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 32 233334444333222 2347899999999999999999998 57789999998753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=331.18 Aligned_cols=255 Identities=26% Similarity=0.361 Sum_probs=208.6
Q ss_pred ccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|.+.+.||+|+||.||+|.+... ...+..||||++++. ......+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~ 84 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT-----------------------------AHSSEREA 84 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCcc-----------------------------CChHHHHH
Confidence 46899999999999999999986431 124668999988643 12234567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+.+|+.+++++.+||||+++++++...+..|+||||+.+|+|.+++.... ..+++.++..++.|++.||.|||++||+|
T Consensus 85 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH 164 (302)
T cd05055 85 LMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIH 164 (302)
T ss_pred HHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeh
Confidence 89999999999559999999999999999999999999999999886543 34899999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GS 351 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~ 351 (482)
|||||+|||+ +.++.+||+|||++........ .....++..|+|||.+. +.++.++||||+||++|+|++ |.
T Consensus 165 ~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~ 241 (302)
T cd05055 165 RDLAARNVLL---THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGS 241 (302)
T ss_pred hhhccceEEE---cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCC
Confidence 9999999999 5677899999999986543221 12234678899999876 458999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.||......+.+........... ....+++++.+|+.+||..+|.+|||+.+++.
T Consensus 242 ~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 242 NPYPGMPVDSKFYKLIKEGYRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCcCCCCchHHHHHHHHcCCcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99988776655555544332222 22347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=322.67 Aligned_cols=247 Identities=25% Similarity=0.395 Sum_probs=210.2
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|........+..||+|++... ......+.+.+|+.+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~-----------------------------~~~~~~~~~~~e~~~l~ 51 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED-----------------------------ASEEERKDFLKEARVMK 51 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccc-----------------------------cchhHHHHHHHHHHHHh
Confidence 4699999999999999763224889999998653 11224678899999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR--------GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+. |+||+++++++.+...+++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+|||
T Consensus 52 ~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~d 130 (262)
T cd00192 52 KLG-HPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRD 130 (262)
T ss_pred hcC-CCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCc
Confidence 997 999999999999999999999999999999998765 47899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRP 353 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~p 353 (482)
|||+||++ +.++.+||+|||.+....... ......++..|+|||.+.. .++.++|||||||++|+|++ |..|
T Consensus 131 i~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 207 (262)
T cd00192 131 LAARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207 (262)
T ss_pred cCcceEEE---CCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCC
Confidence 99999999 567889999999998765432 2344567889999998864 68999999999999999999 6999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|......+....+..... . .....+++++.+++.+||..||.+|||+.+++++
T Consensus 208 ~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 208 YPGLSNEEVLEYLRKGYR-L--PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCCCHHHHHHHHHcCCC-C--CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 998888888777765322 1 1123578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=328.67 Aligned_cols=253 Identities=19% Similarity=0.330 Sum_probs=209.1
Q ss_pred cceEecceeecCCceEEEEEEEec-CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKK-GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~-~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
++|++.+.||+|+||.||+|.... +...+..||+|.+... ........+.
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~-----------------------------~~~~~~~~~~ 55 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI-----------------------------NNPQQWGEFQ 55 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC-----------------------------CCHHHHHHHH
Confidence 578999999999999999998642 1125688999998542 2234456788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC----------------CCCCHHHHHHHHHHHH
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG----------------GKYSEEDAKIVMVQIL 263 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~l~~~~~~~i~~qi~ 263 (482)
+|+.+++.+. ||||+++++++...+..|+||||+++++|.+++..+. ..+++..+..++.|++
T Consensus 56 ~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 134 (283)
T cd05090 56 QEASLMAELH-HPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIA 134 (283)
T ss_pred HHHHHHhhCC-CCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHH
Confidence 9999999996 9999999999999999999999999999999885331 2478899999999999
Q ss_pred HHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchhhh
Q 011582 264 SVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADMWS 339 (482)
Q Consensus 264 ~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwS 339 (482)
.||.|||++||+||||||+|||+ +.++.+||+|||+++...... ......++..|+|||++. +.++.++||||
T Consensus 135 ~al~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 211 (283)
T cd05090 135 AGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211 (283)
T ss_pred HHHHHHHhcCeehhccccceEEE---cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHH
Confidence 99999999999999999999999 567789999999998654322 123345677899999876 46899999999
Q ss_pred hHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 340 IGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 340 lGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|||++|+|++ |..||.+.....+...+...... .....+++++.+++.+||+.||.+||++.+++++
T Consensus 212 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 212 FGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLL---PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9999999998 99999888776666666544321 2234588999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=332.76 Aligned_cols=255 Identities=22% Similarity=0.360 Sum_probs=208.4
Q ss_pred ccceEecceeecCCceEEEEEEEecCC----CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGS----LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~----~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.++|.+++.||+|+||.||+|++.... .++..||+|.+... ......
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~-----------------------------~~~~~~ 67 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSD-----------------------------ATEKDL 67 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCC-----------------------------CChHHH
Confidence 468999999999999999999874311 13457999998642 123345
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHH
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMV 260 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ 260 (482)
..+.+|+.+++++.+||||+++++++...+..|+||||+++|+|.+++.... ..+++.++..++.
T Consensus 68 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 147 (307)
T cd05098 68 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAY 147 (307)
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHH
Confidence 6788999999999569999999999999999999999999999999987542 2488899999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcch
Q 011582 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEAD 336 (482)
Q Consensus 261 qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~D 336 (482)
|++.||.|||++|++||||||+|||+ +.++.+||+|||++........ .....+++.|+|||++.+ .++.++|
T Consensus 148 qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 224 (307)
T cd05098 148 QVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224 (307)
T ss_pred HHHHHHHHHHHCCcccccccHHheEE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHH
Confidence 99999999999999999999999999 5677899999999876543221 112234578999998764 5899999
Q ss_pred hhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 337 MWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 337 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||||||++|+|++ |..||.+....++...+..... . .....++.++.+||.+||..+|.+||++.+++++
T Consensus 225 vwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 225 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR-M--DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCC-C--CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 9999999999998 8999988877777666654432 1 2224578999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=324.98 Aligned_cols=247 Identities=23% Similarity=0.360 Sum_probs=208.7
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|.+.+.||+|+||.||+|.... .++.||+|++.+. ......+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~---~~~~~~~K~~~~~-------------------------------~~~~~~~~~ 51 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-------------------------------TMEVEEFLK 51 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEec---CCceEEEEEecCC-------------------------------chHHHHHHH
Confidence 468999999999999999999886 7889999987542 122456889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
|+.+++.+. |+||+++++++..++.+++||||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||
T Consensus 52 e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 130 (263)
T cd05052 52 EAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDL 130 (263)
T ss_pred HHHHHHhCC-CCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 999999996 999999999999999999999999999999988654 346899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcc--cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERL--NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
||+||++ ++++.+||+|||++......... ....++..|+|||.+. ..++.++|||||||++|+|++ |..||.
T Consensus 131 kp~nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~ 207 (263)
T cd05052 131 AARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 207 (263)
T ss_pred CcceEEE---cCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999 56788999999999876543221 1223466899999876 468899999999999999998 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+....+....+..... . .....++.++.++|.+||..||++||++.++++
T Consensus 208 ~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 208 GIDLSQVYELLEKGYR-M--ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCHHHHHHHHHCCCC-C--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 8887777777655321 1 222458899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=340.14 Aligned_cols=259 Identities=37% Similarity=0.605 Sum_probs=216.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||.|+||.||+|+... +|+.||||++.+. .......+.+.+|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~---~~~~~~iK~~~~~----------------------------~~~~~~~~~~~~e 49 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKR---TGRKVAIKKISNV----------------------------FDDLIDAKRILRE 49 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCC---CCcEEEEEeeccc----------------------------cccchhhhhHHHH
Confidence 58999999999999999999876 6899999998653 0122344678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCC-----eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDD-----NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+.+++.+. |+||+++++++...+ .+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||++||+|
T Consensus 50 ~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H 126 (330)
T cd07834 50 IKLLRHLR-HENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIH 126 (330)
T ss_pred HHHHHhcC-CcchhhhhhhhcccCcccccceEEEecchhh-hHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 99999996 999999999998775 89999999974 78887754 358999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCC----cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg 350 (482)
|||||+|||+ +.++.++|+|||++....... ......+|..|+|||++.+ .++.++|+||||+++|+|++|
T Consensus 127 ~dlkp~nili---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g 203 (330)
T cd07834 127 RDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR 203 (330)
T ss_pred CCCCHHHEEE---cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcC
Confidence 9999999999 567889999999998765443 2445678999999998864 588999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCC---------------------------CCCCCCHHHHHHHHHhchhccccCCCH
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEA---------------------------PWPSLSPEAIDFVKRLLNKDYRKRLTA 403 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~ 403 (482)
..||.+.+..+.+..+.......... ..+.++.++.+||.+||+.||.+||++
T Consensus 204 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 283 (330)
T cd07834 204 KPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITA 283 (330)
T ss_pred CCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCH
Confidence 99999888877777666543221111 123478899999999999999999999
Q ss_pred HHHhcCcccccCCC
Q 011582 404 AQALSHPWLANSHD 417 (482)
Q Consensus 404 ~e~L~hp~~~~~~~ 417 (482)
+++|.||||+....
T Consensus 284 ~~ll~~~~~~~~~~ 297 (330)
T cd07834 284 DEALAHPYLAQLHD 297 (330)
T ss_pred HHHHhCccHHhhcc
Confidence 99999999986543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=323.54 Aligned_cols=261 Identities=30% Similarity=0.513 Sum_probs=222.4
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+.|+-..+||+|.||.||+|+.+. +|+.||+|++-- ..|+..+ -....
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n---~~kkvalkkvlm------------eneKeGf----------------pital 64 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKN---TGKKVALKKVLM------------ENEKEGF----------------PITAL 64 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcC---ccchhHHHHHHH------------hccccCC----------------cHHHH
Confidence 4678888999999999999999987 789999987522 1111111 13457
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEe--------CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 200 REVKILRALTGHKNLVQFYDAYED--------DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+|+++|..|. |+|++.++++|.. ...+|+||.+|+. +|.-.+.+...+|+..++..++.+++.||.|+|.
T Consensus 65 reikiL~~lk-Henv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr 142 (376)
T KOG0669|consen 65 REIKILQLLK-HENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR 142 (376)
T ss_pred HHHHHHHHhc-chhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHH
Confidence 8999999997 9999999998753 3458999999976 8888877777889999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCC-----CcccccccCccccCcccccc--cCCCcchhhhhHHHH
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-----ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIA 344 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil 344 (482)
..|+|||+|++|+|| +.++.+||+|||+++.+... ...+..+.|.+|++||.+.+ .|+++.|||..|||+
T Consensus 143 ~kilHRDmKaaNvLI---t~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCim 219 (376)
T KOG0669|consen 143 NKILHRDMKAANVLI---TKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIM 219 (376)
T ss_pred hhHHhhcccHhhEEE---cCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHH
Confidence 999999999999999 67899999999999765432 23455678999999998864 699999999999999
Q ss_pred HHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC-------------------------------CHHHHHHHHHhc
Q 011582 345 YILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL-------------------------------SPEAIDFVKRLL 393 (482)
Q Consensus 345 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-------------------------------s~~~~~li~~~L 393 (482)
.||.||.+.|.+.++...+..|......+..+.|+++ ++++.+|+.+||
T Consensus 220 aeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll 299 (376)
T KOG0669|consen 220 AEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLL 299 (376)
T ss_pred HHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHh
Confidence 9999999999999999988888877777777888754 257889999999
Q ss_pred hhccccCCCHHHHhcCcccccCC
Q 011582 394 NKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 394 ~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..||.+|+++.++|+|.||.+..
T Consensus 300 ~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 300 KLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred ccCcccCcchHhhhchhhhhcCC
Confidence 99999999999999999999764
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=330.68 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=214.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+.|...++||+|+||.||+|++.. +|..||+|++... ..........+.
T Consensus 20 ~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~v~ik~~~~~---------------------------~~~~~~~~~~~~ 69 (313)
T cd06633 20 EEIFVGLHEIGHGSFGAVYFATNSH---TNEVVAVKKMSYS---------------------------GKQTNEKWQDII 69 (313)
T ss_pred HHHhhcceeeccCCCeEEEEEEECC---CCcEEEEEEEecc---------------------------ccCchHHHHHHH
Confidence 3457778889999999999999876 7899999998653 012233446788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.++ |||++++++++.+....|+||||+. |+|.+.+......+++.++..++.||+.||.|||++||+||||
T Consensus 70 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl 147 (313)
T cd06633 70 KEVKFLQQLK-HPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147 (313)
T ss_pred HHHHHHHhCC-CCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCC
Confidence 9999999996 9999999999999999999999996 5788877766677999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
+|+||++ +.++.+||+|||++.... ......|+..|+|||++. +.++.++|||||||++|+|++|..||.
T Consensus 148 ~p~nili---~~~~~~kL~dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~ 221 (313)
T cd06633 148 KAGNILL---TEPGQVKLADFGSASKSS---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 221 (313)
T ss_pred ChhhEEE---CCCCCEEEeecCCCcccC---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999 567789999999986532 233567899999999873 458889999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..+.......+..... +......++..+++||.+||+.+|.+||++.+++.||||....
T Consensus 222 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 222 NMNAMSALYHIAQNDS--PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred CCChHHHHHHHHhcCC--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 8776665555544332 2222345788999999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=335.79 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=203.0
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.+.+.||+|+||.||+|..... ..|..||+|.+.+.. .......+.+.+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~-~~~~~~alK~~~~~~---------------------------~~~~~~~~~~~~e 52 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNG-KDGKEYAIKKFKGDK---------------------------EQYTGISQSACRE 52 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCC-CCCCeEEEEEecccc---------------------------ccccCccHHHHHH
Confidence 488999999999999999998652 147899999986530 0011123456789
Q ss_pred HHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 202 VKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSR----GGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
+.+++.+. ||||+++++++.+. +.+|+||||+++ +|.+.+... ...+++..++.++.||+.||.|||++||+
T Consensus 53 ~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 130 (316)
T cd07842 53 IALLRELK-HENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVL 130 (316)
T ss_pred HHHHHhcC-CCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 99999996 99999999999988 889999999975 677766432 23689999999999999999999999999
Q ss_pred ccCCCCCceEEec-CCCCCcEEEEecccccccCCCC----cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHh
Q 011582 276 HRDLKPENFLFTS-KEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 276 HrDlkp~NIll~~-~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ell 348 (482)
||||||+|||++. ++.++.+||+|||++....... ......+|..|+|||++.+ .++.++|||||||++|+|+
T Consensus 131 h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~ 210 (316)
T cd07842 131 HRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210 (316)
T ss_pred eCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999953 2227889999999998764322 1234578999999998754 4789999999999999999
Q ss_pred hCCCCCCCCChHH---------HHHHHHhcCC---------------------CCCCCCC------------CCCCHHHH
Q 011582 349 CGSRPFWARTESG---------IFRAVLKADP---------------------SFDEAPW------------PSLSPEAI 386 (482)
Q Consensus 349 tg~~pf~~~~~~~---------~~~~i~~~~~---------------------~~~~~~~------------~~~s~~~~ 386 (482)
+|+.||.+..... .+..+..... ......+ ...+.++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (316)
T cd07842 211 TLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF 290 (316)
T ss_pred hcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHH
Confidence 9999997654322 1111111000 0000111 14678899
Q ss_pred HHHHHhchhccccCCCHHHHhcCccc
Q 011582 387 DFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 387 ~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
++|.+||+.||++|||+.++++||||
T Consensus 291 ~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 291 DLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 99999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=336.25 Aligned_cols=261 Identities=33% Similarity=0.534 Sum_probs=208.4
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|+.... ..+..||||++... .......+.+.+|
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~-~~~~~~aiK~~~~~----------------------------~~~~~~~~~~~~E 51 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAET-SEEETVAIKKITNV----------------------------FSKKILAKRALRE 51 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCC-CcCceEEEEEeccc----------------------------cccchhHHHHHHH
Confidence 488999999999999999998751 12889999998642 0112234567889
Q ss_pred HHHHHhhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 202 VKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+++++.+||||+++++++.. ....|++|||+. ++|.+.+.. ...+++..++.++.||+.||.|||++||+||
T Consensus 52 ~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~ 129 (332)
T cd07857 52 LKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHR 129 (332)
T ss_pred HHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 9999999779999999987543 256789999995 588887754 4679999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC-----cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg 350 (482)
||||+|||+ +.++.+||+|||++....... ......||+.|+|||.+.+ .++.++||||+||++|+|++|
T Consensus 130 dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g 206 (332)
T cd07857 130 DLKPGNLLV---NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206 (332)
T ss_pred CCCHHHeEE---cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 999999999 567789999999998654321 2234578999999998754 589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCC---------------------------CCCCCCCCCHHHHHHHHHhchhccccCCCH
Q 011582 351 SRPFWARTESGIFRAVLKADPSF---------------------------DEAPWPSLSPEAIDFVKRLLNKDYRKRLTA 403 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~ 403 (482)
..||...+....+..+....... ....++.++.++.+||.+||+.||.+|||+
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~ 286 (332)
T cd07857 207 KPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV 286 (332)
T ss_pred CcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 99998776555544433321110 011234578899999999999999999999
Q ss_pred HHHhcCcccccCC
Q 011582 404 AQALSHPWLANSH 416 (482)
Q Consensus 404 ~e~L~hp~~~~~~ 416 (482)
.+++.||||....
T Consensus 287 ~~ll~~~~~~~~~ 299 (332)
T cd07857 287 EEALEHPYLAIWH 299 (332)
T ss_pred HHHhcChhhhhhc
Confidence 9999999998654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=329.26 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=209.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCC--CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGS--LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~--~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++.+.||+|+||.||++...... .....+|+|++... ........
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~-----------------------------~~~~~~~~ 61 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDD-----------------------------ATEKDLSD 61 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCC-----------------------------CCHHHHHH
Confidence 357999999999999999999876422 23478999988642 12233466
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc---------------CCCCCHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---------------GGKYSEEDAKIVMVQI 262 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi 262 (482)
+.+|+.+++++.+|+||+++++++..++.+++||||+++|+|.+++..+ ...+++..+..++.|+
T Consensus 62 ~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 141 (293)
T cd05053 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQV 141 (293)
T ss_pred HHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHH
Confidence 8899999999955999999999999999999999999999999988642 3468999999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhh
Q 011582 263 LSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMW 338 (482)
Q Consensus 263 ~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Diw 338 (482)
+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... .....++..|+|||++. ..++.++|||
T Consensus 142 ~~al~~LH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 218 (293)
T cd05053 142 ARGMEFLASKKCIHRDLAARNVLV---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVW 218 (293)
T ss_pred HHHHHHHHHCCccccccceeeEEE---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCccccee
Confidence 999999999999999999999999 5677899999999987643321 12223567899999875 4689999999
Q ss_pred hhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 339 SIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 339 SlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||||++|+|++ |..||.+....+....+..... .. .....+.++.+|+.+||..||.+|||+.+++++
T Consensus 219 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 219 SFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR-ME--KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred ehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc-CC--CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 99999999997 9999998887777776655432 11 123578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=324.64 Aligned_cols=252 Identities=22% Similarity=0.372 Sum_probs=209.3
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|+.+.....+..||||++.+. ........+.+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~-----------------------------~~~~~~~~~~~ 54 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-----------------------------YTEKQRRDFLS 54 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC-----------------------------CCHHHHHHHHH
Confidence 5699999999999999999998763223346999998542 23344578899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++.+++..++||||+++++|.+++....+.+++.++..++.|++.||.|||++|++|||||
T Consensus 55 e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~ 133 (269)
T cd05065 55 EASIMGQFD-HPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLA 133 (269)
T ss_pred HHHHHHhCC-CcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence 999999996 9999999999999999999999999999999887666779999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcc---cc-cc--cCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERL---ND-IV--GSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSR 352 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~---~~-~~--gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~ 352 (482)
|+||++ +.++.+||+|||++......... .. .. ++..|+|||.+. +.++.++|||||||++|||++ |..
T Consensus 134 p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~ 210 (269)
T cd05065 134 ARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210 (269)
T ss_pred hheEEE---cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCC
Confidence 999999 56778999999998765432211 11 11 245799999886 468999999999999999886 999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||......+....+... . .......++.++.+++.+||..+|.+||++.+++.
T Consensus 211 p~~~~~~~~~~~~i~~~-~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 211 PYWDMSNQDVINAIEQD-Y--RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CCCCCCHHHHHHHHHcC-C--cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99988877777776433 2 22223467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=322.00 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=210.5
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|++.+.||+|+||.||+|++.. +|..||+|.+..... ..........+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~~~-------------------------~~~~~~~~~~~~~ 53 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDAD---TGRELAVKQVPFDPD-------------------------SQETSKEVNALEC 53 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcC---CCCEEEEEEEecCcc-------------------------cchhhHHHHHHHH
Confidence 479999999999999999999876 799999998753200 0012334568899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
|+.+++++. |+||+++++++.+. +.+++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++|||
T Consensus 54 ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~i~H~d 131 (264)
T cd06653 54 EIQLLKNLR-HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSYLHSNMIVHRD 131 (264)
T ss_pred HHHHHHHcC-CCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCC
Confidence 999999997 99999999998764 5689999999999999988654 5689999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCC----CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPD----ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~p 353 (482)
|||+||++ +.++.++|+|||++...... .......|+..|+|||.+.+ .++.++|+|||||++|+|++|+.|
T Consensus 132 l~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 208 (264)
T cd06653 132 IKGANILR---DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208 (264)
T ss_pred CCHHHEEE---cCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 99999999 56778999999999765321 12234578999999998865 588999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
|......+....+...... ......+++++.++|.+||. +|.+||++.++|.|||+
T Consensus 209 ~~~~~~~~~~~~~~~~~~~--~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 209 WAEYEAMAAIFKIATQPTK--PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CCccCHHHHHHHHHcCCCC--CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 9877665555554433221 12234589999999999999 57999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=329.45 Aligned_cols=254 Identities=33% Similarity=0.553 Sum_probs=212.1
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|++.+.||.|++|.||+|.... +|+.+|+|.+.... ........+.+|+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~----------------------------~~~~~~~~~~~e~ 49 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKL---TGEIVAIKKIKLRF----------------------------ESEGIPKTALREI 49 (283)
T ss_pred CccceeeecCCCceEEEEEcCC---CCcEEEEEEecccc----------------------------ccchhHHHHHHHH
Confidence 6678899999999999999876 78999999986531 1122346788899
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~ 282 (482)
.+++++. |+||+++++++.+++..++||||+++ +|.+.+......+++..+..++.|++.||.|||+.||+|+||||+
T Consensus 50 ~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ 127 (283)
T cd05118 50 KLLKELN-HPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPE 127 (283)
T ss_pred HHHHHhc-CCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHH
Confidence 9999997 99999999999999999999999975 888888776678999999999999999999999999999999999
Q ss_pred ceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 283 NFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 283 NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
||++ +.++.+||+|||.+....... ......++..|+|||.+.+ .++.++|+||||+++|+|++|+.||...+.
T Consensus 128 nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 128 NLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred HEEE---CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999 567789999999998765443 2334568889999998753 588999999999999999999999988777
Q ss_pred HHHHHHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 360 SGIFRAVLKADPSFDE--------------------------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.+.+..+......... ..++.++.++.+||.+||..||.+||++.++++||||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 205 IDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred HHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 6655555432211100 1223478899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=324.76 Aligned_cols=252 Identities=20% Similarity=0.297 Sum_probs=206.2
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|.+++.||+|+||.||+|........+..||||+++.. .........+.+|+
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~----------------------------~~~~~~~~~~~~e~ 52 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLD----------------------------IHTYSEIEEFLSEA 52 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccC----------------------------cCCHHHHHHHHHHH
Confidence 56888999999999999998754334578999998642 12234456789999
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCe------EEEEEecCCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDN------IYIVMELCKGGELLDRILSR-----GGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
.+++.+. ||||+++++++..... .++||||+++|+|..++... ...+++..+..++.|++.||.|||+
T Consensus 53 ~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~ 131 (273)
T cd05035 53 ACMKDFD-HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN 131 (273)
T ss_pred HHHHhCC-CCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999996 9999999998866554 79999999999999887543 2368999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcchhhhhHHHHHHH
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el 347 (482)
+||+||||||+||++ ++++.+||+|||+++....... .....++..|+|||.+.+ .++.++|||||||++|||
T Consensus 132 ~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el 208 (273)
T cd05035 132 RNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEI 208 (273)
T ss_pred CCeeccccchheEEE---CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHH
Confidence 999999999999999 5677899999999987643321 112335678999998864 589999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 348 LC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 348 lt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
++ |..||.+....+....+...... . ....++.++.++|.+||+.||.+||++.+++++
T Consensus 209 ~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 209 ATRGQTPYPGVENHEIYDYLRHGNRL-K--QPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCC-C--CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99 99999888877777766654321 1 123588999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=338.94 Aligned_cols=263 Identities=30% Similarity=0.506 Sum_probs=212.3
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++.+.||+|+||.||+|.+.. +|..||||++.+.. .......
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~vK~~~~~~----------------------------~~~~~~~ 51 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRR---TKEVVALKKIFDAF----------------------------RNATDAQ 51 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcC---CCeEEEEEeecccc----------------------------Ccchhhh
Confidence 3466889999999999999999999876 68999999885420 1122335
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGV 274 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i 274 (482)
.+.+|+.+++++.+||||+++++++... ..+|+||||+++ +|..++... .+++..+..++.||+.||.|||++||
T Consensus 52 ~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i 128 (337)
T cd07852 52 RTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNV 128 (337)
T ss_pred hhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 6778999999994499999999998654 468999999974 888877543 78999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCCCC------cccccccCccccCcccccc--cCCCcchhhhhHHHHHH
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE------RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYI 346 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~e 346 (482)
+||||||+||++ +.++.+||+|||++....... ......||..|+|||.+.+ .++.++|||||||++|+
T Consensus 129 ~H~dl~p~nill---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~e 205 (337)
T cd07852 129 IHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGE 205 (337)
T ss_pred ecCCCCHHHEEE---cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHH
Confidence 999999999999 678899999999997654322 2334578999999998743 57889999999999999
Q ss_pred HhhCCCCCCCCChHHHHHHHHhcCCCC---------------------------CCCCCCCCCHHHHHHHHHhchhcccc
Q 011582 347 LLCGSRPFWARTESGIFRAVLKADPSF---------------------------DEAPWPSLSPEAIDFVKRLLNKDYRK 399 (482)
Q Consensus 347 lltg~~pf~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~ 399 (482)
|++|+.||.+....+....+....... .....+.++.++.++|.+||+.||.+
T Consensus 206 l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~ 285 (337)
T cd07852 206 MLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNK 285 (337)
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccc
Confidence 999999998776655444443322110 11123457899999999999999999
Q ss_pred CCCHHHHhcCcccccCC
Q 011582 400 RLTAAQALSHPWLANSH 416 (482)
Q Consensus 400 R~s~~e~L~hp~~~~~~ 416 (482)
|||+.++++||||+...
T Consensus 286 Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 286 RLTAEEALEHPYVAQFH 302 (337)
T ss_pred ccCHHHHhhChhhhhhc
Confidence 99999999999998653
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=314.80 Aligned_cols=251 Identities=24% Similarity=0.356 Sum_probs=206.7
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|||+.||+++.-. ++..||+|++.- ...+..+...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s---~~~~YAlKkI~c------------------------------~~~~~~e~~~ 66 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLS---TGHLYALKKILC------------------------------HSQEDIEEAL 66 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccC---cccchhhheeec------------------------------cchHHHHHHH
Confidence 3689999999999999999998655 899999999842 3456778999
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeC-----CeEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDD-----DNIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+|++..+++. |||+++++++...+ ...||+++|...|+|.+.|... +..++|.++..|+.+|++||++||+
T Consensus 67 rEid~~rkf~-s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~ 145 (302)
T KOG2345|consen 67 REIDNHRKFN-SPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHE 145 (302)
T ss_pred HHHHHHHhhC-CcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhc
Confidence 9999999996 99999999876443 4599999999999999988643 4579999999999999999999999
Q ss_pred CC--CcccCCCCCceEEecCCCCCcEEEEecccccccCCCC----------cccccccCccccCcccccc----cCCCcc
Q 011582 272 QG--VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----------RLNDIVGSAYYVAPEVLHR----SYGTEA 335 (482)
Q Consensus 272 ~~--ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~ 335 (482)
.. ++||||||.|||+ .+.+.++|+|||.++...-.- ....-..|..|+|||.++- ..+.++
T Consensus 146 ~~~~yAH~DiKP~NILl---s~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ert 222 (302)
T KOG2345|consen 146 KEPPYAHRDIKPANILL---SDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERT 222 (302)
T ss_pred cCCcccccCCCcceeEe---cCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccccccc
Confidence 99 9999999999999 457889999999987643211 1123457899999999862 378899
Q ss_pred hhhhhHHHHHHHhhCCCCCCCCCh--HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 336 DMWSIGVIAYILLCGSRPFWARTE--SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 336 DiwSlGvil~elltg~~pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|||||||+||.|+.|..||...-. ..+.-.+.++...++... .+|+.+.+||+.||++||.+||++.+++.+
T Consensus 223 DIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 223 DIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred chhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 999999999999999999953221 122334555555565543 499999999999999999999999999864
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=340.50 Aligned_cols=260 Identities=32% Similarity=0.587 Sum_probs=214.6
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|++.. +++.||||++... .........
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~---~~~~~aiK~~~~~----------------------------~~~~~~~~~ 60 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTK---TGRKVAIKKLSRP----------------------------FQSAIHAKR 60 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECC---CCcEEEEEecccc----------------------------cchhhHHHH
Confidence 356789999999999999999999976 7899999987542 012233456
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCe------EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDN------IYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+.+|+.+++++. ||||+++++++...+. .|+|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+
T Consensus 61 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~ 136 (343)
T cd07851 61 TYRELRLLKHMD-HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHS 136 (343)
T ss_pred HHHHHHHHHhcc-CCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 778999999996 9999999998876654 89999999 6689887753 479999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhh
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ellt 349 (482)
.||+||||||+||++ +.++.+||+|||++...... .....++..|+|||.+.+ .++.++|||||||++|+|++
T Consensus 137 ~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~ellt 211 (343)
T cd07851 137 AGIIHRDLKPSNIAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 211 (343)
T ss_pred CCeecCCCCHHHeEE---CCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHh
Confidence 999999999999999 56778999999999865432 345678999999998754 57889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCC-----------------------C----CCCCCCCHHHHHHHHHhchhccccCCC
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFD-----------------------E----APWPSLSPEAIDFVKRLLNKDYRKRLT 402 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~-----------------------~----~~~~~~s~~~~~li~~~L~~dP~~R~s 402 (482)
|+.||.+....+.+..+.......+ . ..+..+++++.+||.+||..||.+|||
T Consensus 212 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt 291 (343)
T cd07851 212 GKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT 291 (343)
T ss_pred CCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC
Confidence 9999988777666666554321111 0 012346899999999999999999999
Q ss_pred HHHHhcCcccccCCC
Q 011582 403 AAQALSHPWLANSHD 417 (482)
Q Consensus 403 ~~e~L~hp~~~~~~~ 417 (482)
+.++|.||||.....
T Consensus 292 ~~ell~h~~~~~~~~ 306 (343)
T cd07851 292 AAEALAHPYLAEYHD 306 (343)
T ss_pred HHHHhcCCCccccCC
Confidence 999999999987654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=326.43 Aligned_cols=249 Identities=28% Similarity=0.477 Sum_probs=203.7
Q ss_pred EecceeecCCceEEEEEEEe-cCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 124 ELGEEVGRGHFGYTCSAKAK-KGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 124 ~~~~~LG~G~fG~V~~a~~~-~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
++.+.||.|+||.||+|..+ .....+..|+||+++.. ......+.+.+|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-----------------------------~~~~~~~~~~~e~ 52 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-----------------------------SSEEEEEEFLNEI 52 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-----------------------------SSHHHHHHHHHHH
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-----------------------------cccccceeeeecc
Confidence 46788999999999999998 44446788999998432 3344578899999
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
.++++++ ||||+++++++...+..++|||||++|+|.+++... ...+++..+..|+.||+.||.|||+++++|+||++
T Consensus 53 ~~l~~l~-h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~ 131 (259)
T PF07714_consen 53 QILRKLR-HPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSP 131 (259)
T ss_dssp HHHHTHS-BTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SG
T ss_pred ccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999995 999999999999888899999999999999999876 57899999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
+|||+ +.++.+||+|||++........ .....+...|+|||.+.. .++.++||||||+++|||++ |+.||..
T Consensus 132 ~nill---~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~ 208 (259)
T PF07714_consen 132 SNILL---DSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSD 208 (259)
T ss_dssp GGEEE---ETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTT
T ss_pred ccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999 5677999999999987632221 233456788999999864 58999999999999999999 7899988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+..++...+..... .. ....++..+.++|.+||..||.+||++.++++
T Consensus 209 ~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 209 YDNEEIIEKLKQGQR-LP--IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp SCHHHHHHHHHTTEE-TT--SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccccccccccccccc-ce--eccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 888888887754433 22 12357999999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=318.39 Aligned_cols=253 Identities=32% Similarity=0.527 Sum_probs=213.0
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.+.+.||+|+||.||+|.... +|..|++|++.... ......+.+.+|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~----------------------------~~~~~~~~~~~e 49 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKD---TGELMAVKSVELSG----------------------------DSEEELEALERE 49 (260)
T ss_pred CceeeeEeeecCceEEEEEEECC---CCcEEEEEEeeccc----------------------------cchHHHHHHHHH
Confidence 47888999999999999999876 78999999986531 113456788999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+.+++++. |+||+++++++.+. +.+++||||+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||
T Consensus 50 ~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl 127 (260)
T cd06606 50 IRILSSLQ-HPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDI 127 (260)
T ss_pred HHHHHHcC-CCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 99999997 99999999999988 8999999999999999988655 48999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+ .++.++||||||+++|+|++|..||.
T Consensus 128 ~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 204 (260)
T cd06606 128 KGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS 204 (260)
T ss_pred CHHHEEE---cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999 5578899999999987765443 445678999999998865 48999999999999999999999997
Q ss_pred CCC-hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 356 ART-ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 356 ~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
... .......+..... .......++.++.++|.+||+.||.+||++.+++.||||
T Consensus 205 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 205 ELGNPMAALYKIGSSGE--PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CCCchHHHHHhccccCC--CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 765 2222222222111 111223468999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=324.80 Aligned_cols=253 Identities=20% Similarity=0.322 Sum_probs=209.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCC--CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGS--LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~--~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|.+.+.||+|+||.||+|..+... ..+..||+|.+... ........
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~-----------------------------~~~~~~~~ 55 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNEN-----------------------------ASMRERIE 55 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCc-----------------------------cCHHHHHH
Confidence 468999999999999999999987532 24578999997542 12233457
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------GKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~y 268 (482)
+.+|+.+++.+. |+||+++++++......|+||||+++|+|.+++.... ..+++..+..++.|++.||.|
T Consensus 56 ~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 134 (277)
T cd05032 56 FLNEASVMKEFN-CHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAY 134 (277)
T ss_pred HHHHHHHHHhCC-CCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHH
Confidence 889999999996 9999999999999999999999999999999886432 247888999999999999999
Q ss_pred HHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchhhhhHHHH
Q 011582 269 CHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIA 344 (482)
Q Consensus 269 LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil 344 (482)
||++||+||||||+|||+ +.++.+||+|||+++...... ......++..|+|||.+. +.++.++|||||||++
T Consensus 135 lH~~~i~H~di~p~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (277)
T cd05032 135 LAAKKFVHRDLAARNCMV---AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVL 211 (277)
T ss_pred HHhCCccccccChheEEE---cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHH
Confidence 999999999999999999 567889999999987654332 123345688999999875 4689999999999999
Q ss_pred HHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 345 YILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 345 ~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|+|++ |..||.+.+..+....+..... ... ...++.++.++|.+||+.+|.+|||+.++++
T Consensus 212 ~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 212 WEMATLAEQPYQGLSNEEVLKFVIDGGH-LDL--PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHhhccCCCCCccCCHHHHHHHHhcCCC-CCC--CCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99998 9999988888777777663322 111 1346899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=357.72 Aligned_cols=252 Identities=24% Similarity=0.382 Sum_probs=218.7
Q ss_pred cccceEecceeecCCceEEEEEEEecCCC--CCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSL--KGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~--~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
-..+.++.++||+|+||+||+|+...... ....||||.+++. .+.+..+
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~-----------------------------a~~~~~~ 534 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK-----------------------------AENQARQ 534 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc-----------------------------ccHHHHH
Confidence 34667788899999999999999876442 3467999998753 4556789
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------C----CCCHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------G----KYSEEDAKIVMVQIL 263 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~----~l~~~~~~~i~~qi~ 263 (482)
+|++|+++|..|+ |||||+|+|+|.+++.+|||+|||..|||.++|..+. . .|+..+...|+.||+
T Consensus 535 dF~REaeLla~l~-H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIA 613 (774)
T KOG1026|consen 535 DFRREAELLAELQ-HPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIA 613 (774)
T ss_pred HHHHHHHHHHhcc-CCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHH
Confidence 9999999999996 9999999999999999999999999999999997532 2 288999999999999
Q ss_pred HHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCccc---ccccCccccCcccc-cccCCCcchhhh
Q 011582 264 SVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN---DIVGSAYYVAPEVL-HRSYGTEADMWS 339 (482)
Q Consensus 264 ~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~---~~~gt~~y~aPE~~-~~~~~~~~DiwS 339 (482)
.|+.||-++.+|||||-..|+|| +++..|||+||||++.+...+... ...-..+|||||.| .+.|++++||||
T Consensus 614 aGM~YLs~~~FVHRDLATRNCLV---ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs 690 (774)
T KOG1026|consen 614 AGMEYLSSHHFVHRDLATRNCLV---GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWS 690 (774)
T ss_pred HHHHHHHhCcccccchhhhhcee---ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhh
Confidence 99999999999999999999999 688999999999999776544322 12235689999966 588999999999
Q ss_pred hHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHH
Q 011582 340 IGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA 406 (482)
Q Consensus 340 lGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 406 (482)
+||+|||+++ |+.||++...++.++.|..+.. ...+ .+.+.++.+|+..|++.+|++||++.|+
T Consensus 691 ~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~~P--e~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 691 FGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LSCP--ENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred hhhhhhhhhccccCcccccchHHHHHHHHcCCc-ccCC--CCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 9999999987 9999999999999999998876 3333 4699999999999999999999999987
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=330.10 Aligned_cols=255 Identities=24% Similarity=0.374 Sum_probs=210.4
Q ss_pred ccceEecceeecCCceEEEEEEEec----CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKK----GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~----~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.++|.+++.||+|+||.||+|++.. ....+..||+|.+... ......
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~-----------------------------~~~~~~ 64 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD-----------------------------ATEKDL 64 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc-----------------------------cchHHH
Confidence 4689999999999999999998632 1124568999987542 223345
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHH
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMV 260 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ 260 (482)
..+.+|+.+++.+.+||||+++++++...+..|+||||+++|+|.+++.... ..+++..+..++.
T Consensus 65 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (304)
T cd05101 65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTY 144 (304)
T ss_pred HHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHH
Confidence 6789999999999559999999999999999999999999999999887532 3478889999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcch
Q 011582 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEAD 336 (482)
Q Consensus 261 qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~D 336 (482)
||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... .....+++.|+|||++.+ .++.++|
T Consensus 145 qi~~al~~LH~~givH~dlkp~Nili---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 221 (304)
T cd05101 145 QVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 221 (304)
T ss_pred HHHHHHHHHHHCCeeecccccceEEE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhh
Confidence 99999999999999999999999999 5677899999999987643221 223345678999998864 5899999
Q ss_pred hhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 337 MWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 337 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|||||+++|+|++ |..||.+....++...+...... . ....++.++.+||.+||..+|.+||++.++++.
T Consensus 222 i~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 222 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM-D--KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-C--CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 9999999999998 88999888888887777554322 1 123578999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=337.43 Aligned_cols=254 Identities=19% Similarity=0.302 Sum_probs=201.2
Q ss_pred ceeecC--CceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHH
Q 011582 127 EEVGRG--HFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKI 204 (482)
Q Consensus 127 ~~LG~G--~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~ 204 (482)
..||+| +||+||+|++.. +|+.||||++... .......+.+.+|+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~~~~e~~~ 52 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTP---TGTLVTVRITDLE----------------------------NCTEEHLKALQNEVVL 52 (328)
T ss_pred HHhCCcccCceeEEEEEEcC---CCcEEEEEEeccc----------------------------cCCHHHHHHHHHHHHH
Confidence 456666 999999999876 7999999998642 0123345788999999
Q ss_pred HHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 011582 205 LRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPEN 283 (482)
Q Consensus 205 l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~N 283 (482)
++.+. ||||++++++|..++..++||||+.+++|.+++... ...+++..+..++.|++.||.|||++||+||||||+|
T Consensus 53 ~~~l~-h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~N 131 (328)
T cd08226 53 SHFFR-HPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASH 131 (328)
T ss_pred HHhCC-CCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 99896 999999999999999999999999999999887654 2458999999999999999999999999999999999
Q ss_pred eEEecCCCCCcEEEEecccccccCCCCc--------ccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhhCCC
Q 011582 284 FLFTSKEENSSLKAIDFGLSDYVKPDER--------LNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 284 Ill~~~~~~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~elltg~~ 352 (482)
||+ +.++.++++|||.+........ .....++..|+|||++.+ .++.++||||+||++|+|++|..
T Consensus 132 ill---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~ 208 (328)
T cd08226 132 ILI---SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRV 208 (328)
T ss_pred EEE---eCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999 5567899999986543321111 011235667999999864 37899999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCC-------------------------------------------CCCCCCCCHHHHHHH
Q 011582 353 PFWARTESGIFRAVLKADPSFD-------------------------------------------EAPWPSLSPEAIDFV 389 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~-------------------------------------------~~~~~~~s~~~~~li 389 (482)
||...........+.......+ ......+++++.+||
T Consensus 209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 288 (328)
T cd08226 209 PFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLV 288 (328)
T ss_pred CCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHH
Confidence 9987665554444333211100 001123577899999
Q ss_pred HHhchhccccCCCHHHHhcCcccccC
Q 011582 390 KRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 390 ~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
++||+.||.+|||++++|+||||...
T Consensus 289 ~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 289 ELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred HHHccCCcccCCCHHHHhhCHHHHHH
Confidence 99999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=325.58 Aligned_cols=249 Identities=21% Similarity=0.283 Sum_probs=204.7
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCc----eEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQ----DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~----~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.++|++.+.||+|+||.||+|+... +|. .||+|++... ......
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~~~~va~K~~~~~-----------------------------~~~~~~ 53 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIP---DGENVKIPVAIKVLREN-----------------------------TSPKAN 53 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEec---CCCccceEEEEEEecCC-----------------------------CCHHHH
Confidence 4679999999999999999998765 444 5899987542 223345
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
..+.+|+.+++.+. |+||+++++++.. ...+++|||+++|+|.+++....+.+++..+..++.|++.||.|||++||+
T Consensus 54 ~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ii 131 (279)
T cd05109 54 KEILDEAYVMAGVG-SPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLV 131 (279)
T ss_pred HHHHHHHHHHHhcC-CCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 67889999999996 9999999999875 457899999999999999877667799999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcc---cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-C
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL---NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-G 350 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g 350 (482)
||||||+|||+ ++++.+||+|||+++........ ....++..|+|||.+. ..++.++|||||||++|||++ |
T Consensus 132 H~dlkp~Nil~---~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g 208 (279)
T cd05109 132 HRDLAARNVLV---KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFG 208 (279)
T ss_pred ccccccceEEE---cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCC
Confidence 99999999999 56678999999999876533221 1233467899999875 468999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
..||.......+...+..... .+ ....++.++.++|.+||..||.+||++.+++.
T Consensus 209 ~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 209 AKPYDGIPAREIPDLLEKGER-LP--QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCCCCCCCHHHHHHHHHCCCc-CC--CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999987766666554444322 22 23458899999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-41 Score=323.65 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=206.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|++.+.||+|+||.||+|..+ .+..+|+|++.+.. .....+.+
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~----~~~~~~iK~~~~~~-------------------------------~~~~~~~~ 48 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR----GKIDVAIKMIREGA-------------------------------MSEDDFIE 48 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec----CCccEEEEEeccCC-------------------------------CCHHHHHH
Confidence 46889999999999999999875 45679999985421 11245778
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++.+.+..|+||||++|++|.+++......+++..+..++.|++.||.|||++||+|||||
T Consensus 49 e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~ 127 (256)
T cd05059 49 EAKVMMKLS-HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLA 127 (256)
T ss_pred HHHHHHhCC-CCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 999999996 9999999999999999999999999999999987666689999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcc--cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERL--NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
|+||++ +.++.+||+|||+++........ ....++..|+|||.+. ..++.++||||||+++|+|++ |..||..
T Consensus 128 p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 204 (256)
T cd05059 128 ARNCLV---GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204 (256)
T ss_pred HhhEEE---CCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCC
Confidence 999999 56778999999999865432211 1123345799999886 468999999999999999999 8999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
....+....+..... .. ....++.++.+++.+||..+|++|||+.++++.
T Consensus 205 ~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 205 FSNSEVVESVSAGYR-LY--RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCHHHHHHHHHcCCc-CC--CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 877777776654422 11 123479999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=337.83 Aligned_cols=255 Identities=26% Similarity=0.394 Sum_probs=201.9
Q ss_pred cceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
++|++++.||+|+||.||+|.+.. ...+++.||||+++.. ........+
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~~ 57 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-----------------------------ATHSEHRAL 57 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccC-----------------------------CChHHHHHH
Confidence 589999999999999999998643 1225789999998642 122334678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC-CeEEEEEecCCCCChHHHHHhcC------------------------------
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD-DNIYIVMELCKGGELLDRILSRG------------------------------ 247 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~------------------------------ 247 (482)
.+|+.++.++.+||||+++++++... ..+++|||||++|+|.+++....
T Consensus 58 ~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 137 (343)
T cd05103 58 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRR 137 (343)
T ss_pred HHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhh
Confidence 89999999997699999999987654 56899999999999999886431
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 011582 248 ------------------------------------GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEE 291 (482)
Q Consensus 248 ------------------------------------~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~ 291 (482)
..+++..+..++.|++.||.|||++||+||||||+|||+ +.
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~ 214 (343)
T cd05103 138 LDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL---SE 214 (343)
T ss_pred ccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE---cC
Confidence 236788889999999999999999999999999999999 56
Q ss_pred CCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCCChHHHHHHH
Q 011582 292 NSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWARTESGIFRAV 366 (482)
Q Consensus 292 ~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i 366 (482)
++.+||+|||++........ .....++..|+|||++. ..++.++||||||+++|+|++ |..||............
T Consensus 215 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 294 (343)
T cd05103 215 NNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 294 (343)
T ss_pred CCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHH
Confidence 77899999999986533221 12234567899999875 468999999999999999997 99999775443333333
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 367 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.......... ..+++++.+++.+||..||.+|||+.++++|
T Consensus 295 ~~~~~~~~~~--~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 295 LKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HhccCCCCCC--CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3322222222 2368899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=328.77 Aligned_cols=253 Identities=18% Similarity=0.291 Sum_probs=210.5
Q ss_pred cceEecceeecCCceEEEEEEEecCC--CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGS--LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~--~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
.+|++.++||+|+||.||+|.+.... ..++.||||+++.. ......+.+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~-----------------------------~~~~~~~~~ 55 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-----------------------------AEGPLREEF 55 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCC-----------------------------CCHHHHHHH
Confidence 46889999999999999999875421 24678999998642 122335678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---------------GGKYSEEDAKIVMVQIL 263 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~ 263 (482)
.+|+.++..+. ||||+++++++.+.+..++++||+.+++|.+++..+ ...+++..+..++.|++
T Consensus 56 ~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~ 134 (283)
T cd05091 56 KHEAMMRSRLQ-HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIA 134 (283)
T ss_pred HHHHHHHhcCC-CCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHH
Confidence 89999999996 999999999999999999999999999999988532 23588899999999999
Q ss_pred HHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhh
Q 011582 264 SVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWS 339 (482)
Q Consensus 264 ~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwS 339 (482)
.||.|||++||+||||||+|||+ ++++.+||+|||+++....... .....+++.|+|||.+. +.++.++||||
T Consensus 135 ~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s 211 (283)
T cd05091 135 AGMEFLSSHHVVHKDLATRNVLV---FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWS 211 (283)
T ss_pred HHHHHHHHcCccccccchhheEe---cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHH
Confidence 99999999999999999999999 5677899999999886543221 23345678999999875 56899999999
Q ss_pred hHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 340 IGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 340 lGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|||++|||++ |..||.+....++...+........ ...++.++.+|+.+||+.+|.+||++.+++..
T Consensus 212 lG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 212 YGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 9999999998 8899988888888888776654321 23588999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.04 Aligned_cols=256 Identities=22% Similarity=0.269 Sum_probs=208.2
Q ss_pred ccceEecceeecCCceEEEEEEEecCC-------------CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhh
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGS-------------LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCC 186 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~-------------~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (482)
.++|++++.||+|+||.||+|...... ..+..||+|++...
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~-------------------------- 57 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPD-------------------------- 57 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCc--------------------------
Confidence 357999999999999999999875421 12356899988653
Q ss_pred hccccHHHHHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC----------CCCCHHHHH
Q 011582 187 LFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG----------GKYSEEDAK 256 (482)
Q Consensus 187 ~~~~~~~~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~ 256 (482)
......+.+.+|+.+++++. ||||+++++++..++..++||||+++++|.+++.... ..+++..++
T Consensus 58 ---~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~ 133 (296)
T cd05051 58 ---ASDNAREDFLKEVKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLL 133 (296)
T ss_pred ---cCHHHHHHHHHHHHHHHhcC-CCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHH
Confidence 22345678899999999997 9999999999999999999999999999999886542 268999999
Q ss_pred HHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc-cCC
Q 011582 257 IVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR-SYG 332 (482)
Q Consensus 257 ~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~ 332 (482)
.++.|++.||.|||++||+||||||+||++ +.++.++|+|||++....... ......+++.|+|||.+.+ .++
T Consensus 134 ~~~~~i~~al~~LH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 210 (296)
T cd05051 134 YMATQIASGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFT 210 (296)
T ss_pred HHHHHHHHHHHHHHHcCccccccchhceee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCC
Confidence 999999999999999999999999999999 566889999999987654332 1234456789999998764 689
Q ss_pred CcchhhhhHHHHHHHhh--CCCCCCCCChHHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHH
Q 011582 333 TEADMWSIGVIAYILLC--GSRPFWARTESGIFRAVLKA----DPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA 406 (482)
Q Consensus 333 ~~~DiwSlGvil~ellt--g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 406 (482)
.++|||||||++|+|++ |..||........+..+... ...........++.++.++|.+||+.||.+|||+.++
T Consensus 211 ~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el 290 (296)
T cd05051 211 TKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290 (296)
T ss_pred ccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHH
Confidence 99999999999999998 78899877777776666543 1111111123467999999999999999999999999
Q ss_pred hc
Q 011582 407 LS 408 (482)
Q Consensus 407 L~ 408 (482)
+.
T Consensus 291 ~~ 292 (296)
T cd05051 291 HL 292 (296)
T ss_pred HH
Confidence 54
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=322.82 Aligned_cols=252 Identities=21% Similarity=0.337 Sum_probs=209.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|+..+.||+|+||.||+|+.+.....+..+|||.+... ......+.+.+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~-----------------------------~~~~~~~~~~~ 55 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPG-----------------------------YTEKQRQDFLS 55 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEecccc-----------------------------CCHHHHHHHHH
Confidence 5788999999999999999998752222347999988542 12233567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. |+||+++++++.+.+..|+||||+++++|.+++....+.+++..+..++.|++.||.|||+.|++|||||
T Consensus 56 e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlk 134 (268)
T cd05063 56 EASIMGQFS-HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLA 134 (268)
T ss_pred HHHHHhcCC-CCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 999999996 9999999999999999999999999999999887766789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcc--c--ccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERL--N--DIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~--~--~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|+||++ +.++.+||+|||++......... . ....+..|+|||++. +.++.++|||||||++|+|++ |..||
T Consensus 135 p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~ 211 (268)
T cd05063 135 ARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211 (268)
T ss_pred hhhEEE---cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCC
Confidence 999999 56778999999998765432211 1 122345799999876 468999999999999999997 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
...+..+....+..... . +....++.++.+++.+||..+|.+||++.++++
T Consensus 212 ~~~~~~~~~~~i~~~~~-~--~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 212 WDMSNHEVMKAINDGFR-L--PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CcCCHHHHHHHHhcCCC-C--CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 98888887777765422 1 222357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=321.43 Aligned_cols=252 Identities=27% Similarity=0.502 Sum_probs=207.8
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.... +|+.||+|.++.. ........+.+.+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~---~~~~~~ik~~~~~---------------------------~~~~~~~~~~~~~ 51 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLL---DGRVVALKKVQIF---------------------------EMMDAKARQDCLK 51 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcC---CCCEEEEEEeecc---------------------------cccchhhHHHHHH
Confidence 579999999999999999999986 7999999998642 1122334567889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
|+.+++++. |+||+++++++.+.+..++||||+++++|.+++.. ....+++..+..++.|++.||.|||+.||+||
T Consensus 52 ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~ 130 (267)
T cd08224 52 EIDLLKQLD-HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHR 130 (267)
T ss_pred HHHHHHhCC-CCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 999999996 99999999999999999999999999999988754 23568999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||+|+||++ +.++.++|+|||++....... ......|+..|+|||.+.+ .++.++|||||||++|+|++|..||.
T Consensus 131 dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 207 (267)
T cd08224 131 DIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY 207 (267)
T ss_pred CcChhhEEE---CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcc
Confidence 999999999 567789999999987654332 2234578999999998764 58999999999999999999999996
Q ss_pred CCCh--HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 356 ARTE--SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 356 ~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.... .+....+.... +.......++.++.++|.+||..+|.+|||+.++++
T Consensus 208 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 208 GDKMNLYSLCKKIEKCD--YPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred cCCccHHHHHhhhhcCC--CCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5432 23333333322 222223357889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=362.17 Aligned_cols=150 Identities=29% Similarity=0.492 Sum_probs=133.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|.+++.||+|+||.||+|++.. +|+.||||++++. ..........+.
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiKvi~~~---------------------------~~~~~~~~~~~~ 52 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKN---NSKLYAVKVVKKA---------------------------DMINKNMVHQVQ 52 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEehh---------------------------hccCHHHHHHHH
Confidence 3689999999999999999999976 7899999998753 112334456788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. ||||+++++++...+.+||||||+.|++|.+++... +.+++..++.|+.||+.||.|||++|||||||
T Consensus 53 ~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDL 130 (669)
T cd05610 53 AERDALALSK-SPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDL 130 (669)
T ss_pred HHHHHHHhcC-CCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCc
Confidence 9999999996 999999999999999999999999999999987544 57899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEeccccc
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSD 304 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~ 304 (482)
||+|||+ +.++.+||+|||+++
T Consensus 131 KP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 131 KPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred cHHHEEE---cCCCCEEEEeCCCCc
Confidence 9999999 567789999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=325.99 Aligned_cols=260 Identities=30% Similarity=0.516 Sum_probs=219.4
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...+.|++.+.||.|+||.||+|.+.. ++..||+|++... .. ..+.
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~---~~~~~~iK~~~~~------------------------------~~-~~~~ 61 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRA---TGKEVAIKKMRLR------------------------------KQ-NKEL 61 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEcc---CCcEEEEEEEecC------------------------------ch-hHHH
Confidence 345679999999999999999999876 6889999998653 11 3567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. |+||+++++++...+..|+|+||+++++|.+++......+++..+..++.|++.||.|||+.||+|+
T Consensus 62 ~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~ 140 (286)
T cd06614 62 IINEILIMKDCK-HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140 (286)
T ss_pred HHHHHHHHHHCC-CCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence 889999999996 9999999999999999999999999999999987664489999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+ .++.++|+|||||++|+|++|..||.
T Consensus 141 dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~ 217 (286)
T cd06614 141 DIKSDNILL---SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL 217 (286)
T ss_pred CCChhhEEE---cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCC
Confidence 999999999 567789999999887654322 2234467889999998764 58999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..........+...... .......++.++.++|.+||+.+|.+||++.++|.|+||.+..
T Consensus 218 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 218 REPPLRALFLITTKGIP-PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred CCCHHHHHHHHHhcCCC-CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 87766655555443322 1122234789999999999999999999999999999998744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-41 Score=337.33 Aligned_cols=259 Identities=30% Similarity=0.558 Sum_probs=209.5
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|.+.+.||+|+||.||+|.+.. +|+.||||++.+.. ......+.+
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~---~~~~vaiK~~~~~~----------------------------~~~~~~~~~ 63 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRPF----------------------------QSIIHAKRT 63 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcC---CCeEEEEEEecCcc----------------------------hhhHHHHHH
Confidence 45789999999999999999999876 78999999986420 122234567
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
.+|+.++++++ ||||+++++++... ...|++++++ +++|.+.+.. ..+++..+..++.|++.||.|||++
T Consensus 64 ~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~ 139 (345)
T cd07877 64 YRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSA 139 (345)
T ss_pred HHHHHHHHHcC-CCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 88999999997 99999999988643 4578999987 7788776643 4699999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg 350 (482)
||+||||||+||++ +.++.+||+|||++..... ......|+..|+|||.+.+ .++.++|||||||++|+|++|
T Consensus 140 ~ivH~dlkp~NIll---~~~~~~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g 214 (345)
T cd07877 140 DIIHRDLKPSNLAV---NEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214 (345)
T ss_pred CeeecCCChHHEEE---cCCCCEEEecccccccccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999 5677899999999876432 3345678999999998754 478899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCC-----------------------CCCC----CCCCCCCHHHHHHHHHhchhccccCCCH
Q 011582 351 SRPFWARTESGIFRAVLKADP-----------------------SFDE----APWPSLSPEAIDFVKRLLNKDYRKRLTA 403 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~-----------------------~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~ 403 (482)
+.||...........+..... ..+. ..+...++++.+||.+||+.||.+|+++
T Consensus 215 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~ 294 (345)
T cd07877 215 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITA 294 (345)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCH
Confidence 999987766554444333211 0111 1122468899999999999999999999
Q ss_pred HHHhcCcccccCCC
Q 011582 404 AQALSHPWLANSHD 417 (482)
Q Consensus 404 ~e~L~hp~~~~~~~ 417 (482)
.++|.||||++...
T Consensus 295 ~e~l~h~~f~~~~~ 308 (345)
T cd07877 295 AQALAHAYFAQYHD 308 (345)
T ss_pred HHHhcChhhhhcCC
Confidence 99999999987543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=319.90 Aligned_cols=252 Identities=26% Similarity=0.429 Sum_probs=215.3
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|.++. +|+.+|+|.+.+.. ........+.+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~----------------------------~~~~~~~~~~~e 49 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLS---DNQFYALKEVDLGS----------------------------MSQKEREDAVNE 49 (256)
T ss_pred CceEeeeecCCCceeEEEEEECC---CCCEEEEEEEehhh----------------------------ccHHHHHHHHHH
Confidence 58899999999999999998876 78999999986531 123345677889
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+.+++.+. |+||+++++++.+....|+||||+++++|.+++... ...+++..++.++.|++.||.|||+.|++|||
T Consensus 50 ~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~ 128 (256)
T cd08530 50 IRILASVN-HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRD 128 (256)
T ss_pred HHHHHhCC-CCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCC
Confidence 99999997 999999999999999999999999999999987652 35689999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|+|+||+++ .++.+||+|||++...... ......|++.|+|||.+.+ .++.++|+||+|+++|+|++|+.||...
T Consensus 129 l~~~ni~~~---~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~ 204 (256)
T cd08530 129 LKSANILLV---ANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR 204 (256)
T ss_pred CCcceEEEe---cCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999994 5678999999999876544 3344578999999998864 5888999999999999999999999888
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
+..+....+...... .. -..++.++.++|.+||..+|.+||++.++|+||++
T Consensus 205 ~~~~~~~~~~~~~~~--~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 205 SMQDLRYKVQRGKYP--PI-PPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CHHHHHHHHhcCCCC--CC-chhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 877776666554322 11 13578999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=316.29 Aligned_cols=252 Identities=31% Similarity=0.569 Sum_probs=213.5
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|++.+.||+|+||.||+|++.. +|+.||+|.+.... ......+.+.+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~---~~~~~~ik~~~~~~----------------------------~~~~~~~~~~~e 49 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLE---TGDFVAIKQISLEK----------------------------IKEEALKSIMQE 49 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcC---CCcEEEEEEecccc----------------------------cCHHHHHHHHHH
Confidence 58899999999999999999876 78899999986531 122455789999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+++++++. |+|++++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||
T Consensus 50 ~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p 127 (254)
T cd06627 50 IDLLKNLK-HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKA 127 (254)
T ss_pred HHHHHhCC-CCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCH
Confidence 99999996 999999999999999999999999999999987654 6899999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCc-ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDER-LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
+||++ +.++.++|+|||++........ .....|+..|+|||.+.+ .++.++||||+|+++|+|++|..||.....
T Consensus 128 ~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~ 204 (254)
T cd06627 128 ANILT---TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP 204 (254)
T ss_pred HHEEE---CCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH
Confidence 99999 4577899999999987654332 234578999999998764 478899999999999999999999987665
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
......+..... ......+++++.++|.+||..+|++||++.+++.||||
T Consensus 205 ~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 205 MAALFRIVQDDH---PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHhccCC---CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 444444332221 12234578999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=330.49 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=214.8
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.....|...+.||+|+||.||+|+++. +|..||+|.+... ..........
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~---~~~~~~ik~~~~~---------------------------~~~~~~~~~~ 61 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYS---------------------------GKQSNEKWQD 61 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcC---CCcEEEEEEEecc---------------------------cccChHHHHH
Confidence 345568888999999999999999876 7889999998642 0122334467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. |+|++++++++.+.+..|+||||+. |+|.+.+......+++..+..++.|++.||.|||++|++||
T Consensus 62 ~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~ 139 (308)
T cd06634 62 IIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139 (308)
T ss_pred HHHHHHHHHhCC-CCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 889999999996 9999999999999999999999996 57888776666679999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~~p 353 (482)
||||+||++ +.++.+||+|||++...... ....|++.|+|||.+. +.++.++|||||||++|+|++|..|
T Consensus 140 dl~p~nil~---~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p 213 (308)
T cd06634 140 DVKAGNILL---SEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213 (308)
T ss_pred CCCHHhEEE---CCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCC
Confidence 999999999 56778999999998765432 3457889999999863 3578899999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|......+....+...... ......++..+.+||++||..+|.+||+++++++|||+....
T Consensus 214 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 214 LFNMNAMSALYHIAQNESP--ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred CccccHHHHHHHHhhcCCC--CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 9876655555544443321 111235789999999999999999999999999999998753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=330.38 Aligned_cols=253 Identities=22% Similarity=0.362 Sum_probs=207.6
Q ss_pred cceEecceeecCCceEEEEEEEecC----CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKG----SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~----~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
++|.+++.||+|+||.||+|+.... ...+..||+|++.+. .......
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~-----------------------------~~~~~~~ 62 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDN-----------------------------ATDKDLA 62 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCC-----------------------------CChHHHH
Confidence 6899999999999999999986421 113567999988642 2233456
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMVQ 261 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~q 261 (482)
.+.+|+.+++.+.+||||+++++++.+.+.+|+||||+++|+|.+++.... ..+++..+..++.|
T Consensus 63 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 142 (314)
T cd05099 63 DLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQ 142 (314)
T ss_pred HHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHH
Confidence 788999999999669999999999999999999999999999999986532 35889999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchh
Q 011582 262 ILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADM 337 (482)
Q Consensus 262 i~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di 337 (482)
|+.||.|||++||+||||||+|||+ +.++.+||+|||+++....... .....++..|||||++. +.++.++||
T Consensus 143 i~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (314)
T cd05099 143 VARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDV 219 (314)
T ss_pred HHHHHHHHHHCCeeeccccceeEEE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchh
Confidence 9999999999999999999999999 5677899999999986543211 12223456799999876 458999999
Q ss_pred hhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 338 WSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 338 wSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|||||++|+|++ |..||.+....+.+..+...... .....++.+++++|.+||..||.+||++.++++
T Consensus 220 wslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 220 WSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred hHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999999999 89999888877777776654321 112357889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.35 Aligned_cols=245 Identities=35% Similarity=0.650 Sum_probs=211.0
Q ss_pred eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhh
Q 011582 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL 208 (482)
Q Consensus 129 LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l 208 (482)
||+|+||.||+|.... +|+.||+|++.+. ..........+.+|+.+++.+
T Consensus 1 lg~G~~~~v~~~~~~~---~~~~~~~k~~~~~---------------------------~~~~~~~~~~~~~e~~~l~~l 50 (250)
T cd05123 1 LGKGSFGKVLLVRKKD---TGKLYAMKVLKKK---------------------------KIIKRKEVEHTLTERNILSRI 50 (250)
T ss_pred CCCCCceEEEEEEECC---CCcEEEEEEeehh---------------------------hhcchHHHHHHHHHHHHHHHc
Confidence 6999999999999875 6899999998764 112233566889999999999
Q ss_pred cCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 011582 209 TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTS 288 (482)
Q Consensus 209 ~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~ 288 (482)
. |+||+++++.++.++..|+||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++
T Consensus 51 ~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~-- 126 (250)
T cd05123 51 N-HPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL-- 126 (250)
T ss_pred C-CCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE--
Confidence 7 999999999999999999999999999999988654 579999999999999999999999999999999999999
Q ss_pred CCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHH
Q 011582 289 KEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366 (482)
Q Consensus 289 ~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i 366 (482)
+.++.++|+|||++...... .......++..|+|||.+.+ .++.++|+||||+++|+|++|..||...........+
T Consensus 127 -~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~ 205 (250)
T cd05123 127 -DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205 (250)
T ss_pred -cCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 56778999999998876443 23445678999999998865 4788999999999999999999999888777777777
Q ss_pred HhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH---HHHhcCccc
Q 011582 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA---AQALSHPWL 412 (482)
Q Consensus 367 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~---~e~L~hp~~ 412 (482)
......++ ..++.++.++|++||..||++||++ +++++||||
T Consensus 206 ~~~~~~~~----~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 206 LKDPLRFP----EFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hcCCCCCC----CCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 66443333 2368999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=326.59 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=208.1
Q ss_pred cceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
.+|.+.+.||+|+||.||+|+.... ..++..+|+|.+... .....+.+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~------------------------------~~~~~~~~ 54 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP------------------------------TLAARKDF 54 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc------------------------------cHHHHHHH
Confidence 5799999999999999999986532 124567999987532 23334678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMVQIL 263 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~ 263 (482)
.+|+.+++++. |+||+++++++...+..++||||+++++|.+++.... +.+++..++.++.||+
T Consensus 55 ~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~ 133 (291)
T cd05094 55 QREAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIA 133 (291)
T ss_pred HHHHHHHhcCC-CCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHH
Confidence 89999999996 9999999999999999999999999999999986532 3489999999999999
Q ss_pred HHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhh
Q 011582 264 SVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWS 339 (482)
Q Consensus 264 ~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwS 339 (482)
.||.|||++||+||||||+|||+ +.++.+||+|||++........ .....++..|+|||.+. ..++.++||||
T Consensus 134 ~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 210 (291)
T cd05094 134 SGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWS 210 (291)
T ss_pred HHHHHHHhCCeeecccCcceEEE---ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHH
Confidence 99999999999999999999999 5677899999999976543221 23345688999999876 45889999999
Q ss_pred hHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 340 IGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 340 lGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|||++|+|+| |..||......+.+..+....... .....+.++.++|.+||+.||.+||++.++++
T Consensus 211 lG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 211 FGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 9999999998 999998888777777665543321 12347899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=337.06 Aligned_cols=257 Identities=31% Similarity=0.593 Sum_probs=208.7
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|.+.+.||+|+||.||+|++.. +|+.||||++.+.. ........+.
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~----------------------------~~~~~~~~~~ 62 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKR---TGEKVAIKKLSRPF----------------------------QSEIFAKRAY 62 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCC---CCcEEEEEEecCcc----------------------------ccccchhHHH
Confidence 4689999999999999999999876 79999999986531 1122235678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
+|+.+++.+. ||||+++++++... ..+|+||||+.+ +|...+ +..+++..+..++.|++.||.|||++|
T Consensus 63 ~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ 137 (342)
T cd07879 63 RELTLLKHMQ-HENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAG 137 (342)
T ss_pred HHHHHHHhcC-CCCccchhheecccccCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 9999999996 99999999998754 357999999964 666543 346899999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCC
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~ 351 (482)
|+||||||+|||+ +.++.+||+|||++..... ......||..|+|||++.+ .++.++|||||||++|+|++|+
T Consensus 138 i~H~dlkp~NIll---~~~~~~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~ 212 (342)
T cd07879 138 IIHRDLKPGNLAV---NEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212 (342)
T ss_pred cccCCCCHHHEEE---CCCCCEEEeeCCCCcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCC
Confidence 9999999999999 5678899999999876432 2344578899999998754 4889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCC-----------------------CCCCC----CCCCCCHHHHHHHHHhchhccccCCCHH
Q 011582 352 RPFWARTESGIFRAVLKADP-----------------------SFDEA----PWPSLSPEAIDFVKRLLNKDYRKRLTAA 404 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~-----------------------~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~ 404 (482)
.||.+.+....+..+..... .+... .++.+++++.+||.+||+.||.+||+++
T Consensus 213 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~ 292 (342)
T cd07879 213 TLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTAT 292 (342)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 99988776555554443211 01111 1345788999999999999999999999
Q ss_pred HHhcCcccccCCC
Q 011582 405 QALSHPWLANSHD 417 (482)
Q Consensus 405 e~L~hp~~~~~~~ 417 (482)
++|.||||....+
T Consensus 293 e~l~h~~f~~~~~ 305 (342)
T cd07879 293 EALEHPYFDSFRD 305 (342)
T ss_pred HHhcCcchhhccc
Confidence 9999999987653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=328.24 Aligned_cols=254 Identities=32% Similarity=0.569 Sum_probs=212.3
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|.....||+|+||.||++..+. +|..||||.+... .......+.+|+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~---~~~~v~iK~~~~~------------------------------~~~~~~~~~~e~ 68 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKS---SGKLVAVKKMDLR------------------------------KQQRRELLFNEV 68 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcC---CCeEEEEEEeccc------------------------------chhHHHHHHHHH
Confidence 4445679999999999999876 7999999987431 223456788999
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~ 282 (482)
.+++.+. |+||+++++++...+..|+||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||+|+
T Consensus 69 ~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~ 145 (292)
T cd06657 69 VIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145 (292)
T ss_pred HHHHhcC-CcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 9999996 99999999999999999999999999999886633 46899999999999999999999999999999999
Q ss_pred ceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChH
Q 011582 283 NFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTES 360 (482)
Q Consensus 283 NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~ 360 (482)
||++ +.++.++|+|||++....... ......|++.|+|||.+.+ .++.++|+||+||++|+|++|..||.+....
T Consensus 146 Nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~ 222 (292)
T cd06657 146 SILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL 222 (292)
T ss_pred HEEE---CCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999 567789999999987654322 2234578999999998754 5889999999999999999999999887766
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 361 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
+....+....... ......+++++.++|.+||+.||.+||++.++|.||||....
T Consensus 223 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 223 KAMKMIRDNLPPK-LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHHhhCCcc-cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 6655554433221 112345789999999999999999999999999999998765
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=320.39 Aligned_cols=247 Identities=26% Similarity=0.341 Sum_probs=206.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|... .++.||||.++.. ....+.+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~----~~~~v~iK~~~~~-------------------------------~~~~~~~~ 49 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN----NTTPVAVKTLKPG-------------------------------TMDPKDFL 49 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec----CCeEEEEEeeCCC-------------------------------cccHHHHH
Confidence 357999999999999999999865 4678999998542 11235688
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+++++. ||||+++++++...+..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|||
T Consensus 50 ~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 128 (261)
T cd05068 50 AEAQIMKKLR-HPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRD 128 (261)
T ss_pred HHHHHHHHCC-CCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 9999999997 9999999999999999999999999999999886543 4689999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcc--cccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL--NDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~--~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|||+||++ +.++.+||+|||++......... ....++..|+|||++.+ .++.++||||||+++|+|++ |+.||
T Consensus 129 l~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 205 (261)
T cd05068 129 LAARNVLV---GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPY 205 (261)
T ss_pred CCcceEEE---cCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCC
Confidence 99999999 56778999999999876532211 11223457999998764 58999999999999999999 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+.+.......+..... .+ ....++..+.+++.+||+.+|.+||++.+++.
T Consensus 206 ~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 206 PGMTNAEVLQQVDQGYR-MP--CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCHHHHHHHHHcCCC-CC--CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 88887777776654422 11 12357899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=324.09 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=207.8
Q ss_pred cceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
.+|.+.++||+|+||.||+|.... ...++..+|+|.+... .......+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~------------------------------~~~~~~~~ 54 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA------------------------------SESARQDF 54 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC------------------------------CHHHHHHH
Confidence 578889999999999999997643 1224678999987542 23445688
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC--------------CCCCHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG--------------GKYSEEDAKIVMVQILS 264 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~qi~~ 264 (482)
.+|+.+++.+. |+||+++++++.+.+..++||||+++++|.+++.... ..+++..+..++.||+.
T Consensus 55 ~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~ 133 (280)
T cd05092 55 QREAELLTVLQ-HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIAS 133 (280)
T ss_pred HHHHHHHhcCC-CCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHH
Confidence 99999999996 9999999999999999999999999999999886542 35889999999999999
Q ss_pred HHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhh
Q 011582 265 VVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSI 340 (482)
Q Consensus 265 ~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSl 340 (482)
||.|||++||+||||||+|||+ ++++.+||+|||++........ .....+++.|+|||.+. ..++.++|||||
T Consensus 134 al~~LH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 210 (280)
T cd05092 134 GMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF 210 (280)
T ss_pred HHHHHHHCCeecccccHhhEEE---cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHH
Confidence 9999999999999999999999 5677899999999876543221 12334578899999876 468999999999
Q ss_pred HHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 341 GVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 341 Gvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||++|+|++ |.+||......+....+...... .....+++.+.+||.+||+.||.+||++++++.
T Consensus 211 G~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 211 GVVLWEIFTYGKQPWYQLSNTEAIECITQGREL---ERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHHHcCCCCCCccCCHHHHHHHHHcCccC---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999999998 99999887777777666554322 112358899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=341.48 Aligned_cols=255 Identities=24% Similarity=0.352 Sum_probs=214.6
Q ss_pred cceEecceeecCCceEEEEEEEecCCCC-CceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLK-GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~-g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
++-.+.++||+|+||.||+|+.+..... ...||||..+.. .......+.++.
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~---------------------------~~~~~~~~~e~m 209 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGS---------------------------SELTKEQIKEFM 209 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeeccc---------------------------ccccHHHHHHHH
Confidence 4556678999999999999999874221 122899987531 124567788999
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+++|+.+. |||||++||+...+..+|||||+|+||+|.++|.+..+.++..+...++.+.+.||+|||++++|||||
T Consensus 210 ~EArvMr~l~-H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDI 288 (474)
T KOG0194|consen 210 KEARVMRQLN-HPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDI 288 (474)
T ss_pred HHHHHHHhCC-CCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhH
Confidence 9999999996 999999999999999999999999999999999887667999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCccc-ccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN-DIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~-~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
-.+|+|+ +.+..+||+|||+++....-.... ...-...|+|||.+. +-|+.++|||||||++||+++ |..||.+
T Consensus 289 AARNcL~---~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g 365 (474)
T KOG0194|consen 289 AARNCLY---SKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPG 365 (474)
T ss_pred hHHHhee---cCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCC
Confidence 9999999 556668999999988654211111 112346899999987 469999999999999999998 8999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
....++...|.........+ ..-+.++..++.+|+..||++|+++.++.+
T Consensus 366 ~~~~~v~~kI~~~~~r~~~~--~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 366 MKNYEVKAKIVKNGYRMPIP--SKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCHHHHHHHHHhcCccCCCC--CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 99999999997766554443 257889999999999999999999998864
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=325.94 Aligned_cols=254 Identities=32% Similarity=0.530 Sum_probs=210.9
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|++.+.||+|+||.||+|+... +|+.||+|++.... ......+.+.+|+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~---~~~~~~iK~~~~~~----------------------------~~~~~~~~~~~e~ 49 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKK---TGEIVALKKIRLDN----------------------------EEEGIPSTALREI 49 (282)
T ss_pred CeeehcccccCcceEEEeeecC---CCcEEEEEEecccc----------------------------ccccccHHHHHHH
Confidence 6677889999999999999876 79999999986531 1122235677899
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~ 282 (482)
.+++++. |+||+++++++.+.+..++||||++ ++|.+++......+++..+..++.|++.||.|||++||+||||+|+
T Consensus 50 ~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ 127 (282)
T cd07829 50 SLLKELK-HPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQ 127 (282)
T ss_pred HHHHhcC-CCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChh
Confidence 9999997 9999999999999999999999997 4899988765467999999999999999999999999999999999
Q ss_pred ceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 283 NFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 283 NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
||++ ++++.+||+|||++....... ......++..|+|||.+.+ .++.++|||||||++|+|++|..||...+.
T Consensus 128 ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 204 (282)
T cd07829 128 NILI---NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSE 204 (282)
T ss_pred eEEE---cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccH
Confidence 9999 567889999999988764432 2334456788999998753 588999999999999999999999988877
Q ss_pred HHHHHHHHhcCCCC------------------C-------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 360 SGIFRAVLKADPSF------------------D-------EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 360 ~~~~~~i~~~~~~~------------------~-------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.+.+..+....... + ...++.++.++.++|.+||..||++||++.++++||||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 205 IDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 66655554321100 0 01233568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=322.39 Aligned_cols=248 Identities=23% Similarity=0.366 Sum_probs=209.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
..+|.+.+.||.|+||.||+|... .+..+|+|++... .......+.
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~----~~~~~~~k~~~~~------------------------------~~~~~~~~~ 50 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWK----NRVRVAIKILKSD------------------------------DLLKQQDFQ 50 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEec----CCCcEEEEecccc------------------------------chhhHHHHH
Confidence 457999999999999999999986 3788999998653 222345688
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+++.++ |+||+++++++.+.+.+++||||+++++|.+++.+. +..+++..+..++.||+.||.|||++||+|||
T Consensus 51 ~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~d 129 (261)
T cd05148 51 KEVQALKRLR-HKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRD 129 (261)
T ss_pred HHHHHHhcCC-CcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 9999999996 999999999999999999999999999999998753 35689999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc-ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER-LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
|||+||++ +.++.+||+|||++........ .....++..|+|||.+. +.++.++||||||+++|+|++ |+.||.
T Consensus 130 l~~~nilv---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~ 206 (261)
T cd05148 130 LAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYP 206 (261)
T ss_pred cCcceEEE---cCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCC
Confidence 99999999 5677899999999977643221 22334577899999876 468899999999999999998 899998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.....+.+..+.... .. .....+++++.++|.+||+.||.+|||+.++++
T Consensus 207 ~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 207 GMNNHEVYDQITAGY-RM--PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred cCCHHHHHHHHHhCC-cC--CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 888877877776432 11 222468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=322.41 Aligned_cols=244 Identities=24% Similarity=0.363 Sum_probs=198.8
Q ss_pred ceeecCCceEEEEEEEecCCCCCc--eEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQ--DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKI 204 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~--~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~ 204 (482)
+.||+|+||.||+|+.+. +|. .+|+|.++.. ......+.+.+|+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~---~~~~~~~~~k~~~~~-----------------------------~~~~~~~~~~~E~~~ 48 (270)
T cd05047 1 DVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY-----------------------------ASKDDHRDFAGELEV 48 (270)
T ss_pred CcCCCCCCceEEEEEEcC---CCCeeEEEEEEcccc-----------------------------CCHHHHHHHHHHHHH
Confidence 358999999999999876 454 5688887532 223345678899999
Q ss_pred HHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHH
Q 011582 205 LRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 205 l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~yL 269 (482)
+.++.+||||+++++++...+..|+||||+++|+|.+++.... ..+++..+..++.|++.||.||
T Consensus 49 l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l 128 (270)
T cd05047 49 LCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL 128 (270)
T ss_pred HHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 9999669999999999999999999999999999999986532 2478999999999999999999
Q ss_pred HHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHh
Q 011582 270 HFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 270 H~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ell 348 (482)
|++|++||||||+|||+ +.++.+||+|||++..............+..|+|||++. ..++.++|||||||++|+|+
T Consensus 129 H~~~i~H~dikp~nili---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~ 205 (270)
T cd05047 129 SQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205 (270)
T ss_pred HHCCEeecccccceEEE---cCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999 567889999999986432111111223456799999875 45889999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 349 C-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 349 t-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+ |..||.+.+..+....+.... .. .....++.++.+|+.+||..||.+|||+.+++.
T Consensus 206 ~~g~~pf~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 206 SLGGTPYCGMTCAELYEKLPQGY-RL--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred cCCCCCccccCHHHHHHHHhCCC-CC--CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 7 999998887777776665432 11 122347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=318.81 Aligned_cols=243 Identities=22% Similarity=0.332 Sum_probs=199.9
Q ss_pred eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
+||+|+||.||+|..+. ..++..||+|+++.. .......+.+.+|+.+++.
T Consensus 2 ~lg~G~~g~v~~~~~~~-~~~~~~~aiK~~~~~----------------------------~~~~~~~~~~~~e~~~l~~ 52 (257)
T cd05116 2 ELGSGNFGTVKKGMYKM-KKSEKTVAVKILKND----------------------------NNDPALKDELLREANVMQQ 52 (257)
T ss_pred cCCCcCCcceEEeEEec-CCCceEEEEEEccCC----------------------------CCcHHHHHHHHHHHHHHHh
Confidence 58999999999997642 125788999998542 1223445788999999999
Q ss_pred hcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 011582 208 LTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFT 287 (482)
Q Consensus 208 l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~ 287 (482)
+. ||||+++++++. .+..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||.||++
T Consensus 53 l~-h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill- 128 (257)
T cd05116 53 LD-NPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKN-KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL- 128 (257)
T ss_pred CC-CCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE-
Confidence 96 999999999875 45679999999999999988544 579999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCc----ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCCCCCChHH
Q 011582 288 SKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPFWARTESG 361 (482)
Q Consensus 288 ~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~ 361 (482)
+.++.+||+|||++........ .....++..|+|||.+.. .++.++|||||||++|||++ |..||...+..+
T Consensus 129 --~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 206 (257)
T cd05116 129 --VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206 (257)
T ss_pred --cCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 5677899999999987643322 122334678999998864 58889999999999999998 999998888877
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 362 IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 362 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+...+..... .+ ....+++++.+||.+||+.||.+||++.++..
T Consensus 207 ~~~~i~~~~~-~~--~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 207 VTQMIESGER-ME--CPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHCCCC-CC--CCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 7777765432 11 12358999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=323.54 Aligned_cols=248 Identities=19% Similarity=0.298 Sum_probs=201.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCce----EEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQD----VAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~----vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
++|++.+.||+|+||.||+|.... +|+. ||+|.+... .......
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~---~~~~~~~~~~~k~~~~~-----------------------------~~~~~~~ 54 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIP---EGDSIKIPVAIKTIQDR-----------------------------SGRQTFQ 54 (279)
T ss_pred hhceeccccCccCCcceEEEEEcC---CCCceeeEEEEeecccc-----------------------------cchHHHH
Confidence 578999999999999999999865 4554 566655321 1223346
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
++..|+.+++++. ||||+++++++. ....++|+||+++|+|.+++......+++..+..++.||+.||.|||++|++|
T Consensus 55 ~~~~~~~~l~~l~-h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH 132 (279)
T cd05111 55 EITDHMLAMGSLD-HAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVH 132 (279)
T ss_pred HHHHHHHHHhcCC-CCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 7788999999996 999999999875 45678999999999999999776678999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GS 351 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~ 351 (482)
|||||+|||+ +.++.+||+|||+++...... ......++..|+|||.+. +.++.++|||||||++|||++ |.
T Consensus 133 ~dlkp~nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~ 209 (279)
T cd05111 133 RNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGA 209 (279)
T ss_pred cccCcceEEE---cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCC
Confidence 9999999999 567889999999998654332 123345778899999886 569999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.||.+.........+..+.. ... ....+.++.+++.+|+..||.+|||+.++++
T Consensus 210 ~p~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 210 EPYAGMRPHEVPDLLEKGER-LAQ--PQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCCCCHHHHHHHHHCCCc-CCC--CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99988776655544443322 221 1236788999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=326.46 Aligned_cols=255 Identities=22% Similarity=0.316 Sum_probs=203.7
Q ss_pred cceEecceeecCCceEEEEEEEecCC---------C--CCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhcc
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGS---------L--KGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFM 189 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~---------~--~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (482)
.+|++.+.||+|+||.||+|++.... . ....||||.++..
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~----------------------------- 55 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD----------------------------- 55 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC-----------------------------
Confidence 58999999999999999999875310 0 2235899988642
Q ss_pred ccHHHHHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-----------CCCCHHHHHHH
Q 011582 190 TTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-----------GKYSEEDAKIV 258 (482)
Q Consensus 190 ~~~~~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------~~l~~~~~~~i 258 (482)
........+.+|+++++++. |+||+++++++...+..++||||+++++|.+++.... ..+++..+..+
T Consensus 56 ~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i 134 (295)
T cd05097 56 VTKTARNDFLKEIKIMSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYM 134 (295)
T ss_pred CCHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHH
Confidence 12334567899999999997 9999999999999999999999999999999885432 23688999999
Q ss_pred HHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCc
Q 011582 259 MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTE 334 (482)
Q Consensus 259 ~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~ 334 (482)
+.|++.||.|||++|++||||||+||++ +.++.+||+|||++........ .....++..|+|||++. +.++.+
T Consensus 135 ~~~i~~al~~lH~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 211 (295)
T cd05097 135 AVQIASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTA 211 (295)
T ss_pred HHHHHHHHHHHHhcCeeccccChhhEEE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCch
Confidence 9999999999999999999999999999 5667899999999976543221 22334577899999875 568999
Q ss_pred chhhhhHHHHHHHhh--CCCCCCCCChHHHHHHHHhcC----CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 335 ADMWSIGVIAYILLC--GSRPFWARTESGIFRAVLKAD----PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 335 ~DiwSlGvil~ellt--g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+|||||||++|+|++ |..||...+..+....+.... ........+.+++.+.+||.+||..||.+||+++++++
T Consensus 212 ~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 212 SDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred hhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999988 778998877766665543311 11111122347899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=318.86 Aligned_cols=243 Identities=23% Similarity=0.361 Sum_probs=199.4
Q ss_pred eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
.||+|+||.||+|..... ..+..||+|++... ......+.+.+|+.++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~-~~~~~vavk~~~~~-----------------------------~~~~~~~~~~~E~~~l~~ 51 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMR-KKQIDVAIKVLKNE-----------------------------NEKSVRDEMMREAEIMHQ 51 (257)
T ss_pred ccCCCCcccEEEEEEecC-CCceeEEEEEcccc-----------------------------cChHHHHHHHHHHHHHHh
Confidence 389999999999987532 14667999988542 223345678999999999
Q ss_pred hcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 011582 208 LTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFT 287 (482)
Q Consensus 208 l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~ 287 (482)
+. ||||++++++++ .+..++||||+++++|.+++......+++..+..++.|++.||.|||++|++||||||+|||+
T Consensus 52 l~-h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~- 128 (257)
T cd05115 52 LD-NPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL- 128 (257)
T ss_pred cC-CCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE-
Confidence 96 999999999886 457899999999999999887666789999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCc----ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCCChHH
Q 011582 288 SKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWARTESG 361 (482)
Q Consensus 288 ~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~ 361 (482)
+.++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |..||......+
T Consensus 129 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 206 (257)
T cd05115 129 --VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206 (257)
T ss_pred --cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence 5677899999999976543321 11123357899999876 468999999999999999996 999998888777
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 362 IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 362 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
....+..+... . .....++++.++|.+||..||++||++.++++
T Consensus 207 ~~~~~~~~~~~-~--~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 207 VMSFIEQGKRL-D--CPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHCCCCC-C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 77666554321 1 11347899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=339.18 Aligned_cols=256 Identities=25% Similarity=0.363 Sum_probs=206.1
Q ss_pred ccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|.+++.||+|+||.||+|++... ...+..||||+++.. ......+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~-----------------------------~~~~~~~~ 86 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKST-----------------------------ARSSEKQA 86 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCC-----------------------------CChhHHHH
Confidence 35789999999999999999987531 124678999998642 11223456
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC------------------------------
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG------------------------------ 247 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------------------------ 247 (482)
+.+|+.+|.++..||||+++++++...+..++|||||++|+|.+++....
T Consensus 87 ~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (401)
T cd05107 87 LMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKS 166 (401)
T ss_pred HHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccccccccccccc
Confidence 88999999999669999999999999999999999999999999886431
Q ss_pred -------------------------------------------------------------------CCCCHHHHHHHHH
Q 011582 248 -------------------------------------------------------------------GKYSEEDAKIVMV 260 (482)
Q Consensus 248 -------------------------------------------------------------------~~l~~~~~~~i~~ 260 (482)
..+++..+..++.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 246 (401)
T cd05107 167 HVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSY 246 (401)
T ss_pred chhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHH
Confidence 1367778899999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc-cCCCcch
Q 011582 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR-SYGTEAD 336 (482)
Q Consensus 261 qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~D 336 (482)
||+.||.|||++||+||||||+|||+ ++++.+||+|||+++...... ......+++.|||||.+.+ .++.++|
T Consensus 247 qi~~aL~~LH~~~ivHrdlkp~NiLl---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 323 (401)
T cd05107 247 QVANGMEFLASKNCVHRDLAARNVLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSD 323 (401)
T ss_pred HHHHHHHHHhcCCcCcccCCcceEEE---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhH
Confidence 99999999999999999999999999 557789999999998653222 1223457889999998864 5899999
Q ss_pred hhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 337 MWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 337 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||||||++|||++ |..||......+............. ....++.++.+||.+|+..+|.+||++.++++.
T Consensus 324 vwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 324 VWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA--KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999998 8999987665555444444332222 223578999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=321.44 Aligned_cols=249 Identities=20% Similarity=0.302 Sum_probs=202.0
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCc--eEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQ--DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~--~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
|.+++.||+|+||.||+|+... .+. .||||.++.. .......+.+.+
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~---~~~~~~~a~k~~~~~----------------------------~~~~~~~~~~~~ 49 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQ---DDSILKVAVKTMKIA----------------------------ICTRSEMEDFLS 49 (272)
T ss_pred CccccccCcccCceEEEeEEcc---CCCeeeEEEEecccC----------------------------cCCHHHHHHHHH
Confidence 3567889999999999999865 343 6999988642 123344678889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHH
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRILSR-----GGKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~yL 269 (482)
|+.+++.+. |+||+++++++... ...++||||+.+|+|.+++... ...+++..+..++.|++.||.||
T Consensus 50 E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~l 128 (272)
T cd05075 50 EAVCMKEFD-HPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYL 128 (272)
T ss_pred HHHHHHhCC-CCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHH
Confidence 999999996 99999999987432 3578999999999998887532 23589999999999999999999
Q ss_pred HHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcchhhhhHHHHH
Q 011582 270 HFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAY 345 (482)
Q Consensus 270 H~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ 345 (482)
|++||+||||||+|||+ +.++.+||+|||++........ .....+++.|+|||.+.+ .++.++|||||||++|
T Consensus 129 H~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~ 205 (272)
T cd05075 129 SSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMW 205 (272)
T ss_pred HHCCeeccccchhheEE---cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHH
Confidence 99999999999999999 5678899999999987643321 122345678999998864 5899999999999999
Q ss_pred HHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 346 ILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 346 ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
+|++ |..||.+....++...+....... ....++..+.++|.+||+.||.+|||+.+++++
T Consensus 206 el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 206 EIATRGQTPYPGVENSEIYDYLRQGNRLK---QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHcCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999 899998887777777766544311 123578999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=330.24 Aligned_cols=260 Identities=35% Similarity=0.572 Sum_probs=209.6
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|.+.+.||.|+||.||+|.+.. +|+.||||++.+.. ......+.
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~---~~~~vaiK~~~~~~----------------------------~~~~~~~~ 55 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQL---TGQNVAIKKIMKPF----------------------------STPVLAKR 55 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECC---CCCEEEEEEecccc----------------------------cccchhHH
Confidence 456889999999999999999999876 79999999886521 11223456
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEe-CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYED-DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+.+|+.+++.+. ||||++++++|.. ....|+||||+ +++|.+.+.. ..+++..+..++.|+++||.|||++||+|
T Consensus 56 ~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH 131 (328)
T cd07856 56 TYRELKLLKHLR-HENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVH 131 (328)
T ss_pred HHHHHHHHHhcC-CCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 789999999997 9999999999876 56789999999 5688776642 46899999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf 354 (482)
|||+|+|||+ +.++.+||+|||++..... ......++..|+|||.+.+ .++.++|||||||++|+|++|..||
T Consensus 132 ~dl~p~Nili---~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f 206 (328)
T cd07856 132 RDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206 (328)
T ss_pred CCCCHHHEeE---CCCCCEEeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCC
Confidence 9999999999 5678899999999876432 2344578899999998754 5899999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCC---------------------------CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHh
Q 011582 355 WARTESGIFRAVLKADP---------------------------SFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~---------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L 407 (482)
...........+.+... .......+.+++++.++|.+||+.+|.+||++++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell 286 (328)
T cd07856 207 PGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEAL 286 (328)
T ss_pred CCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 77654333222211100 000011245789999999999999999999999999
Q ss_pred cCcccccCCC
Q 011582 408 SHPWLANSHD 417 (482)
Q Consensus 408 ~hp~~~~~~~ 417 (482)
.||||.....
T Consensus 287 ~~~~~~~~~~ 296 (328)
T cd07856 287 AHPYLAPYHD 296 (328)
T ss_pred cCCccccccC
Confidence 9999986654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=321.85 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=196.1
Q ss_pred cce-EecceeecCCceEEEEEEEecC-CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHY-ELGEEVGRGHFGYTCSAKAKKG-SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y-~~~~~LG~G~fG~V~~a~~~~~-~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
++| ++.+.||+|+||+||++..... ..++..||+|+++.. ........+
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-----------------------------~~~~~~~~~ 53 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE-----------------------------CGQQNTSGW 53 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccc-----------------------------cChHHHHHH
Confidence 455 9999999999999998764321 226889999998642 122334678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+|+.+++++. ||||+++++++... ..+|+||||+++++|.+++.. ..+++.++..++.|++.||.|||++||+|
T Consensus 54 ~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H 130 (283)
T cd05080 54 KKEINILKTLY-HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIH 130 (283)
T ss_pred HHHHHHHHhCC-CCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 89999999996 99999999988653 468999999999999998854 36999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~ 351 (482)
|||||+|||+ +.++.+||+|||++........ .....++..|+|||++. +.++.++||||||+++|+|++|.
T Consensus 131 ~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~ 207 (283)
T cd05080 131 RDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHC 207 (283)
T ss_pred cccChheEEE---cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCC
Confidence 9999999999 5677899999999987643322 12234567799999886 46899999999999999999999
Q ss_pred CCCCCCChH--HH------------HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 352 RPFWARTES--GI------------FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 352 ~pf~~~~~~--~~------------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.||...... +. ...........+ .-..++.++.+++.+||..||++|||+++++.
T Consensus 208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 208 DSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred CCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 998543211 00 011111111111 12347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=324.12 Aligned_cols=251 Identities=24% Similarity=0.347 Sum_probs=204.7
Q ss_pred ceEecceeecCCceEEEEEEEecCC--CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGS--LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~--~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
+|++.+.||+|+||.||+|+..... ..+..+|+|.+.+. ........+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~-----------------------------~~~~~~~~~~ 51 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKEN-----------------------------ASSSELRDLL 51 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCC-----------------------------CCHHHHHHHH
Confidence 4788899999999999999875311 12457999987543 2233456789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-----------------------CCCCCHHHHH
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-----------------------GGKYSEEDAK 256 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-----------------------~~~l~~~~~~ 256 (482)
+|+.+++.+. ||||+++++.+...+..++||||+.+++|.+++... ...+++..+.
T Consensus 52 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 130 (290)
T cd05045 52 SEFNLLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLI 130 (290)
T ss_pred HHHHHHhhCC-CCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHH
Confidence 9999999996 999999999999999999999999999999987542 1347889999
Q ss_pred HHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCC
Q 011582 257 IVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYG 332 (482)
Q Consensus 257 ~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~ 332 (482)
.++.|++.||.|||++||+||||||+|||+ ++++.+||+|||+++....... .....++..|+|||.+.+ .++
T Consensus 131 ~i~~~i~~~l~~LH~~~ivH~dikp~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~ 207 (290)
T cd05045 131 SFAWQISRGMQYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT 207 (290)
T ss_pred HHHHHHHHHHHHHHHCCeehhhhhhheEEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc
Confidence 999999999999999999999999999999 5677899999999976533221 223345778999998754 589
Q ss_pred CcchhhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 333 TEADMWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 333 ~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.++||||||+++|+|++ |..||.+.....++..+.... ..+ ....++.++.++|.+||+.||.+||+++++++
T Consensus 208 ~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 208 TQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGY-RME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred hHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC-CCC--CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 99999999999999998 999998888777766554432 222 22458899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.08 Aligned_cols=259 Identities=27% Similarity=0.513 Sum_probs=228.4
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|.++++||+|+|++|.+++.++ +.+.||+|+++|.. ....+.+.-+.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~---t~qiyamkvvkkel---------------------------~nddedidwvq 298 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKK---TDQIYAMKVVKKEL---------------------------VNDDEDIDWVQ 298 (593)
T ss_pred cccceeeeeecCcchhhhhheehcc---cceeeehhhHHHHh---------------------------cCCcccchhHH
Confidence 4689999999999999999999988 89999999998752 23444566778
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
.|-.+.....+||.+|-|..+|+.+..+++|.||++||+|.-++... .+++++.++.+...|+.||.|||++|||+|||
T Consensus 299 tek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq-rklpeeharfys~ei~lal~flh~rgiiyrdl 377 (593)
T KOG0695|consen 299 TEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEICLALNFLHERGIIYRDL 377 (593)
T ss_pred hhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhh-hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeec
Confidence 88888888889999999999999999999999999999999887544 68999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccc-cCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC--
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDY-VKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW-- 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~-~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~-- 355 (482)
|.+|+|+ |..+++||.|+|+++- +.++...+++||||.|.|||++++ .|+..+|.|+|||+++||+.|+.||.
T Consensus 378 kldnvll---daeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdiv 454 (593)
T KOG0695|consen 378 KLDNVLL---DAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIV 454 (593)
T ss_pred cccceEE---ccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCccee
Confidence 9999999 7788999999999975 455677889999999999999997 59999999999999999999999994
Q ss_pred ------CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC------CHHHHhcCcccccCC
Q 011582 356 ------ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL------TAAQALSHPWLANSH 416 (482)
Q Consensus 356 ------~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~------s~~e~L~hp~~~~~~ 416 (482)
..++..+++-|++....++.. +|-.+..+++..|++||++|. ...++-.|+||+...
T Consensus 455 gm~n~d~ntedylfqvilekqiriprs----lsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 455 GMDNPDMNTEDYLFQVILEKQIRIPRS----LSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred cCCCcccchhHHHHHHHhhhcccccce----eehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 234456777888887777654 788899999999999999997 468999999998543
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=316.90 Aligned_cols=246 Identities=23% Similarity=0.357 Sum_probs=205.5
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|.+.........||||.+.... .....+.+.+|+.+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~-----------------------------~~~~~~~~~~e~~~l~ 51 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDK-----------------------------LSDIMDDFLKEAAIMH 51 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcc-----------------------------cHHHHHHHHHHHHHHh
Confidence 36899999999999986532234479999986531 1145678899999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL 285 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIl 285 (482)
++. ||||+++++++.+ ..+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+
T Consensus 52 ~l~-h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil 129 (257)
T cd05040 52 SLD-HENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNIL 129 (257)
T ss_pred hcC-CCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEE
Confidence 997 9999999999988 89999999999999999987654 57899999999999999999999999999999999999
Q ss_pred EecCCCCCcEEEEecccccccCCCCc----ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCCCCCCh
Q 011582 286 FTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPFWARTE 359 (482)
Q Consensus 286 l~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf~~~~~ 359 (482)
+ +.++.+||+|||++........ .....++..|+|||.+.. .++.++|||||||++|+|++ |..||...+.
T Consensus 130 ~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 206 (257)
T cd05040 130 L---ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG 206 (257)
T ss_pred E---ecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9 5668899999999987644221 123457789999998864 68999999999999999998 9999988888
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+....+......... ...++..+.+++.+||..+|++||++.++++
T Consensus 207 ~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 207 SQILKKIDKEGERLER--PEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHHHHhcCCcCCC--CccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 8777777653332222 1347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=330.62 Aligned_cols=254 Identities=23% Similarity=0.364 Sum_probs=208.4
Q ss_pred cceEecceeecCCceEEEEEEEecCC----CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGS----LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~----~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
.+|++++.||+|+||.||+|++.... ..+..||+|++... ......+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-----------------------------~~~~~~~ 62 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-----------------------------ATDKDLS 62 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-----------------------------cCHHHHH
Confidence 47999999999999999999864311 12347999987542 2234457
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMVQ 261 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~q 261 (482)
.+.+|+.+++++.+||||+++++++.+.+..|+||||+++|+|.+++.... ..+++..+..++.|
T Consensus 63 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 142 (334)
T cd05100 63 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQ 142 (334)
T ss_pred HHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHH
Confidence 889999999999559999999999999999999999999999999886532 24788899999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcchh
Q 011582 262 ILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEADM 337 (482)
Q Consensus 262 i~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~Di 337 (482)
++.||.|||++||+||||||+|||+ +.++.+||+|||+++....... .....++..|+|||++.+ .++.++||
T Consensus 143 i~~al~~LH~~givH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (334)
T cd05100 143 VARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219 (334)
T ss_pred HHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhh
Confidence 9999999999999999999999999 5677899999999986543221 122334568999998864 58999999
Q ss_pred hhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 338 WSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 338 wSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|||||++|+|++ |..||.+.+..+....+...... .....++.++.+||.+||..+|.+||++.+++++
T Consensus 220 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 220 WSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 999999999998 89999988888877777654321 1223578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=319.17 Aligned_cols=246 Identities=25% Similarity=0.343 Sum_probs=203.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.++||+|+||.||+|++.. +..||+|++++.. ...+.+.
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~----~~~valK~~~~~~-------------------------------~~~~~~~ 49 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNG----TTRVAIKTLKPGT-------------------------------MSPEAFL 49 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecC----CceEEEEecccCc-------------------------------cCHHHHH
Confidence 3579999999999999999998754 3469999986420 1124678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+++.+. |+||+++++++. .+..|+||||+++|+|.+++... ...+++..+..++.|++.||.|||+.||+|||
T Consensus 50 ~E~~~l~~l~-~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~d 127 (262)
T cd05071 50 QEAQVMKKLR-HEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127 (262)
T ss_pred HHHHHHHhCC-CCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 9999999996 999999999875 45689999999999999998753 34689999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|||+||++ ++++.+||+|||++........ .....++..|+|||++. +.++.++|||||||++|+|++ |..||
T Consensus 128 l~p~Nill---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~ 204 (262)
T cd05071 128 LRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 204 (262)
T ss_pred cCcccEEE---cCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCC
Confidence 99999999 5677899999999986643322 12344677899999875 468999999999999999999 89999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+....+....+...... .....++..+.++|.+||+.||.+||+++++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 205 PGMVNREVLDQVERGYRM---PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCChHHHHHHHhcCCCC---CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 888777777766554321 112358899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=314.40 Aligned_cols=242 Identities=24% Similarity=0.331 Sum_probs=201.5
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|... ++..||+|++... ........+.+|+.+++
T Consensus 1 ~~ig~g~~g~vy~~~~~----~~~~~a~K~~~~~-----------------------------~~~~~~~~~~~e~~~l~ 47 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK----DKTPVAVKTCKED-----------------------------LPQELKIKFLSEARILK 47 (250)
T ss_pred CccCCCCCceEEEEEec----CCcEEEEEecCCc-----------------------------CCHHHHHHHHHHHHHHH
Confidence 36899999999999854 5788999988643 12333457889999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+. ||||+++++++...+..++||||+++++|.+++......+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 48 ~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili 126 (250)
T cd05085 48 QYD-HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV 126 (250)
T ss_pred hCC-CCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE
Confidence 996 9999999999999999999999999999999887666678999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCCCCcc--cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCCChHHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKPDERL--NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWARTESGI 362 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~ 362 (482)
+.++.+||+|||++......... ....++..|+|||++. +.++.++||||||+++|++++ |..||........
T Consensus 127 ---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~ 203 (250)
T cd05085 127 ---GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA 203 (250)
T ss_pred ---cCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 56778999999998764332211 1223466799999886 458899999999999999998 9999988877776
Q ss_pred HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 363 FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 363 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
...+..... . .....++.++.+++.+||..+|.+||++.++++
T Consensus 204 ~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 204 REQVEKGYR-M--SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHcCCC-C--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 666654321 1 222458899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=317.24 Aligned_cols=242 Identities=25% Similarity=0.377 Sum_probs=202.8
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|++.+.||+|+||.||++.. .|..||+|.+... ...+.+.+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-----~~~~~~~k~~~~~--------------------------------~~~~~~~~ 48 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKND--------------------------------ATAQAFLA 48 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-----cCCcEEEEEeCCC--------------------------------chHHHHHH
Confidence 5799999999999999999965 4778999987532 12356889
Q ss_pred HHHHHHhhcCCCCcceeeEEEE-eCCeEEEEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 201 EVKILRALTGHKNLVQFYDAYE-DDDNIYIVMELCKGGELLDRILSRGG-KYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
|+.+++++. |+|++++++++. .++..|+||||+++++|.+++..... .+++..+..++.|++.||.|||++||+|||
T Consensus 49 e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 127 (256)
T cd05082 49 EASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRD 127 (256)
T ss_pred HHHHHHhCC-CCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccc
Confidence 999999996 999999999754 55679999999999999998876533 489999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
|||+||++ ++++.+||+|||++....... ....++..|+|||++.+ .++.++|||||||++|+|++ |+.||..
T Consensus 128 lkp~nil~---~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 128 LAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred cchheEEE---cCCCcEEecCCccceeccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 99999999 567889999999987654322 23345678999998864 58899999999999999997 9999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
....+....+..... ......+++.+.++|.+||..+|++|||+.++++
T Consensus 203 ~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 203 IPLKDVVPRVEKGYK---MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCHHHHHHHHhcCCC---CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 877777776655422 1223468899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=319.63 Aligned_cols=252 Identities=21% Similarity=0.290 Sum_probs=208.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCC-CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGS-LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~-~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..+|++.+.||+|+||.||+|..+... .....||+|.+.+. ........+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~-----------------------------~~~~~~~~~ 56 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREE-----------------------------TSPKANKEI 56 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCC-----------------------------CCHHHHHHH
Confidence 367999999999999999999976511 11236899987543 223455778
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++++. ||||+++++++.. ...++||||+++|+|.+++......+++..+..++.|++.||.|||++||+|||
T Consensus 57 ~~e~~~l~~l~-h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~d 134 (279)
T cd05057 57 LDEAYVMASVD-HPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRD 134 (279)
T ss_pred HHHHHHHHhCC-CCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecc
Confidence 89999999996 9999999999887 789999999999999999877666799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCccc---ccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN---DIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRP 353 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~---~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~p 353 (482)
|||+|||+ +.++.+||+|||+++......... ...++..|+|||.+. +.++.++|+|||||++|++++ |..|
T Consensus 135 i~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p 211 (279)
T cd05057 135 LAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211 (279)
T ss_pred cCcceEEE---cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCC
Confidence 99999999 567789999999998765332211 122356899999875 568999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|.+....++...+..... ...+ ...+.++.+++.+||..||.+||++.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 212 YEGIPAVEIPDLLEKGER-LPQP--PICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCCHHHHHHHHhCCCC-CCCC--CCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 998888777776665432 2222 236789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=317.70 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=204.7
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|+++++||+|+||.||+|... +++.||+|.+.+. ......+.
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~----~~~~~a~K~~~~~-------------------------------~~~~~~~~ 49 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYN----GHTKVAIKSLKQG-------------------------------SMSPEAFL 49 (260)
T ss_pred hHHceeeeeeccCccceEEeeecC----CCceEEEEEecCC-------------------------------CCcHHHHH
Confidence 468999999999999999999865 5788999998643 01235688
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+++++. |+||+++++++. .+..|+||||+.+++|.+++... +..+++.++..++.|++.||.|||+.|++|||
T Consensus 50 ~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~d 127 (260)
T cd05067 50 AEANLMKQLQ-HPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRD 127 (260)
T ss_pred HHHHHHHhcC-CcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeeccc
Confidence 9999999996 999999999874 56789999999999999988653 35789999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|||+||++ +.++.++|+|||++........ .....++..|+|||++. ..++.++||||||+++|+|++ |+.||
T Consensus 128 l~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~ 204 (260)
T cd05067 128 LRAANILV---SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPY 204 (260)
T ss_pred ccHHhEEE---cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCC
Confidence 99999999 5677899999999977653221 12344677899999886 458899999999999999999 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+.+..+....+.... .. .....++.++.++|.+||..+|++||+++++++
T Consensus 205 ~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 205 PGMTNPEVIQNLERGY-RM--PRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCChHHHHHHHHcCC-CC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 8887777766654432 11 223457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=318.16 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=206.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|.+.+.||+|+||.||+|.+.........||||.+... ......+.+.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~-----------------------------~~~~~~~~~~~ 56 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC-----------------------------TSPSVREKFLQ 56 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc-----------------------------CCHHHHHHHHH
Confidence 5689999999999999999987653223457999987542 22344568899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++.+ +..|+||||+++++|.+++......+++..+..++.|++.||.|||+.|++|||||
T Consensus 57 e~~~l~~~~-h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~ 134 (270)
T cd05056 57 EAYIMRQFD-HPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIA 134 (270)
T ss_pred HHHHHHhCC-CCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccC
Confidence 999999996 9999999998875 55789999999999999987655679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcc--cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERL--NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~--~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
|+|||+ +.++.+||+|||++......... ....++..|+|||.+. ..++.++|||||||++|+|++ |..||..
T Consensus 135 p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 211 (270)
T cd05056 135 ARNVLV---SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211 (270)
T ss_pred hheEEE---ecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCC
Confidence 999999 55678999999999876443221 1223456899999876 458999999999999999986 9999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
....+....+...... .....++.++.++|.+|+..+|.+|||+.+++.
T Consensus 212 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 212 VKNNDVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CCHHHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8877776666554322 223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=314.98 Aligned_cols=249 Identities=28% Similarity=0.418 Sum_probs=208.1
Q ss_pred EecceeecCCceEEEEEEEecCC-CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 124 ELGEEVGRGHFGYTCSAKAKKGS-LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 124 ~~~~~LG~G~fG~V~~a~~~~~~-~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
.+.+.||+|+||.||+|+..... ..+..||+|++... ........+.+|+
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~-----------------------------~~~~~~~~~~~e~ 52 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKED-----------------------------ADEQQIEEFLREA 52 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCC-----------------------------CChHHHHHHHHHH
Confidence 56788999999999999987521 12488999998542 1222456889999
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGK-YSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
.+++.+. |+||+++++++.+.+..|+||||+++++|.+++...... +++..+..++.|++.||.|||+.|++||||||
T Consensus 53 ~~l~~l~-~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~ 131 (258)
T smart00219 53 RIMRKLD-HPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAA 131 (258)
T ss_pred HHHHhcC-CCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeeccccc
Confidence 9999995 999999999999999999999999999999988765434 99999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCccc--ccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDERLN--DIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWAR 357 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~--~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~ 357 (482)
+||++ +.++.++|+|||++.......... ...+++.|+|||.+. ..++.++||||+|+++|+|++ |..||...
T Consensus 132 ~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 132 RNCLV---GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred ceEEE---ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999 567789999999998765432221 133678999999885 458999999999999999998 89999888
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+.......+........ ...++.++.+++.+||..||.+|||+.++++
T Consensus 209 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 209 SNEEVLEYLKKGYRLPK---PENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CHHHHHHHHhcCCCCCC---CCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 88888777766543221 2348999999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=322.49 Aligned_cols=253 Identities=22% Similarity=0.301 Sum_probs=208.6
Q ss_pred ccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++.+.||+|+||.||+|.+... ..++..||+|++... ........
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~-----------------------------~~~~~~~~ 54 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-----------------------------ASADMQAD 54 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCC-----------------------------cCHHHHHH
Confidence 36799999999999999999987531 125678999998643 22334567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------------CCCCHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------------GKYSEEDAK 256 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------------~~l~~~~~~ 256 (482)
+.+|+.+++++. ||||+++++++.+++..++||||+++|+|.+++.... ..+++..+.
T Consensus 55 ~~~ei~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 133 (288)
T cd05050 55 FQREAALMAEFD-HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQL 133 (288)
T ss_pred HHHHHHHHHhcC-CCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHH
Confidence 889999999996 9999999999999999999999999999999886431 247888999
Q ss_pred HHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCC
Q 011582 257 IVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYG 332 (482)
Q Consensus 257 ~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~ 332 (482)
.++.|++.||.|||++|++||||||+|||+ +.++.++|+|||++........ .....++..|+|||.+. ..++
T Consensus 134 ~~~~~i~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 210 (288)
T cd05050 134 CIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT 210 (288)
T ss_pred HHHHHHHHHHHHHHhCCeecccccHhheEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC
Confidence 999999999999999999999999999999 5677899999999876533221 22234567899999876 4689
Q ss_pred CcchhhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 333 TEADMWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 333 ~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.++|||||||++|+|++ |..||.+....+....+....... ....++.++.+||.+||+.||.+|||+.|+++
T Consensus 211 ~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 211 TESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999999999999997 889998888888777776554321 11347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=328.65 Aligned_cols=256 Identities=21% Similarity=0.303 Sum_probs=198.5
Q ss_pred EecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHH
Q 011582 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVK 203 (482)
Q Consensus 124 ~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~ 203 (482)
.+++.+|.|++ ||.++... +|+.||||++... .........+.+|+.
T Consensus 5 ~i~~~~~~~~~--v~~~~~~~---~~~~~avK~~~~~----------------------------~~~~~~~~~~~~Ei~ 51 (314)
T cd08216 5 LIGKCFEDLMI--VHLAKHKP---TNTLVAVKKINLD----------------------------SCSKEDLKLLQQEII 51 (314)
T ss_pred hhhHhhcCCce--EEEEEecC---CCCEEEEEEEecc----------------------------ccchhHHHHHHHHHH
Confidence 34444555544 55555544 7899999998652 123345678999999
Q ss_pred HHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 011582 204 ILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282 (482)
Q Consensus 204 ~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~ 282 (482)
+++.++ |+||+++++++.+.+..|++|||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+
T Consensus 52 ~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~ 130 (314)
T cd08216 52 TSRQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKAS 130 (314)
T ss_pred HHHhcC-CcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcc
Confidence 999997 999999999999999999999999999999988653 356899999999999999999999999999999999
Q ss_pred ceEEecCCCCCcEEEEecccccccCCCC--------cccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhhCC
Q 011582 283 NFLFTSKEENSSLKAIDFGLSDYVKPDE--------RLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 283 NIll~~~~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~elltg~ 351 (482)
||++ +.++.+||+|||.+....... ......++..|+|||++.. .|+.++||||+||++|+|++|.
T Consensus 131 Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~ 207 (314)
T cd08216 131 HILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGH 207 (314)
T ss_pred eEEE---ecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCC
Confidence 9999 566789999999886543221 1233457888999998854 4889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCC-------C-----------------------CCCCCCCCHHHHHHHHHhchhccccCC
Q 011582 352 RPFWARTESGIFRAVLKADPSF-------D-----------------------EAPWPSLSPEAIDFVKRLLNKDYRKRL 401 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~-------~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~ 401 (482)
.||................... + ......++.++.+||.+||..||++||
T Consensus 208 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp 287 (314)
T cd08216 208 VPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP 287 (314)
T ss_pred CCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc
Confidence 9998765443322222111000 0 000012357889999999999999999
Q ss_pred CHHHHhcCcccccCC
Q 011582 402 TAAQALSHPWLANSH 416 (482)
Q Consensus 402 s~~e~L~hp~~~~~~ 416 (482)
|++++|+||||+...
T Consensus 288 t~~~ll~~p~~~~~~ 302 (314)
T cd08216 288 SASQLLNHSFFKQCK 302 (314)
T ss_pred CHHHHhcCchHhhhc
Confidence 999999999998653
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=339.15 Aligned_cols=260 Identities=29% Similarity=0.517 Sum_probs=218.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
+-|..++.||-|+||.|++|+... +...||+|.+.|..+.. ......++.
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvD---T~~lYAmKTLrKaDVl~---------------------------rnQvaHVKA 678 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVD---TRALYAMKTLRKADVLM---------------------------RNQVAHVKA 678 (1034)
T ss_pred cceEEEeeecccccceeEEEeecc---hhhHHHHhhhHHHHHHh---------------------------hhhhhhhhh
Confidence 467888899999999999998766 78899999998863322 223345677
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|-.||... +.+-||+||-.|++++++|+||+|++||+++.+|.+. +-|.|..++.++..+..|+++.|..|+||||||
T Consensus 679 ERDILAEA-Dn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm-gIFeE~LARFYIAEltcAiesVHkmGFIHRDiK 756 (1034)
T KOG0608|consen 679 ERDILAEA-DNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-GIFEEDLARFYIAELTCAIESVHKMGFIHRDIK 756 (1034)
T ss_pred hhhhHhhc-CCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHh-ccCHHHHHHHHHHHHHHHHHHHHhccceecccC
Confidence 88899888 4999999999999999999999999999999988776 689999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccC---------CCC----------------------------------ccccccc
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVK---------PDE----------------------------------RLNDIVG 317 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~---------~~~----------------------------------~~~~~~g 317 (482)
|+|||| |.+|++||.||||++-+. .+. .....+|
T Consensus 757 PDNILI---DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvg 833 (1034)
T KOG0608|consen 757 PDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVG 833 (1034)
T ss_pred ccceEE---ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcC
Confidence 999999 789999999999986321 000 0012579
Q ss_pred CccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhc
Q 011582 318 SAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKD 396 (482)
Q Consensus 318 t~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 396 (482)
|+.|+|||++.+ .|+.-+|.||.|||||||+.|+.||...+..+...+|.+-..........++|+++.++|.++. .+
T Consensus 834 t~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~s 912 (1034)
T KOG0608|consen 834 TPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CS 912 (1034)
T ss_pred CCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cC
Confidence 999999998864 6999999999999999999999999988887776666655544444555679999999999976 56
Q ss_pred cccCC---CHHHHhcCcccccCC
Q 011582 397 YRKRL---TAAQALSHPWLANSH 416 (482)
Q Consensus 397 P~~R~---s~~e~L~hp~~~~~~ 416 (482)
++.|. .++++..||||+...
T Consensus 913 ad~RLGkng~d~vKaHpfFkgID 935 (1034)
T KOG0608|consen 913 ADSRLGKNGADQVKAHPFFKGID 935 (1034)
T ss_pred hhhhhcccchhhhhcCccccccc
Confidence 78887 577899999998753
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=315.67 Aligned_cols=247 Identities=25% Similarity=0.421 Sum_probs=207.3
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|++.+.||+|+||.||+|... .+..+|+|.+.... .....+.+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~----~~~~~~~k~~~~~~-------------------------------~~~~~~~~ 48 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL----EKRKVAIKTIREGA-------------------------------MSEEDFIE 48 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe----CCCeEEEEECCCCC-------------------------------CCHHHHHH
Confidence 47899999999999999999875 46789999875421 11246788
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++++. ||||+++++++......++||||+++++|.+++....+.+++..+..++.|++.||.|||+.|++|||||
T Consensus 49 e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~ 127 (256)
T cd05112 49 EAQVMMKLS-HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLA 127 (256)
T ss_pred HHHHHHhCC-CCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccc
Confidence 999999996 9999999999999999999999999999999887666678999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
|+||++ +.++.+||+|||++........ .....++..|+|||.+. +.++.++||||||+++|+|++ |..||..
T Consensus 128 p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~ 204 (256)
T cd05112 128 ARNCLV---GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYEN 204 (256)
T ss_pred cceEEE---cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 999999 5677899999999876543221 12233567899999886 568899999999999999998 9999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
....+....+......+.. ...+.++.+|+.+||..+|++||++.+++++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 205 RSNSEVVETINAGFRLYKP---RLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCHHHHHHHHhCCCCCCCC---CCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 8887777777654322221 2368999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=315.11 Aligned_cols=244 Identities=23% Similarity=0.316 Sum_probs=199.9
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
++||+|+||.||+|+.......+..||+|.+... ......+.+.+|+.+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~-----------------------------~~~~~~~~~~~e~~~l~ 51 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQE-----------------------------HIAAGKKEFLREASVMA 51 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccc-----------------------------cchHHHHHHHHHHHHHH
Confidence 4699999999999987653323478999998653 11134567889999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+. |+||+++++++. .+..++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++||||||+|||+
T Consensus 52 ~l~-h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili 128 (257)
T cd05060 52 QLD-HPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL 128 (257)
T ss_pred hcC-CCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE
Confidence 996 999999999876 45689999999999999988655 479999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCCCCcc----cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCCChH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKPDERL----NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWARTES 360 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~ 360 (482)
+.++.+||+|||+++........ ....++..|+|||.+. ..++.++|||||||++|+|++ |..||...+..
T Consensus 129 ---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~ 205 (257)
T cd05060 129 ---VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205 (257)
T ss_pred ---cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 56778999999999876443321 1122356799999876 458999999999999999998 99999887777
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 361 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+....+...... .....++..+.++|.+||..||.+||++.++++
T Consensus 206 ~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 206 EVIAMLESGERL---PRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHcCCcC---CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 776666554321 222457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=315.84 Aligned_cols=246 Identities=21% Similarity=0.299 Sum_probs=197.4
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|........+..||+|.+... ......+.+.+|+.+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~-----------------------------~~~~~~~~~~~e~~~l~ 51 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI-----------------------------TDLEEVEQFLKEGIIMK 51 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc-----------------------------CCHHHHHHHHHHHHHHc
Confidence 4689999999999997643334567999987432 22334567889999999
Q ss_pred hhcCCCCcceeeEEEE-eCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceE
Q 011582 207 ALTGHKNLVQFYDAYE-DDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL 285 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIl 285 (482)
.+. ||||+++++++. .++..++||||+.+|+|.+++......+++..+..++.|++.||.|||+.||+||||||+|||
T Consensus 52 ~l~-h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nil 130 (262)
T cd05058 52 DFS-HPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCM 130 (262)
T ss_pred cCC-CCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEE
Confidence 996 999999999765 456789999999999999998766566788889999999999999999999999999999999
Q ss_pred EecCCCCCcEEEEecccccccCCCC-----cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCCC
Q 011582 286 FTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWART 358 (482)
Q Consensus 286 l~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~~ 358 (482)
+ +.++.+||+|||+++...... ......++..|+|||.+. ..++.++|||||||++|+|++ |.+||...+
T Consensus 131 i---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 207 (262)
T cd05058 131 L---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207 (262)
T ss_pred E---cCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9 567789999999997654321 112334677899999875 468999999999999999999 566777766
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
..+....+...... .. -..+++.+.+++.+||..+|++||++.++++
T Consensus 208 ~~~~~~~~~~~~~~-~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 208 SFDITVYLLQGRRL-LQ--PEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred HHHHHHHHhcCCCC-CC--CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 66666665544321 11 1246889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=322.35 Aligned_cols=255 Identities=19% Similarity=0.269 Sum_probs=202.4
Q ss_pred cceEecceeecCCceEEEEEEEec-------------CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhh
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKK-------------GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCL 187 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~-------------~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (482)
++|++.+.||+|+||.||+|.... ...++..||+|++...
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~--------------------------- 57 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLRED--------------------------- 57 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEecccc---------------------------
Confidence 579999999999999999986532 1113457999988542
Q ss_pred ccccHHHHHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC----------CCCCHHHHHH
Q 011582 188 FMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG----------GKYSEEDAKI 257 (482)
Q Consensus 188 ~~~~~~~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------~~l~~~~~~~ 257 (482)
........+.+|+.+++.+. |+||+++++++...+..++||||+++++|.+++.... ..+++..+..
T Consensus 58 --~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 134 (296)
T cd05095 58 --ANKNARNDFLKEIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIF 134 (296)
T ss_pred --CCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHH
Confidence 22334568899999999996 9999999999999999999999999999999886532 2477889999
Q ss_pred HHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCC
Q 011582 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGT 333 (482)
Q Consensus 258 i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~ 333 (482)
++.|++.||.|||+.||+||||||+|||+ +.++.++|+|||++..+..... .....++..|++||+.. +.++.
T Consensus 135 ~~~~i~~al~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~ 211 (296)
T cd05095 135 MATQIASGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTT 211 (296)
T ss_pred HHHHHHHHHHHHHHCCeecccCChheEEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccc
Confidence 99999999999999999999999999999 5677899999999986543321 12234467899999754 56999
Q ss_pred cchhhhhHHHHHHHhh--CCCCCCCCChHHHHHHHHhc----CCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHh
Q 011582 334 EADMWSIGVIAYILLC--GSRPFWARTESGIFRAVLKA----DPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407 (482)
Q Consensus 334 ~~DiwSlGvil~ellt--g~~pf~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L 407 (482)
++|||||||++|||++ |..||......+.+...... ......+....+++.+.+|+.+||+.||.+||++.+++
T Consensus 212 ~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~ 291 (296)
T cd05095 212 ASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291 (296)
T ss_pred hhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 9999999999999998 78999877766655443221 01111111234779999999999999999999999986
Q ss_pred c
Q 011582 408 S 408 (482)
Q Consensus 408 ~ 408 (482)
+
T Consensus 292 ~ 292 (296)
T cd05095 292 A 292 (296)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=320.33 Aligned_cols=244 Identities=20% Similarity=0.256 Sum_probs=194.1
Q ss_pred ceeecCCceEEEEEEEecCC----CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGS----LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~----~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
+.||+|+||.||+|..+... .....||+|.+.+. .....+.+.+|+
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~------------------------------~~~~~~~~~~e~ 50 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS------------------------------HRNYSESFFEAA 50 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch------------------------------hHHHHHHHHHHH
Confidence 36999999999999876421 12345888876432 223456788899
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~ 282 (482)
.+++.+. ||||+++++++..++..++||||+++|+|.+++...+..+++..+..++.||+.||.|||++||+||||||+
T Consensus 51 ~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~ 129 (258)
T cd05078 51 SMMSQLS-HKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAK 129 (258)
T ss_pred HHHHhCC-CCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 9999996 999999999999999999999999999999998766667999999999999999999999999999999999
Q ss_pred ceEEecCCC-----CCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCC-CCC
Q 011582 283 NFLFTSKEE-----NSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGS-RPF 354 (482)
Q Consensus 283 NIll~~~~~-----~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~-~pf 354 (482)
|||++.++. ...++++|||++..... .....++..|+|||++.+ .++.++|||||||++|+|++|. .||
T Consensus 130 nili~~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~ 206 (258)
T cd05078 130 NVLLIREEDRKTGNPPFIKLSDPGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPL 206 (258)
T ss_pred eEEEecccccccCCCceEEecccccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCCh
Confidence 999964321 12479999999876543 233568899999999864 4789999999999999999995 566
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
........ ..+......++. ..+.++.+||.+||+.||++|||++++++.
T Consensus 207 ~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 207 SALDSQKK-LQFYEDRHQLPA----PKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred hhccHHHH-HHHHHccccCCC----CCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 55444333 333333333332 356889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.17 Aligned_cols=243 Identities=26% Similarity=0.393 Sum_probs=206.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.. .|+.||||.+... ....+.+.+
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~-----~~~~v~iK~~~~~-------------------------------~~~~~~~~~ 49 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDY-----RGQKVAVKCLKDD-------------------------------STAAQAFLA 49 (256)
T ss_pred hhccceeeeecCCCceEEEEEe-----cCcEEEEEEeccc-------------------------------hhHHHHHHH
Confidence 5789999999999999999976 4788999998642 114567899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
|+.+++.+. |+||+++++++.+.+..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||
T Consensus 50 e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di 128 (256)
T cd05039 50 EASVMTTLR-HPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDL 128 (256)
T ss_pred HHHHHHhcC-CcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhc
Confidence 999999996 9999999999999999999999999999999886553 26899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~ 357 (482)
||+||++ +.++.+||+|||++....... ....++..|+|||.+. +.++.++||||||+++|+|++ |..||...
T Consensus 129 ~p~Nili---~~~~~~~l~d~g~~~~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 129 AARNVLV---SEDLVAKVSDFGLAKEASQGQ--DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ccceEEE---eCCCCEEEccccccccccccc--ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999 567789999999998763322 2334567899999876 568899999999999999997 99999888
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
...++...+..... . .....+++++.++|.+||..+|.+||++.++++
T Consensus 204 ~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 204 PLKDVVPHVEKGYR-M--EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CHHHHHHHHhcCCC-C--CCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 87777666554321 1 112357899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=316.53 Aligned_cols=246 Identities=24% Similarity=0.336 Sum_probs=203.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.++||+|+||.||+|... .+..||+|.+.... . ..+.+.
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~----~~~~~~~k~~~~~~----------------------------~---~~~~~~ 49 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN----GNTKVAVKTLKPGT----------------------------M---SPESFL 49 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec----CCceeEEEEecCCC----------------------------C---CHHHHH
Confidence 457999999999999999999765 46779999986420 1 124688
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+++++. |+||+++++++. .+..|+||||+++++|.+++... ...+++..+..++.|++.||.|||++||+|||
T Consensus 50 ~E~~~l~~l~-~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~d 127 (260)
T cd05070 50 EEAQIMKKLR-HDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRD 127 (260)
T ss_pred HHHHHHHhcC-CCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCC
Confidence 9999999996 999999999875 45689999999999999988653 34689999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|||+||++ ++++.++|+|||++........ .....++..|+|||.+. ..++.++||||||+++|+|++ |..||
T Consensus 128 i~p~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~ 204 (260)
T cd05070 128 LRSANILV---GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204 (260)
T ss_pred CccceEEE---eCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCC
Confidence 99999999 5677899999999987643321 12234567899999875 468899999999999999999 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+.+..+....+..... . ......+.++.+||.+||..||.+|||+++++.
T Consensus 205 ~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 205 PGMNNREVLEQVERGYR-M--PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCCCHHHHHHHHHcCCC-C--CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 88887777776654321 1 222457899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=318.29 Aligned_cols=255 Identities=27% Similarity=0.456 Sum_probs=208.0
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.+.+.||+|+||.||+|++.. .+..+++|+++.... ..........+.+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~---~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~e 52 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKK---AVAEERLKVLKEIPV-------------------------GELNPNETVQANQE 52 (260)
T ss_pred CceeeeeecCCCCceEEEEEecC---CCCcceEEEeccccc-------------------------cccCcchHHHHHHH
Confidence 58999999999999999998876 566677777643200 00111223456789
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+.+++.+. ||||+++++++.+....++||||+++++|.+.+.. ....+++..++.++.|++.||.|||++|++|+|
T Consensus 53 ~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~ 131 (260)
T cd08222 53 AQLLSKLD-HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRD 131 (260)
T ss_pred HHHHHhCC-CCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccC
Confidence 99999996 99999999999999999999999999999887753 345799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||+||+++ ++.+||+|||++....... ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||..
T Consensus 132 l~~~nili~----~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 132 LKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CChhheEee----cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 999999994 2459999999987764332 2334568899999998764 588899999999999999999999987
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.........+....... ....++.++.++|.+||..||.+||++.+++.||||
T Consensus 208 ~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 208 QNFLSVVLRIVEGPTPS---LPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred ccHHHHHHHHHcCCCCC---CcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 77666666655433211 113578999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=370.77 Aligned_cols=259 Identities=32% Similarity=0.536 Sum_probs=217.2
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.-+|.-+..||.|.||.||.|.... +|...|||-|.... ........
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~---tGellAvKEI~iq~----------------------------~~~k~~~~ 1280 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLD---TGELLAVKEIKIQD----------------------------SDHKTFKL 1280 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCC---ccchhhhhhhhcCc----------------------------cccccCcc
Confidence 445577788899999999999999877 89999999986431 11233456
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|..++..+. |||+|++||+-.+.+..+|.||||+||+|.+.+ ++++-.+|.....+-.|++.|+.|||+.|||||
T Consensus 1281 i~eEm~vlE~ln-HpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll-~~gri~dE~vt~vyt~qll~gla~LH~~gIVHR 1358 (1509)
T KOG4645|consen 1281 IAEEMKVLEGLN-HPNLVRYYGVEVHREKVYIFMEYCEGGSLASLL-EHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHR 1358 (1509)
T ss_pred hHHHHHHHHhcc-CccccccCceeecHHHHHHHHHHhccCcHHHHH-HhcchhhhhHHHHHHHHHHHHHHHHHhcCceec
Confidence 789999999996 999999999999999999999999999999865 565677888888899999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC-----cccccccCccccCcccccc----cCCCcchhhhhHHHHHHHh
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLHR----SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~ell 348 (482)
||||+||+| +.++.+|++|||.|..+.... .+....||+.|||||++.+ ...-+.|||||||++.||+
T Consensus 1359 DIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~ 1435 (1509)
T KOG4645|consen 1359 DIKPANILL---DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMA 1435 (1509)
T ss_pred CCCccceee---ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEee
Confidence 999999999 678899999999998876542 3456789999999999964 3566899999999999999
Q ss_pred hCCCCCCCC-ChHHHHHHHHhcC-CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 349 CGSRPFWAR-TESGIFRAVLKAD-PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 349 tg~~pf~~~-~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
||+.||..- ++-.++-.+-.+. +.++. .+|++.++||.+||+.||++|+++.|+|+|-|-+...
T Consensus 1436 tGkrPW~~~dne~aIMy~V~~gh~Pq~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1436 TGKRPWAELDNEWAIMYHVAAGHKPQIPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred cCCCchhhccchhHHHhHHhccCCCCCch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 999999654 3334555554443 33333 3999999999999999999999999999999986543
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=321.19 Aligned_cols=253 Identities=26% Similarity=0.384 Sum_probs=200.4
Q ss_pred ceEecceeecCCceEEEEEEEec-CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKK-GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~-~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.|++.+.||+|+||.||+|.... +..++..||+|.++.. ........+.+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~-----------------------------~~~~~~~~~~~ 55 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-----------------------------SGGNHIADLKK 55 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc-----------------------------ccHHHHHHHHH
Confidence 57899999999999999997532 2236889999998542 22334567899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
|+.+++.+. ||||+++++++.+. ...++||||++|++|.+++......+++..+..++.|++.||.|||++||+|||
T Consensus 56 e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~d 134 (284)
T cd05079 56 EIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRD 134 (284)
T ss_pred HHHHHHhCC-CCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 999999996 99999999998875 678999999999999998866555789999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~p 353 (482)
|||+||++ +.++.+||+|||++........ .....|+..|+|||++. +.++.++|||||||++|+|+++..|
T Consensus 135 lkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~ 211 (284)
T cd05079 135 LAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDS 211 (284)
T ss_pred cchheEEE---cCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCC
Confidence 99999999 5677899999999987643321 22355677899999875 4689999999999999999998776
Q ss_pred CCCCCh--------------HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 354 FWARTE--------------SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 354 f~~~~~--------------~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
+..... ............. ...+..++.++.+||.+||+.||.+||++++++.+
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 212 ESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR--LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred CccccchhhhhcccccccccHHHHHHHHHcCcc--CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 532110 0111111221111 12345689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=315.09 Aligned_cols=245 Identities=24% Similarity=0.342 Sum_probs=202.5
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.... +..+|+|.+... ....+.+.+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~----~~~~~lK~~~~~-------------------------------~~~~~~~~~ 50 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNG----TTKVAIKTLKPG-------------------------------TMMPEAFLQ 50 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcC----CceEEEEEcccC-------------------------------CccHHHHHH
Confidence 579999999999999999998753 456999987542 012356788
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
|+.+++.+. |+||+++++++. .+..|+||||+.+++|.+++... ...+++..+..++.|++.||.|||+.||+||||
T Consensus 51 E~~~l~~l~-h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl 128 (260)
T cd05069 51 EAQIMKKLR-HDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDL 128 (260)
T ss_pred HHHHHHhCC-CCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeeccc
Confidence 999999997 999999999875 45689999999999999988654 345899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
||+||++ ++++.++|+|||++........ .....++..|+|||.+. +.++.++|||||||++|+|++ |..||.
T Consensus 129 ~~~Nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~ 205 (260)
T cd05069 129 RAANILV---GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYP 205 (260)
T ss_pred CcceEEE---cCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999 5678899999999986643321 12334677899999876 468899999999999999999 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+....+....+.... .. .....++..+.++|++||..||.+||+++++++
T Consensus 206 ~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 206 GMVNREVLEQVERGY-RM--PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCHHHHHHHHHcCC-CC--CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 888777777665432 11 223458899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=314.31 Aligned_cols=247 Identities=27% Similarity=0.377 Sum_probs=206.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|.+.+.||+|+||.||+|... .++.||||.+... ....+.+.
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~----~~~~~~vK~~~~~-------------------------------~~~~~~~~ 49 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWN----GTTKVAVKTLKPG-------------------------------TMSPEAFL 49 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEc----CCceEEEEEecCC-------------------------------ccCHHHHH
Confidence 468999999999999999999875 3578999998642 11235688
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+++++. |+||+++++++......++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|||
T Consensus 50 ~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~d 128 (261)
T cd05034 50 QEAQIMKKLR-HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRD 128 (261)
T ss_pred HHHHHHhhCC-CCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 9999999997 9999999999999999999999999999999887643 4789999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|||+||++ +.++.+||+|||++........ .....++..|+|||.+.+ .++.++||||+||++|+|++ |+.||
T Consensus 129 i~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~ 205 (261)
T cd05034 129 LAARNILV---GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPY 205 (261)
T ss_pred cchheEEE---cCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCC
Confidence 99999999 5678899999999887643211 112234578999998864 58899999999999999998 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+.........+...... ......+.++.+++.+||..+|.+||++++++.
T Consensus 206 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 206 PGMTNREVLEQVERGYRM---PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 888877777777654221 112346899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=315.31 Aligned_cols=247 Identities=21% Similarity=0.318 Sum_probs=195.1
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
++||+|+||.||+|....+ .....+|+|.+... ........+.+|+.+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~-~~~~~~~~k~~~~~-----------------------------~~~~~~~~~~~e~~~~~ 50 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRG-MSKARVVVKELRAS-----------------------------ATPDEQLLFLQEVQPYR 50 (269)
T ss_pred CcCCccCCceEEEEEEecC-CCCeEEEEeecCcc-----------------------------CChHHHHHHHHHHHHHH
Confidence 3699999999999976543 24567888876432 22334567889999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG----GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~ 282 (482)
.+. |+||+++++++.+.+.+|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 51 ~l~-h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~ 129 (269)
T cd05042 51 ELN-HPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALR 129 (269)
T ss_pred hCC-CCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHh
Confidence 996 9999999999999999999999999999999886543 23567888999999999999999999999999999
Q ss_pred ceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc--------ccCCCcchhhhhHHHHHHHhh-C
Q 011582 283 NFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH--------RSYGTEADMWSIGVIAYILLC-G 350 (482)
Q Consensus 283 NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~--------~~~~~~~DiwSlGvil~ellt-g 350 (482)
|||+ +.++.+||+|||++........ .....++..|+|||++. ..++.++|||||||++|+|++ |
T Consensus 130 Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (269)
T cd05042 130 NCQL---TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAA 206 (269)
T ss_pred heEe---cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCC
Confidence 9999 5677899999999865432211 12334677899999863 246789999999999999999 7
Q ss_pred CCCCCCCChHHHHHHHHhcC-CCCCCCCC-CCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 351 SRPFWARTESGIFRAVLKAD-PSFDEAPW-PSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~-~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
..||......+....+.... ...+.+.+ ..+++.+.+++..|+ .||++|||++++++
T Consensus 207 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 207 DQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 88998777666655554432 23333222 357888999999988 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=315.89 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=209.9
Q ss_pred cceEecceeecCCceEEEEEEEecCC--CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGS--LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~--~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
++|++.+.||+|+||.||+|+.+... ...+.||+|.+... ......+.+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~-----------------------------~~~~~~~~~ 55 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT-----------------------------KDENLQSEF 55 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc-----------------------------cchHHHHHH
Confidence 57899999999999999999976422 13567999987532 122345778
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG--------GKYSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~yLH 270 (482)
.+|+.+++++. |+||+++++++.+.+..|+||||+++|+|.+++.... ..+++..+..++.|++.||.|||
T Consensus 56 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH 134 (275)
T cd05046 56 RRELDMFRKLS-HKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134 (275)
T ss_pred HHHHHHHHhcC-CcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh
Confidence 99999999996 9999999999999999999999999999999886543 15899999999999999999999
Q ss_pred HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHH
Q 011582 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el 347 (482)
++||+||||||+||++ +.++.++|+|||++....... ......++..|+|||.+. +.++.++||||||+++|+|
T Consensus 135 ~~~i~H~dlkp~Nili---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l 211 (275)
T cd05046 135 NARFVHRDLAARNCLV---SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211 (275)
T ss_pred hcCcccCcCccceEEE---eCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHH
Confidence 9999999999999999 557789999999987543221 233446678899999875 4588899999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 348 LC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 348 lt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
++ |..||...........+......+.. ...++..+.++|.+||..||.+||++.+++.+
T Consensus 212 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 212 FTQGELPFYGLSDEEVLNRLQAGKLELPV--PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HhCCCCCccccchHHHHHHHHcCCcCCCC--CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 98 88999877777777766655443322 23588999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=311.79 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=204.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|... .+..+|+|.+... ....+.+.
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~----~~~~~~iK~~~~~-------------------------------~~~~~~~~ 49 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPG-------------------------------SMSVEAFL 49 (260)
T ss_pred ccceeEEeEecCccceEEEEEEec----CCccEEEEecCCC-------------------------------hhHHHHHH
Confidence 468999999999999999999865 4567999987542 12346788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+++++. |+||+++++++.+ ...|+||||+++++|.+++... +..+++..+..++.|++.||.|||+.|++|||
T Consensus 50 ~e~~~l~~l~-~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~d 127 (260)
T cd05073 50 AEANVMKTLQ-HDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 127 (260)
T ss_pred HHHHHHHhcC-CCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 9999999996 9999999999887 7889999999999999998753 45688999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|||+||++ +.++.+||+|||++........ .....++..|+|||++.. .++.++|+|||||++|++++ |..||
T Consensus 128 l~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~ 204 (260)
T cd05073 128 LRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPY 204 (260)
T ss_pred cCcceEEE---cCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCC
Confidence 99999999 5678899999999876543222 122345678999998864 58889999999999999998 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+.+.......+.... .......++.++.+++.+||+.+|.+||++.+++.
T Consensus 205 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 205 PGMSNPEVIRALERGY---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCCCHHHHHHHHhCCC---CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 8887777766665432 12223468899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=315.27 Aligned_cols=244 Identities=19% Similarity=0.217 Sum_probs=192.4
Q ss_pred ceeecCCceEEEEEEEecCC---------CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGS---------LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~---------~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
+.||+|+||.||+|+..... .....||+|++... .......
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~------------------------------~~~~~~~ 50 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS------------------------------HRDISLA 50 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh------------------------------hhhHHHH
Confidence 36899999999999853211 12345888876432 1233457
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. ||||+++++++..+...++||||+++++|..++......+++..+..++.||+.||.|||++||+||
T Consensus 51 ~~~~~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 129 (262)
T cd05077 51 FFETASMMRQVS-HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHG 129 (262)
T ss_pred HHHHHHHHHhCC-CCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECC
Confidence 888999999996 9999999999999999999999999999888776666779999999999999999999999999999
Q ss_pred CCCCCceEEecCC----CCCcEEEEecccccccCCCCcccccccCccccCccccc--ccCCCcchhhhhHHHHHHHh-hC
Q 011582 278 DLKPENFLFTSKE----ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILL-CG 350 (482)
Q Consensus 278 Dlkp~NIll~~~~----~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~ell-tg 350 (482)
||||+|||+..+. ....+|++|||++..... .....|+..|+|||.+. +.++.++|||||||++|+|+ +|
T Consensus 130 dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~ 206 (262)
T cd05077 130 NVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206 (262)
T ss_pred CCCcccEEEecCCccCCCCceeEeCCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence 9999999995322 112389999999876532 23456788999999885 45899999999999999998 58
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
..||......+... ........ ....++++.+||.+||+.||.+||++.++|.+
T Consensus 207 ~~p~~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 207 EIPLKDKTLAEKER-FYEGQCML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CCCCCCcchhHHHH-HHhcCccC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 88887765544322 22222221 12356889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=357.84 Aligned_cols=256 Identities=34% Similarity=0.552 Sum_probs=205.1
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+..+|+.++.||+||||.||+|+.+- +|+.||||+|.-. .+......
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKl---DGr~YAIKKIpl~-----------------------------~s~~~~sk 523 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKL---DGREYAIKKIPLK-----------------------------ASDKLYSK 523 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecc---cchhhhhhhccCc-----------------------------hHHHHHHH
Confidence 466789999999999999999999987 8999999999653 24455678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeC-----------------------------------------------------
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDD----------------------------------------------------- 224 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~----------------------------------------------------- 224 (482)
+.+|+.+|.+|. |||||+++..|.+.
T Consensus 524 I~rEVk~LArLn-HpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~s 602 (1351)
T KOG1035|consen 524 ILREVKLLARLN-HPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKS 602 (1351)
T ss_pred HHHHHHHHhhcC-CcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccc
Confidence 999999999996 99999998754100
Q ss_pred ------------------------------------------------------------------CeEEEEEecCCCCC
Q 011582 225 ------------------------------------------------------------------DNIYIVMELCKGGE 238 (482)
Q Consensus 225 ------------------------------------------------------------------~~~~lv~e~~~~g~ 238 (482)
-.+||-||||+...
T Consensus 603 ss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~l 682 (1351)
T KOG1035|consen 603 SSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTL 682 (1351)
T ss_pred cccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhH
Confidence 12689999998865
Q ss_pred hHHHHHhcCCCC-CHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccC----------
Q 011582 239 LLDRILSRGGKY-SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK---------- 307 (482)
Q Consensus 239 L~~~l~~~~~~l-~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~---------- 307 (482)
|.+.+ .++... ....+++++++|++||.|+|+.|||||||||.||++ +.+..|||+|||+|+...
T Consensus 683 l~~iI-~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~~~~~~~~d~~~ 758 (1351)
T KOG1035|consen 683 LRDII-RRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDLKENLESIDQDL 758 (1351)
T ss_pred HHHHH-HhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE---cCCCCeeecccccchhhhhhhhhHhhcc
Confidence 55544 443322 478899999999999999999999999999999999 677789999999998621
Q ss_pred ---------CCCcccccccCccccCcccccc----cCCCcchhhhhHHHHHHHhhCCCCCCCCChH-HHHHHHHhcCCCC
Q 011582 308 ---------PDERLNDIVGSAYYVAPEVLHR----SYGTEADMWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSF 373 (482)
Q Consensus 308 ---------~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~elltg~~pf~~~~~~-~~~~~i~~~~~~~ 373 (482)
.....++.+||..|+|||++.+ .|+.|+|||||||||+||+. ||....+. .++.++..+...+
T Consensus 759 ~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~ 835 (1351)
T KOG1035|consen 759 SFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPE 835 (1351)
T ss_pred CccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCC
Confidence 0113456789999999999853 59999999999999999995 57665554 3444555444444
Q ss_pred CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 374 DEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 374 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
+...|..--+....+|+.||+.||.+||||.|+|++.||.
T Consensus 836 ~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 836 PADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred CcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 4333444557788999999999999999999999999997
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=317.18 Aligned_cols=243 Identities=19% Similarity=0.206 Sum_probs=192.7
Q ss_pred eeecCCceEEEEEEEecC---------------------CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhh
Q 011582 128 EVGRGHFGYTCSAKAKKG---------------------SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCC 186 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~---------------------~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (482)
.||+|+||.||+|..... ......||+|++...
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~-------------------------- 55 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS-------------------------- 55 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH--------------------------
Confidence 599999999999975321 012245888877432
Q ss_pred hccccHHHHHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 011582 187 LFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVV 266 (482)
Q Consensus 187 ~~~~~~~~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L 266 (482)
.......+.+|+.+++.+. ||||+++++++.+.+..++||||+++|+|..++....+.+++..+..++.||+.||
T Consensus 56 ----~~~~~~~~~~~~~~~~~l~-h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l 130 (274)
T cd05076 56 ----HRDIALAFFETASLMSQVS-HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASAL 130 (274)
T ss_pred ----HHHHHHHHHHHHHHHhcCC-CCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 1223456888999999997 99999999999999999999999999999888866567899999999999999999
Q ss_pred HHHHHCCCcccCCCCCceEEecCC----CCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhh
Q 011582 267 AFCHFQGVVHRDLKPENFLFTSKE----ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSI 340 (482)
Q Consensus 267 ~yLH~~~ivHrDlkp~NIll~~~~----~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSl 340 (482)
.|||++||+||||||+|||++..+ ....+||+|||++...... ....++..|+|||.+.+ .++.++|||||
T Consensus 131 ~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl 207 (274)
T cd05076 131 SYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSF 207 (274)
T ss_pred HHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHH
Confidence 999999999999999999996321 2235899999988654321 23467888999998864 48999999999
Q ss_pred HHHHHHH-hhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 341 GVIAYIL-LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 341 Gvil~el-ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||++||| ++|..||......+.... ......++. ..++++.++|.+||+.+|.+|||+.++|++
T Consensus 208 G~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 208 GTTLLEICFDGEVPLKERTPSEKERF-YEKKHRLPE----PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHHHhCCCCCccccChHHHHHH-HHhccCCCC----CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 9999998 479999987765554332 222222222 256789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=315.82 Aligned_cols=253 Identities=19% Similarity=0.257 Sum_probs=206.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCC-CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGS-LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~-~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
.++|.+.+.||+|+||.||+|.+.... ..+..||+|++... ......+.+
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-----------------------------~~~~~~~~~ 55 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-----------------------------ASEIQVTLL 55 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-----------------------------CCHHHHHHH
Confidence 468999999999999999999987521 13678999987542 234446778
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEe-CCeEEEEEecCCCCChHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYED-DDNIYIVMELCKGGELLDRILSRG-------GKYSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~yLH 270 (482)
.+|+.+++++. |+||+++++++.. ....++++||+++++|.+++.... ..+++..+..++.|++.||.|||
T Consensus 56 ~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 134 (280)
T cd05043 56 LQESCLLYGLS-HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134 (280)
T ss_pred HHHHHHHHhCC-CCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 99999999996 9999999998766 577899999999999999886532 45899999999999999999999
Q ss_pred HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcchhhhhHHHHHH
Q 011582 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYI 346 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~e 346 (482)
++|++||||||+||++ +.++.+||+|||+++.+..... .....++..|+|||++.+ .++.++|||||||++|+
T Consensus 135 ~~~i~H~di~p~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~e 211 (280)
T cd05043 135 KRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWE 211 (280)
T ss_pred HCCEeecccCHhhEEE---cCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHH
Confidence 9999999999999999 5668899999999986543221 122345778999998864 58999999999999999
Q ss_pred Hhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 347 LLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 347 llt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+++ |+.||...+..++...+.... .+. ....+++++.+++.+||..||++|||+.++++
T Consensus 212 l~~~g~~p~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 212 LMTLGQTPYVEIDPFEMAAYLKDGY-RLA--QPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HhcCCCCCcCcCCHHHHHHHHHcCC-CCC--CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 998 999998877766665554432 222 23457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=309.77 Aligned_cols=242 Identities=23% Similarity=0.339 Sum_probs=201.3
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||.|+||.||+|.+. .|+.||+|.+... ........+.+|+.+++
T Consensus 1 ~~lg~g~~g~v~~~~~~----~~~~v~~K~~~~~-----------------------------~~~~~~~~~~~e~~~l~ 47 (251)
T cd05041 1 EKIGKGNFGDVYKGVLK----GNTEVAVKTCRST-----------------------------LPPDLKRKFLQEAEILK 47 (251)
T ss_pred CccccCCCceEEEEEEe----CCCcEEEEecccc-----------------------------CCHHHHHHHHHHHHHHH
Confidence 36999999999999875 3789999988653 11234567899999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
++. |+||+++++++.+.+..++||||+++++|.+++......+++..+..++.|++.||.|||++|++||||||+|||+
T Consensus 48 ~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili 126 (251)
T cd05041 48 QYD-HPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV 126 (251)
T ss_pred hCC-CCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE
Confidence 996 9999999999999999999999999999999987666678999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCCCCcc---cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCCChHH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKPDERL---NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWARTESG 361 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~ 361 (482)
+.++.+||+|||++......... ....++..|+|||.+. +.++.++|+|||||++|+|++ |..||.......
T Consensus 127 ---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~ 203 (251)
T cd05041 127 ---GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ 203 (251)
T ss_pred ---cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH
Confidence 56778999999998765422111 1123456799999876 468999999999999999999 899998877766
Q ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 362 IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 362 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
....+.... ... ....++.++.+++.+||..+|.+|||+.++|+
T Consensus 204 ~~~~~~~~~-~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 204 TRERIESGY-RMP--APQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHhcCC-CCC--CCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 666654432 111 12357899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=313.42 Aligned_cols=247 Identities=20% Similarity=0.300 Sum_probs=194.5
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|+||.||+|.... ..++..+|+|.++.. ........+.+|+.+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~-~~~~~~~~~k~~~~~-----------------------------~~~~~~~~~~~E~~~l~ 50 (269)
T cd05087 1 KEIGNGWFGKVILGEVNS-GYTPAQVVVKELRVS-----------------------------ASVQEQMKFLEEAQPYR 50 (269)
T ss_pred CcccccCCceEEEEEEcC-CCCceEEEEEecCCC-----------------------------CChHHHHHHHHHHHHHH
Confidence 369999999999998753 225678999987542 11223457889999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG----GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~ 282 (482)
.+. ||||+++++++.+....++||||+++|+|.+++.... ...++..+..++.|++.||.|||++|++||||||+
T Consensus 51 ~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~ 129 (269)
T cd05087 51 SLQ-HSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALR 129 (269)
T ss_pred hCC-CCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence 996 9999999999999999999999999999999886432 24577788899999999999999999999999999
Q ss_pred ceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc--------cCCCcchhhhhHHHHHHHhh-C
Q 011582 283 NFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR--------SYGTEADMWSIGVIAYILLC-G 350 (482)
Q Consensus 283 NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlGvil~ellt-g 350 (482)
||++ +.++.+||+|||++........ .....|+..|+|||++.+ .++.++|||||||++|+|++ |
T Consensus 130 nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g 206 (269)
T cd05087 130 NCLL---TADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELG 206 (269)
T ss_pred eEEE---cCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCC
Confidence 9999 5677899999999875433221 123467889999998753 25789999999999999996 9
Q ss_pred CCCCCCCChHHHHHHHH-hcCCCCCCCCC-CCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 351 SRPFWARTESGIFRAVL-KADPSFDEAPW-PSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~-~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
..||......+...... .....+..+.. ...++.+.+++.+|+ .+|.+|||+++++.
T Consensus 207 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 207 SQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 99998766655544332 22222332222 246788999999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=315.79 Aligned_cols=252 Identities=25% Similarity=0.376 Sum_probs=198.7
Q ss_pred cceEecceeecCCceEEEEEEEec-CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKK-GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~-~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+|++.+.||+|+||.||+|.... +..+|..||||.+... .....+.+.
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~------------------------------~~~~~~~~~ 53 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS------------------------------TAEHLRDFE 53 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC------------------------------CHHHHHHHH
Confidence 479999999999999999997532 1226889999998542 233456789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 200 REVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+|+.+++.+. ||||+++++++.. ...+++||||+++++|.+++......+++..+..++.|++.||.|||++||+||
T Consensus 54 ~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~ 132 (284)
T cd05081 54 REIEILKSLQ-HDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHR 132 (284)
T ss_pred HHHHHHHhCC-CCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 9999999996 9999999998754 356899999999999999987665679999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcc----cccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL----NDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~----~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~ 352 (482)
||||+||++ +.++.+||+|||++......... ....++..|+|||++.+ .++.++|||||||++|||++|..
T Consensus 133 dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~ 209 (284)
T cd05081 133 DLATRNILV---ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSD 209 (284)
T ss_pred cCCHhhEEE---CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCC
Confidence 999999999 56778999999999876433221 11223456999998864 58999999999999999999887
Q ss_pred CCCCCChHH---------------HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 353 PFWARTESG---------------IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 353 pf~~~~~~~---------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
++....... .+..+......++ ....++.++.+||.+||..+|.+|||+.++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 210 KSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred cCCCcchhhhhhcccccccccchHHHHHHHhcCCcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 764332110 0111222222221 22457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=322.97 Aligned_cols=253 Identities=22% Similarity=0.326 Sum_probs=211.1
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
+.-.+...+.++||+|-||.|.+|+.. .+..||||.++.. .......
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeve----g~lkVAVK~Lr~~-----------------------------a~~~~r~ 580 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVE----GPLKVAVKILRPD-----------------------------ATKNARN 580 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEec----CceEEEEeecCcc-----------------------------cchhHHH
Confidence 344567889999999999999999885 3689999998653 3334568
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGK-YSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
+|.+||++|.+|+ ||||++|+++|..++.+++|+||+++|+|..++...... +.-....+|+.||+.||+||.+.++|
T Consensus 581 ~F~kEIkiLsqLk-hPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfV 659 (807)
T KOG1094|consen 581 DFLKEIKILSRLK-HPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFV 659 (807)
T ss_pred HHHHHHHHHhccC-CCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchh
Confidence 8999999999997 999999999999999999999999999999999876333 35566677999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcc---cccccCccccCcccc-cccCCCcchhhhhHHHHHHHh--h
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL---NDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILL--C 349 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~-~~~~~~~~DiwSlGvil~ell--t 349 (482)
||||.+.|+|+ +.++++||+|||+++.+..+... ...+-..+|||+|.+ .+++++++|+|+||+++||++ |
T Consensus 660 Hrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C 736 (807)
T KOG1094|consen 660 HRDLATRNCLV---DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLC 736 (807)
T ss_pred hccccccceee---cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHH
Confidence 99999999999 78999999999999977655432 234456799999955 689999999999999999974 6
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCC----CCCCCCHHHHHHHHHhchhccccCCCHHHH
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFDEA----PWPSLSPEAIDFVKRLLNKDYRKRLTAAQA 406 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 406 (482)
...||...+++++.++...-....... ..+.++.++.+++-+|+..|-.+||+.+++
T Consensus 737 ~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~l 797 (807)
T KOG1094|consen 737 REQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQL 797 (807)
T ss_pred hhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHH
Confidence 889999888888877765533222221 123478899999999999999999999997
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=318.95 Aligned_cols=250 Identities=22% Similarity=0.307 Sum_probs=202.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCc----eEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQ----DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~----~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
..+|+..+.||+|+||.||+|.+.. +|. .||+|++... ......
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~---~~~~~~~~vaiK~~~~~-----------------------------~~~~~~ 53 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVP---EGETVKIPVAIKILNET-----------------------------TGPKAN 53 (303)
T ss_pred hhhceeccccccCCCccEEEEEEec---CCCcceeeEEEEecccc-----------------------------CCHHHH
Confidence 3578999999999999999999865 444 5788877542 122334
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
..+.+|+.+++.+. ||||+++++++... ..++|+||+++|+|.+++......+++..+..++.|++.||.|||++||+
T Consensus 54 ~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iv 131 (303)
T cd05110 54 VEFMDEALIMASMD-HPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131 (303)
T ss_pred HHHHHHHHHHHhCC-CCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence 56889999999996 99999999998754 57899999999999999877666799999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-C
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-G 350 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g 350 (482)
||||||+|||+ +.++.+||+|||+++....... .....++..|+|||.+. ..++.++|||||||++|+|++ |
T Consensus 132 H~dikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g 208 (303)
T cd05110 132 HRDLAARNVLV---KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208 (303)
T ss_pred ccccccceeee---cCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCC
Confidence 99999999999 5567899999999987643322 22334577899999886 458999999999999999997 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
..||.+....+....+.. ...++. .+..+..+.+++.+|+..+|.+||++++++..
T Consensus 209 ~~p~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 209 GKPYDGIPTREIPDLLEK-GERLPQ--PPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCCCCCCHHHHHHHHHC-CCCCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999987766555444433 222222 24478899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=310.51 Aligned_cols=241 Identities=25% Similarity=0.401 Sum_probs=201.0
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||++.. +|+.||+|.++.. ...+.+.+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-----~~~~~~iK~~~~~--------------------------------~~~~~~~~ 48 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-----TGQKVAVKNIKCD--------------------------------VTAQAFLE 48 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-----CCCceEEEeecCc--------------------------------chHHHHHH
Confidence 5799999999999999998853 6788999987532 12356889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
|+.+++++. ||||+++++++..+ ..++||||+.+++|.+++.... ..+++..+..++.|++.||.|||++|++||||
T Consensus 49 e~~~l~~~~-~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl 126 (254)
T cd05083 49 ETAVMTKLH-HKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126 (254)
T ss_pred HHHHHHhCC-CCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 999999996 99999999998764 4799999999999999887543 35899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~ 357 (482)
||+||++ +.++.+||+|||++...... ......+..|+|||.+. +.++.++|+|||||++|+|++ |+.||...
T Consensus 127 ~p~nili---~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 127 AARNILV---SEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred CcceEEE---cCCCcEEECCCccceecccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 9999999 56778999999998764322 22334467899999876 468999999999999999997 99999888
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
...+....+.... .. .....+++++.++|.+||..+|.+||++++++.
T Consensus 202 ~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 202 SLKEVKECVEKGY-RM--EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CHHHHHHHHhCCC-CC--CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 7777766665432 11 223468899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.23 Aligned_cols=253 Identities=21% Similarity=0.355 Sum_probs=217.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCC--CceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLK--GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~--g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...-.+++.||+|+||.||.|.......+ -..||||.+.+. .+.+...+
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~-----------------------------~~~~~~~~ 741 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL-----------------------------SSEQEVSD 741 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc-----------------------------CCHHHHHH
Confidence 45677888999999999999998763222 334899988653 56778899
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR------GGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
|.+|..+|+++. |||||+++|++.+....+|++|||+||+|..+|.+. ...++..+...++.||++|+.||++
T Consensus 742 Fl~Ea~~m~~f~-HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~ 820 (1025)
T KOG1095|consen 742 FLKEALLMSKFD-HPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES 820 (1025)
T ss_pred HHHHHHHHhcCC-CcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh
Confidence 999999999996 999999999999999999999999999999999876 5679999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccc-c--ccCccccCccccc-ccCCCcchhhhhHHHHHHH
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLND-I--VGSAYYVAPEVLH-RSYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~-~--~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el 347 (482)
+++|||||-..|+|| +....+||+|||||+.+...+.... - .--..|||||.+. +.++.|+|||||||+|||+
T Consensus 821 ~~fvHRDLAaRNCLL---~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEi 897 (1025)
T KOG1095|consen 821 KHFVHRDLAARNCLL---DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEI 897 (1025)
T ss_pred CCCcCcchhhhheee---cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHH
Confidence 999999999999999 5668999999999995543322111 1 1235799999987 6799999999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 348 LC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 348 lt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+| |..||.+.+..+++.-++++. ..+.+ ..++..+.+++..|++.+|++||+...+++
T Consensus 898 fslG~~PY~~~~n~~v~~~~~~gg-RL~~P--~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 898 FSLGATPYPSRSNFEVLLDVLEGG-RLDPP--SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HhCCCCCCCCcchHHHHHHHHhCC-ccCCC--CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 98 899999999999988787776 44433 458999999999999999999999999997
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=298.61 Aligned_cols=254 Identities=28% Similarity=0.580 Sum_probs=212.4
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+++|+|.|+.||.|.... +.+.++||+++. .....+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~---~~eK~ViKiLKP---------------------------------VkkkKI 79 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINIT---NNEKCVIKILKP---------------------------------VKKKKI 79 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccC---CCceEEEeeech---------------------------------HHHHHH
Confidence 45789999999999999999999876 788999999854 235789
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+|+.||..|++||||+.|+++..+. ....||+||+++.+..... ..|+..+++.++.+++.||.|||+.||+|
T Consensus 80 kREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImH 155 (338)
T KOG0668|consen 80 KREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMH 155 (338)
T ss_pred HHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCccc
Confidence 99999999999999999999999875 4568999999987754432 46899999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc--ccCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~elltg~~pf 354 (482)
||+||.|++++ .....++|+|+|+|.+..++...+..+.+..|--||.+- ..|+...|+|||||+|..|+..+.||
T Consensus 156 RDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepF 233 (338)
T KOG0668|consen 156 RDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 233 (338)
T ss_pred ccCCcceeeec--hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcc
Confidence 99999999996 455679999999999998888888889999999999875 46999999999999999999999997
Q ss_pred C-CCChHHHHHHHHhc-------------CC-----------CCCCCCCC---------CCCHHHHHHHHHhchhccccC
Q 011582 355 W-ARTESGIFRAVLKA-------------DP-----------SFDEAPWP---------SLSPEAIDFVKRLLNKDYRKR 400 (482)
Q Consensus 355 ~-~~~~~~~~~~i~~~-------------~~-----------~~~~~~~~---------~~s~~~~~li~~~L~~dP~~R 400 (482)
. +.+..+.+.+|.+. .. ......|. -+++++.||+.++|..|-.+|
T Consensus 234 FhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeR 313 (338)
T KOG0668|consen 234 FHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQER 313 (338)
T ss_pred cCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccc
Confidence 4 44443433333221 11 11112232 257999999999999999999
Q ss_pred CCHHHHhcCccccc
Q 011582 401 LTAAQALSHPWLAN 414 (482)
Q Consensus 401 ~s~~e~L~hp~~~~ 414 (482)
+|+.|++.||||..
T Consensus 314 lTakEam~HpyF~~ 327 (338)
T KOG0668|consen 314 LTAKEAMAHPYFAP 327 (338)
T ss_pred cchHHHhcCchHHH
Confidence 99999999999974
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=309.88 Aligned_cols=228 Identities=23% Similarity=0.325 Sum_probs=187.0
Q ss_pred CCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhhcCC
Q 011582 132 GHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGH 211 (482)
Q Consensus 132 G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h 211 (482)
|.||.||+|++.. +|+.||+|++.+. ....+|...+.... |
T Consensus 4 g~~~~v~~~~~~~---~~~~~~~K~i~~~-----------------------------------~~~~~~~~~~~~~~-~ 44 (237)
T cd05576 4 GVIDKVLLVMDTR---TQQTFILKGLRKS-----------------------------------SEYSRERLTIIPHC-V 44 (237)
T ss_pred cccceEEEEEEcc---CCcEEEEEeecch-----------------------------------hhhhhHHHHHHhcC-C
Confidence 8999999999987 8999999998653 11233444454554 9
Q ss_pred CCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCC
Q 011582 212 KNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEE 291 (482)
Q Consensus 212 pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~ 291 (482)
|||+++++++.+.+..|+||||++||+|.+++... ..+++..+..++.|++.||.|||++||+||||||+||++ +.
T Consensus 45 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~---~~ 120 (237)
T cd05576 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL---DD 120 (237)
T ss_pred CceeehhhheecCCeEEEEEecCCCCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE---cC
Confidence 99999999999999999999999999999988654 569999999999999999999999999999999999999 56
Q ss_pred CCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcC
Q 011582 292 NSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 370 (482)
Q Consensus 292 ~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~ 370 (482)
++.++|+|||++...... .....++..|+|||.+. +.++.++|+||+|+++|+|++|..||...... +. ..
T Consensus 121 ~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~-~~ 192 (237)
T cd05576 121 RGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----IN-TH 192 (237)
T ss_pred CCCEEEecccchhccccc--cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----cc-cc
Confidence 778999999988665432 23445678899999886 45889999999999999999999988643221 00 01
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhchhccccCCCH-----HHHhcCccc
Q 011582 371 PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA-----AQALSHPWL 412 (482)
Q Consensus 371 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~e~L~hp~~ 412 (482)
..+..+ ..++++++++|.+||+.||.+|+++ +++++||||
T Consensus 193 ~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 193 TTLNIP--EWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccCCc--ccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 111111 2478999999999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=313.46 Aligned_cols=249 Identities=22% Similarity=0.331 Sum_probs=200.0
Q ss_pred ceeecCCceEEEEEEEecCC---CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGS---LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVK 203 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~---~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~ 203 (482)
+.||+|+||.||+|+.+... ..+..||||.+.+. ........+.+|+.
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~-----------------------------~~~~~~~~~~~e~~ 51 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKG-----------------------------ATDQEKKEFLKEAH 51 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcc-----------------------------cchhhHHHHHHHHH
Confidence 35899999999999876421 12367999987542 11233467889999
Q ss_pred HHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 204 ILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR------GGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 204 ~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+++.+. ||||+++++++.+.+..++||||+++++|.+++... ...+++..+..++.|++.||.|||+++++|+
T Consensus 52 ~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~ 130 (269)
T cd05044 52 LMSNFN-HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHR 130 (269)
T ss_pred HHHhcC-CCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 999996 999999999999999999999999999999998642 2347899999999999999999999999999
Q ss_pred CCCCCceEEecCC--CCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-C
Q 011582 278 DLKPENFLFTSKE--ENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-G 350 (482)
Q Consensus 278 Dlkp~NIll~~~~--~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g 350 (482)
||||+||+++.++ ....++|+|||++........ .....++..|+|||++. +.++.++|||||||++|+|++ |
T Consensus 131 dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g 210 (269)
T cd05044 131 DLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLG 210 (269)
T ss_pred CCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcC
Confidence 9999999996432 223799999999876543221 12334578899999886 468999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
..||...+..+....+.... .+ .....++..+.++|.+||..+|.+||+++++++
T Consensus 211 ~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 211 QQPYPALNNQEVLQHVTAGG-RL--QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred CCCCcccCHHHHHHHHhcCC-cc--CCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99998877777666554332 11 122458899999999999999999999999865
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=310.14 Aligned_cols=261 Identities=27% Similarity=0.489 Sum_probs=211.6
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.|++.+.||+|+||.||+|.+..+ .++.+|+|.+...... .... ..........+.+|
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~--~~~~~avk~~~~~~~~------~~~~--------------~~~~~~~~~~~~~e 58 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNN--GQNLLALKEINVHNPA------FGKD--------------KRERDKSIGDIVSE 58 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCC--CCceeeeeEeeccccc------cccc--------------cccchHHHHHHHHH
Confidence 478889999999999999998752 4688999998643100 0000 01223445677889
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHR 277 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHr 277 (482)
+.++.+..+||||+++++++.+++..++||||++|++|.+.+.. ....+++..++.++.|++.||.|||+ .|++||
T Consensus 59 ~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~ 138 (269)
T cd08528 59 VTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHR 138 (269)
T ss_pred HHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeec
Confidence 99887644599999999999999999999999999999887743 34679999999999999999999996 789999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||+|+||++ +.++.+||+|||++.............|+..|+|||.+.+ .++.++||||||+++|+|++|..||..
T Consensus 139 dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~ 215 (269)
T cd08528 139 DLTPNNIML---GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215 (269)
T ss_pred CCCHHHEEE---CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccc
Confidence 999999999 5677899999999987655444556678999999998864 588999999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.........+....... .....+++++.++|.+||+.||++||++.++..+
T Consensus 216 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 216 TNMLSLATKIVEAVYEP--LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCHHHHHHHHhhccCCc--CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 77776666665544321 1123478999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=311.26 Aligned_cols=251 Identities=22% Similarity=0.335 Sum_probs=203.9
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|.+.+.||+|+||.||+|.......+|+.||||++... .......+.+.+|+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~----------------------------~~~~~~~~~~~~E~ 52 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKAD----------------------------IFSSSDIEEFLREA 52 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccc----------------------------cCChHHHHHHHHHH
Confidence 67788999999999999998765456899999998643 12334467788999
Q ss_pred HHHHhhcCCCCcceeeEEEEeCC------eEEEEEecCCCCChHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 203 KILRALTGHKNLVQFYDAYEDDD------NIYIVMELCKGGELLDRILSR-----GGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
.+++.+. ||||+++++++.... ..++++||+.+|+|.+++... ...+++..+..++.|++.||.|||+
T Consensus 53 ~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~ 131 (273)
T cd05074 53 ACMKEFD-HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS 131 (273)
T ss_pred HHHhcCC-CCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 9999996 999999999886542 247899999999998877532 1257899999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcchhhhhHHHHHHH
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el 347 (482)
+||+||||||+||++ +.++.+||+|||+++....... .....+++.|++||.+.. .++.++|||||||++|+|
T Consensus 132 ~~i~H~dikp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el 208 (273)
T cd05074 132 KNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEI 208 (273)
T ss_pred CCEeecccchhhEEE---cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHH
Confidence 999999999999999 5677899999999986643321 223345678999998864 588899999999999999
Q ss_pred hh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 348 LC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 348 lt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
++ |..||.+.+..+....+...... . .....+..+.+++.+||..+|++||++.+++.
T Consensus 209 ~~~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 209 MTRGQTPYAGVENSEIYNYLIKGNRL-K--QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred hhCCCCCCCCCCHHHHHHHHHcCCcC-C--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99 89999888777776666554321 1 11347899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=308.79 Aligned_cols=238 Identities=21% Similarity=0.216 Sum_probs=189.7
Q ss_pred ceeecCCceEEEEEEEecCCCCC----------ceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKG----------QDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g----------~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
+.||+|+||.||+|.+.. ++ ..|++|++... .....
T Consensus 1 ~~lg~G~~~~v~~~~~~~---~~~~~~~~~~~~~~v~~k~~~~~-------------------------------~~~~~ 46 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRV---QSDLDIVGPGQEVSVVLKVLGSD-------------------------------HRDSL 46 (259)
T ss_pred CcccccccceEEEEEEec---cCCccccCCccceeeeeeccccc-------------------------------hhhHH
Confidence 469999999999999876 33 34777765432 11146
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+.+++.+. ||||+++++++.. +..++||||+++|+|.+++......+++..+..++.||+.||.|||++||+|
T Consensus 47 ~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H 124 (259)
T cd05037 47 AFFETASLMSQLS-HKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVH 124 (259)
T ss_pred HHHHHHHHHHcCC-CcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeec
Confidence 7889999999996 9999999999988 7889999999999999988766557999999999999999999999999999
Q ss_pred cCCCCCceEEecCC----CCCcEEEEecccccccCCCCcccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhh
Q 011582 277 RDLKPENFLFTSKE----ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 277 rDlkp~NIll~~~~----~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~ellt 349 (482)
|||||+|||++.+. ....+||+|||++..... .....++..|+|||++.+ .++.++|||||||++|+|++
T Consensus 125 ~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~ 201 (259)
T cd05037 125 GNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICS 201 (259)
T ss_pred ccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHh
Confidence 99999999995322 112799999999987543 233457788999998864 48899999999999999999
Q ss_pred -CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 350 -GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 350 -g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|..||......+...... .....+. ....++.++|.+||..+|.+|||+.++++
T Consensus 202 ~~~~p~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 202 NGEEPLSTLSSSEKERFYQ-DQHRLPM----PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCcccCCchhHHHHHh-cCCCCCC----CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 588886665443333332 1111111 12378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=308.11 Aligned_cols=246 Identities=18% Similarity=0.261 Sum_probs=193.1
Q ss_pred eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
+||+|+||.||+|....+. ....+++|.+... ......+.+.+|+.+++.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~-~~~~~~~k~~~~~-----------------------------~~~~~~~~~~~e~~~~~~ 51 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDT-GVARVVVKELKAN-----------------------------ASSKEQNEFLQQGDPYRI 51 (268)
T ss_pred cCCCCcCceEEEEEEEcCC-CcceEEEEEecCC-----------------------------CChHHHHHHHHHHHHHhc
Confidence 5999999999999865321 2344666665432 122345688999999999
Q ss_pred hcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 011582 208 LTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENF 284 (482)
Q Consensus 208 l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NI 284 (482)
+. ||||+++++.+.+....|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+|+||||||+||
T Consensus 52 l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~ni 130 (268)
T cd05086 52 LQ-HPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNC 130 (268)
T ss_pred cC-CcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceE
Confidence 96 9999999999999999999999999999999886532 3467778889999999999999999999999999999
Q ss_pred EEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc--------cCCCcchhhhhHHHHHHHhh-CCC
Q 011582 285 LFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR--------SYGTEADMWSIGVIAYILLC-GSR 352 (482)
Q Consensus 285 ll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~--------~~~~~~DiwSlGvil~ellt-g~~ 352 (482)
|+ +.++.+||+|||++....... .....+|+..|+|||++.. .++.++|||||||++|+|++ |..
T Consensus 131 l~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~ 207 (268)
T cd05086 131 FL---TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQ 207 (268)
T ss_pred EE---cCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCC
Confidence 99 567789999999986432211 1234578899999998742 35778999999999999996 577
Q ss_pred CCCCCChHHHHHHHHhcCC-CCCCCC-CCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 353 PFWARTESGIFRAVLKADP-SFDEAP-WPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~-~~~~~~-~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||......+.+..+..... ....+. ...+++.+.+++..|+ .+|++||+++++++
T Consensus 208 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 208 PYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred CCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 8887777777776654432 222222 2347899999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=340.91 Aligned_cols=257 Identities=23% Similarity=0.293 Sum_probs=177.6
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCC----CceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLK----GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~----g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
..++|++.+.||+|+||.||+|++.. + +..||||.+.... .
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~---~~~~~~~~vAvK~~~~~~--------------------------------~ 174 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVN---KQSKKEGKYVLKKATEYG--------------------------------A 174 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcC---CccccCcEEEEEEecccc--------------------------------h
Confidence 45789999999999999999999876 5 8899999875320 0
Q ss_pred HHHHHHHHHHHHhhcCCCCcceeeEE------EEeCCeEEEEEecCCCCChHHHHHhcCCC-------------------
Q 011582 195 IEDVRREVKILRALTGHKNLVQFYDA------YEDDDNIYIVMELCKGGELLDRILSRGGK------------------- 249 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~hpniv~l~~~------~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------------------- 249 (482)
.+...+| .+.... +.+++.++.. ...+..+++||||+.+++|.+++......
T Consensus 175 ~e~~~~e--~l~~~~-~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~ 251 (566)
T PLN03225 175 VEIWMNE--RVRRAC-PNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLE 251 (566)
T ss_pred hHHHHHH--HHHhhc-hhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccch
Confidence 0011111 111111 2222222211 24567899999999999999988644211
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCC--CcccccccCccccCcccc
Q 011582 250 YSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD--ERLNDIVGSAYYVAPEVL 327 (482)
Q Consensus 250 l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~--~~~~~~~gt~~y~aPE~~ 327 (482)
..+..+..++.||+.||.|||++||+||||||+|||++ ++++.+||+|||+|+.+... ......+||+.|||||.+
T Consensus 252 r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~ 329 (566)
T PLN03225 252 RENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY 329 (566)
T ss_pred hhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence 12345678999999999999999999999999999995 23568999999999865432 233567899999999965
Q ss_pred cc-----------------------cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHh-cCCCC-------CC-
Q 011582 328 HR-----------------------SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLK-ADPSF-------DE- 375 (482)
Q Consensus 328 ~~-----------------------~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~-~~~~~-------~~- 375 (482)
.. .++.++|||||||+||||+++..++.. ....+..++. ..... ..
T Consensus 330 ~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~ 407 (566)
T PLN03225 330 IMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPR 407 (566)
T ss_pred hccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccc
Confidence 21 234567999999999999998766532 2222222211 11100 00
Q ss_pred ---------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 376 ---------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 376 ---------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
..+.......++||.+||+.||.+|||+.++|+||||.....
T Consensus 408 ~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 408 ASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPYFDREGL 458 (566)
T ss_pred cchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCCc
Confidence 001112345669999999999999999999999999987654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=307.87 Aligned_cols=260 Identities=22% Similarity=0.310 Sum_probs=214.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++.+-+..||.|+||+|++-.++. +|+.+|||.|+-. .......+++.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~---sg~~mAVKrIr~~-----------------------------n~~keq~rll~ 111 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKP---SGKLMAVKRIRSN-----------------------------NIEKEQKRLLM 111 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCc---cCcEEEEEEeeec-----------------------------cchHHHHHHHH
Confidence 345556789999999999999987 8999999999753 22445678899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHH----hcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCc
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRIL----SRGGKYSEEDAKIVMVQILSVVAFCHF-QGVV 275 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~----~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~iv 275 (482)
|.+...+-.++||||++||.+..++..||.||+|+- ||..+.. -+...++|..+..|..-++.||.||-. .+||
T Consensus 112 e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiI 190 (361)
T KOG1006|consen 112 EHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKII 190 (361)
T ss_pred HHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhh
Confidence 999888888899999999999999999999999954 5433221 124679999999999999999999986 5899
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc--c-cCCCcchhhhhHHHHHHHhhCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH--R-SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~--~-~~~~~~DiwSlGvil~elltg~~ 352 (482)
|||+||+|||+ +..|.+||||||++..+...-..+..+|...|||||.+. + .|+.++||||||++|||+.||..
T Consensus 191 HRDvKPSNILl---dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~f 267 (361)
T KOG1006|consen 191 HRDVKPSNILL---DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNF 267 (361)
T ss_pred hccCChhheEE---ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCC
Confidence 99999999999 778899999999998876655556678999999999885 3 49999999999999999999999
Q ss_pred CCCCCCh-HHHHHHHHhcCCCCCCCCC--CCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 353 PFWARTE-SGIFRAVLKADPSFDEAPW--PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 353 pf~~~~~-~~~~~~i~~~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
||.+.+. -+.+..+..+.+....... -.++..+..+|..||.+|-..||+..+++.+||++-..
T Consensus 268 Pyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~ 334 (361)
T KOG1006|consen 268 PYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYA 334 (361)
T ss_pred CcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhh
Confidence 9988654 3455555555543322211 24789999999999999999999999999999998654
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=318.66 Aligned_cols=268 Identities=28% Similarity=0.468 Sum_probs=216.9
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|-++..||+|||+.||+|.+-. ..+.||||+-..... +. .........
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~---EqRYvAvKIHqlNK~---------------Wr--------dEKKeNYhK 512 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLT---EQRYVAVKIHQLNKN---------------WR--------DEKKENYHK 512 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccc---hhheeeEeeehhccc---------------hh--------hHhhhhHHH
Confidence 4566889999999999999999999876 688999998432100 00 001223345
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEE-eCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYE-DDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG-- 273 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-- 273 (482)
...+|..|.+.|. ||.||++|++|. +.+.+|-|+|||+|.+|..+| +....++|.+++.|+.||+.||.||.+..
T Consensus 513 HAcREyrIHKeLD-HpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYL-KQhklmSEKEARSIiMQiVnAL~YLNEikpP 590 (775)
T KOG1151|consen 513 HACREYRIHKELD-HPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL-KQHKLMSEKEARSIIMQIVNALKYLNEIKPP 590 (775)
T ss_pred HHHHHHhhhhccC-cceeeeeeeeeeeccccceeeeeecCCCchhHHH-HhhhhhhHHHHHHHHHHHHHHHHHHhccCCC
Confidence 5678999999995 999999999986 567789999999999987666 45578999999999999999999999875
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCC--------cccccccCccccCccccc-c----cCCCcchhhhh
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--------RLNDIVGSAYYVAPEVLH-R----SYGTEADMWSI 340 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~-~----~~~~~~DiwSl 340 (482)
|||-||||.|||+.+....+.+||.|||+++.+..+. ......||.||++||++- + ..+.|+||||+
T Consensus 591 IIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv 670 (775)
T KOG1151|consen 591 IIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 670 (775)
T ss_pred eeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence 9999999999999988888999999999999886543 234578999999999873 2 37889999999
Q ss_pred HHHHHHHhhCCCCCCCCC-hHHHHHH--HHhc-CCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 341 GVIAYILLCGSRPFWART-ESGIFRA--VLKA-DPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 341 Gvil~elltg~~pf~~~~-~~~~~~~--i~~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
|||+|.++.|+.||.... ..++++. |++. ...|+.. +.++.++++||++||+.--+.|....++-.||||.-
T Consensus 671 GVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 671 GVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred ehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 999999999999996543 3334332 3322 2344433 569999999999999999999999999999999964
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=309.66 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=202.9
Q ss_pred cceEecceeecCCceEEEEEEEecC-CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKG-SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~-~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+|++.+.||+|+||.||+|+.... ..++..||||++... ......+.+.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~-----------------------------~~~~~~~~~~ 54 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS-----------------------------GEEQHRSDFE 54 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccc-----------------------------cchHHHHHHH
Confidence 4688889999999999999986431 225789999998653 1113457899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 200 REVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+|+.+++.+. |+||+++++++.. ....++||||+++++|.+++......+++..+..++.|++.||.|||++||+||
T Consensus 55 ~ei~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~ 133 (284)
T cd05038 55 REIEILRTLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHR 133 (284)
T ss_pred HHHHHHHhCC-CCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 9999999996 9999999999887 568999999999999999987765679999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcc----cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL----NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~----~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~ 352 (482)
||||+||++ +.++.++|+|||++......... ....++..|+|||.+. ..++.++||||||+++|+|++|..
T Consensus 134 dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~ 210 (284)
T cd05038 134 DLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGD 210 (284)
T ss_pred CCCHHhEEE---cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCC
Confidence 999999999 56788999999999876532211 1234456799999875 468899999999999999999999
Q ss_pred CCCCCChHH--------------HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 353 PFWARTESG--------------IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 353 pf~~~~~~~--------------~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||....... .+...+......+. ...++.++.+|+.+||..+|.+|||+.++++
T Consensus 211 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 211 PSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR--PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred CcccccchhccccccccccccHHHHHHHHHcCCcCCC--CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 986532211 12222333222222 2346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=332.62 Aligned_cols=272 Identities=29% Similarity=0.509 Sum_probs=222.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+.|+|.++||.|.+|.||+++.++ +|+..|||+..-. ....++++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~---~~~~aa~kI~~~~-------------------------------~d~deEiE 63 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVK---TGQLAAIKIMDPT-------------------------------EDEEEEIE 63 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeee---cCceeeeEeecCC-------------------------------ccccHHHH
Confidence 4679999999999999999999988 8999999997532 22346788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEe-----CCeEEEEEecCCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYED-----DDNIYIVMELCKGGELLDRILS-RGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
.|.++|+.+.+|||++.+|++|.- ++.+|||||||.||+.-|.+.. .+.++.|+.++.|++.++.||.+||.+.
T Consensus 64 ~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk 143 (953)
T KOG0587|consen 64 LEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK 143 (953)
T ss_pred HHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc
Confidence 899999999999999999999863 5789999999999999998764 3678999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCccccc------ccCCCcchhhhhHHHHHH
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYI 346 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~e 346 (482)
++|||||-.|||+ ..++.|||+|||++..+... ....+.+|||.|||||++. ..|+..+|+||||++..|
T Consensus 144 viHRDikG~NiLL---T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIE 220 (953)
T KOG0587|consen 144 VIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIE 220 (953)
T ss_pred eeeecccCceEEE---eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeeh
Confidence 9999999999999 57888999999999877543 4567789999999999884 237889999999999999
Q ss_pred HhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCCCccHHH
Q 011582 347 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIV 426 (482)
Q Consensus 347 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~~~~~ 426 (482)
|--|.+|+-+....-.+-.|-... ......|...+.++.+||..||.+|-.+||+..++|.|||+.... ....+
T Consensus 221 ladG~PPl~DmHPmraLF~IpRNP-PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~~-----~e~qi 294 (953)
T KOG0587|consen 221 MAEGAPPLCDMHPMRALFLIPRNP-PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQP-----NERQV 294 (953)
T ss_pred hcCCCCCccCcchhhhhccCCCCC-CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccccc-----cHHHH
Confidence 999999986655433332222221 111223566899999999999999999999999999999998321 44444
Q ss_pred HHHHHHHh
Q 011582 427 YKLIKAYI 434 (482)
Q Consensus 427 ~~~~~~~~ 434 (482)
...++...
T Consensus 295 r~~ik~~~ 302 (953)
T KOG0587|consen 295 RIQIKDHI 302 (953)
T ss_pred HHHHHHHH
Confidence 44444443
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=333.71 Aligned_cols=247 Identities=30% Similarity=0.485 Sum_probs=197.7
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.|...+.||+||||.||+++++. +|+.||||.+.+. ......+..-+|
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnke---tG~~vAvK~~~~~-----------------------------~~~r~~e~~~~E 61 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKE---TGRLVAVKTFNKE-----------------------------SSLRPRERWCRE 61 (732)
T ss_pred ceeehhhhcCCccceeeeecccc---cccchhHHhhhhh-----------------------------cccchHHHHHHH
Confidence 46667789999999999999988 8999999998653 122334667899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCC------eEEEEEecCCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDD------NIYIVMELCKGGELLDRILSR--GGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
+++|++|. |+|||+++++-++.. ...+|||||.||||...+.+. ...|++.+...++..+..||.|||++|
T Consensus 62 ieilkKLn-h~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~ 140 (732)
T KOG4250|consen 62 IEILKKLN-HPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG 140 (732)
T ss_pred HHHHHHcC-chhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 99999997 999999999865543 568999999999999988643 467999999999999999999999999
Q ss_pred CcccCCCCCceEEecCC-CCCcEEEEecccccccCCCCcccccccCccccCccccc--ccCCCcchhhhhHHHHHHHhhC
Q 011582 274 VVHRDLKPENFLFTSKE-ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~-~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~elltg 350 (482)
||||||||+||++-... ....-||+|||.|+-+.++....+.+||+.|.+||.+. +.|+.-+|.|||||++|+++||
T Consensus 141 IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG 220 (732)
T KOG4250|consen 141 IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATG 220 (732)
T ss_pred ceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhcc
Confidence 99999999999996433 34457999999999999999999999999999999987 5689999999999999999999
Q ss_pred CCCCCCCCh----HHHHHHHHhcCCCCC----------CCCC-------CCCCH----HHHHHHHHhchhccccCC
Q 011582 351 SRPFWARTE----SGIFRAVLKADPSFD----------EAPW-------PSLSP----EAIDFVKRLLNKDYRKRL 401 (482)
Q Consensus 351 ~~pf~~~~~----~~~~~~i~~~~~~~~----------~~~~-------~~~s~----~~~~li~~~L~~dP~~R~ 401 (482)
..||..... .++.-.+....+.-. ...| ..+++ .+-..+..||..+|++|.
T Consensus 221 ~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 221 ELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 999954322 223333333221100 0001 12233 345788899999999999
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=309.35 Aligned_cols=261 Identities=16% Similarity=0.198 Sum_probs=187.8
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++.+.||+|+||.||+|........+..+|+|+..... +. ...+... ........
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~------------~~----~~~e~~~---~~~~~~~~ 69 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLEN------------ET----IVMETLV---YNNIYDID 69 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccC------------Cc----hhhHHHH---HHhhhhHH
Confidence 44578999999999999999999987522225677777643210 00 0000000 00000112
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCC----eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDD----NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
...++..+..+. |+||+++++++.... ..++++|++.. ++.+.+. ....+++..+..++.|++.||.|||++|
T Consensus 70 ~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 146 (294)
T PHA02882 70 KIALWKNIHNID-HLGIPKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFK-RIKCKNKKLIKNIMKDMLTTLEYIHEHG 146 (294)
T ss_pred HHHHHHHhccCC-CCCCCcEEEeeeEecCCceEEEEEEehhcc-CHHHHHH-hhccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 233444455564 999999999876543 45788898744 5665543 3345789999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCC--------cccccccCccccCcccccc-cCCCcchhhhhHHHH
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--------RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIA 344 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil 344 (482)
|+||||||+|||+ +.++.++|+|||+|+.+.... ......||+.|+|||++.+ .++.++|||||||++
T Consensus 147 iiHrDiKp~Nill---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l 223 (294)
T PHA02882 147 ISHGDIKPENIMV---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCM 223 (294)
T ss_pred eecCCCCHHHEEE---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHH
Confidence 9999999999999 567789999999998653221 1223579999999998865 589999999999999
Q ss_pred HHHhhCCCCCCCCCh-HHH--------HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 345 YILLCGSRPFWARTE-SGI--------FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 345 ~elltg~~pf~~~~~-~~~--------~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|+|++|..||.+... ... +..+..... ..+..++++.++++.|+..+|.+||+++++++
T Consensus 224 ~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 224 LKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKI-----KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred HHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhh-----ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 999999999987632 222 222222221 23457899999999999999999999999874
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=324.34 Aligned_cols=274 Identities=22% Similarity=0.270 Sum_probs=193.3
Q ss_pred cccceEecceeecCCceEEEEEEEec-------------CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhh
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKK-------------GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYC 185 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~-------------~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (482)
-.++|++.++||+|+||.||+|.... ....++.||||.+..... .. ...+..+.
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~-----------~~-~~~fl~e~- 209 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ-----------GV-RQDFLKTG- 209 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch-----------hh-HHHHHhhh-
Confidence 46789999999999999999997521 112467899999853200 00 00000000
Q ss_pred hhccccHHHHHHHHHHHHHHHhhcCCCC-----cceeeEEEEe--------CCeEEEEEecCCCCChHHHHHhcC-----
Q 011582 186 CLFMTTAIAIEDVRREVKILRALTGHKN-----LVQFYDAYED--------DDNIYIVMELCKGGELLDRILSRG----- 247 (482)
Q Consensus 186 ~~~~~~~~~~~~~~~Ei~~l~~l~~hpn-----iv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~----- 247 (482)
.......+....|+.++.+++ |.+ +++++++|.. ++..+|||||+++++|.+++....
T Consensus 210 ---~~~~~~~e~~~vE~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~ 285 (507)
T PLN03224 210 ---TLAKGSAETGMVEAYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPG 285 (507)
T ss_pred ---hhhhcccchhHHHHHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcc
Confidence 000111234456788888886 544 4677777653 467899999999999999876421
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCC
Q 011582 248 ------------------GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD 309 (482)
Q Consensus 248 ------------------~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~ 309 (482)
..+++..++.++.|++.||.|||+.+|+||||||+|||+ +.++.+||+|||++......
T Consensus 286 ~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~ 362 (507)
T PLN03224 286 CLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTG 362 (507)
T ss_pred hHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccC
Confidence 124567888999999999999999999999999999999 56678999999999765443
Q ss_pred Cccccc--ccCccccCccccccc---------------------CC--CcchhhhhHHHHHHHhhCCC-CCCCCC-----
Q 011582 310 ERLNDI--VGSAYYVAPEVLHRS---------------------YG--TEADMWSIGVIAYILLCGSR-PFWART----- 358 (482)
Q Consensus 310 ~~~~~~--~gt~~y~aPE~~~~~---------------------~~--~~~DiwSlGvil~elltg~~-pf~~~~----- 358 (482)
...... .+|+.|+|||.+... |+ .+.||||+||++|+|++|.. ||....
T Consensus 363 ~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~ 442 (507)
T PLN03224 363 INFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE 442 (507)
T ss_pred CccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH
Confidence 322222 348899999986421 12 24799999999999999986 664321
Q ss_pred ------hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhcc---ccCCCHHHHhcCccccc
Q 011582 359 ------ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDY---RKRLTAAQALSHPWLAN 414 (482)
Q Consensus 359 ------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~R~s~~e~L~hp~~~~ 414 (482)
....++.+..... ....|..+++.+++||.+||..+| .+|+|++|+|+||||..
T Consensus 443 ~~~~~~~~~~~r~~~~~~~--~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 443 LRQYDNDLNRWRMYKGQKY--DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred HhhccchHHHHHhhcccCC--CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 1112222222333 334567789999999999999876 68999999999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=318.75 Aligned_cols=266 Identities=25% Similarity=0.444 Sum_probs=224.8
Q ss_pred cccccccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccc
Q 011582 111 KNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMT 190 (482)
Q Consensus 111 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (482)
..+.+.+.+-.+|.+....|+|-|++|.+|.+.. .|+.||||+|...
T Consensus 422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~---r~~~vAiKIIRnN------------------------------ 468 (752)
T KOG0670|consen 422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQA---RGQEVAIKIIRNN------------------------------ 468 (752)
T ss_pred EEEehhhhhcceeEEEeccccceeeeeeeccccC---CCCeeEEEEeecc------------------------------
Confidence 3455677888999999999999999999999987 7889999999764
Q ss_pred cHHHHHHHHHHHHHHHhhcC-----CCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC--CCCCHHHHHHHHHHHH
Q 011582 191 TAIAIEDVRREVKILRALTG-----HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG--GKYSEEDAKIVMVQIL 263 (482)
Q Consensus 191 ~~~~~~~~~~Ei~~l~~l~~-----hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~ 263 (482)
+.....-+.|++||++|.+ --|+++|+..|...+++|||+|-+. .+|.+.|.+-+ -.|....+..|+.|++
T Consensus 469 -E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLf 546 (752)
T KOG0670|consen 469 -EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLF 546 (752)
T ss_pred -hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHH
Confidence 1223445789999999972 3589999999999999999999984 48899887643 4588899999999999
Q ss_pred HHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHH
Q 011582 264 SVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGV 342 (482)
Q Consensus 264 ~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGv 342 (482)
.||..|-..||+|.||||+|||++ .....+||||||.|..+..++ .+.+..+..|.|||++.| .|+...|+||+||
T Consensus 547 lALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 547 LALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGC 623 (752)
T ss_pred HHHHHHHhcCeeecccCccceEec--cCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCcccCCccceeece
Confidence 999999999999999999999996 455689999999998876544 455667788999999887 6999999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCC--------------------------------------------
Q 011582 343 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW-------------------------------------------- 378 (482)
Q Consensus 343 il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-------------------------------------------- 378 (482)
+||||.||+..|.+.+...++.-.+.....|+...+
T Consensus 624 tLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s 703 (752)
T KOG0670|consen 624 TLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGS 703 (752)
T ss_pred eeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHH
Confidence 999999999999999999998888776666654221
Q ss_pred -----CCCC-------HHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 379 -----PSLS-------PEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 379 -----~~~s-------~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
+.++ ..+++|+.+||..||.+|.|..++|.||||..
T Consensus 704 ~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 704 ELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 0011 45789999999999999999999999999974
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=326.85 Aligned_cols=258 Identities=23% Similarity=0.399 Sum_probs=223.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
+...|.++||.|.||.||+|+.+........||||.++.. ..+....+|+.
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-----------------------------ytekqrrdFL~ 679 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-----------------------------YTEKQRRDFLS 679 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-----------------------------ccHHHHhhhhh
Confidence 4456778899999999999999874444567999999764 45566789999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.||-++. ||||++|.|+........||+|||++|+|..+|..+.+.|+..+..-+++.|+.|++||-+.|+|||||-
T Consensus 680 EAsIMGQFd-HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLA 758 (996)
T KOG0196|consen 680 EASIMGQFD-HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLA 758 (996)
T ss_pred hhhhcccCC-CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhh
Confidence 999999996 9999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-c-cccccc--CccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-R-LNDIVG--SAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~-~~~~~g--t~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
..|||+ +.+..+|++|||+++.+.++. . .++..| ..+|.|||++. +.++.++||||+||+|||.++ |..||
T Consensus 759 ARNILV---NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPY 835 (996)
T KOG0196|consen 759 ARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 835 (996)
T ss_pred hhheee---ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcc
Confidence 999999 678899999999999886554 1 222222 36899999875 789999999999999999764 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc--Cccccc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS--HPWLAN 414 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~--hp~~~~ 414 (482)
|+.+.++.++.|..+- ..+.+ .+++..+.+|+..|+++|-.+||+..|+++ |..+++
T Consensus 836 WdmSNQdVIkaIe~gy-RLPpP--mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 836 WDMSNQDVIKAIEQGY-RLPPP--MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred cccchHHHHHHHHhcc-CCCCC--CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 9999999999988763 33322 468999999999999999999999999987 455554
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=320.17 Aligned_cols=257 Identities=24% Similarity=0.336 Sum_probs=217.0
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
+...+.++||+|+||.|++|.......+--.||||+++.. .-......|++
T Consensus 110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d-----------------------------~l~~~mddflr 160 (1039)
T KOG0199|consen 110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDD-----------------------------SLNAIMDDFLR 160 (1039)
T ss_pred HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCC-----------------------------ccchhHHHHHH
Confidence 3466788999999999999998764333456999998653 11225788999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS-RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
|+.+|.+|+ |+|+++|||+..+ ..+.||||++++|+|+++|.+ ....|.......|+.||+.||.||.++++|||||
T Consensus 161 Eas~M~~L~-H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDL 238 (1039)
T KOG0199|consen 161 EASHMLKLQ-HPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDL 238 (1039)
T ss_pred HHHHHHhcc-CcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhh
Confidence 999999997 9999999999887 788999999999999999987 5567889999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCccccc----ccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDI----VGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRP 353 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~----~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~p 353 (482)
-..|||+. ....|||+||||.+.+..++..... .-...|+|||.++ +.++.++|||++||++|||++ |..|
T Consensus 239 AARNllla---sprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEeP 315 (1039)
T KOG0199|consen 239 AARNLLLA---SPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEP 315 (1039)
T ss_pred hhhhheec---ccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCC
Confidence 99999995 4668999999999988766544322 2345799999986 679999999999999999997 8999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
|.+.....++++|-.+ ...+.+ +.+++++.++++.|+..+|.+|||...+.+.-++..
T Consensus 316 W~G~~g~qIL~~iD~~-erLpRP--k~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 316 WVGCRGIQILKNIDAG-ERLPRP--KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred CCCCCHHHHHHhcccc-ccCCCC--CCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 9999999999998843 334443 348999999999999999999999999876655544
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=298.68 Aligned_cols=267 Identities=29% Similarity=0.483 Sum_probs=208.7
Q ss_pred ccccccc-cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccH
Q 011582 114 GFSKQFV-AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTA 192 (482)
Q Consensus 114 ~~~~~~~-~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (482)
.+++.|. .+|.+.++||.|.|++||+|.+.. ..+.||+|+.+. .+
T Consensus 70 ~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq---~~r~VAlKVvKS-------------------------------Aq 115 (590)
T KOG1290|consen 70 RIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQ---NKRYVALKVVKS-------------------------------AQ 115 (590)
T ss_pred eccccccCceEEEEEeccccccceeEEEeecc---CCeEEEEEEEeh-------------------------------hh
Confidence 3566777 899999999999999999999987 788999999854 34
Q ss_pred HHHHHHHHHHHHHHhhcCC-------CCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHH
Q 011582 193 IAIEDVRREVKILRALTGH-------KNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMV 260 (482)
Q Consensus 193 ~~~~~~~~Ei~~l~~l~~h-------pniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~ 260 (482)
...+....||++|++++.+ .+||+|++.|.. +.++|||+|++ |.+|+.+|...+ ..++...++.|++
T Consensus 116 hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~ 194 (590)
T KOG1290|consen 116 HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICR 194 (590)
T ss_pred HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHH
Confidence 4567788999999998743 369999999975 46899999999 779999887543 5699999999999
Q ss_pred HHHHHHHHHHHC-CCcccCCCCCceEEecCC-------------------------------------------------
Q 011582 261 QILSVVAFCHFQ-GVVHRDLKPENFLFTSKE------------------------------------------------- 290 (482)
Q Consensus 261 qi~~~L~yLH~~-~ivHrDlkp~NIll~~~~------------------------------------------------- 290 (482)
||+.||.|||.. ||||-||||+|||+...+
T Consensus 195 qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~ 274 (590)
T KOG1290|consen 195 QVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMK 274 (590)
T ss_pred HHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHH
Confidence 999999999985 899999999999993221
Q ss_pred --------------------------------------------------------------C-----------------
Q 011582 291 --------------------------------------------------------------E----------------- 291 (482)
Q Consensus 291 --------------------------------------------------------------~----------------- 291 (482)
.
T Consensus 275 kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~ 354 (590)
T KOG1290|consen 275 KKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQL 354 (590)
T ss_pred HHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhc
Confidence 0
Q ss_pred -----------------------------------CCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcc
Q 011582 292 -----------------------------------NSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEA 335 (482)
Q Consensus 292 -----------------------------------~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~ 335 (482)
+..+||+|||-|..+. ...+..+-|..|+|||++.+ .|++.+
T Consensus 355 ~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsgY~~~A 432 (590)
T KOG1290|consen 355 RDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSGYSTSA 432 (590)
T ss_pred ccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCCCCCch
Confidence 0125677777666543 22344567889999999876 699999
Q ss_pred hhhhhHHHHHHHhhCCCCCCCC------ChHHHHHHHHhcCCCCCC-------------------------CCCC-----
Q 011582 336 DMWSIGVIAYILLCGSRPFWAR------TESGIFRAVLKADPSFDE-------------------------APWP----- 379 (482)
Q Consensus 336 DiwSlGvil~elltg~~pf~~~------~~~~~~~~i~~~~~~~~~-------------------------~~~~----- 379 (482)
||||++|++|||+||-..|... .+++.+..|++....++. ..|+
T Consensus 433 DiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL 512 (590)
T KOG1290|consen 433 DIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVL 512 (590)
T ss_pred hHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHH
Confidence 9999999999999999999532 234445555443222221 1122
Q ss_pred ----CC----CHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 380 ----SL----SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 380 ----~~----s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.+ ..++.+|+.-||+.+|.+|+||.++|+|||++....
T Consensus 513 ~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 513 IEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCC
Confidence 11 255779999999999999999999999999986543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=287.78 Aligned_cols=242 Identities=45% Similarity=0.778 Sum_probs=204.0
Q ss_pred CceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhhcCCC
Q 011582 133 HFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHK 212 (482)
Q Consensus 133 ~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp 212 (482)
+||.||+|+... +|+.+|+|++.... .....+.+.+|+.+++++. |+
T Consensus 1 ~~g~v~~~~~~~---~~~~~~~k~~~~~~-----------------------------~~~~~~~~~~e~~~~~~l~-~~ 47 (244)
T smart00220 1 SFGKVYLARDKK---TGKLVAIKVIKKEK-----------------------------IKKKRERILREISILKKLK-HP 47 (244)
T ss_pred CceEEEEEEECC---CCcEEEEEEecccc-----------------------------cccHHHHHHHHHHHHHhCC-CC
Confidence 589999999876 68999999986531 1111578899999999995 99
Q ss_pred CcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCC
Q 011582 213 NLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEEN 292 (482)
Q Consensus 213 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~ 292 (482)
||+++++++......+++|||+.+++|.+++... ..+++..+..++.+++.+|.|||+.|++|+||+|+||++ +.+
T Consensus 48 ~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~---~~~ 123 (244)
T smart00220 48 NIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKR-GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL---DED 123 (244)
T ss_pred cHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE---CCC
Confidence 9999999999999999999999999999988654 348999999999999999999999999999999999999 556
Q ss_pred CcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCC-CChHHHHHHHHhcC
Q 011582 293 SSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWA-RTESGIFRAVLKAD 370 (482)
Q Consensus 293 ~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~-~~~~~~~~~i~~~~ 370 (482)
+.++|+|||++.............++..|++||.+. ..++.++||||||+++++|++|..||.. .....+...+....
T Consensus 124 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~ 203 (244)
T smart00220 124 GHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPK 203 (244)
T ss_pred CcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC
Confidence 889999999998876554556678899999999886 5688899999999999999999999987 44555555444433
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 371 PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 371 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
... ...+..++.++.+++.+||..+|++||++.++++||||
T Consensus 204 ~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 204 PPF-PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CCC-ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 322 22222388999999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=311.75 Aligned_cols=248 Identities=24% Similarity=0.392 Sum_probs=208.8
Q ss_pred eEecceeecCCceEEEEEEEecCC-CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGS-LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~-~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
..+.+.||.|-||.||.|+....+ ...--||||.-+.. .+.+..+.|..|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d-----------------------------~t~d~tekflqE 441 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTD-----------------------------CTPDDTEKFLQE 441 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccC-----------------------------CChhhHHHHHHH
Confidence 344567999999999999876532 12345888886543 345557899999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
..+|+.+. ||||++|+|+|.+ ...|||||+++-|.|.+++..+...|+......++.||+.||.|||+.++|||||-.
T Consensus 442 a~iMrnfd-HphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAa 519 (974)
T KOG4257|consen 442 ASIMRNFD-HPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAA 519 (974)
T ss_pred HHHHHhCC-Ccchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhh
Confidence 99999996 9999999999875 568999999999999999998888999999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCccccccc--CccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVG--SAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWAR 357 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~g--t~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~ 357 (482)
.|||+. ....+||+|||+++.+.+........| ..-|||||.++ +.++.++|||-|||++||+++ |..||.+-
T Consensus 520 RNiLVs---Sp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgv 596 (974)
T KOG4257|consen 520 RNILVS---SPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGV 596 (974)
T ss_pred hheeec---CcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccc
Confidence 999994 566799999999999887665544444 34699999887 789999999999999999876 99999998
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHh
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L 407 (482)
...+.+-.|.++.. .+.+ +++++.+..|+.+|++.||.+||+..++.
T Consensus 597 kNsDVI~~iEnGeR-lP~P--~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 597 KNSDVIGHIENGER-LPCP--PNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred cccceEEEecCCCC-CCCC--CCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 87777777666643 2222 46899999999999999999999887764
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=324.42 Aligned_cols=248 Identities=33% Similarity=0.475 Sum_probs=197.9
Q ss_pred cceeecCCce-EEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFG-YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKI 204 (482)
Q Consensus 126 ~~~LG~G~fG-~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~ 204 (482)
.+.+|.|+-| .||+|.. .|+.||||++-. +......+||..
T Consensus 514 ~eilG~Gs~Gt~Vf~G~y-----e~R~VAVKrll~---------------------------------e~~~~A~rEi~l 555 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVY-----EGREVAVKRLLE---------------------------------EFFDFAQREIQL 555 (903)
T ss_pred HHHcccCCCCcEEEEEee-----CCceehHHHHhh---------------------------------HhHHHHHHHHHH
Confidence 3568999998 4788876 689999998632 223457899999
Q ss_pred HHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCC---CCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 205 LRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGK---YSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 205 l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
|+.-.+|||||++|+.-.+....||..|.|.. +|.+++...... ......+.++.|+++||.+||+.+||||||||
T Consensus 556 L~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkP 634 (903)
T KOG1027|consen 556 LQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKP 634 (903)
T ss_pred HHhccCCCceEEEEeeccCCceEEEEehHhhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCC
Confidence 99998999999999999999999999999965 899988653111 11145678899999999999999999999999
Q ss_pred CceEEecC--CCCCcEEEEecccccccCCCC----cccccccCccccCccccccc-CCCcchhhhhHHHHHHHhhC-CCC
Q 011582 282 ENFLFTSK--EENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCG-SRP 353 (482)
Q Consensus 282 ~NIll~~~--~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlGvil~elltg-~~p 353 (482)
.||||... +....++|+|||+++.+..+. ...+..||.+|+|||++... -+.++||||+||++|+.++| .+|
T Consensus 635 QNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~Hp 714 (903)
T KOG1027|consen 635 QNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHP 714 (903)
T ss_pred ceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccC
Confidence 99999854 234578999999999876543 34567899999999999754 56689999999999999997 999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
|...... -.+|+.+.+....-. +....++.+||.+||.++|..||+|.++|+||+|+..
T Consensus 715 FGd~~~R--~~NIl~~~~~L~~L~-~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ 773 (903)
T KOG1027|consen 715 FGDSLER--QANILTGNYTLVHLE-PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS 773 (903)
T ss_pred CCchHHh--hhhhhcCccceeeec-cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence 9654332 335666655433221 1122389999999999999999999999999999865
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=293.36 Aligned_cols=255 Identities=27% Similarity=0.478 Sum_probs=209.8
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
...+|.-+..+|.|.- .|+.|.+.- .++.||+|.+... ........+.
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v---~~~~v~ikk~~~p----------------------------f~n~~~akra 62 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQV---LGRPVAIKKLSRP----------------------------FQNQTHAKRA 62 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhh---ccCceehhhhcCc----------------------------cccCccchhh
Confidence 4467888899999998 787887765 7999999987542 0112334567
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
.+|..++..+. |+||++++.+|.-. .+.|+|||||.. +|...+. -.++...+..++.|++.|++|||+.
T Consensus 63 ~rel~l~~~v~-~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~ 137 (369)
T KOG0665|consen 63 YRELKLMKCVN-HKNIISLLNVFTPQKTLEEFQEVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSA 137 (369)
T ss_pred hhhhhhhhhhc-ccceeeeeeccCccccHHHHHhHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhc
Confidence 89999999996 99999999998543 468999999965 7888776 3578899999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~ 351 (482)
||+||||||+||++ ..+..+||.|||+|+.....-.++.++.|..|.|||++-+ .|...+||||+||++.||++|.
T Consensus 138 ~IihRdLkPsnivv---~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~ 214 (369)
T KOG0665|consen 138 GIIHRDLKPSNIVV---NSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGT 214 (369)
T ss_pred ceeecccCccccee---cchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhce
Confidence 99999999999999 5677899999999998776667788999999999998754 5999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCC-------------------------------CCCCCCC-------CCHHHHHHHHHhc
Q 011582 352 RPFWARTESGIFRAVLKADPSF-------------------------------DEAPWPS-------LSPEAIDFVKRLL 393 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~-------------------------------~~~~~~~-------~s~~~~~li~~~L 393 (482)
..|.+.+.-+.+.++....... +...|+. =+..+++++.+||
T Consensus 215 Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~ML 294 (369)
T KOG0665|consen 215 VLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKML 294 (369)
T ss_pred EEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhh
Confidence 9999888766666655432221 1112221 1356889999999
Q ss_pred hhccccCCCHHHHhcCcccc
Q 011582 394 NKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 394 ~~dP~~R~s~~e~L~hp~~~ 413 (482)
..||++|.+++++|.||||+
T Consensus 295 vi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 295 VIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred ccChhhcccHHHHhcCCeee
Confidence 99999999999999999997
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=302.79 Aligned_cols=243 Identities=24% Similarity=0.407 Sum_probs=206.6
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+.....+||-|-||.||.++.++ -.-.||||.++. +....++|+.|
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKk---yslTvAVKtLKE-------------------------------DtMeveEFLkE 313 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKE-------------------------------DTMEVEEFLKE 313 (1157)
T ss_pred heeeeeccCCCcccceeeeeeec---cceeeehhhhhh-------------------------------cchhHHHHHHH
Confidence 34455679999999999999998 456799999853 23457899999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
+.+|+.+. |||+|+|+++|..+..+|||+|||..|+|+++|.+.+ ..++.-....++.||..|++||..+++|||||-
T Consensus 314 AAvMKeik-HpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLA 392 (1157)
T KOG4278|consen 314 AAVMKEIK-HPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLA 392 (1157)
T ss_pred HHHHHhhc-CccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhh
Confidence 99999997 9999999999999999999999999999999997654 346666777888999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCccccccc---CccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVG---SAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~g---t~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
..|+|+ +++..+|++|||+++++..+.. +...| ...|.|||-+. ..++.|+|||+|||+|||+.| |..||.
T Consensus 393 ARNCLV---gEnhiVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYP 468 (1157)
T KOG4278|consen 393 ARNCLV---GENHIVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYP 468 (1157)
T ss_pred hhhccc---cccceEEeeccchhhhhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCC
Confidence 999999 6888999999999999875432 33333 45799999775 679999999999999999987 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHH
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA 406 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 406 (482)
+-+...++..+ +..+....+ .++++.+.+|++.|++++|..||+.+|+
T Consensus 469 GidlSqVY~LL-EkgyRM~~P--eGCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 469 GIDLSQVYGLL-EKGYRMDGP--EGCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CccHHHHHHHH-hccccccCC--CCCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 98887776544 444444433 5799999999999999999999999987
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=289.94 Aligned_cols=252 Identities=29% Similarity=0.487 Sum_probs=204.8
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.||-|+||.||.+.+-+ +|+.||+|.+... +..-...+.+.+|+++|
T Consensus 58 DRPIGYGAFGVVWsVTDPR---dgrrvalkK~pnv----------------------------fq~L~s~krvFre~kmL 106 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPR---SGKRVALKKMPNV----------------------------FQNLASCKRVFREIKML 106 (449)
T ss_pred CCcccccceeEEEeccCCC---CccchhHhhcchH----------------------------HHHHHHHHHHHHHHHHH
Confidence 3569999999999999987 8999999987542 22334567889999999
Q ss_pred HhhcCCCCcceeeEEEEeC-----CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 206 RALTGHKNLVQFYDAYEDD-----DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
..++ |.|++..+++.+-. .++|+|+|++.. +|...|... ..++...++-++.||++||+|||+.||.|||||
T Consensus 107 cfFk-HdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSP-Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIK 183 (449)
T KOG0664|consen 107 SSFR-HDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSP-QALTPDHVKVFVYQILRGLKYLHTANILHRDIK 183 (449)
T ss_pred Hhhc-cccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccC-CCCCcchhhhhHHHHHhhhHHHhhcchhhccCC
Confidence 9998 99999999987654 357899999954 777766554 689999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|.|+|+ +.+..+||||||+|+..+.++ .++..+.|..|+|||++.+ .|+.++||||+|||+.||+..+..|..
T Consensus 184 PGNLLV---NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQA 260 (449)
T KOG0664|consen 184 PGNLLV---NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQA 260 (449)
T ss_pred CccEEe---ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhc
Confidence 999999 567889999999999876544 3455678999999999986 599999999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCC-----------------------CCC-CCC------CCCHHHHHHHHHhchhccccCCCHHHH
Q 011582 357 RTESGIFRAVLKADPSF-----------------------DEA-PWP------SLSPEAIDFVKRLLNKDYRKRLTAAQA 406 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~-----------------------~~~-~~~------~~s~~~~~li~~~L~~dP~~R~s~~e~ 406 (482)
.+.-+.++.|....... +.. ..- .-.-+..+++.+||.+||++|++.+++
T Consensus 261 q~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A 340 (449)
T KOG0664|consen 261 AGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEA 340 (449)
T ss_pred cChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhh
Confidence 77766555544321111 100 000 123567899999999999999999999
Q ss_pred hcCccccc
Q 011582 407 LSHPWLAN 414 (482)
Q Consensus 407 L~hp~~~~ 414 (482)
+.|+++.+
T Consensus 341 ~~~~~~~e 348 (449)
T KOG0664|consen 341 LQHRYLEE 348 (449)
T ss_pred cccccccc
Confidence 99999864
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=264.38 Aligned_cols=214 Identities=26% Similarity=0.411 Sum_probs=180.5
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++..-+..||+|+||.|-+.++.. +|+..|+|.+... .......++.+
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~---sg~imAvKri~~t-----------------------------vn~q~q~r~L~ 93 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQ---SGTIMAVKRIRAT-----------------------------VNSQEQKRLLM 93 (282)
T ss_pred hhhhhhhhhcCCccchhhheeecc---CCeEEEEeeehhh-----------------------------cChHHHHHHHH
Confidence 345566789999999998888877 8999999999654 33455678899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCcc
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI---LSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVH 276 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l---~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivH 276 (482)
|+.+..+..++|.+|++||.+..++..+|.||.|+. ||..+. .++++.++|..+-+|+..++.||.|||++ .+||
T Consensus 94 dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIH 172 (282)
T KOG0984|consen 94 DLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIH 172 (282)
T ss_pred hhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhh
Confidence 999988888899999999999999999999999954 654433 35678899999999999999999999986 8999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-----cCCCcchhhhhHHHHHHHhhCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-----SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~DiwSlGvil~elltg~ 351 (482)
||+||+|||+ +.++.+|+||||++..+.+.-..+...|...|||||.+.. .|+.++||||||++++||.+++
T Consensus 173 RDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr 249 (282)
T KOG0984|consen 173 RDVKPSNILI---NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILR 249 (282)
T ss_pred ccCCcceEEE---ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcc
Confidence 9999999999 6788999999999988776555455678899999998852 5899999999999999999999
Q ss_pred CCCCCC-ChHHHHHHHHhcC
Q 011582 352 RPFWAR-TESGIFRAVLKAD 370 (482)
Q Consensus 352 ~pf~~~-~~~~~~~~i~~~~ 370 (482)
.||... +.-+.++++.+..
T Consensus 250 ~PY~~w~tpF~qLkqvVeep 269 (282)
T KOG0984|consen 250 FPYESWGTPFQQLKQVVEEP 269 (282)
T ss_pred ccccccCCHHHHHHHHhcCC
Confidence 999765 4456666666543
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=332.29 Aligned_cols=241 Identities=21% Similarity=0.279 Sum_probs=183.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
...|...+.||+|+||.||+|+.+. +|..||||.+.... ....
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~---~~~~vavK~~~~~~----------------------------------~~~~ 731 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIK---NGMQFVVKEINDVN----------------------------------SIPS 731 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECC---CCcEEEEEEccCCc----------------------------------cccH
Confidence 3457777899999999999999876 78999999885420 0113
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---HCCCcc
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCH---FQGVVH 276 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH---~~~ivH 276 (482)
+|+.++++++ |||||++++++.+.+..|+||||+++|+|.+++. .+++..+..++.|++.||.||| +.+|+|
T Consensus 732 ~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 806 (968)
T PLN00113 732 SEIADMGKLQ-HPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806 (968)
T ss_pred HHHHHHhhCC-CCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence 4688899996 9999999999999999999999999999999884 4899999999999999999999 669999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||||+||++ +.+...++. ||....... .....||+.|||||++.+ .|+.++|||||||++|||+||+.||.
T Consensus 807 ~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 807 GNLSPEKIII---DGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred CCCCHHhEEE---CCCCceEEE-ecccccccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 9999999999 455556664 665543321 123478999999998864 69999999999999999999999985
Q ss_pred CCCh--HHHHH--HHHhcCCC---CCCCC----CC---CCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 356 ARTE--SGIFR--AVLKADPS---FDEAP----WP---SLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 356 ~~~~--~~~~~--~i~~~~~~---~~~~~----~~---~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.... ..+.. ........ ...+. .. ....++.+++.+|++.||++|||+.|+++.
T Consensus 880 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 880 AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 4221 11111 10000000 00000 00 112356789999999999999999999764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=306.58 Aligned_cols=252 Identities=24% Similarity=0.409 Sum_probs=207.4
Q ss_pred ceEecceeecCCceEEEEEEEecCCCC----CceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLK----GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~----g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
+..+.+.||+|.||.|++|..+..... ...||||.++.. ......+.
T Consensus 297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~-----------------------------~~~~~~~~ 347 (609)
T KOG0200|consen 297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKEN-----------------------------ASSSEKKD 347 (609)
T ss_pred hccccceeecccccceEeEEEeecccccccceEEEEEEecccc-----------------------------cCcHHHHH
Confidence 345667899999999999987643322 457999998653 23356788
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMVQI 262 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi 262 (482)
+..|+++|+.+..|+||+.+++++...+.+++|+|||..|+|.+++...+ ..++..+...++.||
T Consensus 348 ~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QI 427 (609)
T KOG0200|consen 348 LMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQI 427 (609)
T ss_pred HHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHH
Confidence 99999999999889999999999999999999999999999999998765 248999999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCccc--cccc--CccccCcccccc-cCCCcchh
Q 011582 263 LSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN--DIVG--SAYYVAPEVLHR-SYGTEADM 337 (482)
Q Consensus 263 ~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~--~~~g--t~~y~aPE~~~~-~~~~~~Di 337 (482)
+.|++||++.++|||||-..|||+ ..+..+||+|||+|+......... ...| -..|||||.+.. .|+.++||
T Consensus 428 a~GMe~L~~~~~vHRDLAaRNVLi---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDV 504 (609)
T KOG0200|consen 428 ANGMEYLASVPCVHRDLAARNVLI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDV 504 (609)
T ss_pred HHHHHHHhhCCccchhhhhhhEEe---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchh
Confidence 999999999999999999999999 567889999999999655443322 2222 235999999875 69999999
Q ss_pred hhhHHHHHHHhh-CCCCCCCCC-hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 338 WSIGVIAYILLC-GSRPFWART-ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 338 wSlGvil~ellt-g~~pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||+||+|||+++ |..||.+-. ..++++.+..+. ....+ ...++++.++++.|+..+|++||+..++.+
T Consensus 505 WSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~-r~~~P--~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 505 WSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGN-RMEQP--EHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred hHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCC-CCCCC--CCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 999999999998 889998855 566666444443 33333 246999999999999999999999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=303.79 Aligned_cols=258 Identities=29% Similarity=0.485 Sum_probs=214.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++...+|.|+||.||+|+++. +|+..|||+++-. ......-+.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~---s~elaavkvVkLe------------------------------p~dd~~~iq 60 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKR---SGELAAVKVVKLE------------------------------PGDDFSGIQ 60 (829)
T ss_pred ccchhheeeecCCcccchhhhcccc---cCchhhheeeecc------------------------------CCccccccc
Confidence 4689999999999999999999998 8999999998642 223345677
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+||-+++.++ |||||.+++.|...+.++++||||.||+|.+.. .--+.+++.++...++..+.||+|||+.|=+||||
T Consensus 61 qei~~~~dc~-h~nivay~gsylr~dklwicMEycgggslQdiy-~~TgplselqiayvcRetl~gl~ylhs~gk~hRdi 138 (829)
T KOG0576|consen 61 QEIGMLRDCR-HPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIY-HVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDI 138 (829)
T ss_pred cceeeeecCC-CcChHHHHhhhhhhcCcEEEEEecCCCccccee-eecccchhHHHHHHHhhhhccchhhhcCCcccccc
Confidence 8999999997 999999999999999999999999999998854 44578999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccc----cccCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVL----HRSYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~----~~~~~~~~DiwSlGvil~elltg~~pf 354 (482)
|-.|||+ .+.+.+|++|||.+..+... .+...+.||+.|||||+. .+.|...+|||++|+...|+---++|.
T Consensus 139 KGanill---td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl 215 (829)
T KOG0576|consen 139 KGANILL---TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL 215 (829)
T ss_pred cccceee---cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence 9999999 56778999999988765432 345678999999999975 357999999999999999998888885
Q ss_pred CCCChHHHHHHHHhcCCCCCCC-CCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 355 WARTESGIFRAVLKADPSFDEA-PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
............-+..+..+.. .-...++.+-+|++.+|.++|++||+++-+|.|||+...
T Consensus 216 fdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 216 FDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred cccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 5444433333333333322221 112468899999999999999999999999999999764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=282.80 Aligned_cols=261 Identities=25% Similarity=0.447 Sum_probs=203.9
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+...|.++++||.|+|+.||+|.+......++.||+|.|... ..-.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--------------------------------s~p~ 79 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--------------------------------SSPS 79 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--------------------------------cCch
Confidence 44567899999999999999999998764335788999998543 1235
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+++|..+.++.||+.+.+++..++...+||||++..+-.+++ ..++..++..+++.++.||.++|.+||||
T Consensus 80 ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~----~~l~~~~i~~Yl~~ll~Al~~~h~~GIvH 155 (418)
T KOG1167|consen 80 RILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLY----RSLSLAEIRWYLRNLLKALAHLHKNGIVH 155 (418)
T ss_pred HHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHH----hcCCHHHHHHHHHHHHHHhhhhhccCccc
Confidence 68999999999999999999999999999999999999988776655 35789999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccC-----------------C--CC--------------------------c
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVK-----------------P--DE--------------------------R 311 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~-----------------~--~~--------------------------~ 311 (482)
|||||+|+|++. ..+.-.|+|||+|.... . +. .
T Consensus 156 RDiKpsNFL~n~--~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~ 233 (418)
T KOG1167|consen 156 RDIKPSNFLYNR--RTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSE 233 (418)
T ss_pred cCCCcccccccc--ccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccce
Confidence 999999999974 45567899999987210 0 00 0
Q ss_pred ccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCCChH-HHHHHHHh--------------cC----
Q 011582 312 LNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWARTES-GIFRAVLK--------------AD---- 370 (482)
Q Consensus 312 ~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~-~~~~~i~~--------------~~---- 370 (482)
.....||++|+|||++.+ .-++++||||.|||+..++++..||....++ +.+..|.. +.
T Consensus 234 ~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~ 313 (418)
T KOG1167|consen 234 RANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLW 313 (418)
T ss_pred ecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeee
Confidence 012469999999999864 5788999999999999999999998543221 11111100 00
Q ss_pred ---------------CC-------------CCCCCCC-CCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 371 ---------------PS-------------FDEAPWP-SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 371 ---------------~~-------------~~~~~~~-~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.. .....|. .++..+.+|+.+||+.||.+|+|++++|.||||...
T Consensus 314 ~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 314 QKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred ccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 00 0001122 235588999999999999999999999999999854
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=288.82 Aligned_cols=206 Identities=31% Similarity=0.553 Sum_probs=176.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|..++.+|.|+||.|++|+++. +...|+||.|.|.....+ .+.....+-.+-.
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~---n~~eVViK~I~KeRIL~D----------------------tWvrDrkLGtVp~ 615 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKE---NNYEVVIKMIFKERILVD----------------------TWVRDRKLGTVPS 615 (772)
T ss_pred ccceeeeeccccccceEEEeeecc---cceEEEeeehhhhhhhhh----------------------hhhcccccCccch
Confidence 569999999999999999999998 688999999988632111 1111122234567
Q ss_pred HHHHHHhhc--CCCCcceeeEEEEeCCeEEEEEecC-CCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 201 EVKILRALT--GHKNLVQFYDAYEDDDNIYIVMELC-KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 201 Ei~~l~~l~--~hpniv~l~~~~~~~~~~~lv~e~~-~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
||.||..|. .|+||++++++|++++++||+||-. +|.+|+++|.. ...++|.++..|++||+.|+++||+.|||||
T Consensus 616 EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhr 694 (772)
T KOG1152|consen 616 EIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHR 694 (772)
T ss_pred hHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceec
Confidence 999999984 3899999999999999999999976 56699998854 4789999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccccc--CCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||-+|+.+ +.+|-+||+|||.|..... .....++||..|.|||++.+. .+..-|||++|++||-++...-||+
T Consensus 695 dikdenviv---d~~g~~klidfgsaa~~ks-gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 695 DIKDENVIV---DSNGFVKLIDFGSAAYTKS-GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccccccEEE---ecCCeEEEeeccchhhhcC-CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999 7889999999999987664 456788999999999999864 5778999999999999999999986
Q ss_pred C
Q 011582 356 A 356 (482)
Q Consensus 356 ~ 356 (482)
.
T Consensus 771 n 771 (772)
T KOG1152|consen 771 N 771 (772)
T ss_pred C
Confidence 4
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.01 Aligned_cols=249 Identities=23% Similarity=0.311 Sum_probs=209.9
Q ss_pred eEecceeecCCceEEEEEEEecC-CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKG-SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~-~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.+..++||+|+||+||+|...-. +.-..+||+|++... .......++.+|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~-----------------------------t~~~~s~e~Lde 748 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF-----------------------------TSPKASIELLDE 748 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeecc-----------------------------CCchhhHHHHHH
Confidence 44567899999999999987652 112457999998643 455567889999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+-+|.+|. |||+++|++++.... +.||++|+++|.|++++...+..+-......|..||++||.|||.+.+|||||-.
T Consensus 749 Al~masld-Hpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaa 826 (1177)
T KOG1025|consen 749 ALRMASLD-HPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAA 826 (1177)
T ss_pred HHHHhcCC-CchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhh
Confidence 99999996 999999999998776 8899999999999999998888999999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCcc-ccc--ccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDERL-NDI--VGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~~-~~~--~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
.|||+ .....+||.|||+++....+... ... .--+.|||-|.++ +.|+.++|||||||++||++| |..|+.+
T Consensus 827 RNVLV---ksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~g 903 (1177)
T KOG1025|consen 827 RNVLV---KSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDG 903 (1177)
T ss_pred hheee---cCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCC
Confidence 99999 56678999999999987665432 221 2245699999876 579999999999999999987 9999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
...+++-..+..+.. ...+ +..+-++..++.+|+..|+..||+++++-.
T Consensus 904 i~~~eI~dlle~geR-LsqP--piCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 904 IPAEEIPDLLEKGER-LSQP--PICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred CCHHHhhHHHhcccc-CCCC--CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 988888776666554 4433 458899999999999999999999998754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=275.94 Aligned_cols=243 Identities=25% Similarity=0.395 Sum_probs=189.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.....+.+.||+|.||.||+|.. .++.||||+++- ...+.+.
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-----~~~~VAVKifp~---------------------------------~~kqs~~ 250 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-----DNRLVAVKIFPE---------------------------------QEKQSFQ 250 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-----cCceeEEEecCH---------------------------------HHHHHHH
Confidence 34567788899999999999987 578999999853 3456777
Q ss_pred HHHHHHHhhc-CCCCcceeeEEEEeCC----eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC--
Q 011582 200 REVKILRALT-GHKNLVQFYDAYEDDD----NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-- 272 (482)
Q Consensus 200 ~Ei~~l~~l~-~hpniv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-- 272 (482)
+|-.|.+... .|+||++++++-+... .++||+||.+.|+|.++|... .++|....+++..+++||.|||+.
T Consensus 251 ~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarGLa~LHee~p 328 (534)
T KOG3653|consen 251 NEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARGLAHLHEELP 328 (534)
T ss_pred hHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHHHHHhcccCC
Confidence 7777766431 4999999999876555 899999999999999999654 799999999999999999999973
Q ss_pred -------CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccccCC-------Ccc
Q 011582 273 -------GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHRSYG-------TEA 335 (482)
Q Consensus 273 -------~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~-------~~~ 335 (482)
.|+|||||..|||+ ..+++..|+|||+|..+..+. .....+||.+|||||++.+... ...
T Consensus 329 ~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~ 405 (534)
T KOG3653|consen 329 RGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRI 405 (534)
T ss_pred cCCCCCCccccccccccceEE---ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHH
Confidence 49999999999999 678899999999999886543 3445789999999999976422 257
Q ss_pred hhhhhHHHHHHHhhCCC------------CCC-----CCChHHHHHHHHhcC--CCCCCCCCCC--CCHHHHHHHHHhch
Q 011582 336 DMWSIGVIAYILLCGSR------------PFW-----ARTESGIFRAVLKAD--PSFDEAPWPS--LSPEAIDFVKRLLN 394 (482)
Q Consensus 336 DiwSlGvil~elltg~~------------pf~-----~~~~~~~~~~i~~~~--~~~~~~~~~~--~s~~~~~li~~~L~ 394 (482)
||||+|.+||||++... ||. ..+.+++...+...+ +.++. .|.. --.-+.+.+..|++
T Consensus 406 DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~-~W~~h~~~~~l~et~EeCWD 484 (534)
T KOG3653|consen 406 DVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPD-AWRKHAGMAVLCETIEECWD 484 (534)
T ss_pred HHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChh-hhhcCccHHHHHHHHHHHcC
Confidence 99999999999998633 332 123344444444433 22222 2322 23557899999999
Q ss_pred hccccCCCHHHH
Q 011582 395 KDYRKRLTAAQA 406 (482)
Q Consensus 395 ~dP~~R~s~~e~ 406 (482)
.|++.|.|+.=+
T Consensus 485 hDaeARLTA~Cv 496 (534)
T KOG3653|consen 485 HDAEARLTAGCV 496 (534)
T ss_pred CchhhhhhhHHH
Confidence 999999998644
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=265.71 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=191.0
Q ss_pred cccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
..+.+..+..+.+.||+|.||.||+|.. .|..||||++... +
T Consensus 205 VQRTiarqI~L~e~IGkGRyGEVwrG~w-----rGe~VAVKiF~sr---------------------------------d 246 (513)
T KOG2052|consen 205 VQRTIARQIVLQEIIGKGRFGEVWRGRW-----RGEDVAVKIFSSR---------------------------------D 246 (513)
T ss_pred hHHhhhheeEEEEEecCccccceeeccc-----cCCceEEEEeccc---------------------------------c
Confidence 3467788899999999999999999876 5899999998542 1
Q ss_pred HHHHHHHHHHHH--hhcCCCCcceeeEEEEeC----CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 011582 195 IEDVRREVKILR--ALTGHKNLVQFYDAYEDD----DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 195 ~~~~~~Ei~~l~--~l~~hpniv~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~y 268 (482)
.....+|.+|.+ .|+ |+||+.+++.-..+ ..+|||++|.+.|||+|+|.. ..++-..+.+++..++.||++
T Consensus 247 E~SWfrEtEIYqTvmLR-HENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaH 323 (513)
T KOG2052|consen 247 ERSWFRETEIYQTVMLR-HENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAH 323 (513)
T ss_pred hhhhhhHHHHHHHHHhc-cchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHH
Confidence 234566766665 466 99999999865433 368999999999999999965 589999999999999999999
Q ss_pred HHHC--------CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC-----cccccccCccccCcccccccCC---
Q 011582 269 CHFQ--------GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLHRSYG--- 332 (482)
Q Consensus 269 LH~~--------~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~--- 332 (482)
||-. .|.|||||..|||+ ..++.+-|+|+|||....... ..+..+||.+|||||++.....
T Consensus 324 LH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~ 400 (513)
T KOG2052|consen 324 LHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKH 400 (513)
T ss_pred HHHHHhcCCCCchhhccccccccEEE---ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhh
Confidence 9963 39999999999999 678999999999998765432 3456799999999999965322
Q ss_pred ----CcchhhhhHHHHHHHhhC----------CCCCCCC-----ChHHHHHHHHhcCCCCCC-CCCCCCC--HHHHHHHH
Q 011582 333 ----TEADMWSIGVIAYILLCG----------SRPFWAR-----TESGIFRAVLKADPSFDE-APWPSLS--PEAIDFVK 390 (482)
Q Consensus 333 ----~~~DiwSlGvil~elltg----------~~pf~~~-----~~~~~~~~i~~~~~~~~~-~~~~~~s--~~~~~li~ 390 (482)
..+||||||.++||+... .+||++- +.+++.+-+......... ..|...+ ..+..+++
T Consensus 401 Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMk 480 (513)
T KOG2052|consen 401 FESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMK 480 (513)
T ss_pred hhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHH
Confidence 347999999999999753 5788553 334444444443333222 2344322 33457899
Q ss_pred HhchhccccCCCHHHH
Q 011582 391 RLLNKDYRKRLTAAQA 406 (482)
Q Consensus 391 ~~L~~dP~~R~s~~e~ 406 (482)
.|+..||.-|.|+--+
T Consensus 481 eCW~~Np~aRltALri 496 (513)
T KOG2052|consen 481 ECWYANPAARLTALRI 496 (513)
T ss_pred HhhcCCchhhhHHHHH
Confidence 9999999999998654
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=256.44 Aligned_cols=258 Identities=24% Similarity=0.423 Sum_probs=205.0
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.+.|.|.+.||+|.||.+.+|+++. +.+.+++|.+++. .....+
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~---s~t~ivlKavp~p-------------------------------~tt~~d 66 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQ---SKTRIVLKAVPRP-------------------------------QTTQAD 66 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccC---CceEEEeeccCcc-------------------------------hhhHHH
Confidence 466889999999999999999999987 7899999998653 234577
Q ss_pred HHHHHHHHHhhcCCCCcceeeEE-EEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 198 VRREVKILRALTGHKNLVQFYDA-YEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~-~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
|.+|...--.|..|.||+.-|++ |+..+.+.++|||++-|+|..-+.. ..+-|...+.++.|+++||.|+|++++||
T Consensus 67 F~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVH 144 (378)
T KOG1345|consen 67 FVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVH 144 (378)
T ss_pred HHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhh
Confidence 88998877677779999988775 7888899999999999999887643 46889999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc----cc--CCCcchhhhhHHHHHHHhhC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH----RS--YGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~--~~~~~DiwSlGvil~elltg 350 (482)
||||.+|||+-..| ..++||||||+.+..+. .....--+..|.+||... +. ..+..|+|.||+++|.+|||
T Consensus 145 RdlK~eNiLif~~d-f~rvKlcDFG~t~k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG 221 (378)
T KOG1345|consen 145 RDLKAENILIFDAD-FYRVKLCDFGLTRKVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTG 221 (378)
T ss_pred cccccceEEEecCC-ccEEEeeecccccccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecC
Confidence 99999999997643 45999999999876532 222333456799999653 22 46789999999999999999
Q ss_pred CCCCCCCChH----HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccC---CCHHHHhcCccccc
Q 011582 351 SRPFWARTES----GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKR---LTAAQALSHPWLAN 414 (482)
Q Consensus 351 ~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---~s~~e~L~hp~~~~ 414 (482)
++||...... -.+.+.....-.-....+..+|+.+..+.++-|..++++| .+++.....-|...
T Consensus 222 ~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 222 KFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred CCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 9999643221 1223333333222233455689999999999999999999 77777777888764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.8e-31 Score=243.20 Aligned_cols=211 Identities=43% Similarity=0.773 Sum_probs=183.5
Q ss_pred eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhh
Q 011582 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL 208 (482)
Q Consensus 129 LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l 208 (482)
||+|++|.||++.... +|+.+++|++.... .....+.+.+|+.+++.+
T Consensus 1 l~~g~~~~v~~~~~~~---~~~~~~~K~~~~~~-----------------------------~~~~~~~~~~e~~~~~~l 48 (215)
T cd00180 1 LGEGGFGTVYLARDKK---TGKKVAIKIIKKED-----------------------------SSSLLEELLREIEILKKL 48 (215)
T ss_pred CCcCCceEEEEEEecC---CCcEEEEEEecccc-----------------------------chhHHHHHHHHHHHHHhc
Confidence 6899999999999865 68999999986531 111346789999999999
Q ss_pred cCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEec
Q 011582 209 TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTS 288 (482)
Q Consensus 209 ~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~ 288 (482)
. |++|+++++++......+++|||+.|++|.+++......+++..+..++.+++.+|.+||+.|++|+||+|.||++.
T Consensus 49 ~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~- 126 (215)
T cd00180 49 N-HPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD- 126 (215)
T ss_pred C-CCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEe-
Confidence 7 99999999999999999999999999999998865545789999999999999999999999999999999999994
Q ss_pred CCC-CCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 289 KEE-NSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 289 ~~~-~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
. ++.++|+|||.+....... ......++..|++||.+.. .++.+.|+|++|+++++|
T Consensus 127 --~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------- 187 (215)
T cd00180 127 --SDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------- 187 (215)
T ss_pred --CCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------
Confidence 4 6789999999998765432 1334567889999998865 688899999999999999
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCc
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 410 (482)
..+.+++.+|+..||.+||++.++++|+
T Consensus 188 ------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 ------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred ------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6789999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=302.82 Aligned_cols=203 Identities=19% Similarity=0.271 Sum_probs=153.0
Q ss_pred HhhcCC-CCcceeeEEE-------EeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 206 RALTGH-KNLVQFYDAY-------EDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 206 ~~l~~h-pniv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+. | .||++++++| .....++++|||+ +++|.++|......+++.+++.++.||++||.|||++|||||
T Consensus 27 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr 104 (793)
T PLN00181 27 KSLS-HIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH 104 (793)
T ss_pred chhh-HHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 3554 6 6888888887 3335678889988 569999987655679999999999999999999999999999
Q ss_pred CCCCCceEEec----------------CCCCCcEEEEecccccccCCCC-----------------cccccccCccccCc
Q 011582 278 DLKPENFLFTS----------------KEENSSLKAIDFGLSDYVKPDE-----------------RLNDIVGSAYYVAP 324 (482)
Q Consensus 278 Dlkp~NIll~~----------------~~~~~~~kl~DfGla~~~~~~~-----------------~~~~~~gt~~y~aP 324 (482)
||||+||||+. .+.++.+||+|||+++...... .....+||++||||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 99999999952 1235567888888876432100 01124689999999
Q ss_pred ccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH
Q 011582 325 EVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA 403 (482)
Q Consensus 325 E~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~ 403 (482)
|++.+ .|+.++|||||||+||||++|..|+.... ..+..+.... .+.. +..-.++..+++.+||..||.+||++
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQ-ILLNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChh-hhhcCHHHHHHHHHhCCCChhhCcCh
Confidence 98764 69999999999999999999998875422 2222222211 1111 11124567899999999999999999
Q ss_pred HHHhcCcccccC
Q 011582 404 AQALSHPWLANS 415 (482)
Q Consensus 404 ~e~L~hp~~~~~ 415 (482)
.|+|+||||.+.
T Consensus 260 ~eil~h~~~~~~ 271 (793)
T PLN00181 260 SELLQSEFINEP 271 (793)
T ss_pred HHHhhchhhhhh
Confidence 999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=242.87 Aligned_cols=212 Identities=42% Similarity=0.751 Sum_probs=178.8
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|.+.+.||.|++|.||+|.... +++.+|+|.+.... .....+.+.+|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~---~~~~~~iK~~~~~~-----------------------------~~~~~~~~~~e~ 48 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKG---TGELVAVKVLKKEK-----------------------------TEKQREEFLREI 48 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcC---CCcEEEEEeecccc-----------------------------chHHHHHHHHHH
Confidence 5678899999999999999876 68899999986530 012456888999
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~ 282 (482)
..++.+. |+|++++++++......++++||+++++|.+++......+++..+..++.+++.+|.|||+.+++|+||+|.
T Consensus 49 ~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ 127 (225)
T smart00221 49 RILKKLK-HPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPE 127 (225)
T ss_pred HHHHhCC-CCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9999996 999999999999999999999999999999988655323899999999999999999999999999999999
Q ss_pred ceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccc-c-ccCCCcchhhhhHHHHHHHhhCCCCCCC--
Q 011582 283 NFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVL-H-RSYGTEADMWSIGVIAYILLCGSRPFWA-- 356 (482)
Q Consensus 283 NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~-~-~~~~~~~DiwSlGvil~elltg~~pf~~-- 356 (482)
||++ +.++.++|+|||++....... ......++..|++||.+ . ..++.++|+|+||+++++|++|+.||..
T Consensus 128 ni~v---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~ 204 (225)
T smart00221 128 NILL---GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEG 204 (225)
T ss_pred HEEE---cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccc
Confidence 9999 556889999999998765442 33456788999999987 3 3577899999999999999999999977
Q ss_pred CChHHHHHHHHhcC
Q 011582 357 RTESGIFRAVLKAD 370 (482)
Q Consensus 357 ~~~~~~~~~i~~~~ 370 (482)
.....+.+.+..+.
T Consensus 205 ~~~~~~~~~~~~~~ 218 (225)
T smart00221 205 EFTSLLSDVWSFGV 218 (225)
T ss_pred hhHHHHHHHHhcCC
Confidence 44446666666554
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=223.11 Aligned_cols=163 Identities=28% Similarity=0.358 Sum_probs=130.5
Q ss_pred CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccc
Q 011582 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIV 316 (482)
Q Consensus 237 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~ 316 (482)
|+|.+++..++..+++.+++.++.||+.||.|||+++ ||+|||+ +.++.+|+ ||++....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 6899988776677999999999999999999999999 9999999 56778888 99998764322 36
Q ss_pred cCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh-HHHHHHHHhcCCCCCC---CCCCCCCH--HHHHHH
Q 011582 317 GSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDE---APWPSLSP--EAIDFV 389 (482)
Q Consensus 317 gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~---~~~~~~s~--~~~~li 389 (482)
||+.|||||++.+ .|+.++|||||||++|||++|+.||..... ...+..+......... .....++. ++.++|
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 8999999998864 689999999999999999999999976543 2334444333222111 11122344 699999
Q ss_pred HHhchhccccCCCHHHHhcCccccc
Q 011582 390 KRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 390 ~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
.+||..||.+||++.+++.|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=235.29 Aligned_cols=255 Identities=24% Similarity=0.303 Sum_probs=193.5
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.+.+.||+|+||.||+|.+.... ...+|+|+..... ... ...+..|
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~--~~~~a~K~e~~~~-----------------------------~~~-~~~l~~E 66 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK--NKEYAKKLEKKEL-----------------------------GSK-PSVLKIE 66 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC--CeeEEEEEEEecc-----------------------------cCC-CccchhH
Confidence 8999999999999999999987621 4679999876520 000 1146788
Q ss_pred HHHHHhhcC---CCCcceeeEEE-EeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 202 VKILRALTG---HKNLVQFYDAY-EDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 202 i~~l~~l~~---hpniv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+.++..+.. .+++..+++.+ ..+...||||+.+ |.+|.+...... +.|+...+..++.|++.+|++||+.|++|
T Consensus 67 ~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iH 145 (322)
T KOG1164|consen 67 IQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIH 145 (322)
T ss_pred HHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCccc
Confidence 899988862 36999999999 5888999999999 889999765444 78999999999999999999999999999
Q ss_pred cCCCCCceEEecCC--CCCcEEEEecccccccC---CCC-------c-ccccccCccccCcccccc-cCCCcchhhhhHH
Q 011582 277 RDLKPENFLFTSKE--ENSSLKAIDFGLSDYVK---PDE-------R-LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGV 342 (482)
Q Consensus 277 rDlkp~NIll~~~~--~~~~~kl~DfGla~~~~---~~~-------~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGv 342 (482)
|||||+|++++... ....+.|.|||+++.+. ... . .....||..|+++.+..+ ..+.+.|+||++.
T Consensus 146 RDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y 225 (322)
T KOG1164|consen 146 RDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFY 225 (322)
T ss_pred CCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHH
Confidence 99999999997543 22579999999998322 111 1 123559999999998765 5899999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCC-CCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 343 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEA-PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 343 il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
++.+++.|..||.+.........+.......... .....+.++.++...+-..+...+|....+...
T Consensus 226 ~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 226 MLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred HHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 9999999999997655433333332222211111 222345677777777777888888888776554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-26 Score=226.38 Aligned_cols=257 Identities=36% Similarity=0.628 Sum_probs=207.2
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|.+.+.||.|+||.||++.+. ..+|+|.+.+.. .........+.+|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~------~~~~~k~~~~~~---------------------------~~~~~~~~~~~~e~ 48 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR------KLVALKVLAKKL---------------------------ESKSKEVERFLREI 48 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec------cEEEEEeechhh---------------------------ccchhHHHHHHHHH
Confidence 788899999999999999875 579999987641 11113467889999
Q ss_pred HHHHhhcCCC-CcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 203 KILRALTGHK-NLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG--GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 203 ~~l~~l~~hp-niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
.++..+. |+ +|+++++++......+++++++.++++.+.+.... ..+.+..+..++.|++.++.|+|+.|++|||+
T Consensus 49 ~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~ 127 (384)
T COG0515 49 QILASLN-HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDI 127 (384)
T ss_pred HHHHHcc-CCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 9999997 66 89999999988888999999999999996654432 27999999999999999999999999999999
Q ss_pred CCCceEEecCCCCC-cEEEEecccccccCCCC-------cccccccCccccCcccccc----cCCCcchhhhhHHHHHHH
Q 011582 280 KPENFLFTSKEENS-SLKAIDFGLSDYVKPDE-------RLNDIVGSAYYVAPEVLHR----SYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 280 kp~NIll~~~~~~~-~~kl~DfGla~~~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~el 347 (482)
||+||++ +... .++++|||++....... ......||..|++||.+.+ .++...|+||+|++++++
T Consensus 128 kp~nil~---~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~ 204 (384)
T COG0515 128 KPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL 204 (384)
T ss_pred CHHHeee---cCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHH
Confidence 9999999 4455 69999999998654432 3467789999999998864 578899999999999999
Q ss_pred hhCCCCCCCCCh----HHHHHHHHhcCCC-CCCCCCCCC----CHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 348 LCGSRPFWARTE----SGIFRAVLKADPS-FDEAPWPSL----SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 348 ltg~~pf~~~~~----~~~~~~i~~~~~~-~~~~~~~~~----s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
++|..||..... ......+...... ......... ...+.+++.+++..+|..|.+..+...++|.....
T Consensus 205 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 205 LTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred HhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 999999877763 4555555444433 222211111 25789999999999999999999999997776543
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=228.00 Aligned_cols=256 Identities=16% Similarity=0.225 Sum_probs=203.0
Q ss_pred cccccceEecceeecCCceEEEEEEEecCC--CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGS--LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~--~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
.....++++...+-+|.||.||.|+..... .+.+.|-||.++.. .++..
T Consensus 280 ~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~-----------------------------AS~iQ 330 (563)
T KOG1024|consen 280 TVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH-----------------------------ASQIQ 330 (563)
T ss_pred hhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc-----------------------------ccHHH
Confidence 344567888889999999999999765421 13456777776432 34556
Q ss_pred HHHHHHHHHHHHhhcCCCCcceeeEEEEe-CCeEEEEEecCCCCChHHHHHh-----c--CCCCCHHHHHHHHHHHHHHH
Q 011582 195 IEDVRREVKILRALTGHKNLVQFYDAYED-DDNIYIVMELCKGGELLDRILS-----R--GGKYSEEDAKIVMVQILSVV 266 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~-----~--~~~l~~~~~~~i~~qi~~~L 266 (482)
...+..|.-++..+. |||+..+.+++.+ ....++++.++.-|+|..++.. . ...++-.+...++.|++.|+
T Consensus 331 v~~~L~es~lly~~s-H~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am 409 (563)
T KOG1024|consen 331 VNLLLQESMLLYGAS-HPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAM 409 (563)
T ss_pred HHHHHHHHHHHhcCc-CCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHH
Confidence 678889999999997 9999999998765 4667899999999999988862 1 23467788888999999999
Q ss_pred HHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcc---cccccCccccCccccc-ccCCCcchhhhhHH
Q 011582 267 AFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL---NDIVGSAYYVAPEVLH-RSYGTEADMWSIGV 342 (482)
Q Consensus 267 ~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGv 342 (482)
+|||+.||||.||-..|+++ ++...+||+|-.+++.+-+.... ..---...||+||.+. ..|+.++|+|||||
T Consensus 410 ~hlh~~~ViHkDiAaRNCvI---dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGV 486 (563)
T KOG1024|consen 410 EHLHNHGVIHKDIAARNCVI---DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGV 486 (563)
T ss_pred HHHHhcCcccchhhhhccee---hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHH
Confidence 99999999999999999999 67789999999999876443211 0111235799999886 56999999999999
Q ss_pred HHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 343 IAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 343 il~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+||||+| |+.||..-+..++..-+..+ ++...+ -++++++..++--|+..+|++||+.+|+..
T Consensus 487 llWELmtlg~~PyaeIDPfEm~~ylkdG-yRlaQP--~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 487 LLWELMTLGKLPYAEIDPFEMEHYLKDG-YRLAQP--FNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHHHHHhcCCCCccccCHHHHHHHHhcc-ceecCC--CCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 9999987 89999888888877666554 333222 368999999999999999999999998753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-29 Score=267.56 Aligned_cols=264 Identities=28% Similarity=0.407 Sum_probs=198.2
Q ss_pred ccce-EecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 120 VAHY-ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 120 ~~~y-~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
.+.| ...+.+|.|++|.|+.+.... ....++.|...... . . ..........+
T Consensus 316 ~~~y~~~~~~~g~ga~g~~~~~~~~~---~~~~~~~~~~r~~~------~---~---------------~~s~~~~~~~i 368 (601)
T KOG0590|consen 316 SEKYGKPGRVLGSGAYGSVRIAKRRS---DLKSFPEKEFRVRV------K---P---------------TESERKYNYNI 368 (601)
T ss_pred ccccCCccceeeecccCceEEEEecC---CCccchhhhhhccc------C---C---------------cccHHHHhhhh
Confidence 3445 456679999999777776654 34445555432100 0 0 00111222236
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
..|+.+-..|. |+|++..+..+.+....+-+||||++ +|+.++... +.++..++..+++|++.||.|||+.||.|||
T Consensus 369 ~sE~~i~~~l~-h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrd 445 (601)
T KOG0590|consen 369 TSEFCIGSSLS-HPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHSMGLAHRD 445 (601)
T ss_pred hhheeeccccc-CCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHhcCceecc
Confidence 77888888887 99999888887777777777999999 999987543 6899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCC-----CcccccccCccccCcccccc-cCCCc-chhhhhHHHHHHHhhCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPD-----ERLNDIVGSAYYVAPEVLHR-SYGTE-ADMWSIGVIAYILLCGS 351 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwSlGvil~elltg~ 351 (482)
||++|+++ ..++.+||+|||.+..+... ......+|+..|+|||++.+ .|.+. .||||.|++++.|++|+
T Consensus 446 lK~enll~---~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~ 522 (601)
T KOG0590|consen 446 LKLENLLV---TENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGR 522 (601)
T ss_pred CccccEEE---ecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCC
Confidence 99999999 56779999999998765432 23467899999999999875 57764 89999999999999999
Q ss_pred CCCCCCChHHHH--HHHHhcCC---CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 352 RPFWARTESGIF--RAVLKADP---SFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 352 ~pf~~~~~~~~~--~~i~~~~~---~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.||......+.. ...-.... .-+...|..++.+.+.+|.+||++||.+|.|++++++.+||+...
T Consensus 523 ~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 523 FPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred CccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 999655443221 11111111 111223456889999999999999999999999999999998753
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-29 Score=256.06 Aligned_cols=246 Identities=27% Similarity=0.438 Sum_probs=211.3
Q ss_pred eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
.+|.|+||.|++++...+...|.-+|+|++++....... ......|-.++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~----------------------------~~~t~~er~il~~ 52 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRD----------------------------RTHTKQERIILAF 52 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccc----------------------------ccccccHHHHHhh
Confidence 379999999999988777778999999999875211100 0133457778888
Q ss_pred hcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 011582 208 LTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFT 287 (482)
Q Consensus 208 l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~ 287 (482)
+++||.+|++...++.+...+++++|..||+|..++.+. ..+++...+.+...++.+++.+|+.+|+|||+|++||++
T Consensus 53 ~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~-~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill- 130 (612)
T KOG0603|consen 53 VHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKE-VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL- 130 (612)
T ss_pred ccCCCceeeeeeeeccccchhHhhhhcccchhhhccccC-CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee-
Confidence 878999999999999999999999999999999887544 678999999999999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHH
Q 011582 288 SKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVL 367 (482)
Q Consensus 288 ~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~ 367 (482)
+.+|++++.|||+++..-..... |||..|||||+++ .....+|.||+|+++++|+||..||.. ++...|+
T Consensus 131 --d~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il 200 (612)
T KOG0603|consen 131 --LLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRIL 200 (612)
T ss_pred --cccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHh
Confidence 78999999999999876543332 9999999999998 667889999999999999999999977 7888888
Q ss_pred hcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH-----HHHhcCcccccCCC
Q 011582 368 KADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA-----AQALSHPWLANSHD 417 (482)
Q Consensus 368 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~e~L~hp~~~~~~~ 417 (482)
.....++.. ++.++++++..|+..+|.+|.-. .++++|+||+....
T Consensus 201 ~~~~~~p~~----l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~ 251 (612)
T KOG0603|consen 201 KAELEMPRE----LSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDW 251 (612)
T ss_pred hhccCCchh----hhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeH
Confidence 887777654 78899999999999999999854 79999999987543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=214.14 Aligned_cols=247 Identities=21% Similarity=0.313 Sum_probs=197.8
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
....|+++++||+|+||.+|+|.... +|..||||+-+... ..-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~---~ge~VAiK~Es~~a--------------------------------~hpqL 57 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISIT---SGEEVAIKLESSKA--------------------------------KHPQL 57 (341)
T ss_pred eccceEEEEeecCCchhheeeeeecc---CCceEEEEeecccC--------------------------------CCcch
Confidence 45789999999999999999999887 89999999865431 11246
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
..|..+...|++...|..+..++.+...-.+||+++ |.+|.+.+.--...|+..++.-++-|++.-++|+|.+++||||
T Consensus 58 ~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRD 136 (341)
T KOG1163|consen 58 LYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRD 136 (341)
T ss_pred hHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhcccccc
Confidence 788999999987789999999999999999999999 8899988765567899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC--------cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--------RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt 349 (482)
|||+|+|++-......+.|+|||+|+.+.+.. .-....||.+|.+=.+..+ .-+...|+-|+|.+|.++.-
T Consensus 137 IKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnr 216 (341)
T KOG1163|consen 137 IKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNR 216 (341)
T ss_pred CCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeec
Confidence 99999999876777889999999998765432 1234679999998776554 46778999999999999999
Q ss_pred CCCCCCCCC---hHHHHHHHHhcCCCCCCC-CCCCCCHHHHHHHHHhchhccccCC
Q 011582 350 GSRPFWART---ESGIFRAVLKADPSFDEA-PWPSLSPEAIDFVKRLLNKDYRKRL 401 (482)
Q Consensus 350 g~~pf~~~~---~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~~L~~dP~~R~ 401 (482)
|..||.+-. ..+-+++|.+.+...+.. ...+++.|+.-.+.-|-..--.+-|
T Consensus 217 G~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~P 272 (341)
T KOG1163|consen 217 GSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKP 272 (341)
T ss_pred CCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCC
Confidence 999998754 344556666655443322 3356777777777766544333333
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=231.48 Aligned_cols=168 Identities=18% Similarity=0.220 Sum_probs=129.1
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|.+.+.||+|+||+||+|+++.. +|+.||||++..... ........+.
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~--~~~~vAiK~~~~~~~-------------------------~~~~~~~~~~ 67 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGD--PGTARAVRRRVSEVP-------------------------WWSKPLARHL 67 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCC--CCeEEEEEEeccccc-------------------------ccccHHHHHH
Confidence 3457899999999999999999987642 477789998743100 0012234567
Q ss_pred HHHHHHHHHhhcCCCCcce-eeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 198 VRREVKILRALTGHKNLVQ-FYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~-l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+.+|+.+|+++. |+|++. +++ .+..|||||||+|++|.. + .. .. ...++.|+++||.|||++||+|
T Consensus 68 ~~~E~~iL~~L~-h~~iv~~l~~----~~~~~LVmE~~~G~~L~~-~-~~---~~---~~~~~~~i~~aL~~lH~~gIiH 134 (365)
T PRK09188 68 AAREIRALKTVR-GIGVVPQLLA----TGKDGLVRGWTEGVPLHL-A-RP---HG---DPAWFRSAHRALRDLHRAGITH 134 (365)
T ss_pred HHHHHHHHHhcc-CCCCCcEEEE----cCCcEEEEEccCCCCHHH-h-Cc---cc---hHHHHHHHHHHHHHHHHCCCee
Confidence 899999999997 999985 543 256899999999998863 2 11 11 1468899999999999999999
Q ss_pred cCC-CCCceEEecCCCCCcEEEEecccccccCCCC---------cccccccCccccCccccc
Q 011582 277 RDL-KPENFLFTSKEENSSLKAIDFGLSDYVKPDE---------RLNDIVGSAYYVAPEVLH 328 (482)
Q Consensus 277 rDl-kp~NIll~~~~~~~~~kl~DfGla~~~~~~~---------~~~~~~gt~~y~aPE~~~ 328 (482)
||| ||+|||+ +.++.+||+|||+|+.+.... ......+++.|+|||++.
T Consensus 135 rDL~KP~NILv---~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 135 NDLAKPQNWLM---GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred CCCCCcceEEE---cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 999 9999999 456789999999998765432 124567899999999985
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=215.40 Aligned_cols=211 Identities=22% Similarity=0.420 Sum_probs=176.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.-+|+++++||+|+||..++|+..- +++.||||.-+.. ...-+++
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~---nne~VAIKfEPrk--------------------------------S~APQLr 71 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLY---NNEPVAIKFEPRK--------------------------------SEAPQLR 71 (449)
T ss_pred cccceeccccccCcceeeecccccc---cCceEEEEecccc--------------------------------CCcchHH
Confidence 3579999999999999999998765 8999999986542 1124678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
.|....+.|.+.++|...|-+..++-+-.||||++ |.+|.|.+.-.+.+|+...+..++.|++.-++|+|++.+|+|||
T Consensus 72 dEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDI 150 (449)
T KOG1165|consen 72 DEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDI 150 (449)
T ss_pred HHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeeccc
Confidence 89999999988999999999999999999999999 88999877656778999999999999999999999999999999
Q ss_pred CCCceEEec--CCCCCcEEEEecccccccCCCCc--------ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHh
Q 011582 280 KPENFLFTS--KEENSSLKAIDFGLSDYVKPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 280 kp~NIll~~--~~~~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ell 348 (482)
||+|+||+. ..+...+.|+|||+|+.+.+... .....||-+||+=....+ .-+...|+-|||-+++++|
T Consensus 151 KPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFL 230 (449)
T KOG1165|consen 151 KPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFL 230 (449)
T ss_pred CccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhc
Confidence 999999973 23445799999999998754332 345689999999775544 5788999999999999999
Q ss_pred hCCCCCCCCC---hHHHHHHH
Q 011582 349 CGSRPFWART---ESGIFRAV 366 (482)
Q Consensus 349 tg~~pf~~~~---~~~~~~~i 366 (482)
-|.+||.+-. ..+-+++|
T Consensus 231 RGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 231 RGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred cCCCccccccCcchHHHHHHh
Confidence 9999997643 33444444
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.8e-24 Score=199.49 Aligned_cols=176 Identities=18% Similarity=0.171 Sum_probs=132.9
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH-
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI- 195 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 195 (482)
+.+.++|++.+.||.|+||.||++.. ++..+|||++.... ...+...
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-----~~~~~iiKvf~~~~---------------------------~~~~~~~~ 74 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-----DYGKYILKVFAPKV---------------------------KRTERFLK 74 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-----CCCcEEEEEechhc---------------------------CchHHHHH
Confidence 34678999999999999999999654 35579999986531 0111222
Q ss_pred -----HHHHHHHHHHHhhcCCCCcceeeEEEEeC--------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHH
Q 011582 196 -----EDVRREVKILRALTGHKNLVQFYDAYEDD--------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQI 262 (482)
Q Consensus 196 -----~~~~~Ei~~l~~l~~hpniv~l~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi 262 (482)
..+.+|+..+.++. |++|..+.+++... +..+|||||++|.+|.+.. .+++ ..+.++
T Consensus 75 ~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i 144 (232)
T PRK10359 75 SFVKGDYYENLIVQTDRVR-SEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKI 144 (232)
T ss_pred hhhhhHHHHHHHHHHHHHH-HCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHH
Confidence 23689999999996 99999999987644 3589999999999987752 2333 346699
Q ss_pred HHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHH
Q 011582 263 LSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGV 342 (482)
Q Consensus 263 ~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGv 342 (482)
+.+|..||+.|++|||+||+||+++ .++ ++|+|||............. =++.+.|+.++|+||||+
T Consensus 145 ~~~l~~lH~~gi~H~Dikp~Nili~---~~g-i~liDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~ 210 (232)
T PRK10359 145 KASIESLHQHGMVSGDPHKGNFIVS---KNG-LRIIDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGY 210 (232)
T ss_pred HHHHHHHHHcCCccCCCChHHEEEe---CCC-EEEEECCCcccccchhhHHH----------HHHHhHhcccccccceeE
Confidence 9999999999999999999999994 455 99999998765432211111 022345778999999999
Q ss_pred HHHHHh
Q 011582 343 IAYILL 348 (482)
Q Consensus 343 il~ell 348 (482)
++..+.
T Consensus 211 ~~~~~~ 216 (232)
T PRK10359 211 YLLIYK 216 (232)
T ss_pred eehHHH
Confidence 987664
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-24 Score=229.83 Aligned_cols=222 Identities=29% Similarity=0.475 Sum_probs=174.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
-.+|+.++.|-.|+||.||+++++. +.+.+|+|+-++. .+.
T Consensus 82 e~df~~IklisngAygavylvrh~~---trqrfa~kiNkq~------------------------------------lil 122 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKE---TRQRFAMKINKQN------------------------------------LIL 122 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccc---cccchhhcccccc------------------------------------hhh
Confidence 4678999999999999999999987 7889999643321 011
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+- ++... +.|.+| |+-...+. .-+.++... +.+++|||+-||+|||+
T Consensus 123 Rn--ilt~a-~npfvv---------------------gDc~tllk-~~g~lPvdm--------vla~Eylh~ygivhrdl 169 (1205)
T KOG0606|consen 123 RN--ILTFA-GNPFVV---------------------GDCATLLK-NIGPLPVDM--------VLAVEYLHSYGIVHRDL 169 (1205)
T ss_pred hc--ccccc-CCccee---------------------chhhhhcc-cCCCCcchh--------hHHhHhhccCCeecCCC
Confidence 11 22222 244444 34444332 224454433 78999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC----------------cccccccCccccCccccc-ccCCCcchhhhhHH
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE----------------RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGV 342 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~----------------~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGv 342 (482)
||+|++|+ .-+++|+.|||+....-... .-..+|||+.|.|||++. ..|+..+|+|++|+
T Consensus 170 kpdnllIT---~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGi 246 (1205)
T KOG0606|consen 170 KPDNLLIT---SMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGI 246 (1205)
T ss_pred CCCcceee---ecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHH
Confidence 99999994 56789999999976431110 123579999999999876 46999999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC---CHHHHhcCcccccCCC
Q 011582 343 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL---TAAQALSHPWLANSHD 417 (482)
Q Consensus 343 il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---s~~e~L~hp~~~~~~~ 417 (482)
|+||++.|..||.+++.++++..+......+++..+ .+++|++++|.++|+.+|..|. .+-++.+|+||+....
T Consensus 247 IlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de-a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw 323 (1205)
T KOG0606|consen 247 ILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE-ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDW 323 (1205)
T ss_pred HHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc-CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeeccc
Confidence 999999999999999999999999999998888854 5899999999999999999996 6778889999987544
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.9e-23 Score=189.47 Aligned_cols=189 Identities=19% Similarity=0.220 Sum_probs=141.0
Q ss_pred ecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHH
Q 011582 125 LGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKI 204 (482)
Q Consensus 125 ~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~ 204 (482)
+...||+|+||+|+++.. .+..++.+.+.-.- ..........+.+|+++
T Consensus 6 ~~~~l~~~~f~~v~~~~~-----~~~k~~~~~l~~~~--------------------------~~~~~~~~~l~~rE~~i 54 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-----GERKFVRRDLSAAP--------------------------WWLRGVAWWLARREALA 54 (218)
T ss_pred cceeecCCCcceEEEeec-----CCceeeecccccch--------------------------hhhhhHHHHHHHHHHHH
Confidence 456799999999997764 46778877664320 00111223368899999
Q ss_pred HHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC-CCCc
Q 011582 205 LRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL-KPEN 283 (482)
Q Consensus 205 l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl-kp~N 283 (482)
|++|.+|++|++++++ +..|++|||+.|.+|...+.. . ...++.|++.+|.++|++||+|||| ||+|
T Consensus 55 L~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~N 122 (218)
T PRK12274 55 LRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEAN 122 (218)
T ss_pred HHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcce
Confidence 9999767899999886 457999999999888654311 1 2357889999999999999999999 7999
Q ss_pred eEEecCCCCCcEEEEecccccccCCCCcc----c----------ccccCccccCccccc--ccCC-CcchhhhhHHHHHH
Q 011582 284 FLFTSKEENSSLKAIDFGLSDYVKPDERL----N----------DIVGSAYYVAPEVLH--RSYG-TEADMWSIGVIAYI 346 (482)
Q Consensus 284 Ill~~~~~~~~~kl~DfGla~~~~~~~~~----~----------~~~gt~~y~aPE~~~--~~~~-~~~DiwSlGvil~e 346 (482)
||+ +.++.++|+|||+|......... . -...++.|++|+... ...+ ...+.++.|+-+|.
T Consensus 123 ILv---~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~ 199 (218)
T PRK12274 123 WLV---QEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYR 199 (218)
T ss_pred EEE---cCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHH
Confidence 999 45678999999999865543321 0 122577888888432 2333 56788999999999
Q ss_pred HhhCCCCCCCCCh
Q 011582 347 LLCGSRPFWARTE 359 (482)
Q Consensus 347 lltg~~pf~~~~~ 359 (482)
++|+..+++++++
T Consensus 200 ~~~~~~~~~~~~~ 212 (218)
T PRK12274 200 FVTRRVLHWEDNE 212 (218)
T ss_pred HHhccCCccccCC
Confidence 9999999987765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.2e-23 Score=192.13 Aligned_cols=166 Identities=18% Similarity=0.178 Sum_probs=112.1
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
...||+|+||.||+|.+. +|+.||||+++............... ...+... ...............+|+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vAvKv~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~~~~~E~~~l 73 (190)
T cd05147 2 NGCISTGKEANVYHATTA----NGEERAIKIYKTSILVFKDRDRYVSG-EFRFRHG---YCKSNPRKMVRTWAEKEMRNL 73 (190)
T ss_pred CCccccccceEEEEEECC----CCCEEEEEEEEecccccccHHHhhcC-Cchhhcc---ccCCCHHHHHHHHHHHHHHHH
Confidence 457999999999999884 68999999997641100000000000 0000000 000001111223446799999
Q ss_pred HhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCce
Q 011582 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFC-HFQGVVHRDLKPENF 284 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~ivHrDlkp~NI 284 (482)
.++. ++++.....+... ..+|||||++|+++...+.. ...+++..+..++.|++.+|.|| |+.||+||||||+||
T Consensus 74 ~~l~-~~~v~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NI 149 (190)
T cd05147 74 KRLV-TAGIPCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNL 149 (190)
T ss_pred HHHH-HCCCCCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence 9997 8777544433222 23899999998877654433 36799999999999999999999 799999999999999
Q ss_pred EEecCCCCCcEEEEecccccccC
Q 011582 285 LFTSKEENSSLKAIDFGLSDYVK 307 (482)
Q Consensus 285 ll~~~~~~~~~kl~DfGla~~~~ 307 (482)
|++ ++.++|+|||+|....
T Consensus 150 li~----~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 150 LYH----DGKLYIIDVSQSVEHD 168 (190)
T ss_pred EEE----CCcEEEEEccccccCC
Confidence 994 3579999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-23 Score=201.48 Aligned_cols=236 Identities=24% Similarity=0.359 Sum_probs=149.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
..+..++.||.|+|+.||.|++.. +|+.+|||+..-.. .......+.+++
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~---t~~~~avkvf~~~~---------------------------~~~~~~~~~~~~ 61 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVE---TGEEFAVKVFLLPA---------------------------DASANEYEQLKE 61 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEEESS---------------------------TTHTTHHHHHHH
T ss_pred eEEEEccccccCCceEEEEEEEcc---CCceEEEEEEeccc---------------------------ccchHHHHHHHH
Confidence 356778899999999999999987 89999999975420 122334566666
Q ss_pred HHHHHHhhcC---------CCCcceeeEEEE---------eC---C-----eEEEEEecCCCCChHHHHH---hcCCC-C
Q 011582 201 EVKILRALTG---------HKNLVQFYDAYE---------DD---D-----NIYIVMELCKGGELLDRIL---SRGGK-Y 250 (482)
Q Consensus 201 Ei~~l~~l~~---------hpniv~l~~~~~---------~~---~-----~~~lv~e~~~~g~L~~~l~---~~~~~-l 250 (482)
|......+.+ |-.++--++... .. . +.+++|+-+. ++|.+.+. ..... .
T Consensus 62 e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~ 140 (288)
T PF14531_consen 62 EQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHS 140 (288)
T ss_dssp HHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSH
T ss_pred HHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccc
Confidence 6655544321 223333333322 11 1 2478888884 47777643 22211 1
Q ss_pred CH--HHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc
Q 011582 251 SE--EDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH 328 (482)
Q Consensus 251 ~~--~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~ 328 (482)
.. .....+..|+++.+++||..|+||+||+|+|+++ +.+|.++|+||+.....+. .......+..|.+||...
T Consensus 141 ~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll---~~~G~v~Lg~F~~~~r~g~--~~~~~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 141 PLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLL---DQDGGVFLGDFSSLVRAGT--RYRCSEFPVAFTPPELES 215 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----TTS-EEE--GGGEEETTE--EEEGGGS-TTTS-HHHHH
T ss_pred hhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEE---cCCCCEEEcChHHHeecCc--eeeccCCCcccCChhhhh
Confidence 12 2223455899999999999999999999999999 6789999999998765432 222234567899999663
Q ss_pred c---------cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhcccc
Q 011582 329 R---------SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRK 399 (482)
Q Consensus 329 ~---------~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 399 (482)
. .++.+.|.|+||+++|.|.||..||........... .|. ...++++.++.||.+||+.||.+
T Consensus 216 ~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~------~f~--~C~~~Pe~v~~LI~~lL~~~~~~ 287 (288)
T PF14531_consen 216 CAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW------DFS--RCRDMPEPVQFLIRGLLQRNPED 287 (288)
T ss_dssp HHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG------GGT--TSS---HHHHHHHHHHT-SSGGG
T ss_pred hhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc------cch--hcCCcCHHHHHHHHHHccCCccc
Confidence 2 378899999999999999999999976543221111 111 12268999999999999999999
Q ss_pred C
Q 011582 400 R 400 (482)
Q Consensus 400 R 400 (482)
|
T Consensus 288 R 288 (288)
T PF14531_consen 288 R 288 (288)
T ss_dssp S
T ss_pred C
Confidence 8
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=183.48 Aligned_cols=167 Identities=17% Similarity=0.144 Sum_probs=114.5
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.||+|+||.||+|++. +|+.||||+++...............+.. + .... ............+.+|+..+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~----~g~~vavKv~~~~~~~~~~~~~~~~~~~~-~--~~~~-~~~~~~~~~~~~~~~E~~~l 73 (190)
T cd05145 2 NGCISTGKEANVYHARTG----DGEELAVKIYKTSTLSFKDRDKYIEGDPR-F--RSRY-SKSNPRKLVFAWAEKEFRNL 73 (190)
T ss_pred CceeecCCCcEEEEEEcC----CCCEEEEEEEEcCcceEeeHHHHhcCCcc-c--cccc-ccCCHHHHHHHHHHHHHHHH
Confidence 467999999999999875 68999999997642100000000000000 0 0000 00000111223456899999
Q ss_pred HhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCce
Q 011582 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHRDLKPENF 284 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDlkp~NI 284 (482)
.++. |+++.....+.... .||||||++|+++....... ..+++..+..++.|++.+|.+||+ .||+||||||+||
T Consensus 74 ~~l~-~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~-~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NI 149 (190)
T cd05145 74 KRLY-EAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD-VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNI 149 (190)
T ss_pred HHHH-hCCCCCceEEEecC--CEEEEEEecCCCchhhhhhh-ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhE
Confidence 9997 99886555444332 48999999988655443333 568899999999999999999999 9999999999999
Q ss_pred EEecCCCCCcEEEEecccccccCC
Q 011582 285 LFTSKEENSSLKAIDFGLSDYVKP 308 (482)
Q Consensus 285 ll~~~~~~~~~kl~DfGla~~~~~ 308 (482)
|++ ++.++|+|||++.....
T Consensus 150 ll~----~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 150 LYH----DGKPYIIDVSQAVELDH 169 (190)
T ss_pred EEE----CCCEEEEEcccceecCC
Confidence 994 56799999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.1e-23 Score=222.56 Aligned_cols=246 Identities=24% Similarity=0.303 Sum_probs=173.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|...+.||++.|=+|++|++.. |. |+||++-+... ..+-....+...|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e----G~-vVvKVFvk~~p--------------------------~~sL~~~~qrL~~ 72 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE----GL-VVVKVFVKQDP--------------------------TISLRPFKQRLEE 72 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC----ce-EEEEEEeccCC--------------------------CCCchHHHHHHHH
Confidence 68888999999999999999864 55 99999866410 0111112233344
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
++ .... .|||++.+.-+.+.+...|||-+|... +|+|++..+ .-+...+.+-|+.||+.||.-+|..||+|||||.
T Consensus 73 ik-~~l~-~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKs 148 (1431)
T KOG1240|consen 73 IK-FALM-KAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKS 148 (1431)
T ss_pred HH-HHhh-cCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHHcCcccccccc
Confidence 45 3344 499999999888888889999999955 899998654 5677888888999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEeccccccc--CCCC--ccc----ccccCccccCcccccc-----------c-CCCcchhhhhH
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYV--KPDE--RLN----DIVGSAYYVAPEVLHR-----------S-YGTEADMWSIG 341 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~--~~~~--~~~----~~~gt~~y~aPE~~~~-----------~-~~~~~DiwSlG 341 (482)
+|||++ .-..+.|+||..-+.. ..++ ... +..--.+|.|||.+.. . .+++.||||+|
T Consensus 149 ENILiT---SWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~G 225 (1431)
T KOG1240|consen 149 ENILIT---SWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAG 225 (1431)
T ss_pred ceEEEe---eechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhh
Confidence 999995 4567899999754322 1111 111 1122346999997631 1 46789999999
Q ss_pred HHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCC-CCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 342 VIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 342 vil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~-~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|+++||++ |++||.- .+ +-+...+....++..... -+..+++||..|++.||.+|.+|++.|+-
T Consensus 226 CViaELf~Eg~PlF~L---SQ-L~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 226 CVIAELFLEGRPLFTL---SQ-LLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHHHhcCCCcccH---HH-HHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 99999988 6888831 11 111111110000000000 13468999999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=180.69 Aligned_cols=138 Identities=18% Similarity=0.259 Sum_probs=105.8
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.||+|+||.||. +.. ++.. +||++... .....+.+.+|+.++
T Consensus 7 ~~~LG~G~~~~Vy~--hp~---~~~k-~IKv~~~~------------------------------~~~~~~~~~rEi~~l 50 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPE---DAQR-CIKIVYHR------------------------------GDGGDKEIRRELKYY 50 (210)
T ss_pred cceecCCCceEEEE--CCC---CcCe-EEEEEecc------------------------------ccchHHHHHHHHHHH
Confidence 35799999999995 443 4444 68887542 111235789999999
Q ss_pred Hhhc----CCCCcceeeEEEEeCC---eEE-EEEec--CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHHCCC
Q 011582 206 RALT----GHKNLVQFYDAYEDDD---NIY-IVMEL--CKGGELLDRILSRGGKYSEEDAKIVMVQILSVV-AFCHFQGV 274 (482)
Q Consensus 206 ~~l~----~hpniv~l~~~~~~~~---~~~-lv~e~--~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L-~yLH~~~i 274 (482)
+.+. +||||++++++++++. ..+ +|||| +.+++|.+++.+ +.+++. ..++.|++.++ +|||+++|
T Consensus 51 ~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~I 126 (210)
T PRK10345 51 AHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRI 126 (210)
T ss_pred HHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCE
Confidence 9994 3799999999999873 434 78999 557999998854 356666 46688888888 99999999
Q ss_pred cccCCCCCceEEecCC-CCCcEEEEecccc
Q 011582 275 VHRDLKPENFLFTSKE-ENSSLKAIDFGLS 303 (482)
Q Consensus 275 vHrDlkp~NIll~~~~-~~~~~kl~DfGla 303 (482)
|||||||+|||++..+ .+..++|+||+.+
T Consensus 127 vhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 127 VTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred eecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9999999999997533 3458999995444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.4e-21 Score=187.35 Aligned_cols=191 Identities=29% Similarity=0.435 Sum_probs=143.7
Q ss_pred CCCCcceeeEEEEe---------------------------CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHH
Q 011582 210 GHKNLVQFYDAYED---------------------------DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQI 262 (482)
Q Consensus 210 ~hpniv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi 262 (482)
.|||||++..+|.+ ...+|+||..++. +|.+++..+ ..+.....-++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHH
Confidence 59999999988754 2358999998865 889888654 57888889999999
Q ss_pred HHHHHHHHHCCCcccCCCCCceEEecC-CCCCcEEEEecccccccCC-------CCcccccccCccccCcccccccC---
Q 011582 263 LSVVAFCHFQGVVHRDLKPENFLFTSK-EENSSLKAIDFGLSDYVKP-------DERLNDIVGSAYYVAPEVLHRSY--- 331 (482)
Q Consensus 263 ~~~L~yLH~~~ivHrDlkp~NIll~~~-~~~~~~kl~DfGla~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~--- 331 (482)
++|+.|||.+||.|||+|.+|||+.-+ |.--.+.|+|||.+---+. ........|.-..||||+...-.
T Consensus 351 LEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~ 430 (598)
T KOG4158|consen 351 LEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPN 430 (598)
T ss_pred HHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCc
Confidence 999999999999999999999999854 3344689999997643222 11223346788899999885321
Q ss_pred ----CCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHH-HHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHH
Q 011582 332 ----GTEADMWSIGVIAYILLCGSRPFWARTESGIFRA-VLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA 406 (482)
Q Consensus 332 ----~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~-i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 406 (482)
-.|+|.|+.|.+.||++...-||++..+.-+-.. ..+... + ..-..+++.+++||..+|+.||.+|++..-+
T Consensus 431 avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qL--P-alp~~vpp~~rqlV~~lL~r~pskRvsp~iA 507 (598)
T KOG4158|consen 431 AVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQL--P-ALPSRVPPVARQLVFDLLKRDPSKRVSPNIA 507 (598)
T ss_pred eeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhC--C-CCcccCChHHHHHHHHHhcCCccccCCccHH
Confidence 2478999999999999999999998554322111 111111 1 1123488999999999999999999986543
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=180.94 Aligned_cols=241 Identities=20% Similarity=0.220 Sum_probs=186.0
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
+...+.-+|.+...|..|+++. .|..+++|++... ..+....+.|..
T Consensus 190 ~~lnl~tkl~e~hsgelwrgrw-----qgndivakil~vr----------------------------~~t~risrdfne 236 (448)
T KOG0195|consen 190 SSLNLITKLAESHSGELWRGRW-----QGNDIVAKILNVR----------------------------EVTARISRDFNE 236 (448)
T ss_pred hhhhhhhhhccCCCcccccccc-----cCcchhhhhhhhh----------------------------hcchhhcchhhh
Confidence 4556677789999998888875 5778889988542 122223356778
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--Cccc
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQG--VVHR 277 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~--ivHr 277 (482)
|.-.|+-+. ||||+.+++.|....++.+|..||+-|+|+..++... -..+..++.+++..+++|+.|||+.. |.--
T Consensus 237 efp~lrifs-hpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~ 315 (448)
T KOG0195|consen 237 EFPALRIFS-HPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRF 315 (448)
T ss_pred hCcceeeec-CCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhh
Confidence 888888786 9999999999999999999999999999999987653 34678899999999999999999975 4444
Q ss_pred CCCCCceEEecCCCCCcEEE--EecccccccCCCCcccccccCccccCccccccc----CCCcchhhhhHHHHHHHhhCC
Q 011582 278 DLKPENFLFTSKEENSSLKA--IDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS----YGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl--~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlGvil~elltg~ 351 (482)
-|....+++ |++.+.+| +|-.++-.. ....-.|.||+||.+.+. .-.++|+|||.+++|||.|..
T Consensus 316 ~lns~hvmi---dedltarismad~kfsfqe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~tre 386 (448)
T KOG0195|consen 316 YLNSKHVMI---DEDLTARISMADTKFSFQE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTRE 386 (448)
T ss_pred hcccceEEe---cchhhhheecccceeeeec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccc
Confidence 688889999 55655554 343333211 122346899999999753 234689999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHH
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA 406 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 406 (482)
.||......+.-.+|.-....... .++++..+..|++-|+..||.+||..+.+
T Consensus 387 vpfadlspmecgmkialeglrv~i--ppgis~hm~klm~icmnedpgkrpkfdmi 439 (448)
T KOG0195|consen 387 VPFADLSPMECGMKIALEGLRVHI--PPGISRHMNKLMNICMNEDPGKRPKFDMI 439 (448)
T ss_pred cccccCCchhhhhhhhhccccccC--CCCccHHHHHHHHHHhcCCCCcCCCccee
Confidence 999888877776666554443322 36799999999999999999999998765
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.7e-22 Score=215.35 Aligned_cols=260 Identities=27% Similarity=0.468 Sum_probs=209.3
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.|.+.+.||+|+|+.|-++..... ....+|+|.+.... ........+..|
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~--~~~~~a~~~~s~~~----------------------------~~~~~~~~i~~e 70 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRD--PESSSATKPISIPP----------------------------KSEDSSEHIDTE 70 (601)
T ss_pred cccccccccccccchhhhhhhcCC--CcceeeccCCCCCC----------------------------CccchhhhcCcc
Confidence 477778899999999988776432 34567777665420 112233455567
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI-LSRGGKYSEEDAKIVMVQILSVVAFCH-FQGVVHRDL 279 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l-~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~ivHrDl 279 (482)
+.+-+.+..|.|++.+++...+.+..+++++|..|+++.+.+ .......+...+..++.|+..++.|+| ..++.||||
T Consensus 71 ~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~i 150 (601)
T KOG0590|consen 71 TDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDI 150 (601)
T ss_pred ccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCC
Confidence 777777767999999999999999999999999999999987 333236888999999999999999999 999999999
Q ss_pred CCCceEEecCCCCC-cEEEEecccccccCC-C---Cccccccc-CccccCcccccc--cCCCcchhhhhHHHHHHHhhCC
Q 011582 280 KPENFLFTSKEENS-SLKAIDFGLSDYVKP-D---ERLNDIVG-SAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 280 kp~NIll~~~~~~~-~~kl~DfGla~~~~~-~---~~~~~~~g-t~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~ 351 (482)
||+|.++ +..+ .+|++|||+|..+.. . ......+| ++.|+|||...+ ...+..|+||+|+++.-+++|.
T Consensus 151 kP~n~~l---~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~ 227 (601)
T KOG0590|consen 151 KPSNSLL---DESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGE 227 (601)
T ss_pred CCccchh---ccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCC
Confidence 9999999 4555 899999999987655 2 23455788 999999998876 4577899999999999999999
Q ss_pred CCCCCCChHHH-HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 352 RPFWARTESGI-FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 352 ~pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
.|+........ +.........+....|..++....+++.++|..+|..|.+.+++-.++|+..
T Consensus 228 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 228 LPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 99866544332 2233333344456788999999999999999999999999999999999988
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.4e-20 Score=204.82 Aligned_cols=196 Identities=21% Similarity=0.297 Sum_probs=157.1
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
-...|.|.++||+|+||.||+|... +|+.||+|+-+....+. |
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~----~~~~~alK~e~P~~~WE---------------------------------f 738 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHS----NGKLVALKVEKPPNPWE---------------------------------F 738 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecC----CCcEEEEEeecCCCcee---------------------------------e
Confidence 3467999999999999999999986 49999999865532110 1
Q ss_pred HHHHHHHHhhc--CCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 199 RREVKILRALT--GHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 199 ~~Ei~~l~~l~--~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.--.+++.+|+ --+-|..+...+.-.+..+||+||.+.|+|++++. ..+.++|..+..+..|++..++.||..+|||
T Consensus 739 YI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIH 817 (974)
T KOG1166|consen 739 YICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIH 817 (974)
T ss_pred eehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceec
Confidence 11112233332 12456666667777888999999999999999875 5678999999999999999999999999999
Q ss_pred cCCCCCceEEec----CCCCCcEEEEeccccccc---CCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHh
Q 011582 277 RDLKPENFLFTS----KEENSSLKAIDFGLSDYV---KPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 277 rDlkp~NIll~~----~~~~~~~kl~DfGla~~~---~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ell 348 (482)
+||||+|+||.. +.+..-++|+|||-+..+ .++......++|-.+-.+|+..| .|+...|.|.|..+++.||
T Consensus 818 gDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mL 897 (974)
T KOG1166|consen 818 GDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVML 897 (974)
T ss_pred ccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHH
Confidence 999999999962 334567999999988544 34456778899999999999875 6999999999999999999
Q ss_pred hCCC
Q 011582 349 CGSR 352 (482)
Q Consensus 349 tg~~ 352 (482)
.|+.
T Consensus 898 FG~y 901 (974)
T KOG1166|consen 898 FGKY 901 (974)
T ss_pred HHHH
Confidence 9965
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-21 Score=192.50 Aligned_cols=176 Identities=29% Similarity=0.467 Sum_probs=137.0
Q ss_pred CeEEEEEecCCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEeccc
Q 011582 225 DNIYIVMELCKGGELLDRILSR--GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302 (482)
Q Consensus 225 ~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGl 302 (482)
.++||.|++|...+|.++|..+ ....+....+.++.|++.|++| +|.+|||+||.||++. .+..+||.|||+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~---~d~q~kIgDFgl 402 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFS---DDDQLKIGDFGL 402 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccc---cchhhhhhhhhh
Confidence 4689999999999999999643 3457788999999999999999 9999999999999994 455799999999
Q ss_pred ccccCCCC-------cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCC
Q 011582 303 SDYVKPDE-------RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSF 373 (482)
Q Consensus 303 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~ 373 (482)
........ ..+..+||.+||+||.+.+ .|+.++||||||+||+|++. -...|.. ...+..+..+ .+
T Consensus 403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~g--~i 477 (516)
T KOG1033|consen 403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRDG--II 477 (516)
T ss_pred eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhcC--CC
Confidence 98776555 4567789999999999985 69999999999999999997 2222211 1122222222 22
Q ss_pred CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 374 DEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 374 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
+...|.++ ++-..|+.+||...|.+||++.+.--|.|+
T Consensus 478 p~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 478 PPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred ChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 32223333 455699999999999999988887777775
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=175.20 Aligned_cols=167 Identities=19% Similarity=0.138 Sum_probs=113.6
Q ss_pred ceEecceeecCCceEEEEEE-EecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAK-AKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~-~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.|.+.+.||+|+||.||+|+ +.. +|+.||||+++................ ..+. ..+ ..........+.+
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~---~g~~vaiK~~~~~~~~~~~~~~~~~~~-~~~~-~~~----~~~~~~~~~~~~~ 99 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDG---SGKERAVKIYRTGTLEFKRRDRYVDGD-FRFK-YRK----INPRKLVRLWAEK 99 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCC---CCcEEEEEEEEcCcceecchhhhcccc-hhhc-cCC----CCHHHHHHHHHHH
Confidence 48889999999999999998 444 799999999875310000000000000 0000 000 0000112235678
Q ss_pred HHHHHHhhcCCC--CcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-Cccc
Q 011582 201 EVKILRALTGHK--NLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG-VVHR 277 (482)
Q Consensus 201 Ei~~l~~l~~hp--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~-ivHr 277 (482)
|+.+++++. +. .+.+++++ ...++||||++|++|....... ..+....+..++.|++.+|.+||+.| |+||
T Consensus 100 E~~~L~~L~-~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~ 173 (237)
T smart00090 100 EFRNLQRLY-EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-VEPEEEEEFELYDDILEEMRKLYKEGELVHG 173 (237)
T ss_pred HHHHHHHHH-hcCCCCCeeeEe----cCceEEEEEecCCccccccccc-CCcchHHHHHHHHHHHHHHHHHHhcCCEEeC
Confidence 999999996 53 23344432 2358999999998876654332 45677778899999999999999999 9999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVK 307 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~ 307 (482)
||||+||+++ ++.++|+|||++....
T Consensus 174 Dikp~NIli~----~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 174 DLSEYNILVH----DGKVVIIDVSQSVELD 199 (237)
T ss_pred CCChhhEEEE----CCCEEEEEChhhhccC
Confidence 9999999994 5679999999987644
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=162.61 Aligned_cols=142 Identities=25% Similarity=0.305 Sum_probs=113.2
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||+|++|.||+|.. .|..|+||+...... ... ..........+.+|+.++.
T Consensus 2 ~~l~~G~~~~vy~~~~-----~~~~~~vK~~~~~~~---------~~~-------------~~~~~~~~~~~~~E~~~l~ 54 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-----LGIKAVIKWRIPKRY---------RHP-------------ELDERIRRERTRREARIMS 54 (211)
T ss_pred cccccCceEEEEEEee-----CCCceEEEEeCCcCC---------cCh-------------HHHHHHHHHHHHHHHHHHH
Confidence 5699999999999976 477899998643200 000 0011123356789999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
.+. |++|.....++.+.+..++||||++|++|.+.+... .. ....++.+++.+|.+||+.|++|||++|+|||+
T Consensus 55 ~l~-~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~ 128 (211)
T PRK14879 55 RAR-KAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL 128 (211)
T ss_pred HHH-HCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE
Confidence 997 999988888888888899999999999999887543 12 788899999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccc
Q 011582 287 TSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~ 305 (482)
. ++.++|+|||++..
T Consensus 129 ~----~~~~~liDf~~a~~ 143 (211)
T PRK14879 129 S----GGKIYLIDFGLAEF 143 (211)
T ss_pred E----CCCEEEEECCcccC
Confidence 4 56799999998875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.5e-19 Score=178.93 Aligned_cols=225 Identities=27% Similarity=0.352 Sum_probs=169.1
Q ss_pred HhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC-cccCCCCCce
Q 011582 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGV-VHRDLKPENF 284 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i-vHrDlkp~NI 284 (482)
+.+. |.|+.+++|.+.++...++|.+||..|+|.|.+......+++.-...+++.|+.||.|||.--| .|+.++..|+
T Consensus 2 ~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred cccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4565 9999999999999999999999999999999998877789999999999999999999999766 9999999999
Q ss_pred EEecCCCCCcEEEEecccccccCCC---CcccccccCccccCccccccc--------CCCcchhhhhHHHHHHHhhCCCC
Q 011582 285 LFTSKEENSSLKAIDFGLSDYVKPD---ERLNDIVGSAYYVAPEVLHRS--------YGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 285 ll~~~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~--------~~~~~DiwSlGvil~elltg~~p 353 (482)
++ +....+||.|||+....... .......-..-|.|||.+... .+.+.||||+|++++|+++.+.|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 77889999999998776421 111112234569999988642 46679999999999999999999
Q ss_pred CCCCC----hHHHHHHHHh-cCCCCCCCCC--CCCCHHHHHHHHHhchhccccCCCHHHHhcC-cccccCCCCCCCccHH
Q 011582 354 FWART----ESGIFRAVLK-ADPSFDEAPW--PSLSPEAIDFVKRLLNKDYRKRLTAAQALSH-PWLANSHDVKIPSDMI 425 (482)
Q Consensus 354 f~~~~----~~~~~~~i~~-~~~~~~~~~~--~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h-p~~~~~~~~~~~~~~~ 425 (482)
|.... ..+++..+.. +...+....+ ..+.+++..++.+|+..+|.+||+++++-.. ..+......+-.....
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~~~~~nl~D~ 237 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGGSSKGNLMDS 237 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccccccchhHHH
Confidence 96632 2356666666 2221222211 1456789999999999999999999998652 2222211111233444
Q ss_pred HHHHHHHHh
Q 011582 426 VYKLIKAYI 434 (482)
Q Consensus 426 ~~~~~~~~~ 434 (482)
.+..+..|.
T Consensus 238 m~~~le~Y~ 246 (484)
T KOG1023|consen 238 LFRMLESYA 246 (484)
T ss_pred HHHHHHHHH
Confidence 555555554
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=184.41 Aligned_cols=151 Identities=23% Similarity=0.271 Sum_probs=116.1
Q ss_pred cccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
........|...+.||+|+||.||++... +..+++|+...... ... .......
T Consensus 327 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~-----~~~~v~k~~~~~~~---------~~~-------------~~~~~~~ 379 (535)
T PRK09605 327 KEEEVKRRKIPDHLIGKGAEADIKKGEYL-----GRDAVIKERVPKGY---------RHP-------------ELDERLR 379 (535)
T ss_pred cccccccccCccceeccCCcEEEEEEeec-----CccceeEEEecccc---------cch-------------hHHHHHH
Confidence 33444556677889999999999998763 44556655322100 000 0011233
Q ss_pred HHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011582 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGV 274 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i 274 (482)
.+.+.+|+.+++.++ |++++....++.+....++||||++|++|.+++. ....++.|++.+|.|||+.||
T Consensus 380 ~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~gi 449 (535)
T PRK09605 380 TERTRAEARLLSEAR-RAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGI 449 (535)
T ss_pred HHHHHHHHHHHHhhc-ccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCC
Confidence 467889999999997 9999998888888888899999999999988774 356789999999999999999
Q ss_pred cccCCCCCceEEecCCCCCcEEEEeccccccc
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYV 306 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~ 306 (482)
+||||||+|||+. ++.++|+|||+++..
T Consensus 450 iHrDlkp~NILl~----~~~~~liDFGla~~~ 477 (535)
T PRK09605 450 VHGDLTTSNFIVR----DDRLYLIDFGLGKYS 477 (535)
T ss_pred ccCCCChHHEEEE----CCcEEEEeCcccccC
Confidence 9999999999992 457999999999764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.5e-18 Score=161.03 Aligned_cols=139 Identities=26% Similarity=0.290 Sum_probs=107.5
Q ss_pred eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
.||+|+||.||+|.. .|..|++|+...... ..+ ..........+.+|+.++..
T Consensus 1 ~ig~G~~~~vy~~~~-----~~~~~viK~~~~~~~---------~~~-------------~~~~~~~~~~~~~E~~~l~~ 53 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-----LGLKAVIKERVPKSY---------RHP-------------ELDERIRRERTRNEARLLSR 53 (199)
T ss_pred CCCCCceEEEEEeec-----CCccEEEEEecCCcC---------cCc-------------hHHHHHHHHHHHHHHHHHHH
Confidence 389999999999983 578899998643200 000 00112234678899999999
Q ss_pred hcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 011582 208 LTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFT 287 (482)
Q Consensus 208 l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~ 287 (482)
+. |+++.....++...+..++||||++|++|.+.+.... . .++.+++.+|.+||+.|++|||++|+||++.
T Consensus 54 l~-~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~-~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~ 124 (199)
T TIGR03724 54 AR-KAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN-D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR 124 (199)
T ss_pred HH-HCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH-H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE
Confidence 97 8876665556667777899999999999988764321 1 7899999999999999999999999999994
Q ss_pred cCCCCCcEEEEeccccccc
Q 011582 288 SKEENSSLKAIDFGLSDYV 306 (482)
Q Consensus 288 ~~~~~~~~kl~DfGla~~~ 306 (482)
++.++++|||++...
T Consensus 125 ----~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 125 ----DDKLYLIDFGLGKYS 139 (199)
T ss_pred ----CCcEEEEECCCCcCC
Confidence 567999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.8e-18 Score=160.61 Aligned_cols=156 Identities=22% Similarity=0.210 Sum_probs=109.8
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhh---ccccHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCL---FMTTAIAIEDVR 199 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 199 (482)
|.+.+.||+|+||.||+|... +|+.||||++...... ...... ...+... ............
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-------~~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 81 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP----DGNPVALKFHRLGRTS-------FRKVKR----KRDYLGDRKHASWLYLSRLAAQ 81 (198)
T ss_pred hhcCCccccCcceEEEEEEcC----CCCEEEEEEEecccch-------hhhhcc----hHHHHhccccchhHHHhHHHHH
Confidence 788899999999999999864 6899999998653100 000000 0000000 000112233467
Q ss_pred HHHHHHHhhcCCCC--cceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 200 REVKILRALTGHKN--LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~~hpn--iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+|+.++..+. |++ +...++ ....++||||++|++|..... ......++.+++.++.++|+.||+||
T Consensus 82 ~E~~~l~~l~-~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~-------~~~~~~~~~~i~~~l~~lh~~gi~H~ 149 (198)
T cd05144 82 KEFAALKALY-EEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV-------LEDPEEVLDEILEEIVKAYKHGIIHG 149 (198)
T ss_pred HHHHHHHHHH-HcCCCCCceee----cCCceEEEEEeCCcchhhccc-------cccHHHHHHHHHHHHHHHHHCCCCcC
Confidence 8999999996 764 444443 345689999999998765421 13467788999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~ 308 (482)
||||+||++ +.++.++|+|||++.....
T Consensus 150 Dl~p~Nill---~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 150 DLSEFNILV---DDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CCCcccEEE---cCCCcEEEEECCccccCCC
Confidence 999999999 5678899999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.9e-18 Score=175.46 Aligned_cols=261 Identities=21% Similarity=0.247 Sum_probs=204.8
Q ss_pred cccccceEecceeec--CCceEEEEEEE--ecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccH
Q 011582 117 KQFVAHYELGEEVGR--GHFGYTCSAKA--KKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTA 192 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~--G~fG~V~~a~~--~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (482)
..+...+.+...+|. |.+|.||.+.. .. ++..+|+|.-+.. . ...
T Consensus 110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~---s~~~~a~k~s~~p----------~------------------s~p 158 (524)
T KOG0601|consen 110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSE---SPHKFAVKKSKIP----------F------------------SPP 158 (524)
T ss_pred chhhhhcccccccccCCCCCceeecccCCccc---CCcccccccccCC----------C------------------CCc
Confidence 445567788888999 99999999987 54 7889999974321 0 111
Q ss_pred HHHHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHH----HHHH
Q 011582 193 IAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILS----VVAF 268 (482)
Q Consensus 193 ~~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~----~L~y 268 (482)
.....=.+|+...+++..|+|.++.+..+++.+..|+-+|+| +.+|..+.......+++..++.++.+... ||..
T Consensus 159 ~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~ 237 (524)
T KOG0601|consen 159 LDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSH 237 (524)
T ss_pred cccccccchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccc
Confidence 111223467777778878999999999999999999999999 47899988877777999999999999999 9999
Q ss_pred HHHCCCcccCCCCCceEEecCCCC-CcEEEEecccccccCCCCcc------cccccCccccCcccccccCCCcchhhhhH
Q 011582 269 CHFQGVVHRDLKPENFLFTSKEEN-SSLKAIDFGLSDYVKPDERL------NDIVGSAYYVAPEVLHRSYGTEADMWSIG 341 (482)
Q Consensus 269 LH~~~ivHrDlkp~NIll~~~~~~-~~~kl~DfGla~~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~DiwSlG 341 (482)
+|+.+++|-|+||+||++. .+ ...+++|||+...+...... ....|...|++||..++-++...|+||+|
T Consensus 238 ~hs~~~~~~~~kp~~i~~~---~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ 314 (524)
T KOG0601|consen 238 LHSNNIVHDDLKPANIFTT---SDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLG 314 (524)
T ss_pred cCCCcccccccchhheecc---cccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchh
Confidence 9999999999999999995 44 78999999999887655421 22357788999999999999999999999
Q ss_pred HHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 342 VIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 342 vil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.++.+..+|..++....... +..+-. ...+.+.....+.++...+..|++.+|..|++++.+++|+++...
T Consensus 315 ev~l~~~l~~~~~~~g~~~~-W~~~r~--~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 315 EVILEAILGSHLPSVGKNSS-WSQLRQ--GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhhHhhHhhcccccCCCCCC-cccccc--ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 99999999877764431111 111111 112233334567778889999999999999999999999999854
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2e-17 Score=151.93 Aligned_cols=162 Identities=20% Similarity=0.119 Sum_probs=101.2
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
++.||+|+||.||+|.+. +|+.||||++............... .....+... .............|...+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~----~~~~vavKv~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~~~~~e~~~l 71 (187)
T cd05119 2 GGPIGTGKEADVYLALDG----DGEPVAVKIYRTGRTSFKKRKRYRT-----GDYRFGRKK-SNWRYLSRLWAEKEFRNL 71 (187)
T ss_pred CcccccccceeEEEEECC----CCCEEEEEEEecCccchhhhhhhhH-----HHHHhccCC-cchhhhhhHHHHHHHHHH
Confidence 567999999999999864 5889999998753110000000000 000000000 000001111234677777
Q ss_pred HhhcCC-CCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCc
Q 011582 206 RALTGH-KNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHRDLKPEN 283 (482)
Q Consensus 206 ~~l~~h-pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDlkp~N 283 (482)
..+..+ -.+.+.+++ ...++||||++|+.+........ .. ...+..++.+++.++.++|. .||+||||||+|
T Consensus 72 ~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N 145 (187)
T cd05119 72 KRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYN 145 (187)
T ss_pred HHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence 777522 234555543 24699999999965432221110 11 16788999999999999999 999999999999
Q ss_pred eEEecCCCCCcEEEEecccccccC
Q 011582 284 FLFTSKEENSSLKAIDFGLSDYVK 307 (482)
Q Consensus 284 Ill~~~~~~~~~kl~DfGla~~~~ 307 (482)
|+++ ++.++|+|||.+....
T Consensus 146 ili~----~~~~~liDfg~a~~~~ 165 (187)
T cd05119 146 ILVD----DGKVYIIDVPQAVEID 165 (187)
T ss_pred EEEE----CCcEEEEECccccccc
Confidence 9994 6789999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.9e-16 Score=151.22 Aligned_cols=148 Identities=22% Similarity=0.225 Sum_probs=104.2
Q ss_pred ceee-cCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 127 EEVG-RGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 127 ~~LG-~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
..|| .||.|+||.+.. .|..++||.+.+.-.. .++.. ++ ...+......+.+|+.++
T Consensus 37 ~~lg~~~g~gtv~~v~~-----~~~~~vlk~~~r~~~i--~kv~~-----------~~----~~~~~~~~~r~~rE~~ll 94 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-----PGVNWVLRHYRRGGLI--GKLSK-----------DR----YLFTGLERTRAFAEFRLL 94 (239)
T ss_pred ceeecCCCCccEEEEEe-----CCceEEEEEeeEcchH--Hhhhh-----------hc----ccccchhhhHHHHHHHHH
Confidence 3577 788888888865 3678999988642100 00000 00 001123446788999999
Q ss_pred HhhcCCCCc--ceeeEEEEeC-Ce---EEEEEecCCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 206 RALTGHKNL--VQFYDAYEDD-DN---IYIVMELCKG-GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 206 ~~l~~hpni--v~l~~~~~~~-~~---~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
..|. |++| ++.+++.... .. .++|||+++| .+|.+++.. ..+++.. +.||+.+|.+||++||+|||
T Consensus 95 ~~L~-~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~~l~~lH~~GI~HrD 167 (239)
T PRK01723 95 AQLY-EAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQLIARFHDAGVYHAD 167 (239)
T ss_pred HHHH-hCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHHHHHHHHHCCCCCCC
Confidence 9997 8775 6777765433 22 3599999997 588777643 3566543 57899999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEeccccccc
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYV 306 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~ 306 (482)
|||+|||++ .++.++|+|||.+...
T Consensus 168 lkp~NILv~---~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 168 LNAHNILLD---PDGKFWLIDFDRGELR 192 (239)
T ss_pred CCchhEEEc---CCCCEEEEECCCcccC
Confidence 999999994 4568999999988764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.70 E-value=1e-16 Score=140.50 Aligned_cols=134 Identities=26% Similarity=0.305 Sum_probs=110.6
Q ss_pred ecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHH
Q 011582 125 LGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKI 204 (482)
Q Consensus 125 ~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~ 204 (482)
+.+.||.|.++.||++... +..++||+.... .. ...+.+|+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-----~~~~~iK~~~~~-----------------------------~~---~~~~~~e~~~ 44 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-----DEDYVLKINPSR-----------------------------EK---GADREREVAI 44 (155)
T ss_pred cceecccccccceEEEEec-----CCeEEEEecCCC-----------------------------Cc---hhHHHHHHHH
Confidence 3567999999999999873 468999987542 00 3568899999
Q ss_pred HHhhcCC-CCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCC
Q 011582 205 LRALTGH-KNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ---GVVHRDLK 280 (482)
Q Consensus 205 l~~l~~h-pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~---~ivHrDlk 280 (482)
++.+..+ .++++++.++...+..+++|||++|+.+... +......++.+++.+|.+||.. +++|+|++
T Consensus 45 ~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~ 116 (155)
T cd05120 45 LQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLH 116 (155)
T ss_pred HHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCC
Confidence 9999733 6899999998888899999999998776542 5566778899999999999985 69999999
Q ss_pred CCceEEecCCCCCcEEEEeccccccc
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYV 306 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~ 306 (482)
|+||+++ ..+.++++|||.+...
T Consensus 117 ~~Nil~~---~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 117 PGNILVD---DGKILGIIDWEYAGYG 139 (155)
T ss_pred cceEEEE---CCcEEEEEecccccCC
Confidence 9999994 4678999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.62 E-value=9.5e-17 Score=172.15 Aligned_cols=265 Identities=26% Similarity=0.385 Sum_probs=202.4
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..+.+.+.+-+-+|+||.++.+.-.. +|...++|+..+.- .+ .....+..
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~---sgh~~~~~v~~~ap-----~i----------------------~~~~~~s~ 851 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAG---SGHTRPSKVHGLAP-----KI----------------------RTNDYESI 851 (1205)
T ss_pred CCccceecccccCCCCcccccCCccc---cccccchhhhccch-----hh----------------------cccccccc
Confidence 34677888889999999999887665 67777777654421 00 00011222
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+.+-.++-.-+ +|-+++..--+......+|+++|+.|++|...++.. +..+++-++.++..+..+++|||...++|||
T Consensus 852 r~~s~~~i~p~-~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~ 929 (1205)
T KOG0606|consen 852 RSKSNILITPR-SPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRD 929 (1205)
T ss_pred CCccCccccCC-CCceecccCCCCCCCCcchhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhccc
Confidence 23323332232 566666555556678899999999999999887655 4688888899999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCC---------------------C-----------CcccccccCccccCccc
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKP---------------------D-----------ERLNDIVGSAYYVAPEV 326 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~---------------------~-----------~~~~~~~gt~~y~aPE~ 326 (482)
++|.|+|. ..++..++.|||....... . .......||+.|.+||.
T Consensus 930 ~~p~~~l~---~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~ 1006 (1205)
T KOG0606|consen 930 LKPDSLLI---AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEI 1006 (1205)
T ss_pred ccccchhh---cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcc
Confidence 99999999 6788899999984322100 0 01123579999999998
Q ss_pred ccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHH-
Q 011582 327 LHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA- 404 (482)
Q Consensus 327 ~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~- 404 (482)
..+ ..+..+|+|++|+++++.++|.+||.....+.++++|.+.....+... ...+.++++++.++|..+|.+|..+.
T Consensus 1007 ~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1007 LLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred cccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCccc
Confidence 865 578899999999999999999999999999999999988876655432 24789999999999999999999988
Q ss_pred --HHhcCcccccCCCCC
Q 011582 405 --QALSHPWLANSHDVK 419 (482)
Q Consensus 405 --e~L~hp~~~~~~~~~ 419 (482)
++-.|+||+......
T Consensus 1086 ~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1086 AAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred ccccccCCccCCCCccc
Confidence 888999998765433
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.56 E-value=3.1e-14 Score=147.52 Aligned_cols=167 Identities=19% Similarity=0.234 Sum_probs=103.2
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhh-------------ccCCCCCC-cchhhhhhhhhhccccH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQ-------------VHCPKHEN-HQFTILDEYCCLFMTTA 192 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~-------------~~~~~~~~-~~~~~~~~~~~~~~~~~ 192 (482)
+.||+|++|.||+|+.+ +|+.||||+.+......... ...+.... ....+.+++. ..-
T Consensus 123 ~plasaSigQVh~A~l~----~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~----~~l 194 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV----DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFE----KTL 194 (437)
T ss_pred cceeeeehhheEEEEec----CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHH----HHH
Confidence 46999999999999976 68999999987653211000 00000000 0001111111 000
Q ss_pred HHHHHHHHHHHHHHhhc----CCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHH-HHH
Q 011582 193 IAIEDVRREVKILRALT----GHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILS-VVA 267 (482)
Q Consensus 193 ~~~~~~~~Ei~~l~~l~----~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~-~L~ 267 (482)
...-++.+|+..+.++. +++++.-..-++...+..+|||||++|++|.+........++ ...++.+++. .+.
T Consensus 195 ~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 195 RRELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLN 271 (437)
T ss_pred HHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHH
Confidence 11114666777776664 344433222223334567999999999999876543222232 3345555555 468
Q ss_pred HHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccC
Q 011582 268 FCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK 307 (482)
Q Consensus 268 yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~ 307 (482)
.+|..|++|+|+||.||++ +.++.++|+|||++..+.
T Consensus 272 ql~~~g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 272 QVLRDGFFHADLHPGNIFV---LKDGKIIALDFGIVGRLS 308 (437)
T ss_pred HHHhCCceeCCCCcccEEE---CCCCcEEEEeCCCeeECC
Confidence 8999999999999999999 567789999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=5.1e-14 Score=147.74 Aligned_cols=174 Identities=21% Similarity=0.318 Sum_probs=100.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhh-h------------hccCCCCCCcc-hhhhhhhh
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIF-L------------QVHCPKHENHQ-FTILDEYC 185 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~-~------------~~~~~~~~~~~-~~~~~~~~ 185 (482)
...|+. +.||+|++|+||+|+.+. +|+.||||++++...... . ....+...... ..+.+|+.
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~---~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKD---NGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECC---CCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 345666 689999999999999875 599999999986532100 0 00000000000 00111110
Q ss_pred hhccccHHHHHHHHHHHHHHHhhc---CCCCcceeeEEEEe-CCeEEEEEecCCCCChHHH--HHhcCC---CCCHHHHH
Q 011582 186 CLFMTTAIAIEDVRREVKILRALT---GHKNLVQFYDAYED-DDNIYIVMELCKGGELLDR--ILSRGG---KYSEEDAK 256 (482)
Q Consensus 186 ~~~~~~~~~~~~~~~Ei~~l~~l~---~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~--l~~~~~---~l~~~~~~ 256 (482)
..-...-++.+|+..+.++. .+.+.+.+-.+|.+ ....+|||||++|+.+.+. +...+. .+.+..+.
T Consensus 195 ----~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~ 270 (537)
T PRK04750 195 ----KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE 270 (537)
T ss_pred ----HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH
Confidence 00001112445555555543 13333333333332 4567899999999998764 222211 24445555
Q ss_pred HHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC-CCCcEEEEecccccccCC
Q 011582 257 IVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKE-ENSSLKAIDFGLSDYVKP 308 (482)
Q Consensus 257 ~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~-~~~~~kl~DfGla~~~~~ 308 (482)
.++.|++ ..|++|+|+||.||+++.++ ..+.++++|||++..+..
T Consensus 271 ~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 271 VFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 5556654 58999999999999995321 223899999999887643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=4.8e-13 Score=122.71 Aligned_cols=169 Identities=17% Similarity=0.170 Sum_probs=107.5
Q ss_pred cceeecCCceEEEEEEEecC---CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKG---SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~---~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
...||.|--+.||.|....+ ...+..+|||+.+.....-........++. .+. ... .............++|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~-rf~--~~~-~k~~~~~~~~~wa~kE~ 77 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDY-RFK--DRF-SKLNPRKIIRMWAEKEM 77 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCc-ccc--cCc-CCCCHHHHHHHHHHHHH
Confidence 34699999999999975421 013578999998643111000000111110 000 000 00001112223345899
Q ss_pred HHHHhhcCC-CCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCC
Q 011582 203 KILRALTGH-KNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFC-HFQGVVHRDLK 280 (482)
Q Consensus 203 ~~l~~l~~h-pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~ivHrDlk 280 (482)
..|+++... -++..++++ ..-+|||||+.++.+.....+. ..+++.++..++.+++.+|..| |..||||+||+
T Consensus 78 r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs 152 (197)
T cd05146 78 HNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLS 152 (197)
T ss_pred HHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 999998743 466677764 5678999999765443322222 3466677788899999999998 89999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVK 307 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~ 307 (482)
+.|||+. ++.+.|+|||.+....
T Consensus 153 ~~NIL~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 153 EYNMLWH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHHEEEE----CCcEEEEECCCceeCC
Confidence 9999994 3569999999887653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.46 E-value=7.5e-14 Score=143.29 Aligned_cols=252 Identities=20% Similarity=0.198 Sum_probs=186.6
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
...+|..+..||.|.|+.|+.+... ..++..|++|.+.+.. ........-
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r--~~~~~~Y~~ke~~~~l----------------------------~~~~~di~s 312 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKR--PEGDCIYAAKELLNGL----------------------------ATFASDIFS 312 (524)
T ss_pred ecCCcceeEEccCCccccceeeeec--CCCCceEeChhhhccc----------------------------cchHhhhcc
Confidence 4567888899999999999987732 2267889999876642 112222334
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
..|+.+...+.-|.++++++..|......|+--|||+++++...+.- ...+++...+++..|++.++.++|+..++|+|
T Consensus 313 l~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~-~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d 391 (524)
T KOG0601|consen 313 LGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT-SQMLDEDPRLRLTAQILTALNVIHSKLFVHLD 391 (524)
T ss_pred hhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHH-HHhcCcchhhhhHHHHHhccccccchhhhccc
Confidence 56777777777799999999999998899999999999987766632 24688899999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCcccc-Ccccccc--cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV-APEVLHR--SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~-aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
+||+||++..++ +..++.|||....+.- ......+.-+++ ..|++.. .+..+.|++|||.-+.+.++|...-+
T Consensus 392 ~~psni~i~~~~--~~~~~~~~~~~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~ 467 (524)
T KOG0601|consen 392 VKPSNILISNDG--FFSKLGDFGCWTRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSE 467 (524)
T ss_pred ccccceeeccch--hhhhccccccccccce--ecccccccccccccchhhccccccccccccccccccccccccCcccCc
Confidence 999999996422 7889999998864221 112223334455 3666654 47889999999999999999876433
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
.... +..|..+.. ...+....++..+.+.|+..++..|+.+.++..|.=|
T Consensus 468 ~~~~---~~~i~~~~~----p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 468 SGVQ---SLTIRSGDT----PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cccc---ceeeecccc----cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 3221 222333322 1123345788999999999999999999998887654
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=4.4e-13 Score=120.80 Aligned_cols=128 Identities=16% Similarity=0.191 Sum_probs=94.0
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.|+.|.++.||+++. .|..|++|+..... .....+.+|+.+++
T Consensus 4 ~~l~~G~~~~vy~~~~-----~~~~~~lK~~~~~~-------------------------------~~~~~~~~E~~~l~ 47 (170)
T cd05151 4 SPLKGGMTNKNYRVEV-----ANKKYVVRIPGNGT-------------------------------ELLINRENEAENSK 47 (170)
T ss_pred eecCCcccCceEEEEE-----CCeEEEEEeCCCCc-------------------------------ccccCHHHHHHHHH
Confidence 4689999999999885 46789999875420 01124578999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC-----cccCCCC
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGV-----VHRDLKP 281 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i-----vHrDlkp 281 (482)
.+.+...+.+++.+. ....++||||++|.++.+. ......++.+++.+|..||+.++ +|+|++|
T Consensus 48 ~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~ 116 (170)
T cd05151 48 LAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE---------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLP 116 (170)
T ss_pred HHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc---------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCc
Confidence 987333344555443 3345899999999877542 01123467899999999999985 9999999
Q ss_pred CceEEecCCCCCcEEEEecccccc
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
.||+++ ++.++++|||.+..
T Consensus 117 ~Nil~~----~~~~~liDf~~a~~ 136 (170)
T cd05151 117 GNFLLD----DGRLWLIDWEYAGM 136 (170)
T ss_pred CcEEEE----CCeEEEEecccccC
Confidence 999994 44699999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.9e-12 Score=114.61 Aligned_cols=152 Identities=22% Similarity=0.221 Sum_probs=117.2
Q ss_pred ecceeecCCceEEEEEEEecCCCCCceEEEEEe-ecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHH
Q 011582 125 LGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVI-PKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVK 203 (482)
Q Consensus 125 ~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i-~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~ 203 (482)
....|-+|+-+.|+++.. .|+.+.||.= .|. |.+......-...+..+|+.
T Consensus 11 ~l~likQGAEArv~~~~~-----~Ge~~iIK~Rf~K~-----------------------YRHP~LD~kLtr~Rt~~Ear 62 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-----SGEAAIIKERFSKR-----------------------YRHPALDQKLTRKRTKQEAR 62 (229)
T ss_pred cceeeeccceeeEeeecc-----CCceeEEeeccccc-----------------------ccchHHHHHHHHHHHHHHHH
Confidence 456788999999998876 6888888852 221 22223345566778899999
Q ss_pred HHHhhcCCCCcceeeEEEEeCCeEEEEEecCCC-CChHHHHHhcCCCCCHHH-HHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 204 ILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG-GELLDRILSRGGKYSEED-AKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 204 ~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~-~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+|.++. --.|.-..-++.+...-.|+|||++| .++.+++......-.+.. ...++++|-+.+.-||.++|||+||..
T Consensus 63 ~l~k~~-~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTT 141 (229)
T KOG3087|consen 63 LLAKCR-ALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTT 141 (229)
T ss_pred HHHHHH-HhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccc
Confidence 999987 55666666678888888999999987 367777765533333333 378999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccc
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
+||++.+.+....+.++|||++..
T Consensus 142 SNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 142 SNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred cceEEecCCCcCceEEEeecchhc
Confidence 999998777777789999999864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=8.2e-13 Score=125.90 Aligned_cols=200 Identities=18% Similarity=0.200 Sum_probs=142.3
Q ss_pred HHhhcCCCCcceeeEEEEeC-----CeEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--C
Q 011582 205 LRALTGHKNLVQFYDAYEDD-----DNIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCHFQG--V 274 (482)
Q Consensus 205 l~~l~~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~--i 274 (482)
|-.+. |-|||+++.||.+. ....+++||+..|+|..+|.+. ...+......+|+.||+.||.|||+.. |
T Consensus 121 llqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 121 LLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 34554 99999999998654 4588999999999999888642 456888899999999999999999975 9
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccc---cCC--CCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHh
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDY---VKP--DERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~---~~~--~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ell 348 (482)
+|+++..+-|++ ..++.+|+.--..... +.. ......-.|-++|.+||.=. ...+.++|||++|....+|.
T Consensus 200 ihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 200 IHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccCCcchhheee---cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 999999999999 5677777652211110 000 00112234678899999643 45677899999999999998
Q ss_pred hCCCC-CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 349 CGSRP-FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 349 tg~~p-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.|..- -.+...-+.-..|.+...... ..--+++|.+||+..|..||++.++|-||-+-+-
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred HheeccCCCcceeehhhhhhhheeecc-------CccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 87654 222222222222222221111 1224578999999999999999999999987654
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.4e-11 Score=109.69 Aligned_cols=138 Identities=26% Similarity=0.317 Sum_probs=103.4
Q ss_pred eeecCCceEEEEEEEecCCCCCceEEEEE-eecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKV-IPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~~~g~~vAvK~-i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
.+++|+-+.++.+.. -|..+++|. ++|.. ... .....-...+..+|+.++.
T Consensus 3 ~i~~GAEa~i~~~~~-----~g~~av~K~Ri~K~Y---------------R~p--------~LD~klrr~Rt~~Earil~ 54 (204)
T COG3642 3 LIKQGAEAIIYLTDF-----LGLPAVVKERIPKRY---------------RHP--------ELDEKLRRERTRREARILA 54 (204)
T ss_pred hhhCCcceeEEeeec-----cCcceEEEeecCccc---------------CCh--------HHHHHHHHHHHHHHHHHHH
Confidence 478999999998854 355677775 33321 111 1223344567789999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
++. --.|.-.+-+..+.+...|+|||.+|..|.+.+... ...++..+-.-+.-||..||||+||.++||++
T Consensus 55 ~a~-~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl 125 (204)
T COG3642 55 KAR-EAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIIL 125 (204)
T ss_pred HHH-HcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHHHHhcCeecCCCccceEEE
Confidence 987 556666666677888999999999998877777543 25677888888899999999999999999999
Q ss_pred ecCCCCCcEEEEeccccccc
Q 011582 287 TSKEENSSLKAIDFGLSDYV 306 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~ 306 (482)
. ++.+.++||||+.+-
T Consensus 126 ~----~~~i~~IDfGLg~~s 141 (204)
T COG3642 126 S----GGRIYFIDFGLGEFS 141 (204)
T ss_pred e----CCcEEEEECCccccc
Confidence 5 334999999999753
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.4e-11 Score=127.84 Aligned_cols=162 Identities=22% Similarity=0.336 Sum_probs=123.3
Q ss_pred CCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeE
Q 011582 148 KGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNI 227 (482)
Q Consensus 148 ~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~ 227 (482)
+|.+|.|.+++.. .....+...+-++.|+.++ ||||+++++.++.++.+
T Consensus 36 ~~~~vsVF~~~~~------------------------------~~~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ 84 (690)
T KOG1243|consen 36 DGGPVSVFVYKRS------------------------------NGEVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTL 84 (690)
T ss_pred cCCceEEEEEeCC------------------------------CchhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCce
Confidence 7889999988653 1133456788889999998 99999999999999999
Q ss_pred EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCceEEecCCCCCcEEEEeccccccc
Q 011582 228 YIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCH-FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV 306 (482)
Q Consensus 228 ~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~ 306 (482)
|||+|-+.- |..++.+ +....+...+.||+.||.||| +.+++|++|..+.|++ +..|..||++|-++...
T Consensus 85 ylvTErV~P--l~~~lk~----l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfV---n~~GeWkLggle~v~~~ 155 (690)
T KOG1243|consen 85 YLVTERVRP--LETVLKE----LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFV---NESGEWKLGGLELVSKA 155 (690)
T ss_pred EEEeecccc--HHHHHHH----hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEE---cCCCcEEEeeeEEEecc
Confidence 999999853 5555643 347788889999999999998 5679999999999999 67888999999987654
Q ss_pred CCCCc-ccccccCccccCcccccccCCCcchhhhhHHHHHHHhhC
Q 011582 307 KPDER-LNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 307 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg 350 (482)
..... .....---.|..|+.+... .-..|.|-|||++++++.|
T Consensus 156 ~~~~~~~~~~~~~~s~~~P~~~~~s-~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 156 SGFNAPAKSLYLIESFDDPEEIDPS-EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred ccCCcccccchhhhcccChhhcCcc-ccchhhhhHHHHHHHHhCc
Confidence 33221 1111112235556544211 1346999999999999999
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.20 E-value=6.7e-11 Score=111.11 Aligned_cols=143 Identities=27% Similarity=0.385 Sum_probs=104.2
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||.|.++.||+++.. +|..+++|+..... .......+.+|+.+++
T Consensus 4 ~~l~~G~~n~~~~v~~~----~g~~~ilK~~~~~~-----------------------------~~~~~~~~~~E~~~~~ 50 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG----GGRRLVLRRPPPGA-----------------------------LLPSAHDVAREYRVLR 50 (223)
T ss_pred eecCCCccceEEEEEec----CCcceEEEeCCCcc-----------------------------cCcccccHHHHHHHHH
Confidence 45899999999999864 36789999875420 0012346789999999
Q ss_pred hhcCC-CCcceeeEEEEeC---CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-----------
Q 011582 207 ALTGH-KNLVQFYDAYEDD---DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF----------- 271 (482)
Q Consensus 207 ~l~~h-pniv~l~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~----------- 271 (482)
.+..+ .++.+++.+.... +..++||||++|.++.+.+.. ..+++.+...++.+++.+|..||+
T Consensus 51 ~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~ 128 (223)
T cd05154 51 ALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDL 128 (223)
T ss_pred HhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCccc
Confidence 99732 3467777776654 367899999999887664421 356777777788888888888874
Q ss_pred ---------------------------------------------CCCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 272 ---------------------------------------------QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 272 ---------------------------------------------~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
..++|+|+++.||+++.+ .++.+.|+||+.+..
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~-~~~~~~iID~e~~~~ 206 (223)
T cd05154 129 GRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD-EPRVVAVLDWELATL 206 (223)
T ss_pred CCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC-CCcEEEEEecccccc
Confidence 236899999999999531 145689999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.2e-10 Score=111.30 Aligned_cols=211 Identities=17% Similarity=0.223 Sum_probs=151.7
Q ss_pred eEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhhcCCCCc
Q 011582 135 GYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNL 214 (482)
Q Consensus 135 G~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hpni 214 (482)
.+.|+|.... +|..|++|+++... . ......-.-+++++++. |+|+
T Consensus 290 ~Ttyk~~s~~---DG~~YvLkRlhg~r------~------------------------~~~nk~t~lve~wkkl~-h~Nv 335 (655)
T KOG3741|consen 290 ITTYKATSNV---DGNAYVLKRLHGDR------D------------------------QSTNKDTSLVEAWKKLC-HTNV 335 (655)
T ss_pred ceeEeeeecc---CCceeeeeeecccc------c------------------------cCcccchHHHHHHHHhc-cCce
Confidence 4778888876 89999999984320 0 00011223467889997 9999
Q ss_pred ceeeEEEE----eCCeEEEEEecCCC-CChHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 215 VQFYDAYE----DDDNIYIVMELCKG-GELLDRILSR--------------GGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 215 v~l~~~~~----~~~~~~lv~e~~~~-g~L~~~l~~~--------------~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
|.+.++|. .+..+++|++|.++ ++|+++.... +.+.+|..+|.++.|+..||.++|+.|+.
T Consensus 336 V~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLA 415 (655)
T KOG3741|consen 336 VPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLA 415 (655)
T ss_pred eehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCce
Confidence 99999987 35679999999986 4777765321 23578899999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCC-
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPF- 354 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf- 354 (482)
-+-|.|.+||+ +.+.+++|+-.|+...+..+.. |-+. --.+-|.=-||.+++.|.||..--
T Consensus 416 ck~L~~~kIlv---~G~~RIriS~C~i~Dvl~~d~~-------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~ 477 (655)
T KOG3741|consen 416 CKTLDLKKILV---TGKMRIRISGCGIMDVLQEDPT-------------EPLE--SQQQNDLRDLGLLLLALATGTENSN 477 (655)
T ss_pred eecccHhHeEe---eCcceEEEecccceeeecCCCC-------------cchh--HHhhhhHHHHHHHHHHHhhcccccc
Confidence 99999999999 4555888888887766543320 1111 123568889999999999996532
Q ss_pred CCCChHHH-HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 355 WARTESGI-FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 355 ~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
......+. +..|. ..+|.+++++|.-+...+++. -++.++|.+
T Consensus 478 ~~d~~~~s~~~~I~-----------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 478 RTDSTQSSHLTRIT-----------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred cccchHHHHHHHhh-----------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 12222222 22222 237899999999999988886 677787764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.9e-09 Score=103.01 Aligned_cols=108 Identities=19% Similarity=0.201 Sum_probs=82.1
Q ss_pred HHHHHHHHHHhhcCCCC--cceeeEEEEe-----CCeEEEEEecCCCC-ChHHHHHhc-CCCCCHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKN--LVQFYDAYED-----DDNIYIVMELCKGG-ELLDRILSR-GGKYSEEDAKIVMVQILSVVA 267 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpn--iv~l~~~~~~-----~~~~~lv~e~~~~g-~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~ 267 (482)
.+.+|...+.+|. .-+ ...++.+++. ....+||||++++. +|.+++... ....+......++.+++..+.
T Consensus 74 ~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~ 152 (268)
T PRK15123 74 GADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVR 152 (268)
T ss_pred HHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHH
Confidence 4678999888885 333 3344555543 23578999999886 788776432 234667788899999999999
Q ss_pred HHHHCCCcccCCCCCceEEec----CCCCCcEEEEecccccc
Q 011582 268 FCHFQGVVHRDLKPENFLFTS----KEENSSLKAIDFGLSDY 305 (482)
Q Consensus 268 yLH~~~ivHrDlkp~NIll~~----~~~~~~~kl~DfGla~~ 305 (482)
-||..||+|+|+++.|||+.. .+++..+.|+||+.+..
T Consensus 153 ~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 153 DMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred HHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999999999999999999963 13457899999998754
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.8e-10 Score=101.51 Aligned_cols=152 Identities=26% Similarity=0.278 Sum_probs=87.0
Q ss_pred EEEEEEEecCCCCCceEEEEEeecccchhhhhcc-CCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhhcCC-CC
Q 011582 136 YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVH-CPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGH-KN 213 (482)
Q Consensus 136 ~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~~h-pn 213 (482)
.||.|... .|..+|||+.+... ..+.... ...... .+. .................+|...|.++... -+
T Consensus 1 ~Vy~~~~~----~~~~~a~K~~r~~~-~~Fk~~~~y~~~~~-r~~---~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~ 71 (188)
T PF01163_consen 1 DVYHAIDP----DGEEVAVKIYRTGR-TSFKRRKKYRDYDY-RFK---KYRHKSSWRYLIREWAKKEFRNLKRLYEAGVP 71 (188)
T ss_dssp EEEEEEEC----TTEEEEEEEE-S----SS-HHHHHTTTST-TST---TC--G--CHHHHHHHHHHHHHHHHHCCCTT-S
T ss_pred CEEEEECC----CCCEEEEEEeccCc-eEEEEeeeeecccc-hhc---ccccccCHHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 38888875 58899999986531 1111100 000000 000 00000112334456778999999999733 25
Q ss_pred cceeeEEEEeCCeEEEEEecCC--CCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHHCCCcccCCCCCceEEecCC
Q 011582 214 LVQFYDAYEDDDNIYIVMELCK--GGELLDRILSRGGKYSEEDAKIVMVQILSVVAF-CHFQGVVHRDLKPENFLFTSKE 290 (482)
Q Consensus 214 iv~l~~~~~~~~~~~lv~e~~~--~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~y-LH~~~ivHrDlkp~NIll~~~~ 290 (482)
+.+++++. .-+|||||++ |..+ ..+... .++......++.+++..+.. +|..||||+||.+.|||+.
T Consensus 72 vP~p~~~~----~~~ivME~I~~~G~~~-~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~--- 141 (188)
T PF01163_consen 72 VPKPYDYN----RNVIVMEYIGEDGVPL-PRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVD--- 141 (188)
T ss_dssp S--EEEEE----TTEEEEE--EETTEEG-GCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEE---
T ss_pred CCcEEEEe----CCEEEEEecCCCccch-hhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEee---
Confidence 66776542 3479999998 5444 334332 23356677788888886655 5899999999999999995
Q ss_pred CCCcEEEEecccccccC
Q 011582 291 ENSSLKAIDFGLSDYVK 307 (482)
Q Consensus 291 ~~~~~kl~DfGla~~~~ 307 (482)
++ .+.|+|||.+....
T Consensus 142 ~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 142 DG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp TT-CEEE--GTTEEETT
T ss_pred cc-eEEEEecCcceecC
Confidence 22 79999999887644
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.01 E-value=7.4e-09 Score=102.42 Aligned_cols=176 Identities=19% Similarity=0.206 Sum_probs=126.4
Q ss_pred EEEEEecCCCCChHHHHHh---c---CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEec
Q 011582 227 IYIVMELCKGGELLDRILS---R---GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300 (482)
Q Consensus 227 ~~lv~e~~~~g~L~~~l~~---~---~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~Df 300 (482)
+-+.|..+.|..-...+.+ + ...+.|.-+.+..+.++.+...||..|.+-+|++++|+|+ .+++.+.|+|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEcc
Confidence 6788998887643333322 1 1346788999999999999999999999999999999999 56778999985
Q ss_pred ccccccCCCCcccccccCccccCccccc-c-----cCCCcchhhhhHHHHHHHhhC-CCCCCCCCh-----HHHHHHHHh
Q 011582 301 GLSDYVKPDERLNDIVGSAYYVAPEVLH-R-----SYGTEADMWSIGVIAYILLCG-SRPFWARTE-----SGIFRAVLK 368 (482)
Q Consensus 301 Gla~~~~~~~~~~~~~gt~~y~aPE~~~-~-----~~~~~~DiwSlGvil~elltg-~~pf~~~~~-----~~~~~~i~~ 368 (482)
..-.....+......+|...|.+||.-. + .-+...|.|.|||+++++|.| ++||.+-.. ...-..|..
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 5433333344455678999999999654 2 246679999999999999987 999965321 011112222
Q ss_pred cCC------------CCCCCCCCCCCHHHHHHHHHhchh--ccccCCCHHH
Q 011582 369 ADP------------SFDEAPWPSLSPEAIDFVKRLLNK--DYRKRLTAAQ 405 (482)
Q Consensus 369 ~~~------------~~~~~~~~~~s~~~~~li~~~L~~--dP~~R~s~~e 405 (482)
+.+ .....+|..+++++..|+.+|++. ++.-|||++.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 221 112234667899999999999976 3668999864
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.6e-10 Score=119.03 Aligned_cols=152 Identities=24% Similarity=0.323 Sum_probs=112.3
Q ss_pred HHHHHHHHHHHHC-CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcc-----c-----ccccCccccCccccc
Q 011582 260 VQILSVVAFCHFQ-GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL-----N-----DIVGSAYYVAPEVLH 328 (482)
Q Consensus 260 ~qi~~~L~yLH~~-~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~-----~-----~~~gt~~y~aPE~~~ 328 (482)
.+++.||.|+|.. ++||+.|.|++|.+ +.++.+||+.|+++......... . -..-...|.|||++.
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3455999999975 89999999999999 67888999999988765442111 0 112356799999886
Q ss_pred c-cCCCcchhhhhHHHHHHHh-hCCCCCCCCChHHHHHHH--HhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHH
Q 011582 329 R-SYGTEADMWSIGVIAYILL-CGSRPFWARTESGIFRAV--LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA 404 (482)
Q Consensus 329 ~-~~~~~~DiwSlGvil~ell-tg~~pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 404 (482)
. ..+.++|+||+||++|.+. .|+..+...+.......- ......+... .++++++++-+.++|..++..||++.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s--~~~p~el~~~l~k~l~~~~~~rp~~~ 260 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYS--NNLPSELRESLKKLLNGDSAVRPTLD 260 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccccccccccc--ccCcHHHHHHHHHHhcCCcccCcchh
Confidence 5 4678999999999999999 666666554332222211 1111111111 46899999999999999999999999
Q ss_pred HHhcCcccccCC
Q 011582 405 QALSHPWLANSH 416 (482)
Q Consensus 405 e~L~hp~~~~~~ 416 (482)
.++..|||....
T Consensus 261 ~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 261 LLLSIPFFSDPG 272 (700)
T ss_pred hhhcccccCCch
Confidence 999999998654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.4e-08 Score=93.27 Aligned_cols=111 Identities=19% Similarity=0.246 Sum_probs=85.2
Q ss_pred HHHHHHHHHHHHhhcC-CCCcceeeEEEEeC----CeEEEEEecCCCC-ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 011582 195 IEDVRREVKILRALTG-HKNLVQFYDAYEDD----DNIYIVMELCKGG-ELLDRILSRGGKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~-hpniv~l~~~~~~~----~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~y 268 (482)
.....+|...+..|.. .=...+.+.+.+.. ...+||+|++++. +|.+++... ..++......++.+++..+.-
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~-~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW-EQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh-cccchhhHHHHHHHHHHHHHH
Confidence 3467788888877752 12345566666553 2458999999885 677776543 237778889999999999999
Q ss_pred HHHCCCcccCCCCCceEEecCCCCCcEEEEeccccccc
Q 011582 269 CHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV 306 (482)
Q Consensus 269 LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~ 306 (482)
||.+||+|+|+++.|||+..++....+.|+||+-++..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999999999999999975555568999999977653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.8e-08 Score=93.80 Aligned_cols=159 Identities=23% Similarity=0.230 Sum_probs=107.1
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
+.++..||.|.-+.||.|.+. .|.++|||.=+-. ..++-.++.... .+.+.. ....-........+|.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~----~g~~~~vKfHR~G-rtsFrkvk~~R~-----y~~~~~--h~sWl~~sRl~A~rEf 160 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP----KGRKVAVKFHRLG-RTSFRKVKRNRD-----YLADKE--HGSWLYVSRLAAEREF 160 (304)
T ss_pred HhhccccccCccceEEEEECC----CCCEEEEEEeecC-chhhhhhcchhh-----hhcccc--CcchhhhHHHHHHHHH
Confidence 567889999999999999986 5899999974322 111111111000 000000 0011233455678999
Q ss_pred HHHHhhcCC-CCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 203 KILRALTGH-KNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 203 ~~l~~l~~h-pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
++|.+|..+ -.+.+.++ .+...+||||++|-.|... +++.+....++..|+.-+.-+-..||||+|+.+
T Consensus 161 ~~L~~L~~~G~~VP~P~~----~nRHaVvMe~ieG~eL~~~------r~~~en~~~il~~il~~~~~~~~~GiVHGDlSe 230 (304)
T COG0478 161 EALQRLYPEGVKVPKPIA----WNRHAVVMEYIEGVELYRL------RLDVENPDEILDKILEEVRKAYRRGIVHGDLSE 230 (304)
T ss_pred HHHHHhhhcCCCCCCccc----cccceeeeehcccceeecc------cCcccCHHHHHHHHHHHHHHHHHcCccccCCch
Confidence 999999633 35666664 3667899999998665432 235566667777777777777799999999999
Q ss_pred CceEEecCCCCCcEEEEeccccccc
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYV 306 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~ 306 (482)
-||++ ++++.+.++||-.+...
T Consensus 231 fNIlV---~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 231 FNILV---TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred heEEE---ecCCCEEEEeCcccccC
Confidence 99999 56778999999766543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=3.4e-08 Score=103.47 Aligned_cols=169 Identities=20% Similarity=0.241 Sum_probs=105.2
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchh-------------hhhccCCCCC-CcchhhhhhhhhhccccH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVI-------------FLQVHCPKHE-NHQFTILDEYCCLFMTTA 192 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~-------------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 192 (482)
.-|+.++-|+||+|+.+ +|+.||||+.+..+... +.+...+... -.-..+.+|+. ..-
T Consensus 131 ~PiAsASIaQVH~A~L~----sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~----~~l 202 (517)
T COG0661 131 EPIASASIAQVHRAVLK----SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFE----KRL 202 (517)
T ss_pred CchhhhhHhhheeEEec----CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHH----HHH
Confidence 35999999999999997 59999999998764320 0011111111 11112223322 111
Q ss_pred HHHHHHHHHHHHHHhhc----CCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 011582 193 IAIEDVRREVKILRALT----GHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 193 ~~~~~~~~Ei~~l~~l~----~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~y 268 (482)
...-++.+|...+.+++ +.+++.--.-|++-.+.-.|+|||++|-.+.+...-+...++...+...+.++. +..
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q 280 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQ 280 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHH
Confidence 12224556666666654 455554444455666788999999999988876433334566444443332222 223
Q ss_pred HHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCC
Q 011582 269 CHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308 (482)
Q Consensus 269 LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~ 308 (482)
+=..|+.|.|.+|.||++ +.++.+.+.|||+.....+
T Consensus 281 ~~~dgffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 281 LLRDGFFHADPHPGNILV---RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHhcCccccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence 334799999999999999 5678999999999877654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.68 E-value=1.4e-09 Score=112.40 Aligned_cols=243 Identities=17% Similarity=0.223 Sum_probs=168.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
...|.....+++|+++.+++.+... -+....+++... ....
T Consensus 241 ~kws~~fh~fvK~altknpKkRpta----eklL~h~fvs~~-----------------------------------l~~r 281 (829)
T KOG0576|consen 241 TKWSEFFHNFVKGALTKNPKKRPTA----EKLLQHPFVSQT-----------------------------------LSRR 281 (829)
T ss_pred ccchHHHHHHHHHHhcCCCccCCCh----hhheeceeeccc-----------------------------------hhhH
Confidence 3456677779999999998877643 223335555321 3456
Q ss_pred HHHHHHHhhcCCCC-cceeeEEEEeCCeEEEEEecCCCC-ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 200 REVKILRALTGHKN-LVQFYDAYEDDDNIYIVMELCKGG-ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~~hpn-iv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
-++++|.+++ ||| .+..++-++.++..+++|++|.++ +...........+.+.+...+.+.-+++|+|||+.-=+||
T Consensus 282 l~~eLLdK~n-~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~ 360 (829)
T KOG0576|consen 282 LAIELLDKVN-NPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHR 360 (829)
T ss_pred HHHHHHHHcc-CCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCc
Confidence 6889999996 999 778888888889999999999887 2222111111235566677788888999999999888999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
| ||+.. +...|..||+....+.......+..+|+.++|||+.. +.+..+.|+|++|+--.+|--|.+|-..
T Consensus 361 d----~~l~s----~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 361 D----NILGS----EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred c----ccccc----ccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 9 88874 4568999999988776665667788999999999776 4689999999999977778777766432
Q ss_pred CChHHHHHHHHhcC--CCC-CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 357 RTESGIFRAVLKAD--PSF-DEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 357 ~~~~~~~~~i~~~~--~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
... ....+-.+. ... ....|... +-.++...|+..-|..|+....++-|.+|..
T Consensus 433 P~~--~~~~~g~~p~s~~L~~~~aw~~~--~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 433 PPA--VLPMIGNGPNSPMLTDKSAWSPV--FHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred Ccc--ccCCCCCCCCccccchhhhcCcc--cccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 100 000000000 000 00112111 1125778899999999999999999988864
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.1e-06 Score=81.43 Aligned_cols=148 Identities=20% Similarity=0.224 Sum_probs=91.8
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
....+|++.+.+-......|.+... +|..+.+|..+.... .. .+.+. ..... . .
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-----~~~kyIlK~pr~~~~--------------r~--er~~~-sf~kg-~---~ 81 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-----DGKKYILKEPREENR--------------RP--ERRFK-SFFKG-S---E 81 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-----CCcEEEEeccchhhh--------------hH--HHHHH-HHhcc-H---H
Confidence 3456788888888888777777654 688899997643210 00 00000 01111 1 2
Q ss_pred HHHHHHHHHhhc--CCCCcceeeEEEE-----eCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALT--GHKNLVQFYDAYE-----DDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 198 ~~~Ei~~l~~l~--~hpniv~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH 270 (482)
..+++..+.++. +--.+..++-+.+ -....+|||||++|..|.+.. .+++ .+...+.+++.-||
T Consensus 82 ~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ikqlH 152 (229)
T PF06176_consen 82 YSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIKQLH 152 (229)
T ss_pred HHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHHHHH
Confidence 233444444443 1333333333322 234567999999998876642 2333 24456778899999
Q ss_pred HCCCcccCCCCCceEEecCCCCCcEEEEeccccc
Q 011582 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSD 304 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~ 304 (482)
+.|++|+|.+|.|++++ ++.++++||+..+
T Consensus 153 ~~G~~HGD~hpgNFlv~----~~~i~iID~~~k~ 182 (229)
T PF06176_consen 153 KHGFYHGDPHPGNFLVS----NNGIRIIDTQGKR 182 (229)
T ss_pred HcCCccCCCCcCcEEEE----CCcEEEEECcccc
Confidence 99999999999999995 3349999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=4.3e-07 Score=94.94 Aligned_cols=170 Identities=19% Similarity=0.197 Sum_probs=100.0
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchh-----------hhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVI-----------FLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
+.||.-+.|.||+|+.+ +|+.||||+-+..+... ..-...-..+..-..+.||........
T Consensus 167 ~piaaASlaQVhrA~L~----~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~E---- 238 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK----NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQE---- 238 (538)
T ss_pred chhhhcchhheEEEEec----CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhh----
Confidence 45999999999999997 59999999987653210 000001111111333344443221111
Q ss_pred HHHHHHHHHHHhhc---CCCC------cceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 011582 196 EDVRREVKILRALT---GHKN------LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVV 266 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~---~hpn------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L 266 (482)
-+|.+|++...+++ .|-+ |.++| +.-.....|+||||+|..+.|.-.-....++...+...+.+...-+
T Consensus 239 LDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy--~~~st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q 316 (538)
T KOG1235|consen 239 LDFTKEAKNAERFRENFKDFSLLTYVLVPKVY--WDLSTKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ 316 (538)
T ss_pred cchHHHHHhHHHHHHHHHhcccccceeCCeeh--hhcCcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH
Confidence 12333443333322 1444 33332 2334577999999999876554322234567666555554443332
Q ss_pred HHHHHCCCcccCCCCCceEEecC-CCCCcEEEEecccccccCC
Q 011582 267 AFCHFQGVVHRDLKPENFLFTSK-EENSSLKAIDFGLSDYVKP 308 (482)
Q Consensus 267 ~yLH~~~ivHrDlkp~NIll~~~-~~~~~~kl~DfGla~~~~~ 308 (482)
- =..|++|+|-+|.||++..+ ..+..+.+-|||+......
T Consensus 317 I--f~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 317 I--FKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred H--HhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 2 34589999999999999743 3577899999999876543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.1e-06 Score=79.31 Aligned_cols=146 Identities=14% Similarity=0.091 Sum_probs=99.5
Q ss_pred eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhh
Q 011582 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL 208 (482)
Q Consensus 129 LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l 208 (482)
-|+||-+-|++... .|+.+-+|.-.......+. -+-....|.+|+..|..|
T Consensus 26 ~~rgG~SgV~r~~~-----~g~~~ylKrq~nhl~~s~r------------------------~P~g~ptf~rE~~~L~~L 76 (216)
T PRK09902 26 YRRNGMSGVQCVER-----NGKKLYVKRMTHHLFHSVR------------------------YPFGRPTIVREVAVIKEL 76 (216)
T ss_pred cCCCCcceEEEEEe-----CCcEEEEEeccCccccccc------------------------CCCCchHHHHHHHHHHHH
Confidence 46788888988765 4567888875321111100 022446789999999988
Q ss_pred cCC-CCcceeeEEEE-e----CCeEEEEEecCCC-CChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 209 TGH-KNLVQFYDAYE-D----DDNIYIVMELCKG-GELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 209 ~~h-pniv~l~~~~~-~----~~~~~lv~e~~~~-g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
... -.+.++. ++. . .-.-+||+|-+.| .+|.+++.+.. .+.++.....++.+++..+.-||+.|+.|+|+.
T Consensus 77 ~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly 155 (216)
T PRK09902 77 ERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCY 155 (216)
T ss_pred HHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 621 1244444 332 1 1236899998864 37777664431 345777788999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccc
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
+.|||+..++ ...++++||--++.
T Consensus 156 ~khIll~~~g-~~~v~lIDlEk~r~ 179 (216)
T PRK09902 156 VRHIYVKTEG-KAEAGFLDLEKSRR 179 (216)
T ss_pred HhheeecCCC-CeeEEEEEhhccch
Confidence 9999995322 33599999986553
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.5e-06 Score=82.27 Aligned_cols=73 Identities=21% Similarity=0.257 Sum_probs=54.1
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
..||.|..+.||+. .|..+++|+.... .....+.+|.++++
T Consensus 7 ~~i~~G~t~~~y~~-------~~~~~VlR~~~~~--------------------------------~~~~~i~~E~~~l~ 47 (226)
T TIGR02172 7 TQTGEGGNGESYTH-------KTGKWMLKLYNPG--------------------------------FDKETIKREFDASR 47 (226)
T ss_pred eeecCCCCcceeEe-------cCCCEEEEeCCCC--------------------------------CCHHHHHHHHHHHH
Confidence 45899999999973 2446888986432 11245688999999
Q ss_pred hhcCCC-CcceeeEEEEeCCeEEEEEecCCCCC
Q 011582 207 ALTGHK-NLVQFYDAYEDDDNIYIVMELCKGGE 238 (482)
Q Consensus 207 ~l~~hp-niv~l~~~~~~~~~~~lv~e~~~~g~ 238 (482)
.+.... .+.+.+++..+.+...+|||+++|..
T Consensus 48 ~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 48 KVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred HHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 986332 25778888888888899999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.49 E-value=9.2e-07 Score=97.66 Aligned_cols=208 Identities=22% Similarity=0.274 Sum_probs=146.1
Q ss_pred HHHHHHHHHHHHHHhhcCCCCcceeeEEEEeCCe----EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 011582 193 IAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN----IYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 193 ~~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~y 268 (482)
.......-|+..+.++. |+|++.++.|...... ..+..++|..-++...+... +..+...++.+..++++||.|
T Consensus 224 ~~i~~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~ 301 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAY 301 (1351)
T ss_pred HHHHHHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHH
Confidence 34455566777888887 9999999998765433 23556788888888766544 678999999999999999999
Q ss_pred HHHCCCcccCCCCCceEEecCCCCCcEEEE--ecccccccCCCCcccccccCccccCcccccccC---CCcchhhhhHHH
Q 011582 269 CHFQGVVHRDLKPENFLFTSKEENSSLKAI--DFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSY---GTEADMWSIGVI 343 (482)
Q Consensus 269 LH~~~ivHrDlkp~NIll~~~~~~~~~kl~--DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~DiwSlGvi 343 (482)
+|+....|.-+..+-..-...+..+.+.+. ||+................+..+.++|...... +...|+|.+|.+
T Consensus 302 ~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 302 LHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred HHHhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 999965555554442222222455566666 888887766555444445566788888776442 334699999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCC-HHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 344 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS-PEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 344 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s-~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
+..+..|..+-... .....++. ..+ .+..+++.+|+.-++++|+++.+++.|+|++...
T Consensus 382 ~~~~~~~~~i~~~~---~~~~~~l~-----------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~ 441 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKS---AVPVSLLD-----------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT 441 (1351)
T ss_pred HhhhhhcCcccccc---cchhhhhc-----------cccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence 99999886653111 11111111 112 2678999999999999999999999999998654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.7e-06 Score=77.91 Aligned_cols=141 Identities=18% Similarity=0.224 Sum_probs=83.1
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
++.|+.|..+.||++... +..+++|+... ......+.+|+.++
T Consensus 2 i~~l~~G~~n~~~~v~~~-----~~~~vlK~~~~--------------------------------~~~~~~~~~e~~~~ 44 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTD-----DGRYVLKFYRP--------------------------------PDAAERLRREAAVL 44 (239)
T ss_dssp EEEEEESSSSEEEEEEET-----TSEEEEEEESS--------------------------------HHHHHHHHHHHHHH
T ss_pred CccCCCCCeeeEEEEEEC-----CcEEEEEEeCC--------------------------------CCCHHHHHHHHHHH
Confidence 356999999999999874 35899998642 13456788999999
Q ss_pred HhhcCC-CCcceeeEEEE---eCCeEEEEEecCCCCChHH----------------HHH---hc---CCCCCHHH-----
Q 011582 206 RALTGH-KNLVQFYDAYE---DDDNIYIVMELCKGGELLD----------------RIL---SR---GGKYSEED----- 254 (482)
Q Consensus 206 ~~l~~h-pniv~l~~~~~---~~~~~~lv~e~~~~g~L~~----------------~l~---~~---~~~l~~~~----- 254 (482)
+.|..+ ..+.+++.+.. .....+++|++++|..+.. .+. .. ...+....
T Consensus 45 ~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~ 124 (239)
T PF01636_consen 45 RQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLE 124 (239)
T ss_dssp HHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHH
T ss_pred HHHHhcCCCCceEEeecccccccccceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccc
Confidence 988744 23567776443 3446799999999987766 111 11 01111100
Q ss_pred ----HHHH------------HHHHHH-HHHHHHH-------CCCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 255 ----AKIV------------MVQILS-VVAFCHF-------QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 255 ----~~~i------------~~qi~~-~L~yLH~-------~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
.... ...+.. .+..+++ ..++|+|+.|.|||++ ..++.+.|+||+.+..
T Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~--~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 125 FLRQLESWTARLRASELFDDLEELEERLLQELEALLPKPLPPVLIHGDLHPGNILVD--PSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEE--SSTTEEEE--GTT-EE
T ss_pred cccccccccccccchhhhhhhHHHHHHHHHHHHhhhccCCCcEEEEeccccccceee--eccceeEEEecccceE
Confidence 0000 111222 3333332 3599999999999995 2455668999987754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.37 E-value=3.6e-06 Score=80.55 Aligned_cols=75 Identities=20% Similarity=0.260 Sum_probs=53.8
Q ss_pred eecCCc-eEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 129 VGRGHF-GYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 129 LG~G~f-G~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
|-.|.. ..||++.. .+..+.||+.... . ...+.+|+.+++.
T Consensus 6 ~~~g~~~~~v~~~~~-----~~~~~~vk~~~~~------------------------------~---~~~~~~E~~~l~~ 47 (244)
T cd05150 6 VTEGQSGATVYRLDG-----KNPGLYLKIAPSG------------------------------P---TYELEREAERLRW 47 (244)
T ss_pred cCCCCCcCeEEEEcC-----CCCcEEEEecCCC------------------------------c---ccchHHHHHHHHH
Confidence 444555 68888854 3457888876431 0 2356789999999
Q ss_pred hcCCCCcceeeEEEEeCCeEEEEEecCCCCChHH
Q 011582 208 LTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241 (482)
Q Consensus 208 l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~ 241 (482)
+.++--+.+++++....+..++|||+++|.+|..
T Consensus 48 l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 48 LAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred HHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 9766556688888877777899999999977653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.33 E-value=9.1e-06 Score=74.56 Aligned_cols=145 Identities=23% Similarity=0.248 Sum_probs=95.4
Q ss_pred cceEecceeecCCc-eEEEEEEEecCCCCCceEEEEEeecccchhhhhccCC--CCCCcchhhhhhhhhhccccHHHHHH
Q 011582 121 AHYELGEEVGRGHF-GYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCP--KHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 121 ~~y~~~~~LG~G~f-G~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
+++++++.||.|.- |.||+++. .|+.||+|+...-.. ...... ..+.+... ..........
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-----~g~~YALKlf~~~~~---~~~~~~~~~~~~~~~~--------~~~~~~y~~P 100 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-----DGRIYALKLFRFWDY---TEPDYTRERFAGHETS--------LSTPAHYADP 100 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-----CCeEEEEEEeecccc---CCCccccccccccccc--------cchhhhhcCh
Confidence 67999999999999 99999987 688999999432100 000000 00000000 0111233457
Q ss_pred HHHHHHHHHhhc--CCCCc--ceeeEEEEeC------------------CeEEEEEecCCCCChHHHHHhcCCCCCHHHH
Q 011582 198 VRREVKILRALT--GHKNL--VQFYDAYEDD------------------DNIYIVMELCKGGELLDRILSRGGKYSEEDA 255 (482)
Q Consensus 198 ~~~Ei~~l~~l~--~hpni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~ 255 (482)
|..|.....+|+ ++.++ |+.+|+..-. ....||.||.+... .+.
T Consensus 101 F~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~---- 166 (207)
T PF13095_consen 101 FNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQ---- 166 (207)
T ss_pred HHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccc----
Confidence 888988888776 24456 8888886322 12468888876643 122
Q ss_pred HHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccc
Q 011582 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303 (482)
Q Consensus 256 ~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla 303 (482)
..-+.+|++-|..+|..||+-+|+++.|..= -||+|||.+
T Consensus 167 ~~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 167 IRDIPQMLRDLKILHKLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred hhHHHHHHHHHHHHHHCCeeeccCccccccC--------CEEEecccC
Confidence 2345678888899999999999999999873 499999964
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.32 E-value=7e-06 Score=77.06 Aligned_cols=169 Identities=17% Similarity=0.136 Sum_probs=99.7
Q ss_pred ccccceEecce---eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhcc-ccHH
Q 011582 118 QFVAHYELGEE---VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFM-TTAI 193 (482)
Q Consensus 118 ~~~~~y~~~~~---LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 193 (482)
.+.++..+... |..|.-+.||+|... .+..+|||+++..............++ ..+. .... ....
T Consensus 42 ~L~~rg~i~~~~g~istGKEA~Vy~a~~~----~~~~~avKiyr~~t~~fk~~~~Yi~gd-~Rf~------~~~~~rr~l 110 (268)
T COG1718 42 RLLSRGVITELVGCISTGKEANVYLAETG----DGRYVAVKIYRTSTSEFKRIRRYIQGD-PRFR------NSRSNRRKL 110 (268)
T ss_pred HHhcCCceeeeEeeecCCcceEEEeeccC----CCceEEEEEEehhhhhhhhHHHHHhcC-hhhh------cCCCCHHHH
Confidence 34445555554 455556689999864 588999999865311100000000000 0000 0000 0111
Q ss_pred HHHHHHHHHHHHHhhcC-CCCcceeeEEEEeCCeEEEEEecCCCCChH-HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 194 AIEDVRREVKILRALTG-HKNLVQFYDAYEDDDNIYIVMELCKGGELL-DRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 194 ~~~~~~~Ei~~l~~l~~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~-~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
...-...|+..|+++.+ +=.+.+.+.+. .-.|||||+....+- -.|. .-.+...++..+..++++.+.-|-.
T Consensus 111 v~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 111 VFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHH
Confidence 22234578888887752 23445555443 347999999543111 1111 1233444788889999999988876
Q ss_pred -CCCcccCCCCCceEEecCCCCCcEEEEecccccccC
Q 011582 272 -QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK 307 (482)
Q Consensus 272 -~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~ 307 (482)
.|+||+||..-|||+. ++.+.|+|||.|....
T Consensus 185 ~a~LVHgDLSEyNiL~~----~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 EAGLVHGDLSEYNILVH----DGEPYIIDVSQAVTID 217 (268)
T ss_pred hcCcccccchhhheEEE----CCeEEEEECccccccC
Confidence 8999999999999993 6679999999887654
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.8e-06 Score=91.49 Aligned_cols=150 Identities=22% Similarity=0.362 Sum_probs=90.3
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.|+.|.++.+|+.....+. ....+++|+.... ........+.+|+.+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~-~~~~~VLR~~p~~-----------------------------~~~~~~~~~~rE~~~l 92 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGG-SVKRYVLRKKPPG-----------------------------KLLQSAHAVEREYQVL 92 (822)
T ss_pred EEEeCCCCcCceEEEEECCCC-cceeEEEEeCCCC-----------------------------ccCccHHHHHHHHHHH
Confidence 355899999999998754311 1146777765431 0001124678999999
Q ss_pred HhhcCCCCc--ceeeEEEEeC---CeEEEEEecCCCCChHH--------------------H---HHhcCC---------
Q 011582 206 RALTGHKNL--VQFYDAYEDD---DNIYIVMELCKGGELLD--------------------R---ILSRGG--------- 248 (482)
Q Consensus 206 ~~l~~hpni--v~l~~~~~~~---~~~~lv~e~~~~g~L~~--------------------~---l~~~~~--------- 248 (482)
+.|.+|.++ .+++.++.+. +..|+||||++|..+.+ . |+.-..
T Consensus 93 ~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g 172 (822)
T PLN02876 93 RALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYG 172 (822)
T ss_pred HHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcC
Confidence 999656654 7788777664 46799999998864321 1 111000
Q ss_pred -C--CCHHHHHHHHHH---------------HHHHHHHHHH-----------CCCcccCCCCCceEEecCCCCCcEEEEe
Q 011582 249 -K--YSEEDAKIVMVQ---------------ILSVVAFCHF-----------QGVVHRDLKPENFLFTSKEENSSLKAID 299 (482)
Q Consensus 249 -~--l~~~~~~~i~~q---------------i~~~L~yLH~-----------~~ivHrDlkp~NIll~~~~~~~~~kl~D 299 (482)
. +...++..+..+ +...+.+|.. ..+||+|+++.|||+..+ +....-|.|
T Consensus 173 ~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~-~~~v~aVLD 251 (822)
T PLN02876 173 RRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPT-EDRVIGILD 251 (822)
T ss_pred CCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCC-CCeEEEEEe
Confidence 0 111233222221 2234566643 249999999999999531 223468999
Q ss_pred ccccccc
Q 011582 300 FGLSDYV 306 (482)
Q Consensus 300 fGla~~~ 306 (482)
|.++..-
T Consensus 252 WE~a~~G 258 (822)
T PLN02876 252 WELSTLG 258 (822)
T ss_pred eeccccC
Confidence 9998753
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.25 E-value=8e-06 Score=72.67 Aligned_cols=131 Identities=24% Similarity=0.348 Sum_probs=90.8
Q ss_pred EecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHH
Q 011582 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVK 203 (482)
Q Consensus 124 ~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~ 203 (482)
+..+.||+|++|.||++.. .|..+|+|+-+.. .....+..|++
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-----~~~~~a~Kvrr~d--------------------------------s~r~~l~kEak 67 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-----RGGEVALKVRRRD--------------------------------SPRRNLEKEAK 67 (201)
T ss_pred hhhhhhhcccccEEEEeec-----cCceEEEEEecCC--------------------------------cchhhHHHHHH
Confidence 4456799999999999986 5779999985432 23467889999
Q ss_pred HHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC-C-
Q 011582 204 ILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK-P- 281 (482)
Q Consensus 204 ~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk-p- 281 (482)
+|..+..----.++|.|.++ ++.|||+.|-.|.+.... .+.. -+..+++.---|-..||-|..|. |
T Consensus 68 iLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~----~~rk----~l~~vlE~a~~LD~~GI~H~El~~~~ 135 (201)
T COG2112 68 ILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIG----GDRK----HLLRVLEKAYKLDRLGIEHGELSRPW 135 (201)
T ss_pred HHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhc----ccHH----HHHHHHHHHHHHHHhccchhhhcCCc
Confidence 99998744444566665443 445999999887764321 1222 33445555555677899999997 3
Q ss_pred CceEEecCCCCCcEEEEecccccccC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVK 307 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~ 307 (482)
.||++. +..+.|+||..|+...
T Consensus 136 k~vlv~----~~~~~iIDFd~At~k~ 157 (201)
T COG2112 136 KNVLVN----DRDVYIIDFDSATFKK 157 (201)
T ss_pred eeEEec----CCcEEEEEccchhhcc
Confidence 366663 3369999999988543
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.14 E-value=7.8e-05 Score=68.85 Aligned_cols=147 Identities=18% Similarity=0.267 Sum_probs=95.9
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
..||+|+.-.||.- . ......||+..... ...........+ .........+..+|+.-..
T Consensus 7 ~~i~~G~~R~cy~H--P----~dp~~cIKV~~~~~---------~~~~~~~~~~~k-----~~~~~~~~~~~~~E~~~y~ 66 (199)
T PF10707_consen 7 DLIAQGGERDCYQH--P----DDPNLCIKVMRPDR---------GERRRPFKRWLK-----RLRPKSRYRQNRRELRYYK 66 (199)
T ss_pred cccccCCCceEEEC--C----CCCCeEEEEEcccc---------ccccccchhHHH-----hhcccchhHHHHHHHHHHH
Confidence 35899999988853 2 35568999987641 000000000000 0111223455666666655
Q ss_pred hhc-----CCCCcceeeEEEEeCCeEEEEEecCCC------CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 207 ALT-----GHKNLVQFYDAYEDDDNIYIVMELCKG------GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 207 ~l~-----~hpniv~l~~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
.+. .+.+|.+++|+.+++-..-+|+|.+.. .+|.+++.+ +.+++ . +...+-+-..||-+++|+
T Consensus 67 ~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~---~~~~L~~f~~~l~~~~Iv 140 (199)
T PF10707_consen 67 QLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-E---LRQALDEFKRYLLDHHIV 140 (199)
T ss_pred HHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-H---HHHHHHHHHHHHHHcCCe
Confidence 553 378999999999999999999998632 267776632 34665 3 333444555788899999
Q ss_pred ccCCCCCceEEecCCCCC-cEEEEe
Q 011582 276 HRDLKPENFLFTSKEENS-SLKAID 299 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~-~~kl~D 299 (482)
.+|++|.||++...++.. .+.|+|
T Consensus 141 ~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 141 IRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ecCCCcccEEEEecCCCceEEEEEe
Confidence 999999999998766555 788888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.92 E-value=5.6e-05 Score=71.97 Aligned_cols=30 Identities=33% Similarity=0.449 Sum_probs=24.4
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
+++|+|+.+.|||++ ++....|+||+.+..
T Consensus 165 ~l~HGD~~~~Nvlv~---~~~i~giIDw~~a~~ 194 (235)
T cd05155 165 VWFHGDLAPGNLLVQ---DGRLSAVIDFGCLGV 194 (235)
T ss_pred eEEeCCCCCCcEEEE---CCCEEEEEeCcccCc
Confidence 489999999999994 444457999998764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.87 E-value=1.5e-06 Score=97.84 Aligned_cols=210 Identities=17% Similarity=0.044 Sum_probs=149.0
Q ss_pred HHHHHHHHHHHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHH
Q 011582 193 IAIEDVRREVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVA 267 (482)
Q Consensus 193 ~~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~ 267 (482)
..++-...|...++... |+++...+.-... ....|.+++||.+|.+++.|.+. ...+.+.-+.....+.+.+..
T Consensus 1271 Plkemll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1271 PLKEMLLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRN 1349 (2724)
T ss_pred HHHHhhhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccc
Confidence 34445556666666666 9998887765543 34579999999999999988754 234555566666666678888
Q ss_pred HHHHCC-----CcccCCCCCceEEecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhh
Q 011582 268 FCHFQG-----VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSI 340 (482)
Q Consensus 268 yLH~~~-----ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSl 340 (482)
-+|+.. .+|+++|+-|.+| ..+.++|++++|+.+...+ .......++++.|+.+++.+. .++.++|+|..
T Consensus 1350 ~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~ 1426 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRR 1426 (2724)
T ss_pred hhhhcccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHH
Confidence 877642 7999999999999 5677899999999984332 233455678899999998875 68888999999
Q ss_pred HHHHHHHhhCCCCCCCCChHHHHHHHHhcCC----CCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 341 GVIAYILLCGSRPFWARTESGIFRAVLKADP----SFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 341 Gvil~elltg~~pf~~~~~~~~~~~i~~~~~----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
|+.+|+..-|..+|.. ..+.++++.. .+..+. -.|.++......+|-+.-..||.-...+.-+.+.
T Consensus 1427 s~~ly~rs~~n~~fi~-----flq~~Lkgiidn~tf~sIe~--l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1427 SLSLYLRSDGNAYFIF-----FLQPALKGIIDNHTFFSIEK--LKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred HHHHHHHhcccHHHHH-----HHHHHHcCcccccccccccc--cCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 9999999999888733 2233333221 111111 1345566666677777777889888888877664
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.81 E-value=0.0002 Score=67.96 Aligned_cols=76 Identities=21% Similarity=0.299 Sum_probs=47.9
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.|..|-...+|++....+ .+..|++|+..... .......+|+.+++
T Consensus 4 ~~l~gG~tN~~~~v~~~~~--~~~~~vlR~~~~~~-------------------------------~~~~d~~~E~~~~~ 50 (235)
T cd05157 4 KRFTGGITNKLVKVSNKED--NQDAVLVRVYGNKT-------------------------------ELIIDRERELRIHK 50 (235)
T ss_pred EEcCCcccceEEEEEcCCC--CCCeEEEEEccCCc-------------------------------cceecHHHHHHHHH
Confidence 4577788889998865311 14678899764310 00112357999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCCh
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 239 (482)
.+..+.-..+++..+. + .+||||++|.++
T Consensus 51 ~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~l 79 (235)
T cd05157 51 LLSKHGLAPKLYATFQ--N--GLIYEFIPGRTL 79 (235)
T ss_pred HHHhCCCCCeEEEEeC--C--cEEEEeeCCCcC
Confidence 8864444555654432 2 479999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.70 E-value=0.00013 Score=66.86 Aligned_cols=101 Identities=21% Similarity=0.238 Sum_probs=79.5
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHH--HhcCCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI--LSRGGKYSEEDAKIVMVQILSVVAFCHF---QG 273 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l--~~~~~~l~~~~~~~i~~qi~~~L~yLH~---~~ 273 (482)
.+|.-+|+.+.+.+++.+++|+|-. ++|.||...+++.... ...-..-+|....+|+.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 3688899999865799999999843 7799999877654210 0111346899999999999999999998 35
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEeccccccc
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV 306 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~ 306 (482)
+.-.|++++|+-+ ++++.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence 8889999999999 46678999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0011 Score=67.75 Aligned_cols=84 Identities=19% Similarity=0.279 Sum_probs=54.2
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||.|.+..||++.... .++.|+||.-.... .+.. + .-....++...|.+.|+
T Consensus 32 ~elggGn~N~VyrV~~~~---g~~svIVKqa~p~~-------r~~g-~---------------~wpl~~eR~~~Eae~L~ 85 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTE---GGKSVIVKQALPYV-------RVVG-E---------------SWPLTLDRARIEAEALK 85 (401)
T ss_pred eEcCCCceEEEEEEEeCC---CCeEEEEEecCccc-------cccc-c---------------cccccHHHHHHHHHHHH
Confidence 469999999999998753 22589999743210 0000 0 00123456777888888
Q ss_pred hhcCC--CCcceeeEEEEeCCeEEEEEecCCCCC
Q 011582 207 ALTGH--KNLVQFYDAYEDDDNIYIVMELCKGGE 238 (482)
Q Consensus 207 ~l~~h--pniv~l~~~~~~~~~~~lv~e~~~~g~ 238 (482)
.+..+ .++.+++.+ +.+..++||||+++..
T Consensus 86 ~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 86 IQAKYVPDLVPKVYHY--DEELAVTVMEDLSDHK 117 (401)
T ss_pred HHHhhCCCCCCeEEEE--CCCCCEEEEecCCCcc
Confidence 76533 456777765 5566899999998754
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00058 Score=67.26 Aligned_cols=139 Identities=17% Similarity=0.137 Sum_probs=81.9
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.|..|....+|++.. .+..+++|+.... ....+..|+.++
T Consensus 19 i~~i~~G~~n~~y~v~~-----~~~~~vLr~~~~~---------------------------------~~~~~~~e~~~l 60 (296)
T cd05153 19 FEGISAGIENTNYFVTT-----DSGRYVLTLFEKV---------------------------------SAEELPFFLALL 60 (296)
T ss_pred eecccCccccceEEEEe-----CCCcEEEEEcCCC---------------------------------ChHhccHHHHHH
Confidence 34577787789998764 3446888986421 124567788888
Q ss_pred HhhcCCC-CcceeeE------EEEeCCeEEEEEecCCCCChHH--------------HHHhcCCCC----------CHHH
Q 011582 206 RALTGHK-NLVQFYD------AYEDDDNIYIVMELCKGGELLD--------------RILSRGGKY----------SEED 254 (482)
Q Consensus 206 ~~l~~hp-niv~l~~------~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~l----------~~~~ 254 (482)
..|..+- .+.+++. +....+..++|++|++|..+.. .++.....+ .+..
T Consensus 61 ~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~ 140 (296)
T cd05153 61 DHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIR 140 (296)
T ss_pred HHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHH
Confidence 8886331 2445443 2234567799999999876421 111100000 1100
Q ss_pred H----------HHHHHHHHHHHHHHHH-------CCCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 255 A----------KIVMVQILSVVAFCHF-------QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 255 ~----------~~i~~qi~~~L~yLH~-------~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
. ......+..++.++.. .++||+|+.|.|||++ ++..+.|+||+.+..
T Consensus 141 ~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~~iIDfe~a~~ 205 (296)
T cd05153 141 ELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFD---GDELSGVIDFYFACT 205 (296)
T ss_pred HHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEe---CCceEEEeehhhhcC
Confidence 0 0111223344555543 4699999999999994 455568999997753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00029 Score=67.95 Aligned_cols=134 Identities=19% Similarity=0.166 Sum_probs=74.7
Q ss_pred eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhh
Q 011582 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL 208 (482)
Q Consensus 129 LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l 208 (482)
+..|-.+.+|+... +|..+++|+..... ....-...+|..+++.+
T Consensus 4 ~~~G~tn~~y~~~~-----~~~~~vlR~~~~~~------------------------------~~~~~~r~~E~~~l~~l 48 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-----PGISFVWRPQSPVC------------------------------KALGVDRQREYQILQAL 48 (256)
T ss_pred CCCcCcCCeEEEEe-----CCccEEEeeCCccc------------------------------ccccCcHHHHHHHHHHH
Confidence 45677778888763 56788898754320 00001246799999988
Q ss_pred cCCCCcceeeEEEEeCCeEEEEEecCCCCChHH----------HH-------Hhc---CCCCCH-HHHHHHHHHH-----
Q 011582 209 TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD----------RI-------LSR---GGKYSE-EDAKIVMVQI----- 262 (482)
Q Consensus 209 ~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~----------~l-------~~~---~~~l~~-~~~~~i~~qi----- 262 (482)
..+.-..+++... . -++||||++|..+.. .+ +.. +..++. ..+..+..++
T Consensus 49 ~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~ 124 (256)
T TIGR02721 49 SALGLAPKPILVN--E--HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARR 124 (256)
T ss_pred HhcCCCCceEEEe--C--CEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccC
Confidence 7442234444433 2 368999999865421 11 111 111221 1122222111
Q ss_pred ----HHHHHHHHH--------CCCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 263 ----LSVVAFCHF--------QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 263 ----~~~L~yLH~--------~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
...+..+-. ..++|+|+.|.||+++ +++ +.|+||..|..
T Consensus 125 ~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~---~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 125 TPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT---PQG-LKLIDWEYASD 175 (256)
T ss_pred ChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe---CCC-CEEEeccccCc
Confidence 111222222 2489999999999995 333 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF00036 EF-hand_1: EF hand; InterPro: IPR018248 Many calcium-binding proteins belong to the same evolutionary family and share a type of calcium-binding domain known as the EF-hand | Back alignment and domain information |
|---|
Probab=97.54 E-value=3.7e-05 Score=47.39 Aligned_cols=23 Identities=26% Similarity=0.534 Sum_probs=21.4
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+.++|+.+|.|+||+||.+||+.
T Consensus 2 ~~~~F~~~D~d~dG~I~~~Ef~~ 24 (29)
T PF00036_consen 2 LKEAFREFDKDGDGKIDFEEFKE 24 (29)
T ss_dssp HHHHHHHHSTTSSSEEEHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHH
Confidence 67899999999999999999975
|
This type of domain consists of a twelve residue loop flanked on both sides by a twelve residue alpha-helical domain. In an EF-hand loop the calcium ion is coordinated in a pentagonal bipyramidal configuration. The six residues involved in the binding are in positions 1, 3, 5, 7, 9 and 12; these residues are denoted by X, Y, Z, -Y, -X and -Z. The invariant Glu or Asp at position 12 provides two oxygens for liganding Ca (bidentate ligand).; PDB: 1BJF_A 1XFW_R 1XFV_O 2K0J_A 2F3Z_A 3BYA_A 1XFU_Q 2R28_B 1ZOT_B 3G43_D .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00095 Score=66.16 Aligned_cols=164 Identities=18% Similarity=0.172 Sum_probs=100.2
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
...|..|.-+.||.|... +|..+|||+++-+..+-...-..-.++.+ +-.-+| .........--...|+..|
T Consensus 149 nGCiSTGKEANVYHat~~----dG~~~AIKIYKTSILvFKDRdRYV~GEfR---FRhgyc-k~NPRKMVk~WAEKE~RNL 220 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEE----DGSEFAIKIYKTSILVFKDRDRYVSGEFR---FRHGYC-KHNPRKMVKTWAEKEMRNL 220 (520)
T ss_pred ccccccCccceeEeeecC----CCceEEEEEEeeeEEEEechhhhccceee---eecccc-cCCcHHHHHHHHHHHHHHH
Confidence 334777888899998765 68889999997764432222222222211 111111 1111222233446788888
Q ss_pred HhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HHCCCcccCCCCCce
Q 011582 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFC-HFQGVVHRDLKPENF 284 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yL-H~~~ivHrDlkp~NI 284 (482)
+++. ...|.-.--+.. ....|||+|+.......-. -+...++...+..+-.|++.-+.-| |..++||.||.--|+
T Consensus 221 kRl~-~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~ 296 (520)
T KOG2270|consen 221 KRLN-NAGIPCPEPILL--KNHVLVMEFLGRDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNL 296 (520)
T ss_pred HHHH-hcCCCCCCceee--ecceEeeeeccCCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhh
Confidence 8886 333322111111 2347999999533221111 1234678888888888888888776 456899999999999
Q ss_pred EEecCCCCCcEEEEecccccc
Q 011582 285 LFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 285 ll~~~~~~~~~kl~DfGla~~ 305 (482)
|+ .++.+.|+|-+-+.-
T Consensus 297 Ly----hdG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 297 LY----HDGKLYIIDVSQSVE 313 (520)
T ss_pred eE----ECCEEEEEEcccccc
Confidence 99 477899999886643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.51 E-value=0.00089 Score=66.42 Aligned_cols=31 Identities=42% Similarity=0.643 Sum_probs=25.5
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
.++||+|+++.||+++ .++.+.|+||+.+..
T Consensus 187 ~~l~HgD~~~~Nvl~~---~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 187 RGVIHADLFPDNVLFD---GDSVKGVIDFYFACT 217 (307)
T ss_pred CccCCCCCCcCcEEEE---CCceEEEeecccccC
Confidence 5799999999999994 445568999997753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF13202 EF-hand_5: EF hand; PDB: 3DD4_A 2Q4U_A 2BE4_A 1UHJ_B 1UHI_A 1UHH_B 1EJ3_B 1UHK_A 2ZFD_A 1UHN_A | Back alignment and domain information |
|---|
Probab=97.48 E-value=6.5e-05 Score=44.60 Aligned_cols=23 Identities=22% Similarity=0.556 Sum_probs=20.9
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
|+..|+.+|.|+||+||.+||+.
T Consensus 1 l~~~F~~~D~d~DG~is~~E~~~ 23 (25)
T PF13202_consen 1 LKDAFQQFDTDGDGKISFEEFQR 23 (25)
T ss_dssp HHHHHHHHTTTSSSEEEHHHHHH
T ss_pred CHHHHHHHcCCCCCcCCHHHHHH
Confidence 56789999999999999999974
|
... |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.00084 Score=66.36 Aligned_cols=78 Identities=14% Similarity=0.158 Sum_probs=48.0
Q ss_pred eeecCCceEEEEEEEecC---CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHH
Q 011582 128 EVGRGHFGYTCSAKAKKG---SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKI 204 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~---~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~ 204 (482)
.|..|-...||++....+ ...++.|++|+.... ........+|+.+
T Consensus 5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~-------------------------------~~~~~~r~~E~~~ 53 (302)
T cd05156 5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQS-------------------------------VELLIDRERELVV 53 (302)
T ss_pred EecCcccceeEEEEcCCcccccCCCCeEEEEEecCC-------------------------------CcceechHHHHHH
Confidence 455566668888865321 112578999986432 0112345789999
Q ss_pred HHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChH
Q 011582 205 LRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240 (482)
Q Consensus 205 l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~ 240 (482)
+..+..+--..+++.++.. .+|+||++|..+.
T Consensus 54 ~~~l~~~g~~P~~~~~~~~----~~v~e~i~G~~l~ 85 (302)
T cd05156 54 FARLSERNLGPKLYGIFPN----GRIEEFIPSRTLT 85 (302)
T ss_pred HHHHHhCCCCCceEEEeCC----CchhheeCCCcCC
Confidence 9888744434456655532 3589999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.00026 Score=68.97 Aligned_cols=155 Identities=15% Similarity=0.196 Sum_probs=97.2
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH--HHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI--EDVR 199 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~ 199 (482)
-|.+++.||-|.-+.||.+-+. .|++.++|+=+-.. ..+-.++... .+. ......+...+ -...
T Consensus 93 v~svGnqIGVGKESDIY~v~d~----~G~~~~lK~HRLGR-tSFR~Vk~kR----DY~-----r~r~~~sWlyLSRlaa~ 158 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADE----EGNPLILKLHRLGR-TSFRNVKNKR----DYL-----RKRKSGSWLYLSRLAAT 158 (465)
T ss_pred hhhhccccccccccceEEEecC----CCCchhHHHHhhhh-hhHHHhhhhh----hhH-----hcCCccchhhhHHHHHH
Confidence 4678899999999999999876 58899999632210 0010110000 000 00001112222 2346
Q ss_pred HHHHHHHhhcCCCC-cceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKN-LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpn-iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|...|+.|..|-. +.+.++ -+..++|||++.|-.|...- ...+ +..+...+..-+.-|-.+|+||+|
T Consensus 159 kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~----~v~d---~~~ly~~lm~~Iv~la~~GlIHgD 227 (465)
T KOG2268|consen 159 KEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVR----HVED---PPTLYDDLMGLIVRLANHGLIHGD 227 (465)
T ss_pred HHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeee----ecCC---hHHHHHHHHHHHHHHHHcCceecc
Confidence 79999999975543 344444 35679999999887765421 1122 333444555566678899999999
Q ss_pred CCCCceEEecCCCCCcEEEEeccccc
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSD 304 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~ 304 (482)
..-=||++ +++..++++||--..
T Consensus 228 FNEFNimv---~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 228 FNEFNIMV---KDDDKIVVIDFPQMV 250 (465)
T ss_pred cchheeEE---ecCCCEEEeechHhh
Confidence 99999999 557789999997543
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0091 Score=59.45 Aligned_cols=31 Identities=35% Similarity=0.493 Sum_probs=24.9
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
.++||+|+.+.|||+. ++...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~---~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFE---GDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEE---CCceEEEEecccccC
Confidence 3799999999999994 344458999997753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.0071 Score=59.90 Aligned_cols=29 Identities=28% Similarity=0.549 Sum_probs=24.1
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEeccccc
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSD 304 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~ 304 (482)
.++||+|+.+.||+++ . +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECcccc
Confidence 4789999999999994 3 458999998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0013 Score=67.86 Aligned_cols=164 Identities=21% Similarity=0.205 Sum_probs=106.1
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeC-CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDD-DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
.+.--..+++.+. |+|.+.++++-... ....+|||++ +.+|.+.+..+. +-..... .
T Consensus 28 ~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--l~~~s~~------------------~ 85 (725)
T KOG1093|consen 28 QILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--LKDESLL------------------A 85 (725)
T ss_pred HHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc--cchhhhc------------------c
Confidence 4556677888897 99999999887643 3478999999 568888775442 2111111 2
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||=+ +-|| ++++| -++... ... ..+|+||||+|.++.++..|...+.
T Consensus 86 ~~~~-~~~~----------~~~td-~~~t~~------~~~---------------~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 86 HGVL-HLNI----------IYITD-HFLTKY------PSP---------------IGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred cccc-eehh----------hhccc-cccccC------CCC---------------CCcchhhhhHHHHHHHHHHhhHHHH
Confidence 2211 1122 23333 111110 111 1249999999999999999988887
Q ss_pred CCChHHHHHHHHhcCCCCCCCC--------CCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 356 ARTESGIFRAVLKADPSFDEAP--------WPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~--------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.....+..+.+.+......... .-..+....++..+|+-..|..||...++.+++-|.+-
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 7776666666665432211110 01245667789999999999999999999999988653
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.0062 Score=61.47 Aligned_cols=141 Identities=15% Similarity=0.175 Sum_probs=79.2
Q ss_pred eeecCCceEEEEEEEecCC-CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 128 EVGRGHFGYTCSAKAKKGS-LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~-~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
.|-.|-.-.+|++....+. ..++.|++|+.... .... -...+|+.+++
T Consensus 43 ~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~------------------------------t~~~-idR~~E~~~~~ 91 (344)
T PLN02236 43 PLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEG------------------------------VELF-FDRDDEIRTFE 91 (344)
T ss_pred EcCCcccceeEEEEeCCCCCCCCCeEEEEEccCC------------------------------CCee-echHHHHHHHH
Confidence 3444677788887643211 13467999987542 0001 12367999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHH-----------------HHhcC---CC-C-CHHHHHHHHHHH--
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR-----------------ILSRG---GK-Y-SEEDAKIVMVQI-- 262 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~-----------------l~~~~---~~-l-~~~~~~~i~~qi-- 262 (482)
.+.++.--.++++.+.. + .|+||++|.+|... ++... .. . ....+..++.++
T Consensus 92 ~l~~~gl~P~~~~~~~~-g---~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~ 167 (344)
T PLN02236 92 CMSRHGQGPRLLGRFPN-G---RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKN 167 (344)
T ss_pred HHHHcCCCCceEEEECC-c---eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHh
Confidence 88755445566766533 2 58999987665311 11111 00 1 122333333221
Q ss_pred ---------------HHHHHHH----H----HCCCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 263 ---------------LSVVAFC----H----FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 263 ---------------~~~L~yL----H----~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
...+..| . ...++|+|+++.|||++. .++.+.|+||..+..
T Consensus 168 l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~--~~~~~~lID~Eya~~ 231 (344)
T PLN02236 168 LCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDE--ETRAITIIDYEYASY 231 (344)
T ss_pred hcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeC--CCCcEEEEeehhccc
Confidence 1112222 1 125899999999999952 245799999987764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0076 Score=58.84 Aligned_cols=32 Identities=25% Similarity=0.351 Sum_probs=24.6
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEeccccccc
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV 306 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~ 306 (482)
.++|+|+++.|||++. +....-|+||+.+...
T Consensus 186 ~lvHGD~~~~Nilv~~--~~~~~gviDWe~a~iG 217 (276)
T cd05152 186 VLVHGDLHPGHILIDE--DARVTGLIDWTEAKVG 217 (276)
T ss_pred eeEeCCCCCCcEEEeC--CCCEEEEECcHhcccC
Confidence 3899999999999952 1334579999988653
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.0072 Score=60.65 Aligned_cols=30 Identities=33% Similarity=0.608 Sum_probs=25.0
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
++|.|+.+.|||++ ++++.++++||..|..
T Consensus 184 ~CHnDl~~~NiL~~--~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLN--EDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEe--CCCCcEEEEcccccCC
Confidence 79999999999995 2345799999998754
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.012 Score=59.10 Aligned_cols=83 Identities=18% Similarity=0.187 Sum_probs=50.1
Q ss_pred eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
+||-|....||++.... .++.|+||.-...+. +.. + .-....++..-|...|+.
T Consensus 2 EigdGnlN~VfrV~~~~---g~~svIVKQAlp~vR-------v~g-~---------------~wpl~~~R~~~E~~~L~~ 55 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQE---GDRAAIVKQALPYVR-------VVG-E---------------SWPLTLDRARIESSALIR 55 (370)
T ss_pred cCCCCceEEEEEEEcCC---CCeeEEEEEcCHHHh-------hcC-C---------------CCCCCccHHHHHHHHHHH
Confidence 58999999999998642 236799997432210 000 0 012233455677777776
Q ss_pred hcCC-C-CcceeeEEEEeCCeEEEEEecCCCCC
Q 011582 208 LTGH-K-NLVQFYDAYEDDDNIYIVMELCKGGE 238 (482)
Q Consensus 208 l~~h-p-niv~l~~~~~~~~~~~lv~e~~~~g~ 238 (482)
.... | .+.++| +.+++...+|||+++...
T Consensus 56 ~~~~~P~~vP~vy--~~D~e~~~~vMEdL~~~~ 86 (370)
T TIGR01767 56 QGEHVPHLVPRIF--HFDTEMAVTVMEDLSHHK 86 (370)
T ss_pred hhccCccccCeEE--EEccccceehHhhCccch
Confidence 5432 3 355554 346677789999996543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.0091 Score=58.99 Aligned_cols=104 Identities=12% Similarity=0.045 Sum_probs=74.4
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.||.|..+.||+.... +| .+.+|+.+.. .....+.+|...|
T Consensus 19 ~~~i~~G~~~~vy~~~~~----~~-~~~~k~~~~~--------------------------------~~~~~~~~Ea~~L 61 (297)
T PRK10593 19 VECISEQPYAALWALYDS----QG-NPMPLMARSF--------------------------------STPGVAQQEAWKL 61 (297)
T ss_pred eeecCCccceeEEEEEcC----CC-CEEEEEeccc--------------------------------ccchHHHHHHHHH
Confidence 345999999999998653 23 4777874320 0124688999999
Q ss_pred HhhcCC--CCcceeeEEEEe---CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 206 RALTGH--KNLVQFYDAYED---DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 206 ~~l~~h--pniv~l~~~~~~---~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
+.|..+ -.+.++++++.+ .+..+||||+++|+++.+ . ..+......+..+++++|.-||+.
T Consensus 62 ~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~-~-----~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 62 SMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEA-P-----ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred HHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCC-C-----CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 999754 367888887764 366899999999987765 1 133445566778888999999974
|
|
| >PF13405 EF-hand_6: EF-hand domain; PDB: 2AMI_A 3QRX_A 1W7J_B 1OE9_B 1W7I_B 1KFU_S 1KFX_S 2BL0_B 1Y1X_B 3MSE_B | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.00063 Score=42.63 Aligned_cols=24 Identities=29% Similarity=0.679 Sum_probs=20.9
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++..|..+|.|+||+|+.+||+.
T Consensus 1 ~l~~~F~~~D~d~dG~I~~~el~~ 24 (31)
T PF13405_consen 1 RLREAFKMFDKDGDGFIDFEELRA 24 (31)
T ss_dssp HHHHHHHHH-TTSSSEEEHHHHHH
T ss_pred CHHHHHHHHCCCCCCcCcHHHHHH
Confidence 378899999999999999999975
|
... |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.65 E-value=0.014 Score=57.89 Aligned_cols=112 Identities=18% Similarity=0.281 Sum_probs=65.3
Q ss_pred HHHHHHHHHHHHHhhcC-CCCcceeeEEEEeCC--eEEEEEecCCCCChH----------HHHH--------hc------
Q 011582 194 AIEDVRREVKILRALTG-HKNLVQFYDAYEDDD--NIYIVMELCKGGELL----------DRIL--------SR------ 246 (482)
Q Consensus 194 ~~~~~~~Ei~~l~~l~~-hpniv~l~~~~~~~~--~~~lv~e~~~~g~L~----------~~l~--------~~------ 246 (482)
......+|..+++.+.. ---+...+++|.++. ..|.||+|++|..+. .+.. .-
T Consensus 64 ~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~ 143 (321)
T COG3173 64 SAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAA 143 (321)
T ss_pred hhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCc
Confidence 34567789999988842 122334555665554 679999999883221 1111 00
Q ss_pred C-------CCCCHHHHHHHHH--------------HHHHHHHHHHHC--------CCcccCCCCCceEEecCCCCCcEEE
Q 011582 247 G-------GKYSEEDAKIVMV--------------QILSVVAFCHFQ--------GVVHRDLKPENFLFTSKEENSSLKA 297 (482)
Q Consensus 247 ~-------~~l~~~~~~~i~~--------------qi~~~L~yLH~~--------~ivHrDlkp~NIll~~~~~~~~~kl 297 (482)
+ ..+...++..+.. ....-..||+.+ .++|+|+.+.||++. ++..+-+
T Consensus 144 ~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~---~~~~~gV 220 (321)
T COG3173 144 GLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIID---PGRPTGV 220 (321)
T ss_pred CCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEe---CCCeeEE
Confidence 0 0011111222211 223334556553 389999999999995 4445999
Q ss_pred EecccccccCC
Q 011582 298 IDFGLSDYVKP 308 (482)
Q Consensus 298 ~DfGla~~~~~ 308 (482)
.||+++....+
T Consensus 221 lDwe~~~lGDP 231 (321)
T COG3173 221 LDWELATLGDP 231 (321)
T ss_pred EeccccccCCc
Confidence 99999876543
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.04 E-value=0.018 Score=58.05 Aligned_cols=61 Identities=21% Similarity=0.240 Sum_probs=44.0
Q ss_pred CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHHCCCcccCCCCCceEEe
Q 011582 225 DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVA-FCHFQGVVHRDLKPENFLFT 287 (482)
Q Consensus 225 ~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~-yLH~~~ivHrDlkp~NIll~ 287 (482)
....|+-+|..|-++..++... ..++...+.++.-...||- .|--.+++|.|+.|.||++.
T Consensus 318 ~~~vl~E~~~~Gl~v~~~v~~~--~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 318 TDLVLVETYERGLSVLRFVKWK--SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR 379 (565)
T ss_pred ccceeeeeccccccHHhhhhcc--cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence 3456777788888887776543 4566666666666666654 44557899999999999996
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.12 Score=51.38 Aligned_cols=30 Identities=27% Similarity=0.466 Sum_probs=25.9
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
++||+|+.++|||+ ++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence 69999999999999 5566799999987764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.031 Score=54.86 Aligned_cols=74 Identities=22% Similarity=0.236 Sum_probs=47.4
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.+|-|....+|+... +++.+.||+-... ....+..|..-|
T Consensus 22 ~~~v~GG~i~~a~~~~~-----~~~~~FvK~~~~~---------------------------------~~~~f~~Ea~gL 63 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDT-----DGGSYFVKVNSES---------------------------------GRDMFEGEAEGL 63 (288)
T ss_dssp EEEE--SSSSEEEEEET-----TS-EEEEEEEEGG---------------------------------GCCHHHHHHHHH
T ss_pred eEecCCCChhheEEEEC-----CCccEEEEecChh---------------------------------hHHHHHHHHHHH
Confidence 34588899999998762 6789999986532 224578888888
Q ss_pred Hhhc--CCCCcceeeEEEEeCCeEEEEEecCCCC
Q 011582 206 RALT--GHKNLVQFYDAYEDDDNIYIVMELCKGG 237 (482)
Q Consensus 206 ~~l~--~hpniv~l~~~~~~~~~~~lv~e~~~~g 237 (482)
+.|. ..-.+.+++.+....+..||||||++.+
T Consensus 64 ~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 64 KALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp HHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred HHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 8883 2345778999888888889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.014 Score=54.48 Aligned_cols=31 Identities=35% Similarity=0.670 Sum_probs=20.3
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
.++|.|+.+.|||+. +.++.++|+||..|..
T Consensus 144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEET--SSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEec--cCCCeEEEecHHHHhh
Confidence 489999999999993 3466799999998764
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.14 Score=51.35 Aligned_cols=28 Identities=21% Similarity=0.328 Sum_probs=23.1
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEeccccc
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSD 304 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~ 304 (482)
.++||+|+.+.|||+. + .+.|+||+-+.
T Consensus 196 ~~liHgD~h~~NvL~~---d--~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR---D--GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc---C--CcEEEeCCCCC
Confidence 3689999999999993 2 37899999765
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.11 Score=53.20 Aligned_cols=81 Identities=17% Similarity=0.195 Sum_probs=49.6
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.||-|....||++... +..|+||.-.... .+.... =.....+-..|+..|
T Consensus 37 ~~eiggGn~N~VyrV~~~-----~~svVVKqa~p~~-------r~vga~----------------wpl~~~R~~~Ea~aL 88 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-----SGSFVIKQALPYI-------RCIGES----------------WPMTKERAYFEATAL 88 (418)
T ss_pred EEEcCCCceeeEEEEEcC-----CccEEEEeCCccc-------cCCCcc----------------ccCCccHHHHHHHHH
Confidence 456899999999998762 3469999754321 000000 001233445566667
Q ss_pred HhhcC--CCCcceeeEEEEeCCeEEEEEecCCC
Q 011582 206 RALTG--HKNLVQFYDAYEDDDNIYIVMELCKG 236 (482)
Q Consensus 206 ~~l~~--hpniv~l~~~~~~~~~~~lv~e~~~~ 236 (482)
+.+.. ..++.+++.++. +..+++|||+++
T Consensus 89 ~~~~~~~p~~VPkVy~~de--d~~vlvME~L~~ 119 (418)
T PLN02756 89 REHGRLCPDHVPEVYHFDR--TMALIGMRYLEP 119 (418)
T ss_pred HHhhhcCCCCCCeEEEECC--CCCEEEEeecCC
Confidence 65532 247778887766 556889999977
|
|
| >PF13499 EF-hand_7: EF-hand domain pair; PDB: 1TCF_A 2TN4_A 1TN4_A 1A2X_A 2CT9_B 2OTG_B 2OS8_B 1SNL_A 3O4Y_A 3J04_E | Back alignment and domain information |
|---|
Probab=95.56 E-value=0.0059 Score=45.40 Aligned_cols=24 Identities=25% Similarity=0.526 Sum_probs=16.7
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+|++.|..+|.|+||+|+.+||+.
T Consensus 1 ~l~~~F~~~D~d~~G~i~~~el~~ 24 (66)
T PF13499_consen 1 RLKEAFKKFDKDGDGYISKEELRR 24 (66)
T ss_dssp HHHHHHHHHSTTSSSEEEHHHHHH
T ss_pred CHHHHHHHHcCCccCCCCHHHHHH
Confidence 356677777777777777777653
|
... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.52 E-value=0.093 Score=53.52 Aligned_cols=83 Identities=19% Similarity=0.220 Sum_probs=52.1
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.||-|.-..||++.+.. .+..|+||.-...+. + ++ .-....++..-|..+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~---~~~svIVKQAlp~vR-----v----~~---------------swpL~~~R~~~E~~aL 86 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQ---KNISVIVKQAGDTAR-----I----SD---------------EFKLSTNRIRIESDVL 86 (409)
T ss_pred eeEcCCCceEEEEEEeeCC---CCceEEEEeccHhhc-----c----CC---------------CCCCChHHHHHHHHHH
Confidence 4568999999999998742 356799996432210 0 00 0022345667777888
Q ss_pred HhhcC-CC-CcceeeEEEEeCCeEEEEEecCCCC
Q 011582 206 RALTG-HK-NLVQFYDAYEDDDNIYIVMELCKGG 237 (482)
Q Consensus 206 ~~l~~-hp-niv~l~~~~~~~~~~~lv~e~~~~g 237 (482)
+.+.. .| .+.++| +.+.....+|||+++..
T Consensus 87 ~~~~~~~P~~VP~vy--~~D~e~~~~vMEdL~~~ 118 (409)
T PRK12396 87 QLEEELAPGLVPKVY--LFDSVMNCCVMEDLSDH 118 (409)
T ss_pred HHHHhhCCCcCCeEE--EECcHHhhHHHHhCccc
Confidence 76643 23 455565 44667788999999653
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.32 E-value=0.11 Score=53.23 Aligned_cols=37 Identities=14% Similarity=0.268 Sum_probs=28.3
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCCh
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 239 (482)
.+|+.+++.|..+.--.++++.+.. ++|.||++|.+|
T Consensus 100 ~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l 136 (383)
T PTZ00384 100 DLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTM 136 (383)
T ss_pred HHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccC
Confidence 5789999999855566677776642 699999998765
|
|
| >PF13833 EF-hand_8: EF-hand domain pair; PDB: 3KF9_A 1TTX_A 1WLZ_A 1ALV_A 1NX3_A 1ALW_A 1NX2_A 1NX1_A 1NX0_A 1DF0_A | Back alignment and domain information |
|---|
Probab=95.25 E-value=0.019 Score=40.83 Aligned_cols=40 Identities=20% Similarity=0.421 Sum_probs=29.7
Q ss_pred hHHHHHHHhhhhc-CCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 438 SLRKAALGALAKT-LTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 438 ~l~~~~~~~~~~~-~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.|+.++ ..+... ++..+ +..+|..+|.|+||.|+.+||..
T Consensus 9 ~~~~~l-~~~g~~~~s~~e---~~~l~~~~D~~~~G~I~~~EF~~ 49 (54)
T PF13833_consen 9 EFRRAL-SKLGIKDLSEEE---VDRLFREFDTDGDGYISFDEFIS 49 (54)
T ss_dssp HHHHHH-HHTTSSSSCHHH---HHHHHHHHTTSSSSSEEHHHHHH
T ss_pred HHHHHH-HHhCCCCCCHHH---HHHHHHhcccCCCCCCCHHHHHH
Confidence 344444 444444 66665 67899999999999999999964
|
... |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 482 | ||||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-52 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-52 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-52 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-50 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 7e-50 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 8e-50 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-49 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-49 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-49 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-49 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-49 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-49 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-49 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-49 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-48 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-47 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-47 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-47 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 4e-47 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-46 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-45 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-45 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-43 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 5e-43 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-42 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-42 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-42 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-42 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-42 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-42 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-42 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-42 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-42 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 8e-42 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-41 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-41 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-41 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 1e-41 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-41 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-41 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 5e-41 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 5e-41 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-41 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-40 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-40 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-40 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-40 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 4e-40 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-39 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-39 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-39 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-39 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 7e-39 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-39 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-39 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 7e-39 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 7e-39 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 7e-39 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 8e-39 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-39 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-38 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-38 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-38 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-37 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-37 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-37 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-36 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 4e-36 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-35 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-35 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-35 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-35 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-35 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 8e-35 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-34 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-34 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-34 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-34 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-34 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-34 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-34 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-34 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-34 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-34 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-34 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-34 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-34 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-34 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-34 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-34 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 7e-34 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-34 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-34 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-34 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-33 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-33 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-33 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-32 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 5e-32 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-31 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-30 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-30 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-30 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-30 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-30 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-30 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-30 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 5e-30 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-30 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-30 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-29 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-29 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-29 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 6e-29 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 7e-29 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 8e-29 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 9e-29 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-28 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-28 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-28 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-28 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-28 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-27 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-27 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-27 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-27 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-27 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-27 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-27 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-27 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-27 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-27 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-27 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-27 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-27 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-27 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-27 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-27 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-27 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-27 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-27 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-27 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-27 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-27 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-27 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-27 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-27 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-27 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-27 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-27 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-27 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-27 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-27 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 7e-27 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 7e-27 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-27 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-27 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 9e-27 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-26 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-26 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-26 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-26 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-26 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-26 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-26 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-26 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-26 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-26 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-26 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-26 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-26 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-26 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-26 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-26 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-26 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-26 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-26 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-26 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 4e-26 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-26 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-26 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-26 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 6e-26 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-26 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-25 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-25 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-25 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-25 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-24 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-24 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-24 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-24 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-23 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-23 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-23 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-23 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-23 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-23 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-23 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-23 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-23 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-23 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-23 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-23 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-23 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-23 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-23 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-23 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-23 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-23 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-23 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-23 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-23 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 3e-23 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-23 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-23 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 4e-23 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-23 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-23 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-23 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-23 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-23 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-23 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 4e-23 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 4e-23 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-23 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-23 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-23 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-23 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-23 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-23 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-23 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 5e-23 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-23 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-23 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-23 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 5e-23 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 5e-23 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 5e-23 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-23 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 6e-23 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-23 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-23 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-23 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-23 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-23 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-23 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-23 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-23 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-23 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 7e-23 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 8e-23 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-23 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 9e-23 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-23 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-23 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 9e-23 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-23 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-22 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-22 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-22 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-22 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-22 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-22 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-22 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-22 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-22 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-22 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-22 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-22 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-22 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-22 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-22 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-22 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-22 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-22 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-22 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-22 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-22 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-22 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-22 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-22 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-22 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-22 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-22 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-22 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-22 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-22 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 5e-22 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-22 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-22 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-22 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-22 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-21 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-21 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-21 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-21 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-21 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-21 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-21 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-21 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-21 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-21 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-21 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-21 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-21 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 5e-21 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-21 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 5e-21 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 5e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-21 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-21 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 8e-21 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 9e-21 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-20 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-20 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-20 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-20 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-20 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-20 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-20 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-20 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-20 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-20 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 6e-20 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 6e-20 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-20 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 6e-20 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 6e-20 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 7e-20 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 7e-20 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 7e-20 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 7e-20 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-20 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 7e-20 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 7e-20 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 7e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 8e-20 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-20 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 9e-20 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-19 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-19 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-19 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-19 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-19 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-19 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-19 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-19 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-19 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-19 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-19 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-19 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-19 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-19 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-19 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-19 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-19 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-19 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-19 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-19 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-19 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-19 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-19 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-19 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-19 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-19 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-19 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-19 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-19 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-19 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-19 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-19 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-19 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-19 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-19 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-19 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-19 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-19 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-19 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-19 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-19 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-19 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-19 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-19 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-19 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-19 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-19 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-19 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-19 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-19 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 4e-19 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-19 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-19 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-19 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 4e-19 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 4e-19 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-19 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-19 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 5e-19 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 5e-19 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 5e-19 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-19 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-19 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-19 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-19 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-19 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-19 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-19 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-19 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-19 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 9e-19 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-18 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-18 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-18 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-18 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-18 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-18 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-18 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-18 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-18 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-18 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-18 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-18 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-18 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-18 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 5e-18 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-18 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-18 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-18 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-18 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-18 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-18 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 5e-18 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 5e-18 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 5e-18 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-18 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-18 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-18 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-18 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 6e-18 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-18 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-18 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-18 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-18 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-18 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-18 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-18 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-18 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-18 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 9e-18 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-18 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-17 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 1e-17 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-17 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-17 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-17 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-17 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-17 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-17 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-17 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-17 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-17 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 2e-17 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-17 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-17 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-17 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-17 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-17 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-17 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-17 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-17 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-17 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-17 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-17 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-17 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-17 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-17 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-17 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 3e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-17 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-17 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-17 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 4e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-17 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-17 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-17 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-17 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-17 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 8e-17 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-17 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 8e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-17 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-17 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 1e-16 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-16 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-16 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-16 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-16 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-16 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-16 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 7e-16 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 7e-16 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-16 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 7e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 7e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-16 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 8e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-16 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-16 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-15 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-15 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-15 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 5e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-15 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 6e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-15 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-14 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 4e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-14 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-14 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-14 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-14 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-14 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-14 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 6e-14 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-14 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-14 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-14 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-14 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-14 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-14 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 7e-14 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 9e-14 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 9e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-14 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 1e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-13 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-13 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-13 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-13 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-13 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-13 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-13 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-13 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-13 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-13 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-13 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-13 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-13 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 8e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 8e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 7e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 8e-12 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-11 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-11 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-11 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-11 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-11 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 5e-11 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-11 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-11 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-11 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 8e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 8e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-10 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-10 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-10 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-10 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 4e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-10 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-10 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-10 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-10 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-10 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 7e-10 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-10 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-10 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-10 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 7e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 9e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 9e-10 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-10 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-09 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 1e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-09 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-09 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-09 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-09 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 5e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 5e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 5e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 5e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-09 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-09 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-09 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 9e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-08 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-08 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 1e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-08 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 1e-08 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-08 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-08 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-08 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-08 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-08 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-08 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-08 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-08 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-08 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-08 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-08 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-08 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-08 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-08 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-08 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 3e-08 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-08 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-08 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-08 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-08 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-08 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-08 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-08 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 6e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-08 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 7e-08 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-08 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-08 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 8e-08 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 9e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 1e-07 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-07 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-07 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-07 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-07 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-07 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-07 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-07 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-07 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-07 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-07 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-07 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-07 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-07 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-07 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-07 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-07 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 5e-07 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 6e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 6e-07 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-07 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 6e-07 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 6e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-06 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-06 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-06 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-06 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-06 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-06 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-06 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 3e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 3e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-06 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 6e-06 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 7e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 7e-06 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 8e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 8e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 8e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 8e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 9e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 9e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 9e-06 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 1e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-05 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-05 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 3e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-05 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-05 |
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 478 bits (1232), Expect = e-166
Identities = 122/381 (32%), Positives = 183/381 (48%), Gaps = 39/381 (10%)
Query: 107 IGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFL 166
+N F F Y + +G+G FG K + Q+ AVKVI K
Sbjct: 8 SSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKA------ 58
Query: 167 QVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN 226
+ REV++L+ L H N+++ ++ ED +
Sbjct: 59 ----------------------SAKNKDTSTILREVELLKKL-DHPNIMKLFEILEDSSS 95
Query: 227 IYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286
YIV EL GGEL D I+ R ++SE DA ++ Q+ S + + H +VHRDLKPEN L
Sbjct: 96 FYIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILL 154
Query: 287 TSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYI 346
SKE++ +K IDFGLS + + ++ D +G+AYY+APEVL +Y + D+WS GVI YI
Sbjct: 155 ESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYI 214
Query: 347 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA 406
LL G+ PF+ + E I + V +FD W ++S +A D ++++L R+TA Q
Sbjct: 215 LLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
Query: 407 LSHPWLAN-----SHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVP-QLAYLR 460
L HPW+ +PS I+ + + L +AAL +A LT + L
Sbjct: 275 LEHPWIQKYSSETPTISDLPSLESAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLT 334
Query: 461 EQFTLLAPNKNGFISMQNYKM 481
E F L N +G +
Sbjct: 335 EIFRKLDTNNDGMLDRDELVR 355
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 475 bits (1224), Expect = e-165
Identities = 121/400 (30%), Positives = 189/400 (47%), Gaps = 30/400 (7%)
Query: 87 RRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGS 146
H S + N + + K G + Y ++G G +G K K G
Sbjct: 5 HHHSSGRENLYFQGIAINPGMYVRKKEG---KIGESYFKVRKLGSGAYGEVLLCKEKNG- 60
Query: 147 LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206
+ A+KVI K Y E++ E+ +L+
Sbjct: 61 --HSEKAIKVIKK-----------------SQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101
Query: 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVV 266
+L H N+++ +D +ED Y+V E +GGEL ++I++R K+ E DA +M QILS +
Sbjct: 102 SL-DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH-KFDECDAANIMKQILSGI 159
Query: 267 AFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEV 326
+ H +VHRD+KPEN L +K ++K +DFGLS + D +L D +G+AYY+APEV
Sbjct: 160 CYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEV 219
Query: 327 LHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAI 386
L + Y + D+WS GVI YILLCG PF + + I + V K FD W ++S EA
Sbjct: 220 LKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAK 279
Query: 387 DFVKRLLNKDYRKRLTAAQALSHPWL----ANSHDVKIPSDMIVYKLIKAYISSSSLRKA 442
+ +K +L DY KR TA +AL+ W+ N + + ++ + S L +A
Sbjct: 280 ELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRKFEGSQKLAQA 339
Query: 443 ALGALAKTLTVP-QLAYLREQFTLLAPNKNGFISMQNYKM 481
A+ + LT + L + F L N +G + +
Sbjct: 340 AILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIE 379
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 463 bits (1192), Expect = e-160
Identities = 119/370 (32%), Positives = 183/370 (49%), Gaps = 37/370 (10%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
+ F Y+ +G+G FG K K GQ+ AVKVI K
Sbjct: 21 TAIFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISK---------------- 61
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCK 235
+ E + REV++L+ L H N+++ Y+ +ED Y+V E+
Sbjct: 62 -----------RQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFEDKGYFYLVGEVYT 109
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
GGEL D I+SR ++SE DA ++ Q+LS + + H +VHRDLKPEN L SK +++++
Sbjct: 110 GGELFDEIISRK-RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANI 168
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFW 355
+ IDFGLS + + +++ D +G+AYY+APEVLH +Y + D+WS GVI YILL G PF
Sbjct: 169 RIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFN 228
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL--- 412
E I + V K +F+ W +S A D ++++L R++A AL H W+
Sbjct: 229 GANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288
Query: 413 -ANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVP-QLAYLREQFTLLAPNK 470
V +PS I+ + + L +AAL + LT + L F + N
Sbjct: 289 TKEQISVDVPSLDNAILNIRQFQGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNG 348
Query: 471 NGFISMQNYK 480
+G +
Sbjct: 349 DGQLDRAELI 358
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 462 bits (1191), Expect = e-160
Identities = 122/402 (30%), Positives = 198/402 (49%), Gaps = 40/402 (9%)
Query: 87 RRHGSVKPNEASIPEGNESDIGLDKNFGFSKQ-FVAHYELGEEVGRGHFGYTCSAKAKKG 145
H ++ + K Y+ +++G G +G + K
Sbjct: 2 HHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVT 61
Query: 146 SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205
+ A+K+I K + + + EV +L
Sbjct: 62 ---HVERAIKIIRKT----------------------------SVSTSSNSKLLEEVAVL 90
Query: 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSV 265
+ L H N+++ YD +ED N Y+VME KGGEL D I+ R K++E DA +++ Q+LS
Sbjct: 91 KLL-DHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-KFNEVDAAVIIKQVLSG 148
Query: 266 VAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPE 325
V + H +VHRDLKPEN L SKE+++ +K +DFGLS + +++ + +G+AYY+APE
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE 208
Query: 326 VLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEA 385
VL + Y + D+WSIGVI +ILL G PF +T+ I R V K +FD W ++S A
Sbjct: 209 VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGA 268
Query: 386 IDFVKRLLNKDYRKRLTAAQALSHPWL-----ANSHDVKIPSDMIVYKLIKAYISSSSLR 440
D +K++L D ++R++A QAL HPW+ +++PS + ++ + +S L
Sbjct: 269 KDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRKFQNSQKLA 328
Query: 441 KAALGALAKTLTVP-QLAYLREQFTLLAPNKNGFISMQNYKM 481
+AAL +A LT + L + F + N +G + Q
Sbjct: 329 QAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELID 370
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 446 bits (1148), Expect = e-156
Identities = 102/391 (26%), Positives = 169/391 (43%), Gaps = 37/391 (9%)
Query: 30 NSQKSKASNFPFYSPSPLPSLFKNSPAIPSVNSTPLRFFKRPFPPPSPAKHIRSLLARRH 89
+ +S + +P++N R F R A++
Sbjct: 2 HHHHHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKL 61
Query: 90 GSVKPNE-ASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLK 148
+P ++ + ++ +K+F Y+ + +GRG +
Sbjct: 62 NDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRA---T 118
Query: 149 GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL 208
G + AVK++ + + E RRE ILR +
Sbjct: 119 GHEFAVKIMEV-----------TAERLSPEQLEEV-----------REATRRETHILRQV 156
Query: 209 TGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAF 268
GH +++ D+YE +++V +L + GEL D + + SE++ + +M +L V+F
Sbjct: 157 AGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV-ALSEKETRSIMRSLLEAVSF 215
Query: 269 CHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL- 327
H +VHRDLKPEN L ++N ++ DFG S +++P E+L ++ G+ Y+APE+L
Sbjct: 216 LHANNIVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272
Query: 328 ------HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL 381
H YG E D+W+ GVI + LL GS PFW R + + R +++ F W
Sbjct: 273 CSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDR 332
Query: 382 SPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
S D + RLL D RLTA QAL HP+
Sbjct: 333 SSTVKDLISRLLQVDPEARLTAEQALQHPFF 363
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 442 bits (1140), Expect = e-155
Identities = 87/355 (24%), Positives = 156/355 (43%), Gaps = 40/355 (11%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
K+ Y + E++GRG FG + K +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKV----------------- 40
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG 236
V++E+ IL H+N++ ++++E + + ++ E G
Sbjct: 41 --------------KGTDQVLVKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISG 85
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
++ +RI + + +E + + Q+ + F H + H D++PEN ++ ++ +S++K
Sbjct: 86 LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIK 144
Query: 297 AIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFW 355
I+FG + +KP + + + Y APEV H T DMWS+G + Y+LL G PF
Sbjct: 145 IIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415
A T I ++ A+ +FDE + +S EA+DFV RLL K+ + R+TA++AL HPWL
Sbjct: 205 AETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264
Query: 416 HDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNK 470
+ V + +K +L K L + + +R Q +
Sbjct: 265 IE---RVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKV 316
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 432 bits (1113), Expect = e-151
Identities = 106/307 (34%), Positives = 158/307 (51%), Gaps = 33/307 (10%)
Query: 108 GLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQ 167
+N F F Y + +G+G FG K + Q+ AVKVI K
Sbjct: 9 SGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKA------- 58
Query: 168 VHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNI 227
+ REV++L+ L H N+++ ++ ED +
Sbjct: 59 ---------------------SAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSF 96
Query: 228 YIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFT 287
YIV EL GGEL D I+ R ++SE DA ++ Q+ S + + H +VHRDLKPEN L
Sbjct: 97 YIVGELYTGGELFDEIIKRK-RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLE 155
Query: 288 SKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYIL 347
SKE++ +K IDFGLS + + ++ D +G+AYY+APEVL +Y + D+WS GVI YIL
Sbjct: 156 SKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYIL 215
Query: 348 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407
L G+ PF+ + E I + V +FD W ++S +A D ++++L R+TA Q L
Sbjct: 216 LSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275
Query: 408 SHPWLAN 414
HPW+
Sbjct: 276 EHPWIQK 282
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 430 bits (1107), Expect = e-151
Identities = 98/311 (31%), Positives = 157/311 (50%), Gaps = 37/311 (11%)
Query: 108 GLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQ 167
+N F + ++G G FG + + G + +K I K
Sbjct: 9 SGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKD------- 58
Query: 168 VHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNI 227
+ + +E + E+++L++L H N+++ ++ +ED N+
Sbjct: 59 ----------------------RSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFEDYHNM 95
Query: 228 YIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENF 284
YIVME C+GGELL+RI+S G SE +M Q+++ +A+ H Q VVH+DLKPEN
Sbjct: 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENI 155
Query: 285 LFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIA 344
LF +S +K IDFGL++ K DE + G+A Y+APEV R + D+WS GV+
Sbjct: 156 LFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVM 215
Query: 345 YILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA 404
Y LL G PF + + + +P++ P L+P+A+D +K++L KD +R +AA
Sbjct: 216 YFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRP-LTPQAVDLLKQMLTKDPERRPSAA 274
Query: 405 QALSHPWLANS 415
Q L H W +
Sbjct: 275 QVLHHEWFKQA 285
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 435 bits (1120), Expect = e-150
Identities = 107/362 (29%), Positives = 173/362 (47%), Gaps = 38/362 (10%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
+F Y+L EE+G+G F GQ+ A +I
Sbjct: 6 CTRFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINT---------------- 46
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCK 235
+A + + RE +I R L H N+V+ +D+ ++ + Y++ +L
Sbjct: 47 ------------KKLSARDHQKLEREARICRLL-KHPNIVRLHDSISEEGHHYLIFDLVT 93
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
GGEL + I++R YSE DA + QIL V CH GVVHR+LKPEN L SK + +++
Sbjct: 94 GGELFEDIVARE-YYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV 152
Query: 296 KAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRP 353
K DFGL+ V+ + G+ Y++PEVL + YG D+W+ GVI YILL G P
Sbjct: 153 KLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212
Query: 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413
FW + +++ + F W +++PEA D + ++L + KR+TAA+AL HPW++
Sbjct: 213 FWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWIS 272
Query: 414 NSHDV-KIPSDMIVYKLIKAYISSSSLRKAALGALA--KTLTVPQLAYLREQFTLLAPNK 470
+ V +K + + L+ A L + + +V + ++ L+
Sbjct: 273 HRSTVASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRKQEIIKVTEQLIEAIS 332
Query: 471 NG 472
NG
Sbjct: 333 NG 334
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 427 bits (1100), Expect = e-150
Identities = 111/313 (35%), Positives = 167/313 (53%), Gaps = 37/313 (11%)
Query: 114 GFSKQ-FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPK 172
G +K +Y L +GRG +G A K A K IPK
Sbjct: 1 GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGT---RIRRAAKKIPK------------- 44
Query: 173 HENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVME 232
++ ++E++I+++L H N+++ Y+ +ED+ +IY+VME
Sbjct: 45 -----------------YFVEDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTDIYLVME 86
Query: 233 LCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEEN 292
LC GGEL +R++ + + E DA +M +LS VA+CH V HRDLKPENFLF + +
Sbjct: 87 LCTGGELFERVVHKR-VFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPD 145
Query: 293 SSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSR 352
S LK IDFGL+ KP + + VG+ YYV+P+VL YG E D WS GV+ Y+LLCG
Sbjct: 146 SPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYP 205
Query: 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
PF A T+S + + + +F E W ++SP+A ++RLL K ++R+T+ QAL H W
Sbjct: 206 PFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWF 265
Query: 413 ANSHDVKIPSDMI 425
P +++
Sbjct: 266 EK-QLSSSPRNLL 277
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 425 bits (1094), Expect = e-148
Identities = 96/360 (26%), Positives = 158/360 (43%), Gaps = 36/360 (10%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
F YEL E +G+G F ++ GQ AVK++
Sbjct: 19 DVLFEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVA--------------- 60
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCK 235
+ ++ ED++RE I L H ++V+ + Y D +Y+V E
Sbjct: 61 ----------KFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSSDGMLYMVFEFMD 109
Query: 236 GGELLDRILSRG---GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEEN 292
G +L I+ R YSE A M QIL + +CH ++HRD+KP L SKE +
Sbjct: 110 GADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENS 169
Query: 293 SSLKAIDFGLSDYV-KPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCG 350
+ +K FG++ + + VG+ +++APEV+ R YG D+W GVI +ILL G
Sbjct: 170 APVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
Query: 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
PF+ T+ +F ++K + W +S A D V+R+L D +R+T +AL+HP
Sbjct: 230 CLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHP 288
Query: 411 WLANSHDV-KIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPN 469
WL + ++ + + L+ A L A++ E+ + +
Sbjct: 289 WLKERDRYAYKIHLPETVEQLRKFNARRKLKGAVLAAVSSHKFNSFYGDPPEELPDFSED 348
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 425 bits (1094), Expect = e-147
Identities = 109/384 (28%), Positives = 174/384 (45%), Gaps = 38/384 (9%)
Query: 94 PNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVA 153
P+ AS+ G + G + S +F +Y++ EE+G+G F K G + A
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTT---GLEFA 58
Query: 154 VKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKN 213
K+I +A + + RE +I R L H N
Sbjct: 59 AKIINTK----------------------------KLSARDFQKLEREARICRKLQ-HPN 89
Query: 214 LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273
+V+ +D+ +++ Y+V +L GGEL + I++R YSE DA + QIL +A+CH G
Sbjct: 90 IVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNG 148
Query: 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-YG 332
+VHR+LKPEN L SK + +++K DFGL+ V E + G+ Y++PEVL + Y
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 208
Query: 333 TEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRL 392
D+W+ GVI YILL G PFW + ++ + + W +++PEA + +
Sbjct: 209 KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSM 268
Query: 393 LNKDYRKRLTAAQALSHPWLANSHDV-KIPSDMIVYKLIKAYISSSSLRKAALGALAKTL 451
L + +KR+TA QAL PW+ N V +K + + L+ A L + T
Sbjct: 269 LTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATR 328
Query: 452 TVPQLAYLREQFTLLAPNKNGFIS 475
+ L
Sbjct: 329 NLSN---LGRNLLNKKEQGPPSTI 349
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 410 bits (1057), Expect = e-143
Identities = 97/300 (32%), Positives = 152/300 (50%), Gaps = 34/300 (11%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
S +F +Y++ EE+G+G F K G + A K+I
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTT---GLEFAAKIINTK--------------- 42
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCK 235
+A + + RE +I R L H N+V+ +D+ +++ Y+V +L
Sbjct: 43 -------------KLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVT 88
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
GGEL + I++R YSE DA + QIL +A+CH G+VHR+LKPEN L SK + +++
Sbjct: 89 GGELFEDIVARE-FYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAV 147
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPF 354
K DFGL+ V E + G+ Y++PEVL + Y D+W+ GVI YILL G PF
Sbjct: 148 KLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPF 207
Query: 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
W + ++ + + W +++PEA + +L + +KR+TA QAL PW+ N
Sbjct: 208 WDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 267
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 408 bits (1052), Expect = e-141
Identities = 89/330 (26%), Positives = 144/330 (43%), Gaps = 36/330 (10%)
Query: 119 FVAHYEL-GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQ 177
F Y L +E+GRG F +K GQ+ A K + K
Sbjct: 26 FNNFYILTSKELGRGKFAVVRQCISKST---GQEYAAKFLKKR----------------- 65
Query: 178 FTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGG 237
++ E+ +L ++ ++ YE+ I +++E GG
Sbjct: 66 -----------RRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG 114
Query: 238 ELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
E+ L SE D ++ QIL V + H +VH DLKP+N L +S +K
Sbjct: 115 EIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIK 174
Query: 297 AIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFW 355
+DFG+S + L +I+G+ Y+APE+L+ T DMW+IG+IAY+LL + PF
Sbjct: 175 IVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFV 234
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL--A 413
+ + + + + E + S+S A DF++ LL K+ KR TA LSH WL
Sbjct: 235 GEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294
Query: 414 NSHDVKIPSDMIVYKLIKAYISSSSLRKAA 443
+ ++ P + + + SS K +
Sbjct: 295 DFENLFHPEETSSSSQTQDHSVRSSEDKTS 324
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 403 bits (1038), Expect = e-140
Identities = 99/313 (31%), Positives = 148/313 (47%), Gaps = 35/313 (11%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
+ F +YE E +GRG K ++ AVK+I G F +
Sbjct: 12 THGFYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELR- 67
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCK 235
E +EV ILR ++GH N++Q D YE + ++V +L K
Sbjct: 68 --------------------EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMK 107
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
GEL D + + SE++ + +M +L V+ H +VHRDLKPEN L +++ ++
Sbjct: 108 KGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL---DDDMNI 163
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-------HRSYGTEADMWSIGVIAYILL 348
K DFG S + P E+L ++ G+ Y+APE++ H YG E DMWS GVI Y LL
Sbjct: 164 KLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL 223
Query: 349 CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
GS PFW R + + R ++ + F W S D V R L +KR TA +AL+
Sbjct: 224 AGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283
Query: 409 HPWLANSHDVKIP 421
HP+ ++
Sbjct: 284 HPFFQQYVVEEVR 296
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 407 bits (1048), Expect = e-140
Identities = 99/404 (24%), Positives = 154/404 (38%), Gaps = 51/404 (12%)
Query: 68 FKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGE 127
P P P P +L P P+ + K + +
Sbjct: 12 VPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD---YKVTSQ 68
Query: 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCL 187
+G G G K+ + A+K++
Sbjct: 69 VLGLGINGKVLQIFNKRT---QEKFALKMLQD---------------------------- 97
Query: 188 FMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRI 243
RREV++ + ++V+ D YE+ + IVME GGEL RI
Sbjct: 98 -------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 150
Query: 244 LSRGGK-YSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
RG + ++E +A +M I + + H + HRD+KPEN L+TSK N+ LK DFG
Sbjct: 151 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 210
Query: 303 SDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA----R 357
+ L + YYVAPEVL Y DMWS+GVI YILLCG PF++
Sbjct: 211 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270
Query: 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
G+ + F W +S E ++ LL + +R+T + ++HPW+ S
Sbjct: 271 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330
Query: 418 VKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLRE 461
V L + +++ ALA + +++
Sbjct: 331 VPQTPLHTSRVLKEDKERWEDVKEEMTSALATMRVDYEQIKIKK 374
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 403 bits (1037), Expect = e-139
Identities = 115/384 (29%), Positives = 173/384 (45%), Gaps = 43/384 (11%)
Query: 69 KRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEE 128
+L + SV + A D +D + +E+ E
Sbjct: 4 HHHHSSGVDLGT-ENLYFQSMSSVTASAAPGTASLVPDYWIDGSN--RDALSDFFEVESE 60
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+GRG K K + A+KV+ K
Sbjct: 61 LGRGATSIVYRCKQKG---TQKPYALKVLKK----------------------------- 88
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+ + VR E+ +L L+ H N+++ + +E I +V+EL GGEL DRI+ +G
Sbjct: 89 ---TVDKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG- 143
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
YSE DA + QIL VA+ H G+VHRDLKPEN L+ + ++ LK DFGLS V+
Sbjct: 144 YYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
Query: 309 DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART-ESGIFRAV 366
+ + G+ Y APE+L +YG E DMWS+G+I YILLCG PF+ + +FR +
Sbjct: 204 QVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI 263
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIV 426
L + F W +S A D V++L+ D +KRLT QAL HPW+
Sbjct: 264 LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG-KAANFVHMDTA 322
Query: 427 YKLIKAYISSSSLRKAALGALAKT 450
K ++ + + L+ A +A +
Sbjct: 323 QKKLQEFNARRKLKAAVKAVVASS 346
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 396 bits (1021), Expect = e-137
Identities = 98/304 (32%), Positives = 155/304 (50%), Gaps = 31/304 (10%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
HYE+GEE+G G F + K G++ A K I K + + +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKK------------RRLSSSRRGV 50
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
E++ REV ILR + H N++ +D +E+ ++ +++EL GGEL D
Sbjct: 51 S------------REEIEREVNILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFD 97
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSK-EENSSLKAIDF 300
+ + +E++A + QIL V + H + + H DLKPEN + K N +K IDF
Sbjct: 98 FLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDF 156
Query: 301 GLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359
G++ ++ +I G+ +VAPE+++ G EADMWSIGVI YILL G+ PF T+
Sbjct: 157 GIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216
Query: 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVK 419
+ + FDE + + S A DF++RLL KD ++R+T AQ+L H W+
Sbjct: 217 QETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276
Query: 420 IPSD 423
+ +
Sbjct: 277 VRGE 280
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 404 bits (1041), Expect = e-136
Identities = 109/414 (26%), Positives = 174/414 (42%), Gaps = 49/414 (11%)
Query: 37 SNFPFYSPSPLPS----LFKNSPAIPSVNSTPLRFFKRPFPPPSPAKHIRSLLARRHGSV 92
S + + + L + F+ S P P K R G +
Sbjct: 62 SRYTYTTIEGLRAGKQYEFRIIAENKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKI 121
Query: 93 KPNEASIPEGNESDIGLDKNFGF-------SKQFVAHYELGEEVGRGHFGYTCSAKAKKG 145
+ ++ ++ + + + HY++ EE+G G FG +
Sbjct: 122 VRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERA- 180
Query: 146 SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205
G + A K + P + E VR+E++ +
Sbjct: 181 --TGNNFAAKFVMT-----------PHESD-------------------KETVRKEIQTM 208
Query: 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSV 265
L H LV +DA+EDD+ + ++ E GGEL +++ K SE++A M Q+
Sbjct: 209 SVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 267
Query: 266 VAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPE 325
+ H VH DLKPEN +FT+K N LK IDFGL+ ++ P + + G+A + APE
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNE-LKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE 326
Query: 326 VL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPE 384
V + G DMWS+GV++YILL G PF + R V D + D++ + +S +
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386
Query: 385 AIDFVKRLLNKDYRKRLTAAQALSHPWL--ANSHDVKIPSDMIVYKLIKAYISS 436
DF+++LL D R+T QAL HPWL N+ Y I+ I +
Sbjct: 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKT 440
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 394 bits (1015), Expect = e-136
Identities = 100/355 (28%), Positives = 160/355 (45%), Gaps = 40/355 (11%)
Query: 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQF 178
+Y+ GEE+G G F + K G A K I K
Sbjct: 9 VDDYYDTGEELGSGQFAVVKKCREKST---GLQYAAKFIKKR------------------ 47
Query: 179 TILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGE 238
++ ED+ REV IL+ + H N++ ++ YE+ ++ +++EL GGE
Sbjct: 48 ------RTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGE 100
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSK-EENSSLKA 297
L D + + +EE+A + QIL+ V + H + H DLKPEN + + +K
Sbjct: 101 LFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 298 IDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356
IDFGL+ + +I G+ +VAPE+++ G EADMWSIGVI YILL G+ PF
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 219
Query: 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416
T+ V + F++ + + S A DF++RLL KD +KR+T +L HPW+
Sbjct: 220 DTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279
Query: 417 DVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKN 471
+ S + ++ +K A + + L + F +
Sbjct: 280 TQQALSRK------ASAVNMEKFKKFAARKKSNNGS---GGGLNDIFEAQKIEWH 325
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 391 bits (1007), Expect = e-134
Identities = 108/340 (31%), Positives = 157/340 (46%), Gaps = 41/340 (12%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
+Y++ EE+G G FG K G+ K I
Sbjct: 46 QGSVYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINT---------------- 86
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCK 235
+ V+ E+ I+ L H L+ +DA+ED + +++E
Sbjct: 87 --------------PYPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFLS 131
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
GGEL DRI + K SE + M Q + H +VH D+KPEN + +K+ SS+
Sbjct: 132 GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKK-ASSV 190
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPF 354
K IDFGL+ + PDE + +A + APE++ R G DMW+IGV+ Y+LL G PF
Sbjct: 191 KIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPF 250
Query: 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
+ + V + D FDE + S+SPEA DF+K LL K+ RKRLT AL HPWL
Sbjct: 251 AGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG 310
Query: 415 SH---DVKIPSDMI--VYKLIKAYISSSSLRKAALGALAK 449
H +IPS + + IK + + A+G +A
Sbjct: 311 DHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPAIGRIAN 350
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-131
Identities = 100/331 (30%), Positives = 157/331 (47%), Gaps = 34/331 (10%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
++ Y++GEE+G G F + K G + A K I K +
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKK------------RQSRA 52
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG 236
+ E++ REV ILR + H N++ +D YE+ ++ +++EL G
Sbjct: 53 SRRGVS------------REEIEREVSILRQVL-HHNVITLHDVYENRTDVVLILELVSG 99
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS-L 295
GEL D + + SEE+A + QIL V + H + + H DLKPEN + K +
Sbjct: 100 GELFDFLAQKE-SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPF 354
K IDFGL+ ++ +I G+ +VAPE+++ G EADMWSIGVI YILL G+ PF
Sbjct: 159 KLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
T+ + FDE + S A DF+++LL K+ RKRLT +AL HPW+
Sbjct: 219 LGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278
Query: 415 SHDVKIPSD---MIVYKLIKAYISSSSLRKA 442
+ + ++ + + + +
Sbjct: 279 VDNQQAMVRRESVVNLENFRKQYVRRRWKLS 309
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 381 bits (981), Expect = e-131
Identities = 96/365 (26%), Positives = 152/365 (41%), Gaps = 77/365 (21%)
Query: 100 PEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPK 159
+ L G + Y L +G+G +G A + A+K++ K
Sbjct: 5 HHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQT---RAIRAIKIMNK 61
Query: 160 MIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD 219
+ +E ++ EV++++ L H N+ + Y+
Sbjct: 62 N-------------------------KIRQINPKDVERIKTEVRLMKKLH-HPNIARLYE 95
Query: 220 AYEDDDNIYIVMELCKGGELLDRILSRGGK------------------------------ 249
YED+ I +VMELC GG LLD++
Sbjct: 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIH 155
Query: 250 ---------YSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
E+ +M QI S + + H QG+ HRD+KPENFLF++ + + +K +DF
Sbjct: 156 GFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK-SFEIKLVDF 214
Query: 301 GLSDYVKP-----DERLNDIVGSAYYVAPEVLH---RSYGTEADMWSIGVIAYILLCGSR 352
GLS + G+ Y+VAPEVL+ SYG + D WS GV+ ++LL G+
Sbjct: 215 GLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAV 274
Query: 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
PF ++ VL F+ + LSP A D + LLN++ +R A +AL HPW+
Sbjct: 275 PFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWI 334
Query: 413 ANSHD 417
+ D
Sbjct: 335 SQFSD 339
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 380 bits (979), Expect = e-130
Identities = 106/418 (25%), Positives = 173/418 (41%), Gaps = 74/418 (17%)
Query: 1 MGLCHGKPVENSQNRSQNEALP-YENEPQPNSQKSKASNFPFYSPSPLPSLFKNSPAIPS 59
MG H ++N +N +S+ +S + L S
Sbjct: 1 MGHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTS 60
Query: 60 VNSTPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQF 119
+ + P PA ++ + G+V
Sbjct: 61 ALAVDI--------PAPPAPFDHRIVTAKQGAVN-------------------------- 86
Query: 120 VAHYELG--EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQ 177
+ Y + E +G G FG + G +A K+I ++
Sbjct: 87 -SFYTVSKTEILGGGRFGQVHKCEETAT---GLKLAAKIIKT-----------RGMKD-- 129
Query: 178 FTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGG 237
E+V+ E+ ++ L H NL+Q YDA+E ++I +VME GG
Sbjct: 130 -----------------KEEVKNEISVMNQL-DHANLIQLYDAFESKNDIVLVMEYVDGG 171
Query: 238 ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKA 297
EL DRI+ +E D + M QI + H ++H DLKPEN L +++ +K
Sbjct: 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKI 230
Query: 298 IDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWA 356
IDFGL+ KP E+L G+ ++APEV++ DMWS+GVIAY+LL G PF
Sbjct: 231 IDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLG 290
Query: 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
++ +L ++ + +S EA +F+ +LL K+ R++A++AL HPWL++
Sbjct: 291 DNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 378 bits (973), Expect = e-130
Identities = 103/352 (29%), Positives = 163/352 (46%), Gaps = 60/352 (17%)
Query: 116 SKQFVAHYELG---EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPK 172
F HY+L + +G G F KK Q AVK+I K
Sbjct: 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKR------------ 47
Query: 173 HENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVME 232
+ ++E+ L+ GH N+V+ ++ + D + ++VME
Sbjct: 48 ---------------------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME 86
Query: 233 LCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEEN 292
L GGEL +RI + +SE +A +M +++S V+ H GVVHRDLKPEN LFT + +N
Sbjct: 87 LLNGGELFERIKKKK-HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDN 145
Query: 293 SSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCG 350
+K IDFG + PD + L + +Y APE+L+++ Y D+WS+GVI Y +L G
Sbjct: 146 LEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205
Query: 351 SRPFWARTES-------GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA 403
PF + S I + + K D SF+ W ++S EA D ++ LL D KRL
Sbjct: 206 QVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKM 265
Query: 404 AQALSHPWLAN----------SHDVKIPSDMIVYKLIKA-YISSSSLRKAAL 444
+ + WL + + D+ S V+ +KA + + + ++
Sbjct: 266 SGLRYNEWLQDGSQLSSNPLMTPDILGSSGAAVHTCVKATFHAFNKYKREGF 317
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 378 bits (972), Expect = e-129
Identities = 101/335 (30%), Positives = 154/335 (45%), Gaps = 34/335 (10%)
Query: 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQF 178
Y++GEE+G G F + K G + A K I K +
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKK------------RQSRASR 54
Query: 179 TILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGE 238
+ E++ REV ILR + H N++ +D YE+ ++ +++EL GGE
Sbjct: 55 RGVC------------REEIEREVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGE 101
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS-LKA 297
L D + + SEE+A + QIL V + H + + H DLKPEN + K +K
Sbjct: 102 LFDFLAQK-ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKL 160
Query: 298 IDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356
IDFGL+ ++ +I G+ +VAPE+++ G EADMWSIGVI YILL G+ PF
Sbjct: 161 IDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 220
Query: 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN-- 414
T+ + FDE + S A DF+++LL K+ RKRLT +AL HPW+
Sbjct: 221 DTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280
Query: 415 -SHDVKIPSDMIVYKLIKAYISSSSLRKAALGALA 448
+ ++ + K + +
Sbjct: 281 TQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSL 315
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 373 bits (961), Expect = e-128
Identities = 100/342 (29%), Positives = 157/342 (45%), Gaps = 65/342 (19%)
Query: 115 FSKQFVAHYELGEEV-GRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKH 173
FS +F Y+L E+V G G + Q+ AVK+I K G
Sbjct: 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQPGH---------- 52
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMEL 233
V REV++L GH+N+++ + +E++D Y+V E
Sbjct: 53 --------------------IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEK 92
Query: 234 CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
+GG +L I R ++E +A +V+ + S + F H +G+ HRDLKPEN L + S
Sbjct: 93 MRGGSILSHIHKRR-HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVS 151
Query: 294 SLKAIDFGLSDYVKPDERLNDI--------VGSAYYVAPEVL------HRSYGTEADMWS 339
+K DF L +K + + I GSA Y+APEV+ Y D+WS
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211
Query: 340 IGVIAYILLCGSRPFWAR---------------TESGIFRAVLKADPSFDEAPWPSLSPE 384
+GVI YILL G PF R ++ +F ++ + F + W +S
Sbjct: 212 LGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCA 271
Query: 385 AIDFVKRLLNKDYRKRLTAAQALSHPWLAN-SHDVKIPSDMI 425
A D + +LL +D ++RL+AAQ L HPW+ + + +P+ M+
Sbjct: 272 AKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPENTLPTPMV 313
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 373 bits (960), Expect = e-128
Identities = 104/375 (27%), Positives = 156/375 (41%), Gaps = 59/375 (15%)
Query: 85 LARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEEV-GRGHFGYTCSAKAK 143
+A H + +G E Y+L ++V G G G +
Sbjct: 1 MAHHHHHHSSGLEVLFQGPEPK---------KYAVTDDYQLSKQVLGLGVNGKVLECFHR 51
Query: 144 KGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVK 203
+ GQ A+K++ R+EV
Sbjct: 52 R---TGQKCALKLLYD-----------------------------------SPKARQEVD 73
Query: 204 ILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRGGK-YSEEDAKIV 258
+G ++V D YE+ + I+ME +GGEL RI RG + ++E +A +
Sbjct: 74 HHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEI 133
Query: 259 MVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGS 318
M I + + F H + HRD+KPEN L+TSKE+++ LK DFG + + L +
Sbjct: 134 MRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYT 192
Query: 319 AYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTES----GIFRAVLKADPSF 373
YYVAPEVL Y DMWS+GVI YILLCG PF++ T G+ R + F
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252
Query: 374 DEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAY 433
W +S +A ++ LL D +RLT Q ++HPW+ S V L +
Sbjct: 253 PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDK 312
Query: 434 ISSSSLRKAALGALA 448
+++ ALA
Sbjct: 313 DHWDEVKEEMTSALA 327
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 368 bits (947), Expect = e-126
Identities = 84/336 (25%), Positives = 130/336 (38%), Gaps = 67/336 (19%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+ + +G G G K+ + A+K++
Sbjct: 19 YKVTSQVLGLGINGKVLQIFNKRT---QEKFALKMLQD---------------------- 53
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGG 237
RREV++ + ++V+ D YE+ + IVME GG
Sbjct: 54 -------------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGG 100
Query: 238 ELLDRILSRGGK-YSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
EL RI RG + ++E +A +M I + + H + HRD+KPEN L+TSK N+ LK
Sbjct: 101 ELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILK 160
Query: 297 AIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWA 356
DFG A E Y DMWS+GVI YILLCG PF++
Sbjct: 161 LTDFGF--------------------AKETTGEKYDKSCDMWSLGVIMYILLCGYPPFYS 200
Query: 357 ----RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
G+ + F W +S E ++ LL + +R+T + ++HPW+
Sbjct: 201 NHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 260
Query: 413 ANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGALA 448
S V L + +++ ALA
Sbjct: 261 MQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALA 296
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 368 bits (948), Expect = e-126
Identities = 104/351 (29%), Positives = 157/351 (44%), Gaps = 55/351 (15%)
Query: 116 SKQFVAHYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKH 173
S QF YE+ E++G G + C KA + AVK+I K
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKAT-----NMEFAVKIIDK-------------- 57
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMEL 233
+ D E++IL H N++ D Y+D +Y+V EL
Sbjct: 58 --------------------SKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL 97
Query: 234 CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEEN- 292
KGGELLD+IL + +SE +A V+ I V + H QGVVHRDLKP N L+ + N
Sbjct: 98 MKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNP 156
Query: 293 SSLKAIDFGLSDYVKPDER-LNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCG 350
S++ DFG + ++ + L +A +VAPEVL R Y D+WS+GV+ Y +L G
Sbjct: 157 ESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216
Query: 351 SRPFWAR---TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407
PF T I + S W S+S A D V ++L+ D +RLTAA L
Sbjct: 217 YTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVL 276
Query: 408 SHPWLANSHDV-------KIPSDMIVYKLIKAYISSSSLRKAALGALAKTL 451
HPW+ + + + ++ + Y + + + L + ++
Sbjct: 277 RHPWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQSPVLEPVGRST 327
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 364 bits (936), Expect = e-124
Identities = 96/335 (28%), Positives = 154/335 (45%), Gaps = 38/335 (11%)
Query: 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHE 174
+ K Y + + +G G G A +K + VA+K+I K
Sbjct: 4 YPKALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIKIISK--------------- 45
Query: 175 NHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELC 234
++ A +V E++IL+ L H +++ + ++ +D YIV+EL
Sbjct: 46 -------RKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDAED-YYIVLELM 96
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
+GGEL D+++ + E K+ Q+L V + H G++HRDLKPEN L +S+EE+
Sbjct: 97 EGGELFDKVVGNK-RLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCL 155
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL----HRSYGTEADMWSIGVIAYILLCG 350
+K DFG S + + + G+ Y+APEVL Y D WS+GVI +I L G
Sbjct: 156 IKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
Query: 351 SRPFWA-RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
PF RT+ + + +F W +S +A+D VK+LL D + R T +AL H
Sbjct: 216 YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH 275
Query: 410 PWLANSHDVKIPSDMIVYKLIKAYISSSSLRKAAL 444
PWL + L+ S++L +
Sbjct: 276 PWLQDE-----DMKRKFQDLLSEENESTALPQVLA 305
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 359 bits (923), Expect = e-121
Identities = 95/325 (29%), Positives = 155/325 (47%), Gaps = 33/325 (10%)
Query: 106 DIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIF 165
D+ +D + K Y + + +G G G A +K + VA+++I K
Sbjct: 120 DLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKT---CKKVAIRIISK------ 170
Query: 166 LQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDD 225
++ A +V E++IL+ L H +++ + ++ +D
Sbjct: 171 ----------------RKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFDAED 213
Query: 226 NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL 285
YIV+EL +GGEL D+++ + E K+ Q+L V + H G++HRDLKPEN L
Sbjct: 214 -YYIVLELMEGGELFDKVVGN-KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 271
Query: 286 FTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL----HRSYGTEADMWSIG 341
+S+EE+ +K DFG S + + + G+ Y+APEVL Y D WS+G
Sbjct: 272 LSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLG 331
Query: 342 VIAYILLCGSRPFWA-RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKR 400
VI +I L G PF RT+ + + +F W +S +A+D VK+LL D + R
Sbjct: 332 VILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 391
Query: 401 LTAAQALSHPWLANSHDVKIPSDMI 425
T +AL HPWL + + D++
Sbjct: 392 FTTEEALRHPWLQDEDMKRKFQDLL 416
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-103
Identities = 72/354 (20%), Positives = 131/354 (37%), Gaps = 53/354 (14%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ + +G G G +G +DVAVK I
Sbjct: 26 FCPKDVLGHGAEGTIV----YRGMFDNRDVAVKRILPE---------------------- 59
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
REV++LR H N+++++ +D YI +ELC L +
Sbjct: 60 -----------CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEY 107
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI--DF 300
+ + + + ++ Q S +A H +VHRDLKP N L + + +KA+ DF
Sbjct: 108 VEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDF 167
Query: 301 GLSDYVKPDE----RLNDIVGSAYYVAPEVL----HRSYGTEADMWSIGVIAYILLC-GS 351
GL + R + + G+ ++APE+L + D++S G + Y ++ GS
Sbjct: 168 GLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS 227
Query: 352 RPFWARTESGIFRAVLKADPSFD-EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
PF + +L S D P A + +++++ D +KR +A L HP
Sbjct: 228 HPFGKSLQRQAN--ILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285
Query: 411 WLANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFT 464
+ + ++ V I+ + K + + +
Sbjct: 286 FFWSLEK-QLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWRENITVPLQ 338
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 309 bits (794), Expect = e-101
Identities = 82/335 (24%), Positives = 130/335 (38%), Gaps = 71/335 (21%)
Query: 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHE 174
F + + +G G G +GS +G+ VAVK +
Sbjct: 9 FEQSLKNLVVSEKILGYGSSGTVV----FQGSFQGRPVAVKRMLI--------------- 49
Query: 175 NHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELC 234
F + E+K+L H N++++Y + D +YI +ELC
Sbjct: 50 --DF----------------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91
Query: 235 KGGELLDRILSRG------GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTS 288
L D + S+ E + ++ QI S VA H ++HRDLKP+N L ++
Sbjct: 92 -NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150
Query: 289 KE----------ENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVL------ 327
EN + DFGL + + LN+ G++ + APE+L
Sbjct: 151 SSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNL 210
Query: 328 --HRSYGTEADMWSIGVIAYILLC-GSRPFWAR--TESGIFRAVLKADPSFDEAPWPSLS 382
R D++S+G + Y +L G PF + ES I R + D SL
Sbjct: 211 QTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDE-MKCLHDRSLI 269
Query: 383 PEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
EA D + ++++ D KR TA + L HP
Sbjct: 270 AEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 9e-87
Identities = 74/340 (21%), Positives = 132/340 (38%), Gaps = 70/340 (20%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
S ++ + +E +G+G FG A+ + A+K I
Sbjct: 1 SLRYASDFEEIAVLGQGAFGQVVKARNALD---SRYYAIKKIRH---------------- 41
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN--------- 226
T + + EV +L +L H+ +V++Y A+ + N
Sbjct: 42 ---------------TEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFVKPMTAVK 85
Query: 227 ----IYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282
++I ME C+ G L D I S ++ + QIL +++ H QG++HRDLKP
Sbjct: 86 KKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPM 145
Query: 283 NFLFTSKEENSSLKAIDFGLS---------------DYVKPDERLNDIVGSAYYVAPEVL 327
N E+ ++K DFGL+ + + L +G+A YVA EVL
Sbjct: 146 NIFID---ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVL 202
Query: 328 HRS--YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEA 385
+ Y + DM+S+G+I + ++ I + + F +
Sbjct: 203 DGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE 260
Query: 386 IDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMI 425
++ L++ D KR A L+ WL H ++ + +
Sbjct: 261 KKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEAL 300
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 257 bits (659), Expect = 9e-83
Identities = 67/329 (20%), Positives = 114/329 (34%), Gaps = 72/329 (21%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ L + +G+G + KK G A+KV +
Sbjct: 11 WLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNI-----------SFLRPV----- 51
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELL 240
+ RE ++L+ L HKN+V+ + E+ + ++ME C G L
Sbjct: 52 -------------DVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLY 97
Query: 241 DRILSRG--GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL-FTSKEENSSLKA 297
+ E + IV+ ++ + G+VHR++KP N + ++ S K
Sbjct: 98 TVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157
Query: 298 IDFGLSDYVKPDERLNDIVGSAYYVAPEVL---------HRSYGTEADMWSIGVIAYILL 348
DFG + ++ DE+ + G+ Y+ P++ + YG D+WSIGV Y
Sbjct: 158 TDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
Query: 349 CGSRPFWA----RTESGIFRAVLKADP-----------------SFDEAPWPSLSPEA-- 385
GS PF R + ++ P S D SLS
Sbjct: 218 TGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQV 277
Query: 386 --IDFVKRLLNKDYRKRLTAAQALSHPWL 412
+ +L D K Q +
Sbjct: 278 LLTPVLANILEADQEKCWGFDQFFAETSD 306
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 251 bits (642), Expect = 3e-80
Identities = 71/313 (22%), Positives = 121/313 (38%), Gaps = 57/313 (18%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKG-SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
Y + +++G G K + + K Q A+K +
Sbjct: 29 IYSILKQIGSGGSS-----KVFQVLNEKKQIYAIKYVNL-------------------EE 64
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGH-KNLVQFYDAYEDDDNIYIVMELCKGGEL 239
D ++ R E+ L L H +++ YD D IY+VME C +L
Sbjct: 65 ADNQ---------TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDL 114
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
+ + + K +L V H G+VH DLKP NFL + LK ID
Sbjct: 115 NSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLID 169
Query: 300 FGLSDYVKPDER---LNDIVGSAYYVAPEVLHRS------------YGTEADMWSIGVIA 344
FG+++ ++PD + VG+ Y+ PE + ++D+WS+G I
Sbjct: 170 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 229
Query: 345 YILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA 404
Y + G PF I + DP+ + + D +K L +D ++R++
Sbjct: 230 YYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 288
Query: 405 QALSHPWLANSHD 417
+ L+HP++
Sbjct: 289 ELLAHPYVQIQTH 301
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 248 bits (635), Expect = 8e-79
Identities = 71/312 (22%), Positives = 121/312 (38%), Gaps = 57/312 (18%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKG-SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
Y + +++G G K + + K Q A+K +
Sbjct: 10 IYSILKQIGSGGSS-----KVFQVLNEKKQIYAIKYVNL-------------------EE 45
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGH-KNLVQFYDAYEDDDNIYIVMELCKGGEL 239
D ++ R E+ L L H +++ YD D IY+VME C +L
Sbjct: 46 ADNQ---------TLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDL 95
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
+ + + K +L V H G+VH DLKP NFL + LK ID
Sbjct: 96 NSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLID 150
Query: 300 FGLSDYVKPDER---LNDIVGSAYYVAPEVLHRS------------YGTEADMWSIGVIA 344
FG+++ ++PD + VG+ Y+ PE + ++D+WS+G I
Sbjct: 151 FGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCIL 210
Query: 345 YILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA 404
Y + G PF I + DP+ + + D +K L +D ++R++
Sbjct: 211 YYMTYGKTPFQQIINQ-ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIP 269
Query: 405 QALSHPWLANSH 416
+ L+HP++
Sbjct: 270 ELLAHPYVQIQT 281
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 245 bits (627), Expect = 2e-78
Identities = 85/309 (27%), Positives = 150/309 (48%), Gaps = 40/309 (12%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
+ + +++G +G+G F A++ G +VA+K+I K ++
Sbjct: 7 GEKIEDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKK------AMYKAGMVQR 57
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG 236
V+ EVKI L H ++++ Y+ +ED + +Y+V+E+C
Sbjct: 58 ---------------------VQNEVKIHCQLK-HPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
GE+ + +R +SE +A+ M QI++ + + H G++HRDL N L T +K
Sbjct: 96 GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN---IK 152
Query: 297 AIDFGLSDYVK-PDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPF 354
DFGL+ +K P E+ + G+ Y++PE+ ++G E+D+WS+G + Y LL G PF
Sbjct: 153 IADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF 212
Query: 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
T V+ AD P LS EA D + +LL ++ RL+ + L HP+++
Sbjct: 213 DTDTVKNTLNKVVLADYEM---P-SFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSR 268
Query: 415 SHDVKIPSD 423
+ K +
Sbjct: 269 NSSTKSKDE 277
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 2e-78
Identities = 73/392 (18%), Positives = 128/392 (32%), Gaps = 79/392 (20%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLK--GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
+ L + +G+G +G K G A+KV +
Sbjct: 11 WLLSDILGQGATA-----NVFRGRHKKTGDLFAIKVFNNI-----------SFLRPV--- 51
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGE 238
+ RE ++L+ L HKN+V+ + E+ + ++ME C G
Sbjct: 52 ---------------DVQMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGS 95
Query: 239 LLDRILSRG--GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL-FTSKEENSSL 295
L + E + IV+ ++ + G+VHR++KP N + ++ S
Sbjct: 96 LYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVY 155
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL---------HRSYGTEADMWSIGVIAYI 346
K DFG + ++ DE+ + G+ Y+ P++ + YG D+WSIGV Y
Sbjct: 156 KLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYH 215
Query: 347 LLCGSRPFWA----RTESGIFRAVLKADPSFDEAPW---------------------PSL 381
GS PF R + ++ PS + L
Sbjct: 216 AATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGL 275
Query: 382 SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYISSSSLRK 441
+ +L D K Q + V + K YI S +
Sbjct: 276 QVLLTPVLANILEADQEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTAT 335
Query: 442 AALGALAKTLTVP---QLAYLREQFTLLAPNK 470
+ K + Q + +L P +
Sbjct: 336 IFHELVYKQTKIISSNQELIYEGRRLVLEPGR 367
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 5e-77
Identities = 81/294 (27%), Positives = 132/294 (44%), Gaps = 45/294 (15%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLK--GQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
Y G +G+G F AK + S + A K++PK +
Sbjct: 16 RYVRGRFLGKGGF-----AKCFEISDADTKEVFAGKIVPKSL------------------ 52
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
+ E + E+ I R+L H+++V F+ +ED+D +++V+ELC+ L
Sbjct: 53 ---------LLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSL 102
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
L+ R +E +A+ + QI+ + H V+HRDLK N E +K D
Sbjct: 103 LELHKRRK-ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGD 158
Query: 300 FGLSDYVK-PDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWAR 357
FGL+ V+ ER + G+ Y+APEVL + + E D+WSIG I Y LL G PF
Sbjct: 159 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218
Query: 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
+ + K + S P ++P A ++++L D R T + L+ +
Sbjct: 219 CLKETYLRIKKNEYSI---P-KHINPVAASLIQKMLQTDPTARPTINELLNDEF 268
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 241 bits (618), Expect = 8e-77
Identities = 74/306 (24%), Positives = 135/306 (44%), Gaps = 26/306 (8%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKH 173
+ Y L +E+G+G +G K A+KV+ K L
Sbjct: 8 DCVQLNQYTLKDEIGKGSYG-----VVKLAYNENDNTYYAMKVLSKKK----LIRQAGFP 58
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED--DDNIYIVM 231
+ IE V +E+ IL+ L H N+V+ + +D +D++Y+V
Sbjct: 59 RRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVF 117
Query: 232 ELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEE 291
EL G +++ SE+ A+ ++ + + H+Q ++HRD+KP N L E
Sbjct: 118 ELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG---E 172
Query: 292 NSSLKAIDFGLS-DYVKPDERLNDIVGSAYYVAPEVL---HRSY-GTEADMWSIGVIAYI 346
+ +K DFG+S ++ D L++ VG+ ++APE L + + G D+W++GV Y
Sbjct: 173 DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232
Query: 347 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA 406
+ G PF + + F + P ++ + D + R+L+K+ R+ +
Sbjct: 233 FVFGQCPFMDERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEI 290
Query: 407 LSHPWL 412
HPW+
Sbjct: 291 KLHPWV 296
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-76
Identities = 77/361 (21%), Positives = 131/361 (36%), Gaps = 61/361 (16%)
Query: 73 PPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRG 132
P S K + R P+ + + S Y + +++G G
Sbjct: 12 PRGSGMKETAAAKFERQHMDSPDLGTDDDDKASS----SANECISVKGRIYSILKQIGSG 67
Query: 133 HFGYTCSAKAKKG-SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTT 191
K + + K Q A+K + D
Sbjct: 68 GSS-----KVFQVLNEKKQIYAIKYVNL-------------------EEADNQT------ 97
Query: 192 AIAIEDVRREVKILRALTGH-KNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKY 250
++ R E+ L L H +++ YD D IY+VME C +L + +
Sbjct: 98 ---LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK-SI 152
Query: 251 SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE 310
+ K +L V H G+VH DLKP NFL + LK IDFG+++ ++PD
Sbjct: 153 DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDT 208
Query: 311 R---LNDIVGSAYYVAPEVLHRS------------YGTEADMWSIGVIAYILLCGSRPFW 355
+ VG+ Y+ PE + ++D+WS+G I Y + G PF
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415
I + DP+ + + D +K L +D ++R++ + L+HP++
Sbjct: 269 QIINQ-ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 327
Query: 416 H 416
Sbjct: 328 T 328
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 2e-76
Identities = 88/345 (25%), Positives = 143/345 (41%), Gaps = 56/345 (16%)
Query: 71 PFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVG 130
P P + + A + P IPE + Y G +G
Sbjct: 2 PAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRR-----------YVRGRFLG 50
Query: 131 RGHFGYTCSAKAKKGSLK--GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G F AK + S + A K++PK +
Sbjct: 51 KGGF-----AKCFEISDADTKEVFAGKIVPKSL--------------------------- 78
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+ E + E+ I R+L H+++V F+ +ED+D +++V+ELC+ LL+ R
Sbjct: 79 LLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK- 136
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK- 307
+E +A+ + QI+ + H V+HRDLK N E +K DFGL+ V+
Sbjct: 137 ALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE---VKIGDFGLATKVEY 193
Query: 308 PDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366
ER + G+ Y+APEVL + + E D+WSIG I Y LL G PF + +
Sbjct: 194 DGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
K + S P ++P A ++++L D R T + L+ +
Sbjct: 254 KKNEYSI---P-KHINPVAASLIQKMLQTDPTARPTINELLNDEF 294
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 7e-76
Identities = 88/305 (28%), Positives = 153/305 (50%), Gaps = 46/305 (15%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHE 174
+ + +Y L + +G+G+F K K L G++VA+K+I K
Sbjct: 11 QPHIGNYRLLKTIGKGNFA-----KVKLARHILTGREVAIKIIDK--------------- 50
Query: 175 NHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELC 234
T L+ +++ + REV+I++ L H N+V+ ++ E + +Y++ME
Sbjct: 51 ----TQLNP---------TSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLYLIMEYA 96
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
GGE+ D +++ G + E++A+ QI+S V +CH + +VHRDLK EN L + + +
Sbjct: 97 SGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL---DADMN 152
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSY-GTEADMWSIGVIAYILLCGSR 352
+K DFG S+ +L+ G+ Y APE+ + Y G E D+WS+GVI Y L+ GS
Sbjct: 153 IKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSL 212
Query: 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
PF + + VL+ + + +S + + +KR L + KR T Q + W+
Sbjct: 213 PFDGQNLKELRERVLRGK--YRIPFY--MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268
Query: 413 ANSHD 417
H+
Sbjct: 269 NAGHE 273
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 1e-73
Identities = 72/382 (18%), Positives = 137/382 (35%), Gaps = 62/382 (16%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
Q +E+ E +G G FGY + G+ VA+K + + PK+
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQELS--------PKNRER 58
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED------DDNIYIV 230
E++I++ L H N+V + + +D +
Sbjct: 59 ---------------------WCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 231 MELCKGGELLDRILSRG--GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTS 288
ME C+GG+L + E + ++ I S + + H ++HRDLKPEN +
Sbjct: 97 MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQP 156
Query: 289 KEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYIL 347
+ K ID G + + E + VG+ Y+APE+L + Y D WS G +A+
Sbjct: 157 GPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFEC 216
Query: 348 LCGSRPFWARTESGIFRAVLKADPSFDEAPW--------------------PSLSPEAID 387
+ G RPF + + ++ + + L+ +
Sbjct: 217 ITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLER 276
Query: 388 FVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGAL 447
+++ +L R+R T Q + + + V ++ + + + +
Sbjct: 277 WLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQN 336
Query: 448 AKTLTVPQLAYLREQFTLLAPN 469
K+ E+ LL +
Sbjct: 337 LKSWLQQDTGIPEEEQELLQAS 358
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 3e-73
Identities = 62/325 (19%), Positives = 127/325 (39%), Gaps = 50/325 (15%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
+++ Y + + +G F K + A+K K + ++
Sbjct: 27 DKYINDYRIIRTLNQGKFN-----KIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDK- 80
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG 236
++ +D + E++I+ + ++ + + D +YI+ E +
Sbjct: 81 ------------ISIKSKYDDFKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMEN 127
Query: 237 GELLDRILSRG-------GKYSEEDAKIVMVQILSVVAFCHFQ-GVVHRDLKPENFLFTS 288
+L + K ++ +L+ ++ H + + HRD+KP N L
Sbjct: 128 DSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM-- 185
Query: 289 KEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS---YGTEADMWSIGVIAY 345
++N +K DFG S+Y+ D+++ G+ ++ PE G + D+WS+G+ Y
Sbjct: 186 -DKNGRVKLSDFGESEYM-VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243
Query: 346 ILLCGSRPFWA-RTESGIFRAVLKADPSF---------------DEAPWPSLSPEAIDFV 389
++ PF + +F + + + LS E IDF+
Sbjct: 244 VMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303
Query: 390 KRLLNKDYRKRLTAAQALSHPWLAN 414
K L K+ +R+T+ AL H WLA+
Sbjct: 304 KLFLRKNPAERITSEDALKHEWLAD 328
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 231 bits (592), Expect = 3e-73
Identities = 81/290 (27%), Positives = 139/290 (47%), Gaps = 41/290 (14%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+E+G +G+G FG A+ K+ +A+KV+ K Q+ E+
Sbjct: 11 FEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKA------QLEKAGVEHQ------ 55
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+RREV+I L H N+++ Y + D +Y+++E G +
Sbjct: 56 ---------------LRREVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRE 99
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
L + K+ E+ + ++ + +++CH + V+HRD+KPEN L S E LK DFG
Sbjct: 100 -LQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE---LKIADFGW 155
Query: 303 SDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTESG 361
S + P R D+ G+ Y+ PE++ R + + D+WS+GV+ Y L G PF A T
Sbjct: 156 SVHA-PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
Query: 362 IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
++ + + + +F P ++ A D + RLL + +R + L HPW
Sbjct: 215 TYKRISRVEFTF---P-DFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 260
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 4e-73
Identities = 77/304 (25%), Positives = 135/304 (44%), Gaps = 49/304 (16%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKH 173
+ FV ++L + +G G +G + + + + VAVK++
Sbjct: 2 AVPFVEDWDLVQTLGEGAYG-----EVQLAVNRVTEEAVAVKIVDMK------------- 43
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMEL 233
+D E++++E+ I + L H+N+V+FY + + Y+ +E
Sbjct: 44 -----RAVD-----------CPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEY 86
Query: 234 CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
C GGEL DRI E DA+ Q+++ V + H G+ HRD+KPEN L +E
Sbjct: 87 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERD 142
Query: 294 SLKAIDFGLS---DYVKPDERLNDIVGSAYYVAPEVL-HRSY-GTEADMWSIGVIAYILL 348
+LK DFGL+ Y + LN + G+ YVAPE+L R + D+WS G++ +L
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 349 CGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407
G P+ ++S + + PW + + + ++L ++ R+T
Sbjct: 203 AGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 408 SHPW 411
W
Sbjct: 261 KDRW 264
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 4e-73
Identities = 51/313 (16%), Positives = 88/313 (28%), Gaps = 37/313 (11%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+L E + G + + +D A+KV + +
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVER---LEDFALKVFTM---------GAENSRSELERLH 110
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRA-----LTGHKNLVQFYDAYEDDD--NIYIVMELC 234
+ + E+ R ++L + Q +D N ++M
Sbjct: 111 EATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA 170
Query: 235 KG-----GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSK 289
LD + G I+ Q++ + A +G+VH P+N
Sbjct: 171 SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIM-- 228
Query: 290 EENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS---YGTEADMWSIGVIAYI 346
+ L D K R Y E L+ S + + W +G+ Y
Sbjct: 229 -PDGRLMLGDVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR 285
Query: 347 LLCGSRPFWARTESGIFRAVLKAD-----PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL 401
+ C PF T + S L + R LN D R+RL
Sbjct: 286 VWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL 345
Query: 402 TAAQALSHPWLAN 414
+A+ P
Sbjct: 346 LPLEAMETPEFLQ 358
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 2e-72
Identities = 79/304 (25%), Positives = 123/304 (40%), Gaps = 51/304 (16%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGS--LKGQDVAVKVIPKMIGVIFLQVHCPKHE 174
+ F A Y LG +G+G FG G VA+KVIP+ +V
Sbjct: 27 EAFEAEYRLGPLLGKGGFG-----TVFAGHRLTDRLQVAIKVIPRN------RVLGWSPL 75
Query: 175 NHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL---TGHKNLVQFYDAYEDDDNIYIVM 231
+ T EV +L + GH +++ D +E + +V+
Sbjct: 76 SDSVTC------------------PLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117
Query: 232 EL-CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKE 290
E +L D I + G E ++ Q+++ + CH +GVVHRD+K EN L
Sbjct: 118 ERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDL-- 174
Query: 291 ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSY-GTEADMWSIGVIAYILL 348
K IDFG + DE D G+ Y PE + Y A +WS+G++ Y ++
Sbjct: 175 RRGCAKLIDFGSGALLH-DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233
Query: 349 CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
CG PF + I A L P+ +SP+ ++R L R + + L
Sbjct: 234 CGDIPF--ERDQEILEAELH-FPAH-------VSPDCCALIRRCLAPKPSSRPSLEEILL 283
Query: 409 HPWL 412
PW+
Sbjct: 284 DPWM 287
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-72
Identities = 95/301 (31%), Positives = 136/301 (45%), Gaps = 45/301 (14%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKH 173
+ + HY LG+ +G G FG K K G L G VAVK++ + K
Sbjct: 6 GRVKIGHYVLGDTLGVGTFG-----KVKIGEHQLTGHKVAVKILNRQ-----------KI 49
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMEL 233
+ + ++RE++ L+ H ++++ Y + ++VME
Sbjct: 50 RSLDV----------------VGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFFMVMEY 92
Query: 234 CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
GGEL D I G + E +A+ + QILS V +CH VVHRDLKPEN L + +
Sbjct: 93 VSGGELFDYICKHG-RVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL---DAHM 148
Query: 294 SLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSY-GTEADMWSIGVIAYILLCGS 351
+ K DFGLS+ + E L GS Y APEV+ R Y G E D+WS GVI Y LLCG+
Sbjct: 149 NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
Query: 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
PF +F+ + F + L+ + +L D KR T H W
Sbjct: 209 LPFDDEHVPTLFKKIRGGV--FYIPEY--LNRSVATLLMHMLQVDPLKRATIKDIREHEW 264
Query: 412 L 412
Sbjct: 265 F 265
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 6e-72
Identities = 86/301 (28%), Positives = 143/301 (47%), Gaps = 42/301 (13%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+++G +G+G FG A+ K+ +A+KV+ K Q+ E+
Sbjct: 16 FDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKS------QLEKEGVEHQ------ 60
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+RRE++I L H N+++ Y+ + D IY+++E GEL
Sbjct: 61 ---------------LRREIEIQSHLR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKE 104
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
L + G++ E+ + M ++ + +CH + V+HRD+KPEN L K E LK DFG
Sbjct: 105 -LQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE---LKIADFGW 160
Query: 303 SDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTESG 361
S + P R + G+ Y+ PE++ +++ + D+W GV+ Y L G PF + + +
Sbjct: 161 SVHA-PSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
Query: 362 IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW-LANSHDVKI 420
R ++ D F P P LS + D + +LL +RL + HPW ANS V
Sbjct: 220 THRRIVNVDLKF---P-PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 275
Query: 421 P 421
P
Sbjct: 276 P 276
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 7e-72
Identities = 89/303 (29%), Positives = 136/303 (44%), Gaps = 49/303 (16%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHE 174
Y+ +++G G+FG A+ L + VAVK I +
Sbjct: 16 MHDSDRYDFVKDIGSGNFG-----VARLMRDKLTKELVAVKYIER--------------- 55
Query: 175 NHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELC 234
A E+V+RE+ R+L H N+V+F + ++ I+ME
Sbjct: 56 ----------------GAAIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIIMEYA 98
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
GGEL +RI + G ++SE++A+ Q+LS V++CH + HRDLK EN L
Sbjct: 99 SGGELYERICNAG-RFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAP-R 156
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSY-GTEADMWSIGVIAYILLCGSR 352
LK DFG S + VG+ Y+APEVL + Y G AD+WS GV Y++L G+
Sbjct: 157 LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAY 216
Query: 353 PFWARTESGIFR----AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
PF E +R +L S + +SPE + R+ D R++ + +
Sbjct: 217 PFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPECCHLISRIFVADPATRISIPEIKT 274
Query: 409 HPW 411
H W
Sbjct: 275 HSW 277
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 7e-72
Identities = 75/301 (24%), Positives = 122/301 (40%), Gaps = 47/301 (15%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
++ Y +G G FG+ +A K K ++V VK I K
Sbjct: 20 GEYSQKYSTMSPLGSGAFGFVWTAVDK---EKNKEVVVKFIKK----------------- 59
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMEL-CK 235
++ + V E+ IL + H N+++ D +E+ +VME
Sbjct: 60 -----EKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGS 113
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
G +L I + E A + Q++S V + + ++HRD+K EN + E+ ++
Sbjct: 114 GLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI---AEDFTI 169
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSY-GTEADMWSIGVIAYILLCGSRP 353
K IDFG + Y++ + G+ Y APEVL Y G E +MWS+GV Y L+ P
Sbjct: 170 KLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
Query: 354 F--WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
F T P +S E + V LL +R T + ++ PW
Sbjct: 230 FCELEETVEAAIH-----PPYL-------VSKELMSLVSGLLQPVPERRTTLEKLVTDPW 277
Query: 412 L 412
+
Sbjct: 278 V 278
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-71
Identities = 77/304 (25%), Positives = 135/304 (44%), Gaps = 49/304 (16%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKH 173
+ FV ++L + +G G +G + + + + VAVK++
Sbjct: 2 AVPFVEDWDLVQTLGEGAYG-----EVQLAVNRVTEEAVAVKIVDMK------------- 43
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMEL 233
+D E++++E+ I + L H+N+V+FY + + Y+ +E
Sbjct: 44 -----RAVD-----------CPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEY 86
Query: 234 CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
C GGEL DRI E DA+ Q+++ V + H G+ HRD+KPEN L +E
Sbjct: 87 CSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL---DERD 142
Query: 294 SLKAIDFGLS---DYVKPDERLNDIVGSAYYVAPEVL-HRSY-GTEADMWSIGVIAYILL 348
+LK DFGL+ Y + LN + G+ YVAPE+L R + D+WS G++ +L
Sbjct: 143 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202
Query: 349 CGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407
G P+ ++S + + PW + + + ++L ++ R+T
Sbjct: 203 AGELPWDQPSDSCQEYSDWKEKK--TYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260
Query: 408 SHPW 411
W
Sbjct: 261 KDRW 264
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 2e-71
Identities = 77/302 (25%), Positives = 123/302 (40%), Gaps = 49/302 (16%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHE 174
+ + Y++G +G G FG G VA+K + K
Sbjct: 39 EPLESQYQVGPLLGSGGFG-----SVYSGIRVSDNLPVAIKHVEK--------------- 78
Query: 175 NHQFTILDEYCCLFMTTAIAIEDVRREVKILRALT-GHKNLVQFYDAYEDDDNIYIVMEL 233
+ ++ L V EV +L+ ++ G +++ D +E D+ +++E
Sbjct: 79 ----DRISDWGELPN-----GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 234 CKG-GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEEN 292
+ +L D I R G EE A+ Q+L V CH GV+HRD+K EN L
Sbjct: 130 PEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE 188
Query: 293 SSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSY-GTEADMWSIGVIAYILLCG 350
LK IDFG +K D D G+ Y PE + + Y G A +WS+G++ Y ++CG
Sbjct: 189 --LKLIDFGSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245
Query: 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
PF + I R + +S E ++ L R T + +HP
Sbjct: 246 DIPF--EHDEEIIRGQVF-FRQR-------VSSECQHLIRWCLALRPSDRPTFEEIQNHP 295
Query: 411 WL 412
W+
Sbjct: 296 WM 297
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 1e-70
Identities = 71/297 (23%), Positives = 104/297 (35%), Gaps = 46/297 (15%)
Query: 119 FVAHYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
F ++ +G G +G + K + G+ AVK PK
Sbjct: 55 FQQSFQRLSRLGHGSYGEVF----KVRS-KEDGRLYAVKRSMS-------PFRGPKDRAR 102
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG 236
+ EV + H V+ A+E+ +Y+ ELC G
Sbjct: 103 K---------------------LAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G 140
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
L + G E + L +A H QG+VH D+KP N K
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLG---PRGRCK 197
Query: 297 AIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCG-SRPFW 355
DFGL + G Y+APE+L SYGT AD++S+G+ + C P
Sbjct: 198 LGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG 257
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+ + L P F LS E + +L D + R TA L+ P L
Sbjct: 258 GEGWQQLRQGYLP--PEF----TAGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 6e-70
Identities = 86/301 (28%), Positives = 139/301 (46%), Gaps = 46/301 (15%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKH 173
SK+ + Y + E +G G FG K K Q VA+K I + +
Sbjct: 4 SKRHIGPYIIRETLGEGSFG-----KVKLATHYKTQQKVALKFISRQL------------ 46
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMEL 233
+ + V RE+ L+ L H ++++ YD +I +V+E
Sbjct: 47 ---------------LKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDIVMVIEY 90
Query: 234 CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
GGEL D I+ + + +E++ + QI+ + +CH +VHRDLKPEN L ++N
Sbjct: 91 A-GGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL---DDNL 145
Query: 294 SLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSY-GTEADMWSIGVIAYILLCGS 351
++K DFGLS+ + L GS Y APEV+ + Y G E D+WS G++ Y++L G
Sbjct: 146 NVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
Query: 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
PF +F+ V + + LSP A ++R++ D +R+T + PW
Sbjct: 206 LPFDDEFIPNLFKKVNSCV--YVMPDF--LSPGAQSLIRRMIVADPMQRITIQEIRRDPW 261
Query: 412 L 412
Sbjct: 262 F 262
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 1e-69
Identities = 98/301 (32%), Positives = 141/301 (46%), Gaps = 45/301 (14%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKH 173
+ + HY LG+ +G G FG K K G L G VAVK++ +
Sbjct: 11 GRVKIGHYILGDTLGVGTFG-----KVKVGKHELTGHKVAVKILNRQK------------ 53
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMEL 233
+ + + +RRE++ L+ H ++++ Y +I++VME
Sbjct: 54 ---------------IRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDIFMVMEY 97
Query: 234 CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
GGEL D I G + E++++ + QILS V +CH VVHRDLKPEN L + +
Sbjct: 98 VSGGELFDYICKNG-RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL---DAHM 153
Query: 294 SLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSY-GTEADMWSIGVIAYILLCGS 351
+ K DFGLS+ + E L GS Y APEV+ R Y G E D+WS GVI Y LLCG+
Sbjct: 154 NAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
Query: 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
PF +F+ + F + L+P I +K +L D KR T H W
Sbjct: 214 LPFDDDHVPTLFKKICDGI--FYTPQY--LNPSVISLLKHMLQVDPMKRATIKDIREHEW 269
Query: 412 L 412
Sbjct: 270 F 270
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 220 bits (561), Expect = 2e-67
Identities = 43/312 (13%), Positives = 89/312 (28%), Gaps = 43/312 (13%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
G +G+ A ++ G+ V V + K E + +L
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL 130
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALT--GHKNLVQFYDAYEDDD--NIYIVMELCKG- 236
+ + R + + K +++ D + + + +
Sbjct: 131 RG-----IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 185
Query: 237 ----GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEEN 292
GE+L S + +Q++ ++A H G+VH L+P + + +
Sbjct: 186 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QR 242
Query: 293 SSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS------------YGTEADMWSI 340
+ F D S + PE+ R D W++
Sbjct: 243 GGVFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWAL 299
Query: 341 GVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKR 400
G++ Y + C P G + + ++ ++ L R
Sbjct: 300 GLVIYWIWCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDR 351
Query: 401 LTAAQALSHPWL 412
L QA+ P
Sbjct: 352 LLPLQAMETPEY 363
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 2e-66
Identities = 74/307 (24%), Positives = 123/307 (40%), Gaps = 53/307 (17%)
Query: 118 QFVAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
+ + Y +G+ +G G +G K K+ S AVK++ K
Sbjct: 2 KLIGKYLMGDLLGEGSYG-----KVKEVLDSETLCRRAVKILKKK--------------- 41
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD--AYEDDDNIYIVMEL 233
+V++E+++LR L HKN++Q D E+ +Y+VME
Sbjct: 42 -----------KLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQKMYMVMEY 89
Query: 234 CKGG--ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEE 291
C G E+LD + ++ A Q++ + + H QG+VH+D+KP N L T
Sbjct: 90 CVCGMQEMLDSVPE--KRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLT---T 144
Query: 292 NSSLKAIDFGLS---DYVKPDERLNDIVGSAYYVAPEVL--HRSY-GTEADMWSIGVIAY 345
+LK G++ D+ GS + PE+ ++ G + D+WS GV Y
Sbjct: 145 GGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLY 204
Query: 346 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQ 405
+ G PF +F + K + P D +K +L + KR + Q
Sbjct: 205 NITTGLYPFEGDNIYKLFENIGKGS--YAIPGD--CGPPLSDLLKGMLEYEPAKRFSIRQ 260
Query: 406 ALSHPWL 412
H W
Sbjct: 261 IRQHSWF 267
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 1e-65
Identities = 69/321 (21%), Positives = 139/321 (43%), Gaps = 43/321 (13%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y +++G G FG K+ + G+ +K I
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTED---GRQYVIKEIN----------------------- 58
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ ++ E+ RREV +L + H N+VQ+ +++E++ ++YIVM+ C+GG+L
Sbjct: 59 -----ISRMSSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIVMDYCEGGDLFK 112
Query: 242 RILSRGGKY-SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
RI ++ G E+ VQI + H + ++HRD+K +N T ++ +++ DF
Sbjct: 113 RINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTVQLGDF 169
Query: 301 GLSDYVKPD-ERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWART 358
G++ + E +G+ YY++PE+ ++ Y ++D+W++G + Y L F A +
Sbjct: 170 GIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGS 229
Query: 359 ESGIFRAVLKADPSFDEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
+ ++ P S + V +L ++ R R + L ++A +
Sbjct: 230 MKNLVLKIISGSF----PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIE 285
Query: 418 VKIPSDMIVYKLIKAYISSSS 438
+ +I + S
Sbjct: 286 KFLSPQLIAEEFCLKTFSKFG 306
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 211 bits (540), Expect = 2e-65
Identities = 81/306 (26%), Positives = 128/306 (41%), Gaps = 52/306 (16%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
YE+ +G G +G + K G+ + K +
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDYG--------------------- 42
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN--IYIVMELCKGGEL 239
MT A + + EV +LR L H N+V++YD D N +YIVME C+GG+L
Sbjct: 43 ------SMTEA-EKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL 94
Query: 240 LDRI--LSRGGKY-SEEDAKIVMVQILSVVAFCH-----FQGVVHRDLKPENFLFTSKEE 291
I ++ +Y EE VM Q+ + CH V+HRDLKP N
Sbjct: 95 ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDG--- 151
Query: 292 NSSLKAIDFGLSDYVKPDERL-NDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLC 349
++K DFGL+ + D VG+ YY++PE + SY ++D+WS+G + Y L
Sbjct: 152 KQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA 211
Query: 350 GSRPFWARTESGIFRAVLKADPSFDEAPWPSL-SPEAIDFVKRLLNKDYRKRLTAAQALS 408
PF A ++ + + + P S E + + R+LN R + + L
Sbjct: 212 LMPPFTAFSQKELAGKIREGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 267
Query: 409 HPWLAN 414
+P +
Sbjct: 268 NPLILE 273
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 6e-63
Identities = 68/316 (21%), Positives = 116/316 (36%), Gaps = 67/316 (21%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
K+F ++ E +G G FG AK + G+ +K +
Sbjct: 7 KRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKY----------------- 46
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDD----------- 225
E REVK L L H N+V + ++ D
Sbjct: 47 -----------------NNEKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSS 88
Query: 226 -----NIYIVMELCKGGELLDRILSRGGKY-SEEDAKIVMVQILSVVAFCHFQGVVHRDL 279
++I ME C G L I R G+ + A + QI V + H + +++RDL
Sbjct: 89 RSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDL 148
Query: 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMW 338
KP N + +K DFGL +K D + G+ Y++PE + + YG E D++
Sbjct: 149 KPSNIFLV---DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLY 205
Query: 339 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYR 398
++G+I LL + ++ F + S + +++LL+K
Sbjct: 206 ALGLILAELLHVCDTAFETSK--FFTDLRDGIIS------DIFDKKEKTLLQKLLSKKPE 257
Query: 399 KRLTAAQALSHPWLAN 414
R ++ L +
Sbjct: 258 DRPNTSEILRTLTVWK 273
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 6e-58
Identities = 57/311 (18%), Positives = 100/311 (32%), Gaps = 59/311 (18%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
HY +++G G F Y + G A+K I C + +
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHD---GHFYALKRI-----------LCHEQQ------- 68
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN----IYIVMELCKGG 237
E+ +RE + R H N+++ + ++++ K G
Sbjct: 69 ------------DREEAQREADMHRLF-NHPNILRLVAYCLRERGAKHEAWLLLPFFKRG 115
Query: 238 ELLDRI---LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
L + I +G +E+ +++ I + H +G HRDLKP N L
Sbjct: 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGD---EGQ 172
Query: 295 LKAIDFGLSDYVKPD----------ERLNDIVGSAYYVAPEVL----HRSYGTEADMWSI 340
+D G + + + Y APE+ H D+WS+
Sbjct: 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSL 232
Query: 341 GVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKR 400
G + Y ++ G P+ + G A L P S + ++ D +R
Sbjct: 233 GCVLYAMMFGEGPYDMVFQKGDSVA-LAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQR 291
Query: 401 LTAAQALSHPW 411
LS
Sbjct: 292 PHIPLLLSQLE 302
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 2e-57
Identities = 67/308 (21%), Positives = 123/308 (39%), Gaps = 43/308 (13%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
+A++ + +++GRG F A G VA+K +
Sbjct: 27 GYNTLANFRIEKKIGRGQFSEVYRAACLLD---GVPVALKKVQIF--------------- 68
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCK 235
+ A A D +E+ +L+ L H N++++Y ++ +D+ + IV+EL
Sbjct: 69 ------------DLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELAD 115
Query: 236 GGELLDRI---LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEEN 292
G+L I + E VQ+ S + H + V+HRD+KP N T+
Sbjct: 116 AGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITA---T 172
Query: 293 SSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCG 350
+K D GL + + +VG+ YY++PE + Y ++D+WS+G + Y +
Sbjct: 173 GVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 351 SRPFWARTES--GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
PF+ + + + + + D + P S E V +N D KR
Sbjct: 233 QSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290
Query: 409 HPWLANSH 416
++
Sbjct: 291 VAKRMHAC 298
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 7e-56
Identities = 79/326 (24%), Positives = 128/326 (39%), Gaps = 69/326 (21%)
Query: 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQF 178
++ +E + +GRG FG AK K + A+K I P E
Sbjct: 3 YLTDFEPIQCLGRGGFGVVFEAKNKVD---DCNYAIKRIR-----------LPNREL--- 45
Query: 179 TILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN------------ 226
A E V REVK L L H +V++++A+ + +
Sbjct: 46 ---------------AREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVY 89
Query: 227 IYIVMELCKGGELLDRILSRGGKYSEEDAKI--VMVQILSVVAFCHFQGVVHRDLKPENF 284
+YI M+LC+ L D + R E + + +QI V F H +G++HRDLKP N
Sbjct: 90 LYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNI 149
Query: 285 LFTSKEENSSLKAIDFGLS-------------DYVKPDERLNDIVGSAYYVAPEVLH-RS 330
FT + +K DFGL + R VG+ Y++PE +H S
Sbjct: 150 FFT---MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206
Query: 331 YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVK 390
Y + D++S+G+I + LL PF + E ++ + F P V+
Sbjct: 207 YSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVR-NLKFPPLF-TQKYPCEYVMVQ 261
Query: 391 RLLNKDYRKRLTAAQALSHPWLANSH 416
+L+ +R A + + +
Sbjct: 262 DMLSPSPMERPEAINIIENAVFEDLD 287
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-55
Identities = 60/321 (18%), Positives = 119/321 (37%), Gaps = 67/321 (20%)
Query: 119 FVAHYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
+ + E++G G FG + K K L G A+K
Sbjct: 9 YTTEFHELEKIGSGEFGSVF----KCVK-RLDGCIYAIKRSK------------------ 45
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG 236
+ ++ ++ REV L H ++V+++ A+ +DD++ I E C G
Sbjct: 46 ----------KPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG 95
Query: 237 GELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
G L D I + E + K +++Q+ + + H +VH D+KP N + +
Sbjct: 96 GSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPN 155
Query: 294 SLKAI----------------DFGLSDYVKPDERLNDIVGSAYYVAPEVLH--RSYGTEA 335
+ D G V G + ++A EVL ++ +A
Sbjct: 156 AASEEGDEDDWASNKVMFKIGDLGH---VTRISSPQVEEGDSRFLANEVLQENYTHLPKA 212
Query: 336 DMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS-LSPEAIDFVKRLLN 394
D++++ + G+ P + + + + P LS E + +K +++
Sbjct: 213 DIFALALTVV-CAAGAEPLPRNGDQ--WHEIRQGRLP----RIPQVLSQEFTELLKVMIH 265
Query: 395 KDYRKRLTAAQALSHPWLANS 415
D +R +A + H L ++
Sbjct: 266 PDPERRPSAMALVKHSVLLSA 286
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 9e-54
Identities = 78/366 (21%), Positives = 126/366 (34%), Gaps = 54/366 (14%)
Query: 69 KRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEE 128
+ S AK S A+ E EG L ++ V
Sbjct: 8 GQAHSLASLAKTWSSGSAKLQR--LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPR 65
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
VGRG FG K K+ G AVK +
Sbjct: 66 VGRGSFGEVHRMKDKQ---TGFQCAVKKVR------------------------------ 92
Query: 189 MTTAIAIEDVR-REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG 247
+E R E+ L+ +V Y A + + I MEL +GG L ++ +
Sbjct: 93 ------LEVFRVEELVACAGLS-SPRIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQM 144
Query: 248 GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK 307
G E+ A + Q L + + H + ++H D+K +N L +S S DFG + ++
Sbjct: 145 GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD--GSRAALCDFGHALCLQ 202
Query: 308 PDE------RLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTES 360
PD + I G+ ++APEV+ + D+WS + +L G P+
Sbjct: 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262
Query: 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKI 420
+ + P E P PS +P ++ L K+ R +A + A +
Sbjct: 263 PLCLKIASEPPPIREIP-PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
Query: 421 PSDMIV 426
S
Sbjct: 322 KSPWKG 327
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 2e-53
Identities = 52/341 (15%), Positives = 105/341 (30%), Gaps = 62/341 (18%)
Query: 122 HYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
+ +G G F Y + + Q +KV
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKP-------------------- 105
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
+ ++ L+ ++FY A+ + +V EL G L
Sbjct: 106 ----------ANPWEFYIGTQLMERLKPSM-QHMFMKFYSAHLFQNGSVLVGELYSYGTL 154
Query: 240 LDRILSRG----GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSK------ 289
L+ I + +++L ++ H ++H D+KP+NF+ +
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214
Query: 290 --EENSSLKAIDFGLSDYVK---PDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVI 343
+ ++ L ID G S +K ++ + E+L ++ + + D + +
Sbjct: 215 EDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274
Query: 344 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA 403
Y +L G+ + E G + W +F +LN L +
Sbjct: 275 VYCMLFGTYMKV-KNEGGECKPEGLFRRLPHLDMWN-------EFFHVMLNIPDCHHLPS 326
Query: 404 AQALSHP---WLANSHDVKIPSDMIVYKLIKAYISSSSLRK 441
L + KI + + +LI + RK
Sbjct: 327 LDLLRQKLKKVFQQHYTNKIRA--LRNRLIVLLLECKRSRK 365
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 183 bits (465), Expect = 4e-53
Identities = 41/312 (13%), Positives = 88/312 (28%), Gaps = 42/312 (13%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
G +G+ A ++ G+ V V + K E + +L
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQET---GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 136
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDD-----NIYIVMELCKG- 236
+ + R + + + D+ + + + +
Sbjct: 137 G-----IKNQKQAKVHLRFIFPFDLVK-DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190
Query: 237 ----GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEEN 292
GE+L S + +Q++ ++A H G+VH L+P + + +
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD---QR 247
Query: 293 SSLKAIDFGLSDYVKPDERLNDIVGSAY----YVAPEVLHRS------YGTEADMWSIGV 342
+ F V+ +G + A +L D W++G+
Sbjct: 248 GGVFLTGFEHL--VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305
Query: 343 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT 402
Y + C P G + ++ ++ ++ L RL
Sbjct: 306 AIYWIWCADLPNTDDAALGGSEWIFRSC--------KNIPQPVRALLEGFLRYPKEDRLL 357
Query: 403 AAQALSHPWLAN 414
QA+ P
Sbjct: 358 PLQAMETPEYEQ 369
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 2e-51
Identities = 80/340 (23%), Positives = 134/340 (39%), Gaps = 58/340 (17%)
Query: 97 ASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAV 154
S EG+ L+ ++ + + +G+G +G Y + +A+
Sbjct: 3 RSTEEGDCESDLLEYDYEYDE-----NGDRVVLGKGTYGIVYAGRDLSN-----QVRIAI 52
Query: 155 KVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNL 214
K IP + + + E+ + + L HKN+
Sbjct: 53 KEIP------------------------------ERDSRYSQPLHEEIALHKHLK-HKNI 81
Query: 215 VQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGK--YSEEDAKIVMVQILSVVAFCHFQ 272
VQ+ ++ ++ I I ME GG L + S+ G +E+ QIL + + H
Sbjct: 82 VQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN 141
Query: 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV-KPDERLNDIVGSAYYVAPEVLH--- 328
+VHRD+K +N L + + LK DFG S + + G+ Y+APE++
Sbjct: 142 QIVHRDIKGDNVLINTY--SGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 329 RSYGTEADMWSIGVIAYILLCGSRPFWARTE--SGIFR-AVLKADPSFDEAPWPSLSPEA 385
R YG AD+WS+G + G PF+ E + +F+ + K P E S+S EA
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPE----SMSAEA 255
Query: 386 IDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMI 425
F+ + D KR A L +L S K +
Sbjct: 256 KAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQPKL 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 4e-51
Identities = 61/319 (19%), Positives = 112/319 (35%), Gaps = 72/319 (22%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+ + G F + A+ G++ A+K + + E
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGS---GREYALKRLL-----------SNEEE------- 67
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN--------IYIVMEL 233
+ +EV ++ L+GH N+VQF A ++ EL
Sbjct: 68 ------------KNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL 115
Query: 234 CKGGELLDRILSR--GGKYSEEDAKIVMVQILSVVAFCHFQG--VVHRDLKPENFLFTSK 289
CKG L++ + G S + + Q V H Q ++HRDLK EN L ++
Sbjct: 116 CKGQ-LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN- 173
Query: 290 EENSSLKAIDFGLSDYVKPD-------------ERLNDIVGSAYYVAPEVL----HRSYG 332
++K DFG + + E + Y PE++ + G
Sbjct: 174 --QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIG 231
Query: 333 TEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRL 392
+ D+W++G I Y+L PF E G ++ + P + ++ +
Sbjct: 232 EKQDIWALGCILYLLCFRQHPF----EDGAKLRIVNG--KYSIPPHDTQYTVFHSLIRAM 285
Query: 393 LNKDYRKRLTAAQALSHPW 411
L + +RL+ A+ +
Sbjct: 286 LQVNPEERLSIAEVVHQLQ 304
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 5e-49
Identities = 80/299 (26%), Positives = 133/299 (44%), Gaps = 49/299 (16%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
++ G+ +G G F A+ ++ A+K++ K + +V
Sbjct: 32 FKFGKILGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENKVPY------------ 76
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
V RE ++ L H V+ Y ++DD+ +Y + K GELL
Sbjct: 77 ---------------VTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKY 120
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ + G + E + +I+S + + H +G++HRDLKPEN L + ++ DFG
Sbjct: 121 -IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE---DMHIQITDFGT 176
Query: 303 S---DYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWART 358
+ R N VG+A YV+PE+L +D+W++G I Y L+ G PF A
Sbjct: 177 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 236
Query: 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA------LSHPW 411
E IF+ ++K + F P P+A D V++LL D KRL + +HP+
Sbjct: 237 EYLIFQKIIKLEYDF---P-EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 291
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-48
Identities = 56/229 (24%), Positives = 120/229 (52%), Gaps = 17/229 (7%)
Query: 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEE 253
+ +V +E++I++ L H LV + +++D++++++V++L GG+L L + + EE
Sbjct: 58 EVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYH-LQQNVHFKEE 115
Query: 254 DAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLN 313
K+ + +++ + + Q ++HRD+KP+N L +E+ + DF ++ + + ++
Sbjct: 116 TVKLFICELVMALDYLQNQRIIHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQIT 172
Query: 314 DIVGSAYYVAPEVLHRS----YGTEADMWSIGVIAYILLCGSRPFWARTESG---IFRAV 366
+ G+ Y+APE+ Y D WS+GV AY LL G RP+ R+ + I
Sbjct: 173 TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL-SHPWLAN 414
++ P + S E + +K+LL + +R + + + P++ +
Sbjct: 233 ETTVVTY---P-SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 3e-48
Identities = 69/343 (20%), Positives = 125/343 (36%), Gaps = 56/343 (16%)
Query: 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQ-------- 167
+ +++ +E + +GRG FG AK K + + A+K I + +
Sbjct: 1 ASRYLTDFEPIQCMGRGGFGVVFEAKNK---VDDCNYAIKRIRLPNRELAREKVMREVKA 57
Query: 168 --------------------VHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207
+ E + + DE +++ ++ +++ +
Sbjct: 58 LAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDP 117
Query: 208 LTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKI--VMVQILSV 265
+ KN V +YI M+LC+ L D + R E + +QI
Sbjct: 118 FS-TKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176
Query: 266 VAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-------------DYVKPDERL 312
V F H +G++HRDLKP N FT + +K DFGL +
Sbjct: 177 VEFLHSKGLMHRDLKPSNIFFTM---DDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233
Query: 313 NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADP 371
VG+ Y++PE +H +Y + D++S+G+I + LL R I V
Sbjct: 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR--IITDVRNLKF 291
Query: 372 SFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
+ P+ V+ +L+ +R A + + N
Sbjct: 292 PLL---FTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 3e-48
Identities = 78/333 (23%), Positives = 129/333 (38%), Gaps = 68/333 (20%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE ++G G +G + + GQ VA+K +
Sbjct: 5 YEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKF----------------------LES 39
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
E + A+ RE+++L+ L H NLV + + +++V E C +L
Sbjct: 40 EDDPVIKKIAL------REIRMLKQLK-HPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHE 91
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ E K + Q L V FCH +HRD+KPEN L T +K DFG
Sbjct: 92 LDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV---IKLCDFGF 148
Query: 303 S-DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFW-ART 358
+ P + +D V + +Y +PE+L YG D+W+IG + LL G P W ++
Sbjct: 149 ARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPLWPGKS 207
Query: 359 E----SGIFRAV-------------LKADPSFDEAPW----------PSLSPEAIDFVKR 391
+ I + + + P++S A+ +K
Sbjct: 208 DVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKG 267
Query: 392 LLNKDYRKRLTAAQALSHPWLANSHDVKIPSDM 424
L+ D +RLT Q L HP+ N +++ +
Sbjct: 268 CLHMDPTERLTCEQLLHHPYFENIREIEDLAKE 300
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 7e-48
Identities = 72/335 (21%), Positives = 125/335 (37%), Gaps = 82/335 (24%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y+L ++GRG + A + V VK++ K +
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITN---NEKVVVKIL--------------KPVKKKKIK- 78
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN---IYIVMELCKGGE 238
RE+KIL L G N++ D +D + + +
Sbjct: 79 ------------------REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV--NNT 118
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
++ ++ D + M +IL + +CH G++HRD+KP N + E+ L+ I
Sbjct: 119 DFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLI 173
Query: 299 DFGLSDYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPF-- 354
D+GL+++ P + N V S Y+ PE+L ++ Y DMWS+G + ++ PF
Sbjct: 174 DWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233
Query: 355 -----------------------WARTESGIFRAVLKADPSFDEAPW---------PSLS 382
+ + W +S
Sbjct: 234 GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVS 293
Query: 383 PEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
PEA+DF+ +LL D++ RLTA +A+ HP+
Sbjct: 294 PEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 3e-46
Identities = 61/301 (20%), Positives = 111/301 (36%), Gaps = 49/301 (16%)
Query: 123 YELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
+ E+GRG F Y + +VA + K E
Sbjct: 28 LKFDIEIGRGSFKTVYKG-----LDTETTVEVAWCELQDR--------KLTKSE------ 68
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKG 236
+ + E ++L+ L H N+V+FYD++E I +V EL
Sbjct: 69 --------------RQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTS 113
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG--VVHRDLKPENFLFTSKEENSS 294
G L L R + + QIL + F H + ++HRDLK +N T S
Sbjct: 114 GTLKT-YLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP--TGS 170
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPF 354
+K D GL+ + ++G+ ++APE+ Y D+++ G+ + P+
Sbjct: 171 VKIGDLGLATLKRASFA-KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPY 229
Query: 355 WARTESG-IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413
+ I+R V + PE + ++ + ++ +R + L+H +
Sbjct: 230 SECQNAAQIYRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
Query: 414 N 414
Sbjct: 288 E 288
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 81/315 (25%), Positives = 134/315 (42%), Gaps = 53/315 (16%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+E+ E+G G FG AK K+ G A KVI
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIE----------------------- 53
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ +ED E++IL H +V+ AY D ++I++E C GG +
Sbjct: 54 -------TKSEEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA 105
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+L +E ++V Q+L + F H + ++HRDLK N L T ++ DFG
Sbjct: 106 IMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMT---LEGDIRLADFG 162
Query: 302 LSDYVKPD-ERLNDIVGSAYYVAPEVLHR------SYGTEADMWSIGVIAYILLCGSRPF 354
+S ++ + +G+ Y++APEV+ Y +AD+WS+G+ + P
Sbjct: 163 VSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH 222
Query: 355 WARTESGIFRAVLK----ADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
E R +LK P+ S E DF+K L+K+ R +AAQ L HP
Sbjct: 223 H---ELNPMRVLLKIAKSDPPTLLT--PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHP 277
Query: 411 WLANSHDVKIPSDMI 425
++++ K +++
Sbjct: 278 FVSSITSNKALRELV 292
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-45
Identities = 83/317 (26%), Positives = 146/317 (46%), Gaps = 51/317 (16%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ ++G G G C A+ K G+ VAVK++
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMD------------------------ 79
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ E + EV I+R H N+V+ Y +Y + ++++ME +GG L D
Sbjct: 80 ------LRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLMEFLQGGALTD- 131
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ + +EE V +L +A+ H QGV+HRD+K ++ L T + +K DFG
Sbjct: 132 -IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT---LDGRVKLSDFGF 187
Query: 303 SDYVKPD-ERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFW----A 356
+ D + +VG+ Y++APEV+ RS Y TE D+WS+G++ ++ G P++
Sbjct: 188 CAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV 247
Query: 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416
+ + R P +SP DF++R+L +D ++R TA + L HP+L +
Sbjct: 248 QA---MKRLRDSPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302
Query: 417 DVKIPSDMI-VYKLIKA 432
+ +I +Y+ +
Sbjct: 303 LPECLVPLIQLYRKQTS 319
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-45
Identities = 75/306 (24%), Positives = 131/306 (42%), Gaps = 44/306 (14%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
Y E++G+G G +A GQ+VA++ +
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMN------------------------ 54
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ E + E+ ++R + N+V + D+Y D +++VME GG L D
Sbjct: 55 ------LQQQPKKELIINEILVMRENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD- 106
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ E V + L + F H V+HRD+K +N L + S+K DFG
Sbjct: 107 -VVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG---MDGSVKLTDFGF 162
Query: 303 SDYVKPDE-RLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTE- 359
+ P++ + + +VG+ Y++APEV+ R YG + D+WS+G++A ++ G P+
Sbjct: 163 CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL 222
Query: 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVK 419
++ P LS DF+ R L D KR +A + L H +L + +
Sbjct: 223 RALYLIATNGTPELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280
Query: 420 IPSDMI 425
+ +I
Sbjct: 281 SLTPLI 286
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 8e-45
Identities = 81/325 (24%), Positives = 142/325 (43%), Gaps = 65/325 (20%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+EL E VG G +G + K GQ A+KV+
Sbjct: 25 IFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMD--------------------VTG 61
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY------EDDDNIYIVMELCK 235
DE E++++E+ +L+ + H+N+ +Y A+ DD +++VME C
Sbjct: 62 DE-----------EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCG 110
Query: 236 GGELLDRI-LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
G + D I ++G EE + +IL ++ H V+HRD+K +N L T EN+
Sbjct: 111 AGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAE 167
Query: 295 LKAIDFGLS-DYVKPDERLNDIVGSAYYVAPEVLHR------SYGTEADMWSIGVIAYIL 347
+K +DFG+S + R N +G+ Y++APEV+ +Y ++D+WS+G+ A +
Sbjct: 168 VKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227
Query: 348 ------LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL 401
LC P A +F P W S + F++ L K++ +R
Sbjct: 228 AEGAPPLCDMHPMRA-----LFLIPRNPAPRLKSKKW---SKKFQSFIESCLVKNHSQRP 279
Query: 402 TAAQALSHPWLANSHDVKIPSDMIV 426
Q + HP++ + + + +
Sbjct: 280 ATEQLMKHPFIRDQPNERQVRIQLK 304
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-44
Identities = 77/309 (24%), Positives = 142/309 (45%), Gaps = 50/309 (16%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+++ E++G G +G A K+ GQ VA+K +P ++
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVP----------------------VE 65
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
++++ +E+ I++ ++V++Y +Y + +++IVME C G + D
Sbjct: 66 S----------DLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDI 114
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
I R +E++ ++ L + + HF +HRD+K N L K DFG+
Sbjct: 115 IRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLN---TEGHAKLADFGV 171
Query: 303 SDYVKPD-ERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTES 360
+ + + N ++G+ +++APEV+ Y AD+WS+G+ A + G P+ +
Sbjct: 172 AGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA---DI 228
Query: 361 GIFRAVL----KADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416
RA+ P+F + S DFVK+ L K +R TA Q L HP++ ++
Sbjct: 229 HPMRAIFMIPTNPPPTFRKPEL--WSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286
Query: 417 DVKIPSDMI 425
V I D+I
Sbjct: 287 GVSILRDLI 295
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 156 bits (398), Expect = 5e-44
Identities = 78/334 (23%), Positives = 126/334 (37%), Gaps = 68/334 (20%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE VG G +G + K G+ VA+K ++
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKF-LE-----------SDDDKMVKK-- 69
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
A+ RE+K+L+ L H+NLV + + Y+V E +LD
Sbjct: 70 --------IAM------REIKLLKQLR-HENLVNLLEVCKKKKRWYLVFEFVDH-TILDD 113
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ + + + QI++ + FCH ++HRD+KPEN L + +K DFG
Sbjct: 114 LELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV---VKLCDFGF 170
Query: 303 S-DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFW-ART 358
+ P E +D V + +Y APE+L YG D+W+IG + + G P + +
Sbjct: 171 ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDS 229
Query: 359 E----SGIFRAV--LKAD--PSFDEAPW-------------------PSLSPEAIDFVKR 391
+ I + L F++ P P LS ID K+
Sbjct: 230 DIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKK 289
Query: 392 LLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMI 425
L+ D KR A+ L H + + S +
Sbjct: 290 CLHIDPDKRPFCAELLHHDFFQMDGFAERFSQEL 323
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-44
Identities = 83/323 (25%), Positives = 144/323 (44%), Gaps = 46/323 (14%)
Query: 101 EGNESDIGLDKNF--GFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIP 158
EG+ +I + + G K + +EL + +G+G FG K GS Q A+KV+
Sbjct: 2 EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61
Query: 159 KMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFY 218
K + +V + E IL H +V+ +
Sbjct: 62 KATLKVRDRVRT----------------------------KMERDIL-VEVNHPFIVKLH 92
Query: 219 DAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278
A++ + +Y++++ +GG+L R LS+ ++EED K + ++ + H G+++RD
Sbjct: 93 YAFQTEGKLYLILDFLRGGDLFTR-LSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 151
Query: 279 LKPENFLFTSKEENSSLKAIDFGLS-DYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEAD 336
LKPEN L +K DFGLS + + +++ G+ Y+APEV++R + AD
Sbjct: 152 LKPENILLDE---EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSAD 208
Query: 337 MWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKD 396
WS GV+ + +L G+ PF + +LKA P LSPEA ++ L ++
Sbjct: 209 WWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGM---P-QFLSPEAQSLLRMLFKRN 264
Query: 397 YRKRL-----TAAQALSHPWLAN 414
RL + H + +
Sbjct: 265 PANRLGAGPDGVEEIKRHSFFST 287
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 6e-44
Identities = 76/298 (25%), Positives = 125/298 (41%), Gaps = 47/298 (15%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
++ + +G G FG K K+ G A+K++ K V Q+
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQKVVKLKQIEH------------ 87
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
E +IL+A+ LV+ +++D+ N+Y+VME GGE+
Sbjct: 88 ---------------TLNEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMF-S 130
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
L R G++SE A+ QI+ + H +++RDLKPEN L ++ DFG
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQ---QGYIQVTDFGF 187
Query: 303 SDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESG 361
+ V R + G+ +APE++ Y D W++GV+ Y + G PF+A
Sbjct: 188 AKRV--KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 362 IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA-----LSHPWLAN 414
I+ ++ F P S + D ++ LL D KR + +H W A
Sbjct: 246 IYEKIVSGKVRF---P-SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-44
Identities = 68/340 (20%), Positives = 117/340 (34%), Gaps = 72/340 (21%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT-- 179
Y + + G +G C+ +G VA+K ++ + +
Sbjct: 23 PYTVQRFISSGSYGAVCAGVDSEG----IPVAIK---RVFNTVSDGRTVNILSDSFLCKR 75
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD-----AYEDDDNIYIVMELC 234
+L RE+++L H N++ D +Y+V EL
Sbjct: 76 VL------------------REIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELM 116
Query: 235 KGGELLDRIL-SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
L +++ + S + + M IL + H GVVHRDL P N L N+
Sbjct: 117 --RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLAD---NN 171
Query: 294 SLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCG- 350
+ DF L+ D V +Y APE++ + + DMWS G + +
Sbjct: 172 DITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
Query: 351 ----------------------SRPFWARTESGIFRAVLKAD-PSFDEAPW----PSLSP 383
S R L+ + W P+ P
Sbjct: 232 ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADP 291
Query: 384 EAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSD 423
A+D + ++L + ++R++ QAL HP+ + D P D
Sbjct: 292 VALDLIAKMLEFNPQRRISTEQALRHPYFESLFD---PLD 328
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-43
Identities = 82/318 (25%), Positives = 143/318 (44%), Gaps = 51/318 (16%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+ E++G+G FG + + VA+K+I L
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIID----------------------L 57
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+E IED+++E+ +L + ++Y +Y D ++I+ME GG LD
Sbjct: 58 EE-------AEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD 109
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
L G E ++ +IL + + H + +HRD+K N L + E+ +K DFG
Sbjct: 110 --LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFG 164
Query: 302 LSDYVKPD-ERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTE 359
++ + + N VG+ +++APEV+ +S Y ++AD+WS+G+ A L G P E
Sbjct: 165 VAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHS---E 221
Query: 360 SGIFRAVL---KADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA-NS 415
+ + K +P E + S +FV+ LNK+ R TA + L H ++ N+
Sbjct: 222 LHPMKVLFLIPKNNPPTLEGNY---SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278
Query: 416 HDVKIPSDMIV-YKLIKA 432
+++I YK KA
Sbjct: 279 KKTSYLTELIDRYKRWKA 296
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-43
Identities = 73/320 (22%), Positives = 130/320 (40%), Gaps = 57/320 (17%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
YEL E +G G +A K + VA+K I L
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRIN----------------------L 50
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
++ +++++ +E++ + H N+V +Y ++ D +++VM+L GG +LD
Sbjct: 51 EK-------CQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVLD 102
Query: 242 -------RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
+ + G E ++ ++L + + H G +HRD+K N L E+ S
Sbjct: 103 IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG---EDGS 159
Query: 295 LKAIDFG----LSDYVKPDERL--NDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYI 346
++ DFG L+ VG+ ++APEV+ + Y +AD+WS G+ A
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 347 LLCGSRPFWARTESGIFRAVLKADP------SFDEAPWPSLSPEAIDFVKRLLNKDYRKR 400
L G+ P+ + L+ DP D+ + L KD KR
Sbjct: 220 LATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279
Query: 401 LTAAQALSHPWLANSHDVKI 420
TAA+ L H + + + +
Sbjct: 280 PTAAELLRHKFFQKAKNKEF 299
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-43
Identities = 73/298 (24%), Positives = 128/298 (42%), Gaps = 47/298 (15%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+++ +G G FG + + + G+ A+KV+ K I V QV E
Sbjct: 8 FQILRTLGTGSFGRVHLIR-SRHN--GRYYAMKVLKKEIVVRLKQVEHTNDER------- 57
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+L +T H +++ + ++D I+++M+ +GGEL
Sbjct: 58 --------------------LMLSIVT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL 96
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
L + ++ AK ++ + + H + +++RDLKPEN L N +K DFG
Sbjct: 97 -LRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDK---NGHIKITDFGF 152
Query: 303 SDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESG 361
+ YV + + G+ Y+APEV+ Y D WS G++ Y +L G PF+
Sbjct: 153 AKYV--PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
Query: 362 IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLAN 414
+ +L A+ F P P + + D + RL+ +D +RL +HPW
Sbjct: 211 TYEKILNAELRF---P-PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-42
Identities = 73/369 (19%), Positives = 127/369 (34%), Gaps = 55/369 (14%)
Query: 65 LRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFVAHYE 124
+ ++ +L + P + D+ F +
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDV---AELFFKDDPEKLFS 57
Query: 125 LGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEY 184
E+G G FG A+ + + VA+K + +
Sbjct: 58 DLREIGHGSFGAVYFARDVR---NSEVVAIKKMS-------YSGKQSNEK---------- 97
Query: 185 CCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRIL 244
+D+ +EV+ L+ L H N +Q+ Y + ++VME C G D +
Sbjct: 98 ----------WQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGS-ASDLLE 145
Query: 245 SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSD 304
E + V L +A+ H ++HRD+K N L + E +K DFG +
Sbjct: 146 VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSAS 202
Query: 305 YVKPDERLNDIVGSAYYVAPEVLHRS----YGTEADMWSIGVIAYILLCGSRPFWARTES 360
+ N VG+ Y++APEV+ Y + D+WS+G+ L P +
Sbjct: 203 IMA---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---NM 256
Query: 361 GIFRAVL----KADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416
A+ P+ W S +FV L K + R T+ L H ++
Sbjct: 257 NAMSALYHIAQNESPALQSGHW---SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313
Query: 417 DVKIPSDMI 425
+ D+I
Sbjct: 314 PPTVIMDLI 322
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 2e-42
Identities = 74/298 (24%), Positives = 124/298 (41%), Gaps = 52/298 (17%)
Query: 129 VGRGHFGYTCSAK---AKKGSLKGQDV--AVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
+G+G +G K +K + A+KV+ K ++
Sbjct: 25 LGKGGYG-----KVFQVRKVTGANTGKIFAMKVLKK--------AMIVRNAKD------- 64
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
+ E IL H +V A++ +Y+++E GGEL +
Sbjct: 65 -----------TAHTKAERNIL-EEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ- 111
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
L R G + E+ A + +I + H +G+++RDLKPEN + +K DFGL
Sbjct: 112 LEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNH---QGHVKLTDFGLC 168
Query: 304 -DYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESG 361
+ + + G+ Y+APE+L RS + D WS+G + Y +L G+ PF
Sbjct: 169 KESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228
Query: 362 IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA-----LSHPWLAN 414
+LK + P P L+ EA D +K+LL ++ RL A +HP+ +
Sbjct: 229 TIDKILKCKLNL---P-PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH 282
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-42
Identities = 74/289 (25%), Positives = 122/289 (42%), Gaps = 41/289 (14%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G+G FG A+ K + Q A+K + K + ++ V C E
Sbjct: 25 LGKGSFGKVFLAE-FKKT--NQFFAIKALKKDVVLMDDDVECTMVEKR------------ 69
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+L H L + ++ +N++ VME GG+L+ I
Sbjct: 70 ---------------VLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI-QSCH 113
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVK 307
K+ A +I+ + F H +G+V+RDLK +N L + +K DFG+ + +
Sbjct: 114 KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDK---DGHIKIADFGMCKENML 170
Query: 308 PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366
D + N G+ Y+APE+L Y D WS GV+ Y +L G PF + E +F ++
Sbjct: 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL-SHPWLAN 414
+P + P L EA D + +L ++ KRL + HP
Sbjct: 231 RMDNPFY---P-RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 275
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-42
Identities = 90/327 (27%), Positives = 139/327 (42%), Gaps = 77/327 (23%)
Query: 123 YELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
Y E++G G +G Y KA+ G+ A+K I ++ + E+
Sbjct: 4 YHGLEKIGEGTYGVVY----KAQNNY--GETFALKKI-RL-----------EKEDEGIPS 45
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELC----KG 236
T I RE+ IL+ L H N+V+ YD + +V E K
Sbjct: 46 ----------TTI------REISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDLKK 88
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
LLD G AK ++Q+L+ +A+CH + V+HRDLKP+N L + E LK
Sbjct: 89 --LLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE---LK 140
Query: 297 AIDFGLS-DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRP 353
DFGL+ + P + + + +Y AP+VL + Y T D+WS+G I ++ G+
Sbjct: 141 IADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200
Query: 354 FWARTE----SGIFRA-----------VLK---ADPSFDEAP-------WPSLSPEAIDF 388
F +E IFR V + DP+F L ID
Sbjct: 201 FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDL 260
Query: 389 VKRLLNKDYRKRLTAAQALSHPWLANS 415
+ ++L D +R+TA QAL H + +
Sbjct: 261 LSKMLKLDPNQRITAKQALEHAYFKEN 287
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-42
Identities = 81/385 (21%), Positives = 143/385 (37%), Gaps = 49/385 (12%)
Query: 41 FYSPSPLPSLFKNSPAIPSVNSTPL---RFFKRPFPPPSPAKHIRSLLARRHGSVKPNEA 97
S S S + + +F P PP + +
Sbjct: 257 MGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTK 316
Query: 98 SIPEGNESDIGLDKNFGFSKQF-VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKV 156
+ E + I N G + + + +G+G FG ++ K + AVK+
Sbjct: 317 APEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKI 373
Query: 157 IPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQ 216
+ K + + V C E +L L Q
Sbjct: 374 LKKDVVIQDDDVECTMVEKR---------------------------VLALPGKPPFLTQ 406
Query: 217 FYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276
+ ++ D +Y VME GG+L+ I + G++ E A +I + F +G+++
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIY 465
Query: 277 RDLKPENFLFTSKEENSSLKAIDFGLS-DYVKPDERLNDIVGSAYYVAPEVLHR-SYGTE 334
RDLK +N + S+ +K DFG+ + + G+ Y+APE++ YG
Sbjct: 466 RDLKLDNVMLDSEGH---IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS 522
Query: 335 ADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLN 394
D W+ GV+ Y +L G PF E +F+++++ + ++ P S+S EA+ K L+
Sbjct: 523 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAY---P-KSMSKEAVAICKGLMT 578
Query: 395 KDYRKRLTAAQA-----LSHPWLAN 414
K KRL H +
Sbjct: 579 KHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 9e-42
Identities = 77/300 (25%), Positives = 127/300 (42%), Gaps = 49/300 (16%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+GRG F K K + GQ A+K++ K + +V C + E
Sbjct: 69 IGRGAFSEVAVVK-MKQT--GQVYAMKIMNKWDMLKRGEVSCFREERD------------ 113
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+L + + Q + A++D++ +Y+VME GG+LL + G
Sbjct: 114 ---------------VL-VNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGE 157
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
+ E A+ + +I+ + H G VHRD+KP+N L ++ DFG ++
Sbjct: 158 RIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDR---CGHIRLADFGSCLKLRA 214
Query: 309 DE--RLNDIVGSAYYVAPEVLHR--------SYGTEADMWSIGVIAYILLCGSRPFWART 358
D R VG+ Y++PE+L SYG E D W++GV AY + G PF+A +
Sbjct: 215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274
Query: 359 ESGIFRAVLKADPSFDEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQAL---SHPWLAN 414
+ + ++ + EA DF++RLL RL A +HP+
Sbjct: 275 TAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLCPP-ETRLGRGGAGDFRTHPFFFG 333
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-41
Identities = 85/328 (25%), Positives = 136/328 (41%), Gaps = 73/328 (22%)
Query: 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
+ YE E++G G +G AK ++ + VA+K + ++ ++
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRET---HEIVALKRV-RL-----------DDDDEGVP 45
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELC----K 235
+A+ RE+ +L+ L HKN+V+ +D D + +V E C K
Sbjct: 46 S----------SAL------REICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLK 88
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
D S G E K + Q+L + FCH + V+HRDLKP+N L E L
Sbjct: 89 K--YFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE---L 140
Query: 296 KAIDFGLS-DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSR 352
K +FGL+ + P + V + +Y P+VL + Y T DMWS G I L R
Sbjct: 141 KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
Query: 353 P-FWARTE----SGIFRAV----------LKADPSFDEAP-----------WPSLSPEAI 386
P F IFR + + P + P P L+
Sbjct: 201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGR 260
Query: 387 DFVKRLLNKDYRKRLTAAQALSHPWLAN 414
D ++ LL + +R++A +AL HP+ ++
Sbjct: 261 DLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-41
Identities = 71/293 (24%), Positives = 125/293 (42%), Gaps = 45/293 (15%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G+G FG ++ +KG+ + AVK++ K + + V C E
Sbjct: 28 LGKGSFGKVMLSE-RKGT--DELYAVKILKKDVVIQDDDVECTMVEKR------------ 72
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+L L Q + ++ D +Y VME GG+L+ I + G
Sbjct: 73 ---------------VLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-QQVG 116
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVK 307
++ E A +I + F +G+++RDLK +N + S+ +K DFG+ + +
Sbjct: 117 RFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH---IKIADFGMCKENIW 173
Query: 308 PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366
G+ Y+APE++ YG D W+ GV+ Y +L G PF E +F+++
Sbjct: 174 DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI 233
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA-----LSHPWLAN 414
++ + ++ P S+S EA+ K L+ K KRL H +
Sbjct: 234 MEHNVAY---P-KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-41
Identities = 78/294 (26%), Positives = 125/294 (42%), Gaps = 46/294 (15%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G+G FG A+ K + G AVKV+ K + + V C E
Sbjct: 31 LGKGSFGKVMLAR-VKET--GDLYAVKVLKKDVILQDDDVECTMTEKR------------ 75
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
IL H L Q + ++ D ++ VME GG+L+ I +
Sbjct: 76 ---------------ILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI-QKSR 119
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVK 307
++ E A+ +I+S + F H +G+++RDLK +N L + K DFG+ + +
Sbjct: 120 RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH---CKLADFGMCKEGIC 176
Query: 308 PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366
G+ Y+APE+L YG D W++GV+ Y +LCG PF A E +F A+
Sbjct: 177 NGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI 236
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQAL-SHPWLAN 414
L + + P L +A +K + K+ RL A+ HP+
Sbjct: 237 LNDEVVY---P-TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE 286
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-41
Identities = 72/298 (24%), Positives = 124/298 (41%), Gaps = 47/298 (15%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+GRG FG K K + + A+K++ K + + C + E
Sbjct: 82 IGRGAFGEVAVVK-LKNA--DKVFAMKILNKWEMLKRAETACFREERD------------ 126
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+L K + + A++DD+N+Y+VM+ GG+LL +
Sbjct: 127 ---------------VL-VNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFED 170
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
+ EE A+ + +++ + H VHRD+KP+N L N ++ DFG +
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDM---NGHIRLADFGSCLKLME 227
Query: 309 DE--RLNDIVGSAYYVAPEVL------HRSYGTEADMWSIGVIAYILLCGSRPFWARTES 360
D + + VG+ Y++PE+L YG E D WS+GV Y +L G PF+A +
Sbjct: 228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287
Query: 361 GIFRAVLKADPSFDEAPWPS-LSPEAIDFVKRLLNKDYRKRLTAAQAL---SHPWLAN 414
+ ++ F + +S A D ++RL+ RL HP+ +
Sbjct: 288 ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSR-EHRLGQNGIEDFKKHPFFSG 344
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-41
Identities = 85/366 (23%), Positives = 144/366 (39%), Gaps = 78/366 (21%)
Query: 85 LARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKK 144
+A H + +G S + + S + Y ++G G +G A
Sbjct: 1 MAHHHHHHMGTLEAQTQGPGS---MSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTV 57
Query: 145 GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKI 204
+ VA+K I ++ +HE TAI REV +
Sbjct: 58 ---TNETVAIKRI-RL-----------EHEEEGVPG----------TAI------REVSL 86
Query: 205 LRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL-LDRILSRGGKYSEEDAKIVMVQIL 263
L+ L H+N+++ + ++++ E E L + + + S K + Q++
Sbjct: 87 LKELQ-HRNIIELKSVIHHNHRLHLIFEYA---ENDLKKYMDKNPDVSMRVIKSFLYQLI 142
Query: 264 SVVAFCHFQGVVHRDLKPENFLFTSKEENSS--LKAIDFGLS-DYVKPDERLNDIVGSAY 320
+ V FCH + +HRDLKP+N L + + + + LK DFGL+ + P + + + +
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202
Query: 321 YVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTE----SGIFRAVLKADPSFD 374
Y PE+L R Y T D+WSI I +L + F +E IF VL P
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE-VLGL-PD-- 258
Query: 375 EAPWP--------------------------SLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
+ WP L E +D + +L D KR++A AL
Sbjct: 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318
Query: 409 HPWLAN 414
HP+ ++
Sbjct: 319 HPYFSH 324
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 4e-41
Identities = 74/296 (25%), Positives = 120/296 (40%), Gaps = 47/296 (15%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+GRG FG + K + + A+K++ K +
Sbjct: 77 IGRGAFGEVQLVR-HKST--RKVYAMKLLSKFEMIKRSDSAF------------------ 115
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
E I+ A +VQ + A++DD +Y+VME GG+L+ ++S
Sbjct: 116 ---------FWEERDIM-AFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNY- 163
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP 308
E+ A+ +++ + H G +HRD+KP+N L + LK DFG +
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDK---SGHLKLADFGTCMKMNK 220
Query: 309 DE--RLNDIVGSAYYVAPEVL-----HRSYGTEADMWSIGVIAYILLCGSRPFWARTESG 361
+ R + VG+ Y++PEVL YG E D WS+GV Y +L G PF+A + G
Sbjct: 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280
Query: 362 IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL---SHPWLAN 414
+ ++ S +S EA + + L D RL H + N
Sbjct: 281 TYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGRNGVEEIKRHLFFKN 335
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-41
Identities = 79/293 (26%), Positives = 131/293 (44%), Gaps = 46/293 (15%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G+G FG + +K + G+ A+K++ K + + +V E+
Sbjct: 13 LGKGTFGKVILVR-EKAT--GRYYAMKILRKEVIIAKDEVAHTVTESR------------ 57
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+L T H L A++ D + VME GGEL LSR
Sbjct: 58 ---------------VL-QNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFH-LSRER 100
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVK 307
++EE A+ +I+S + + H + VV+RD+K EN + + +K DFGL + +
Sbjct: 101 VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDK---DGHIKITDFGLCKEGIS 157
Query: 308 PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366
+ G+ Y+APEVL YG D W +GV+ Y ++CG PF+ + +F +
Sbjct: 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 217
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA-----LSHPWLAN 414
L + F P +LSPEA + LL KD ++RL + + H + +
Sbjct: 218 LMEEIRF---P-RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 1e-40
Identities = 85/338 (25%), Positives = 138/338 (40%), Gaps = 79/338 (23%)
Query: 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
Y VG G +G CSA K+ G+ VA+K + + F + E
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSR----PF------QSEIFAKRA 70
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA------YEDDDNIYIVMELC 234
RE+ +L+ + H+N++ D + + Y+VM
Sbjct: 71 Y------------------RELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFM 111
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
L +I+ K+SEE + ++ Q+L + + H GVVHRDLKP N +
Sbjct: 112 --QTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNE---DCE 164
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCG-- 350
LK +DFGL+ + + + V + +Y APEV+ Y D+WS+G I +L G
Sbjct: 165 LKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
Query: 351 ---------------------SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSPEA 385
F + ++ +++ P + P SP+A
Sbjct: 223 LFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQA 282
Query: 386 IDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSD 423
D ++++L D KRLTAAQAL+HP+ D P +
Sbjct: 283 ADLLEKMLELDVDKRLTAAQALTHPFFEPFRD---PEE 317
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 74/346 (21%), Positives = 127/346 (36%), Gaps = 61/346 (17%)
Query: 98 SIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVI 157
SI + I ++++ F+ + + E+GRG +G K GQ +AVK I
Sbjct: 2 SIESSGKLKISPEQHWDFTAE---DLKDLGEIGRGAYGSVNKMVHKPS---GQIMAVKRI 55
Query: 158 PKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA-IEDVRREVKILRALTGHKNLVQ 216
T + + ++ ++ + +VQ
Sbjct: 56 R------------------------------STVDEKEQKQLLMDLDVVMRSSDCPYIVQ 85
Query: 217 FYDAYEDDDNIYIVMELCKGGELLDRILS-----RGGKYSEEDAKIVMVQILSVVAFCHF 271
FY A + + +I MEL D+ EE + + + +
Sbjct: 86 FYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE 143
Query: 272 QG-VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-- 328
++HRD+KP N L +K DFG+S + G Y+APE +
Sbjct: 144 NLKIIHRDIKPSNILLDRSGN---IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200
Query: 329 ---RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRA---VLKAD-PSFDEAPWPSL 381
+ Y +D+WS+G+ Y L G P+ + +F V+K D P +
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQLSNSEEREF 258
Query: 382 SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVY 427
SP I+FV L KD KR + L HP++ + + ++ Y
Sbjct: 259 SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAV--EVACY 302
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-40
Identities = 100/422 (23%), Positives = 172/422 (40%), Gaps = 63/422 (14%)
Query: 15 RSQNEALPYENEPQPNSQKSKA-SNFPFYSPSPLPSL--FKNSPAIPSVNSTPLRFFKRP 71
++ + Y+ PQ Q+ +NF + + N+ I + T +R
Sbjct: 30 KNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWT--TVIERT 87
Query: 72 FPPPSPA---------KHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFV-- 120
F +P + + L ++ + + P N ++ + K V
Sbjct: 88 FHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTM 147
Query: 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
+E + +G+G FG K +K + G+ A+K++ K + V +V EN
Sbjct: 148 NEFEYLKLLGKGTFGKVILVK-EKAT--GRYYAMKILKKEVIVAKDEVAHTLTENR---- 200
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
+L + H L +++ D + VME GGEL
Sbjct: 201 -----------------------VL-QNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVHRDLKPENFLFTSKEENSSLKAID 299
LSR +SE+ A+ +I+S + + H + VV+RDLK EN + + +K D
Sbjct: 237 FH-LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDK---DGHIKITD 292
Query: 300 FGLS-DYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWAR 357
FGL + +K + G+ Y+APEVL + YG D W +GV+ Y ++CG PF+ +
Sbjct: 293 FGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 352
Query: 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA-----LSHPWL 412
+F +L + F P +L PEA + LL KD ++RL + H +
Sbjct: 353 DHEKLFELILMEEIRF---P-RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
Query: 413 AN 414
A
Sbjct: 409 AG 410
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 1e-40
Identities = 70/322 (21%), Positives = 122/322 (37%), Gaps = 63/322 (19%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
E E+G G G + +K G +AVK + +
Sbjct: 26 DLENLGEMGSGTCGQVWKMRFRKT---GHVIAVKQMR-------------------RSGN 63
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
E + + ++ ++ +VQ + + + +++I MEL
Sbjct: 64 KE----------ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTC-AEK 112
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVHRDLKPENFLFTSKEENSSLKAIDF 300
G E + V I+ + + + GV+HRD+KP N L + + +K DF
Sbjct: 113 LKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDF 169
Query: 301 GLSDYVKPDERLNDIVGSAYYVAPEVL------HRSYGTEADMWSIGVIAYILLCGSRPF 354
G+S + D+ + G A Y+APE + Y AD+WS+G+ L G P+
Sbjct: 170 GISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY 229
Query: 355 WARTESGIFR---AVLKADPSFDEAPWPSL------SPEAIDFVKRLLNKDYRKRLTAAQ 405
+ F VL+ +P P L S + FVK L KD+RKR +
Sbjct: 230 --KNCKTDFEVLTKVLQEEP-------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280
Query: 406 ALSHPWLANSHDVKIPSDMIVY 427
L H ++ +++ D+ +
Sbjct: 281 LLEHSFIKRYETLEV--DVASW 300
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 1e-40
Identities = 88/335 (26%), Positives = 137/335 (40%), Gaps = 78/335 (23%)
Query: 115 FSKQFVAHYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPK 172
+ + + Y+ E+VG G +G Y KAK +G+ VA+K I ++
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVY----KAK--DSQGRIVALKRI-RL-----------D 56
Query: 173 HENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVME 232
E+ TAI RE+ +L+ L H N+V D + + +V E
Sbjct: 57 AEDEGIPS----------TAI------REISLLKELH-HPNIVSLIDVIHSERCLTLVFE 99
Query: 233 LC----KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTS 288
K +LD + KI + Q+L VA CH ++HRDLKP+N L S
Sbjct: 100 FMEKDLKK--VLD---ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS 154
Query: 289 KEENSSLKAIDFGLS-DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAY 345
LK DFGL+ + P V + +Y AP+VL + Y T D+WSIG I
Sbjct: 155 DGA---LKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFA 211
Query: 346 ILLCGSRPFWARTE----SGIFRAV----------LKADPSFDEAP------------WP 379
++ G F T+ IF + ++ P + + P
Sbjct: 212 EMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIP 271
Query: 380 SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
E ID + +L D KR++A A++HP+ +
Sbjct: 272 GFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-40
Identities = 84/349 (24%), Positives = 131/349 (37%), Gaps = 90/349 (25%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y + +G G G SA + VA+K I KH L
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIV------LTDPQSVKH------AL 56
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD--------------AYEDDDNI 227
RE+KI+R L H N+V+ ++ + + +++
Sbjct: 57 ------------------REIKIIRRL-DHDNIVKVFEILGPSGSQLTDDVGSLTELNSV 97
Query: 228 YIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFT 287
YIV E L +L G EE A++ M Q+L + + H V+HRDLKP N
Sbjct: 98 YIVQEYM--ETDLANVL-EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN 154
Query: 288 SKEENSSLKAIDFGLSDYVKPDERLNDI----VGSAYYVAPEVL--HRSYGTEADMWSIG 341
+ E+ LK DFGL+ + P + + +Y +P +L +Y DMW+ G
Sbjct: 155 T--EDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAG 212
Query: 342 VIAYILLCG-----------------------SRPFWARTESGIFRAVLKADPSFDEAPW 378
I +L G S ++ D + P
Sbjct: 213 CIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSV-IPVYIRNDMTEPHKPL 271
Query: 379 ----PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSD 423
P +S EA+DF++++L RLTA +ALSHP+++ P D
Sbjct: 272 TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF---PMD 317
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-40
Identities = 80/339 (23%), Positives = 141/339 (41%), Gaps = 82/339 (24%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT-- 179
Y+ VG G +G C+A K G VAVK + + F ++
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSR----PF--------QSIIHAKR 74
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD------AYEDDDNIYIVMEL 233
RE+++L+ + H+N++ D + E+ +++Y+V L
Sbjct: 75 TY------------------RELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHL 115
Query: 234 CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
G L+ I+ + K +++ + ++ QIL + + H ++HRDLKP N +
Sbjct: 116 M--GADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNE---DC 169
Query: 294 SLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCG- 350
LK +DFGL+ + + + V + +Y APE++ Y D+WS+G I LL G
Sbjct: 170 ELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
Query: 351 ----------------------SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSPE 384
+ S R +++ + + +P
Sbjct: 228 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL 287
Query: 385 AIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSD 423
A+D ++++L D KR+TAAQAL+H + A HD P D
Sbjct: 288 AVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD---PDD 323
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-40
Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 44/292 (15%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G+G FG A+ K AVKV+ K + + E +
Sbjct: 46 IGKGSFGKVLLAR-HKAE--EVFYAVKVLQKKAILKKKEEKHIMSERN------------ 90
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+L H LV + +++ D +Y V++ GGEL L R
Sbjct: 91 ---------------VLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYH-LQRER 134
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVK 307
+ E A+ +I S + + H +V+RDLKPEN L S + DFGL + ++
Sbjct: 135 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDS---QGHIVLTDFGLCKENIE 191
Query: 308 PDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAV 366
+ + G+ Y+APEVLH+ Y D W +G + Y +L G PF++R + ++ +
Sbjct: 192 HNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNI 251
Query: 367 LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL----TAAQALSHPWLAN 414
L P+++ A ++ LL KD KRL + SH + +
Sbjct: 252 LNKPLQL---K-PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 4e-40
Identities = 79/334 (23%), Positives = 125/334 (37%), Gaps = 70/334 (20%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE + +G G F A+ K Q VA+K I K +
Sbjct: 12 YEKLDFLGEGQFATVYKARDKN---TNQIVAIKKI--------------KLGH-----RS 49
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELC----KGGE 238
E TA+ RE+K+L+ L+ H N++ DA+ NI +V + +
Sbjct: 50 EAKDGINRTAL------REIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEV-- 100
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
++ + K M+ L + + H ++HRDLKP N L LK
Sbjct: 101 IIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV---LKLA 154
Query: 299 DFGLS-DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFW 355
DFGL+ + P+ V + +Y APE+L R YG DMW++G I LL PF
Sbjct: 155 DFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFL 213
Query: 356 A-RTE----SGIFRAV----------------LKADPSFDEAPW----PSLSPEAIDFVK 390
++ + IF + SF P + + +D ++
Sbjct: 214 PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQ 273
Query: 391 RLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDM 424
L + R+TA QAL + +N +
Sbjct: 274 GLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 307
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 4e-40
Identities = 68/234 (29%), Positives = 118/234 (50%), Gaps = 22/234 (9%)
Query: 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEED 254
E R E ++L + LV + A++ + ++++++ GGEL LS+ +++E +
Sbjct: 102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTH-LSQRERFTEHE 160
Query: 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS--DYVKPDERL 312
+I + +I+ + H G+++RD+K EN L S N + DFGLS ER
Sbjct: 161 VQIYVGEIVLALEHLHKLGIIYRDIKLENILLDS---NGHVVLTDFGLSKEFVADETERA 217
Query: 313 NDIVGSAYYVAPEVLHRS---YGTEADMWSIGVIAYILLCGSRPFWA----RTESGIFRA 365
D G+ Y+AP+++ + D WS+GV+ Y LL G+ PF +++ I R
Sbjct: 218 YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277
Query: 366 VLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLAN 414
+LK++P + P +S A D ++RLL KD +KRL A + H +
Sbjct: 278 ILKSEPPY---P-QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-40
Identities = 71/273 (26%), Positives = 110/273 (40%), Gaps = 51/273 (18%)
Query: 191 TAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELC----KGGELLD--RIL 244
TAI RE+ +++ L H+N+V+ YD ++ + +V E K +D +
Sbjct: 49 TAI------REISLMKELK-HENIVRLYDVIHTENKLTLVFEFMDNDLKK--YMDSRTVG 99
Query: 245 SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS- 303
+ K Q+L +AFCH ++HRDLKP+N L + + LK DFGL+
Sbjct: 100 NTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ---LKLGDFGLAR 156
Query: 304 DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTE-- 359
+ P + V + +Y AP+VL R+Y T D+WS G I ++ G F +
Sbjct: 157 AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE 216
Query: 360 --SGIFR--------------------AVLKADPS------FDEAPWPSLSPEAIDFVKR 391
IF ++ P L +DF+
Sbjct: 217 QLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHG 276
Query: 392 LLNKDYRKRLTAAQALSHPWLANSHDVKIPSDM 424
LL + RL+A QAL HPW A +
Sbjct: 277 LLQLNPDMRLSAKQALHHPWFAEYYHHASMGGS 309
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-40
Identities = 79/338 (23%), Positives = 141/338 (41%), Gaps = 78/338 (23%)
Query: 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
A Y + VG G +G CSA + G VA+K + + F + E
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYR----PF------QSELFAKRA 71
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA------YEDDDNIYIVMELC 234
RE+++L+ + H+N++ D +D + Y+VM
Sbjct: 72 Y------------------RELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM 112
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
G L +++ + K E+ + ++ Q+L + + H G++HRDLKP N +
Sbjct: 113 --GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNE---DCE 166
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCG-- 350
LK +DFGL+ + + V + +Y APEV+ Y D+WS+G I ++ G
Sbjct: 167 LKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT 224
Query: 351 ---------------------SRPFWARTESGIFRAVLKADPSFDEAPW----PSLSPEA 385
F R +S + +K P ++ + + SP A
Sbjct: 225 LFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLA 284
Query: 386 IDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSD 423
++ ++++L D +R+TA +AL+HP+ + HD D
Sbjct: 285 VNLLEKMLVLDAEQRVTAGEALAHPYFESLHD---TED 319
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-40
Identities = 68/316 (21%), Positives = 121/316 (38%), Gaps = 56/316 (17%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
E E+GRG +G + GQ +AVK I
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPS---GQIMAVKRIR----------------------- 41
Query: 182 DEYCCLFMTTAIA-IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGG--E 238
T + + ++ I V FY A + +++I MEL +
Sbjct: 42 -------ATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDK 94
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG-VVHRDLKPENFLFTSKEENSSLKA 297
+++ +G E+ + V I+ + H + V+HRD+KP N L + + +K
Sbjct: 95 FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ---VKM 151
Query: 298 IDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-----RSYGTEADMWSIGVIAYILLCGSR 352
DFG+S Y+ D + G Y+APE ++ + Y ++D+WS+G+ L
Sbjct: 152 CDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF 211
Query: 353 PFWARTESGIFRA----VLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
P+ + F+ V + P + S E +DF + L K+ ++R T + +
Sbjct: 212 PY--DSWGTPFQQLKQVVEEPSPQLPADKF---SAEFVDFTSQCLKKNSKERPTYPELMQ 266
Query: 409 HPWLANSHDVKIPSDM 424
HP+ D+
Sbjct: 267 HPFFTLHESKGT--DV 280
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 83/325 (25%), Positives = 134/325 (41%), Gaps = 74/325 (22%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
Y +++G G + K+K VA+K I ++ +HE
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKL---TDNLVALKEI-RL-----------EHEEG------ 42
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELC----KGGE 238
TAI REV +L+ L H N+V +D + ++ +V E K
Sbjct: 43 -----APCTAI------REVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLDKDLKQ-- 88
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
LD G + + K+ + Q+L +A+CH Q V+HRDLKP+N L + E LK
Sbjct: 89 YLD---DCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE---LKLA 142
Query: 299 DFGLS-DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFW 355
DFGL+ P + ++ V + +Y P++L Y T+ DMW +G I Y + G F
Sbjct: 143 DFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFP 202
Query: 356 ARTE----SGIFRAV----------LKADPSFDEAP------------WPSLSPEAIDFV 389
T IFR + + ++ F P L + D +
Sbjct: 203 GSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLL 262
Query: 390 KRLLNKDYRKRLTAAQALSHPWLAN 414
+LL + R R++A A+ HP+ +
Sbjct: 263 TKLLQFEGRNRISAEDAMKHPFFLS 287
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 1e-39
Identities = 84/404 (20%), Positives = 148/404 (36%), Gaps = 55/404 (13%)
Query: 19 EALPYENEPQPNSQKSKASNFPFYSPSPLPSLFKNSPAIPSVNSTPLRFFKRPFPPPSPA 78
E L E E S++ + + K++ + + F P
Sbjct: 93 EKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDLFQPYIEE 152
Query: 79 KHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQF-VAHYELGEEVGRGHFGYT 137
++ + I + KN + + + + +GRG FG
Sbjct: 153 IC-------QNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMNDFSVHRIIGRGGFGEV 205
Query: 138 CSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197
+ K + G+ A+K + K + +E +++ C F
Sbjct: 206 YGCR-KADT--GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF--------- 253
Query: 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKI 257
+V A+ D + +++L GG+L LS+ G +SE D +
Sbjct: 254 ----------------IVCMSYAFHTPDKLSFILDLMNGGDLHYH-LSQHGVFSEADMRF 296
Query: 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVG 317
+I+ + H + VV+RDLKP N L E+ ++ D GL+ ++ + VG
Sbjct: 297 YAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLGLACDF-SKKKPHASVG 352
Query: 318 SAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWARTESG---IFRAVLKADPS 372
+ Y+APEVL + +Y + AD +S+G + + LL G PF I R L
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 412
Query: 373 FDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPW 411
S SPE ++ LL +D +RL A + P+
Sbjct: 413 LP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 452
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-39
Identities = 81/335 (24%), Positives = 121/335 (36%), Gaps = 70/335 (20%)
Query: 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHE 174
+ YE E+G G +G A+ G VA+K + ++
Sbjct: 3 LGSMATSRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSV-RV-------------P 45
Query: 175 NHQFTILDEYCCLFMTTAIAIEDVRREVKILRAL--TGHKNLVQFYD-----AYEDDDNI 227
N + + REV +LR L H N+V+ D + + +
Sbjct: 46 NG-----GGGGGGLPISTV------REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKV 94
Query: 228 YIVMELC----KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPEN 283
+V E + LD+ E K +M Q L + F H +VHRDLKPEN
Sbjct: 95 TLVFEHVDQDLRT--YLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPEN 150
Query: 284 FLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGV 342
L TS +K DFGL+ L +V + +Y APEVL +Y T DMWS+G
Sbjct: 151 ILVTSGGT---VKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGC 207
Query: 343 IAYILLCGSRPFWARTE----SGIFRAVLKAD----PSFDEAPW---------------P 379
I + F +E IF + P P P
Sbjct: 208 IFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVP 267
Query: 380 SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
+ + +L + KR++A +AL H +L
Sbjct: 268 EMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHK 302
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-39
Identities = 72/303 (23%), Positives = 130/303 (42%), Gaps = 55/303 (18%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+GRG + + K + + A+KV+ K + + + E H
Sbjct: 17 IGRGSYAKVLLVR-LKKT--DRIYAMKVVKKELVNDDEDIDWVQTEKH------------ 61
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+ + H LV + ++ + ++ V+E GG+L+ + R
Sbjct: 62 ---------------VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQR 105
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVK 307
K EE A+ +I + + H +G+++RDLK +N L S +K D+G+ + ++
Sbjct: 106 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLR 162
Query: 308 PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW---------AR 357
P + + G+ Y+APE+L YG D W++GV+ + ++ G PF
Sbjct: 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
Query: 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQAL-SHPW 411
TE +F+ +L+ P SLS +A +K LNKD ++RL T + HP+
Sbjct: 223 TEDYLFQVILEKQIRI---P-RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278
Query: 412 LAN 414
N
Sbjct: 279 FRN 281
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-39
Identities = 81/332 (24%), Positives = 127/332 (38%), Gaps = 76/332 (22%)
Query: 120 VAHYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQ 177
YE E+G G +G + KA+ G+ VA+K + ++ +
Sbjct: 10 DQQYECVAEIGEGAYGKVF----KARDLKNGGRFVALKRV-RV-----------QTGEEG 53
Query: 178 FTILDEYCCLFMTTAIAIEDVRREVKILRAL--TGHKNLVQFYD-----AYEDDDNIYIV 230
+ + I REV +LR L H N+V+ +D + + + +V
Sbjct: 54 MPL----------STI------REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLV 97
Query: 231 MELC----KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286
E LD++ E K +M Q+L + F H VVHRDLKP+N L
Sbjct: 98 FEHVDQDLTT--YLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV 153
Query: 287 TSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY 345
TS + +K DFGL+ L +V + +Y APEVL SY T D+WS+G I
Sbjct: 154 TSSGQ---IKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210
Query: 346 ILLCGSRPFWARTE----SGIFRAVLKAD----PSFDEAPW---------------PSLS 382
+ F ++ I + P P +
Sbjct: 211 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDID 270
Query: 383 PEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
D + + L + KR++A ALSHP+ +
Sbjct: 271 ELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 4e-39
Identities = 83/345 (24%), Positives = 132/345 (38%), Gaps = 87/345 (25%)
Query: 114 GFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKH 173
G + Y + +G G FG AK G+ VA+K K + +
Sbjct: 47 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIK---K----VLQD---KRF 93
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY------EDDDNI 227
+N RE++I+R L H N+V+ + +D+ +
Sbjct: 94 KN------------------------RELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYL 128
Query: 228 YIVMELCKGGELLDRIL----SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPEN 283
+V++ E + R+ K+ M Q+ +A+ H G+ HRD+KP+N
Sbjct: 129 NLVLDYV--PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186
Query: 284 FLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIG 341
L + + LK DFG + + E + S YY APE++ + Y + D+WS G
Sbjct: 187 LLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAG 244
Query: 342 -VIAYILLCGSRPFWARTESG------IFRAVL----KAD-------------PSFDEAP 377
V+A +LL +P + +SG I + VL + P P
Sbjct: 245 CVLAELLLG--QPIF-PGDSGVDQLVEIIK-VLGTPTREQIREMNPNYTEFKFPQIKAHP 300
Query: 378 W-----PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
W P PEAI RLL RLT +A +H + D
Sbjct: 301 WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-39
Identities = 68/297 (22%), Positives = 117/297 (39%), Gaps = 52/297 (17%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+GRG FG + + K + G+ A K + K E IL + F
Sbjct: 193 LGRGGFGEVFACQ-MKAT--GKLYACKKLNKKRLKKRKGYQGAMVEKK---ILAKVHSRF 246
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL---LDRILS 245
+V A+E ++ +VM + GG++ + +
Sbjct: 247 -------------------------IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDE 281
Query: 246 RGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-D 304
+ E A QI+S + H + +++RDLKPEN L + +++ D GL+ +
Sbjct: 282 DNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDD---DGNVRISDLGLAVE 338
Query: 305 YVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESG-- 361
+ G+ ++APE+L Y D +++GV Y ++ PF AR E
Sbjct: 339 LKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398
Query: 362 --IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPW 411
+ + VL+ ++ SP + DF + LL KD KRL + +HP
Sbjct: 399 KELKQRVLEQAVTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 8e-39
Identities = 71/303 (23%), Positives = 130/303 (42%), Gaps = 55/303 (18%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+GRG + + K + + A++V+ K + + + E H
Sbjct: 60 IGRGSYAKVLLVR-LKKT--DRIYAMRVVKKELVNDDEDIDWVQTEKH------------ 104
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG 248
+ + H LV + ++ + ++ V+E GG+L+ + R
Sbjct: 105 ---------------VFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH-MQRQR 148
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS-DYVK 307
K EE A+ +I + + H +G+++RDLK +N L S +K D+G+ + ++
Sbjct: 149 KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDS---EGHIKLTDYGMCKEGLR 205
Query: 308 PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW---------AR 357
P + + G+ Y+APE+L YG D W++GV+ + ++ G PF
Sbjct: 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 265
Query: 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQAL-SHPW 411
TE +F+ +L+ P SLS +A +K LNKD ++RL T + HP+
Sbjct: 266 TEDYLFQVILEKQIRI---P-RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321
Query: 412 LAN 414
N
Sbjct: 322 FRN 324
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 84/343 (24%), Positives = 129/343 (37%), Gaps = 84/343 (24%)
Query: 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
Y +G G +G CSA VA+K I + Q
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPFEHQTYCQ------------- 70
Query: 181 LDEYCCLFMTTAIAIEDVR--REVKILRALTGHKNLVQFYD-----AYEDDDNIYIVMEL 233
R RE+KIL H+N++ D E ++YIV +L
Sbjct: 71 ------------------RTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDL 111
Query: 234 CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
L ++L + S + + QIL + + H V+HRDLKP N L +
Sbjct: 112 M--ETDLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNT---TC 165
Query: 294 SLKAIDFGLSDYVKPDERLNDI----VGSAYYVAPEVL--HRSYGTEADMWSIGVIAYIL 347
LK DFGL+ PD V + +Y APE++ + Y D+WS+G I +
Sbjct: 166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225
Query: 348 LCG-----------------------SRPFWARTESGIFRAVLKADPSFDEAPW----PS 380
L S+ + R L + P ++ PW P+
Sbjct: 226 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPN 285
Query: 381 LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSD 423
+A+D + ++L + KR+ QAL+HP+L +D PSD
Sbjct: 286 ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD---PSD 325
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 92/355 (25%), Positives = 138/355 (38%), Gaps = 88/355 (24%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
++L +G G +G CSA K G+ VA+K I + L
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKP---TGEIVAIK----KIEPFDKPLFA-LR------TL 57
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD-----AYEDDDNIYIVMELCKG 236
RE+KIL+ H+N++ ++ ++E+ + +YI+ EL
Sbjct: 58 ------------------REIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELM-- 96
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
L R++ S++ + + Q L V H V+HRDLKP N L S N LK
Sbjct: 97 QTDLHRVI-STQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS---NCDLK 152
Query: 297 AIDFGLSDYVKPDERLNDIVGSA-----------YYVAPEVL--HRSYGTEADMWSIGVI 343
DFGL+ + N +Y APEV+ Y D+WS G I
Sbjct: 153 VCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCI 212
Query: 344 AYILLCG------------------------SRPFWARTESGIFRAVLKADPSFDEAPW- 378
L S ES R +K+ P + AP
Sbjct: 213 LAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE 272
Query: 379 ---PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLI 430
P ++P+ ID ++R+L D KR+TA +AL HP+L HD P+D + I
Sbjct: 273 KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD---PNDEPEGEPI 324
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 6e-38
Identities = 71/294 (24%), Positives = 116/294 (39%), Gaps = 49/294 (16%)
Query: 129 VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLF 188
+G+G FG C+ + + + G+ A K + K +E IL
Sbjct: 192 LGKGGFGEVCACQ-VRAT--GKMYACKKLEKKRIKKRKGEAMALNEKQ---IL------- 238
Query: 189 MTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG- 247
+ +V AYE D + +V+ L GG+L I G
Sbjct: 239 ------------------EKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280
Query: 248 GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK 307
+ E A +I + H + +V+RDLKPEN L + ++ D GL+ +V
Sbjct: 281 AGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDD---HGHIRISDLGLAVHVP 337
Query: 308 PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESG----I 362
+ + VG+ Y+APEV+ Y D W++G + Y ++ G PF R + +
Sbjct: 338 EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV 397
Query: 363 FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPW 411
R V + + SP+A +LL KD +RL +A + HP
Sbjct: 398 ERLVKEVPEEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPL 447
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 73/350 (20%), Positives = 135/350 (38%), Gaps = 93/350 (26%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT-- 179
Y+ + +G G G C+A ++VA+K + + F +N
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSR----PF--------QNQTHAKR 107
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA------YEDDDNIYIVMEL 233
RE+ +++ + HKN++ + E+ ++Y+VMEL
Sbjct: 108 AY------------------RELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 234 CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
L +++ + E ++ Q+L + H G++HRDLKP N + S +
Sbjct: 149 --MDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DC 201
Query: 294 SLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCG-- 350
+LK +DFGL+ + V + YY APEV L Y D+WS+G I ++
Sbjct: 202 TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
Query: 351 ---------------------SRPFWARTESGIFRAVLKADPSFDEAPWPSL-------- 381
F + + + R ++ P + +P L
Sbjct: 262 LFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV-RNYVENRPKYAGLTFPKLFPDSLFPA 320
Query: 382 --------SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSD 423
+ +A D + ++L D KR++ AL HP++ +D P++
Sbjct: 321 DSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD---PAE 367
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-37
Identities = 81/334 (24%), Positives = 126/334 (37%), Gaps = 82/334 (24%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y + +G G FG AK ++ +VA+K +
Sbjct: 41 AYTNCKVIGNGSFGVVFQAK----LVESDEVAIKKVL----------------------Q 74
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY------EDDDNIYIVMELCK 235
D+ RE++I+R + H N+V + +D+ + +V+E
Sbjct: 75 DK------------RFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP 121
Query: 236 G--GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
K+ M Q+L +A+ H G+ HRD+KP+N L +
Sbjct: 122 ETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLD--PPSG 179
Query: 294 SLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGS 351
LK IDFG + + E + S YY APE++ + Y T D+WS G + L+ G
Sbjct: 180 VLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG- 238
Query: 352 RPFWARTESG------IFRAVL--------------KADPSF---DEAPW-----PSLSP 383
+P + ESG I + VL + F P+ P P
Sbjct: 239 QPLF-PGESGIDQLVEIIK-VLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPP 296
Query: 384 EAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
+AID + RLL RLTA +AL HP+
Sbjct: 297 DAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 6e-37
Identities = 65/240 (27%), Positives = 102/240 (42%), Gaps = 44/240 (18%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
L E +G G FG K + G +VAVK +H+ +
Sbjct: 10 TLEEIIGIGGFG-----KVYRAFWIGDEVAVKAA--------------RHDPDEDI---- 46
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
+ IE+VR+E K+ L H N++ + N+ +VME +GG L +
Sbjct: 47 --------SQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL 97
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQG---VVHRDLKPENFLFTSKEE-----NSSL 295
G + + VQI + + H + ++HRDLK N L K E N L
Sbjct: 98 --SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPF 354
K DFGL+ +++ G+ ++APEV+ + +D+WS GV+ + LL G PF
Sbjct: 156 KITDFGLAREWHRTTKMSA-AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 7e-37
Identities = 74/349 (21%), Positives = 137/349 (39%), Gaps = 89/349 (25%)
Query: 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
Y+ + +G G G C+A ++VA+K + + F +++ H
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSR----PF------QNQTHAKRA 71
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA------YEDDDNIYIVMELC 234
RE+ +++ + HKN++ + E+ ++YIVMEL
Sbjct: 72 Y------------------RELVLMKCV-NHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 112
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
L +++ + E ++ Q+L + H G++HRDLKP N + S + +
Sbjct: 113 --DANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCT 165
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCG--- 350
LK +DFGL+ + V + YY APEV L Y D+WS+G I ++ G
Sbjct: 166 LKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVL 225
Query: 351 --------------------SRPFWARTESGIFRAVLKADPSFDEAPW------------ 378
F + + + R ++ P + +
Sbjct: 226 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV-RTYVENRPKYAGYSFEKLFPDVLFPAD 284
Query: 379 ----PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSD 423
+ +A D + ++L D KR++ +AL HP++ +D PS+
Sbjct: 285 SEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD---PSE 330
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 76/370 (20%), Positives = 131/370 (35%), Gaps = 114/370 (30%)
Query: 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT- 179
YEL +++G+G +G + ++ G+ VAVK I F +N
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFD----AF--------QNSTDAQ 53
Query: 180 -ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY--EDDDNIYIVMELCKG 236
RE+ IL L+GH+N+V + ++D ++Y+V +
Sbjct: 54 RTF------------------REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-- 93
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
L ++ R + V+ Q++ V+ + H G++HRD+KP N L + +K
Sbjct: 94 ETDLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNA---ECHVK 149
Query: 297 AIDFGLSDYVKPDERLNDIVGSA----------------------YYVAPEVL--HRSYG 332
DFGLS R+ + + + +Y APE+L Y
Sbjct: 150 VADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYT 209
Query: 333 TEADMWSIGVI--------------------------------------------AYILL 348
DMWS+G I I
Sbjct: 210 KGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIES 269
Query: 349 CGSRPFWARTESGIFRAVLKADPSFDEA-PWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407
+ +S K + P + EA+D + +LL + KR++A AL
Sbjct: 270 LKEKV--EIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDAL 327
Query: 408 SHPWLANSHD 417
HP+++ H+
Sbjct: 328 KHPFVSIFHN 337
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 73/340 (21%), Positives = 123/340 (36%), Gaps = 80/340 (23%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+E E+G G+ G K G +A K+I L+
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPS---GLVMARKLIH----------------------LE 69
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ RE+++L +V FY A+ D I I ME GG LD+
Sbjct: 70 I-------KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGG-SLDQ 120
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQG-VVHRDLKPENFLFTSKEENSSLKAIDFG 301
+L + G+ E+ V + ++ + + + ++HRD+KP N L S+ E +K DFG
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFG 177
Query: 302 LSDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPF------ 354
+S + D N VG+ Y++PE L + Y ++D+WS+G+ + G P
Sbjct: 178 VSGQLI-DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236
Query: 355 --------------WARTESGIFRAVLKADPSFDEAPWPSL------------------- 381
D P ++
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
Query: 382 -SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKI 420
S E DFV + L K+ +R Q + H ++ S ++
Sbjct: 297 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 336
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-36
Identities = 61/376 (16%), Positives = 129/376 (34%), Gaps = 92/376 (24%)
Query: 122 HYELGEEVGRGHFGYTCSAKAK-KGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
YEL +G+G A+ K + G+ V V+ I L+ C
Sbjct: 26 CYELLTVIGKGFEDLMTVNLARYKPT--GEYVTVRRIN-------LE-ACSNEM------ 69
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
+ ++ E+ + + H N+V + + D+ +++V G
Sbjct: 70 --------------VTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAK 114
Query: 241 DRI-LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
D I +E ++ +L + + H G VHR +K + L + + +
Sbjct: 115 DLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILIS---VDGKVYLSG 171
Query: 300 FG----LSDYVK----PDERLNDIVGSAYYVAPEVLHRS---YGTEADMWSIGVIAYILL 348
+ + + + V +++PEVL ++ Y ++D++S+G+ A L
Sbjct: 172 LRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELA 231
Query: 349 CGSRPF------------------------------------WARTESGIFRAVLKADPS 372
G PF + SG+ ++ + P
Sbjct: 232 NGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPR 291
Query: 373 FDEAPWPS------LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIV 426
PS SP FV++ L ++ R +A+ L+H + +K + +
Sbjct: 292 PSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ---IKRRASEAL 348
Query: 427 YKLIKAYISSSSLRKA 442
+L++ ++ +
Sbjct: 349 PELLRPVTPITNFEGS 364
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-35
Identities = 78/355 (21%), Positives = 128/355 (36%), Gaps = 92/355 (25%)
Query: 111 KNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHC 170
S++ + +++ G+G FG K K G VA+K +
Sbjct: 13 AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKV------------- 56
Query: 171 PKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALT--GHKNLVQFYDAY-----ED 223
++ +F RE++I++ L H N+VQ + D
Sbjct: 57 --IQDPRFRN-------------------RELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95
Query: 224 DDNIY--IVMELCKGGELLDRILSRGGKY----SEEDAKIVMVQILSVVAFCHFQ--GVV 275
+IY +VME + L R + K+ + Q++ + H V
Sbjct: 96 RRDIYLNVVMEYV--PDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVC 153
Query: 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL--HRSYGT 333
HRD+KP N L E + +LK DFG + + P E + S YY APE++ ++ Y T
Sbjct: 154 HRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTT 211
Query: 334 EADMWSIG-VIAYILL-----CG-----------------SRPFWARTESGIFRAVLKAD 370
D+WS+G + A ++L G SR +
Sbjct: 212 AVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTD---VDL 268
Query: 371 PSFDEAPW--------PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
+ PW + EA D + LL +R+ +AL HP+ HD
Sbjct: 269 YNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHD 323
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 80/389 (20%), Positives = 131/389 (33%), Gaps = 129/389 (33%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT-- 179
+Y + +GRG +GY A K ++VA+K + + +F E+
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNR----MF--------EDLIDCKR 71
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD-----AYEDDDNIYIVMELC 234
IL RE+ IL L +++ YD D +YIV+E+
Sbjct: 72 IL------------------REITILNRL-KSDYIIRLYDLIIPDDLLKFDELYIVLEIA 112
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
L ++ +EE K ++ +L F H G++HRDLKP N L + S
Sbjct: 113 --DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ---DCS 167
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSA-----------------------YYVAPEVL--HR 329
+K DFGL+ + ++ N + +Y APE++
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE 227
Query: 330 SYGTEADMWSIGVIAYILLCGSRPFWARTESG---------------------------- 361
+Y D+WS G I LL + +
Sbjct: 228 NYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRD 287
Query: 362 ----IF-------------------RAVLKADPSFDEAPW----PSLSPEAIDFVKRLLN 394
IF +K P PS+S + I+ ++ +L
Sbjct: 288 QLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLK 347
Query: 395 KDYRKRLTAAQALSHPWLANSHDVKIPSD 423
+ KR+T QAL HP+L +
Sbjct: 348 FNPNKRITIDQALDHPYLKDVRK---KKL 373
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 3e-35
Identities = 63/293 (21%), Positives = 106/293 (36%), Gaps = 61/293 (20%)
Query: 123 YELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
YE+ + G G Y A ++ G+ V +K +
Sbjct: 82 YEVKGCIAHGGLGWIY----LALDRNVNGRPVVLKGL----------------------- 114
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNI-----YIVMELCK 235
+ A A E + L + H ++VQ ++ E D YIVME
Sbjct: 115 ------VHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVG 167
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
G L G K +A +++IL +++ H G+V+ DLKPEN + T L
Sbjct: 168 GQSLKRSK---GQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT----EEQL 220
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFW 355
K ID G V + G+ + APE++ D++++G L
Sbjct: 221 KLIDLGA---VSRINSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRN 277
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
R + P ++ P ++R ++ D R+R T A+ +S
Sbjct: 278 GRY--------VDGLP--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMS 320
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-35
Identities = 54/249 (21%), Positives = 100/249 (40%), Gaps = 59/249 (23%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
E+GE +G+G FG Y G G +VA+++I + +N
Sbjct: 36 EIGELIGKGRFGQVY-------HGRWHG-EVAIRLID------------IERDNED---- 71
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
++ +REV R H+N+V F A ++ I+ LCKG L
Sbjct: 72 ------------QLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAIITSLCKGRTLYS 118
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ + + +I+ + + H +G++H+DLK +N + +N + DFG
Sbjct: 119 VVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFG 174
Query: 302 LS------DYVKPDERLNDIVGSAYYVAPEVL----------HRSYGTEADMWSIGVIAY 345
L + +++L G ++APE++ + +D++++G I Y
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWY 234
Query: 346 ILLCGSRPF 354
L PF
Sbjct: 235 ELHAREWPF 243
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 63/240 (26%), Positives = 100/240 (41%), Gaps = 42/240 (17%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLK--GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
E +++G+G FG KG L VA+K L + + E
Sbjct: 22 EYEKQIGKGGFG-----LVHKGRLVKDKSVVAIKS---------LILGDSEGETEMIEKF 67
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
E+ +REV I+ L H N+V+ Y + +VME G+L
Sbjct: 68 QEF--------------QREVFIMSNLN-HPNIVKLYGLMHN--PPRMVMEFVPCGDLYH 110
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQG--VVHRDLKPENFLFTSKEENS--SLKA 297
R+L + +M+ I + + Q +VHRDL+ N S +EN+ K
Sbjct: 111 RLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKV 170
Query: 298 IDFGLSDYVKPDERLNDIVGSAYYVAPEVL---HRSYGTEADMWSIGVIAYILLCGSRPF 354
DFGLS ++ ++G+ ++APE + SY +AD +S +I Y +L G PF
Sbjct: 171 ADFGLSQQS--VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 62/237 (26%), Positives = 103/237 (43%), Gaps = 50/237 (21%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
E+ E VGRG FG C K + +DVA+K I + E+
Sbjct: 11 EVEEVVGRGAFGVVC-----KAKWRAKDVAIKQI--------------ESESE------- 44
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
+ E++ L + H N+V+ Y A + + +VME +GG L + +
Sbjct: 45 -----------RKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCLVMEYAEGGSLYNVL 90
Query: 244 LSRG--GKYSEEDAKIVMVQILSVVAFCH---FQGVVHRDLKPENFLFTSKEENSSLKAI 298
Y+ A +Q VA+ H + ++HRDLKP N L + LK
Sbjct: 91 HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKIC 148
Query: 299 DFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPF 354
DFG + ++ + + GSA ++APEV +Y + D++S G+I + ++ +PF
Sbjct: 149 DFGTACDIQ--THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPF 203
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 5e-34
Identities = 65/333 (19%), Positives = 122/333 (36%), Gaps = 47/333 (14%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQ--FT 179
Y LG+ +G G FG C + G+ A+K + + ++ K +H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIK 64
Query: 180 ILD-EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGE 238
++D Y + + + + + ++ME +
Sbjct: 65 LVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV--PD 122
Query: 239 LLDRILSRGGKY----SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
L ++L + I + Q+ V F H G+ HRD+KP+N L S ++++
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS--KDNT 180
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIG-VIAYILL--- 348
LK DFG + + P E + S +Y APE++ Y D+WSIG V ++L
Sbjct: 181 LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
Query: 349 --CG-----------------SRPFWARTESGIFRAVLKADPSFDEAPWPSL-----SPE 384
G ++ R P+ W +
Sbjct: 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRF---PTLKAKDWRKILPEGTPSL 297
Query: 385 AIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
AID ++++L + R+ +A++HP+ + +
Sbjct: 298 AIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-34
Identities = 57/237 (24%), Positives = 92/237 (38%), Gaps = 43/237 (18%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
+ E++G G FG + G DVAVK++ +
Sbjct: 40 NIKEKIGAGSFG-----TVHRAEWHGSDVAVKILMEQ----------------------- 71
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
A + + REV I++ L H N+V F A N+ IV E G L +
Sbjct: 72 -----DFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL 125
Query: 244 LSRGGK--YSEEDAKIVMVQILSVVAFCHFQG--VVHRDLKPENFLFTSKEENSSLKAID 299
G + E + + + + H + +VHR+LK N L + ++K D
Sbjct: 126 HKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD---KKYTVKVCD 182
Query: 300 FGLS-DYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPF 354
FGLS G+ ++APEVL ++D++S GVI + L +P+
Sbjct: 183 FGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPW 239
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 85/360 (23%), Positives = 131/360 (36%), Gaps = 103/360 (28%)
Query: 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
V+ YE ++G+G FG A+ +K GQ VA+K + M ++E F
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKV-LM-----------ENEKEGFP 60
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD--------AYEDDDNIYIVM 231
I TA+ RE+KIL+ L H+N+V + +IY+V
Sbjct: 61 I----------TAL------REIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVF 103
Query: 232 ELC----KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFT 287
+ C G LL + K++ + K VM +L+ + + H ++HRD+K N L T
Sbjct: 104 DFCEHDLAG--LLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT 158
Query: 288 SKEENSSLKAIDFGLSDYVKPDERLNDIVGSAY--------YVAPEVL--HRSYGTEADM 337
LK DFGL+ + + Y Y PE+L R YG D+
Sbjct: 159 RDGV---LKLADFGLARAFSLAKNSQP---NRYTNRVVTLWYRPPELLLGERDYGPPIDL 212
Query: 338 WSIGVIAYILLCGSRP-FWARTESG----IFRAVLKADPSFDEAPWP------------- 379
W G I + P TE I + S WP
Sbjct: 213 WGAGCIMAEMWTR-SPIMQGNTEQHQLALISQLC----GSITPEVWPNVDNYELYEKLEL 267
Query: 380 ---------------SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDM 424
P A+D + +LL D +R+ + AL+H + + M
Sbjct: 268 VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGM 327
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 56/240 (23%), Positives = 99/240 (41%), Gaps = 50/240 (20%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+G+ +G G FG Y KG G DVAVK++
Sbjct: 27 TVGQRIGSGSFGTVY-------KGKWHG-DVAVKML--------------NVTA------ 58
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
T ++ + EV +LR H N++ F Y + IV + C+G L
Sbjct: 59 --------PTPQQLQAFKNEVGVLRKTR-HVNILLFM-GYSTAPQLAIVTQWCEGSSLYH 108
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ + K+ + + Q + + H + ++HRDLK N E++++K DFG
Sbjct: 109 HLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL---HEDNTVKIGDFG 165
Query: 302 LS---DYVKPDERLNDIVGSAYYVAPEVL----HRSYGTEADMWSIGVIAYILLCGSRPF 354
L+ + + GS ++APEV+ Y ++D+++ G++ Y L+ G P+
Sbjct: 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY 225
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-32
Identities = 71/292 (24%), Positives = 116/292 (39%), Gaps = 45/292 (15%)
Query: 123 YELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
Y++ +++G G Y A+ L VA+K I
Sbjct: 13 YKIVDKLGGGGMSTVY----LAEDTIL-NIKVAIKAI---------------FIP----- 47
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
++ REV L+ H+N+V D E+DD Y+VME +G L
Sbjct: 48 -------PREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLS 99
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
+ + G S + A QIL + H +VHRD+KP+N L N +LK DF
Sbjct: 100 E-YIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILID---SNKTLKIFDF 155
Query: 301 GLSDYVKPDERL---NDIVGSAYYVAPE-VLHRSYGTEADMWSIGVIAYILLCGSRPFWA 356
G++ + + L N ++G+ Y +PE + D++SIG++ Y +L G PF
Sbjct: 156 GIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214
Query: 357 RTESGI-FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407
T I + + + P+ + + + R KD R Q +
Sbjct: 215 ETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEM 266
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 59/277 (21%), Positives = 99/277 (35%), Gaps = 66/277 (23%)
Query: 200 REVKILRALTGHKNLVQFYDAYED--DDNIYIVMELC----KGGELLD-----RILSRGG 248
RE+ +LR L H N++ + D ++++ + ++ + +
Sbjct: 67 REIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWH--IIKFHRASKANKKPV 123
Query: 249 KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS-SLKAIDFGL----S 303
+ K ++ QIL + + H V+HRDLKP N L + +K D G +
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 304 DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRP-FWARTES 360
+KP L+ +V + +Y APE+L R Y D+W+IG I LL P F R E
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQED 242
Query: 361 GIFRAVLKAD-----------------PSFDEAPW------------------------- 378
D + P
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 379 -PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
+A +++LL D KR+T+ QA+ P+
Sbjct: 303 KVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLE 339
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 55/249 (22%), Positives = 98/249 (39%), Gaps = 57/249 (22%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLK--GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
GE +G+G FG +A K + + G+ + +K + +
Sbjct: 13 IHGEVLGKGCFG-----QAIKVTHRETGEVMVMKELIR---------------------- 45
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+EVK++R L H N+++F D + + E KGG L
Sbjct: 46 --------FDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFITEYIKGGTLRG 96
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
I S +Y I S +A+ H ++HRDL N L EN ++ DFG
Sbjct: 97 IIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVR---ENKNVVVADFG 153
Query: 302 LSDYVKPDERLND---------------IVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY 345
L+ + ++ + +VG+ Y++APE++ RSY + D++S G++
Sbjct: 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLC 213
Query: 346 ILLCGSRPF 354
++
Sbjct: 214 EIIGRVNAD 222
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 40/240 (16%), Positives = 74/240 (30%), Gaps = 50/240 (20%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
++ H G KG +G D+ VKV+
Sbjct: 13 NFLTKLNENHSGELW-----KGRWQGNDIVVKVLKVR----------------------- 44
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLD 241
+ D E LR + H N++ A + + ++ G L +
Sbjct: 45 -----DWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYN 98
Query: 242 RILSRGG-KYSEEDAKIVMVQILSVVAFCHFQG--VVHRDLKPENFLFTSKEENSSLKAI 298
+ + A + + +AF H + L + + E+ + +
Sbjct: 99 VLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMID---EDMTARIS 155
Query: 299 DFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTE---ADMWSIGVIAYILLCGSRPF 354
+ + R + + +VAPE L + T ADMWS V+ + L+ PF
Sbjct: 156 MADVKFSFQSPGR----MYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPF 211
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-31
Identities = 75/298 (25%), Positives = 120/298 (40%), Gaps = 52/298 (17%)
Query: 123 YELGEEVGRGHFG----YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQF 178
YELGE +G G G + A+ +DVAVKV+ +
Sbjct: 14 YELGEILGFG--GMSEVH----LARDLRD-HRDVAVKVL---------------RAD--- 48
Query: 179 TILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNI----YIVMELC 234
RRE + AL H +V YD E + YIVME
Sbjct: 49 ---------LARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYV 98
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
G L D I+ G + + A V+ + F H G++HRD+KP N + + ++
Sbjct: 99 DGVTLRD-IVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMIS---ATNA 154
Query: 295 LKAIDFGL----SDYVKPDERLNDIVGSAYYVAPE-VLHRSYGTEADMWSIGVIAYILLC 349
+K +DFG+ +D + ++G+A Y++PE S +D++S+G + Y +L
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214
Query: 350 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407
G PF + + ++ DP A LS + V + L K+ R A +
Sbjct: 215 GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEM 272
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-31
Identities = 79/329 (24%), Positives = 127/329 (38%), Gaps = 64/329 (19%)
Query: 90 GSVKPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFG--YTCSAKAKKGSL 147
+ P + + ES G Y L VGRG G Y +A+
Sbjct: 12 SGLVPRGSHMDGTAESREG---------TQFGPYRLRRLVGRGGMGDVY----EAEDTVR 58
Query: 148 KGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207
+ VA+K++ + + + F ++RE +
Sbjct: 59 -ERIVALKLMSETLS-----------SDPVF----------------RTRMQREARTAGR 90
Query: 208 LTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVA 267
L ++V +D E D +Y+ M L G +L +L R G + A ++ QI S +
Sbjct: 91 LQ-EPHVVPIHDFGEIDGQLYVDMRLINGVDL-AAMLRRQGPLAPPRAVAIVRQIGSALD 148
Query: 268 FCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL---NDIVGSAYYVAP 324
H G HRD+KPEN L + + +DFG++ DE+L + VG+ YY+AP
Sbjct: 149 AAHAAGATHRDVKPENILVS---ADDFAYLVDFGIA-SATTDEKLTQLGNTVGTLYYMAP 204
Query: 325 EVLHRSYGTE-ADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS- 382
E S+ T AD++++ + Y L GS P+ S + + P PS
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI------NQAIPRPSTVR 258
Query: 383 ---PEAID-FVKRLLNKDYRKRLTAAQAL 407
P A D + R + K+ R L
Sbjct: 259 PGIPVAFDAVIARGMAKNPEDRYVTCGDL 287
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 80/440 (18%), Positives = 140/440 (31%), Gaps = 136/440 (30%)
Query: 73 PPPSPAKHIRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRG 132
+ ++ + + + + S ++ YE+ +G G
Sbjct: 9 AQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD----RYEIRHLIGTG 64
Query: 133 HFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTA 192
+G+ C A K + + VA+K I + +F + K IL
Sbjct: 65 SYGHVCEAYDKL---EKRVVAIKKILR----VFEDLIDCK------RIL----------- 100
Query: 193 IAIEDVRREVKILRALTGHKNLVQFYD-----AYEDDDNIYIVMELCKGGEL-LDRILSR 246
RE+ IL L H ++V+ D E D +Y+V+E+ + ++
Sbjct: 101 -------REIAILNRL-NHDHVVKVLDIVIPKDVEKFDELYVVLEIA---DSDFKKLFRT 149
Query: 247 GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV 306
+E K ++ +L V + H G++HRDLKP N L + S+K DFGL+ V
Sbjct: 150 PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ---DCSVKVCDFGLARTV 206
Query: 307 KPDERLNDIVGSA----------------------------YYVAPEVL--HRSYGTEAD 336
E N + + +Y APE++ +Y D
Sbjct: 207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAID 266
Query: 337 MWSIGVI-AYILLC----------------GSRPFWARTESGIFRAVLKADPSF------ 373
+WSIG I A +L GS F +
Sbjct: 267 VWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNV 326
Query: 374 --------DEAPWPSL-SPEAIDFVKR----------------------LLNK----DYR 398
E +L +A +++ LL + +
Sbjct: 327 IFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPN 386
Query: 399 KRLTAAQALSHPWLANSHDV 418
KR+T + L+HP+
Sbjct: 387 KRITINECLAHPFFKEVRIA 406
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 74/357 (20%), Positives = 126/357 (35%), Gaps = 101/357 (28%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
Y L ++G GHF AK VA+K++ + +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIV--------------RGDKV------ 57
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALT----------GHKNLVQFYDAYE----DDDNIY 228
+ A E+K+L+ + G ++++ D + + ++
Sbjct: 58 -----YTEAAE------DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV 106
Query: 229 IVMELCKGGELLDRI-LSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVHRDLKPENFLF 286
+V E+ G LL I K + Q+L + + H + G++H D+KPEN L
Sbjct: 107 MVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165
Query: 287 ---TSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEV-LHRSYGTEADMWSIGV 342
S E +K D G + + DE + + + Y +PEV L +G AD+WS
Sbjct: 166 EIVDSPENLIQIKIADLGNACWY--DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTAC 223
Query: 343 IAYILLCGSRPFWARTESGIFR---------AVLKADPS------------FDE------ 375
+ + L+ G F + +L PS F+
Sbjct: 224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 283
Query: 376 ----APWP---------SLSPEA----IDFVKRLLNKDYRKRLTAAQALSHPWLANS 415
WP S + DF+ +L D RKR A ++HPWL ++
Sbjct: 284 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 340
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 72/361 (19%), Positives = 115/361 (31%), Gaps = 105/361 (29%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVI---PKMIGVIFLQVHCPKHENHQFT 179
YE+ +G G FG + + VA+K+I K
Sbjct: 21 YEIVGNLGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYR------------------ 60
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRAL-----TGHKNLVQFYDAYEDDDNIYIVMELC 234
E R E+ +L+ + V D + ++ I EL
Sbjct: 61 ----------------EAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL 104
Query: 235 KGGELLDRILSRGGK-YSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKE--- 290
G + + + Y + + Q+ + F H + H DLKPEN LF + E
Sbjct: 105 -GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFET 163
Query: 291 -------------ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEV-LHRSYGTEAD 336
+N+S++ DFG + + E IV + +Y PEV L + D
Sbjct: 164 LYNEHKSCEEKSVKNTSIRVADFGSATFD--HEHHTTIVATRHYRPPEVILELGWAQPCD 221
Query: 337 MWSIGVIAYILLCGSRPFWARTE---------------SGIFRAVLKADPSFDE-APWPS 380
+WSIG I + G F S + K + W
Sbjct: 222 VWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDE 281
Query: 381 LSPEA------------------------IDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416
S + D ++R+L D +R+T A+AL HP+ A
Sbjct: 282 NSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341
Query: 417 D 417
Sbjct: 342 P 342
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 76/354 (21%), Positives = 119/354 (33%), Gaps = 101/354 (28%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE+ + +G G FG + G+ VAVK++ +N
Sbjct: 16 YEIVDTLGEGAFGKV--VECIDHKAGGRHVAVKIV----------------KNVD----- 52
Query: 183 EYCCLFMTTAIAIEDVRREVKILRAL-----TGHKNLVQFYDAYEDDDNIYIVMELCKGG 237
+ A R E+++L L VQ + +E +I IV EL
Sbjct: 53 ----RYCEAA------RSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLS 102
Query: 238 --ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKE----- 290
+ + + + + + QI V F H + H DLKPEN LF +
Sbjct: 103 TYDFIKENGFLP--FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAY 160
Query: 291 -----------ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEV-LHRSYGTEADMW 338
N +K +DFG + Y DE + +V + +Y APEV L + D+W
Sbjct: 161 NPKIKRDERTLINPDIKVVDFGSATYD--DEHHSTLVSTRHYRAPEVILALGWSQPCDVW 218
Query: 339 SIGVIAYILLCGSRPFWARTES----------GIF-RAVLKADPS-----FDEAPWPSLS 382
SIG I G F G + +++ D W S
Sbjct: 219 SIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHS 278
Query: 383 P------------------------EAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
D ++++L D KR+T +AL HP+
Sbjct: 279 SAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 8e-26
Identities = 82/353 (23%), Positives = 121/353 (34%), Gaps = 102/353 (28%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE+ + +G+G FG A K Q VA+K++ N +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMV----------------RNEKR---- 135
Query: 183 EYCCLFMTTAIAIEDVRREVKILRAL-----TGHKNLVQFYDAYEDDDNIYIVMELCKGG 237
F A E++IL L N++ + + ++I + EL
Sbjct: 136 -----FHRQA------AEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMN 184
Query: 238 --ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
EL+ + +G +S + IL + H ++H DLKPEN L + S +
Sbjct: 185 LYELIKKNKFQG--FSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ-QGRSGI 241
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCGSRPF 354
K IDFG S Y +R+ + S +Y APEV L YG DMWS+G I LL G
Sbjct: 242 KVIDFGSSCYE--HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLL 299
Query: 355 WARTE---------------SGIFRAVLKADPSFDEAPWP-------------------- 379
E + A +A +P
Sbjct: 300 PGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRS 359
Query: 380 -----SLSPEAIDFVKRLLNKDYR---------------KRLTAAQALSHPWL 412
PE+ ++ L D R+T QAL HPWL
Sbjct: 360 RRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 31/289 (10%), Positives = 59/289 (20%), Gaps = 69/289 (23%)
Query: 123 YELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
Y L G + +A +L + VA+ V
Sbjct: 33 YRLLIFHGGVPPLQFW----QALDTAL-DRQVALTF-----------VDPQGVLPDDV-- 74
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
+++ L + + + D +V E +GG L
Sbjct: 75 --------------LQETLSRTLRLSRID-KPGVARVLDVVHTRAGGLVVAEWIRGGSLQ 119
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
+ + + + + H GV P +
Sbjct: 120 EVA--DTSPSPVGAIRAM-QSLAAAADAAHRAGVALSIDHPSRVRVSI------------ 164
Query: 301 GLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTES 360
V + + + D+ IG Y LL P
Sbjct: 165 --DGDVV--------LAYPATMPDA------NPQDDIRGIGASLYALLVNRWPLPEAGVR 208
Query: 361 GIFRAVLKADPSFDEAPW---PSLSPEAIDFVKRLLNKDYRKRLTAAQA 406
+ P + + R + D R +
Sbjct: 209 SGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRSASTLL 257
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 64/360 (17%), Positives = 119/360 (33%), Gaps = 107/360 (29%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ + ++G G FG + + AVKV+ N +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVV----------------RNIK----- 72
Query: 183 EYCCLFMTTAIAIEDVRREVKILRAL----TGHKNLVQFYDAYEDDDNIYIVMELCKGGE 238
+ +A + E IL+ + + N+V+++ + D++ ++ E G
Sbjct: 73 ----KYTRSA------KIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPS 121
Query: 239 LLDRILSRGGK-YSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKE------- 290
L + I + ED K+ ++IL + + + H DLKPEN L
Sbjct: 122 LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLIT 181
Query: 291 ---------------ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEV-LHRSYGTE 334
+++ +K IDFG + + + I+ + Y APEV L+ +
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFK--SDYHGSIINTRQYRAPEVILNLGWDVS 239
Query: 335 ADMWSIGVIAYIL---------------------LCGSRPFW-----ARTESGIFRAVLK 368
+DMWS G + L + P +T + +
Sbjct: 240 SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDE 299
Query: 369 ADPSFDE--------APWPSLSPEA--------IDFVKRLLNKDYRKRLTAAQALSHPWL 412
++ E P DF+ +L D R + A+ L H +L
Sbjct: 300 LKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 72/342 (21%), Positives = 128/342 (37%), Gaps = 89/342 (26%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
L E +G+G FG +G +G++VAVK+ E + E
Sbjct: 45 VLQESIGKGRFGEVW-----RGKWRGEEVAVKIFSS-------------REERSW--FRE 84
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN----IYIVMELCKGGEL 239
E+ L H+N++ F A D+ +++V + + G L
Sbjct: 85 ----------------AEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 127
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ--------GVVHRDLKPENFLFTSKEE 291
D L+R + E + + S +A H + + HRDLK +N L +
Sbjct: 128 FD-YLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK---K 182
Query: 292 NSSLKAIDFGLSDYVKPDERLNDI-----VGSAYYVAPEVL-------HRSYGTEADMWS 339
N + D GL+ DI VG+ Y+APEVL H AD+++
Sbjct: 183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYA 242
Query: 340 IGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDEA-------------PWPSLSPEA 385
+G++ + + + + + ++ +DPS +E P S EA
Sbjct: 243 MGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA 302
Query: 386 IDFVKRLL----NKDYRKRLTAAQA---LSHPWLANSHDVKI 420
+ + +++ + RLTA + LS L+ +K+
Sbjct: 303 LRVMAKIMRECWYANGAARLTALRIKKTLSQ--LSQQEGIKM 342
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 66/344 (19%), Positives = 124/344 (36%), Gaps = 93/344 (27%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
++ +++G+G +G + G +G+ VAVKV E +
Sbjct: 40 QMVKQIGKGRYGEVW-------MGKWRGEKVAVKVFFT-------------TEEASWF-- 77
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDD----NIYIVMELCKGG 237
E+ + H+N++ F A +Y++ + + G
Sbjct: 78 ----------------RETEIYQTVLM-RHENILGFIAADIKGTGSWTQLYLITDYHENG 120
Query: 238 ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ--------GVVHRDLKPENFLFTSK 289
L D + + + + +S + H + + HRDLK +N L
Sbjct: 121 SLYDYL--KSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK-- 176
Query: 290 EENSSLKAIDFGLSDYVKPDERLNDI-----VGSAYYVAPEVL-------HRSYGTEADM 337
+N + D GL+ D DI VG+ Y+ PEVL H ADM
Sbjct: 177 -KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 338 WSIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDEA-------------PWPSLSP 383
+S G+I + + E + + ++ +DPS+++ P S
Sbjct: 236 YSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD 295
Query: 384 EAIDFVKRLL----NKDYRKRLTAAQ---ALSHPWLANSHDVKI 420
E + + +L+ + RLTA + L+ ++ S D+K+
Sbjct: 296 ECLRQMGKLMTECWAHNPASRLTALRVKKTLAK--MSESQDIKL 337
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 55/278 (19%), Positives = 101/278 (36%), Gaps = 69/278 (24%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
L E VG+G +G + +GS +G++VAVK+ + +
Sbjct: 11 TLLECVGKGRYG-----EVWRGSWQGENVAVKIFSS-------------RDEKSW----- 47
Query: 184 YCCLFMTTAIAIEDVRREVKILR-ALTGHKNLVQFYDA----YEDDDNIYIVMELCKGGE 238
RE ++ + H+N++ F + ++++ + G
Sbjct: 48 ---------------FRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGS 92
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ--------GVVHRDLKPENFLFTSKE 290
L D + + +++ I S +A H + + HRDLK +N L
Sbjct: 93 LYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVK--- 147
Query: 291 ENSSLKAIDFGLS-----DYVKPDERLNDIVGSAYYVAPEVL-------HRSYGTEADMW 338
+N D GL+ + D N VG+ Y+APEVL D+W
Sbjct: 148 KNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIW 207
Query: 339 SIGVIAYILLCGSRPFWARTESGI-FRAVLKADPSFDE 375
+ G++ + + + F V+ DPSF++
Sbjct: 208 AFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFED 245
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 60/260 (23%), Positives = 97/260 (37%), Gaps = 61/260 (23%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
LGE++GRG+FG S + + + VAVK +
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTL---VAVKSCRET----------------------- 150
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
+E +IL+ + H N+V+ IYIVMEL +GG+ L +
Sbjct: 151 ------LPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL 203
Query: 244 LSRGGKYSEEDAKIVM-VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ G + + + M + + + + +HRDL N L T E + LK DFG+
Sbjct: 204 RTEGARLRVKT-LLQMVGDAAAGMEYLESKCCIHRDLAARNCLVT---EKNVLKISDFGM 259
Query: 303 SDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIGVIAY-ILL 348
S Y APE L + Y +E+D+WS G++ +
Sbjct: 260 SREEADGV---------YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFS 310
Query: 349 CGSRPFWARTESGIFRAVLK 368
G+ P+ + V K
Sbjct: 311 LGASPYPNLSNQQTREFVEK 330
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 52/288 (18%), Positives = 100/288 (34%), Gaps = 72/288 (25%)
Query: 93 KPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQ-D 151
PN+A + E++ + + +G G FG K +
Sbjct: 3 APNQALLRILKETEF----------------KKIKVLGSGAFGTVYKGLWIPEGEKVKIP 46
Query: 152 VAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGH 211
VA+K + + T+ A +++ E ++ ++ +
Sbjct: 47 VAIKELREA-----------------------------TSPKANKEILDEAYVMASVD-N 76
Query: 212 KNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271
++ + + ++ +L G LLD + + VQI + +
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV--------- 322
+ +VHRDL N L + +K DFGL+ + +E Y
Sbjct: 136 RRLVHRDLAARNVLVKT---PQHVKITDFGLAKLLGAEE--------KEYHAEGGKVPIK 184
Query: 323 --APEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPFWARTESGIFRAV 366
A E + HR Y ++D+WS GV + ++ GS+P+ S I +
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 58/248 (23%), Positives = 100/248 (40%), Gaps = 49/248 (19%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
YE+ +G+G FG A + + + VA+K+I +N +
Sbjct: 55 RYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKII----------------KNKK---- 91
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRAL-----TGHKNLVQFYDAYEDDDNIYIVMELCKG 236
F+ A + EV++L + +V + +++ +V E+
Sbjct: 92 -----AFLNQA------QIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY 140
Query: 237 G--ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ--GVVHRDLKPENFLFTSKEEN 292
+LL RG S + Q+ + + F ++H DLKPEN L + +
Sbjct: 141 NLYDLLRNTNFRG--VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKR 197
Query: 293 SSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCGS 351
S++K +DFG S + +R+ + S +Y +PEV L Y DMWS+G I + G
Sbjct: 198 SAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
Query: 352 RPFWARTE 359
F E
Sbjct: 256 PLFSGANE 263
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 8/27 (29%), Positives = 14/27 (51%)
Query: 386 IDFVKRLLNKDYRKRLTAAQALSHPWL 412
D + R+L+ D + R+ AL H +
Sbjct: 350 KDLILRMLDYDPKTRIQPYYALQHSFF 376
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-23
Identities = 60/258 (23%), Positives = 96/258 (37%), Gaps = 52/258 (20%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
L E++G G FG + S K VAVK + K +
Sbjct: 21 RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCL--------------KPDV-------- 58
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
++ A++D REV + +L H+NL++ Y + +V EL G LLDR+
Sbjct: 59 -----LSQPEAMDDFIREVNAMHSLD-HRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRL 111
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
G + VQ+ + + + +HRDL N L + +K DFGL
Sbjct: 112 RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLAT---RDLVKIGDFGLM 168
Query: 304 DYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILLCG 350
+ ++ Y + APE L R++ +D W GV + + G
Sbjct: 169 RALPQND-------DHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYG 221
Query: 351 SRPFWARTESGIFRAVLK 368
P+ S I + K
Sbjct: 222 QEPWIGLNGSQILHKIDK 239
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 2e-22
Identities = 55/250 (22%), Positives = 92/250 (36%), Gaps = 43/250 (17%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
+ ++G G +G KK VAVK + K
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTL--------------KE---------- 255
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
+ +E+ +E +++ + H NLVQ + YI+ E G LLD +
Sbjct: 256 -------DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307
Query: 244 LSRGGKYSEEDAKIVM-VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ + M QI S + + + +HR+L N L EN +K DFGL
Sbjct: 308 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGL 364
Query: 303 SDYVKPDERLNDIVGSAYY--VAPEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPFWART 358
S + D APE L + + ++D+W+ GV+ + I G P+
Sbjct: 365 SRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 424
Query: 359 ESGIFRAVLK 368
S ++ + K
Sbjct: 425 LSQVYELLEK 434
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 2e-22
Identities = 58/257 (22%), Positives = 100/257 (38%), Gaps = 63/257 (24%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQ-DVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+E+G G FG G + VA+K I +
Sbjct: 11 TFVQEIGSGQFGLVH-----LGYWLNKDKVAIKTIRE----------------------- 42
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
A++ ED E +++ L+ H LVQ Y + I +V E + G L D
Sbjct: 43 --------GAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY 93
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ ++ G ++ E + + + +A+ V+HRDL N L EN +K DFG+
Sbjct: 94 LRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGM 150
Query: 303 SDYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILLC 349
+ +V D+ Y +PEV Y +++D+WS GV+ + +
Sbjct: 151 TRFVLDDQ---------YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSE 201
Query: 350 GSRPFWARTESGIFRAV 366
G P+ R+ S + +
Sbjct: 202 GKIPYENRSNSEVVEDI 218
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 95.3 bits (238), Expect = 3e-22
Identities = 62/256 (24%), Positives = 100/256 (39%), Gaps = 63/256 (24%)
Query: 125 LGEEVGRGHFGYTCSAKAKKGSLKGQ-DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
L +E+G G FG G KGQ DVAVK+I +
Sbjct: 12 LLKELGSGQFGVVK-----LGKWKGQYDVAVKMIKE------------------------ 42
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
+++ ++ +E + + L+ H LV+FY + IYIV E G LL+ +
Sbjct: 43 -------GSMSEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYL 94
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
S G + + +AF +HRDL N L + +K DFG++
Sbjct: 95 RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMT 151
Query: 304 DYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILLCG 350
YV D+ Y APEV + Y +++D+W+ G++ + + G
Sbjct: 152 RYVLDDQ---------YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202
Query: 351 SRPFWARTESGIFRAV 366
P+ T S + V
Sbjct: 203 KMPYDLYTNSEVVLKV 218
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 60/253 (23%), Positives = 95/253 (37%), Gaps = 55/253 (21%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
+L + +G+G FG G +G VAVK I K++
Sbjct: 196 KLLQTIGKGEFGDVM-----LGDYRGNKVAVKCI--------------KNDATA------ 230
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA-YEDDDNIYIVMELCKGGELLDR 242
+ E ++ L H NLVQ E+ +YIV E G L+D
Sbjct: 231 ------------QAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 277
Query: 243 ILSRGGKYSEEDAKIVM-VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ SRG D + + + + + VHRDL N L + E++ K DFG
Sbjct: 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFG 334
Query: 302 LS-DYVKPDERLNDIVGSAYYV---APEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPFW 355
L+ + + V APE L + + T++D+WS G++ + I G P+
Sbjct: 335 LTKEASSTQD------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388
Query: 356 ARTESGIFRAVLK 368
+ V K
Sbjct: 389 RIPLKDVVPRVEK 401
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 5e-22
Identities = 53/256 (20%), Positives = 93/256 (36%), Gaps = 53/256 (20%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
+ + +G G G C + + + VA+K L+ + + F
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA---------LKAGYTERQRRDF----- 97
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
E I+ H N+++ IV E + G L +
Sbjct: 98 ---------------LSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL 141
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
+ G+++ ++ + + + + G VHRDL N L N K DFGLS
Sbjct: 142 RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLS 198
Query: 304 DYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILLCG 350
++ D A Y APE + R++ + +D+WS GV+ + +L G
Sbjct: 199 RVLEDDP-------DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYG 251
Query: 351 SRPFWARTESGIFRAV 366
RP+W T + +V
Sbjct: 252 ERPYWNMTNRDVISSV 267
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 62/323 (19%), Positives = 104/323 (32%), Gaps = 107/323 (33%)
Query: 196 EDVRREVKILRALT-------GHKNLVQFYDAYE----DDDNIYIVMELCKGGELLD-RI 243
E E+++L+++ + +VQ D ++ + +I +V E+ G LL I
Sbjct: 78 ETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWII 136
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVHRDLKPENFLFTSKE------------ 290
S K ++ Q+L + + H + ++H D+KPEN L + E
Sbjct: 137 KSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 291 ----------------------------------ENSSLKAIDFGLSDYVKPDERLNDIV 316
E +K D G + + + +
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDI 254
Query: 317 GSAYYVAPEV-LHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR---------AV 366
+ Y + EV + Y T AD+WS +A+ L G F + R +
Sbjct: 255 QTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314
Query: 367 LKADPS------------FDE----------APWPSLS-------------PEAIDFVKR 391
L P F + PW DF+
Sbjct: 315 LGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLP 374
Query: 392 LLNKDYRKRLTAAQALSHPWLAN 414
+L KR TAA+ L HPWL +
Sbjct: 375 MLELIPEKRATAAECLRHPWLNS 397
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 7e-22
Identities = 53/290 (18%), Positives = 100/290 (34%), Gaps = 72/290 (24%)
Query: 93 KPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQ-D 151
PN+A + E++ + + +G G FG K +
Sbjct: 3 APNQALLRILKETEF----------------KKIKVLGSGAFGTVYKGLWIPEGEKVKIP 46
Query: 152 VAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGH 211
VA+K + + T+ A +++ E ++ ++ +
Sbjct: 47 VAIKELREA-----------------------------TSPKANKEILDEAYVMASVD-N 76
Query: 212 KNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271
++ + + ++ +L G LLD + + VQI + +
Sbjct: 77 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV--------- 322
+ +VHRDL N L +K DFGL+ + +E Y
Sbjct: 136 RRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEE--------KEYHAEGGKVPIK 184
Query: 323 --APEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 368
A E + HR Y ++D+WS GV + ++ GS+P+ S I + K
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 8e-22
Identities = 57/259 (22%), Positives = 99/259 (38%), Gaps = 63/259 (24%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQ-DVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+E+G G FG G +GQ DVA+K+I +
Sbjct: 27 TFLKELGTGQFGVVK-----YGKWRGQYDVAIKMIKE----------------------- 58
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+++ ++ E K++ L+ H+ LVQ Y I+I+ E G LL+
Sbjct: 59 --------GSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ ++ + + + + + + +HRDL N L + +K DFGL
Sbjct: 110 LREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGL 166
Query: 303 SDYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILLC 349
S YV DE Y PEVL + + +++D+W+ GV+ + I
Sbjct: 167 SRYVLDDE---------YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 217
Query: 350 GSRPFWARTESGIFRAVLK 368
G P+ T S + +
Sbjct: 218 GKMPYERFTNSETAEHIAQ 236
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 57/255 (22%), Positives = 96/255 (37%), Gaps = 53/255 (20%)
Query: 125 LGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEY 184
+ + VG G FG CS + K S K VA+K L+V + + F
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT---------LKVGYTEKQRRDFL----- 94
Query: 185 CCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRIL 244
E I+ H N+++ + IV E + G L +
Sbjct: 95 ---------------GEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 245 SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSD 304
+++ ++ I S + + G VHRDL N L N K DFGL
Sbjct: 139 KHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGR 195
Query: 305 YVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILLCGS 351
++ D A Y +PE + +R + + +D+WS G++ + ++ G
Sbjct: 196 VLEDDP-------EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE 248
Query: 352 RPFWARTESGIFRAV 366
RP+W + + +AV
Sbjct: 249 RPYWEMSNQDVIKAV 263
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-21
Identities = 47/261 (18%), Positives = 78/261 (29%), Gaps = 58/261 (22%)
Query: 124 ELGEEVGRGHFGYTCSAKAK----KGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
E +G+G F + G L +V +KV+ K
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-------------------- 50
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
E ++ L+ HK+LV Y D +V E K G L
Sbjct: 51 ----------AHRNYSESFFEAASMMSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSL 99
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKE-----ENSS 294
+ + V Q+ + + F ++H ++ +N L +E
Sbjct: 100 DTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYY------VAPEVLH--RSYGTEADMWSIGVIAY- 345
+K D G+S V P + V PE + ++ D WS G +
Sbjct: 160 IKLSDPGISITVLPKD---------ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWE 210
Query: 346 ILLCGSRPFWARTESGIFRAV 366
I G +P A +
Sbjct: 211 ICSGGDKPLSALDSQRKLQFY 231
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 2e-21
Identities = 58/259 (22%), Positives = 95/259 (36%), Gaps = 61/259 (23%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
+ ++G G +G KK SL VAVK + +
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLT---VAVKTLKE------------------------ 48
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
+ +E+ +E +++ + H NLVQ + YI+ E G LLD +
Sbjct: 49 -------DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100
Query: 244 LSRGGKYSEEDAKIVM-VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ + M QI S + + + +HRDL N L EN +K DFGL
Sbjct: 101 RECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGL 157
Query: 303 SDYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILLC 349
S + D Y APE L + + ++D+W+ GV+ + I
Sbjct: 158 SRLMTGDT---------YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 208
Query: 350 GSRPFWARTESGIFRAVLK 368
G P+ S ++ + K
Sbjct: 209 GMSPYPGIDLSQVYELLEK 227
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 55/256 (21%), Positives = 92/256 (35%), Gaps = 56/256 (21%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
ELG +G G FG VA+K + +F
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT---------CKNCTSDSVREKFL---- 64
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
+E +R H ++V+ ++ ++I+MELC GEL +
Sbjct: 65 ----------------QEALTMRQFD-HPHIVKLI-GVITENPVWIIMELCTLGELRSFL 106
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
R + Q+ + +A+ + VHRD+ N L + N +K DFGLS
Sbjct: 107 QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLS 163
Query: 304 DYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILLCG 350
Y++ YY APE + R + + +D+W GV + IL+ G
Sbjct: 164 RYMEDST---------YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHG 214
Query: 351 SRPFWARTESGIFRAV 366
+PF + + +
Sbjct: 215 VKPFQGVKNNDVIGRI 230
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-21
Identities = 61/292 (20%), Positives = 100/292 (34%), Gaps = 72/292 (24%)
Query: 124 ELGEEVGRGHFGYTCSAKAKK-GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ ++G+G+FG + G G VAVK LQ P +
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ---------LQHSGPDQQ-------- 68
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD--AYEDDDNIYIVMELCKGGELL 240
D +RE++IL+AL +V++ ++ +VME G L
Sbjct: 69 -------------RDFQREIQILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLR 114
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
D + + + QI + + + VHRDL N L E + +K DF
Sbjct: 115 DFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV---ESEAHVKIADF 171
Query: 301 GLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIGVIAY-I 346
GL+ + D+ YYV APE L + ++D+WS GV+ Y +
Sbjct: 172 GLAKLLPLDK--------DYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYEL 223
Query: 347 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYR 398
+ E + P+ + LL + R
Sbjct: 224 FTYCDKSCSPSAEFLRMMGCERDVPALSR-------------LLELLEEGQR 262
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 8e-21
Identities = 55/256 (21%), Positives = 85/256 (33%), Gaps = 56/256 (21%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
L +G G FG + +VAVK K
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD----------------------- 51
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
T E E I++ L H ++V+ +++ +I+MEL GEL +
Sbjct: 52 ------CTLDNKEKFMSEAVIMKNLD-HPHIVKLI-GIIEEEPTWIIMELYPYGELGHYL 103
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
+ +QI +A+ VHRD+ N L +K DFGLS
Sbjct: 104 ERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLS 160
Query: 304 DYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILLCG 350
R I YY +PE + R + T +D+W V + IL G
Sbjct: 161 -------R--YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFG 211
Query: 351 SRPFWARTESGIFRAV 366
+PF+ + +
Sbjct: 212 KQPFFWLENKDVIGVL 227
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 9e-21
Identities = 58/251 (23%), Positives = 92/251 (36%), Gaps = 55/251 (21%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
+L + +G+G FG G +G VAVK I +
Sbjct: 24 KLLQTIGKGEFGDVM-----LGDYRGNKVAVKCI---------------KNDAT------ 57
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA-YEDDDNIYIVMELCKGGELLDR 242
+ E ++ L H NLVQ E+ +YIV E G L+D
Sbjct: 58 -----------AQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 105
Query: 243 ILSRGGKYSEEDAKIVM-VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ SRG D + + + + + VHRDL N L + E++ K DFG
Sbjct: 106 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFG 162
Query: 302 LS-DYVKPDERLNDIVGSAYYV---APEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPFW 355
L+ + + V APE L + + T++D+WS G++ + I G P+
Sbjct: 163 LTKEASSTQD------TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216
Query: 356 ARTESGIFRAV 366
+ V
Sbjct: 217 RIPLKDVVPRV 227
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-20
Identities = 61/290 (21%), Positives = 96/290 (33%), Gaps = 83/290 (28%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+L E +GRG +G Y KGSL + VAVKV F
Sbjct: 16 KLLELIGRGRYGAVY-------KGSLDERPVAVKVFSF-------------ANRQNF--- 52
Query: 182 DEYCCLFMTTAIAIEDVRREVKILR-ALTGHKNLVQFYDA-----YEDDDNIYIVMELCK 235
E I R L H N+ +F + +VME
Sbjct: 53 -----------------INEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP 95
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ---------GVVHRDLKPENFLF 286
G L + + + + +A+ H + + HRDL N L
Sbjct: 96 NGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV 153
Query: 287 TSKEENSSLKAIDFGLS---------DYVKPDERLNDIVGSAYYVAPEVL--------HR 329
+ + DFGLS + D VG+ Y+APEVL
Sbjct: 154 K---NDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXE 210
Query: 330 SYGTEADMWSIGVIAYILL---CGSRPFWARTESGI-FRAVLKADPSFDE 375
S + DM+++G+I + + P + E + F+ + P+F++
Sbjct: 211 SALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFED 260
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 53/256 (20%), Positives = 95/256 (37%), Gaps = 54/256 (21%)
Query: 125 LGEEVGRGHFGYTCSAKAKKGSLKGQ-DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
+ +G G FG K S K + VA+K L+ + + F
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT---------LKAGYTEKQRVDFL---- 94
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
E I+ + H N+++ + I+ E + G L +
Sbjct: 95 ----------------GEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
+ G++S ++ I + + + VHRDL N L N K DFGLS
Sbjct: 138 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLS 194
Query: 304 DYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILLCG 350
++ D A Y APE + +R + + +D+WS G++ + ++ G
Sbjct: 195 RVLEDDP-------EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYG 247
Query: 351 SRPFWARTESGIFRAV 366
RP+W + + +A+
Sbjct: 248 ERPYWELSNHEVMKAI 263
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 46/259 (17%), Positives = 88/259 (33%), Gaps = 56/259 (21%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQ-DVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ +G G FG + V +KVI
Sbjct: 16 RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK---------------------- 53
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ + + V + + +L H ++V+ ++ +V + G LLD
Sbjct: 54 -------SGRQSFQAVTDHMLAIGSLD-HAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDH 104
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ G + VQI + + G+VHR+L N L S ++ DFG+
Sbjct: 105 VRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGV 161
Query: 303 SDYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILLC 349
+D + PD+ + A E + Y ++D+WS GV + ++
Sbjct: 162 ADLLPPDD--------KQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF 213
Query: 350 GSRPFWARTESGIFRAVLK 368
G+ P+ + + + K
Sbjct: 214 GAEPYAGLRLAEVPDLLEK 232
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 93.0 bits (231), Expect = 2e-20
Identities = 68/328 (20%), Positives = 114/328 (34%), Gaps = 64/328 (19%)
Query: 60 VNSTPLRFFKRPFPPPSPAKH-IRSLLARRHGSVKPNEASIPEGNESDIGLDKNFGFSKQ 118
VN F RP A I L V+ + S+ E ++ +D+ ++
Sbjct: 321 VNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMP 380
Query: 119 FVAHYE-------LGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCP 171
YE LG +G G FG VA+K +
Sbjct: 381 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKT---------CKNCTS 431
Query: 172 KHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVM 231
+F +E +R H ++V+ ++ ++I+M
Sbjct: 432 DSVREKFL--------------------QEALTMRQFD-HPHIVKLI-GVITENPVWIIM 469
Query: 232 ELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEE 291
ELC GEL + R + Q+ + +A+ + VHRD+ N L +
Sbjct: 470 ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVS---S 526
Query: 292 NSSLKAIDFGLSDYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWS 339
N +K DFGLS Y++ YY APE + R + + +D+W
Sbjct: 527 NDCVKLGDFGLSRYMEDST---------YYKASKGKLPIKWMAPESINFRRFTSASDVWM 577
Query: 340 IGVIAY-ILLCGSRPFWARTESGIFRAV 366
GV + IL+ G +PF + + +
Sbjct: 578 FGVCMWEILMHGVKPFQGVKNNDVIGRI 605
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 57/301 (18%), Positives = 103/301 (34%), Gaps = 67/301 (22%)
Query: 100 PEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPK 159
+ G+D +L E RG FG K L + VAVK+ P
Sbjct: 3 HHHHHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVW-----KAQLLNEYVAVKIFPI 57
Query: 160 MIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD 219
+ + EV L + H+N++QF
Sbjct: 58 -------------QDKQSW------------------QNEYEVYSLPGMK-HENILQFIG 85
Query: 220 AYEDDDNI----YIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ--- 272
A + ++ +++ + G L D + + S + + + +A+ H
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFL--KANVVSWNELCHIAETMARGLAYLHEDIPG 143
Query: 273 -------GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDI---VGSAYYV 322
+ HRD+K +N L + N + DFGL+ + + D VG+ Y+
Sbjct: 144 LKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM 200
Query: 323 APEVL------HRSYGTEADMWSIGVIAYILLCGSRPFWARTESGI--FRAVLKADPSFD 374
APEVL R DM+++G++ + L + + F + PS +
Sbjct: 201 APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLE 260
Query: 375 E 375
+
Sbjct: 261 D 261
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 4e-20
Identities = 62/260 (23%), Positives = 98/260 (37%), Gaps = 65/260 (25%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQ-DVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
L ++G+G FG G+ G VA+K +
Sbjct: 187 RLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKP----------------------- 218
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
++ E +E ++++ L H+ LVQ Y A ++ IYIV E G LLD
Sbjct: 219 --------GTMSPEAFLQEAQVMKKLR-HEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDF 268
Query: 243 ILSRGGKYSEEDAKIVM-VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ GKY + M QI S +A+ VHRDL+ N L EN K DFG
Sbjct: 269 LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFG 325
Query: 302 LSDYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILL 348
L+ ++ +E Y APE + + ++D+WS G++ +
Sbjct: 326 LARLIEDNE---------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 376
Query: 349 CGSRPFWARTESGIFRAVLK 368
G P+ + V +
Sbjct: 377 KGRVPYPGMVNREVLDQVER 396
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-20
Identities = 56/287 (19%), Positives = 99/287 (34%), Gaps = 71/287 (24%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+ +++G+G+FG C + + G+ VAVK LQ +H
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKK---------LQHSTEEH-------- 54
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA--YEDDDNIYIVMELCKGGEL 239
+ D RE++IL++L H N+V++ N+ ++ME G L
Sbjct: 55 -------------LRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 100
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
D + + QI + + + +HRDL N L E + +K D
Sbjct: 101 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGD 157
Query: 300 FGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIGVIAY- 345
FGL+ + D+ ++ APE L + +D+WS GV+ Y
Sbjct: 158 FGLTKVLPQDK--------EFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 209
Query: 346 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS-PEAIDFVKR 391
+ + E + I+ +K
Sbjct: 210 LFTYIEKSKSPPAEFMRMIG---------NDKQGQMIVFHLIELLKN 247
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 5e-20
Identities = 57/260 (21%), Positives = 98/260 (37%), Gaps = 65/260 (25%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQ-DVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+L +++G G FG + VAVK +
Sbjct: 191 KLEKKLGAGQFGEVW-----MATYNKHTKVAVKTMKP----------------------- 222
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
++++E E +++ L H LV+ + A + IYI+ E G LLD
Sbjct: 223 --------GSMSVEAFLAEANVMKTLQ-HDKLVKLH-AVVTKEPIYIITEFMAKGSLLDF 272
Query: 243 ILSRGGKYSEEDAKIVM-VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ S G I QI +AF + +HRDL+ N L + + K DFG
Sbjct: 273 LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFG 329
Query: 302 LSDYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILL 348
L+ ++ +E Y APE + S+ ++D+WS G++ I+
Sbjct: 330 LARVIEDNE---------YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
Query: 349 CGSRPFWARTESGIFRAVLK 368
G P+ + + RA+ +
Sbjct: 381 YGRIPYPGMSNPEVIRALER 400
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 58/287 (20%), Positives = 99/287 (34%), Gaps = 71/287 (24%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+ +++G+G+FG C + + G+ VAVK LQ +H
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDN-TGEVVAVKK---------LQHSTEEH-------- 85
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA--YEDDDNIYIVMELCKGGEL 239
+ D RE++IL++L H N+V++ N+ ++ME G L
Sbjct: 86 -------------LRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSL 131
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
D + + QI + + + +HRDL N L E + +K D
Sbjct: 132 RDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV---ENENRVKIGD 188
Query: 300 FGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIGVIAY- 345
FGL+ + D+ YY APE L + +D+WS GV+ Y
Sbjct: 189 FGLTKVLPQDK--------EYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYE 240
Query: 346 ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS-PEAIDFVKR 391
+ + E + I+ +K
Sbjct: 241 LFTYIEKSKSPPAEFMRMIG---------NDKQGQMIVFHLIELLKN 278
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 7e-20
Identities = 56/286 (19%), Positives = 98/286 (34%), Gaps = 69/286 (24%)
Query: 124 ELGEEVGRGHFGYTCSAKAK-KGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ ++G GHFG + +G G+ VAVK L+ +
Sbjct: 24 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS---------LKPESGGNHIADL---- 70
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA--YEDDDNIYIVMELCKGGELL 240
++E++ILR L H+N+V++ + + I ++ME G L
Sbjct: 71 ----------------KKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLK 113
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
+ + K + + VQI + + + VHRDL N L E +K DF
Sbjct: 114 EYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV---ESEHQVKIGDF 170
Query: 301 GLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIGVIAY-I 346
GL+ ++ D+ YY APE L + +D+WS GV + +
Sbjct: 171 GLTKAIETDK--------EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222
Query: 347 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS-PEAIDFVKR 391
L ++ ++ +K
Sbjct: 223 LTYCDSDSSPMALF----------LKMIGPTHGQMTVTRLVNTLKE 258
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 7e-20
Identities = 57/260 (21%), Positives = 103/260 (39%), Gaps = 65/260 (25%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQ-DVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+L E +G G FG G G VAVK + +
Sbjct: 16 KLVERLGAGQFGEVW-----MGYYNGHTKVAVKSLKQ----------------------- 47
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+++ + E +++ L H+ LV+ Y A + IYI+ E + G L+D
Sbjct: 48 --------GSMSPDAFLAEANLMKQLQ-HQRLVRLY-AVVTQEPIYIITEYMENGSLVDF 97
Query: 243 ILSRGGKYSEEDAKIVM-VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ + G + + M QI +AF + +HRDL+ N L + + S K DFG
Sbjct: 98 LKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFG 154
Query: 302 LSDYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILL 348
L+ ++ +E Y APE + + ++ ++D+WS G++ I+
Sbjct: 155 LARLIEDNE---------YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
Query: 349 CGSRPFWARTESGIFRAVLK 368
G P+ T + + + +
Sbjct: 206 HGRIPYPGMTNPEVIQNLER 225
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 52/248 (20%), Positives = 98/248 (39%), Gaps = 54/248 (21%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
++ +G+++G G+FG K + VA+K+ P K Q
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPM------------KSRAPQL--- 51
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
E + + L + Q Y +V+EL G L D
Sbjct: 52 -----------------HLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLED 93
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF--TSKEENSSLKAID 299
+S + ++ +Q++S + + H + +++RD+KPENFL + + ID
Sbjct: 94 LFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIID 153
Query: 300 FGLS-DYVKPDERL-------NDIVGSAYYVAPEVLHRSYGTEA----DMWSIGVIAYIL 347
F L+ +Y+ P+ + + G+A Y++ ++ G E D+ ++G +
Sbjct: 154 FALAKEYIDPETKKHIPYREHKSLTGTARYMS---INTHLGKEQSRRDDLEALGHMFMYF 210
Query: 348 LCGSRPFW 355
L GS P W
Sbjct: 211 LRGSLP-W 217
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-19
Identities = 52/262 (19%), Positives = 94/262 (35%), Gaps = 59/262 (22%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
E +GRGHFG K AVK + ++
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------------------- 64
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA-YEDDDNIYIVMELCKGGELLDR 242
T + E I++ + H N++ + + +V+ K G+L +
Sbjct: 65 ------TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 117
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
I + + +D +Q+ + + + VHRDL N + E ++K DFGL
Sbjct: 118 IRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLD---EKFTVKVADFGL 174
Query: 303 SDYVKPDERLNDIVGSAYYV--------------APEVLH-RSYGTEADMWSIGVIAY-I 346
+ R D+ YY A E L + + T++D+WS GV+ + +
Sbjct: 175 A-------R--DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 225
Query: 347 LLCGSRPFWARTESGIFRAVLK 368
+ G+ P+ I +L+
Sbjct: 226 MTRGAPPYPDVNTFDITVYLLQ 247
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 3e-19
Identities = 53/257 (20%), Positives = 95/257 (36%), Gaps = 65/257 (25%)
Query: 128 EVGRGHFGYTCSAKAKKGSLKGQ----DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
E+G G+FG +G + + DVA+KV L+ K + +
Sbjct: 17 ELGCGNFGSVR-----QGVYRMRKKQIDVAIKV---------LKQGTEKADTEEMM---- 58
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
RE +I+ L + +V+ + + +VME+ GG L +
Sbjct: 59 ----------------REAQIMHQLD-NPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFL 100
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
+ + + + ++ Q+ + + + VHRDL N L K DFGLS
Sbjct: 101 VGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLS 157
Query: 304 DYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIGVIAY-ILLC 349
+ D+ +YY APE + R + + +D+WS GV + L
Sbjct: 158 KALGADD--------SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSY 209
Query: 350 GSRPFWARTESGIFRAV 366
G +P+ + +
Sbjct: 210 GQKPYKKMKGPEVMAFI 226
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 3e-19
Identities = 55/266 (20%), Positives = 92/266 (34%), Gaps = 63/266 (23%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
L +G G FG Y VAVK +P++
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--------------------- 71
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ D E I+ H+N+V+ +I+MEL GG+L
Sbjct: 72 --------CSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKS 122
Query: 242 RILSRGGKYSEEDAKIVMVQILSV---VAF-CHF---QGVVHRDLKPENFLFTSKEENSS 294
+ + + + + M+ +L V +A C + +HRD+ N L T
Sbjct: 123 FLRETRPR-PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIG 341
K DFG++ R DI ++YY PE + ++ D WS G
Sbjct: 182 AKIGDFGMA-------R--DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232
Query: 342 VIAY-ILLCGSRPFWARTESGIFRAV 366
V+ + I G P+ +++ + V
Sbjct: 233 VLLWEIFSLGYMPYPSKSNQEVLEFV 258
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 4e-19
Identities = 62/260 (23%), Positives = 98/260 (37%), Gaps = 65/260 (25%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQ-DVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
L ++G+G FG G+ G VA+K +
Sbjct: 270 RLEVKLGQGCFGEVW-----MGTWNGTTRVAIKTLKP----------------------- 301
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
++ E +E ++++ L H+ LVQ Y A ++ IYIV E G LLD
Sbjct: 302 --------GTMSPEAFLQEAQVMKKLR-HEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDF 351
Query: 243 ILSRGGKYSEEDAKIVM-VQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ GKY + M QI S +A+ VHRDL+ N L EN K DFG
Sbjct: 352 LKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFG 408
Query: 302 LSDYVKPDERLNDIVGSAYYV-----------APEVL-HRSYGTEADMWSIGVIAY-ILL 348
L+ ++ +E Y APE + + ++D+WS G++ +
Sbjct: 409 LARLIEDNE---------YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTT 459
Query: 349 CGSRPFWARTESGIFRAVLK 368
G P+ + V +
Sbjct: 460 KGRVPYPGMVNREVLDQVER 479
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 61/271 (22%), Positives = 92/271 (33%), Gaps = 74/271 (27%)
Query: 125 LGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEY 184
+ +G G+FG A+ KK L+ D A+K + +
Sbjct: 29 FQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRMKEY------------------------ 63
Query: 185 CCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD--R 242
+ D E+++L L H N++ A E +Y+ +E G LLD R
Sbjct: 64 -----ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 118
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHF-------------QGVVHRDLKPENFLFTSK 289
LS HF + +HRDL N L
Sbjct: 119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-- 176
Query: 290 EENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEAD 336
EN K DFGLS R + YV A E L + Y T +D
Sbjct: 177 -ENYVAKIADFGLS-------RGQE-----VYVKKTMGRLPVRWMAIESLNYSVYTTNSD 223
Query: 337 MWSIGVIAY-ILLCGSRPFWARTESGIFRAV 366
+WS GV+ + I+ G P+ T + ++ +
Sbjct: 224 VWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-18
Identities = 54/266 (20%), Positives = 91/266 (34%), Gaps = 63/266 (23%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
L +G G FG Y VAVK +P++
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--------------------- 112
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ D E I+ H+N+V+ +I++EL GG+L
Sbjct: 113 --------CSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKS 163
Query: 242 RILSRGGKYSEEDAKIVMVQILSV---VAF-CHF---QGVVHRDLKPENFLFTSKEENSS 294
+ + + + + M+ +L V +A C + +HRD+ N L T
Sbjct: 164 FLRETRPR-PSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIG 341
K DFG++ R DI + YY PE + ++ D WS G
Sbjct: 223 AKIGDFGMA-------R--DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273
Query: 342 VIAY-ILLCGSRPFWARTESGIFRAV 366
V+ + I G P+ +++ + V
Sbjct: 274 VLLWEIFSLGYMPYPSKSNQEVLEFV 299
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 2e-18
Identities = 52/262 (19%), Positives = 96/262 (36%), Gaps = 59/262 (22%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
+G+GHFG + + A+K + ++
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI----------------------- 60
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNI-YIVMELCKGGELLDR 242
T +E RE ++R L H N++ + + ++++ G+LL
Sbjct: 61 ------TEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQF 113
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
I S + +D +Q+ + + Q VHRDL N + E+ ++K DFGL
Sbjct: 114 IRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGL 170
Query: 303 SDYVKPDERLNDIVGSAYYV--------------APEVLH-RSYGTEADMWSIGVIAY-I 346
+ R DI+ YY A E L + T++D+WS GV+ + +
Sbjct: 171 A-------R--DILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWEL 221
Query: 347 LLCGSRPFWARTESGIFRAVLK 368
L G+ P+ + + +
Sbjct: 222 LTRGAPPYRHIDPFDLTHFLAQ 243
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 2e-18
Identities = 51/262 (19%), Positives = 93/262 (35%), Gaps = 59/262 (22%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
E +GRGHFG K AVK + ++
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----------------------- 128
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA-YEDDDNIYIVMELCKGGELLDR 242
T + E I++ + H N++ + + +V+ K G+L +
Sbjct: 129 ------TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 181
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
I + + +D +Q+ + F + VHRDL N + E ++K DFGL
Sbjct: 182 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFGL 238
Query: 303 SDYVKPDERLNDIVGSAYYV--------------APEVLH-RSYGTEADMWSIGVIAY-I 346
+ R D+ + A E L + + T++D+WS GV+ + +
Sbjct: 239 A-------R--DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWEL 289
Query: 347 LLCGSRPFWARTESGIFRAVLK 368
+ G+ P+ I +L+
Sbjct: 290 MTRGAPPYPDVNTFDITVYLLQ 311
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 58/247 (23%), Positives = 98/247 (39%), Gaps = 54/247 (21%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y LG ++G G FG G++VA+K+ K ++ Q
Sbjct: 10 RYRLGRKIGSGSFGDIYLGTDIAA---GEEVAIKLECV------------KTKHPQ---- 50
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ E KI + + G + + D +VMEL G L D
Sbjct: 51 ----------------LHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLED 93
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
K+S + ++ Q++S + + H + +HRD+KP+NFL ++ + + IDFG
Sbjct: 94 LFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153
Query: 302 LS-DYVKPDERL-------NDIVGSAYYVAPEVLHRSYGTEA----DMWSIG-VIAYILL 348
L+ Y ++ G+A Y + ++ G E D+ S+G V+ Y
Sbjct: 154 LAKKYRDARTHQHIPYRENKNLTGTARYAS---INTHLGIEQSRRDDLESLGYVLMY-FN 209
Query: 349 CGSRPFW 355
GS P W
Sbjct: 210 LGSLP-W 215
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 55/259 (21%), Positives = 89/259 (34%), Gaps = 70/259 (27%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+ G+ +G G FG +A VAVK++
Sbjct: 49 QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--------------------- 87
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
A E + E+KI+ L H+N+V A + ++ E C G+LL+
Sbjct: 88 --------AHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHF-------------QGVVHRDLKPENFLFTS 288
+ + + A + S HF + +HRD+ N L T
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT- 198
Query: 289 KEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEA 335
K DFGL+ R DI+ + Y+ APE + Y ++
Sbjct: 199 --NGHVAKIGDFGLA-------R--DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 247
Query: 336 DMWSIGVIAY-ILLCGSRP 353
D+WS G++ + I G P
Sbjct: 248 DVWSYGILLWEIFSLGLNP 266
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 86.2 bits (213), Expect = 4e-18
Identities = 65/348 (18%), Positives = 119/348 (34%), Gaps = 67/348 (19%)
Query: 39 FPFYSPSPLPSLFKNSPAIPSVNSTPLRFFKRPFPPPSPAKHIRSLLARRHGSVK--PNE 96
+ S + +P +P+ ST +R S + P +
Sbjct: 252 EACPNSSASNASGAAAPTLPAHPSTLTHPQRRIDTLNSDGYTPEPARITSPDKPRPMPMD 311
Query: 97 ASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQ----DV 152
S+ E SD K+ + E+G G+FG +G + + DV
Sbjct: 312 TSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGSVR-----QGVYRMRKKQIDV 366
Query: 153 AVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHK 212
A+KV L+ K + + RE +I+ L +
Sbjct: 367 AIKV---------LKQGTEKADTEEM--------------------MREAQIMHQLD-NP 396
Query: 213 NLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272
+V+ + + +VME+ GG L ++ + + + ++ Q+ + + +
Sbjct: 397 YIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV---------- 322
VHR+L N L K DFGLS + D+ +YY
Sbjct: 456 NFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADD--------SYYTARSAGKWPLK 504
Query: 323 --APEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPFWARTESGIFRAV 366
APE + R + + +D+WS GV + L G +P+ + +
Sbjct: 505 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 552
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 6e-18
Identities = 51/256 (19%), Positives = 98/256 (38%), Gaps = 57/256 (22%)
Query: 125 LGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEY 184
+E+G G+FG + + VAVK++ K+E + + DE
Sbjct: 21 EDKELGSGNFGTVKKGYYQ-MKKVVKTVAVKIL--------------KNEANDPALKDE- 64
Query: 185 CCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRIL 244
+ E +++ L + +V+ + ++ +VME+ + G L L
Sbjct: 65 ---LL----------AEANVMQQLD-NPYIVRMI-GICEAESWMLVMEMAELGPLNKY-L 108
Query: 245 SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSD 304
+ +++ ++ Q+ + + VHRDL N L K DFGLS
Sbjct: 109 QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSK 165
Query: 305 YVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIGVIAY-ILLCG 350
++ DE YY APE + + + +++D+WS GV+ + G
Sbjct: 166 ALRADE--------NYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 217
Query: 351 SRPFWARTESGIFRAV 366
+P+ S + +
Sbjct: 218 QKPYRGMKGSEVTAML 233
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 7e-18
Identities = 58/249 (23%), Positives = 101/249 (40%), Gaps = 56/249 (22%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
HY++G +G G FG Q VA+K P+ + + Q
Sbjct: 11 HYKVGRRIGEGSFGVIFEGTNLLN---NQQVAIKFEPR------------RSDAPQ---- 51
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+R E + + L G + Y ++ + +V++L G L D
Sbjct: 52 ----------------LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLED 94
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF---TSKEENSSLKAI 298
+ G K+S + + Q+L+ V H + +V+RD+KP+NFL SK N + +
Sbjct: 95 LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN-MIYVV 153
Query: 299 DFGLS-DYVKPDERL-------NDIVGSAYYVAPEVLHRSYGTEA----DMWSIGVIAYI 346
DFG+ Y P + ++ G+A Y++ ++ G E D+ ++G +
Sbjct: 154 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS---INTHLGREQSRRDDLEALGHVFMY 210
Query: 347 LLCGSRPFW 355
L GS P W
Sbjct: 211 FLRGSLP-W 218
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 51/272 (18%), Positives = 92/272 (33%), Gaps = 70/272 (25%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
LG +G+G FG A+ K+ VAVK++ I
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI---------------------- 63
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFY------DAYEDDDNIYIVMELCKGG 237
+ IE+ RE ++ H ++ + A +++ K G
Sbjct: 64 ------IASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG 116
Query: 238 ELLDRILSRGGKYSEEDAKIVMVQILSV---VAF-CHF---QGVVHRDLKPENFLFTSKE 290
+L + + E + + ++ +A + + +HRDL N +
Sbjct: 117 DLHAFL--LASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA--- 171
Query: 291 ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVLH-RSYGTEADM 337
E+ ++ DFGLS R I YY A E L Y +D+
Sbjct: 172 EDMTVCVADFGLS-------R--KIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDV 222
Query: 338 WSIGVIAY-ILLCGSRPFWARTESGIFRAVLK 368
W+ GV + I+ G P+ + I+ ++
Sbjct: 223 WAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 57/286 (19%), Positives = 94/286 (32%), Gaps = 71/286 (24%)
Query: 124 ELGEEVGRGHFGYTCSAKAK-KGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ ++G GHFG G+ VAVK L+ +
Sbjct: 34 KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA---------LKADAGPQHRSGW---- 80
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN--IYIVMELCKGGELL 240
++E+ ILR L H++++++ ED + +VME G L
Sbjct: 81 ----------------KQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR 123
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
D + + QI +A+ H Q +HRDL N L + + +K DF
Sbjct: 124 DYL--PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL---DNDRLVKIGDF 178
Query: 301 GLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIGVIAY-I 346
GL+ V YY APE L + +D+WS GV Y +
Sbjct: 179 GLAKAVPEGHE--------YYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYEL 230
Query: 347 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLS-PEAIDFVKR 391
L T+ + ++ + ++R
Sbjct: 231 LTHCDSSQSPPTKFLELIGI----------AQGQMTVLRLTELLER 266
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 50/266 (18%), Positives = 84/266 (31%), Gaps = 73/266 (27%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
EE+G FG Y + Q VA+K +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK--------------------- 50
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
E+ R E + L H N+V D + ++ C G+L +
Sbjct: 51 --------AEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHE 101
Query: 242 --RILSRGGKYSEEDAKIVMVQILSVVAFCHF-------------QGVVHRDLKPENFLF 286
+ S D + L F H VVH+DL N L
Sbjct: 102 FLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 161
Query: 287 TSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APE-VLHRSYGT 333
+ ++K D GL R ++ + YY APE +++ +
Sbjct: 162 Y---DKLNVKISDLGLF-------R--EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSI 209
Query: 334 EADMWSIGVIAY-ILLCGSRPFWART 358
++D+WS GV+ + + G +P+ +
Sbjct: 210 DSDIWSYGVVLWEVFSYGLQPYCGYS 235
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 57/246 (23%), Positives = 94/246 (38%), Gaps = 52/246 (21%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+ LG ++G G FG + ++VA+K+ K ++ Q
Sbjct: 8 KFRLGRKIGSGSFGEIYLGTNIQT---NEEVAIKLENV------------KTKHPQ---- 48
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ E KI R L G + + D +VM+L G L D
Sbjct: 49 ----------------LLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLED 91
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
K S + ++ Q+++ V F H + +HRD+KP+NFL + + IDFG
Sbjct: 92 LFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFG 151
Query: 302 LS-DYVKPDERL-------NDIVGSAYYVAPEVLHRSYGTEA----DMWSIGVIAYILLC 349
L+ Y ++ G+A Y + ++ G E D+ S+G + L
Sbjct: 152 LAKKYRDTSTHQHIPYRENKNLTGTARYAS---VNTHLGIEQSRRDDLESLGYVLMYFLR 208
Query: 350 GSRPFW 355
GS P W
Sbjct: 209 GSLP-W 213
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 50/271 (18%), Positives = 94/271 (34%), Gaps = 69/271 (25%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
LG+ +G G FG K+ VAVK + K +N
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM--------------KLDN-------- 74
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFY-----DAYEDDDNIYIVMELCKGGE 238
++ IE+ E ++ + H N+++ + + +++ K G+
Sbjct: 75 ------SSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGD 127
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSV---VAF-CHF---QGVVHRDLKPENFLFTSKEE 291
L + + I + +L +A + + +HRDL N + +
Sbjct: 128 LHTYL--LYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR---D 182
Query: 292 NSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMW 338
+ ++ DFGLS + I YY A E L R Y +++D+W
Sbjct: 183 DMTVCVADFGLS-------K--KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 233
Query: 339 SIGVIAY-ILLCGSRPFWARTESGIFRAVLK 368
+ GV + I G P+ ++ +L
Sbjct: 234 AFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 58/263 (22%), Positives = 90/263 (34%), Gaps = 74/263 (28%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
G+ +G G FG +A S VAVK++
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--------------------- 64
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
E + E+K+L L H N+V A ++ E C G+LL+
Sbjct: 65 --------AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116
Query: 242 ----------RILSRGGKYSEEDAKIVMVQILSV-------VAFCHFQGVVHRDLKPENF 284
+ +++ + + +LS +AF + +HRDL N
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176
Query: 285 LFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSY 331
L T K DFGL+ R DI + YV APE + + Y
Sbjct: 177 LLT---HGRITKICDFGLA-------R--DIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224
Query: 332 GTEADMWSIGVIAY-ILLCGSRP 353
E+D+WS G+ + + GS P
Sbjct: 225 TFESDVWSYGIFLWELFSLGSSP 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 2e-16
Identities = 58/264 (21%), Positives = 95/264 (35%), Gaps = 73/264 (27%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+LG+ +GRG FG A + + VAVK++ +
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--------------------- 68
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA-YEDDDNIYIVMELCKGGELL 240
T + E+KIL + H N+V A + + +++E CK G L
Sbjct: 69 --------ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120
Query: 241 D--RILSRGGKYSEEDAKIVMVQILSVVAFCHF-------------QGVVHRDLKPENFL 285
R + + + L++ + + +HRDL N L
Sbjct: 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 180
Query: 286 FTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYG 332
+ E + +K DFGL+ R DI YV APE + R Y
Sbjct: 181 LS---EKNVVKICDFGLA-------R--DIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 228
Query: 333 TEADMWSIGVIAY-ILLCGSRPFW 355
++D+WS GV+ + I G+ P+
Sbjct: 229 IQSDVWSFGVLLWEIFSLGASPYP 252
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-16
Identities = 50/270 (18%), Positives = 93/270 (34%), Gaps = 67/270 (24%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+ E+G+G FG Y AK VA+K + +
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--------------------- 66
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ + E +++ ++V+ ++MEL G+L
Sbjct: 67 --------ASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117
Query: 242 RILSRGGKYSEEDAKI---------VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEEN 292
+ S + + +I +A+ + VHRDL N + E+
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---ED 174
Query: 293 SSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWS 339
++K DFG++ R DI + YY +PE L + T +D+WS
Sbjct: 175 FTVKIGDFGMT-------R--DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 225
Query: 340 IGVIAY-ILLCGSRPFWARTESGIFRAVLK 368
GV+ + I +P+ + + R V++
Sbjct: 226 FGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 66/288 (22%), Positives = 102/288 (35%), Gaps = 79/288 (27%)
Query: 87 RRHGSVKPNEASIPEGNESDIGLDKNFGFSKQFVAHYELGEEVGRGHFG--YTCSAK--A 142
H S P A + E ++ D + F + + LG+ +G G FG A
Sbjct: 7 HHHHSQDPMLAGVSE---YELPEDPKWEFPRDKL---TLGKPLGEGAFGQVVMAEAVGID 60
Query: 143 KKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202
K + VAVK++ T + D+ E+
Sbjct: 61 KDKPKEAVTVAVKMLKDD-----------------------------ATEKDLSDLVSEM 91
Query: 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD--RILSRGGKYSEEDAKIVMV 260
++++ + HKN++ A D +Y+++E G L + R G D V
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 261 QILSVVAFCHF-------------QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK 307
+ ++ Q +HRDL N L T EN+ +K DFGL+
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLA---- 204
Query: 308 PDERLNDIVGSAYYV------------APEVL-HRSYGTEADMWSIGV 342
R DI YY APE L R Y ++D+WS GV
Sbjct: 205 ---R--DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 60/276 (21%), Positives = 98/276 (35%), Gaps = 74/276 (26%)
Query: 124 ELGEEVGRGHFG--YTCSAK--AKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
LG+ +G G FG A K + VAVK++
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD------------------- 112
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
T + D+ E+++++ + HKN++ A D +Y+++E G L
Sbjct: 113 ----------ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162
Query: 240 LD--RILSRGGKYSEEDAKIVMVQILSVVAFCHF-------------QGVVHRDLKPENF 284
+ + G + + LS + +HRDL N
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222
Query: 285 LFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSY 331
L T E++ +K DFGL+ R DI YY APE L R Y
Sbjct: 223 LVT---EDNVMKIADFGLA-------R--DIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 270
Query: 332 GTEADMWSIGVIAY-ILLCGSRPFWARTESGIFRAV 366
++D+WS GV+ + I G P+ +F+ +
Sbjct: 271 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 306
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 59/256 (23%), Positives = 91/256 (35%), Gaps = 78/256 (30%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
E G+ +G G FG +A + VAVK++ +
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--------------------- 86
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ E + E+K++ L H+N+V A IY++ E C G+LL+
Sbjct: 87 --------ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138
Query: 242 ---------------RILSRGGKYSEEDAKIVMVQILSV---VA----FCHFQGVVHRDL 279
+ + E+ + +L VA F F+ VHRDL
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 198
Query: 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL 327
N L T +K DFGL+ R DI+ + YV APE L
Sbjct: 199 AARNVLVT---HGKVVKICDFGLA-------R--DIMSDSNYVVRGNARLPVKWMAPESL 246
Query: 328 -HRSYGTEADMWSIGV 342
Y ++D+WS G+
Sbjct: 247 FEGIYTIKSDVWSYGI 262
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 59/251 (23%), Positives = 89/251 (35%), Gaps = 73/251 (29%)
Query: 124 ELGEEVGRGHFG--YTCSAK--AKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
LG+ +G G FG A K + VAVK++
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------------------- 124
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
T + D+ E+++++ + HKN++ A D +Y+++E G L
Sbjct: 125 ----------ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 174
Query: 240 LD--RILSRGGKYSEEDAKIVMVQILSVVAFCHF-------------QGVVHRDLKPENF 284
+ R G D V + ++ Q +HRDL N
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234
Query: 285 LFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSY 331
L T EN+ +K DFGL+ R DI YY APE L R Y
Sbjct: 235 LVT---ENNVMKIADFGLA-------R--DINNIDYYKKTTNGRLPVKWMAPEALFDRVY 282
Query: 332 GTEADMWSIGV 342
++D+WS GV
Sbjct: 283 THQSDVWSFGV 293
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 9e-16
Identities = 63/266 (23%), Positives = 94/266 (35%), Gaps = 74/266 (27%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
L E+G G FG + + VAVK +
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--------------------- 56
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
T A +D +RE ++L L H+++V+FY D D + +V E K G+L
Sbjct: 57 ---------TLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNK 106
Query: 242 --RILSRGGKYSEEDAKIVMVQILSVVAFCHF-------------QGVVHRDLKPENFLF 286
R + L + H Q VHRDL N L
Sbjct: 107 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV 166
Query: 287 TSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYGT 333
N +K DFG+S R D+ + YY PE + +R + T
Sbjct: 167 G---ANLLVKIGDFGMS-------R--DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTT 214
Query: 334 EADMWSIGVIAY-ILLCGSRPFWART 358
E+D+WS GVI + I G +P++ +
Sbjct: 215 ESDVWSFGVILWEIFTYGKQPWFQLS 240
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 42/253 (16%), Positives = 88/253 (34%), Gaps = 46/253 (18%)
Query: 122 HYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
+++G +G+G FG Y + + VKV P G +F E +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLF-------TELKFYQ 88
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFY----DAYEDDDNIYIVMELCK 235
A + ++ R L + + +++ +++M+
Sbjct: 89 RA------------AKPEQIQKWIRTRKL-KYLGVPKYWGSGLHDKNGKSYRFMIMDRF- 134
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
G +L + ++S + + ++IL ++ + H VH D+K N L K + +
Sbjct: 135 GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD-QV 193
Query: 296 KAIDFGLSDYVKPDERLNDI--------VGSAYYVAPEVLHRSYGTEA----DMWSIG-V 342
+D+GL+ P+ G+ + + + G D+ +G
Sbjct: 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTS---IDAHNGVAPSRRGDLEILGYC 250
Query: 343 IAYILLCGSRPFW 355
+ L G P W
Sbjct: 251 MIQ-WLTGHLP-W 261
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 61/282 (21%), Positives = 97/282 (34%), Gaps = 81/282 (28%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
LG+ +G G FG +A KG VAVK++ +
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--------------------- 64
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ + D+ E +L+ + H ++++ Y A D + +++E K G L
Sbjct: 65 --------ASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRG 115
Query: 242 ----------RILSRGGKYSEEDAKIVMVQILSVVAFCHF-------------QGVVHRD 278
L GG + + L++ F +VHRD
Sbjct: 116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175
Query: 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEV 326
L N L E +K DFGLS R D+ YV A E
Sbjct: 176 LAARNILVA---EGRKMKISDFGLS-------R--DVYEEDSYVKRSQGRIPVKWMAIES 223
Query: 327 L-HRSYGTEADMWSIGVIAY-ILLCGSRPFWARTESGIFRAV 366
L Y T++D+WS GV+ + I+ G P+ +F +
Sbjct: 224 LFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLL 265
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 60/267 (22%), Positives = 96/267 (35%), Gaps = 77/267 (28%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQD---VAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
L E+G G FG A+ L QD VAVK + +
Sbjct: 44 VLKWELGEGAFGKVFLAECH-NLLPEQDKMLVAVKALKE--------------------- 81
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
+ A +D +RE ++L L H+++V+F+ + + +V E + G+L
Sbjct: 82 ---------ASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 241 D--RILSRGGKYSEEDAKIVMVQILSVVAFCHF-------------QGVVHRDLKPENFL 285
R + V L + VHRDL N L
Sbjct: 132 RFLR-SHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCL 190
Query: 286 FTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEVL-HRSYG 332
+ +K DFG+S R DI + YY PE + +R +
Sbjct: 191 VG---QGLVVKIGDFGMS-------R--DIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238
Query: 333 TEADMWSIGVIAY-ILLCGSRPFWART 358
TE+D+WS GV+ + I G +P++ +
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLS 265
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 47/265 (17%), Positives = 86/265 (32%), Gaps = 73/265 (27%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+ LG+++G G FG A K + A V+ K E + L
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTN---KPEKDARHVV--------------KVEYQENGPL 80
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD------------------AYED 223
E+K + + + ++ + ++
Sbjct: 81 -----------------FSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKG 123
Query: 224 DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPEN 283
++VME G L +I + G + + + +++L V+ + H VH D+K N
Sbjct: 124 RSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAAN 181
Query: 284 FLFTSKEENSSLKAIDFGLSDYVKPDERLNDI--------VGSAYYVAPEVLHRSYGTEA 335
L K + + D+GLS P+ G+ + H+ G
Sbjct: 182 LLLGYKNPD-QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEF-TSLDAHK--GVAL 237
Query: 336 ----DMWSIG-VIAYILLCGSRPFW 355
D+ +G + LCG P W
Sbjct: 238 SRRSDVEILGYCMLR-WLCGKLP-W 260
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 54/274 (19%), Positives = 87/274 (31%), Gaps = 81/274 (29%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
E ++G G FG + A VAVK++ +
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--------------------- 88
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+A D +RE ++ + N+V+ + ++ E G+L +
Sbjct: 89 --------ASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNE 139
Query: 242 ----------RILSRGGKYSEEDAKIVMVQILSVVAFCHF-------------QGVVHRD 278
LS + LS + VHRD
Sbjct: 140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199
Query: 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV------------APEV 326
L N L EN +K DFGLS R +I + YY PE
Sbjct: 200 LATRNCLVG---ENMVVKIADFGLS-------R--NIYSADYYKADGNDAIPIRWMPPES 247
Query: 327 L-HRSYGTEADMWSIGVIAY-ILLCGSRPFWART 358
+ + Y TE+D+W+ GV+ + I G +P++
Sbjct: 248 IFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 281
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 40/257 (15%), Positives = 76/257 (29%), Gaps = 54/257 (21%)
Query: 122 HYELGEEVGRGHFG-----YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
++L R + G S + Q ++K+ +
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL-----------------DAK 85
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYD-AYEDDDNIYIVMELCK 235
+ +E F A V + K+ T + D ++V+
Sbjct: 86 DGRLFNEQ--NFFQRAAKPLQVNKWKKLYS--TPLLAIPTCMGFGVHQDKYRFLVLPSL- 140
Query: 236 GGELLDRIL--SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS 293
G L L S SE V ++L + F H VH ++ EN ++++
Sbjct: 141 -GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQS- 198
Query: 294 SLKAIDFGLS----------DYVKPDERLNDIVGSAYYVAPEVLHRSYGTEA----DMWS 339
+ +G + Y R + G +++ + G D+ S
Sbjct: 199 QVTLAGYGFAFRYCPSGKHVAY-VEGSR-SPHEGDLEFIS---MDLHKGCGPSRRSDLQS 253
Query: 340 IG-VIAYILLCGSRPFW 355
+G + L G P W
Sbjct: 254 LGYCMLK-WLYGFLP-W 268
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.7 bits (172), Expect = 1e-13
Identities = 38/187 (20%), Positives = 69/187 (36%), Gaps = 32/187 (17%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ E++G G FG + + VA+K+I + + H+ IL
Sbjct: 22 LQRCEKIGEGVFG-----EVFQTIADHTPVAIKIIA----IEGPDLVNGSHQKTFEEILP 72
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGH-------KNLVQFYDAYE------------- 222
E + ++ E R + + H L++ +D Y
Sbjct: 73 EIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFF 132
Query: 223 DDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVHRDLKP 281
DD ++IV+E GG L+++ ++ S AK ++ Q+ + +A HRDL
Sbjct: 133 KDDQLFIVLEFEFGGIDLEQMRTK--LSSLATAKSILHQLTASLAVAEASLRFEHRDLHW 190
Query: 282 ENFLFTS 288
N L
Sbjct: 191 GNVLLKK 197
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A Length = 191 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-09
Identities = 13/72 (18%), Positives = 28/72 (38%), Gaps = 1/72 (1%)
Query: 407 LSHPWLANSHDV-KIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTL 465
+ H +S + V + K Y +K A+ +A+ + L+ F +
Sbjct: 1 MHHHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLV 60
Query: 466 LAPNKNGFISMQ 477
L + G+I+ +
Sbjct: 61 LDEDGKGYITKE 72
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 57.9 bits (141), Expect = 2e-09
Identities = 66/299 (22%), Positives = 103/299 (34%), Gaps = 86/299 (28%)
Query: 111 KNFGFSKQFVAHYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQV 168
NF V ++GE G FG Y KG + VAVK + M+ + ++
Sbjct: 25 NNFDERPISVGGNKMGE----GGFGVVY-------KGYVNNTTVAVKKLAAMVDITTEEL 73
Query: 169 HCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIY 228
QF +E+K++ H+NLV+ D D++
Sbjct: 74 K------QQF--------------------DQEIKVMAKCQ-HENLVELLGFSSDGDDLC 106
Query: 229 IVMELCKGGELLDRILSRGGKYS---EEDAKIVMVQILSV---VAFCHFQGVVHRDLKPE 282
+V G LLDR+ G KI + F H +HRD+K
Sbjct: 107 LVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKI----AQGAANGINFLHENHHIHRDIKSA 162
Query: 283 NFLFTSKEENSSLKAIDFGLSDYVKPDERLND----------IVGSAYYVAPEVLHRSYG 332
N L +E + K DFGL+ R ++ IVG+ Y+APE L
Sbjct: 163 NILL---DEAFTAKISDFGLA-------RASEKFAQTVMTSRIVGTTAYMAPEALRGEIT 212
Query: 333 TEADMWSIGVIAYILLCGSRPF-----------WAR---TESGIFRAVLKADPSFDEAP 377
++D++S GV+ ++ G E D ++A
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDY--IDKKMNDAD 269
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} Length = 197 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 3e-09
Identities = 17/75 (22%), Positives = 30/75 (40%), Gaps = 2/75 (2%)
Query: 405 QALSHPWLANSHDV--KIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQ 462
H + + + K +K + + L+K AL +AK L ++ LR
Sbjct: 3 HHHHHSSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNI 62
Query: 463 FTLLAPNKNGFISMQ 477
F L + +G +S Q
Sbjct: 63 FIALDVDNSGTLSSQ 77
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 52.9 bits (126), Expect = 2e-07
Identities = 58/428 (13%), Positives = 131/428 (30%), Gaps = 125/428 (29%)
Query: 106 DIGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIF 165
L K ++FV EEV R ++ + S +K + P M+ ++
Sbjct: 69 WTLLSKQEEMVQKFV------EEVLRINYKFLMSP------IKTEQRQ----PSMMTRMY 112
Query: 166 LQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDD 225
++ + ++Q + +Y +V R L+ + L E
Sbjct: 113 IEQRDRLYNDNQ--VFAKY------------NVSRLQPYLKL---RQAL------LELRP 149
Query: 226 NIYIV---M----------ELCKGGELLDRILSRG------GKYSEEDAKIVMVQILSVV 266
++ + ++C ++ + + + + + M+Q L
Sbjct: 150 AKNVLIDGVLGSGKTWVALDVCLSYKVQCK-MDFKIFWLNLKNCNSPETVLEMLQKLLYQ 208
Query: 267 AFCHFQGVVHR---------DLKPE-NFLFTSKEENSSL------------KAIDFGLSD 304
++ ++ E L SK + L A +
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLS--- 265
Query: 305 YVK-----PDERLNDIVGSAYYVAPEVLHRSYG-TEADMWSIGVIAYILLCGSR--PFWA 356
K +++ D + +A + H S T + ++ L C + P
Sbjct: 266 -CKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDE--VKSLLLKYLDCRPQDLPREV 322
Query: 357 RTES----GIFRAVLKADPS-FDEAPWPSLSPEAID-----FVKRLLNKDYRKRLTAAQA 406
T + I ++ + +D W ++ + + + L +YRK
Sbjct: 323 LTTNPRRLSIIAESIRDGLATWD--NWKHVNCDKLTTIIESSLNVLEPAEYRKMF---DR 377
Query: 407 LS-HPWLANSHDVKIPSD--MIVYKLIKAYISSSSLRKAALGALAK------TLTVPQLA 457
LS P IP+ +++ + + K +L + T+++P +
Sbjct: 378 LSVFP-----PSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI- 431
Query: 458 YLREQFTL 465
YL + L
Sbjct: 432 YLELKVKL 439
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.5 bits (117), Expect = 2e-06
Identities = 73/535 (13%), Positives = 144/535 (26%), Gaps = 162/535 (30%)
Query: 1 MGLCHGKPV---ENSQNRSQNEALPYE-------NEPQPNSQKSKASNFPFYSPSPLPSL 50
+ GK + + + ++ N P + + S
Sbjct: 158 VLGS-GKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSR 216
Query: 51 FKNSPAIP----SVNSTPLRFFKRPFPPPSPAKHIRSLLARRHGSVKPNEASIPEGNESD 106
+S I S+ + R K + LL
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSK-------PYENCLL--------------------- 248
Query: 107 IGLDKNFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAV--KVIPKMIGVI 164
+ L V + + F +C K L + V + I
Sbjct: 249 V-LLN--------VQNAKAWN-----AFNLSC-----KILLTTRFKQVTDFLSAATTTHI 289
Query: 165 FLQVHCPKHENHQFTILDEYCCLFMT-TAIAIEDVRREVK---------ILRALTGHKNL 214
L H + T DE L + +D+ REV I ++
Sbjct: 290 SL-----DHHSMTLT-PDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT 343
Query: 215 VQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSE-----EDAKIVMVQILS----- 264
+ + + D + ++E +L+ R + A I +LS
Sbjct: 344 WDNWK-HVNCDKLTTIIESSL--NVLEPAEYRK-MFDRLSVFPPSAHI-PTILLSLIWFD 398
Query: 265 --------VVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIV 316
VV H +V + KE S+ +I L ++ + L+ +
Sbjct: 399 VIKSDVMVVVNKLHKYSLVEKQ---------PKESTISIPSIYLELKVKLENEYALHRSI 449
Query: 317 GSAYYVAPEVLHRSYGTE------ADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKAD 370
Y + +++ ++ D + I + L P +FR V
Sbjct: 450 VDHYN-----IPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHP----ERMTLFRMVF--- 497
Query: 371 PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLI 430
D F+++ + D S W A+ + + YK
Sbjct: 498 --LD-----------FRFLEQKIRHD-----------STAWNASGSILNTLQQLKFYK-- 531
Query: 431 KAYIS-SSSLRKAALGALAKTLTVPQLAYLREQFTLLAP----NKNGFISMQNYK 480
YI + + + A+ L + + ++T L ++ I + +K
Sbjct: 532 -PYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIFEEAHK 585
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 49.9 bits (119), Expect = 9e-07
Identities = 60/284 (21%), Positives = 91/284 (32%), Gaps = 67/284 (23%)
Query: 124 ELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIP------------------KMIG- 162
+LG+ +GRG FG A + + VAVK++ IG
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH 84
Query: 163 ---VIFLQVHCPKHENHQFTILDEYCC-------------LFMTTAIAIEDVRREVKILR 206
V+ L C K I+ E+C F+ R+ +
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIV-EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143
Query: 207 ALTGHKNLVQFYDAYEDDDNIYIVME---LCKGGELLDRILSRGGKYSEEDAKIVMVQIL 263
A+ +E L E + E Q+
Sbjct: 144 AIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVA 203
Query: 264 SVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYV- 322
+ F + +HRDL N L + E + +K DFGL+ R DI YV
Sbjct: 204 KGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLA-------R--DIYKDPDYVR 251
Query: 323 -----------APEVL-HRSYGTEADMWSIGVIAY-ILLCGSRP 353
APE + R Y ++D+WS GV+ + I G+ P
Sbjct: 252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 2e-06
Identities = 58/288 (20%), Positives = 103/288 (35%), Gaps = 84/288 (29%)
Query: 114 GFSKQFVAHYELGEEVGRGHFG--YTCSAKAKKGSLK-GQDVAVKVIPKMIGVIFLQVHC 170
F +F+ +G G FG Y KG L+ G VA+K
Sbjct: 40 NFDHKFL--------IGHGVFGKVY-------KGVLRDGAKVALKRR------------- 71
Query: 171 PKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIV 230
E+ Q IE+ E++ L H +LV ++ + + ++
Sbjct: 72 -TPESSQ----------------GIEEFETEIETLSFCR-HPHLVSLIGFCDERNEMILI 113
Query: 231 MELCKGGELLDRILSRGGKYSEEDAKIVMVQI-------LSVVAFCHFQGVVHRDLKPEN 283
+ + G L + + + +I L + H + ++HRD+K N
Sbjct: 114 YKYMENGNLKRHLYGSDLPTMSMSWEQRL-EICIGAARGL---HYLHTRAIIHRDVKSIN 169
Query: 284 FLFTSKEENSSLKAIDFGLSDYVKPDERLN---DIVGSAYYVAPEVLHRSYGTE-ADMWS 339
L +EN K DFG+S ++ + + G+ Y+ PE + TE +D++S
Sbjct: 170 ILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYS 226
Query: 340 IGVIAYILLCGSRPF-------------WART--ESGIFRAVLKADPS 372
GV+ + +LC WA +G + DP+
Sbjct: 227 FGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQI--VDPN 272
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 43.9 bits (103), Expect = 4e-05
Identities = 23/112 (20%), Positives = 42/112 (37%), Gaps = 15/112 (13%)
Query: 199 RREVKILRALTGHKNLVQFYDA-------YEDDDNIYIVMELCKGGEL-LDRILSRGGKY 250
+E + +NL + +A Y N+ ++ME EL ++ G +
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNV-LLMEFIGEDELPAPTLVELGREL 167
Query: 251 SEEDAKIVMVQILS-VVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
E D + + ++ V +VH DL N ++ K + ID G
Sbjct: 168 KELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK-----VYFIDMG 214
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} Length = 180 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 8e-05
Identities = 16/57 (28%), Positives = 28/57 (49%), Gaps = 2/57 (3%)
Query: 423 DMIVYKLIKAYISSSSLRKAALGALAKTLTVP--QLAYLREQFTLLAPNKNGFISMQ 477
V +K+Y+ S++R + +A L+V + Y+ E F L N NG +S +
Sbjct: 3 SPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHR 59
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 62/289 (21%), Positives = 98/289 (33%), Gaps = 89/289 (30%)
Query: 129 VGRGHFG--YTCSAKAKKGSLK-GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYC 185
+GRG FG Y KG L G VAVK + K E Q L
Sbjct: 38 LGRGGFGKVY-------KGRLADGTLVAVKRL--------------KEERTQGGELQ--- 73
Query: 186 CLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS 245
F T EV+++ H+NL++ +V G + +
Sbjct: 74 --FQT----------EVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 246 RGGKYSEED----AKIVMVQILSVVAFCHFQG---VVHRDLKPENFLFTSKEENSSLKAI 298
R D +I + +A+ H ++HRD+K N L +E
Sbjct: 121 RPESQPPLDWPKRQRIA-LGSARGLAYLHDHCDPKIIHRDVKAANILL---DEEFEAVVG 176
Query: 299 DFGLSDYVKPDERLND---------IVGSAYYVAPEVLHRSYGTE-ADMWSIGVIAYILL 348
DFGL+ +L D + G+ ++APE L +E D++ GV+ L+
Sbjct: 177 DFGLA-------KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI 229
Query: 349 CGSRPF---------------WART--ESGIFRAV----LKADPSFDEA 376
G R F W + + A+ L+ + +E
Sbjct: 230 TGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEV 278
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 482 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.76 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.29 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.21 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.92 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.74 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.71 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.5 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 98.45 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.35 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.33 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 98.3 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.27 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.26 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.91 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.84 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.72 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 97.52 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.48 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.46 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 97.43 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.37 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.36 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.2 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.08 | |
| 1ij5_A | 323 | Plasmodial specific LAV1-2 protein; fourty kDa cal | 96.99 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.95 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.78 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.58 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 96.32 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 96.31 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.27 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 96.14 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 95.96 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 95.94 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 95.87 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.84 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 95.75 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 95.72 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 95.45 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 95.27 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 95.2 | |
| 1iq3_A | 110 | Ralbp1-interacting protein (partner of ralbp1); EF | 94.63 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 94.28 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 94.18 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 94.08 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 94.06 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 93.69 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 93.42 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 93.32 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 93.29 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.11 | |
| 1wy9_A | 147 | Allograft inflammatory factor 1; EF-hand, calucium | 93.02 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 92.97 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 92.92 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 92.89 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 92.81 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 92.78 | |
| 2d58_A | 107 | Allograft inflammatory factor 1; EF-hand, metal bi | 92.58 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 92.32 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 92.29 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 92.16 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 92.14 | |
| 1pva_A | 110 | Parvalbumin; calcium binding; 1.65A {Esox lucius} | 92.14 | |
| 2pvb_A | 108 | Protein (parvalbumin); calcium binding protein, me | 92.1 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 91.97 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 91.82 | |
| 1rro_A | 108 | RAT oncomodulin; calcium-binding protein; 1.30A {R | 91.8 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 91.77 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 91.75 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 91.69 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 91.56 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 91.54 | |
| 1rwy_A | 109 | Parvalbumin alpha; EF-hand, calcium-binding, calci | 91.47 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 91.36 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 91.35 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 91.3 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 91.26 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 91.22 | |
| 1bu3_A | 109 | Calcium-binding protein; 1.65A {Merluccius bilinea | 91.13 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 91.13 | |
| 1cb1_A | 78 | Calbindin D9K; calcium-binding protein; NMR {Sus s | 91.12 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 91.12 | |
| 3i5g_C | 159 | Myosin catalytic light chain LC-1, mantle muscle; | 91.04 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 90.99 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 90.87 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 90.86 | |
| 1snl_A | 103 | Nucleobindin 1, calnuc; EF-hand, calcium-binding, | 90.83 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 90.82 | |
| 3li6_A | 66 | Calcium-binding protein; calcium signaling protein | 90.72 | |
| 2jjz_A | 150 | Ionized calcium-binding adapter molecule 2; EF-han | 90.65 | |
| 3i5g_B | 153 | Myosin regulatory light chain LC-2, mantle muscle; | 90.47 | |
| 1psr_A | 100 | Psoriasin, S100A7; EF-hand protein, MAD phasing, p | 90.42 | |
| 4eto_A | 93 | Protein S100-A4; calcium-binding protein, EF-hand, | 90.41 | |
| 2kyc_A | 108 | Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p | 90.41 | |
| 2lv7_A | 100 | Calcium-binding protein 7; metal binding protein; | 90.32 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 90.23 | |
| 1tiz_A | 67 | Calmodulin-related protein, putative; helix-turn-h | 90.14 | |
| 3nxa_A | 100 | Protein S100-A16; S100 family, calcium binding pro | 90.09 | |
| 2jq6_A | 139 | EH domain-containing protein 1; metal binding prot | 90.08 | |
| 1k8u_A | 90 | S100A6, calcyclin, CACY; calcium regulatory protei | 89.9 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 89.87 | |
| 3h4s_E | 135 | KCBP interacting Ca2+-binding protein; kinesin, mo | 89.85 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 89.45 | |
| 3a8r_A | 179 | Putative uncharacterized protein; EF-hand, membran | 89.33 | |
| 2lhi_A | 176 | Calmodulin, serine/threonine-protein phosphatase c | 88.75 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 88.74 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 88.63 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 88.6 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 88.24 | |
| 1j7q_A | 86 | CAVP, calcium vector protein; EF-hand family, calc | 88.24 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 88.19 | |
| 3rm1_A | 92 | Protein S100-B; alpha-helical, EF hand, metal bind | 88.18 | |
| 3n22_A | 98 | Protein S100-A2; EF-hand, calcium-binding, zinc-bi | 88.18 | |
| 3zwh_A | 104 | Protein S100-A4; Ca-binding protein-motor protein | 87.96 | |
| 3fia_A | 121 | Intersectin-1; EH 1 domain, NESG, structural genom | 87.92 | |
| 1ggw_A | 140 | Protein (CDC4P); light chain, cytokinesis, cell cy | 87.89 | |
| 2ovk_B | 153 | RLC, myosin regulatory light chain LC-2, mantle mu | 87.78 | |
| 3e3r_A | 204 | Calcyphosin, calcyphosine; human calcyphosine, EF- | 87.72 | |
| 2ovk_C | 159 | Myosin catalytic light chain LC-1, mantle muscle, | 87.65 | |
| 1k9u_A | 78 | Polcalcin PHL P 7; pollen allergen, calcium-bindin | 87.54 | |
| 2i7a_A | 174 | Calpain 13; calcium-dependent cytoplasmic cysteine | 87.31 | |
| 1exr_A | 148 | Calmodulin; high resolution, disorder, metal trans | 87.22 | |
| 1s6c_A | 183 | KV4 potassium channel-interacting protein kchip1B; | 87.2 | |
| 2lmt_A | 148 | Calmodulin-related protein 97A; spermatogenesis, m | 87.18 | |
| 1s6j_A | 87 | CDPK, calcium-dependent protein kinase SK5; EF-han | 87.16 | |
| 4drw_A | 121 | Protein S100-A10/annexin A2 chimeric protein; atyp | 87.15 | |
| 2qac_A | 146 | Myosin A tail domain interacting protein MTIP; mal | 87.13 | |
| 3k21_A | 191 | PFCDPK3, calcium-dependent protein kinase 3; calci | 87.07 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 86.99 | |
| 3ll8_B | 155 | Calcineurin subunit B type 1; protein-peptide dock | 86.91 | |
| 2kz2_A | 94 | Calmodulin, CAM; TR2C, metal binding protein; NMR | 86.77 | |
| 2bl0_C | 142 | Myosin regulatory light chain; muscle protein, sli | 86.76 | |
| 1q80_A | 174 | SCP, sarcoplasmic calcium-binding protein; all-alp | 86.7 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 86.68 | |
| 2bl0_B | 145 | Myosin regulatory light chain; muscle protein, sli | 86.54 | |
| 2mys_B | 166 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 86.44 | |
| 3a4u_B | 143 | Multiple coagulation factor deficiency protein 2; | 86.44 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 86.35 | |
| 2mys_C | 149 | Myosin; muscle protein, motor protein; HET: MLY; 2 | 86.29 | |
| 1dtl_A | 161 | Cardiac troponin C; helix-turn-helix, structural p | 86.25 | |
| 1yx7_A | 83 | Calsensin, LAN3-6 antigen; calcium-binding protein | 86.2 | |
| 2b1u_A | 71 | Calmodulin-like protein 5; CLSP, calmodulin-like S | 86.12 | |
| 1m45_A | 148 | MLC1P, myosin light chain; protein-peptide complex | 86.11 | |
| 1snl_A | 103 | Nucleobindin 1, calnuc; EF-hand, calcium-binding, | 86.07 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 85.79 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 85.72 | |
| 4ds7_A | 147 | Calmodulin, CAM; protein binding, metal binding, s | 85.68 | |
| 1qjt_A | 99 | EH1, epidermal growth factor receptor substrate su | 85.6 | |
| 1wdc_B | 156 | Scallop myosin; calcium binding protein, muscle pr | 85.53 | |
| 3fwb_A | 161 | Cell division control protein 31; gene gating, com | 85.47 | |
| 1eh2_A | 106 | EPS15; calcium binding, signaling domain, NPF bind | 85.44 | |
| 2joj_A | 77 | Centrin protein; N-terminal domain, centrin soluti | 85.33 | |
| 2ccm_A | 191 | Calexcitin; EF hand, calcium, signaling protein; 1 | 85.28 | |
| 1wdc_C | 156 | Scallop myosin; calcium binding protein, muscle pr | 85.25 | |
| 1s1e_A | 224 | KV channel interacting protein 1; kchip, calcium-b | 85.25 | |
| 2ct9_A | 208 | Calcium-binding protein P22; EF-hand, metal bindin | 85.08 | |
| 1c07_A | 95 | Protein (epidermal growth factor receptor pathway | 85.07 | |
| 1top_A | 162 | Troponin C; contractIle system protein; 1.78A {Gal | 85.01 | |
| 2pmy_A | 91 | RAS and EF-hand domain-containing protein; rasef, | 84.98 | |
| 1avs_A | 90 | Troponin C; muscle contraction, calcium-activated, | 84.92 | |
| 1w7j_B | 151 | Myosin light chain 1; motor protein, unconventiona | 84.91 | |
| 3mse_B | 180 | Calcium-dependent protein kinase, putative; CDPKS, | 84.91 | |
| 1jfj_A | 134 | Ehcabp, calcium-binding protein; EF-hand, helix-lo | 84.9 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 84.79 | |
| 2opo_A | 86 | Polcalcin CHE A 3; calcium-binding protein, dimer, | 84.75 | |
| 3pm8_A | 197 | PFCDPK2, calcium-dependent protein kinase 2; malar | 84.71 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 84.61 | |
| 3nso_A | 101 | Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, meta | 84.59 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 84.45 | |
| 1fi6_A | 92 | EH domain protein REPS1; EPS15 homology domain, EF | 84.42 | |
| 3sg6_A | 450 | Gcamp2, myosin light chain kinase, green fluoresce | 84.38 | |
| 2l4h_A | 214 | Calcium and integrin-binding protein 1; metal bind | 84.34 | |
| 2kn2_A | 92 | Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco | 84.24 | |
| 1dgu_A | 183 | Calcium-saturated CIB; helical, EF-hands, blood cl | 84.15 | |
| 1h8b_A | 75 | ACT-EF34, alpha-actinin 2, skeletal muscle isoform | 84.07 | |
| 1sra_A | 151 | Sparc; extracellular matrix protein, calcium-bindi | 84.06 | |
| 1a4p_A | 96 | S100A10; S100 family, EF-hand protein, ligand of a | 84.05 | |
| 2sas_A | 185 | Sarcoplasmic calcium-binding protein; 2.40A {Branc | 83.99 | |
| 1qx2_A | 76 | Vitamin D-dependent calcium-binding protein, INTE; | 83.98 | |
| 2lvv_A | 226 | Flagellar calcium-binding protein TB-24; EF-hand, | 83.97 | |
| 2obh_A | 143 | Centrin-2; DNA repair complex EF hand superfamily | 83.87 | |
| 2ktg_A | 85 | Calmodulin, putative; ehcam, Ca-binding protein, p | 83.86 | |
| 1qls_A | 99 | S100C protein, calgizzarin; metal-binding protein/ | 83.76 | |
| 3khe_A | 191 | Calmodulin-like domain protein kinase isoform 3; c | 83.62 | |
| 2bec_A | 202 | Calcineurin B homologous protein 2; calcineurin-ho | 83.59 | |
| 3dtp_E | 196 | RLC, myosin regulatory light chain; muscle protein | 83.56 | |
| 2ggz_A | 211 | Guanylyl cyclase-activating protein 3; EF hand, gu | 83.49 | |
| 3akb_A | 166 | Putative calcium binding protein; EF-hand, metal b | 83.31 | |
| 1xk4_C | 113 | Calgranulin B; S100 family, heterotetramer, metal | 83.09 | |
| 3fs7_A | 109 | Parvalbumin, thymic; calcium-binding protein, EF-h | 83.07 | |
| 1j55_A | 95 | S-100P protein; metal binding protein; 2.00A {Homo | 83.01 | |
| 2jnf_A | 158 | Troponin C; stretch activated muscle contraction, | 82.99 | |
| 1k94_A | 165 | Grancalcin; penta-EF-hand protein, calcium binding | 82.99 | |
| 2kgr_A | 111 | Intersectin-1; structure, alternative splicing, ca | 82.88 | |
| 2y5i_A | 99 | S100Z, S100 calcium binding protein Z; metal-bindi | 82.87 | |
| 2hpk_A | 208 | Photoprotein berovin; structural genomics, PSI, pr | 82.85 | |
| 1xk4_A | 93 | Calgranulin A; S100 family, heterotetramer, metal | 82.7 | |
| 2znd_A | 172 | Programmed cell death protein 6; penta-EF-hand pro | 82.57 | |
| 2aao_A | 166 | CDPK, calcium-dependent protein kinase, isoform AK | 82.53 | |
| 2f2o_A | 179 | Calmodulin fused with calmodulin-binding domain of | 82.5 | |
| 2lnk_A | 113 | Protein S100-A4; EF-hand, calcium binding, all alp | 82.49 | |
| 1gjy_A | 167 | Sorcin, CP-22, V19; calcium binding, calcium-bindi | 82.46 | |
| 2wcb_A | 95 | Protein S100-A12; calcium signalling, HOST-parasit | 82.4 | |
| 2kax_A | 92 | Protein S100-A5; EF-hand, calcium binding protien, | 82.32 | |
| 1alv_A | 173 | Calpain, S-camld; calcium binding, calmodulin like | 82.13 | |
| 3ox6_A | 153 | Calcium-binding protein 1; EF-hand, calcium-sensor | 82.09 | |
| 2r2i_A | 198 | Guanylyl cyclase-activating protein 1; EF hand, GC | 82.04 | |
| 1uhk_A | 191 | Aequorin 2, aequorin; EF-hand motif, complex, lumi | 81.83 | |
| 1c7v_A | 81 | CAVP, calcium vector protein; EF-hand family, calc | 81.8 | |
| 1juo_A | 198 | Sorcin; calcium-binding proteins, penta-EF-hand, P | 81.58 | |
| 3qrx_A | 169 | Centrin; calcium-binding, EF-hand, cell division, | 81.56 | |
| 2h2k_A | 106 | Protein S100-A13; calcium binding protein, metal b | 81.53 | |
| 2zfd_A | 226 | Calcineurin B-like protein 2; calcium binding prot | 81.49 | |
| 1qv0_A | 195 | Obelin, OBL; photoprotein, bioluminescence, atomic | 81.44 | |
| 1nya_A | 176 | Calerythrin; EF-hand, metal binding protein; NMR { | 81.44 | |
| 1y1x_A | 191 | Leishmania major homolog of programmed cell death | 81.31 | |
| 5pal_A | 109 | Parvalbumin; calcium-binding protein; 1.54A {Triak | 81.27 | |
| 1s6i_A | 188 | CDPK, calcium-dependent protein kinase SK5; EF-han | 81.08 | |
| 3cs1_A | 219 | Flagellar calcium-binding protein; myristoylated, | 81.05 | |
| 3fia_A | 121 | Intersectin-1; EH 1 domain, NESG, structural genom | 81.04 | |
| 3dd4_A | 229 | KV channel-interacting protein 4; EF-hands protein | 80.94 | |
| 1k2h_A | 93 | S100A1, S-100 protein, alpha chain; non-covalent h | 80.85 | |
| 2ehb_A | 207 | Calcineurin B-like protein 4; protein complex, Ca( | 80.81 | |
| 3u0k_A | 440 | Rcamp; fluorescent protein, calcium binding, EF-ha | 80.68 | |
| 1cb1_A | 78 | Calbindin D9K; calcium-binding protein; NMR {Sus s | 80.63 | |
| 1wlz_A | 105 | DJBP, CAP-binding protein complex interacting prot | 80.55 | |
| 3j04_B | 143 | Myosin regulatory light chain 2, smooth muscle MA | 80.42 | |
| 3sjs_A | 220 | URE3-BP sequence specific DNA binding protein; EF- | 80.05 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-65 Score=504.55 Aligned_cols=258 Identities=32% Similarity=0.595 Sum_probs=232.0
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||+||+|+++. +|+.||||++.+.. .......+.+.+
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~---~~~~~AiK~i~k~~---------------------------~~~~~~~~~~~~ 81 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRH---------------------------IIKENKVPYVTR 81 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHHHH
T ss_pred cccEEEEEEecccCeEEEEEEECC---CCCEEEEEEEEHHH---------------------------CCCHHHHHHHHH
Confidence 579999999999999999999987 89999999997641 112233567899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|++|. |||||+++++|++++.+|||||||+||+|.+++.+. +.+++.+++.|+.||+.||.|||++||||||||
T Consensus 82 E~~il~~l~-HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlK 159 (311)
T 4aw0_A 82 ERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 159 (311)
T ss_dssp HHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHHhCC-CCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence 999999996 999999999999999999999999999999998765 689999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC---CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD---ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|+|||+ +.++.+||+|||+|+.+... ....+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+
T Consensus 160 PeNILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~ 236 (311)
T 4aw0_A 160 PENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 236 (311)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred HHHeEE---cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999 67789999999999987533 24567899999999999975 699999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHH------HhcCcccccCCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQ------ALSHPWLANSHD 417 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e------~L~hp~~~~~~~ 417 (482)
.+..+++.+|.+....++. .+|+++++||++||++||.+|+|++| +++||||++...
T Consensus 237 ~~~~~~~~~i~~~~~~~p~----~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw 299 (311)
T 4aw0_A 237 GNEGLIFAKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 299 (311)
T ss_dssp SSHHHHHHHHHHTCCCCCT----TCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred CCHHHHHHHHHcCCCCCCc----ccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCH
Confidence 9999999999998877654 48999999999999999999999987 589999987654
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-64 Score=490.91 Aligned_cols=256 Identities=35% Similarity=0.641 Sum_probs=213.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||+||+|+++. +|+.||||++++.. .........+.
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~~---------------------------~~~~~~~~~~~ 61 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTT---TGQKVALKIINKKV---------------------------LAKSDMQGRIE 61 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTT---TCCEEEEEEEECC---------------------------------CHHHHH
T ss_pred eeCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEeHHH---------------------------cCCHHHHHHHH
Confidence 3689999999999999999999877 89999999997641 12223356789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|++++ |||||++++++++++.+||||||| +|+|.+++.++ +.+++.+++.++.||+.||.|||++||+||||
T Consensus 62 ~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDi 138 (275)
T 3hyh_A 62 REISYLRLLR-HPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQR-DKMSEQEARRFFQQIISAVEYCHRHKIVHRDL 138 (275)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHHHHHCC-CCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccC
Confidence 9999999997 999999999999999999999999 67999988765 68999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccccc-C-CCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-Y-GTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||+ +.++.+||+|||+|+.........+.+||+.|||||++.+. | +.++||||+||++|+|+||+.||.+.
T Consensus 139 KP~NILl---~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~ 215 (275)
T 3hyh_A 139 KPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE 215 (275)
T ss_dssp CTTTEEE---CTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ChHHeEE---CCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence 9999999 67788999999999987766667788999999999999753 4 68999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
+..++++.|......++ ..+|+++++||++||+.||.+|||++|+|+||||+..
T Consensus 216 ~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 216 SIPVLFKNISNGVYTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp SHHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred CHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 99999999998877654 3489999999999999999999999999999999754
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-64 Score=504.25 Aligned_cols=259 Identities=24% Similarity=0.481 Sum_probs=225.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|+++++||+|+||+||+|+++. +|+.||||++.+.. ......+.+.
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~~----------------------------~~~~~~~~~~ 71 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTE---DGRQYVIKEINISR----------------------------MSSKEREESR 71 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETT---TCCEEEEEEEECTT----------------------------SCHHHHHHHH
T ss_pred ccceEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEehHH----------------------------CCHHHHHHHH
Confidence 4789999999999999999999987 89999999997641 2334567899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+|++|+ |||||+++++|++++.+|||||||+||+|.++|..++ ..+++.+++.|+.||+.||.|||++||||||
T Consensus 72 ~E~~il~~l~-HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRD 150 (350)
T 4b9d_A 72 REVAVLANMK-HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRD 150 (350)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETT
T ss_pred HHHHHHHHCC-CCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 9999999997 9999999999999999999999999999999997553 4689999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||+|||| +.++.+||+|||+|+.+.... ...+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+
T Consensus 151 lKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~ 227 (350)
T 4b9d_A 151 IKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227 (350)
T ss_dssp CCGGGEEE---CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CCHHHEEE---CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999 677889999999998765432 3456789999999999975 599999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.+..+++.+|...... ..+..+|+++++||.+||++||.+|||++|+|+||||++..
T Consensus 228 ~~~~~~~~~i~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 228 GSMKNLVLKIISGSFP---PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp SSHHHHHHHHHHTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred cCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCC
Confidence 9999999999987643 23456999999999999999999999999999999998653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-64 Score=501.34 Aligned_cols=256 Identities=31% Similarity=0.560 Sum_probs=228.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
..|+++++||+|+||.||+|+++. +|+.||||++.+.. ....+.+.+
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~------------------------------~~~~~~~~~ 120 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRK------------------------------QQRRELLFN 120 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGGG------------------------------CSSGGGGHH
T ss_pred HhcEEeEEeecCcCeEEEEEEECC---CCCEEEEEEEecCc------------------------------hhHHHHHHH
Confidence 579999999999999999999987 89999999997531 011235789
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|+.|+ |||||+++++|++++.+|||||||+||+|.+++.+ +.+++.+++.|+.||+.||.|||++||||||||
T Consensus 121 Ei~il~~l~-HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK 197 (346)
T 4fih_A 121 EVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197 (346)
T ss_dssp HHHHHHHCC-CTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHHhCC-CCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCC
Confidence 999999996 99999999999999999999999999999998754 479999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+|||| +.++.+||+|||+|+.+... ....+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.+
T Consensus 198 p~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~ 274 (346)
T 4fih_A 198 SDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 274 (346)
T ss_dssp GGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred HHHEEE---CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 999999 67789999999999887543 45667899999999999875 69999999999999999999999999999
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..+++..|..... .....|..+|+++++||.+||++||++|||++|+|+||||++..
T Consensus 275 ~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 275 PLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp HHHHHHHHHHSSC-CCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHHcCCC-CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999988877543 23344567999999999999999999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-63 Score=509.81 Aligned_cols=257 Identities=31% Similarity=0.556 Sum_probs=229.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+.|+++++||+|+||.||+|+++. +|+.||||++.+.. ....+.+.
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~---tg~~vAiK~i~~~~------------------------------~~~~~~~~ 196 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRS---SGKLVAVKKMDLRK------------------------------QQRRELLF 196 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEESTT------------------------------CSSGGGHH
T ss_pred hHhcEeeeEeccCcCcEEEEEEECC---CCCEEEEEEEeccc------------------------------hhHHHHHH
Confidence 4679999999999999999999987 89999999996530 11124578
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|+.|+ |||||+++++|++++.+|||||||+||+|.+++.. +.+++.+++.|+.||+.||.|||++|||||||
T Consensus 197 ~Ei~il~~l~-HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDi 273 (423)
T 4fie_A 197 NEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDI 273 (423)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHHHhCC-CCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence 9999999997 99999999999999999999999999999998754 46999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||| +.++.+||+|||+|+.+... ....+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.
T Consensus 274 Kp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~ 350 (423)
T 4fie_A 274 KSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 350 (423)
T ss_dssp STTTEEE---CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred CHHHEEE---cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999 67788999999999877543 45677899999999999875 6999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
+..+++..|..... .....+..+|+++++||.+||++||.+|||++|+|+||||++..
T Consensus 351 ~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 351 PPLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp CHHHHHHHHHHSCC-CCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CHHHHHHHHHcCCC-CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 99999988877643 23345677999999999999999999999999999999998754
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-64 Score=491.80 Aligned_cols=258 Identities=29% Similarity=0.508 Sum_probs=222.7
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||+||+|++..+..+|+.||||++++... .......+.+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----------------------------~~~~~~~~~~ 75 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATL----------------------------KVRDRVRTKM 75 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEE----------------------------EEEECC----
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHc----------------------------ChHHHHHHHH
Confidence 579999999999999999999876555789999999976411 0111235778
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|++|+ |||||++++++++++.+|||||||+||+|.+++.+. +.+++.+++.++.||+.||.|||++||||||||
T Consensus 76 E~~il~~l~-HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlK 153 (304)
T 3ubd_A 76 ERDILVEVN-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDHLHSLGIIYRDLK 153 (304)
T ss_dssp --CCCCCCC-CTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred HHHHHHHCC-CCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 999999996 999999999999999999999999999999998765 689999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+|||+ +.++.+||+|||+|+.... .....+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||.+.+
T Consensus 154 p~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~ 230 (304)
T 3ubd_A 154 PENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230 (304)
T ss_dssp GGGEEE---CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHeEE---cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence 999999 6778899999999986543 344567899999999999874 69999999999999999999999999999
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
..+++..|.+....++ ..+|+++++||++||++||.+||| ++|+|+||||++.
T Consensus 231 ~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i 288 (304)
T 3ubd_A 231 RKETMTMILKAKLGMP----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI 288 (304)
T ss_dssp HHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence 9999999999877654 358999999999999999999998 5899999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-62 Score=480.30 Aligned_cols=255 Identities=22% Similarity=0.369 Sum_probs=217.9
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|++.++||+|+||.||+|+++. +|..||||++.+. .......+.+.+|+
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~----------------------------~~~~~~~~~~~~E~ 76 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDR----------------------------KLTKSERQRFKEEA 76 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGG----------------------------GSCHHHHHHHHHHH
T ss_pred EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchh----------------------------hCCHHHHHHHHHHH
Confidence 4788899999999999999987 8999999999763 12344567899999
Q ss_pred HHHHhhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Q 011582 203 KILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG--VVH 276 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivH 276 (482)
.+|++|+ |||||+++++|++ ++.+|||||||+||+|.+++.+. +.+++..++.|+.||+.||.|||++| |||
T Consensus 77 ~il~~l~-HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiH 154 (290)
T 3fpq_A 77 EMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIH 154 (290)
T ss_dssp HHHHTCC-CTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCC
T ss_pred HHHHhCC-CCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEe
Confidence 9999997 9999999999976 35689999999999999998654 68999999999999999999999999 999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||||+||||+ +.++.+||+|||+|+... .....+.+||+.|||||++.+.|+.++|||||||++|||+||+.||.+
T Consensus 155 RDlKp~NILl~--~~~g~vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~ 231 (290)
T 3fpq_A 155 RDLKCDNIFIT--GPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE 231 (290)
T ss_dssp CCCCGGGEEES--STTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccChhheeEE--CCCCCEEEEeCcCCEeCC-CCccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999994 246789999999998644 345567899999999999998999999999999999999999999977
Q ss_pred CCh-HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 357 RTE-SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 357 ~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
... ..++..+..... +......+++++++||.+||+.||.+|||++|+|+||||++.
T Consensus 232 ~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 232 CQNAAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCcHHHHHHHHHcCCC--CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 544 455555544432 222234578999999999999999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-62 Score=483.05 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=221.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+.|++.++||+|+||.||+|+++. +|+.||||++++.. ...
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~---~g~~vAiK~i~~~~-----------------------------------~~~ 98 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQ---TGFQCAVKKVRLEV-----------------------------------FRV 98 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTT-----------------------------------CCT
T ss_pred hhheEeCcEeccCCCeEEEEEEECC---CCCEEEEEEECHHH-----------------------------------hHH
Confidence 3579999999999999999999987 89999999997531 113
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|+.|+ |||||+++++|++++.+|||||||+||+|.++|.+. +.+++.+++.|+.||+.||.|||++|||||||
T Consensus 99 ~E~~il~~l~-HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 176 (336)
T 4g3f_A 99 EELVACAGLS-SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176 (336)
T ss_dssp HHHHTTTTCC-CTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred HHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Confidence 6999999997 999999999999999999999999999999998665 68999999999999999999999999999999
Q ss_pred CCCceEEecCCCCC-cEEEEecccccccCCCCc------ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCC
Q 011582 280 KPENFLFTSKEENS-SLKAIDFGLSDYVKPDER------LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 280 kp~NIll~~~~~~~-~~kl~DfGla~~~~~~~~------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~ 351 (482)
||+||||+ .++ .+||+|||+|+.+..... ....+||+.|||||++.+ .|+.++|||||||++|||+||+
T Consensus 177 Kp~NILl~---~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~ 253 (336)
T 4g3f_A 177 KADNVLLS---SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253 (336)
T ss_dssp CGGGEEEC---TTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CHHHEEEe---CCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCc
Confidence 99999994 454 699999999987754321 234689999999999875 5999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHH-------------hcCcccccCCC
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA-------------LSHPWLANSHD 417 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~-------------L~hp~~~~~~~ 417 (482)
.||.+.+..+++..|......+. ..++.+|+++++||.+||++||.+|||+.|+ |+|||+.+...
T Consensus 254 ~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 254 HPWTQYFRGPLCLKIASEPPPIR-EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp CSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred CCCCCCCHHHHHHHHHcCCCCch-hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 99999888888888888765432 3356799999999999999999999999997 68999987644
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-61 Score=504.13 Aligned_cols=330 Identities=36% Similarity=0.644 Sum_probs=293.2
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|+++. +|+.||||++.+.. ........
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~----------------------------~~~~~~~~ 67 (486)
T 3mwu_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKAS----------------------------AKNKDTST 67 (486)
T ss_dssp HHHHHEEEEEEEECCSSSEEEEEEETT---TCCEEEEEEEEHHH----------------------------HBCSCHHH
T ss_pred ChhcceEEeEEEeecCCEEEEEEEECC---CCCEEEEEEEeccc----------------------------ccchHHHH
Confidence 467899999999999999999999876 79999999996531 11123467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+|+++. ||||+++++++.+.+.+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 68 ~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~ 145 (486)
T 3mwu_A 68 ILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIVHR 145 (486)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHhCC-CCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 889999999996 999999999999999999999999999999988765 579999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||||+|||++..+.++.+||+|||++............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+.
T Consensus 146 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 225 (486)
T 3mwu_A 146 DLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGK 225 (486)
T ss_dssp CCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999976667778999999999887766666778899999999999999999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCC-----CccHHHHHHHHH
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKI-----PSDMIVYKLIKA 432 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~-----~~~~~~~~~~~~ 432 (482)
+..+++..+......+..+.|..+|+++++||.+||+.||.+|||+.++|+||||+....... +........+++
T Consensus 226 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (486)
T 3mwu_A 226 NEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNIRQ 305 (486)
T ss_dssp SHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHHHH
Confidence 999999999999888888888899999999999999999999999999999999987654321 122345677889
Q ss_pred HhccchHHHHHHHhhhhcC-CHHHHHHHHHHHhhhCCCCCCccchhhhh
Q 011582 433 YISSSSLRKAALGALAKTL-TVPQLAYLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 433 ~~~~~~l~~~~~~~~~~~~-~~~~~~~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+.....++++++..++..+ +.++...++++|..+|.|+||.|+.+||.
T Consensus 306 ~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~F~~~D~d~dG~I~~~El~ 354 (486)
T 3mwu_A 306 FQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELV 354 (486)
T ss_dssp HHHSCHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCCCCceeeHHHHH
Confidence 9999999999999998776 88899999999999999999999999994
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-61 Score=505.33 Aligned_cols=331 Identities=36% Similarity=0.632 Sum_probs=292.9
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|+++. +|..||||++.+.. ........
T Consensus 34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~----------------------------~~~~~~~~ 82 (494)
T 3lij_A 34 HLSEMYQRVKKLGSGAYGEVLLCRDKV---THVERAIKIIRKTS----------------------------VSTSSNSK 82 (494)
T ss_dssp CHHHHEEEEEEEECC---EEEEEEETT---TCCEEEEEEEEC---------------------------------CTTHH
T ss_pred chhcCeEEeeEEecCCCEEEEEEEECC---CCcEEEEEEEeccc----------------------------cCchHHHH
Confidence 456789999999999999999999976 79999999997631 11122457
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. ||||++++++|.+.+.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 83 ~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 160 (494)
T 3lij_A 83 LLEEVAVLKLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGVTYLHKHNIVHR 160 (494)
T ss_dssp HHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Confidence 889999999996 999999999999999999999999999999988765 679999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||||+|||++..+.++.+||+|||++............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+.
T Consensus 161 Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 240 (494)
T 3lij_A 161 DLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQ 240 (494)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999976556778999999999988766667778999999999999888999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC-----CCCCCccHHHHHHHHH
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH-----DVKIPSDMIVYKLIKA 432 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~-----~~~~~~~~~~~~~~~~ 432 (482)
+..+++..+......+....|..+++++++||++||+.||.+|||+.++|+||||++.. ....+......+.+++
T Consensus 241 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (494)
T 3lij_A 241 TDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANAIENMRK 320 (494)
T ss_dssp SHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHHHHC---CCCCSSHHHHHHT
T ss_pred CHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcccccccccccccHHHHHHHHH
Confidence 99999999999999888888999999999999999999999999999999999998642 1234444556788899
Q ss_pred HhccchHHHHHHHhhhhcC-CHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 433 YISSSSLRKAALGALAKTL-TVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 433 ~~~~~~l~~~~~~~~~~~~-~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+...+.++++++..++..+ +.++...+++.|..+|.|+||+|+.+||..
T Consensus 321 ~~~~~~l~qa~l~~ia~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~ 370 (494)
T 3lij_A 321 FQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELID 370 (494)
T ss_dssp TTTCCHHHHHHHHHHHHHSCCHHHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHhHHHHHHHHHHHHHhcccHHHHHHHHHHHHHhCcCCCCeEcHHHHHH
Confidence 9999999999999998876 889999999999999999999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=502.51 Aligned_cols=331 Identities=36% Similarity=0.611 Sum_probs=297.9
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|+++. +|+.||||++.+.. .......+.
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~---------------------------~~~~~~~~~ 72 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKI---TGQECAVKVISKRQ---------------------------VKQKTDKES 72 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETTT---------------------------CCBSSCHHH
T ss_pred cccCceEEeeEEecCCCEEEEEEEECC---CCCEEEEEEEEhhh---------------------------cccchHHHH
Confidence 466899999999999999999999886 79999999997631 111223567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++++. ||||+++++++.+.+.+|+|||||.||+|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 73 ~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 150 (484)
T 3nyv_A 73 LLREVQLLKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGITYMHKNKIVHR 150 (484)
T ss_dssp HHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence 899999999996 999999999999999999999999999999988654 679999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||||+|||+...+.++.+||+|||++............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+.
T Consensus 151 Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 230 (484)
T 3nyv_A 151 DLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGA 230 (484)
T ss_dssp CCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCC
Confidence 99999999976667789999999999988776666778899999999999989999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC----CCCCccHHHHHHHHHH
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD----VKIPSDMIVYKLIKAY 433 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~----~~~~~~~~~~~~~~~~ 433 (482)
+..+++..+......+..+.|..+|+++++||++||+.||.+|||+.++|+||||+.... ...+........++++
T Consensus 231 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (484)
T 3nyv_A 231 NEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILNIRQF 310 (484)
T ss_dssp SHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC-----CCCBCHHHHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccccccccccccchHHHHHHHHHH
Confidence 999999999999988888888899999999999999999999999999999999986543 2344555677788999
Q ss_pred hccchHHHHHHHhhhhcC-CHHHHHHHHHHHhhhCCCCCCccchhhhh
Q 011582 434 ISSSSLRKAALGALAKTL-TVPQLAYLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 434 ~~~~~l~~~~~~~~~~~~-~~~~~~~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
...+.++++++..++..+ +.++...+++.|..+|.|+||+|+.+||.
T Consensus 311 ~~~~kl~qa~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~ 358 (484)
T 3nyv_A 311 QGTQKLAQAALLYMGSKLTSQDETKELTAIFHKMDKNGDGQLDRAELI 358 (484)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSEEEHHHHH
T ss_pred hhhhHHHHHHHHHHHhccCcHHHHHHHHHHHHHhCcCCCceEeHHHHH
Confidence 999999999999998776 77889999999999999999999999994
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-60 Score=500.38 Aligned_cols=343 Identities=33% Similarity=0.549 Sum_probs=293.5
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|.+++.||+|+||.||+|+++. +|+.||||++.+...... .... . ........+
T Consensus 32 ~~i~~~Y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~~~~~---~~~~-~-------------~~~~~~~~~ 91 (504)
T 3q5i_A 32 GKIGESYFKVRKLGSGAYGEVLLCKEKN---GHSEKAIKVIKKSQFDKG---RYSD-D-------------NKNIEKFHE 91 (504)
T ss_dssp SCGGGTEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEC---------------------------------CTHH
T ss_pred CCcccceEEEeEecccCCeEEEEEEECC---CCcEEEEEEEEhhhcccc---cccc-c-------------chhhHHHHH
Confidence 3467899999999999999999999987 789999999976410000 0000 0 001112356
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+.+|+++. ||||+++++++.+.+.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+|
T Consensus 92 ~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 169 (504)
T 3q5i_A 92 EIYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGICYLHKHNIVH 169 (504)
T ss_dssp HHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 7899999999996 999999999999999999999999999999988765 67999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||||+|||++.++....+||+|||++............+||+.|+|||++.+.|+.++|||||||++|+|++|..||.+
T Consensus 170 ~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 170 RDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp SCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999997544445799999999998877666777899999999999998899999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCCCc----cHHHHHHHHH
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPS----DMIVYKLIKA 432 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~----~~~~~~~~~~ 432 (482)
.+..+++..+......++...|..+|+++++||++||+.||.+|||++|+|+||||++........ ....+..+++
T Consensus 250 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (504)
T 3q5i_A 250 QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMRK 329 (504)
T ss_dssp SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHHH
Confidence 999999999999988887777888999999999999999999999999999999998765433222 2235677889
Q ss_pred HhccchHHHHHHHhhhhcC-CHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 433 YISSSSLRKAALGALAKTL-TVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 433 ~~~~~~l~~~~~~~~~~~~-~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
|...+.++++++..++.++ +.++...+++.|..+|.|+||+||.+||..
T Consensus 330 ~~~~~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~ 379 (504)
T 3q5i_A 330 FEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIE 379 (504)
T ss_dssp CCCCSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHH
Confidence 9999999999999998776 889999999999999999999999999864
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-60 Score=483.87 Aligned_cols=261 Identities=30% Similarity=0.499 Sum_probs=224.8
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||+||+|+++. +|+.||||++++. .......+.+
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~---t~~~vAiK~i~~~----------------------------~~~~~~~~~~ 100 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRL---TGQQVAIKKIPNA----------------------------FDVVTNAKRT 100 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEETTT----------------------------TSSHHHHHHH
T ss_pred CCCCeEEEEEEecccCeEEEEEEECC---CCCEEEEEEECcc----------------------------ccchHHHHHH
Confidence 45689999999999999999999987 8999999999653 1233445678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEe------CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYED------DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
.+|+.+|+.|+ |||||++++++.. .+.+|||||||+ |+|.+++.+ .+.+++.+++.|+.||+.||.|||++
T Consensus 101 ~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~ 177 (398)
T 4b99_A 101 LRELKILKHFK-HDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSA 177 (398)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcC-CCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 89999999997 9999999999764 367999999996 579988754 47899999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCC-----CCcccccccCccccCcccccc--cCCCcchhhhhHHHHH
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP-----DERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAY 345 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ 345 (482)
|||||||||+|||+ +.++.+||+|||+|+.+.. .....+.+||+.|||||++.+ .|+.++||||+||++|
T Consensus 178 ~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ 254 (398)
T 4b99_A 178 QVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFG 254 (398)
T ss_dssp TCBCCCCCGGGEEE---CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred cCcCCCcCcccccc---CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHH
Confidence 99999999999999 6788999999999987643 234567899999999998764 4799999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHhcCCCCCCCC---------------------------CCCCCHHHHHHHHHhchhccc
Q 011582 346 ILLCGSRPFWARTESGIFRAVLKADPSFDEAP---------------------------WPSLSPEAIDFVKRLLNKDYR 398 (482)
Q Consensus 346 elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~---------------------------~~~~s~~~~~li~~~L~~dP~ 398 (482)
||++|++||.+.+..+.+..|......++... ++.+|+++++||.+||++||.
T Consensus 255 ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~ 334 (398)
T 4b99_A 255 EMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPS 334 (398)
T ss_dssp HHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTT
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChh
Confidence 99999999999999999988877544333211 245799999999999999999
Q ss_pred cCCCHHHHhcCcccccCC
Q 011582 399 KRLTAAQALSHPWLANSH 416 (482)
Q Consensus 399 ~R~s~~e~L~hp~~~~~~ 416 (482)
+|||++|+|+||||++..
T Consensus 335 ~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 335 ARISAAAALRHPFLAKYH 352 (398)
T ss_dssp TSCCHHHHTTSGGGTTTC
T ss_pred HCcCHHHHhcCHhhCcCC
Confidence 999999999999998764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=501.61 Aligned_cols=265 Identities=35% Similarity=0.638 Sum_probs=243.9
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|+++. +|+.||||++.+. .....+.
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~---tg~~~AiK~i~~~------------------------------~~~~~~~ 200 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTP------------------------------HESDKET 200 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC------------------------------SHHHHHH
T ss_pred cCccccEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEecc------------------------------chhhHHH
Confidence 456899999999999999999999987 8999999999653 2334567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+|+.|+ |||||+++++|++++.+|||||||+||+|.++|..+.+.|++.+++.|+.||+.||.|||++||+||
T Consensus 201 ~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHR 279 (573)
T 3uto_A 201 VRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 279 (573)
T ss_dssp HHHHHHHHHHTC-CTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 899999999997 9999999999999999999999999999999997776789999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||||+|||++. +..+.+||+|||+|+.+.........+||+.|||||++.+ .|+.++|||||||++|+|++|..||.+
T Consensus 280 DlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~ 358 (573)
T 3uto_A 280 DLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 358 (573)
T ss_dssp CCCGGGEEESS-SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred cCChhhccccC-CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999964 2347899999999999887777788899999999999875 599999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.+..+++..|......++...|..+|+++++||++||+.||.+|||+.|+|+||||+....
T Consensus 359 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 359 ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp SSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred cCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 9999999999999988888888999999999999999999999999999999999997654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-59 Score=471.23 Aligned_cols=260 Identities=25% Similarity=0.451 Sum_probs=214.0
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|+++++||+|+||+||+|+++....+++.||||++.+. .....
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--------------------------------~~~~~ 65 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--------------------------------SHPIR 65 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--------------------------------SCHHH
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--------------------------------cCHHH
Confidence 4568899999999999999999998754446889999998543 11245
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+|+.+.+|||||+++++|++.+++|||||||+||+|.+++ +.+++.+++.++.||+.||.|||++|||||
T Consensus 66 ~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~----~~l~~~~~~~~~~qll~al~ylH~~gIiHR 141 (361)
T 4f9c_A 66 IAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL----NSLSFQEVREYMLNLFKALKRIHQFGIVHR 141 (361)
T ss_dssp HHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH----TTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCCeEeC
Confidence 7899999999977999999999999999999999999999999987 369999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCC-----------------------------CcccccccCccccCccccc
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-----------------------------ERLNDIVGSAYYVAPEVLH 328 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-----------------------------~~~~~~~gt~~y~aPE~~~ 328 (482)
||||+|||++ .+.+.+||+|||+|+..... ....+.+||+.|||||++.
T Consensus 142 DiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 219 (361)
T 4f9c_A 142 DVKPSNFLYN--RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLT 219 (361)
T ss_dssp CCSGGGEEEE--TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHT
T ss_pred cCCHHHeEEe--CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHc
Confidence 9999999995 23468999999999764322 1234568999999999886
Q ss_pred c--cCCCcchhhhhHHHHHHHhhCCCCCCCC-ChHHHHHHHHhcC-----------------------------------
Q 011582 329 R--SYGTEADMWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKAD----------------------------------- 370 (482)
Q Consensus 329 ~--~~~~~~DiwSlGvil~elltg~~pf~~~-~~~~~~~~i~~~~----------------------------------- 370 (482)
+ .|+.++||||+||++|||+||+.||... ++.+.+..|....
T Consensus 220 ~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 299 (361)
T 4f9c_A 220 KCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLR 299 (361)
T ss_dssp TCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC
T ss_pred CCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhc
Confidence 5 4899999999999999999999999654 4444444443210
Q ss_pred ---------------CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 371 ---------------PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 371 ---------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.......|..+|++++|||++||++||.+|+|++|+|+||||++.
T Consensus 300 ~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 300 GMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp ----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred cccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 001123467799999999999999999999999999999999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-59 Score=457.72 Aligned_cols=255 Identities=31% Similarity=0.509 Sum_probs=200.9
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||.||+|+++. +|+.||||+++.. ......+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~-----------------------------~~~~~~~~~ 50 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKV---DDCNYAIKRIRLP-----------------------------NRELAREKV 50 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETT---TCCEEEEEEEEEC-----------------------------SSHHHHHHH
T ss_pred cchhCEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEecc-----------------------------CCHHHHHHH
Confidence 35679999999999999999999987 8999999999653 233455788
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCC------------eEEEEEecCCCCChHHHHHhcC--CCCCHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDD------------NIYIVMELCKGGELLDRILSRG--GKYSEEDAKIVMVQILS 264 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~------------~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~ 264 (482)
.+|+.+|++|+ |||||+++++|.+.+ .+|||||||+||+|.+++..+. ...++..++.|+.||+.
T Consensus 51 ~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~ 129 (299)
T 4g31_A 51 MREVKALAKLE-HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAE 129 (299)
T ss_dssp HHHHHHHTTCC-CTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCC-CCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHH
Confidence 99999999996 999999999997654 3799999999999999986543 12456778999999999
Q ss_pred HHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC-------------cccccccCccccCcccccc-c
Q 011582 265 VVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-------------RLNDIVGSAYYVAPEVLHR-S 330 (482)
Q Consensus 265 ~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-------------~~~~~~gt~~y~aPE~~~~-~ 330 (482)
||.|||++|||||||||+|||+ +.++.+||+|||+|+.+.... ...+.+||+.|||||++.+ .
T Consensus 130 al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~ 206 (299)
T 4g31_A 130 AVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS 206 (299)
T ss_dssp HHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCC
T ss_pred HHHHHHHCcCccccCcHHHeEE---CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC
Confidence 9999999999999999999999 567889999999998765432 1234689999999999875 5
Q ss_pred CCCcchhhhhHHHHHHHhhCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 331 YGTEADMWSIGVIAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 331 ~~~~~DiwSlGvil~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|+.++|||||||++|||++ ||.+.... ..+..+... .++ ..+...++++.+||++||+.||.+|||+.|+|+|
T Consensus 207 y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~--~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 207 YSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL--KFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp CCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTT--CCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred CCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcC--CCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 9999999999999999996 88653322 223333322 222 2233467888999999999999999999999999
Q ss_pred cccccC
Q 011582 410 PWLANS 415 (482)
Q Consensus 410 p~~~~~ 415 (482)
|||++.
T Consensus 281 ~~~~~~ 286 (299)
T 4g31_A 281 AVFEDL 286 (299)
T ss_dssp GGGCCC
T ss_pred HhhCCC
Confidence 999865
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-58 Score=450.99 Aligned_cols=256 Identities=25% Similarity=0.378 Sum_probs=218.3
Q ss_pred ccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|.+.++||+|+||.||+|+.... ..+|..||||++++. .....+.
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~------------------------------~~~~~~~ 61 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA------------------------------SDNARKD 61 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC------------------------------CHHHHHH
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC------------------------------ChHHHHH
Confidence 46899999999999999999987531 125889999998642 3345678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC------------CCCCHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG------------GKYSEEDAKIVMVQILSV 265 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~l~~~~~~~i~~qi~~~ 265 (482)
|.+|+.+|++|+ |||||+++++|.+++.+|||||||+||+|.++|...+ ..+++.++..|+.||+.|
T Consensus 62 f~~E~~il~~l~-HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~g 140 (299)
T 4asz_A 62 FHREAELLTNLQ-HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140 (299)
T ss_dssp HHHHHHHHTTCC-CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCC-CCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHH
Confidence 999999999997 9999999999999999999999999999999997532 469999999999999999
Q ss_pred HHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhH
Q 011582 266 VAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIG 341 (482)
Q Consensus 266 L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlG 341 (482)
|.|||+++||||||||+|||+ +.++.+||+|||+|+....... ....+||+.|||||++. +.|+.++||||||
T Consensus 141 l~yLH~~~iiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~G 217 (299)
T 4asz_A 141 MVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 217 (299)
T ss_dssp HHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHhCCcccCccCHhhEEE---CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHH
Confidence 999999999999999999999 6678899999999987654332 23457999999999986 5799999999999
Q ss_pred HHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 342 VIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 342 vil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
|++|||+| |+.||.+.+..+++..+..+.... ....+|+++.+||.+||+.||++|||+.++ ++|+++
T Consensus 218 vvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 218 VVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ---RPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp HHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 99999998 999999999999999988865321 224589999999999999999999999998 456643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-57 Score=449.50 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=208.0
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++++++++||+|+||+||+|+.+ ..||||+++.. .......+.|.+
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~------~~vAvK~~~~~----------------------------~~~~~~~~~f~~ 81 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH------GDVAVKILKVV----------------------------DPTPEQFQAFRN 81 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS------SEEEEEECCCS----------------------------SCCHHHHHHHHH
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC------CcEEEEEEEec----------------------------CCCHHHHHHHHH
Confidence 57889999999999999999753 25999998642 133455678999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|++++ |||||++++++. ++.+|||||||+||+|.++|......+++.++..|+.||+.||.|||++||||||||
T Consensus 82 E~~il~~l~-HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlK 159 (307)
T 3omv_A 82 EVAVLRKTR-HVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMK 159 (307)
T ss_dssp HHHHHTTCC-CTTBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCC
T ss_pred HHHHHHhCC-CCCEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccC
Confidence 999999997 999999999875 467899999999999999998777789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC---CcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD---ERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~~p 353 (482)
|+|||| +.++.+||+|||+|+..... ......+||+.|||||++. +.|+.++|||||||+||||+||+.|
T Consensus 160 p~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~P 236 (307)
T 3omv_A 160 SNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELP 236 (307)
T ss_dssp SSSEEE---ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred HHHEEE---CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCC
Confidence 999999 56789999999999876432 2345678999999999985 2489999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCC--CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 354 FWARTESGIFRAVLKADPSFD--EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|.+.+....+..+.......+ ...+..+++++.+||.+||+.||++|||+.|++++
T Consensus 237 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 237 YSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp TTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred CCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 988766655555554433322 23456789999999999999999999999988654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-57 Score=482.61 Aligned_cols=259 Identities=26% Similarity=0.427 Sum_probs=220.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+++. +|+.||||++.+.... ...........+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~---tg~~~AiK~i~K~~i~------------------------~~~~~~~~~~E~ 240 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKRIK------------------------MKQGETLALNER 240 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHHH------------------------HTTCHHHHHHHH
T ss_pred hHHeEEEEEEecccCeEEEEEEECC---CCCEEEEEEEeHHHcc------------------------hhhhHHHHHHHH
Confidence 5789999999999999999999987 8999999999874110 001111222233
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+++.+++.+. |||||+++++|++.+.+|||||||+||+|.++|.+. +.|++..++.|+.||+.||.|||++|||||||
T Consensus 241 ~~l~ll~~~~-HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDL 318 (689)
T 3v5w_A 241 IMLSLVSTGD-CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVYRDL 318 (689)
T ss_dssp HHHHHHSSSC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred HHHHHHhhCC-CCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 4456666665 999999999999999999999999999999998765 68999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-c-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-R-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||| +.++.+||+|||+|+.+.. ....+.+||+.|||||++. + .|+.++|||||||++|||++|.+||.+.
T Consensus 319 KPeNILl---d~~G~vKL~DFGlA~~~~~-~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 319 KPANILL---DEHGHVRISDLGLACDFSK-KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp SGGGEEE---CTTSCEEECCCTTCEECSS-CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred chHHeEE---eCCCCEEecccceeeecCC-CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999 6788999999999987654 3456789999999999985 3 5999999999999999999999999764
Q ss_pred ---ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 358 ---TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 358 ---~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
...++...+......++ ..+|+++++||.+||++||.+|++ ++|+++||||++.
T Consensus 395 ~~~~~~~i~~~i~~~~~~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 395 KTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp GCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred ChHHHHHHHHhhcCCCCCCC----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 34466777777766554 459999999999999999999998 7999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-57 Score=448.74 Aligned_cols=253 Identities=22% Similarity=0.364 Sum_probs=210.8
Q ss_pred ccceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|.+.++||+|+||.||+|+.+. ...+|+.||||++++ ......+.
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~------------------------------~~~~~~~~ 89 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE------------------------------ASESARQD 89 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESC------------------------------CSHHHHHH
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECc------------------------------CCHHHHHH
Confidence 3679999999999999999998753 122588999999864 23445678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC--------------CCCCHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG--------------GKYSEEDAKIVMVQIL 263 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--------------~~l~~~~~~~i~~qi~ 263 (482)
|.+|+.+|++|+ |||||+++++|.+.+.+|||||||++|+|.+++.... +.+++.++..|+.||+
T Consensus 90 f~~E~~il~~l~-HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia 168 (329)
T 4aoj_A 90 FQREAELLTMLQ-HQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168 (329)
T ss_dssp HHHHHHHHTTCC-CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHH
Confidence 999999999997 9999999999999999999999999999999986532 4699999999999999
Q ss_pred HHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc-cCCCcchhhh
Q 011582 264 SVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR-SYGTEADMWS 339 (482)
Q Consensus 264 ~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwS 339 (482)
.||.|||+++||||||||+|||| +.++.+||+|||+|+.+.... .....+||+.|||||++.+ .|+.++||||
T Consensus 169 ~gl~yLH~~~iiHRDLKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS 245 (329)
T 4aoj_A 169 AGMVYLAGLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWS 245 (329)
T ss_dssp HHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHH
T ss_pred HHHHHHhcCCeecccccHhhEEE---CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccc
Confidence 99999999999999999999999 578899999999998764432 2345689999999998875 6999999999
Q ss_pred hHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 340 IGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 340 lGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|||+||||+| |+.||.+.+..+++..+..+.. . .....+++++.+||.+||+.||++|||+.|++.+
T Consensus 246 ~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~-~--~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 246 FGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE-L--ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC-C--CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred hHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC-C--CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999999 9999999999999988887642 1 1224589999999999999999999999999753
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-57 Score=443.97 Aligned_cols=255 Identities=20% Similarity=0.302 Sum_probs=217.0
Q ss_pred cccceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
-.+++++.++||+|+||.||+|+... ...+++.||||+++.. ......+
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~-----------------------------~~~~~~~ 74 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK-----------------------------AEGPLRE 74 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC------------------------------CCC-CHH
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcc-----------------------------cChHHHH
Confidence 34678999999999999999998642 1125789999998643 1223356
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMVQ 261 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~q 261 (482)
.|.+|+.+|++|+ |||||+++++|.+++.+|||||||++|+|.++|..+. ..+++.++..|+.|
T Consensus 75 ~f~~E~~il~~l~-HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 153 (308)
T 4gt4_A 75 EFRHEAMLRARLQ-HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153 (308)
T ss_dssp HHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHhCC-CCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHH
Confidence 7999999999997 9999999999999999999999999999999996532 45899999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchh
Q 011582 262 ILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADM 337 (482)
Q Consensus 262 i~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di 337 (482)
|+.||.|||+++||||||||+|||| ++++.+||+|||+|+...... .....+||+.|||||++. +.|+.++||
T Consensus 154 ia~gl~yLH~~~iiHRDLK~~NILl---~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDV 230 (308)
T 4gt4_A 154 IAAGMEYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDI 230 (308)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhCCCCCCCccccceEE---CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchh
Confidence 9999999999999999999999999 667889999999998764332 345578999999999886 579999999
Q ss_pred hhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 338 WSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 338 wSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|||||+||||+| |..||.+.+..+++..+..+... +....+++++.+|+.+||+.||.+|||+.|++++
T Consensus 231 wSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 231 WSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVL---PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999998 89999999999999888776432 1234689999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-56 Score=459.97 Aligned_cols=322 Identities=33% Similarity=0.602 Sum_probs=275.0
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++++.||+|+||.||+|.++. +|+.||+|++.+. .......+
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~---~~~~~a~K~i~~~----------------------------~~~~~~~~ 55 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVL---AGQEYAAMIINTK----------------------------KLSARDHQ 55 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETT---TTEEEEEEEEESC----------------------------SCHHHHHH
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECC---CCcEEEEEEEEcc----------------------------cCCHHHHH
Confidence 3567899999999999999999999887 8999999999763 12334456
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+.+++.+. ||||+++++++.+++..|+|||||+||+|.+++..+ +.+++..+..++.||+.||.|||++||+|
T Consensus 56 ~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~lH~~givH 133 (444)
T 3soa_A 56 KLEREARICRLLK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLHCHQMGVVH 133 (444)
T ss_dssp HHHHHHHHHHHCC-BTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHHHHHHHHhCC-CcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 7899999999996 999999999999999999999999999999988765 67999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf 354 (482)
|||||+|||++.+..++.+||+|||++....... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||
T Consensus 134 rDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf 213 (444)
T 3soa_A 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPF 213 (444)
T ss_dssp CCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSC
T ss_pred cCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCC
Confidence 9999999999765567899999999998765433 3456789999999999875 5999999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC-CCCCccHHHHHHHHHH
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD-VKIPSDMIVYKLIKAY 433 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~-~~~~~~~~~~~~~~~~ 433 (482)
.+.+..+++..+..+...++...|..+++++++||.+||+.||.+|||+.|+|+||||+.... ..........+.++++
T Consensus 214 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~~~~~~~~~~~~~~~l~~~ 293 (444)
T 3soa_A 214 WDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKF 293 (444)
T ss_dssp CCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHHHHSCCCCCHHHHHHHHHH
T ss_pred CCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCccccccchhhHHHHHHHHH
Confidence 999999999999999999999999999999999999999999999999999999999986432 1222345667888999
Q ss_pred hccchHHHHHHHhhh--hcCC--HHHHHHHHHHHhhhCCCCC
Q 011582 434 ISSSSLRKAALGALA--KTLT--VPQLAYLREQFTLLAPNKN 471 (482)
Q Consensus 434 ~~~~~l~~~~~~~~~--~~~~--~~~~~~l~~~f~~~d~n~d 471 (482)
...+.++.+++..+. ..+. .++..++.+.|.....|+|
T Consensus 294 ~~~~klk~~~~~~~~~~~~~~~~~~e~~~~~~~~l~~i~~gD 335 (444)
T 3soa_A 294 NARRKLKGAILTVMLATRNFSVRKQEIIKVTEQLIEAISNGD 335 (444)
T ss_dssp HHHHHHHTTCSCEECCCCSCCHHHHHHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHHHHHHhhhcccchHHHHHHHHHHHhhhhcCC
Confidence 999999998887774 3343 2445556666666666655
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-55 Score=444.47 Aligned_cols=299 Identities=33% Similarity=0.636 Sum_probs=262.4
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++.+.||+|+||.||+|+++. +|+.||||++.+. .......+
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~----------------------------~~~~~~~~ 73 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTK----------------------------KLSARDFQ 73 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETT----------------------------TCCHHHHH
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECC---CCCEEEEEEEEcc----------------------------cCCHHHHH
Confidence 4567899999999999999999999876 7999999999753 12334557
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+.+++.+. ||||+++++++.+.+..|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++||+|
T Consensus 74 ~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH 151 (362)
T 2bdw_A 74 KLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVH 151 (362)
T ss_dssp HHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred HHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 7899999999996 999999999999999999999999999999988654 67999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||||+|||++.++.++.+||+|||++............+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.
T Consensus 152 ~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~ 231 (362)
T 2bdw_A 152 RNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW 231 (362)
T ss_dssp CCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence 99999999997655567899999999988776666667899999999999875 69999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC-CCCCccHHHHHHHHHHh
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD-VKIPSDMIVYKLIKAYI 434 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~-~~~~~~~~~~~~~~~~~ 434 (482)
+.+..+++..+..+...++...|..+++++++||.+||+.||.+|||+.++|+||||..... ............++++.
T Consensus 232 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~~~~ 311 (362)
T 2bdw_A 232 DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFN 311 (362)
T ss_dssp CSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTHHHHSCCCCCHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCCcccccccchhhHHHHHHHHH
Confidence 99999999999999888888888899999999999999999999999999999999986432 11223345667788888
Q ss_pred ccchHHHHHHHhhh
Q 011582 435 SSSSLRKAALGALA 448 (482)
Q Consensus 435 ~~~~l~~~~~~~~~ 448 (482)
..+.++.+++..++
T Consensus 312 ~~~~~~~~~~~~~~ 325 (362)
T 2bdw_A 312 ARRKLKGAILTTMI 325 (362)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 88888888877664
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=443.99 Aligned_cols=256 Identities=26% Similarity=0.378 Sum_probs=213.7
Q ss_pred ccceEecceeecCCceEEEEEEEecCC--CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGS--LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~--~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++++.||+|+||.||+|+..... .+++.||||++... ......+.
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~-----------------------------~~~~~~~~ 113 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-----------------------------ATHSEHRA 113 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTT-----------------------------CCHHHHHH
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccc-----------------------------cChHHHHH
Confidence 468999999999999999999987521 24578999998653 23344678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeC-CeEEEEEecCCCCChHHHHHhc---------------CCCCCHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDD-DNIYIVMELCKGGELLDRILSR---------------GGKYSEEDAKIVMVQ 261 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~q 261 (482)
+.+|+.+|+++..|||||+++++|.+. +.+|||||||++|+|.++|... ...+++.++..|+.|
T Consensus 114 ~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 193 (353)
T 4ase_A 114 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQ 193 (353)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHH
T ss_pred HHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHH
Confidence 999999999997569999999998764 5789999999999999999753 235899999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchh
Q 011582 262 ILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADM 337 (482)
Q Consensus 262 i~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di 337 (482)
|+.||.|||+++||||||||+|||+ +.++.+||+|||+|+.+.... .....+||+.|||||++. +.|+.++||
T Consensus 194 ia~gl~yLH~~~iiHRDLK~~NILl---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDV 270 (353)
T 4ase_A 194 VAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV 270 (353)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHhHhhCCeecCccCccceee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccE
Confidence 9999999999999999999999999 567889999999998765433 234568999999999886 569999999
Q ss_pred hhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 338 WSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 338 wSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|||||+||||+| |..||.+....+.+..+.........+ ..+++++.+||.+||+.||.+|||+.++++|
T Consensus 271 wS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p--~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 271 WSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred eehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCC--ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 999999999998 999998876544444444433333222 3589999999999999999999999999987
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-53 Score=424.98 Aligned_cols=258 Identities=33% Similarity=0.629 Sum_probs=233.3
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++.. +|+.||||++.+. .......+.+
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~~ 61 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHIL---TGREVAIKIIDKT----------------------------QLNPTSLQKL 61 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGG----------------------------GSCHHHHHHH
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhh----------------------------cCCHHHHHHH
Confidence 45789999999999999999999876 8999999999763 1234456788
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+|+.++ ||||+++++++.+.+.+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+|||
T Consensus 62 ~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrD 139 (328)
T 3fe3_A 62 FREVRIMKILN-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQYCHQKRIVHRD 139 (328)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHhCC-CCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeccC
Confidence 99999999997 999999999999999999999999999999988765 6799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cC-CCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SY-GTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||+|||+ +.++.+||+|||++............+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+
T Consensus 140 lkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 216 (328)
T 3fe3_A 140 LKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 216 (328)
T ss_dssp CCGGGEEE---CTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCHHHEEE---cCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 99999999 6778899999999988777677778899999999999875 34 4789999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.+..++...+......++. .+++++.+||++||+.||.+|||++|+|+||||+...
T Consensus 217 ~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 217 QNLKELRERVLRGKYRIPF----YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp SSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999988766553 3899999999999999999999999999999998654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=428.28 Aligned_cols=263 Identities=30% Similarity=0.589 Sum_probs=238.2
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|++.. +|+.||+|++... ......
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~-------------------------------~~~~~~ 47 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVK-------------------------------GTDQVL 47 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC-------------------------------THHHHH
T ss_pred chhhceEeeeEEecCCCeEEEEEEECC---CCcEEEEEEEecC-------------------------------cccHHH
Confidence 356899999999999999999999876 7999999998542 123456
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. ||||+++++++.+.+.+|+|||||+||+|.+++......+++..++.++.||+.||.|||++||+||
T Consensus 48 ~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~ 126 (321)
T 1tki_A 48 VKKEISILNIAR-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126 (321)
T ss_dssp HHHHHHHHHHSC-CTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcC
Confidence 889999999997 9999999999999999999999999999999987665689999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccccc-CCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||||+|||++.+ .++.+||+|||++............+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+
T Consensus 127 Dlkp~NIl~~~~-~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~ 205 (321)
T 1tki_A 127 DIRPENIIYQTR-RSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp CCCGGGEEESSS-SCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCCHHHEEEccC-CCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcC
Confidence 999999999532 2678999999999988766666778899999999998754 79999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.+..+++..+......++...|+.+++++.+||.+||..||.+|||+.|+|+||||++..
T Consensus 206 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 206 ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred CCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 999999999999988887777788999999999999999999999999999999998754
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-54 Score=433.41 Aligned_cols=299 Identities=34% Similarity=0.577 Sum_probs=243.4
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++++.||+|+||.||+|+++. +|+.||||++.+.... . .......+
T Consensus 8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~---~~~~~avK~i~~~~~~--------~----------------~~~~~~~~ 60 (361)
T 2yab_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSR--------A----------------SRRGVCRE 60 (361)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEBCSST--------T----------------CSSSBCHH
T ss_pred CChhhceEEeeEEeeCcCEEEEEEEECC---CCCEEEEEEEEccccc--------c----------------ccchhHHH
Confidence 3466789999999999999999999986 7999999999764100 0 00111346
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+.+|+.+. ||||+++++++.+.+.+|+|||||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+|
T Consensus 61 ~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH 138 (361)
T 2yab_A 61 EIEREVSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAH 138 (361)
T ss_dssp HHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHhCC-CcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 7899999999997 99999999999999999999999999999998854 468999999999999999999999999999
Q ss_pred cCCCCCceEEecCCC-CCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 277 RDLKPENFLFTSKEE-NSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 277 rDlkp~NIll~~~~~-~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf 354 (482)
|||||+|||+..++. ...+||+|||++............+||+.|+|||++.+ .|+.++|||||||++|+|++|..||
T Consensus 139 rDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf 218 (361)
T 2yab_A 139 FDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218 (361)
T ss_dssp CCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSS
T ss_pred CCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999953221 22799999999998776666677899999999999875 6999999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCCC---ccHHHHHHHH
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIP---SDMIVYKLIK 431 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~---~~~~~~~~~~ 431 (482)
.+.+..+.+..|......++...|..+++++++||.+||..||.+|||++|+|+||||+........ ........++
T Consensus 219 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~ 298 (361)
T 2yab_A 219 LGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFK 298 (361)
T ss_dssp CCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHHHHHHHHTCBCCHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchhhhhhcccchhhHHHHH
Confidence 9999999999999988888777778899999999999999999999999999999999854311000 0001123445
Q ss_pred HHhccchHHHHHH
Q 011582 432 AYISSSSLRKAAL 444 (482)
Q Consensus 432 ~~~~~~~l~~~~~ 444 (482)
++...+.++.++.
T Consensus 299 ~~~~~~~~~~~~~ 311 (361)
T 2yab_A 299 KQYVRRRWKLSFS 311 (361)
T ss_dssp HHTC---------
T ss_pred HHHHHhHHHHHHH
Confidence 5555566665543
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=438.56 Aligned_cols=261 Identities=33% Similarity=0.611 Sum_probs=219.4
Q ss_pred ccccceEec-ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 118 QFVAHYELG-EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 118 ~~~~~y~~~-~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
.+.++|.+. +.||+|+||.||+|+++. +|+.||||++.+. .
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~---~~~~vAiK~~~~~-----------------------------------~ 99 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC-----------------------------------P 99 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS-----------------------------------H
T ss_pred cccccceeccceeeeccCeEEEEEEECC---CCCEEEEEEeCcc-----------------------------------h
Confidence 345678887 689999999999999876 7999999998642 3
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
.+.+|+.++.++.+||||++++++|.. .+.+|||||||+||+|.+++.... ..+++..++.++.||+.||.|||+
T Consensus 100 ~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 179 (400)
T 1nxk_A 100 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 179 (400)
T ss_dssp HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 567899988776679999999999876 667999999999999999987653 469999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhC
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg 350 (482)
+||+||||||+|||++..+.++.+||+|||+++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|
T Consensus 180 ~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 259 (400)
T 1nxk_A 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259 (400)
T ss_dssp TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHS
T ss_pred CCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhC
Confidence 9999999999999997544478999999999988766556677899999999999864 699999999999999999999
Q ss_pred CCCCCCCChH----HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 351 SRPFWARTES----GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 351 ~~pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..||.+.... .+...+......++...|..+++++.+||++||+.||.+|||+.++|+||||.+..
T Consensus 260 ~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 260 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp SCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred CCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 9999876543 35667777888888888889999999999999999999999999999999998754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=426.00 Aligned_cols=294 Identities=37% Similarity=0.644 Sum_probs=237.7
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++.+.||+|+||.||+|++.. +++.||||++.+. ...+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vavK~~~~~--------------------------------~~~~ 93 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKG---TQKPYALKVLKKT--------------------------------VDKK 93 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEC-------------------------------------
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECC---CCcEEEEEEeccc--------------------------------hhHH
Confidence 3456789999999999999999999876 7899999998653 1234
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+.+++++. ||||+++++++.+.+..|+||||+++++|.+++... +.+++..++.++.||+.||.|||++||+|
T Consensus 94 ~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH 171 (349)
T 2w4o_A 94 IVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK-GYYSERDAADAVKQILEAVAYLHENGIVH 171 (349)
T ss_dssp -----CHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhCC-CCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 5788999999997 999999999999999999999999999999988544 67999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||||+|||++..+.++.+||+|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 172 ~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 251 (349)
T 2w4o_A 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFY 251 (349)
T ss_dssp CCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred cCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence 99999999997545578999999999987765555567789999999999875 59999999999999999999999997
Q ss_pred CCChH-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCCCccHHHHHHHHHHh
Q 011582 356 ARTES-GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYI 434 (482)
Q Consensus 356 ~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~ 434 (482)
..... .++..+......+....|..++.++.+||.+||+.||.+|||+.++|+||||........ ........++++.
T Consensus 252 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~~~-~~~~~~~~~~~~~ 330 (349)
T 2w4o_A 252 DERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAANFV-HMDTAQKKLQEFN 330 (349)
T ss_dssp CTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCCCS-CCHHHHHHHHHHH
T ss_pred CCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccchh-hhcchHHHHHHHH
Confidence 76554 477788887777777778889999999999999999999999999999999987654433 3345667788888
Q ss_pred ccchHHHHHHHhhh
Q 011582 435 SSSSLRKAALGALA 448 (482)
Q Consensus 435 ~~~~l~~~~~~~~~ 448 (482)
..+.++++....++
T Consensus 331 ~~~~~~~~~~~~~~ 344 (349)
T 2w4o_A 331 ARRKLKAAVKAVVA 344 (349)
T ss_dssp HHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHH
Confidence 88888888777664
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-54 Score=431.63 Aligned_cols=301 Identities=32% Similarity=0.561 Sum_probs=243.2
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|+++. +|+.||||++.+... ........+.
T Consensus 21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~~-------------------------~~~~~~~~~~ 72 (351)
T 3c0i_A 21 LFEDVYELCEVIGKGPFSVVRRCINRE---TGQQFAVKIVDVAKF-------------------------TSSPGLSTED 72 (351)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHH-------------------------HTSSSCCHHH
T ss_pred ccccceEEeeEEeeCCCEEEEEEEECC---CCCEEEEEEEEhhhc-------------------------cccccchHHH
Confidence 356789999999999999999999877 799999999865310 0011113467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCHFQGV 274 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~i 274 (482)
+.+|+.+++.+. ||||+++++++.+++.+|+|||||+|++|.+.+... +..+++..++.++.||+.||.|||++||
T Consensus 73 ~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i 151 (351)
T 3c0i_A 73 LKREASICHMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNI 151 (351)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 899999999996 999999999999999999999999999998887653 3458999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCCCCc-ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCC
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER-LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~ 352 (482)
+||||||+|||++.++....+||+|||++........ ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..
T Consensus 152 vHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~ 231 (351)
T 3c0i_A 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL 231 (351)
T ss_dssp ECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCC
Confidence 9999999999997655566799999999987765433 456789999999999875 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC-CCCCccHHHHHHHH
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD-VKIPSDMIVYKLIK 431 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~-~~~~~~~~~~~~~~ 431 (482)
||.+. ..+++..+......+....|..+++++++||.+||+.||.+|||+.++|+||||+.... ..........+.++
T Consensus 232 pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~~~~~~~~~~~~~l~ 310 (351)
T 3c0i_A 232 PFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLR 310 (351)
T ss_dssp SSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHHHHSCCSCCHHHHHHHH
T ss_pred CCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCccccccccchHHHHHHH
Confidence 99875 45677788887776666667789999999999999999999999999999999986432 11122234556777
Q ss_pred HHhccchHHHHHHHhhh
Q 011582 432 AYISSSSLRKAALGALA 448 (482)
Q Consensus 432 ~~~~~~~l~~~~~~~~~ 448 (482)
++...+.++.+++..++
T Consensus 311 ~~~~~~~~~~~~~~~~~ 327 (351)
T 3c0i_A 311 KFNARRKLKGAVLAAVS 327 (351)
T ss_dssp HHHHHHC----------
T ss_pred HHHHHHHHHHHHHHHHH
Confidence 88877888887777664
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=428.04 Aligned_cols=258 Identities=30% Similarity=0.553 Sum_probs=225.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+++. +|+.||||++++.. .......+.+.
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AvK~~~~~~---------------------------~~~~~~~~~~~ 71 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKE---TGDLYAVKVLKKDV---------------------------ILQDDDVECTM 71 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHHTTHHHHH
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcC---CCCEEEEEEEEHHH---------------------------hcchhHHHHHH
Confidence 4689999999999999999999986 79999999997631 11223456788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+.+||||+++++++.+.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||
T Consensus 72 ~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrDl 150 (353)
T 3txo_A 72 TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISALMFLHDKGIIYRDL 150 (353)
T ss_dssp HHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Confidence 99999999867999999999999999999999999999999988665 67999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||+ +.++.+||+|||+++.... .......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.
T Consensus 151 kp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~ 227 (353)
T 3txo_A 151 KLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227 (353)
T ss_dssp CGGGEEE---CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEE---CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC
Confidence 9999999 6778899999999986432 334566789999999999875 5999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH------HHHhcCcccccC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA------AQALSHPWLANS 415 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~------~e~L~hp~~~~~ 415 (482)
+..+++..|......++. .+++++.+||++||+.||.+|+++ +++++||||++.
T Consensus 228 ~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 228 NEDDLFEAILNDEVVYPT----WLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp SHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred CHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 999999999998876653 389999999999999999999999 999999999864
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-53 Score=426.44 Aligned_cols=318 Identities=28% Similarity=0.457 Sum_probs=209.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|+++. +|+.||||++.+.. ...+.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-------------------------------~~~~~~~ 64 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKL---TKELVAVKYIERGA-------------------------------AIDENVQ 64 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETT---TCCEEEEEEEESST-------------------------------TSCHHHH
T ss_pred CCcEEEEEEeccCCCEEEEEEEECC---CCcEEEEEEEecCc-------------------------------cccHHHH
Confidence 4689999999999999999999986 79999999986531 1124578
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.++ ||||+++++++.+.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||
T Consensus 65 ~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dl 142 (361)
T 3uc3_A 65 REIINHRSLR-HPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGVSYCHSMQICHRDL 142 (361)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCC
T ss_pred HHHHHHHhCC-CCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 9999999997 999999999999999999999999999999988655 57999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCc-chhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTE-ADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||++. +..+.+||+|||+++...........+||+.|+|||++.+ .++.+ +|||||||++|+|++|+.||.+.
T Consensus 143 kp~Nill~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (361)
T 3uc3_A 143 KLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDP 221 (361)
T ss_dssp CGGGEEECS-SSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC--
T ss_pred CHHHEEEcC-CCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCC
Confidence 999999942 1233599999999986555555566789999999998864 45544 89999999999999999999875
Q ss_pred Ch----HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCCCc-----------
Q 011582 358 TE----SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPS----------- 422 (482)
Q Consensus 358 ~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~----------- 422 (482)
.. ...+..+......++. ...+++++.+||.+||+.||.+|||+.++|+||||..........
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~ 299 (361)
T 3uc3_A 222 EEPRDYRKTIQRILSVKYSIPD--DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEP 299 (361)
T ss_dssp --CCCHHHHHHHHHTTCCCCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCCC--------------
T ss_pred ccHHHHHHHHHHHhcCCCCCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCchhhhccccccccccCC
Confidence 43 4555556555544433 345899999999999999999999999999999997543221110
Q ss_pred ------cHHHHHHHHHHhccchHHHHHHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccch
Q 011582 423 ------DMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFISM 476 (482)
Q Consensus 423 ------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~ 476 (482)
...+.+.+..-.......+.....+..++..++.....+.|..+|.|+||.|+.
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~d~~~~~~d~~~~~d~d~~g~~~~ 359 (361)
T 3uc3_A 300 EQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDIDSSGEIVY 359 (361)
T ss_dssp ----CCHHHHHHHHHHHTCC----------------------------------------
T ss_pred cccccCHHHHHHHHhhccCcccccccchhccccccccccccccccchhhhccCCCCcEEe
Confidence 001112222211112222333344455555555555668899999999999975
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-52 Score=418.86 Aligned_cols=257 Identities=29% Similarity=0.559 Sum_probs=228.4
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+++. +|+.||||++++.. .........+.
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~---------------------------~~~~~~~~~~~ 53 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEV---------------------------IIAKDEVAHTV 53 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHHH
T ss_pred hHHeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEeHHH---------------------------hhhhhHHHHHH
Confidence 4689999999999999999999876 79999999997631 01122346788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|+.+. ||||+++++++.+.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||
T Consensus 54 ~E~~~l~~l~-hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 131 (337)
T 1o6l_A 54 TESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131 (337)
T ss_dssp HHHHHHHSCC-CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HHHHHHHhCC-CCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcC
Confidence 9999999996 999999999999999999999999999999988654 67999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||+ +.++.+||+|||+++... ........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.
T Consensus 132 kp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 208 (337)
T 1o6l_A 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHEEE---CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence 9999999 677899999999998643 3345567899999999999865 5899999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
+...+...+......++. .+++++++||.+||+.||.+|| +++++++||||...
T Consensus 209 ~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 209 DHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp SHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 999999999888766653 4899999999999999999999 99999999999864
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=425.45 Aligned_cols=264 Identities=38% Similarity=0.627 Sum_probs=238.1
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|+++. +|+.||+|++... .......
T Consensus 48 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~~a~K~~~~~------------------------------~~~~~~~ 94 (387)
T 1kob_A 48 SVYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTP------------------------------YPLDKYT 94 (387)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC------------------------------SHHHHHH
T ss_pred ccccceEEEEEEecCCCEEEEEEEECC---CCCEEEEEEeccc------------------------------chhhHHH
Confidence 356789999999999999999999986 7999999998653 2233457
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+|+.+. ||||+++++++.+.+.+|+|||||+||+|.+++......+++..++.++.||+.||.|||++||+||
T Consensus 95 ~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHr 173 (387)
T 1kob_A 95 VKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHL 173 (387)
T ss_dssp HHHHHHHHTTCC-STTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 889999999996 9999999999999999999999999999999887665689999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||||+|||++. +..+.+||+|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus 174 Dlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~ 252 (387)
T 1kob_A 174 DIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG 252 (387)
T ss_dssp CCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC
T ss_pred ccchHHeEEec-CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCC
Confidence 99999999953 2356799999999998776666666789999999999875 589999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.+..+.+..+......++...+..+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 253 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 253 EDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp SSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 999999999999888888888888999999999999999999999999999999998754
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=403.41 Aligned_cols=267 Identities=36% Similarity=0.698 Sum_probs=241.6
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|.++. +|+.||+|++... .......+.
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----------------------------~~~~~~~~~ 51 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKT---TGLEFAAKIINTK----------------------------KLSARDFQK 51 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGG----------------------------GCCHHHHHH
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcC---CCceEEEEEeecc----------------------------cCCHHHHHH
Confidence 467899999999999999999999876 7999999998653 123445678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++++. ||||+++++++.+.+..|+||||+++++|.+.+... ..+++..+..++.|++.||.|||++||+||
T Consensus 52 ~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 129 (284)
T 3kk8_A 52 LEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAYCHSNGIVHR 129 (284)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHcC-CCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcCcC
Confidence 899999999996 999999999999999999999999999999988765 679999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||||+|||++.++.++.+||+|||++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+
T Consensus 130 dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 209 (284)
T 3kk8_A 130 NLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 209 (284)
T ss_dssp CCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCC
Confidence 9999999997655566799999999988776666667889999999998875 589999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.........+......++...+..+++++.+||.+||+.||.+|||++|+|+||||++...
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 210 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp SSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred CchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999999999888888888899999999999999999999999999999999987643
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=425.16 Aligned_cols=258 Identities=28% Similarity=0.533 Sum_probs=223.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+++. +|+.||||++++.. .......+.+.
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AvK~~~k~~---------------------------~~~~~~~~~~~ 100 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMRVVKKEL---------------------------VNDDEDIDWVQ 100 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGGG---------------------------TC----CCHHH
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhh---------------------------ccCHHHHHHHH
Confidence 4689999999999999999999987 79999999998741 11222345678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|..++.++.+||||+++++++.+.+.+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||
T Consensus 101 ~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDL 179 (396)
T 4dc2_A 101 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDL 179 (396)
T ss_dssp HHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccC
Confidence 99999998866999999999999999999999999999999988655 67999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEeccccccc-CCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYV-KPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~-~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||+ +.++.+||+|||+++.. .........+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...
T Consensus 180 Kp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 180 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp CGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred CHHHEEE---CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 9999999 67789999999999863 34455677899999999999875 5999999999999999999999999632
Q ss_pred ---------ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH------HHHhcCcccccC
Q 011582 358 ---------TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA------AQALSHPWLANS 415 (482)
Q Consensus 358 ---------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~------~e~L~hp~~~~~ 415 (482)
....+...+......++. .+++++++||++||+.||.+|+++ +++++||||++.
T Consensus 257 ~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 257 GSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp TC------CCHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred ccccccchhhHHHHHHHHhccccCCCC----cCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 334567777777766553 489999999999999999999985 899999999864
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-52 Score=415.44 Aligned_cols=269 Identities=35% Similarity=0.628 Sum_probs=234.9
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|+++. +|+.||||++.+.... . .......+.
T Consensus 8 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~---------~---------------~~~~~~~~~ 60 (326)
T 2y0a_A 8 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTK---------S---------------SRRGVSRED 60 (326)
T ss_dssp CHHHHEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEBCCST---------T---------------CSSSBCHHH
T ss_pred CcccceEeceEEeeCCCeEEEEEEECC---CCcEEEEEEEEccccc---------c---------------ccchhhHHH
Confidence 456789999999999999999999876 7999999999764100 0 001113467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+|+.+. ||||+++++++.+.+.+|+|||||+|++|.+++.. ...+++..++.++.||+.||.|||++||+||
T Consensus 61 ~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~ 138 (326)
T 2y0a_A 61 IEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHF 138 (326)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcC
Confidence 899999999997 99999999999999999999999999999998754 4679999999999999999999999999999
Q ss_pred CCCCCceEEecCC-CCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKE-ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~-~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+|||++.++ ....+||+|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 139 Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~ 218 (326)
T 2y0a_A 139 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 218 (326)
T ss_dssp CCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCC
Confidence 9999999995322 223799999999998766666667889999999999874 69999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
+....+.+..+......+....+..+++++.+||.+||+.||.+|||+.++|+||||+..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 219 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp CSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred CCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 999999999988887777666667899999999999999999999999999999999864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-52 Score=418.33 Aligned_cols=259 Identities=29% Similarity=0.502 Sum_probs=228.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|+++. +|+.||||++++... ......+.+.
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~vaiK~~~~~~~---------------------------~~~~~~~~~~ 65 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDVV---------------------------LMDDDVECTM 65 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHHH---------------------------HHTTCHHHHH
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhHHh---------------------------hhhhhHHHHH
Confidence 4689999999999999999999986 799999999976310 1112345678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|..++..+.+||||+++++++.+.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||
T Consensus 66 ~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 144 (345)
T 1xjd_A 66 VEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDL 144 (345)
T ss_dssp HHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCC
Confidence 89999988756999999999999999999999999999999988654 57999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||+ +.++.+||+|||+++.... .......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.
T Consensus 145 kp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 221 (345)
T 1xjd_A 145 KLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ 221 (345)
T ss_dssp CGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred ChhhEEE---CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC
Confidence 9999999 6778899999999986432 334567799999999998865 5899999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHH-HHhcCcccccCC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA-QALSHPWLANSH 416 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~-e~L~hp~~~~~~ 416 (482)
+..+++..|......++. .+++++++||.+||+.||.+||++. ++++||||+...
T Consensus 222 ~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 222 DEEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp SHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred CHHHHHHHHHhCCCCCCc----ccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 999999999888766543 4899999999999999999999998 999999998753
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-52 Score=405.16 Aligned_cols=265 Identities=36% Similarity=0.674 Sum_probs=226.8
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
...+.++|.+.+.||+|+||.||+|++.. +|..||+|++.+. ......
T Consensus 17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~-----------------------------~~~~~~ 64 (285)
T 3is5_A 17 QGTIDDLFIFKRKLGSGAFGDVHLVEERS---SGLERVIKTINKD-----------------------------RSQVPM 64 (285)
T ss_dssp SSCHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEGG-----------------------------GCCSCH
T ss_pred CCChhhheeecceeccCCCeEEEEEEEcc---CCceEEEEEeecc-----------------------------ccchhH
Confidence 34566899999999999999999999876 7999999998753 112234
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
+.+.+|+.+++.+. ||||+++++++.+.+..|+||||+++|+|.+++... +..+++..++.++.||+.||.|||++
T Consensus 65 ~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 143 (285)
T 3is5_A 65 EQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ 143 (285)
T ss_dssp HHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHhCC-CchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 67889999999996 999999999999999999999999999999988643 46799999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~ 352 (482)
||+||||||+|||+...+.++.+||+|||++.............||+.|+|||++.+.++.++|||||||++|+|++|..
T Consensus 144 ~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~ 223 (285)
T 3is5_A 144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCL 223 (285)
T ss_dssp TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCC
Confidence 99999999999999765667889999999998776655566778999999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
||.+....+....+......+... ...+++++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 224 pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 224 PFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CCCCCCHHHHHhhhccCCcccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 999999888888877766555433 2348999999999999999999999999999999975
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-51 Score=413.05 Aligned_cols=258 Identities=28% Similarity=0.529 Sum_probs=225.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+++. +|+.||||++.+. ........+.+.
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~aiK~~~~~---------------------------~~~~~~~~~~~~ 57 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKK---TDRIYAMKVVKKE---------------------------LVNDDEDIDWVQ 57 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEGG---------------------------GSCSHHHHHHHH
T ss_pred hhheEEEEEEEecCCeEEEEEEECC---CCCEEEEEEEEhH---------------------------HhcchHHHHHHH
Confidence 4689999999999999999999976 7999999999764 123345567788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++++.+||||+++++++.+.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||
T Consensus 58 ~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 136 (345)
T 3a8x_A 58 TEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALNYLHERGIIYRDL 136 (345)
T ss_dssp HHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCC
Confidence 99999998856999999999999999999999999999999988654 57999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC-
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA- 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~- 356 (482)
||+|||+ +.++.+||+|||+++... ........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||..
T Consensus 137 kp~NIll---~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 213 (345)
T 3a8x_A 137 KLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213 (345)
T ss_dssp CGGGEEE---CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTT
T ss_pred CHHHEEE---CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCc
Confidence 9999999 677899999999998643 3345567799999999998875 689999999999999999999999975
Q ss_pred --------CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH------HHHhcCcccccC
Q 011582 357 --------RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA------AQALSHPWLANS 415 (482)
Q Consensus 357 --------~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~------~e~L~hp~~~~~ 415 (482)
.....+...+......++. .+++++++||.+||+.||.+||++ +++++||||++.
T Consensus 214 ~~~~~~~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 214 GSSDNPDQNTEDYLFQVILEKQIRIPR----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp TC-------CHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred ccccccccccHHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 3445667777777665543 489999999999999999999995 899999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-52 Score=420.82 Aligned_cols=260 Identities=38% Similarity=0.642 Sum_probs=229.3
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|+++. +|+.||||++.+.. ..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~avK~~~~~~----------------------------------~~ 61 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKA---TNMEFAVKIIDKSK----------------------------------RD 61 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTT----------------------------------CC
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEccc----------------------------------CC
Confidence 456889999999999999999999987 79999999997631 11
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
..+|+.++.++.+||||+++++++.+.+.+|+|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||
T Consensus 62 ~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~lH~~givHr 140 (342)
T 2qr7_A 62 PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEYLHAQGVVHR 140 (342)
T ss_dssp CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcEec
Confidence 3468888988866999999999999999999999999999999988654 679999999999999999999999999999
Q ss_pred CCCCCceEEecCC-CCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 278 DLKPENFLFTSKE-ENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 278 Dlkp~NIll~~~~-~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf 354 (482)
||||+|||+..++ ..+.+||+|||++...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||
T Consensus 141 Dlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf 220 (342)
T 2qr7_A 141 DLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPF 220 (342)
T ss_dssp CCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCC
Confidence 9999999996432 2346999999999876543 34556789999999999875 4899999999999999999999999
Q ss_pred CC---CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 355 WA---RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 355 ~~---~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.+ ....+++..+......+....|..+++++++||++||..||.+|||+.++|+||||...
T Consensus 221 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 221 ANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp CSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred CCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 86 46678888999988888888888999999999999999999999999999999999764
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=413.19 Aligned_cols=247 Identities=23% Similarity=0.299 Sum_probs=191.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
..+|.+.++||+|+||.||+|+. +|+.||||+++.. ........
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-----~g~~VAvK~l~~~-------------------------------~~~~~~~e 45 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR-------------------------------EERSWFRE 45 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-----TTEEEEEEEECGG-------------------------------GHHHHHHH
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECcc-------------------------------chhhHHHH
Confidence 45799999999999999999976 5889999998642 11112234
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCC----eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDD----NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ--- 272 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--- 272 (482)
.|+..+.+++ |||||++++++.+++ .+|||||||+||+|.+++.. ..+++..+..++.|++.||.|||++
T Consensus 46 ~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~ 122 (303)
T 3hmm_A 46 AEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVG 122 (303)
T ss_dssp HHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HHHHHHhcCC-CCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 5676677786 999999999998754 68999999999999999865 3699999999999999999999987
Q ss_pred -----CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc-----ccccccCccccCcccccc-------cCCCcc
Q 011582 273 -----GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER-----LNDIVGSAYYVAPEVLHR-------SYGTEA 335 (482)
Q Consensus 273 -----~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~ 335 (482)
+||||||||+|||| +.++.+||+|||+|+....... ....+||+.|||||++.+ .|+.++
T Consensus 123 ~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~ 199 (303)
T 3hmm_A 123 TQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199 (303)
T ss_dssp TTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHH
T ss_pred ccCCCCEeeccCCcccEEE---CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhH
Confidence 99999999999999 6788999999999987654322 234689999999999864 367799
Q ss_pred hhhhhHHHHHHHhhCCCCCCCC---------------ChHHHHHHHHhcCCCCCCCC-C--CCCCHHHHHHHHHhchhcc
Q 011582 336 DMWSIGVIAYILLCGSRPFWAR---------------TESGIFRAVLKADPSFDEAP-W--PSLSPEAIDFVKRLLNKDY 397 (482)
Q Consensus 336 DiwSlGvil~elltg~~pf~~~---------------~~~~~~~~i~~~~~~~~~~~-~--~~~s~~~~~li~~~L~~dP 397 (482)
|||||||+||||+||..||... ....+...+.........+. + ...++.+.+|+.+||+.||
T Consensus 200 DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP 279 (303)
T 3hmm_A 200 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp HHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSG
T ss_pred hhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCH
Confidence 9999999999999997765321 12333443433332211110 1 1123578899999999999
Q ss_pred ccCCCHHHHhc
Q 011582 398 RKRLTAAQALS 408 (482)
Q Consensus 398 ~~R~s~~e~L~ 408 (482)
++|||+.|+++
T Consensus 280 ~~RPt~~ei~~ 290 (303)
T 3hmm_A 280 AARLTALRIKK 290 (303)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999875
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-52 Score=403.79 Aligned_cols=263 Identities=41% Similarity=0.777 Sum_probs=238.7
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|++.. ++..||+|++.+. .....+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~a~k~~~~~------------------------------~~~~~~~ 52 (277)
T 3f3z_A 6 DINQYYTLENTIGRGSWGEVKIAVQKG---TRIRRAAKKIPKY------------------------------FVEDVDR 52 (277)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGG------------------------------GCSCHHH
T ss_pred hhhhhEEeeeEEeecCCEEEEEEEeCC---CCcEEEEEeehhh------------------------------ccchHHH
Confidence 456789999999999999999999876 7889999998653 1112467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++++. ||||+++++++.+.+..|+||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||
T Consensus 53 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~ 130 (277)
T 3f3z_A 53 FKQEIEIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVAYCHKLNVAHR 130 (277)
T ss_dssp HHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccCC
Confidence 889999999996 999999999999999999999999999999988665 579999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||||+|||+..++.++.+||+|||++.............||+.|+|||++.+.++.++||||||+++|+|++|..||...
T Consensus 131 dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 210 (277)
T 3f3z_A 131 DLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAP 210 (277)
T ss_dssp CCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCC
Confidence 99999999976667788999999999887766666778899999999999888999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
...+....+......++...|..+++++.+||.+||+.||.+|||+.++|+||||++.
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~ 268 (277)
T 3f3z_A 211 TDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268 (277)
T ss_dssp SHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHH
T ss_pred CHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcc
Confidence 9999999999988777766667899999999999999999999999999999999764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-52 Score=428.96 Aligned_cols=263 Identities=27% Similarity=0.466 Sum_probs=227.8
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++++.||+|+||.||+|+++. +|+.||||++.+... ......+.
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~---------------------------~~~~~~~~ 115 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKS---TRKVYAMKLLSKFEM---------------------------IKRSDSAF 115 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHHH---------------------------HHTCCCST
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECC---CCcEEEEEEEehhhh---------------------------hhhHHHHH
Confidence 345789999999999999999999987 799999999976310 00111234
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. ||||++++++|.+.+.+|||||||+||+|.+++.. ..+++..++.++.||+.||.|||++||+||
T Consensus 116 ~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHr 192 (410)
T 3v8s_A 116 FWEERDIMAFAN-SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHR 192 (410)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 778999999996 99999999999999999999999999999998754 469999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccccc-----CCCcchhhhhHHHHHHHhhC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHRS-----YGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~~-----~~~~~DiwSlGvil~elltg 350 (482)
||||+|||+ +.++.+||+|||+++...... ...+.+||+.|+|||++.+. |+.++|||||||++|+|++|
T Consensus 193 DLKp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G 269 (410)
T 3v8s_A 193 DVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269 (410)
T ss_dssp CCSGGGEEE---CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHS
T ss_pred cCCHHHeeE---CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhC
Confidence 999999999 678899999999998765443 23467899999999988632 78999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhcccc--CCCHHHHhcCcccccCC
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRK--RLTAAQALSHPWLANSH 416 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~~ 416 (482)
+.||.+.+..+++..|+.....+..+.+..+|+++++||++||+.+|.+ |++++|+++||||++..
T Consensus 270 ~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 270 DTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp SCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred CCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 9999999999999999876533334445679999999999999999998 99999999999998754
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=410.80 Aligned_cols=255 Identities=27% Similarity=0.587 Sum_probs=227.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|+++. +|+.||||++.+.. .......+.+.
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~ 54 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEI---------------------------VVRLKQVEHTN 54 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHHH
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhhhhHHHHHH
Confidence 4689999999999999999999876 79999999997631 01112346778
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. ||||+++++++.+.+.+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 55 ~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 132 (318)
T 1fot_A 55 DERLMLSIVT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDL 132 (318)
T ss_dssp HHHHHHHSCC-BTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred HHHHHHhhCC-CCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCC
Confidence 9999999996 999999999999999999999999999999988654 67999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
||+|||+ +.++.+||+|||+++.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+
T Consensus 133 kp~NIll---~~~g~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 207 (318)
T 1fot_A 133 KPENILL---DKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 207 (318)
T ss_dssp CGGGEEE---CTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ChheEEE---cCCCCEEEeecCcceecCC--ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 9999999 6778999999999987543 3456789999999998864 58999999999999999999999999999
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
..+.+..+......++. .+++++.+||++||..||.+|+ +++++++||||++.
T Consensus 208 ~~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 208 TMKTYEKILNAELRFPP----FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp HHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 99999999988766553 4899999999999999999999 99999999999864
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=417.31 Aligned_cols=259 Identities=26% Similarity=0.467 Sum_probs=228.4
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|+++. +|+.||||++++.. .......+.+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~---------------------------~~~~~~~~~~ 67 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDV---------------------------VIQDDDVECT 67 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETT---EEEEEEEEEEEHHH---------------------------HHHTTCHHHH
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEHHH---------------------------hhcchHHHHH
Confidence 35789999999999999999999876 78999999997641 0112234677
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|..++..+.+||||+++++++++.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+|||
T Consensus 68 ~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrD 146 (353)
T 2i0e_A 68 MVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRD 146 (353)
T ss_dssp HHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCC
T ss_pred HHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEEecc
Confidence 899999988866999999999999999999999999999999988655 5799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||+|||+ +.++.+||+|||++.... ........+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.+
T Consensus 147 lkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 223 (353)
T 2i0e_A 147 LKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223 (353)
T ss_dssp CCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCHHHEEE---cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCC
Confidence 99999999 677899999999998643 2344567799999999998864 689999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
.+..+++..|......++. .+++++.+||.+||..||.+|| +++++++||||+..
T Consensus 224 ~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~ 283 (353)
T 2i0e_A 224 EDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI 283 (353)
T ss_dssp SSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHhCCCCCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence 9999999999998776653 4899999999999999999999 47999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=420.18 Aligned_cols=260 Identities=33% Similarity=0.616 Sum_probs=223.2
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.....++|++.+.||+|+||.||+|++.. +|+.||||++.+.. .......
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~~---------------------------~~~~~~~ 53 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYK---TQQKVALKFISRQL---------------------------LKKSDMH 53 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCS
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEehHH---------------------------ccchhHH
Confidence 34556899999999999999999999876 79999999997531 0111223
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
..+.+|+.+++.++ ||||+++++++.+.+.+|+||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+
T Consensus 54 ~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giv 130 (336)
T 3h4j_B 54 MRVEREISYLKLLR-HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK-KRMTEDEGRRFFQQIICAIEYCHRHKIV 130 (336)
T ss_dssp HHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHTCC
T ss_pred HHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 56889999999997 999999999999999999999999 77999988765 5799999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccccc-C-CCcchhhhhHHHHHHHhhCCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-Y-GTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlGvil~elltg~~p 353 (482)
||||||+|||+ +.++.+||+|||++............+||+.|+|||++.+. + +.++|||||||++|+|++|..|
T Consensus 131 H~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~P 207 (336)
T 3h4j_B 131 HRDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207 (336)
T ss_dssp CCCCSTTTEEE---CTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ecCCchhhEEE---cCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCC
Confidence 99999999999 67788999999999987776667788999999999998754 3 7899999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
|.+.....+...+......++ ..+++++.+||++||+.||.+|||++|+++||||+..
T Consensus 208 f~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 208 FDDEFIPNLFKKVNSCVYVMP----DFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp SBCSSSTTCBCCCCSSCCCCC----TTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred CCCccHHHHHHHHHcCCCCCc----ccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 987765554444333332222 3489999999999999999999999999999999864
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=408.06 Aligned_cols=264 Identities=28% Similarity=0.461 Sum_probs=221.3
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.+.+.++|++++.||+|+||.||+|++. +|+.||||++... .......
T Consensus 16 ~q~l~~~y~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~----------------------------~~~~~~~ 63 (311)
T 3niz_A 16 FQGLMEKYQKLEKVGEGTYGVVYKAKDS----QGRIVALKRIRLD----------------------------AEDEGIP 63 (311)
T ss_dssp EECSSCEEEEEEEEEECSSCEEEEEEET----TSCEEEEEEEC----------------------------------CHH
T ss_pred ecchHhhhHhhhhccCCCCeEEEEEEEC----CCCEEEEEEEecc----------------------------cccchhh
Confidence 3456789999999999999999999984 5889999998642 0122234
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
..+.+|+.+++++. ||||+++++++.+++.+|+|||||++ +|.+.+......+++..++.++.||+.||.|||++||+
T Consensus 64 ~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 141 (311)
T 3niz_A 64 STAIREISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRIL 141 (311)
T ss_dssp HHHHHHHHHHHHCC-CTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHcC-CCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 67889999999996 99999999999999999999999975 88888877767799999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~ 352 (482)
||||||+|||+ +.++.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.
T Consensus 142 H~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 218 (311)
T 3niz_A 142 HRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP 218 (311)
T ss_dssp CCCCCGGGEEE---CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCchHhEEE---CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCC
Confidence 99999999999 56778999999999876533 33455689999999998864 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCC--------------------------CCCCCHHHHHHHHHhchhccccCCCHHHH
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAP--------------------------WPSLSPEAIDFVKRLLNKDYRKRLTAAQA 406 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~--------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 406 (482)
||.+....+....+........... .+.+++++.+||.+||+.||.+|||++|+
T Consensus 219 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el 298 (311)
T 3niz_A 219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA 298 (311)
T ss_dssp SCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred CCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence 9998887777777665322222111 23478999999999999999999999999
Q ss_pred hcCcccccCC
Q 011582 407 LSHPWLANSH 416 (482)
Q Consensus 407 L~hp~~~~~~ 416 (482)
|+||||++..
T Consensus 299 l~hp~f~~~~ 308 (311)
T 3niz_A 299 MNHPYFKDLD 308 (311)
T ss_dssp HTSGGGTTSC
T ss_pred hcCcccccCC
Confidence 9999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=430.61 Aligned_cols=264 Identities=27% Similarity=0.466 Sum_probs=227.8
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++++.||+|+||.||+|+++. +|+.||||++.+... ........
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~~~~~~~---------------------------~~~~~~~~ 120 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKN---ADKVFAMKILNKWEM---------------------------LKRAETAC 120 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHHH---------------------------HHTTTTCC
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcC---CCcEEEEEEEEHHHh---------------------------hhHHHHHH
Confidence 345789999999999999999999986 789999999976310 01111234
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.++..+. ||||++++++|.+.+.+|||||||+||+|.+++......+++..++.++.||+.||.|||++|||||
T Consensus 121 ~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHr 199 (437)
T 4aw2_A 121 FREERDVLVNGD-SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHR 199 (437)
T ss_dssp HHHHHHHHHHSC-TTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence 788999999996 9999999999999999999999999999999987756789999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc------ccCCCcchhhhhHHHHHHHhh
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~ellt 349 (482)
||||+|||+ +.++.+||+|||+++....... ....+||+.|+|||++. +.|+.++|||||||++|||++
T Consensus 200 DLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~ellt 276 (437)
T 4aw2_A 200 DIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276 (437)
T ss_dssp CCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHH
T ss_pred ccCHHHeeE---cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHh
Confidence 999999999 6788999999999987654432 34468999999999885 358999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcC--CCCCCCCCCCCCHHHHHHHHHhchhcccc--CCCHHHHhcCcccccCC
Q 011582 350 GSRPFWARTESGIFRAVLKAD--PSFDEAPWPSLSPEAIDFVKRLLNKDYRK--RLTAAQALSHPWLANSH 416 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~--R~s~~e~L~hp~~~~~~ 416 (482)
|+.||.+.+..+.+..|+... ..++. .+..+++++++||++||..+|++ |++++|+++||||++..
T Consensus 277 G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 277 GETPFYAESLVETYGKIMNHKERFQFPT-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp SSCTTCCSSHHHHHHHHHTHHHHCCCCS-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred CCCCCCCCChhHHHHhhhhccccccCCc-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 999999999999999987643 33332 23569999999999999999988 99999999999998654
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=408.72 Aligned_cols=268 Identities=35% Similarity=0.629 Sum_probs=222.2
Q ss_pred cccccccceEec-ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHH
Q 011582 115 FSKQFVAHYELG-EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAI 193 (482)
Q Consensus 115 ~~~~~~~~y~~~-~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (482)
+...+.+.|++. +.||+|+||.||+|++.. +|+.||||++.+. ...
T Consensus 6 ~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~------------------------------~~~ 52 (316)
T 2ac3_A 6 FSGRFEDVYQLQEDVLGEGAHARVQTCINLI---TSQEYAVKIIEKQ------------------------------PGH 52 (316)
T ss_dssp SCCCTTTSCEECCCCCCCCSSEEEEEEECSS---SCCEEEEEEEECC------------------------------SSC
T ss_pred cCcccceeEEecCceecCCceEEEEEEEEcC---CCcEEEEEEEeeC------------------------------cch
Confidence 345677899995 789999999999999876 7999999998653 112
Q ss_pred HHHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 194 AIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 194 ~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
..+.+.+|+.++.++.+||||+++++++.+++.+|+|||||+|++|.+++... ..+++..++.++.||+.||.|||++|
T Consensus 53 ~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ 131 (316)
T 2ac3_A 53 IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASALDFLHNKG 131 (316)
T ss_dssp CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 24578899999999656999999999999999999999999999999988765 57999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCC--------cccccccCccccCccccc------ccCCCcchhhh
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--------RLNDIVGSAYYVAPEVLH------RSYGTEADMWS 339 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~------~~~~~~~DiwS 339 (482)
|+||||||+|||++.++....+||+|||++....... .....+||+.|+|||++. ..++.++||||
T Consensus 132 ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws 211 (316)
T 2ac3_A 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211 (316)
T ss_dssp CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHH
T ss_pred ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHh
Confidence 9999999999999654444559999999987654221 223457999999999885 34899999999
Q ss_pred hHHHHHHHhhCCCCCCCCC---------------hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHH
Q 011582 340 IGVIAYILLCGSRPFWART---------------ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA 404 (482)
Q Consensus 340 lGvil~elltg~~pf~~~~---------------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~ 404 (482)
|||++|+|++|..||.+.. ...+...+......++...|..+++++++||.+||+.||.+|||++
T Consensus 212 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ 291 (316)
T 2ac3_A 212 LGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAA 291 (316)
T ss_dssp HHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHH
T ss_pred HHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHH
Confidence 9999999999999998764 2456777777777666655667999999999999999999999999
Q ss_pred HHhcCcccccCC
Q 011582 405 QALSHPWLANSH 416 (482)
Q Consensus 405 e~L~hp~~~~~~ 416 (482)
|+|+||||++..
T Consensus 292 e~l~hp~~~~~~ 303 (316)
T 2ac3_A 292 QVLQHPWVQGCA 303 (316)
T ss_dssp HHHHSTTCC---
T ss_pred HHhcChhhcCCC
Confidence 999999998653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-51 Score=399.84 Aligned_cols=259 Identities=30% Similarity=0.486 Sum_probs=220.3
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|++.. +|+.||||++.... ........+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~----------------------------~~~~~~~~~~~ 50 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDD----------------------------DDEGVPSSALR 50 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSC----------------------------SSTTHHHHHHH
T ss_pred CCceeeeEecCCCCeEEEEEEECC---CCceEEEEeeeccC----------------------------CcCCcchHHHH
Confidence 579999999999999999999987 79999999997531 22233467889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.++++++ ||||+++++++.+++.+|+|||||++ +|.+.+....+.+++..++.++.||+.||.|||++||+|||||
T Consensus 51 E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dik 128 (292)
T 3o0g_A 51 EICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128 (292)
T ss_dssp HHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHhcCC-CCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 999999997 99999999999999999999999975 7777777767889999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-c-CCCcchhhhhHHHHHHHhhCCCC-CCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-S-YGTEADMWSIGVIAYILLCGSRP-FWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlGvil~elltg~~p-f~~ 356 (482)
|+|||+ +.++.+||+|||++...... ......+||+.|+|||++.+ . ++.++|||||||++|+|++|..| |.+
T Consensus 129 p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~ 205 (292)
T 3o0g_A 129 PQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred HHHEEE---cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCC
Confidence 999999 56788999999999876533 33456689999999998864 3 89999999999999999988877 566
Q ss_pred CChHHHHHHHHhcCCCCCCCC-------------------------CCCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 357 RTESGIFRAVLKADPSFDEAP-------------------------WPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
.+..+.+..+........... .+.+++++++||.+||+.||.+|||++|+|+|||
T Consensus 206 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 666777777765432222221 2357899999999999999999999999999999
Q ss_pred cccC
Q 011582 412 LANS 415 (482)
Q Consensus 412 ~~~~ 415 (482)
|++.
T Consensus 286 f~~~ 289 (292)
T 3o0g_A 286 FSDF 289 (292)
T ss_dssp GTTC
T ss_pred cccC
Confidence 9864
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-51 Score=419.39 Aligned_cols=260 Identities=35% Similarity=0.635 Sum_probs=228.6
Q ss_pred cceEe--cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYEL--GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~--~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.|.+ .+.||+|+||.||+|++.. +|+.||||++... .....+.+
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~---~g~~vavK~~~~~------------------------------~~~~~~~~ 133 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETA---TGLKLAAKIIKTR------------------------------GMKDKEEV 133 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETT---TCCEEEEEEEECC------------------------------SHHHHHHH
T ss_pred cceeeecceEEecCcCEEEEEEEEcC---CCcEEEEEEEccc------------------------------ccccHHHH
Confidence 34555 6789999999999999876 7999999998652 22345678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+|+++. ||||+++++++.+.+.+|||||||++++|.+++......+++..+..++.||+.||.|||++||+|||
T Consensus 134 ~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 212 (373)
T 2x4f_A 134 KNEISVMNQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLD 212 (373)
T ss_dssp HHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccccc
Confidence 99999999996 99999999999999999999999999999999887667799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|||+|||+.. +.++.+||+|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 213 lkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 291 (373)
T 2x4f_A 213 LKPENILCVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGD 291 (373)
T ss_dssp CCGGGEEEEE-TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCHHHEEEec-CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999954 3457899999999998776666667789999999998864 5899999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
+..+.+..+......+....+..+++++++||.+||+.||.+|||++++|+||||...
T Consensus 292 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 292 NDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp SHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred CHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 9999999999988777777778899999999999999999999999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=423.74 Aligned_cols=264 Identities=29% Similarity=0.473 Sum_probs=226.2
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++++.||+|+||.||+|+++. +|+.||||++.+.. .......+.
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~---~~~~vAiK~l~k~~---------------------------~~~~~~~~~ 107 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQ---TGQVYAMKIMNKWD---------------------------MLKRGEVSC 107 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHHGGGCC
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEeHHH---------------------------hhhHHHHHH
Confidence 345789999999999999999999976 89999999997631 011122345
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.++..+. ||||+++++++.+.+.+|||||||+||+|.+++.+.+..+++..++.++.||+.||.|||++|||||
T Consensus 108 ~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHr 186 (412)
T 2vd5_A 108 FREERDVLVNGD-RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHR 186 (412)
T ss_dssp HHHHHHHHHHSC-TTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhcC-CCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 788999999996 9999999999999999999999999999999998766689999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc--------ccCCCcchhhhhHHHHHHH
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH--------RSYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~--------~~~~~~~DiwSlGvil~el 347 (482)
||||+|||+ +.++.+||+|||+++....... ....+||+.|+|||++. +.|+.++|||||||++|||
T Consensus 187 DLKp~NILl---d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyel 263 (412)
T 2vd5_A 187 DIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263 (412)
T ss_dssp CCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHH
T ss_pred ccCHHHeee---cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHH
Confidence 999999999 6778999999999987654433 33568999999999886 3589999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHhcC--CCCCCCCCCCCCHHHHHHHHHhchhccccC---CCHHHHhcCcccccCCC
Q 011582 348 LCGSRPFWARTESGIFRAVLKAD--PSFDEAPWPSLSPEAIDFVKRLLNKDYRKR---LTAAQALSHPWLANSHD 417 (482)
Q Consensus 348 ltg~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---~s~~e~L~hp~~~~~~~ 417 (482)
++|+.||.+.+..+++..|.... ..++. ....+|+++++||++||. +|.+| ++++++++||||+....
T Consensus 264 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w 336 (412)
T 2vd5_A 264 FYGQTPFYADSTAETYGKIVHYKEHLSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW 336 (412)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred HhCCCCCCCCCHHHHHHHHHhcccCcCCCc-cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence 99999999999999988887643 22221 124689999999999999 99998 59999999999987654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-51 Score=401.62 Aligned_cols=258 Identities=28% Similarity=0.481 Sum_probs=223.3
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++.. +|+.||||++... .....+.+
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~------------------------------~~~~~~~~ 64 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQ------------------------------QQPKKELI 64 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTT---TCCEEEEEEEEGG------------------------------GCSCHHHH
T ss_pred hhhceeeeeeeccCCCeEEEEEEECC---CCcEEEEEEeecc------------------------------cccHHHHH
Confidence 45789999999999999999999876 7999999998643 11123568
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+.+.+|+|||||+||+|.+++... .+++..++.++.|++.||.|||++||+|||
T Consensus 65 ~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~i~H~D 141 (297)
T 3fxz_A 65 INEILVMRENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSNQVIHRD 141 (297)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHhcCC-CCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Confidence 89999999996 999999999999999999999999999999988654 699999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||+|||+ +.++.+||+|||++....... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+
T Consensus 142 lkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 218 (297)
T 3fxz_A 142 IKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN 218 (297)
T ss_dssp CSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCHHHEEE---CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999 567789999999998765433 3456789999999998864 689999999999999999999999998
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.+.......+....... ......+++.+.+||.+||+.||.+|||++++|+||||+...
T Consensus 219 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 219 ENPLRALYLIATNGTPE-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp SCHHHHHHHHHHHCSCC-CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCHHHHHHHHHhCCCCC-CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 88877766665544321 122346899999999999999999999999999999998653
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-51 Score=409.98 Aligned_cols=262 Identities=37% Similarity=0.663 Sum_probs=209.6
Q ss_pred cccceEec---ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 119 FVAHYELG---EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 119 ~~~~y~~~---~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
+.++|++. +.||+|+||.||+|+++. +|+.||||++.+. ..
T Consensus 6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~---------------------------------~~ 49 (325)
T 3kn6_A 6 FYQHYDLDLKDKPLGEGSFSICRKCVHKK---SNQAFAVKIISKR---------------------------------ME 49 (325)
T ss_dssp HHHHEEECTTSCCSEEETTEEEEEEEETT---TCCEEEEEEEEGG---------------------------------GH
T ss_pred chhccccccCCCccccCCCeEEEEEEECC---CCCEEEEEEEChh---------------------------------hh
Confidence 45678885 789999999999999986 7999999998653 13
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
..+.+|+.+++.+.+||||+++++++.+++..|+|||||+||+|.+++... ..+++..+..++.||+.||.|||++||+
T Consensus 50 ~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iv 128 (325)
T 3kn6_A 50 ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAVSHMHDVGVV 128 (325)
T ss_dssp HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCe
Confidence 567789999999977999999999999999999999999999999988664 6899999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~p 353 (482)
||||||+|||++.++.+..+||+|||++...... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..|
T Consensus 129 H~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~p 208 (325)
T 3kn6_A 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208 (325)
T ss_dssp CCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred ecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCC
Confidence 9999999999976555568999999999876543 33456789999999999864 599999999999999999999999
Q ss_pred CCCCC-------hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 354 FWART-------ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 354 f~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
|.+.. ..++...+......+....|..+++++++||.+||+.||.+|||++++|+||||++...
T Consensus 209 f~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 209 FQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp TC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred CCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 97643 35677778777777776667789999999999999999999999999999999987643
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=412.79 Aligned_cols=255 Identities=29% Similarity=0.558 Sum_probs=227.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+++. +|+.||||++.+.. .......+.+.
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~~aiK~~~~~~---------------------------~~~~~~~~~~~ 89 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQK---------------------------VVKLKQIEHTL 89 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHHH
T ss_pred HHHCEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEEhHH---------------------------hccHHHHHHHH
Confidence 4789999999999999999999876 79999999997631 01122346788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|+.+. ||||+++++++.+.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+||||
T Consensus 90 ~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDl 167 (350)
T 1rdq_E 90 NEKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDL 167 (350)
T ss_dssp HHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHHHhCC-CCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccC
Confidence 9999999996 999999999999999999999999999999988765 57999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
||+|||+ +.++.+||+|||+++.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+
T Consensus 168 kp~NIll---~~~g~~kL~DFg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~ 242 (350)
T 1rdq_E 168 KPENLLI---DQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp SGGGEEE---CTTSCEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceEEE---CCCCCEEEcccccceeccC--CcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCC
Confidence 9999999 6778899999999987643 3456789999999998864 68999999999999999999999999999
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
..+++..+......++. .+++++.+||.+||+.||.+||+ ++++++||||...
T Consensus 243 ~~~~~~~i~~~~~~~p~----~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 243 PIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHHHHHCCCCCCT----TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHHHHcCCCCCCC----CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 99999999988766553 48999999999999999999998 9999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-51 Score=414.87 Aligned_cols=257 Identities=25% Similarity=0.559 Sum_probs=224.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|++.. +|+.||||++.+.. .......+.+.
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~~~~---------------------------~~~~~~~~~~~ 63 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKND---TKKMYAMKYMNKQK---------------------------CVERNEVRNVF 63 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHHH
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehhh---------------------------cccHHHHHHHH
Confidence 4789999999999999999999876 79999999997631 11122346788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|+.+. ||||++++++|.+.+.+|+|||||.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||
T Consensus 64 ~E~~il~~l~-hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDl 141 (384)
T 4fr4_A 64 KELQIMQGLE-HPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDM 141 (384)
T ss_dssp HHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHHHhCC-CCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Confidence 9999999996 99999999999999999999999999999998754 468999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc----cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR----SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||+|||+ +.++.+||+|||++............+||+.|+|||++.. .|+.++|||||||++|+|++|..||.
T Consensus 142 kp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~ 218 (384)
T 4fr4_A 142 KPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218 (384)
T ss_dssp SGGGEEE---CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSC
T ss_pred cHHHeEE---CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCC
Confidence 9999999 6778999999999998776667778899999999999852 48999999999999999999999997
Q ss_pred CC---ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-HHHHhcCcccccC
Q 011582 356 AR---TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-AAQALSHPWLANS 415 (482)
Q Consensus 356 ~~---~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-~~e~L~hp~~~~~ 415 (482)
.. ...++...+......++. .+++++.+||.+||+.||.+||+ ++++++||||...
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 219 IRSSTSSKEIVHTFETTVVTYPS----AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp CCTTSCHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred CCCCccHHHHHHHHhhcccCCCC----cCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 53 345566666666555443 48999999999999999999998 9999999999854
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=408.58 Aligned_cols=275 Identities=31% Similarity=0.523 Sum_probs=237.3
Q ss_pred ccccccccccceEec-ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccc
Q 011582 112 NFGFSKQFVAHYELG-EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMT 190 (482)
Q Consensus 112 ~~~~~~~~~~~y~~~-~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (482)
.+...+.+.++|.+. +.||+|+||.||+|++.. +|+.||||++.+.. .
T Consensus 19 ~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~----------------------------~ 67 (327)
T 3lm5_A 19 YFQSMENFNNFYILTSKELGRGKFAVVRQCISKS---TGQEYAAKFLKKRR----------------------------R 67 (327)
T ss_dssp CSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESEE----------------------------T
T ss_pred HHHHHHhhhhEEeeccceeCCCCCeEEEEEEECC---CCCEEEEEEEehhh----------------------------c
Confidence 345567788999998 889999999999999876 79999999997631 1
Q ss_pred cHHHHHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH
Q 011582 191 TAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 191 ~~~~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yL 269 (482)
.......+.+|+.+++.+.+||||+++++++.+.+.+|+|||||++|+|.+++... ...+++..++.++.||+.||.||
T Consensus 68 ~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~L 147 (327)
T 3lm5_A 68 GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147 (327)
T ss_dssp TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 12234678899999999987899999999999999999999999999999887533 36799999999999999999999
Q ss_pred HHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHh
Q 011582 270 HFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 270 H~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ell 348 (482)
|++||+||||||+|||++....++.+||+|||++............+||+.|+|||++.+ .++.++|||||||++|+|+
T Consensus 148 H~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll 227 (327)
T 3lm5_A 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLL 227 (327)
T ss_dssp HHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred HHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHH
Confidence 999999999999999996444478899999999998766655667789999999999874 6899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 349 CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 349 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
+|..||.+....+....+......+....+..+++++.+||.+||+.||.+|||++++|+||||++...
T Consensus 228 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 228 THTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp HSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred hCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 999999999999999999988888888888889999999999999999999999999999999987654
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=412.89 Aligned_cols=257 Identities=28% Similarity=0.506 Sum_probs=217.7
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+++. +|+.||||++.+.. .........+.
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~~~~~~---------------------------~~~~~~~~~~~ 86 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKA---EEVFYAVKVLQKKA---------------------------ILKKKEEKHIM 86 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETT---TCCEEEEEEEEGGG---------------------------BC---------
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcC---CCCEEEEEEEEHHH---------------------------hhhhHHHHHHH
Confidence 4689999999999999999999876 79999999997641 11222334566
Q ss_pred HHHHH-HHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKI-LRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~-l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|..+ ++.+. ||||+++++++.+.+.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++||+|||
T Consensus 87 ~e~~~ll~~~~-hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~givHrD 164 (373)
T 2r5t_A 87 SERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASALGYLHSLNIVYRD 164 (373)
T ss_dssp ----CCBCCCC-CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHHhCC-CCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence 77776 45564 999999999999999999999999999999988654 5799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccC-CCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||+|||+ +.++.+||+|||+++... ........+||+.|+|||++.+ .|+.++|||||||++|||++|..||.+
T Consensus 165 lkp~NIll---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~ 241 (373)
T 2r5t_A 165 LKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS 241 (373)
T ss_dssp CCGGGEEE---CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCHHHEEE---CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCC
Confidence 99999999 677899999999998643 3345567899999999999875 599999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH----HHHhcCcccccC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA----AQALSHPWLANS 415 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~----~e~L~hp~~~~~ 415 (482)
.+..+++..|......++ +.+++++++||.+||+.||.+|+++ .++++||||+..
T Consensus 242 ~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 242 RNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp SBHHHHHHHHHHSCCCCC----SSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHhcccCCC----CCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 999999999998866554 3589999999999999999999986 699999999864
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=399.67 Aligned_cols=258 Identities=28% Similarity=0.465 Sum_probs=215.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||.||+|++. +|+.||||++.... ......+.+.+
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~aiK~~~~~~----------------------------~~~~~~~~~~~ 49 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEK----------------------------EDEGIPSTTIR 49 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSS----------------------------GGGCCCHHHHH
T ss_pred ccchhhhhcccCCCEEEEEEEcC----CCCEEEEEEEeccc----------------------------cccccchhHHH
Confidence 57999999999999999999883 68999999986431 11112356789
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++.+.+.+|+||||+++ +|.+++....+.+++..++.++.||+.||.|||++||+|||||
T Consensus 50 E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 127 (288)
T 1ob3_A 50 EISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127 (288)
T ss_dssp HHHGGGGCC-CTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHHhcC-CCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence 999999997 99999999999999999999999976 8999887666789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|+|||+ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 128 p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (288)
T 1ob3_A 128 PQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (288)
T ss_dssp GGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred HHHEEE---cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999 66788999999999876532 23445689999999998864 4899999999999999999999999998
Q ss_pred ChHHHHHHHHhcCCCCCCC-------------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 358 TESGIFRAVLKADPSFDEA-------------------------PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
+..+....+.......... .+..+++++.+||.+||+.||.+|||++|+|+||||
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f 284 (288)
T 1ob3_A 205 SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (288)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred CHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence 8888777776532111111 123588999999999999999999999999999999
Q ss_pred ccC
Q 011582 413 ANS 415 (482)
Q Consensus 413 ~~~ 415 (482)
++.
T Consensus 285 ~~~ 287 (288)
T 1ob3_A 285 KEN 287 (288)
T ss_dssp GC-
T ss_pred hhc
Confidence 864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=403.87 Aligned_cols=261 Identities=28% Similarity=0.514 Sum_probs=218.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|++..+..+|+.||||++++... .........+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~--------------------------~~~~~~~~~~~ 69 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMI--------------------------VRNAKDTAHTK 69 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC---------------------------------------
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHh--------------------------hhhhhHHHHHH
Confidence 4689999999999999999999865444799999999976410 01122345678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|+.+. ||||+++++++.+.+.+|+|||||+|++|.+++... +.+++..+..++.||+.||.|||++||+||||
T Consensus 70 ~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dl 147 (327)
T 3a62_A 70 AERNILEEVK-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALGHLHQKGIIYRDL 147 (327)
T ss_dssp -HHHHHHHCC-CTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHHHHhCC-CCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccC
Confidence 9999999997 999999999999999999999999999999988654 57999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||+ +.++.+||+|||++..... .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.
T Consensus 148 kp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 224 (327)
T 3a62_A 148 KPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE 224 (327)
T ss_dssp CTTTEEE---CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CHHHeEE---CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC
Confidence 9999999 5678899999999976433 233456789999999998864 5899999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
+..+.+..+......++ +.+++++.+||.+||..||.+|| +++++|+||||+..
T Consensus 225 ~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 225 NRKKTIDKILKCKLNLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp SHHHHHHHHHHTCCCCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred CHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 99999999988776554 34899999999999999999999 89999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=399.40 Aligned_cols=268 Identities=28% Similarity=0.415 Sum_probs=218.5
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++.+.||+|+||.||+|++.. +|+.||||++..... .. .......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~---------~~----------------~~~~~~~ 56 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPH---SGHFVALKSVRVPNG---------GG----------------GGGGLPI 56 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTT---TCCEEEEEEEEEECC---------CT----------------TSSCCCH
T ss_pred cccccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEecccc---------cc----------------cccccch
Confidence 3456799999999999999999999876 799999999865310 00 0001123
Q ss_pred HHHHHHHHHHhhc--CCCCcceeeEEEEeCC-----eEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALT--GHKNLVQFYDAYEDDD-----NIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 197 ~~~~Ei~~l~~l~--~hpniv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~y 268 (482)
.+.+|+.+++.+. +||||+++++++.... .+++||||+. ++|.+++.... ..+++..++.++.||+.||.|
T Consensus 57 ~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~ 135 (308)
T 3g33_A 57 STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDF 135 (308)
T ss_dssp HHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHH
Confidence 4567777777664 4999999999998765 5899999997 59999887553 349999999999999999999
Q ss_pred HHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHH
Q 011582 269 CHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 269 LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el 347 (482)
||++||+||||||+|||+ +.++.+||+|||++............+||+.|+|||++. ..++.++|||||||++|+|
T Consensus 136 lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 212 (308)
T 3g33_A 136 LHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212 (308)
T ss_dssp HHHTTCCCSCCCTTTEEE---CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHT
T ss_pred HHHCCcccCCCCHHHEEE---cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHH
Confidence 999999999999999999 567789999999998877666667789999999999885 5699999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHhcCCCCCCCCC-----------------------CCCCHHHHHHHHHhchhccccCCCHH
Q 011582 348 LCGSRPFWARTESGIFRAVLKADPSFDEAPW-----------------------PSLSPEAIDFVKRLLNKDYRKRLTAA 404 (482)
Q Consensus 348 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~-----------------------~~~s~~~~~li~~~L~~dP~~R~s~~ 404 (482)
++|..||.+.+..+....+.......+...| +.+++++.+||.+||+.||.+|||+.
T Consensus 213 ~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 292 (308)
T 3g33_A 213 FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAF 292 (308)
T ss_dssp TTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHH
Confidence 9999999999998888888765433333322 35789999999999999999999999
Q ss_pred HHhcCcccccCC
Q 011582 405 QALSHPWLANSH 416 (482)
Q Consensus 405 e~L~hp~~~~~~ 416 (482)
|+|+||||++..
T Consensus 293 e~l~h~~~~~~~ 304 (308)
T 3g33_A 293 RALQHSYLHKDE 304 (308)
T ss_dssp HHHTSTTC----
T ss_pred HHhcCccccCCC
Confidence 999999998753
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-51 Score=417.40 Aligned_cols=263 Identities=29% Similarity=0.529 Sum_probs=213.1
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++++.||+|+||.||+|.+.. +|+.||||++.+. ........
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~----------------------------~~~~~~~~ 53 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRR---TGEVVAVKKIFDA----------------------------FQNSTDAQ 53 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETT---TCCEEEEEEECC------------------------------CCHHHHH
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECC---CCCEEEEEEeccc----------------------------ccChHHHH
Confidence 4567899999999999999999999887 8999999998652 13345567
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCC--eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDD--NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGV 274 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i 274 (482)
.+.+|+.+++.+.+||||+++++++..++ .+|+|||||+ ++|.+++.. ..+++..+..++.||+.||.|||++||
T Consensus 54 ~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~i 130 (388)
T 3oz6_A 54 RTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGL 130 (388)
T ss_dssp HHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 78899999999977999999999998654 7999999997 588887754 479999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCC----------------------CCcccccccCccccCcccccc--c
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP----------------------DERLNDIVGSAYYVAPEVLHR--S 330 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~----------------------~~~~~~~~gt~~y~aPE~~~~--~ 330 (482)
+||||||+|||+ +.++.+||+|||+|+.+.. .......+||++|+|||++.+ .
T Consensus 131 vHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 207 (388)
T 3oz6_A 131 LHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK 207 (388)
T ss_dssp ECCCCCGGGEEE---CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCC
T ss_pred EeCCCCHHHeEE---cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCC
Confidence 999999999999 6778899999999986532 112345689999999998864 5
Q ss_pred CCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCC-----------------------------------
Q 011582 331 YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE----------------------------------- 375 (482)
Q Consensus 331 ~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~----------------------------------- 375 (482)
|+.++|||||||++|+|++|++||.+.+..+.+..|.........
T Consensus 208 ~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 287 (388)
T 3oz6_A 208 YTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTK 287 (388)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHH
T ss_pred CCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcc
Confidence 899999999999999999999999999988887777643211110
Q ss_pred --------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 376 --------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 376 --------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..+..+++++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 288 ~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 288 WKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred hhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence 01126789999999999999999999999999999997654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=403.98 Aligned_cols=261 Identities=28% Similarity=0.454 Sum_probs=207.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+++. +|+.||||++.... .....+.+.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~-----------------------------~~~~~~~~~ 51 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKT---TGVYVALKEVKLDS-----------------------------EEGTPSTAI 51 (317)
T ss_dssp ---------------CEEEEEECSS---SCCEEEEEEEECCS-----------------------------TTCSCHHHH
T ss_pred ccceeEeeEECCCCCEEEEEEEECC---CCcEEEEEEeeccc-----------------------------ccccHHHHH
Confidence 3679999999999999999999876 79999999986530 111225678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-----GKYSEEDAKIVMVQILSVVAFCHFQGV 274 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~i 274 (482)
+|+.+++.+. ||||+++++++.+++.+|+|||||+ |+|.+++.... ..+++..++.++.||+.||.|||++||
T Consensus 52 ~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i 129 (317)
T 2pmi_A 52 REISLMKELK-HENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKI 129 (317)
T ss_dssp HHHHHHTTCC-BTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHhcC-CCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 9999999996 9999999999999999999999998 58999886542 459999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCC
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~ 351 (482)
+||||||+|||+ +.++.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+
T Consensus 130 vH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~ 206 (317)
T 2pmi_A 130 LHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206 (317)
T ss_dssp ECCCCCGGGEEE---CTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred eeCCCChHHeEE---cCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999 56788999999999876533 33456689999999999864 5899999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCC------------------------------CCCCCHHHHHHHHHhchhccccCC
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAP------------------------------WPSLSPEAIDFVKRLLNKDYRKRL 401 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~------------------------------~~~~s~~~~~li~~~L~~dP~~R~ 401 (482)
.||.+.+..+.+..+........... ...+++++.+||.+||+.||.+||
T Consensus 207 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 286 (317)
T 2pmi_A 207 PLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL 286 (317)
T ss_dssp CSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSC
T ss_pred CCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCC
Confidence 99999998888877765322211111 124789999999999999999999
Q ss_pred CHHHHhcCcccccCCC
Q 011582 402 TAAQALSHPWLANSHD 417 (482)
Q Consensus 402 s~~e~L~hp~~~~~~~ 417 (482)
|++|+|+||||++...
T Consensus 287 t~~e~l~hp~f~~~~~ 302 (317)
T 2pmi_A 287 SAKQALHHPWFAEYYH 302 (317)
T ss_dssp CHHHHTTSGGGGGGCC
T ss_pred CHHHHhCChhhhcccc
Confidence 9999999999997653
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=396.48 Aligned_cols=267 Identities=39% Similarity=0.725 Sum_probs=239.0
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
...+.++|++++.||+|+||.||+|++.. +|+.||||++.+.. ......
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~valK~~~~~~----------------------------~~~~~~ 65 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRI---TQQEYAVKVINKAS----------------------------AKNKDT 65 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGG----------------------------BSSSCH
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcC---CCcEEEEEEecccc----------------------------cchHHH
Confidence 34567899999999999999999999876 79999999987531 112234
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
+.+.+|+.+++++. ||||+++++++.+.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+
T Consensus 66 ~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~ 143 (287)
T 2wei_A 66 STILREVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGITYMHKHNIV 143 (287)
T ss_dssp HHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhcc-CCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 67889999999996 999999999999999999999999999999988665 5799999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||||+||+++.++.+..+||+|||++.............||+.|+|||++.+.++.++||||||+++|+|++|..||.
T Consensus 144 H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 223 (287)
T 2wei_A 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFY 223 (287)
T ss_dssp CSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCC
Confidence 99999999999765556789999999998876655556677999999999998889999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
+.+..++...+......++...+..+++++.+||.+||..||.+|||+.++|+||||++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 224 GKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp CSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999999998888777767777899999999999999999999999999999999864
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-51 Score=402.46 Aligned_cols=258 Identities=25% Similarity=0.320 Sum_probs=214.3
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++.++||+|+||+||+|++.. +|+.||||++... ........
T Consensus 53 ~~~~~~y~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~----------------------------~~~~~~~~ 101 (311)
T 3p1a_A 53 SFFQQSFQRLSRLGHGSYGEVFKVRSKE---DGRLYAVKRSMSP----------------------------FRGPKDRA 101 (311)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETT---TSCEEEEEEESSS----------------------------CCSHHHHH
T ss_pred chhhhheeeeheeccCCCeEEEEEEECC---CCeEEEEEEeccc----------------------------ccChHHHH
Confidence 3456789999999999999999999986 7999999998542 12233345
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
....|+..+.++.+||||+++++++.+.+.+|+||||| +++|.+++...+..+++..++.++.||+.||.|||++||+|
T Consensus 102 ~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 180 (311)
T 3p1a_A 102 RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVH 180 (311)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEec
Confidence 56677777777756999999999999999999999999 67999998887778999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||||+|||+ +.++.+||+|||++.............||+.|+|||++.+.++.++|||||||++|+|++|..||.+
T Consensus 181 ~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~ 257 (311)
T 3p1a_A 181 LDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHG 257 (311)
T ss_dssp CCCSGGGEEE---CGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred CCCCHHHEEE---CCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999 5677899999999988766555566789999999999998999999999999999999999877755
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
.. ....+.... .+......+++++.+||.+||+.||.+|||++++|+||||++
T Consensus 258 ~~---~~~~~~~~~--~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 258 GE---GWQQLRQGY--LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HH---HHHHHTTTC--CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred cc---HHHHHhccC--CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 32 233333222 122223468999999999999999999999999999999975
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=422.24 Aligned_cols=258 Identities=29% Similarity=0.556 Sum_probs=218.7
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|++.. +|+.||||++.+.. .........+
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~---------------------------~~~~~~~~~~ 195 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKA---TGRYYAMKILKKEV---------------------------IVAKDEVAHT 195 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHH---------------------------HC--------
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcC---CCCEEEEEEEEhhh---------------------------hhhhHHHHHH
Confidence 45789999999999999999999876 89999999997531 1222334567
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHR 277 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHr 277 (482)
.+|+.+++.+. ||||+++++++.+.+.+|+|||||+||+|.+++... ..+++..+..++.||+.||.|||+ +|||||
T Consensus 196 ~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~giiHr 273 (446)
T 4ejn_A 196 LTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273 (446)
T ss_dssp -----CCCCCS-CTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCC
T ss_pred HHHHHHHHhCC-CCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHhhcCCEEEC
Confidence 88999999997 999999999999999999999999999999988654 579999999999999999999998 999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCC-CCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+|||+ +.++.+||+|||+++.... .......+||+.|+|||++. ..|+.++|||||||++|+|++|+.||.
T Consensus 274 Dlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~ 350 (446)
T 4ejn_A 274 DLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350 (446)
T ss_dssp CCCGGGEEE---CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCCHHHEEE---CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCC
Confidence 999999999 5678899999999986433 34456688999999999886 469999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
+.+...+...+......++. .+++++.+||.+||+.||.+|| +++++|+||||...
T Consensus 351 ~~~~~~~~~~i~~~~~~~p~----~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 351 NQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp CSSHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999999888776653 4899999999999999999999 99999999999864
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=402.86 Aligned_cols=269 Identities=37% Similarity=0.646 Sum_probs=232.8
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|+++. +|+.||||++.+.... . .......+.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~---------~---------------~~~~~~~~~ 61 (321)
T 2a2a_A 9 KVEDFYDIGEELGSGQFAIVKKCREKS---TGLEYAAKFIKKRQSR---------A---------------SRRGVSREE 61 (321)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSSS---------S---------------CSSSBCHHH
T ss_pred hhhccEEEeeEeeecCCEEEEEEEECC---CCeEEEEEEEeccccc---------c---------------cccchhHHH
Confidence 456789999999999999999999876 7999999999764100 0 001113467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. ||||+++++++.+.+.+|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||
T Consensus 62 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~ 139 (321)
T 2a2a_A 62 IEREVSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHF 139 (321)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 899999999997 99999999999999999999999999999998854 4679999999999999999999999999999
Q ss_pred CCCCCceEEecCCC-CCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEE-NSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~-~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+|||++.++. ...+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 140 dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 219 (321)
T 2a2a_A 140 DLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 219 (321)
T ss_dssp CCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSC
T ss_pred CCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCC
Confidence 99999999953211 11799999999988776656667789999999998874 68999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
+....+....+......++...+..+++++.+||.+||..||.+|||++++|+||||...
T Consensus 220 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 220 GDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred CCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 999999998888877666555556789999999999999999999999999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-51 Score=425.51 Aligned_cols=259 Identities=36% Similarity=0.625 Sum_probs=229.9
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|.+++.||+|+||.||+|++.. +|+.||||++.+.. .........
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~---~g~~vAvK~i~~~~---------------------------~~~~~~~~~ 62 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHEL---TGHKVAVKILNRQK---------------------------IRSLDVVGK 62 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTTHHH
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEEhhh---------------------------ccCHHHHHH
Confidence 345789999999999999999999876 79999999997531 011223467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. ||||+++++++.+.+.+|+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||
T Consensus 63 ~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHr 140 (476)
T 2y94_A 63 IRREIQNLKLFR-HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHR 140 (476)
T ss_dssp HHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECS
T ss_pred HHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcc
Confidence 899999999997 99999999999999999999999999999998754 4679999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccccc--CCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+|||+ +.++.+||+|||++............+||+.|+|||++.+. ++.++|||||||++|+|++|..||.
T Consensus 141 DLkp~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~ 217 (476)
T 2y94_A 141 DLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217 (476)
T ss_dssp CCSGGGEEE---CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cccHHHEEE---ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC
Confidence 999999999 66788999999999987766666778999999999998754 4789999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
+.+...++..+..+....+ ..+++++.+||++||+.||.+|||++++++||||+..
T Consensus 218 ~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 218 DDHVPTLFKKICDGIFYTP----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp CSSSHHHHHHHHTTCCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred CCCHHHHHHHHhcCCcCCC----ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 9998899999888765443 2489999999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=409.15 Aligned_cols=269 Identities=35% Similarity=0.653 Sum_probs=235.8
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++.+.||+|+||.||+|+++. +|+.||||++...... .. ........+
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~---~g~~vavK~~~~~~~~---------~~-------------~~~~~~~~~ 144 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRA---TGHEFAVKIMEVTAER---------LS-------------PEQLEEVRE 144 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEETTSSC---------CC-------------HHHHHHHHH
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECC---CCcEEEEEEEEccccc---------cC-------------HHHHHHHHH
Confidence 4566889999999999999999999876 7999999998753100 00 001123356
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+.+++++.+||||+++++++...+..|+||||++|++|.+++... ..+++..+..++.||+.||.|||+.||+|
T Consensus 145 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~gi~H 223 (365)
T 2y7j_A 145 ATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVSFLHANNIVH 223 (365)
T ss_dssp HHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 78899999999956999999999999999999999999999999988654 57999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-------cCCCcchhhhhHHHHHHHhh
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-------SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~DiwSlGvil~ellt 349 (482)
|||||+|||+ +.++.+||+|||++..+.........+||+.|+|||++.+ .++.++|||||||++|+|++
T Consensus 224 ~Dlkp~NIl~---~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~ 300 (365)
T 2y7j_A 224 RDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLA 300 (365)
T ss_dssp SCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHH
T ss_pred CCCCHHHEEE---CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHH
Confidence 9999999999 6778899999999988876666677899999999998752 48889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
|..||...........+......+....|..+++++.+||.+||+.||.+|||++++|+||||+.
T Consensus 301 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 301 GSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp SSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 99999999988888989888877766667789999999999999999999999999999999963
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=402.80 Aligned_cols=264 Identities=26% Similarity=0.439 Sum_probs=214.6
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|++.. +|+.||||++.... ......+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~----------------------------~~~~~~~~~ 80 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTV---TNETVAIKRIRLEH----------------------------EEEGVPGTA 80 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECCCCC------------------------------------C
T ss_pred chhhEEEEEEEEecCCeEEEEEEECC---CCceEEEEEEcccc----------------------------cccccchhH
Confidence 45789999999999999999999876 79999999986531 122234567
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++++. ||||+++++++.+++.+|+|||||+| +|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 81 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~-~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~D 157 (329)
T 3gbz_A 81 IREVSLLKELQ-HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKN-PDVSMRVIKSFLYQLINGVNFCHSRRCLHRD 157 (329)
T ss_dssp HHHHHHGGGCC-CTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHHcC-CCCcceEEEEEecCCEEEEEEecCCC-CHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEECCC
Confidence 79999999996 99999999999999999999999975 899988654 5799999999999999999999999999999
Q ss_pred CCCCceEEecC--CCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCC
Q 011582 279 LKPENFLFTSK--EENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 279 lkp~NIll~~~--~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~p 353 (482)
|||+|||+..+ +..+.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..|
T Consensus 158 lkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p 237 (329)
T 3gbz_A 158 LKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPL 237 (329)
T ss_dssp CCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999643 24556999999999876533 33455688999999998864 489999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCC--------------------------CCHHHHHHHHHhchhccccCCCHHHHh
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPS--------------------------LSPEAIDFVKRLLNKDYRKRLTAAQAL 407 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~--------------------------~s~~~~~li~~~L~~dP~~R~s~~e~L 407 (482)
|.+....+.+..+...........|+. +++++.+||.+||+.||.+|||++|+|
T Consensus 238 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 317 (329)
T 3gbz_A 238 FPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNAL 317 (329)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred cCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 999998888888776543333222221 679999999999999999999999999
Q ss_pred cCcccccCC
Q 011582 408 SHPWLANSH 416 (482)
Q Consensus 408 ~hp~~~~~~ 416 (482)
+||||++..
T Consensus 318 ~hp~f~~~~ 326 (329)
T 3gbz_A 318 EHPYFSHND 326 (329)
T ss_dssp TSGGGSSSC
T ss_pred CCcccCCCC
Confidence 999998753
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=390.50 Aligned_cols=271 Identities=36% Similarity=0.618 Sum_probs=237.0
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|+++. +|+.||||++...... ... ........+.
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~----------~~~-----------~~~~~~~~~~ 69 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGG----------SFS-----------AEEVQELREA 69 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCST----------TCC-----------HHHHHHHHHH
T ss_pred chhhccceeeeecCCCceEEEEEEEcC---cCceEEEEEEeccccc----------ccC-----------HHHHHHHHHH
Confidence 456799999999999999999999976 7999999998653100 000 0011234567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++++.+||||+++++++.+.+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||
T Consensus 70 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 148 (298)
T 1phk_A 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHR 148 (298)
T ss_dssp HHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 8899999999977999999999999999999999999999999988654 679999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-------ccCCCcchhhhhHHHHHHHhhC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-------RSYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlGvil~elltg 350 (482)
||||+||++ +.++.+||+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|
T Consensus 149 dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g 225 (298)
T 1phk_A 149 DLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225 (298)
T ss_dssp CCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CCCcceEEE---cCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHC
Confidence 999999999 567789999999998877666667778999999999874 3478899999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..||...+.......+......+....+..+++++.+||.+||+.||.+|||+.++|+||||++..
T Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 226 SPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp SCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred CCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 999999999999999998888777777778999999999999999999999999999999998753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=404.22 Aligned_cols=260 Identities=29% Similarity=0.546 Sum_probs=217.4
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|++.. +|+.||||++... ......+.
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~-----------------------------~~~~~~~~ 51 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMK-----------------------------RAVDCPEN 51 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC------------------------------------C
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECC---CCcEEEEEEEEcc-----------------------------cccchHHH
Confidence 356899999999999999999999886 7999999998653 11122356
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. ||||+++++++.+++..|+|||||+||+|.+++. ....+++..++.++.||+.||.|||++||+||
T Consensus 52 ~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~ 129 (323)
T 3tki_A 52 IKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHR 129 (323)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHHhCC-CCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 789999999996 9999999999999999999999999999999774 44679999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCC---CcccccccCccccCcccccc-c-CCCcchhhhhHHHHHHHhhCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPD---ERLNDIVGSAYYVAPEVLHR-S-YGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlGvil~elltg~~ 352 (482)
||||+|||+ +.++.+||+|||++..+... ......+||+.|+|||++.+ . ++.++|||||||++|+|++|..
T Consensus 130 Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~ 206 (323)
T 3tki_A 130 DIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL 206 (323)
T ss_dssp CCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred ccchHHEEE---eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 999999999 66778999999999865422 23446789999999999864 3 4778999999999999999999
Q ss_pred CCCCCChHH-HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 353 PFWARTESG-IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 353 pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
||....... .+..+..... ....+..+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 207 pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 207 PWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp SCSSSCTTSHHHHHHHTTCT--TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCCCCchHHHHHHHHhcccc--cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 998766543 3333333222 2234567999999999999999999999999999999998653
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-50 Score=422.90 Aligned_cols=260 Identities=25% Similarity=0.454 Sum_probs=213.0
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|++.. +|+.||||++.+. .......+.
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~----------------------------~~~~~~~~~ 107 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRP----------------------------FQNQTHAKR 107 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEESG----------------------------GGSHHHHHH
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECC---CCCEEEEEEECcc----------------------------ccChHHHHH
Confidence 456899999999999999999999887 7999999999753 123445678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+.+|+.+|+.+. ||||+++++++... ..+|||||||++ +|.+.+. ..+++..++.++.||+.||.|||+
T Consensus 108 ~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~ 182 (464)
T 3ttj_A 108 AYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS 182 (464)
T ss_dssp HHHHHHHHHHCC-CTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCC-CCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHH
Confidence 899999999996 99999999999654 468999999976 5666653 359999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhC
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg 350 (482)
+||+||||||+|||+ +.++.+||+|||+++...........+||+.|+|||++.+ .|+.++|||||||++|+|++|
T Consensus 183 ~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g 259 (464)
T 3ttj_A 183 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 259 (464)
T ss_dssp TTCCCCCCCGGGEEE---CTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred CCcccCCCChHhEEE---eCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhC
Confidence 999999999999999 6678899999999998776666677899999999998865 699999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCC----------------------CCCC----CC------------CCHHHHHHHHHh
Q 011582 351 SRPFWARTESGIFRAVLKADPSFD----------------------EAPW----PS------------LSPEAIDFVKRL 392 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~----------------------~~~~----~~------------~s~~~~~li~~~ 392 (482)
+.||.+.+..+.+..|........ ...+ +. .++++++||.+|
T Consensus 260 ~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~m 339 (464)
T 3ttj_A 260 KILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 339 (464)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHH
Confidence 999999998888777765322111 0000 00 156799999999
Q ss_pred chhccccCCCHHHHhcCcccccCC
Q 011582 393 LNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 393 L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|+.||.+|||++|+|+||||+...
T Consensus 340 L~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 340 LVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp SCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred cCCChhhCCCHHHHhcChhhhhcc
Confidence 999999999999999999998643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=404.04 Aligned_cols=260 Identities=28% Similarity=0.478 Sum_probs=215.5
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||.||+|++.. +|+.||||++.... .......+.+
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~~-----------------------------~~~~~~~~~~ 49 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKL---TDNLVALKEIRLEH-----------------------------EEGAPCTAIR 49 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECC-----------------------------------CCCCCC
T ss_pred CceEEEEEEcCCCCEEEEEEEECC---CCcEEEEEEEeccc-----------------------------ccccchhHHH
Confidence 579999999999999999999876 79999999986431 0001112347
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++.+.+..|+||||++ |+|.+++...+..+++..++.++.||+.||.|||++||+|||||
T Consensus 50 E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dik 127 (324)
T 3mtl_A 50 EVSLLKDLK-HANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLK 127 (324)
T ss_dssp CHHHHSCCC-CTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCC
T ss_pred HHHHHHhcC-CCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcC
Confidence 899999997 9999999999999999999999997 48999888777789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|+|||+ +.++.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+.
T Consensus 128 p~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 204 (324)
T 3mtl_A 128 PQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGS 204 (324)
T ss_dssp GGGEEE---CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred HHHEEE---CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999 56778999999999865432 23445688999999998864 5899999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCC--------------------------CCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 358 TESGIFRAVLKADPSFDEAPW--------------------------PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~--------------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
+..+....+...........| +.+++++.+||.+||+.||.+|||++|+|+|||
T Consensus 205 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 205 TVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred CHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 988888887764433333322 347899999999999999999999999999999
Q ss_pred cccCCC
Q 011582 412 LANSHD 417 (482)
Q Consensus 412 ~~~~~~ 417 (482)
|.+...
T Consensus 285 f~~~~~ 290 (324)
T 3mtl_A 285 FLSLGE 290 (324)
T ss_dssp GGGGCS
T ss_pred hhhccc
Confidence 987654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=395.09 Aligned_cols=279 Identities=26% Similarity=0.492 Sum_probs=217.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|++.. +|+.||||++.+................ ................+.+.
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 84 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNEN---DNTYYAMKVLSKKKLIRQAGFPRRPPPR----GTRPAPGGCIQPRGPIEQVY 84 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETT---TTEEEEEEEEECC-----------------------------------CHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECC---CCcEEEEEEeehhhhhhhcccccccccc----cccccccccccccchHHHHH
Confidence 4789999999999999999999876 7999999999764210000000000000 00000000001122346789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 200 REVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+|+.+++++. ||||+++++++.+ .+.+|+||||+++++|.+++ ....+++..++.++.||+.||.|||++||+||
T Consensus 85 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~ 161 (298)
T 2zv2_A 85 QEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP--TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHR 161 (298)
T ss_dssp HHHHHHHTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS--CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 9999999996 9999999999987 67899999999999998754 33579999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCccccccc----CCCcchhhhhHHHHHHHhhCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHRS----YGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlGvil~elltg~~ 352 (482)
||||+|||+ +.++.+||+|||++....... ......||+.|+|||++.+. ++.++|||||||++|+|++|..
T Consensus 162 Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~ 238 (298)
T 2zv2_A 162 DIKPSNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC 238 (298)
T ss_dssp CCCGGGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCHHHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 999999999 567789999999998765432 34557899999999998653 3778999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
||...........+......++. .+.+++++.+||.+||+.||.+|||+.|+|+||||+
T Consensus 239 pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 239 PFMDERIMCLHSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SSCCSSHHHHHHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred CCCCccHHHHHHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 99998888888888776655443 356899999999999999999999999999999996
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=402.74 Aligned_cols=263 Identities=28% Similarity=0.452 Sum_probs=224.7
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|++.. +|+.||||++.... ........+
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~----------------------------~~~~~~~~~ 63 (351)
T 3mi9_A 15 EVSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMEN----------------------------EKEGFPITA 63 (351)
T ss_dssp BGGGEEEEEECSSCSTTSEEEEEETT---TCCEEEEEECCCSS----------------------------CSSSSCHHH
T ss_pred cccceeEEEEEecCCCcEEEEEEECC---CCCEEEEEEEeccc----------------------------ccccchHHH
Confidence 35789999999999999999999976 79999999986531 111122457
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEe--------CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYED--------DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH 270 (482)
.+|+.+++.+. ||||+++++++.+ .+.+|+|||||++ +|.+.+......+++..++.++.||+.||.|||
T Consensus 64 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH 141 (351)
T 3mi9_A 64 LREIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 141 (351)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcc-CCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 79999999997 9999999999987 4578999999975 888888776678999999999999999999999
Q ss_pred HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCC-----CCcccccccCccccCcccccc--cCCCcchhhhhHHH
Q 011582 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP-----DERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVI 343 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvi 343 (482)
++||+||||||+|||+ +.++.+||+|||++..+.. .......+||+.|+|||++.+ .++.++|||||||+
T Consensus 142 ~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i 218 (351)
T 3mi9_A 142 RNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCI 218 (351)
T ss_dssp HTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred HCCeeCCCCCHHHEEE---cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHH
Confidence 9999999999999999 6677899999999987642 223455689999999998864 48999999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCC----------------------------CHHHHHHHHHhchh
Q 011582 344 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL----------------------------SPEAIDFVKRLLNK 395 (482)
Q Consensus 344 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~----------------------------s~~~~~li~~~L~~ 395 (482)
+|+|++|..||.+.........+......++...|+.+ ++++.+||.+||+.
T Consensus 219 l~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 298 (351)
T 3mi9_A 219 MAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298 (351)
T ss_dssp HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCS
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcC
Confidence 99999999999999998888888776665555555443 78899999999999
Q ss_pred ccccCCCHHHHhcCcccccCCC
Q 011582 396 DYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 396 dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
||.+|||++|+|+||||+....
T Consensus 299 dP~~R~t~~e~l~hp~f~~~~~ 320 (351)
T 3mi9_A 299 DPAQRIDSDDALNHDFFWSDPM 320 (351)
T ss_dssp SGGGSCCHHHHHTSGGGGSSSC
T ss_pred ChhhCCCHHHHhCCCCcCCCCC
Confidence 9999999999999999987543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=418.17 Aligned_cols=272 Identities=33% Similarity=0.582 Sum_probs=218.4
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
...+.++|.+.+.||+|+||.||+|.+.. +|+.||||++.+.... .. ........
T Consensus 130 ~~~~~~~y~~~~~LG~G~~g~V~~a~~~~---~~~~vavK~~~~~~~~------~~----------------~~~~~~~~ 184 (419)
T 3i6u_A 130 PKALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIRIISKRKFA------IG----------------SAREADPA 184 (419)
T ss_dssp CHHHHTTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGGGGT------TC------------------------
T ss_pred chhhhccEEEEeEEeeCCCeEEEEEEECC---CCcEEEEEEEEechhc------cc----------------ccccchhH
Confidence 34567899999999999999999999887 7999999999764100 00 00111223
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
..+.+|+.+|+++. ||||+++++++. .+.+|+|||||++|+|.+++.. ...+++..++.++.||+.||.|||++||+
T Consensus 185 ~~~~~E~~~l~~l~-hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iv 261 (419)
T 3i6u_A 185 LNVETEIEILKKLN-HPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGII 261 (419)
T ss_dssp CCHHHHHHHHHHCC-CTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhCC-CCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 35789999999996 999999999975 5568999999999999987754 46899999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~ 351 (482)
||||||+|||++.++.+..+||+|||+++...........+||+.|+|||++. ..|+.++|||||||++|+|++|.
T Consensus 262 HrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~ 341 (419)
T 3i6u_A 262 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341 (419)
T ss_dssp CSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSS
T ss_pred ccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence 99999999999766666789999999999877666667789999999999874 45888999999999999999999
Q ss_pred CCCCCCCh-HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 352 RPFWARTE-SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 352 ~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.||..... ..+...+......+....|..+++++.+||.+||+.||.+|||++++|+||||++.
T Consensus 342 ~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 342 PPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp CSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 99976544 34555666666655555567799999999999999999999999999999999753
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-50 Score=424.95 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=225.8
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|+++. +|+.||||++.+.. .........+
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAvK~l~k~~---------------------------~~~~~~~~~~ 231 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEKKR---------------------------IKKRKGEAMA 231 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHH
T ss_pred cccceEEEEEEeeCCCEEEEEEEECC---CCCEEEEEEEEhHh---------------------------hhhhHHHHHH
Confidence 45789999999999999999999876 89999999997631 0112234567
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
.+|+.+|+.+. ||||+++++++.+.+.+|+|||||+||+|.+++...+ ..+++..++.++.||+.||.|||++|||||
T Consensus 232 ~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHr 310 (576)
T 2acx_A 232 LNEKQILEKVN-SRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYR 310 (576)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHcC-CCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEecc
Confidence 89999999996 9999999999999999999999999999999886543 349999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||||+|||+ +.++.+||+|||++............+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+
T Consensus 311 DLKPeNILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~ 387 (576)
T 2acx_A 311 DLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ 387 (576)
T ss_dssp CCCGGGEEE---CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSC
T ss_pred CCchheEEE---eCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcc
Confidence 999999999 6778999999999998776666667799999999999875 599999999999999999999999987
Q ss_pred CC----hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 357 RT----ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 357 ~~----~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
.. ...+...+......++ ..+++++++||++||+.||.+|| +++|+++||||++.
T Consensus 388 ~~~~~~~~~i~~~i~~~~~~~p----~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i 451 (576)
T 2acx_A 388 RKKKIKREEVERLVKEVPEEYS----ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL 451 (576)
T ss_dssp SSSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred cccchhHHHHHHHhhcccccCC----ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence 63 3556666666554443 45899999999999999999999 89999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=438.05 Aligned_cols=261 Identities=26% Similarity=0.467 Sum_probs=230.9
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++++.||+|+||.||+|+++. +|+.||||++++.. .......+.
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~---~~~~vAvK~l~~~~---------------------------~~~~~~~~~ 387 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKG---TDELYAVKILKKDV---------------------------VIQDDDVEC 387 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESS---SCCEEEEEEEEHHH---------------------------HHHTTTTHH
T ss_pred ccccceEEEEEEccCCCEEEEEEEECC---CCcEEEEEEEeccc---------------------------cccHHHHHH
Confidence 345789999999999999999999987 79999999997641 011223456
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|..+|..+.+||||+++++++++.+.+||||||++||+|.+++... +.+++..++.|+.||+.||.|||++|||||
T Consensus 388 ~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~gIiHr 466 (674)
T 3pfq_A 388 TMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466 (674)
T ss_dssp HHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTSEECC
T ss_pred HHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEec
Confidence 7889999998877999999999999999999999999999999988765 579999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccC-CCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVK-PDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+|||| +.++.+||+|||+++... ........+||+.|+|||++. ..|+.++|||||||++|||++|..||.
T Consensus 467 DLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~ 543 (674)
T 3pfq_A 467 DLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 543 (674)
T ss_dssp CCCSTTEEE---CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred cCChhhEEE---cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCC
Confidence 999999999 677899999999998643 334556789999999999987 469999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCH-----HHHhcCcccccCC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA-----AQALSHPWLANSH 416 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~-----~e~L~hp~~~~~~ 416 (482)
+.+..+++..|......++. .+++++++||++||+.||.+|+++ +++++||||+...
T Consensus 544 ~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 544 GEDEDELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp CSSHHHHHHHHHSSCCCCCT----TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred CCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 99999999999998877664 489999999999999999999997 9999999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=407.52 Aligned_cols=262 Identities=20% Similarity=0.323 Sum_probs=217.0
Q ss_pred ccceEecceeecC--CceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRG--HFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G--~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++++.||+| +||.||+|+++. +|+.||||++... .......+.
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~---~~~~vavK~~~~~----------------------------~~~~~~~~~ 72 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKP---TGEYVTVRRINLE----------------------------ACSNEMVTF 72 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETT---TCCEEEEEEEEGG----------------------------GSCHHHHHH
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcC---CCCEEEEEEeccc----------------------------ccChHHHHH
Confidence 4689999999999 999999999987 7999999999753 123455678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+.+|+.+++.+. ||||+++++++.+++.+|+|||||++|+|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus 73 ~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH 151 (389)
T 3gni_B 73 LQGELHVSKLFN-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVH 151 (389)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhCC-CCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 899999999997 999999999999999999999999999999988764 357999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCC--------CcccccccCccccCcccccc---cCCCcchhhhhHHHHH
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD--------ERLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAY 345 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~--------~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~ 345 (482)
|||||+|||+ +.++.+||+|||++...... ......+||+.|+|||++.+ .|+.++|||||||++|
T Consensus 152 rDlkp~NIll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~ 228 (389)
T 3gni_B 152 RSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITAC 228 (389)
T ss_dssp CCCSGGGEEE---CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHH
T ss_pred CCCCHHHEEE---cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHH
Confidence 9999999999 66789999999988654221 12233579999999999865 5899999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHhcCCCC------------------------------------------CCCCCCCCCH
Q 011582 346 ILLCGSRPFWARTESGIFRAVLKADPSF------------------------------------------DEAPWPSLSP 383 (482)
Q Consensus 346 elltg~~pf~~~~~~~~~~~i~~~~~~~------------------------------------------~~~~~~~~s~ 383 (482)
+|++|+.||.+....+....+....... ....+..+++
T Consensus 229 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 308 (389)
T 3gni_B 229 ELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSP 308 (389)
T ss_dssp HHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------CCH
T ss_pred HHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCH
Confidence 9999999998876655554443322110 0112345889
Q ss_pred HHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 384 EAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 384 ~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 309 ~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~ 341 (389)
T 3gni_B 309 HFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 341 (389)
T ss_dssp HHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred HHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence 999999999999999999999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=417.80 Aligned_cols=261 Identities=29% Similarity=0.472 Sum_probs=199.3
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||.||+|+++. +|+.||||++.+. .......+.+
T Consensus 51 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~i~~~----------------------------~~~~~~~~~~ 99 (458)
T 3rp9_A 51 IPDRYEIRHLIGTGSYGHVCEAYDKL---EKRVVAIKKILRV----------------------------FEDLIDCKRI 99 (458)
T ss_dssp SCTTEEECCC-------CEEEEEECC-----CEEEEEEECST----------------------------TSSHHHHHHH
T ss_pred cCCCeEEeeEeeecCCeEEEEEEECC---CCcEEEEEEechh----------------------------hcCHHHHHHH
Confidence 45789999999999999999999987 7999999998652 1334456788
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEe-----CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYED-----DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
.+|+.+|+.+. ||||+++++++.. .+.+|+||||+ +++|.+++.. ...+++..++.++.||+.||.|||++|
T Consensus 100 ~~E~~~l~~l~-h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ 176 (458)
T 3rp9_A 100 LREIAILNRLN-HDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAG 176 (458)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhCC-CCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999996 9999999999844 36799999998 5688887754 467999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCC----------------------------CcccccccCccccCcc
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD----------------------------ERLNDIVGSAYYVAPE 325 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~----------------------------~~~~~~~gt~~y~aPE 325 (482)
||||||||+|||+ +.++.+||+|||+++..... ......+||++|+|||
T Consensus 177 iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE 253 (458)
T 3rp9_A 177 ILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253 (458)
T ss_dssp CBCCCCCGGGEEE---CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHH
T ss_pred cCCCCCChhhEEE---CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChH
Confidence 9999999999999 67788999999999876422 1234568999999999
Q ss_pred cc-c-ccCCCcchhhhhHHHHHHHhh-----------CCCCCCCCCh--------------------HHHHHHHHhcCCC
Q 011582 326 VL-H-RSYGTEADMWSIGVIAYILLC-----------GSRPFWARTE--------------------SGIFRAVLKADPS 372 (482)
Q Consensus 326 ~~-~-~~~~~~~DiwSlGvil~ellt-----------g~~pf~~~~~--------------------~~~~~~i~~~~~~ 372 (482)
++ . ..|+.++|||||||++|||++ |.++|.+... .+.+..|......
T Consensus 254 ~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~ 333 (458)
T 3rp9_A 254 LILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGT 333 (458)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCC
T ss_pred HhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCC
Confidence 76 3 459999999999999999999 7777766541 2222222221100
Q ss_pred ---------------------------CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 373 ---------------------------FDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 373 ---------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.....++.+++++.+||++||.+||.+|||++|+|+||||+...
T Consensus 334 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~ 404 (458)
T 3rp9_A 334 PSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR 404 (458)
T ss_dssp CCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence 00123456799999999999999999999999999999998764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=387.63 Aligned_cols=258 Identities=29% Similarity=0.575 Sum_probs=223.0
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|++.. ++..||||++.+.. .........+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~---------------------------~~~~~~~~~~ 56 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQ---------------------------LEKAGVEHQL 56 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHHTCHHHH
T ss_pred ecccEEEeeEEecCCCeEEEEEEEcc---CCcEEEEEEEeccc---------------------------cchhhHHHHH
Confidence 45789999999999999999999876 78999999986531 1112234678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|||
T Consensus 57 ~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~d 134 (279)
T 3fdn_A 57 RREVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRD 134 (279)
T ss_dssp HHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTCEECC
T ss_pred HHHHHHHHcCC-CCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEeccc
Confidence 89999999997 999999999999999999999999999999988655 5799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|||+|||+ +.++.+||+|||++..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...
T Consensus 135 lkp~Nili---~~~~~~~l~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 210 (279)
T 3fdn_A 135 IKPENLLL---GSAGELKIADFGWSVHAPS-SRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210 (279)
T ss_dssp CCGGGEEE---CTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CChHhEEE---cCCCCEEEEeccccccCCc-ccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence 99999999 6778899999999865443 23355689999999998875 5889999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
...+....+......++. .+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 211 ~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 211 TYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp SHHHHHHHHHHTCCCCCT----TSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred cHHHHHHHHHhCCCCCCC----cCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 999888888887665543 4899999999999999999999999999999998754
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=404.21 Aligned_cols=271 Identities=35% Similarity=0.621 Sum_probs=228.3
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++.+.||+|+||.||+|++.. ++..||||++.+... ........+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~-------------------------~~~~~~~~~ 73 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQ---TRAIRAIKIMNKNKI-------------------------RQINPKDVE 73 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHHH-------------------------HC---CHHH
T ss_pred hhhhhheeecceeeecCCeEEEEEEECC---CCceEEEeehhhhhh-------------------------cccCHHHHH
Confidence 3567899999999999999999999876 799999999875310 011234457
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc------------------------------
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR------------------------------ 246 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~------------------------------ 246 (482)
.+.+|+.++++++ ||||+++++++.+.+..|+|||||+||+|.+++...
T Consensus 74 ~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (345)
T 3hko_A 74 RIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152 (345)
T ss_dssp HHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHS
T ss_pred HHHHHHHHHHhCC-CCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccc
Confidence 8999999999997 999999999999999999999999999999977310
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC-----cc
Q 011582 247 ---------GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RL 312 (482)
Q Consensus 247 ---------~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~ 312 (482)
...+++..++.++.||+.||.|||++||+||||||+|||++. +....+||+|||++..+.... ..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 231 (345)
T 3hko_A 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGM 231 (345)
T ss_dssp CC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESC-SSSCCEEECCCTTCEEGGGTTCC-----
T ss_pred ccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEec-CCCceEEEeeccccccccccCccccccc
Confidence 112467889999999999999999999999999999999953 223379999999998653211 23
Q ss_pred cccccCccccCccccc---ccCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHH
Q 011582 313 NDIVGSAYYVAPEVLH---RSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFV 389 (482)
Q Consensus 313 ~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 389 (482)
....||+.|+|||++. ..++.++|||||||++|+|++|..||.+....+....+......+....+..+++++.+||
T Consensus 232 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 311 (345)
T 3hko_A 232 TTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLL 311 (345)
T ss_dssp ---CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHH
T ss_pred cccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHH
Confidence 4568999999999885 4689999999999999999999999999999999999999888777777777999999999
Q ss_pred HHhchhccccCCCHHHHhcCcccccCCC
Q 011582 390 KRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 390 ~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.+||+.||.+|||+.++|+||||++..+
T Consensus 312 ~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 312 SNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp HHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred HHHcCCChhHCCCHHHHhcChhhccChH
Confidence 9999999999999999999999987643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=400.56 Aligned_cols=265 Identities=23% Similarity=0.397 Sum_probs=223.1
Q ss_pred ccccccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhcccc
Q 011582 112 NFGFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTT 191 (482)
Q Consensus 112 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (482)
.+.....+.++|++.+.||+|+||.||+|++.. +|+.||||++...
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~------------------------------- 71 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHID---NKKYYAVKVVRNI------------------------------- 71 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSC-------------------------------
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECC---CCeEEEEEEeccc-------------------------------
Confidence 344556778999999999999999999999876 7999999998532
Q ss_pred HHHHHHHHHHHHHHHhhc----CCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHH
Q 011582 192 AIAIEDVRREVKILRALT----GHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVV 266 (482)
Q Consensus 192 ~~~~~~~~~Ei~~l~~l~----~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L 266 (482)
......+..|+.+++.+. +||||+++++++...+..|+||||+ +++|.+++.... ..+++..++.++.||+.||
T Consensus 72 ~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL 150 (360)
T 3llt_A 72 KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150 (360)
T ss_dssp HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence 233456788999999986 4999999999999999999999999 889999887653 4599999999999999999
Q ss_pred HHHHHCCCcccCCCCCceEEecC----------------------CCCCcEEEEecccccccCCCCcccccccCccccCc
Q 011582 267 AFCHFQGVVHRDLKPENFLFTSK----------------------EENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAP 324 (482)
Q Consensus 267 ~yLH~~~ivHrDlkp~NIll~~~----------------------~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aP 324 (482)
.|||++||+||||||+|||++.. ..++.+||+|||++..... .....+||+.|+||
T Consensus 151 ~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aP 228 (360)
T 3llt_A 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAP 228 (360)
T ss_dssp HHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCH
T ss_pred HHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCc
Confidence 99999999999999999999531 1267899999999986543 33567899999999
Q ss_pred ccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCC---------------------CCC---
Q 011582 325 EVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA---------------------PWP--- 379 (482)
Q Consensus 325 E~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~---------------------~~~--- 379 (482)
|++.+ .|+.++|||||||++|+|++|+.||.+.+..+....+......++.. .|+
T Consensus 229 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 308 (360)
T 3llt_A 229 EVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA 308 (360)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTC
T ss_pred HHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccc
Confidence 98864 69999999999999999999999999988888877776654333210 011
Q ss_pred ------------------CCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 380 ------------------SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 380 ------------------~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
..++++.+||.+||+.||.+|||++|+|+||||+
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 309 SSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 1247788999999999999999999999999995
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=392.16 Aligned_cols=262 Identities=28% Similarity=0.489 Sum_probs=215.4
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|++.. +|+.||||++... .......+.+.
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----------------------------~~~~~~~~~~~ 50 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRD---TGQIVAIKKFLES----------------------------EDDPVIKKIAL 50 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCC----------------------------CC-HHHHHHHH
T ss_pred cccceEeeEEeecCCeEEEEEEeCC---CCcEEEEEEeecc----------------------------ccchHHHHHHH
Confidence 4689999999999999999999876 7999999998653 12334456788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++++. ||||+++++++.+.+..++|||||++++|.+++. ....+++..+..++.|++.||.|||++||+||||
T Consensus 51 ~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dl 128 (311)
T 4agu_A 51 REIRMLKQLK-HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR-YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDV 128 (311)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHHHhCC-CCCccchhheeecCCeEEEEEEeCCCchHHHHHh-hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 9999999997 9999999999999999999999999988877654 4467999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||+|||+ +.++.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+
T Consensus 129 kp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 205 (311)
T 4agu_A 129 KPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPG 205 (311)
T ss_dssp SGGGEEE---CTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred ChhhEEE---cCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 9999999 56788999999999876533 33456689999999998864 589999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCC-------------------CCCC--------CCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 357 RTESGIFRAVLKADPS-------------------FDEA--------PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~-------------------~~~~--------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
....+....+...... .+.. .++.+++++.+||.+||+.||.+|||++|+|+|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 285 (311)
T 4agu_A 206 KSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH 285 (311)
T ss_dssp SSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred CCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 8887776665442111 1100 125689999999999999999999999999999
Q ss_pred cccccCCC
Q 011582 410 PWLANSHD 417 (482)
Q Consensus 410 p~~~~~~~ 417 (482)
|||++...
T Consensus 286 p~f~~~~~ 293 (311)
T 4agu_A 286 PYFENIRE 293 (311)
T ss_dssp GGGTTCC-
T ss_pred hHHHhccC
Confidence 99987643
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=396.74 Aligned_cols=259 Identities=25% Similarity=0.391 Sum_probs=224.0
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...+.|++.+.||+|+||.||+|++.. +|+.||||++... ........+.
T Consensus 51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vaiK~~~~~---------------------------~~~~~~~~~~ 100 (348)
T 1u5q_A 51 DPEKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYS---------------------------GKQSNEKWQD 100 (348)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEESC---------------------------SSCHHHHHHH
T ss_pred chhhheeeeeEEccCCCEEEEEEEEcc---CCeEEEEEEEccc---------------------------cccchHHHHH
Confidence 345679999999999999999999876 7999999998653 1123344578
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.++++++ ||||+++++++.+++..|+|||||. |+|.+.+......+++..++.++.|++.||.|||++||+||
T Consensus 101 ~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 178 (348)
T 1u5q_A 101 IIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 178 (348)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCC
T ss_pred HHHHHHHHHhCC-CCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeC
Confidence 899999999997 9999999999999999999999997 58888887666789999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~~p 353 (482)
||||+|||+ +.++.+||+|||++..... ....+||+.|+|||++. +.++.++|||||||++|+|++|..|
T Consensus 179 Dlkp~NIll---~~~~~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p 252 (348)
T 1u5q_A 179 DVKAGNILL---SEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252 (348)
T ss_dssp CCSGGGEEE---ETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCHHHEEE---CCCCCEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 999999999 5677899999999987543 34568999999999873 4689999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|.+.+.......+....... .....+++++.+||.+||+.||.+|||++++|+||||....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 253 LFNMNAMSALYHIAQNESPA--LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp TTTSCHHHHHHHHHHSCCCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCCChHHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 99888877777776654322 22245899999999999999999999999999999998653
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=387.78 Aligned_cols=268 Identities=37% Similarity=0.669 Sum_probs=226.8
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||.||+|++.. +|+.||||++.+.... . .......+.+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~~~--------~----------------~~~~~~~~~~ 55 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKG---TGKEYAAKFIKKRRLS--------S----------------SRRGVSREEI 55 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSST--------T----------------CSSSBCHHHH
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcC---CCCeeehHHhhhcccc--------c----------------cccchHHHHH
Confidence 34689999999999999999999876 7999999999764100 0 0111234678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++++. ||||+++++++.+.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+|||
T Consensus 56 ~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 133 (283)
T 3bhy_A 56 EREVNILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVHYLHSKRIAHFD 133 (283)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhCC-CCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 99999999997 999999999999999999999999999999988654 5799999999999999999999999999999
Q ss_pred CCCCceEEecCC-CCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKE-ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~-~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||+||+++.++ ....+||+|||++.............||+.|+|||++. ..++.++||||||+++|+|++|..||.+
T Consensus 134 l~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 213 (283)
T 3bhy_A 134 LKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG 213 (283)
T ss_dssp CSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCC
Confidence 999999995322 23379999999998876655556678999999999886 4689999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
....+....+......+....+..+++++.+||.+||..||.+|||+.++|+||||+..
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 214 ETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp SSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred cchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence 99888888888777666555556789999999999999999999999999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=402.39 Aligned_cols=260 Identities=28% Similarity=0.546 Sum_probs=215.8
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++.+. .......+.
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~ 70 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRP----------------------------FQSELFAKR 70 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSST----------------------------TSSHHHHHH
T ss_pred eecceEEEeEEeeecCCeEEEEEEECC---CCCEEEEEEeCcc----------------------------ccCHHHHHH
Confidence 346789999999999999999999876 8999999998542 123345677
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+.+|+.+|+.++ ||||+++++++... ..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+
T Consensus 71 ~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~ 146 (367)
T 1cm8_A 71 AYRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHA 146 (367)
T ss_dssp HHHHHHHHHHCC-BTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCC-CcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 899999999997 99999999999876 3569999999 7899887754 479999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhh
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ellt 349 (482)
+||+||||||+|||+ +.++.+||+|||+++.... .....+||+.|+|||++.+ .|+.++||||+||++|+|++
T Consensus 147 ~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 221 (367)
T 1cm8_A 147 AGIIHRDLKPGNLAV---NEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMIT 221 (367)
T ss_dssp TTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHH
T ss_pred CCccccCcCHHHEEE---cCCCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHh
Confidence 999999999999999 5678899999999987543 3456789999999998864 69999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCC-----------------------C----CCCCCCCHHHHHHHHHhchhccccCCC
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFD-----------------------E----APWPSLSPEAIDFVKRLLNKDYRKRLT 402 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~-----------------------~----~~~~~~s~~~~~li~~~L~~dP~~R~s 402 (482)
|+.||.+.+..+.+..|.......+ . ..++.+++++.+||.+||+.||.+|||
T Consensus 222 g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t 301 (367)
T 1cm8_A 222 GKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT 301 (367)
T ss_dssp SSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC
Confidence 9999999888877777665322111 1 123567999999999999999999999
Q ss_pred HHHHhcCcccccCCC
Q 011582 403 AAQALSHPWLANSHD 417 (482)
Q Consensus 403 ~~e~L~hp~~~~~~~ 417 (482)
++++|+||||+....
T Consensus 302 ~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 302 AGEALAHPYFESLHD 316 (367)
T ss_dssp HHHHHHSGGGTTTC-
T ss_pred HHHHhcChHHHhhcC
Confidence 999999999987643
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=385.46 Aligned_cols=263 Identities=29% Similarity=0.578 Sum_probs=228.2
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++.. +++.||||++.+.. .......+.+
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~~---------------------------~~~~~~~~~~ 61 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQ---NKFIMALKVLFKSQ---------------------------LEKEGVEHQL 61 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEEHHH---------------------------HHHTTCHHHH
T ss_pred hhhhceeeheecCCCCeEEEEEEEcC---CCcEEEEEEEcccc---------------------------cchHHHHHHH
Confidence 45789999999999999999999876 78899999986531 0111224678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+.+..|+||||+++++|.+++... +.+++..+..++.||+.||.|||++||+|||
T Consensus 62 ~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 139 (284)
T 2vgo_A 62 RREIEIQSHLR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRD 139 (284)
T ss_dssp HHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred HHHHHHHhcCC-CCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecC
Confidence 89999999996 999999999999999999999999999999988665 5799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|||+||++ +.++.+||+|||++..... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||...
T Consensus 140 l~p~Nil~---~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 215 (284)
T 2vgo_A 140 IKPENLLM---GYKGELKIADFGWSVHAPS-LRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215 (284)
T ss_dssp CSGGGEEE---CTTCCEEECCCTTCEECSS-SCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred CCHHHEEE---cCCCCEEEecccccccCcc-cccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence 99999999 5677899999999976543 23345689999999998875 5899999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCCC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIP 421 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~ 421 (482)
...+....+......++ ..+++++.+||.+||..||.+|||++++|+||||+.......+
T Consensus 216 ~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p 275 (284)
T 2vgo_A 216 SHTETHRRIVNVDLKFP----PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 275 (284)
T ss_dssp SHHHHHHHHHTTCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCC
T ss_pred CHhHHHHHHhccccCCC----CcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCC
Confidence 88888888887665544 3489999999999999999999999999999999876544433
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=386.84 Aligned_cols=260 Identities=33% Similarity=0.593 Sum_probs=198.7
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++.. +|+.||||++.+.. .......+.+
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~---------------------------~~~~~~~~~~ 58 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIH---TGLEVAIKMIDKKA---------------------------MYKAGMVQRV 58 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHH
T ss_pred ccccceeeeeecCCCceEEEEEEEcc---CCceEEEEEeehhh---------------------------hhhhhHHHHH
Confidence 34689999999999999999999876 79999999986531 0111234678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+.+..|+||||+++++|.+++......+++..++.++.|++.||.|||++||+|||
T Consensus 59 ~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 137 (278)
T 3cok_A 59 QNEVKIHCQLK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRD 137 (278)
T ss_dssp HHHHHHHTTBC-CTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSS
T ss_pred HHHHHHHHhCC-CCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 99999999997 99999999999999999999999999999999877667899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||+||++ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||||+++|+|++|+.||..
T Consensus 138 l~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 214 (278)
T 3cok_A 138 LTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDT 214 (278)
T ss_dssp CCGGGEEE---CTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCC
T ss_pred CCHHHEEE---cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999 56788999999999876532 23345679999999998865 588999999999999999999999988
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
....+....+....... ...++.++.+||.+||+.||.+|||++++|+||||....
T Consensus 215 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 215 DTVKNTLNKVVLADYEM----PSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp CSCC-----CCSSCCCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred hhHHHHHHHHhhcccCC----ccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 77665555443333222 234899999999999999999999999999999998653
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=418.35 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=225.1
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|+++. +|+.||||++.+.. .......+.+
T Consensus 183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~---tg~~vAiK~l~k~~---------------------------~~~~~~~~~~ 232 (543)
T 3c4z_A 183 GEDWFLDFRVLGRGGFGEVFACQMKA---TGKLYACKKLNKKR---------------------------LKKRKGYQGA 232 (543)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHH
T ss_pred ChhheEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEEhHH---------------------------hhhhHHHHHH
Confidence 35789999999999999999999876 79999999997641 1112234678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
.+|+.+|+++. ||||+++++++.+.+.+|+|||||+||+|.+++... ...+++..++.++.||+.||.|||++||+
T Consensus 233 ~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIv 311 (543)
T 3c4z_A 233 MVEKKILAKVH-SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNII 311 (543)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHhcC-CCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCc
Confidence 89999999996 999999999999999999999999999999988754 34699999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCc-ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER-LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~p 353 (482)
||||||+|||+ +.++.+||+|||++........ ....+||+.|+|||++.+ .|+.++|||||||++|||++|..|
T Consensus 312 HrDLKP~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~P 388 (543)
T 3c4z_A 312 YRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388 (543)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCChHHEEE---eCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCC
Confidence 99999999999 6788999999999987755433 345699999999999875 599999999999999999999999
Q ss_pred CCCC----ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 354 FWAR----TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 354 f~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
|.+. ...++...+......++ ..+++++++||++||+.||.+||+ ++++++||||+..
T Consensus 389 F~~~~~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 389 FRARGEKVENKELKQRVLEQAVTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp SCCTTCCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred CCCCccchhHHHHHHHHhhcccCCC----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 9875 34677777877766554 358999999999999999999995 5899999999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=382.55 Aligned_cols=260 Identities=34% Similarity=0.604 Sum_probs=217.8
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|.+++.||+|+||.||+|++.. +|+.||||++.... .......+.
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~---------------------------~~~~~~~~~ 57 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQL---TGHKVAVKILNRQK---------------------------IRSLDVVGK 57 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHH
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECC---CCceEEEEEecccc---------------------------ccchhHHHH
Confidence 345789999999999999999999876 79999999986530 011223467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. ||||+++++++.+.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||
T Consensus 58 ~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~ 135 (276)
T 2h6d_A 58 IKREIQNLKLFR-HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDYCHRHMVVHR 135 (276)
T ss_dssp HHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHCSSCC
T ss_pred HHHHHHHHhcCC-CCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccC
Confidence 889999999997 999999999999999999999999999999988665 579999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccccc-C-CCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-Y-GTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+|||+ +.++.+||+|||++.............||+.|+|||++.+. + +.++||||||+++|+|++|..||.
T Consensus 136 dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 212 (276)
T 2h6d_A 136 DLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212 (276)
T ss_dssp CCCGGGEEE---CTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCChhhEEE---CCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCC
Confidence 999999999 56778999999999887665555667899999999998764 3 679999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..........+......++ ..++.++.+||.+||+.||.+|||+.++++||||++..
T Consensus 213 ~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~ 269 (276)
T 2h6d_A 213 DEHVPTLFKKIRGGVFYIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDL 269 (276)
T ss_dssp CSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred CCcHHHHHHHhhcCcccCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCc
Confidence 9888888888877655443 24789999999999999999999999999999998653
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=391.36 Aligned_cols=255 Identities=31% Similarity=0.563 Sum_probs=220.9
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.|+..+.||+|+||.||+|++.. +|+.||||++... .....+.+.+|
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~---~g~~vavK~~~~~------------------------------~~~~~~~~~~E 92 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKH---SGRQVAVKMMDLR------------------------------KQQRRELLFNE 92 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEETT------------------------------TCCSHHHHHHH
T ss_pred hhhccEEeccCCCeEEEEEEECC---CCcEEEEEEEecc------------------------------chhHHHHHHHH
Confidence 47888899999999999999876 7999999998642 11224568899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+++.++ ||||+++++++...+..|+||||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||
T Consensus 93 ~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp 169 (321)
T 2c30_A 93 VVIMRDYQ-HFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKS 169 (321)
T ss_dssp HHHHTTCC-CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred HHHHHhCC-CCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 99999997 99999999999999999999999999999987643 5799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
+|||+ +.++.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|+.||.....
T Consensus 170 ~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~ 246 (321)
T 2c30_A 170 DSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP 246 (321)
T ss_dssp GGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred HHEEE---CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999 56788999999999876543 23456789999999998864 589999999999999999999999999888
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.+....+........ .....+++++.+||.+||+.||.+|||+.++|+||||....
T Consensus 247 ~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 247 VQAMKRLRDSPPPKL-KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHHHHSSCCCC-TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHHhcCCCCCc-CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 888777766543221 22345899999999999999999999999999999998653
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-50 Score=398.26 Aligned_cols=271 Identities=34% Similarity=0.595 Sum_probs=221.7
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++.+.||+|+||.||+|++.. +|+.||||++.+..... . .........
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~~~~--------~--------------~~~~~~~~~ 60 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERK---TCKKVAIKIISKRKFAI--------G--------------SAREADPAL 60 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECC-------------------------------------
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcC---CCcEEEEEEeehhhhhh--------c--------------ccccchhhh
Confidence 4566899999999999999999999876 78999999986531000 0 001112234
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+.+++++. ||||+++++++..++ +|+||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+|
T Consensus 61 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 137 (322)
T 2ycf_A 61 NVETEIEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIH 137 (322)
T ss_dssp CHHHHHHHHHHCC-CTTBCCEEEEEESSS-EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred hHHHHHHHHHhCC-CCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 6789999999996 999999999987665 8999999999999998754 468999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~~ 352 (482)
|||||+|||++.++.+..+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|..
T Consensus 138 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (322)
T 2ycf_A 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 217 (322)
T ss_dssp CCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999755555679999999998876554455678999999999873 458999999999999999999999
Q ss_pred CCCCCChH-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 353 PFWARTES-GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 353 pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
||...... .+...+......+....+..+++++.+||.+||..||.+|||++++|+||||+..
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 218 PFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp SSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred CCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 99765443 4455566655554444456789999999999999999999999999999999763
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=398.12 Aligned_cols=265 Identities=27% Similarity=0.400 Sum_probs=218.3
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|++.. +|+.||||++..... ........+.+
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~-------------------------~~~~~~~~~~~ 59 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHR-------------------------SEAKDGINRTA 59 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSS---CCSEEEEEEC-------------------------------------CTHH
T ss_pred HhcccEEEeEEeecCCEEEEEEEECC---CCcEEEEEEEecCCc-------------------------chhhhhhhHHH
Confidence 45789999999999999999999876 799999999865310 00011112467
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+.+..++||||+++ +|.+++......+++..+..++.|++.||.|||++||+|||
T Consensus 60 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~D 137 (346)
T 1ua2_A 60 LREIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRD 137 (346)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHhhCC-CCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCC
Confidence 89999999997 99999999999999999999999976 88888876666799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||+|||+ +.++.+||+|||++...... ......+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.
T Consensus 138 lkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~ 214 (346)
T 1ua2_A 138 LKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 214 (346)
T ss_dssp CCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred CCHHHEEE---cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence 99999999 56788999999999876433 34456789999999998854 48999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCC------------------------CCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPW------------------------PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~------------------------~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
+.+..+.+..+...........| ..+++++.+||.+||+.||.+|||++|+|+|||
T Consensus 215 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~ 294 (346)
T 1ua2_A 215 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294 (346)
T ss_dssp CSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred CCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence 99988888888765333222222 456799999999999999999999999999999
Q ss_pred cccCC
Q 011582 412 LANSH 416 (482)
Q Consensus 412 ~~~~~ 416 (482)
|.+..
T Consensus 295 f~~~~ 299 (346)
T 1ua2_A 295 FSNRP 299 (346)
T ss_dssp GTSSS
T ss_pred hhcCC
Confidence 98754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-49 Score=401.12 Aligned_cols=257 Identities=26% Similarity=0.453 Sum_probs=214.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
..+|++++.||+|+||.||+|.+. +|+.||||++... .......+.+.
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~----~~~~vaiK~~~~~----------------------------~~~~~~~~~~~ 102 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLE----------------------------EADNQTLDSYR 102 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECT----------------------------TCCHHHHHHHH
T ss_pred CCceEEEEEEccCCCeEEEEEEcC----CCCEEEEEEEecc----------------------------cccHHHHHHHH
Confidence 356999999999999999999875 4889999999753 12344567899
Q ss_pred HHHHHHHhhcC-CCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTG-HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+|+++.. ||||+++++++..++.+||||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 103 ~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrD 180 (390)
T 2zmd_A 103 NEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHSD 180 (390)
T ss_dssp HHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCC
T ss_pred HHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecC
Confidence 99999999973 6999999999999999999999 5688999988655 5899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc------------cCCCcchhhhhHHH
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR------------SYGTEADMWSIGVI 343 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwSlGvi 343 (482)
|||+|||+. ++.+||+|||+++.+.... .....+||+.|+|||++.+ .|+.++|||||||+
T Consensus 181 lkp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvi 256 (390)
T 2zmd_A 181 LKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCI 256 (390)
T ss_dssp CCGGGEEES----SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHH
T ss_pred CCHHHEEEE----CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHH
Confidence 999999993 4679999999998765432 2345689999999998854 58899999999999
Q ss_pred HHHHhhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 344 AYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 344 l~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
+|+|++|..||..... ...+..+......+..+ ...++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 257 l~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 257 LYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC--CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC--ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 9999999999987543 34555565544433332 23588999999999999999999999999999998654
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=391.53 Aligned_cols=259 Identities=30% Similarity=0.503 Sum_probs=228.6
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|.+++.||+|+||.||+|++.. +|+.||+|++.+. ........+.+
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~---------------------------~~~~~~~~~~~ 88 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKS---------------------------LLLKPHQREKM 88 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGG---------------------------GCCSHHHHHHH
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEechh---------------------------hhcCHHHHHHH
Confidence 45789999999999999999999876 7899999998764 11334556788
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+.+.+|+||||+++++|.+++... ..+++.+++.++.||+.||.|||++||+|||
T Consensus 89 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~d 166 (335)
T 2owb_A 89 SMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHRD 166 (335)
T ss_dssp HHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhCC-CCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCEecC
Confidence 99999999996 999999999999999999999999999999987654 6799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||+|||+ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||..
T Consensus 167 lkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 243 (335)
T 2owb_A 167 LKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFET 243 (335)
T ss_dssp CCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred CCchhEEE---cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCC
Confidence 99999999 56788999999999876532 33455689999999998865 588999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
....+.+..+......++. .+++++.+||.+||+.||.+|||++++|+||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 244 SCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp SSHHHHHHHHHHTCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred CCHHHHHHHHhcCCCCCCc----cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 9888888888877655443 4899999999999999999999999999999998654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-50 Score=396.84 Aligned_cols=265 Identities=27% Similarity=0.434 Sum_probs=221.5
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
...+.++|++.+.||+|+||.||+|++.. +|+.||||++... ........
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---------------------------~~~~~~~~ 56 (311)
T 3ork_A 7 PSHLSDRYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRAD---------------------------LARDPSFY 56 (311)
T ss_dssp CSEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECTT---------------------------TTTSHHHH
T ss_pred cceecCcEEEEEEEccCCCEEEEEEEECC---CCceEEEEEeCcc---------------------------ccCCHHHH
Confidence 34567899999999999999999999876 7999999998653 11234456
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCC----eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDD----NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
..+.+|+.+++++. ||||+++++++.... ..|+|||||+|++|.+++... +.+++..++.++.||+.||.|||+
T Consensus 57 ~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~ 134 (311)
T 3ork_A 57 LRFRREAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQ 134 (311)
T ss_dssp HHHHHHHTTCCCCC-CTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCC-CCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 78899999999996 999999999987654 359999999999999988655 579999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC----cccccccCccccCcccccc-cCCCcchhhhhHHHHHH
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYI 346 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~e 346 (482)
+||+||||||+|||+ +.++.+||+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+
T Consensus 135 ~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 211 (311)
T 3ork_A 135 NGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYE 211 (311)
T ss_dssp TTCCCCCCCGGGEEE---ETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred CCCCcCCCCHHHEEE---cCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHH
Confidence 999999999999999 456789999999998764332 2334679999999998875 58999999999999999
Q ss_pred HhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 347 LLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 347 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
|++|+.||.+....+....+...........+..+++++.+||.+||+.||.+||++.++|.|+|++..
T Consensus 212 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 212 VLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 999999999999888888877776655444456799999999999999999999999999999999743
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=382.67 Aligned_cols=260 Identities=30% Similarity=0.501 Sum_probs=228.4
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|.+++.||+|+||.||+|.+.. +|+.||+|++.+. ........+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~a~K~~~~~---------------------------~~~~~~~~~~ 61 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDAD---TKEVFAGKIVPKS---------------------------LLLKPHQREK 61 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGG---------------------------GCCSHHHHHH
T ss_pred CcccceEEEEEEeecCCEEEEEEEECC---CCceEEEEEechh---------------------------hccCHHHHHH
Confidence 345789999999999999999999876 7899999998764 1123455678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. ||||+++++++.+.+..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||
T Consensus 62 ~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~ 139 (294)
T 2rku_A 62 MSMEISIHRSLA-HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-KALTEPEARYYLRQIVLGCQYLHRNRVIHR 139 (294)
T ss_dssp HHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 899999999996 999999999999999999999999999999977654 679999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+|||+ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 140 dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 216 (294)
T 2rku_A 140 DLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE 216 (294)
T ss_dssp CCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTC
T ss_pred CCChHhEEE---cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999 56788999999999876532 33455679999999998865 58899999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.....+....+......++ ..+++++.+||.+||+.||.+|||++++|+||||....
T Consensus 217 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 217 TSCLKETYLRIKKNEYSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY 273 (294)
T ss_dssp CSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred CCCHHHHHHHHhhccCCCc----cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence 9988888888877655443 34889999999999999999999999999999998754
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=405.94 Aligned_cols=263 Identities=29% Similarity=0.514 Sum_probs=210.2
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|+++. +|+.||||++.+. .......+.
T Consensus 23 ~i~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vAiK~~~~~----------------------------~~~~~~~~~ 71 (432)
T 3n9x_A 23 HVPDNYIIKHLIGRGSYGYVYLAYDKN---TEKNVAIKKVNRM----------------------------FEDLIDCKR 71 (432)
T ss_dssp CCCTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECST----------------------------TTSHHHHHH
T ss_pred eecCCEEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeCch----------------------------hcChHHHHH
Confidence 356789999999999999999999887 7999999999652 133445678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeC-----CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDD-----DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
+.+|+.+|+.++ ||||+++++++... +.+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++
T Consensus 72 ~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~ 148 (432)
T 3n9x_A 72 ILREITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHES 148 (432)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHcC-CCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 899999999997 99999999999876 67999999996 599988754 46799999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC-----------------------cccccccCccccCcccc-c
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----------------------RLNDIVGSAYYVAPEVL-H 328 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----------------------~~~~~~gt~~y~aPE~~-~ 328 (482)
||+||||||+|||+ +.++.+||+|||+++...... .....+||++|+|||++ .
T Consensus 149 givHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~ 225 (432)
T 3n9x_A 149 GIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225 (432)
T ss_dssp TEECCCCCGGGEEE---CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT
T ss_pred CCCCCCCCHHHeEE---CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc
Confidence 99999999999999 667889999999998764332 23667899999999986 3
Q ss_pred -ccCCCcchhhhhHHHHHHHhhC-----------CCCCCCCC-----------------hHHHHHHHHhcCC--------
Q 011582 329 -RSYGTEADMWSIGVIAYILLCG-----------SRPFWART-----------------ESGIFRAVLKADP-------- 371 (482)
Q Consensus 329 -~~~~~~~DiwSlGvil~elltg-----------~~pf~~~~-----------------~~~~~~~i~~~~~-------- 371 (482)
..|+.++|||||||++|||++| .++|.+.+ ..+.+..|.....
T Consensus 226 ~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~ 305 (432)
T 3n9x_A 226 QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK 305 (432)
T ss_dssp CSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHH
T ss_pred CCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHH
Confidence 4599999999999999999984 44444433 1122222221111
Q ss_pred ---------------CCCC----CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 372 ---------------SFDE----APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 372 ---------------~~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.... ..++.+++++.+||.+||+.||.+|||++|+|+||||+....
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 306 NINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred hccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 0000 113568999999999999999999999999999999997653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=399.92 Aligned_cols=259 Identities=26% Similarity=0.467 Sum_probs=207.4
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|++.. +|+.||||++.+. .......+.
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~----------------------------~~~~~~~~~ 70 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAI---LERNVAIKKLSRP----------------------------FQNQTHAKR 70 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECT----------------------------TSSHHHHHH
T ss_pred chhhheeEeeeeEecCCEEEEEEEECC---CCceEEEEEeccc----------------------------cCChHHHHH
Confidence 356899999999999999999999876 7999999998653 123445577
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCC------eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDD------NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+.+|+.+++.+. ||||+++++++...+ .+|+|||||++ +|.+.+. ..+++..+..++.||+.||.|||+
T Consensus 71 ~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~ 145 (371)
T 2xrw_A 71 AYRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHS 145 (371)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcC-CCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHH
Confidence 889999999996 999999999998765 78999999975 7888774 359999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhC
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg 350 (482)
+||+||||||+|||+ +.++.+||+|||++............+||+.|+|||++.+ .|+.++|||||||++|+|++|
T Consensus 146 ~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g 222 (371)
T 2xrw_A 146 AGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222 (371)
T ss_dssp TTCCCSCCCGGGEEE---CTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHS
T ss_pred CCeecccCCHHHEEE---cCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhC
Confidence 999999999999999 5678899999999987765555566789999999998865 589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCC-----------------CCC--------------C-------CCCHHHHHHHHHh
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDE-----------------APW--------------P-------SLSPEAIDFVKRL 392 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~-----------------~~~--------------~-------~~s~~~~~li~~~ 392 (482)
..||.+.+..+.+..+......... ..+ + ..++++++||.+|
T Consensus 223 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m 302 (371)
T 2xrw_A 223 GVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKM 302 (371)
T ss_dssp SCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHH
Confidence 9999999888887777654321110 000 0 0156899999999
Q ss_pred chhccccCCCHHHHhcCcccccC
Q 011582 393 LNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 393 L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
|+.||.+|||++|+|+||||+..
T Consensus 303 L~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 303 LVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp SCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CcCChhhCCCHHHHhCCcchhhh
Confidence 99999999999999999999854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=406.84 Aligned_cols=258 Identities=29% Similarity=0.447 Sum_probs=212.5
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
+....+|++.+.||+|+||.||+|++.. +..||+|++.+.. .
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~----~~~~aikk~~~~~----------------------------------~ 77 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVE----SDEVAIKKVLQDK----------------------------------R 77 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETT----TEEEEEEEEECCT----------------------------------T
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECC----CCeEEEEEEecCc----------------------------------c
Confidence 4456789999999999999999999864 4458999875420 0
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCe------EEEEEecCCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDN------IYIVMELCKGGELLDRIL---SRGGKYSEEDAKIVMVQILSVVA 267 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~------~~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~ 267 (482)
...+|+.+++.+. ||||+++++++...+. +|+|||||+++ +...+. .....+++..++.++.||+.||.
T Consensus 78 ~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~ 155 (394)
T 4e7w_A 78 FKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLA 155 (394)
T ss_dssp SCCHHHHHHHTCC-CTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHhCC-CCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHH
Confidence 1136999999997 9999999999965443 88999999874 444433 23568999999999999999999
Q ss_pred HHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHH
Q 011582 268 FCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAY 345 (482)
Q Consensus 268 yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ 345 (482)
|||++||+||||||+|||++ ..++.+||+|||+++...........+||+.|+|||++.+ .|+.++|||||||++|
T Consensus 156 ~LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 233 (394)
T 4e7w_A 156 YIHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMA 233 (394)
T ss_dssp HHHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHH
Confidence 99999999999999999994 2577899999999998766666667889999999998854 5899999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHhcCCC-----------------CCC--------CCCCCCCHHHHHHHHHhchhccccC
Q 011582 346 ILLCGSRPFWARTESGIFRAVLKADPS-----------------FDE--------APWPSLSPEAIDFVKRLLNKDYRKR 400 (482)
Q Consensus 346 elltg~~pf~~~~~~~~~~~i~~~~~~-----------------~~~--------~~~~~~s~~~~~li~~~L~~dP~~R 400 (482)
+|++|+.||.+.+..+.+..+...... ++. ...+.+++++.+||.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (394)
T 4e7w_A 234 ELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313 (394)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhC
Confidence 999999999999888777776653111 111 0123488999999999999999999
Q ss_pred CCHHHHhcCcccccCC
Q 011582 401 LTAAQALSHPWLANSH 416 (482)
Q Consensus 401 ~s~~e~L~hp~~~~~~ 416 (482)
||+.++|+||||+...
T Consensus 314 ~t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 314 LTAIEALCHPFFDELR 329 (394)
T ss_dssp CCHHHHHTSGGGSTTT
T ss_pred CCHHHHhcChhhhhhc
Confidence 9999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=379.05 Aligned_cols=257 Identities=22% Similarity=0.366 Sum_probs=216.5
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
..|++.+.||+|+||.||+|.+.. ++..||+|++... .......+.+.+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~---~~~~va~k~~~~~----------------------------~~~~~~~~~~~~ 74 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDR----------------------------KLTKSERQRFKE 74 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGG----------------------------GSCHHHHHHHHH
T ss_pred eeEEeeeeccCCCCeEEEEeEecC---CceEEEEEEecch----------------------------hhCHHHHHHHHH
Confidence 469999999999999999999876 7899999998653 123455678999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--C
Q 011582 201 EVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG--V 274 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--i 274 (482)
|+.+++.+. ||||+++++++.. ...+|+||||+++++|.+++... ..+++..++.++.||+.||.|||++| |
T Consensus 75 e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~~i 152 (290)
T 1t4h_A 75 EAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPI 152 (290)
T ss_dssp HHHHHTTCC-CTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred HHHHHHhCC-CCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHcCCCCE
Confidence 999999996 9999999999876 46689999999999999988654 67999999999999999999999999 9
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf 354 (482)
+||||||+|||++ +.++.+||+|||++..... .......||+.|+|||++.+.++.++|||||||++|+|++|..||
T Consensus 153 ~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf 229 (290)
T 1t4h_A 153 IHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPY 229 (290)
T ss_dssp CCSCCCGGGEEES--STTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred EECCCCHHHEEEE--CCCCCEEEeeCCCcccccc-cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCC
Confidence 9999999999994 2567899999999976543 334556899999999999888999999999999999999999999
Q ss_pred CCCChH-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 355 WARTES-GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 355 ~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
...... .....+..... +.......++++.+||.+||+.||.+|||++++|+||||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 230 SECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp TTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCcCcHHHHHHHHhccCC--ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 885544 44444433322 112223477999999999999999999999999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=393.98 Aligned_cols=256 Identities=29% Similarity=0.483 Sum_probs=207.3
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|+++. +|+.||||++... ......+.
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~-----------------------------~~~~~~~~ 50 (332)
T 3qd2_B 3 RYLTDFEPIQCMGRGGFGVVFEAKNKV---DDCNYAIKRIRLP-----------------------------NRELAREK 50 (332)
T ss_dssp HHHHHEEEEEEEECC-CSEEEEEEETT---TCCEEEEEEEECC-----------------------------STTTHHHH
T ss_pred hhhhcCceeeEecCCCCeEEEEEEEcC---CCcEEEEEEeecC-----------------------------CchhHHHH
Confidence 356789999999999999999999876 7999999999653 12234577
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCC----------------------------------------------------
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDD---------------------------------------------------- 225 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~---------------------------------------------------- 225 (482)
+.+|+.+|++++ ||||++++++|.+.+
T Consensus 51 ~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 129 (332)
T 3qd2_B 51 VMREVKALAKLE-HPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129 (332)
T ss_dssp HHHHHHHHTSCC-CTTBCCEEEEEEECCSCHHHHHHHC------------------------------------------
T ss_pred HHHHHHHHHhCC-CCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccC
Confidence 899999999996 999999999986654
Q ss_pred -----eEEEEEecCCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEE
Q 011582 226 -----NIYIVMELCKGGELLDRILSRG--GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298 (482)
Q Consensus 226 -----~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~ 298 (482)
..|+|||||+|++|.+++.... ...++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 130 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~ 206 (332)
T 3qd2_B 130 SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVG 206 (332)
T ss_dssp --CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTCCEEEC
T ss_pred CCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCCCEEEe
Confidence 3899999999999999886542 235667799999999999999999999999999999999 567789999
Q ss_pred ecccccccCCCC-------------cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHH
Q 011582 299 DFGLSDYVKPDE-------------RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFR 364 (482)
Q Consensus 299 DfGla~~~~~~~-------------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~ 364 (482)
|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|..|+.. ......
T Consensus 207 DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~ 284 (332)
T 3qd2_B 207 DFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIIT 284 (332)
T ss_dssp CCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHH
T ss_pred ecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHH
Confidence 999998765432 2244679999999998865 689999999999999999998776521 122223
Q ss_pred HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 365 AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 365 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
.+.... ++ ..+...++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 285 ~~~~~~--~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 285 DVRNLK--FP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHTTC--CC-HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HhhccC--CC-cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 332221 11 112346788999999999999999999999999999975
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=379.03 Aligned_cols=261 Identities=21% Similarity=0.335 Sum_probs=215.1
Q ss_pred cccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
+...+.++|++.+.||+|+||.||+|++.. +|+.||||++.+.. .....
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~----------------------------~~~~~ 53 (289)
T 1x8b_A 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRL---DGCIYAIKRSKKPL----------------------------AGSVD 53 (289)
T ss_dssp CCCHHHHHEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCC----------------------------TTSHH
T ss_pred ccccccchhhhhhhhcCCCceEEEEEEEcC---CCceEEEEEecccc----------------------------cccHH
Confidence 445677899999999999999999999876 79999999987531 22334
Q ss_pred HHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
...+.+|+.++..+.+||||+++++++.+.+..++||||+++++|.+++... ...+++..++.++.||+.||.|||+
T Consensus 54 ~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 133 (289)
T 1x8b_A 54 EQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133 (289)
T ss_dssp HHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 5678899999999955999999999999999999999999999999988653 2579999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCC----------------CCCcEEEEecccccccCCCCcccccccCccccCccccccc--CCC
Q 011582 272 QGVVHRDLKPENFLFTSKE----------------ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS--YGT 333 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~----------------~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~ 333 (482)
+||+||||||+|||++.++ ....+||+|||++...... ....||+.|+|||++.+. ++.
T Consensus 134 ~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~ 210 (289)
T 1x8b_A 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLP 210 (289)
T ss_dssp TTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHH
T ss_pred CCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCc
Confidence 9999999999999996432 4557999999999876543 234699999999998754 567
Q ss_pred cchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 334 EADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 334 ~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
++|||||||++|+|++|.+++.... ....+...... .....+++++.+||.+||+.||.+|||+.++|+||||.
T Consensus 211 ~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~ 284 (289)
T 1x8b_A 211 KADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284 (289)
T ss_dssp HHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC-
T ss_pred hhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhh
Confidence 9999999999999999998875442 34444443321 12245899999999999999999999999999999998
Q ss_pred cC
Q 011582 414 NS 415 (482)
Q Consensus 414 ~~ 415 (482)
+.
T Consensus 285 ~~ 286 (289)
T 1x8b_A 285 SA 286 (289)
T ss_dssp --
T ss_pred hh
Confidence 64
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-49 Score=400.05 Aligned_cols=262 Identities=30% Similarity=0.530 Sum_probs=219.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|++..+..+|+.||||++++.... ......+.+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~~~~ 106 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIV--------------------------QKAKTTEHTR 106 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEE--------------------------EEESSGGGCC
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhh--------------------------hhhhHHHHHH
Confidence 46899999999999999999998655457999999998653100 0011123456
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|+.+.+||||+++++++.+.+.+|+|||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 107 ~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dl 185 (355)
T 1vzo_A 107 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDI 185 (355)
T ss_dssp CHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 79999999977999999999999999999999999999999988765 57999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC--CcccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD--ERLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~elltg~~pf 354 (482)
||+|||+ +.++.+||+|||+++..... ......+||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 186 kp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf 262 (355)
T 1vzo_A 186 KLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262 (355)
T ss_dssp CGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred CHHHEEE---CCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999 66788999999999865432 22345689999999999864 3789999999999999999999999
Q ss_pred CCC----ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 355 WAR----TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 355 ~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
... ....+...+......++ ..+++.+.+||.+||..||.+|| +++++++||||...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 263 TVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp SCTTSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred ccCCccchHHHHHHHHhccCCCCC----cccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 754 33455566666554443 35899999999999999999999 99999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=386.88 Aligned_cols=255 Identities=29% Similarity=0.547 Sum_probs=213.0
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|++.. +|+.||||++... ..+.+
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~---------------------------------~~~~~ 77 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPV---------------------------------KKKKI 77 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECSC---------------------------------CHHHH
T ss_pred CCCceEEEEEecccCCeEEEEEEECC---CCcEEEEEEeccc---------------------------------chHHH
Confidence 35789999999999999999999876 7999999998642 13568
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+|+.+++.+.+||||+++++++.+ ....++||||+++++|.+++ ..+++..++.++.||+.||.|||++||+|
T Consensus 78 ~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 153 (330)
T 3nsz_A 78 KREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMH 153 (330)
T ss_dssp HHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHH----HhCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 8999999999779999999999998 67899999999999998876 24899999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf 354 (482)
|||||+|||++ .++..+||+|||++............+||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 154 ~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~ 231 (330)
T 3nsz_A 154 RDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231 (330)
T ss_dssp CCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred CCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCc
Confidence 99999999995 2334899999999998776666677789999999998864 5899999999999999999999999
Q ss_pred CCC-ChHHHHHHHH-------------hcCCCCC--------------------CCCCCCCCHHHHHHHHHhchhccccC
Q 011582 355 WAR-TESGIFRAVL-------------KADPSFD--------------------EAPWPSLSPEAIDFVKRLLNKDYRKR 400 (482)
Q Consensus 355 ~~~-~~~~~~~~i~-------------~~~~~~~--------------------~~~~~~~s~~~~~li~~~L~~dP~~R 400 (482)
... ...+.+..+. ....... ......+++++.+||.+||+.||.+|
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 311 (330)
T 3nsz_A 232 FHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311 (330)
T ss_dssp SCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGS
T ss_pred ccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccC
Confidence 543 3323222221 1111111 01112379999999999999999999
Q ss_pred CCHHHHhcCcccccC
Q 011582 401 LTAAQALSHPWLANS 415 (482)
Q Consensus 401 ~s~~e~L~hp~~~~~ 415 (482)
||++|+|+||||++.
T Consensus 312 pta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 312 LTAREAMEHPYFYTV 326 (330)
T ss_dssp CCHHHHHTSGGGTTC
T ss_pred CCHHHHhcCccHhhh
Confidence 999999999999865
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=390.74 Aligned_cols=260 Identities=36% Similarity=0.642 Sum_probs=192.0
Q ss_pred ccccceEecc-eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 118 QFVAHYELGE-EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 118 ~~~~~y~~~~-~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
.+.++|.+.+ .||+|+||.||+|+++. +|+.||||++.+. .
T Consensus 25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~-----------------------------------~ 66 (336)
T 3fhr_A 25 AVTDDYQLSKQVLGLGVNGKVLECFHRR---TGQKCALKLLYDS-----------------------------------P 66 (336)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEESS-----------------------------------H
T ss_pred cccceeEecceeeeeCCCeEEEEEEECC---CCCEEEEEEecCc-----------------------------------H
Confidence 3567899965 59999999999999987 7999999998643 1
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
...+|+..+.++.+||||+++++++.. ...+|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||+
T Consensus 67 ~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~ 146 (336)
T 3fhr_A 67 KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146 (336)
T ss_dssp HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 233444443344459999999999986 456899999999999999987653 469999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhC
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg 350 (482)
+||+||||||+|||++.++.++.+||+|||++..... ......+||+.|+|||++. ..++.++|||||||++|+|++|
T Consensus 147 ~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 225 (336)
T 3fhr_A 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225 (336)
T ss_dssp TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHS
T ss_pred CCeecCCCCHHHEEEEecCCCceEEEeccccceeccc-cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999997655677899999999987643 3345668899999999986 4588999999999999999999
Q ss_pred CCCCCCCChHHH----HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 351 SRPFWARTESGI----FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 351 ~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..||........ ...+......++...|..+++++.+||.+||+.||.+|||++++|+||||++..
T Consensus 226 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 226 FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp SCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred CCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 999977665443 334444555666667778999999999999999999999999999999998754
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=403.81 Aligned_cols=260 Identities=29% Similarity=0.436 Sum_probs=217.0
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+..+|++++.||+|+||.||+|++.. +|+.||||++... .....
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~---~~~~vAvK~~~~~-------------------------------~~~~~ 138 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHK---VHQHVALKMVRNE-------------------------------KRFHR 138 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETT---TTEEEEEEEECSC-------------------------------HHHHH
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECC---CCcEEEEEEECCc-------------------------------cchHH
Confidence 4567889999999999999999999876 7999999998542 23345
Q ss_pred HHHHHHHHHHhhc-----CCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALT-----GHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 197 ~~~~Ei~~l~~l~-----~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH 270 (482)
.+.+|+.+++.++ +|+||+++++++...+.+|+||||+. ++|.+++.... ..+++..++.++.||+.||.|||
T Consensus 139 ~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH 217 (429)
T 3kvw_A 139 QAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALH 217 (429)
T ss_dssp HHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 6788999998885 47799999999999999999999996 58999887653 45999999999999999999999
Q ss_pred HCCCcccCCCCCceEEecCCCCCc--EEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHH
Q 011582 271 FQGVVHRDLKPENFLFTSKEENSS--LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~~~~~~~--~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el 347 (482)
++|||||||||+|||++ .++. +||+|||++.... ......+||+.|+|||++.+ .|+.++|||||||++|+|
T Consensus 218 ~~~ivHrDlKp~NILl~---~~~~~~vkL~DFG~a~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 292 (429)
T 3kvw_A 218 KNRIIHCDLKPENILLK---QQGRSGIKVIDFGSSCYEH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAEL 292 (429)
T ss_dssp HHTEECSCCSGGGEEES---STTSCCEEECCCTTCEETT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHH
T ss_pred HCCeecCCCCHHHeEEc---cCCCcceEEeecccceecC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHH
Confidence 99999999999999994 4444 9999999997653 33456789999999998865 699999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHhcCCCCCCC--------------------------------------------------C
Q 011582 348 LCGSRPFWARTESGIFRAVLKADPSFDEA--------------------------------------------------P 377 (482)
Q Consensus 348 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~--------------------------------------------------~ 377 (482)
++|..||.+.+..+.+..+.......+.. .
T Consensus 293 ltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 372 (429)
T 3kvw_A 293 LTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESRE 372 (429)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchh
Confidence 99999999999888877766431111000 0
Q ss_pred -----CCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 378 -----WPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 378 -----~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
....++++.+||++||+.||.+|||++|+|+||||+...
T Consensus 373 ~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 373 WGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp HHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred hHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 012478899999999999999999999999999998754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=399.58 Aligned_cols=256 Identities=26% Similarity=0.459 Sum_probs=214.1
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|++.. +|+.||||++.... ...
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~---~~~~vAiK~~~~~~----------------------------------~~~ 47 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIE---SGKRFALKKVLQDP----------------------------------RYK 47 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETT---TCCEEEEEEEECCT----------------------------------TSC
T ss_pred ccceEEEEEEEEeccCEEEEEEEECC---CCCEEEEEEEecCc----------------------------------chH
Confidence 45689999999999999999999877 89999999986530 112
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEe--------------------------------------CCeEEEEEecCCCCChH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYED--------------------------------------DDNIYIVMELCKGGELL 240 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~--------------------------------------~~~~~lv~e~~~~g~L~ 240 (482)
.+|+.+|+.+. ||||+++++++.. ...+++|||||++ +|.
T Consensus 48 ~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~ 125 (383)
T 3eb0_A 48 NRELDIMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH 125 (383)
T ss_dssp CHHHHHHTTCC-CTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSE-EHH
T ss_pred HHHHHHHHHcC-CCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHH
Confidence 37999999996 9999999999844 3448999999985 777
Q ss_pred HHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCccccccc
Q 011582 241 DRIL---SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVG 317 (482)
Q Consensus 241 ~~l~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~g 317 (482)
+.+. ..+..+++..++.++.||+.||.|||++||+||||||+|||++ ..++.+||+|||++.............|
T Consensus 126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 203 (383)
T 3eb0_A 126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAYIC 203 (383)
T ss_dssp HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCCCC
T ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCccc
Confidence 6664 3457899999999999999999999999999999999999995 2567899999999998776666677889
Q ss_pred CccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCC-----------------CCC---
Q 011582 318 SAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPS-----------------FDE--- 375 (482)
Q Consensus 318 t~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~-----------------~~~--- 375 (482)
|+.|+|||++.+ .|+.++||||+||++|+|++|+.||.+.+..+.+..+...... ++.
T Consensus 204 t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 283 (383)
T 3eb0_A 204 SRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA 283 (383)
T ss_dssp CSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCC
T ss_pred CCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCc
Confidence 999999998764 4899999999999999999999999999888877777652111 111
Q ss_pred C-----CCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 376 A-----PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 376 ~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
. ....+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus 284 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 284 KDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred ccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 0 112478999999999999999999999999999999764
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=382.58 Aligned_cols=264 Identities=27% Similarity=0.393 Sum_probs=218.6
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.+.+.++|++.+.||+|+||.||+|++.. +|+.||||++... ........
T Consensus 6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~---------------------------~~~~~~~~ 55 (294)
T 4eqm_A 6 GKIINERYKIVDKLGGGGMSTVYLAEDTI---LNIKVAIKAIFIP---------------------------PREKEETL 55 (294)
T ss_dssp SSCEETTEEEEEEEEEETTEEEEEEEETT---TCSEEEEEEEECC---------------------------SSCCHHHH
T ss_pred hhHhhccEEEEEEEccCCCEEEEEEEECC---CCCeEEEEEeccC---------------------------ccccHHHH
Confidence 45567899999999999999999999876 7999999998653 11334556
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
+.+.+|+.+++.+. ||||+++++++.+.+.+|+||||++|++|.+++... +.+++..+..++.||+.||.|||++||+
T Consensus 56 ~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 133 (294)
T 4eqm_A 56 KRFEREVHNSSQLS-HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKHAHDMRIV 133 (294)
T ss_dssp HHHHHHHHHHTTCC-BTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhcCC-CCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 78999999999997 999999999999999999999999999999988665 5799999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~ 352 (482)
||||||+|||+ +.++.+||+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|+.
T Consensus 134 H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~ 210 (294)
T 4eqm_A 134 HRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210 (294)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSC
T ss_pred cCCCCHHHEEE---CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCC
Confidence 99999999999 567889999999998765432 2344679999999998865 58899999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCC-CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 353 PFWARTESGIFRAVLKADPS-FDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
||.+.+.............. ......+.+++.+.++|.+||+.||.+||+..+.+.+.|..-
T Consensus 211 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~ 273 (294)
T 4eqm_A 211 PFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSV 273 (294)
T ss_dssp SSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTS
T ss_pred CCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHH
Confidence 99998877766655554322 112234568999999999999999999997777777776543
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=390.69 Aligned_cols=261 Identities=28% Similarity=0.456 Sum_probs=216.1
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++.. +|+.||||++... .......+.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~----------------------------~~~~~~~~~~ 71 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKD---TGRIVAIKKFLES----------------------------DDDKMVKKIA 71 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETT---TCCEEEEEEEESC----------------------------SSCHHHHHHH
T ss_pred hhhhheeeeEEeecCCEEEEEEEECC---CCceEEEEEEecC----------------------------CCchHHHHHH
Confidence 35789999999999999999999876 7999999998653 1233445678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+.+..|+||||+++++|.+++ .....+++..+..++.||+.||.|||++||+|||
T Consensus 72 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~d 149 (331)
T 4aaa_A 72 MREIKLLKQLR-HENLVNLLEVCKKKKRWYLVFEFVDHTILDDLE-LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRD 149 (331)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH-HSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred HHHHHHHhhCC-CCCEeeEEEEeecCCEEEEEEecCCcchHHHHH-hhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccC
Confidence 89999999997 999999999999999999999999988777654 4456799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||+|||+ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.
T Consensus 150 lkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (331)
T 4aaa_A 150 IKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFP 226 (331)
T ss_dssp CCGGGEEE---CTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cChheEEE---cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCC
Confidence 99999999 66778999999999876443 33455689999999998865 58999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCC-------------------CC--------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 356 ARTESGIFRAVLKADPSF-------------------DE--------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~-------------------~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+....+....+....... +. ..++.+++++.+||.+||+.||.+|||++|+|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 227 GDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp CSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred CCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 988877766655321111 00 012467999999999999999999999999999
Q ss_pred CcccccC
Q 011582 409 HPWLANS 415 (482)
Q Consensus 409 hp~~~~~ 415 (482)
||||+..
T Consensus 307 hp~f~~~ 313 (331)
T 4aaa_A 307 HDFFQMD 313 (331)
T ss_dssp SHHHHGG
T ss_pred CchhccC
Confidence 9999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=398.71 Aligned_cols=260 Identities=30% Similarity=0.552 Sum_probs=203.4
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|.+.. +|+.||||++.+. .......+.
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~ 74 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRP----------------------------FQSIIHAKR 74 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETT---TTEEEEEEECSST----------------------------TSSHHHHHH
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECC---CCCEEEEEEeCcc----------------------------ccCHHHHHH
Confidence 456899999999999999999999876 7999999998642 123345677
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+.+|+.+|+.+. ||||+++++++... ..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||+
T Consensus 75 ~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~ 150 (367)
T 2fst_X 75 TYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHS 150 (367)
T ss_dssp HHHHHHHHHHCC-CTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhCC-CCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH
Confidence 889999999997 99999999999754 6689999999 6799887754 579999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhh
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ellt 349 (482)
+||+||||||+|||+ +.++.+||+|||+++.... .....+||+.|+|||++.+ .|+.++|||||||++|+|++
T Consensus 151 ~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~ 225 (367)
T 2fst_X 151 ADIIHRDLKPSNLAV---NEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225 (367)
T ss_dssp TTCCCCCCCGGGEEE---CTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHH
T ss_pred CCeeeCCCCHhhEEE---CCCCCEEEeeccccccccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHh
Confidence 999999999999999 5678899999999987543 3456789999999998864 68999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCC-----------------------CCC----CCCCCCHHHHHHHHHhchhccccCCC
Q 011582 350 GSRPFWARTESGIFRAVLKADPSF-----------------------DEA----PWPSLSPEAIDFVKRLLNKDYRKRLT 402 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~-----------------------~~~----~~~~~s~~~~~li~~~L~~dP~~R~s 402 (482)
|+.||.+.+..+.+..|....... +.. .++.+++++.+||.+||+.||.+|||
T Consensus 226 g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t 305 (367)
T 2fst_X 226 GRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT 305 (367)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC
Confidence 999999988887777766532111 111 12457899999999999999999999
Q ss_pred HHHHhcCcccccCCC
Q 011582 403 AAQALSHPWLANSHD 417 (482)
Q Consensus 403 ~~e~L~hp~~~~~~~ 417 (482)
++++|+||||.....
T Consensus 306 ~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 306 AAQALAHAYFAQYHD 320 (367)
T ss_dssp HHHHHTSGGGTTTCC
T ss_pred HHHHhcChhhhhccC
Confidence 999999999987543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=402.77 Aligned_cols=257 Identities=28% Similarity=0.432 Sum_probs=212.4
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
...+|++.+.||+|+||.||+|++.. +|+.||||++.+.. ...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~---~~~~vaiK~~~~~~----------------------------------~~~ 94 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDK----------------------------------RFK 94 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEECCT----------------------------------TSC
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECC---CCcEEEEEEecccc----------------------------------hhH
Confidence 34579999999999999999999976 79999999986530 112
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRIL---SRGGKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~yL 269 (482)
.+|+.+|+.+. ||||++++++|... ..+++||||+++ +|.+.+. .....+++..++.++.||+.||.||
T Consensus 95 ~~E~~il~~l~-hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~L 172 (420)
T 1j1b_A 95 NRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 172 (420)
T ss_dssp CHHHHHHHTCC-CTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcC-CCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 37999999997 99999999998542 236799999976 5666554 2356899999999999999999999
Q ss_pred HHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHH
Q 011582 270 HFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 270 H~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el 347 (482)
|++||+||||||+|||++ .+.+.+||+|||+++...........+||+.|+|||++.+ .|+.++|||||||++|||
T Consensus 173 H~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el 250 (420)
T 1j1b_A 173 HSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 250 (420)
T ss_dssp HTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEe--CCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHH
Confidence 999999999999999995 2345789999999998766655667789999999998854 599999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHhc------------CCCCCCC--------C-----CCCCCHHHHHHHHHhchhccccCCC
Q 011582 348 LCGSRPFWARTESGIFRAVLKA------------DPSFDEA--------P-----WPSLSPEAIDFVKRLLNKDYRKRLT 402 (482)
Q Consensus 348 ltg~~pf~~~~~~~~~~~i~~~------------~~~~~~~--------~-----~~~~s~~~~~li~~~L~~dP~~R~s 402 (482)
++|+.||.+.+..+.+..+... ...+... . .+.+++++.+||++||+.||.+|||
T Consensus 251 l~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t 330 (420)
T 1j1b_A 251 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330 (420)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC
Confidence 9999999998877777666542 1111111 1 1346899999999999999999999
Q ss_pred HHHHhcCcccccCC
Q 011582 403 AAQALSHPWLANSH 416 (482)
Q Consensus 403 ~~e~L~hp~~~~~~ 416 (482)
+.|+|+||||....
T Consensus 331 ~~e~l~hp~f~~~~ 344 (420)
T 1j1b_A 331 PLEACAHSFFDELR 344 (420)
T ss_dssp HHHHHTSGGGGGGG
T ss_pred HHHHhCCHhhcccc
Confidence 99999999998654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-49 Score=388.89 Aligned_cols=260 Identities=24% Similarity=0.410 Sum_probs=215.9
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++... ......+.
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-----------------------------~~~~~~~~ 53 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNI-----------------------------SFLRPVDV 53 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGG-----------------------------GGGSCHHH
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECC---CCcEEEEEEeccc-----------------------------cccchHHH
Confidence 345789999999999999999999976 7999999998653 11122456
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCC--eEEEEEecCCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDD--NIYIVMELCKGGELLDRILSRG--GKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
+.+|+.++++++ ||||+++++++.+.+ ..|+|||||++++|.+++.... ..+++..++.++.||+.||.|||++|
T Consensus 54 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 132 (319)
T 4euu_A 54 QMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132 (319)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcC-CCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 789999999997 999999999998765 7899999999999999887542 23999999999999999999999999
Q ss_pred CcccCCCCCceEEe-cCCCCCcEEEEecccccccCCCCcccccccCccccCccccc---------ccCCCcchhhhhHHH
Q 011582 274 VVHRDLKPENFLFT-SKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH---------RSYGTEADMWSIGVI 343 (482)
Q Consensus 274 ivHrDlkp~NIll~-~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwSlGvi 343 (482)
|+||||||+|||+. .++.++.+||+|||++.............||+.|+|||++. ..++.++|||||||+
T Consensus 133 ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~i 212 (319)
T 4euu_A 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (319)
T ss_dssp EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHH
T ss_pred EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHH
Confidence 99999999999984 23456679999999999877666667788999999999874 468999999999999
Q ss_pred HHHHhhCCCCCCCC----ChHHHHHHHHhcCCCC-------------------CC--CCCCCCCHHHHHHHHHhchhccc
Q 011582 344 AYILLCGSRPFWAR----TESGIFRAVLKADPSF-------------------DE--APWPSLSPEAIDFVKRLLNKDYR 398 (482)
Q Consensus 344 l~elltg~~pf~~~----~~~~~~~~i~~~~~~~-------------------~~--~~~~~~s~~~~~li~~~L~~dP~ 398 (482)
+|+|++|..||... ...+.+..+....+.- +. .....+++.+.+||.+||+.||.
T Consensus 213 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~ 292 (319)
T 4euu_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292 (319)
T ss_dssp HHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTT
T ss_pred HHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChh
Confidence 99999999999643 3355666666654311 00 11123456889999999999999
Q ss_pred cCCCHHHHhcCc
Q 011582 399 KRLTAAQALSHP 410 (482)
Q Consensus 399 ~R~s~~e~L~hp 410 (482)
+|||++|+|+||
T Consensus 293 ~R~s~~ell~h~ 304 (319)
T 4euu_A 293 KCWGFDQFFAET 304 (319)
T ss_dssp TSCCHHHHHHHH
T ss_pred hhccHHHhhhcc
Confidence 999999999998
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=377.37 Aligned_cols=259 Identities=29% Similarity=0.551 Sum_probs=218.9
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||.||+|++.. +|+.||||++... ......+.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-----------------------------~~~~~~~~~ 52 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMK-----------------------------RAVDCPENI 52 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEEGG-----------------------------GCTTHHHHH
T ss_pred eecceEEEEEeecCCCcEEEEEEECC---CCcEEEEEEeeec-----------------------------cchhhhHHH
Confidence 46789999999999999999999876 7999999998653 112335678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+.+..|+||||+++++|.+++. ....+++..+..++.|++.||.|||++||+|||
T Consensus 53 ~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~d 130 (276)
T 2yex_A 53 KKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130 (276)
T ss_dssp HHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhcC-CCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHh-hccCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence 99999999996 9999999999999999999999999999998774 346799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCC---CcccccccCccccCcccccc-c-CCCcchhhhhHHHHHHHhhCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPD---ERLNDIVGSAYYVAPEVLHR-S-YGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlGvil~elltg~~p 353 (482)
|||+||++ +.++.+||+|||++...... .......||+.|+|||++.+ . ++.++||||||+++|+|++|..|
T Consensus 131 l~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 207 (276)
T 2yex_A 131 IKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207 (276)
T ss_dssp CSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCC
T ss_pred CChHHEEE---ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCC
Confidence 99999999 56778999999999765432 22445689999999999865 3 47789999999999999999999
Q ss_pred CCCCChH-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 354 FWARTES-GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 354 f~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|...... ..+..+...... ...+..+++++.+||.+||+.||.+|||++++++||||++..
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 208 WDQPSDSCQEYSDWKEKKTY--LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp CSCSCTTSHHHHHHHTTCTT--STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCCCchHHHHHHHhhhcccc--cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 9876553 333333333222 233567899999999999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-49 Score=394.12 Aligned_cols=260 Identities=29% Similarity=0.500 Sum_probs=215.8
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++.+.||+|+||.||+|+++. +|+.||||++.+..... . .........
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~---~~~~vavK~~~~~~~~~--------~--------------~~~~~~~~~ 74 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKE---KNKEVVVKFIKKEKVLE--------D--------------CWIEDPKLG 74 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETT---TTEEEEEEEEESTTSCT--------T--------------SEEEETTTE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECC---CCcEEEEEEEehhhccc--------c--------------cccchHHHH
Confidence 3567899999999999999999999876 79999999997641100 0 000011223
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCC-ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGG-ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
.+.+|+.+++++. ||||+++++++.+.+.+++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+
T Consensus 75 ~~~~E~~~l~~l~-h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iv 152 (335)
T 3dls_A 75 KVTLEIAILSRVE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDII 152 (335)
T ss_dssp EEEHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHhCC-CCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeE
Confidence 4668999999996 999999999999999999999999776 88887754 46799999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cC-CCcchhhhhHHHHHHHhhCCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SY-GTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwSlGvil~elltg~~p 353 (482)
||||||+|||+ +.++.+||+|||++............+||+.|+|||++.+ .+ +.++|||||||++|+|++|..|
T Consensus 153 H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p 229 (335)
T 3dls_A 153 HRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229 (335)
T ss_dssp CSCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred EeccCHHHEEE---cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCc
Confidence 99999999999 5678899999999998776666677889999999998865 34 7899999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|..... ...... .....+++++.+||.+||+.||.+|||++++|+||||+...
T Consensus 230 f~~~~~------~~~~~~----~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 230 FCELEE------TVEAAI----HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp CSSGGG------GTTTCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred hhhHHH------HHhhcc----CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 976322 111111 12234899999999999999999999999999999998653
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=377.25 Aligned_cols=260 Identities=26% Similarity=0.387 Sum_probs=200.4
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++.. +|+.||||++.... ......+.+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~----------------------------~~~~~~~~~ 53 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVP---SGQIMAVKRIRATV----------------------------NSQEQKRLL 53 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEC-------------------------------CHHHHHHHH
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecC---CCeEEEEEEeeccc----------------------------CcHHHHHHH
Confidence 35789999999999999999999876 79999999986530 122223344
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHFQ-GV 274 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~-~i 274 (482)
.++...++.+. ||||+++++++.+++..|+||||++| +|.+++.. .+..+++..++.++.||+.||.|||++ ||
T Consensus 54 ~~~~~~~~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i 131 (290)
T 3fme_A 54 MDLDISMRTVD-CPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSV 131 (290)
T ss_dssp HHHHHHHTTCC-CTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHhCC-CCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCe
Confidence 44555566665 99999999999999999999999975 78776643 457899999999999999999999998 99
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-----ccCCCcchhhhhHHHHHHHhh
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-----RSYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwSlGvil~ellt 349 (482)
+||||||+|||+ +.++.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++
T Consensus 132 ~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~ 208 (290)
T 3fme_A 132 IHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAI 208 (290)
T ss_dssp CCCCCSGGGCEE---CTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEE---CCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHH
Confidence 999999999999 567789999999998776655555668999999999862 358899999999999999999
Q ss_pred CCCCCCCC-ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 350 GSRPFWAR-TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 350 g~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|..||... .....+..+...... ......+++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 209 g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 209 LRFPYDSWGTPFQQLKQVVEEPSP--QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp TSCSSCCCSCHHHHHHHHHHSCCC--CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCCCccccCchHHHHHHHhccCCC--CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 99999863 334444444443321 222346899999999999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=394.21 Aligned_cols=259 Identities=29% Similarity=0.485 Sum_probs=218.6
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||.||+|++.. +|+.||||++... ......+.+
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----------------------------~~~~~~~~~ 72 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNL---NKVRVAIKKISPF-----------------------------EHQTYCQRT 72 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCT-----------------------------TCHHHHHHH
T ss_pred ccccEEEEEEeecCCCeEEEEEEECC---CCeEEEEEEeccc-----------------------------cCcHHHHHH
Confidence 34689999999999999999999876 7899999998642 233445778
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC-----CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD-----DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
.+|+.+++++. ||||+++++++... ...|+||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++|
T Consensus 73 ~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ 148 (364)
T 3qyz_A 73 LREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSAN 148 (364)
T ss_dssp HHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCCEEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhcC-CCCCccceeEEecCCccccceEEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999997 99999999999765 478999999974 89888754 46999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCC----cccccccCccccCccccc--ccCCCcchhhhhHHHHHHH
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~el 347 (482)
|+||||||+|||+ +.++.+||+|||++....... .....+||+.|+|||++. ..++.++|||||||++|+|
T Consensus 149 ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el 225 (364)
T 3qyz_A 149 VLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 225 (364)
T ss_dssp EECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHH
T ss_pred eecCCCChHhEEE---CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHH
Confidence 9999999999999 667889999999998764332 234568999999999864 3489999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHhcCCCCCC-----------------------C----CCCCCCHHHHHHHHHhchhccccC
Q 011582 348 LCGSRPFWARTESGIFRAVLKADPSFDE-----------------------A----PWPSLSPEAIDFVKRLLNKDYRKR 400 (482)
Q Consensus 348 ltg~~pf~~~~~~~~~~~i~~~~~~~~~-----------------------~----~~~~~s~~~~~li~~~L~~dP~~R 400 (482)
++|+.||.+.+..+.+..+......... . .++.+++++.+||.+||+.||.+|
T Consensus 226 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 305 (364)
T 3qyz_A 226 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 305 (364)
T ss_dssp HHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTS
T ss_pred HHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhC
Confidence 9999999998887777766542211110 0 124678999999999999999999
Q ss_pred CCHHHHhcCcccccCC
Q 011582 401 LTAAQALSHPWLANSH 416 (482)
Q Consensus 401 ~s~~e~L~hp~~~~~~ 416 (482)
||++|+|+||||+...
T Consensus 306 ~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 306 IEVEQALAHPYLEQYY 321 (364)
T ss_dssp CCHHHHHTSGGGTTTC
T ss_pred CCHHHHhcCcchhhcc
Confidence 9999999999998754
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=401.84 Aligned_cols=264 Identities=27% Similarity=0.456 Sum_probs=201.6
Q ss_pred ccccceEe-cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 118 QFVAHYEL-GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 118 ~~~~~y~~-~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
.+.+.|++ +++||+|+||.||+|+++.. .+++.||||++.... ...
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~-~~~~~vaiK~~~~~~--------------------------------~~~ 63 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDG-KDDKDYALKQIEGTG--------------------------------ISM 63 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSS-SCCCCEEEEECSSSS--------------------------------CCH
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccC-CCCeEEEEEEECCCC--------------------------------CCH
Confidence 45677888 55799999999999997632 258899999986420 013
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhc--------CCCCCHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSR--------GGKYSEEDAKIVMVQILSVV 266 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~--------~~~l~~~~~~~i~~qi~~~L 266 (482)
.+.+|+.+|+.+. ||||+++++++.. ...+|+||||+.+ +|.+.+... ...+++..++.++.||+.||
T Consensus 64 ~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al 141 (405)
T 3rgf_A 64 SACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 141 (405)
T ss_dssp HHHHHHHHHHHCC-CTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcC-CCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHH
Confidence 5779999999997 9999999999965 6789999999965 788877532 12499999999999999999
Q ss_pred HHHHHCCCcccCCCCCceEEecC-CCCCcEEEEecccccccCCC----CcccccccCccccCcccccc--cCCCcchhhh
Q 011582 267 AFCHFQGVVHRDLKPENFLFTSK-EENSSLKAIDFGLSDYVKPD----ERLNDIVGSAYYVAPEVLHR--SYGTEADMWS 339 (482)
Q Consensus 267 ~yLH~~~ivHrDlkp~NIll~~~-~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwS 339 (482)
.|||++||+||||||+|||+... +.++.+||+|||+++..... ......+||+.|+|||++.+ .|+.++||||
T Consensus 142 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS 221 (405)
T 3rgf_A 142 HYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWA 221 (405)
T ss_dssp HHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHH
T ss_pred HHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHH
Confidence 99999999999999999999643 45678999999999876532 23455789999999998864 4899999999
Q ss_pred hHHHHHHHhhCCCCCCCCCh---------HHHHHHHHhcCCCCCCCCCCC------------------------------
Q 011582 340 IGVIAYILLCGSRPFWARTE---------SGIFRAVLKADPSFDEAPWPS------------------------------ 380 (482)
Q Consensus 340 lGvil~elltg~~pf~~~~~---------~~~~~~i~~~~~~~~~~~~~~------------------------------ 380 (482)
|||++|+|++|..||.+... .+.+..+...........|..
T Consensus 222 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 301 (405)
T 3rgf_A 222 IGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 301 (405)
T ss_dssp HHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhh
Confidence 99999999999999977654 245555555433333333332
Q ss_pred ----CCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 381 ----LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 381 ----~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.++++.+||.+||+.||.+|||++|+|+||||.+..
T Consensus 302 ~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 302 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp TTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred cCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 278899999999999999999999999999998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-48 Score=387.36 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=209.7
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|.+. +|+.||||++... .......+.+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~----~~~~vavK~~~~~----------------------------~~~~~~~~~~ 54 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLE----------------------------EADNQTLDSY 54 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT----TSCEEEEEEEECT----------------------------TCCHHHHHHH
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC----CCCEEEEEEeecc----------------------------ccchHHHHHH
Confidence 3567999999999999999999874 5889999998653 1234456788
Q ss_pred HHHHHHHHhhcCC-CCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 199 RREVKILRALTGH-KNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 199 ~~Ei~~l~~l~~h-pniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
.+|+.+|+.+..| +||+++++++.+++.+|+|||+ .+++|.+++... ..+++.++..++.||+.||.|||++||+||
T Consensus 55 ~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~~lH~~~iiHr 132 (343)
T 3dbq_A 55 RNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVHS 132 (343)
T ss_dssp HHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 9999999999722 9999999999999999999995 578999988664 689999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc------------ccCCCcchhhhhHH
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH------------RSYGTEADMWSIGV 342 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~------------~~~~~~~DiwSlGv 342 (482)
||||+|||++ ++.+||+|||++....... .....+||+.|+|||++. ..++.++|||||||
T Consensus 133 Dikp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~ 208 (343)
T 3dbq_A 133 DLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGC 208 (343)
T ss_dssp CCCGGGEEEE----TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHH
T ss_pred CCCcceEEEE----CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHH
Confidence 9999999994 4679999999998765432 234568999999999874 45888999999999
Q ss_pred HHHHHhhCCCCCCCCChH-HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 343 IAYILLCGSRPFWARTES-GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 343 il~elltg~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
++|+|++|+.||...... ..+..+........ .....++++.+||.+||+.||.+|||+.++|+||||+...
T Consensus 209 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 209 ILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE--FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp HHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC--CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC--CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 999999999999775433 33444443332222 1234678999999999999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=392.39 Aligned_cols=261 Identities=26% Similarity=0.401 Sum_probs=218.5
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
+...++|++.+.||+|+||.||+|++.. +|+.||+|++... ......+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~va~K~~~~~-----------------------------~~~~~~~ 76 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLE-----------------------------IKPAIRN 76 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECC-----------------------------CCHHHHH
T ss_pred ccccccceeeeeecCCCCeEEEEEEECC---CCcEEEEEEeccc-----------------------------cCHHHHH
Confidence 4456789999999999999999999876 7999999998653 2344567
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVV 275 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~iv 275 (482)
.+.+|+.+++.+. ||||+++++++.+++.+|+||||++|++|.+++... +.+++..+..++.|++.||.|||++ ||+
T Consensus 77 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~i~ 154 (360)
T 3eqc_A 77 QIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIM 154 (360)
T ss_dssp HHHHHHGGGGGCC-CTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHHHHCC-CCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEE
Confidence 8899999999996 999999999999999999999999999999988655 5799999999999999999999996 999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf 354 (482)
||||||+|||+ +.++.+||+|||++..... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||
T Consensus 155 H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 230 (360)
T 3eqc_A 155 HRDVKPSNILV---NSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 230 (360)
T ss_dssp CSCCSGGGEEE---CTTCCEEECCCCCCHHHHH-HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCS
T ss_pred cCCccHHHEEE---CCCCCEEEEECCCCccccc-ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999999999 5677899999999976532 22345689999999998875 5899999999999999999999999
Q ss_pred CCCChHHHHHH------------------------------------------HHhcCCCCCCCCCCCCCHHHHHHHHHh
Q 011582 355 WARTESGIFRA------------------------------------------VLKADPSFDEAPWPSLSPEAIDFVKRL 392 (482)
Q Consensus 355 ~~~~~~~~~~~------------------------------------------i~~~~~~~~~~~~~~~s~~~~~li~~~ 392 (482)
......++... +..... .......+++++.+||.+|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~ 308 (360)
T 3eqc_A 231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKC 308 (360)
T ss_dssp SCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHH
T ss_pred CCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHH
Confidence 87665543222 222211 1112234789999999999
Q ss_pred chhccccCCCHHHHhcCcccccCCC
Q 011582 393 LNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 393 L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
|+.||.+|||++++|+||||+....
T Consensus 309 L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 309 LIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp HCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred hhcChhhCCCHHHHhhChHhhcchH
Confidence 9999999999999999999987543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=393.27 Aligned_cols=263 Identities=24% Similarity=0.405 Sum_probs=218.6
Q ss_pred cccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
..+.+.++|++.+.||+|+||.||+|++.. +|+.||||++... ...
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vaiK~~~~~-------------------------------~~~ 93 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRV---EQEWVAIKIIKNK-------------------------------KAF 93 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECSS-------------------------------HHH
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcC---CCcEEEEEEEecc-------------------------------HHH
Confidence 345678899999999999999999999876 7899999998542 233
Q ss_pred HHHHHHHHHHHHhhcCCCC-----cceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHH
Q 011582 195 IEDVRREVKILRALTGHKN-----LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~hpn-----iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~y 268 (482)
...+.+|+.+++.+..|++ |+++++++...+.+|+||||+.+ +|.+++.... ..+++..++.++.||+.||.|
T Consensus 94 ~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~ 172 (382)
T 2vx3_A 94 LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLF 172 (382)
T ss_dssp HHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4677889999998865664 99999999999999999999964 9999887653 569999999999999999999
Q ss_pred HH--HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHH
Q 011582 269 CH--FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAY 345 (482)
Q Consensus 269 LH--~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ 345 (482)
|| +.|||||||||+|||++. +.++.+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|
T Consensus 173 lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ 249 (382)
T 2vx3_A 173 LATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILV 249 (382)
T ss_dssp HTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred hccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHH
Confidence 99 579999999999999953 2466899999999987643 3456789999999998875 6999999999999999
Q ss_pred HHhhCCCCCCCCChHHHHHHHHhcCCCCCC------------------CCC-----------------CC----------
Q 011582 346 ILLCGSRPFWARTESGIFRAVLKADPSFDE------------------APW-----------------PS---------- 380 (482)
Q Consensus 346 elltg~~pf~~~~~~~~~~~i~~~~~~~~~------------------~~~-----------------~~---------- 380 (482)
+|++|+.||.+.+..+.+..+.......+. ..| ..
T Consensus 250 elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 329 (382)
T 2vx3_A 250 EMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETG 329 (382)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhcccc
Confidence 999999999999988888777653221110 000 00
Q ss_pred ---------------CCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 381 ---------------LSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 381 ---------------~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 330 GPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp SGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred CCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 01478999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=380.29 Aligned_cols=261 Identities=30% Similarity=0.478 Sum_probs=219.2
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++.+.||+|+||.||+|++.. +|+.||+|++... .....+.
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~aiK~~~~~------------------------------~~~~~~~ 62 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKE---TGALAAAKVIETK------------------------------SEEELED 62 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETT---TCCEEEEEEEC----------------------------------CCHHH
T ss_pred CCccceeecceeccCCCeEEEEEEEcC---CCcEEEEEEecCC------------------------------CHHHHHH
Confidence 356789999999999999999999876 7999999998542 1223467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. ||||+++++++.+.+..|+||||+++++|.+++......+++..+..++.||+.||.|||++||+||
T Consensus 63 ~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 141 (302)
T 2j7t_A 63 YIVEIEILATCD-HPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHR 141 (302)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHhcCC-CCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence 889999999996 9999999999999999999999999999999887766789999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCccccc------ccCCCcchhhhhHHHHHHHhhC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~elltg 350 (482)
||||+|||+ +.++.+||+|||++...... .......||+.|+|||++. ..++.++||||||+++|+|++|
T Consensus 142 dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g 218 (302)
T 2j7t_A 142 DLKAGNVLM---TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218 (302)
T ss_dssp CCSGGGEEE---CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHS
T ss_pred CCCHHHEEE---CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcC
Confidence 999999999 56778999999987643211 1234467999999999872 4588999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..||...+.......+........ .....++.++.+||.+||..||.+|||+.++++||||....
T Consensus 219 ~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 219 EPPHHELNPMRVLLKIAKSDPPTL-LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp SCTTTTSCHHHHHHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred CCCCccCCHHHHHHHHhccCCccc-CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 999999888887777776653321 12245789999999999999999999999999999998754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=375.89 Aligned_cols=258 Identities=27% Similarity=0.484 Sum_probs=223.3
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..+.|++++.||+|+||.||+|++.. +|+.||||++... ......+.+
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----------------------------~~~~~~~~~ 67 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNR---TQKVVAIKIIDLE-----------------------------EAEDEIEDI 67 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEETT-----------------------------TCSTTHHHH
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECC---CCcEEEEEEeccc-----------------------------ccHHHHHHH
Confidence 34679999999999999999999876 7999999998653 112235678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+.+.+|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+|||
T Consensus 68 ~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 144 (303)
T 3a7i_A 68 QQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRD 144 (303)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence 99999999996 99999999999999999999999999999997743 5799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||+|||+ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus 145 l~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 221 (303)
T 3a7i_A 145 IKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSE 221 (303)
T ss_dssp CSGGGEEE---CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CChheEEE---CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCC
Confidence 99999999 567789999999998765433 3345689999999998864 589999999999999999999999998
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.........+...... .....++.++.+||.+||..||.+|||+.++|+||||.....
T Consensus 222 ~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 222 LHPMKVLFLIPKNNPP---TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp SCHHHHHHHHHHSCCC---CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred cCHHHHHHHhhcCCCC---CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 8887777776665432 223468999999999999999999999999999999986543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=379.88 Aligned_cols=260 Identities=28% Similarity=0.520 Sum_probs=215.2
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
....++|++++.||+|+||.||+|++.. +|+.||||++... ....+
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~-------------------------------~~~~~ 65 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVK---TGQLAAIKVMDVT-------------------------------GDEEE 65 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC-------------------------------SSTTH
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECC---CCCeEEEEEEecC-------------------------------cccHH
Confidence 3456789999999999999999999876 7999999998642 01135
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEe------CCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYED------DDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yL 269 (482)
.+.+|+.+++++.+||||+++++++.. .+.+|+||||+++++|.+++... ...+++..++.++.||+.||.||
T Consensus 66 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 145 (326)
T 2x7f_A 66 EIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHL 145 (326)
T ss_dssp HHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 688999999999569999999999987 56899999999999999988754 35799999999999999999999
Q ss_pred HHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCccccc------ccCCCcchhhhhHH
Q 011582 270 HFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGV 342 (482)
Q Consensus 270 H~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGv 342 (482)
|++||+||||||+|||+ +.++.+||+|||++...... .......||+.|+|||++. ..++.++|||||||
T Consensus 146 H~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~ 222 (326)
T 2x7f_A 146 HQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222 (326)
T ss_dssp HHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHH
T ss_pred HHCCccccCCcHHHEEE---cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHH
Confidence 99999999999999999 56788999999999876432 2334567999999999884 35899999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 343 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 343 il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
++|+|++|..||...........+...... ......+++++.+||.+||..||.+||+++++|+||||+..
T Consensus 223 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 223 TAIEMAEGAPPLCDMHPMRALFLIPRNPAP--RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHHHHHSSCTTTTSCHHHHHHHHHHSCCC--CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HHHHHHhCCCCCCCCcHHHHHHHhhcCccc--cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence 999999999999888877776666554332 22234689999999999999999999999999999999865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=381.22 Aligned_cols=265 Identities=29% Similarity=0.410 Sum_probs=219.0
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++... +|+.||||++..... .......+
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~~~----------------------------~~~~~~~~ 58 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQTG----------------------------EEGMPLST 58 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEBC----------------------------TTSCBCTH
T ss_pred chhceeeeeeecccccEEEEEEEecCC--CCEEEEEEEeccCcc----------------------------cccCCchh
Confidence 457899999999999999999998531 688999999865310 00011235
Q ss_pred HHHHHHHHhhc--CCCCcceeeEEEE-----eCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALT--GHKNLVQFYDAYE-----DDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 199 ~~Ei~~l~~l~--~hpniv~l~~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH 270 (482)
.+|+.+++.+. +||||+++++++. ....+++||||+. |+|.+++.... ..+++..++.++.||+.||.|||
T Consensus 59 ~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH 137 (326)
T 1blx_A 59 IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 137 (326)
T ss_dssp HHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 67888877773 4999999999987 5678999999997 59999887653 45999999999999999999999
Q ss_pred HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh
Q 011582 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt 349 (482)
++||+||||||+|||+ +.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++
T Consensus 138 ~~gi~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 214 (326)
T 1blx_A 138 SHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR 214 (326)
T ss_dssp HTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHH
T ss_pred HCCceeccCCHHHeEE---cCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHc
Confidence 9999999999999999 5678899999999987665445566789999999998864 68999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCC-----------------------CCCCCCCCHHHHHHHHHhchhccccCCCHHHH
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFD-----------------------EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA 406 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~-----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~ 406 (482)
|..||.+....+.+..+........ ...+..+++++.+||.+||+.||.+|||+.++
T Consensus 215 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 294 (326)
T 1blx_A 215 RKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 294 (326)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 9999999988888877765321111 01234689999999999999999999999999
Q ss_pred hcCcccccCCC
Q 011582 407 LSHPWLANSHD 417 (482)
Q Consensus 407 L~hp~~~~~~~ 417 (482)
|+||||+....
T Consensus 295 l~hp~~~~~~~ 305 (326)
T 1blx_A 295 LSHPYFQDLER 305 (326)
T ss_dssp HTSGGGTTCCC
T ss_pred hcCccccccch
Confidence 99999987654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=375.81 Aligned_cols=256 Identities=29% Similarity=0.499 Sum_probs=212.6
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||.||+|++.. +|+.||||++... ....+.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-------------------------------~~~~~~~ 49 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNAL---DSRYYAIKKIRHT-------------------------------EEKLSTI 49 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEEE-------------------------------HHHHHHH
T ss_pred ccccchhhheeccCCcEEEEEEEEcC---CCeEEEEEEEecc-------------------------------HHHHHHH
Confidence 56789999999999999999999876 7999999998542 2345778
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEe-------------CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYED-------------DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSV 265 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~ 265 (482)
.+|+.+++.+. ||||+++++++.+ .+..|+||||+++++|.+++......+++..++.++.||+.|
T Consensus 50 ~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~ 128 (303)
T 1zy4_A 50 LSEVMLLASLN-HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128 (303)
T ss_dssp HHHHHHHTTCC-CTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcC-chHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHH
Confidence 99999999996 9999999999865 457899999999999999998776678999999999999999
Q ss_pred HHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCC---------------CcccccccCccccCcccccc-
Q 011582 266 VAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD---------------ERLNDIVGSAYYVAPEVLHR- 329 (482)
Q Consensus 266 L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~---------------~~~~~~~gt~~y~aPE~~~~- 329 (482)
|.|||++||+||||||+|||+ +.++.+||+|||++...... .......||+.|+|||++.+
T Consensus 129 l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 205 (303)
T 1zy4_A 129 LSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGT 205 (303)
T ss_dssp HHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSC
T ss_pred HHHHHhCCeecccCCHHhEEE---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCC
Confidence 999999999999999999999 56778999999999865421 22345679999999999864
Q ss_pred -cCCCcchhhhhHHHHHHHhhCCCCCCCC-ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHh
Q 011582 330 -SYGTEADMWSIGVIAYILLCGSRPFWAR-TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQAL 407 (482)
Q Consensus 330 -~~~~~~DiwSlGvil~elltg~~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L 407 (482)
.++.++|||||||++|+|++ ||... ...+....+......++.......++.+.+||.+||+.||.+|||+.++|
T Consensus 206 ~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll 282 (303)
T 1zy4_A 206 GHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282 (303)
T ss_dssp SCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHh
Confidence 58999999999999999998 55432 33455666666555555555566889999999999999999999999999
Q ss_pred cCcccccC
Q 011582 408 SHPWLANS 415 (482)
Q Consensus 408 ~hp~~~~~ 415 (482)
+||||...
T Consensus 283 ~h~~~~~~ 290 (303)
T 1zy4_A 283 NSGWLPVK 290 (303)
T ss_dssp HSSCSCCC
T ss_pred CCCCcCCC
Confidence 99999764
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=390.04 Aligned_cols=265 Identities=18% Similarity=0.238 Sum_probs=224.1
Q ss_pred cccccceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
+...++|++++.||+|+||.||+|+... ...+++.||||+++.. .....
T Consensus 67 ~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~ 117 (367)
T 3l9p_A 67 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-----------------------------CSEQD 117 (367)
T ss_dssp BCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS-----------------------------CCHHH
T ss_pred hcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc-----------------------------cChhh
Confidence 3445789999999999999999999543 1226789999998642 23445
Q ss_pred HHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHH
Q 011582 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG------GKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~~L~y 268 (482)
...+.+|+.+++++. ||||+++++++.+.+..|+|||||+||+|.+++.... ..+++..++.++.||+.||.|
T Consensus 118 ~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 196 (367)
T 3l9p_A 118 ELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196 (367)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhCC-CCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHH
Confidence 567889999999996 9999999999999999999999999999999987653 459999999999999999999
Q ss_pred HHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCC---CCcccccccCccccCccccc-ccCCCcchhhhhHHHH
Q 011582 269 CHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKP---DERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIA 344 (482)
Q Consensus 269 LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil 344 (482)
||++||+||||||+|||++.++.+..+||+|||+++.... ........||+.|+|||++. +.++.++|||||||++
T Consensus 197 LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il 276 (367)
T 3l9p_A 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276 (367)
T ss_dssp HHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHH
Confidence 9999999999999999997555666799999999975422 12334567899999999885 5699999999999999
Q ss_pred HHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 345 YILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 345 ~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
|+|++ |..||.+....++...+........ ...+++++.+||.+||+.||.+|||+.+++++.|+..
T Consensus 277 ~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 277 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 99998 9999999999888888877653222 2458999999999999999999999999999987754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=393.40 Aligned_cols=264 Identities=25% Similarity=0.406 Sum_probs=211.5
Q ss_pred ccccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHH
Q 011582 114 GFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAI 193 (482)
Q Consensus 114 ~~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (482)
...+.+.++|++.+.||+|+||.||+|++.. +|+.||||++.+. ..
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~-------------------------------~~ 75 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQ---GKKFVAMKVVKSA-------------------------------EH 75 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC-------------------------------HH
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecC---CCeEEEEEEEecC-------------------------------Cc
Confidence 3455677899999999999999999999876 7999999998542 23
Q ss_pred HHHHHHHHHHHHHhhc-------CCCCcceeeEEEE----eCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHH
Q 011582 194 AIEDVRREVKILRALT-------GHKNLVQFYDAYE----DDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQ 261 (482)
Q Consensus 194 ~~~~~~~Ei~~l~~l~-------~hpniv~l~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~q 261 (482)
..+.+.+|+.+++.++ +|+||+++++++. +...+|+||||+ +++|.+.+.... ..+++..++.++.|
T Consensus 76 ~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~q 154 (397)
T 1wak_A 76 YTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQ 154 (397)
T ss_dssp HHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHH
Confidence 4567889999999996 2788999999988 556899999999 667888776653 57999999999999
Q ss_pred HHHHHHHHHHC-CCcccCCCCCceEEecCC----------------------------------------------CCCc
Q 011582 262 ILSVVAFCHFQ-GVVHRDLKPENFLFTSKE----------------------------------------------ENSS 294 (482)
Q Consensus 262 i~~~L~yLH~~-~ivHrDlkp~NIll~~~~----------------------------------------------~~~~ 294 (482)
|+.||.|||++ ||+||||||+|||++.++ ....
T Consensus 155 i~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (397)
T 1wak_A 155 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK 234 (397)
T ss_dssp HHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCC
T ss_pred HHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccc
Confidence 99999999999 999999999999995321 1137
Q ss_pred EEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC------hHHHHHHHH
Q 011582 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART------ESGIFRAVL 367 (482)
Q Consensus 295 ~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~------~~~~~~~i~ 367 (482)
+||+|||++..... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...+ ....+..+.
T Consensus 235 ~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~ 312 (397)
T 1wak_A 235 VKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312 (397)
T ss_dssp EEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHH
T ss_pred eEeccccccccccc--cCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHH
Confidence 99999999987643 3455689999999998865 59999999999999999999999997654 223333332
Q ss_pred hcCCCCCC--------------------------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 368 KADPSFDE--------------------------------------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 368 ~~~~~~~~--------------------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
......+. ......++++.+||.+||+.||.+|||++|+|+|
T Consensus 313 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 313 ELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp HHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred HhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 21111100 0001234678899999999999999999999999
Q ss_pred ccccc
Q 011582 410 PWLAN 414 (482)
Q Consensus 410 p~~~~ 414 (482)
|||+.
T Consensus 393 p~~~~ 397 (397)
T 1wak_A 393 PWLNS 397 (397)
T ss_dssp GGGGC
T ss_pred ccccC
Confidence 99963
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=381.26 Aligned_cols=254 Identities=22% Similarity=0.332 Sum_probs=216.6
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++......+..||||++... ......+.+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~~ 97 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG-----------------------------YTERQRRDF 97 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT-----------------------------CCHHHHHHH
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC-----------------------------CCHHHHHHH
Confidence 357899999999999999999999763334556999998653 234456789
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++.+.+..|+||||++||+|.+++......+++..+..++.||+.||.|||++||+|||
T Consensus 98 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~D 176 (325)
T 3kul_A 98 LSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRD 176 (325)
T ss_dssp HHHHHHHTTCC-CTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhCC-CCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCC
Confidence 99999999996 99999999999999999999999999999999877767899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSR 352 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~ 352 (482)
|||+|||+ +.++.+||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..
T Consensus 177 lkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~ 253 (325)
T 3kul_A 177 LAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253 (325)
T ss_dssp CSGGGEEE---CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCcceEEE---CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCC
Confidence 99999999 6778999999999987654321 22345678899999987 468999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||.+....++...+...... .....+++++.+||.+||..||.+|||+.++++
T Consensus 254 p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 254 PYWNMTNRDVISSVEEGYRL---PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp TTTTSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccCCHHHHHHHHHcCCCC---CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999998888887765322 222468999999999999999999999999876
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-49 Score=397.55 Aligned_cols=260 Identities=18% Similarity=0.193 Sum_probs=198.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
..+|++++.||+|+||.||+|++.. +|+.||||++.+. ........+.+.
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~---------------------------~~~~~~~~~~~~ 110 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVE---RLEDFALKVFTMG---------------------------AENSRSELERLH 110 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEECC---------------------------STTHHHHHHHHH
T ss_pred ceeeeeeeeccCCCCEEEEEEEECC---CCceeEEEEEEec---------------------------ccccccHHHHHH
Confidence 3469999999999999999999876 7999999999764 112344566788
Q ss_pred HHHHHHHhhc-CCCCcceee-------EEEEeC-----------------CeEEEEEecCCCCChHHHHHhcCCCCCHHH
Q 011582 200 REVKILRALT-GHKNLVQFY-------DAYEDD-----------------DNIYIVMELCKGGELLDRILSRGGKYSEED 254 (482)
Q Consensus 200 ~Ei~~l~~l~-~hpniv~l~-------~~~~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~ 254 (482)
+|+.+++.|. +||||++++ +++... ..+|||||||+ |+|.+++...+..+.+..
T Consensus 111 ~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~ 189 (371)
T 3q60_A 111 EATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRG 189 (371)
T ss_dssp HHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCH
T ss_pred HHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhh
Confidence 8976666664 499987755 565544 34899999998 799999976544555555
Q ss_pred H------HHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc
Q 011582 255 A------KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH 328 (482)
Q Consensus 255 ~------~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~ 328 (482)
. ..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.... ......||+.|+|||++.
T Consensus 190 ~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~ 264 (371)
T 3q60_A 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLN 264 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---CTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHT
T ss_pred hhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE---CCCCCEEEEecceeeecCC--CccCccCCcCCcChhhcc
Confidence 5 6777999999999999999999999999999 6678899999999987642 222556779999999986
Q ss_pred c---cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHH--HHH---HHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccC
Q 011582 329 R---SYGTEADMWSIGVIAYILLCGSRPFWARTESGI--FRA---VLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKR 400 (482)
Q Consensus 329 ~---~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 400 (482)
+ .|+.++|||||||++|+|++|+.||.+...... +.. .......+....++.+++++.+||.+||+.||.+|
T Consensus 265 ~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 344 (371)
T 3q60_A 265 ASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRR 344 (371)
T ss_dssp CSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTC
T ss_pred CCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhC
Confidence 4 599999999999999999999999977643211 000 01111222333345789999999999999999999
Q ss_pred CCHHHHhcCcccccC
Q 011582 401 LTAAQALSHPWLANS 415 (482)
Q Consensus 401 ~s~~e~L~hp~~~~~ 415 (482)
||+.++|+||||++.
T Consensus 345 pt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 345 LLPLEAMETPEFLQL 359 (371)
T ss_dssp CCHHHHTTSHHHHHH
T ss_pred CCHHHHhcCHHHHHH
Confidence 999999999999753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=378.44 Aligned_cols=259 Identities=27% Similarity=0.501 Sum_probs=216.9
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++.+.||+|+||.||+|++.. +|+.||||++... ...+.
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~--------------------------------~~~~~ 70 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKE---TGQIVAIKQVPVE--------------------------------SDLQE 70 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETT---TCCEEEEEEEETT--------------------------------SCCHH
T ss_pred cchhhhhhheeeccCCCeEEEEEEECC---CCCEEEEEecCch--------------------------------HHHHH
Confidence 445789999999999999999999876 7999999998642 01256
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. ||||+++++++.+.+.+|+||||+++++|.+++......+++..++.++.||+.||.|||++||+||
T Consensus 71 ~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~ 149 (314)
T 3com_A 71 IIKEISIMQQCD-SPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHR 149 (314)
T ss_dssp HHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCC
Confidence 889999999996 9999999999999999999999999999999987666789999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+||++ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 150 dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 226 (314)
T 3com_A 150 DIKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA 226 (314)
T ss_dssp CCSGGGEEE---CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTT
T ss_pred CcCHHHEEE---CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCC
Confidence 999999999 567789999999998765432 3345679999999998865 58999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..........+...... .......+++++.+||.+||..||.+|||+.++|+||||+...
T Consensus 227 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 227 DIHPMRAIFMIPTNPPP-TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp TSCHHHHHHHHHHSCCC-CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred CCChHHHHHHHhcCCCc-ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 88776666555544321 1112234789999999999999999999999999999998754
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=380.06 Aligned_cols=261 Identities=28% Similarity=0.493 Sum_probs=199.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|++.. +|+.||||++... ......+.+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----------------------------~~~~~~~~~~ 61 (303)
T 2vwi_A 14 RDDYELQEVIGSGATAVVQAAYCAP---KKEKVAIKRINLE-----------------------------KCQTSMDELL 61 (303)
T ss_dssp CCCCEEEEECC---CCCEEEEEC-------CEEEEECCC-----------------------------------------
T ss_pred hhhhhhhheeccccceEEEEEEECC---CCcEEEEEEEEhh-----------------------------hcchhHHHHH
Confidence 4689999999999999999999876 7899999988542 1122345688
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS-------RGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~-------~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
+|+.+++.+. ||||+++++++...+..|+||||+++++|.+++.. ....+++..++.++.||+.||.|||++
T Consensus 62 ~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 140 (303)
T 2vwi_A 62 KEIQAMSQCH-HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140 (303)
T ss_dssp ----CCCCCC-CTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHhhcC-CCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999999996 99999999999999999999999999999998864 245699999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC------cccccccCccccCcccccc--cCCCcchhhhhHHHH
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE------RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIA 344 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil 344 (482)
||+||||||+|||+ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++
T Consensus 141 ~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il 217 (303)
T 2vwi_A 141 GQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 217 (303)
T ss_dssp TCCCCCCSGGGEEE---CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHH
T ss_pred CCCCCCCChhhEEE---cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHH
Confidence 99999999999999 567889999999997664322 2234679999999998863 589999999999999
Q ss_pred HHHhhCCCCCCCCChHHHHHHHHhcCCCCC------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 345 YILLCGSRPFWARTESGIFRAVLKADPSFD------EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 345 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|+|++|..||.................... ...+..+++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 218 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 218 IELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp HHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred HHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 999999999988777666655554432211 122356899999999999999999999999999999998653
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=390.03 Aligned_cols=258 Identities=32% Similarity=0.576 Sum_probs=215.1
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|.+.+.||+|+||.||+|++.. +|+.||||++.+. .........
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~ 87 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRP----------------------------FQSEIFAKR 87 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECST----------------------------TSSHHHHHH
T ss_pred cccccEEEEeEEecCCCeEEEEEEECC---CCCEEEEEEeccc----------------------------ccchhHHHH
Confidence 356799999999999999999999887 7999999998653 123445678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeE------EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNI------YIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+.+|+.+++.++ ||||+++++++...+.. |+||||+. ++|.+.+ ...+++..++.++.||+.||.|||+
T Consensus 88 ~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~ 162 (371)
T 4exu_A 88 AYRELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHS 162 (371)
T ss_dssp HHHHHHHHHHCC-CTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcC-CCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHH
Confidence 899999999997 99999999999887655 99999997 5787765 3469999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhh
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ellt 349 (482)
+||+||||||+|||+ +.++.+||+|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++
T Consensus 163 ~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 237 (371)
T 4exu_A 163 AGVVHRDLKPGNLAV---NEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237 (371)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHH
T ss_pred CCCcCCCcCHHHeEE---CCCCCEEEEecCccccccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHh
Confidence 999999999999999 6678899999999986543 3456689999999998864 68999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCC-----------------------CCC----CCCCCCHHHHHHHHHhchhccccCCC
Q 011582 350 GSRPFWARTESGIFRAVLKADPSF-----------------------DEA----PWPSLSPEAIDFVKRLLNKDYRKRLT 402 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~-----------------------~~~----~~~~~s~~~~~li~~~L~~dP~~R~s 402 (482)
|+.||.+.+..+.+..+....... ... .++.+++++.+||.+||+.||.+|||
T Consensus 238 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 317 (371)
T 4exu_A 238 GKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT 317 (371)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC
T ss_pred CCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC
Confidence 999999988887777765532111 100 12457999999999999999999999
Q ss_pred HHHHhcCcccccCC
Q 011582 403 AAQALSHPWLANSH 416 (482)
Q Consensus 403 ~~e~L~hp~~~~~~ 416 (482)
++|+|+||||+...
T Consensus 318 ~~ell~hp~f~~~~ 331 (371)
T 4exu_A 318 AAQALTHPFFEPFR 331 (371)
T ss_dssp HHHHHTSGGGTTTC
T ss_pred HHHHhcCcccccCC
Confidence 99999999998643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=376.70 Aligned_cols=257 Identities=26% Similarity=0.382 Sum_probs=210.0
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++ +|+.||||++.+. .......+.+
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-----~~~~vavK~~~~~----------------------------~~~~~~~~~~ 81 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-----HGSDVAVKILMEQ----------------------------DFHAERVNEF 81 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECCC----------------------------CCSHHHHHHH
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-----CCCcEEEEEecCC----------------------------CCCHHHHHHH
Confidence 356899999999999999999976 5789999998653 1234456788
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--C
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG--GKYSEEDAKIVMVQILSVVAFCHFQG--V 274 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~--i 274 (482)
.+|+.++++++ ||||+++++++.+.+.+++|||||++|+|.+++.... ..+++..++.++.||+.||.|||++| |
T Consensus 82 ~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~i 160 (309)
T 3p86_A 82 LREVAIMKRLR-HPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPI 160 (309)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred HHHHHHHHhCC-CCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCE
Confidence 99999999997 9999999999999999999999999999999886542 13999999999999999999999999 9
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCC
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~ 352 (482)
+||||||+|||+ +.++.+||+|||+++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..
T Consensus 161 vH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 237 (309)
T 3p86_A 161 VHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQ 237 (309)
T ss_dssp CCTTCCGGGEEE---CTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCC
T ss_pred ECCCCChhhEEE---eCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 677899999999998654332 2345689999999999875 58999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc--Cccccc
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS--HPWLAN 414 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~--hp~~~~ 414 (482)
||.+.+..+....+......... ...+++++.+||.+||+.||.+|||++++++ .+|+..
T Consensus 238 Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 238 PWGNLNPAQVVAAVGFKCKRLEI--PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TTTTSCHHHHHHHHHHSCCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred CCCCCCHHHHHHHHHhcCCCCCC--CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 99999888887777654433322 2468999999999999999999999999987 555544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=381.66 Aligned_cols=261 Identities=31% Similarity=0.532 Sum_probs=217.1
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++... ........
T Consensus 8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----------------------------~~~~~~~~ 55 (353)
T 2b9h_A 8 NISSDFQLKSLLGEGAYGVVCSATHKP---TGEIVAIKKIEPF-----------------------------DKPLFALR 55 (353)
T ss_dssp CSCTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC-----------------------------SSHHHHHH
T ss_pred ccccceEEeeEEcCCCCeEEEEEEECC---CCcEEEEEeeccc-----------------------------ccchHHHH
Confidence 456899999999999999999999876 7999999998542 23344567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeC-----CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDD-----DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
+.+|+.+++.+. ||||+++++++... ...|+||||+. ++|.+++.. ..+++..+..++.||+.||.|||++
T Consensus 56 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~ 131 (353)
T 2b9h_A 56 TLREIKILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGS 131 (353)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhCc-CCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 889999999997 99999999988764 77999999997 588887765 4799999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC-----------cccccccCccccCccccc--ccCCCcchhhh
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----------RLNDIVGSAYYVAPEVLH--RSYGTEADMWS 339 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----------~~~~~~gt~~y~aPE~~~--~~~~~~~DiwS 339 (482)
||+||||||+|||+ +.++.+||+|||++....... .....+||+.|+|||++. ..++.++||||
T Consensus 132 ~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s 208 (353)
T 2b9h_A 132 NVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWS 208 (353)
T ss_dssp TEECSCCCGGGEEE---CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHH
T ss_pred CeecCCCCHHHeEE---cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHH
Confidence 99999999999999 567889999999998764321 123457899999999874 46899999999
Q ss_pred hHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCC------------------------CCC----CCCCCCHHHHHHHHH
Q 011582 340 IGVIAYILLCGSRPFWARTESGIFRAVLKADPSF------------------------DEA----PWPSLSPEAIDFVKR 391 (482)
Q Consensus 340 lGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~------------------------~~~----~~~~~s~~~~~li~~ 391 (482)
|||++|+|++|..||.+.+..+.+..+....... ... .++.+++++.+||.+
T Consensus 209 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 288 (353)
T 2b9h_A 209 CGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQR 288 (353)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHH
Confidence 9999999999999999988776665554321111 100 134689999999999
Q ss_pred hchhccccCCCHHHHhcCcccccCCC
Q 011582 392 LLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 392 ~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
||+.||.+|||++++|+||||+....
T Consensus 289 ~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 289 MLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hcCcCcccCCCHHHHhcCccccccCC
Confidence 99999999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=386.90 Aligned_cols=272 Identities=24% Similarity=0.423 Sum_probs=213.9
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.++|++++.||+|+||.||+|.+. .|..||||++..... ...... ........+
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~---------~~~~~~----------~~~~~~~~~ 74 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDS----EGIPVAIKRVFNTVS---------DGRTVN----------ILSDSFLCK 74 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECT----TSCEEEEEEECEECC---------TTSCEE----------GGGSHHHHH
T ss_pred HHhccceEEeEEeccCCCEEEEEEECC----CCCeEEEEeccccCC---------ccchhh----------hhhhhhHHH
Confidence 345689999999999999999999875 589999999865310 000000 112344567
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEe-----CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYED-----DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
.+.+|+.+++++. ||||+++++++.. ...+|+||||+. |+|.+.+......+++..+..++.||+.||.|||+
T Consensus 75 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 152 (362)
T 3pg1_A 75 RVLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE 152 (362)
T ss_dssp HHHHHHHHHHHCC-CTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhCC-CcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 8999999999997 9999999999854 346899999997 58999888776789999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhh
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~ellt 349 (482)
+||+||||||+|||+ +.++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++|+|++
T Consensus 153 ~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 229 (362)
T 3pg1_A 153 AGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFN 229 (362)
T ss_dssp TTCCCCCCCGGGEEE---CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHH
T ss_pred CcCEecCCChHHEEE---cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHh
Confidence 999999999999999 5677899999999987665555666789999999998864 58999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCC------------------------CCC----CCCCCCHHHHHHHHHhchhccccCC
Q 011582 350 GSRPFWARTESGIFRAVLKADPSF------------------------DEA----PWPSLSPEAIDFVKRLLNKDYRKRL 401 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~------------------------~~~----~~~~~s~~~~~li~~~L~~dP~~R~ 401 (482)
|+.||.+.+..+....+....... +.. ..+.+++++.+||.+||+.||.+||
T Consensus 230 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 309 (362)
T 3pg1_A 230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI 309 (362)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred CCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCC
Confidence 999999988888777765422111 111 1235689999999999999999999
Q ss_pred CHHHHhcCcccccCC
Q 011582 402 TAAQALSHPWLANSH 416 (482)
Q Consensus 402 s~~e~L~hp~~~~~~ 416 (482)
|+.++|+||||+...
T Consensus 310 t~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 310 STEQALRHPYFESLF 324 (362)
T ss_dssp CHHHHHTSGGGTTTC
T ss_pred CHHHHHcCchhhhcc
Confidence 999999999998753
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=378.48 Aligned_cols=260 Identities=32% Similarity=0.508 Sum_probs=213.4
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|++.. +|+.||||++.. ......+.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~------------------------------~~~~~~~~ 54 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDND---CDKRVAIKKIVL------------------------------TDPQSVKH 54 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETT---TTEEEEEEEEEC------------------------------CSHHHHHH
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECC---CCeEEEEEEEec------------------------------CChHHHHH
Confidence 456899999999999999999999876 799999999854 23345678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEE--------------eCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYE--------------DDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQIL 263 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~--------------~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~ 263 (482)
+.+|+.+++.+. ||||+++++++. +.+..|+||||++ |+|.+++. .+.+++..++.++.||+
T Consensus 55 ~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~--~~~~~~~~~~~~~~qi~ 130 (320)
T 2i6l_A 55 ALREIKIIRRLD-HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE--QGPLLEEHARLFMYQLL 130 (320)
T ss_dssp HHHHHHHHHTCC-CTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT--TCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHhcC-CCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh--cCCccHHHHHHHHHHHH
Confidence 899999999996 999999999873 4578999999997 58988774 35799999999999999
Q ss_pred HHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCC----CcccccccCccccCccccc--ccCCCcchh
Q 011582 264 SVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD----ERLNDIVGSAYYVAPEVLH--RSYGTEADM 337 (482)
Q Consensus 264 ~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~--~~~~~~~Di 337 (482)
.||.|||++||+||||||+|||++ ..++.+||+|||++...... .......||+.|+|||++. ..++.++||
T Consensus 131 ~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 208 (320)
T 2i6l_A 131 RGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDM 208 (320)
T ss_dssp HHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHH
T ss_pred HHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhh
Confidence 999999999999999999999995 24568999999999876432 2234557899999999875 468999999
Q ss_pred hhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCC--------------------------CCCCCCCHHHHHHHHH
Q 011582 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE--------------------------APWPSLSPEAIDFVKR 391 (482)
Q Consensus 338 wSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~ 391 (482)
|||||++|+|++|+.||.+....+....+......... ..++.+++++.+||.+
T Consensus 209 ~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 288 (320)
T 2i6l_A 209 WAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQ 288 (320)
T ss_dssp HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHT
T ss_pred HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHH
Confidence 99999999999999999999888877777655332110 0124689999999999
Q ss_pred hchhccccCCCHHHHhcCcccccCC
Q 011582 392 LLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 392 ~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
||+.||.+|||++++|+||||+...
T Consensus 289 ~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 289 ILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp TSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred HcCCCccccCCHHHHhCCccccccc
Confidence 9999999999999999999998654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=401.44 Aligned_cols=249 Identities=18% Similarity=0.210 Sum_probs=200.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|++.. +|+.||||++.+. ........+.+.
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~---~~~~vavK~~~~~---------------------------~~~~~~~~~~~~ 121 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFT---------------------------ERPPSNAIKQMK 121 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-C---CCCEEEEEEEEEC---------------------------C-CCTTHHHHHH
T ss_pred CceEEEcceeecCCCEEEEEEEECC---CCcEEEEEEEeec---------------------------cccchHHHHHHH
Confidence 4789999999999999999999876 7999999999753 112233457889
Q ss_pred HHHHHHHhhc--CCCCcceee-------EEEEeCCe-----------------EEEEEecCCCCChHHHHHhcCCCCCH-
Q 011582 200 REVKILRALT--GHKNLVQFY-------DAYEDDDN-----------------IYIVMELCKGGELLDRILSRGGKYSE- 252 (482)
Q Consensus 200 ~Ei~~l~~l~--~hpniv~l~-------~~~~~~~~-----------------~~lv~e~~~~g~L~~~l~~~~~~l~~- 252 (482)
+|+.+++.+. +||||++++ +++++.+. .||||||| +|+|.+++... +.+++
T Consensus 122 ~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~ 199 (377)
T 3byv_A 122 EEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSST 199 (377)
T ss_dssp HHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTT
T ss_pred HHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccc
Confidence 9995554443 499999998 77776643 89999999 67999988754 23444
Q ss_pred ------HHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccc
Q 011582 253 ------EDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEV 326 (482)
Q Consensus 253 ------~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~ 326 (482)
..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++... ......+| +.|+|||+
T Consensus 200 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~ 273 (377)
T 3byv_A 200 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPEL 273 (377)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHH
T ss_pred cccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEechhheecC--CcccCCCC-cCccChhh
Confidence 8888899999999999999999999999999999 567889999999998643 34456678 99999998
Q ss_pred ccc------------cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhch
Q 011582 327 LHR------------SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLN 394 (482)
Q Consensus 327 ~~~------------~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 394 (482)
+.+ .|+.++|||||||++|+|++|+.||.+.........+. ..+..+++++.+||.+||+
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~ 345 (377)
T 3byv_A 274 EARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLR 345 (377)
T ss_dssp HHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTC
T ss_pred hcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcC
Confidence 864 59999999999999999999999997765443333222 1235689999999999999
Q ss_pred hccccCCCHHHHhcCccccc
Q 011582 395 KDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 395 ~dP~~R~s~~e~L~hp~~~~ 414 (482)
.||.+|||+.++|+||||+.
T Consensus 346 ~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 346 YPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp SSGGGCCCHHHHHTSHHHHH
T ss_pred CCchhCCCHHHHhhChHHHH
Confidence 99999999999999999975
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=385.93 Aligned_cols=255 Identities=23% Similarity=0.371 Sum_probs=216.8
Q ss_pred ccceEecceeecCCceEEEEEEEecC----CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG----SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~----~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.++|++++.||+|+||.||+|++... ..++..||||+++.. ......
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~ 130 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-----------------------------ATEKDL 130 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT-----------------------------CBHHHH
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC-----------------------------cCHHHH
Confidence 47899999999999999999997531 124678999998653 234456
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHH
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMV 260 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ 260 (482)
+.+.+|+.+|+.+.+||||+++++++.+.+.+|+||||+++|+|.+++.... ..+++.++..++.
T Consensus 131 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 210 (370)
T 2psq_A 131 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 210 (370)
T ss_dssp HHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHH
Confidence 7899999999999459999999999999999999999999999999987643 3589999999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc-cCCCcch
Q 011582 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR-SYGTEAD 336 (482)
Q Consensus 261 qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~D 336 (482)
||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...... ......||+.|+|||++.+ .|+.++|
T Consensus 211 qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 287 (370)
T 2psq_A 211 QLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287 (370)
T ss_dssp HHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHH
T ss_pred HHHHHHHHHHhCCeeccccchhhEEE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHH
Confidence 99999999999999999999999999 677889999999998765432 2334567889999998864 6999999
Q ss_pred hhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 337 MWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 337 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||||||++|||++ |..||.+....+++..+...... .....+++++.+||.+||+.||.+||++.+++++
T Consensus 288 vwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 288 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999 99999998888888777665422 1224589999999999999999999999999863
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=384.73 Aligned_cols=257 Identities=26% Similarity=0.379 Sum_probs=213.0
Q ss_pred cccceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..++|++++.||+|+||.||+|++.. ...+|+.||||++++. ......+
T Consensus 20 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~ 70 (359)
T 3vhe_A 20 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-----------------------------ATHSEHR 70 (359)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-----------------------------CCHHHHH
T ss_pred cccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc-----------------------------CCHHHHH
Confidence 35789999999999999999999654 2236789999999653 2334457
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCe-EEEEEecCCCCChHHHHHhcCC---------------------------
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDN-IYIVMELCKGGELLDRILSRGG--------------------------- 248 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~--------------------------- 248 (482)
.+.+|+.+++++.+||||+++++++.+.+. +++|||||+||+|.+++.....
T Consensus 71 ~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (359)
T 3vhe_A 71 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLK 150 (359)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------
T ss_pred HHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhh
Confidence 899999999999669999999999988654 8999999999999999875432
Q ss_pred --------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCC
Q 011582 249 --------------------------------------KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKE 290 (482)
Q Consensus 249 --------------------------------------~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~ 290 (482)
.+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll---~ 227 (359)
T 3vhe_A 151 RRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL---S 227 (359)
T ss_dssp ---------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---C
T ss_pred ccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE---c
Confidence 18999999999999999999999999999999999999 5
Q ss_pred CCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCCChHHHHHH
Q 011582 291 ENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWARTESGIFRA 365 (482)
Q Consensus 291 ~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~ 365 (482)
.++.+||+|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++ |..||.+....+.+..
T Consensus 228 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~ 307 (359)
T 3vhe_A 228 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 307 (359)
T ss_dssp GGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHH
Confidence 67789999999998664332 234567899999999886 468999999999999999998 9999988775555544
Q ss_pred HHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 366 VLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 366 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
........... ..+++++.++|.+||+.||.+|||+.++++|
T Consensus 308 ~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 308 RLKEGTRMRAP--DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHTCCCCCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCC--CCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 44443332222 3589999999999999999999999999875
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=380.56 Aligned_cols=264 Identities=28% Similarity=0.459 Sum_probs=217.6
Q ss_pred cccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
..+.+.++|++.+.||+|+||.||+|.+... +|+.||||++... ...
T Consensus 8 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~--~~~~vavK~~~~~-------------------------------~~~ 54 (339)
T 1z57_A 8 SGDVLSARYEIVDTLGEGAFGKVVECIDHKA--GGRHVAVKIVKNV-------------------------------DRY 54 (339)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEECSS-------------------------------HHH
T ss_pred cCCCccCceEEEEEEecCCCeEEEEEEecCC--CCcEEEEEEEecC-------------------------------Cch
Confidence 3456678999999999999999999988431 6889999998542 233
Q ss_pred HHHHHHHHHHHHhhcCCC------CcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHH
Q 011582 195 IEDVRREVKILRALTGHK------NLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVA 267 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~hp------niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~ 267 (482)
.+.+.+|+.+++.+. |+ +|+++++++.+.+.+|+||||+ +++|.+++.... ..+++..+..++.||+.||.
T Consensus 55 ~~~~~~e~~~l~~l~-~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~ 132 (339)
T 1z57_A 55 CEAARSEIQVLEHLN-TTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVN 132 (339)
T ss_dssp HHHHHHHHHHHHHHH-HHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhh-hcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHH
Confidence 567889999999986 55 4999999999999999999999 889999887653 36899999999999999999
Q ss_pred HHHHCCCcccCCCCCceEEecCCC----------------CCcEEEEecccccccCCCCcccccccCccccCcccccc-c
Q 011582 268 FCHFQGVVHRDLKPENFLFTSKEE----------------NSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-S 330 (482)
Q Consensus 268 yLH~~~ivHrDlkp~NIll~~~~~----------------~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~ 330 (482)
|||++||+||||||+|||++..+. ++.+||+|||++..... .....+||+.|+|||++.+ .
T Consensus 133 ~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~ 210 (339)
T 1z57_A 133 FLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALG 210 (339)
T ss_dssp HHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSC
T ss_pred HHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCC
Confidence 999999999999999999953221 56799999999987543 3355689999999998865 6
Q ss_pred CCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCC----------------CCCC---------------
Q 011582 331 YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDE----------------APWP--------------- 379 (482)
Q Consensus 331 ~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~----------------~~~~--------------- 379 (482)
++.++|||||||++|+|++|..||...+..+....+......++. ..|.
T Consensus 211 ~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (339)
T 1z57_A 211 WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKP 290 (339)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCC
T ss_pred CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcc
Confidence 899999999999999999999999988877766555443222111 0111
Q ss_pred ---------CCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 380 ---------SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 380 ---------~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
..++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 291 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 291 LKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp GGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred hhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 135678899999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=368.52 Aligned_cols=259 Identities=30% Similarity=0.492 Sum_probs=221.2
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|+++. +|+.||+|++... .......+.+.
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~~~ 53 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYG----------------------------SMTEAEKQMLV 53 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEECT----------------------------TCCHHHHHHHH
T ss_pred hhheeeehhccCCCCcEEEEEEECC---CCcEEEEEEEEcc----------------------------cCCHHHHHHHH
Confidence 4689999999999999999999876 7999999998653 12344567899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC-
Q 011582 200 REVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSR---GGKYSEEDAKIVMVQILSVVAFCHFQG- 273 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~- 273 (482)
+|+.++++++ ||||+++++++.+ .+.+|+||||+++++|.+++... ...+++..++.++.||+.||.|||++|
T Consensus 54 ~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 132 (279)
T 2w5a_A 54 SEVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132 (279)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC-
T ss_pred HHHHHHHhcC-CCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccC
Confidence 9999999996 9999999998864 67899999999999999988653 345999999999999999999999999
Q ss_pred ----CcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc-ccccccCccccCcccccc-cCCCcchhhhhHHHHHHH
Q 011582 274 ----VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER-LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 274 ----ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el 347 (482)
|+||||||+|||+ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|
T Consensus 133 ~~~~ivH~dl~p~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 209 (279)
T 2w5a_A 133 GGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209 (279)
T ss_dssp -----CCCCCSGGGEEE---CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHH
T ss_pred CCCeeEEeccchhhEEE---cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHH
Confidence 9999999999999 5678899999999987654322 334679999999998865 589999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 348 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 348 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
++|..||......++...+....... ....+++++.+||.+||+.||.+|||+.++|+|+|+....
T Consensus 210 ~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 210 CALMPPFTAFSQKELAGKIREGKFRR---IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHSSCSSCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHCCCCCcccCHHHHHHHHhhccccc---CCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 99999999988888888887765421 1235899999999999999999999999999999998653
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=376.14 Aligned_cols=260 Identities=26% Similarity=0.478 Sum_probs=218.8
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||.||+|.+.. +|+.||||++.+.. ........+.+
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~---~~~~~avK~~~~~~--------------------------~~~~~~~~~~~ 53 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSE---TLCRRAVKILKKKK--------------------------LRRIPNGEANV 53 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTT---TCCEEEEEEECHHH--------------------------HHHSTTHHHHH
T ss_pred cccceeEeeEEecCCCeEEEEEEECC---CCcEEEEEEecccc--------------------------ccccchhHHHH
Confidence 45789999999999999999999876 79999999986531 00112345678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEE--eCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYE--DDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
.+|+.+++.++ ||||+++++++. +.+..|+|||||+++ |.+.+... ...+++..+..++.||+.||.|||++||+
T Consensus 54 ~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~ 131 (305)
T 2wtk_C 54 KKEIQLLRRLR-HKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIV 131 (305)
T ss_dssp HHHHHHHTTCC-CTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHhcC-CCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 99999999997 999999999984 456899999999876 77766543 46799999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCC---CcccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhh
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD---ERLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~ellt 349 (482)
||||||+|||+ +.++.+||+|||++...... .......||+.|+|||++.+ .++.++||||||+++|+|++
T Consensus 132 H~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 208 (305)
T 2wtk_C 132 HKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208 (305)
T ss_dssp CSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH
T ss_pred ecCCCcccEEE---cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh
Confidence 99999999999 56788999999999876432 23345679999999998864 24779999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|..||.+.+..+....+......++ ..+++++.+||.+||+.||.+|||++++++||||++..
T Consensus 209 g~~p~~~~~~~~~~~~i~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 209 GLYPFEGDNIYKLFENIGKGSYAIP----GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp SSCSCCCSSHHHHHHHHHHCCCCCC----SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred CCCCCCCchHHHHHHHHhcCCCCCC----CccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 9999999998888888888765443 34899999999999999999999999999999998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=379.48 Aligned_cols=264 Identities=26% Similarity=0.439 Sum_probs=218.0
Q ss_pred cccccccceEecceeecCCceEEEEEEEecCCCCC-ceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHH
Q 011582 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKG-QDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAI 193 (482)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g-~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (482)
..+.+.++|++.+.||+|+||.||+|++.. ++ +.||||++++. ..
T Consensus 13 ~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~vavK~~~~~-------------------------------~~ 58 (355)
T 2eu9_A 13 IGDWLQERYEIVGNLGEGTFGKVVECLDHA---RGKSQVALKIIRNV-------------------------------GK 58 (355)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETT---TTTEEEEEEEECSC-------------------------------HH
T ss_pred cCceecccEEEEEEeeccCCeEEEEEEecC---CCceEEEEEEEccc-------------------------------cc
Confidence 455677899999999999999999999875 44 78999998542 23
Q ss_pred HHHHHHHHHHHHHhhcCCCC------cceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHH
Q 011582 194 AIEDVRREVKILRALTGHKN------LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVV 266 (482)
Q Consensus 194 ~~~~~~~Ei~~l~~l~~hpn------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L 266 (482)
..+.+.+|+.+++.+. |++ ++.+++++...+.+|+||||+ +++|.+++.... ..+++..++.++.||+.||
T Consensus 59 ~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L 136 (355)
T 2eu9_A 59 YREAARLEINVLKKIK-EKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136 (355)
T ss_dssp HHHHHHHHHHHHHHHH-HHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHh-hcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 3567889999999997 655 999999999999999999999 667888776653 5799999999999999999
Q ss_pred HHHHHCCCcccCCCCCceEEecC----------------CCCCcEEEEecccccccCCCCcccccccCccccCcccccc-
Q 011582 267 AFCHFQGVVHRDLKPENFLFTSK----------------EENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR- 329 (482)
Q Consensus 267 ~yLH~~~ivHrDlkp~NIll~~~----------------~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~- 329 (482)
.|||++||+||||||+|||+... +.++.+||+|||++..... .....+||+.|+|||++.+
T Consensus 137 ~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 214 (355)
T 2eu9_A 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILEL 214 (355)
T ss_dssp HHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTC
T ss_pred HHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecC
Confidence 99999999999999999999532 2467899999999986443 3355689999999998864
Q ss_pred cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCC----------------CCC--------------
Q 011582 330 SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEA----------------PWP-------------- 379 (482)
Q Consensus 330 ~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~----------------~~~-------------- 379 (482)
.++.++|||||||++|+|++|..||......+.+..+......++.. .|.
T Consensus 215 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (355)
T 2eu9_A 215 GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294 (355)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC
Confidence 69999999999999999999999999888777666554432222110 111
Q ss_pred ----------CCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 380 ----------SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 380 ----------~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
..+.++.+||.+||+.||.+|||+.|+|+||||+...
T Consensus 295 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred cccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 1245788999999999999999999999999998753
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=381.87 Aligned_cols=260 Identities=26% Similarity=0.372 Sum_probs=204.8
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++.. +|+.||||++.... ......
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~-------------------------------~~~~~~ 66 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKS---TGMSVAIKKVIQDP-------------------------------RFRNRE 66 (360)
T ss_dssp HHTTEEEC----------CEEEEETT---TCCEEEEEEEECCT-------------------------------TCCCHH
T ss_pred hccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEecCc-------------------------------cccHHH
Confidence 45789999999999999999999876 79999999985430 011245
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCe-------EEEEEecCCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDN-------IYIVMELCKGGELLDRIL---SRGGKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~-------~~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~y 268 (482)
.+|+..++.+. ||||+++++++...+. +++||||+++ +|.+.+. .....+++..++.++.|++.||.|
T Consensus 67 ~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~ 144 (360)
T 3e3p_A 67 LQIMQDLAVLH-HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGC 144 (360)
T ss_dssp HHHHHHHHHHC-CTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcC-CCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 67788888886 9999999999976443 8999999976 5555444 245679999999999999999999
Q ss_pred HH--HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHH
Q 011582 269 CH--FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIA 344 (482)
Q Consensus 269 LH--~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil 344 (482)
|| ++||+||||||+|||++ ..++.+||+|||++.............||+.|+|||++.+ .++.++|||||||++
T Consensus 145 lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il 222 (360)
T 3e3p_A 145 LHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIF 222 (360)
T ss_dssp HTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHH
Confidence 99 99999999999999995 2367899999999998776666667789999999998853 489999999999999
Q ss_pred HHHhhCCCCCCCCChHHHHHHHHhcCCCCCC----------------------------CCCCCCCHHHHHHHHHhchhc
Q 011582 345 YILLCGSRPFWARTESGIFRAVLKADPSFDE----------------------------APWPSLSPEAIDFVKRLLNKD 396 (482)
Q Consensus 345 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~----------------------------~~~~~~s~~~~~li~~~L~~d 396 (482)
|+|++|+.||.+.+....+..+......... ......++++.+||.+||+.|
T Consensus 223 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 302 (360)
T 3e3p_A 223 AEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302 (360)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSS
T ss_pred HHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccC
Confidence 9999999999999888887777653211100 011225789999999999999
Q ss_pred cccCCCHHHHhcCcccccCC
Q 011582 397 YRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 397 P~~R~s~~e~L~hp~~~~~~ 416 (482)
|.+|||+.|+|+||||++..
T Consensus 303 P~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 303 PEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp GGGSCCHHHHTTSGGGGGGG
T ss_pred ccccCCHHHHhcCccccccC
Confidence 99999999999999998764
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=365.70 Aligned_cols=248 Identities=23% Similarity=0.388 Sum_probs=215.7
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|++. +++.||||++.... ...+.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-------------------------------~~~~~~~ 53 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGA-------------------------------MSEEDFI 53 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET----TTEEEEEEEECTTS-------------------------------BCHHHHH
T ss_pred hhhceeeheecCCCccEEEEEEec----CCCeEEEEEecccc-------------------------------cCHHHHH
Confidence 368999999999999999999976 47789999986531 1125688
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.++++++ ||||+++++++.+.+..|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||
T Consensus 54 ~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~di 132 (269)
T 4hcu_A 54 EEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 132 (269)
T ss_dssp HHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHHHHHhCC-CCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCc
Confidence 9999999997 999999999999999999999999999999999777778999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
||+|||+ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++ |..||.
T Consensus 133 kp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~ 209 (269)
T 4hcu_A 133 AARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE 209 (269)
T ss_dssp CGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred chheEEE---cCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCC
Confidence 9999999 566789999999998764432 233456788999999986 569999999999999999999 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.....+....+........ ...+++++.++|.+||+.||.+|||+.++++|
T Consensus 210 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 210 NRSNSEVVEDISTGFRLYK---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp TCCHHHHHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHhcCccCCC---CCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999888888877643222 23479999999999999999999999999875
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=379.77 Aligned_cols=257 Identities=33% Similarity=0.569 Sum_probs=213.5
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|.+.+.||+|+||.||+|+++. +|+.||||++.+. .......+.+
T Consensus 22 l~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~----------------------------~~~~~~~~~~ 70 (353)
T 3coi_A 22 LPKTYVSPTHVGSGAYGSVCSAIDKR---SGEKVAIKKLSRP----------------------------FQSEIFAKRA 70 (353)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEESST----------------------------TSSHHHHHHH
T ss_pred cCceEEEeeeEecCCCeEEEEEEECC---CCCEEEEEEeccc----------------------------ccchHHHHHH
Confidence 45789999999999999999999876 7999999998653 1233456778
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCe------EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDN------IYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~------~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
.+|+.+++.+. ||||+++++++...+. +|+||||+. ++|.+.+ ...+++..+..++.||+.||.|||++
T Consensus 71 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~---~~~~~~~~~~~i~~qi~~al~~LH~~ 145 (353)
T 3coi_A 71 YRELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIM---GLKFSEEKIQYLVYQMLKGLKYIHSA 145 (353)
T ss_dssp HHHHHHHHHCC-CTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTT---TSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcC-CCCcccHhheEecccccccceeEEEEecccc-CCHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 99999999997 9999999999987654 599999997 5887765 24699999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg 350 (482)
||+||||||+|||+ +.++.+||+|||++..... .....+||+.|+|||++.+ .++.++|||||||++|+|++|
T Consensus 146 ~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g 220 (353)
T 3coi_A 146 GVVHRDLKPGNLAV---NEDCELKILDFGLARHADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220 (353)
T ss_dssp TCCCSSCCGGGEEE---CTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred CcccCCCCHHHEeE---CCCCcEEEeecccccCCCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999 5678899999999986543 2445689999999998864 589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCC---------------------------CCCCCCCCCCHHHHHHHHHhchhccccCCCH
Q 011582 351 SRPFWARTESGIFRAVLKADPS---------------------------FDEAPWPSLSPEAIDFVKRLLNKDYRKRLTA 403 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~---------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~ 403 (482)
..||.+.+..+.+..+...... .....++.+++++.+||.+||+.||.+|||+
T Consensus 221 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~ 300 (353)
T 3coi_A 221 KTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTA 300 (353)
T ss_dssp SCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCH
Confidence 9999998877776666542110 0112235689999999999999999999999
Q ss_pred HHHhcCcccccCC
Q 011582 404 AQALSHPWLANSH 416 (482)
Q Consensus 404 ~e~L~hp~~~~~~ 416 (482)
+++|+||||+...
T Consensus 301 ~e~l~hp~f~~~~ 313 (353)
T 3coi_A 301 AQALTHPFFEPFR 313 (353)
T ss_dssp HHHHTSGGGTTTC
T ss_pred HHHhcCcchhhcc
Confidence 9999999998654
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=381.24 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=218.4
Q ss_pred ccceEecceeecCCceEEEEEEEecC----CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG----SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~----~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.++|.+++.||+|+||.||+|++... ...+..||||++... ......
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~ 118 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----------------------------ATEKDL 118 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT-----------------------------CCHHHH
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc-----------------------------cCHHHH
Confidence 46899999999999999999997541 123568999998653 234456
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHH
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMV 260 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ 260 (482)
..+.+|+.+++++.+||||+++++++.+++..|+|||||++|+|.+++.... ..+++..++.++.
T Consensus 119 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 198 (382)
T 3tt0_A 119 SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAY 198 (382)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHH
Confidence 7899999999999559999999999999999999999999999999987653 3599999999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc-cCCCcch
Q 011582 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR-SYGTEAD 336 (482)
Q Consensus 261 qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~D 336 (482)
||+.||.|||++||+||||||+|||+ +.++.+||+|||+++...... ......||+.|+|||++.+ .++.++|
T Consensus 199 qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 275 (382)
T 3tt0_A 199 QVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275 (382)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHH
T ss_pred HHHHHHHHHHhCCEecCCCCcceEEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhH
Confidence 99999999999999999999999999 567889999999998765432 2344567899999998865 5899999
Q ss_pred hhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 337 MWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 337 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||||||++|+|++ |..||.+....++...+....... ....+++++.+||.+||+.||.+|||+.+++++
T Consensus 276 iwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 276 VWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC---CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999 999999998888888777654321 224589999999999999999999999999875
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=371.33 Aligned_cols=262 Identities=26% Similarity=0.394 Sum_probs=199.2
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|+++. +|+.||||++.... ......+.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~----------------------------~~~~~~~~~ 71 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRK---TGHVIAVKQMRRSG----------------------------NKEENKRIL 71 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETT---TCCEEEEEEEETTS----------------------------CHHHHHHHH
T ss_pred hhccccccceeeecCCeeEEEEEEec---CCeEEEEEEecccc----------------------------cchHHHHHH
Confidence 35789999999999999999999976 79999999986531 112223344
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVHR 277 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ivHr 277 (482)
.++..+++.+. ||||+++++++.+.+..|+||||+ ++.+..........+++..+..++.||+.||.|||++ ||+||
T Consensus 72 ~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~ 149 (318)
T 2dyl_A 72 MDLDVVLKSHD-CPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHR 149 (318)
T ss_dssp HHHHHHHHTTT-CTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_pred HHHHHHHHhcC-CCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeC
Confidence 44555666675 999999999999999999999999 5555554444467899999999999999999999995 99999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc------ccCCCcchhhhhHHHHHHHhhCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~elltg~ 351 (482)
||||+|||+ +.++.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++|.
T Consensus 150 dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 226 (318)
T 2dyl_A 150 DVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226 (318)
T ss_dssp CCCGGGEEE---CTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSS
T ss_pred CCCHHHEEE---CCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCC
Confidence 999999999 567789999999998766555555678999999999883 35889999999999999999999
Q ss_pred CCCCCC-ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 352 RPFWAR-TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 352 ~pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.||... ...+.+..+........ .....+++++.+||.+||+.||.+||+++++|+||||+....
T Consensus 227 ~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (318)
T 2dyl_A 227 FPYKNCKTDFEVLTKVLQEEPPLL-PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYET 292 (318)
T ss_dssp CTTTTCCSHHHHHHHHHHSCCCCC-CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHH
T ss_pred CCCCCCCccHHHHHHHhccCCCCC-CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhccc
Confidence 999873 45566666666543322 223468999999999999999999999999999999986543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=382.83 Aligned_cols=277 Identities=22% Similarity=0.419 Sum_probs=224.9
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
...+.++|++++.||+|+||.||+|++ +|+.||||++................. ........
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~ 87 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK-----DNKFYALKKYEKSLLEKKRDFTKSNND-------------KISIKSKY 87 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE-----TTEEEEEEEEEHHHHSSCEEECCCSSS-------------SCCEEEHH
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc-----CCceEEEEEeecccccchhhhccccch-------------hhhHHhHH
Confidence 345668999999999999999999987 589999999975411000000000000 00111233
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHH
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR------ILSR-GGKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~-~~~l~~~~~~~i~~qi~~~L~y 268 (482)
+.+.+|+.+++++. ||||+++++++.+.+..|+||||+++++|.++ +... ...+++..++.++.||+.||.|
T Consensus 88 ~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 166 (348)
T 2pml_X 88 DDFKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSY 166 (348)
T ss_dssp HHHHHHHHHHTTCC-CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHH
Confidence 67899999999997 99999999999999999999999999999887 4332 4679999999999999999999
Q ss_pred HHH-CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccccc--CCC-cchhhhhHHHH
Q 011582 269 CHF-QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS--YGT-EADMWSIGVIA 344 (482)
Q Consensus 269 LH~-~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~-~~DiwSlGvil 344 (482)
||+ +||+||||||+|||+ +.++.+||+|||++...... ......||+.|+|||++.+. ++. ++|||||||++
T Consensus 167 lH~~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 242 (348)
T 2pml_X 167 IHNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242 (348)
T ss_dssp HHHTSCEECCCCCGGGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHH
T ss_pred HhccCCEeecCCChHhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHH
Confidence 999 999999999999999 56778999999999876543 44567899999999998753 555 89999999999
Q ss_pred HHHhhCCCCCCCCCh-HHHHHHHHhcCCCCCCCC---------------CCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 345 YILLCGSRPFWARTE-SGIFRAVLKADPSFDEAP---------------WPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 345 ~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~---------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|+|++|..||..... .+....+......++... ...+++++.+||.+||+.||.+|||++++|+
T Consensus 243 ~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 243 YVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHHhCCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 999999999988777 777777776655544211 1468999999999999999999999999999
Q ss_pred CcccccC
Q 011582 409 HPWLANS 415 (482)
Q Consensus 409 hp~~~~~ 415 (482)
||||.+.
T Consensus 323 hp~f~~~ 329 (348)
T 2pml_X 323 HEWLADT 329 (348)
T ss_dssp SGGGTTC
T ss_pred CccccCC
Confidence 9999864
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=367.03 Aligned_cols=253 Identities=23% Similarity=0.364 Sum_probs=204.7
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|++......+..||||++... ......+.+
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~-----------------------------~~~~~~~~~ 63 (281)
T 1mp8_A 13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-----------------------------TSDSVREKF 63 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-----------------------------TSHHHHHHH
T ss_pred ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc-----------------------------CCHHHHHHH
Confidence 357899999999999999999998764335678999987542 234456788
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++++. ||||+++++++ .++..|+||||+++++|.+++......+++..+..++.|++.||.|||++||+|||
T Consensus 64 ~~e~~~l~~l~-h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 141 (281)
T 1mp8_A 64 LQEALTMRQFD-HPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRD 141 (281)
T ss_dssp HHHHHHHHTCC-CTTBCCEEEEE-CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHhCC-CCccceEEEEE-ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 99999999996 99999999998 45678999999999999999987766899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|||+|||++ .++.+||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |..||
T Consensus 142 lkp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf 218 (281)
T 1mp8_A 142 IAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218 (281)
T ss_dssp CSGGGEEEE---ETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred ccHHHEEEC---CCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCC
Confidence 999999994 567899999999987654332 23345788999999886 468999999999999999996 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+....+....+...... .....+++++.+||.+||..||.+|||+.++++
T Consensus 219 ~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 269 (281)
T 1mp8_A 219 QGVKNNDVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 269 (281)
T ss_dssp TTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 998888888877765432 223468999999999999999999999999876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=370.53 Aligned_cols=246 Identities=24% Similarity=0.376 Sum_probs=208.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|.+++.||+|+||.||+|++.. +|+.||+|++.. ......+.+.
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~va~K~~~~------------------------------~~~~~~~~~~ 55 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRE---TGEVMVMKELIR------------------------------FDEETQRTFL 55 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEESC------------------------------CCHHHHHHHH
T ss_pred hhHeeccceecCCCCEEEEEEEECC---CCcEEEEEEecc------------------------------CCHHHHHHHH
Confidence 4689999999999999999999876 799999998843 2345567899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.++++++ ||||+++++++.+++..++||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||
T Consensus 56 ~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dl 134 (310)
T 3s95_A 56 KEVKVMRCLE-HPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134 (310)
T ss_dssp HHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHhCC-CcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCC
Confidence 9999999997 999999999999999999999999999999999876788999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcc---------------cccccCccccCcccccc-cCCCcchhhhhHHH
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERL---------------NDIVGSAYYVAPEVLHR-SYGTEADMWSIGVI 343 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~---------------~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvi 343 (482)
||+|||+ +.++.+||+|||++......... ...+||+.|+|||++.+ .++.++|||||||+
T Consensus 135 kp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~ 211 (310)
T 3s95_A 135 NSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIV 211 (310)
T ss_dssp STTSEEE---CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred CcCeEEE---CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHH
Confidence 9999999 67788999999999876433211 15689999999999875 58999999999999
Q ss_pred HHHHhhCCCCCCCCChHH-----HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 344 AYILLCGSRPFWARTESG-----IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 344 l~elltg~~pf~~~~~~~-----~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+|+|++|..||....... ......... ..+.+++++.+||.+||+.||.+|||+.++++
T Consensus 212 l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 212 LCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhcCCCCCcchhhhHHHHhhhhhcccccc------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999999999986532211 111111111 11357889999999999999999999999976
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=374.53 Aligned_cols=265 Identities=20% Similarity=0.310 Sum_probs=199.9
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|++.........||||++... .......+.+
T Consensus 21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~----------------------------~~~~~~~~~~ 72 (323)
T 3qup_A 21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKAD----------------------------IIASSDIEEF 72 (323)
T ss_dssp C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC----------------------------------CHHHHHH
T ss_pred ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccc----------------------------ccCHHHHHHH
Confidence 356899999999999999999998762212248999998653 1223446789
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeE------EEEEecCCCCChHHHHHhcC-----CCCCHHHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNI------YIVMELCKGGELLDRILSRG-----GKYSEEDAKIVMVQILSVVA 267 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~------~lv~e~~~~g~L~~~l~~~~-----~~l~~~~~~~i~~qi~~~L~ 267 (482)
.+|+.+++++. ||||+++++++.+.+.. ++||||+++|+|.+++.... ..+++..++.++.||+.||.
T Consensus 73 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~ 151 (323)
T 3qup_A 73 LREAACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGME 151 (323)
T ss_dssp HHHHHHHTTCC-CTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHCC-CCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHH
Confidence 99999999996 99999999999887665 99999999999999886432 25999999999999999999
Q ss_pred HHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcchhhhhHHH
Q 011582 268 FCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVI 343 (482)
Q Consensus 268 yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvi 343 (482)
|||++||+||||||+|||+ +.++.+||+|||++........ .....+|+.|+|||++.+ .++.++|||||||+
T Consensus 152 ~LH~~~ivH~Dikp~NIli---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 228 (323)
T 3qup_A 152 YLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVT 228 (323)
T ss_dssp HHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHcCCcccCCCCcceEEE---cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHH
Confidence 9999999999999999999 5678899999999987654332 223457889999998864 58999999999999
Q ss_pred HHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-------HHHHhcCcccccC
Q 011582 344 AYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-------AAQALSHPWLANS 415 (482)
Q Consensus 344 l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-------~~e~L~hp~~~~~ 415 (482)
+|+|++ |..||.+....+....+....... ....+++++.+||.+||+.||.+||| +++++.|+|+...
T Consensus 229 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~ 305 (323)
T 3qup_A 229 MWEIMTRGQTPYAGIENAEIYNYLIGGNRLK---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST 305 (323)
T ss_dssp HHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred HHHHHhCCCCCccccChHHHHHHHhcCCCCC---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence 999999 999999988888888877664322 22468999999999999999999999 8889999999876
Q ss_pred CCC
Q 011582 416 HDV 418 (482)
Q Consensus 416 ~~~ 418 (482)
...
T Consensus 306 ~~~ 308 (323)
T 3qup_A 306 SQD 308 (323)
T ss_dssp ---
T ss_pred CCC
Confidence 443
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=369.18 Aligned_cols=258 Identities=27% Similarity=0.404 Sum_probs=207.8
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|.....||+|+||.||+|++.. +|+.||||++... .....+.+.+|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~------------------------------~~~~~~~~~~e 69 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLS---NQVRIAIKEIPER------------------------------DSRYSQPLHEE 69 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETT---TCCEEEEEEEECC------------------------------CC---HHHHHH
T ss_pred CCCCcEEEeecCcEEEEEEEECC---CCeEEEEEEccCC------------------------------chHHHHHHHHH
Confidence 34445589999999999999876 7899999998652 12234678899
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG--GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+.+++.+. ||||+++++++.+.+..++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||
T Consensus 70 ~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl 148 (295)
T 2clq_A 70 IALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDI 148 (295)
T ss_dssp HHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHhCC-CCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCC
Confidence 99999996 9999999999999999999999999999999887653 34679999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||+|||++. .++.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 149 ~p~Nil~~~--~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 226 (295)
T 2clq_A 149 KGDNVLINT--YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFY 226 (295)
T ss_dssp SGGGEEEET--TTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTG
T ss_pred ChhhEEEEC--CCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCcc
Confidence 999999952 36789999999998765422 2345689999999999864 38899999999999999999999997
Q ss_pred CCChHH-HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 356 ARTESG-IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 356 ~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
...... .......... .......+++++.+||.+||+.||.+||+++++|+||||+....
T Consensus 227 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 227 ELGEPQAAMFKVGMFKV--HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp GGSSHHHHHHHHHHHCC--CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred CCCchhHHHHhhccccc--cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 654332 2222211111 11223468999999999999999999999999999999987643
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=362.71 Aligned_cols=249 Identities=27% Similarity=0.385 Sum_probs=216.0
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-------------------------------~~~~~~ 50 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK----GQYDVAVKMIKEGS-------------------------------MSEDEF 50 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECBTT-------------------------------BCHHHH
T ss_pred chhheeeeeeeccCCCceEEEEEec----CceeEEEEEeccCC-------------------------------CcHHHH
Confidence 3578999999999999999999775 46789999986530 113568
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++++. ||||+++++++.+.+..|+||||+++++|.+++...+..+++..++.++.|++.||.|||++||+|||
T Consensus 51 ~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 129 (268)
T 3sxs_A 51 FQEAQTMMKLS-HPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRD 129 (268)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESS
T ss_pred HHHHHHHHhCC-CCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 89999999997 99999999999999999999999999999999987766799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|||+|||+ +.++.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||
T Consensus 130 ikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~ 206 (268)
T 3sxs_A 130 LAARNCLV---DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPY 206 (268)
T ss_dssp CSGGGEEE---CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTT
T ss_pred cCcceEEE---CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCc
Confidence 99999999 6778899999999987654432 233456778999999875 68999999999999999999 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
......+....+......... ..+++++.+||.+||+.||.+|||+.+++++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 207 DLYTNSEVVLKVSQGHRLYRP---HLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp TTSCHHHHHHHHHTTCCCCCC---TTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cccChHHHHHHHHcCCCCCCC---CcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999888888877766543322 3478999999999999999999999999985
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=375.43 Aligned_cols=261 Identities=26% Similarity=0.402 Sum_probs=191.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|.++. +|+.||||++... ........+.
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~-----------------------------~~~~~~~~~~ 68 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKP---SGQIMAVKRIRST-----------------------------VDEKEQKQLL 68 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETT---TTEEEEEEEEECC-----------------------------CCHHHHHHHH
T ss_pred HHHhhehheeccCCCEEEEEEEEcC---CCCEEEEEEeecc-----------------------------cCchHHHHHH
Confidence 4789999999999999999999876 7999999999653 1223345566
Q ss_pred HHHH-HHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC-C
Q 011582 200 REVK-ILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS----RGGKYSEEDAKIVMVQILSVVAFCHFQ-G 273 (482)
Q Consensus 200 ~Ei~-~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~yLH~~-~ 273 (482)
.|+. +++.+ +||||+++++++.+.+..|+||||+++ +|.+++.. ....+++..+..++.|++.||.|||++ |
T Consensus 69 ~e~~~~~~~~-~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ 146 (327)
T 3aln_A 69 MDLDVVMRSS-DCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146 (327)
T ss_dssp HHHHHHHSSC-CCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS
T ss_pred HHHHHHHHcC-CCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC
Confidence 6766 55555 599999999999999999999999976 77776653 256799999999999999999999999 9
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-----ccCCCcchhhhhHHHHHHHh
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-----RSYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~DiwSlGvil~ell 348 (482)
|+||||||+|||+ +.++.+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|+
T Consensus 147 ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~ 223 (327)
T 3aln_A 147 IIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELA 223 (327)
T ss_dssp CCCSCCCGGGEEE---ETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHH
T ss_pred EeECCCCHHHEEE---cCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999 567789999999998776554455568999999999983 35899999999999999999
Q ss_pred hCCCCCCCCChH-HHHHHHHhcC-CCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 349 CGSRPFWARTES-GIFRAVLKAD-PSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 349 tg~~pf~~~~~~-~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
+|..||.+.... +.+..+.... ..+....+..+++++.+||.+||+.||.+|||+.++|+||||.....
T Consensus 224 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 224 TGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp HSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 999999765432 2222222211 12223334568999999999999999999999999999999986543
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=368.62 Aligned_cols=256 Identities=26% Similarity=0.349 Sum_probs=215.4
Q ss_pred ccceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++++.||+|+||.||+|++.. ...+++.||||++... ......+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~ 72 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----------------------------AHLTEREA 72 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-----------------------------CCHHHHHH
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc-----------------------------hhHHHHHH
Confidence 4689999999999999999998743 2236789999998653 22334578
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCC-----------------CCCHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG-----------------KYSEEDAKIVMV 260 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------------~l~~~~~~~i~~ 260 (482)
+.+|+.+++++.+||||+++++++.+.+..++||||+++|+|.+++..... .+++..++.++.
T Consensus 73 ~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (313)
T 1t46_A 73 LMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSY 152 (313)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHH
T ss_pred HHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHH
Confidence 899999999995599999999999999999999999999999999876533 489999999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcch
Q 011582 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEAD 336 (482)
Q Consensus 261 qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~D 336 (482)
||+.||.|||++||+||||||+|||+ +.++.+||+|||++........ .....||+.|+|||++. ..++.++|
T Consensus 153 qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 229 (313)
T 1t46_A 153 QVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESD 229 (313)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHHCCeecCCCccceEEE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHH
Confidence 99999999999999999999999999 5677899999999987654432 23456788999999875 46899999
Q ss_pred hhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 337 MWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 337 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||||||++|+|++ |..||.+.........+......... ...+++++.+||.+||+.||.+|||+.+++++
T Consensus 230 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 230 VWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS--PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCC--CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCC--cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 9999999999999 99999887766555555554433222 24589999999999999999999999999863
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=374.53 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=216.7
Q ss_pred cccceEecceeecCCceEEEEEEEecCC--CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGS--LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~--~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..++|++++.||+|+||.||+|++.... .+++.||||++++. ......+
T Consensus 45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~ 95 (343)
T 1luf_A 45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-----------------------------ASADMQA 95 (343)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-----------------------------CCHHHHH
T ss_pred cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccc-----------------------------cCHHHHH
Confidence 4578999999999999999999987421 24689999998653 2334567
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-----------------------CCCCHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-----------------------GKYSEE 253 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~ 253 (482)
.+.+|+.+++++. ||||+++++++.+.+..|+||||+++|+|.+++.... ..+++.
T Consensus 96 ~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 174 (343)
T 1luf_A 96 DFQREAALMAEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174 (343)
T ss_dssp HHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHH
T ss_pred HHHHHHHHHHhCC-CCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHH
Confidence 8999999999996 9999999999999999999999999999999987642 579999
Q ss_pred HHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-c
Q 011582 254 DAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-R 329 (482)
Q Consensus 254 ~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~ 329 (482)
+++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....... ......||+.|+|||++. +
T Consensus 175 ~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~ 251 (343)
T 1luf_A 175 EQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251 (343)
T ss_dssp HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC
Confidence 999999999999999999999999999999999 567789999999998654322 233457899999999886 4
Q ss_pred cCCCcchhhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 330 SYGTEADMWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 330 ~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.++.++|||||||++|+|++ |..||.+....++...+....... ....+++++.+||.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp CCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 69999999999999999999 999999999888888887765422 12358999999999999999999999999976
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=378.78 Aligned_cols=251 Identities=20% Similarity=0.275 Sum_probs=207.3
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||.||+|++.. +|+.||||++.... ..+.+
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--------------------------------~~~~~ 51 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLY---TNEYVAIKLEPMKS--------------------------------RAPQL 51 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETT---TTEEEEEEEEETTC--------------------------------SSCCH
T ss_pred EcCCeEEEEEeeccCCceEEEEEECC---CCcEEEEEEecccc--------------------------------chHHH
Confidence 45789999999999999999999876 79999999986430 01247
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+.+||||+++++++.+.+..|+||||+ +++|.+++......+++..+..++.||+.||.|||++||+|||
T Consensus 52 ~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrD 130 (330)
T 2izr_A 52 HLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRD 130 (330)
T ss_dssp HHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Confidence 789999999955999999999999999999999999 9999999877667899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCc-----EEEEecccccccCCCCc--------ccccccCccccCcccccc-cCCCcchhhhhHHHH
Q 011582 279 LKPENFLFTSKEENSS-----LKAIDFGLSDYVKPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIA 344 (482)
Q Consensus 279 lkp~NIll~~~~~~~~-----~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil 344 (482)
|||+|||++ .++. +||+|||++........ ....+||+.|+|||++.+ .++.++|||||||++
T Consensus 131 lkp~Nill~---~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 207 (330)
T 2izr_A 131 VKPENFLIG---RPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMF 207 (330)
T ss_dssp CCGGGEEEC---CGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred CCHHHeeec---cCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHH
Confidence 999999995 4444 99999999987644322 246789999999999875 589999999999999
Q ss_pred HHHhhCCCCCCCCC---hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 345 YILLCGSRPFWART---ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 345 ~elltg~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|+|++|..||.+.. ..+.+..+.......+...+....+++.+||..||+.||.+||+++++++
T Consensus 208 ~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 208 MYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 99999999998743 34445555443322221111112349999999999999999999998876
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=366.98 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=210.0
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++.+.||+|+||.||+|.+. +|+.||||++... .......+.
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~----------------------------~~~~~~~~~ 72 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNE----KKQIYAIKYVNLE----------------------------EADNQTLDS 72 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECT----TCCEEEEEEEECS----------------------------SCCHHHHHH
T ss_pred eccceEEEEEEecCCCCEEEEEEEcC----CCcEEEEEEeccc----------------------------cccccchHH
Confidence 34568999999999999999999874 5889999998653 123445678
Q ss_pred HHHHHHHHHhhcC-CCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 198 VRREVKILRALTG-HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 198 ~~~Ei~~l~~l~~-hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+.+|+.+++++.. |+||+++++++.+.+..|+||| +.+++|.+++... ..+++..++.++.||+.||.|||++||+|
T Consensus 73 ~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 150 (313)
T 3cek_A 73 YRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIHQHGIVH 150 (313)
T ss_dssp HHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 8999999999973 6999999999999999999999 5578999988654 68999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc------------cCCCcchhhhhH
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR------------SYGTEADMWSIG 341 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~------------~~~~~~DiwSlG 341 (482)
|||||+|||++ ++.+||+|||++....... .....+||+.|+|||++.+ .++.++||||||
T Consensus 151 ~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG 226 (313)
T 3cek_A 151 SDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLG 226 (313)
T ss_dssp CCCCGGGEEEE----TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHH
T ss_pred cCCCcccEEEE----CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHH
Confidence 99999999994 3689999999998764432 2235679999999998854 578899999999
Q ss_pred HHHHHHhhCCCCCCCCCh-HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 342 VIAYILLCGSRPFWARTE-SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 342 vil~elltg~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
|++|+|++|..||..... ...+..+......... ....++++.+||.+||+.||.+||++.++|+||||+...
T Consensus 227 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 227 CILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF--PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp HHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC--CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred HHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCC--cccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 999999999999977543 3344444443322221 234689999999999999999999999999999998754
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=366.98 Aligned_cols=252 Identities=19% Similarity=0.228 Sum_probs=207.8
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCC-------ceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhcc
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKG-------QDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFM 189 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g-------~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (482)
+...++|++.+.||+|+||.||+|++.. +| ..||+|++.+.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~~~~~~~~va~K~~~~~----------------------------- 51 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRRE---VGDYGQLHETEVLLKVLDKA----------------------------- 51 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEE---ECGGGCEEEEEEEEEEECGG-----------------------------
T ss_pred EechhHeeeeeeeccCCCceEEEEEEec---ccccccccchhhhhhhcccc-----------------------------
Confidence 3446789999999999999999999876 44 57999998542
Q ss_pred ccHHHHHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 011582 190 TTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 190 ~~~~~~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yL 269 (482)
.....+.+.+|+.+++++. ||||+++++++.+++..|+||||++||+|.+++......+++..+..++.||+.||.||
T Consensus 52 -~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~L 129 (289)
T 4fvq_A 52 -HRNYSESFFEAASMMSKLS-HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129 (289)
T ss_dssp -GGGGHHHHHHHHHHHHTSC-CTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred -cHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 2233567899999999997 99999999999999999999999999999999977655699999999999999999999
Q ss_pred HHCCCcccCCCCCceEEecCCC-----CCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHH
Q 011582 270 HFQGVVHRDLKPENFLFTSKEE-----NSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGV 342 (482)
Q Consensus 270 H~~~ivHrDlkp~NIll~~~~~-----~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGv 342 (482)
|++||+||||||+|||++.++. ...+||+|||++..... .....||+.|+|||++.+ .++.++|||||||
T Consensus 130 H~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~ 206 (289)
T 4fvq_A 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGT 206 (289)
T ss_dssp HHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHH
T ss_pred hhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHH
Confidence 9999999999999999964321 11299999999876532 234568999999998864 5899999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 343 IAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 343 il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
++|+|++|..|+...........+......++ ...++++.+||.+||+.||.+|||+.++++|
T Consensus 207 il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 207 TLWEICSGGDKPLSALDSQRKLQFYEDRHQLP----APKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC----CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCccccchHHHHHHhhccCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999996555555444444444444444333 2368899999999999999999999999875
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-46 Score=363.58 Aligned_cols=248 Identities=23% Similarity=0.364 Sum_probs=212.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|.+. ++..||||++.... ...+.+.
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-------------------------------~~~~~~~ 67 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGS-------------------------------MSEDEFI 67 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEET----TTEEEEEEEECTTS-------------------------------BCHHHHH
T ss_pred HHHHHhHhhcCCCCCceEEEEEEc----CCCeEEEEEecCCC-------------------------------CCHHHHH
Confidence 468999999999999999999775 47789999986530 1125688
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++++. ||||+++++++.+.+..|+||||+++++|.+++......+++..++.++.|++.||.|||++||+||||
T Consensus 68 ~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~di 146 (283)
T 3gen_A 68 EEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 146 (283)
T ss_dssp HHHHHHHTCC-CTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSC
T ss_pred HHHHHHhcCC-CCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCC
Confidence 9999999997 999999999999999999999999999999998775678999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
||+|||+ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++ |+.||.
T Consensus 147 kp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~ 223 (283)
T 3gen_A 147 AARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYE 223 (283)
T ss_dssp SGGGEEE---CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccceEEE---cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcc
Confidence 9999999 567789999999998764332 223445788999999886 568999999999999999998 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.....+....+........ ...+++++.+||.+||+.||.+|||+.++++|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 224 RFTNSETAEHIAQGLRLYR---PHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp TSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ccChhHHHHHHhcccCCCC---CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9998888888876643322 23478999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=383.16 Aligned_cols=250 Identities=23% Similarity=0.351 Sum_probs=213.7
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+++. +|+.||||+++.. ......+.+.
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~---~~~~vavK~~~~~-----------------------------~~~~~~~~~~ 160 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRA---DNTLVAVKSCRET-----------------------------LPPDLKAKFL 160 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETT---TCCEEEEEECCTT-----------------------------SCHHHHTTTT
T ss_pred hHHeEEeeEeccCCCCeEEEEEEec---CCeEEEEEEcccc-----------------------------CCHHHHHHHH
Confidence 4689999999999999999999876 7899999998642 2233445688
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|+++. ||||+++++++.+.+.+|+|||||++|+|.+++...+..+++..+..++.||+.||.|||++||+||||
T Consensus 161 ~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDl 239 (377)
T 3cbl_A 161 QEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239 (377)
T ss_dssp HHHHHHTTCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHhCC-CCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCccc
Confidence 9999999996 999999999999999999999999999999999877667999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcc---cccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERL---NDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~---~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
||+|||+ +.++.+||+|||+++........ ....+++.|+|||++. +.++.++|||||||++|||++ |..||
T Consensus 240 kp~Nil~---~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~ 316 (377)
T 3cbl_A 240 AARNCLV---TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPY 316 (377)
T ss_dssp SGGGEEE---CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CHHHEEE---cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999 66788999999999865432211 1223577899999886 568999999999999999998 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+....+....+..... .+. ...+++++.+||.+||+.||.+|||++++++
T Consensus 317 ~~~~~~~~~~~~~~~~~-~~~--~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 317 PNLSNQQTREFVEKGGR-LPC--PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp TTSCHHHHHHHHHTTCC-CCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCC-CCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 99888777776665432 221 2358899999999999999999999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=375.34 Aligned_cols=258 Identities=25% Similarity=0.363 Sum_probs=213.9
Q ss_pred ccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++++.||+|+||.||+|++... ..++..||||++... ......+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~ 94 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-----------------------------ADSSEREA 94 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------------------------------CHH
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccc-----------------------------cCHHHHHH
Confidence 47899999999999999999998532 125678999998643 12223467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCC----------------------CCCHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGG----------------------KYSEEDA 255 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------~l~~~~~ 255 (482)
+.+|+.+++++.+||||+++++++.+.+..|+|||||++|+|.+++..... .+++..+
T Consensus 95 ~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 174 (344)
T 1rjb_A 95 LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDL 174 (344)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHH
T ss_pred HHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHH
Confidence 899999999995599999999999999999999999999999999876532 3799999
Q ss_pred HHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccC
Q 011582 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSY 331 (482)
Q Consensus 256 ~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~ 331 (482)
+.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........ .....||+.|+|||++. +.+
T Consensus 175 ~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 251 (344)
T 1rjb_A 175 LCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY 251 (344)
T ss_dssp HHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCCcccCCCChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC
Confidence 9999999999999999999999999999999 5677899999999986643322 23456788999999885 569
Q ss_pred CCcchhhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCc
Q 011582 332 GTEADMWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410 (482)
Q Consensus 332 ~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 410 (482)
+.++|||||||++|+|+| |..||.+......+..+......... ...+++++.+||.+||..||.+|||+.++++|-
T Consensus 252 ~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 252 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 999999999999999998 99999888766666666555433322 245899999999999999999999999999865
Q ss_pred c
Q 011582 411 W 411 (482)
Q Consensus 411 ~ 411 (482)
.
T Consensus 330 ~ 330 (344)
T 1rjb_A 330 G 330 (344)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=362.09 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=208.4
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++.. +|+.||||++..... ..+ .......+.+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~---------~~~--------------~~~~~~~~~~ 70 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVK---DKSVVAIKSLILGDS---------EGE--------------TEMIEKFQEF 70 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETT---TCCEEEEEECCCCTT---------TCC--------------HHHHCCSHHH
T ss_pred hhccceehhccccCCceeEEEEEEcC---CceEEEEEEeecccc---------ccc--------------hhHHHHHHHH
Confidence 35789999999999999999999976 799999999865310 000 0000112678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG--VVH 276 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivH 276 (482)
.+|+.+++++. ||||+++++++.+.. ++||||+++|+|.+++......+++..+..++.|++.||.|||++| |+|
T Consensus 71 ~~E~~~l~~l~-h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH 147 (287)
T 4f0f_A 71 QREVFIMSNLN-HPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVH 147 (287)
T ss_dssp HHHHHHHTTCC-CTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBC
T ss_pred HHHHHHHHhCC-CCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeec
Confidence 99999999996 999999999987665 7999999999999999877778999999999999999999999999 999
Q ss_pred cCCCCCceEEecCC--CCCcEEEEecccccccCCCCcccccccCccccCccccc---ccCCCcchhhhhHHHHHHHhhCC
Q 011582 277 RDLKPENFLFTSKE--ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH---RSYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 277 rDlkp~NIll~~~~--~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwSlGvil~elltg~ 351 (482)
|||||+|||++.++ ....+||+|||++.... .......||+.|+|||++. ..++.++|||||||++|+|++|.
T Consensus 148 ~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~ 225 (287)
T 4f0f_A 148 RDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE 225 (287)
T ss_dssp SCCSGGGEEESCCCTTCSCCEEECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CCCCcceEEEeccCCCCceeEEeCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCC
Confidence 99999999995322 12239999999998543 3345678999999999983 34788999999999999999999
Q ss_pred CCCCCCChHHH--HHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 352 RPFWARTESGI--FRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 352 ~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.||........ ...+...... ......+++++.+||.+||+.||.+|||++++++
T Consensus 226 ~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 226 GPFDEYSYGKIKFINMIREEGLR--PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp CTTTTCCCCHHHHHHHHHHSCCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccccccHHHHHHHHhccCCC--CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99987654443 4444443322 2233568999999999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=372.46 Aligned_cols=265 Identities=19% Similarity=0.253 Sum_probs=219.2
Q ss_pred cccccceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
+...++|++++.||+|+||.||+|++.. ...+|..||||++... .....
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~ 76 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV-----------------------------CSEQD 76 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS-----------------------------CCHHH
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc-----------------------------cchhh
Confidence 3456789999999999999999998532 1226889999998542 23345
Q ss_pred HHHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC------CCCCHHHHHHHHHHHHHHHHH
Q 011582 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG------GKYSEEDAKIVMVQILSVVAF 268 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~------~~l~~~~~~~i~~qi~~~L~y 268 (482)
...+.+|+.+++++. ||||+++++++.+.+..|+||||+++++|.+++.... ..+++..++.++.||+.||.|
T Consensus 77 ~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~ 155 (327)
T 2yfx_A 77 ELDFLMEALIISKFN-HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155 (327)
T ss_dssp HHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhCC-CCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHH
Confidence 567899999999996 9999999999999999999999999999999987653 358999999999999999999
Q ss_pred HHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchhhhhHHHH
Q 011582 269 CHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIA 344 (482)
Q Consensus 269 LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil 344 (482)
||++||+||||||+|||++.++.+..+||+|||++....... ......||+.|+|||++. +.++.++|||||||++
T Consensus 156 LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 235 (327)
T 2yfx_A 156 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235 (327)
T ss_dssp HHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHH
Confidence 999999999999999999755566789999999997653322 223457899999999885 5689999999999999
Q ss_pred HHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 345 YILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 345 ~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
|+|++ |..||......+....+....... ....+++++.+||.+||+.||.+||++.++++|.|+..
T Consensus 236 ~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 236 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHTTSCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCcCHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 99998 999999988888887777654322 22458999999999999999999999999999988753
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=367.18 Aligned_cols=255 Identities=21% Similarity=0.326 Sum_probs=211.4
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|++.. +|+.||||++.... ..+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--------------------------------~~~~ 51 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRS--------------------------------DAPQ 51 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCT--------------------------------TSCC
T ss_pred ccccceEEEEEEeecCCEEEEEEEECC---CCcEEEEEEeccCC--------------------------------ccHH
Confidence 456789999999999999999999876 79999999986430 1134
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+.+|+|++++++++.+....|+||||+ +++|.+++...+..+++..+..++.||+.||.|||++||+||
T Consensus 52 ~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 130 (298)
T 1csn_A 52 LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYR 130 (298)
T ss_dssp HHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECC
T ss_pred HHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence 6789999999977999999999999999999999999 999999998766679999999999999999999999999999
Q ss_pred CCCCCceEEecC--CCCCcEEEEecccccccCCCC--------cccccccCccccCcccccc-cCCCcchhhhhHHHHHH
Q 011582 278 DLKPENFLFTSK--EENSSLKAIDFGLSDYVKPDE--------RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYI 346 (482)
Q Consensus 278 Dlkp~NIll~~~--~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~e 346 (482)
||||+|||++.+ +....+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+
T Consensus 131 Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 210 (298)
T 1csn_A 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 210 (298)
T ss_dssp CCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHH
Confidence 999999999532 123349999999998765432 2345679999999999865 58999999999999999
Q ss_pred HhhCCCCCCCC---ChHHHHHHHHhcCCCCC-CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 347 LLCGSRPFWAR---TESGIFRAVLKADPSFD-EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 347 lltg~~pf~~~---~~~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|++|+.||.+. ...+.+..+.......+ ......+++++.+||.+||+.||.+||+++++++
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 211 FLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 99999999874 34444444443322111 1122468999999999999999999999999865
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=359.96 Aligned_cols=253 Identities=23% Similarity=0.322 Sum_probs=212.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|++.....++..||||++.+. ......+.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~~~ 61 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD-----------------------------CTLDNKEKFM 61 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTT-----------------------------SCHHHHHHHH
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccc-----------------------------cCchHHHHHH
Confidence 46899999999999999999998764445567999998653 2334567899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. ||||+++++++.+ +..|+||||+++++|.+++......+++..+..++.|++.||.|||++||+||||
T Consensus 62 ~E~~~l~~l~-h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl 139 (281)
T 3cc6_A 62 SEAVIMKNLD-HPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDI 139 (281)
T ss_dssp HHHHHHHHHC-CTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHHHHhCC-CCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 9999999996 9999999999865 4568999999999999999877677999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
||+|||++ .++.+||+|||++....... ......+|+.|+|||++. ..++.++||||||+++|+|++ |+.||.
T Consensus 140 kp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~ 216 (281)
T 3cc6_A 140 AVRNILVA---SPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216 (281)
T ss_dssp SGGGEEEE---ETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred ccceEEEC---CCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcc
Confidence 99999994 56789999999998765432 223456788999999886 468999999999999999998 999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.....+....+....... ....+++++.+||.+||..||.+|||+.+++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 217 WLENKDVIGVLEKGDRLP---KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TSCGGGHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCChHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 887777777766654321 123589999999999999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=371.46 Aligned_cols=250 Identities=20% Similarity=0.286 Sum_probs=205.2
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceE----EEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDV----AVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~v----AvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.++|++.+.||+|+||.||+|++.. +|+.+ |+|.+... ......
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~~vaiK~~~~~-----------------------------~~~~~~ 61 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREA-----------------------------TSPKAN 61 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC-------CCEEEEEEEC------------------------------------CH
T ss_pred HHHcccceEEeeCCCeEEEEEEEcC---CCceEEEEEEEeecccc-----------------------------cCHHHH
Confidence 4689999999999999999999865 55554 66665331 122345
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
+.+.+|+.+++++. ||||+++++++.+.+ .++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+
T Consensus 62 ~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~iv 139 (327)
T 3poz_A 62 KEILDEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 139 (327)
T ss_dssp HHHHHHHHHHHHCC-BTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHhCC-CCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 67899999999997 999999999998755 7899999999999999988778899999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-C
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-G 350 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g 350 (482)
||||||+|||+ +.++.+||+|||+++....... .....||+.|+|||++. +.++.++|||||||++|+|++ |
T Consensus 140 H~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g 216 (327)
T 3poz_A 140 HRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFG 216 (327)
T ss_dssp CSCCCGGGEEE---EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCCCChheEEE---CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcC
Confidence 99999999999 4567899999999987654332 23345788999999886 468999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
..||.+....++...+...... . ....++.++.+||.+||+.||.+||++.+++++
T Consensus 217 ~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 217 SKPYDGIPASEISSILEKGERL-P--QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCTTTTCCGGGHHHHHHTTCCC-C--CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCCccCCCHHHHHHHHHcCCCC-C--CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9999988887777666654322 2 224589999999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=367.12 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=216.1
Q ss_pred ccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|.+++.||+|+||.||+|++... ..+|..||||++... ......+.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~ 72 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN-----------------------------ASPSELRD 72 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT-----------------------------CCHHHHHH
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC-----------------------------CCHHHHHH
Confidence 47899999999999999999988431 225689999998643 23445678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-----------------------CCCCHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-----------------------GKYSEED 254 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~ 254 (482)
+.+|+.+++.+. ||||+++++++.+.+..|+||||+++++|.+++.... ..+++..
T Consensus 73 ~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 151 (314)
T 2ivs_A 73 LLSEFNVLKQVN-HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGD 151 (314)
T ss_dssp HHHHHHHHTTCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHH
T ss_pred HHHHHHHHhhCC-CCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHH
Confidence 899999999996 9999999999999999999999999999999987642 2389999
Q ss_pred HHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-c
Q 011582 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-S 330 (482)
Q Consensus 255 ~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~ 330 (482)
++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........ .....||+.|+|||++.+ .
T Consensus 152 ~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 228 (314)
T 2ivs_A 152 LISFAWQISQGMQYLAEMKLVHRDLAARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI 228 (314)
T ss_dssp HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE
T ss_pred HHHHHHHHHHHHHHHHHCCCcccccchheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCC
Confidence 99999999999999999999999999999999 4677899999999987654322 234567889999998864 5
Q ss_pred CCCcchhhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 331 YGTEADMWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 331 ~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
++.++|||||||++|+|++ |..||.+.....+...+...... .....+++++.+||.+||+.||.+|||+.+++++
T Consensus 229 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 229 YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 8999999999999999999 99999998888877777665422 2234689999999999999999999999999864
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=364.10 Aligned_cols=254 Identities=24% Similarity=0.365 Sum_probs=205.1
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|++.. +|+.||||++.+. ........+.+
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vaiK~~~~~---------------------------~~~~~~~~~~~ 81 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTV---RERIVALKLMSET---------------------------LSSDPVFRTRM 81 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETT---TTEEEEEEECGGG---------------------------GGGSHHHHHHH
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcC---CCeEEEEEecCcc---------------------------cccCHHHHHHH
Confidence 35789999999999999999999876 7899999998653 11234456789
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++++. ||||+++++++.+++..|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+|||
T Consensus 82 ~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 159 (309)
T 2h34_A 82 QREARTAGRLQ-EPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDAAHAAGATHRD 159 (309)
T ss_dssp HHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHhhcC-CCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCC
Confidence 99999999996 999999999999999999999999999999988654 5799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||+|||+ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.
T Consensus 160 lkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (309)
T 2h34_A 160 VKPENILV---SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQ 236 (309)
T ss_dssp CCGGGEEE---CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSC
T ss_pred CChHHEEE---cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCC
Confidence 99999999 567789999999997764432 2345679999999998864 58999999999999999999999998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-CHHHHhc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-TAAQALS 408 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-s~~e~L~ 408 (482)
+.....+.. .............+.+++++.+||.+||+.||.+|| +++++++
T Consensus 237 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 237 GDQLSVMGA-HINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp SCHHHHHHH-HHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CchHHHHHH-HhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 876654443 344433333344567999999999999999999999 7887765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=370.76 Aligned_cols=254 Identities=23% Similarity=0.327 Sum_probs=211.7
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceE--EEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDV--AVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~v--AvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.-.++|++.+.||+|+||.||+|++.. +|..+ |||++... ......
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~~~v~iK~~~~~-----------------------------~~~~~~ 69 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY-----------------------------ASKDDH 69 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC-----------------------------------
T ss_pred ccHHHccceeeeecCCCceEEEEEEcc---CCcccceeeeeeccc-----------------------------cchHHH
Confidence 345789999999999999999999887 67655 99988642 122334
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHH
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMV 260 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ 260 (482)
+.+.+|+.+++++.+||||+++++++.+.+..|+||||+++++|.+++.... ..+++..++.++.
T Consensus 70 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 149 (327)
T 1fvr_A 70 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149 (327)
T ss_dssp CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHH
Confidence 5788999999999559999999999999999999999999999999886543 4799999999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhh
Q 011582 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWS 339 (482)
Q Consensus 261 qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwS 339 (482)
||+.||.|||++||+||||||+|||+ +.++.+||+|||++.............+|+.|+|||++.+ .++.++||||
T Consensus 150 qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 226 (327)
T 1fvr_A 150 DVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWS 226 (327)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHH
T ss_pred HHHHHHHHHHhCCccCCCCccceEEE---cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchH
Confidence 99999999999999999999999999 5667899999999975443333344567899999998864 5899999999
Q ss_pred hHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 340 IGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 340 lGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|||++|+|++ |..||.+....++...+...... .....+++++.+||.+||..||.+|||+++++++
T Consensus 227 lG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 227 YGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC---CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999998 99999999888887776654221 2224589999999999999999999999999975
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=365.70 Aligned_cols=242 Identities=32% Similarity=0.597 Sum_probs=197.1
Q ss_pred ccccceEec-ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 118 QFVAHYELG-EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 118 ~~~~~y~~~-~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
.+.++|.+. +.||+|+||.||+|.+.. +|+.||||++... .
T Consensus 14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----------------------------------~ 55 (299)
T 3m2w_A 14 AIIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC-----------------------------------P 55 (299)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS-----------------------------------H
T ss_pred ccccchhhcCcccccCCCeEEEEEEEcC---CCcEEEEEEeccc-----------------------------------H
Confidence 456778887 779999999999999876 7999999998642 3
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
.+.+|+.++.++.+||||+++++++.. .+.+|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||+
T Consensus 56 ~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 135 (299)
T 3m2w_A 56 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 135 (299)
T ss_dssp HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 567899998666569999999999987 778999999999999999987653 469999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCC
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~ 351 (482)
+||+||||||+|||++..+.++.+||+|||++..... ..|+.++|||||||++|+|++|.
T Consensus 136 ~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~--------------------~~~~~~~DiwslG~il~el~tg~ 195 (299)
T 3m2w_A 136 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG--------------------EKYDKSCDMWSLGVIMYILLCGY 195 (299)
T ss_dssp TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT--------------------CGGGGHHHHHHHHHHHHHHHHSS
T ss_pred CCcccCCCCHHHEEEecCCCCCcEEEecccccccccc--------------------ccCCchhhHHHHHHHHHHHHHCC
Confidence 9999999999999997544478899999999865431 34678999999999999999999
Q ss_pred CCCCCCChHHHHHHHH----hcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 352 RPFWARTESGIFRAVL----KADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.||.+.........+. .....++...+..+++++.+||.+||+.||.+|||+.++|+||||.+...
T Consensus 196 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 196 PPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp CSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred CCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 9997765543322111 11112222223568999999999999999999999999999999987654
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=378.34 Aligned_cols=253 Identities=24% Similarity=0.376 Sum_probs=205.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|+++....++..||||+++.. ......+.+.
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~-----------------------------~~~~~~~~~~ 94 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG-----------------------------YTEKQRRDFL 94 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT-----------------------------CCHHHHHHHH
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc-----------------------------cCHHHHHHHH
Confidence 46899999999999999999998743336788999998642 2334567899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++++. ||||+++++++.+.+..|+|||||++|+|.+++...+..+++.++..++.||+.||.|||++||+||||
T Consensus 95 ~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dl 173 (373)
T 2qol_A 95 GEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDL 173 (373)
T ss_dssp HHHHHHTTCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHHHHHhCC-CCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCC
Confidence 9999999996 999999999999999999999999999999999776678999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRP 353 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~p 353 (482)
||+|||+ +.++.+||+|||+++....... .....+|+.|+|||++. +.++.++|||||||++|||++ |+.|
T Consensus 174 kp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P 250 (373)
T 2qol_A 174 AARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250 (373)
T ss_dssp CGGGEEE---CTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CT
T ss_pred CcceEEE---cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCC
Confidence 9999999 6778899999999987654321 12234578899999886 569999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|......++...+..... . .....++.++.+||.+||+.||.+||++.++++
T Consensus 251 ~~~~~~~~~~~~i~~~~~-~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 251 YWEMSNQDVIKAVDEGYR-L--PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp TTTCCHHHHHHHHHTTEE-C--CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCC-C--CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 999888888877765432 1 122358899999999999999999999999886
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=357.59 Aligned_cols=253 Identities=27% Similarity=0.377 Sum_probs=202.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|.+ .|+.||||++.... ........+.+.
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~~--------------------------~~~~~~~~~~~~ 54 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-----IGDEVAVKAARHDP--------------------------DEDISQTIENVR 54 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-----TTEEEEEEEC------------------------------------CHHHHH
T ss_pred hhheeeeeeeccCCCeEEEEEEE-----cCCeEEEEEEecCC--------------------------cccHHHHHHHHH
Confidence 46899999999999999999986 47899999986531 001123356789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG---VVH 276 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---ivH 276 (482)
+|+.+++.++ ||||+++++++.+.+..|+||||+++++|.+++. ...+++..++.++.|++.||.|||++| |+|
T Consensus 55 ~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H 131 (271)
T 3dtc_A 55 QEAKLFAMLK-HPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIH 131 (271)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCC
T ss_pred HHHHHHHhcC-CCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceee
Confidence 9999999997 9999999999999999999999999999988763 357999999999999999999999999 999
Q ss_pred cCCCCCceEEecCC-----CCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhC
Q 011582 277 RDLKPENFLFTSKE-----ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 277 rDlkp~NIll~~~~-----~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg 350 (482)
|||||+|||++... .++.+||+|||++....... .....||+.|+|||++.+ .++.++||||||+++|+|++|
T Consensus 132 ~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 210 (271)
T 3dtc_A 132 RDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210 (271)
T ss_dssp SCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHC
T ss_pred cCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999996322 26789999999998765433 335689999999998864 589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
+.||.+.........+......... ...+++++.+||.+||+.||.+|||+.+++++
T Consensus 211 ~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 211 EVPFRGIDGLAVAYGVAMNKLALPI--PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCTTTTSCHHHHHHHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHhhhcCCCCCCC--CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 9999998888777777666544332 24589999999999999999999999999874
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=378.37 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=208.5
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|++.. +|+.||||++.+. ....+.+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-------------------------------~~~~~~~~ 63 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGD-------------------------------KVYTEAAE 63 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC-------------------------------HHHHHHHH
T ss_pred CCeEEEEEeeeecCCeEEEEEEecC---CCcEEEEEEecCC-------------------------------ccchhhhh
Confidence 4689999999999999999999876 7999999998542 22346678
Q ss_pred HHHHHHHhhc----------CCCCcceeeEEEEeCC----eEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHH
Q 011582 200 REVKILRALT----------GHKNLVQFYDAYEDDD----NIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILS 264 (482)
Q Consensus 200 ~Ei~~l~~l~----------~hpniv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~ 264 (482)
+|+.+++++. +||||+++++++...+ .+++||||+ +++|.+++... ...+++..++.++.||+.
T Consensus 64 ~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~ 142 (373)
T 1q8y_A 64 DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142 (373)
T ss_dssp HHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHH
Confidence 9999998875 2789999999998754 789999999 88999988764 356999999999999999
Q ss_pred HHHHHHHC-CCcccCCCCCceEEecC---CCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhh
Q 011582 265 VVAFCHFQ-GVVHRDLKPENFLFTSK---EENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWS 339 (482)
Q Consensus 265 ~L~yLH~~-~ivHrDlkp~NIll~~~---~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwS 339 (482)
||.|||++ ||+||||||+|||++.. +..+.+||+|||++..... .....+||+.|+|||++.+ .++.++||||
T Consensus 143 aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s 220 (373)
T 1q8y_A 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWS 220 (373)
T ss_dssp HHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHH
T ss_pred HHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHH
Confidence 99999998 99999999999999642 2345799999999987643 3445689999999998865 5899999999
Q ss_pred hHHHHHHHhhCCCCCCCCC------hHHHHHHHHhcCCCCCC--------------------------------------
Q 011582 340 IGVIAYILLCGSRPFWART------ESGIFRAVLKADPSFDE-------------------------------------- 375 (482)
Q Consensus 340 lGvil~elltg~~pf~~~~------~~~~~~~i~~~~~~~~~-------------------------------------- 375 (482)
|||++|+|++|..||.... ....+..+.......+.
T Consensus 221 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (373)
T 1q8y_A 221 TACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY 300 (373)
T ss_dssp HHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTT
T ss_pred HHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcc
Confidence 9999999999999997654 23333333321111110
Q ss_pred CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 376 APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 376 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.....+++++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 301 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 301 KFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp CCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred cCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 00012467889999999999999999999999999998754
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-46 Score=366.29 Aligned_cols=257 Identities=25% Similarity=0.370 Sum_probs=211.6
Q ss_pred cccceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..++|++++.||+|+||.||+|++.. ...+|+.||||++.+. ......+
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~ 75 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-----------------------------ATHSEHR 75 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-----------------------------CCHHHHH
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccC-----------------------------CCcHHHH
Confidence 35789999999999999999998753 2236789999998653 2334456
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCC-eEEEEEecCCCCChHHHHHhcCCC---------------CCHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDD-NIYIVMELCKGGELLDRILSRGGK---------------YSEEDAKIVMV 260 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~---------------l~~~~~~~i~~ 260 (482)
.+.+|+.+++++.+||||+++++++...+ .+|+|||||++++|.+++...... +++..++.++.
T Consensus 76 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (316)
T 2xir_A 76 ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155 (316)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHH
T ss_pred HHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHH
Confidence 78999999999966999999999988755 599999999999999998765322 89999999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcch
Q 011582 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEAD 336 (482)
Q Consensus 261 qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~D 336 (482)
||+.||.|||++||+||||||+|||+ +.++.+||+|||++........ .....||+.|+|||++. ..++.++|
T Consensus 156 qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~D 232 (316)
T 2xir_A 156 QVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSD 232 (316)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHhCCcccccCccceEEE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhH
Confidence 99999999999999999999999999 5667899999999987644322 23456889999999886 46899999
Q ss_pred hhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 337 MWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 337 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||||||++|+|++ |..||.+....+.+............ ...+++++.++|.+||+.||.+|||+.++++|
T Consensus 233 i~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 233 VWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCC--CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999998 99999887654444333333322222 23489999999999999999999999999876
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=372.19 Aligned_cols=258 Identities=28% Similarity=0.477 Sum_probs=212.5
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
+.+.++|++++.||+|+||.||+|++.. +|+.||||++.+....... .....+
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~------------------------~~~~~~ 91 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDWG------------------------ELPNGT 91 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETT---TTEEEEEEEEEGGGCCCEE------------------------ECTTCC
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEEecccchhhh------------------------hhhhhh
Confidence 3456789999999999999999999876 7999999999764110000 000112
Q ss_pred HHHHHHHHHHhhc-CCCCcceeeEEEEeCCeEEEEEecCCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011582 197 DVRREVKILRALT-GHKNLVQFYDAYEDDDNIYIVMELCKG-GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGV 274 (482)
Q Consensus 197 ~~~~Ei~~l~~l~-~hpniv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i 274 (482)
.+.+|+.+++++. +|+||+++++++.+.+..++|||++.+ ++|.+++... +.+++..++.++.||+.||.|||++||
T Consensus 92 ~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~i 170 (320)
T 3a99_A 92 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGV 170 (320)
T ss_dssp EEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 4568999999997 369999999999999999999999976 8999988664 679999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-c-CCCcchhhhhHHHHHHHhhCCC
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-S-YGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlGvil~elltg~~ 352 (482)
+||||||+|||++ .+++.+||+|||++..... .......||+.|+|||++.+ . ++.++|||||||++|+|++|..
T Consensus 171 vH~Dlkp~NIll~--~~~~~~kL~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~ 247 (320)
T 3a99_A 171 LHRDIKDENILID--LNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247 (320)
T ss_dssp ECCCCSGGGEEEE--TTTTEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred EeCCCCHHHEEEe--CCCCCEEEeeCcccccccc-ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCC
Confidence 9999999999994 2567899999999987653 33455689999999998864 3 4678999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
||.... .+......+. ..+++++.+||.+||+.||.+|||++++++||||++.
T Consensus 248 pf~~~~------~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 248 PFEHDE------EIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp SCCSHH------HHHHCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCChh------hhhccccccc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 996532 2333333222 3589999999999999999999999999999999865
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=361.00 Aligned_cols=254 Identities=26% Similarity=0.491 Sum_probs=201.0
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|.+.. +|+.||||++... ........+.+
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~---------------------------~~~~~~~~~~~ 79 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLL---DGVPVALKKVQIF---------------------------DLMDAKARADC 79 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETT---TCCEEEEEEECTT---------------------------SSCCHHHHHHH
T ss_pred cccceEEEEeecCCCCceEEEEEEcC---CCceEEEEeeehh---------------------------hccCHHHHHHH
Confidence 35689999999999999999999876 7999999998642 11234556788
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
.+|+.+++++. ||||+++++++.+.+..++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+
T Consensus 80 ~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~ 158 (310)
T 2wqm_A 80 IKEIDLLKQLN-HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVM 158 (310)
T ss_dssp HHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHhCC-CCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 99999999996 99999999999999999999999999999998864 346799999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~p 353 (482)
||||||+|||+ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++||||||+++|+|++|..|
T Consensus 159 H~dl~p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 235 (310)
T 2wqm_A 159 HRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 235 (310)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCCcHHHEEE---cCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 567889999999998764432 2345679999999998864 589999999999999999999999
Q ss_pred CCCCC--hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 354 FWART--ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 354 f~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|.+.. .......+.... ++......+++++.+||.+||..||.+|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 236 FYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp TC---CCHHHHHHHHHTTC--SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccchhHHHHHHHhhccc--CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 97653 334444444433 333334568999999999999999999999999876
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-46 Score=363.54 Aligned_cols=253 Identities=22% Similarity=0.321 Sum_probs=202.8
Q ss_pred cccceEecceeecCCceEEEEEEEec-CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKK-GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~-~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
..++|++++.||+|+||.||+|+... ...+|+.||||++.. ......+.
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~------------------------------~~~~~~~~ 57 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH------------------------------STEEHLRD 57 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESC------------------------------CCHHHHHH
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEccc------------------------------CCHHHHHH
Confidence 45789999999999999999998432 122689999999854 23445678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
+.+|+.++++++ ||||+++++++.. ...+++|||||++|+|.+++......+++..+..++.||+.||.|||++||+
T Consensus 58 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 136 (295)
T 3ugc_A 58 FEREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYI 136 (295)
T ss_dssp HHHHHHHHHTCC-CTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHhCC-CCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcc
Confidence 899999999997 9999999999865 3568999999999999999987666799999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCC----cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg 350 (482)
||||||+|||+ +.++.+||+|||++....... ......||..|+|||++. ..++.++|||||||++|+|++|
T Consensus 137 H~Dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g 213 (295)
T 3ugc_A 137 HRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTY 213 (295)
T ss_dssp CSCCSGGGEEE---EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred cCCCCHhhEEE---cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhc
Confidence 99999999999 456789999999998765432 123345788899999886 4689999999999999999999
Q ss_pred CCCCCCCChH----------------HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 351 SRPFWARTES----------------GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 351 ~~pf~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
..||...... .....+. ..... .....+++++.+||.+||+.||.+|||+.++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 214 IEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK-NNGRL--PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp TCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH-TTCCC--CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCCChHHHHhhhcCccccchhHHHHHHHHh-ccCcC--CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9998543221 1122222 22222 223468999999999999999999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=382.60 Aligned_cols=258 Identities=29% Similarity=0.425 Sum_probs=200.0
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..+.+.|.+.+.||+|+||+||.+... +|+.||||++... ..+
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~~~~----~g~~vAvK~~~~~---------------------------------~~~ 53 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQGSF----QGRPVAVKRMLID---------------------------------FCD 53 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEEEES----SSSEEEEEEEEGG---------------------------------GHH
T ss_pred hhhhheeeccCeEeeCCCeEEEEEEEE----CCeEEEEEEEcHH---------------------------------HHH
Confidence 344567888899999999999875432 6999999998542 124
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGK------YSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~------l~~~~~~~i~~qi~~~L~yLH 270 (482)
.+.+|+.+|+++.+||||+++++++.+++.+|||||||+ |+|.+++...... .++..++.++.||+.||.|||
T Consensus 54 ~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 132 (434)
T 2rio_A 54 IALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132 (434)
T ss_dssp HHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH
Confidence 567899999987569999999999999999999999996 5999988654211 133356789999999999999
Q ss_pred HCCCcccCCCCCceEEecC----------CCCCcEEEEecccccccCCCC-----cccccccCccccCccccc-------
Q 011582 271 FQGVVHRDLKPENFLFTSK----------EENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLH------- 328 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~~----------~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~------- 328 (482)
++||+||||||+|||++.. +.+..+||+|||++....... .....+||+.|+|||++.
T Consensus 133 ~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 212 (434)
T 2rio_A 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQT 212 (434)
T ss_dssp HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSC
T ss_pred HCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccccc
Confidence 9999999999999999643 245689999999998765432 223568999999999885
Q ss_pred -ccCCCcchhhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCC---CCCCCHHHHHHHHHhchhccccCCCH
Q 011582 329 -RSYGTEADMWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAP---WPSLSPEAIDFVKRLLNKDYRKRLTA 403 (482)
Q Consensus 329 -~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~ 403 (482)
..++.++|||||||++|+|++ |..||......+ ..+........... ...+++++.+||.+||+.||.+|||+
T Consensus 213 ~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 290 (434)
T 2rio_A 213 KRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTA 290 (434)
T ss_dssp CCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCH
T ss_pred ccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCH
Confidence 358899999999999999999 999997665443 34555444333221 12346889999999999999999999
Q ss_pred HHHhcCccccc
Q 011582 404 AQALSHPWLAN 414 (482)
Q Consensus 404 ~e~L~hp~~~~ 414 (482)
.++|+||||+.
T Consensus 291 ~eil~hp~f~~ 301 (434)
T 2rio_A 291 MKVLRHPLFWP 301 (434)
T ss_dssp HHHHTSGGGSC
T ss_pred HHHHhCCccCC
Confidence 99999999975
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=366.58 Aligned_cols=255 Identities=23% Similarity=0.372 Sum_probs=215.4
Q ss_pred ccceEecceeecCCceEEEEEEEecC----CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG----SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~----~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.++|++++.||+|+||.||+|++... ..++..||||++... ......
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~ 84 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD-----------------------------ATEKDL 84 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT-----------------------------CCHHHH
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC-----------------------------CcHHHH
Confidence 47899999999999999999997531 125788999998653 233456
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHH
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMV 260 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~ 260 (482)
+.+.+|+.+++++.+||||+++++++.+.+.+|+||||+++|+|.+++.... ..+++..++.++.
T Consensus 85 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 164 (334)
T 2pvf_A 85 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTY 164 (334)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHH
Confidence 7889999999999559999999999999999999999999999999987543 2489999999999
Q ss_pred HHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcch
Q 011582 261 QILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEAD 336 (482)
Q Consensus 261 qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~D 336 (482)
||+.||.|||++||+||||||+|||+ +.++.+||+|||++........ .....+|+.|+|||++. ..++.++|
T Consensus 165 qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 241 (334)
T 2pvf_A 165 QLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241 (334)
T ss_dssp HHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHH
T ss_pred HHHHHHHHHHhCCeeCCCCccceEEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHH
Confidence 99999999999999999999999999 5678899999999987654322 23446788999999886 45899999
Q ss_pred hhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 337 MWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 337 iwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||||||++|+|++ |..||.+....++...+...... .....+++++.+||.+||..||.+|||+.+++++
T Consensus 242 i~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999 99999999888888877766432 1224589999999999999999999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=365.97 Aligned_cols=255 Identities=18% Similarity=0.284 Sum_probs=216.6
Q ss_pred cccceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..++|++.+.||+|+||.||+|++.. ...+++.||||++... .......
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~-----------------------------~~~~~~~ 73 (322)
T 1p4o_A 23 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-----------------------------ASMRERI 73 (322)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-----------------------------SCHHHHH
T ss_pred hhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc-----------------------------cCHHHHH
Confidence 45789999999999999999998762 1125788999998643 2234456
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------GKYSEEDAKIVMVQILSVVA 267 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~ 267 (482)
.+.+|+.+++.+. ||||+++++++.+.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||.
T Consensus 74 ~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~ 152 (322)
T 1p4o_A 74 EFLNEASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 152 (322)
T ss_dssp HHHHHHHHGGGCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHhcC-CCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHH
Confidence 7899999999996 9999999999999999999999999999999886532 45799999999999999999
Q ss_pred HHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchhhhhHHH
Q 011582 268 FCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVI 343 (482)
Q Consensus 268 yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvi 343 (482)
|||++||+||||||+|||+ +.++.+||+|||++....... ......||+.|+|||++. +.++.++|||||||+
T Consensus 153 ~lH~~~i~H~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 229 (322)
T 1p4o_A 153 YLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVV 229 (322)
T ss_dssp HHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHH
T ss_pred HHHHCCCccCCCccceEEE---cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHH
Confidence 9999999999999999999 567889999999998654332 123446789999999886 468999999999999
Q ss_pred HHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 344 AYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 344 l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
+|+|++ |..||.+....+....+....... ....+++++.+||.+||+.||.+|||+.++++|
T Consensus 230 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 230 LWEIATLAEQPYQGLSNEQVLRFVMEGGLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCccccCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999 899999988888888777654321 224589999999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=372.89 Aligned_cols=250 Identities=21% Similarity=0.301 Sum_probs=206.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCce----EEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQD----VAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~----vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.++|++.+.||+|+||.||+|++.. +|+. ||+|++.... .....
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~kv~~K~~~~~~-----------------------------~~~~~ 59 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIP---EGESIKIPVCIKVIEDKS-----------------------------GRQSF 59 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECC---TTCSCCEEEEEEEECCTT-----------------------------SCSCB
T ss_pred HhHceeeeeeeecCCceEEEEEEcC---CCceEEEEEEEEeccccc-----------------------------cHHHH
Confidence 4689999999999999999999876 5665 5666553210 00111
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
..+.+|+.+++.+. ||||+++++++. ++..++||||+.+|+|.+++....+.+++..+..++.||+.||.|||++||+
T Consensus 60 ~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 137 (325)
T 3kex_A 60 QAVTDHMLAIGSLD-HAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137 (325)
T ss_dssp CSCCHHHHHHHTCC-CTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHhcCC-CCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 24568999999996 999999999886 5668999999999999999877667899999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-C
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-G 350 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g 350 (482)
||||||+|||+ +.++.+||+|||+++...... ......||..|+|||++. +.++.++|||||||++|+|++ |
T Consensus 138 H~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g 214 (325)
T 3kex_A 138 HRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFG 214 (325)
T ss_dssp CSCCSSTTEEE---SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CCccchheEEE---CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCC
Confidence 99999999999 567889999999998765432 234567888999999886 569999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
..||.+....++...+........ ...+++++.+||.+||..||.+|||+.+++++
T Consensus 215 ~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 215 AEPYAGLRLAEVPDLLEKGERLAQ---PQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CCTTTTSCTTHHHHHHHTTCBCCC---CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCCccccCHHHHHHHHHcCCCCCC---CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999888888777766543221 12478899999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=359.29 Aligned_cols=253 Identities=23% Similarity=0.402 Sum_probs=199.0
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
+...++|++.+.||+|+||.||+|+.. ..||||+++.. .......+
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~------~~vavK~~~~~----------------------------~~~~~~~~ 65 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVT----------------------------APTPQQLQ 65 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESS------SEEEEEEESCS----------------------------SCCHHHHH
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEc------CceEEEEEecc----------------------------CCCHHHHH
Confidence 344578999999999999999999753 35999998643 13345567
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+.+++.+. ||||+++++++ ..+..++|||||++++|.+++......+++..+..++.||+.||.|||++||+|
T Consensus 66 ~~~~E~~~l~~l~-h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H 143 (289)
T 3og7_A 66 AFKNEVGVLRKTR-HVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIH 143 (289)
T ss_dssp HHHHHHHHHTTCC-CTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhCC-CCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 8999999999997 99999999954 566789999999999999988766678999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCC---CCcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhh
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKP---DERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~---~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~ellt 349 (482)
|||||+|||+ +.++.+||+|||++..... ........||+.|+|||++. ..++.++|||||||++|+|++
T Consensus 144 ~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~ 220 (289)
T 3og7_A 144 RDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMT 220 (289)
T ss_dssp SCCCGGGEEE---ETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHH
T ss_pred ccCccceEEE---CCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHH
Confidence 9999999999 4677899999999976543 22334567999999999884 357889999999999999999
Q ss_pred CCCCCCCCChHHHHHH-HHhcCCCCC-CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 350 GSRPFWARTESGIFRA-VLKADPSFD-EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~-i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|..||.+....+.+.. +........ ......+++++.+||.+||+.||.+|||+.++++
T Consensus 221 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 221 GQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp SSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999988665544444 444333222 1223468999999999999999999999999875
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=354.74 Aligned_cols=247 Identities=23% Similarity=0.389 Sum_probs=214.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|.+. +++.||||++.... ...+.+.+
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-------------------------------~~~~~~~~ 52 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREGA-------------------------------MSEEDFIE 52 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTTT-------------------------------BCHHHHHH
T ss_pred hheeeeeEecCCCceeEEEEEec----CCCeEEEEEccccC-------------------------------CCHHHHHH
Confidence 68999999999999999999885 47789999986531 11256889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+++.+. ||||+++++++.+.+..|+||||+++++|.+++......+++..+..++.|++.||.|||++||+|||||
T Consensus 53 e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~ 131 (267)
T 3t9t_A 53 EAEVMMKLS-HPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 131 (267)
T ss_dssp HHHHHHTCC-CTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCC
T ss_pred HHHHHHhCC-CCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCc
Confidence 999999996 9999999999999999999999999999999998776789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
|+||++ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++ |..||..
T Consensus 132 p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~ 208 (267)
T 3t9t_A 132 ARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 208 (267)
T ss_dssp GGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hheEEE---CCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCC
Confidence 999999 567789999999998764321 223456788999999986 568999999999999999999 9999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
....+....+........ ...+++++.++|.+||+.||.+|||+.+++++
T Consensus 209 ~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 209 RSNSEVVEDISTGFRLYK---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CCHHHHHHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHhcCCcCCC---CccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 988888888876643222 23478999999999999999999999999863
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=358.45 Aligned_cols=254 Identities=22% Similarity=0.343 Sum_probs=214.6
Q ss_pred ccceEecc-eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 120 VAHYELGE-EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 120 ~~~y~~~~-~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
.++|.+.+ .||+|+||.||+|++... .++..||||++... ......+.+
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~-----------------------------~~~~~~~~~ 57 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQG-----------------------------TEKADTEEM 57 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSS-----------------------------CCHHHHHHH
T ss_pred HHHhhhhhccccccCceeEEEeEeccC-CCcceEEEEecCCc-----------------------------cchhHHHHH
Confidence 35788877 899999999999986431 15788999998653 234556789
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++ ..+..++||||+++++|.+++......+++..++.++.||+.||.|||++||+|||
T Consensus 58 ~~E~~~l~~l~-h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~d 135 (287)
T 1u59_A 58 MREAQIMHQLD-NPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRD 135 (287)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCC-CCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCC
Confidence 99999999996 99999999999 56679999999999999998876667799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSR 352 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~ 352 (482)
|||+|||++ .++.+||+|||++........ .....||+.|+|||++. ..++.++|||||||++|+|++ |..
T Consensus 136 lkp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~ 212 (287)
T 1u59_A 136 LAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212 (287)
T ss_dssp CSGGGEEEE---ETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred CchheEEEc---CCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCC
Confidence 999999994 567899999999987654322 22345689999999886 468999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
||......+....+...... .....+++++.+||.+||..||.+||++.+++++.+
T Consensus 213 p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 213 PYKKMKGPEVMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp TTTTCCTHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred CcccCCHHHHHHHHhcCCcC---CCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence 99998888888777765422 122468999999999999999999999999998754
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=382.97 Aligned_cols=258 Identities=25% Similarity=0.419 Sum_probs=211.9
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++.+.||+|+||.||+|++.. +|+.||||++... ......+.
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~---~~~~vaiK~~~~~-----------------------------~~~~~~~~ 53 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKK---TGDLFAIKVFNNI-----------------------------SFLRPVDV 53 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECGG-----------------------------GGGSCHHH
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECC---CCcEEEEEEeccc-----------------------------cccchHHH
Confidence 345789999999999999999999976 7999999998653 11122456
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCC--eEEEEEecCCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDD--NIYIVMELCKGGELLDRILSRG--GKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
+.+|+.++++++ ||||+++++++.+.+ ..|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||++|
T Consensus 54 ~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 132 (396)
T 4eut_A 54 QMREFEVLKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132 (396)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcC-CCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 789999999997 999999999998765 7899999999999999886432 33999999999999999999999999
Q ss_pred CcccCCCCCceEEec-CCCCCcEEEEecccccccCCCCcccccccCccccCccccc---------ccCCCcchhhhhHHH
Q 011582 274 VVHRDLKPENFLFTS-KEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH---------RSYGTEADMWSIGVI 343 (482)
Q Consensus 274 ivHrDlkp~NIll~~-~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~~DiwSlGvi 343 (482)
|+||||||+|||+.. ++.++.+||+|||+++...........+||+.|+|||++. ..++.++|||||||+
T Consensus 133 ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~i 212 (396)
T 4eut_A 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVT 212 (396)
T ss_dssp EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHH
T ss_pred EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHH
Confidence 999999999999842 3455679999999999877666666778999999999875 357889999999999
Q ss_pred HHHHhhCCCCCCC----CChHHHHHHHHhcCCCCCC---------------------CCCCCCCHHHHHHHHHhchhccc
Q 011582 344 AYILLCGSRPFWA----RTESGIFRAVLKADPSFDE---------------------APWPSLSPEAIDFVKRLLNKDYR 398 (482)
Q Consensus 344 l~elltg~~pf~~----~~~~~~~~~i~~~~~~~~~---------------------~~~~~~s~~~~~li~~~L~~dP~ 398 (482)
+|+|++|+.||.. ....+.+..+....+.... .....+++.+.++|.+||+.||.
T Consensus 213 l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~ 292 (396)
T 4eut_A 213 FYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292 (396)
T ss_dssp HHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTT
T ss_pred HHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChh
Confidence 9999999999964 3345666667665432100 00122456788999999999999
Q ss_pred cCCCHHHHhc
Q 011582 399 KRLTAAQALS 408 (482)
Q Consensus 399 ~R~s~~e~L~ 408 (482)
+||++.++++
T Consensus 293 ~R~s~~e~l~ 302 (396)
T 4eut_A 293 KCWGFDQFFA 302 (396)
T ss_dssp TSCCHHHHHH
T ss_pred hhccHHHHHH
Confidence 9999999854
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=385.55 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=199.4
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
.+|.+.+.||+|+||.|+.... . +|+.||||++.+.. ...+.+
T Consensus 24 ~~y~~~~~LG~G~~G~V~~~~~-~---~~~~vAvK~~~~~~---------------------------------~~~~~~ 66 (432)
T 3p23_A 24 ISFCPKDVLGHGAEGTIVYRGM-F---DNRDVAVKRILPEC---------------------------------FSFADR 66 (432)
T ss_dssp EEEEEEEEEEECGGGCEEEEEE-S---SSSEEEEEEECTTT---------------------------------EEECHH
T ss_pred EEEecCCeeecCcCEEEEEEEE-e---CCeEEEEEEECHHH---------------------------------HHHHHH
Confidence 4699999999999999764332 2 68999999985420 012458
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|+.+.+||||+++++++.+.+..|||||||. |+|.+++......+.+..+..++.||+.||.|||++||+|||||
T Consensus 67 E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlK 145 (432)
T 3p23_A 67 EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLK 145 (432)
T ss_dssp HHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred HHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCC
Confidence 99999999559999999999999999999999996 59999988766667777888999999999999999999999999
Q ss_pred CCceEEecCC--CCCcEEEEecccccccCCC----CcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhh-
Q 011582 281 PENFLFTSKE--ENSSLKAIDFGLSDYVKPD----ERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLC- 349 (482)
Q Consensus 281 p~NIll~~~~--~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~ellt- 349 (482)
|+|||++..+ ....+||+|||+++..... ......+||+.|+|||++. ..++.++|||||||++|+|++
T Consensus 146 p~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~ 225 (432)
T 3p23_A 146 PHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225 (432)
T ss_dssp TTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTT
T ss_pred HHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcC
Confidence 9999996432 3346889999999876543 2344578999999999986 347889999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccccc
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFDE-APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~ 414 (482)
|..||.......... ......... ......+..+.+||.+||+.||.+|||++++|+||||+.
T Consensus 226 g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 226 GSHPFGKSLQRQANI--LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp SCBTTBSTTTHHHHH--HTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred CCCCcchhhHHHHHH--HhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 999996655444322 222221111 112234567899999999999999999999999999975
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=361.07 Aligned_cols=257 Identities=19% Similarity=0.258 Sum_probs=207.5
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|.+++.||+|+||.||+|.......++..||||+++.. .......+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~----------------------------~~~~~~~~~ 82 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLD----------------------------NSSQREIEE 82 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC-------------------------------CCCHHHHHH
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecc----------------------------ccchhHHHH
Confidence 3457899999999999999999998765446778999998642 123445678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCC-----eEEEEEecCCCCChHHHHHh-----cCCCCCHHHHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDD-----NIYIVMELCKGGELLDRILS-----RGGKYSEEDAKIVMVQILSVVA 267 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~-----~~~~l~~~~~~~i~~qi~~~L~ 267 (482)
+.+|+.++++++ ||||+++++++.+.+ ..|+||||+++++|.+++.. ....+++..++.++.||+.||.
T Consensus 83 ~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~ 161 (313)
T 3brb_A 83 FLSEAACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161 (313)
T ss_dssp HHHHHHHHHTCC-CTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhcCC-CCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHH
Confidence 899999999997 999999999998765 35999999999999998853 2356999999999999999999
Q ss_pred HHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc-cCCCcchhhhhHHH
Q 011582 268 FCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVI 343 (482)
Q Consensus 268 yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvi 343 (482)
|||++||+||||||+|||+ +.++.+||+|||++....... ......+++.|+|||++.+ .++.++||||||++
T Consensus 162 ~LH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~i 238 (313)
T 3brb_A 162 YLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238 (313)
T ss_dssp HHHTTTCCCCCCSGGGEEE---CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHH
T ss_pred HHHhCCcccCCCCcceEEE---cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHH
Confidence 9999999999999999999 567789999999998764432 1233467889999998864 58999999999999
Q ss_pred HHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 344 AYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 344 l~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
+|+|++ |..||.+....+....+...... .....+++++.+||.+||..||.+|||+.+++++
T Consensus 239 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 239 MWEIATRGMTPYPGVQNHEMYDYLLHGHRL---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCccCCHHHHHHHHHcCCCC---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999 99999998888888877765432 2234689999999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=367.28 Aligned_cols=255 Identities=23% Similarity=0.323 Sum_probs=213.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCC--CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGS--LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~--~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++++.||+|+||.||+|.+.... ..+..||||++... ......+.
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~ 95 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST-----------------------------AHADEKEA 95 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTT-----------------------------CCHHHHHH
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccc-----------------------------cChHHHHH
Confidence 478999999999999999999986521 12458999998653 23345678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-------------CCCCCHHHHHHHHHHHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-------------GGKYSEEDAKIVMVQILS 264 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------------~~~l~~~~~~~i~~qi~~ 264 (482)
+.+|+.+++.+.+||||+++++++.+.+.+|+|||||++|+|.+++... ...+++..+..++.||+.
T Consensus 96 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 175 (333)
T 2i1m_A 96 LMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQ 175 (333)
T ss_dssp HHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHH
Confidence 8999999999944999999999999999999999999999999988653 346899999999999999
Q ss_pred HHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhh
Q 011582 265 VVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSI 340 (482)
Q Consensus 265 ~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSl 340 (482)
||.|||++||+||||||+|||+ +.++.+||+|||++........ .....||+.|+|||++. ..++.++|||||
T Consensus 176 ~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 252 (333)
T 2i1m_A 176 GMAFLASKNCIHRDVAARNVLL---TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252 (333)
T ss_dssp HHHHHHHTTEECSCCSGGGCEE---EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHH
T ss_pred HHHHHhcCCcccCCcccceEEE---CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHH
Confidence 9999999999999999999999 4567899999999986543322 23456788999999876 468999999999
Q ss_pred HHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 341 GVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 341 Gvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||++|+|++ |..||.+......+..+......... ...+++++.+||.+||+.||.+|||+.++++
T Consensus 253 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 253 GILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ--PAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCC--CCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 999999998 99999887766666666655443332 2347899999999999999999999999986
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=359.38 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=209.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
..+|++.+.||+|+||.||+|++......+..||||.+.+. ......+.+.
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~-----------------------------~~~~~~~~~~ 74 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-----------------------------TDIGEVSQFL 74 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC-----------------------------CSHHHHHHHH
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC-----------------------------CCHHHHHHHH
Confidence 35799999999999999999997653334557899988542 3344567889
Q ss_pred HHHHHHHhhcCCCCcceeeEEE-EeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAY-EDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+++++. ||||+++++++ ..++..|+||||+++|+|.+++......+++..+..++.|++.||.|||++||+|||
T Consensus 75 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~d 153 (298)
T 3f66_A 75 TEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRD 153 (298)
T ss_dssp HHHHHHHTCC-CTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHhCC-CCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCC
Confidence 9999999997 99999999985 456788999999999999999977667899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC-----cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GS 351 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~ 351 (482)
|||+|||+ +.++.+||+|||++....... ......||+.|+|||++. ..++.++||||||+++|+|++ |.
T Consensus 154 ikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~ 230 (298)
T 3f66_A 154 LAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 230 (298)
T ss_dssp CSGGGEEE---CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CchheEEE---CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCC
Confidence 99999999 677889999999998664322 223456788999999886 468999999999999999999 67
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+||...+..+....+......... ..+++++.++|.+||+.||.+|||+.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 231 PPYPDVNTFDITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CSSTTSCTTTHHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccCCHHHHHHHHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 778777777777777666543322 347899999999999999999999999876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=353.14 Aligned_cols=246 Identities=19% Similarity=0.232 Sum_probs=211.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|++ .|+.||||++... .......+.+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~avK~~~~~----------------------------~~~~~~~~~~~ 55 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-----QGNDIVVKVLKVR----------------------------DWSTRKSRDFN 55 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECCT----------------------------TCCHHHHHHHH
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-----CCeeEEEEEeccc----------------------------ccCHHHHHHHH
Confidence 46899999999999999999987 4788999998653 12344567899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCC--C
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGG-KYSEEDAKIVMVQILSVVAFCHFQG--V 274 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~--i 274 (482)
+|+.++++++ ||||+++++++.+. +..++||||+++|+|.+++..... .+++..++.++.||+.||.|||++| |
T Consensus 56 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i 134 (271)
T 3kmu_A 56 EECPRLRIFS-HPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLI 134 (271)
T ss_dssp HHGGGGCCCS-CTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCC
T ss_pred HHHHHHHhcC-CCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCce
Confidence 9999999996 99999999999887 789999999999999999876433 5899999999999999999999999 9
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccccc----CCCcchhhhhHHHHHHHhhC
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS----YGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~DiwSlGvil~elltg 350 (482)
+||||||+|||+ +.++.++|+|||++.... .....||+.|+|||++.+. ++.++|||||||++|+|++|
T Consensus 135 ~H~dikp~Nil~---~~~~~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g 207 (271)
T 3kmu_A 135 PRHALNSRSVMI---DEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR 207 (271)
T ss_dssp TTCCCSGGGEEE---CTTSCEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHC
T ss_pred ecCCCccceEEE---cCCcceeEEeccceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999 667889999999876533 2345789999999998642 33479999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
..||.+....+....+........ ....+++++.+||.+||+.||.+|||++++++
T Consensus 208 ~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 208 EVPFADLSNMEIGMKVALEGLRPT--IPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp SCTTTTSCHHHHHHHHHHSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccccChHHHHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999888888777776654332 23468999999999999999999999999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=357.29 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=215.6
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++.+.||+|+||.||+|.+.. +|..||||++... ....+.
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-------------------------------~~~~~~ 55 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-------------------------------TMEVEE 55 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGG---GTEEEEEEEECSC-------------------------------STHHHH
T ss_pred ccccceeEEeecCCCCceeEEEeEecC---CCEEEEEEecCcC-------------------------------HHHHHH
Confidence 346789999999999999999999987 7899999998542 123467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+.+|+.+++.++ ||||+++++++.+++.+|+||||++|++|.+++... ...+++..++.++.||+.||.|||++||+|
T Consensus 56 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H 134 (288)
T 3kfa_A 56 FLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134 (288)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHhCC-CCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccC
Confidence 889999999997 999999999999999999999999999999998764 356999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSR 352 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~ 352 (482)
|||||+||++ +.++.+||+|||++....... ......+|+.|+|||++. ..++.++||||||+++|+|++ |..
T Consensus 135 ~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~ 211 (288)
T 3kfa_A 135 RDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211 (288)
T ss_dssp SCCSGGGEEE---CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCCCcceEEE---cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999 566789999999998765433 223456788999999886 568999999999999999999 999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||.+.........+...... .....+++++.+||.+||..||.+|||+.++++
T Consensus 212 p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 212 PYPGIDLSQVYELLEKDYRM---ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp SSTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHhccCCC---CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 99988887777766654321 223468999999999999999999999999865
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=359.26 Aligned_cols=252 Identities=27% Similarity=0.424 Sum_probs=213.8
Q ss_pred cccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
+...+..+|++.+.||+|+||.||+|++.. +|+.||||++....
T Consensus 5 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--------------------------------- 48 (284)
T 2a19_B 5 VDKRFGMDFKEIELIGSGGFGQVFKAKHRI---DGKTYVIKRVKYNN--------------------------------- 48 (284)
T ss_dssp CCHHHHHHEEEEEEEECSSSCCEEEEEETT---TCCEEEEEEEECCS---------------------------------
T ss_pred ccchhccccceeeeeccCCceEEEEEEEcC---CCeEEEEEEecccc---------------------------------
Confidence 345677899999999999999999999876 79999999986530
Q ss_pred HHHHHHHHHHHHhhcCCCCcceeeEEEEe----------------CCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHH
Q 011582 195 IEDVRREVKILRALTGHKNLVQFYDAYED----------------DDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKI 257 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~hpniv~l~~~~~~----------------~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~ 257 (482)
+.+.+|+.+++++. ||||+++++++.. ...+|+||||+++++|.+++... ...+++..++.
T Consensus 49 -~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 126 (284)
T 2a19_B 49 -EKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126 (284)
T ss_dssp -GGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHH
T ss_pred -HHHHHHHHHHHhCC-CCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHH
Confidence 24568999999997 9999999999865 45689999999999999998754 36799999999
Q ss_pred HHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcch
Q 011582 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEAD 336 (482)
Q Consensus 258 i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~D 336 (482)
++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.............||+.|+|||++.+ .++.++|
T Consensus 127 i~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 203 (284)
T 2a19_B 127 LFEQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVD 203 (284)
T ss_dssp HHHHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHH
T ss_pred HHHHHHHHHHHHHhCCeeeccCCHHHEEE---cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhh
Confidence 99999999999999999999999999999 4567899999999988776655666789999999998864 5899999
Q ss_pred hhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 337 MWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 337 iwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
|||||+++|+|++|..||.. .......+.... + ...+++++.+||.+||..||.+|||+.++++|.|....
T Consensus 204 i~slG~il~~l~~~~~~~~~--~~~~~~~~~~~~--~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 204 LYALGLILAELLHVCDTAFE--TSKFFTDLRDGI--I----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HHHHHHHHHHHHSCCSSHHH--HHHHHHHHHTTC--C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred hHHHHHHHHHHHhcCCcchh--HHHHHHHhhccc--c----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 99999999999999998843 223333333322 1 13488999999999999999999999999999887654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=357.98 Aligned_cols=255 Identities=24% Similarity=0.350 Sum_probs=205.3
Q ss_pred cccceEecceeecCCceEEEEEEEec-CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKK-GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~-~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...+|++++.||+|+||.||+|+... +..+|+.||||++... ......+.
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~ 69 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE-----------------------------SGGNHIAD 69 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC----------------------------------CCHHH
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEeccc-----------------------------ccchhHHH
Confidence 34679999999999999999998422 1227899999998643 11223467
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVV 275 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iv 275 (482)
+.+|+.+++.+. ||||+++++++.+. +.+++||||+++++|.+++......+++..++.++.|++.||.|||++||+
T Consensus 70 ~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 148 (302)
T 4e5w_A 70 LKKEIEILRNLY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYV 148 (302)
T ss_dssp HHHHHHHHHTCC-CTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHhCC-CCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcc
Confidence 889999999997 99999999999877 678999999999999999977777899999999999999999999999999
Q ss_pred ccCCCCCceEEecCCCCCcEEEEecccccccCCCC----cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhC
Q 011582 276 HRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 276 HrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg 350 (482)
||||||+|||+ +.++.+||+|||++....... ......||..|+|||++. ..++.++|||||||++|+|++|
T Consensus 149 H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 225 (302)
T 4e5w_A 149 HRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTY 225 (302)
T ss_dssp CSCCSGGGEEE---EETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTT
T ss_pred cCCCchheEEE---cCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHc
Confidence 99999999999 456789999999998765443 233467888999999886 4588999999999999999999
Q ss_pred CCCCCCC--------------ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 351 SRPFWAR--------------TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 351 ~~pf~~~--------------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
..|+... ................ .....+++++.+||.+||+.||.+|||+.++++
T Consensus 226 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 226 CDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRL--PCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp TCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred cCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCC--CCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9876321 1222222222222222 223568999999999999999999999999875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=360.62 Aligned_cols=255 Identities=23% Similarity=0.344 Sum_probs=207.2
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|++......+..||||+++.. ........+.+.
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~---------------------------~~~~~~~~~~~~ 69 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD---------------------------VLSQPEAMDDFI 69 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-----------------------------------CHHHHHHH
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccC---------------------------ccCCHHHHHHHH
Confidence 46899999999999999999987643223347999998653 112334567899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. ||||+++++++.+.+ .++||||+++++|.+++......+++..+..++.||+.||.|||++||+||||
T Consensus 70 ~e~~~l~~l~-h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di 147 (291)
T 1u46_A 70 REVNAMHSLD-HRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDL 147 (291)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHhCC-CCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 9999999996 999999999998765 89999999999999999876677999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRP 353 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~p 353 (482)
||+|||++ .++.+||+|||++........ .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..|
T Consensus 148 kp~Nili~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p 224 (291)
T 1u46_A 148 AARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224 (291)
T ss_dssp CGGGEEEE---ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCT
T ss_pred chheEEEc---CCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence 99999994 567899999999987654332 234567889999998864 58899999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|.+.+..+....+.......+. ...+++++.++|.+||..||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 225 WIGLNGSQILHKIDKEGERLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TTTCCHHHHHHHHHTSCCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCCHHHHHHHHHccCCCCCC--CcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999998888888776544433 3468999999999999999999999999986
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=363.43 Aligned_cols=255 Identities=21% Similarity=0.328 Sum_probs=210.2
Q ss_pred cccceEecceeecCCceEEEEEEEecCC-CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGS-LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~-~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
..++|.+.+.||+|+||.||+|++.... ..+..||||++... ........
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~ 92 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-----------------------------YTEKQRVD 92 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-----------------------------CCHHHHHH
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCC-----------------------------CCHHHHHH
Confidence 3468999999999999999999987521 12456999998643 23344567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.+. ||||+++++++.+.+..++||||+++++|.+++......+++..+..++.||+.||.|||++||+||
T Consensus 93 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~ 171 (333)
T 1mqb_A 93 FLGEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHR 171 (333)
T ss_dssp HHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHHhCC-CCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 899999999996 9999999999999999999999999999999998776789999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GS 351 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~ 351 (482)
||||+|||+ +.++.+||+|||++........ .....+|+.|+|||++. ..++.++|||||||++|+|++ |.
T Consensus 172 Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~ 248 (333)
T 1mqb_A 172 DLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE 248 (333)
T ss_dssp CCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred CCChheEEE---CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCC
Confidence 999999999 5678899999999987654321 22345688999999886 468999999999999999998 99
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.||.+....++...+..... .+ ....+++++.+||.+||+.||.+||++.+++++
T Consensus 249 ~pf~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 249 RPYWELSNHEVMKAINDGFR-LP--TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CTTTTCCHHHHHHHHHTTCC-CC--CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCcccCCHHHHHHHHHCCCc-CC--CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999888888887766532 11 224589999999999999999999999998864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=367.06 Aligned_cols=258 Identities=29% Similarity=0.543 Sum_probs=203.0
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|++.. +|+.||||++....... .........
T Consensus 28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~------------------------~~~~~~~~~ 80 (312)
T 2iwi_A 28 AFEAEYRLGPLLGKGGFGTVFAGHRLT---DRLQVAIKVIPRNRVLG------------------------WSPLSDSVT 80 (312)
T ss_dssp -----CEEEEEEEEETTEEEEEEECTT---TCCEEEEEECCSTTTC--------------------------------CC
T ss_pred hhhhceEEeeEEEcCCCEEEEEEEEcc---CCeEEEEEEEecccccc------------------------cccchhhHH
Confidence 456789999999999999999999876 78999999986531000 000012234
Q ss_pred HHHHHHHHHhhc---CCCCcceeeEEEEeCCeEEEEEec-CCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 198 VRREVKILRALT---GHKNLVQFYDAYEDDDNIYIVMEL-CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 198 ~~~Ei~~l~~l~---~hpniv~l~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
+.+|+.+++++. +||||+++++++.+.+..++|||| +.+++|.+++... +.+++..++.++.||+.||.|||++|
T Consensus 81 ~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ 159 (312)
T 2iwi_A 81 CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQVVAAIQHCHSRG 159 (312)
T ss_dssp CCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 567999999983 399999999999999999999999 7899999988765 57999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cC-CCcchhhhhHHHHHHHhhCC
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SY-GTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwSlGvil~elltg~ 351 (482)
|+||||||+|||++ ..++.+||+|||++...... ......||+.|+|||++.+ .+ +.++|||||||++|+|++|+
T Consensus 160 i~H~dlkp~Nil~~--~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~ 236 (312)
T 2iwi_A 160 VVHRDIKDENILID--LRRGCAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236 (312)
T ss_dssp EECCCCSGGGEEEE--TTTTEEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred eeecCCChhhEEEe--CCCCeEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCC
Confidence 99999999999995 25678999999999876543 3456689999999998864 34 45899999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.||.... .+......++ ..+++++.+||.+||+.||.+|||++++|+||||+...
T Consensus 237 ~pf~~~~------~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 237 IPFERDQ------EILEAELHFP----AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp CSCCSHH------HHHHTCCCCC----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred CCCCChH------HHhhhccCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 9996532 2333333332 35899999999999999999999999999999998753
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=365.21 Aligned_cols=253 Identities=20% Similarity=0.271 Sum_probs=203.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|++.. +|+.||+|+..|... ........+.+.
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~~~~kv~iK~~~-------------------------~~~~~~~~~~~~ 65 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELR-------------------------EATSPKANKEIL 65 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC---TTCSCCEEEEEEEEC-------------------------CCSSCCCHHHHH
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcC---CCceEEEEEEEEeec-------------------------cccCHHHHHHHH
Confidence 4789999999999999999999876 566664444332100 001222346788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+++.+. ||||+++++++.+.. .++||||+.+|+|.+++......+++..++.++.||+.||.|||++||+||||
T Consensus 66 ~E~~~l~~l~-hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Di 143 (327)
T 3lzb_A 66 DEAYVMASVD-NPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDL 143 (327)
T ss_dssp HHHHHHTTCC-BTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHHHHHhCC-CCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCC
Confidence 9999999997 999999999998765 88999999999999999887788999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
||+|||+ +.++.+||+|||++........ .....||+.|+|||++.+ .|+.++|||||||++|+|++ |..||
T Consensus 144 kp~NIl~---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~ 220 (327)
T 3lzb_A 144 AARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY 220 (327)
T ss_dssp CGGGEEE---EETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred CHHHEEE---cCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCC
Confidence 9999999 4567899999999987643322 233457889999998864 68999999999999999999 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+....++...+...... + ....++.++.+||.+||..||.+|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 221 DGIPASEISSILEKGERL-P--QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TTCCGGGHHHHHHTTCCC-C--CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCC-C--CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 998888877766655422 2 22458999999999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=355.72 Aligned_cols=253 Identities=20% Similarity=0.273 Sum_probs=210.2
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.-.|.+.+.||+|+||.||+|++......+..||+|++.+. ......+.+.
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~-----------------------------~~~~~~~~~~ 70 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI-----------------------------TEMQQVEAFL 70 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC-----------------------------CSHHHHHHHH
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc-----------------------------ccHHHHHHHH
Confidence 34688889999999999999998764334558999998642 3344567889
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeE-EEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNI-YIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~-~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+++.+. ||||+++++++.+.+.. ++||||+.+|+|.+++......+++..+..++.|++.||.|||++||+|||
T Consensus 71 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~d 149 (298)
T 3pls_A 71 REGLLMRGLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRD 149 (298)
T ss_dssp HHHHHHHTCC-CTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHhCC-CCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 9999999996 99999999999876665 999999999999999977677899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCC-----CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhC-C
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPD-----ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCG-S 351 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg-~ 351 (482)
|||+|||+ +.++.+||+|||++...... .......||+.|+|||.+.+ .++.++|||||||++|+|++| .
T Consensus 150 ikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 226 (298)
T 3pls_A 150 LAARNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA 226 (298)
T ss_dssp CSGGGEEE---CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSC
T ss_pred CCcceEEE---cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCC
Confidence 99999999 67788999999999765432 22344578899999999875 589999999999999999995 5
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+||...+..+....+...... . ....+++++.+||.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 227 PPYRHIDPFDLTHFLAQGRRL-P--QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CTTTTSCGGGHHHHHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccCCHHHHHHHhhcCCCC-C--CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 555555666666655554422 2 12458999999999999999999999999876
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=359.20 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=206.6
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++.... ....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--------------------------------~~~~ 50 (296)
T 3uzp_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKT--------------------------------KHPQ 50 (296)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEEESCS--------------------------------SCCH
T ss_pred eeccEEEEEEEEccCCCeEEEEEEEcC---CCcEEEEEEecCCc--------------------------------chhH
Confidence 456789999999999999999999876 79999999986430 0135
Q ss_pred HHHHHHHHHhhcCCCCcc-eeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 198 VRREVKILRALTGHKNLV-QFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv-~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+.+|+.+++.+. |++++ .+..++.+.+..++||||+ +++|.+++......+++..+..++.||+.||.|||++||+|
T Consensus 51 ~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH 128 (296)
T 3uzp_A 51 LHIESKIYKMMQ-GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128 (296)
T ss_dssp HHHHHHHHHHHT-TSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHhh-cCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeee
Confidence 789999999998 66655 4545557788899999999 89999998766678999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCc--------ccccccCccccCcccccc-cCCCcchhhhhHHHHHHH
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el 347 (482)
|||||+|||++..+.++.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 129 ~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 208 (296)
T 3uzp_A 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 208 (296)
T ss_dssp SCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHH
Confidence 99999999996445677899999999987654322 245689999999999875 589999999999999999
Q ss_pred hhCCCCCCCCC---hHHHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 348 LCGSRPFWART---ESGIFRAVLKADPSFDE-APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 348 ltg~~pf~~~~---~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
++|+.||.+.. ..+.+..+.......+. .....+++++.+||.+||+.||.+|||+.++++
T Consensus 209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 209 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 99999997643 22333343332222211 112458999999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=375.90 Aligned_cols=269 Identities=17% Similarity=0.243 Sum_probs=202.8
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCC--CCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSL--KGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~--~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
...++|++++.||+|+||.||+|.+..+.. .++.||||++..... ....|.. .......
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~----------------~~~~e~~---~~~~~~~ 92 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNG----------------PLFTELK---FYQRAAK 92 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCH----------------HHHHHHH---HHHHHCC
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccch----------------hHHHHHH---HHHhhhh
Confidence 345689999999999999999999875321 368899999875310 0111110 0111112
Q ss_pred HHHHHHHHHHHhhcCCCCcceeeEEEEeC----CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 196 EDVRREVKILRALTGHKNLVQFYDAYEDD----DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~~hpniv~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
..+..|+..+..+. ||||+++++++... ...||||||| |++|.+++......+++..+..++.||+.||.|||+
T Consensus 93 ~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~ 170 (364)
T 3op5_A 93 PEQIQKWIRTRKLK-YLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE 170 (364)
T ss_dssp HHHHHHHHHHTTCS-CCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHhhcc-CCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34456677777775 99999999998775 5589999999 999999988776789999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc--------ccccccCccccCcccccc-cCCCcchhhhhHH
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGV 342 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGv 342 (482)
+||+||||||+|||++. +.++.+||+|||+++.+..... ....+||+.|+|||++.+ .++.++|||||||
T Consensus 171 ~~iiHrDlkp~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 249 (364)
T 3op5_A 171 HEYVHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGY 249 (364)
T ss_dssp TTEECCCCCGGGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCeEEecCCHHHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHH
Confidence 99999999999999953 2567899999999977543221 234569999999999875 5999999999999
Q ss_pred HHHHHhhCCCCCCCCChHHHHHHHHhcCC--CCC---C--CCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 343 IAYILLCGSRPFWARTESGIFRAVLKADP--SFD---E--APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 343 il~elltg~~pf~~~~~~~~~~~i~~~~~--~~~---~--~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
++|+|++|+.||.+............... ... . .....+++++.+||..||..||.+||++.++++
T Consensus 250 ~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 250 CMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 99999999999986433222111111000 000 0 001357999999999999999999999999875
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=365.63 Aligned_cols=247 Identities=22% Similarity=0.296 Sum_probs=197.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|++ .|+.||||++... ........
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~-------------------------------~~~~~~~~ 66 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-----LNEYVAVKIFPIQ-------------------------------DKQSWQNE 66 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-----TTEEEEEEEECGG-------------------------------GHHHHHHH
T ss_pred hhhchhhheecccCceEEEEEEE-----CCCEEEEEEeecC-------------------------------chHHHHHH
Confidence 36899999999999999999976 4789999998542 12234556
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCC----eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDD----NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ--- 272 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--- 272 (482)
+|+.++++++ ||||+++++++.+.. .+|+|||||++|+|.+++.. ..+++..++.++.||+.||.|||+.
T Consensus 67 ~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~ 143 (322)
T 3soc_A 67 YEVYSLPGMK-HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPG 143 (322)
T ss_dssp HHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEE
T ss_pred HHHHHHhcCC-CCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccc
Confidence 7999999997 999999999998744 47999999999999998865 3599999999999999999999999
Q ss_pred -------CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc------cCCCcch
Q 011582 273 -------GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR------SYGTEAD 336 (482)
Q Consensus 273 -------~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~------~~~~~~D 336 (482)
||+||||||+|||+ +.++.+||+|||+++...... .....+||+.|+|||++.+ .++.++|
T Consensus 144 l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~D 220 (322)
T 3soc_A 144 LKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220 (322)
T ss_dssp ETTEEECEEECSCCSGGGEEE---CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHH
T ss_pred cccccCCCEEeCCCChHhEEE---CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccch
Confidence 99999999999999 667889999999998765432 2344689999999999864 3567889
Q ss_pred hhhhHHHHHHHhhCCCCCCCCCh----------------HHHHHHHHhcCCCCCCC-CCC--CCCHHHHHHHHHhchhcc
Q 011582 337 MWSIGVIAYILLCGSRPFWARTE----------------SGIFRAVLKADPSFDEA-PWP--SLSPEAIDFVKRLLNKDY 397 (482)
Q Consensus 337 iwSlGvil~elltg~~pf~~~~~----------------~~~~~~i~~~~~~~~~~-~~~--~~s~~~~~li~~~L~~dP 397 (482)
||||||++|+|++|+.||.+... ..+...+.......... .|. ..++++.+||.+||+.||
T Consensus 221 iwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP 300 (322)
T 3soc_A 221 MYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300 (322)
T ss_dssp HHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSG
T ss_pred hHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCCh
Confidence 99999999999999999975432 22222222222111110 011 123569999999999999
Q ss_pred ccCCCHHHHhc
Q 011582 398 RKRLTAAQALS 408 (482)
Q Consensus 398 ~~R~s~~e~L~ 408 (482)
.+|||+.++++
T Consensus 301 ~~Rps~~ell~ 311 (322)
T 3soc_A 301 EARLSAGCVGE 311 (322)
T ss_dssp GGSCCHHHHHH
T ss_pred hhCcCHHHHHH
Confidence 99999999875
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=358.40 Aligned_cols=254 Identities=20% Similarity=0.275 Sum_probs=201.7
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++.... ....
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~~--------------------------------~~~~ 50 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKT--------------------------------KHPQ 50 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEC-----------------------------------CCC
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcC---CCceEEEEeecccc--------------------------------cchH
Confidence 456789999999999999999999876 79999999875420 1124
Q ss_pred HHHHHHHHHhhcCCCCcce-eeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 198 VRREVKILRALTGHKNLVQ-FYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~-l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+.+|+.+++.+. |++++. +..++.+.+..++||||+ +++|.+++......+++..+..++.||+.||.|||++||+|
T Consensus 51 ~~~e~~~l~~l~-~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 128 (296)
T 4hgt_A 51 LHIESKIYKMMQ-GGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIH 128 (296)
T ss_dssp HHHHHHHHHHHT-TSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHhc-CCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 778999999998 655554 555557888999999999 89999998766678999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCc--------ccccccCccccCcccccc-cCCCcchhhhhHHHHHHH
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el 347 (482)
|||||+|||+...+.++.+||+|||++........ .....||+.|+|||++.+ .++.++|||||||++|+|
T Consensus 129 ~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 208 (296)
T 4hgt_A 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYF 208 (296)
T ss_dssp SCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHH
Confidence 99999999996545677899999999987654322 235689999999998875 689999999999999999
Q ss_pred hhCCCCCCCCChH---HHHHHHHhcCCCCCC-CCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 348 LCGSRPFWARTES---GIFRAVLKADPSFDE-APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 348 ltg~~pf~~~~~~---~~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
++|+.||.+.... ..+..+.......+. .....+++++.+||.+||+.||.+|||+.++++
T Consensus 209 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 209 NLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 9999999764322 233333322221111 112457899999999999999999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=363.13 Aligned_cols=253 Identities=22% Similarity=0.327 Sum_probs=207.8
Q ss_pred ccceEecceeecCCceEEEEEEEec-CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKK-GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~-~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
.++|++.+.||+|+||.||+|+... +..+|+.||||++... .....+.+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~------------------------------~~~~~~~~ 71 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS------------------------------GPDQQRDF 71 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC------------------------------CHHHHHHH
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC------------------------------CHHHHHHH
Confidence 3689999999999999999998532 1227899999998642 33445678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEE--eCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYE--DDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+|+.+++++. ||||+++++++. +.+..|+||||+++++|.+++......+++..++.++.||+.||.|||++||+|
T Consensus 72 ~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH 150 (327)
T 3lxl_A 72 QREIQILKALH-SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVH 150 (327)
T ss_dssp HHHHHHHHTCC-CTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHhcC-CCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccC
Confidence 99999999996 999999999987 456799999999999999998776667999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCC----cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~ 351 (482)
|||||+|||+ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|.
T Consensus 151 ~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~ 227 (327)
T 3lxl_A 151 RDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYC 227 (327)
T ss_dssp SCCSGGGEEE---EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTT
T ss_pred CCCChhhEEE---CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCC
Confidence 9999999999 457789999999998765433 2234568889999998864 5899999999999999999999
Q ss_pred CCCCCCChH---------------HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 352 RPFWARTES---------------GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 352 ~pf~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.||...... .....+. ..... .....+++++.+||.+||+.||.+|||+.+++++
T Consensus 228 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 228 DKSCSPSAEFLRMMGCERDVPALSRLLELLE-EGQRL--PAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp CGGGSHHHHHHHHCC----CCHHHHHHHHHH-TTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccccchhhhhcccccccccHHHHHHHhh-cccCC--CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 998654332 2222222 22222 2235689999999999999999999999999654
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=373.33 Aligned_cols=253 Identities=21% Similarity=0.297 Sum_probs=202.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
..|++.+.||+|+||.||+|+.......+..||||.+... ......+.+.+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~~~~ 139 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-----------------------------TDIGEVSQFLT 139 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC-----------------------------SCSHHHHHHHH
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC-----------------------------CCHHHHHHHHH
Confidence 4689999999999999999998753223457899988542 23345678999
Q ss_pred HHHHHHhhcCCCCcceeeEEEE-eCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYE-DDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
|+.+++++. ||||+++++++. .++..|+||||+++|+|.+++......+++..+..++.||+.||.|||++||+||||
T Consensus 140 E~~il~~l~-hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDl 218 (373)
T 3c1x_A 140 EGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDL 218 (373)
T ss_dssp HHTTSTTCC-CTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHHHHhCC-CCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCcc
Confidence 999999996 999999999865 456889999999999999999776677999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC-----cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSR 352 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~ 352 (482)
||+|||+ +.++.+||+|||+++...... ......+|+.|+|||++. ..++.++|||||||++|+|++ |.+
T Consensus 219 kp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~ 295 (373)
T 3c1x_A 219 AARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 295 (373)
T ss_dssp CGGGEEE---CTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred chheEEE---CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCC
Confidence 9999999 667889999999998654322 123456788999999886 468999999999999999999 788
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||...+..+....+........ ...+++++.++|.+||..||.+|||+.+++++
T Consensus 296 p~~~~~~~~~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 296 PYPDVNTFDITVYLLQGRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp SCTTSCSSCHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 8887777777666666543222 23589999999999999999999999999864
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=362.03 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=203.4
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|++.. +|+.||||++.. ......+.+.
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~------------------------------~~~~~~~~~~ 74 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLH---DGHFYALKRILC------------------------------HEQQDREEAQ 74 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETT---TCCEEEEEEEEE------------------------------SSHHHHHHHH
T ss_pred CeEEEEEEEecCCCCeEEEEEEecC---CCcEEEEEEEec------------------------------CCHHHHHHHH
Confidence 4689999999999999999999876 799999999854 2334567889
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 200 REVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
+|+.+++.+. ||||+++++++.. ....|+||||+++|+|.+++.. .+..+++..++.++.||+.||.|||++
T Consensus 75 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~ 153 (317)
T 2buj_A 75 READMHRLFN-HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK 153 (317)
T ss_dssp HHHHHHHTCC-CTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHhhcC-CCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 9999999996 9999999999873 3578999999999999998875 356799999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC----------cccccccCccccCcccccc----cCCCcchhh
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----------RLNDIVGSAYYVAPEVLHR----SYGTEADMW 338 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~----------~~~~~~gt~~y~aPE~~~~----~~~~~~Diw 338 (482)
||+||||||+|||+ +.++.+||+|||++....... ......||+.|+|||++.+ .++.++|||
T Consensus 154 ~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~ 230 (317)
T 2buj_A 154 GYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVW 230 (317)
T ss_dssp TEECCCCCGGGEEE---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHH
T ss_pred CcccCCCCHHHEEE---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHH
Confidence 99999999999999 567789999999987653211 1123467999999999863 268999999
Q ss_pred hhHHHHHHHhhCCCCCCCCC--hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCc
Q 011582 339 SIGVIAYILLCGSRPFWART--ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410 (482)
Q Consensus 339 SlGvil~elltg~~pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 410 (482)
||||++|+|++|..||.... .......+ .....+ .....+++++.+||.+||+.||.+|||+.+++++-
T Consensus 231 slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 231 SLGCVLYAMMFGEGPYDMVFQKGDSVALAV-QNQLSI--PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp HHHHHHHHHHHSSCTTHHHHHTTSCHHHHH-HCC--C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHHHhCCCChhhhhcccchhhHHh-hccCCC--CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 99999999999999995311 11122222 222222 22356899999999999999999999999999863
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-46 Score=368.88 Aligned_cols=255 Identities=19% Similarity=0.292 Sum_probs=205.5
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
...++|++.+.||+|+||.||+|++. +|+.||||++... .....+.
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~------------------------------~~~~~~~ 81 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLR----DGAKVALKRRTPE------------------------------SSQGIEE 81 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECT----TCCEEEEEECCSC------------------------------CSSHHHH
T ss_pred HHHhccCccceeecCCCeeEEEEEEC----CCCEEEEEEeccc------------------------------ChHHHHH
Confidence 35678999999999999999999864 5889999987542 1233567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---GKYSEEDAKIVMVQILSVVAFCHFQGV 274 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~~i 274 (482)
+.+|+.+++.+. ||||+++++++.+.+..|+||||+++|+|.+++.... ..+++..+..++.||+.||.|||++||
T Consensus 82 ~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 160 (321)
T 2qkw_B 82 FETEIETLSFCR-HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAI 160 (321)
T ss_dssp HHHHHHGGGSCC-CTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCe
Confidence 899999999997 9999999999999999999999999999999875432 358999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCCC---CcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhC
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD---ERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg 350 (482)
+||||||+|||+ +.++.+||+|||++...... .......||+.|+|||++. +.++.++|||||||++|+|++|
T Consensus 161 vH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g 237 (321)
T 2qkw_B 161 IHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237 (321)
T ss_dssp ECSCCCSTTEEE---CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHC
T ss_pred ecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhC
Confidence 999999999999 67789999999999865432 2234456999999999885 5699999999999999999999
Q ss_pred CCCCCCCChHHHHHHH-----HhcCCCCC--------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCc
Q 011582 351 SRPFWARTESGIFRAV-----LKADPSFD--------EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i-----~~~~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 410 (482)
+.||.+....+....+ ......+. ....+..+.++.++|.+||+.||.+|||+.+++++-
T Consensus 238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 9999765432211100 11111111 111122456789999999999999999999998764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=375.76 Aligned_cols=243 Identities=25% Similarity=0.384 Sum_probs=207.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|.. .|+.||||+++.. ...+.+.
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-----~~~~vavK~~~~~--------------------------------~~~~~~~ 234 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKND--------------------------------ATAQAFL 234 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEESSC--------------------------------TTSHHHH
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-----cCCeEEEEEeCCc--------------------------------hHHHHHH
Confidence 47899999999999999999976 4779999998642 0235788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCC-eEEEEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDD-NIYIVMELCKGGELLDRILSRGG-KYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+|+.+|++++ ||||+++++++.+.+ .+|+|||||++|+|.+++...+. .+++..+..++.||+.||.|||++||+||
T Consensus 235 ~E~~~l~~l~-h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr 313 (450)
T 1k9a_A 235 AEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313 (450)
T ss_dssp HHHHHHHTCC-CTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHhcc-CCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 9999999997 999999999987765 79999999999999999987643 37999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
||||+|||+ +.++.+||+|||+++..... .....+++.|+|||++. +.++.++|||||||++|||++ |..||.
T Consensus 314 Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~ 388 (450)
T 1k9a_A 314 DLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 388 (450)
T ss_dssp CCCGGGEEE---CTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred CCCHhhEEE---CCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999 56788999999999865432 23346789999999886 469999999999999999998 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+....+....+..+.. . .....+++++.+||.+||+.||.+|||+.++++
T Consensus 389 ~~~~~~~~~~i~~~~~-~--~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 389 RIPLKDVVPRVEKGYK-M--DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp TSCTTTHHHHHHTTCC-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCC-C--CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 8888777777765532 2 222468999999999999999999999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=353.26 Aligned_cols=251 Identities=20% Similarity=0.304 Sum_probs=208.8
Q ss_pred ccceEecc-eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 120 VAHYELGE-EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 120 ~~~y~~~~-~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
.++|.+.+ .||+|+||.||+|.+... ..++.||||++... .......+.+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~-~~~~~vavK~~~~~----------------------------~~~~~~~~~~ 65 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNE----------------------------ANDPALKDEL 65 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECS-SSEEEEEEEEEC---------------------------------CHHHHHH
T ss_pred chhhhhccCccccccCeeeEeeeecCC-CceeeEEEEeeccc----------------------------ccCHHHHHHH
Confidence 36799998 999999999999965431 25789999998653 1223345789
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++.+. ||||+++++++ ..+..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+|||
T Consensus 66 ~~e~~~l~~l~-h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~d 142 (291)
T 1xbb_A 66 LAEANVMQQLD-NPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQN-RHVKDKNIIELVHQVSMGMKYLEESNFVHRD 142 (291)
T ss_dssp HHHHHHHHTCC-CTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHC-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhCC-CCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhC-cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCC
Confidence 99999999996 99999999999 667889999999999999988654 6799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSR 352 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~ 352 (482)
|||+|||++ .++.+||+|||++........ .....||+.|+|||++.+ .++.++||||||+++|+|++ |..
T Consensus 143 ikp~Nil~~---~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~ 219 (291)
T 1xbb_A 143 LAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219 (291)
T ss_dssp CSGGGEEEE---ETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCcceEEEe---CCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCC
Confidence 999999994 567899999999987654332 123456789999998864 58899999999999999999 999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||.+....++...+...... .....+++++.++|.+||+.||.+||++.++++
T Consensus 220 p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 220 PYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp SSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99998888887777665422 122458999999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=361.91 Aligned_cols=250 Identities=24% Similarity=0.399 Sum_probs=188.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
..+|++.+.||+|+||.||+|++.. +|+.||||++... .....+.+.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vavK~~~~~------------------------------~~~~~~~~~ 73 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVG---SGREYALKRLLSN------------------------------EEEKNRAII 73 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETT---TCCEEEEEEEEES------------------------------SHHHHHHHH
T ss_pred CceEEEEEEEccCCceEEEEEEECC---CCcEEEEEEecCC------------------------------chHHHHHHH
Confidence 4589999999999999999999876 7999999998542 334456789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEE--------eCCeEEEEEecCCCCChHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHH
Q 011582 200 REVKILRALTGHKNLVQFYDAYE--------DDDNIYIVMELCKGGELLDRILS--RGGKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~--------~~~~~~lv~e~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~yL 269 (482)
+|+.+++++.+||||+++++++. ....+++||||+. |+|.+++.. ..+.+++..++.++.||+.||.||
T Consensus 74 ~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~L 152 (337)
T 3ll6_A 74 QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHM 152 (337)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999999977999999999994 3445899999996 689888864 346799999999999999999999
Q ss_pred HHCC--CcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcc-------------cccccCccccCccccc----cc
Q 011582 270 HFQG--VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL-------------NDIVGSAYYVAPEVLH----RS 330 (482)
Q Consensus 270 H~~~--ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~-------------~~~~gt~~y~aPE~~~----~~ 330 (482)
|++| |+||||||+|||+ +.++.+||+|||++......... ....||+.|+|||++. ..
T Consensus 153 H~~~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ 229 (337)
T 3ll6_A 153 HRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFP 229 (337)
T ss_dssp HTSSSCCBCCCCCGGGCEE---CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSC
T ss_pred HhCCCCEEEccCCcccEEE---CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCC
Confidence 9999 9999999999999 56778999999999876543221 2456999999999873 35
Q ss_pred CCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCc
Q 011582 331 YGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410 (482)
Q Consensus 331 ~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 410 (482)
++.++|||||||++|+|++|..||.......+.. ..... ......+..+.+||.+||+.||.+|||+.++++|-
T Consensus 230 ~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l 303 (337)
T 3ll6_A 230 IGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN----GKYSI--PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303 (337)
T ss_dssp SSHHHHHHHHHHHHHHHHHSSCCC----------------CCC--CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred CChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc----CcccC--CcccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence 8889999999999999999999997655443322 22222 22345788899999999999999999999999875
Q ss_pred cc
Q 011582 411 WL 412 (482)
Q Consensus 411 ~~ 412 (482)
+-
T Consensus 304 ~~ 305 (337)
T 3ll6_A 304 QE 305 (337)
T ss_dssp HH
T ss_pred HH
Confidence 43
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=355.72 Aligned_cols=249 Identities=23% Similarity=0.349 Sum_probs=196.5
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
.+.+.++|++.+.||+|+||.||+|++ +|+.||||++... ..
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~---------------------------------~~ 44 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW-----QGENVAVKIFSSR---------------------------------DE 44 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE-----TTEEEEEEEECGG---------------------------------GH
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE-----CCEEEEEEEeccc---------------------------------cc
Confidence 345678999999999999999999976 5889999998542 12
Q ss_pred HHHHHHHHHHHh--hcCCCCcceeeEEEEeC----CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 011582 196 EDVRREVKILRA--LTGHKNLVQFYDAYEDD----DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 196 ~~~~~Ei~~l~~--l~~hpniv~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yL 269 (482)
..+.+|.+++.. +. ||||+++++++.+. ..+|+||||+++|+|.+++. ...+++..+..++.||+.||.||
T Consensus 45 ~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~l 121 (301)
T 3q4u_A 45 KSWFRETELYNTVMLR-HENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHL 121 (301)
T ss_dssp HHHHHHHHHHHHTCCC-CTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHhhcc-CcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHH
Confidence 445667777766 65 99999999987653 56899999999999999883 35799999999999999999999
Q ss_pred H--------HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc-----ccccccCccccCccccccc------
Q 011582 270 H--------FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER-----LNDIVGSAYYVAPEVLHRS------ 330 (482)
Q Consensus 270 H--------~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~------ 330 (482)
| ++||+||||||+|||+ +.++.+||+|||++........ ....+||+.|+|||++.+.
T Consensus 122 H~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 198 (301)
T 3q4u_A 122 HIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCF 198 (301)
T ss_dssp HSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCH
T ss_pred HHhhhhccCCCCeecCCCChHhEEE---cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcc
Confidence 9 9999999999999999 5678899999999976544322 2345899999999998653
Q ss_pred -CCCcchhhhhHHHHHHHhhC----------CCCCCCCC----hHHHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHH
Q 011582 331 -YGTEADMWSIGVIAYILLCG----------SRPFWART----ESGIFRAVLKADPSFDEAP----WPSLSPEAIDFVKR 391 (482)
Q Consensus 331 -~~~~~DiwSlGvil~elltg----------~~pf~~~~----~~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~ 391 (482)
++.++|||||||++|+|++| ..||.... .......+.......+... ...+++++.+||.+
T Consensus 199 ~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 278 (301)
T 3q4u_A 199 DSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKE 278 (301)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHH
T ss_pred cCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHH
Confidence 44689999999999999999 88986532 2233333332222211111 01245789999999
Q ss_pred hchhccccCCCHHHHhc
Q 011582 392 LLNKDYRKRLTAAQALS 408 (482)
Q Consensus 392 ~L~~dP~~R~s~~e~L~ 408 (482)
||+.||.+|||+.++++
T Consensus 279 cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 279 CWYQNPSARLTALRIKK 295 (301)
T ss_dssp HCCSSGGGSCCHHHHHH
T ss_pred HhhcChhhCCCHHHHHH
Confidence 99999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=377.19 Aligned_cols=247 Identities=25% Similarity=0.368 Sum_probs=211.3
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|... .+..||||+++.. ....+.+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~----~~~~vavK~~~~~-------------------------------~~~~~~~ 230 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN----KHTKVAVKTMKPG-------------------------------SMSVEAF 230 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET----TTEEEEEEEECTT-------------------------------SBCHHHH
T ss_pred chHHeEEEEEcccCCceEEEEEEEC----CccEEEEEEecCC-------------------------------CccHHHH
Confidence 4578999999999999999999875 4778999998642 0124678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
.+|+.+|++++ ||||+++++++. .+..|+|||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||
T Consensus 231 ~~E~~~l~~l~-h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHr 308 (454)
T 1qcf_A 231 LAEANVMKTLQ-HDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308 (454)
T ss_dssp HHHHHHHTTCC-CTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHhhCC-CCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCC
Confidence 99999999997 999999999986 66789999999999999998743 2368999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRP 353 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~p 353 (482)
||||+|||+ +.++.+||+|||+++...... ......+|..|+|||++. +.++.++|||||||++|||++ |+.|
T Consensus 309 Dlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P 385 (454)
T 1qcf_A 309 DLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385 (454)
T ss_dssp SCSGGGEEE---CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCCHHHEEE---CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCC
Confidence 999999999 667889999999998765322 123345678999999986 569999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|.+....++...+..... .+ ....+++++.+||.+||..||.+|||+++++.
T Consensus 386 ~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 386 YPGMSNPEVIRALERGYR-MP--RPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp STTCCHHHHHHHHHHTCC-CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCC-CC--CCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 999988888888776532 22 22468999999999999999999999999875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=380.14 Aligned_cols=249 Identities=22% Similarity=0.336 Sum_probs=214.1
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|+++. ++..||||+++.. ....+.+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~---~~~~vavK~~~~~-------------------------------~~~~~~~ 263 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-------------------------------TMEVEEF 263 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGG---GTEEEEEEECCSS-------------------------------SSCHHHH
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcC---CCeEEEEEEecCc-------------------------------ccchHHH
Confidence 45789999999999999999999976 6899999998642 1124678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
.+|+.+|++++ ||||+++++++.+.+.+|||||||++|+|.+++... ...+++..+..++.||+.||.|||++||+||
T Consensus 264 ~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHr 342 (495)
T 1opk_A 264 LKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHR 342 (495)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHhcC-CCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999997 999999999999999999999999999999998764 3569999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRP 353 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~p 353 (482)
||||+|||+ +.++.+||+|||+++....... .....+++.|+|||++. +.++.++|||||||++|||++ |..|
T Consensus 343 Dlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p 419 (495)
T 1opk_A 343 NLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 419 (495)
T ss_dssp CCSGGGEEE---CGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred CCChhhEEE---CCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCC
Confidence 999999999 5677899999999987654322 23345678999999886 468999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|.+.+..++...+.... .. .....+++++.+||.+||+.||.+|||+.++++
T Consensus 420 ~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 420 YPGIDLSQVYELLEKDY-RM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp STTCCGGGHHHHHHTTC-CC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHHHHHHHcCC-CC--CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 99988877777665542 22 223468999999999999999999999999976
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=357.04 Aligned_cols=253 Identities=24% Similarity=0.339 Sum_probs=204.4
Q ss_pred cccce-EecceeecCCceEEEEEEEec-CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 119 FVAHY-ELGEEVGRGHFGYTCSAKAKK-GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 119 ~~~~y-~~~~~LG~G~fG~V~~a~~~~-~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
+.++| ++++.||+|+||.||+|.... ...+|+.||||++.+. ......+
T Consensus 28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~ 78 (318)
T 3lxp_A 28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-----------------------------AGPQHRS 78 (318)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-----------------------------CCHHHHH
T ss_pred ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-----------------------------cChHHHH
Confidence 44455 999999999999999986532 2236899999998653 2344567
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGV 274 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i 274 (482)
.+.+|+.+++++. ||||+++++++.+ ...+++||||+++|+|.+++... .+++..++.++.||+.||.|||++||
T Consensus 79 ~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~LH~~~i 155 (318)
T 3lxp_A 79 GWKQEIDILRTLY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQHY 155 (318)
T ss_dssp HHHHHHHHHHHCC-CTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHhCC-CcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 8899999999997 9999999999988 46899999999999999987543 59999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt 349 (482)
+||||||+|||+ +.++.+||+|||++........ .....||..|+|||++.+ .++.++|||||||++|+|++
T Consensus 156 vH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~ 232 (318)
T 3lxp_A 156 IHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232 (318)
T ss_dssp ECSCCSGGGEEE---CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred cCCCCchheEEE---cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999 6678899999999987754432 234568889999998865 68899999999999999999
Q ss_pred CCCCCCCCChH--------------HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 350 GSRPFWARTES--------------GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 350 g~~pf~~~~~~--------------~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|..||...... ............. .....+++++.+||.+||+.||.+|||+.++++
T Consensus 233 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 233 HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERL--PRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp TTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccccchhhhhhhcccccchhHHHHHHHHhcccCC--CCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999654321 0112222222222 223468999999999999999999999999974
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=348.70 Aligned_cols=246 Identities=22% Similarity=0.344 Sum_probs=208.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|.+. ++..||||++... ....+.+.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-------------------------------~~~~~~~~ 56 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQG-------------------------------SMSPDAFL 56 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTT-------------------------------SSCHHHHH
T ss_pred HHhhhheeeecCCCCeEEEEEEEc----CCcEEEEEEecCC-------------------------------cccHHHHH
Confidence 468999999999999999999875 4678999998642 01235788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+++.+. ||||+++++++. .+..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|||
T Consensus 57 ~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 134 (279)
T 1qpc_A 57 AEANLMKQLQ-HQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134 (279)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHhCC-CcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 9999999996 999999999886 456899999999999999875432 3699999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|||+|||+ +.++.+||+|||++........ .....+|+.|+|||++. +.++.++||||||+++|+|++ |..||
T Consensus 135 ikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~ 211 (279)
T 1qpc_A 135 LRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (279)
T ss_dssp CSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred CCHhhEEE---cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999 5678899999999987654332 23446788999999886 468999999999999999999 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+....+....+...... .....+++++.+||.+||..||.+|||+.++++
T Consensus 212 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 212 PGMTNPEVIQNLERGYRM---VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccCHHHHHHHHhcccCC---CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 998888888777665322 222468999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=384.27 Aligned_cols=251 Identities=22% Similarity=0.347 Sum_probs=207.3
Q ss_pred ccceEecc-eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 120 VAHYELGE-EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 120 ~~~y~~~~-~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
.+++.+.+ .||+|+||.||+|..+.. .++..||||++++. ......+.+
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~-----------------------------~~~~~~~~~ 383 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQG-----------------------------TEKADTEEM 383 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECS-SCEEEEEEEECCCC-----------------------------CSSTTHHHH
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecC-CCcEEEEEEEcCCC-----------------------------CChHHHHHH
Confidence 34566666 799999999999987642 14678999998653 122235678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+|++++ |||||++++++.+ +.+|+|||||++|+|.+++......+++..+..++.||+.||.|||++||||||
T Consensus 384 ~~E~~il~~l~-hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrD 461 (613)
T 2ozo_A 384 MREAQIMHQLD-NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRN 461 (613)
T ss_dssp HHHHHHHTTCC-CTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHhCC-CCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCc
Confidence 99999999996 9999999999976 569999999999999999876667799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSR 352 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~ 352 (482)
|||+|||+ +.++.+||+|||+++....... .....+|+.|+|||++. +.++.++|||||||++|||++ |+.
T Consensus 462 lkp~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~ 538 (613)
T 2ozo_A 462 LAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538 (613)
T ss_dssp CSGGGEEE---EETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred CCHHHEEE---cCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99999999 4567899999999987643322 12234568999999886 579999999999999999998 999
Q ss_pred CCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||.+.+..++...+..+... .....+++++.+||.+||..||.+||++.++++
T Consensus 539 Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 539 PYKKMKGPEVMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TTTTCCSHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CCCCCCHHHHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999888888888765421 122458999999999999999999999999853
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=362.83 Aligned_cols=259 Identities=18% Similarity=0.219 Sum_probs=204.5
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
....++|++.+.||+|+||.||+|+.. +|+.||||++.... ......
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-----------------------------~~~~~~ 72 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRLA----DGTLVAVKRLKEER-----------------------------TQGGEL 72 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECCS----SSCCEEEEECCC----------------------------------CCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEec----CCCEEEEEEecccc-----------------------------CchHHH
Confidence 345678999999999999999999754 58899999986531 111122
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHC-
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---GKYSEEDAKIVMVQILSVVAFCHFQ- 272 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~l~~~~~~~i~~qi~~~L~yLH~~- 272 (482)
.+.+|+.+++.+. ||||+++++++.+.+..++|||||++|+|.+++.... ..+++..+..++.|++.||.|||++
T Consensus 73 ~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ 151 (326)
T 3uim_A 73 QFQTEVEMISMAV-HRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151 (326)
T ss_dssp HHHHHHHGGGTCC-CTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSS
T ss_pred HHHHHHHHHHhcc-CCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5789999999997 9999999999999999999999999999999887542 3499999999999999999999999
Q ss_pred --CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHH
Q 011582 273 --GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 273 --~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~el 347 (482)
||+||||||+|||+ +.++.+||+|||++....... ......||+.|+|||++. +.++.++|||||||++|+|
T Consensus 152 ~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l 228 (326)
T 3uim_A 152 DPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLEL 228 (326)
T ss_dssp SSCEECCCCSGGGEEE---CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHH
T ss_pred CCCeEeCCCchhhEEE---CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHH
Confidence 99999999999999 667889999999998764332 234456999999999885 4689999999999999999
Q ss_pred hhCCCCCCCC----ChHHHHHHHHhcCCC---CC--------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 348 LCGSRPFWAR----TESGIFRAVLKADPS---FD--------EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 348 ltg~~pf~~~----~~~~~~~~i~~~~~~---~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
++|..||... ............... .. .......++++.+||.+||+.||.+|||+.++++|-+-
T Consensus 229 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~ 308 (326)
T 3uim_A 229 ITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308 (326)
T ss_dssp HHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred HhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence 9999999521 111111111111100 00 00011124779999999999999999999999998654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=367.83 Aligned_cols=267 Identities=19% Similarity=0.239 Sum_probs=199.9
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|++.....++..||||++.+... ....|. ..........+
T Consensus 35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~----------------~~~~e~---~~~~~~~~~~~ 95 (345)
T 2v62_A 35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENG----------------PLFSEL---KFYQRVAKKDC 95 (345)
T ss_dssp TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-C----------------HHHHHH---HHHHHHCCHHH
T ss_pred cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCc----------------chHHHH---HHHHHHhhhHH
Confidence 35789999999999999999999976444678999999875310 000110 00111223457
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGV 274 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i 274 (482)
.+|+.+++.+. ||||+++++++.+ ....|+||||| +++|.+++... +.+++..++.++.||+.||.|||++||
T Consensus 96 ~~e~~~~~~l~-h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~i 172 (345)
T 2v62_A 96 IKKWIERKQLD-YLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEY 172 (345)
T ss_dssp HHHHHHHHTCS-CCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHhhcccc-ccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 78999999996 9999999999988 78899999999 99999987554 489999999999999999999999999
Q ss_pred cccCCCCCceEEecCCCCCcEEEEecccccccCCCC--------cccccccCccccCcccccc-cCCCcchhhhhHHHHH
Q 011582 275 VHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--------RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAY 345 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ 345 (482)
+||||||+|||++.+ ..+.+||+|||+++.+.... ......||+.|+|||++.+ .++.++|||||||++|
T Consensus 173 vH~Dlkp~NIll~~~-~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 251 (345)
T 2v62_A 173 VHGDIKAANLLLGYK-NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCML 251 (345)
T ss_dssp ECSCCSGGGEEEESS-STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred eCCCcCHHHEEEccC-CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHH
Confidence 999999999999642 22389999999998764321 1245689999999999875 5899999999999999
Q ss_pred HHhhCCCCCCCC--ChHHHHHHHHhcCCCCCCC-----CCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 346 ILLCGSRPFWAR--TESGIFRAVLKADPSFDEA-----PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 346 elltg~~pf~~~--~~~~~~~~i~~~~~~~~~~-----~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+|++|..||.+. ...............++.. ....+++++.+||.+||..||.+|||++++++
T Consensus 252 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 252 RWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 999999999653 2222222111111111110 01258999999999999999999999999986
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=378.53 Aligned_cols=255 Identities=21% Similarity=0.293 Sum_probs=210.2
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|++.. +|+.||||++.... ....
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~--------------------------------~~~~ 48 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQ---TNEEVAIKLENVKT--------------------------------KHPQ 48 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETT---TCCEEEEEEEETTC--------------------------------SSCC
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECC---CCcEEEEEEecccc--------------------------------ccHH
Confidence 456789999999999999999999876 79999999876431 0124
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++.|..|++|..+..++.+.+..||||||+ +++|.+++......+++..++.|+.||+.||.|||++|||||
T Consensus 49 ~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHr 127 (483)
T 3sv0_A 49 LLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHR 127 (483)
T ss_dssp HHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 6789999999985677888888888999999999999 899999987667789999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCc--------ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHh
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--------LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ell 348 (482)
||||+||||+..+.++.+||+|||+++.+..... ....+||+.|+|||++.+ .++.++|||||||+||+|+
T Consensus 128 DIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~ell 207 (483)
T 3sv0_A 128 DIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFL 207 (483)
T ss_dssp CCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHH
Confidence 9999999996545678899999999987654322 225789999999999875 6899999999999999999
Q ss_pred hCCCCCCCCCh---HHHHHHHHhcCCCCC-CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 349 CGSRPFWARTE---SGIFRAVLKADPSFD-EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 349 tg~~pf~~~~~---~~~~~~i~~~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+|+.||.+... .+.+..+........ ......+++++.+||..||..||.+||++.++++
T Consensus 208 tG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 208 RGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999987543 333444433221111 1112457899999999999999999999998775
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=363.46 Aligned_cols=249 Identities=16% Similarity=0.180 Sum_probs=200.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCC-----CCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSL-----KGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~-----~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
.++|++.+.||+|+||.||+|++..... .|+.||||++.+.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~---------------------------------- 86 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD---------------------------------- 86 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT----------------------------------
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----------------------------------
Confidence 4689999999999999999999875211 3789999998652
Q ss_pred HHHHHHHHHHHHhhcCCCCcce---------------eeEEEEe-CCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHH
Q 011582 195 IEDVRREVKILRALTGHKNLVQ---------------FYDAYED-DDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKI 257 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~hpniv~---------------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~ 257 (482)
+.+.+|+.+++++. ||||++ +++++.. ++..|+||||+ +++|.+++... ...+++..++.
T Consensus 87 -~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~ 163 (352)
T 2jii_A 87 -GRLFNEQNFFQRAA-KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQ 163 (352)
T ss_dssp -STHHHHHHHHHHHC-CHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHH
T ss_pred -chHHHHHHHHHHhc-ccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHH
Confidence 24779999999997 999887 6778776 78899999999 99999998754 36799999999
Q ss_pred HHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCC--cEEEEecccccccCCCC--------cccccccCccccCcccc
Q 011582 258 VMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENS--SLKAIDFGLSDYVKPDE--------RLNDIVGSAYYVAPEVL 327 (482)
Q Consensus 258 i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~--~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~ 327 (482)
++.||+.||.|||++||+||||||+|||++ .++ .+||+|||+++...... ......||+.|+|||++
T Consensus 164 i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~---~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 240 (352)
T 2jii_A 164 VACRLLDALEFLHENEYVHGNVTAENIFVD---PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLH 240 (352)
T ss_dssp HHHHHHHHHHHHHHTTCBCSCCCGGGEEEE---TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHH
T ss_pred HHHHHHHHHHHHHhCCccCCCCCHHHEEEc---CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHH
Confidence 999999999999999999999999999994 455 89999999997654322 12345899999999998
Q ss_pred cc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC--hHHHHHHHH---hcCCCCC--CCCCCCCCHHHHHHHHHhchhcccc
Q 011582 328 HR-SYGTEADMWSIGVIAYILLCGSRPFWART--ESGIFRAVL---KADPSFD--EAPWPSLSPEAIDFVKRLLNKDYRK 399 (482)
Q Consensus 328 ~~-~~~~~~DiwSlGvil~elltg~~pf~~~~--~~~~~~~i~---~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~ 399 (482)
.+ .++.++|||||||++|+|++|+.||.... ...+..... .....+. ...|..+++++.+||.+||+.||.+
T Consensus 241 ~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 320 (352)
T 2jii_A 241 KGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEE 320 (352)
T ss_dssp TTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTC
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhh
Confidence 75 68999999999999999999999998753 333333222 2222211 1223467999999999999999999
Q ss_pred CCCHHHHhc
Q 011582 400 RLTAAQALS 408 (482)
Q Consensus 400 R~s~~e~L~ 408 (482)
|||++++++
T Consensus 321 Rps~~~l~~ 329 (352)
T 2jii_A 321 KPPYAMLRN 329 (352)
T ss_dssp CCCHHHHHH
T ss_pred CCCHHHHHH
Confidence 999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=383.22 Aligned_cols=248 Identities=21% Similarity=0.302 Sum_probs=204.5
Q ss_pred eEec-ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 123 YELG-EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 123 y~~~-~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+.+. ++||+|+||.||+|.+... ..++.||||+++.. .......+.+.+|
T Consensus 370 ~~l~~~~LG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~----------------------------~~~~~~~~~~~~E 420 (635)
T 4fl3_A 370 LTLEDKELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNE----------------------------ANDPALKDELLAE 420 (635)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECS-SCEEEEEEEEECGG----------------------------GGCGGGHHHHHHH
T ss_pred ccccCCEeccCCCEEEEEEEEcCC-CcceEEEEEEeccc----------------------------cCCHHHHHHHHHH
Confidence 4443 4799999999999976432 25789999998653 1223345789999
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
+.+|++++ |||||++++++.+ +.+++|||||++|+|.+++.. ...+++..+..++.||+.||.|||++|||||||||
T Consensus 421 ~~il~~l~-hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp 497 (635)
T 4fl3_A 421 ANVMQQLD-NPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAA 497 (635)
T ss_dssp HHHHHHCC-CTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred HHHHHhCC-CCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCCh
Confidence 99999997 9999999999864 568999999999999998864 46799999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
+|||+ +.++.+||+|||+++.+..... .....||+.|+|||++.+ .++.++|||||||++|||++ |+.||.
T Consensus 498 ~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~ 574 (635)
T 4fl3_A 498 RNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYR 574 (635)
T ss_dssp GGEEE---EETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred HhEEE---eCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999 4567899999999987654322 233457889999999874 69999999999999999998 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+....++...+....... ....+++++.+||.+||..||.+||+++++++
T Consensus 575 ~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 575 GMKGSEVTAMLEKGERMG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp TCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999988888877664321 12458999999999999999999999999875
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=364.24 Aligned_cols=250 Identities=18% Similarity=0.216 Sum_probs=197.6
Q ss_pred cccceEecceeecCCceEEEEEEEec--CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKK--GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~--~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
..++|.+.+.||+|+||.||+|+... ...+|+.||||++... ...
T Consensus 63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---------------------------------~~~ 109 (365)
T 3e7e_A 63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---------------------------------NPW 109 (365)
T ss_dssp SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---------------------------------CHH
T ss_pred CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---------------------------------Chh
Confidence 35789999999999999999995322 1127899999998643 124
Q ss_pred HHHHHHHHHHhhcC--CCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTG--HKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILS----RGGKYSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~--hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~l~~~~~~~i~~qi~~~L~yLH 270 (482)
.+.+|+.+++.+.. |+||+++++++...+..|||||||+||+|.+++.. ....+++..++.++.||+.||.|||
T Consensus 110 ~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH 189 (365)
T 3e7e_A 110 EFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189 (365)
T ss_dssp HHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh
Confidence 56778888877742 89999999999999999999999999999999864 3467999999999999999999999
Q ss_pred HCCCcccCCCCCceEEec--------CCCCCcEEEEecccccccC---CCCcccccccCccccCcccccc-cCCCcchhh
Q 011582 271 FQGVVHRDLKPENFLFTS--------KEENSSLKAIDFGLSDYVK---PDERLNDIVGSAYYVAPEVLHR-SYGTEADMW 338 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~--------~~~~~~~kl~DfGla~~~~---~~~~~~~~~gt~~y~aPE~~~~-~~~~~~Diw 338 (482)
++|||||||||+|||++. .+.++.+||+|||+|+.+. ........+||+.|||||++.+ .|+.++|||
T Consensus 190 ~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 269 (365)
T 3e7e_A 190 DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYF 269 (365)
T ss_dssp TTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHH
T ss_pred hCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHH
Confidence 999999999999999953 1227889999999996543 3344566789999999999875 589999999
Q ss_pred hhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 339 SIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 339 SlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||||++|+|+||+.||........ .....+... ..++.+.+++..||+.+|.+|++..+.|.+
T Consensus 270 slG~il~elltg~~pf~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~ 332 (365)
T 3e7e_A 270 GVAATVYCMLFGTYMKVKNEGGEC-----KPEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ 332 (365)
T ss_dssp HHHHHHHHHHHSSCCCEEEETTEE-----EECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHHhCCCccccCCCCce-----eechhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence 999999999999999965432110 011111111 246789999999999999999765555543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=348.97 Aligned_cols=243 Identities=24% Similarity=0.372 Sum_probs=199.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|.+ +|+.||||++... ...+.+.
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~--------------------------------~~~~~~~ 62 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKND--------------------------------ATAQAFL 62 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCC--------------------------------C--HHHH
T ss_pred hhhceEEeEEecCCCceEEEEEE-----cCCEEEEEEecch--------------------------------hHHHHHH
Confidence 46899999999999999999976 4789999998542 1245788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeC-CeEEEEEecCCCCChHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDD-DNIYIVMELCKGGELLDRILSRGG-KYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+|+.+++++. ||||+++++++.+. +..|+||||+++++|.+++..... .+++..+..++.|++.||.|||++||+||
T Consensus 63 ~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~ 141 (278)
T 1byg_A 63 AEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 141 (278)
T ss_dssp HTHHHHTTCC-CTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHhCC-CCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCcccc
Confidence 9999999997 99999999987554 578999999999999998875432 38999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
||||+||++ +.++.+||+|||++...... .....+++.|+|||++. ..++.++||||||+++|+|++ |..||.
T Consensus 142 dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 216 (278)
T 1byg_A 142 DLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216 (278)
T ss_dssp CCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred CCCcceEEE---eCCCcEEEeecccccccccc--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCC
Confidence 999999999 56778999999999865432 23446789999999886 468999999999999999998 999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.....+....+..... ......+++++.++|.+||..||.+|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 217 RIPLKDVVPRVEKGYK---MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp TSCGGGHHHHHTTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHhcCCC---CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 8888777776655422 2223468999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=355.41 Aligned_cols=252 Identities=23% Similarity=0.318 Sum_probs=203.9
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|..++.||+|+||.||+|.. +|+.||||++.... ........+.+.+|+
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~--------------------------~~~~~~~~~~~~~E~ 81 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV-----NNTTVAVKKLAAMV--------------------------DITTEELKQQFDQEI 81 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES-----SSCEEEEEEECCCT--------------------------TSCTTTHHHHHHHHH
T ss_pred cccCCccccCCCeEEEEEEE-----CCceEEEEEEeccc--------------------------CcchHHHHHHHHHHH
Confidence 45568899999999999975 57899999986531 012234457889999
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR--GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
.+++.++ ||||+++++++.+.+..|+||||+++++|.+++... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 82 ~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlk 160 (307)
T 2nru_A 82 KVMAKCQ-HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIK 160 (307)
T ss_dssp HHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HHHHhcC-CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCC
Confidence 9999997 999999999999999999999999999999988643 3569999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|+|||+ +.++.+||+|||++....... ......||+.|+|||++.+.++.++||||||+++|+|++|..||...
T Consensus 161 p~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 237 (307)
T 2nru_A 161 SANILL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEH 237 (307)
T ss_dssp GGGEEE---CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTT
T ss_pred HHHEEE---cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccC
Confidence 999999 677899999999998764322 13346799999999999888999999999999999999999999775
Q ss_pred ChHH----HHHHHHhcCCCC-------CCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 358 TESG----IFRAVLKADPSF-------DEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 358 ~~~~----~~~~i~~~~~~~-------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.... +...+......+ ........++.+.++|.+||..||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 238 REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp BSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5432 222222211110 001112245778999999999999999999999863
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=350.89 Aligned_cols=241 Identities=29% Similarity=0.453 Sum_probs=193.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|+. .++.||||++... ...+.+.
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~--------------------------------~~~~~~~ 49 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKW-----RAKDVAIKQIESE--------------------------------SERKAFI 49 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEECSST--------------------------------THHHHHH
T ss_pred HhHeeeeeEeecCCCceEEEEEE-----CCeeEEEEEecCh--------------------------------hHHHHHH
Confidence 46899999999999999999986 4788999998432 2346788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG--GKYSEEDAKIVMVQILSVVAFCHF---QGV 274 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH~---~~i 274 (482)
+|+.+++++. ||||+++++++. +..|+||||++||+|.+++.... ..+++..+..++.|++.||.|||+ +||
T Consensus 50 ~E~~~l~~l~-hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~i 126 (307)
T 2eva_A 50 VELRQLSRVN-HPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126 (307)
T ss_dssp HHHHHHHHCC-CTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCC
T ss_pred HHHHHHhcCC-CCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCe
Confidence 9999999996 999999999876 44799999999999999886543 247899999999999999999999 899
Q ss_pred cccCCCCCceEEecCCCCC-cEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCC
Q 011582 275 VHRDLKPENFLFTSKEENS-SLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 275 vHrDlkp~NIll~~~~~~~-~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~ 352 (482)
+||||||+|||++ .++ .+||+|||++..... ......||+.|+|||++.+ .++.++|||||||++|+|++|+.
T Consensus 127 vH~dlkp~NIll~---~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 201 (307)
T 2eva_A 127 IHRDLKPPNLLLV---AGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201 (307)
T ss_dssp CCCCCSGGGEEEE---TTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCC
T ss_pred ecCCCChhHEEEe---CCCCEEEEccccccccccc--ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 9999999999995 344 489999999976543 2344579999999999875 68999999999999999999999
Q ss_pred CCCCCChH--HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 353 PFWARTES--GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 353 pf~~~~~~--~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||...... .....+.... .......+++++.+||.+||+.||.+|||++++++
T Consensus 202 p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 202 PFDEIGGPAFRIMWAVHNGT---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp TTTTTCSSHHHHHHHHHTTC---CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CchhhCccHHHHHHHHhcCC---CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99764332 2333333322 12233568999999999999999999999999987
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=371.73 Aligned_cols=253 Identities=24% Similarity=0.342 Sum_probs=207.9
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|.+. .+..||||+++... ...+.+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-------------------------------~~~~~~ 226 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGT-------------------------------MSPEAF 226 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEET----TTEEEEEEECCTTS-------------------------------SCHHHH
T ss_pred ChhHceeeeeecCCCCeEEEEEEEC----CCceEEEEEeccCC-------------------------------CCHHHH
Confidence 3468999999999999999999886 35679999986420 113578
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
.+|+.+|++++ ||||+++++++.+ +..|+|||||++|+|.+++... +..+++..+..++.||+.||.|||++||+||
T Consensus 227 ~~E~~~l~~l~-hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHr 304 (452)
T 1fmk_A 227 LQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHR 304 (452)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHHhCC-CCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence 99999999997 9999999999876 7789999999999999998643 3569999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRP 353 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~p 353 (482)
||||+|||+ +.++.+||+|||+++...... ......+|..|+|||++. +.++.++|||||||++|||++ |..|
T Consensus 305 Dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P 381 (452)
T 1fmk_A 305 DLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381 (452)
T ss_dssp CCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCS
T ss_pred CCChhhEEE---CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCC
Confidence 999999999 567789999999998765332 123345788999999886 569999999999999999999 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc--Cccccc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS--HPWLAN 414 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~--hp~~~~ 414 (482)
|.+....++...+..+.. .+ ....+++++.+||.+||+.||.+|||++++++ ..++..
T Consensus 382 ~~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 382 YPGMVNREVLDQVERGYR-MP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp STTCCHHHHHHHHHTTCC-CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCHHHHHHHHHcCCC-CC--CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 999988888887765532 22 22458999999999999999999999999987 355543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=394.54 Aligned_cols=263 Identities=25% Similarity=0.415 Sum_probs=210.9
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++.+.||+|+||.||+|.+.. +|+.||||++... ......+.+
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~---tg~~VAVKvi~~~-----------------------------~~~~~~~~~ 59 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQD---TGEQVAIKQCRQE-----------------------------LSPKNRERW 59 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTT---TTCCEEECCCCSC-----------------------------CCHHHHHHH
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECC---CCcEEEEEEeccc-----------------------------CCHHHHHHH
Confidence 34789999999999999999999876 7999999998642 234456788
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEe------CCeEEEEEecCCCCChHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYED------DDNIYIVMELCKGGELLDRILSRG--GKYSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~yLH 270 (482)
.+|+.+++++. ||||+++++++.. .+..|+|||||+||+|.+++.... ..+++..++.++.||+.||.|||
T Consensus 60 ~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLH 138 (676)
T 3qa8_A 60 CLEIQIMKKLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138 (676)
T ss_dssp HHHHHHHHHCC-BTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhCC-CCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99999999996 9999999998765 677899999999999999887543 36999999999999999999999
Q ss_pred HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh
Q 011582 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt 349 (482)
++||+||||||+|||++.++....+||+|||++.............||+.|+|||++. ..++.++|||||||++|+|++
T Consensus 139 s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLlt 218 (676)
T 3qa8_A 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218 (676)
T ss_dssp HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHS
T ss_pred HCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 9999999999999999765555679999999999877666667788999999999987 469999999999999999999
Q ss_pred CCCCCCCCChHHHHHH---------H-----HhcCCCCC------CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 350 GSRPFWARTESGIFRA---------V-----LKADPSFD------EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~---------i-----~~~~~~~~------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
|..||........+.. + ..+...+. ......+++++.+||.+||..||.+|||+.++|+|
T Consensus 219 G~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h 298 (676)
T 3qa8_A 219 GFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV 298 (676)
T ss_dssp SCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred CCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence 9999976543221100 0 00111111 11122367899999999999999999999999999
Q ss_pred ccccc
Q 011582 410 PWLAN 414 (482)
Q Consensus 410 p~~~~ 414 (482)
|||..
T Consensus 299 p~F~~ 303 (676)
T 3qa8_A 299 GCFQA 303 (676)
T ss_dssp TTHHH
T ss_pred HHHHH
Confidence 99975
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=380.37 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=213.4
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||.||+|++......+..||||++... ......+.+
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~-----------------------------~~~~~~~~~ 438 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC-----------------------------TSDSVREKF 438 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST-----------------------------TCHHHHHHH
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc-----------------------------CCHHHHHHH
Confidence 457899999999999999999998764445678999987542 234456789
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+++++. ||||+++++++. ++..|+|||||++|+|.+++......+++..+..++.||+.||.|||++||+|||
T Consensus 439 ~~E~~~l~~l~-HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrD 516 (656)
T 2j0j_A 439 LQEALTMRQFD-HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRD 516 (656)
T ss_dssp HHHHHHHHHCC-CTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHHhCC-CCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccc
Confidence 99999999996 999999999984 5678999999999999999987766899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|||+|||++ .++.+||+|||+++....... .....||+.|+|||++. ..++.++|||||||++|||++ |..||
T Consensus 517 ikp~NILl~---~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf 593 (656)
T 2j0j_A 517 IAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 593 (656)
T ss_dssp CSGGGEEEE---ETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred cchHhEEEe---CCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCC
Confidence 999999994 567899999999987654332 23346788999999886 469999999999999999997 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+....+....+....... ..+.+++++.+||.+||..||.+|||+.++++
T Consensus 594 ~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 594 QGVKNNDVIGRIENGERLP---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp TTCCHHHHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCC---CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999888888887764321 22458999999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=351.35 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=204.3
Q ss_pred ccceEecceeecCCceEEEEEEEec-CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKK-GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~-~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
.++|++++.||+|+||.||+|+... ...+|+.||||++... .....+.+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~------------------------------~~~~~~~~ 89 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS------------------------------TEEHLRDF 89 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC------------------------------CSHHHHHH
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC------------------------------CHHHHHHH
Confidence 4679999999999999999998432 1226899999998542 23345678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCC--eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDD--NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+|+.++++++ ||||+++++++...+ .+++||||+++++|.+++......+++..++.++.||+.||.|||++||+|
T Consensus 90 ~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 168 (326)
T 2w1i_A 90 EREIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 168 (326)
T ss_dssp HHHHHHHHTCC-CTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHhCC-CCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 99999999996 999999999987654 789999999999999999877677999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~ 351 (482)
|||||+|||+ +.++.+||+|||++........ .....+|..|+|||++.+ .++.++|||||||++|+|++|.
T Consensus 169 ~dikp~NIli---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~ 245 (326)
T 2w1i_A 169 RDLATRNILV---ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI 245 (326)
T ss_dssp SCCCGGGEEE---EETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTT
T ss_pred cCCCcceEEE---cCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcC
Confidence 9999999999 4567899999999987654332 233467888999998864 5889999999999999999999
Q ss_pred CCCCCCCh------------HH---HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 352 RPFWARTE------------SG---IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 352 ~pf~~~~~------------~~---~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.||..... .. .+..........+ ....+++++.+||.+||..||.+|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 246 EKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLP--RPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp CGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCC--CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCC--CCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99854211 01 1112222222222 23468999999999999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=375.93 Aligned_cols=252 Identities=24% Similarity=0.348 Sum_probs=212.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|.+. .+..||||+++... ...+.+.
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~----~~~~vavK~~~~~~-------------------------------~~~~~~~ 310 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPGT-------------------------------MSPEAFL 310 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET----TTEEEEEEEECTTS-------------------------------SCHHHHH
T ss_pred hhhhhhheecccCCCeEEEEEEEC----CCceEEEEEeCCCC-------------------------------CCHHHHH
Confidence 467999999999999999999886 35679999986420 1135789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+|++|+ ||||+++++++.+ +.+|||||||++|+|.+++... +..+++.++..++.||+.||.|||++||||||
T Consensus 311 ~E~~~l~~l~-hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrD 388 (535)
T 2h8h_A 311 QEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388 (535)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHhCC-CCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCC
Confidence 9999999997 9999999999876 7789999999999999998643 35699999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|||+|||+ +.++.+||+|||+++...... ......++..|+|||++. +.++.++|||||||++|||++ |..||
T Consensus 389 lkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~ 465 (535)
T 2h8h_A 389 LRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY 465 (535)
T ss_dssp CSGGGEEE---CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSS
T ss_pred CCHhhEEE---cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 99999999 567789999999998765322 123345778999999886 569999999999999999999 99999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC--ccccc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH--PWLAN 414 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h--p~~~~ 414 (482)
.+....+++..+..... .+ ....+++++.+||.+||+.||.+|||++++++. .++..
T Consensus 466 ~~~~~~~~~~~i~~~~~-~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 466 PGMVNREVLDQVERGYR-MP--CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp TTCCHHHHHHHHHTTCC-CC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred CCCCHHHHHHHHHcCCC-CC--CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 99988888887765532 22 224689999999999999999999999999873 45543
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=350.13 Aligned_cols=251 Identities=23% Similarity=0.337 Sum_probs=194.7
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
...+.++|++.+.||+|+||.||+|++ +|+.||||++... ..
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~vavK~~~~~---------------------------------~~ 73 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW-----RGEKVAVKVFFTT---------------------------------EE 73 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEEEGG---------------------------------GH
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE-----CCceEEEEEEecc---------------------------------cc
Confidence 455678999999999999999999986 4889999998542 11
Q ss_pred HHHHHHHHHHHhh-cCCCCcceeeEEEEeC----CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 011582 196 EDVRREVKILRAL-TGHKNLVQFYDAYEDD----DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCH 270 (482)
Q Consensus 196 ~~~~~Ei~~l~~l-~~hpniv~l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH 270 (482)
....+|.+++..+ .+||||+++++++.+. ..+|+|||||++|+|.+++... .+++..++.++.|++.||.|||
T Consensus 74 ~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~l~~lH 151 (337)
T 3mdy_A 74 ASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLH 151 (337)
T ss_dssp HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHH
T ss_pred chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHH
Confidence 2344555555443 1499999999999987 7899999999999999988553 6999999999999999999999
Q ss_pred HC--------CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc-----ccccccCccccCccccccc-CCC---
Q 011582 271 FQ--------GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER-----LNDIVGSAYYVAPEVLHRS-YGT--- 333 (482)
Q Consensus 271 ~~--------~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~--- 333 (482)
++ ||+||||||+|||+ +.++.+||+|||++........ ....+||+.|+|||++.+. ++.
T Consensus 152 ~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 228 (337)
T 3mdy_A 152 TEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQ 228 (337)
T ss_dssp SCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTH
T ss_pred HhhhhhccCCCEEecccchHHEEE---CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCcccc
Confidence 99 99999999999999 5677899999999976643322 2356899999999998753 444
Q ss_pred ---cchhhhhHHHHHHHhhC----------CCCCCCCC----hHHHHHHHHhcCCCCCCCC----CCCCCHHHHHHHHHh
Q 011582 334 ---EADMWSIGVIAYILLCG----------SRPFWART----ESGIFRAVLKADPSFDEAP----WPSLSPEAIDFVKRL 392 (482)
Q Consensus 334 ---~~DiwSlGvil~elltg----------~~pf~~~~----~~~~~~~i~~~~~~~~~~~----~~~~s~~~~~li~~~ 392 (482)
++|||||||++|+|++| ..||.... .......+.......+... ...+++++.+||.+|
T Consensus 229 ~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 308 (337)
T 3mdy_A 229 SYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTEC 308 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHH
T ss_pred CccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHh
Confidence 38999999999999999 77775432 1222233222211111110 013567799999999
Q ss_pred chhccccCCCHHHHhcC
Q 011582 393 LNKDYRKRLTAAQALSH 409 (482)
Q Consensus 393 L~~dP~~R~s~~e~L~h 409 (482)
|+.||.+|||+.++++|
T Consensus 309 l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 309 WAHNPASRLTALRVKKT 325 (337)
T ss_dssp SCSSGGGSCCHHHHHHH
T ss_pred hhhChhhCCCHHHHHHH
Confidence 99999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=355.40 Aligned_cols=248 Identities=22% Similarity=0.373 Sum_probs=204.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|++.. .||||++.... ......+.+.
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~------~~avk~~~~~~----------------------------~~~~~~~~~~ 77 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG------EVAIRLIDIER----------------------------DNEDQLKAFK 77 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS------SEEEEECCCCS----------------------------CCCCCCCCCC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC------eEEEEEeecCC----------------------------CCHHHHHHHH
Confidence 4689999999999999999998742 49999986531 0011113356
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.++++++ ||||+++++++.+.+.+++||||++|++|.+++......+++..++.++.||+.||.|||++||+||||
T Consensus 78 ~e~~~l~~l~-h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl 156 (319)
T 2y4i_B 78 REVMAYRQTR-HENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156 (319)
T ss_dssp TTGGGGTTCC-CTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHHHhcCC-CCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Confidence 7889999996 999999999999999999999999999999988666567999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCC------CCcccccccCccccCcccccc----------cCCCcchhhhhHHH
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKP------DERLNDIVGSAYYVAPEVLHR----------SYGTEADMWSIGVI 343 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~------~~~~~~~~gt~~y~aPE~~~~----------~~~~~~DiwSlGvi 343 (482)
||+|||++ ++.+||+|||++..... ........||+.|+|||++.+ .++.++|||||||+
T Consensus 157 kp~NIl~~----~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~i 232 (319)
T 2y4i_B 157 KSKNVFYD----NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTI 232 (319)
T ss_dssp CSTTEEEC------CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHH
T ss_pred ChhhEEEe----CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHH
Confidence 99999993 46899999999875432 122344569999999998753 37889999999999
Q ss_pred HHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 344 AYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 344 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+|+|++|..||...........+....... .....+++++.+||.+||..||.+|||+.++++
T Consensus 233 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 233 WYELHAREWPFKTQPAEAIIWQMGTGMKPN--LSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHHHSSCSSSSCCHHHHHHHHHTTCCCC--CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHHhCCCCCCCCCHHHHHHHhccCCCCC--CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999988888877776654322 222358899999999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=363.14 Aligned_cols=256 Identities=19% Similarity=0.207 Sum_probs=198.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|++ +|+.||||++.+.... .. ........+.+.
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-----~~~~vAvK~~~~~~~~--------~~--------------~~~~~~~~~~~~ 71 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-----DHTPVAIKIIAIEGPD--------LV--------------NGSHQKTFEEIL 71 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-----TTEEEEEEEEEESCSS--------CB--------------TTBCCBCHHHHH
T ss_pred cccchheeeecccCceEEEEEEe-----CCceEEEEEEecCCcc--------cc--------------ccccchhHHHHH
Confidence 46899999999999999999987 5799999999764100 00 001122346788
Q ss_pred HHHHHHHhhc--------CCCCcceeeEEEE------------------------------eCCeEEEEEecCCCCChHH
Q 011582 200 REVKILRALT--------GHKNLVQFYDAYE------------------------------DDDNIYIVMELCKGGELLD 241 (482)
Q Consensus 200 ~Ei~~l~~l~--------~hpniv~l~~~~~------------------------------~~~~~~lv~e~~~~g~L~~ 241 (482)
+|+.+|+.++ .||||+++.+++. +.+.+|||||||++|++++
T Consensus 72 ~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~ 151 (336)
T 2vuw_A 72 PEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLE 151 (336)
T ss_dssp HHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETG
T ss_pred HHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHH
Confidence 9999999886 5888888887753 2688999999999998877
Q ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHH-HCCCcccCCCCCceEEecCC-----------------CCCcEEEEecccc
Q 011582 242 RILSRGGKYSEEDAKIVMVQILSVVAFCH-FQGVVHRDLKPENFLFTSKE-----------------ENSSLKAIDFGLS 303 (482)
Q Consensus 242 ~l~~~~~~l~~~~~~~i~~qi~~~L~yLH-~~~ivHrDlkp~NIll~~~~-----------------~~~~~kl~DfGla 303 (482)
.+.+ ..+++..++.++.||+.||.||| ++||+||||||+|||++.++ ....+||+|||+|
T Consensus 152 ~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a 229 (336)
T 2vuw_A 152 QMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLS 229 (336)
T ss_dssp GGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTC
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeecccc
Confidence 7743 57899999999999999999999 99999999999999996432 1238999999999
Q ss_pred cccCCCCcccccccCccccCcccccccCCCcchhhhhHHH-HHHHhhCCCCCCCCCh-HHHHHHHHhcCCC---CCCCCC
Q 011582 304 DYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVI-AYILLCGSRPFWARTE-SGIFRAVLKADPS---FDEAPW 378 (482)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvi-l~elltg~~pf~~~~~-~~~~~~i~~~~~~---~~~~~~ 378 (482)
+..... ..+||+.|||||++.+..+.++||||+|++ .+++++|..||.+... ......+...... .....+
T Consensus 230 ~~~~~~----~~~gt~~y~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (336)
T 2vuw_A 230 RLERDG----IVVFCDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAM 305 (336)
T ss_dssp BEEETT----EEECCCCTTCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHH
T ss_pred EecCCC----cEEEeecccChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhh
Confidence 876532 458999999999998877889999998777 7889999999943211 2233333322111 111123
Q ss_pred CCCCHHHHHHHHHhchhccccCCCHHHHh-cCcccc
Q 011582 379 PSLSPEAIDFVKRLLNKDYRKRLTAAQAL-SHPWLA 413 (482)
Q Consensus 379 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L-~hp~~~ 413 (482)
+.+++++++||++||+.| |++|+| +||||+
T Consensus 306 ~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 306 KQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred hhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 357899999999999976 999999 999995
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=350.98 Aligned_cols=252 Identities=23% Similarity=0.342 Sum_probs=189.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+. +|+.||||++... ....+.
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---------------------------------~~~~~~ 53 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-----DERPVAVKVFSFA---------------------------------NRQNFI 53 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-----TTEEEEEEEEEGG---------------------------------GHHHHH
T ss_pred hHHhheeeecccCCCeEEEEEEE-----CCeEEEEEEeecc---------------------------------chhhHH
Confidence 46899999999999999999965 5889999998642 012333
Q ss_pred HHHHH--HHhhcCCCCcceeeEEEEe-----CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 200 REVKI--LRALTGHKNLVQFYDAYED-----DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 200 ~Ei~~--l~~l~~hpniv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
.|..+ +..+. ||||+++++.+.. ...+|+|||||++|+|.+++... .+++..+..++.||+.||.|||++
T Consensus 54 ~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~ 130 (336)
T 3g2f_A 54 NEKNIYRVPLME-HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTE 130 (336)
T ss_dssp HHHHHHTSTTCC-CTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHHhcc-CcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhh
Confidence 34444 44565 9999999986643 33679999999999999988654 569999999999999999999999
Q ss_pred ---------CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---------cccccccCccccCcccccc-----
Q 011582 273 ---------GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---------RLNDIVGSAYYVAPEVLHR----- 329 (482)
Q Consensus 273 ---------~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---------~~~~~~gt~~y~aPE~~~~----- 329 (482)
||+||||||+|||+ +.++.+||+|||++..+.... .....+||+.|+|||++.+
T Consensus 131 ~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 207 (336)
T 3g2f_A 131 LPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLR 207 (336)
T ss_dssp BCCGGGCBCCEECSSCSGGGEEE---CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGG
T ss_pred hccccccccceeecccccceEEE---cCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccc
Confidence 99999999999999 567889999999998764321 2234579999999999864
Q ss_pred ---cCCCcchhhhhHHHHHHHhhCCCCCCCCCh-----------------HHHHHHHHhcCC---CCCCCCCC---CCCH
Q 011582 330 ---SYGTEADMWSIGVIAYILLCGSRPFWARTE-----------------SGIFRAVLKADP---SFDEAPWP---SLSP 383 (482)
Q Consensus 330 ---~~~~~~DiwSlGvil~elltg~~pf~~~~~-----------------~~~~~~i~~~~~---~~~~~~~~---~~s~ 383 (482)
.++.++|||||||++|+|++|..||..... .+.......... .++ ..|. .+++
T Consensus 208 ~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 286 (336)
T 3g2f_A 208 DXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFP-EAWKENSLAVR 286 (336)
T ss_dssp GHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCC-TTCCCCSHHHH
T ss_pred cccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCC-cccccccchHH
Confidence 366789999999999999999777643211 111122221111 111 1111 2456
Q ss_pred HHHHHHHHhchhccccCCCHHHHh------cCcccccCC
Q 011582 384 EAIDFVKRLLNKDYRKRLTAAQAL------SHPWLANSH 416 (482)
Q Consensus 384 ~~~~li~~~L~~dP~~R~s~~e~L------~hp~~~~~~ 416 (482)
++.+||.+||+.||.+|||+.|++ -++|-++..
T Consensus 287 ~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~~ 325 (336)
T 3g2f_A 287 SLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKS 325 (336)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC---
T ss_pred HHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhccc
Confidence 899999999999999999999994 567776654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=349.79 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=202.3
Q ss_pred ccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 116 SKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 116 ~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
...+.++|++.+.||+|+||.||+|++ +|+.||||++... ..
T Consensus 37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~---------------------------------~~ 78 (342)
T 1b6c_B 37 QRTIARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR---------------------------------EE 78 (342)
T ss_dssp HHHHHHHCEEEEEEEEETTEEEEEEEE-----TTEEEEEEEECGG---------------------------------GH
T ss_pred cccccccEEEEeeecCCCCcEEEEEEE-----cCccEEEEEeCch---------------------------------hH
Confidence 445678999999999999999999986 5889999998542 13
Q ss_pred HHHHHHHHHHHh--hcCCCCcceeeEEEEeCC----eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 011582 196 EDVRREVKILRA--LTGHKNLVQFYDAYEDDD----NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 196 ~~~~~Ei~~l~~--l~~hpniv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yL 269 (482)
..+.+|++++.. +. ||||+++++++...+ .+|+||||+++|+|.+++.. ..+++..++.++.|++.||.||
T Consensus 79 ~~~~~e~~~~~~~~l~-h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~l 155 (342)
T 1b6c_B 79 RSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHL 155 (342)
T ss_dssp HHHHHHHHHHHHSCCC-CTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhhcC-CCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHH
Confidence 467789999887 54 999999999998876 89999999999999998865 3699999999999999999999
Q ss_pred H--------HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC-----cccccccCccccCccccccc------
Q 011582 270 H--------FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLHRS------ 330 (482)
Q Consensus 270 H--------~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~------ 330 (482)
| ++||+||||||+|||+ +.++.+||+|||++....... ......||+.|+|||++.+.
T Consensus 156 H~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 232 (342)
T 1b6c_B 156 HMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF 232 (342)
T ss_dssp HCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCH
T ss_pred HHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhccccccccc
Confidence 9 8999999999999999 567789999999998765443 23456899999999998653
Q ss_pred -CCCcchhhhhHHHHHHHhhC----------CCCCCCCC-----hHHHHHHHHhcCCCCCCC-CC--CCCCHHHHHHHHH
Q 011582 331 -YGTEADMWSIGVIAYILLCG----------SRPFWART-----ESGIFRAVLKADPSFDEA-PW--PSLSPEAIDFVKR 391 (482)
Q Consensus 331 -~~~~~DiwSlGvil~elltg----------~~pf~~~~-----~~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~ 391 (482)
++.++|||||||++|+|++| ..||.... ...+...+.......... .| ...++.+.+||.+
T Consensus 233 ~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 312 (342)
T 1b6c_B 233 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRE 312 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHH
T ss_pred ccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHH
Confidence 23689999999999999999 78986642 233444443332221111 01 1234678999999
Q ss_pred hchhccccCCCHHHHhcC
Q 011582 392 LLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 392 ~L~~dP~~R~s~~e~L~h 409 (482)
||+.||.+|||+.++++|
T Consensus 313 cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 313 CWYANGAARLTALRIKKT 330 (342)
T ss_dssp HCCSSGGGSCCHHHHHHH
T ss_pred HhccChhhCCCHHHHHHH
Confidence 999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=368.59 Aligned_cols=249 Identities=17% Similarity=0.197 Sum_probs=193.7
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
...|.+++.||+|+||.||+|++.. +|+.||||++.... .......+.+.
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~---~g~~vAvK~~~~~~---------------------------~~~~~~~~~~~ 126 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQE---TGESFEVHVPYFTE---------------------------RPPSNAIKQMK 126 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEECCSC---------------------------C----CCHHHH
T ss_pred ceeEEEecccccCCCEEEEEEEecC---CCCceEEEEEecCC---------------------------CccHHHHHHHH
Confidence 3468899999999999999999876 79999999986320 01122346788
Q ss_pred HHHHHHHhhcCC-CCc---------ce------------eeEEEEe-----CCeEEEEEecCCCCChHHHHHh------c
Q 011582 200 REVKILRALTGH-KNL---------VQ------------FYDAYED-----DDNIYIVMELCKGGELLDRILS------R 246 (482)
Q Consensus 200 ~Ei~~l~~l~~h-pni---------v~------------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~------~ 246 (482)
+|+.+++.+. | +|. +. +..++.. ...++++|+++ +++|.+++.. .
T Consensus 127 ~E~~~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~ 204 (413)
T 3dzo_A 127 EEVLRLRLLR-GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSST 204 (413)
T ss_dssp HHHHGGGGST-TCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTT
T ss_pred HHHHHHHhhc-cCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhccccc
Confidence 9999999886 5 321 11 1111121 23468888877 5789887741 2
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccc
Q 011582 247 GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEV 326 (482)
Q Consensus 247 ~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~ 326 (482)
...+++..+..++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+++.... .....+| +.|+|||+
T Consensus 205 ~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~ 278 (413)
T 3dzo_A 205 HKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--SAVSPIG-RGFAPPET 278 (413)
T ss_dssp SHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTE--EECCCCC-TTTCCHHH
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE---ecCCeEEEEeccceeecCC--ccccCCC-CceeCchh
Confidence 3457888999999999999999999999999999999999 6677899999999886543 2556678 99999998
Q ss_pred c----------cc-cCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchh
Q 011582 327 L----------HR-SYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNK 395 (482)
Q Consensus 327 ~----------~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 395 (482)
+ .+ .|+.++|||||||++|+|++|+.||...+..+....+.. .+..+++++.+||.+||+.
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~ 350 (413)
T 3dzo_A 279 TAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRY 350 (413)
T ss_dssp HHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCS
T ss_pred hhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccC
Confidence 8 32 378899999999999999999999987765444333322 2346899999999999999
Q ss_pred ccccCCCHHHHhcCccccc
Q 011582 396 DYRKRLTAAQALSHPWLAN 414 (482)
Q Consensus 396 dP~~R~s~~e~L~hp~~~~ 414 (482)
||.+||++.++|+||||+.
T Consensus 351 dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 351 PKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp SGGGSCCHHHHTTSHHHHH
T ss_pred ChhhCcCHHHHHhCHHHHH
Confidence 9999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.73 Aligned_cols=228 Identities=14% Similarity=0.062 Sum_probs=186.0
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++... ........+.
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~---~~~~vavK~~~~~---------------------------~~~~~~~~~~ 77 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTA---LDRQVALTFVDPQ---------------------------GVLPDDVLQE 77 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETT---TTEEEEEEESCTT---------------------------CCSCHHHHHH
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecC---CCceEEEEEECcc---------------------------cccCHHHHHH
Confidence 345789999999999999999999876 7999999998653 1123455678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+++++. ||||+++++++.+.+..|+||||++|++|.+++. . .....++..++.||+.||.|||++||+||
T Consensus 78 ~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~-~--~~~~~~~~~i~~ql~~aL~~lH~~givH~ 153 (286)
T 3uqc_A 78 TLSRTLRLSRID-KPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-T--SPSPVGAIRAMQSLAAAADAAHRAGVALS 153 (286)
T ss_dssp HHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHT-T--CCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred HHHHHHHHhcCC-CCCcceeeEEEEECCcEEEEEEecCCCCHHHHHh-c--CCChHHHHHHHHHHHHHHHHHHHCCCccC
Confidence 999999999996 9999999999999999999999999999999873 2 34677889999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||||+|||+ +.++.+||+++| |++| ++.++|||||||++|+|++|+.||.+.
T Consensus 154 Dikp~NIll---~~~g~~kl~~~~-------------------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~ 205 (286)
T 3uqc_A 154 IDHPSRVRV---SIDGDVVLAYPA-------------------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEA 205 (286)
T ss_dssp CCSGGGEEE---ETTSCEEECSCC-------------------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCC
T ss_pred CCCcccEEE---cCCCCEEEEecc-------------------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 999999999 466788887443 4443 688999999999999999999999876
Q ss_pred ChHHHHH---HHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 358 TESGIFR---AVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 358 ~~~~~~~---~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+..+.+. ..............+.+++++.+||.+||+.||.+| |+.++++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 206 GVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp SBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred CcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 5432110 011111111112235689999999999999999999 9999987
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-43 Score=381.29 Aligned_cols=247 Identities=25% Similarity=0.346 Sum_probs=203.6
Q ss_pred cccccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHH
Q 011582 115 FSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIA 194 (482)
Q Consensus 115 ~~~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (482)
..+.+.++|++.+.||+|+||.||+|++... +|+.||||++... .....
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~--~~~~vaiK~~~~~-----------------------------~~~~~ 122 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNV--NGRPVVLKGLVHS-----------------------------GDAEA 122 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGG--TTEEEEEEESCSS-----------------------------CCHHH
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCC--CCcEEEEEEeCcc-----------------------------CCHHH
Confidence 3455678999999999999999999998642 5889999998542 23345
Q ss_pred HHHHHHHHHHHHhhcCCCCcceeeEEEEeCCe-----EEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 011582 195 IEDVRREVKILRALTGHKNLVQFYDAYEDDDN-----IYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 195 ~~~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yL 269 (482)
...+.+|+.+++++. ||||+++++++.+.+. .||||||++|++|.+++. ..+++.++..++.||+.||.||
T Consensus 123 ~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~---~~l~~~~~~~~~~qi~~aL~~l 198 (681)
T 2pzi_A 123 QAMAMAERQFLAEVV-HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG---QKLPVAEAIAYLLEILPALSYL 198 (681)
T ss_dssp HHHHHHHHGGGGGCC-CTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcC-CCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHh---CCCCHHHHHHHHHHHHHHHHHH
Confidence 567899999999997 9999999999987665 799999999999988663 2799999999999999999999
Q ss_pred HHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhh
Q 011582 270 HFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 270 H~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~ellt 349 (482)
|++|||||||||+|||++ . +.+||+|||++...... ...+||+.|+|||++.+.++.++|||||||++|+|++
T Consensus 199 H~~giiHrDlkp~NIll~---~-~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~ 271 (681)
T 2pzi_A 199 HSIGLVYNDLKPENIMLT---E-EQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTL 271 (681)
T ss_dssp HHTTEECCCCSGGGEEEC---S-SCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHS
T ss_pred HHCCCeecccChHHeEEe---C-CcEEEEecccchhcccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHh
Confidence 999999999999999994 3 37999999999876543 5568999999999998778999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 350 GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
|..||.+.....+ ........+++.+.+||.+||+.||.+||+..+++.|+|+.
T Consensus 272 g~~~~~~~~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 272 DLPTRNGRYVDGL----------PEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp CCCEETTEECSSC----------CTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCCCCcccccccc----------cccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence 9999865321100 00111112468899999999999999999999999998874
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-36 Score=323.03 Aligned_cols=196 Identities=18% Similarity=0.122 Sum_probs=138.6
Q ss_pred eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
.++.|++|.+..++... .|+.||||++.+..... ... ........+++.+|+++|++
T Consensus 241 ~~~~~~~~~h~~~rr~~---fg~~~~~K~~~~~~~~~------~~~--------------~~~~~~~~~~~~~E~~~l~~ 297 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYF---FGEDYVCKFFYYDMPHG------ILT--------------AEESQRNKYELHNEIKFLTQ 297 (569)
T ss_dssp C-C--------CCEEEE---ECSSEEEEEEESSCSTT------CSC--------------HHHHHHHHHHHHHHHHHHHS
T ss_pred ccccCCccccccccccc---ccceeEEEEEecccccc------cch--------------hhhhHHHHHHHHHHHHHHHh
Confidence 46778888777777665 79999999997642100 000 01234456789999999999
Q ss_pred hcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEEe
Q 011582 208 LTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFT 287 (482)
Q Consensus 208 l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~ 287 (482)
+..|+||+++++++++++.+|||||||+|++|.++|.. ++.+++. .|+.||+.||.|||++|||||||||+|||+
T Consensus 298 ~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL- 372 (569)
T 4azs_A 298 PPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV- 372 (569)
T ss_dssp CCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE-
T ss_pred cCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE-
Confidence 97799999999999999999999999999999998865 4678765 488999999999999999999999999999
Q ss_pred cCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCC
Q 011582 288 SKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 288 ~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~p 353 (482)
+.++.+||+|||+|+..... ....+.+||+.|||||++.+.+..++|+||+|+++++|.++..+
T Consensus 373 --~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 373 --DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-----------------CCCCTTHHH
T ss_pred --CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCCCCCcccccccccchhhhccccch
Confidence 66788999999999876543 34567899999999999999889999999999999988776544
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-29 Score=268.17 Aligned_cols=189 Identities=23% Similarity=0.214 Sum_probs=145.4
Q ss_pred EecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHH
Q 011582 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVK 203 (482)
Q Consensus 124 ~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~ 203 (482)
...+.||+|+||.||+|.. .+..+|+|+...... . . .........+.+.+|+.
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-----~~~~~~~k~~~~~~~---------~--~-----------~~~~~~~~~~~~~~E~~ 391 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-----LDFDVIIKERVKKGY---------R--D-----------ERLDENIRKSRTAREAR 391 (540)
T ss_dssp ---------CCEEEEEEEC-----SSCEEEEEEECCCTT---------S--C-----------HHHHHHHHHHHHHHHHH
T ss_pred CCCCEEeeCCCEEEEEEEE-----CCCeEEEEEEecccc---------c--c-----------hhhhhHHHHHHHHHHHH
Confidence 4466899999999999943 578999998643200 0 0 00112234567899999
Q ss_pred HHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCc
Q 011582 204 ILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPEN 283 (482)
Q Consensus 204 ~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~N 283 (482)
+|++++ ||||+++..++...+..|||||||+|++|.+++.. +..++.|++.||.|||++||+||||||+|
T Consensus 392 il~~l~-h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~N 461 (540)
T 3en9_A 392 YLALVK-DFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSN 461 (540)
T ss_dssp HHHHGG-GGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTS
T ss_pred HHHhcC-CCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHH
Confidence 999997 99999766666688888999999999999998743 66899999999999999999999999999
Q ss_pred eEEecCCCCCcEEEEecccccccCCCCc--------ccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhhCCC
Q 011582 284 FLFTSKEENSSLKAIDFGLSDYVKPDER--------LNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 284 Ill~~~~~~~~~kl~DfGla~~~~~~~~--------~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~elltg~~ 352 (482)
||++ . .+||+|||+++....... ....+||+.|||||++.. .|+..+|+||..+-..+.+-++.
T Consensus 462 ILl~---~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~ 536 (540)
T 3en9_A 462 FIFD---K--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRA 536 (540)
T ss_dssp EEES---S--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCS
T ss_pred EEEC---C--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcc
Confidence 9994 3 899999999998754322 236789999999999864 58888999999999888888777
Q ss_pred CC
Q 011582 353 PF 354 (482)
Q Consensus 353 pf 354 (482)
+|
T Consensus 537 rY 538 (540)
T 3en9_A 537 RY 538 (540)
T ss_dssp CC
T ss_pred cc
Confidence 66
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.5e-26 Score=219.86 Aligned_cols=174 Identities=26% Similarity=0.273 Sum_probs=123.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
..|.+++.||+|+||.||+|.+ . +|+.||||+++..... ....... .++. ...........+.+
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~-~---~g~~valK~~~~~~~~------~~~~~~~-----~~~~-~~~w~~~~~~~~~~ 153 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYS-E---KFGECVVKFHKVGHTS------FKKVKEK-----RDYG-DLHFSVLAIRSARN 153 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEE-T---TTEEEEEEEECC------------CCCC-------------CHHHHHHHHHHH
T ss_pred eEEEecCEeccCCCceEEEEEe-C---CCCEEEEEEEECCCCc------hhhhhhh-----hhhc-chhhHHHHHHHHHH
Confidence 3466779999999999999998 4 7999999998643100 0000000 0000 00001124567899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|+++. | +++.+++.. +..|+|||||+|++|.+ +. ......++.|++.||.|||++||+|||||
T Consensus 154 E~~~l~~l~-~---~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~lH~~giiHrDlk 220 (282)
T 1zar_A 154 EFRALQKLQ-G---LAVPKVYAW-EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAKFYHRGIVHGDLS 220 (282)
T ss_dssp HHHHHHHTT-T---SSSCCEEEE-ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHHhcc-C---CCcCeEEec-cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHHHHHCCCEeCCCC
Confidence 999999996 4 555555443 55699999999999987 41 12355799999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-----------cCCCcchhhh
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-----------SYGTEADMWS 339 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~DiwS 339 (482)
|+|||+ + ++.+||+|||+|+. +..++|||++.+ .|+..+|+|.
T Consensus 221 p~NILl---~-~~~vkl~DFG~a~~------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 221 QYNVLV---S-EEGIWIIDFPQSVE------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp TTSEEE---E-TTEEEECCCTTCEE------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred HHHEEE---E-CCcEEEEECCCCeE------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999 4 77899999999864 345789998742 3555566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=3.3e-22 Score=192.20 Aligned_cols=162 Identities=16% Similarity=0.140 Sum_probs=109.6
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCce--EEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQD--VAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~--vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
-|++.+.||+|+||.||+|.+.. +|+. ||||+++...............+. .+.... ..........+.
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~---~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~~~ 118 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVF---DGKPVAMAVKIYRIETSEFDKMDEYLYGDE-RFDMRR-----ISPKEKVFIWTE 118 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEE---TTEEEEEEEEEECCC-------GGGTTTCT-TSCC---------CHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcC---CCcEeeEEEEEEECCccchhhHHHhhcccc-hhhhhc-----cChHHHHHHHHH
Confidence 37899999999999999999855 6888 999997543100000000000000 000000 000122345688
Q ss_pred HHHHHHHhhcCCCCc--ceeeEEEEeCCeEEEEEecCCC-C----ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-H
Q 011582 200 REVKILRALTGHKNL--VQFYDAYEDDDNIYIVMELCKG-G----ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCH-F 271 (482)
Q Consensus 200 ~Ei~~l~~l~~hpni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH-~ 271 (482)
+|+.+|+.+. |+++ ..++++ +..+|||||+.+ | +|.+... ..++..+..++.|++.||.||| +
T Consensus 119 ~E~~~l~~l~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~ 189 (258)
T 1zth_A 119 KEFRNLERAK-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGR----ELKELDVEGIFNDVVENVKRLYQE 189 (258)
T ss_dssp HHHHHHHHHH-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGG----GGGGSCHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHH-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhh----ccChHHHHHHHHHHHHHHHHHHHH
Confidence 9999999997 7754 444432 356899999942 3 5655432 1345678899999999999999 9
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEeccccccc
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV 306 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~ 306 (482)
.|||||||||+|||++ . .++|+|||+|...
T Consensus 190 ~givHrDlkp~NILl~---~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 190 AELVHADLSEYNIMYI---D--KVYFIDMGQAVTL 219 (258)
T ss_dssp SCEECSSCSTTSEEES---S--SEEECCCTTCEET
T ss_pred CCEEeCCCCHHHEEEc---C--cEEEEECcccccC
Confidence 9999999999999994 3 7999999999764
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.76 E-value=1.1e-18 Score=175.50 Aligned_cols=162 Identities=16% Similarity=0.168 Sum_probs=103.0
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|.+++.||+|+||.||+|.+. +|+.||||+++..... + ...... ..+ ...... ........-...+|.
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~----~G~~vAvKi~r~~~~s-f---r~v~~~-r~~--~~~~~~-~~~~~~~rl~A~kE~ 164 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE----KGKQKVLKIHRLGRIS-F---RTVKAN-RDY--LRNRST-GSWMYLSRLAAIKEF 164 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT----TCCEEEEEEECTTEEC-C---CCCC---CEE--CTTSCH-HHHHHHHHHHHHHHH
T ss_pred EEecCEeeeCCceEEEEEECC----CCCEEEEEEEeccccc-H---HHHHHH-HHH--HHhhcc-ccHHHHHHHHHHHHH
Confidence 999999999999999999875 6999999998653110 0 000000 000 000000 000001112234678
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~ 282 (482)
..|.++. +.++.-..-+.... .+|||||++|++|.... ....+..++.||+.+|.|||+.|||||||||.
T Consensus 165 ~nL~rL~-~~gv~vp~p~~~~~--~~LVME~i~G~~L~~l~-------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~ 234 (397)
T 4gyi_A 165 AFMKALY-EEGFPVPEPIAQSR--HTIVMSLVDALPMRQVS-------SVPDPASLYADLIALILRLAKHGLIHGDFNEF 234 (397)
T ss_dssp HHHHHHH-HTTCSCCCEEEEET--TEEEEECCSCEEGGGCC-------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTT
T ss_pred HHHHHHH-hcCCCCCeeeeccC--ceEEEEecCCccHhhhc-------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHH
Confidence 8888885 44443222222222 37999999998875421 22345678899999999999999999999999
Q ss_pred ceEEecCCCC-------CcEEEEeccccccc
Q 011582 283 NFLFTSKEEN-------SSLKAIDFGLSDYV 306 (482)
Q Consensus 283 NIll~~~~~~-------~~~kl~DfGla~~~ 306 (482)
|||++.+++. ..+.|+||+-+...
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 9999743211 13899999977653
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=1.8e-13 Score=130.87 Aligned_cols=142 Identities=15% Similarity=0.141 Sum_probs=111.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.+.|.+...+|.|+++.||++.. .|..+++|+..... ......+.
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~-----~~~~~vlK~~~~~~------------------------------~~~~~~~~ 57 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRY------------------------------KGTTYDVE 57 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEEC-----SSCEEEEEEECGGG------------------------------TTSTTCHH
T ss_pred hccceeEeeccCCCCCeEEEEEC-----CCCcEEEEeCCccc------------------------------CCCHHHHH
Confidence 45688999999999999999864 46789999975420 00112478
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-------- 271 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-------- 271 (482)
+|+.+++.|..+..+.++++++.+.+..|+||||++|.+|.+.+ .+......++.+++.+|..||+
T Consensus 58 ~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~ 131 (263)
T 3tm0_A 58 REKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEY------EDEQSPEKIIELYAECIRLFHSIDISDCPY 131 (263)
T ss_dssp HHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHC------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSC
T ss_pred HHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhcc------CCcccHHHHHHHHHHHHHHHhCCCcccCCC
Confidence 99999999976788889999999999999999999999887642 1223345788999999999999
Q ss_pred ---------------------------------------------------CCCcccCCCCCceEEecCCCCCcEEEEec
Q 011582 272 ---------------------------------------------------QGVVHRDLKPENFLFTSKEENSSLKAIDF 300 (482)
Q Consensus 272 ---------------------------------------------------~~ivHrDlkp~NIll~~~~~~~~~kl~Df 300 (482)
..++|+|++|.|||++ ++..+.|+||
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~lIDw 208 (263)
T 3tm0_A 132 TNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK---DGKVSGFIDL 208 (263)
T ss_dssp BCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE---TTEEEEECCC
T ss_pred cchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE---CCcEEEEEEc
Confidence 4589999999999994 3445679999
Q ss_pred ccccc
Q 011582 301 GLSDY 305 (482)
Q Consensus 301 Gla~~ 305 (482)
+.+..
T Consensus 209 e~a~~ 213 (263)
T 3tm0_A 209 GRSGR 213 (263)
T ss_dssp TTCEE
T ss_pred hhccc
Confidence 97754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.29 E-value=4.3e-12 Score=120.58 Aligned_cols=137 Identities=15% Similarity=0.098 Sum_probs=98.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
...|.+....+.|..+.||++... +|..++||+.... ....+.
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~----~g~~~vlK~~~~~---------------------------------~~~~~~ 61 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQ----GRPVLFVKTDLSG---------------------------------ALNELQ 61 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECT----TSCCEEEEEECSC---------------------------------TTSCHH
T ss_pred cCCCceEecccCCCCceEEEEecC----CCCeEEEEeCCcc---------------------------------cchhhh
Confidence 345666554456677999998642 5778999986431 013467
Q ss_pred HHHHHHHhhcCCCC-cceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC-----
Q 011582 200 REVKILRALTGHKN-LVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG----- 273 (482)
Q Consensus 200 ~Ei~~l~~l~~hpn-iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~----- 273 (482)
+|+.+++.+..+.- +.++++++.+.+..++||||++|.+|. . ...+ ...++.+++..|..||+..
T Consensus 62 ~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~----~~~~---~~~~~~~l~~~l~~lh~~~~~~~~ 132 (264)
T 1nd4_A 62 DEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S----SHLA---PAEKVSIMADAMRRLHTLDPATCP 132 (264)
T ss_dssp HHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T----SCCC---HHHHHHHHHHHHHHHTTSCGGGCC
T ss_pred HHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c----CcCC---HhHHHHHHHHHHHHHhCCCCCCCC
Confidence 89999999974422 566899888888899999999998873 2 1122 2356677777788887643
Q ss_pred -----------------------------------------------------CcccCCCCCceEEecCCCCCcEEEEec
Q 011582 274 -----------------------------------------------------VVHRDLKPENFLFTSKEENSSLKAIDF 300 (482)
Q Consensus 274 -----------------------------------------------------ivHrDlkp~NIll~~~~~~~~~kl~Df 300 (482)
++|+|++|.|||++ ++..+.|+||
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~---~~~~~~liD~ 209 (264)
T 1nd4_A 133 FDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVE---NGRFSGFIDC 209 (264)
T ss_dssp CBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEE---TTEEEEECCC
T ss_pred CchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEE---CCcEEEEEcc
Confidence 99999999999994 3445679999
Q ss_pred ccccc
Q 011582 301 GLSDY 305 (482)
Q Consensus 301 Gla~~ 305 (482)
|.+..
T Consensus 210 ~~a~~ 214 (264)
T 1nd4_A 210 GRLGV 214 (264)
T ss_dssp TTCEE
T ss_pred hhccc
Confidence 98764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.21 E-value=3.6e-11 Score=120.49 Aligned_cols=143 Identities=24% Similarity=0.368 Sum_probs=104.5
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEee--cccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIP--KMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVK 203 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~--k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~ 203 (482)
.+.|+.|.++.||++.. .+..+++|+.. .. ........+.+|+.
T Consensus 43 ~~~l~~G~sn~~y~v~~-----~~~~~vlr~~~~p~~-----------------------------~~~~~~~~~~~E~~ 88 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVT-----PGQTYVMRAKPGPKS-----------------------------KLLPSAHAIEREYR 88 (359)
T ss_dssp EEECCC-CCSCEEEEEC-----SSCEEEEECCCC---------------------------------------CHHHHHH
T ss_pred EEEcCCcccceEEEEEE-----CCceEEEEeCCCCCC-----------------------------CCCCcHHHHHHHHH
Confidence 45689999999999875 34678898764 21 00012246788999
Q ss_pred HHHhhcC-CCCcceeeEEEEeC---CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH--------
Q 011582 204 ILRALTG-HKNLVQFYDAYEDD---DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-------- 271 (482)
Q Consensus 204 ~l~~l~~-hpniv~l~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-------- 271 (482)
+++.|.. +..+.+++.++.+. +..|+||||++|..+.+.. -..+++.+...++.+++..|..||+
T Consensus 89 ~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~ 165 (359)
T 3dxp_A 89 VMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGL 165 (359)
T ss_dssp HHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTC
T ss_pred HHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccc
Confidence 9999973 34578899888776 4589999999998774421 2357888899999999999999997
Q ss_pred --------------------------------------------------CCCcccCCCCCceEEecCCCCCcEEEEecc
Q 011582 272 --------------------------------------------------QGVVHRDLKPENFLFTSKEENSSLKAIDFG 301 (482)
Q Consensus 272 --------------------------------------------------~~ivHrDlkp~NIll~~~~~~~~~kl~DfG 301 (482)
.++||+|+++.|||++.++ ...+.|+||+
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~-~~v~~viDwe 244 (359)
T 3dxp_A 166 GDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTE-PRVLAVLDWE 244 (359)
T ss_dssp TTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSS-SCEEEECCCT
T ss_pred cccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCC-CcEEEEECcc
Confidence 3589999999999995321 1346999999
Q ss_pred ccccc
Q 011582 302 LSDYV 306 (482)
Q Consensus 302 la~~~ 306 (482)
.+...
T Consensus 245 ~a~~g 249 (359)
T 3dxp_A 245 LSTLG 249 (359)
T ss_dssp TCEEE
T ss_pred ccccC
Confidence 88753
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=6.9e-11 Score=115.64 Aligned_cols=184 Identities=17% Similarity=0.246 Sum_probs=123.4
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.++.|.+..||++. ..+++|+... ......+.+|+.+|+
T Consensus 26 ~~~~~G~~n~v~~v~--------~~~vlR~~~~--------------------------------~~~~~~~~~E~~~l~ 65 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN--------RDFIFKFPKH--------------------------------SRGSTNLFNEVNILK 65 (304)
T ss_dssp CEEEECSSEEEEEST--------TSEEEEEESS--------------------------------HHHHHHHHHHHHHHH
T ss_pred EecCCCCcceEEEEC--------CEEEEEecCC--------------------------------cchHHHHHHHHHHHH
Confidence 348999999998762 3589997532 133467899999999
Q ss_pred hhcCCCC--cceeeEEEEeCC---eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----------
Q 011582 207 ALTGHKN--LVQFYDAYEDDD---NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF---------- 271 (482)
Q Consensus 207 ~l~~hpn--iv~l~~~~~~~~---~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~---------- 271 (482)
.+..+.. +.+++......+ ..|+|||+++|.+|.+... ..++..+...++.+++..|..||+
T Consensus 66 ~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~ 142 (304)
T 3sg8_A 66 RIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNL 142 (304)
T ss_dssp HHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGG
T ss_pred HHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccc
Confidence 9853433 344544433333 3489999999988876443 357888888999999999999996
Q ss_pred ------------------------------------------------CCCcccCCCCCceEEecCCCCCcEEEEecccc
Q 011582 272 ------------------------------------------------QGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303 (482)
Q Consensus 272 ------------------------------------------------~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla 303 (482)
..++|+|++|.||+++.+ ....+.|+||+.+
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~-~~~~~~~iD~~~~ 221 (304)
T 3sg8_A 143 VLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE-KNTICGIIDFGDA 221 (304)
T ss_dssp BCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT-TTEEEEECCCTTC
T ss_pred hhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC-CCCEEEEEeCCCC
Confidence 136999999999999531 1456789999998
Q ss_pred cccCCCCcccccccCccccCccccc---ccCCC------------cchhhhhHHHHHHHhhCCCCC
Q 011582 304 DYVKPDERLNDIVGSAYYVAPEVLH---RSYGT------------EADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 304 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~------------~~DiwSlGvil~elltg~~pf 354 (482)
........+........-..|+... ..|.. -.+.|++|.++|.+.+|..+|
T Consensus 222 ~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 222 AISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp EEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred ccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 7643321111111000002333221 11221 258999999999999998876
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.74 E-value=1.9e-07 Score=91.31 Aligned_cols=137 Identities=19% Similarity=0.307 Sum_probs=96.0
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.++.|....||++ |..++||+-.. ......+.+|+.+|+
T Consensus 25 ~~l~~G~~n~v~~v--------g~~~VlR~~~~--------------------------------~~~~~~~~~E~~~L~ 64 (306)
T 3tdw_A 25 ESLGEGFRNYAILV--------NGDWVFRFPKS--------------------------------QQGADELNKEIQLLP 64 (306)
T ss_dssp EEEEECSSEEEEEE--------TTTEEEEEESS--------------------------------HHHHHHHHHHHHHHH
T ss_pred eecCCCcceeEEEE--------CCEEEEEecCC--------------------------------chHHHHHHHHHHHHH
Confidence 34788888899987 34688887421 223467899999999
Q ss_pred hhcCCC--CcceeeEEEE-eCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------
Q 011582 207 ALTGHK--NLVQFYDAYE-DDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ----------- 272 (482)
Q Consensus 207 ~l~~hp--niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~----------- 272 (482)
.|..|- .+.+++.++. ..+..|+||||++|..|.+... ..++..+...++.++...|..||+.
T Consensus 65 ~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p 141 (306)
T 3tdw_A 65 LLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVP 141 (306)
T ss_dssp HHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCC
T ss_pred HHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCC
Confidence 997432 3566776664 4566789999999988766332 2356666666666666666666642
Q ss_pred -------------------------------------------------CCcccCCCCCceEEecCCCCCc-EEEEeccc
Q 011582 273 -------------------------------------------------GVVHRDLKPENFLFTSKEENSS-LKAIDFGL 302 (482)
Q Consensus 273 -------------------------------------------------~ivHrDlkp~NIll~~~~~~~~-~kl~DfGl 302 (482)
.++|+|+++.|||++.++.++. +.|+||+.
T Consensus 142 ~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~ 221 (306)
T 3tdw_A 142 VTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGD 221 (306)
T ss_dssp BCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTT
T ss_pred hHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhh
Confidence 2489999999999953222344 58999998
Q ss_pred cccc
Q 011582 303 SDYV 306 (482)
Q Consensus 303 a~~~ 306 (482)
+...
T Consensus 222 a~~g 225 (306)
T 3tdw_A 222 AAIS 225 (306)
T ss_dssp CEEE
T ss_pred cCCC
Confidence 7653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=1.7e-07 Score=89.43 Aligned_cols=133 Identities=17% Similarity=0.190 Sum_probs=96.1
Q ss_pred eecCCce-EEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 129 VGRGHFG-YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 129 LG~G~fG-~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
+..|..| .||+..... .+..++||+-+.. ....+.+|..+|+.
T Consensus 32 ~~~G~S~~~v~rl~~~~---~~~~~~lk~~~~~---------------------------------~~~~~~~E~~~l~~ 75 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKP---NAPELFLKHGKGS---------------------------------VANDVTDEMVRLNW 75 (272)
T ss_dssp EECSSSSCEEEEEECCT---TCCCEEEEEEETH---------------------------------HHHHHHHHHHHHHH
T ss_pred ccCCCcCCeEEEEEecC---CCeEEEEEECCCC---------------------------------CHhHHHHHHHHHHH
Confidence 4455555 689887654 5678999986431 23568899999999
Q ss_pred hcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---------------
Q 011582 208 LTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ--------------- 272 (482)
Q Consensus 208 l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~--------------- 272 (482)
|..+--+.+++.++.+.+..|+|||+++|.++.+..... ......+..++...|.-||+.
T Consensus 76 l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~ 150 (272)
T 4gkh_A 76 LTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRL 150 (272)
T ss_dssp HTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHH
T ss_pred hccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccch
Confidence 976555778999999999999999999998876654321 222334556666666666631
Q ss_pred -------------------------------------------CCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 273 -------------------------------------------GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 273 -------------------------------------------~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
.++|+|+.+.|||++ +++.+-|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~---~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 151 AQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFD---EGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEE---TTEEEEECCCTTCEE
T ss_pred hhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEE---CCeEEEEEECccccc
Confidence 168999999999994 445567999998764
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=98.45 E-value=1.6e-07 Score=85.48 Aligned_cols=74 Identities=23% Similarity=0.217 Sum_probs=62.2
Q ss_pred cCcccccCCCCCCCccHHHHHHHHHHhccchHHHHHHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 408 SHPWLANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 408 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.|||.+.......+.+..++..+++|...+.++++++..++..++.++...|+++|..+|.|+||+||.+||+.
T Consensus 8 ~~~~~~~~~~~~~~l~~~~~~~l~~f~~~~~lk~~~l~~i~~~l~~~e~~~l~~~F~~~D~d~~G~Is~~El~~ 81 (197)
T 3pm8_A 8 SSGRENLYFQGHVELSSTLLKNLKNFKKENELKKIALTIIAKHLCDVEINNLRNIFIALDVDNSGTLSSQEILD 81 (197)
T ss_dssp ---------CCSCCCCTTHHHHHHHTTTSCHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred cchHhhhccCCCCCCCHHHHHHHHHHHHccHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHH
Confidence 48999998888888888999999999999999999999999999999999999999999999999999999975
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.35 E-value=1.3e-06 Score=88.28 Aligned_cols=85 Identities=18% Similarity=0.227 Sum_probs=50.7
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.||.|.++.||++.... .++.|+||....... +. ++ ......+.+..|+.+|
T Consensus 35 ~~~lg~G~~n~vyrv~~~~---~~~~~vvK~~~~~~r-------~~-~~---------------~~~~~~~r~~~E~~~L 88 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYAK-------VV-GE---------------SWPLTIDRARIESSAL 88 (397)
T ss_dssp EEECCSSSSEEEEEEEC-------CEEEEEEECCC------------------------------CCCCTTHHHHHHHHH
T ss_pred EEECCCCceEEEEEEEECC---CCcEEEEEecchhhc-------cc-CC---------------CCcCcHHHHHHHHHHH
Confidence 3468999999999997654 467899998653210 00 00 0001123567788999
Q ss_pred HhhcCC-CC-cceeeEEEEeCCeEEEEEecCCCCC
Q 011582 206 RALTGH-KN-LVQFYDAYEDDDNIYIVMELCKGGE 238 (482)
Q Consensus 206 ~~l~~h-pn-iv~l~~~~~~~~~~~lv~e~~~~g~ 238 (482)
+.+..+ +. +.+++.+ +.+..++||||++|..
T Consensus 89 ~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~g~~ 121 (397)
T 2olc_A 89 IRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHLK 121 (397)
T ss_dssp HHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTSE
T ss_pred HHhhhhCCCCcCeEEEE--cCCccEEEEEeCCCcc
Confidence 888633 33 3455543 4556789999998743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.33 E-value=4.4e-06 Score=82.15 Aligned_cols=31 Identities=26% Similarity=0.433 Sum_probs=25.8
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
.++||+|+++.|||++ .++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~---~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLG---ENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEEC---GGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEe---CCCcEEEEehhhccc
Confidence 5799999999999994 345799999997653
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=98.30 E-value=2.7e-07 Score=83.53 Aligned_cols=74 Identities=18% Similarity=0.227 Sum_probs=59.9
Q ss_pred cCcccccCCCCCCCccHHHHHHHHHHhccchHHHHHHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 408 SHPWLANSHDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 408 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.|||+........+.+..+++.+++|...+.++++++..++..++.++...+++.|..+|.|+||+|+.+||+.
T Consensus 3 ~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~ 76 (191)
T 3k21_A 3 HHHHHSSGRENLYFQGIHVLENFKNYGLLLKFQKLAMTIIAQQSNDYDVEKLKSTFLVLDEDGKGYITKEQLKK 76 (191)
T ss_dssp -----------CHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCCCHHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred CCccccCCccccccccHHHHHHHHHHHhhHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 58888777777777888899999999999999999999999999999999999999999999999999999975
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.27 E-value=5.2e-07 Score=89.80 Aligned_cols=88 Identities=14% Similarity=0.136 Sum_probs=55.4
Q ss_pred eccee-ecCCceEEEEEEEec---CCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 125 LGEEV-GRGHFGYTCSAKAKK---GSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 125 ~~~~L-G~G~fG~V~~a~~~~---~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
..+.| +.|....+|++.... +...|..+++|+...... . .......+.+
T Consensus 24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~-----~----------------------~~~~~~~~~~ 76 (357)
T 3ats_A 24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAED-----V----------------------PVFPTYRLDH 76 (357)
T ss_dssp EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGG-----C----------------------CSSSCCCHHH
T ss_pred EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCc-----c----------------------ccCchhHHHH
Confidence 34567 788889999887531 000156789997643200 0 0000124678
Q ss_pred HHHHHHhhcCC--CCcceeeEEEEeC---CeEEEEEecCCCCCh
Q 011582 201 EVKILRALTGH--KNLVQFYDAYEDD---DNIYIVMELCKGGEL 239 (482)
Q Consensus 201 Ei~~l~~l~~h--pniv~l~~~~~~~---~~~~lv~e~~~~g~L 239 (482)
|+.+++.|..+ -.+.+++.++.+. +..|+||||++|..+
T Consensus 77 E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 77 QFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp HHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred HHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence 99999988754 3567788777655 357899999988654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.91 E-value=6.5e-05 Score=73.35 Aligned_cols=76 Identities=17% Similarity=0.152 Sum_probs=60.0
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.|+.|.+..+|++.. .+..++||+.... ....+.+|+..|
T Consensus 41 ~~~l~gG~~n~~y~v~~-----~~~~~vlK~~~~~---------------------------------~~~~~~~E~~~L 82 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-----EVQTVFVKINERS---------------------------------YRSMFRAEADQL 82 (312)
T ss_dssp EEEECCSSSSEEEEEES-----SSCEEEEEEEEGG---------------------------------GHHHHHHHHHHH
T ss_pred eEEeCCccceeeeEEEE-----CCCeEEEEeCCcc---------------------------------cHHHHHHHHHHH
Confidence 34689999999999874 4668899986431 235678999999
Q ss_pred HhhcCC--CCcceeeEEEEeCCeEEEEEecCCCCCh
Q 011582 206 RALTGH--KNLVQFYDAYEDDDNIYIVMELCKGGEL 239 (482)
Q Consensus 206 ~~l~~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L 239 (482)
+.|..+ ..+.+++.++...+..|+||||++|..+
T Consensus 83 ~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 83 ALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp HHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred HHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 988643 5688899988888999999999998754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.84 E-value=7.7e-05 Score=75.92 Aligned_cols=75 Identities=17% Similarity=0.147 Sum_probs=43.7
Q ss_pred HCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCccccccc--CccccCccccccc----CCCcchhhhhHHHH
Q 011582 271 FQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVG--SAYYVAPEVLHRS----YGTEADMWSIGVIA 344 (482)
Q Consensus 271 ~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~g--t~~y~aPE~~~~~----~~~~~DiwSlGvil 344 (482)
...++|+|+++.|||++ .++ ++|+||+.+.............+ ...|++|+..... -....++.++...+
T Consensus 231 ~~~liHGDl~~~Nil~~---~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVT---QDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEEC---SSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEe---CCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45799999999999994 333 99999998876432211111111 1345555544211 01123444667777
Q ss_pred HHHhh
Q 011582 345 YILLC 349 (482)
Q Consensus 345 ~ellt 349 (482)
+..++
T Consensus 307 ~~~y~ 311 (420)
T 2pyw_A 307 WNLFN 311 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77665
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00019 Score=65.47 Aligned_cols=122 Identities=18% Similarity=0.098 Sum_probs=80.7
Q ss_pred ChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccc
Q 011582 238 ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIV 316 (482)
Q Consensus 238 ~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~ 316 (482)
+|.+.|...+.+++|+++|.++.|.+.+|.-+-. +.-..+=+-|..|++ ..+|.|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AADD-----------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C---------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-cccc-----------c
Confidence 7889888888999999999999999999877622 222233345688888 4566665543 1110 1
Q ss_pred cCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchh
Q 011582 317 GSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNK 395 (482)
Q Consensus 317 gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 395 (482)
....+.|||......+.+.=|||||+++|..+-=..| ...-..+|+++.+||..|..-
T Consensus 99 ~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence 1234668887755567788999999999998852222 222245999999999999866
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=97.52 E-value=6.9e-05 Score=66.58 Aligned_cols=59 Identities=25% Similarity=0.407 Sum_probs=54.2
Q ss_pred cHHHHHHHHHHhccchHHHHHHHhhhhcCC--HHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 423 DMIVYKLIKAYISSSSLRKAALGALAKTLT--VPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 423 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~--~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..++..+++|...+.+++.++..++..++ .++...++++|..+|.|+||+|+.+||+.
T Consensus 3 ~~~~~~~l~~~~~~~~l~~~~l~~~~~~l~~~~~~~~~l~~~F~~~D~d~~G~i~~~El~~ 63 (180)
T 3mse_B 3 SPNVLNNMKSYMKHSNIRNIIINIMAHELSVINNHIKYINELFYKLDTNHNGSLSHREIYT 63 (180)
T ss_dssp CHHHHHHHHHHTTSCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHCTTCSSSEEHHHHHH
T ss_pred CHHHHHHHHHHHHHhHHHHHHHHHHHHHccCCHHHHHHHHHHHHHhCCCCCCcCCHHHHHH
Confidence 356788999999999999999999998887 88899999999999999999999999975
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.48 E-value=0.00013 Score=70.58 Aligned_cols=72 Identities=13% Similarity=0.003 Sum_probs=45.7
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.|+.|....+|++ ..+++|+..... .......+|+.++
T Consensus 23 i~~l~gG~tN~~~~~---------~~~vlR~~~~~~-------------------------------~~~~~r~~E~~~l 62 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA---------GDLCLRIPGKGT-------------------------------EEYINRANEAVAA 62 (301)
T ss_dssp CEEEESCSSEEEEEE---------TTEEEEEECC-----------------------------------CCCHHHHHHHH
T ss_pred eeEcCCcccccccee---------eeEEEECCCCCc-------------------------------cceeCHHHHHHHH
Confidence 567899999999998 248899864320 0001235688888
Q ss_pred HhhcCCCCcceeeEEEEeCCeEEEEEecC-CCCCh
Q 011582 206 RALTGHKNLVQFYDAYEDDDNIYIVMELC-KGGEL 239 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~-~~g~L 239 (482)
+.+..+.-..+++.+ +.+.-++|+||+ +|.+|
T Consensus 63 ~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 63 REAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp HHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred HHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 888644333456543 444457899999 66544
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00013 Score=71.02 Aligned_cols=140 Identities=14% Similarity=0.097 Sum_probs=78.3
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.|+.|....||++... .| .+++|+.... ...+.+..|+.++
T Consensus 27 ~~~i~~G~~n~~~~v~~~----~g-~~vlk~~~~~--------------------------------~~~~~l~~e~~~l 69 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT----KD-PLILTLYEKR--------------------------------VEKNDLPFFLGLM 69 (322)
T ss_dssp EEEECC---EEEEEEEES----SC-CEEEEEECC-----------------------------------CCHHHHHHHHH
T ss_pred eeccCCCcccceEEEEeC----Cc-cEEEEEeCCC--------------------------------CCHHHHHHHHHHH
Confidence 345778888999998753 23 6889987531 0113456788888
Q ss_pred HhhcCCC-CcceeeE------EEEeCCeEEEEEecCCCCChH--------------HHHHhcCCCC--------C---HH
Q 011582 206 RALTGHK-NLVQFYD------AYEDDDNIYIVMELCKGGELL--------------DRILSRGGKY--------S---EE 253 (482)
Q Consensus 206 ~~l~~hp-niv~l~~------~~~~~~~~~lv~e~~~~g~L~--------------~~l~~~~~~l--------~---~~ 253 (482)
..|..+. .+.+++. +....+..++||+|++|..+. ..++.....+ . +.
T Consensus 70 ~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~ 149 (322)
T 2ppq_A 70 QHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWK 149 (322)
T ss_dssp HHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHH
T ss_pred HHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHH
Confidence 8876431 1233332 123457789999999986431 1122211111 1 11
Q ss_pred HHHH------------HHHHHHHHHHHHHH-------CCCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 254 DAKI------------VMVQILSVVAFCHF-------QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 254 ~~~~------------i~~qi~~~L~yLH~-------~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
.... +-..+...+.+++. .++||+|+++.|||+. ++..+.|+||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~---~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 150 VLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFL---GDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEe---CCceEEEecchhccC
Confidence 1000 00124445566653 3699999999999994 334457999997753
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=97.43 E-value=6.5e-05 Score=67.00 Aligned_cols=61 Identities=21% Similarity=0.193 Sum_probs=55.3
Q ss_pred CccHHHHHHHHHHhccchHHHHHHHhhhhcC-CHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 421 PSDMIVYKLIKAYISSSSLRKAALGALAKTL-TVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+....++..+++|...+.++++++..++..+ +.++...+.+.|..+|.|+||.|+.+||+.
T Consensus 3 ~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~e~~~ 64 (191)
T 3khe_A 3 HALTGALGNMKKFQSSQKLAQAAMLFMGSKLTTLEETKELTQIFRQLDNNGDGQLDRKELIE 64 (191)
T ss_dssp CHHHHHHHHHHHCCCCCHHHHHHHHHHHHHSSCTTTTHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcCHHHHHHHHHHHHHHcCCCCCCCcHHHHHH
Confidence 3455678899999999999999999999888 888899999999999999999999999974
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00067 Score=65.03 Aligned_cols=80 Identities=20% Similarity=0.064 Sum_probs=54.2
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
...-.+.+|.|..+.||+++.. +|+.|.||+..... ......+.+|
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~----DG~~~~vK~~~~~~------------------------------~~~~~~~~~E 61 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA----DGTPLFVKALPDDA------------------------------PALDGLFRAE 61 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET----TSCEEEEEECCTTC------------------------------CCCTTHHHHH
T ss_pred CeEEEEecCCCCCeEEEEEEEC----CCCEEEEEEeCCCC------------------------------cchhhHHHHH
Confidence 3455677999999999999865 68899999864320 0011347789
Q ss_pred HHHHHhhcCCC--CcceeeEEEEeCCeEEEEEecCCCCCh
Q 011582 202 VKILRALTGHK--NLVQFYDAYEDDDNIYIVMELCKGGEL 239 (482)
Q Consensus 202 i~~l~~l~~hp--niv~l~~~~~~~~~~~lv~e~~~~g~L 239 (482)
+..|+.|...- -+.+++.+ +. -++||||++++..
T Consensus 62 a~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 62 ALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEWVDERPP 97 (288)
T ss_dssp HHHHHHHTCSTTCCSCCEEEE--ET--TEEEEECCCCCCC
T ss_pred HHHHHHHHhhCCCCcceEEec--cC--ceEEEEeecccCC
Confidence 99999885332 24455543 22 3789999987653
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00032 Score=68.77 Aligned_cols=35 Identities=29% Similarity=0.426 Sum_probs=26.6
Q ss_pred CCCcccCCCCCceEEecCCC-CCcEEEEeccccccc
Q 011582 272 QGVVHRDLKPENFLFTSKEE-NSSLKAIDFGLSDYV 306 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~-~~~~kl~DfGla~~~ 306 (482)
..++|||+.+.|||+..+.. ...+.|+||+.+...
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 46999999999999953110 257899999988653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0005 Score=67.09 Aligned_cols=75 Identities=8% Similarity=0.045 Sum_probs=47.8
Q ss_pred eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 128 ~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
.|+ |....||++... +|+.+++|+..... .....+..|+.+++.
T Consensus 33 ~l~-g~~n~~y~v~~~----~g~~~vlK~~~~~~-------------------------------~~~~~~~~E~~~~~~ 76 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDE----DRRRFVVKFYRPER-------------------------------WTADQILEEHQFALQ 76 (328)
T ss_dssp EEC-CSSSEEEEECCT----TCCCEEEEEECTTT-------------------------------SCHHHHHHHHHHHHH
T ss_pred eec-CcccceEEEEcC----CCCEEEEEEcCCCC-------------------------------CCHHHHHHHHHHHHH
Confidence 356 777889987543 46679999875310 012456778888888
Q ss_pred hcCCC-CcceeeEE-----EEeCCeEEEEEecCCCCC
Q 011582 208 LTGHK-NLVQFYDA-----YEDDDNIYIVMELCKGGE 238 (482)
Q Consensus 208 l~~hp-niv~l~~~-----~~~~~~~~lv~e~~~~g~ 238 (482)
|..+. .+.+++.. ....+..++||+|++|..
T Consensus 77 L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~ 113 (328)
T 1zyl_A 77 LVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 113 (328)
T ss_dssp HHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred HHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCC
Confidence 86331 13444432 234667789999998854
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.20 E-value=0.0005 Score=70.14 Aligned_cols=77 Identities=12% Similarity=0.034 Sum_probs=49.6
Q ss_pred cceeecCCceEEEEEEEecCC----CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGS----LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~----~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
.+.|+.|....||++....+. ..+..|++|+.... .. .+.+.+|
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-----------------------------~~---~~~li~E 125 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-----------------------------ET---ESHLVAE 125 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-----------------------------CC---HHHHHHH
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-----------------------------Cc---HHHHHHH
Confidence 345888888999999764210 02578999986320 00 1344579
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGE 238 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 238 (482)
+.+++.|..+.-..++++.+. + .+||||++|.+
T Consensus 126 ~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l~G~~ 158 (429)
T 1nw1_A 126 SVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPSRP 158 (429)
T ss_dssp HHHHHHHHHTTSSSCEEEEET--T--EEEECCCCEEE
T ss_pred HHHHHHHHhCCCCCcEEEEeC--C--CEEEEEeCCcc
Confidence 999998875544467776543 3 28999998743
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0012 Score=66.09 Aligned_cols=144 Identities=15% Similarity=0.141 Sum_probs=82.9
Q ss_pred ceeecCCceEEEEEEEecC----CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKG----SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~----~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
+.|..|-...+|++....+ ...+..|++|+.... ......+.+|.
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-------------------------------~~~~~~~~rE~ 104 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-------------------------------LQGVDSLVLES 104 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----------------------------------CCHHHHHHHH
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-------------------------------cchHHHHHHHH
Confidence 3466677788898876321 113578999985321 01134566899
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHH----------H-------HHhcC----CCC--CHHHHHHHH
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD----------R-------ILSRG----GKY--SEEDAKIVM 259 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~----------~-------l~~~~----~~l--~~~~~~~i~ 259 (482)
.+++.|..+.-..++++++.+ .+||||++|..|.. . |+... ... -+.++..++
T Consensus 105 ~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~ 180 (379)
T 3feg_A 105 VMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYL 180 (379)
T ss_dssp HHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHH
T ss_pred HHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHH
Confidence 999998755545677766543 29999998865421 1 11111 112 245666666
Q ss_pred HHHHH-------------------HHHHHHH--------CCCcccCCCCCceEEecC-CCCCcEEEEecccccc
Q 011582 260 VQILS-------------------VVAFCHF--------QGVVHRDLKPENFLFTSK-EENSSLKAIDFGLSDY 305 (482)
Q Consensus 260 ~qi~~-------------------~L~yLH~--------~~ivHrDlkp~NIll~~~-~~~~~~kl~DfGla~~ 305 (482)
.++.. .+..|.. ..++|+|+.+.|||+..+ +..+.+.|+||..+..
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 181 KQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 55432 2333332 248999999999999642 1235799999988764
|
| >1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00013 Score=71.50 Aligned_cols=98 Identities=17% Similarity=0.107 Sum_probs=61.8
Q ss_pred CCCCHHHHHHHHHhc---hhccccCCCHHHHhcC------cccccCCCCC-----------------C-Cc------cHH
Q 011582 379 PSLSPEAIDFVKRLL---NKDYRKRLTAAQALSH------PWLANSHDVK-----------------I-PS------DMI 425 (482)
Q Consensus 379 ~~~s~~~~~li~~~L---~~dP~~R~s~~e~L~h------p~~~~~~~~~-----------------~-~~------~~~ 425 (482)
..++.++.+|.++++ ..+|..|.+.++.+.| +|+....... . .. ...
T Consensus 15 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~a~g~~~~e~q~~~~ 94 (323)
T 1ij5_A 15 KKVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQKVQNEFDARERAEREREAARGDAAAEKQRLAS 94 (323)
T ss_dssp HHHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHTTSCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcChhhhhHHHHHHHHhhcCCCCCcchhhHH
Confidence 346788999999999 8899999999999999 8987652110 0 00 011
Q ss_pred HHHHHH-HHhccchHHHHHHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 426 VYKLIK-AYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 426 ~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++..++ +|...+.+++ ++..++..++..|...|..+|.|+||+||.+||+.
T Consensus 95 vl~~l~~~f~~~~~lkk-----~~~~Ls~~e~~~l~~~F~~~D~d~dG~Is~~El~~ 146 (323)
T 1ij5_A 95 LLKDLEDDASGYNRLRP-----SKPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQ 146 (323)
T ss_dssp HHHHC------------------CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHH
T ss_pred HHHHHHHHHHHhhhHHH-----HHHhCCHHHHHHHHHHHHHHhCCCCCCCcHHHHHH
Confidence 233333 4444455444 45788999999999999999999999999999975
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.001 Score=66.23 Aligned_cols=77 Identities=12% Similarity=0.130 Sum_probs=44.3
Q ss_pred ceeecCCceEEEEEEEecCC-----CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGS-----LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~-----~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+.|+.|....+|++....+. ..+..+++|+..... ........|
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-------------------------------~~~~~~~~E 87 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-------------------------------DELYNTISE 87 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-------------------------------GGTSCHHHH
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-------------------------------cceecHHHH
Confidence 45778888899998764210 013678888864310 000123578
Q ss_pred HHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGE 238 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~ 238 (482)
..+++.|..+.-..++++.. .+ ++||||++|..
T Consensus 88 ~~~l~~L~~~g~~P~~~~~~--~~--~~v~e~i~G~~ 120 (369)
T 3c5i_A 88 FEVYKTMSKYKIAPQLLNTF--NG--GRIEEWLYGDP 120 (369)
T ss_dssp HHHHHHHHHTTSSCCEEEEE--TT--EEEEECCCSEE
T ss_pred HHHHHHHHhcCCCCceEEec--CC--cEEEEEecCCc
Confidence 88998887443344676544 33 68999998754
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.78 E-value=0.0026 Score=62.64 Aligned_cols=31 Identities=23% Similarity=0.324 Sum_probs=25.6
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEeccccccc
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYV 306 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~ 306 (482)
.++|+|+.+.||+++ .++.+.|+||+.+...
T Consensus 207 ~~~HgD~~~~N~l~~---~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLVG---NEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEEC---GGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEEe---CCCeEEEEECCCCeeC
Confidence 599999999999994 4456999999877653
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.58 E-value=0.017 Score=59.13 Aligned_cols=76 Identities=17% Similarity=0.140 Sum_probs=47.2
Q ss_pred cceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHH
Q 011582 126 GEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKIL 205 (482)
Q Consensus 126 ~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l 205 (482)
.+.|+.|-...+|++.... .+..+++|+..... + . .-...+|..++
T Consensus 113 i~~lsgG~tN~~y~v~~~~---~~~~~vLRi~g~~~------------~-------------~------~idR~~E~~vl 158 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMS---KQAKYLIRLYGPKT------------D-------------E------IINREREKKIS 158 (458)
T ss_dssp EEEECC--CEEEEEEEETT---TTEEEEEEEECC-C------------C-------------S------CSCHHHHHHHH
T ss_pred EEEcCCCeEeEEEEEEECC---CCceEEEEECCCCh------------h-------------h------hcCHHHHHHHH
Confidence 3468888889999987632 24789999864320 0 0 00125899999
Q ss_pred HhhcCCCCcceeeEEEEeCCeEEEEEecCCCCCh
Q 011582 206 RALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239 (482)
Q Consensus 206 ~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 239 (482)
+.|..+.-..++++++ .+. +||||++|.+|
T Consensus 159 ~~L~~~gl~P~ll~~~--~~G--~v~e~I~G~~l 188 (458)
T 2qg7_A 159 CILYNKNIAKKIYVFF--TNG--RIEEFMDGYAL 188 (458)
T ss_dssp HHHTTSSSBCCEEEEE--TTE--EEEECCCSEEC
T ss_pred HHHHhcCCCCCEEEEe--CCe--EEEEeeCCccC
Confidence 9997444345777766 232 59999987543
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0016 Score=49.79 Aligned_cols=34 Identities=24% Similarity=0.150 Sum_probs=20.6
Q ss_pred hhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..++.++...++..|..+|.|+||+|+.+||+.
T Consensus 2 ~~~~~~~~~~~l~~~F~~~D~d~~G~i~~~el~~ 35 (86)
T 2opo_A 2 AAEDTPQDIADRERIFKRFDTNGDGKISSSELGD 35 (86)
T ss_dssp ----CHHHHHHHHHHHHHHCTTCSSEEEHHHHHH
T ss_pred CccCCHhhHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence 3455666666677777777777777777777653
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.31 E-value=0.0014 Score=52.28 Aligned_cols=33 Identities=30% Similarity=0.480 Sum_probs=25.1
Q ss_pred hcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 449 KTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 449 ~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++.++...|++.|..+|.|+||+|+.+||+.
T Consensus 28 ~~l~~~~~~el~~~F~~~D~d~~G~I~~~El~~ 60 (100)
T 2lv7_A 28 VDIPEDELEEIREAFKVFDRDGNGFISKQELGT 60 (100)
T ss_dssp CCCCGGGHHHHHHHHHHTCSSCSSCBCHHHHHH
T ss_pred ccCCHHHHHHHHHHHHHHcCCCCCcCCHHHHHH
Confidence 345667777788888888888888888888764
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=95.96 E-value=0.0033 Score=48.57 Aligned_cols=35 Identities=17% Similarity=0.253 Sum_probs=25.6
Q ss_pred hhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 447 LAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 447 ~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++..++..+...++..|..+|.|+||+|+.+||+.
T Consensus 10 ~~~~l~~~~~~~l~~~F~~~D~d~~G~i~~~el~~ 44 (90)
T 1avs_A 10 ARAFLSEEMIAEFKAAFDMFDADGGGDISTKELGT 44 (90)
T ss_dssp HHHHBCHHHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 44556677777777788888888888888777753
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=95.94 E-value=0.0034 Score=49.06 Aligned_cols=31 Identities=35% Similarity=0.484 Sum_probs=24.3
Q ss_pred CCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 451 LTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 451 ~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++.++...+++.|..+|.|+||+|+.+||+.
T Consensus 3 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~ 33 (92)
T 1fi6_A 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAKE 33 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 4566777788888888888888888888764
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=95.87 E-value=0.0026 Score=48.59 Aligned_cols=34 Identities=12% Similarity=0.126 Sum_probs=23.1
Q ss_pred hhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..++..+...++..|..+|.|+||+|+.+||+.
T Consensus 5 ~~~l~~~~~~~l~~~F~~~D~d~~G~I~~~el~~ 38 (86)
T 1j7q_A 5 ARALGPEEKDECMKIFDIFDRNAENIAPVSDTMD 38 (86)
T ss_dssp CCCCSSTHHHHHHHHHHHHSTTTTSCBCHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 3445566666777777777777777777777653
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.84 E-value=0.0081 Score=60.94 Aligned_cols=78 Identities=13% Similarity=0.158 Sum_probs=48.3
Q ss_pred ceeecCCceEEEEEEEecCCCC----CceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLK----GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~----g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
+.|..|-...+|++....+..+ +..|++++..... ...-...+|.
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-------------------------------~~~idR~~E~ 124 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-------------------------------GKFYDSKVEL 124 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--------------------------------CCCCHHHHH
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-------------------------------chhcCHHHHH
Confidence 3466677788999886532111 5789999864320 0001235789
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCCh
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 239 (482)
.+++.|..+.-..++++.+ .+ ++||||++|..|
T Consensus 125 ~~l~~L~~~gi~P~l~~~~--~~--~~I~efI~G~~l 157 (424)
T 3mes_A 125 DVFRYLSNINIAPNIIADF--PE--GRIEEFIDGEPL 157 (424)
T ss_dssp HHHHHHHHTTSSCCEEEEE--TT--EEEEECCCSEEC
T ss_pred HHHHHHHhcCCCCCEEEEc--CC--CEEEEEeCCccC
Confidence 9998887554455666533 33 789999998653
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=95.75 E-value=0.0046 Score=45.93 Aligned_cols=30 Identities=30% Similarity=0.457 Sum_probs=21.6
Q ss_pred CHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 452 TVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 452 ~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+.++...++..|..+|.|+||+|+.+||+.
T Consensus 2 s~~~~~~l~~~F~~~D~d~~G~i~~~el~~ 31 (77)
T 2joj_A 2 SEEQKQEIKEAFDLFDTNKTGSIDYHELKV 31 (77)
T ss_dssp CHHHHHHHHHHHHHHCCSSSSEEEHHHHHH
T ss_pred CHHHHHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 455666777777777777777777777754
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=95.72 E-value=0.0044 Score=48.76 Aligned_cols=31 Identities=19% Similarity=0.236 Sum_probs=21.3
Q ss_pred CCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 451 LTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 451 ~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++.++...++++|..+|.|+||+|+.+||+.
T Consensus 4 ls~~~~~~~~~~F~~~D~d~dG~I~~~el~~ 34 (95)
T 1c07_A 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVRE 34 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCCCCcEeHHHHHH
Confidence 3445666677777777777777777777653
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=95.45 E-value=0.0085 Score=54.87 Aligned_cols=53 Identities=17% Similarity=0.223 Sum_probs=45.2
Q ss_pred HHHHhccchHHHHHHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhcC
Q 011582 430 IKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKMT 482 (482)
Q Consensus 430 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~~ 482 (482)
...+.....+++.....+...++.++...+++.|..+|.|+||.|+.+||+.+
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~l~~~e~~~l~~~F~~~D~d~~G~I~~~El~~~ 76 (220)
T 3sjs_A 24 ACIYQMPPSVRNTWWFPLLNTIPLDQYTRIYQWFMGVDRDRSGTLEINELMMG 76 (220)
T ss_dssp HHHHHSCHHHHTSTTGGGGGGCCHHHHHHHHHHHHHHCTTCCSSBCHHHHHHC
T ss_pred hhccCCChhHHHHHHHHHHhcCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHHH
Confidence 35566677777777778888999999999999999999999999999999753
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.27 E-value=0.008 Score=48.79 Aligned_cols=31 Identities=10% Similarity=0.116 Sum_probs=20.6
Q ss_pred CCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 451 LTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 451 ~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++.++...++++|..+|.|+||+|+.+||+.
T Consensus 8 ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~ 38 (111)
T 2kgr_A 8 VPQSSRLKYRQLFNSHDKTMSGHLTGPQART 38 (111)
T ss_dssp SCHHHHHHHHHHHHTTSCSSCCEEEHHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 3455666667777777777777777777653
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.20 E-value=0.0049 Score=47.84 Aligned_cols=27 Identities=26% Similarity=0.502 Sum_probs=12.5
Q ss_pred HHHHHHHHHHhhhCCCCCCccchhhhh
Q 011582 454 PQLAYLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 454 ~~~~~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
++...++..|..+|.|+||+|+.+||+
T Consensus 24 ~~~~~l~~~F~~~D~d~~G~I~~~El~ 50 (91)
T 2pmy_A 24 EELARLRSVFAACDANRSGRLEREEFR 50 (91)
T ss_dssp HHHHHHHHHHHHHCTTCSSSEEHHHHH
T ss_pred HHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 344444444444444444444444443
|
| >1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=94.63 E-value=0.0076 Score=48.89 Aligned_cols=29 Identities=38% Similarity=0.434 Sum_probs=17.7
Q ss_pred CHHHHHHHHHHHhhhCCCCCCccchhhhh
Q 011582 452 TVPQLAYLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 452 ~~~~~~~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+.++...++++|..+|.|+||+|+.+||+
T Consensus 17 s~~~~~~~~~~F~~~D~d~dG~Is~~el~ 45 (110)
T 1iq3_A 17 TEEQREYYVNQFRSLQPDPSSFISGSVAK 45 (110)
T ss_dssp SSSSHHHHHHHHHHHCCSSSSEEEHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCeEcHHHHH
Confidence 33445556666666666666666666665
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=94.28 E-value=0.0068 Score=45.76 Aligned_cols=27 Identities=22% Similarity=0.372 Sum_probs=23.7
Q ss_pred HHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 455 QLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+...+...|..+|.|+||+|+.+||+.
T Consensus 5 ~~~~l~~~F~~~D~d~~G~i~~~el~~ 31 (83)
T 1yx7_A 5 VKAELEAAFKKLDANGDGYVTALELQT 31 (83)
T ss_dssp SCTHHHHHHHHHSSSCSSSCSHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 345688999999999999999999974
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=94.18 E-value=0.021 Score=43.89 Aligned_cols=29 Identities=24% Similarity=0.471 Sum_probs=18.6
Q ss_pred HHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 453 VPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 453 ~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++...++..|..+|.|+||+|+.+||+.
T Consensus 5 ~~~~~~l~~~F~~~D~d~~G~i~~~el~~ 33 (92)
T 2kn2_A 5 TDAEEELKEAFKVFDKDQNGYISASELRH 33 (92)
T ss_dssp CHHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred ccHHHHHHHHHHHHCCCCCCeEcHHHHHH
Confidence 34455666677777777777777766653
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=94.08 E-value=0.031 Score=50.89 Aligned_cols=36 Identities=17% Similarity=0.150 Sum_probs=31.8
Q ss_pred hhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 446 ALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 446 ~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+...++.++...+++.|..+|.|+||+|+.+||+.
T Consensus 37 ~~~~~ls~~~~~~l~~~F~~~D~d~dG~I~~~El~~ 72 (219)
T 3cs1_A 37 AIPREKTAEAKQRRIELFKKFDKNETGKLCYDEVYS 72 (219)
T ss_dssp HSCCSSSHHHHHHHHHHHHHHCTTCSSCBCHHHHHH
T ss_pred HhcccCCHHHHHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 344567889999999999999999999999999974
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=94.06 E-value=0.023 Score=56.85 Aligned_cols=34 Identities=26% Similarity=0.434 Sum_probs=31.1
Q ss_pred hhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+++.+|+..|+++|..+|.|+||+|+.+||+.
T Consensus 293 ~E~Lt~EEI~ELREaF~~fDkDgdG~IS~eELk~ 326 (440)
T 3u0k_A 293 RDQLTEEQIAEFKEAFSLFDKDGDGTITTKELGT 326 (440)
T ss_dssp CBCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HhhhhHHHHHHHHHHHHHHcCCCCCEECHHHHHH
Confidence 4678999999999999999999999999999975
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.69 E-value=0.023 Score=41.17 Aligned_cols=25 Identities=16% Similarity=0.367 Sum_probs=17.7
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++..|..+|.|+||+|+.+||+.
T Consensus 6 ~~l~~~F~~~D~d~~G~i~~~el~~ 30 (71)
T 2b1u_A 6 EDLQVAFRAFDQDGDGHITVDELRR 30 (71)
T ss_dssp HHHHHHHTTSCCSSSSEEEHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 4566777777777777777777753
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=93.42 E-value=0.0058 Score=46.64 Aligned_cols=24 Identities=13% Similarity=0.243 Sum_probs=20.3
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.|+.+||..
T Consensus 60 ~~~~l~~~~d~~~~g~i~~~eF~~ 83 (87)
T 1s6j_A 60 EIKDLMDAADIDKSGTIDYGEFIA 83 (87)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHTT
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHH
Confidence 466788899999999999999865
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=93.32 E-value=0.026 Score=40.23 Aligned_cols=19 Identities=16% Similarity=0.349 Sum_probs=9.9
Q ss_pred HHhhhCCCCCCccchhhhh
Q 011582 462 QFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 462 ~f~~~d~n~dg~i~~~e~~ 480 (482)
+|..+|.|+||.|+.+||.
T Consensus 42 ~~~~~D~~~dg~i~~~ef~ 60 (67)
T 1tiz_A 42 FFEEIDVDGNGELNADEFT 60 (67)
T ss_dssp HHHHHCCSSSSEECHHHHH
T ss_pred HHHHHCCCCCCcCcHHHHH
Confidence 4455555555555555543
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=93.29 E-value=0.016 Score=41.40 Aligned_cols=20 Identities=20% Similarity=0.366 Sum_probs=14.0
Q ss_pred HHhhhCCCCCCccchhhhhc
Q 011582 462 QFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 462 ~f~~~d~n~dg~i~~~e~~~ 481 (482)
+|..+|.|+||.|+.+||..
T Consensus 41 ~~~~~D~~~~g~i~~~ef~~ 60 (66)
T 3li6_A 41 IFKSIDADGNGEIDQNEFAK 60 (66)
T ss_dssp HHHHHCTTCSSSCCHHHHHH
T ss_pred HHHHHCCCCCCCCCHHHHHH
Confidence 56677777777777777653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.11 E-value=0.43 Score=47.68 Aligned_cols=32 Identities=34% Similarity=0.542 Sum_probs=26.0
Q ss_pred CcccCCCCCceEEec---CCCCCcEEEEecccccc
Q 011582 274 VVHRDLKPENFLFTS---KEENSSLKAIDFGLSDY 305 (482)
Q Consensus 274 ivHrDlkp~NIll~~---~~~~~~~kl~DfGla~~ 305 (482)
++|+|+.+.|||+.. ++++..+.++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 689999999999953 23566799999988764
|
| >1wy9_A Allograft inflammatory factor 1; EF-hand, calucium binding, metal binding protein; 2.10A {Mus musculus} PDB: 2g2b_A | Back alignment and structure |
|---|
Probab=93.02 E-value=0.053 Score=46.07 Aligned_cols=29 Identities=21% Similarity=0.281 Sum_probs=26.5
Q ss_pred HHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 453 VPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 453 ~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...++..|..+|.|+||+|+.+||+.
T Consensus 44 ~~~~~~l~~~F~~~D~d~dG~I~~~El~~ 72 (147)
T 1wy9_A 44 PSKLEAFKVKYMEFDLNGNGDIDIMSLKR 72 (147)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSEEHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 57788899999999999999999999974
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=92.97 E-value=0.017 Score=45.78 Aligned_cols=21 Identities=19% Similarity=0.352 Sum_probs=11.0
Q ss_pred HHHHhhhCCCCCCccchhhhh
Q 011582 460 REQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 460 ~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.++|..+|.|+||+|+++||.
T Consensus 48 ~~i~~~~D~d~dG~i~~~EF~ 68 (99)
T 1qjt_A 48 GKIWDLADTDGKGVLSKQEFF 68 (99)
T ss_dssp HHHHHHHCCSSSSSCCSHHHH
T ss_pred HHHHHHHCCCCCCcCCHHHHH
Confidence 345555555555555555553
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=92.92 E-value=0.052 Score=43.56 Aligned_cols=22 Identities=14% Similarity=0.391 Sum_probs=13.3
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+.+++...|.|+||.|+++||.
T Consensus 50 l~~i~~~~D~d~dG~id~~EF~ 71 (106)
T 1eh2_A 50 LGRVWELSDIDHDGMLDRDEFA 71 (106)
T ss_dssp HHHHHHHHCSSCSSBCCHHHHH
T ss_pred HHHHHHHHcCCCCCcCcHHHHH
Confidence 3445666666666666666664
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=92.89 E-value=0.055 Score=49.53 Aligned_cols=37 Identities=14% Similarity=0.122 Sum_probs=32.8
Q ss_pred HhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 445 GALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 445 ~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...++.++...|++.|..+|.|+||+|+.+||+.
T Consensus 39 ~~l~~~ls~~~~~~l~~~F~~~D~d~dG~Is~~El~~ 75 (226)
T 2lvv_A 39 CAIPRDKDAESKSRRIELFKQFDTNGTGKLGFREVLD 75 (226)
T ss_dssp HHSCSSCCHHHHHHHHHHHHHHGGGSCSCBCSHHHHH
T ss_pred HHhchhCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 3355678899999999999999999999999999975
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=92.81 E-value=0.038 Score=40.90 Aligned_cols=22 Identities=23% Similarity=0.407 Sum_probs=12.9
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
++..|..+|.|+||+|+.+||+
T Consensus 5 l~~~F~~~D~~~~G~i~~~el~ 26 (78)
T 1k9u_A 5 MERIFKRFDTNGDGKISLSELT 26 (78)
T ss_dssp HHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHHCCCCCCcCcHHHHH
Confidence 4555666666666666666554
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=92.78 E-value=0.049 Score=42.39 Aligned_cols=23 Identities=30% Similarity=0.560 Sum_probs=12.2
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+++.|..+|.|+||+|+.+||+
T Consensus 30 ~l~~~F~~~D~d~~G~I~~~El~ 52 (94)
T 2kz2_A 30 EIREAFRVEDKDGNGYISAAELR 52 (94)
T ss_dssp HHHHHHHHHCTTCCSCBCHHHHH
T ss_pred HHHHHHHHHCCCCcCcCCHHHHH
Confidence 34455555555555555555554
|
| >2d58_A Allograft inflammatory factor 1; EF-hand, metal binding protein; 1.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.58 E-value=0.053 Score=43.14 Aligned_cols=29 Identities=24% Similarity=0.323 Sum_probs=25.1
Q ss_pred HHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 453 VPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 453 ~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...++..|..+|.|+||+|+.+||+.
T Consensus 28 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~ 56 (107)
T 2d58_A 28 PSKLEGFKEKYMEFDLNGNGDIDIMSLKR 56 (107)
T ss_dssp HHHHHHHHHHHTTSCCCTTSCEEHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 56777889999999999999999999864
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=92.32 E-value=0.045 Score=42.45 Aligned_cols=25 Identities=16% Similarity=0.195 Sum_probs=14.6
Q ss_pred HHHHHHHHhhhC-CCCCC-ccchhhhh
Q 011582 456 LAYLREQFTLLA-PNKNG-FISMQNYK 480 (482)
Q Consensus 456 ~~~l~~~f~~~d-~n~dg-~i~~~e~~ 480 (482)
...+++.|..+| .|+|| +|+.+||+
T Consensus 9 ~~~l~~~F~~~D~~d~dG~~I~~~El~ 35 (92)
T 2kax_A 9 LTTMVTTFHKYSGREGSKLTLSRKELK 35 (92)
T ss_dssp HHHHHHHHHHHHTTSSCSSEEEHHHHH
T ss_pred HHHHHHHHHHHHhhCCCCCeeCHHHHH
Confidence 444555666666 56666 66666654
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=92.29 E-value=0.081 Score=41.92 Aligned_cols=25 Identities=24% Similarity=0.593 Sum_probs=16.7
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++..|..+|.|+||+|+.+||+.
T Consensus 42 ~~l~~~F~~~D~d~~G~i~~~el~~ 66 (109)
T 3fs7_A 42 DQIKKVFGILDQDKSGFIEEEELQL 66 (109)
T ss_dssp HHHHHHHHHHSTTCSSSBCHHHHHT
T ss_pred HHHHHHHHHHCCCCCCeEeHHHHHH
Confidence 3466667777777777777777654
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=92.16 E-value=0.075 Score=43.18 Aligned_cols=29 Identities=10% Similarity=0.096 Sum_probs=25.1
Q ss_pred HHHHHHHHHHHhhhC-CCCCC-ccchhhhhc
Q 011582 453 VPQLAYLREQFTLLA-PNKNG-FISMQNYKM 481 (482)
Q Consensus 453 ~~~~~~l~~~f~~~d-~n~dg-~i~~~e~~~ 481 (482)
..+...|+++|..+| .|+|| +|+.+||+.
T Consensus 18 ~~~~~~l~~aF~~fD~~dgdGG~Is~~EL~~ 48 (113)
T 2lnk_A 18 EKALDVMVSTFHKYSGKEGDKFKLNKSELKE 48 (113)
T ss_dssp HHHHHHHHHHHHHTTTTTSCTTCBCHHHHHH
T ss_pred hhHHHHHHHHHHHHcccCCCCCEECHHHHHH
Confidence 346778999999999 89997 999999975
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=92.14 E-value=0.047 Score=48.63 Aligned_cols=33 Identities=30% Similarity=0.547 Sum_probs=29.5
Q ss_pred hcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 449 KTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 449 ~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++..++..|+++|..+|.|+||+||.+||+.
T Consensus 49 ~~ls~~~~~~l~~~F~~~D~d~~G~i~~~el~~ 81 (196)
T 3dtp_E 49 AMFTQHQVQEFKEAFQLIDQDKDGFISKNDIRA 81 (196)
T ss_dssp CSSCTTTHHHHHHHHHHHCCSCSSBCCHHHHHH
T ss_pred hhCCHHHHHHHHHHHHHHCCCCCCcCCHHHHHH
Confidence 456778889999999999999999999999974
|
| >1pva_A Parvalbumin; calcium binding; 1.65A {Esox lucius} SCOP: a.39.1.4 PDB: 2pas_A 3pat_A | Back alignment and structure |
|---|
Probab=92.14 E-value=0.078 Score=42.04 Aligned_cols=26 Identities=19% Similarity=0.443 Sum_probs=19.7
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++..|..+|.|+||+|+.+||+.
T Consensus 41 ~~~l~~~F~~~D~d~~G~I~~~el~~ 66 (110)
T 1pva_A 41 ANDVKKVFKAIDADASGFIEEEELKF 66 (110)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHT
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 45677788888888888888888764
|
| >2pvb_A Protein (parvalbumin); calcium binding protein, metal binding protein; 0.91A {Esox lucius} SCOP: a.39.1.4 PDB: 1pvb_A 2pal_A 1pal_A 3pal_A 4pal_A 4cpv_A 1cdp_A 5cpv_A 1b8r_A 1b9a_A 1b8l_A 1b8c_A 1a75_B 1a75_A | Back alignment and structure |
|---|
Probab=92.10 E-value=0.08 Score=41.88 Aligned_cols=26 Identities=27% Similarity=0.584 Sum_probs=18.4
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++.+|..+|.|+||+|+.+||+.
T Consensus 40 ~~~l~~~F~~~D~d~~G~I~~~el~~ 65 (108)
T 2pvb_A 40 LDDVKKAFYVIDQDKSGFIEEDELKL 65 (108)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHT
T ss_pred HHHHHHHHHHHCCCCCCcCCHHHHHH
Confidence 44566777777777777777777764
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=91.97 E-value=0.033 Score=41.60 Aligned_cols=25 Identities=28% Similarity=0.604 Sum_probs=17.7
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++ .|..+|.|+||+|+.+||+.
T Consensus 8 ~~~l~-~F~~~D~d~~G~i~~~el~~ 32 (81)
T 1c7v_A 8 EEILR-AFKVFDANGDGVIDFDEFKF 32 (81)
T ss_dssp HHHHH-HHHHHSCSGGGEECHHHHHH
T ss_pred HHHHH-HHHHHCCCCCCcCCHHHHHH
Confidence 44566 77777777777777777753
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=91.82 E-value=0.066 Score=41.40 Aligned_cols=19 Identities=26% Similarity=0.445 Sum_probs=11.8
Q ss_pred HHhhhCCCCCCccchhhhh
Q 011582 462 QFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 462 ~f~~~d~n~dg~i~~~e~~ 480 (482)
+|..+|.|+||.|+.+||.
T Consensus 54 l~~~~D~d~dG~I~~~EF~ 72 (93)
T 1xk4_A 54 WFKELDINTDGAVNFQEFL 72 (93)
T ss_dssp HHHHHCTTCSSSBCHHHHH
T ss_pred HHHHhCCCCCCCCcHHHHH
Confidence 5556666666666666664
|
| >1rro_A RAT oncomodulin; calcium-binding protein; 1.30A {Rattus rattus} SCOP: a.39.1.4 PDB: 1omd_A 2nln_A 1ttx_A | Back alignment and structure |
|---|
Probab=91.80 E-value=0.081 Score=41.84 Aligned_cols=26 Identities=12% Similarity=0.447 Sum_probs=19.5
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++.+|..+|.|+||+|+.+||+.
T Consensus 40 ~~~l~~~F~~~D~d~~G~I~~~el~~ 65 (108)
T 1rro_A 40 ASQVKDIFRFIDNDQSGYLDGDELKY 65 (108)
T ss_dssp HHHHHHHHHHHCTTCSSEECTHHHHT
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHH
Confidence 44567788888888888888888764
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=91.77 E-value=0.064 Score=42.29 Aligned_cols=20 Identities=10% Similarity=0.280 Sum_probs=10.7
Q ss_pred HHHhhhCCCCCCccchhhhh
Q 011582 461 EQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 461 ~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+|..+|.|+||.|+.+||.
T Consensus 64 ~l~~~~d~~~~g~i~~~eF~ 83 (105)
T 1wlz_A 64 RLWNEMPVNAKGRLKYPDFL 83 (105)
T ss_dssp HHHTTSCBCTTSCBCHHHHH
T ss_pred HHHHHcCCCCCCCCcHHHHH
Confidence 44555555555555555553
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=91.75 E-value=0.062 Score=42.71 Aligned_cols=27 Identities=15% Similarity=0.016 Sum_probs=23.8
Q ss_pred HHHHHHHHHhhhC-CCCC-Cccchhhhhc
Q 011582 455 QLAYLREQFTLLA-PNKN-GFISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~d-~n~d-g~i~~~e~~~ 481 (482)
.+..|.++|..+| .|+| |+||.+||+.
T Consensus 8 ~i~~l~~aF~~fd~~dg~~G~Is~~EL~~ 36 (101)
T 3nso_A 8 AVAAIVCTFQEYAGRCGDKYKLCQAELKE 36 (101)
T ss_dssp HHHHHHHHHHHHHTTSSCTTEECHHHHHH
T ss_pred HHHHHHHHHHHHhhcCCCCCEECHHHHHH
Confidence 4677999999997 8998 9999999975
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=91.69 E-value=0.082 Score=41.28 Aligned_cols=28 Identities=7% Similarity=0.205 Sum_probs=23.9
Q ss_pred HHHHHHHHHHhhhC-CCC-CCccchhhhhc
Q 011582 454 PQLAYLREQFTLLA-PNK-NGFISMQNYKM 481 (482)
Q Consensus 454 ~~~~~l~~~f~~~d-~n~-dg~i~~~e~~~ 481 (482)
.+...|+++|..+| .|+ +|+|+.+||+.
T Consensus 6 ~~~~~l~~~F~~fD~~dgd~G~I~~~El~~ 35 (95)
T 1j55_A 6 TAMGMIIDVFSRYSGSEGSTQTLTKGELKV 35 (95)
T ss_dssp HHHHHHHHHHHHHTTSSSCTTEECHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCcCCHHHHHH
Confidence 35678999999999 698 48999999975
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=91.56 E-value=0.071 Score=40.92 Aligned_cols=28 Identities=14% Similarity=0.118 Sum_probs=24.6
Q ss_pred HHHHHHHHHHhhhC-CCCCC-ccchhhhhc
Q 011582 454 PQLAYLREQFTLLA-PNKNG-FISMQNYKM 481 (482)
Q Consensus 454 ~~~~~l~~~f~~~d-~n~dg-~i~~~e~~~ 481 (482)
.+...++..|..+| .|+|| +|+.+||+.
T Consensus 6 ~~~~~l~~~F~~~D~~d~~G~~I~~~el~~ 35 (93)
T 1k2h_A 6 TAMETLINVFHAHSGKEGDKYKLSKKELKD 35 (93)
T ss_dssp HHHHHHHHHHHHHHTTSSCCSSCCHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCcCccCHHHHHH
Confidence 35677999999999 79999 999999975
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=91.54 E-value=0.05 Score=48.74 Aligned_cols=33 Identities=18% Similarity=0.284 Sum_probs=23.7
Q ss_pred hcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 449 KTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 449 ~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++.+++..+++.|..+|.|+||.|+.+||+.
T Consensus 28 ~~l~~~~~~~l~~~F~~~D~d~~G~i~~~El~~ 60 (208)
T 2hpk_A 28 EDLHPKMLSRLYKRFDTFDLDSDGKMEMDEVLY 60 (208)
T ss_dssp --------CHHHHHHHHHCTTCSSEECHHHHTH
T ss_pred HHcCHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 456677888999999999999999999999974
|
| >1rwy_A Parvalbumin alpha; EF-hand, calcium-binding, calcium-binding protein; HET: PG4; 1.05A {Rattus norvegicus} SCOP: a.39.1.4 PDB: 1rtp_1* 2jww_A 3f45_A 1s3p_A 1xvj_A 1rjv_A 1rk9_A 1g33_A | Back alignment and structure |
|---|
Probab=91.47 E-value=0.08 Score=41.90 Aligned_cols=26 Identities=23% Similarity=0.436 Sum_probs=16.9
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++..|..+|.|+||+|+.+||+.
T Consensus 40 ~~~l~~~F~~~D~d~~G~I~~~el~~ 65 (109)
T 1rwy_A 40 ADDVKKVFHILDKDKSGFIEEDELGS 65 (109)
T ss_dssp HHHHHHHHHHHSTTCSSEECHHHHHT
T ss_pred HHHHHHHHHHHCCCCCCeEcHHHHHH
Confidence 34566667777777777777776653
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=91.36 E-value=0.069 Score=42.81 Aligned_cols=19 Identities=16% Similarity=0.307 Sum_probs=10.1
Q ss_pred HHhhhCCCCCCccchhhhh
Q 011582 462 QFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 462 ~f~~~d~n~dg~i~~~e~~ 480 (482)
+|..+|.|+||.|+++||.
T Consensus 67 li~~~D~d~dG~Idf~EF~ 85 (106)
T 2h2k_A 67 KMKSLDVNQDSELKFNEYW 85 (106)
T ss_dssp HHHHHCTTCSSSEEHHHHH
T ss_pred HHHHHCCCCCCCCcHHHHH
Confidence 3444555555555555553
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=91.35 E-value=0.088 Score=40.95 Aligned_cols=27 Identities=22% Similarity=0.198 Sum_probs=24.0
Q ss_pred HHHHHHHHHhhhC-CCCCC-ccchhhhhc
Q 011582 455 QLAYLREQFTLLA-PNKNG-FISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~d-~n~dg-~i~~~e~~~ 481 (482)
....+...|..+| .|+|| +|+.+||+.
T Consensus 11 ~~~~l~~~F~~~Dd~d~~G~~I~~~el~~ 39 (99)
T 1qls_A 11 CIESLIAIFQKHAGRDGNNTKISKTEFLI 39 (99)
T ss_dssp HHHHHHHHHHHHHTTSSCTTCBCHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCcCeeCHHHHHH
Confidence 4567899999998 99999 999999974
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=91.26 E-value=0.067 Score=41.81 Aligned_cols=28 Identities=14% Similarity=0.062 Sum_probs=24.3
Q ss_pred HHHHHHHHHHhhhC-CCCCC-ccchhhhhc
Q 011582 454 PQLAYLREQFTLLA-PNKNG-FISMQNYKM 481 (482)
Q Consensus 454 ~~~~~l~~~f~~~d-~n~dg-~i~~~e~~~ 481 (482)
.+...|++.|..+| .|+|| +|+.+||+.
T Consensus 9 ~~~~~l~~~F~~fD~~dg~gg~I~~~El~~ 38 (95)
T 2wcb_A 9 EHLEGIVNIFHQYSVRKGHFDTLSKGELKQ 38 (95)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEEEHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCccCHHHHHH
Confidence 35678999999999 89998 999999975
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=91.22 E-value=0.17 Score=40.04 Aligned_cols=26 Identities=23% Similarity=0.240 Sum_probs=22.8
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...+.++|..+|.|+||.|+++||..
T Consensus 54 ~~ev~~~i~~~D~d~DG~Idf~EF~~ 79 (100)
T 3nxa_A 54 RKAADKLIQNLDANHDGRISFDEYWT 79 (100)
T ss_dssp HHHHHHHHHHSCCCSSCCBCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCcHHHHHH
Confidence 34688999999999999999999964
|
| >1bu3_A Calcium-binding protein; 1.65A {Merluccius bilinearis} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=91.13 E-value=0.089 Score=41.67 Aligned_cols=26 Identities=23% Similarity=0.526 Sum_probs=16.4
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++..|..+|.|+||+|+.+||+.
T Consensus 41 ~~~l~~~F~~~D~d~~G~I~~~el~~ 66 (109)
T 1bu3_A 41 ADDIKKAFFVIDQDKSGFIEEDELKL 66 (109)
T ss_dssp HHHHHHHHHHHCTTCSSSEEHHHHHT
T ss_pred HHHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 33456666666666666666666653
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=91.13 E-value=0.092 Score=41.57 Aligned_cols=23 Identities=30% Similarity=0.637 Sum_probs=12.5
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.++..|..+|.|+||+|+.+||+
T Consensus 42 ~l~~~F~~~D~d~~G~i~~~el~ 64 (109)
T 5pal_A 42 QVKEVFEILDKDQSGFIEEEELK 64 (109)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHH
Confidence 34555555555555555555554
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 | Back alignment and structure |
|---|
Probab=91.12 E-value=0.051 Score=40.06 Aligned_cols=24 Identities=25% Similarity=0.271 Sum_probs=12.9
Q ss_pred HHHHHHHhhhCC-CCCC-ccchhhhh
Q 011582 457 AYLREQFTLLAP-NKNG-FISMQNYK 480 (482)
Q Consensus 457 ~~l~~~f~~~d~-n~dg-~i~~~e~~ 480 (482)
..++..|..+|. |+|| .|+.+||+
T Consensus 7 ~~l~~~F~~~D~~d~~G~~i~~~el~ 32 (78)
T 1cb1_A 7 AELKSIFEKYAAKEGDPNQLSKEELK 32 (78)
T ss_dssp HHHHHHHHHHHTTSSSTTEECHHHHH
T ss_pred HHHHHHHHHHhccCCCcCEeCHHHHH
Confidence 345555555555 5555 55555554
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=91.12 E-value=0.084 Score=38.58 Aligned_cols=23 Identities=22% Similarity=0.359 Sum_probs=15.3
Q ss_pred HHHHHHhhh-CCCCC-Cccchhhhh
Q 011582 458 YLREQFTLL-APNKN-GFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~-d~n~d-g~i~~~e~~ 480 (482)
.++..|..+ |.|+| |+|+.+||+
T Consensus 6 ~l~~~F~~~~D~d~~~G~i~~~el~ 30 (76)
T 1qx2_A 6 EIKGAFEVFAAKEGDPNQISKEELK 30 (76)
T ss_dssp HHHHHHHHHHTSSSCTTSEEHHHHH
T ss_pred HHHHHHHHHcccCCCcCeECHHHHH
Confidence 456666666 66666 777666665
|
| >3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C | Back alignment and structure |
|---|
Probab=91.04 E-value=0.082 Score=45.52 Aligned_cols=23 Identities=22% Similarity=0.352 Sum_probs=13.4
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.|+++|+.+|.|++|+||.+||+
T Consensus 86 ~l~~aF~~fD~d~~G~I~~~el~ 108 (159)
T 3i5g_C 86 EFMEAFKTFDREGQGLISSAEIR 108 (159)
T ss_dssp HHHHHHHHHCTTSSSEECHHHHH
T ss_pred HHHHHHHHHhcCCCCcCcHHHHH
Confidence 35555666666666666666554
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=90.99 E-value=0.08 Score=41.77 Aligned_cols=28 Identities=14% Similarity=0.074 Sum_probs=24.1
Q ss_pred HHHHHHHHHHhhhC-CCCCC-ccchhhhhc
Q 011582 454 PQLAYLREQFTLLA-PNKNG-FISMQNYKM 481 (482)
Q Consensus 454 ~~~~~l~~~f~~~d-~n~dg-~i~~~e~~~ 481 (482)
.+...|+++|..+| .|+|| +|+.+||+.
T Consensus 7 ~~~~~l~~~F~~fDd~dg~gG~I~~~El~~ 36 (99)
T 2y5i_A 7 GAMDALITVFHNYSGSEGDKYKLSKGELKE 36 (99)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCcCcCCHHHHHH
Confidence 35678999999997 89998 999999975
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=90.87 E-value=0.25 Score=41.25 Aligned_cols=28 Identities=25% Similarity=0.312 Sum_probs=24.4
Q ss_pred HHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 454 PQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 454 ~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.....+..+|..+|.|+||+||.+||+.
T Consensus 72 ~~~~~~~~~F~~~D~d~~G~i~~~e~~~ 99 (155)
T 3ll8_B 72 DKEQKLRFAFRIYDMDKDGYISNGELFQ 99 (155)
T ss_dssp CHHHHHHHHHHHHCTTCSSCBCHHHHHH
T ss_pred CHHHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 3446789999999999999999999975
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=90.86 E-value=0.16 Score=39.50 Aligned_cols=24 Identities=17% Similarity=0.358 Sum_probs=21.1
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.+++..+|.|+||+|+.+||..
T Consensus 54 ev~~~i~~~D~d~DG~Idf~EF~~ 77 (93)
T 4eto_A 54 AFQKLMSNLDSNRDNEVDFQEYCV 77 (93)
T ss_dssp HHHHHHHHHCTTSSSSBCHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCcHHHHHH
Confidence 467889999999999999999863
|
| >1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=90.83 E-value=0.072 Score=42.10 Aligned_cols=23 Identities=22% Similarity=0.313 Sum_probs=21.1
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++..|..+|.|+||+|+.+||+.
T Consensus 22 ~~~~F~~~D~d~dG~I~~~El~~ 44 (103)
T 1snl_A 22 PKTFFILHDINSDGVLDEQELEA 44 (103)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHH
T ss_pred HHHHHHHHcCCCCCcccHHHHHH
Confidence 67899999999999999999974
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=90.82 E-value=0.12 Score=46.13 Aligned_cols=32 Identities=25% Similarity=0.523 Sum_probs=25.8
Q ss_pred cCCHHHHHHHHHHHhhhCCC--CCCccchhhhhc
Q 011582 450 TLTVPQLAYLREQFTLLAPN--KNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~l~~~f~~~d~n--~dg~i~~~e~~~ 481 (482)
.++..++..+.+.|..+|.| +||.|+.+||+.
T Consensus 30 ~~s~~~~~~l~~~F~~~D~d~~~~G~i~~~e~~~ 63 (207)
T 2ehb_A 30 PFTVEEVEALYELFKKLSSSIIDDGLIHKEEFQL 63 (207)
T ss_dssp SCCHHHHHHHHHHHHHHTTSSSCSSCEEHHHHHH
T ss_pred CCCHHHHHHHHHHHHHhccccCCCCccCHHHHHH
Confidence 46777888888888888888 888888888864
|
| >3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica} | Back alignment and structure |
|---|
Probab=90.72 E-value=0.14 Score=36.26 Aligned_cols=22 Identities=23% Similarity=0.329 Sum_probs=19.6
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
++.+|..+|.|+||+|+.+||+
T Consensus 2 l~~~F~~~D~d~~G~i~~~e~~ 23 (66)
T 3li6_A 2 AEALFKEIDVNGDGAVSYEEVK 23 (66)
T ss_dssp CCHHHHHHCTTCSSSCCHHHHH
T ss_pred HHHHHHHHCCCCCCcccHHHHH
Confidence 3578999999999999999986
|
| >2jjz_A Ionized calcium-binding adapter molecule 2; EF-hand, actin crosslinking, ionized calciu binding adapter molecule 2, metal-binding protein; 2.15A {Homo sapiens} PDB: 2jjz_B 2vtg_A | Back alignment and structure |
|---|
Probab=90.65 E-value=0.12 Score=43.91 Aligned_cols=29 Identities=21% Similarity=0.339 Sum_probs=23.9
Q ss_pred HHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 453 VPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 453 ~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...++..|..+|.|+||+|+.+||+.
T Consensus 46 ~~~~~~l~~~F~~~D~d~~G~I~~~el~~ 74 (150)
T 2jjz_A 46 PEKLTAFKEKYMEFDLNNEGEIDLMSLKR 74 (150)
T ss_dssp HHHHHHHHHHHTTSCCCTTSSBCHHHHHH
T ss_pred HHHHHHHHHHHHHhCCCCcCcCCHHHHHH
Confidence 45677788899999999999999988864
|
| >3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B | Back alignment and structure |
|---|
Probab=90.47 E-value=0.1 Score=44.67 Aligned_cols=25 Identities=28% Similarity=0.493 Sum_probs=22.6
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..|+..|..+|.|++|+||.+||+.
T Consensus 85 ~~l~~aF~~fD~d~~G~I~~~el~~ 109 (153)
T 3i5g_B 85 DALRNAFSMFDEDGQGFIPEDYLKD 109 (153)
T ss_dssp HHHHHHHHTTCSSCSSCCCHHHHHH
T ss_pred HHHHHHHhccccCCCCeEeHHHHHH
Confidence 4688999999999999999999975
|
| >1psr_A Psoriasin, S100A7; EF-hand protein, MAD phasing, psoriasis, S100 protein family; 1.05A {Homo sapiens} SCOP: a.39.1.2 PDB: 2psr_A 2wor_A* 2wos_A* 3psr_A 2wnd_A | Back alignment and structure |
|---|
Probab=90.42 E-value=0.14 Score=40.33 Aligned_cols=27 Identities=7% Similarity=0.053 Sum_probs=23.6
Q ss_pred HHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 454 PQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 454 ~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+...|+++|..+|.+ ||+|+.+||+.
T Consensus 7 ~~~~~l~~~F~~fD~~-~g~Is~~El~~ 33 (100)
T 1psr_A 7 RSIIGMIDMFHKYTRR-DDKIDKPSLLT 33 (100)
T ss_dssp HHHHHHHHHHHHTCCT-TSCBCHHHHHH
T ss_pred HHHHHHHHHHHHHhCC-CCeECHHHHHH
Confidence 4677899999999976 89999999975
|
| >4eto_A Protein S100-A4; calcium-binding protein, EF-hand, structural genomics, PSI-B protein structure initiative, NEW YORK structural genomics consortium; 1.54A {Homo sapiens} PDB: 1m31_A 2q91_A 3cga_A 3ko0_A* 3m0w_A* | Back alignment and structure |
|---|
Probab=90.41 E-value=0.11 Score=40.54 Aligned_cols=28 Identities=11% Similarity=0.074 Sum_probs=23.3
Q ss_pred HHHHHHHHHHhhhC-CCCC-Cccchhhhhc
Q 011582 454 PQLAYLREQFTLLA-PNKN-GFISMQNYKM 481 (482)
Q Consensus 454 ~~~~~l~~~f~~~d-~n~d-g~i~~~e~~~ 481 (482)
.....|+++|..+| .|+| |+||.+||+.
T Consensus 7 ~~~~~l~~~F~~fd~~dg~~G~Is~~EL~~ 36 (93)
T 4eto_A 7 KALDVMVSTFHKYSGKEGDKFKLNKSELKE 36 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCeECHHHHHH
Confidence 35678999999998 5775 8999999975
|
| >2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A | Back alignment and structure |
|---|
Probab=90.41 E-value=0.1 Score=41.17 Aligned_cols=26 Identities=31% Similarity=0.554 Sum_probs=22.0
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhcC
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKMT 482 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~~ 482 (482)
..++..|..+|.|+||+|+.+||+.+
T Consensus 41 ~~l~~~F~~~D~d~~G~I~~~el~~~ 66 (108)
T 2kyc_A 41 SQLKEIFRILDNDQSGFIEEDELKYF 66 (108)
T ss_dssp SSHHHHCSSSCSCCSSCCCGGGTTTS
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHHH
Confidence 45778999999999999999998753
|
| >2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.32 E-value=0.16 Score=40.12 Aligned_cols=34 Identities=12% Similarity=0.166 Sum_probs=25.6
Q ss_pred HhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 445 GALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 445 ~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...++..+ +.++|..+|.|+||.|+.+||..
T Consensus 63 ~~lg~~~~~~e---i~~l~~~~D~d~dG~I~~~EF~~ 96 (100)
T 2lv7_A 63 RSLGYMPNEVE---LEVIIQRLDMDGDGQVDFEEFVT 96 (100)
T ss_dssp HHHTCCCCTTT---HHHHHHHHCSSCSSSBCHHHHHH
T ss_pred HHhCCCCCHHH---HHHHHHHHCCCCCCeEeHHHHHH
Confidence 33444555544 55788999999999999999964
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=90.23 E-value=0.13 Score=43.36 Aligned_cols=26 Identities=8% Similarity=0.079 Sum_probs=22.8
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhcC
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKMT 482 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~~ 482 (482)
..+...|+.+|.|+||+|+.+||+.+
T Consensus 68 ~~l~~~F~~~D~d~dG~I~~~El~~~ 93 (143)
T 3a4u_B 68 ELQLHYFKMHDYDGNNLLDGLELSTA 93 (143)
T ss_dssp HHHHHHHHHTCTTCSSCEEHHHHHHT
T ss_pred HHHHHHHHHhCCCCCCccCHHHHHHH
Confidence 45778899999999999999999753
|
| >1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=90.14 E-value=0.26 Score=34.74 Aligned_cols=24 Identities=21% Similarity=0.450 Sum_probs=21.5
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++..|..+|.|+||+|+.+||+.
T Consensus 2 ~l~~~F~~~D~d~~G~i~~~el~~ 25 (67)
T 1tiz_A 2 SAKRVFEKFDKNKDGKLSLDEFRE 25 (67)
T ss_dssp THHHHHHHHCTTSSSCEEHHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHH
Confidence 367899999999999999999974
|
| >3nxa_A Protein S100-A16; S100 family, calcium binding protein, APO, EF-hand calcium binding proteins, S100 proteins, protein dynamics, binding protein; 2.10A {Homo sapiens} SCOP: a.39.1.0 PDB: 2l0u_A 2l0v_A 2l50_A 2l51_A | Back alignment and structure |
|---|
Probab=90.09 E-value=0.16 Score=40.09 Aligned_cols=28 Identities=18% Similarity=0.207 Sum_probs=23.8
Q ss_pred HHHHHHHHHHhhhCCCC---CCccchhhhhc
Q 011582 454 PQLAYLREQFTLLAPNK---NGFISMQNYKM 481 (482)
Q Consensus 454 ~~~~~l~~~f~~~d~n~---dg~i~~~e~~~ 481 (482)
.....|+++|..+|.|+ ||+||.+||+.
T Consensus 8 ~~i~~l~~~F~~fD~~~g~~~G~Is~~EL~~ 38 (100)
T 3nxa_A 8 KAVIVLVENFYKYVSKYSLVKNKISKSSFRE 38 (100)
T ss_dssp HHHHHHHHHHHHTSCTTCSCTTCBCHHHHHH
T ss_pred HHHHHHHHHHHHHcCcCCCCCCeEcHHHHHH
Confidence 35667999999999974 79999999975
|
| >2jq6_A EH domain-containing protein 1; metal binding protein; NMR {Homo sapiens} PDB: 2kff_A 2kfg_A 2kfh_A 2ksp_A | Back alignment and structure |
|---|
Probab=90.08 E-value=0.081 Score=44.67 Aligned_cols=22 Identities=18% Similarity=0.463 Sum_probs=15.3
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
|.+++...|.|+||+|+++||.
T Consensus 86 l~~I~~~~D~d~dG~Ld~~EF~ 107 (139)
T 2jq6_A 86 LGKIWKLADVDKDGLLDDEEFA 107 (139)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHH
Confidence 3456777777777777777775
|
| >1k8u_A S100A6, calcyclin, CACY; calcium regulatory protein, calcium free, signaling protein; HET: MSE; 1.15A {Homo sapiens} SCOP: a.39.1.2 PDB: 1k96_A 1k9k_A 1k9p_A 1a03_A 1cnp_A 1jwd_A 2cnp_A 2jtt_A | Back alignment and structure |
|---|
Probab=89.90 E-value=0.11 Score=39.51 Aligned_cols=27 Identities=15% Similarity=0.174 Sum_probs=23.4
Q ss_pred HHHHHHHHHhhhC-CCCCC-ccchhhhhc
Q 011582 455 QLAYLREQFTLLA-PNKNG-FISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~d-~n~dg-~i~~~e~~~ 481 (482)
+...+...|..+| .|+|| +|+.+||+.
T Consensus 8 ~~~~l~~~F~~~D~~d~~G~~i~~~el~~ 36 (90)
T 1k8u_A 8 AIGLLVAIFHKYSGREGDKHTLSKKELKE 36 (90)
T ss_dssp HHHHHHHHHHHHHTSSSCTTEEEHHHHHH
T ss_pred HHHHHHHHHHHHhccCCCCCcCCHHHHHH
Confidence 4567899999999 59999 999999974
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=89.87 E-value=0.12 Score=47.17 Aligned_cols=40 Identities=20% Similarity=0.456 Sum_probs=29.8
Q ss_pred HHHHhhhh--cCCHHHHHHHHHHHhhhCCC--CCCccchhhhhc
Q 011582 442 AALGALAK--TLTVPQLAYLREQFTLLAPN--KNGFISMQNYKM 481 (482)
Q Consensus 442 ~~~~~~~~--~~~~~~~~~l~~~f~~~d~n--~dg~i~~~e~~~ 481 (482)
..+..+.. .++..++..+.+.|..+|.| +||.|+.+||+.
T Consensus 31 ~~~~~l~~~~~ls~~ei~~l~~~F~~~D~d~~~~G~I~~~El~~ 74 (226)
T 2zfd_A 31 GDPELLARDTVFSVSEIEALYELFKKISSAVIDDGLINKEEFQL 74 (226)
T ss_dssp -CTHHHHHHSSCCHHHHHHHHHHHHHHHTSSSCSSSBCHHHHHH
T ss_pred HHHHHHHHhCCCCHHHHHHHHHHHHHhCcccCCCCeEcHHHHHH
Confidence 33444433 56888888888899999988 899999888864
|
| >3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=89.85 E-value=0.14 Score=42.60 Aligned_cols=25 Identities=24% Similarity=0.377 Sum_probs=15.9
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++..|..+|.|+||+|+.+||+.
T Consensus 40 ~~l~~~F~~~D~d~~G~I~~~el~~ 64 (135)
T 3h4s_E 40 SELCKGFSLLADPERHLITAESLRR 64 (135)
T ss_dssp HHHHHHHHHHSBTTTTBBCHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCCHHHHHH
Confidence 4456666666666666666666653
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.45 E-value=0.14 Score=40.84 Aligned_cols=28 Identities=11% Similarity=0.074 Sum_probs=23.2
Q ss_pred HHHHHHHHHHhhhC-CCCC-Cccchhhhhc
Q 011582 454 PQLAYLREQFTLLA-PNKN-GFISMQNYKM 481 (482)
Q Consensus 454 ~~~~~l~~~f~~~d-~n~d-g~i~~~e~~~ 481 (482)
.....|+++|..+| .|+| |+||.+||+.
T Consensus 10 ~~~~~l~~aF~~fD~~dgd~G~Is~~EL~~ 39 (104)
T 3zwh_A 10 KALDVMVSTFHKYSGKEGDKFKLNKSELKE 39 (104)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTSBCHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCCCeECHHHHHH
Confidence 35678999999997 6775 7999999975
|
| >3a8r_A Putative uncharacterized protein; EF-hand, membrane, oxidoreductase, transmembrane, calcium BI protein; 2.40A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=89.33 E-value=0.16 Score=44.55 Aligned_cols=27 Identities=22% Similarity=0.289 Sum_probs=24.1
Q ss_pred HHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 455 QLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
....++..|..+|.|+||+|+.+||+.
T Consensus 96 ~~~~l~~~F~~~D~d~dG~Is~~El~~ 122 (179)
T 3a8r_A 96 FDNRLRTFFDMVDKNADGRLTAEEVKE 122 (179)
T ss_dssp HHHHHHHHHHHHCTTCSSCBCHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCcCCHHHHHH
Confidence 455789999999999999999999975
|
| >2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae} | Back alignment and structure |
|---|
Probab=88.75 E-value=0.2 Score=43.87 Aligned_cols=26 Identities=31% Similarity=0.400 Sum_probs=20.5
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...|...|+.+|.|+||+|+.+||+.
T Consensus 83 ~~~l~~aF~~fD~d~~G~I~~~el~~ 108 (176)
T 2lhi_A 83 EQELLEAFKVFDKNGDGLISAAELKH 108 (176)
T ss_dssp HHHHHHHHHHHCSSCSSSBCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 44577888888888888888888864
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=88.74 E-value=0.12 Score=43.57 Aligned_cols=19 Identities=11% Similarity=0.246 Sum_probs=10.5
Q ss_pred HHhhhCCCCCCccchhhhh
Q 011582 462 QFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 462 ~f~~~d~n~dg~i~~~e~~ 480 (482)
+|..+|.|+||.|+.+||.
T Consensus 124 l~~~~D~d~dG~I~~~EF~ 142 (148)
T 2lmt_A 124 MIREADFDGDGMINYEEFV 142 (148)
T ss_dssp HHHHHCCSCCSSEEHHHHH
T ss_pred HHHHhCCCCCCeEeHHHHH
Confidence 4555555555555555553
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=88.63 E-value=0.17 Score=39.04 Aligned_cols=26 Identities=15% Similarity=0.253 Sum_probs=22.7
Q ss_pred HHHHHHHHHhhhCCCCCC---ccchhhhhc
Q 011582 455 QLAYLREQFTLLAPNKNG---FISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~d~n~dg---~i~~~e~~~ 481 (482)
.+..|.++|..+| |+|| +||.+||+.
T Consensus 7 ~~~~l~~~F~~~D-~~dG~~g~Is~~EL~~ 35 (92)
T 3rm1_A 7 AVVALIDVFHQYS-GREGDKHKLKKSELKE 35 (92)
T ss_dssp HHHHHHHHHHHHH-TSSSSTTSBCHHHHHH
T ss_pred HHHHHHHHHHHHc-cCCCCcCeECHHHHHH
Confidence 4667899999999 8888 999999975
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=88.60 E-value=0.21 Score=41.56 Aligned_cols=23 Identities=30% Similarity=0.501 Sum_probs=11.8
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+...|..+|.|+||+|+.+||+
T Consensus 80 ~l~~~F~~~D~d~~G~I~~~el~ 102 (143)
T 2obh_A 80 EILKAFKLFDDDETGKISFKNLK 102 (143)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHH
Confidence 34455555555555555555554
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.24 E-value=0.39 Score=42.32 Aligned_cols=33 Identities=12% Similarity=0.306 Sum_probs=26.7
Q ss_pred hcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 449 KTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 449 ~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..........+..+|..+|.|+||+||.+||+.
T Consensus 101 ~~~~~~~~~~~~~~F~~~D~d~~G~I~~~El~~ 133 (204)
T 3e3r_A 101 PPMSQAREAVIAAAFAKLDRSGDGVVTVDDLRG 133 (204)
T ss_dssp CCCCHHHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred hhcCchHHHHHHHHHHHhCcCCCCeEeHHHHHH
Confidence 333444556789999999999999999999974
|
| >1j7q_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1j7r_A | Back alignment and structure |
|---|
Probab=88.24 E-value=0.43 Score=35.73 Aligned_cols=35 Identities=11% Similarity=0.029 Sum_probs=26.6
Q ss_pred hhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 446 ALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 446 ~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+...++..+...+..+|..+|.|+||.|+. ||..
T Consensus 42 ~~g~~~~~~~~~~~~~~~~~~d~~~~g~i~~-eF~~ 76 (86)
T 1j7q_A 42 KLGQTYTKRETEAIMKEARGPKGDKKNIGPE-EWLT 76 (86)
T ss_dssp HTSCCCSHHHHHHHHHHHHCSSCSSCCBCTT-HHHH
T ss_pred HHcCCCCHHHHHHHHHHHHHhCCCCCCcCCH-HHHH
Confidence 3444556655445778999999999999999 9863
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=88.19 E-value=0.16 Score=41.94 Aligned_cols=25 Identities=20% Similarity=0.450 Sum_probs=19.3
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...|..+|.|+||+||.+||+.
T Consensus 76 ~~l~~~F~~~D~d~~G~I~~~El~~ 100 (143)
T 3j04_B 76 DVIRNAFACFDEEASGFIHEDHLRE 100 (143)
T ss_dssp HHHHHHHTTSCSSSCCCCCTTTHHH
T ss_pred HHHHHHHHHHCCCCCCeEcHHHHHH
Confidence 4567788888888888888888764
|
| >3rm1_A Protein S100-B; alpha-helical, EF hand, metal binding protein-protein bindin; 1.24A {Bos taurus} PDB: 3rlz_A 1cfp_A 3cr2_A 3cr4_X* 3cr5_X* 3gk1_A* 3gk2_A* 3gk4_X* 3iqo_A 3iqq_A 3lle_A* 1psb_A 3czt_X 2h61_A 3d0y_A* 3d10_A* 3hcm_A* 3lk1_A* 3lk0_A* 1b4c_A ... | Back alignment and structure |
|---|
Probab=88.18 E-value=0.26 Score=38.01 Aligned_cols=24 Identities=17% Similarity=0.274 Sum_probs=21.1
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++|..+|.|+||+|+.+||..
T Consensus 53 ~v~~~~~~~D~d~dG~I~f~EF~~ 76 (92)
T 3rm1_A 53 VVDKVMETLDSNGDGECDFQEFMA 76 (92)
T ss_dssp HHHHHHHHHCTTSSSSBCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCcHHHHHH
Confidence 466889999999999999999964
|
| >3zwh_A Protein S100-A4; Ca-binding protein-motor protein complex, S100 proteins, EF-; 1.94A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.96 E-value=0.29 Score=38.98 Aligned_cols=24 Identities=17% Similarity=0.358 Sum_probs=21.0
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++|..+|.|+||.|+++||..
T Consensus 57 ev~~~i~~~D~dgDG~Idf~EF~~ 80 (104)
T 3zwh_A 57 AFQKLMSNLDSNRDNEVDFQEYCV 80 (104)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCcHHHHHH
Confidence 467888999999999999999963
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A | Back alignment and structure |
|---|
Probab=87.92 E-value=0.32 Score=39.86 Aligned_cols=24 Identities=17% Similarity=0.358 Sum_probs=18.6
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.|.+++...|.|+||+|+++||..
T Consensus 67 ~L~~Iw~laD~d~dG~Ld~~EF~~ 90 (121)
T 3fia_A 67 VLAQIWALADMNNDGRMDQVEFSI 90 (121)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHHHcCCCCCcCCHHHHHH
Confidence 366778888888888888888753
|
| >1ggw_A Protein (CDC4P); light chain, cytokinesis, cell cycle, EF-hand; NMR {Schizosaccharomyces pombe} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=87.89 E-value=0.21 Score=41.08 Aligned_cols=25 Identities=12% Similarity=0.352 Sum_probs=18.3
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...|..+|.|+||+|+.+||+.
T Consensus 76 ~~~~~~F~~~D~d~~G~i~~~el~~ 100 (140)
T 1ggw_A 76 EEFVKGFQVFDKDATGMIGVGELRY 100 (140)
T ss_dssp HHHHHHHHTTCSSCSSCCCHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcEeHHHHHH
Confidence 4566777777777788777777763
|
| >3e3r_A Calcyphosin, calcyphosine; human calcyphosine, EF-hand, phosphoprotein, calcium binding; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.72 E-value=0.14 Score=45.30 Aligned_cols=22 Identities=9% Similarity=0.178 Sum_probs=11.5
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+..+|..+|.|+||.|+.+||.
T Consensus 75 ~~~~~~~~D~d~dg~i~~~ef~ 96 (204)
T 3e3r_A 75 AEGVCRKWDRNGSGTLDLEEFL 96 (204)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHhccCCCCcCcHHHHH
Confidence 3344555555555555555553
|
| >1k9u_A Polcalcin PHL P 7; pollen allergen, calcium-binding, EF-hand, cross-reactivity; 1.75A {Phleum pratense} SCOP: a.39.1.10 | Back alignment and structure |
|---|
Probab=87.54 E-value=0.55 Score=34.29 Aligned_cols=29 Identities=10% Similarity=0.389 Sum_probs=23.3
Q ss_pred cCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 450 TLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++..+ +..+|..+|.|+||.|+.+||..
T Consensus 34 ~~~~~~---~~~~~~~~D~~~dg~i~~~ef~~ 62 (78)
T 1k9u_A 34 STSADE---VQRMMAEIDTDGDGFIDFNEFIS 62 (78)
T ss_dssp TCCHHH---HHHHHHHHCTTCSSSEEHHHHHH
T ss_pred CCCHHH---HHHHHHHhCCCCCCeEcHHHHHH
Confidence 455444 56789999999999999999864
|
| >2i7a_A Calpain 13; calcium-dependent cytoplasmic cysteine proteinases, like, EF-hand, structural genomics, structural genomics CON SGC, hydrolase; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.31 E-value=0.24 Score=43.30 Aligned_cols=24 Identities=8% Similarity=0.113 Sum_probs=21.3
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++.+|..+| |+||+|+.+||+.
T Consensus 76 ~~l~~aF~~fD-d~~G~I~~~El~~ 99 (174)
T 2i7a_A 76 VHYQHVFQKVQ-TSPGVLLSSDLWK 99 (174)
T ss_dssp HHHHHHHHHHC-SBTTBEEGGGHHH
T ss_pred HHHHHHHHHhc-CCCCcCCHHHHHH
Confidence 46889999999 9999999999975
|
| >1exr_A Calmodulin; high resolution, disorder, metal transport; 1.00A {Paramecium tetraurelia} SCOP: a.39.1.5 PDB: 1n0y_A 1osa_A 1clm_A 1mxe_A 2bbm_A 2bbn_A 4cln_A 4djc_A 2wel_D* 2x51_B 2vas_B* 2bkh_B 3gn4_B 3l9i_C 2ygg_B* 2w73_A 1lvc_D* 1wrz_A 2bki_B 2r28_A ... | Back alignment and structure |
|---|
Probab=87.22 E-value=0.3 Score=40.73 Aligned_cols=23 Identities=30% Similarity=0.499 Sum_probs=12.7
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+...|..+|.|+||+||.+||+
T Consensus 84 ~l~~~F~~~D~d~~G~I~~~el~ 106 (148)
T 1exr_A 84 ELIEAFKVFDRDGNGLISAAELR 106 (148)
T ss_dssp HHHHHHHHHSTTCSSCBCHHHHH
T ss_pred HHHHHHHHhCCCCCCcCCHHHHH
Confidence 34455555555555555555554
|
| >1s6c_A KV4 potassium channel-interacting protein kchip1B; EF-hand, transport protein; 2.00A {Rattus norvegicus} SCOP: a.39.1.5 PDB: 2nz0_A 2i2r_E | Back alignment and structure |
|---|
Probab=87.20 E-value=0.15 Score=44.40 Aligned_cols=25 Identities=32% Similarity=0.445 Sum_probs=22.5
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+..+|..+|.|+||+|+.+||+.
T Consensus 92 ~~~~~~f~~~D~d~~G~i~~~e~~~ 116 (183)
T 1s6c_A 92 EKLRWTFNLYDINKDGYINKEEMMD 116 (183)
T ss_dssp HHHHHHHHHHCTTCSSCEEHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeEcHHHHHH
Confidence 4678899999999999999999974
|
| >2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A | Back alignment and structure |
|---|
Probab=87.18 E-value=0.48 Score=39.66 Aligned_cols=25 Identities=28% Similarity=0.595 Sum_probs=22.4
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..|+.+|..+|.|+||+||.+||+.
T Consensus 83 ~~l~~aF~~~D~d~~G~I~~~El~~ 107 (148)
T 2lmt_A 83 EEMREAFKIFDRDGDGFISPAELRF 107 (148)
T ss_dssp HHHHHHHHHHHSSCSSEECHHHHHH
T ss_pred HHHHHHHHHHCCCCcCcCcHHHHHH
Confidence 3578899999999999999999975
|
| >1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=87.16 E-value=0.59 Score=34.91 Aligned_cols=35 Identities=23% Similarity=0.467 Sum_probs=28.4
Q ss_pred hhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 447 LAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 447 ~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++..++..+...++..|..+|.|+||+|+.+||+.
T Consensus 13 ~~~~l~~~~~~~~~~~F~~~D~d~~G~i~~~el~~ 47 (87)
T 1s6j_A 13 MAERLSEEEIGGLKELFKMIDTDNSGTITFDELKD 47 (87)
T ss_dssp SSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHH
T ss_pred HHHHCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 34455555666788999999999999999999975
|
| >4drw_A Protein S100-A10/annexin A2 chimeric protein; atypical EF-hand, heteropentameric complex, membrane repair; 3.50A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.15 E-value=0.3 Score=40.03 Aligned_cols=24 Identities=13% Similarity=0.214 Sum_probs=21.1
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++++.+|.|+||.|+++||..
T Consensus 56 ~v~~~i~~~D~d~DG~IdF~EF~~ 79 (121)
T 4drw_A 56 AVDKIMKDLDQCRDGKVGFQSFFS 79 (121)
T ss_dssp HHHHHHHHHCTTCSSCCCHHHHHH
T ss_pred HHHHHHHHHcCCCCCcCcHHHHHH
Confidence 466889999999999999999963
|
| >2qac_A Myosin A tail domain interacting protein MTIP; malaria invasion, structural genomics, PSI, protein structur initiative, structural genomics of pathogenic protozoa CONS SGPP; 1.70A {Plasmodium falciparum} PDB: 2auc_A | Back alignment and structure |
|---|
Probab=87.13 E-value=0.22 Score=41.38 Aligned_cols=26 Identities=19% Similarity=0.324 Sum_probs=22.8
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...+...|..+|.|+||+||.+||+.
T Consensus 83 ~~~l~~~F~~~D~d~~G~I~~~el~~ 108 (146)
T 2qac_A 83 VEELIKMFAHFDNNCTGYLTKSQMKN 108 (146)
T ss_dssp HHHHHHHHHTTCTTCSSEEEHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 44688999999999999999999974
|
| >3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A | Back alignment and structure |
|---|
Probab=87.07 E-value=0.51 Score=41.56 Aligned_cols=33 Identities=12% Similarity=0.264 Sum_probs=27.9
Q ss_pred hcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 449 KTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 449 ~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++..+...+..+|..+|.|+||.||.+||..
T Consensus 155 ~~l~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~ 187 (191)
T 3k21_A 155 GNITQRDVNRVKRMIRDVDKNNDGKIDFHEFSE 187 (191)
T ss_dssp SCCCHHHHHHHHHHHHHHCSSSSSSBCHHHHHH
T ss_pred CCCCHhHHHHHHHHHHHhcCCCCCeECHHHHHH
Confidence 345666667789999999999999999999974
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=86.99 E-value=0.5 Score=40.36 Aligned_cols=37 Identities=11% Similarity=0.103 Sum_probs=26.6
Q ss_pred HhhhhcCCHHHHHHH--------HHHHhhhCCCCCCccchhhhhc
Q 011582 445 GALAKTLTVPQLAYL--------REQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 445 ~~~~~~~~~~~~~~l--------~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+....+..++..+ ..+|..+|.|+||.|+.+||..
T Consensus 38 ~~~g~~~~~~~~~~l~~~~~~~~~~lf~~~D~d~dg~i~~~Ef~~ 82 (176)
T 1nya_A 38 EAFGKDAGAAEVQTLKNAFGGLFDYLAKEAGVGSDGSLTEEQFIR 82 (176)
T ss_dssp HHTSSCSSSHHHHHHHHHHHHHHHHHHHHHTSCTTCCBCHHHHHH
T ss_pred HHcCCCCCcHHHHHHHHHHHHHHHHHHHHhCCCCCCeEcHHHHHH
Confidence 333444455555433 4899999999999999999964
|
| >3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B* | Back alignment and structure |
|---|
Probab=86.91 E-value=0.65 Score=38.61 Aligned_cols=35 Identities=17% Similarity=0.263 Sum_probs=26.5
Q ss_pred hhhcCCHHHHHHH-HHHHhhhCCCCCCccchhhhhc
Q 011582 447 LAKTLTVPQLAYL-REQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 447 ~~~~~~~~~~~~l-~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
....++..++..+ ...|..+|.|+||.||.+||..
T Consensus 105 ~~~~~~~~~~~~~~~~~~~~~D~~~dg~i~~~eF~~ 140 (155)
T 3ll8_B 105 VGNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCA 140 (155)
T ss_dssp HGGGSCHHHHHHHHHHHHHHHCTTSSSSBCHHHHHH
T ss_pred hccCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 3556676666554 4467779999999999999964
|
| >2kz2_A Calmodulin, CAM; TR2C, metal binding protein; NMR {Gallus gallus} | Back alignment and structure |
|---|
Probab=86.77 E-value=0.66 Score=35.69 Aligned_cols=31 Identities=13% Similarity=0.224 Sum_probs=24.0
Q ss_pred hhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++..+ +..+|..+|.|+||.|+.+||..
T Consensus 59 g~~~~~~e---~~~l~~~~D~d~dG~I~~~EF~~ 89 (94)
T 2kz2_A 59 GEKLTDEE---VDEMIREADIDGDGQVNYEEFVQ 89 (94)
T ss_dssp TCCCCHHH---HHHHHHHHCTTCSSSBCHHHHHH
T ss_pred CCCCCHHH---HHHHHHHhCCCCCCcEeHHHHHH
Confidence 34455444 56788999999999999999964
|
| >2bl0_C Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=86.76 E-value=0.25 Score=40.66 Aligned_cols=24 Identities=25% Similarity=0.519 Sum_probs=16.3
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+...|..+|.|+||+|+.+||+.
T Consensus 80 ~~~~~F~~~D~d~~G~i~~~el~~ 103 (142)
T 2bl0_C 80 ILRQAFRTFDPEGTGYIPKAALQD 103 (142)
T ss_dssp HHHHHHHHTCCSSCSCEEHHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHH
Confidence 456677777777777777777653
|
| >1q80_A SCP, sarcoplasmic calcium-binding protein; all-alpha, metal binding protein; NMR {Neanthes diversicolor} SCOP: a.39.1.5 PDB: 2scp_A | Back alignment and structure |
|---|
Probab=86.70 E-value=0.42 Score=40.79 Aligned_cols=20 Identities=20% Similarity=0.630 Sum_probs=10.2
Q ss_pred HHHhhhCCCCCCccchhhhh
Q 011582 461 EQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 461 ~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+|..+|.|+||.|+.+||.
T Consensus 132 ~~~~~~D~d~dg~i~~~ef~ 151 (174)
T 1q80_A 132 ASFDAIDTNNDGLLSLEEFV 151 (174)
T ss_dssp HHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHhCCCCCceEeHHHHH
Confidence 34555555555555555543
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.68 E-value=0.37 Score=42.64 Aligned_cols=28 Identities=21% Similarity=0.253 Sum_probs=24.7
Q ss_pred HHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 454 PQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 454 ~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.....+..+|..+|.|+||+|+.+||+.
T Consensus 111 ~~~~~l~~~F~~~D~d~dG~Is~~El~~ 138 (202)
T 2bec_A 111 SRRNKLHYAFQLYDLDRDGKISRHEMLQ 138 (202)
T ss_dssp SHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred cHHHHHHHHHHHhCCCCCCeEcHHHHHH
Confidence 3566789999999999999999999975
|
| >2bl0_B Myosin regulatory light chain; muscle protein, slime mould, EF-hand; 1.75A {Physarum polycephalum} | Back alignment and structure |
|---|
Probab=86.54 E-value=0.24 Score=40.85 Aligned_cols=22 Identities=23% Similarity=0.386 Sum_probs=11.1
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+...|..+|.|+||+|+.+||+
T Consensus 78 l~~~F~~~D~d~~G~i~~~e~~ 99 (145)
T 2bl0_B 78 MLDAFRALDKEGNGTIQEAELR 99 (145)
T ss_dssp HHHHHHHHCSSSSSEEEHHHHH
T ss_pred HHHHHHHhCCCCCCeEcHHHHH
Confidence 4445555555555555555543
|
| >2mys_B Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1i84_U* 1m8q_B* 1mvw_B* 1o18_E* 1o19_B* 1o1a_B* 1o1b_B* 1o1c_B* 1o1d_B* 1o1e_B* 1o1f_B* 1o1g_B* 2w4a_B 2w4g_B 2w4h_B | Back alignment and structure |
|---|
Probab=86.44 E-value=0.26 Score=41.94 Aligned_cols=23 Identities=22% Similarity=0.377 Sum_probs=14.2
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+...|..+|.|+||+||.+||+
T Consensus 96 ~l~~~F~~~D~d~~G~I~~~el~ 118 (166)
T 2mys_B 96 VIMGAFKVLDPDGKGSIKKSFLE 118 (166)
T ss_pred HHHHHHHHhCCCCCcceeHHHHH
Confidence 45556666666666666666664
|
| >3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C | Back alignment and structure |
|---|
Probab=86.44 E-value=0.49 Score=39.70 Aligned_cols=32 Identities=13% Similarity=0.250 Sum_probs=25.0
Q ss_pred cCCHHHHHHH-HHHHhhhCCCCCCccchhhhhc
Q 011582 450 TLTVPQLAYL-REQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~l-~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++.+++..+ ..+|..+|.|+||+||++||..
T Consensus 108 ~~s~~e~~~~~~~~f~~~D~d~dG~Is~~EF~~ 140 (143)
T 3a4u_B 108 LMSEDELINIIDGVLRDDDKNNDGYIDYAEFAK 140 (143)
T ss_dssp -CCHHHHHHHHHHHHHHHCTTCSSEECHHHHHC
T ss_pred CCCHHHHHHHHHHHHHHcCCCCCCcEeHHHHHH
Confidence 3555555543 6788999999999999999975
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=86.35 E-value=0.31 Score=40.50 Aligned_cols=22 Identities=32% Similarity=0.516 Sum_probs=10.5
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+...|..+|.|+||+||.+||+
T Consensus 90 ~~~~F~~~D~d~~G~i~~~el~ 111 (153)
T 3ox6_A 90 LRDAFREFDTNGDGEISTSELR 111 (153)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHH
Confidence 4444444444444444444443
|
| >2mys_C Myosin; muscle protein, motor protein; HET: MLY; 2.80A {Gallus gallus} SCOP: a.39.1.5 PDB: 1m8q_C* 1mvw_C* 1o18_F* 1o19_C* 1o1a_C* 1o1b_C* 1o1c_C* 1o1d_C* 1o1e_C* 1o1f_C* 1o1g_C* | Back alignment and structure |
|---|
Probab=86.29 E-value=0.4 Score=39.61 Aligned_cols=22 Identities=18% Similarity=0.317 Sum_probs=15.0
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+|.. |.|+||.|+.+||..
T Consensus 123 ~~~~~~~-d~~~dg~i~~~eF~~ 144 (149)
T 2mys_C 123 VEELMKG-QEDSNGCINYEAFVK 144 (149)
T ss_pred HHHHHhh-CCCCCCcEeHHHHHH
Confidence 4455666 777777777777753
|
| >1dtl_A Cardiac troponin C; helix-turn-helix, structural protein; HET: BEP; 2.15A {Gallus gallus} SCOP: a.39.1.5 PDB: 1j1d_A 1j1e_A 2jt3_A 2jt0_A 1la0_A 2jtz_A* 2jt8_A* 2kfx_T* 1wrk_A* 1wrl_A* 1ap4_A 1lxf_C* 1mxl_C 1spy_A 2krd_C* 2l1r_A* 3rv5_A* 2ctn_A 2kgb_C 2jxl_A ... | Back alignment and structure |
|---|
Probab=86.25 E-value=0.36 Score=40.62 Aligned_cols=26 Identities=23% Similarity=0.552 Sum_probs=18.4
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...+...|..+|.|+||+|+.+||+.
T Consensus 94 ~~~~~~~F~~~D~d~~G~i~~~El~~ 119 (161)
T 1dtl_A 94 EEELSDLFRMFDKNADGYIDLEELKI 119 (161)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHGG
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 34466777777777777777777764
|
| >1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A | Back alignment and structure |
|---|
Probab=86.20 E-value=0.44 Score=35.28 Aligned_cols=22 Identities=18% Similarity=0.280 Sum_probs=19.4
Q ss_pred HHHHhhhCCCCCCccchhhhhc
Q 011582 460 REQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 460 ~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+|..+|.|+||.|+.+||..
T Consensus 52 ~~~~~~~D~~~dg~I~~~eF~~ 73 (83)
T 1yx7_A 52 AKLIKMADKNSDGKISKEEFLN 73 (83)
T ss_dssp HHHHTTTCSSSCSCCSHHHHHH
T ss_pred HHHHHHhCCCCCCCCcHHHHHH
Confidence 4489999999999999999863
|
| >2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.12 E-value=0.3 Score=34.86 Aligned_cols=24 Identities=8% Similarity=0.188 Sum_probs=21.0
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.|+.+||..
T Consensus 43 ~~~~~~~~~d~~~~g~i~~~eF~~ 66 (71)
T 2b1u_A 43 ELDAMIREADVDQDGRVNYEEFAR 66 (71)
T ss_dssp HHHHHHHHCCSSSSSEEETTHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHH
Confidence 366889999999999999999864
|
| >1m45_A MLC1P, myosin light chain; protein-peptide complex, myosin light chain, cell cycle protein; 1.65A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 1m46_A 1n2d_A 2fcd_A 2fce_A | Back alignment and structure |
|---|
Probab=86.11 E-value=0.25 Score=41.09 Aligned_cols=22 Identities=14% Similarity=0.403 Sum_probs=12.3
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+...|..+|.|+||+||.+||+
T Consensus 85 ~~~~F~~~D~d~~G~I~~~el~ 106 (148)
T 1m45_A 85 FVKAFQVFDKESTGKVSVGDLR 106 (148)
T ss_dssp HHHHHHTTCSSSSSEEEHHHHH
T ss_pred HHHHHHHhCCCCCCcCCHHHHH
Confidence 4455555555555555555554
|
| >1snl_A Nucleobindin 1, calnuc; EF-hand, calcium-binding, metal binding protein; NMR {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=86.07 E-value=0.33 Score=38.14 Aligned_cols=24 Identities=4% Similarity=0.252 Sum_probs=21.4
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.||++||..
T Consensus 73 ~~~~~~~~~D~d~dG~Is~~EF~~ 96 (103)
T 1snl_A 73 MREHVMKNVDTNQDRLVTLEEFLA 96 (103)
T ss_dssp HHHHHHHHTCSSCSSEEEHHHHHH
T ss_pred HHHHHHHHcCCCCCCcCCHHHHHH
Confidence 467889999999999999999964
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=85.79 E-value=0.53 Score=41.88 Aligned_cols=34 Identities=12% Similarity=0.169 Sum_probs=26.8
Q ss_pred hhcCCHHHHHHH-HHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYL-REQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l-~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++..++..+ ...|..+|.|+||.|+.+||..
T Consensus 144 g~~~s~~~~~~l~~~~~~~~D~d~dG~Is~~EF~~ 178 (208)
T 2ct9_A 144 GVNISDEQLGSIADRTIQEADQDGDSAISFTEFVK 178 (208)
T ss_dssp CTTCCHHHHHHHHHHHHHHHCSSSSSSEEHHHHHH
T ss_pred CCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 445666666654 5569999999999999999975
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=85.72 E-value=0.38 Score=40.90 Aligned_cols=22 Identities=18% Similarity=0.548 Sum_probs=11.0
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+...|..+|.|+||+||.+||+
T Consensus 103 ~~~~F~~~D~d~~G~i~~~el~ 124 (169)
T 3qrx_A 103 ILKAFRLFDDDNSGTITIKDLR 124 (169)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHhCCCCCCcCCHHHHH
Confidence 4444555555555555555543
|
| >4ds7_A Calmodulin, CAM; protein binding, metal binding, structura; 2.15A {Kluyveromyces lactis} PDB: 1lkj_A 2lhh_A 1f54_A 1f55_A | Back alignment and structure |
|---|
Probab=85.68 E-value=0.38 Score=39.61 Aligned_cols=25 Identities=32% Similarity=0.453 Sum_probs=17.3
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+..+|..+|.|+||.|+.+||+.
T Consensus 84 ~~~~~~F~~~D~d~~G~i~~~e~~~ 108 (147)
T 4ds7_A 84 QELLEAFKVFDKNGDGLISAAELKH 108 (147)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHH
Confidence 3466677777777777777777753
|
| >1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=85.60 E-value=0.31 Score=38.26 Aligned_cols=27 Identities=4% Similarity=0.042 Sum_probs=23.7
Q ss_pred HHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 455 QLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+...++++|..+|.|+||+|+.+|++.
T Consensus 9 ~~~~~~~~F~~~D~d~dG~Is~~el~~ 35 (99)
T 1qjt_A 9 GNPVYEKYYRQVEAGNTGRVLALDAAA 35 (99)
T ss_dssp TCTHHHHHHHHHCCTTSSCCCSHHHHH
T ss_pred hHHHHHHHHHHHCCCCCCcCCHHHHHH
Confidence 455688999999999999999999974
|
| >1wdc_B Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Y 1kqm_B* 1kwo_B* 1l2o_B* 1qvi_Y* 1s5g_Y* 1sr6_B 1b7t_Y 3jtd_B 3jvt_B 1scm_B 1kk8_B* 1dfk_Y 1dfl_Y* 2w4t_Y 2w4v_Y 2w4w_Y 2otg_B* 2os8_B* 3pn7_B ... | Back alignment and structure |
|---|
Probab=85.53 E-value=0.3 Score=41.06 Aligned_cols=25 Identities=12% Similarity=0.293 Sum_probs=21.2
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+..+|..+|.|+||+|+.+||+.
T Consensus 87 ~~l~~~F~~~D~d~~G~I~~~el~~ 111 (156)
T 1wdc_B 87 ETIRNAFAMFDEQETKKLNIEYIKD 111 (156)
T ss_dssp HHHHHHHHTTCTTCCSCEEHHHHHH
T ss_pred HHHHHHHHHHCcCCCCccCHHHHHH
Confidence 4577889999999999999999864
|
| >3fwb_A Cell division control protein 31; gene gating, complex, cell cycle, cell division, mitosis, MR transport, nuclear pore complex, nucleus, phosphoprotein; 2.50A {Saccharomyces cerevisiae} SCOP: a.39.1.5 PDB: 2gv5_A 2doq_A 3fwc_A | Back alignment and structure |
|---|
Probab=85.47 E-value=0.35 Score=40.66 Aligned_cols=25 Identities=24% Similarity=0.485 Sum_probs=15.3
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...|..+|.|+||+|+.+||+.
T Consensus 96 ~~~~~~F~~~D~d~~G~i~~~el~~ 120 (161)
T 3fwb_A 96 DEIKRAFQLFDDDHTGKISIKNLRR 120 (161)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHHHHcCCCCCeEeHHHHHH
Confidence 3455666666666666666666653
|
| >1eh2_A EPS15; calcium binding, signaling domain, NPF binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 PDB: 2jxc_A 1f8h_A 1ff1_A | Back alignment and structure |
|---|
Probab=85.44 E-value=0.34 Score=38.64 Aligned_cols=30 Identities=30% Similarity=0.365 Sum_probs=27.2
Q ss_pred CCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 451 LTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 451 ~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++.++...++++|..+|. +||+||.+|++.
T Consensus 9 ls~~e~~~~~~~F~~~D~-~dG~Is~~el~~ 38 (106)
T 1eh2_A 9 VKPEDKAKYDAIFDSLSP-VNGFLSGDKVKP 38 (106)
T ss_dssp SCHHHHHHHHHHHTTSCC-SSSCCBHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeEcHHHHHH
Confidence 567888999999999999 999999999975
|
| >2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus} | Back alignment and structure |
|---|
Probab=85.33 E-value=0.39 Score=34.94 Aligned_cols=24 Identities=17% Similarity=0.313 Sum_probs=21.1
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.|+.+||..
T Consensus 44 ~~~~~~~~~d~~~~g~i~~~eF~~ 67 (77)
T 2joj_A 44 EILELMNEYDREGNGYIGFDDFLD 67 (77)
T ss_dssp HHHHHHHHHCCSSSSEEEHHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHH
Confidence 466889999999999999999964
|
| >2ccm_A Calexcitin; EF hand, calcium, signaling protein; 1.8A {Loligo pealeii} | Back alignment and structure |
|---|
Probab=85.28 E-value=0.58 Score=40.74 Aligned_cols=21 Identities=10% Similarity=0.267 Sum_probs=13.7
Q ss_pred HHHHhhhCCCCCCccchhhhh
Q 011582 460 REQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 460 ~~~f~~~d~n~dg~i~~~e~~ 480 (482)
..+|..+|.|+||+||.+||.
T Consensus 146 ~~~~~~~D~d~dG~i~~~Ef~ 166 (191)
T 2ccm_A 146 DAAFDTLSDGGKTMVTREIFA 166 (191)
T ss_dssp HHHHHHHTTTTTSCCBHHHHH
T ss_pred HHHHHHhCCCCCCCcCHHHHH
Confidence 446666666666666666665
|
| >1wdc_C Scallop myosin; calcium binding protein, muscle protein; 2.00A {Argopecten irradians} SCOP: a.39.1.5 PDB: 1kk7_Z 1kqm_C* 1kwo_C* 1l2o_C* 1qvi_Z* 1s5g_Z* 1sr6_C 1b7t_Z 3jvt_C 3jtd_C 1kk8_C* 2ec6_C 1dfk_Z 1dfl_Z* 2w4t_Z 2w4v_Z 2w4w_Z 2otg_C* 2os8_C* 3pn7_C ... | Back alignment and structure |
|---|
Probab=85.25 E-value=0.3 Score=40.99 Aligned_cols=23 Identities=26% Similarity=0.374 Sum_probs=14.9
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+...|..+|.|+||+|+.+||+
T Consensus 85 ~l~~~F~~~D~d~~G~I~~~el~ 107 (156)
T 1wdc_C 85 DYMEAFKTFDREGQGFISGAELR 107 (156)
T ss_dssp HHHHHHHTTCSSSSSEEEHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHH
Confidence 45566666666666666666665
|
| >1s1e_A KV channel interacting protein 1; kchip, calcium-binding protein, EF-finger, transport protein; 2.30A {Homo sapiens} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=85.25 E-value=0.32 Score=44.20 Aligned_cols=25 Identities=32% Similarity=0.445 Sum_probs=22.4
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++.+|..+|.|+||+|+.+||+.
T Consensus 125 ~~l~~~F~~~D~d~dG~Is~~E~~~ 149 (224)
T 1s1e_A 125 EKLRWTFNLYDINKDGYINKEEMMD 149 (224)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHH
T ss_pred HHHHHHHHHHcCCCCCeECHHHHHH
Confidence 4578899999999999999999974
|
| >2ct9_A Calcium-binding protein P22; EF-hand, metal binding protein; 2.20A {Rattus norvegicus} PDB: 2e30_A | Back alignment and structure |
|---|
Probab=85.08 E-value=0.36 Score=43.02 Aligned_cols=27 Identities=22% Similarity=0.166 Sum_probs=24.0
Q ss_pred HHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 455 QLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
....+...|..+|.|+||+||.+||+.
T Consensus 111 ~~~~l~~~F~~~D~d~dG~Is~~El~~ 137 (208)
T 2ct9_A 111 RSNKLHFAFRLYDLDKDDKISRDELLQ 137 (208)
T ss_dssp HHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHHHHHHCCCCCCEEcHHHHHH
Confidence 455688999999999999999999975
|
| >1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=85.07 E-value=0.31 Score=37.78 Aligned_cols=24 Identities=17% Similarity=0.346 Sum_probs=21.0
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++|..+|.|+||+|+++||..
T Consensus 45 ~~~~i~~~~D~d~dG~i~~~EF~~ 68 (95)
T 1c07_A 45 LLAHIWSLCDTKDCGKLSKDQFAL 68 (95)
T ss_dssp HHHHHHHHHCTTCSSSEETTTHHH
T ss_pred HHHHHHHHHCCCCCCcCCHHHHHH
Confidence 467788999999999999999964
|
| >1top_A Troponin C; contractIle system protein; 1.78A {Gallus gallus} SCOP: a.39.1.5 PDB: 1ncy_A 1ncz_A 1ncx_A 1ytz_C* 1yv0_C 1tnw_A 1tnx_A 5tnc_A 2w49_0 2w4u_0 4tnc_A 1a2x_A 1tcf_A 1tn4_A 2tn4_A 1aj4_A 1jc2_A 1fi5_A 1sbj_A 1scv_A ... | Back alignment and structure |
|---|
Probab=85.01 E-value=0.44 Score=40.08 Aligned_cols=23 Identities=26% Similarity=0.546 Sum_probs=12.3
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+...|..+|.|+||+|+.+||+
T Consensus 97 ~~~~~F~~~D~d~~G~I~~~e~~ 119 (162)
T 1top_A 97 ELANCFRIFDKNADGFIDIEELG 119 (162)
T ss_dssp HHHHHHHHHCTTCSSCBCHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHH
Confidence 34455555555555555555554
|
| >2pmy_A RAS and EF-hand domain-containing protein; rasef, calcium-binding domain, structural genomics, structural genomics consortium, SGC; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.98 E-value=0.46 Score=36.26 Aligned_cols=24 Identities=21% Similarity=0.401 Sum_probs=21.2
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.|+.+||..
T Consensus 62 ~~~~~~~~~D~d~dg~I~~~EF~~ 85 (91)
T 2pmy_A 62 DAEAVFQRLDADRDGAITFQEFAR 85 (91)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHTH
T ss_pred HHHHHHHHhCCCCCCCEeHHHHHH
Confidence 467889999999999999999964
|
| >1avs_A Troponin C; muscle contraction, calcium-activated, E-F hand calcium-binding protein; 1.75A {Gallus gallus} SCOP: a.39.1.5 PDB: 1blq_A 1skt_A 1tnp_A 1tnq_A 1zac_A 1smg_A 1npq_A 1trf_A | Back alignment and structure |
|---|
Probab=84.92 E-value=0.79 Score=34.58 Aligned_cols=30 Identities=13% Similarity=0.249 Sum_probs=23.4
Q ss_pred hcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 449 KTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 449 ~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++..+ +..+|..+|.|+||.|+.+||..
T Consensus 51 ~~~~~~~---~~~l~~~~D~~~dg~i~~~eF~~ 80 (90)
T 1avs_A 51 QNPTKEE---LDAIIEEVDEDGSGTIDFEEFLV 80 (90)
T ss_dssp CCCCHHH---HHHHHHHHCTTCCSSEEHHHHHH
T ss_pred CCCCHHH---HHHHHHHhCCCCCCeEeHHHHHH
Confidence 3445443 56788999999999999999864
|
| >1w7j_B Myosin light chain 1; motor protein, unconventional myosin, myosin V, chicken, molecular motor, ATPase, ELC, IQ motif, muscle protein, ATP-binding; HET: ADP; 2A {Homo sapiens} SCOP: a.39.1.5 PDB: 1w7i_B* 1oe9_B* 3j04_C 1br1_B* 1br4_B* 1i84_T* 3dtp_C 2w4a_C 2w4g_C 2w4h_C | Back alignment and structure |
|---|
Probab=84.91 E-value=0.22 Score=41.61 Aligned_cols=21 Identities=14% Similarity=0.286 Sum_probs=14.3
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+..+|..+| |+||.|+.+||.
T Consensus 125 ~~~~~~~~d-~~dg~i~~~eF~ 145 (151)
T 1w7j_B 125 VETVLAGHE-DSNGCINYEAFL 145 (151)
T ss_dssp HHHHHTTCC-CTTSEEEHHHHH
T ss_pred HHHHHHhcc-CCCCeEeHHHHH
Confidence 445666777 777777777765
|
| >3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum} | Back alignment and structure |
|---|
Probab=84.91 E-value=0.34 Score=42.11 Aligned_cols=25 Identities=20% Similarity=0.537 Sum_probs=22.7
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...|..+|.|+||+||.+||+.
T Consensus 108 ~~~~~~F~~~D~d~~G~I~~~El~~ 132 (180)
T 3mse_B 108 TFLKAAFNKIDKDEDGYISKSDIVS 132 (180)
T ss_dssp CHHHHHHHHHCTTCSSCBCHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 4678999999999999999999975
|
| >1jfj_A Ehcabp, calcium-binding protein; EF-hand, helix-loop-helix, metal binding protein; NMR {Entamoeba histolytica} SCOP: a.39.1.5 PDB: 1jfk_A 2nxq_A 3px1_A 3qjk_A 2jnx_A 2i18_A | Back alignment and structure |
|---|
Probab=84.90 E-value=0.77 Score=36.86 Aligned_cols=23 Identities=22% Similarity=0.468 Sum_probs=16.6
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+|..+|.|+||.||.+||..
T Consensus 109 ~~~~~~~~D~~~dg~i~~~ef~~ 131 (134)
T 1jfj_A 109 VAEQVMKADANGDGYITLEEFLE 131 (134)
T ss_dssp HHHHHHHHHCSSSSEEEHHHHHH
T ss_pred HHHHHHHhCCCCCCcEeHHHHHH
Confidence 56677777777777777777753
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=84.79 E-value=0.26 Score=38.44 Aligned_cols=27 Identities=11% Similarity=0.351 Sum_probs=22.7
Q ss_pred HHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 454 PQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 454 ~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+...|+++|..+|. +||+|+.+||+.
T Consensus 6 ~~~~~l~~~F~~fD~-~dg~Is~~El~~ 32 (96)
T 1a4p_A 6 HAMETMMFTFHKFAG-DKGYLTKEDLRV 32 (96)
T ss_dssp HHHHHHHHHHHHHHG-GGCSBCHHHHHH
T ss_pred HHHHHHHHHHHHHcC-CCCeECHHHHHH
Confidence 356779999999994 788999999975
|
| >2opo_A Polcalcin CHE A 3; calcium-binding protein, dimer, domain-swapping, EF-hand; 1.75A {Chenopodium album} SCOP: a.39.1.10 PDB: 1h4b_A | Back alignment and structure |
|---|
Probab=84.75 E-value=0.47 Score=35.44 Aligned_cols=24 Identities=21% Similarity=0.472 Sum_probs=21.0
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.|+.+||..
T Consensus 47 ~~~~~~~~~D~~~dg~i~~~eF~~ 70 (86)
T 2opo_A 47 EVRRMMAEIDTDGDGFISFDEFTD 70 (86)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHH
Confidence 366889999999999999999864
|
| >3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1} | Back alignment and structure |
|---|
Probab=84.71 E-value=0.34 Score=42.95 Aligned_cols=24 Identities=25% Similarity=0.288 Sum_probs=15.1
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+...|..+|.|+||+||.+||+.
T Consensus 130 ~l~~~F~~~D~d~~G~Is~~El~~ 153 (197)
T 3pm8_A 130 VCLIPFKFFDIDGNGKISVEELKR 153 (197)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHH
Confidence 455666666666666666666653
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=84.61 E-value=0.45 Score=40.97 Aligned_cols=24 Identities=8% Similarity=0.319 Sum_probs=14.2
Q ss_pred HHHHHHHhhhCCCCCCccchhhhh
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
..+..+|..+|.|+||+||.+||+
T Consensus 105 ~~~~~~F~~~D~d~dG~Is~~E~~ 128 (185)
T 2sas_A 105 NRIPFLFKGMDVSGDGIVDLEEFQ 128 (185)
T ss_dssp HHHHHHHHHHCTTSSSCCCHHHHH
T ss_pred HHHHHHHHHHcCCCCCeEcHHHHH
Confidence 345556666666666666666654
|
| >3nso_A Protein S100-A3; EF-hand, Ca2+, Zn2+ binding, metal binding protein; 1.45A {Homo sapiens} SCOP: a.39.1.2 PDB: 3nsi_A 1kso_A 3nsk_A 3nsl_A | Back alignment and structure |
|---|
Probab=84.59 E-value=0.29 Score=38.77 Aligned_cols=24 Identities=17% Similarity=0.239 Sum_probs=20.9
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.+++..+|.|+||.|+++||..
T Consensus 54 ev~~~i~~~D~dgDG~Idf~EF~~ 77 (101)
T 3nso_A 54 DYNKFMSVLDTNKDCEVDFVEYVR 77 (101)
T ss_dssp HHHHHHHHHHHCCCSCEEHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCcHHHHHH
Confidence 466888899999999999999863
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=84.45 E-value=0.46 Score=40.09 Aligned_cols=20 Identities=10% Similarity=0.152 Sum_probs=12.7
Q ss_pred HHHhhhCCCCCCccchhhhh
Q 011582 461 EQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 461 ~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+|..+|.|+||.||.+||.
T Consensus 136 ~~~~~~D~d~dg~i~~~ef~ 155 (166)
T 3akb_A 136 QAAAALDTDGDGKVGETEIV 155 (166)
T ss_dssp HHHHHHCTTCSSBCCHHHHH
T ss_pred HHHHHhCCCCCCcCcHHHHH
Confidence 45666666666666666664
|
| >1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6 | Back alignment and structure |
|---|
Probab=84.42 E-value=0.36 Score=37.14 Aligned_cols=24 Identities=17% Similarity=0.325 Sum_probs=20.9
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++|..+|.|+||+|+++||..
T Consensus 44 ~~~~i~~~~D~d~dG~i~~~EF~~ 67 (92)
T 1fi6_A 44 ELSHIWELSDFDKDGALTLDEFCA 67 (92)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHH
Confidence 466788899999999999999964
|
| >3sg6_A Gcamp2, myosin light chain kinase, green fluorescent PROT calmodulin chimera; calcium sensor, fluorescent protein; HET: CRO; 1.70A {Gallus gallus} PDB: 3evu_A* 3ek4_A* 3ek7_A* 3evv_A* 3ek8_A* 3ekh_A* 3sg2_A* 3sg3_A* 3sg7_A* 3ekj_A* 3sg4_A* 3sg5_A* 3evr_A* 3o78_A* 3o77_A* 1trf_A | Back alignment and structure |
|---|
Probab=84.38 E-value=0.48 Score=48.07 Aligned_cols=32 Identities=28% Similarity=0.462 Sum_probs=21.6
Q ss_pred cCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 450 TLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++.++...+++.|..+|.|+||.|+.+||+.
T Consensus 305 ~ls~eei~el~~~F~~fD~D~dG~Is~~EL~~ 336 (450)
T 3sg6_A 305 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGT 336 (450)
T ss_dssp CCCHHHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 45566666677777777777777777777653
|
| >2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A | Back alignment and structure |
|---|
Probab=84.34 E-value=0.39 Score=43.31 Aligned_cols=26 Identities=8% Similarity=0.162 Sum_probs=0.0
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhcC
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKMT 482 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~~ 482 (482)
..++.+|..+|.|+||+|+.+||+.+
T Consensus 129 ~~l~~~F~~~D~d~dG~Is~~El~~~ 154 (214)
T 2l4h_A 129 IKSHYAFRIFDFDDDGTLNREDLSRL 154 (214)
T ss_dssp HHHHHHHHHHCTTCSSCBCHHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHHH
|
| >2kn2_A Calmodulin; S MAPK phosphatase 1, NTMKP1, tobacco MKP1, metal binding Pro; NMR {Glycine max} | Back alignment and structure |
|---|
Probab=84.24 E-value=0.86 Score=34.44 Aligned_cols=31 Identities=10% Similarity=0.214 Sum_probs=24.0
Q ss_pred hhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++..+ +..+|..+|.|+||.|+.+||..
T Consensus 39 g~~~~~~~---~~~l~~~~d~~~dg~i~~~eF~~ 69 (92)
T 2kn2_A 39 GEKLTDEE---VEQMIKEADLDGDGQVNYEEFVK 69 (92)
T ss_dssp TCCCCHHH---HHHHHHHHCSSCCSSEEHHHHHH
T ss_pred CCCCCHHH---HHHHHHHhCCCCCCcEeHHHHHH
Confidence 34455444 56788999999999999999864
|
| >1dgu_A Calcium-saturated CIB; helical, EF-hands, blood clotting; NMR {Homo sapiens} SCOP: a.39.1.5 PDB: 1dgv_A 1xo5_A 1y1a_A* | Back alignment and structure |
|---|
Probab=84.15 E-value=0.35 Score=41.98 Aligned_cols=25 Identities=8% Similarity=0.186 Sum_probs=22.8
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+..+|..+|.|+||+|+.+||+.
T Consensus 98 ~~l~~~F~~~D~d~~G~I~~~El~~ 122 (183)
T 1dgu_A 98 IKSHYAFRIFDFDDDGTLNREDLSR 122 (183)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHH
Confidence 4688999999999999999999975
|
| >1sra_A Sparc; extracellular matrix protein, calcium-binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.3 | Back alignment and structure |
|---|
Probab=84.06 E-value=0.42 Score=40.64 Aligned_cols=22 Identities=9% Similarity=0.311 Sum_probs=18.3
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
....|..+|.|+||+||++|+.
T Consensus 114 v~~ff~~cD~d~Dg~ISl~Ew~ 135 (151)
T 1sra_A 114 TTRFFETCDLDNDKYIALDEWA 135 (151)
T ss_dssp HHHHHHHHCTTCSSSEEHHHHH
T ss_pred HHHHHHHhCCCCCCcCCHHHHH
Confidence 5678888899999999888875
|
| >1a4p_A S100A10; S100 family, EF-hand protein, ligand of annexin II, calcium/phospholipid binding protein, calcium-phospholipid protein complex; 2.25A {Homo sapiens} SCOP: a.39.1.2 PDB: 1bt6_A | Back alignment and structure |
|---|
Probab=84.05 E-value=0.52 Score=36.63 Aligned_cols=24 Identities=13% Similarity=0.214 Sum_probs=20.7
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++|..+|.|+||.|+++||..
T Consensus 50 ev~~l~~~~D~d~dG~I~f~EF~~ 73 (96)
T 1a4p_A 50 AVDKIMKDLDQCRDGKVGFQSFFS 73 (96)
T ss_dssp HHHHHHHHHCTTSSSCBCHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHH
Confidence 356788899999999999999964
|
| >2sas_A Sarcoplasmic calcium-binding protein; 2.40A {Branchiostoma lanceolatum} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=83.99 E-value=1 Score=38.59 Aligned_cols=32 Identities=16% Similarity=0.200 Sum_probs=24.5
Q ss_pred cCCHHHHHHHH--------HHHhhhCCCCCCccchhhhhc
Q 011582 450 TLTVPQLAYLR--------EQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~l~--------~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++..++..+. .+|..+|.|+||.|+.+||..
T Consensus 45 ~~~~~~~~~l~~~~~~~~~~~f~~~D~d~dG~I~~~Ef~~ 84 (185)
T 2sas_A 45 SLSDADYKSMQASLEDEWRDLKGRADINKDDVVSWEEYLA 84 (185)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHHHCTTCSSCEEHHHHHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHhcCCCCCCeEcHHHHHH
Confidence 44555555553 569999999999999999864
|
| >1qx2_A Vitamin D-dependent calcium-binding protein, INTE; EF-hand (helix-loop-helix) calcium binding protein, four-HEL domain, protein engineering; HET: FME; 1.44A {Bos taurus} SCOP: a.39.1.1 PDB: 1kcy_A 1kqv_A 1ksm_A 1n65_A 1ht9_A 4icb_A 1cdn_A 1clb_A 2bca_A 1ig5_A 1igv_A 3icb_A 1d1o_A 1b1g_A 2bcb_A 1boc_A 1bod_A | Back alignment and structure |
|---|
Probab=83.98 E-value=0.48 Score=34.30 Aligned_cols=23 Identities=22% Similarity=0.393 Sum_probs=20.3
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+|..+|.|+||.|+.+||..
T Consensus 47 ~~~l~~~~D~~~~g~i~~~eF~~ 69 (76)
T 1qx2_A 47 LDEMIEEVDKNGDGEVSFEEFLV 69 (76)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHhCCCCCCcEeHHHHHH
Confidence 56788999999999999999964
|
| >2lvv_A Flagellar calcium-binding protein TB-24; EF-hand, metal binding protein; NMR {Trypanosoma brucei brucei} | Back alignment and structure |
|---|
Probab=83.97 E-value=0.37 Score=43.81 Aligned_cols=25 Identities=16% Similarity=0.252 Sum_probs=17.1
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+..+|..+|.|+||+||.+||+.
T Consensus 133 ~~l~~~F~~~D~d~dG~Is~~El~~ 157 (226)
T 2lvv_A 133 FELTVMFDTMDKDGSLLLELQEFKE 157 (226)
T ss_dssp HHHHHHHHHHSCSSCCEECHHHHHH
T ss_pred HHHHHHHHHHcCCCCCeEcHHHHHH
Confidence 3566677777777777777777654
|
| >2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A | Back alignment and structure |
|---|
Probab=83.87 E-value=0.9 Score=37.59 Aligned_cols=33 Identities=24% Similarity=0.296 Sum_probs=25.2
Q ss_pred hhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 446 ALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 446 ~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+...++..+ +..+|..+|.|+||.|+.+||..
T Consensus 107 ~~g~~~~~~~---~~~~~~~~D~d~dG~I~~~eF~~ 139 (143)
T 2obh_A 107 ELGENLTDEE---LQEMIDEADRDGDGEVSEQEFLR 139 (143)
T ss_dssp HTTCCCCHHH---HHHHHHHHCTTSSSSBCHHHHHH
T ss_pred HhCCCCCHHH---HHHHHHHhCCCCCCcEeHHHHHH
Confidence 3444566555 45678899999999999999964
|
| >1qls_A S100C protein, calgizzarin; metal-binding protein/inhibitor, S100 family, EF-hand protein, complex (ligand/annexin), ligand of annexin II; 2.3A {Sus scrofa} SCOP: a.39.1.2 PDB: 1nsh_A | Back alignment and structure |
|---|
Probab=83.76 E-value=0.59 Score=36.02 Aligned_cols=24 Identities=17% Similarity=0.291 Sum_probs=20.8
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.|+.+||..
T Consensus 57 ~~~~l~~~~D~~~dg~I~~~EF~~ 80 (99)
T 1qls_A 57 VLDRMMKKLDLDSDGQLDFQEFLN 80 (99)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHH
Confidence 356788999999999999999963
|
| >3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=83.62 E-value=0.41 Score=41.64 Aligned_cols=22 Identities=18% Similarity=0.292 Sum_probs=13.2
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+..+|..+|.|+||+||.+||+
T Consensus 125 ~~~~F~~~D~d~~G~I~~~E~~ 146 (191)
T 3khe_A 125 LLAAFQQFDSDGSGKITNEELG 146 (191)
T ss_dssp HHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHHCCCCcCcCCHHHHH
Confidence 4556666666666666666654
|
| >2bec_A Calcineurin B homologous protein 2; calcineurin-homologous protein, calcium-binding protein, NHE1 regulating protein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.59 E-value=0.69 Score=40.83 Aligned_cols=34 Identities=15% Similarity=0.217 Sum_probs=26.0
Q ss_pred hhcCCHHHHHHH-HHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYL-REQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l-~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++..++..+ ..+|..+|.|+||.|+.+||..
T Consensus 145 g~~~~~~~~~~~~~~~~~~~D~d~dG~Is~~EF~~ 179 (202)
T 2bec_A 145 GVQVTEEQLENIADRTVQEADEDGDGAVSFVEFTK 179 (202)
T ss_dssp CSCCCHHHHHHHHHHHHHHHCSSCSSSEEHHHHHH
T ss_pred CCCCCHHHHHHHHHHHHHHcCCCCCCcCcHHHHHH
Confidence 445666666654 4467779999999999999975
|
| >3dtp_E RLC, myosin regulatory light chain; muscle protein, smooth muscle, myosin subfragment 2, heavy meromyosin, essential light chain; 20.00A {Avicularia avicularia} | Back alignment and structure |
|---|
Probab=83.56 E-value=0.37 Score=42.61 Aligned_cols=25 Identities=8% Similarity=0.062 Sum_probs=20.8
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+..+|..+|.|+||+||.+||+.
T Consensus 126 ~~l~~~F~~~D~d~~G~Is~~El~~ 150 (196)
T 3dtp_E 126 DVIVNAFNLFDEGDGKCKEETLKRS 150 (196)
T ss_dssp HHHHHHHHTTCSSSSCCBHHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 4577889999999999999998874
|
| >2ggz_A Guanylyl cyclase-activating protein 3; EF hand, guanylate cyclase activating protein, GCAP, GCAP3, GCAP-3, lyase activator; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.49 E-value=0.57 Score=41.86 Aligned_cols=26 Identities=23% Similarity=0.194 Sum_probs=22.9
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...+..+|..+|.|+||+|+.+||+.
T Consensus 92 ~~~l~~~F~~~D~d~~G~I~~~E~~~ 117 (211)
T 2ggz_A 92 EQKLKWYFKLYDADGNGSIDKNELLD 117 (211)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHHH
Confidence 34678899999999999999999974
|
| >3akb_A Putative calcium binding protein; EF-hand, metal binding protein; 1.50A {Streptomyces coelicolor} PDB: 3aka_A | Back alignment and structure |
|---|
Probab=83.31 E-value=0.94 Score=38.03 Aligned_cols=22 Identities=5% Similarity=0.069 Sum_probs=19.9
Q ss_pred HHHHhhhCCCCCCccchhhhhc
Q 011582 460 REQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 460 ~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+|..+|.|+||.|+.+||..
T Consensus 58 ~~~f~~~D~d~~g~i~~~ef~~ 79 (166)
T 3akb_A 58 QGLAGIADRDGDQRITREEFVT 79 (166)
T ss_dssp HHHHHHHCTTSSSCEEHHHHHH
T ss_pred HHHHHHhCCCCCCcCcHHHHHH
Confidence 4789999999999999999964
|
| >1xk4_C Calgranulin B; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1irj_A* | Back alignment and structure |
|---|
Probab=83.09 E-value=0.64 Score=37.33 Aligned_cols=24 Identities=17% Similarity=0.284 Sum_probs=21.3
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.|+++||..
T Consensus 57 ~v~~l~~~~D~d~dG~I~f~EF~~ 80 (113)
T 1xk4_C 57 VIEHIMEDLDTNADKQLSFEEFIM 80 (113)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHH
T ss_pred HHHHHHHHhCCCCCCCEeHHHHHH
Confidence 467889999999999999999963
|
| >3fs7_A Parvalbumin, thymic; calcium-binding protein, EF-hand, acetylation, calcium, metal binding protein; 1.95A {Gallus gallus} SCOP: a.39.1.4 PDB: 2kqy_A | Back alignment and structure |
|---|
Probab=83.07 E-value=0.64 Score=36.45 Aligned_cols=23 Identities=9% Similarity=0.234 Sum_probs=20.4
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+|..+|.|+||.|+.+||..
T Consensus 83 ~~~~~~~~D~~~dg~i~~~EF~~ 105 (109)
T 3fs7_A 83 TKAFLAAGDTDGDGKIGVEEFQS 105 (109)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHHH
Confidence 56788999999999999999964
|
| >1j55_A S-100P protein; metal binding protein; 2.00A {Homo sapiens} SCOP: a.39.1.2 PDB: 1ozo_A | Back alignment and structure |
|---|
Probab=83.01 E-value=0.53 Score=36.50 Aligned_cols=24 Identities=8% Similarity=0.206 Sum_probs=21.2
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++|..+|.|+||.|+.+||..
T Consensus 53 ~v~~l~~~~D~d~dG~I~f~EF~~ 76 (95)
T 1j55_A 53 AVDKLLKDLDANGDAQVDFSEFIV 76 (95)
T ss_dssp HHHHHHHHHCSSSSSSEEHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCCHHHHHH
Confidence 467889999999999999999963
|
| >2jnf_A Troponin C; stretch activated muscle contraction, EF-hand, metal binding protein; NMR {Lethocerus indicus} PDB: 2k2a_A | Back alignment and structure |
|---|
Probab=82.99 E-value=0.38 Score=40.41 Aligned_cols=22 Identities=41% Similarity=0.668 Sum_probs=10.7
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+...|..+|.|+||+|+.+||+
T Consensus 93 ~~~~F~~~D~d~~G~I~~~el~ 114 (158)
T 2jnf_A 93 LREAFRLYDKEGNGYISTDVMR 114 (158)
T ss_dssp HHHHHHHHCSSSSSSEEHHHHH
T ss_pred HHHHHHHhCCCCCCeEcHHHHH
Confidence 4444455555555555555443
|
| >1k94_A Grancalcin; penta-EF-hand protein, calcium binding protein, metal binding protein; 1.70A {Homo sapiens} SCOP: a.39.1.8 PDB: 1k95_A 1f4q_A 1f4o_A | Back alignment and structure |
|---|
Probab=82.99 E-value=0.5 Score=40.19 Aligned_cols=25 Identities=12% Similarity=0.300 Sum_probs=21.9
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...|..+|.|+||+|+.+||+.
T Consensus 70 ~~~~~~F~~~D~d~~G~i~~~el~~ 94 (165)
T 1k94_A 70 NAWKENFMTVDQDGSGTVEHHELRQ 94 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHH
T ss_pred HHHHHHHHHhCCCCCceECHHHHHH
Confidence 4678899999999999999999874
|
| >2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.88 E-value=0.45 Score=38.19 Aligned_cols=23 Identities=13% Similarity=0.378 Sum_probs=20.3
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+|..+|.|+||+|+++||..
T Consensus 50 ~~~i~~~~D~d~dG~I~~~EF~~ 72 (111)
T 2kgr_A 50 LASIWNLSDIDQDGKLTAEEFIL 72 (111)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHH
T ss_pred HHHHHHHHCCCCCCCCcHHHHHH
Confidence 56788999999999999999964
|
| >2y5i_A S100Z, S100 calcium binding protein Z; metal-binding protein, EF-hand, calcium regulation, oligomer neuronal development, spine2; 2.03A {Danio rerio} | Back alignment and structure |
|---|
Probab=82.87 E-value=0.63 Score=36.44 Aligned_cols=24 Identities=13% Similarity=0.296 Sum_probs=20.9
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++|..+|.|+||.|+++||..
T Consensus 54 ~v~~l~~~~D~d~dG~I~f~EF~~ 77 (99)
T 2y5i_A 54 LVEKIMNDLDSNKDNEVDFNEFVV 77 (99)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHH
T ss_pred HHHHHHHHHCCCCCCcCcHHHHHH
Confidence 466788999999999999999963
|
| >2hpk_A Photoprotein berovin; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics, secsg; 2.00A {Beroe abyssicola} | Back alignment and structure |
|---|
Probab=82.85 E-value=0.44 Score=42.38 Aligned_cols=22 Identities=14% Similarity=0.372 Sum_probs=13.9
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+...|..+|.|+||+||.+||+
T Consensus 130 ~~~~F~~~D~d~~G~Is~~El~ 151 (208)
T 2hpk_A 130 SNSYYDVLDDDGDGTVDVDELK 151 (208)
T ss_dssp HHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHhCCCCCCcCCHHHHH
Confidence 5556666666666666666664
|
| >1xk4_A Calgranulin A; S100 family, heterotetramer, metal binding protein; HET: FLC; 1.80A {Homo sapiens} SCOP: a.39.1.2 PDB: 1mr8_A | Back alignment and structure |
|---|
Probab=82.70 E-value=0.61 Score=35.71 Aligned_cols=27 Identities=11% Similarity=0.075 Sum_probs=23.9
Q ss_pred HHHHHHHHHHhhhCC-CCCC-ccchhhhh
Q 011582 454 PQLAYLREQFTLLAP-NKNG-FISMQNYK 480 (482)
Q Consensus 454 ~~~~~l~~~f~~~d~-n~dg-~i~~~e~~ 480 (482)
.+...+...|..+|. |+|| +|+.+||+
T Consensus 7 ~~~~~l~~~F~~~D~~d~dG~~I~~~El~ 35 (93)
T 1xk4_A 7 KALNSIIDVYHKYSLIKGNFHAVYRDDLK 35 (93)
T ss_dssp HHHHHHHHHHHHHHTSSSCTTCBCHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCcCeECHHHHH
Confidence 346679999999999 9999 99999986
|
| >2znd_A Programmed cell death protein 6; penta-EF-hand protein, calcium binding protein, apoptosis, calcium, endoplasmic reticulum, membrane, nucleus; 1.70A {Homo sapiens} PDB: 2zn9_A 2zn8_A 1hqv_A 3aak_A 2zne_A 2zrs_A 2zrt_A 3aaj_A | Back alignment and structure |
|---|
Probab=82.57 E-value=0.58 Score=40.07 Aligned_cols=23 Identities=17% Similarity=0.316 Sum_probs=13.3
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.++..|..+|.|+||+|+.+||+
T Consensus 75 ~~~~~F~~~D~d~~G~i~~~el~ 97 (172)
T 2znd_A 75 DWQNVFRTYDRDNSGMIDKNELK 97 (172)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHHHCCCCCCccCHHHHH
Confidence 35555666666666666666554
|
| >2aao_A CDPK, calcium-dependent protein kinase, isoform AK1; calmodulin-like domain, EF calcium binding protein, transferase; 2.00A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=82.53 E-value=0.53 Score=39.85 Aligned_cols=23 Identities=22% Similarity=0.423 Sum_probs=13.7
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+...|..+|.|+||.|+.+||+
T Consensus 100 ~~~~~F~~~D~d~~G~i~~~e~~ 122 (166)
T 2aao_A 100 HLFAAFTYFDKDGSGYITPDELQ 122 (166)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHH
Confidence 35556666666666666666654
|
| >2f2o_A Calmodulin fused with calmodulin-binding domain of calcineurin; EF-hands, calcium, metal binding protein; 2.17A {Bos taurus} PDB: 2f2p_A | Back alignment and structure |
|---|
Probab=82.50 E-value=0.71 Score=39.62 Aligned_cols=22 Identities=32% Similarity=0.699 Sum_probs=10.5
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+...|..+|.|+||+|+.+||+
T Consensus 86 ~~~~F~~~D~d~~G~I~~~E~~ 107 (179)
T 2f2o_A 86 IREAFRVFDKDGNGYISAAELR 107 (179)
T ss_dssp HHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHhCCCCCCcCcHHHHH
Confidence 3444444444444444444443
|
| >2lnk_A Protein S100-A4; EF-hand, calcium binding, all alpha, metal binding protein, binding protein; NMR {Homo sapiens} PDB: 3c1v_A | Back alignment and structure |
|---|
Probab=82.49 E-value=0.63 Score=37.58 Aligned_cols=24 Identities=17% Similarity=0.358 Sum_probs=20.7
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.+++..+|.|+||.|+++||..
T Consensus 66 ev~~li~~~D~dgdG~Idf~EF~~ 89 (113)
T 2lnk_A 66 AFQKLMSNLDSNRDNEVDFQEYCV 89 (113)
T ss_dssp HHHHHHHHHCSSSSSCBCHHHHHH
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHH
Confidence 456788899999999999999963
|
| >1gjy_A Sorcin, CP-22, V19; calcium binding, calcium-binding, phosphorylation; 2.2A {Chinese hamster} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=82.46 E-value=0.5 Score=40.30 Aligned_cols=25 Identities=16% Similarity=0.323 Sum_probs=22.2
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...|..+|.|+||+|+.+||+.
T Consensus 72 ~~~~~~F~~~D~d~~G~i~~~el~~ 96 (167)
T 1gjy_A 72 NGWRQHFISFDSDRSGTVDPQELQK 96 (167)
T ss_dssp HHHHHHHHHHCTTCCSEECHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHH
Confidence 4688899999999999999999874
|
| >2wcb_A Protein S100-A12; calcium signalling, HOST-parasite response, metal binding PR; 1.73A {Homo sapiens} PDB: 1odb_A* 2wc8_A 2wcf_A 2wce_A 1e8a_A 1gqm_A | Back alignment and structure |
|---|
Probab=82.40 E-value=0.55 Score=36.39 Aligned_cols=24 Identities=21% Similarity=0.338 Sum_probs=21.2
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++|..+|.|+||.|+++||..
T Consensus 56 ~v~~~~~~~D~d~dG~I~f~EF~~ 79 (95)
T 2wcb_A 56 VIDEIFQGLDANQDEQVDFQEFIS 79 (95)
T ss_dssp HHHHHHTTSSSSTTSEEEHHHHHH
T ss_pred HHHHHHHHHcCCCCCcCcHHHHHH
Confidence 467889999999999999999964
|
| >2kax_A Protein S100-A5; EF-hand, calcium binding protien, calcium, polymorphism, structural genomics, spine2, structural proteomics in europe, spine; NMR {Homo sapiens} PDB: 2kay_A | Back alignment and structure |
|---|
Probab=82.32 E-value=0.54 Score=36.13 Aligned_cols=24 Identities=17% Similarity=0.329 Sum_probs=20.8
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.|+.+||..
T Consensus 51 ~i~~~~~~~D~d~dG~I~f~EF~~ 74 (92)
T 2kax_A 51 SIDDLMKSLDKNSDQEIDFKEYSV 74 (92)
T ss_dssp THHHHHHHHTTTCSSEEEHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHH
Confidence 366788999999999999999963
|
| >1alv_A Calpain, S-camld; calcium binding, calmodulin like, domain of cystein protease; 1.90A {Sus scrofa} SCOP: a.39.1.8 PDB: 1alw_A* 1nx0_A 1nx1_A 1nx2_A 1nx3_A* 1kfu_S 1kfx_S 3bow_B 1u5i_B 1df0_B 3df0_B 1aj5_A 1dvi_A 1np8_A | Back alignment and structure |
|---|
Probab=82.13 E-value=0.59 Score=40.09 Aligned_cols=25 Identities=8% Similarity=0.137 Sum_probs=20.2
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++..|..+|.|+||+|+.+||+.
T Consensus 77 ~~~~~~F~~~D~d~~G~i~~~el~~ 101 (173)
T 1alv_A 77 KKWQAIYKQFDVDRSGTIGSSELPG 101 (173)
T ss_dssp HHHHHHHHHHCTTCCSSBCTTTHHH
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 4577888888888888888888864
|
| >3ox6_A Calcium-binding protein 1; EF-hand, calcium-sensor; 2.40A {Homo sapiens} PDB: 3ox5_A 2lan_A 2lap_A 2k7b_A 2k7c_A 2k7d_A | Back alignment and structure |
|---|
Probab=82.09 E-value=1.1 Score=36.99 Aligned_cols=32 Identities=13% Similarity=0.236 Sum_probs=24.9
Q ss_pred hhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 447 LAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 447 ~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+...++..+ +..+|..+|.|+||.||.+||..
T Consensus 118 ~~~~~~~~~---~~~~~~~~d~~~dg~i~~~eF~~ 149 (153)
T 3ox6_A 118 LGHQVGHRD---IEEIIRDVDLNGDGRVDFEEFVR 149 (153)
T ss_dssp HSSCCCHHH---HHHHHHHHCSSSSSSBCHHHHHH
T ss_pred hcCCCCHHH---HHHHHHHhCCCCCCeEeHHHHHH
Confidence 444566554 55778899999999999999964
|
| >2r2i_A Guanylyl cyclase-activating protein 1; EF hand, GCAP, guanylate cyclase activating protein, GCAP1, GCAP-1, calcium, lipoprotein, myristate; HET: MYR; 2.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=82.04 E-value=0.6 Score=41.07 Aligned_cols=25 Identities=28% Similarity=0.248 Sum_probs=22.3
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+..+|..+|.|+||+|+.+||+.
T Consensus 88 ~~~~~~F~~~D~d~~G~I~~~Ef~~ 112 (198)
T 2r2i_A 88 QKLRWYFKLYDVDGNGCIDRGELLN 112 (198)
T ss_dssp HHHHHHHHHHCTTCSSCEEHHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCcHHHHHH
Confidence 4578899999999999999999974
|
| >1uhk_A Aequorin 2, aequorin; EF-hand motif, complex, luminescent protein; HET: CZN; 1.60A {Aequorea victoria} SCOP: a.39.1.5 PDB: 1ej3_A* 1uhi_A* 1uhj_A* 1uhh_A* 1sl8_A | Back alignment and structure |
|---|
Probab=81.83 E-value=0.47 Score=41.20 Aligned_cols=20 Identities=25% Similarity=0.639 Sum_probs=12.7
Q ss_pred HHHhhhCCCCCCccchhhhh
Q 011582 461 EQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 461 ~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+|..+|.|+||+||.+||+
T Consensus 113 ~~F~~~D~d~~G~Is~~El~ 132 (191)
T 1uhk_A 113 ALFDIVDKDQNGAITLDEWK 132 (191)
T ss_dssp HHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHhcCCCCCcCcHHHHH
Confidence 56666666666666666664
|
| >1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A | Back alignment and structure |
|---|
Probab=81.80 E-value=0.5 Score=34.83 Aligned_cols=24 Identities=17% Similarity=0.277 Sum_probs=20.8
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.|+.+||..
T Consensus 46 ~~~~~~~~~D~~~dg~i~~~eF~~ 69 (81)
T 1c7v_A 46 EVEEAMKEADEDGNGVIDIPEFMD 69 (81)
T ss_dssp HHHHHHHHHCSSGGGSEEHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHH
Confidence 356788999999999999999864
|
| >1juo_A Sorcin; calcium-binding proteins, penta-EF-hand, PEF, X-RAY, metal transport; 2.20A {Homo sapiens} SCOP: a.39.1.8 PDB: 2jc2_A | Back alignment and structure |
|---|
Probab=81.58 E-value=0.69 Score=40.74 Aligned_cols=25 Identities=16% Similarity=0.319 Sum_probs=22.3
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...|..+|.|+||+|+.+||+.
T Consensus 103 ~~~~~~F~~~D~d~~G~I~~~el~~ 127 (198)
T 1juo_A 103 NGWRQHFISFDTDRSGTVDPQELQK 127 (198)
T ss_dssp HHHHHHHHTTCTTCCSEECHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCCHHHHHH
Confidence 4688999999999999999999874
|
| >3qrx_A Centrin; calcium-binding, EF-hand, cell division, calcium binding, ME binding protein-toxin complex; 2.20A {Chlamydomonas reinhardtii} PDB: 2ggm_A 2ami_A 1zmz_A | Back alignment and structure |
|---|
Probab=81.56 E-value=1.2 Score=37.64 Aligned_cols=31 Identities=19% Similarity=0.229 Sum_probs=24.5
Q ss_pred hhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++.++ +..+|..+|.|+||.||.+||..
T Consensus 131 g~~~~~~~---~~~~~~~~D~~~dg~i~~~eF~~ 161 (169)
T 3qrx_A 131 GENLTEEE---LQEMIAEADRNDDNEIDEDEFIR 161 (169)
T ss_dssp TCCCCHHH---HHHHHHHHCCSSSSCBCHHHHHH
T ss_pred CCCCCHHH---HHHHHHHhCCCCCCCEeHHHHHH
Confidence 34556554 55779999999999999999964
|
| >2h2k_A Protein S100-A13; calcium binding protein, metal binding protein; 2.00A {Homo sapiens} PDB: 1yur_A 1yus_A 1yut_A 1yuu_A 2egd_A 2k8m_B 2ki4_B* 2ki6_C* 2kot_A* 2l5x_B 2cxj_A | Back alignment and structure |
|---|
Probab=81.53 E-value=0.65 Score=36.96 Aligned_cols=26 Identities=12% Similarity=0.241 Sum_probs=22.5
Q ss_pred HHHHHHHHHHhhhC-CCCC-Cccchhhh
Q 011582 454 PQLAYLREQFTLLA-PNKN-GFISMQNY 479 (482)
Q Consensus 454 ~~~~~l~~~f~~~d-~n~d-g~i~~~e~ 479 (482)
.+...|+++|..+| .|+| |+|+.+||
T Consensus 19 ~~~~~l~~aF~~fD~~dg~~G~Is~~EL 46 (106)
T 2h2k_A 19 ESIETVVTTFFTFARQEGRKDSLSVNEF 46 (106)
T ss_dssp HHHHHHHHHHHHHHTSSSSTTEECHHHH
T ss_pred HHHHHHHHHHHHHcccCCCCCEECHHHH
Confidence 35678999999999 7997 79999986
|
| >2zfd_A Calcineurin B-like protein 2; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} SCOP: a.39.1.5 PDB: 1uhn_A | Back alignment and structure |
|---|
Probab=81.49 E-value=1.1 Score=40.40 Aligned_cols=34 Identities=12% Similarity=0.235 Sum_probs=27.6
Q ss_pred hhcCCHHHHHHH-HHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYL-REQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l-~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++.+++..+ ...|..+|.|+||.|+.+||..
T Consensus 156 g~~~~~~~~~~~~~~~f~~~D~d~dG~I~~~EF~~ 190 (226)
T 2zfd_A 156 GMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRS 190 (226)
T ss_dssp TCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHH
T ss_pred CCCCCHHHHHHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 445666666654 7899999999999999999974
|
| >1qv0_A Obelin, OBL; photoprotein, bioluminescence, atomic resolution, Ca binding, EF-hand, luminescent protein; HET: CZH; 1.10A {Obelia longissima} SCOP: a.39.1.5 PDB: 1qv1_A* 1sl9_A* 1el4_A* 2f8p_A* 1sl7_A 1jf2_A* 1s36_A* 1jf0_A* 3kpx_A* | Back alignment and structure |
|---|
Probab=81.44 E-value=0.47 Score=41.43 Aligned_cols=19 Identities=11% Similarity=0.216 Sum_probs=9.5
Q ss_pred HHhhhCCCCCCccchhhhh
Q 011582 462 QFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 462 ~f~~~d~n~dg~i~~~e~~ 480 (482)
+|..+|.|+||.|+.+||.
T Consensus 154 ~~~~~D~d~dg~i~~~eF~ 172 (195)
T 1qv0_A 154 TFRHCDLDNAGDLDVDEMT 172 (195)
T ss_dssp HHHHSCCCTTSCEEHHHHH
T ss_pred HHHHhCCCCCCcCCHHHHH
Confidence 3444555555555555543
|
| >1nya_A Calerythrin; EF-hand, metal binding protein; NMR {Saccharopolyspora erythraea} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=81.44 E-value=0.64 Score=39.64 Aligned_cols=19 Identities=26% Similarity=0.422 Sum_probs=9.6
Q ss_pred HHhhhCCCCCCccchhhhh
Q 011582 462 QFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 462 ~f~~~d~n~dg~i~~~e~~ 480 (482)
+|..+|.|+||.|+.+||.
T Consensus 141 ~~~~~D~d~dg~i~~~ef~ 159 (176)
T 1nya_A 141 AFNQVDTNGNGELSLDELL 159 (176)
T ss_dssp HHHHHCTTCSSEEEHHHHH
T ss_pred HHHHhCCCCCCCCcHHHHH
Confidence 4455555555555555543
|
| >1y1x_A Leishmania major homolog of programmed cell death protein; SGPP, structural genomics, PSI; 1.95A {Leishmania major} SCOP: a.39.1.8 | Back alignment and structure |
|---|
Probab=81.31 E-value=0.6 Score=40.98 Aligned_cols=28 Identities=11% Similarity=0.114 Sum_probs=15.8
Q ss_pred CCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 381 LSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 381 ~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
++.+....+-+.+..|-..+++.+|.+.
T Consensus 60 ~~~~~~~~l~~~~D~d~dG~I~~~EF~~ 87 (191)
T 1y1x_A 60 FSLATTEKLLHMYDKNHSGEITFDEFKD 87 (191)
T ss_dssp CCHHHHHHHHHHHCTTCSSSBCHHHHHH
T ss_pred CCHHHHHHHHHHhCCCCCCeEcHHHHHH
Confidence 3444444455555666666777666543
|
| >5pal_A Parvalbumin; calcium-binding protein; 1.54A {Triakis semifasciata} SCOP: a.39.1.4 | Back alignment and structure |
|---|
Probab=81.27 E-value=0.73 Score=36.12 Aligned_cols=31 Identities=10% Similarity=0.223 Sum_probs=24.3
Q ss_pred hhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++..+ +..+|..+|.|+||.|+.+||..
T Consensus 74 g~~~~~~~---~~~~~~~~D~~~dg~i~~~eF~~ 104 (109)
T 5pal_A 74 GRDLNDTE---TKALLAAGDSDHDGKIGADEFAK 104 (109)
T ss_dssp CCCCCHHH---HHHHHHHHCTTCSSSEEHHHHHH
T ss_pred CCCCCHHH---HHHHHHHhCCCCCCcCcHHHHHH
Confidence 34455554 56778899999999999999964
|
| >1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5 | Back alignment and structure |
|---|
Probab=81.08 E-value=0.51 Score=41.46 Aligned_cols=19 Identities=11% Similarity=0.312 Sum_probs=10.3
Q ss_pred HHhhhCCCCCCccchhhhh
Q 011582 462 QFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 462 ~f~~~d~n~dg~i~~~e~~ 480 (482)
+|..+|.|+||.|+.+||.
T Consensus 121 ~~~~~D~d~dG~Is~~EF~ 139 (188)
T 1s6i_A 121 MIKEIDQDNDGQIDYGEFA 139 (188)
T ss_dssp HHHHHCSSSSSEEETTHHH
T ss_pred HHHHHCCCCCCcEeHHHHH
Confidence 4555555555555555554
|
| >3cs1_A Flagellar calcium-binding protein; myristoylated, palmitoylated, SEN membrane targeting, EF-hand, cell projection, cilium; 2.00A {Trypanosoma cruzi} | Back alignment and structure |
|---|
Probab=81.05 E-value=0.51 Score=42.54 Aligned_cols=25 Identities=16% Similarity=0.212 Sum_probs=19.6
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...|..+|.|+||+|+.+||+.
T Consensus 130 ~~l~~~F~~~D~d~~G~Is~~El~~ 154 (219)
T 3cs1_A 130 FELTVMFDEIDASGNMLVDEEEFKR 154 (219)
T ss_dssp HHHHHHHHTTCSSSSSEEEHHHHHH
T ss_pred HHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 4577888888888888888888764
|
| >3fia_A Intersectin-1; EH 1 domain, NESG, structural genomics, PSI- 2, protein structure initiative, northeast structural genomics consortium; 1.45A {Homo sapiens} PDB: 2khn_A | Back alignment and structure |
|---|
Probab=81.04 E-value=0.63 Score=38.09 Aligned_cols=30 Identities=33% Similarity=0.449 Sum_probs=27.0
Q ss_pred CCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 451 LTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 451 ~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++.++..++.++|..+|. +||+||-+|++.
T Consensus 27 it~ee~~~y~~iF~~lD~-~dG~Isg~elr~ 56 (121)
T 3fia_A 27 ITVEERAKHDQQFHSLKP-ISGFITGDQARN 56 (121)
T ss_dssp CCHHHHHHHHHHHHHTCC-BTTBEEHHHHHH
T ss_pred CCHHHHHHHHHHHHHhCC-CCCeECHHHHHH
Confidence 678899999999999999 899999999874
|
| >3dd4_A KV channel-interacting protein 4; EF-hands protein, ION transport, ionic channel, membrane, PO potassium channel, potassium transport, transport; 3.00A {Mus musculus} PDB: 2e6w_A | Back alignment and structure |
|---|
Probab=80.94 E-value=0.61 Score=42.43 Aligned_cols=25 Identities=28% Similarity=0.383 Sum_probs=22.6
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++..|..+|.|+||+|+.+||+.
T Consensus 138 ~~l~~~F~~~D~d~dG~Is~~E~~~ 162 (229)
T 3dd4_A 138 EKLNWAFNLYDINKDGYITKEEMLD 162 (229)
T ss_dssp HHHHHHHHHHCTTCSSCCBHHHHHH
T ss_pred HHHHHHHHHhCCCCCCeECHHHHHH
Confidence 4678899999999999999999975
|
| >1k2h_A S100A1, S-100 protein, alpha chain; non-covalent homodimer, X-type four-helix bundle, metal binding protein; NMR {Rattus norvegicus} SCOP: a.39.1.2 PDB: 1zfs_A 2k2f_A 2kbm_A 2l0p_A 2jpt_A | Back alignment and structure |
|---|
Probab=80.85 E-value=0.98 Score=34.19 Aligned_cols=31 Identities=13% Similarity=0.210 Sum_probs=23.9
Q ss_pred hhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++..+ +..+|..+|.|+||.|+.+||..
T Consensus 46 g~~~~~~~---~~~~~~~~D~d~dg~i~~~eF~~ 76 (93)
T 1k2h_A 46 DVQKDADA---VDKIMKELDENGDGEVDFQEFVV 76 (93)
T ss_dssp HCCCCHHH---HHHHHHHHHHCTTSCCCHHHHHH
T ss_pred CCCCCHHH---HHHHHHHhCCCCCCcCcHHHHHH
Confidence 34455544 56788899999999999999964
|
| >2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A | Back alignment and structure |
|---|
Probab=80.81 E-value=0.59 Score=41.41 Aligned_cols=26 Identities=23% Similarity=0.349 Sum_probs=23.1
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...+..+|..+|.|+||+|+.+||+.
T Consensus 110 ~~~l~~~F~~~D~d~~G~I~~~E~~~ 135 (207)
T 2ehb_A 110 HEKVKFAFKLYDLRQTGFIEREELKE 135 (207)
T ss_dssp HHHHHHHHHHHCTTCCSSEEHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 45688999999999999999999974
|
| >3u0k_A Rcamp; fluorescent protein, calcium binding, EF-hand, genetically E calcium indicator; HET: NFA CRK; 2.10A {Entacmaea quadricolor} | Back alignment and structure |
|---|
Probab=80.68 E-value=0.75 Score=46.06 Aligned_cols=93 Identities=11% Similarity=0.169 Sum_probs=48.4
Q ss_pred CHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCCCccHHHHHHHHHHhc-------cchHHHHHHHhhhhcCCHH
Q 011582 382 SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYIS-------SSSLRKAALGALAKTLTVP 454 (482)
Q Consensus 382 s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~l~~~~~~~~~~~~~~~ 454 (482)
+++-.+-|-..+..|-+.+++..|.+. ++..... .......+....+.+-. ...| +.++..+...++.+
T Consensus 336 TeeEI~~Lf~~~D~DgDG~IdFeEFl~--lms~~lk-~~d~eeeLreAFk~fDkDgdG~IS~eEL-r~vL~~lGe~LSde 411 (440)
T 3u0k_A 336 TEAELQDMINEVDADGDGTIDFPEFLI--MMARKMK-DTDSEEEIREAFRVFDKDGNGYISAAEL-RHVMTNLGEKLTDE 411 (440)
T ss_dssp CHHHHHHHHHHHCSSCSSSEEHHHHHH--HHHTC-------CHHHHHHHHHHCTTCSSEECHHHH-HHHHHHHTCCCCHH
T ss_pred CHHHHHHHHHHhCCCCCCcCcHHHHHH--HHHHHhc-CCChHHHHHHHHHHHCCCCcCcCCHHHH-HHHHHHhCCCCCHH
Confidence 333333333445677777888888654 1211111 01111222222333321 1222 23455555666666
Q ss_pred HHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 455 QLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+ +.++|..+|.|+||.|+.+||.+
T Consensus 412 E---IdeLfke~D~DgDGkIsyeEFvk 435 (440)
T 3u0k_A 412 E---VDEMIREADIDGDGQVNYEEFVQ 435 (440)
T ss_dssp H---HHHHHHHHCTTCSSSEEHHHHHH
T ss_pred H---HHHHHHHhCCCCCCcEeHHHHHH
Confidence 5 45678888999999999999864
|
| >1cb1_A Calbindin D9K; calcium-binding protein; NMR {Sus scrofa} SCOP: a.39.1.1 | Back alignment and structure |
|---|
Probab=80.63 E-value=0.41 Score=34.85 Aligned_cols=23 Identities=26% Similarity=0.543 Sum_probs=20.1
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+|..+|.|+||.|+.+||..
T Consensus 49 ~~~~~~~~D~~~dg~i~~~eF~~ 71 (78)
T 1cb1_A 49 LDDLFQELDKNGDGEVSFEEFQV 71 (78)
T ss_dssp SSHHHHHTCCCSSSSEEHHHHHH
T ss_pred HHHHHHHhcCCCCCCCcHHHHHH
Confidence 45788999999999999999964
|
| >1wlz_A DJBP, CAP-binding protein complex interacting protein 1 isoform A; EF-hand like, unknown function; 1.60A {Homo sapiens} SCOP: a.39.1.7 | Back alignment and structure |
|---|
Probab=80.55 E-value=1.5 Score=34.11 Aligned_cols=27 Identities=15% Similarity=0.295 Sum_probs=23.9
Q ss_pred HHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 455 QLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
....++..|..+|.|+||+|+.+||+.
T Consensus 22 ~~~~l~~~F~~~D~d~~G~i~~~el~~ 48 (105)
T 1wlz_A 22 HYHAITQEFENFDTMKTNTISREEFRA 48 (105)
T ss_dssp THHHHHHHHHHHCTTCSSCBCHHHHHH
T ss_pred hHHHHHHHHHHHCCCCCCcCcHHHHHH
Confidence 356788999999999999999999975
|
| >3j04_B Myosin regulatory light chain 2, smooth muscle MA isoform; phosphorylation, 2D crystalline arrays, myosin regulation, M light chains, structural protein; 20.00A {Gallus gallus} | Back alignment and structure |
|---|
Probab=80.42 E-value=1.1 Score=36.64 Aligned_cols=32 Identities=13% Similarity=0.245 Sum_probs=24.7
Q ss_pred hhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 447 LAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 447 ~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+...++..+ +..+|..+|.|+||.|+.+||..
T Consensus 105 ~g~~~~~~~---~~~~~~~~D~d~dg~i~~~eF~~ 136 (143)
T 3j04_B 105 MGDRFTDEE---VDEMYREAPIDKKGNFNYVEFTR 136 (143)
T ss_dssp SSSCCCHHH---HHHHHHHTTCCSSSCCCSTHHHH
T ss_pred cCCCCCHHH---HHHHHHHcCCCCCCcCcHHHHHH
Confidence 344556554 55788899999999999999964
|
| >3sjs_A URE3-BP sequence specific DNA binding protein; EF-hand, structural genomics, seattle S genomics center for infectious disease, ssgcid; 1.90A {Entamoeba histolytica} PDB: 3sia_A 3sib_A | Back alignment and structure |
|---|
Probab=80.05 E-value=0.64 Score=42.05 Aligned_cols=25 Identities=12% Similarity=0.133 Sum_probs=20.7
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...|..+|.|+||+|+.+||+.
T Consensus 117 ~~l~~~F~~~D~d~~G~I~~~El~~ 141 (220)
T 3sjs_A 117 ELAYNLFVMNARARSGTLEPHEILP 141 (220)
T ss_dssp HHHHHHHHHHCCSSTTEECHHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 4577888889999999999888864
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 482 | ||||
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-81 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 7e-81 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-80 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-78 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-77 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-74 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 9e-74 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-71 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-70 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-70 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-69 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-69 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 7e-69 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-64 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-64 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-63 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-63 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-62 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-60 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-58 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-58 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 1e-57 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-57 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-57 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-56 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-55 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 6e-55 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-54 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-54 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-54 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 8e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 5e-53 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-53 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-53 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-53 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-52 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-52 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-52 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-51 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-50 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-50 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-50 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-48 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-47 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-47 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-47 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-47 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-46 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-45 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-43 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-42 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-38 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-34 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-20 | |
| d1j7la_ | 263 | d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phos | 0.001 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 254 bits (649), Expect = 2e-81
Identities = 103/342 (30%), Positives = 161/342 (47%), Gaps = 36/342 (10%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
HY++ EE+G G FG + G + A K + HE+ +
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMT------------PHESDK---- 67
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
E VR+E++ + L H LV +DA+EDD+ + ++ E GGEL +
Sbjct: 68 --------------ETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
++ K SE++A M Q+ + H VH DLKPEN +FT+K ++ LK IDFG
Sbjct: 113 KVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTK-RSNELKLIDFG 171
Query: 302 LSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTES 360
L+ ++ P + + G+A + APEV + G DMWS+GV++YILL G PF +
Sbjct: 172 LTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231
Query: 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKI 420
R V D + D++ + +S + DF+++LL D R+T QAL HPWL +
Sbjct: 232 ETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 291
Query: 421 PSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQ 462
S + + K S + A L + + LR+
Sbjct: 292 DSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 333
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 253 bits (646), Expect = 7e-81
Identities = 100/302 (33%), Positives = 142/302 (47%), Gaps = 36/302 (11%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
+Y++ EE+G G FG K G+ K I
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINT----------------- 64
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG 236
+ V+ E+ I+ L H L+ +DA+ED + +++E G
Sbjct: 65 -------------PYPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSG 110
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
GEL DRI + K SE + M Q + H +VH D+KPEN + +K + SS+K
Sbjct: 111 GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETK-KASSVK 169
Query: 297 AIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFW 355
IDFGL+ + PDE + +A + APE++ R G DMW+IGV+ Y+LL G PF
Sbjct: 170 IIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA 229
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415
+ + V + D FDE + S+SPEA DF+K LL K+ RKRLT AL HPWL
Sbjct: 230 GEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289
Query: 416 HD 417
H
Sbjct: 290 HS 291
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 249 bits (637), Expect = 3e-80
Identities = 114/322 (35%), Positives = 163/322 (50%), Gaps = 35/322 (10%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y+ + +G G F A+ K+ + VA+K I K E +
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRT---QKLVAIKCIAK-----------KALEGKE---- 51
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ E+ +L + H N+V D YE ++Y++M+L GGEL D
Sbjct: 52 --------------GSMENEIAVLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFD 96
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
RI+ + G Y+E DA ++ Q+L V + H G+VHRDLKPEN L+ S +E+S + DFG
Sbjct: 97 RIVEK-GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFG 155
Query: 302 LSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTES 360
LS P L+ G+ YVAPEVL + Y D WSIGVIAYILLCG PF+ ++
Sbjct: 156 LSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA 215
Query: 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKI 420
+F +LKA+ FD W +S A DF++ L+ KD KR T QAL HPW+A +
Sbjct: 216 KLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDK 275
Query: 421 PSDMIVYKLIKAYISSSSLRKA 442
V + IK + S ++A
Sbjct: 276 NIHQSVSEQIKKNFAKSKWKQA 297
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 244 bits (624), Expect = 1e-78
Identities = 99/301 (32%), Positives = 144/301 (47%), Gaps = 35/301 (11%)
Query: 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQF 178
F +YE E +GRG K ++ AVK+I G F +
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPT---CKEYAVKIIDVTGGGSFSAEEVQELR---- 53
Query: 179 TILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGE 238
E +EV ILR ++GH N++Q D YE + ++V +L K GE
Sbjct: 54 -----------------EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGE 96
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
L D + + SE++ + +M +L V+ H +VHRDLKPEN L ++ ++K
Sbjct: 97 LFDYL-TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLD---DDMNIKLT 152
Query: 299 DFGLSDYVKPDERLNDIVGSAYYVAPEVL-------HRSYGTEADMWSIGVIAYILLCGS 351
DFG S + P E+L ++ G+ Y+APE++ H YG E DMWS GVI Y LL GS
Sbjct: 153 DFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
Query: 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
PFW R + + R ++ + F W S D V R L +KR TA +AL+HP+
Sbjct: 213 PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272
Query: 412 L 412
Sbjct: 273 F 273
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (620), Expect = 2e-77
Identities = 88/350 (25%), Positives = 162/350 (46%), Gaps = 40/350 (11%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
K+ Y + E++GRG FG + K + K +
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSS---KKTYMAKFVKV------------KGTDQ 45
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG 236
V++E+ IL H+N++ ++++E + + ++ E G
Sbjct: 46 VL-------------------VKKEISILNIA-RHRNILHLHESFESMEELVMIFEFISG 85
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
++ +RI + + +E + + Q+ + F H + H D++PEN ++ ++ +S++K
Sbjct: 86 LDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRR-SSTIK 144
Query: 297 AIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFW 355
I+FG + +KP + + + Y APEV H T DMWS+G + Y+LL G PF
Sbjct: 145 IIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL 204
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415
A T I ++ A+ +FDE + +S EA+DFV RLL K+ + R+TA++AL HPWL
Sbjct: 205 AETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264
Query: 416 HDVKIPSDMIVYKLIKAYISSSSLRKAALGALAKTLTVPQLAYLREQFTL 465
+ ++ + +I + +K +L K L + + +R Q +
Sbjct: 265 IE-RVSTKVI--RTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGV 311
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (595), Expect = 4e-74
Identities = 79/307 (25%), Positives = 133/307 (43%), Gaps = 45/307 (14%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+E+ E+G G FG A+ K+ A KVI
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKET---SVLAAAKVIDTK--------------------- 48
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ +ED E+ IL + H N+V+ DA+ ++N++I++E C GG +
Sbjct: 49 ---------SEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDA 98
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+L +E ++V Q L + + H ++HRDLK N LFT + +K DFG
Sbjct: 99 VMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT---LDGDIKLADFG 155
Query: 302 LS-DYVKPDERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYILLCGSRPF 354
+S + +R + +G+ Y++APEV+ R Y +AD+WS+G+ + P
Sbjct: 156 VSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH 215
Query: 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
+ + K++P P S DF+K+ L K+ R T +Q L HP++
Sbjct: 216 HELNPMRVLLKIAKSEPPTLAQP-SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274
Query: 415 SHDVKIP 421
+ I
Sbjct: 275 DSNKPIR 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (590), Expect = 9e-74
Identities = 78/292 (26%), Positives = 136/292 (46%), Gaps = 41/292 (14%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+E+G +G+G FG A+ K+ +A+KV+ K
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQS---KFILALKVLFKA--------------------- 42
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ A +RREV+I L H N+++ Y + D +Y+++E G +
Sbjct: 43 ------QLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDATRVYLILEYAPLGTV-Y 94
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
R L + K+ E+ + ++ + +++CH + V+HRD+KPEN L S LK DFG
Sbjct: 95 RELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGS---AGELKIADFG 151
Query: 302 LSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTES 360
S + P R + G+ Y+ PE++ R + + D+WS+GV+ Y L G PF A T
Sbjct: 152 WSVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210
Query: 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
++ + + + +F ++ A D + RLL + +R + L HPW+
Sbjct: 211 ETYKRISRVEFTF----PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 225 bits (573), Expect = 8e-71
Identities = 97/303 (32%), Positives = 150/303 (49%), Gaps = 32/303 (10%)
Query: 115 FSKQFVA-HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKH 173
F ++ V +Y+ GEE+G G F + K G A K I K
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKK--------RRTKSS 51
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMEL 233
++ ED+ REV IL+ + H N++ ++ YE+ ++ +++EL
Sbjct: 52 RR----------------GVSREDIEREVSILKEIQ-HPNVITLHEVYENKTDVILILEL 94
Query: 234 CKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSK-EEN 292
GGEL D + + +EE+A + QIL+ V + H + H DLKPEN + +
Sbjct: 95 VAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPK 153
Query: 293 SSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGS 351
+K IDFGL+ + +I G+ +VAPE++ + G EADMWSIGVI YILL G+
Sbjct: 154 PRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
Query: 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411
PF T+ V + F++ + + S A DF++RLL KD +KR+T +L HPW
Sbjct: 214 SPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 273
Query: 412 LAN 414
+
Sbjct: 274 IKP 276
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 224 bits (571), Expect = 2e-70
Identities = 73/306 (23%), Positives = 133/306 (43%), Gaps = 42/306 (13%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y E++G+G G +A GQ+VA++ +
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNL---------------------- 55
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
E + E+ ++R + N+V + D+Y D +++VME GG L D
Sbjct: 56 --------QQQPKKELIINEILVMREN-KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ E V + L + F H V+HRD+K +N L + S+K DFG
Sbjct: 107 VV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGM---DGSVKLTDFG 161
Query: 302 LSDYVKPDE-RLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTE 359
+ P++ + + +VG+ Y++APEV+ ++YG + D+WS+G++A ++ G P+
Sbjct: 162 FCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221
Query: 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVK 419
+ + + + LS DF+ R L+ D KR +A + L H +L + +
Sbjct: 222 LRALYLIAT-NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLS 280
Query: 420 IPSDMI 425
+ +I
Sbjct: 281 SLTPLI 286
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 9e-70
Identities = 84/308 (27%), Positives = 141/308 (45%), Gaps = 49/308 (15%)
Query: 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENH 176
K+ ++ G+ +G G F A+ ++ A+K++ K
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELAT---SREYAIKILEKR---------------- 44
Query: 177 QFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKG 236
+ + V RE ++ L H V+ Y ++DD+ +Y + K
Sbjct: 45 -----------HIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKN 92
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
GELL I + G + E + +I+S + + H +G++HRDLKPEN L E+ ++
Sbjct: 93 GELLKYI-RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN---EDMHIQ 148
Query: 297 AIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSR 352
DFG + + P+ R N VG+A YV+PE+L +S +D+W++G I Y L+ G
Sbjct: 149 ITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLP 208
Query: 353 PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA------ 406
PF A E IF+ ++K + F E P+A D V++LL D KRL +
Sbjct: 209 PFRAGNEYLIFQKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPL 264
Query: 407 LSHPWLAN 414
+HP+ +
Sbjct: 265 KAHPFFES 272
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (567), Expect = 2e-69
Identities = 89/313 (28%), Positives = 134/313 (42%), Gaps = 49/313 (15%)
Query: 117 KQFVAHYELGEEV-GRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHEN 175
+ Y++ +V G G G K+ + A+K++
Sbjct: 7 NAIIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQD---------------- 47
Query: 176 HQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED----DDNIYIVM 231
RREV++ + ++V+ D YE+ + IVM
Sbjct: 48 -------------------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88
Query: 232 ELCKGGELLDRILSRGGK-YSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKE 290
E GGEL RI RG + ++E +A +M I + + H + HRD+KPEN L+TSK
Sbjct: 89 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKR 148
Query: 291 ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLC 349
N+ LK DFG + L + YYVAPEVL Y DMWS+GVI YILLC
Sbjct: 149 PNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 208
Query: 350 GSRPFWARTE----SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQ 405
G PF++ G+ + F W +S E ++ LL + +R+T +
Sbjct: 209 GYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITE 268
Query: 406 ALSHPWLANSHDV 418
++HPW+ S V
Sbjct: 269 FMNHPWIMQSTKV 281
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 221 bits (564), Expect = 3e-69
Identities = 67/308 (21%), Positives = 115/308 (37%), Gaps = 44/308 (14%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+ E+G G FG A+ + + VA+K +
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRN---SEVVAIKKMSYS--------------------- 51
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ +D+ +EV+ L+ L H N +Q+ Y + ++VME C G D
Sbjct: 52 ------GKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGS-ASD 103
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ E + V L +A+ H ++HRD+K N L + E +K DFG
Sbjct: 104 LLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFG 160
Query: 302 LSDYVKPDERLNDIVGSAYYVAPEVL----HRSYGTEADMWSIGVIAYILLCGSRPFWAR 357
+ + P N VG+ Y++APEV+ Y + D+WS+G+ L P +
Sbjct: 161 SASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 217
Query: 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
+ + + S +FV L K + R T+ L H ++
Sbjct: 218 NAMSALYHIAQNES--PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275
Query: 418 VKIPSDMI 425
+ D+I
Sbjct: 276 PTVIMDLI 283
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 219 bits (558), Expect = 7e-69
Identities = 79/299 (26%), Positives = 134/299 (44%), Gaps = 43/299 (14%)
Query: 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQF 178
FV ++L + +G G +G A + + VAVK++ K
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVT---EEAVAVKIVDM------------KRAVD-- 45
Query: 179 TILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGE 238
E++++E+ I + L H+N+V+FY + + Y+ +E C GGE
Sbjct: 46 ---------------CPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGE 89
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAI 298
L DRI G E DA+ Q+++ V + H G+ HRD+KPEN L +LK
Sbjct: 90 LFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDE---RDNLKIS 145
Query: 299 DFGLSDYVKPDER---LNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRP 353
DFGL+ + + R LN + G+ YVAPE+L R + D+WS G++ +L G P
Sbjct: 146 DFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205
Query: 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+ ++S + K ++ PW + + + ++L ++ R+T W
Sbjct: 206 WDQPSDSCQEYSDWKEKKTYLN-PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 6e-65
Identities = 62/297 (20%), Positives = 112/297 (37%), Gaps = 45/297 (15%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ E+GRG F + +VA + K E +F
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTET---TVEVAWCELQDR--------KLTKSERQRF---- 55
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGE 238
+ E ++L+ L H N+V+FYD++E I +V EL G
Sbjct: 56 ----------------KEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSG- 97
Query: 239 LLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG--VVHRDLKPENFLFTSKEENSSLK 296
L L R + + QIL + F H + ++HRDLK +N T S+K
Sbjct: 98 TLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG--PTGSVK 155
Query: 297 AIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFW- 355
D GL+ +K ++G+ ++APE+ Y D+++ G+ + P+
Sbjct: 156 IGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE 214
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+ + I+R V PE + ++ + ++ +R + L+H +
Sbjct: 215 CQNAAQIYRRVTSGVKPAS--FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 1e-64
Identities = 74/341 (21%), Positives = 125/341 (36%), Gaps = 80/341 (23%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+E E+G G+ G K G +A K+I I
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPS---GLVMARKLIHLEI-------------------- 43
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ RE+++L +V FY A+ D I I ME GG L D
Sbjct: 44 ---------KPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSL-D 92
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVHRDLKPENFLFTSKEENSSLKAIDF 300
++L + G+ E+ V + ++ + + + ++HRD+KP N L S+ E +K DF
Sbjct: 93 QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDF 149
Query: 301 GLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFWARTE 359
G+S + D N VG+ Y++PE L Y ++D+WS+G+ + G P
Sbjct: 150 GVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208
Query: 360 S---GIFRAVLKADPSF-------------------------------------DEAPWP 379
+F ++ D + + P
Sbjct: 209 KELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSG 268
Query: 380 SLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKI 420
S E DFV + L K+ +R Q + H ++ S ++
Sbjct: 269 VFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV 309
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 4e-64
Identities = 74/295 (25%), Positives = 124/295 (42%), Gaps = 41/295 (13%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ L + +G+G FG A+ KK Q A+K + K
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKT---NQFFAIKALKKD---------------------- 38
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ +E E ++L H L + ++ +N++ VME GG+L+
Sbjct: 39 -----VVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH 93
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
I K+ A +I+ + F H +G+V+RDLK +N L ++ +K DFG+
Sbjct: 94 I-QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD---KDGHIKIADFGM 149
Query: 303 S-DYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTES 360
+ + D + N G+ Y+APE+L + Y D WS GV+ Y +L G PF + E
Sbjct: 150 CKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209
Query: 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA-LSHPWLAN 414
+F ++ +P + L EA D + +L ++ KRL HP
Sbjct: 210 ELFHSIRMDNPFY----PRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (523), Expect = 1e-63
Identities = 74/306 (24%), Positives = 126/306 (41%), Gaps = 43/306 (14%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y++G +G G FG S VA+K + K + ++
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSD---NLPVAIKHVEKDRISDWGELPNGTR-------- 53
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRAL-TGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
V EV +L+ + +G +++ D +E D+ +++E + + L
Sbjct: 54 ----------------VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL 97
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
++ G EE A+ Q+L V CH GV+HRD+K EN L LK IDF
Sbjct: 98 FDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDF 155
Query: 301 GLSDYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWART 358
G +K D D G+ Y PE + HR +G A +WS+G++ Y ++CG PF
Sbjct: 156 GSGALLK-DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214
Query: 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDV 418
E +++ F +S E ++ L R T + +HPW+ +
Sbjct: 215 E------IIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264
Query: 419 KIPSDM 424
+ +++
Sbjct: 265 QETAEI 270
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 205 bits (522), Expect = 1e-63
Identities = 70/297 (23%), Positives = 113/297 (38%), Gaps = 38/297 (12%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
YELGE +G G A+ + +DVAVKV+
Sbjct: 8 RYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRAD--------------------- 43
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN----IYIVMELCKGG 237
RRE + AL H +V YD E + YIVME G
Sbjct: 44 ------LARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 96
Query: 238 ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKA 297
L D I+ G + + A V+ + F H G++HRD+KP N + ++ +
Sbjct: 97 TLRD-IVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDF 155
Query: 298 IDFG-LSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFW 355
++D + ++G+A Y++PE S +D++S+G + Y +L G PF
Sbjct: 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT 215
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412
+ + ++ DP A LS + V + L K+ R A + +
Sbjct: 216 GDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV 272
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 4e-63
Identities = 78/302 (25%), Positives = 125/302 (41%), Gaps = 50/302 (16%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE+ +G G +G + K G+ + K +
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSD---GKILVWKELDY----------------------- 39
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELL 240
T + + EV +LR L H N+V++YD D + +YIVME C+GG+L
Sbjct: 40 -----GSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLA 93
Query: 241 DRI---LSRGGKYSEEDAKIVMVQILSVVAFCHFQG-----VVHRDLKPENFLFTSKEEN 292
I EE VM Q+ + CH + V+HRDLKP N K+
Sbjct: 94 SVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN- 152
Query: 293 SSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCG 350
+K DFGL+ + D VG+ YY++PE ++R SY ++D+WS+G + Y L
Sbjct: 153 --VKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCAL 210
Query: 351 SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410
PF A ++ + + + S E + + R+LN R + + L +P
Sbjct: 211 MPPFTAFSQKELAGKIREGKFRR---IPYRYSDELNEIITRMLNLKDYHRPSVEEILENP 267
Query: 411 WL 412
+
Sbjct: 268 LI 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-62
Identities = 60/297 (20%), Positives = 107/297 (36%), Gaps = 48/297 (16%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+G+ +G G FG KG G DVAVK++ Q
Sbjct: 9 QITVGQRIGSGSFG-----TVYKGKWHG-DVAVKMLNV------------TAPTPQQ--- 47
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
++ + EV +LR H N++ F Y + IV + C+G L
Sbjct: 48 -------------LQAFKNEVGVLRKTR-HVNILLFMG-YSTAPQLAIVTQWCEGSSLYH 92
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ K+ + Q + + H + ++HRDLK N E+ ++K DFG
Sbjct: 93 HLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLH---EDLTVKIGDFG 149
Query: 302 LSDYVKPDE---RLNDIVGSAYYVAPEVL----HRSYGTEADMWSIGVIAYILLCGSRPF 354
L+ + + GS ++APEV+ Y ++D+++ G++ Y L+ G P+
Sbjct: 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY 209
Query: 355 WARTESGIFRAVLKADPSFDEAP--WPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
++ + + + L K +R Q L+
Sbjct: 210 SNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 198 bits (505), Expect = 8e-60
Identities = 70/300 (23%), Positives = 124/300 (41%), Gaps = 41/300 (13%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+ + +GRG FG + G+ A+K + K K + + L
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDK---------KRIKMKQGETLAL 52
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+E R + ++ +V A+ D + +++L GG+L
Sbjct: 53 NE---------------RIMLSLVSTG-DCPFIVCMSYAFHTPDKLSFILDLMNGGDL-H 95
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
LS+ G +SE D + +I+ + H + VV+RDLKP N L E+ ++ D G
Sbjct: 96 YHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD---EHGHVRISDLG 152
Query: 302 LSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWARTE 359
L+ ++ + VG+ Y+APEVL + +Y + AD +S+G + + LL G PF
Sbjct: 153 LACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT 211
Query: 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLAN 414
+ + + S SPE ++ LL +D +RL A + P+ +
Sbjct: 212 KDKH-EIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 270
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-58
Identities = 79/321 (24%), Positives = 137/321 (42%), Gaps = 45/321 (14%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
++EL + +G G +G + G G+ A+KV+ K
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA--------------------- 63
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ A E R E ++L + LV + A++ + ++++++ GGEL
Sbjct: 64 -----TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL-F 117
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
LS+ +++E + +I + +I+ + H G+++RD+K EN L N + DFG
Sbjct: 118 THLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD---SNGHVVLTDFG 174
Query: 302 LSDYVKP--DERLNDIVGSAYYVAPEVL---HRSYGTEADMWSIGVIAYILLCGSRPFWA 356
LS ER D G+ Y+AP+++ + D WS+GV+ Y LL G+ PF
Sbjct: 175 LSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 234
Query: 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPW 411
E + + + +S A D ++RLL KD +KRL A + H +
Sbjct: 235 DGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294
Query: 412 LANSHDVKIPSDMIVYKLIKA 432
KI D + K + A
Sbjct: 295 FQ-----KINWDDLAAKKVPA 310
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 192 bits (489), Expect = 3e-58
Identities = 69/299 (23%), Positives = 129/299 (43%), Gaps = 47/299 (15%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+++ +G G FG +++ G+ A+KV+ K
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKE--------------------- 40
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ +E E +L +T H +++ + ++D I+++M+ +GGEL
Sbjct: 41 ------IVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+L + ++ AK ++ + + H + +++RDLKPEN L +N +K DFG
Sbjct: 94 -LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD---KNGHIKITDFG 149
Query: 302 LSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTES 360
+ YV + + G+ Y+APEV+ + Y D WS G++ Y +L G PF+
Sbjct: 150 FAKYV--PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM 207
Query: 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLAN 414
+ +L A+ F P + + D + RL+ +D +RL +HPW
Sbjct: 208 KTYEKILNAELRF----PPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 1e-57
Identities = 81/329 (24%), Positives = 119/329 (36%), Gaps = 64/329 (19%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
YE E+G G +G A+ K G+ VA+K + G
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNG--GRFVALKRVRVQTG------------------- 46
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTG--HKNLVQFYDAY-----EDDDNIYIVMELC 234
REV +LR L H N+V+ +D + + + +V E
Sbjct: 47 ---------EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV 97
Query: 235 KGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSS 294
E K +M Q+L + F H VVHRDLKP+N L TS +
Sbjct: 98 DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI-- 155
Query: 295 LKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRP 353
K DFGL+ L +V + +Y APEVL +S Y T D+WS+G I +
Sbjct: 156 -KLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214
Query: 354 FWARTESGIFRAVLKADPSFDEAPWP-----------------------SLSPEAIDFVK 390
F ++ +L E WP + D +
Sbjct: 215 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLL 274
Query: 391 RLLNKDYRKRLTAAQALSHPWLANSHDVK 419
+ L + KR++A ALSHP+ + K
Sbjct: 275 KCLTFNPAKRISAYSALSHPYFQDLERCK 303
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 3e-57
Identities = 75/328 (22%), Positives = 121/328 (36%), Gaps = 60/328 (18%)
Query: 124 ELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDE 183
E + +G G F A+ K Q VA+K I H+ D
Sbjct: 1 EKLDFLGEGQFATVYKARDKNT---NQIVAIKKIKL---------------GHRSEAKDG 42
Query: 184 YCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRI 243
+ RE+K+L+ L+ H N++ DA+ NI +V + + + I
Sbjct: 43 INRTAL----------REIKLLQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVI-I 90
Query: 244 LSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLS 303
+ K M+ L + + H ++HRDLKP N L EN LK DFGL+
Sbjct: 91 KDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLD---ENGVLKLADFGLA 147
Query: 304 -DYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWARTES 360
+ P+ V + +Y APE+L R YG DMW++G I LL ++
Sbjct: 148 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL 207
Query: 361 GIFRAVLKADPSFDEAPWP------------------------SLSPEAIDFVKRLLNKD 396
+ + + E WP + + +D ++ L +
Sbjct: 208 DQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN 267
Query: 397 YRKRLTAAQALSHPWLANSHDVKIPSDM 424
R+TA QAL + +N +
Sbjct: 268 PCARITATQALKMKYFSNRPGPTPGCQL 295
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 190 bits (483), Expect = 4e-57
Identities = 76/331 (22%), Positives = 134/331 (40%), Gaps = 80/331 (24%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y+L ++GRG + A + V VK++
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITN---NEKVVVKILKP---------------------- 70
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDN--IYIVMELCKGGEL 239
+ + ++RE+KIL L G N++ D +D + +V E +
Sbjct: 71 -----------VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDF 119
Query: 240 LDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
++ D + M +IL + +CH G++HRD+KP N + E+ L+ ID
Sbjct: 120 KQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDH--EHRKLRLID 173
Query: 300 FGLSDYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIAYILLCGSRPFWA- 356
+GL+++ P + N V S Y+ PE+L ++ Y DMWS+G + ++ PF+
Sbjct: 174 WGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHG 233
Query: 357 -----------------RTESGIFRAVLKADPSFDE----------------APWPSLSP 383
I + ++ DP F++ +SP
Sbjct: 234 HDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSP 293
Query: 384 EAIDFVKRLLNKDYRKRLTAAQALSHPWLAN 414
EA+DF+ +LL D++ RLTA +A+ HP+
Sbjct: 294 EALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 1e-56
Identities = 76/300 (25%), Positives = 130/300 (43%), Gaps = 46/300 (15%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
++ + +G+G FG + K G+ A+K++ K
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKE--------------------- 41
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ + E ++L+ H L A++ D + VME GGEL
Sbjct: 42 ------VIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANGGELFF 94
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ SR ++EE A+ +I+S + + H + VV+RD+K EN + ++ +K DFG
Sbjct: 95 HL-SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD---KDGHIKITDFG 150
Query: 302 LSDYV-KPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYILLCGSRPFWARTE 359
L + G+ Y+APEVL + YG D W +GV+ Y ++CG PF+ +
Sbjct: 151 LCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210
Query: 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLAN 414
+F +L + F +LSPEA + LL KD ++RL A + + H + +
Sbjct: 211 ERLFELILMEEIRF----PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 185 bits (470), Expect = 1e-55
Identities = 78/318 (24%), Positives = 126/318 (39%), Gaps = 65/318 (20%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
Y E++G G +G A+ G + A+K I + E+
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNNYG----ETFALKKIRL------------EKEDEGI---- 43
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
RE+ IL+ L H N+V+ YD + +V E +L
Sbjct: 44 ------------PSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKL 89
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ G AK ++Q+L+ +A+CH + V+HRDLKP+N L LK DFGL
Sbjct: 90 LDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR---EGELKIADFGL 146
Query: 303 SDYV-KPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFWARTE 359
+ P + + + +Y AP+VL S Y T D+WS+G I ++ G+ F +E
Sbjct: 147 ARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206
Query: 360 SGIFRAVLKADPSFDEAPWP-------------------------SLSPEAIDFVKRLLN 394
+ + + + + WP L ID + ++L
Sbjct: 207 ADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLK 266
Query: 395 KDYRKRLTAAQALSHPWL 412
D +R+TA QAL H +
Sbjct: 267 LDPNQRITAKQALEHAYF 284
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 3e-55
Identities = 61/292 (20%), Positives = 101/292 (34%), Gaps = 50/292 (17%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+L + +G+G FG G +G VAVK I
Sbjct: 8 ELKLLQTIGKGEFG-----DVMLGDYRGNKVAVKCIKN---------------------- 40
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA-YEDDDNIYIVMELCKGGELL 240
+ E ++ L H NLVQ E+ +YIV E G L+
Sbjct: 41 ----------DATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 89
Query: 241 DRILSRGGKY-SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
D + SRG + + + + + VHRDL N L + E++ K D
Sbjct: 90 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSD 146
Query: 300 FGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILL-CGSRPFWAR 357
FGL+ + + + APE L + + T++D+WS G++ + + G P+
Sbjct: 147 FGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 204
Query: 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
+ V K + P + +K + D R + Q
Sbjct: 205 PLKDVVPRVEK---GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 6e-55
Identities = 60/293 (20%), Positives = 110/293 (37%), Gaps = 48/293 (16%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLK-GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
+E+G G FG K G + DVA+K+I +
Sbjct: 5 DLTFLKELGTGQFG-----VVKYGKWRGQYDVAIKMIKE--------------------- 38
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
+++ ++ E K++ L+ H+ LVQ Y I+I+ E G LL
Sbjct: 39 ----------GSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLL 87
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
+ + ++ + + + + + + +HRDL N L + +K DF
Sbjct: 88 NYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDF 144
Query: 301 GLSDYVKPDE--RLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPFWA 356
GLS YV DE + PEVL + + +++D+W+ GV+ + I G P+
Sbjct: 145 GLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204
Query: 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
T S + + + S + + ++ +R T LS+
Sbjct: 205 FTNSETAEHIAQGLRLYRP---HLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 2e-54
Identities = 60/294 (20%), Positives = 98/294 (33%), Gaps = 40/294 (13%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
L E++G G FG + S K VAVK +
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD--------------------- 47
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
++ A++D REV + +L H+NL++ Y + +V EL G LLD
Sbjct: 48 ------VLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP-MKMVTELAPLGSLLD 99
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
R+ G + VQ+ + + + +HRDL N L +K DFG
Sbjct: 100 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFG 156
Query: 302 LSDYVKPDE----RLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLC-GSRPFW 355
L + ++ + APE L R++ +D W GV + + G P+
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
S I + K + + + + R T
Sbjct: 217 GLNGSQILHKIDKEGERLPR--PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-54
Identities = 80/346 (23%), Positives = 127/346 (36%), Gaps = 80/346 (23%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y +G G +G CSA VA+K I +H+ +
Sbjct: 9 RYTNLSYIGEGAYGMVCSAYDNVN---KVRVAIKKISPF-----------EHQTY----- 49
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDD-----NIYIVMELCKG 236
+ RE+KIL H+N++ D ++Y+V L G
Sbjct: 50 -------------CQRTLREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYLVTHLM-G 94
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
+L + + S + + QIL + + H V+HRDLKP N L LK
Sbjct: 95 ADLYKLL--KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLN---TTCDLK 149
Query: 297 AIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCG 350
DFGL+ PD L + V + +Y APE++ S Y D+WS+G I +L
Sbjct: 150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSN 209
Query: 351 SRPFWARTESGIFRAVLKADPSFDEAPW---------------------------PSLSP 383
F + +L S + P+
Sbjct: 210 RPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADS 269
Query: 384 EAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKL 429
+A+D + ++L + KR+ QAL+HP+L +D PSD + +
Sbjct: 270 KALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD---PSDEPIAEA 312
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-54
Identities = 74/346 (21%), Positives = 122/346 (35%), Gaps = 77/346 (22%)
Query: 114 GFSKQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKH 173
G + Y + +G G FG AK G+ VA+K + +
Sbjct: 13 GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQ-------------- 55
Query: 174 ENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY------EDDDNI 227
RE++I+R L H N+V+ + +D+ +
Sbjct: 56 --------------------DKRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYL 94
Query: 228 YIVMELCKGG--ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFL 285
+V++ + K+ M Q+ +A+ H G+ HRD+KP+N L
Sbjct: 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 286 FTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVI 343
+ + LK DFG + + E + S YY APE++ + Y + D+WS G +
Sbjct: 155 LDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV 212
Query: 344 AYILLCGSRPFWARTESGIFRAVLKA-------------------------DPSFDEAPW 378
LL G F + ++K + +
Sbjct: 213 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFR 272
Query: 379 PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD--VKIPS 422
P PEAI RLL RLT +A +H + D VK+P+
Sbjct: 273 PRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPN 318
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 8e-54
Identities = 81/348 (23%), Positives = 136/348 (39%), Gaps = 82/348 (23%)
Query: 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
V+ YE ++G+G FG A+ +K GQ VA+K + ++E F
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLM------------ENEKEGF- 52
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED--------DDNIYIVM 231
RE+KIL+ L H+N+V + +IY+V
Sbjct: 53 ---------------PITALREIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVF 96
Query: 232 ELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEE 291
+ C+ L + + K++ + K VM +L+ + + H ++HRD+K N L T
Sbjct: 97 DFCEHD-LAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLIT---R 152
Query: 292 NSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVL--HRSYGTEADMWSIGVIA 344
+ LK DFGL+ + R + V + +Y PE+L R YG D+W G I
Sbjct: 153 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 212
Query: 345 YILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSL----------------------- 381
+ S TE + + S WP++
Sbjct: 213 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL 272
Query: 382 -----SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDM 424
P A+D + +LL D +R+ + AL+H + + +PSD+
Sbjct: 273 KAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP---MPSDL 317
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-53
Identities = 69/317 (21%), Positives = 114/317 (35%), Gaps = 63/317 (19%)
Query: 122 HYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
+ E G+ +G G FG +A + VAVK++ +
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK------------------- 78
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
+ E + E+K++ L H+N+V A IY++ E C G+L
Sbjct: 79 ----------ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128
Query: 240 LDRILSRGGKYSE----------------------EDAKIVMVQILSVVAFCHFQGVVHR 277
L+ + S+ K+SE ED Q+ + F F+ VHR
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188
Query: 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL---NDIVGSAYYVAPEVLHRS-YGT 333
DL N L T +K DFGL+ + D + ++APE L Y
Sbjct: 189 DLAARNVLVT---HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245
Query: 334 EADMWSIGVIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRL 392
++D+WS G++ + I G P+ F +++ D + E ++
Sbjct: 246 KSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD--QPFYATEEIYIIMQSC 303
Query: 393 LNKDYRKRLTAAQALSH 409
D RKR + S
Sbjct: 304 WAFDSRKRPSFPNLTSF 320
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 5e-53
Identities = 80/354 (22%), Positives = 145/354 (40%), Gaps = 83/354 (23%)
Query: 114 GFSKQFV--------AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIF 165
GF +Q V A Y + VG G +G CSA + G VA+K + +
Sbjct: 3 GFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYR------ 53
Query: 166 LQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDD 225
++ F + RE+++L+ + H+N++ D + D+
Sbjct: 54 ------PFQSELF----------------AKRAYRELRLLKHMR-HENVIGLLDVFTPDE 90
Query: 226 ------NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279
+ Y+VM G L +++ K E+ + ++ Q+L + + H G++HRDL
Sbjct: 91 TLDDFTDFYLVMPFM--GTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDL 147
Query: 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL--HRSYGTEADM 337
KP N E+ LK +DFGL+ + D + V + +Y APEV+ Y D+
Sbjct: 148 KPGNLAVN---EDCELKILDFGLAR--QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDI 202
Query: 338 WSIGVIAYILLCGSRPFWARTESGIFRAVLKADPSFDEAPW------------------- 378
WS+G I ++ G F + ++K +
Sbjct: 203 WSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELE 262
Query: 379 --------PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDM 424
+ SP A++ ++++L D +R+TA +AL+HP+ + HD + +
Sbjct: 263 KKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV 316
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 6e-53
Identities = 58/293 (19%), Positives = 107/293 (36%), Gaps = 48/293 (16%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLK-GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
+E+G G FG G VA+K I +
Sbjct: 6 ELTFVQEIGSGQFG-----LVHLGYWLNKDKVAIKTIRE--------------------- 39
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
A++ ED E +++ L+ H LVQ Y + I +V E + G L
Sbjct: 40 ----------GAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLS 88
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
D + ++ G ++ E + + + +A+ V+HRDL N L EN +K DF
Sbjct: 89 DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDF 145
Query: 301 GLSDYVKPDERLND--IVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFW-A 356
G++ +V D+ + + +PEV Y +++D+WS GV+ + + + +
Sbjct: 146 GMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205
Query: 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
R+ S + + + S + + R ++ L
Sbjct: 206 RSNSEVVEDISTGFRLYK---PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (451), Expect = 8e-53
Identities = 75/324 (23%), Positives = 122/324 (37%), Gaps = 63/324 (19%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+++ E++G G +G A+ K G+ VA+K I E
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRL------------DTETEGV--- 44
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
RE+ +L+ L H N+V+ D ++ +Y+V E
Sbjct: 45 -------------PSTAIREISLLKEL-NHPNIVKLLDVIHTENKLYLVFEFLHQDLKKF 90
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
S K + Q+L +AFCH V+HRDLKP+N L ++K DFG
Sbjct: 91 MDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLIN---TEGAIKLADFG 147
Query: 302 LSDYV-KPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPFWART 358
L+ P V + +Y APE+L Y T D+WS+G I ++ F +
Sbjct: 148 LARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 207
Query: 359 ESGIFRAVLKADPSFDEAPWPS-------------------------LSPEAIDFVKRLL 393
E + + + DE WP L + + ++L
Sbjct: 208 EIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQML 267
Query: 394 NKDYRKRLTAAQALSHPWLANSHD 417
+ D KR++A AL+HP+ +
Sbjct: 268 HYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 177 bits (450), Expect = 1e-52
Identities = 57/318 (17%), Positives = 107/318 (33%), Gaps = 52/318 (16%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y LG ++G G FG G++VA+K+ C K ++ Q
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLE------------CVKTKHPQL--- 49
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
E KI + + G + + D +VMEL G L D
Sbjct: 50 -----------------HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLED 91
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
K+S + ++ Q++S + + H + +HRD+KP+NFL ++ + + IDFG
Sbjct: 92 LFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 151
Query: 302 LSDYVKPDE--------RLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSR 352
L+ + ++ G+A Y + D+ S+G + GS
Sbjct: 152 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSL 211
Query: 353 PFWARTESGIFRAVLKADPSFDEAP----WPSLSPEAIDFVKRLLNKDYRKRLTAA---Q 405
P+ + + + P E ++ + + + + Q
Sbjct: 212 PWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 271
Query: 406 ALSHPWLANSHDVKIPSD 423
+ + D
Sbjct: 272 LFRNLFHRQGFSYDYVFD 289
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (448), Expect = 2e-52
Identities = 78/324 (24%), Positives = 124/324 (38%), Gaps = 65/324 (20%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
YE E++G G +G AK ++ + VA+K + ++
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRET---HEIVALKRVRL------------DDDDEGV---- 44
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
RE+ +L+ L HKN+V+ +D D + +V E C
Sbjct: 45 ------------PSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF 91
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
G E K + Q+L + FCH + V+HRDLKP+N L E K +FGL
Sbjct: 92 DSCNG-DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGEL---KLANFGL 147
Query: 303 SDYV-KPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRP-FWART 358
+ P + V + +Y P+VL + Y T DMWS G I L RP F
Sbjct: 148 ARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207
Query: 359 ESGIFRAVLKADPSFDEAPWPS-------------------------LSPEAIDFVKRLL 393
+ + + + E WPS L+ D ++ LL
Sbjct: 208 VDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLL 267
Query: 394 NKDYRKRLTAAQALSHPWLANSHD 417
+ +R++A +AL HP+ ++
Sbjct: 268 KCNPVQRISAEEALQHPYFSDFCP 291
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 5e-52
Identities = 58/292 (19%), Positives = 106/292 (36%), Gaps = 41/292 (14%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
ELG +G G FG VA+K
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--------------------- 46
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
T+ E +E +R H ++V+ ++ ++I+MELC GEL
Sbjct: 47 --------TSDSVREKFLQEALTMRQF-DHPHIVKLIGVITEN-PVWIIMELCTLGELRS 96
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
+ R + Q+ + +A+ + VHRD+ N L +S + +K DFG
Sbjct: 97 FLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC---VKLGDFG 153
Query: 302 LSDYVKPDE--RLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPFWAR 357
LS Y++ + + ++APE + R + + +D+W GV + IL+ G +PF
Sbjct: 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213
Query: 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
+ + + + P+ P + + D +R + +
Sbjct: 214 KNNDVIGRIENGER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 174 bits (441), Expect = 3e-51
Identities = 60/317 (18%), Positives = 112/317 (35%), Gaps = 47/317 (14%)
Query: 114 GFSKQF-VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPK 172
F+K+ ++ ++ + +G G FG CS K + VA+K +
Sbjct: 18 EFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY----------- 66
Query: 173 HENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVME 232
T D E I+ H N++ + I+ E
Sbjct: 67 ------------------TEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPVMIITE 107
Query: 233 LCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEEN 292
+ G L + G+++ ++ I + + + VHRDL N L N
Sbjct: 108 FMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVN---SN 164
Query: 293 SSLKAIDFGLSDYVKPDERLND------IVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY 345
K DFGLS +++ D + APE + +R + + +D+WS G++ +
Sbjct: 165 LVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMW 224
Query: 346 -ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA 404
++ G RP+W T + A+ + + P + KD R
Sbjct: 225 EVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG 281
Query: 405 QALSH--PWLANSHDVK 419
Q ++ + N + +K
Sbjct: 282 QIVNTLDKMIRNPNSLK 298
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (433), Expect = 2e-50
Identities = 56/302 (18%), Positives = 107/302 (35%), Gaps = 48/302 (15%)
Query: 122 HYELGE-EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
+ + + E+G G+FG + K DVA+KV+ +
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQG-------------------- 47
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
T E++ RE +I+ L + +V+ + + + +VME+ GG L
Sbjct: 48 ---------TEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQAE-ALMLVMEMAGGGPLH 96
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
++ + + + ++ Q+ + + + VHRDL N L K DF
Sbjct: 97 KFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDF 153
Query: 301 GLSDYVKPDERLND----IVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY-ILLCGSRPF 354
GLS + D+ + APE + R + + +D+WS GV + L G +P+
Sbjct: 154 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPY 213
Query: 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA---QALSHPW 411
+ + + P PE + + R Q + +
Sbjct: 214 KKMKGPEVMAFIEQGKR---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270
Query: 412 LA 413
+
Sbjct: 271 YS 272
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 172 bits (437), Expect = 3e-50
Identities = 74/299 (24%), Positives = 125/299 (41%), Gaps = 47/299 (15%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
++ + +G G FG K K+ G A+K++ K
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQ--------------------- 77
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ IE E +IL+A+ LV+ +++D+ N+Y+VME GGE+
Sbjct: 78 ------KVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
L R G++SE A+ QI+ + H +++RDLKPEN L + ++ DFG
Sbjct: 131 -HLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID---QQGYIQVTDFG 186
Query: 302 LSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWARTES 360
+ + R + G+ +APE++ + Y D W++GV+ Y + G PF+A
Sbjct: 187 FAK--RVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLAN 414
I+ ++ F S + D ++ LL D KR +H W A
Sbjct: 245 QIYEKIVSGKVRF----PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 6e-50
Identities = 63/309 (20%), Positives = 108/309 (34%), Gaps = 50/309 (16%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
L ++G+G FG VA+K +
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGT----TRVAIKTLKP---------------------- 51
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
++ E +E ++++ L H+ LVQ Y ++ IYIV E G LLD
Sbjct: 52 ---------GTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLD 100
Query: 242 RILSRGGKYS-EEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
+ GKY + QI S +A+ VHRDL+ N L EN K DF
Sbjct: 101 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADF 157
Query: 301 GLSDYVKPDE--RLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFW-A 356
GL+ ++ +E + APE + + ++D+WS G++ L R +
Sbjct: 158 GLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217
Query: 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS--HPWLAN 414
+ V + + P D + + K+ +R T + + +
Sbjct: 218 MVNREVLDQVERG---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
Query: 415 SHDVKIPSD 423
+ P +
Sbjct: 275 TEPQYQPGE 283
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 1e-48
Identities = 61/304 (20%), Positives = 111/304 (36%), Gaps = 53/304 (17%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+ + +G G+FG A+ KK L+ D A+K + +
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLR-MDAAIKRMKEYA--------------------- 49
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+ D E+++L L H N++ A E +Y+ +E G LLD
Sbjct: 50 --------SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDF 101
Query: 243 IL---------------SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFT 287
+ S S + + + + + +HRDL N L
Sbjct: 102 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG 161
Query: 288 SKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS-YGTEADMWSIGVIAYI 346
EN K DFGLS + + ++A E L+ S Y T +D+WS GV+ +
Sbjct: 162 ---ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 218
Query: 347 LL-CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQ 405
++ G P+ T + ++ + + + + E D +++ + +R + AQ
Sbjct: 219 IVSLGGTPYCGMTCAELYEKLPQG---YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQ 275
Query: 406 ALSH 409
L
Sbjct: 276 ILVS 279
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 2e-48
Identities = 53/293 (18%), Positives = 106/293 (36%), Gaps = 47/293 (16%)
Query: 128 EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCL 187
E+G G+FG + + + VAVK++
Sbjct: 14 ELGSGNFGTVKKGYYQMKKV-VKTVAVKILKNE--------------------------- 45
Query: 188 FMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG 247
+++ E +++ L + +V+ E + + +VME+ + G L ++ L +
Sbjct: 46 -ANDPALKDELLAEANVMQQLD-NPYIVRMIGICEAE-SWMLVMEMAELGPL-NKYLQQN 101
Query: 248 GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVK 307
+++ ++ Q+ + + VHRDL N L + K DFGLS ++
Sbjct: 102 RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT---QHYAKISDFGLSKALR 158
Query: 308 PDERLND----IVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLC-GSRPFWARTESG 361
DE + APE + + + +++D+WS GV+ + G +P+ S
Sbjct: 159 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
Query: 362 IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQ---ALSHPW 411
+ + K + E D + D R A L + +
Sbjct: 219 VTAMLEKGER---MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (420), Expect = 4e-48
Identities = 64/310 (20%), Positives = 101/310 (32%), Gaps = 58/310 (18%)
Query: 122 HYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
G+ +G G FG +A S VAVK++ H +
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----------AHLTER-- 70
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
E + E+K+L L H N+V A ++ E C G+L
Sbjct: 71 ----------------EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 114
Query: 240 LDRILSRGGKY-----------------SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282
L+ + + + ED Q+ +AF + +HRDL
Sbjct: 115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174
Query: 283 NFLFTSKEENSSLKAIDFGLSDYVKPDERL---NDIVGSAYYVAPEVLHRSYGT-EADMW 338
N L K DFGL+ +K D + ++APE + T E+D+W
Sbjct: 175 NIL---LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVW 231
Query: 339 SIGVIAYILLCGSRP-FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDY 397
S G+ + L + F ++K E D +K + D
Sbjct: 232 SYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADP 289
Query: 398 RKRLTAAQAL 407
KR T Q +
Sbjct: 290 LKRPTFKQIV 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 1e-47
Identities = 56/293 (19%), Positives = 108/293 (36%), Gaps = 50/293 (17%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLK-GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
+L E +G G FG + G VAVK + +
Sbjct: 14 TLKLVERLGAGQFG-----EVWMGYYNGHTKVAVKSLKQ--------------------- 47
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
+++ + E +++ L H+ LV+ Y + IYI+ E + G L+
Sbjct: 48 ----------GSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQE-PIYIITEYMENGSLV 95
Query: 241 DRILSRGG-KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAID 299
D + + G K + + QI +AF + +HRDL+ N L + K D
Sbjct: 96 DFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSC---KIAD 152
Query: 300 FGLSDYVKPDE--RLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLC-GSRPFW 355
FGL+ ++ +E + APE + + ++ ++D+WS G++ ++ G P+
Sbjct: 153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212
Query: 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
T + + + + + E ++ + R T S
Sbjct: 213 GMTNPEVIQNLERGYRMVR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-47
Identities = 70/341 (20%), Positives = 128/341 (37%), Gaps = 84/341 (24%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y+ + +G G G C+A ++VA+K + + +N
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSR------------PFQNQTH--- 59
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAY------EDDDNIYIVMELCK 235
+ RE+ +++ + HKN++ + + E+ ++Y+VMEL
Sbjct: 60 -------------AKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQDVYLVMELMD 105
Query: 236 GGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSL 295
+ E ++ Q+L + H G++HRDLKP N + S + +L
Sbjct: 106 ANLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS---DCTL 158
Query: 296 KAIDFGLSDYVKPDERLNDIVGSAYYVAPE-VLHRSYGTEADMWSIGVIAYILLCGSRPF 354
K +DFGL+ + V + YY APE +L Y D+WS+G I ++ F
Sbjct: 159 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF 218
Query: 355 WARTESGIFRAVLKA----------------------DPSFDEAPWPSL----------- 381
R + V++ P + +P L
Sbjct: 219 PGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSE 278
Query: 382 -----SPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
+ +A D + ++L D KR++ AL HP++ +D
Sbjct: 279 HNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-47
Identities = 76/330 (23%), Positives = 134/330 (40%), Gaps = 73/330 (22%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
Y+ VG G +G C+A K G VAVK + +
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRP--------------------- 54
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYED-----DDNIYIVMELCKG 236
+ I + RE+++L+ + H+N++ D + + N ++ G
Sbjct: 55 -------FQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMG 106
Query: 237 GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLK 296
+L + + + K +++ + ++ QIL + + H ++HRDLKP N E+ LK
Sbjct: 107 ADLNN--IVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN---EDCELK 161
Query: 297 AIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRS--YGTEADMWSIGVIAYILLCGSRPF 354
+DFGL+ + D+ + V + +Y APE++ Y D+WS+G I LL G F
Sbjct: 162 ILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219
Query: 355 WARTESGIFRAVLKADPSFDEAPW---------------------------PSLSPEAID 387
+ +L+ + +P A+D
Sbjct: 220 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 279
Query: 388 FVKRLLNKDYRKRLTAAQALSHPWLANSHD 417
++++L D KR+TAAQAL+H + A HD
Sbjct: 280 LLEKMLVLDSDKRITAAQALAHAYFAQYHD 309
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 163 bits (412), Expect = 3e-47
Identities = 54/302 (17%), Positives = 101/302 (33%), Gaps = 51/302 (16%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
HY++G +G G FG Q VA+K P+
Sbjct: 6 HYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRSDA------------------ 44
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+R E + + L G + Y ++ + +V++L G L D
Sbjct: 45 --------------PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLED 89
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKE--ENSSLKAID 299
+ G K+S + + Q+L+ V H + +V+RD+KP+NFL + + +D
Sbjct: 90 LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149
Query: 300 FGLSDYVKPDE--------RLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCG 350
FG+ + + ++ G+A Y++ R D+ ++G + L G
Sbjct: 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 209
Query: 351 SRPFWARTESG----IFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA 406
S P+ + R K + E ++ N +
Sbjct: 210 SLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYL 269
Query: 407 LS 408
Sbjct: 270 QG 271
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 1e-46
Identities = 55/309 (17%), Positives = 109/309 (35%), Gaps = 53/309 (17%)
Query: 122 HYELGEEVGRGHFGYTCSAKA----KKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQ 177
LG+ +G G FG A+A K + VAVK++
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA---------------- 57
Query: 178 FTILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGG 237
T + D+ E+++++ + HKN++ A D +Y+++E G
Sbjct: 58 -------------TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 104
Query: 238 ELLDRILSRG---------------GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282
L + + +R + S +D Q+ + + + +HRDL
Sbjct: 105 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164
Query: 283 NFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIG 341
N L T ++ ++ + ++APE L R Y ++D+WS G
Sbjct: 165 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 224
Query: 342 VIAY-ILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKR 400
V+ + I G P+ +F+ + + + + E ++ + +R
Sbjct: 225 VLLWEIFTLGGSPYPGVPVEELFKLLKEGHR---MDKPSNCTNELYMMMRDCWHAVPSQR 281
Query: 401 LTAAQALSH 409
T Q +
Sbjct: 282 PTFKQLVED 290
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (405), Expect = 3e-46
Identities = 54/291 (18%), Positives = 101/291 (34%), Gaps = 44/291 (15%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTIL 181
+ ++G G +G KK VAVK + +
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKY---SLTVAVKTLKE---------------------- 52
Query: 182 DEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLD 241
+ +E+ +E +++ + H NLVQ + YI+ E G LLD
Sbjct: 53 ---------DTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLD 102
Query: 242 RILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
+ + S + QI S + + + +HRDL N L EN +K DF
Sbjct: 103 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADF 159
Query: 301 GLSDYVKPDE--RLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLCGSRPFWAR 357
GLS + D + APE L + + ++D+W+ GV+ + + +
Sbjct: 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219
Query: 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
+ +L+ D + + + ++ + R + A+
Sbjct: 220 IDLSQVYELLEKDYRME--RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-46
Identities = 52/292 (17%), Positives = 105/292 (35%), Gaps = 41/292 (14%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
++ + +G G FG +G+ V + V K +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKEL--------------------- 46
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
T+ A +++ E ++ ++ + ++ + + ++ +L G LLD
Sbjct: 47 ----REATSPKANKEILDEAYVMASVD-NPHVCRLLGICL-TSTVQLITQLMPFGCLLDY 100
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ + VQI + + + +VHRDL N L +K DFGL
Sbjct: 101 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGL 157
Query: 303 SDYVKPDER---LNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLC-GSRPFWAR 357
+ + +E+ ++A E + HR Y ++D+WS GV + L+ GS+P+
Sbjct: 158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 217
Query: 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
S I + K + P + + + + D R + +
Sbjct: 218 PASEISSILEKGER---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 1e-45
Identities = 53/317 (16%), Positives = 104/317 (32%), Gaps = 66/317 (20%)
Query: 122 HYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
+ E ++G G FG + A VAVK++ +
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE------------------- 54
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
+A D +RE ++ + N+V+ + ++ E G+L
Sbjct: 55 ----------ASADMQADFQREAALMAEF-DNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 103
Query: 240 LDRILSRGGKY-----------------------SEEDAKIVMVQILSVVAFCHFQGVVH 276
+ + S S + + Q+ + +A+ + VH
Sbjct: 104 NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 163
Query: 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERL---NDIVGSAYYVAPEVL-HRSYG 332
RDL N L EN +K DFGLS + + + ++ PE + + Y
Sbjct: 164 RDLATRNCLVG---ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT 220
Query: 333 TEADMWSIGVIAYILLCGSR-PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKR 391
TE+D+W+ GV+ + + P++ + V + A + E + ++
Sbjct: 221 TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNI---LACPENCPLELYNLMRL 277
Query: 392 LLNKDYRKRLTAAQALS 408
+K R +
Sbjct: 278 CWSKLPADRPSFCSIHR 294
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 3e-43
Identities = 52/295 (17%), Positives = 101/295 (34%), Gaps = 44/295 (14%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
E +GRGHFG K AVK + ++
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI---------------------- 66
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA-YEDDDNIYIVMELCKGGELLD 241
T + E I++ + H N++ + + +V+ K G+L +
Sbjct: 67 -------TDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN 118
Query: 242 RILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFG 301
I + + +D +Q+ + F + VHRDL N + E ++K DFG
Sbjct: 119 FIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD---EKFTVKVADFG 175
Query: 302 LSDYVKPDE-----RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFW 355
L+ + E ++A E L + + T++D+WS GV+ + L+ P +
Sbjct: 176 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235
Query: 356 A-RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409
I +L+ + + + + R + ++ +S
Sbjct: 236 PDVNTFDITVYLLQGRRLLQP---EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 2e-42
Identities = 55/294 (18%), Positives = 102/294 (34%), Gaps = 43/294 (14%)
Query: 122 HYELGEEVGRGHFGYTCSAKAKKGSLK-GQDVAVKVIPKMIGVIFLQVHCPKHENHQFTI 180
+ +G G FG K S K VA+K +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY------------------- 48
Query: 181 LDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELL 240
T D E I+ H N+++ + I+ E + G L
Sbjct: 49 ----------TEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISKYKPMMIITEYMENGALD 97
Query: 241 DRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDF 300
+ + G++S ++ I + + + VHRDL N L N K DF
Sbjct: 98 KFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDF 154
Query: 301 GLSDYVKPDER----LNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYILLC-GSRPF 354
GLS ++ D + + APE + +R + + +D+WS G++ + ++ G RP+
Sbjct: 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY 214
Query: 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408
W + + +A+ + F + + ++ +R A +S
Sbjct: 215 WELSNHEVMKAI---NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-40
Identities = 61/342 (17%), Positives = 115/342 (33%), Gaps = 87/342 (25%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
L E +G+G FG + +G +G++VAVK+
Sbjct: 5 IVLQESIGKGRFG-----EVWRGKWRGEEVAVKIFSSR---------------------- 37
Query: 183 EYCCLFMTTAIAIEDVRREVKILR-ALTGHKNLVQFYDAYEDDDN----IYIVMELCKGG 237
RE +I + + H+N++ F A D+ +++V + + G
Sbjct: 38 -----------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG 86
Query: 238 ELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ--------GVVHRDLKPENFLFTSK 289
L D + + E + + S +A H + + HRDLK +N L
Sbjct: 87 SLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK-- 142
Query: 290 EENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVL-------HRSYGTEADM 337
+N + D GL+ N VG+ Y+APEVL H AD+
Sbjct: 143 -KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 201
Query: 338 WSIGVIAYILLCGSRPFWARTESG---------------IFRAVL--KADPSFDEAPWPS 380
+++G++ + + + + + V K P+
Sbjct: 202 YAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSC 261
Query: 381 LSPEAI-DFVKRLLNKDYRKRLTAAQALSH-PWLANSHDVKI 420
+ + ++ + RLTA + L+ +K+
Sbjct: 262 EALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM 303
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 8e-40
Identities = 47/304 (15%), Positives = 103/304 (33%), Gaps = 52/304 (17%)
Query: 122 HYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
+ E+G+G FG Y AK VA+K + +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA------------------- 61
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239
+ + E +++ ++V+ ++MEL G+L
Sbjct: 62 ----------ASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQGQPTLVIMELMTRGDL 110
Query: 240 LDRILSRGG---------KYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKE 290
+ S S + +I +A+ + VHRDL N +
Sbjct: 111 KSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA--- 167
Query: 291 ENSSLKAIDFGLSDYVKPDERL---NDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAYI 346
E+ ++K DFG++ + + + +++PE L + T +D+WS GV+ +
Sbjct: 168 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 227
Query: 347 LLCGSR-PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQ 405
+ + P+ + + R V++ + + ++ + + R + +
Sbjct: 228 IATLAEQPYQGLSNEQVLRFVMEGGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLE 284
Query: 406 ALSH 409
+S
Sbjct: 285 IISS 288
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 1e-38
Identities = 64/311 (20%), Positives = 113/311 (36%), Gaps = 57/311 (18%)
Query: 122 HYELGEEVGRGHFG--YTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFT 179
+LG+ +GRG FG A + + VAVK++ +
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG------------------- 54
Query: 180 ILDEYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDA-YEDDDNIYIVMELCKGGE 238
T + E+KIL + H N+V A + + +++E CK G
Sbjct: 55 ----------ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGN 104
Query: 239 LLDRILSRGGKY---------------SEEDAKIVMVQILSVVAFCHFQGVVHRDLKPEN 283
L + S+ ++ + E Q+ + F + +HRDL N
Sbjct: 105 LSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 164
Query: 284 FLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVL-HRSYGTEADMWS 339
L + E + +K DFGL+ + D R D ++APE + R Y ++D+WS
Sbjct: 165 ILLS---EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWS 221
Query: 340 IGVIAYILLCGSR-PFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYR 398
GV+ + + P+ F LK +PE + + +
Sbjct: 222 FGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--APDYTTPEMYQTMLDCWHGEPS 279
Query: 399 KRLTAAQALSH 409
+R T ++ + H
Sbjct: 280 QRPTFSELVEH 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 130 bits (327), Expect = 2e-34
Identities = 66/358 (18%), Positives = 116/358 (32%), Gaps = 95/358 (26%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
Y L ++G GHF AK VA+K++
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVN---NTHVAMKIVRG----------------------- 48
Query: 183 EYCCLFMTTAIAIEDVRREVKILRAL----------TGHKNLVQ----FYDAYEDDDNIY 228
+ E E+K+L+ + G ++++ F + ++
Sbjct: 49 --------DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVV 100
Query: 229 IVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ-GVVHRDLKPENFLFT 287
+V E+ L K + Q+L + + H + G++H D+KPEN L
Sbjct: 101 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160
Query: 288 SKEENSSLKAI-DFGLSDYVKPDERLNDIVGSAYYVAPEVL-HRSYGTEADMWSIGVIAY 345
+ +L I L + DE + + + Y +PEVL +G AD+WS + +
Sbjct: 161 IVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 220
Query: 346 ILLCGSRPFWARTESGIF---------------------------------RAVLKADPS 372
L+ G F R +L+
Sbjct: 221 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK 280
Query: 373 FDEAPW-----------PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVK 419
P + E DF+ +L D RKR A ++HPWL ++ ++
Sbjct: 281 LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 87.5 bits (216), Expect = 1e-20
Identities = 46/226 (20%), Positives = 77/226 (34%), Gaps = 38/226 (16%)
Query: 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILD 182
+G+ +G G + ++K + VK + + F+
Sbjct: 2 DAIGKLMGEGKESAVFNCYSEKF----GECVVKFHKVGHTSFKKVKEKRDYGDLHFS--- 54
Query: 183 EYCCLFMTTAIAIEDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242
+AI R E + L+ L + + Y + ++MEL
Sbjct: 55 ---------VLAIRSARNEFRALQKL-QGLAVPKVYAWEGN----AVLMELIDAK----- 95
Query: 243 ILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGL 302
+ E+ V+ IL VA + +G+VH DL N L + + IDF
Sbjct: 96 ---ELYRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS----EEGIWIIDFPQ 148
Query: 303 SDYVKPD-ERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYIL 347
S V+ E +I+ R+Y TE D+ S I IL
Sbjct: 149 S--VEVGEEGWREILERDVRNIITYFSRTYRTEKDINS--AIDRIL 190
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Score = 38.8 bits (89), Expect = 0.001
Identities = 17/153 (11%), Positives = 41/153 (26%), Gaps = 1/153 (0%)
Query: 196 EDVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDA 255
DV RE ++ L G + + D ++M G + +
Sbjct: 54 YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDEQSPEKIIEL 113
Query: 256 KIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDI 315
+++ + D + + + + + ++ K L D
Sbjct: 114 YAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDF 173
Query: 316 VGSAYYVAPEVL-HRSYGTEADMWSIGVIAYIL 347
+ + V H G G ++ +
Sbjct: 174 LKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFI 206
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 482 | |||
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.6 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.04 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.98 | |
| d2hf5a1 | 33 | Troponin C {Human (Homo sapiens), cardiac isoform | 97.34 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.19 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 97.02 | |
| d1ctda_ | 34 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 96.97 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.9 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 96.77 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 96.5 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 96.42 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 96.31 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 96.19 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.4 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 95.38 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 95.31 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 95.15 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 94.97 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 94.47 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 94.45 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 94.44 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 94.4 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 94.07 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 93.9 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 93.69 | |
| d1tiza_ | 67 | Calmodulin-related protein T21P5.17 {Thale cress ( | 93.6 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 93.55 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 93.44 | |
| d1k94a_ | 165 | Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | 93.28 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 92.98 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 92.9 | |
| d1snla_ | 99 | Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [Tax | 92.69 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 92.42 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 92.23 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 92.09 | |
| d3c1va1 | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a4 [Ta | 91.81 | |
| d1s6ja_ | 87 | Calcium-dependent protein kinase sk5 CLD {Soybean | 91.73 | |
| d1fw4a_ | 65 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 91.43 | |
| d2fcea1 | 61 | Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | 91.41 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 91.4 | |
| d1e8aa_ | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 91.4 | |
| d1fi5a_ | 81 | Troponin C {Chicken (Gallus gallus), cardiac isofo | 90.68 | |
| d1c7va_ | 68 | Calcium vector protein {Amphioxus (Branchiostoma l | 90.54 | |
| d1ksoa_ | 93 | Calcyclin (S100) {Human (Homo sapiens), s100a3 [Ta | 90.46 | |
| d1c07a_ | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 90.41 | |
| d1oqpa_ | 77 | Caltractin (centrin 2) {Green algae (Chlamydomonas | 90.27 | |
| d2opoa1 | 81 | Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta | 90.2 | |
| d1jc2a_ | 75 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 89.93 | |
| d3cr5x1 | 90 | Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: | 89.86 | |
| d1xk4c1 | 83 | Calcyclin (S100) {Human (Homo sapiens), s100a9 (mr | 89.86 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 89.7 | |
| d1wrka1 | 82 | Troponin C {Human (Homo sapiens), cardiac isoform | 89.66 | |
| d1jfja_ | 134 | EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: | 89.57 | |
| d1xk4a1 | 87 | Calcyclin (S100) {Human (Homo sapiens), calgranuli | 89.34 | |
| d1f54a_ | 77 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 89.15 | |
| d2pq3a1 | 73 | Calmodulin {Rattus norvegicus [TaxId: 10116]} | 89.14 | |
| d1fi6a_ | 92 | Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | 88.97 | |
| d2mysc_ | 145 | Myosin Regulatory Chain {Chicken (Gallus gallus) [ | 88.93 | |
| d1avsa_ | 81 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 88.67 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 88.62 | |
| d1qxpa2 | 188 | Calpain large subunit, C-terminal domain (domain I | 88.6 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 88.55 | |
| d1wdcb_ | 142 | Myosin Essential Chain {Bay scallop (Aequipecten i | 88.53 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 88.33 | |
| d1lkja_ | 146 | Calmodulin {Baker's yeast (Saccharomyces cerevisia | 88.31 | |
| d2obha1 | 141 | Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | 88.31 | |
| d1qjta_ | 99 | Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | 88.19 | |
| d1rroa_ | 108 | Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116 | 87.71 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 87.62 | |
| d1pvaa_ | 109 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 87.54 | |
| d1j55a_ | 94 | Calcyclin (S100) {Human (Homo sapiens), s100p [Tax | 87.42 | |
| d1ggwa_ | 140 | Cdc4p {Fission yeast (Schizosaccharomyces pombe) [ | 87.42 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 87.38 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 87.35 | |
| d1a4pa_ | 92 | Calcyclin (S100) {Human (Homo sapiens), P11 s100a1 | 87.18 | |
| d1ij5a_ | 321 | Cbp40 (plasmodial specific CaII-binding protein LA | 87.12 | |
| d1qlsa_ | 95 | Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s1 | 87.03 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 87.01 | |
| d1wlza1 | 83 | DJ-1-binding protein, DJBP {Human (Homo sapiens) [ | 86.9 | |
| d1rwya_ | 109 | Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | 86.73 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 86.55 | |
| d1bjfa_ | 181 | Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | 86.36 | |
| d2pvba_ | 107 | Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | 86.33 | |
| d1s6ca_ | 178 | Kchip1, Kv4 potassium channel-interacting protein | 86.04 | |
| d1w7jb1 | 139 | Myosin Essential Chain {Human (Homo sapiens) [TaxI | 86.04 | |
| d1cb1a_ | 78 | Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | 86.0 | |
| d2zfda1 | 183 | Calcineurin B-like protein 2 {Thale cress (Arabido | 85.9 | |
| d2jxca1 | 95 | Eps15 {Human (Homo sapiens) [TaxId: 9606]} | 85.74 | |
| d1k8ua_ | 89 | Calcyclin (S100) {Human (Homo sapiens), s100a6 [Ta | 85.73 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 85.45 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 85.37 | |
| d1wdcc_ | 152 | Myosin Regulatory Chain {Bay scallop (Aequipecten | 85.32 | |
| d1g8ia_ | 187 | Frequenin (neuronal calcium sensor 1) {Human (Homo | 85.29 | |
| d1zfsa1 | 93 | Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 | 85.23 | |
| d5pala_ | 109 | Parvalbumin {Leopard shark (Triakis semifasciata) | 85.18 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 84.89 | |
| d1df0a1 | 186 | Calpain large subunit, C-terminal domain (domain I | 84.82 | |
| d1auib_ | 165 | Calcineurin regulatory subunit (B-chain) {Human (H | 84.79 | |
| d2sasa_ | 185 | Sarcoplasmic calcium-binding protein {Amphioxus (B | 84.41 | |
| d1qv0a_ | 189 | Calcium-regulated photoprotein {Hydrozoa (Obelia l | 84.4 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 84.3 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 84.02 | |
| d1topa_ | 162 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 83.96 | |
| d1exra_ | 146 | Calmodulin {Ciliate (Paramecium tetraurelia) [TaxI | 83.95 | |
| d1qx2a_ | 76 | Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | 83.94 | |
| d1xo5a_ | 180 | Calcium- and integrin-binding protein, CIB {Human | 83.68 | |
| d1nyaa_ | 176 | Calerythrin {Saccharopolyspora erythraea [TaxId: 1 | 83.57 | |
| d1jbaa_ | 189 | Guanylate cyclase activating protein 2, GCAP-2 {Co | 83.53 | |
| d1uhka1 | 187 | Calcium-regulated photoprotein {Jellyfish (Aequore | 83.53 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 83.52 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 82.99 | |
| d1psra_ | 100 | Calcyclin (S100) {Human (Homo sapiens), psoriasin | 82.93 | |
| d1yuta1 | 98 | Calcyclin (S100) {Human (Homo sapiens), s100a13 [T | 82.65 | |
| d1iq3a_ | 110 | Pob1 {Human (Homo sapiens) [TaxId: 9606]} | 82.54 | |
| d2scpa_ | 174 | Sarcoplasmic calcium-binding protein {Sandworm (Ne | 82.48 | |
| d1m45a_ | 146 | Myosin Light Chain Mlc1p {Baker's yeast (Saccharom | 82.29 | |
| d1omra_ | 201 | Recoverin {Cow (Bos taurus) [TaxId: 9913]} | 82.23 | |
| d1alva_ | 173 | Calpain small (regulatory) subunit (domain VI) {Pi | 82.01 | |
| d1fpwa_ | 190 | Frequenin (neuronal calcium sensor 1) {Baker's yea | 80.21 | |
| d1dtla_ | 156 | Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | 80.2 |
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-64 Score=497.99 Aligned_cols=291 Identities=38% Similarity=0.677 Sum_probs=238.1
Q ss_pred cccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 117 KQFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 117 ~~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
+.+.+.|++++.||+|+||+||+|+++. +|+.||||++.+.. ......
T Consensus 5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~-----------------------------~~~~~~ 52 (307)
T d1a06a_ 5 EDIRDIYDFRDVLGTGAFSEVILAEDKR---TQKLVAIKCIAKKA-----------------------------LEGKEG 52 (307)
T ss_dssp SCGGGTEEEEEESBSGGGGGEEEEEETT---TCCEEEEEEEEC-------------------------------------
T ss_pred CCCccceEEEEEEeeccCeEEEEEEECC---CCCEEEEEEEchHH-----------------------------hhhHHH
Confidence 4567889999999999999999999886 79999999997641 111234
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+.+|++++ |||||++++++.+++.+|||||||+||+|.+++.. .+.+++.++..++.||+.||.|||++||||
T Consensus 53 ~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiH 130 (307)
T d1a06a_ 53 SMENEIAVLHKIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVH 130 (307)
T ss_dssp --CHHHHHHHTCC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeee
Confidence 6789999999996 99999999999999999999999999999998865 468999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||||+|||+...++++.+||+|||+|+.........+.+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.
T Consensus 131 rDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 210 (307)
T d1a06a_ 131 RDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY 210 (307)
T ss_dssp SCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred EEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCC
Confidence 99999999998666788999999999998776666777899999999999875 59999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCCCccHHHHHHHHHHhc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYIS 435 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (482)
+....++...+......++...++.+|+++++||.+||+.||.+|||++|+|+||||++...........+.+.+++...
T Consensus 211 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (307)
T d1a06a_ 211 DENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFA 290 (307)
T ss_dssp CSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSCCCCCCCHHHHHHHHHHHSC
T ss_pred CCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCccccccchhHHHHHHHHHH
Confidence 99999999999999988888888899999999999999999999999999999999987655444455555566676666
Q ss_pred cchHHH
Q 011582 436 SSSLRK 441 (482)
Q Consensus 436 ~~~l~~ 441 (482)
.+.+++
T Consensus 291 ~~~~~~ 296 (307)
T d1a06a_ 291 KSKWKQ 296 (307)
T ss_dssp CCTTTS
T ss_pred Hhhhhh
Confidence 655543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-62 Score=473.76 Aligned_cols=256 Identities=29% Similarity=0.577 Sum_probs=229.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||+||+|+++. +|+.||||++.+.. .......+.+.
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~---~~~~vAiK~i~~~~---------------------------~~~~~~~~~~~ 54 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQ---SKFILALKVLFKAQ---------------------------LEKAGVEHQLR 54 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHHH
T ss_pred hhHeEEEEEEecCCCcEEEEEEECC---CCcEEEEEEEchHH---------------------------ccChHHHHHHH
Confidence 4689999999999999999999987 79999999997631 11223356788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|++++ |||||++++++.+++.+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||
T Consensus 55 ~E~~il~~l~-hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDi 132 (263)
T d2j4za1 55 REVEIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALSYCHSKRVIHRDI 132 (263)
T ss_dssp HHHHHHHTCC-CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHHHHhcC-CCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeee
Confidence 9999999996 999999999999999999999999999999988655 67999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
||+|||+ +.++.+||+|||+|..... ......+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+.+
T Consensus 133 Kp~Nill---~~~~~~kl~DFG~a~~~~~-~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 208 (263)
T d2j4za1 133 KPENLLL---GSAGELKIADFGWSVHAPS-SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANT 208 (263)
T ss_dssp CGGGEEE---CTTSCEEECCCCSCSCCCC-CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred cccccee---cCCCCEeecccceeeecCC-CcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCC
Confidence 9999999 5678899999999987653 34456789999999999976 58999999999999999999999999999
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
..+++..+......++. .+|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus 209 ~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 209 YQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp HHHHHHHHHTTCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred HHHHHHHHHcCCCCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 99999999888766543 489999999999999999999999999999999754
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4e-62 Score=488.83 Aligned_cols=265 Identities=35% Similarity=0.638 Sum_probs=241.5
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||.||+|+++. +|+.||||++.+. .....+.
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~---~g~~vAvK~i~~~------------------------------~~~~~~~ 69 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERA---TGNNFAAKFVMTP------------------------------HESDKET 69 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETT---TTEEEEEEEECCC------------------------------SHHHHHH
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEccc------------------------------chhhHHH
Confidence 356789999999999999999999987 8999999998653 2234567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+|++|+ |||||++++++.+++.+|||||||+||+|.+++.+..+.+++..++.|+.||+.||.|||++|||||
T Consensus 70 ~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHr 148 (350)
T d1koaa2 70 VRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHL 148 (350)
T ss_dssp HHHHHHHHHHTC-CTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeee
Confidence 899999999997 9999999999999999999999999999999987666789999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||||+|||+.. +.++.+||+|||+|+.+.........+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+
T Consensus 149 DiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 227 (350)
T d1koaa2 149 DLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGG 227 (350)
T ss_dssp CCCGGGEEESS-TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred eechhHeeecc-CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCC
Confidence 99999999964 2357899999999998877777778899999999999875 589999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
.+..+++..|......++...++.+|+++++||.+||+.||++|||++|+|+||||+....
T Consensus 228 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 228 ENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp SSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred CCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 9999999999999888887777889999999999999999999999999999999987643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-62 Score=474.65 Aligned_cols=259 Identities=30% Similarity=0.546 Sum_probs=219.1
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||.||+|+++. +|+.||||++.+. ......+.+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~-----------------------------~~~~~~~~~ 50 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRV---TEEAVAVKIVDMK-----------------------------RAVDCPENI 50 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC------------------------------------CH
T ss_pred CCcceEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehh-----------------------------hcchHHHHH
Confidence 35789999999999999999999987 7999999999753 111223568
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+|++++ |||||++++++.+++.+|||||||+||+|.+++. ..+.+++.+++.++.||+.||.|||++||||||
T Consensus 51 ~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~-~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrD 128 (271)
T d1nvra_ 51 KKEICINKMLN-HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 128 (271)
T ss_dssp HHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSB-TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHhCC-CCCEeeEeeeeccCceeEEEEeccCCCcHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCc
Confidence 89999999997 9999999999999999999999999999999874 446899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc-c-CCCcchhhhhHHHHHHHhhCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR-S-YGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlGvil~elltg~~p 353 (482)
|||+|||+ +.++.+||+|||+|+...... .....+||+.|||||++.+ . ++.++|||||||++|+|+||+.|
T Consensus 129 iKp~NILl---~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~p 205 (271)
T d1nvra_ 129 IKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 205 (271)
T ss_dssp CCGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccHHHEEE---CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCC
Confidence 99999999 567789999999998764332 3456789999999999865 4 46789999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
|.................. ....+..+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus 206 f~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 206 WDQPSDSCQEYSDWKEKKT-YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp CSSSSTTSHHHHHHHTTCT-TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCCCChHHHHHHHHhcCCC-CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 9876654433333333322 234467799999999999999999999999999999999854
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-61 Score=485.58 Aligned_cols=263 Identities=38% Similarity=0.629 Sum_probs=240.9
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||.||+|+++. +|+.||||++++. .....+.+
T Consensus 27 ~~d~Y~i~~~lG~G~fg~V~~a~~~~---~~~~vAiK~i~~~------------------------------~~~~~~~~ 73 (352)
T d1koba_ 27 VYDYYDILEELGSGAFGVVHRCVEKA---TGRVFVAKFINTP------------------------------YPLDKYTV 73 (352)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECC------------------------------SHHHHHHH
T ss_pred cccceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECCc------------------------------chhHHHHH
Confidence 45789999999999999999999887 8999999999753 22334678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+|++|. |||||+++++|.+++.+|||||||+||+|.+++...+..+++.+++.|+.||+.||.|||++||||||
T Consensus 74 ~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRD 152 (352)
T d1koba_ 74 KNEISIMNQLH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 152 (352)
T ss_dssp HHHHHHHTTCC-STTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred HHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 89999999996 99999999999999999999999999999998877667899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|||+|||++. ..++.+||+|||+|..+.........+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.
T Consensus 153 iKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~ 231 (352)
T d1koba_ 153 IKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE 231 (352)
T ss_dssp CCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred cccccccccc-cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence 9999999953 2467899999999999887777778899999999999875 5999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
+..+++..|......++...++.+|+++++||++||+.||.+|||++|+|+||||+...
T Consensus 232 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 232 DDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp SHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred CHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 99999999999998888888889999999999999999999999999999999998654
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-61 Score=470.54 Aligned_cols=257 Identities=32% Similarity=0.604 Sum_probs=225.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||+||+|+++. +|+.||||++.+.. .......+.+.+
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~---------------------------~~~~~~~~~~~~ 57 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELA---TSREYAIKILEKRH---------------------------IIKENKVPYVTR 57 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHHHH
T ss_pred CCCEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHH---------------------------ccCHHHHHHHHH
Confidence 679999999999999999999987 79999999997631 112233467899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|+++. |||||++++++.+++.+|||||||+||+|.+++... +.+++..++.++.|++.||.|||++||||||||
T Consensus 58 E~~il~~l~-HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiK 135 (288)
T d1uu3a_ 58 ERDVMSRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLK 135 (288)
T ss_dssp HHHHHHHCC-STTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHHHHHHcC-CCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCC
Confidence 999999996 999999999999999999999999999999987655 689999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC---CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD---ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|+|||+ +.++.+||+|||+|+.+... ......+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.+
T Consensus 136 p~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (288)
T d1uu3a_ 136 PENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212 (288)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred cccccc---CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCC
Confidence 999999 67788999999999876533 23456789999999999875 599999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHH------HhcCcccccCC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQ------ALSHPWLANSH 416 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e------~L~hp~~~~~~ 416 (482)
.+..+++.+|......++. .+++++++||++||+.||.+|||++| +++||||++..
T Consensus 213 ~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~ 274 (288)
T d1uu3a_ 213 GNEYLIFQKIIKLEYDFPE----KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 274 (288)
T ss_dssp SSHHHHHHHHHTTCCCCCT----TCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred cCHHHHHHHHHcCCCCCCc----cCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCC
Confidence 9999999999988776653 58999999999999999999999987 58899998754
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-61 Score=468.00 Aligned_cols=256 Identities=29% Similarity=0.496 Sum_probs=224.2
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.++||+|+||+||+|+++. +|+.||||++.+. .....+.+.
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~~~~~------------------------------~~~~~~~~~ 65 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVA---TGQEVAIRQMNLQ------------------------------QQPKKELII 65 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTT---TCCEEEEEEEEGG------------------------------GCSCHHHHH
T ss_pred ccccEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEecc------------------------------cChHHHHHH
Confidence 3579999999999999999999876 8999999998753 111235789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|++++ |||||+++++|.+++.+|||||||+||+|.+++.+ ..+++.+++.++.||+.||.|||++|||||||
T Consensus 66 ~E~~il~~l~-HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDi 142 (293)
T d1yhwa1 66 NEILVMRENK-NPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDI 142 (293)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHHHhCC-CCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Confidence 9999999997 99999999999999999999999999999987654 46999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||+ +.++.+||+|||+|+.+... ......+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.
T Consensus 143 Kp~NILl---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~ 219 (293)
T d1yhwa1 143 KSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNE 219 (293)
T ss_dssp SGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred cHHHeEE---CCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCC
Confidence 9999999 56788999999999887543 34566789999999999875 5899999999999999999999999998
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
+..+.+..+...... ....+..+|+++++||.+||+.||.+|||++|+|+||||+..
T Consensus 220 ~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~ 276 (293)
T d1yhwa1 220 NPLRALYLIATNGTP-ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (293)
T ss_dssp CHHHHHHHHHHHCSC-CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred CHHHHHHHHHhCCCC-CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 887777777665432 223345689999999999999999999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.1e-61 Score=469.21 Aligned_cols=269 Identities=35% Similarity=0.630 Sum_probs=238.1
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||+||+|+++. +|+.||||++++.... ........+.
T Consensus 7 ~i~d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~~AvK~i~~~~~~------------------------~~~~~~~~~~ 59 (293)
T d1jksa_ 7 NVDDYYDTGEELGSGQFAVVKKCREKS---TGLQYAAKFIKKRRTK------------------------SSRRGVSRED 59 (293)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEBCSST------------------------TCSSSBCHHH
T ss_pred CcccCEEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEEhhhcc------------------------hhhhhHHHHH
Confidence 356789999999999999999999976 8999999999764110 0011223567
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+|++++ |||||+++++|.+++.+|||||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||
T Consensus 60 ~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~yLH~~~ivHr 137 (293)
T d1jksa_ 60 IEREVSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVYYLHSLQIAHF 137 (293)
T ss_dssp HHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHHhhhhcceeec
Confidence 899999999996 999999999999999999999999999999988665 579999999999999999999999999999
Q ss_pred CCCCCceEEecCC-CCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKE-ENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~-~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+|||++.++ ....+||+|||+|............+||+.|||||++.+ .|+.++|||||||++|+|++|+.||.
T Consensus 138 DiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 217 (293)
T d1jksa_ 138 DLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL 217 (293)
T ss_dssp CCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred ccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCC
Confidence 9999999996432 233699999999998877777778899999999999875 59999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
+.+..+.+..+......++...++.+|+++++||++||+.||.+|||++|+|+||||+..
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 218 GDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp CSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred CCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999999988877766667899999999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-61 Score=469.58 Aligned_cols=257 Identities=30% Similarity=0.507 Sum_probs=226.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
+.|++++.||+|+||.||+|+++. +|+.||||++++. .....+.+.+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~------------------------------~~~~~~~~~~ 58 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKE---TSVLAAAKVIDTK------------------------------SEEELEDYMV 58 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECS------------------------------SSGGGGGTHH
T ss_pred cCeEEeEEEeeCCCcEEEEEEECC---CCeEEEEEEECcC------------------------------CHHHHHHHHH
Confidence 579999999999999999999987 8999999999753 1122356789
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|++++ |||||++++++.+++.+|||||||+||+|.+++.+..+.+++.+++.++.||+.||.|||++||||||||
T Consensus 59 E~~il~~l~-HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiK 137 (288)
T d2jfla1 59 EIDILASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLK 137 (288)
T ss_dssp HHHHHHHCC-CTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHHhCC-CCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecC
Confidence 999999997 9999999999999999999999999999999887777789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCccccc------ccCCCcchhhhhHHHHHHHhhCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLH------RSYGTEADMWSIGVIAYILLCGSRP 353 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~------~~~~~~~DiwSlGvil~elltg~~p 353 (482)
|+|||+ +.++.+||+|||+|...... ....+.+||+.|||||++. ..|+.++|||||||++|+|+||+.|
T Consensus 138 p~NIll---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~P 214 (288)
T d2jfla1 138 AGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPP 214 (288)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCT
T ss_pred hhheeE---CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCC
Confidence 999999 56788999999999765322 2345678999999999873 3489999999999999999999999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
|.+.+..+++..+........ .....+|+++++||++||+.||.+|||++|+|+||||+..
T Consensus 215 f~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 215 HHELNPMRVLLKIAKSEPPTL-AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp TTTSCGGGHHHHHHHSCCCCC-SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred CCCCCHHHHHHHHHcCCCCCC-CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999899888888764322 2235689999999999999999999999999999999754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-61 Score=475.55 Aligned_cols=262 Identities=30% Similarity=0.589 Sum_probs=238.8
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++++.||+|+||+||+|+++. +|+.||||++++. ......
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~---~~~~~AiK~i~~~-------------------------------~~~~~~ 47 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETS---SKKTYMAKFVKVK-------------------------------GTDQVL 47 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECCC-------------------------------THHHHH
T ss_pred CCccceEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEcCC-------------------------------cccHHH
Confidence 456899999999999999999999987 7999999999653 122346
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+.+|+.+|+.++ |||||+++++|++++.+|||||||+||+|.+++...+..+++.+++.|+.||+.||.|||++||+||
T Consensus 48 ~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHr 126 (321)
T d1tkia_ 48 VKKEISILNIAR-HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHF 126 (321)
T ss_dssp HHHHHHHHHHSC-CTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcc
Confidence 789999999997 9999999999999999999999999999999987666689999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||||+|||++. ++...+||+|||+++...........+||+.|+|||.+.+ .|+.++|||||||++|+|++|..||.+
T Consensus 127 DlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~ 205 (321)
T d1tkia_ 127 DIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205 (321)
T ss_dssp CCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred cccccceeecC-CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCC
Confidence 99999999954 2456899999999998876666777889999999998865 589999999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.+..+++..|......++...|+.+|+++++||++||+.||.+|||++|+|+||||++.
T Consensus 206 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 206 ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp SSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred CCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 99999999999999888887788899999999999999999999999999999999764
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.1e-60 Score=459.51 Aligned_cols=269 Identities=36% Similarity=0.632 Sum_probs=238.9
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
|.++|++++.||+|+||+||+|+++. +|+.||||++++.... ... ........+.+
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~---~~~~~AvK~i~~~~~~-----------~~~----------~~~~~~~~~~~ 56 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKP---TCKEYAVKIIDVTGGG-----------SFS----------AEEVQELREAT 56 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEEETTCST-----------TCC----------HHHHHHHHHHH
T ss_pred CcccCEEceEEecCcCeEEEEEEECC---CCCEEEEEEEeccccc-----------chh----------HHHHHHHHHHH
Confidence 35789999999999999999999876 7999999999764100 000 00112345678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+.+|+++..||||+++++++.+++.+|||||||+||+|.++|..+ +.+++.+++.++.||+.||+|||++||||||
T Consensus 57 ~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~~lH~~~ivHrD 135 (277)
T d1phka_ 57 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVICALHKLNIVHRD 135 (277)
T ss_dssp HHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCcccc
Confidence 899999999977999999999999999999999999999999998765 6899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-------ccCCCcchhhhhHHHHHHHhhCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-------RSYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~DiwSlGvil~elltg~ 351 (482)
|||+|||+ +.++.+||+|||+++...........+||+.|+|||++. ..++.++||||+||++|+|++|+
T Consensus 136 lkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~ 212 (277)
T d1phka_ 136 LKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212 (277)
T ss_dssp CSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred cccceEEE---cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCC
Confidence 99999999 678889999999999887766677789999999999874 23788999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
.||.+.+..+....+......++...+..+|+++++||++||+.||++|||++|+|+||||++.
T Consensus 213 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 213 PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp CSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred CCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 9999999999999999998888777788899999999999999999999999999999999863
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-60 Score=471.16 Aligned_cols=257 Identities=29% Similarity=0.559 Sum_probs=231.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+++. +|+.||||++++.. .......+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~---~~~~~AiK~i~k~~---------------------------~~~~~~~~~~~ 53 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKA---TGRYYAMKILRKEV---------------------------IIAKDEVAHTV 53 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHHH
T ss_pred hHhcEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEchhh---------------------------ccCHHHHHHHH
Confidence 4689999999999999999999987 89999999998641 11222356788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|+++. ||||++++++|++++.+|+|||||+||+|.+++... +.+++..++.++.||+.||.|||++|||||||
T Consensus 54 ~E~~il~~l~-hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~-~~~~e~~~~~~~~qil~al~ylH~~~iiHRDl 131 (337)
T d1o6la_ 54 TESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131 (337)
T ss_dssp HHHHHHHSCC-CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HHHHHHHhCC-CCCEEEEEeeeccccccccceeccCCCchhhhhhcc-cCCcHHHHHHHHHHHhhhhhhhhhcCcccccc
Confidence 9999999997 999999999999999999999999999999988655 68999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCC-CCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKP-DERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
||+|||+ +.++.+||+|||+|+.... .......+||+.|||||++.+ .|+.++|||||||++|||++|++||.+.
T Consensus 132 KP~NILl---~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~ 208 (337)
T d1o6la_ 132 KLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208 (337)
T ss_dssp CGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred CHHHeEe---cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc
Confidence 9999999 6778999999999987644 345667899999999999875 6999999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 358 TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
+..+++..+......++. .+|+++++||++||++||.+|++ ++|+++||||++.
T Consensus 209 ~~~~~~~~i~~~~~~~p~----~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 209 DHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp SHHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CHHHHHHHHhcCCCCCCc----cCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 999999999998876653 58999999999999999999994 9999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-60 Score=456.29 Aligned_cols=253 Identities=23% Similarity=0.369 Sum_probs=217.1
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|++.++||+|+||+||+|+++. +|+.||||++.+. .......+.+.+|+
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~---~~~~va~K~i~~~----------------------------~~~~~~~~~~~~E~ 59 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTE---TTVEVAWCELQDR----------------------------KLTKSERQRFKEEA 59 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETT---TCCEEEEEEEEGG----------------------------GSCHHHHHHHHHHH
T ss_pred EEeeeEEecCcCcEEEEEEECC---CCeEEEEEEEchh----------------------------hCCHHHHHHHHHHH
Confidence 4788899999999999999976 7999999998753 12344567899999
Q ss_pred HHHHhhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--Ccc
Q 011582 203 KILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG--VVH 276 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~--ivH 276 (482)
++|++++ |||||+++++|++ +..+|||||||+||+|.+++.+. ..+++..++.++.||+.||.|||++| |||
T Consensus 60 ~il~~l~-HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiH 137 (270)
T d1t4ha_ 60 EMLKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIH 137 (270)
T ss_dssp HHHTTCC-CTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCC
T ss_pred HHHHhCC-CCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHHHHHCCCCEEe
Confidence 9999997 9999999999976 45689999999999999988654 68999999999999999999999999 999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccccCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHRSYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
|||||+|||++ ++++.+||+|||+|+... .......+||+.|||||++.+.|+.++|||||||++|+|++|+.||.+
T Consensus 138 rDiKp~NILl~--~~~~~~Kl~DFGla~~~~-~~~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~ 214 (270)
T d1t4ha_ 138 RDLKCDNIFIT--GPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSE 214 (270)
T ss_dssp SCCCGGGEEES--STTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCcChhhceee--CCCCCEEEeecCcceecc-CCccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCC
Confidence 99999999995 346789999999998654 334567799999999999998999999999999999999999999976
Q ss_pred CC-hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 357 RT-ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 357 ~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
.. ..++.+.+..... +......+++++++||.+||+.||++|||++|+|+||||+
T Consensus 215 ~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 215 CQNAAQIYRRVTSGVK--PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred cccHHHHHHHHHcCCC--CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 54 4455555554432 2222345899999999999999999999999999999995
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-60 Score=457.94 Aligned_cols=255 Identities=30% Similarity=0.490 Sum_probs=213.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||.||+|+++. +|+.||||++.+. .......+.+.
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~----------------------------~~~~~~~~~~~ 51 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKS---DGKILVWKELDYG----------------------------SMTEAEKQMLV 51 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TCCEEEEEEECCT----------------------------TSCHHHHHHHH
T ss_pred chhCEEeEEEecCCCeEEEEEEECC---CCCEEEEEEEChh----------------------------hCCHHHHHHHH
Confidence 3689999999999999999999987 8999999999763 12344567899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC-
Q 011582 200 REVKILRALTGHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRILS---RGGKYSEEDAKIVMVQILSVVAFCHFQG- 273 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~yLH~~~- 273 (482)
+|+.+|+++. |||||++++++.+ ++.+|||||||+||+|.+++.+ .+..+++..++.++.||+.||.|||++|
T Consensus 52 ~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~ 130 (269)
T d2java1 52 SEVNLLRELK-HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130 (269)
T ss_dssp HHHHHTTSCC-CTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred HHHHHHHHCC-CCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence 9999999996 9999999999865 4668999999999999998864 3467999999999999999999999976
Q ss_pred ----CcccCCCCCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc-cCCCcchhhhhHHHHHHH
Q 011582 274 ----VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 274 ----ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el 347 (482)
||||||||+|||+ +.++.+||+|||+|+.+.... .....+||+.|||||++.+ .|+.++|||||||++|||
T Consensus 131 ~~~~IiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel 207 (269)
T d2java1 131 GGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 207 (269)
T ss_dssp ---------CCGGGEEE---CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCCCEEeCcCchhhcCc---CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHH
Confidence 9999999999999 567889999999998876543 3456789999999999875 699999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 348 LCGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 348 ltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
+||+.||.+.+..++...|....... ....+|+++++||++||+.||.+|||++|+|+|||+
T Consensus 208 ~tg~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 208 CALMPPFTAFSQKELAGKIREGKFRR---IPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred hhCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 99999999999999999988876432 224689999999999999999999999999999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.2e-60 Score=464.72 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=225.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
...|+++++||+|+||.||+|+++. +|+.||||++++. ........+.+.
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~---------------------------~~~~~~~~~~~~ 63 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVR---NSEVVAIKKMSYS---------------------------GKQSNEKWQDII 63 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEECC---------------------------SSCHHHHHHHHH
T ss_pred HHhcEeeEEEecCCCeEEEEEEECC---CCcEEEEEEEchh---------------------------hccCHHHHHHHH
Confidence 4569999999999999999999887 7999999999764 112344567899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|++|+ |||||++++++.+++.+|||||||.||+|..++ ...+.+++.+++.++.||+.||.|||++|||||||
T Consensus 64 ~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~-~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDi 141 (309)
T d1u5ra_ 64 KEVRFLQKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE-VHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDV 141 (309)
T ss_dssp HHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCSEEHHHHHH-HHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCC
T ss_pred HHHHHHHHCC-CCCEeeEEEEEEECCEEEEEEEecCCCchHHHH-HhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCC
Confidence 9999999997 999999999999999999999999998876554 44478999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc----ccCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH----RSYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||+|||+ +.++.+||+|||+|..... ....+||+.|||||++. +.|+.++|||||||++|||++|..||.
T Consensus 142 Kp~NILl---~~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~ 215 (309)
T d1u5ra_ 142 KAGNILL---SEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215 (309)
T ss_dssp SGGGEEE---ETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT
T ss_pred CcceEEE---CCCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC
Confidence 9999999 5678899999999987543 34568999999999884 358999999999999999999999999
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
+.+..+.+..+........ ....+|+++++||.+||+.||.+|||++|+|+||||....
T Consensus 216 ~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 216 NMNAMSALYHIAQNESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp TSCHHHHHHHHHHSCCCCC--SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCHHHHHHHHHhCCCCCC--CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 9988888888877654332 2346899999999999999999999999999999998643
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-60 Score=471.96 Aligned_cols=262 Identities=33% Similarity=0.601 Sum_probs=224.5
Q ss_pred ccccceEecc-eeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 118 QFVAHYELGE-EVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 118 ~~~~~y~~~~-~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
.+.++|++.+ .||+|+||+||+|+++. +|+.||||++++. .
T Consensus 8 ~i~~~y~i~~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~-----------------------------------~ 49 (335)
T d2ozaa1 8 AIIDDYKVTSQVLGLGINGKVLQIFNKR---TQEKFALKMLQDC-----------------------------------P 49 (335)
T ss_dssp CGGGTEEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEECS-----------------------------------H
T ss_pred CcccCEEEeeEEeeeccCeEEEEEEECC---CCCEEEEEEECCc-----------------------------------H
Confidence 4567899875 59999999999999977 8999999999653 3
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEe----CCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYED----DDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
.+.+|+.++.++.+|||||+++++|++ +..+|||||||+||+|.++|.+++ ..|++.+++.|+.||+.||.|||+
T Consensus 50 ~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~ 129 (335)
T d2ozaa1 50 KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129 (335)
T ss_dssp HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 567899998777569999999999976 467999999999999999997653 469999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhC
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg 350 (482)
+||+||||||+|||++..+..+.+||+|||+|+...........+||+.|||||++.+ .|+.++|||||||++|+|+||
T Consensus 130 ~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg 209 (335)
T d2ozaa1 130 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 209 (335)
T ss_dssp TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTS
T ss_pred cCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhC
Confidence 9999999999999998666678899999999998877777778899999999999875 599999999999999999999
Q ss_pred CCCCCCCChHHHHHHH----HhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCC
Q 011582 351 SRPFWARTESGIFRAV----LKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHD 417 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~ 417 (482)
+.||.+.+..+....+ ......++...|..+|+++++||++||+.||.+|||+.|+|+||||.+...
T Consensus 210 ~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~ 280 (335)
T d2ozaa1 210 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280 (335)
T ss_dssp SCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTS
T ss_pred CCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCC
Confidence 9999877655544433 334445555555679999999999999999999999999999999976543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-59 Score=462.46 Aligned_cols=255 Identities=27% Similarity=0.599 Sum_probs=228.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||+||+|+++. +|+.||||++++.. .......+.+.
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~---~g~~vAvK~i~~~~---------------------------~~~~~~~~~~~ 52 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRH---NGRYYAMKVLKKEI---------------------------VVRLKQVEHTN 52 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHHH
T ss_pred hhHeEEEEEEecCcCcEEEEEEECC---CCCEEEEEEEchHH---------------------------ccCHHHHHHHH
Confidence 3689999999999999999999987 89999999997641 11222356789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|+.++ |||||++++++.+++.+|+|||||+||+|..++.. ...+++..++.++.||+.||.|||++|||||||
T Consensus 53 ~E~~il~~l~-HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDi 130 (316)
T d1fota_ 53 DERLMLSIVT-HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDL 130 (316)
T ss_dssp HHHHHHHSCC-BTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCC
T ss_pred HHHHHHHhcc-CcChhheeeeEeeCCeeeeEeeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEcccc
Confidence 9999999996 99999999999999999999999999998887754 468999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
||+|||+ +.++.+||+|||+|+.... ...+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.+
T Consensus 131 Kp~NILl---~~~g~vkL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~ 205 (316)
T d1fota_ 131 KPENILL---DKNGHIKITDFGFAKYVPD--VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSN 205 (316)
T ss_dssp CGGGEEE---CTTSCEEECCCSSCEECSS--CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred CchheeE---cCCCCEEEecCccceEecc--ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcC
Confidence 9999999 6778999999999988653 3456799999999999976 59999999999999999999999999999
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
..+++..+......++ +.+|++++++|.+||+.||.+|+ |++++|+||||++.
T Consensus 206 ~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 206 TMKTYEKILNAELRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp HHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred HHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence 9999999999876654 35899999999999999999996 99999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-60 Score=468.01 Aligned_cols=258 Identities=26% Similarity=0.391 Sum_probs=215.5
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
..++|++++.||+|+||+||+|+++. +|+.||||++++. ......+.+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~---~~~~vAiK~i~~~-----------------------------~~~~~~~~~ 51 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKP---SGLVMARKLIHLE-----------------------------IKPAIRNQI 51 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETT---TTEEEEEEEEECC-----------------------------CCTTHHHHH
T ss_pred CccCCEEEEEEecCCCeEEEEEEECC---CCcEEEEEEEChh-----------------------------hCHHHHHHH
Confidence 35789999999999999999999976 8999999999753 122345678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH-CCCccc
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF-QGVVHR 277 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~-~~ivHr 277 (482)
.+|+.+|++++ |||||+++++|.+++.+|||||||+||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||
T Consensus 52 ~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~aL~yLH~~~~IiHR 129 (322)
T d1s9ja_ 52 IRELQVLHECN-SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTYLREKHKIMHR 129 (322)
T ss_dssp HHHGGGGGGCC-CTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCS
T ss_pred HHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcc
Confidence 99999999996 999999999999999999999999999999988655 679999999999999999999997 599999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||||+|||+ +.++.+||+|||+|+.... ....+.+||+.|||||++.+ .|+.++||||+||++|||++|+.||.+
T Consensus 130 DiKP~NILl---~~~~~vkl~DFGla~~~~~-~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~ 205 (322)
T d1s9ja_ 130 DVKPSNILV---NSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPP 205 (322)
T ss_dssp CCSGGGEEE---CTTCCEEECCCCCCHHHHH-HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSC
T ss_pred ccCHHHeeE---CCCCCEEEeeCCCccccCC-CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999 5678899999999987643 23456799999999999875 699999999999999999999999987
Q ss_pred CChHHHHHH------------------------------------------HHhcCCCCCCCCCCCCCHHHHHHHHHhch
Q 011582 357 RTESGIFRA------------------------------------------VLKADPSFDEAPWPSLSPEAIDFVKRLLN 394 (482)
Q Consensus 357 ~~~~~~~~~------------------------------------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 394 (482)
.+..+.... +.... .+......+|+++++||.+||+
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~ 283 (322)
T d1s9ja_ 206 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLI 283 (322)
T ss_dssp CCTTHHHHHC------------------------------CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTC
T ss_pred CCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcC
Confidence 654322110 01000 0111112368999999999999
Q ss_pred hccccCCCHHHHhcCcccccCC
Q 011582 395 KDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 395 ~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.||.+|||++|+|+||||++..
T Consensus 284 ~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 284 KNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp SSTTTSCCHHHHHTSHHHHHHH
T ss_pred CChhHCcCHHHHhhCHhhCcCC
Confidence 9999999999999999998654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-58 Score=463.29 Aligned_cols=254 Identities=29% Similarity=0.558 Sum_probs=228.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||.||+|+++. +|+.||||++.+.. .......+.+.+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~---~g~~~AvK~i~~~~---------------------------~~~~~~~~~~~~ 90 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKE---SGNHYAMKILDKQK---------------------------VVKLKQIEHTLN 90 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHTTCHHHHHH
T ss_pred cCeEEEEEeecCcCcEEEEEEECC---CCCEEEEEEEchHH---------------------------ccCHHHHHHHHH
Confidence 689999999999999999999987 89999999997631 112233467899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|+.+. |||||++++++.+.+.+|+||||+.||+|.+++... +.+++..++.++.||+.||.|||++||||||||
T Consensus 91 E~~il~~l~-hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIK 168 (350)
T d1rdqe_ 91 EKRILQAVN-FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168 (350)
T ss_dssp HHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHHHcC-CCcEeecccccccccccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCC
Confidence 999999996 999999999999999999999999999999988665 579999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCCh
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWARTE 359 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~~ 359 (482)
|+|||+ +.++.+||+|||+|+.+.. ...+.+||+.|||||++.+ .|+.++|||||||++|+|+||+.||.+.+.
T Consensus 169 P~NILl---~~~g~ikL~DFG~a~~~~~--~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 243 (350)
T d1rdqe_ 169 PENLLI---DQQGYIQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECSS--CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHccc---CCCCCEEeeeceeeeeccc--ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH
Confidence 999999 6678999999999998753 3456789999999999875 599999999999999999999999999999
Q ss_pred HHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 360 SGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 360 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
..++..|......++ ..+|+++.+||++||+.||.+|+ |++++|+||||++.
T Consensus 244 ~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 244 IQIYEKIVSGKVRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHHHHHHHHCCCCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHHHHHHhcCCCCCC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence 999999998876654 35899999999999999999995 99999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-58 Score=455.34 Aligned_cols=257 Identities=29% Similarity=0.500 Sum_probs=225.7
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||+||+|+++. +|+.||||++++.. .......+.+.+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~---t~~~vAvK~i~k~~---------------------------~~~~~~~~~~~~ 51 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKK---TNQFFAIKALKKDV---------------------------VLMDDDVECTMV 51 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEEHHH---------------------------HHHTTCHHHHHH
T ss_pred CCeEEeeEEecCCCcEEEEEEECC---CCCEEEEEEEchhh---------------------------ccChHHHHHHHH
Confidence 579999999999999999999987 89999999997641 112223456777
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.++.+..+|||||++++++.+++.+|||||||+||+|.+++... ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 52 e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~-~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDik 130 (320)
T d1xjda_ 52 EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLK 130 (320)
T ss_dssp HHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCC
T ss_pred HHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 8777764335999999999999999999999999999999988654 679999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGSRPFWART 358 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~~pf~~~~ 358 (482)
|+|||+ +.++.+||+|||+++..... ......+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+
T Consensus 131 p~NiL~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~ 207 (320)
T d1xjda_ 131 LDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQD 207 (320)
T ss_dssp GGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccceee---cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence 999999 67789999999999876543 34455789999999999875 69999999999999999999999999999
Q ss_pred hHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHH-HHhcCcccccC
Q 011582 359 ESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA-QALSHPWLANS 415 (482)
Q Consensus 359 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~-e~L~hp~~~~~ 415 (482)
..+++..+....+.++. .+|+++++||++||+.||.+|||+. ++++||||++.
T Consensus 208 ~~~~~~~i~~~~~~~p~----~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 208 EEELFHSIRMDNPFYPR----WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp HHHHHHHHHHCCCCCCT----TSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHHHHHHHcCCCCCCc----cCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 99999999988766543 4899999999999999999999995 89999999864
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-57 Score=459.23 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=215.7
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+++. +|+.||||++.+.. .........+.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~---t~~~vAiK~i~~~~---------------------------~~~~~~~~~~~ 52 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKAD---TGKMYAMKCLDKKR---------------------------IKMKQGETLAL 52 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETT---TCCEEEEEEEEHHH---------------------------HHHHTCHHHHH
T ss_pred HHhCeeeeEEecCCCeEEEEEEECC---CCCEEEEEEEchHH---------------------------cchhhHHHHHH
Confidence 3689999999999999999999987 89999999997631 01111122333
Q ss_pred ---HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 200 ---REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 200 ---~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
+|+.+++.+. |||||+++++|.+++.+|||||||+||+|.+++.+. ..+++..++.++.||+.||.|||++||||
T Consensus 53 ~e~~~~~~l~~~~-hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~iiH 130 (364)
T d1omwa3 53 NERIMLSLVSTGD-CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGLEHMHNRFVVY 130 (364)
T ss_dssp HHHHHHHHHSSSC-CTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHhcCC-CCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 4466666665 999999999999999999999999999999988665 68999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-c-cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-R-SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~~DiwSlGvil~elltg~~pf 354 (482)
|||||+|||+ +.++.+||+|||+|+.+... .....+||+.|||||++. + .|+.++|||||||++|+|+||+.||
T Consensus 131 rDlKP~NILl---~~~g~iKl~DFGla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf 206 (364)
T d1omwa3 131 RDLKPANILL---DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 206 (364)
T ss_dssp CCCSGGGEEE---CSSSCEEECCCTTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred eeeccceeEE---cCCCcEEEeeeceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCC
Confidence 9999999999 67788999999999876543 445678999999999885 3 4899999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCC-----HHHHhcCcccccC
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLT-----AAQALSHPWLANS 415 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s-----~~e~L~hp~~~~~ 415 (482)
.+.+..+... +...........+..+|+++++||.+||+.||.+||| ++|+|+||||++.
T Consensus 207 ~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 207 RQHKTKDKHE-IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp CSSCSSCHHH-HHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred CCCCHHHHHH-HHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 8765443332 2223333333444579999999999999999999999 8999999999864
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-57 Score=442.44 Aligned_cols=261 Identities=28% Similarity=0.454 Sum_probs=219.6
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||.||+|++.. +|+.||||+++... ......+.+.+
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~----------------------------~~~~~~~~~~~ 50 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKL---TGEVVALKKIRLDT----------------------------ETEGVPSTAIR 50 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEC-----------------------------------CCHHHHH
T ss_pred CCCEeccEEecCcCeEEEEEEECC---CCCEEEEEEEehhh----------------------------cChHHHHHHHH
Confidence 689999999999999999999987 89999999996531 11122467889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRIL-SRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
|+.+|+++. |||||++++++.+++.+|+|||||.++ +.+++. .....+++..++.++.||+.||.|||++|||||||
T Consensus 51 Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv~e~~~~~-~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDi 128 (298)
T d1gz8a_ 51 EISLLKELN-HPNIVKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 128 (298)
T ss_dssp HHHHHTTCC-CTTBCCEEEEEEETTEEEEEEECCSEE-HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHHHHhCC-CCcEEEeccccccccceeEEEeecCCc-hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEcccc
Confidence 999999996 999999999999999999999999765 455444 44567999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWA 356 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~ 356 (482)
||+|||+ +.++.+||+|||+|+..... ......+||+.|+|||++.. .++.++||||+||++|+|++|+.||.+
T Consensus 129 KpeNIl~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~ 205 (298)
T d1gz8a_ 129 KPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPG 205 (298)
T ss_dssp CGGGEEE---CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred Cchheee---cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCC
Confidence 9999999 66778999999999877543 34556789999999998653 468899999999999999999999999
Q ss_pred CChHHHHHHHHhcCCCCCCCC-------------------------CCCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 357 RTESGIFRAVLKADPSFDEAP-------------------------WPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
.+..+.+..+........... ++.+|+++++||++||+.||.+|||++|+|+|||
T Consensus 206 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~f 285 (298)
T d1gz8a_ 206 DSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPF 285 (298)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred CCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHh
Confidence 988888777765433322221 2356899999999999999999999999999999
Q ss_pred cccCCC
Q 011582 412 LANSHD 417 (482)
Q Consensus 412 ~~~~~~ 417 (482)
|++...
T Consensus 286 f~~~~~ 291 (298)
T d1gz8a_ 286 FQDVTK 291 (298)
T ss_dssp GTTCCC
T ss_pred hccCCC
Confidence 987644
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-57 Score=445.20 Aligned_cols=259 Identities=26% Similarity=0.377 Sum_probs=215.2
Q ss_pred ecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHH
Q 011582 125 LGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKI 204 (482)
Q Consensus 125 ~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~ 204 (482)
.++.||+|+||+||+|+++. +|+.||||++++... ........+.+.+|+.+
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~~~-------------------------~~~~~~~~~~~~~Ei~i 53 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKN---TNQIVAIKKIKLGHR-------------------------SEAKDGINRTALREIKL 53 (299)
T ss_dssp EEEEEEEETTEEEEEEECSS---CCSEEEEEEC-------------------------------------CTHHHHHHHH
T ss_pred cceEeccCcCeEEEEEEECC---CCcEEEEEEEehhhh-------------------------hhhhHHHHHHHHHHHHH
Confidence 45789999999999999887 899999999965310 00111123468899999
Q ss_pred HHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCce
Q 011582 205 LRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENF 284 (482)
Q Consensus 205 l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NI 284 (482)
|++++ |||||++++++.+++.+|||||||.|+++.. +...+..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 54 l~~l~-hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~-~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NI 131 (299)
T d1ua2a_ 54 LQELS-HPNIIGLLDAFGHKSNISLVFDFMETDLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL 131 (299)
T ss_dssp HHHCC-CTTBCCEEEEECCTTCCEEEEECCSEEHHHH-HTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred HHhCC-CCCEeEEEeeeccCCceeehhhhhcchHHhh-hhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceE
Confidence 99997 9999999999999999999999998876554 445567899999999999999999999999999999999999
Q ss_pred EEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCCChHH
Q 011582 285 LFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWARTESG 361 (482)
Q Consensus 285 ll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~~~~~ 361 (482)
|+ +.++.+||+|||+|+..... ......+||+.|||||++.+ .|+.++|||||||++|||+||..||.+.+..+
T Consensus 132 li---~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~ 208 (299)
T d1ua2a_ 132 LL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD 208 (299)
T ss_dssp EE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred Ee---cCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH
Confidence 99 67789999999999876543 34456789999999998753 48999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCCCC------------------------CCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCC
Q 011582 362 IFRAVLKADPSFDEAP------------------------WPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSH 416 (482)
Q Consensus 362 ~~~~i~~~~~~~~~~~------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~ 416 (482)
.+..|.+......... ++.+++++++||++||+.||++|||++|+|+||||++..
T Consensus 209 ~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 209 QLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp HHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred HHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 8888876432222111 235789999999999999999999999999999998754
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=440.83 Aligned_cols=264 Identities=28% Similarity=0.379 Sum_probs=219.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|+++++||+|+||+||+|++... +++.||||++++.. ........+.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~--~~~~vAiK~i~~~~----------------------------~~~~~~~~~~ 55 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKN--GGRFVALKRVRVQT----------------------------GEEGMPLSTI 55 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTT--TTEEEEEEEEEEEB----------------------------CTTSCBCTHH
T ss_pred cCCEEEEEEEecccCeEEEEEEEECC--CCEEEEEEEEehhh----------------------------ccchHHHHHH
Confidence 46899999999999999999998651 36789999997531 0011112356
Q ss_pred HHHHHHHhhc--CCCCcceeeEEEEe-----CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 200 REVKILRALT--GHKNLVQFYDAYED-----DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 200 ~Ei~~l~~l~--~hpniv~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
+|+.+|+.|. +||||++++++|.. ...+|++||||.++.+..........+++..++.++.||+.||.|||++
T Consensus 56 ~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~ 135 (305)
T d1blxa_ 56 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH 135 (305)
T ss_dssp HHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 7888877763 49999999999863 3578999999998776555555567899999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~ 351 (482)
|||||||||+|||+ +..+.+||+|||++............+||+.|||||++.+ .|+.++||||+||++|||++|+
T Consensus 136 ~ivHrDiKp~NILi---~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~ 212 (305)
T d1blxa_ 136 RVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212 (305)
T ss_dssp TCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CEEecCCCccEEEE---cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCC
Confidence 99999999999999 6778899999999987766666778899999999998864 6999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCC-----------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 352 RPFWARTESGIFRAVLKADPSFDE-----------------------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~-----------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.||.+.+..+.+..+......... ..+..+++++++||++||+.||.+|||++|+|+
T Consensus 213 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 213 PLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 999999998888887653221111 123457999999999999999999999999999
Q ss_pred CcccccCC
Q 011582 409 HPWLANSH 416 (482)
Q Consensus 409 hp~~~~~~ 416 (482)
||||++..
T Consensus 293 Hpff~~i~ 300 (305)
T d1blxa_ 293 HPYFQDLE 300 (305)
T ss_dssp SGGGTTCC
T ss_pred ChhhcCch
Confidence 99998754
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-57 Score=436.00 Aligned_cols=255 Identities=29% Similarity=0.483 Sum_probs=212.1
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+++. +|+.||||++.+...... ........+.
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~~~~~------------------------~~~~~~~~~~ 55 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVS---DNLPVAIKHVEKDRISDW------------------------GELPNGTRVP 55 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEEGGGCCCE------------------------EECTTCCEEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEehHHccch------------------------hhhhHHHHHH
Confidence 4689999999999999999999987 799999999976421000 0000112356
Q ss_pred HHHHHHHhhc-CCCCcceeeEEEEeCCeEEEEEecCCC-CChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 200 REVKILRALT-GHKNLVQFYDAYEDDDNIYIVMELCKG-GELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~-~hpniv~l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+|+.+|+++. +|||||++++++.+++..|+||||+.+ +++.+++... ..+++.+++.++.||+.||.|||++|||||
T Consensus 56 ~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~-~~l~e~~~~~~~~qi~~al~~lH~~~iiHr 134 (273)
T d1xwsa_ 56 MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEAVRHCHNCGVLHR 134 (273)
T ss_dssp HHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 8999999985 489999999999999999999999986 5666766544 689999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-c-CCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-S-YGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+|||++ .+++.+||+|||+|+.... ....+.+||+.|||||++.+ . ++.++|||||||++|+|++|+.||.
T Consensus 135 DiKp~NIll~--~~~~~vkl~DFG~a~~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~ 211 (273)
T d1xwsa_ 135 DIKDENILID--LNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211 (273)
T ss_dssp CCSGGGEEEE--TTTTEEEECCCTTCEECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred cCcccceEEe--cCCCeEEECccccceeccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCC
Confidence 9999999995 2456899999999987543 44567789999999999864 3 5678999999999999999999997
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
+. ..+......++ ..+|+++++||++||+.||.+|||++|+|+||||++.
T Consensus 212 ~~------~~i~~~~~~~~----~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 212 HD------EEIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SH------HHHHHCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred Cc------hHHhhcccCCC----CCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 53 23555554443 3589999999999999999999999999999999764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.4e-56 Score=433.39 Aligned_cols=261 Identities=28% Similarity=0.440 Sum_probs=219.7
Q ss_pred ccccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 118 QFVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 118 ~~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.+.++|++.+.||+|+||.||+|++.. +|+.||||++++. ........+.
T Consensus 4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~---------------------------~~~~~~~~~~ 53 (277)
T d1o6ya_ 4 HLSDRYELGEILGFGGMSEVHLARDLR---LHRDVAVKVLRAD---------------------------LARDPSFYLR 53 (277)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECST---------------------------TTTCHHHHHH
T ss_pred CccceeEEeEEEeeCCCeEEEEEEECC---CCCEEEEEEEchh---------------------------hccCHHHHHH
Confidence 456789999999999999999999987 8999999999764 1233455678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCC----eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDD----NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
+.+|+.+|+.++ |||||++++++...+ .+|||||||+|++|.+++... +.+++.+++.++.||+.||.|||++|
T Consensus 54 ~~~E~~~l~~~~-hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~-~~l~~~~~~~i~~qi~~al~~lH~~~ 131 (277)
T d1o6ya_ 54 FRREAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSHQNG 131 (277)
T ss_dssp HHHHHHHHHTCC-CTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHhcC-CCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhccc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 999999999996 999999999998754 489999999999999887655 68999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCC----CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHh
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD----ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILL 348 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ell 348 (482)
||||||||+|||+ +.++.++|+|||++...... ......+||+.|||||++.+ .|+.++|||||||++|+|+
T Consensus 132 iiHrDiKP~NIll---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyell 208 (277)
T d1o6ya_ 132 IIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVL 208 (277)
T ss_dssp EECCCCSGGGEEE---ETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred ccCccccCccccc---CccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHH
Confidence 9999999999999 56778999999998765332 23456789999999999875 5999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccc
Q 011582 349 CGSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLA 413 (482)
Q Consensus 349 tg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~ 413 (482)
||++||.+.+..+....+.......+...++.+|+++.+||.+||+.||.+||+..+.|.|+|++
T Consensus 209 tG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 209 TGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp HSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred hCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 99999999999999999988887777777788999999999999999999999555555577764
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-56 Score=428.53 Aligned_cols=251 Identities=23% Similarity=0.368 Sum_probs=207.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+.+ ..||||+++.. .......+.+.
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~------~~vAvK~~~~~----------------------------~~~~~~~~~~~ 52 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH------GDVAVKMLNVT----------------------------APTPQQLQAFK 52 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS------SEEEEEECCCS----------------------------SCCTTHHHHHH
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC------CEEEEEEEEcc----------------------------cCCHHHHHHHH
Confidence 367999999999999999999743 35999998653 12234567899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|++++ |||||++++++. ++.+|||||||+||+|.+++......+++..+..++.||+.||.|||++|||||||
T Consensus 53 ~E~~~l~~l~-HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDl 130 (276)
T d1uwha_ 53 NEVGVLRKTR-HVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130 (276)
T ss_dssp HHHHHHTTCC-CTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHHHHHhCC-CCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEecccc
Confidence 9999999997 999999999864 56789999999999999999877778999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC---CcccccccCccccCcccccc----cCCCcchhhhhHHHHHHHhhCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD---ERLNDIVGSAYYVAPEVLHR----SYGTEADMWSIGVIAYILLCGSR 352 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~---~~~~~~~gt~~y~aPE~~~~----~~~~~~DiwSlGvil~elltg~~ 352 (482)
||+|||+ +.++.+||+|||+|+..... .......||+.|||||++.+ .|+.++|||||||++|||+||+.
T Consensus 131 Kp~NiLl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~ 207 (276)
T d1uwha_ 131 KSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207 (276)
T ss_dssp CGGGEEE---ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CHHHEEE---cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCC
Confidence 9999999 56788999999999876432 23456789999999999852 48999999999999999999999
Q ss_pred CCCCCChHHHHHHHHhcCCCCC--CCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 353 PFWARTESGIFRAVLKADPSFD--EAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 353 pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||.+.+....+..+.......+ ......+++++.+||.+||+.||++|||+++++++
T Consensus 208 Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 208 PYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp TTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9988766655554444433222 22345689999999999999999999999999876
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=3.2e-55 Score=427.34 Aligned_cols=257 Identities=28% Similarity=0.454 Sum_probs=214.8
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|+++++||+|+||+||+|+++ +|+.||||++++.. ......+.+.+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~~----------------------------~~~~~~~~~~~ 49 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNN----YGETFALKKIRLEK----------------------------EDEGIPSTTIR 49 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET----TSCEEEEEEECCSS----------------------------GGGCCCHHHHH
T ss_pred CCceeccEEecCCCcEEEEEEeC----CCCEEEEEEEehhh----------------------------cChHHHHHHHH
Confidence 68999999999999999999885 68999999996531 11222467889
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|++++ |||||++++++.+++..|++|||+.++. ...+....+.+++..++.++.||+.||+|||++||||||||
T Consensus 50 E~~il~~l~-hpnIv~~~~~~~~~~~~~i~~e~~~~~~-~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiK 127 (286)
T d1ob3a_ 50 EISILKELK-HSNIVKLYDVIHTKKRLVLVFEHLDQDL-KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLK 127 (286)
T ss_dssp HHHGGGGCC-CTTBCCEEEEEECSSCEEEEEECCSEEH-HHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCC
T ss_pred HHHHHHhCC-CCcEEeeeeecccCCceeEEEEeehhhh-HHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCC
Confidence 999999997 9999999999999999999999997754 45555666889999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCC-CcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPD-ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFWAR 357 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~~~ 357 (482)
|+|||+ +.++.+||+|||++...... .......||+.|+|||.+.+ .++.++|||||||++|||++|+.||.+.
T Consensus 128 p~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 128 PQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp GGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred CceeeE---cCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence 999999 66788999999999876543 23455679999999998853 4799999999999999999999999999
Q ss_pred ChHHHHHHHHhcCCCCCCC-------------------------CCCCCCHHHHHHHHHhchhccccCCCHHHHhcCccc
Q 011582 358 TESGIFRAVLKADPSFDEA-------------------------PWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWL 412 (482)
Q Consensus 358 ~~~~~~~~i~~~~~~~~~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~ 412 (482)
+..+.+.++.......... ..+.+++++.+||++||+.||++|||+.|+|+||||
T Consensus 205 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f 284 (286)
T d1ob3a_ 205 SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284 (286)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred CHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence 8888877776533222111 124578999999999999999999999999999999
Q ss_pred cc
Q 011582 413 AN 414 (482)
Q Consensus 413 ~~ 414 (482)
++
T Consensus 285 ~~ 286 (286)
T d1ob3a_ 285 KE 286 (286)
T ss_dssp GC
T ss_pred Cc
Confidence 74
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=435.10 Aligned_cols=255 Identities=26% Similarity=0.383 Sum_probs=214.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCC--CCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSL--KGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~--~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
++|++++.||+|+||+||+|+++.... .+..||||.+.+. ........+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~~ 87 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-----------------------------ADSSEREAL 87 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-----------------------------------CHHH
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccc-----------------------------cCHHHHHHH
Confidence 689999999999999999999875321 2346999988643 122334678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC----------------------CCCCHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG----------------------GKYSEEDAK 256 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------------~~l~~~~~~ 256 (482)
.+|+.+|+++.+|||||++++++.+.+.+|||||||+||+|.++|..+. ..+++..++
T Consensus 88 ~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 167 (325)
T d1rjba_ 88 MSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLL 167 (325)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHH
T ss_pred HHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHH
Confidence 8999999999559999999999999999999999999999999987543 248899999
Q ss_pred HHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCC
Q 011582 257 IVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYG 332 (482)
Q Consensus 257 ~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~ 332 (482)
.++.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+....... ..+.+||+.|||||++. +.|+
T Consensus 168 ~i~~qi~~gl~yLH~~~IiHRDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~ 244 (325)
T d1rjba_ 168 CFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 244 (325)
T ss_dssp HHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHhCCeeeccCchhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC
Confidence 999999999999999999999999999999 5678999999999987654332 33567899999999886 5799
Q ss_pred CcchhhhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 333 TEADMWSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 333 ~~~DiwSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.++|||||||++|||+| |..||.+.+..+.+.++......++. ...+|+++++||.+||+.||++|||++|+++|
T Consensus 245 ~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~--p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 245 IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQ--PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC--CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999999997 89999988777777777766554433 24589999999999999999999999999875
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.3e-55 Score=428.29 Aligned_cols=254 Identities=22% Similarity=0.369 Sum_probs=207.9
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.+.||+|+||+||+|+++........||||.+... ......+.+.
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~-----------------------------~~~~~~~~~~ 75 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-----------------------------YTEKQRRDFL 75 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS-----------------------------CCHHHHHHHH
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc-----------------------------cCHHHHHHHH
Confidence 46899999999999999999998752222346889987543 2344567899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|++++ |||||++++++.+++.+|+|||||+||+|.+++....+.+++.++..++.||+.||.|||++|||||||
T Consensus 76 ~E~~~l~~l~-HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDl 154 (299)
T d1jpaa_ 76 SEASIMGQFD-HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDL 154 (299)
T ss_dssp HHHHHHTTCC-CTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHHHHHhCC-CCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCcc
Confidence 9999999996 999999999999999999999999999999988776778999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCc------ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDER------LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GS 351 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~------~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~ 351 (482)
||+|||| +.++.+||+|||+|+.+..... .....||+.|||||++. +.|+.++|||||||++|||+| |+
T Consensus 155 Kp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~ 231 (299)
T d1jpaa_ 155 AARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231 (299)
T ss_dssp CGGGEEE---CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred ccceEEE---CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCC
Confidence 9999999 6788999999999987654322 12245799999999886 569999999999999999998 89
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.||.+.+..++...+..... . +....+++++.+||.+||+.||++|||+.|++++
T Consensus 232 ~Pf~~~~~~~~~~~i~~~~~-~--~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 232 RPYWDMTNQDVINAIEQDYR-L--PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CTTTTCCHHHHHHHHHTTCC-C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCC-C--CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999888888876532 2 2234689999999999999999999999998864
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-55 Score=421.56 Aligned_cols=247 Identities=24% Similarity=0.391 Sum_probs=205.5
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||.||+|+++ +++.||||++++. ....+++.+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~i~~~-------------------------------~~~~~~~~~ 49 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL----NKDKVAIKTIREG-------------------------------AMSEEDFIE 49 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET----TTEEEEEEECCSS-------------------------------SSCHHHHHH
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC----CCCEEEEEEECCC-------------------------------cCcHHHHHH
Confidence 57999999999999999999875 5778999998653 112357899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.++++++ |||||++++++.+++.+|+|||||++|+|.+++......+++..+..++.||+.||.|||+++|+|||||
T Consensus 50 E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlK 128 (263)
T d1sm2a_ 50 EAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLA 128 (263)
T ss_dssp HHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCS
T ss_pred HHHHHHhcC-CCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccc
Confidence 999999997 9999999999999999999999999999999988777789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
|+|||+ +.++.+||+|||+++....... .....||+.|||||++.+ .|+.++|||||||++|||+| |.+||..
T Consensus 129 p~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 129 ARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp GGGEEE---CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred hhheee---cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC
Confidence 999999 6678899999999987654332 334679999999999874 69999999999999999999 5777777
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.+..+++..+..+..... ...+++++.+||.+||+.||.+|||++++++|
T Consensus 206 ~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 206 RSNSEVVEDISTGFRLYK---PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CCHHHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHhcCCCCC---ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 788888888877643222 23578999999999999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-55 Score=423.52 Aligned_cols=255 Identities=21% Similarity=0.348 Sum_probs=216.5
Q ss_pred cceEecce-eecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 121 AHYELGEE-VGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 121 ~~y~~~~~-LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
++|.+.+. ||+|+||.||+|.++.. .++..||||++++. ......+.+.
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~-~~~~~vAvK~l~~~-----------------------------~~~~~~~~~~ 57 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMR-KKQIDVAIKVLKQG-----------------------------TEKADTEEMM 57 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC----CCEEEEEEEECSS-----------------------------CCHHHHHHHH
T ss_pred cCeEECCcEEecccCeEEEEEEEecC-CCcEEEEEEEEChh-----------------------------cCHHHHHHHH
Confidence 57888884 99999999999987542 14668999998653 2344567899
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|++++ |||||++++++.+ +.+|||||||+||+|.+++...+..+++.++..++.||+.||.|||++|||||||
T Consensus 58 ~E~~il~~l~-HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDl 135 (285)
T d1u59a_ 58 REAQIMHQLD-NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDL 135 (285)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred HHHHHHHhCC-CCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcC
Confidence 9999999996 9999999999875 5689999999999999988766678999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRP 353 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~p 353 (482)
||+|||+ +.++.+||+|||+|+.+..... ....+||+.|||||++. +.|+.++|||||||++|||+| |..|
T Consensus 136 Kp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~P 212 (285)
T d1u59a_ 136 AARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 212 (285)
T ss_dssp SGGGEEE---EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCT
T ss_pred chhheee---ccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCC
Confidence 9999999 4577899999999987754332 23457899999999986 569999999999999999998 9999
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHH---hcCcccc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA---LSHPWLA 413 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~---L~hp~~~ 413 (482)
|.+.+..++...|..+... ...+.+|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 213 f~~~~~~~~~~~i~~~~~~---~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 213 YKKMKGPEVMAFIEQGKRM---ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TTTCCTHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHcCCCC---CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9998888888888765432 2224689999999999999999999999888 5677764
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.8e-55 Score=424.24 Aligned_cols=248 Identities=22% Similarity=0.329 Sum_probs=210.4
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++.++||+|+||.||+|+++. +|+.||||++++. ....+.+.
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~-------------------------------~~~~~~~~ 61 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKK---YSLTVAVKTLKED-------------------------------TMEVEEFL 61 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGG---GTEEEEEEECCTT-------------------------------CSCHHHHH
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECC---CCeEEEEEEECCc-------------------------------cchHHHHH
Confidence 3689999999999999999999986 7999999998653 11235789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
+|+.+|++++ |||||+++++|.+++.+|||||||++|+|.+++... ...+++..+..++.||+.||.|||++||||||
T Consensus 62 ~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrD 140 (287)
T d1opja_ 62 KEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRD 140 (287)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred HHHHHHHhCC-CCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCc
Confidence 9999999997 999999999999999999999999999999988754 46799999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
|||+|||+ +.++.+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||++|..||.
T Consensus 141 lKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~ 217 (287)
T d1opja_ 141 LAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY 217 (287)
T ss_dssp CSGGGEEE---CGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccCeEEE---CCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCC
Confidence 99999999 5678899999999987654432 23456899999999876 579999999999999999999766654
Q ss_pred -CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 356 -ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 356 -~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+.+...+...+.. .... .....+++++.+||.+||+.||++|||++++++
T Consensus 218 ~~~~~~~~~~~i~~-~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 218 PGIDLSQVYELLEK-DYRM--ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TTCCHHHHHHHHHT-TCCC--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcchHHHHHHHHhc-CCCC--CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 4455555554443 3322 233568999999999999999999999999965
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.8e-54 Score=428.90 Aligned_cols=254 Identities=29% Similarity=0.552 Sum_probs=212.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|+++++||+|+||+||+|+++. +|+.||||++++. ..+.+.
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~---~~~~vAiK~i~~~---------------------------------~~~~~~ 77 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINIT---NNEKVVVKILKPV---------------------------------KKKKIK 77 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSS---------------------------------CHHHHH
T ss_pred CcCeEEEEEEecCcCeEEEEEEECC---CCCEEEEEEECHH---------------------------------HHHHHH
Confidence 4789999999999999999999987 8999999998653 135678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeC--CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDD--DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+|+.+|+.+.+||||++++++|... ..+|+|||||.+++|.... ..+++..++.++.||+.||.|||++|||||
T Consensus 78 ~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHr 153 (328)
T d3bqca1 78 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHR 153 (328)
T ss_dssp HHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred HHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccc
Confidence 9999999997799999999999854 5699999999999987642 579999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
||||+|||++. ++..+||+|||+|+...........+||+.|+|||.+.+ .|+.++||||+||++|+|++|+.||.
T Consensus 154 DiKp~NILi~~--~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~ 231 (328)
T d3bqca1 154 DVKPHNVMIDH--EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 231 (328)
T ss_dssp CCSGGGEEEET--TTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSS
T ss_pred cccccceEEcC--CCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCC
Confidence 99999999962 345799999999998877777778899999999998764 48999999999999999999999997
Q ss_pred CCChH-HHHHHHHhc-------------CCC--------------------CCCCCCCCCCHHHHHHHHHhchhccccCC
Q 011582 356 ARTES-GIFRAVLKA-------------DPS--------------------FDEAPWPSLSPEAIDFVKRLLNKDYRKRL 401 (482)
Q Consensus 356 ~~~~~-~~~~~i~~~-------------~~~--------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~ 401 (482)
..... +....+... ... +....+..+++++++||++||+.||.+||
T Consensus 232 ~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ 311 (328)
T d3bqca1 232 HGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL 311 (328)
T ss_dssp CCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSC
T ss_pred CCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCc
Confidence 65432 222222110 000 01112234789999999999999999999
Q ss_pred CHHHHhcCcccccC
Q 011582 402 TAAQALSHPWLANS 415 (482)
Q Consensus 402 s~~e~L~hp~~~~~ 415 (482)
|++|+|+||||++-
T Consensus 312 ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 312 TAREAMEHPYFYTV 325 (328)
T ss_dssp CHHHHHTSGGGTTS
T ss_pred CHHHHhcCcccCCC
Confidence 99999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=433.52 Aligned_cols=254 Identities=27% Similarity=0.410 Sum_probs=213.0
Q ss_pred ceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHH
Q 011582 122 HYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRRE 201 (482)
Q Consensus 122 ~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 201 (482)
+|+.+++||+|+||+||+|+++. +|+.||||++.+.. ....+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~~----------------------------------~~~~~E 63 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCD---SGELVAIKKVLQDK----------------------------------RFKNRE 63 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETT---TCCEEEEEEEECCS----------------------------------SSCCHH
T ss_pred CcEeeeEEeeCcCeEEEEEEECC---CCCEEEEEEECccc----------------------------------hHHHHH
Confidence 69999999999999999999987 89999999997531 112379
Q ss_pred HHHHHhhcCCCCcceeeEEEEeC------CeEEEEEecCCCCChHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 202 VKILRALTGHKNLVQFYDAYEDD------DNIYIVMELCKGGELLDRIL---SRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 202 i~~l~~l~~hpniv~l~~~~~~~------~~~~lv~e~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
+.+|++++ ||||++++++|... .++|||||||+++ +.+.+. .....+++.+++.++.||+.||+|||++
T Consensus 64 i~il~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~ 141 (350)
T d1q5ka_ 64 LQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF 141 (350)
T ss_dssp HHHHHHCC-CTTBCCEEEEEEEC--CCSCCEEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHhcC-CCCCCcEEEEEEecCccCCceEEEEEEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 99999996 99999999998643 3589999999765 333332 3456799999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc--ccCCCcchhhhhHHHHHHHhhC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH--RSYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwSlGvil~elltg 350 (482)
|||||||||+|||++. ++..+||+|||++..+.......+.+||+.|+|||.+. ..|+.++||||+||++|||++|
T Consensus 142 ~IiHrDiKp~NILl~~--~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g 219 (350)
T d1q5ka_ 142 GICHRDIKPQNLLLDP--DTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219 (350)
T ss_dssp TEECCCCCGGGEEECT--TTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCCcceEEEec--CCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhC
Confidence 9999999999999942 33479999999999887777777889999999999775 3589999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCC-----------------CCCC--------CCCCCCCHHHHHHHHHhchhccccCCCHHH
Q 011582 351 SRPFWARTESGIFRAVLKADP-----------------SFDE--------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQ 405 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~-----------------~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e 405 (482)
+.||...+..+.+..+.+... .++. ...+.+++++.+||.+||+.||++|||+.|
T Consensus 220 ~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e 299 (350)
T d1q5ka_ 220 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299 (350)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHH
Confidence 999999888887777654211 1110 113457999999999999999999999999
Q ss_pred HhcCcccccCC
Q 011582 406 ALSHPWLANSH 416 (482)
Q Consensus 406 ~L~hp~~~~~~ 416 (482)
+|+||||++..
T Consensus 300 ~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 300 ACAHSFFDELR 310 (350)
T ss_dssp HHTSGGGGGGG
T ss_pred HhcCHhhcccc
Confidence 99999998654
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-54 Score=425.88 Aligned_cols=260 Identities=28% Similarity=0.451 Sum_probs=216.3
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|+++++||+|+||+||+|++.. +|+.||||++.+.. ........+.
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAvK~i~~~~----------------------------~~~~~~~~~~ 57 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRK---TGQKVALKKVLMEN----------------------------EKEGFPITAL 57 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEC--------------------------------CTTSSCHHHH
T ss_pred cCCEEEEEEEecCcCeEEEEEEECC---CCCEEEEEEEehhh----------------------------cchHHHHHHH
Confidence 4799999999999999999999986 89999999986531 1122235678
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEe--------CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Q 011582 200 REVKILRALTGHKNLVQFYDAYED--------DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF 271 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~ 271 (482)
+|+.+|++++ ||||+++++++.. ++.+|+|||||.++. ...+......+++..++.++.||+.||.|||+
T Consensus 58 ~E~~il~~l~-h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~-~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~ 135 (318)
T d3blha1 58 REIKILQLLK-HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL-AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135 (318)
T ss_dssp HHHHHHHHCC-CTTBCCEEEEEEC----------CEEEEEECCCEEH-HHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHhc-CCCccceEeeeecccccccccCceEEEEEeccCCCc-cchhhhcccccccHHHHHHHHHHHHHHHHhcc
Confidence 9999999997 9999999999855 456899999997765 44454556789999999999999999999999
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCC-----CcccccccCccccCcccccc--cCCCcchhhhhHHHH
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPD-----ERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIA 344 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil 344 (482)
+||+||||||+|||+ +.++.+||+|||+++..... ......+||+.|+|||++.+ .|+.++||||+||++
T Consensus 136 ~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil 212 (318)
T d3blha1 136 NKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 212 (318)
T ss_dssp TTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred CCEEecCcCchheee---cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCcee
Confidence 999999999999999 67788999999999766432 23345689999999998753 589999999999999
Q ss_pred HHHhhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCC----------------------------CCHHHHHHHHHhchhc
Q 011582 345 YILLCGSRPFWARTESGIFRAVLKADPSFDEAPWPS----------------------------LSPEAIDFVKRLLNKD 396 (482)
Q Consensus 345 ~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~----------------------------~s~~~~~li~~~L~~d 396 (482)
|||++|+.||.+.+..+....+......+....+.. .++++++||.+||+.|
T Consensus 213 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~d 292 (318)
T d3blha1 213 AEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292 (318)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSS
T ss_pred eeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCC
Confidence 999999999999998888888777655544443322 2678899999999999
Q ss_pred cccCCCHHHHhcCcccccC
Q 011582 397 YRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 397 P~~R~s~~e~L~hp~~~~~ 415 (482)
|++|||++|+|+||||++.
T Consensus 293 P~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 293 PAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp TTTSCCHHHHHHSGGGSSS
T ss_pred hhHCcCHHHHHcChhhccC
Confidence 9999999999999999864
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=414.62 Aligned_cols=247 Identities=23% Similarity=0.365 Sum_probs=217.8
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|+++++||+|+||+||+|+.+ +++.||||++++.. ...+.+.+
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~l~~~~-------------------------------~~~~~~~~ 48 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR----GQYDVAIKMIKEGS-------------------------------MSEDEFIE 48 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET----TTEEEEEEEEESSS-------------------------------SCHHHHHH
T ss_pred HHCEEeEEEecCCCeEEEEEEEC----CCCEEEEEEECcCc-------------------------------CCHHHHHH
Confidence 57899999999999999999974 57899999997631 11357899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.++++++ ||||+++++++.+++.+++|||||++|+|.+++......+++..+..++.|+++||.|||++||+|||||
T Consensus 49 Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk 127 (258)
T d1k2pa_ 49 EAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLA 127 (258)
T ss_dssp HHHHHHTCC-CTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCS
T ss_pred HHHHHHhcC-CCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCccccccc
Confidence 999999997 9999999999999999999999999999999887777789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc--ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER--LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~--~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
|+|||+ +.++.+||+|||+++....... .....||+.|+|||++. ..|+.++|||||||++|||+| |+.||.+
T Consensus 128 ~~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~ 204 (258)
T d1k2pa_ 128 ARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYER 204 (258)
T ss_dssp GGGEEE---CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred ceeEEE---cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCC
Confidence 999999 6788999999999987654332 33467999999999986 569999999999999999998 8999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.+..++...+....... .....++++.+||++||+.||.+|||++++|+|
T Consensus 205 ~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 205 FTNSETAEHIAQGLRLY---RPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp SCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHhCCCCC---CcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 99999988887754322 224588999999999999999999999999987
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-54 Score=429.71 Aligned_cols=266 Identities=28% Similarity=0.459 Sum_probs=220.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||+||+|++..+..+|+.||||++++... .......+.+.
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~--------------------------~~~~~~~~~~~ 76 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATI--------------------------VQKAKTTEHTR 76 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEE--------------------------EEEESSGGGCC
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHh--------------------------ccchHHHHHHH
Confidence 4789999999999999999999876666899999999976410 01111234577
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|+++++||||+++++++.+...+|+|||||.+|+|.+++... +.+++..+..++.||+.||.|||++|||||||
T Consensus 77 ~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~-~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDi 155 (322)
T d1vzoa_ 77 TERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDI 155 (322)
T ss_dssp CHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred HHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhc-ccccHHHHHHHHHHHHHHHHHhhcCCEEeccC
Confidence 89999999984589999999999999999999999999999988655 57899999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCC--CcccccccCccccCcccccc---cCCCcchhhhhHHHHHHHhhCCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPD--ERLNDIVGSAYYVAPEVLHR---SYGTEADMWSIGVIAYILLCGSRPF 354 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~--~~~~~~~gt~~y~aPE~~~~---~~~~~~DiwSlGvil~elltg~~pf 354 (482)
||+|||+ +.++.+||+|||+++.+... .......||+.|+|||.+.+ .++.++|||||||+||+|++|+.||
T Consensus 156 Kp~Nill---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF 232 (322)
T d1vzoa_ 156 KLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF 232 (322)
T ss_dssp CGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTT
T ss_pred Cccceee---cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCC
Confidence 9999999 66788999999999876432 23456789999999998853 4788999999999999999999999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCC-----CHHHHhcCcccccC
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRL-----TAAQALSHPWLANS 415 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~-----s~~e~L~hp~~~~~ 415 (482)
.+.+..+....+..............+|+++.+||++||+.||.+|| |++|+|+||||+..
T Consensus 233 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i 298 (322)
T d1vzoa_ 233 TVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298 (322)
T ss_dssp SCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence 87765554444444332222233346899999999999999999999 58999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-54 Score=431.00 Aligned_cols=258 Identities=28% Similarity=0.553 Sum_probs=213.3
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|+++++||+|+||+||+|+++. +|+.||||++++. .......+.+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~---~~~~vAiK~i~~~----------------------------~~~~~~~~~~ 64 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGR---TGAKVAIKKLYRP----------------------------FQSELFAKRA 64 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETT---TCCEEEEEECSST----------------------------TSSHHHHHHH
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEchh----------------------------hcChHHHHHH
Confidence 56899999999999999999999987 8999999999753 1334456788
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCC------eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDD------NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~------~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
.+|+.+|+.+. |||||+++++|...+ .+||||||| +++|...+ +. ..+++..++.++.||+.||.|||++
T Consensus 65 ~~Ei~il~~l~-hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~-~~-~~l~~~~~~~~~~qi~~aL~~LH~~ 140 (346)
T d1cm8a_ 65 YRELRLLKHMR-HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLM-KH-EKLGEDRIQFLVYQMLKGLRYIHAA 140 (346)
T ss_dssp HHHHHHHHHCC-BTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHH-HH-CCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcC-CCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHH-Hh-ccccHHHHHHHHHHHHHHHHHHHhC
Confidence 99999999996 999999999998765 579999999 55666654 33 5799999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCG 350 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg 350 (482)
|||||||||+|||+ +.++.+||+|||+|+... ......+||+.|+|||++.+ .++.++||||+||++|+|++|
T Consensus 141 ~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g 215 (346)
T d1cm8a_ 141 GIIHRDLKPGNLAV---NEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 215 (346)
T ss_dssp TEECCCCCGGGEEE---CTTCCEEECCCTTCEECC--SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHS
T ss_pred CCcccccCcchhhc---ccccccccccccceeccC--CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHC
Confidence 99999999999999 678899999999998764 34566789999999998854 478999999999999999999
Q ss_pred CCCCCCCChHHHHHHHHhcCCCC-----------------------CC----CCCCCCCHHHHHHHHHhchhccccCCCH
Q 011582 351 SRPFWARTESGIFRAVLKADPSF-----------------------DE----APWPSLSPEAIDFVKRLLNKDYRKRLTA 403 (482)
Q Consensus 351 ~~pf~~~~~~~~~~~i~~~~~~~-----------------------~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~ 403 (482)
+.||.+.+....+..+....... .. .....+++++.+||++||+.||.+|||+
T Consensus 216 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta 295 (346)
T d1cm8a_ 216 KTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTA 295 (346)
T ss_dssp SCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCH
T ss_pred cCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCH
Confidence 99999988777666554432211 11 1234679999999999999999999999
Q ss_pred HHHhcCcccccCC
Q 011582 404 AQALSHPWLANSH 416 (482)
Q Consensus 404 ~e~L~hp~~~~~~ 416 (482)
+|+|+||||++..
T Consensus 296 ~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 296 GEALAHPYFESLH 308 (346)
T ss_dssp HHHHHSGGGTTTC
T ss_pred HHHhcChhhCcCC
Confidence 9999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-54 Score=416.54 Aligned_cols=252 Identities=23% Similarity=0.377 Sum_probs=207.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||.||+|++......+..||||.++.. ......+.+.+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~-----------------------------~~~~~~~~~~~ 57 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC-----------------------------TSDSVREKFLQ 57 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT-----------------------------TSHHHHHHHHH
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc-----------------------------cCHHHHHHHHH
Confidence 6899999999999999999998764334667899987542 33455678999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|++++ |||||++++++. ++.+|+|||||++|+|.+++......+++..+..++.||+.||.|||++||||||||
T Consensus 58 E~~~l~~l~-HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlK 135 (273)
T d1mp8a_ 58 EALTMRQFD-HPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 135 (273)
T ss_dssp HHHHHHTCC-CTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred HHHHHHhCC-CCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccc
Confidence 999999996 999999999985 577899999999999999888777889999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~ 356 (482)
|+|||+ +.++.+||+|||+|+...... ......||+.|+|||++. +.|+.++|||||||++|||+| |.+||.+
T Consensus 136 p~NIll---~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~ 212 (273)
T d1mp8a_ 136 ARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212 (273)
T ss_dssp GGGEEE---EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred hhheee---cCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC
Confidence 999999 456789999999998765432 234567899999999986 579999999999999999998 8999999
Q ss_pred CChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 357 RTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.+..++...+..+... ..++.+|+++.+||.+||+.||.+|||+.|+++|
T Consensus 213 ~~~~~~~~~i~~~~~~---~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 213 VKNNDVIGRIENGERL---PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CCGGGHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999998888776432 3346799999999999999999999999999865
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-54 Score=418.45 Aligned_cols=250 Identities=22% Similarity=0.349 Sum_probs=211.9
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||.||+|+.+ +++.||||++++. ....+.+.+
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~----~~~~vAvK~~~~~-------------------------------~~~~~~~~~ 57 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN----GHTKVAVKSLKQG-------------------------------SMSPDAFLA 57 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET----TTEEEEEEEECTT-------------------------------SSCHHHHHH
T ss_pred HHeEEeEEEecCCCcEEEEEEEC----CCCEEEEEEEccC-------------------------------cCCHHHHHH
Confidence 68999999999999999999975 4778999998653 112356899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
|+.+|++++ |||||++++++. ++.+|||||||++|+|.+++... ...+++..+..|+.||+.||.|||++||+||||
T Consensus 58 E~~~l~~l~-HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDi 135 (272)
T d1qpca_ 58 EANLMKQLQ-HQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135 (272)
T ss_dssp HHHHHHHCC-CTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHhCC-CCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCcc
Confidence 999999996 999999999875 45679999999999999876533 236999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhC-CCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCG-SRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg-~~pf~ 355 (482)
||+|||| +.++.+||+|||+|+...... ......||+.|||||++. +.|+.++|||||||++|||+|| .+||.
T Consensus 136 Kp~NIll---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 136 RAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp SGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred chhheee---ecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCC
Confidence 9999999 678899999999999875443 234567999999999887 5699999999999999999995 55666
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc--Ccccc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS--HPWLA 413 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~--hp~~~ 413 (482)
..+..+++..+....... ....+++++.+||.+||+.||++|||++++++ |+||.
T Consensus 213 ~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 213 GMTNPEVIQNLERGYRMV---RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp TCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCC---CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 777777777776653221 22458999999999999999999999999998 78875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-54 Score=417.39 Aligned_cols=248 Identities=21% Similarity=0.320 Sum_probs=205.9
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
++||+|+||.||+|.+... .+++.||||+++.. ..+....+.+.+|+.+|+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~-~~~~~vAvK~~~~~----------------------------~~~~~~~~~~~~E~~il~ 63 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMK-KVVKTVAVKILKNE----------------------------ANDPALKDELLAEANVMQ 63 (277)
T ss_dssp EEEEECSSEEEEEEEEECS-SSEEEEEEEEEC---------------------------------CHHHHHHHHHHHHHH
T ss_pred CCcccCCCeEEEEEEEccC-CcCeEEEEEEEChh----------------------------hCCHHHHHHHHHHHHHHH
Confidence 4699999999999987542 25678999998653 123344578999999999
Q ss_pred hhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCCceEE
Q 011582 207 ALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPENFLF 286 (482)
Q Consensus 207 ~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll 286 (482)
+++ |||||++++++.+ +..|||||||++|+|.+++.. ...+++..+..++.||+.||.|||++|||||||||+|||+
T Consensus 64 ~l~-HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill 140 (277)
T d1xbba_ 64 QLD-NPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL 140 (277)
T ss_dssp TCC-CTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred hCC-CCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc
Confidence 996 9999999999865 457899999999999998765 4679999999999999999999999999999999999999
Q ss_pred ecCCCCCcEEEEecccccccCCCCc----ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCCCCChH
Q 011582 287 TSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFWARTES 360 (482)
Q Consensus 287 ~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~~~~~~ 360 (482)
+.++.+||+|||+++.+..... .....||+.|||||++. +.|+.++|||||||++|||+| |+.||.+.+..
T Consensus 141 ---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~ 217 (277)
T d1xbba_ 141 ---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217 (277)
T ss_dssp ---EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred ---cccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence 5677899999999987654322 23457899999999886 468999999999999999998 89999999988
Q ss_pred HHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHH---hcCccc
Q 011582 361 GIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQA---LSHPWL 412 (482)
Q Consensus 361 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~---L~hp~~ 412 (482)
++...+..+... .....+|+++.+||.+||+.||.+|||++++ |+|+|+
T Consensus 218 ~~~~~i~~~~~~---~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 218 EVTAMLEKGERM---GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCC---CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 888888765421 1224689999999999999999999999998 456654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=427.28 Aligned_cols=259 Identities=28% Similarity=0.480 Sum_probs=212.1
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||+||+|+++. +|+.||||++.+. ......+.+
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~---~~~~vAvK~i~~~-----------------------------~~~~~~~~~ 53 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNV---NKVRVAIKKISPF-----------------------------EHQTYCQRT 53 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETT---TCSEEEEEEECCT-----------------------------TCHHHHHHH
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECC---CCcEEEEEEEehh-----------------------------cChHHHHHH
Confidence 45689999999999999999999876 8999999999653 233445678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCC-----eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDD-----NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
.+|+.+|++|+ ||||+++++++.... .+|++ +|+.||+|.+++... .+++..++.++.||+.||+|||++|
T Consensus 54 ~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~~ 129 (345)
T d1pmea_ 54 LREIKILLRFR-HENIIGINDIIRAPTIEQMKDVYLV-THLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSAN 129 (345)
T ss_dssp HHHHHHHHHCC-CTTBCCCCEEECCSSTTTCCCEEEE-EECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHcC-CCCCCcEEEEEeeccccccceEEEE-EeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999996 999999999997653 34555 556689999988653 7999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCC----cccccccCccccCcccccc--cCCCcchhhhhHHHHHHH
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~el 347 (482)
||||||||+|||+ +.++.+||+|||+|....... .....+||+.|+|||++.. .|+.++||||+||++|+|
T Consensus 130 iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~em 206 (345)
T d1pmea_ 130 VLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 206 (345)
T ss_dssp EECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHH
T ss_pred CcCCCCCcceEEE---CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHH
Confidence 9999999999999 677899999999998764332 2455789999999998853 578999999999999999
Q ss_pred hhCCCCCCCCChHHHHHHHHhcCCCC-----------------------CC----CCCCCCCHHHHHHHHHhchhccccC
Q 011582 348 LCGSRPFWARTESGIFRAVLKADPSF-----------------------DE----APWPSLSPEAIDFVKRLLNKDYRKR 400 (482)
Q Consensus 348 ltg~~pf~~~~~~~~~~~i~~~~~~~-----------------------~~----~~~~~~s~~~~~li~~~L~~dP~~R 400 (482)
++|+.||.+.+..+............ .. ..++.+|+++++||.+||+.||.+|
T Consensus 207 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 286 (345)
T d1pmea_ 207 LSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKR 286 (345)
T ss_dssp HHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTS
T ss_pred hhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHC
Confidence 99999999887766655544321111 00 1245688999999999999999999
Q ss_pred CCHHHHhcCcccccCC
Q 011582 401 LTAAQALSHPWLANSH 416 (482)
Q Consensus 401 ~s~~e~L~hp~~~~~~ 416 (482)
||++|+|+||||+...
T Consensus 287 ~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 287 IEVEQALAHPYLEQYY 302 (345)
T ss_dssp CCHHHHHTSGGGTTTC
T ss_pred cCHHHHhcCHhhccCC
Confidence 9999999999998654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-53 Score=412.46 Aligned_cols=260 Identities=29% Similarity=0.446 Sum_probs=219.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|+++++||+|+||+||+|+++. +|+.||||+++... ........+.+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~---~~~~vAvK~i~~~~----------------------------~~~~~~~~~~~ 50 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRE---THEIVALKRVRLDD----------------------------DDEGVPSSALR 50 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETT---TCCEEEEEEEESSC----------------------------SSTTHHHHHHH
T ss_pred CCCEeeeEEecCcCeEEEEEEECC---CCcEEEEEEEehhh----------------------------CChHHHHHHHH
Confidence 589999999999999999999987 89999999996531 22334578899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|+.++ ||||++++++|.+.+.+++|||++.+++|..++ ...+.+++..++.++.|++.||+|||++||||||||
T Consensus 51 E~~il~~l~-h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiK 128 (292)
T d1unla_ 51 EICLLKELK-HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD-SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLK 128 (292)
T ss_dssp HHHHHTTCC-CTTBCCEEEEEECSSEEEEEEECCSEEHHHHHH-HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHHhcC-cCCEEeeccccccccceeEEeeecccccccccc-ccccccchhHHHHHHHHHHHHHHHhhcCCEeeeccc
Confidence 999999997 999999999999999999999999888776655 556789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCC-cccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCCCCC-CC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDE-RLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGSRPF-WA 356 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~~pf-~~ 356 (482)
|+|||+ +.++.+||+|||++....... ......+++.|+|||++.+ .++.++||||+||++|||++|+.|| .+
T Consensus 129 P~NIli---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 205 (292)
T d1unla_ 129 PQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp GGGEEE---CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred Cccccc---ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence 999999 567789999999998775433 3445567899999998764 3789999999999999999999985 55
Q ss_pred CChHHHHHHHHhcCCCCCC-------------------------CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcc
Q 011582 357 RTESGIFRAVLKADPSFDE-------------------------APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPW 411 (482)
Q Consensus 357 ~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~ 411 (482)
.+..+.+..+......... .....+++++.+||++||+.||++|||++|+|+|||
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred CCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChh
Confidence 5666666666543322211 122457899999999999999999999999999999
Q ss_pred cccCC
Q 011582 412 LANSH 416 (482)
Q Consensus 412 ~~~~~ 416 (482)
|++..
T Consensus 286 f~~~~ 290 (292)
T d1unla_ 286 FSDFC 290 (292)
T ss_dssp GSSCS
T ss_pred hcCCC
Confidence 98753
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=411.09 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=208.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++.+.||+|+||.||+|+.......+..||||++.+. ........+.+.+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~---------------------------~~~~~~~~~~~~~ 60 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD---------------------------VLSQPEAMDDFIR 60 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC-----------------------------------CHHHHHHHH
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChh---------------------------hcCCHHHHHHHHH
Confidence 5799999999999999999987654333457999998653 1123345678999
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLK 280 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlk 280 (482)
|+.+|++++ ||||+++++++.+ +.+++|||||++|+|.+++..+.+.+++..+..++.||+.||.|||++||+|||||
T Consensus 61 Ei~~l~~l~-H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDik 138 (273)
T d1u46a_ 61 EVNAMHSLD-HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLA 138 (273)
T ss_dssp HHHHHHHCC-CTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred HHHHHHhCC-CCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeec
Confidence 999999996 9999999999965 56789999999999999888777789999999999999999999999999999999
Q ss_pred CCceEEecCCCCCcEEEEecccccccCCCCc----ccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh-CCCCC
Q 011582 281 PENFLFTSKEENSSLKAIDFGLSDYVKPDER----LNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC-GSRPF 354 (482)
Q Consensus 281 p~NIll~~~~~~~~~kl~DfGla~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt-g~~pf 354 (482)
|+|||++ .++.+||+|||+++....... .....||..|+|||++.+ .++.++|||||||++|||+| |..||
T Consensus 139 p~NIll~---~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf 215 (273)
T d1u46a_ 139 ARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 215 (273)
T ss_dssp GGGEEEE---ETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred HHHhccc---cccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCC
Confidence 9999994 567899999999998754332 234568889999998864 58999999999999999998 89999
Q ss_pred CCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 355 WARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 355 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
.+.+..++...+......++ ....+|+++.+||.+||..||++|||+.++++
T Consensus 216 ~~~~~~~~~~~i~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 216 IGLNGSQILHKIDKEGERLP--RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp TTCCHHHHHHHHHTSCCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcCHHHHHHHHHhCCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999887765443 33578999999999999999999999999863
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-52 Score=407.23 Aligned_cols=252 Identities=21% Similarity=0.312 Sum_probs=205.7
Q ss_pred cceEecceeecCCceEEEEEEEecCCC-CCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSL-KGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~-~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
+.|++.+.||+|+||.||+|..+.... ....||||+++.. ........+.
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~-----------------------------~~~~~~~~~~ 57 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-----------------------------YTEKQRVDFL 57 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT-----------------------------CCHHHHHHHH
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc-----------------------------cChHHHHHHH
Confidence 579999999999999999999875211 1247999998653 2334456789
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
+|+.+|++++ |||||++++++.+.+..++|||||.++++.+.+......+++.++..++.||+.||.|||++||+||||
T Consensus 58 ~E~~il~~l~-H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDl 136 (283)
T d1mqba_ 58 GEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDL 136 (283)
T ss_dssp HHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHHHHHhcC-CCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCcc
Confidence 9999999997 999999999999999999999999999999988877788999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC----cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhC-CCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE----RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCG-SRP 353 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg-~~p 353 (482)
||+|||| +.++.+||+|||+++...... ......||+.|||||++.+ .|+.++|||||||++|||++| .+|
T Consensus 137 Kp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~ 213 (283)
T d1mqba_ 137 AARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 213 (283)
T ss_dssp CGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred ccceEEE---CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCc
Confidence 9999999 678899999999998765432 2234578999999998864 699999999999999999995 555
Q ss_pred CCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 354 FWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 354 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|...+..+++..+..+.. . +....+++++.+||.+||+.||++|||+.++++
T Consensus 214 ~~~~~~~~~~~~i~~~~~-~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 214 YWELSNHEVMKAINDGFR-L--PTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp TTTCCHHHHHHHHHTTCC-C--CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cccCCHHHHHHHHhccCC-C--CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 666677777777665432 2 222458999999999999999999999999876
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=423.78 Aligned_cols=259 Identities=29% Similarity=0.510 Sum_probs=215.9
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|+++++||+|+||+||+|+++. +|+.||||++++. .......+.+
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~---~~~~vAiK~i~~~----------------------------~~~~~~~~~~ 64 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTK---TGLRVAVKKLSRP----------------------------FQSIIHAKRT 64 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETT---TTEEEEEEECSCT----------------------------TSSHHHHHHH
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECC---CCCEEEEEEECch----------------------------hcChHHHHHH
Confidence 35789999999999999999999887 8999999999763 1234455678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC-----CeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD-----DNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQG 273 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ 273 (482)
.+|+.+|++++ |||||++++++... ...++||+|+.||+|.+++.. +++++..++.++.||+.||.|||++|
T Consensus 65 ~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~g 141 (348)
T d2gfsa1 65 YRELRLLKHMK-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSAD 141 (348)
T ss_dssp HHHHHHHHHCC-CTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHhcC-CCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999997 99999999998643 344666777889999987733 57999999999999999999999999
Q ss_pred CcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc--cCCCcchhhhhHHHHHHHhhCC
Q 011582 274 VVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR--SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 274 ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwSlGvil~elltg~ 351 (482)
|+||||||+|||+ +.++.+|++|||++.... ....+..||+.|+|||++.+ .++.++|||||||++|+|++|+
T Consensus 142 iiHrDiKp~NILi---~~~~~~kl~dfg~a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~ 216 (348)
T d2gfsa1 142 IIHRDLKPSNLAV---NEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216 (348)
T ss_dssp CCCCCCCGGGEEE---CTTCCEEECCC----CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred CcccccCCccccc---cccccccccccchhcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCC
Confidence 9999999999999 677889999999997653 34556789999999998654 4789999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCC-----------------------C----CCCCCCHHHHHHHHHhchhccccCCCHH
Q 011582 352 RPFWARTESGIFRAVLKADPSFDE-----------------------A----PWPSLSPEAIDFVKRLLNKDYRKRLTAA 404 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~-----------------------~----~~~~~s~~~~~li~~~L~~dP~~R~s~~ 404 (482)
.||.+.+.......+......... . .+..+++++++||++||+.||.+|||++
T Consensus 217 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ 296 (348)
T d2gfsa1 217 TLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296 (348)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHH
Confidence 999999888887777665332211 0 1346899999999999999999999999
Q ss_pred HHhcCcccccCC
Q 011582 405 QALSHPWLANSH 416 (482)
Q Consensus 405 e~L~hp~~~~~~ 416 (482)
|+|+||||++..
T Consensus 297 elL~Hp~f~~~~ 308 (348)
T d2gfsa1 297 QALAHAYFAQYH 308 (348)
T ss_dssp HHHTSGGGTTTC
T ss_pred HHhcCHhhCCCC
Confidence 999999998754
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=411.69 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=203.7
Q ss_pred cceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
++|+++++||+|+||.||+|++... ..+++.||||++++. ......+.+
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~-----------------------------~~~~~~~~~ 63 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG-----------------------------ATHSEHRAL 63 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC---------------------------------CHHHHHHH
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccc-----------------------------cCcHHHHHH
Confidence 6899999999999999999998652 225678999998653 233445678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeC-CeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDD-DNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMVQI 262 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~qi 262 (482)
.+|+.++.++..|+||+.+++++.+. +.+++|||||++|+|.+++.... ..+++.++..++.||
T Consensus 64 ~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 143 (299)
T d1ywna1 64 MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQV 143 (299)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHH
T ss_pred HHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHH
Confidence 88999998887799999999988764 56899999999999999986532 358999999999999
Q ss_pred HHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchhh
Q 011582 263 LSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADMW 338 (482)
Q Consensus 263 ~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Diw 338 (482)
+.||.|||++|||||||||+|||+ +.++.+||+|||+|+...... .....+||+.|||||++. +.|+.++|||
T Consensus 144 ~~gl~ylH~~~ivHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiw 220 (299)
T d1ywna1 144 AKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVW 220 (299)
T ss_dssp HHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHHhCCCcCCcCCccceeE---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCccccee
Confidence 999999999999999999999999 567889999999998764332 234568999999999886 4699999999
Q ss_pred hhHHHHHHHhhC-CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 339 SIGVIAYILLCG-SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 339 SlGvil~elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
||||++|||+|| .+||.+....+.+..+......... ...+++++++||.+||+.||.+|||++|+++|
T Consensus 221 S~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 221 SFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA--PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCC--CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC--CccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999986 5678776655555555444433322 24589999999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-53 Score=408.90 Aligned_cols=258 Identities=24% Similarity=0.340 Sum_probs=210.2
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRR 200 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (482)
++|++++.||+|+||.||+|+++ +++.||||+++.. ....+.+.+
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~----~~~~vAiK~l~~~-------------------------------~~~~~~~~~ 61 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWN----GTTRVAIKTLKPG-------------------------------TMSPEAFLQ 61 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET----TTEEEEEEECCTT-------------------------------SSCHHHHHH
T ss_pred HHEEEeeEEeeCCCeEEEEEEEC----CCCEEEEEEECcc-------------------------------cCCHHHHHH
Confidence 68999999999999999999886 3567999998653 112357899
Q ss_pred HHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCC
Q 011582 201 EVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR-GGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDL 279 (482)
Q Consensus 201 Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDl 279 (482)
|+.+|++++ |||||++++++. ++.+|+|||||++|+|.+++... ...+++.++..++.||+.||.|||++||+||||
T Consensus 62 E~~~l~~l~-h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~Dl 139 (285)
T d1fmka3 62 EAQVMKKLR-HEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDL 139 (285)
T ss_dssp HHHHHHHCC-CTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred HHHHHHhcc-cCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccc
Confidence 999999997 999999999985 45689999999999999887643 356999999999999999999999999999999
Q ss_pred CCCceEEecCCCCCcEEEEecccccccCCCC--cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhC-CCCCC
Q 011582 280 KPENFLFTSKEENSSLKAIDFGLSDYVKPDE--RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCG-SRPFW 355 (482)
Q Consensus 280 kp~NIll~~~~~~~~~kl~DfGla~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg-~~pf~ 355 (482)
||+|||| +.++.+||+|||+|+...... ......||+.|+|||++. +.++.++|||||||++|||+|| .+||.
T Consensus 140 Kp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 140 RAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp SGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred cceEEEE---CCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 9999999 567889999999998765433 234467999999999886 5799999999999999999995 55566
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc--CcccccCCCCCCC
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS--HPWLANSHDVKIP 421 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~--hp~~~~~~~~~~~ 421 (482)
+....+++..+..... . +....+++++++||.+||+.||++|||++++++ ++||........|
T Consensus 217 ~~~~~~~~~~i~~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~~~p 281 (285)
T d1fmka3 217 GMVNREVLDQVERGYR-M--PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQP 281 (285)
T ss_dssp TCCHHHHHHHHHTTCC-C--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCCCCC
T ss_pred CCCHHHHHHHHHhcCC-C--CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCCCCC
Confidence 6777777777776532 2 234568999999999999999999999999988 8899876544333
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=413.47 Aligned_cols=250 Identities=20% Similarity=0.282 Sum_probs=208.1
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCc----eEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQ----DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~----~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
++|++++.||+|+||.||+|++.. +|+ .||||.++.. ......+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~---~~~~~~~~vavK~~~~~-----------------------------~~~~~~~ 56 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIP---EGEKVKIPVAIKELREA-----------------------------TSPKANK 56 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC-------CCEEEEEEEECC---------------------------------CTHH
T ss_pred HHCEEeeEEecCCCeEEEEEEEcC---CCCEEEEEEEEEEeccc-----------------------------cCHHHHH
Confidence 469999999999999999999875 554 5777776532 1223456
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcc
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVH 276 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivH 276 (482)
.+.+|+.+|++++ |||||++++++.++ ..+++|||+.+|+|.+.+......+++..+..++.||+.||.|||++||||
T Consensus 57 ~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiH 134 (317)
T d1xkka_ 57 EILDEAYVMASVD-NPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVH 134 (317)
T ss_dssp HHHHHHHHHHHCC-CTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHhCC-CCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCccc
Confidence 7899999999997 99999999999865 567888999999999999888788999999999999999999999999999
Q ss_pred cCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CC
Q 011582 277 RDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GS 351 (482)
Q Consensus 277 rDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~ 351 (482)
|||||+|||+ +.++.+||+|||+|+....... .....||+.|||||++. +.|+.++|||||||++|||+| |.
T Consensus 135 rDlKp~NIll---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~ 211 (317)
T d1xkka_ 135 RDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211 (317)
T ss_dssp SCCCGGGEEE---EETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred Ccchhhccee---CCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCC
Confidence 9999999999 5677899999999988754332 33457899999999876 569999999999999999998 89
Q ss_pred CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCc
Q 011582 352 RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHP 410 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp 410 (482)
+||.+.+..++...+..+... + ..+.+++++.+||.+||..||.+|||+.|++.|-
T Consensus 212 ~p~~~~~~~~~~~~i~~~~~~-~--~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 212 KPYDGIPASEISSILEKGERL-P--QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp CTTTTSCGGGHHHHHHHTCCC-C--CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHcCCCC-C--CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence 999988888887777665422 1 2245899999999999999999999999999873
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-52 Score=422.13 Aligned_cols=258 Identities=25% Similarity=0.454 Sum_probs=204.8
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|+++++||+|+||+||+|+++. +|+.||||++++. .........+
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~---t~~~vAvK~i~~~----------------------------~~~~~~~~~~ 63 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAV---LDRNVAIKKLSRP----------------------------FQNQTHAKRA 63 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETT---TTEEEEEEEEEST----------------------------TSSHHHHHHH
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECC---CCCEEEEEEEChh----------------------------hcCHHHHHHH
Confidence 44789999999999999999999987 8999999999763 1334556788
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEe------CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYED------DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQ 272 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~------~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~ 272 (482)
.+|+.+|++++ |||||+++++|.. .+.+|+|||||.++ +++.+ ...+++..++.++.||+.||.|||++
T Consensus 64 ~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~ 138 (355)
T d2b1pa1 64 YRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKHLHSA 138 (355)
T ss_dssp HHHHHHHHHCC-CTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHhcC-CCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhc
Confidence 99999999996 9999999999964 47899999999764 55544 25799999999999999999999999
Q ss_pred CCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhhCC
Q 011582 273 GVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLCGS 351 (482)
Q Consensus 273 ~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~elltg~ 351 (482)
||+||||||+|||+ +.++.+|++|||+++...........+||+.|+|||++.+ .++.++||||+||++|+|++|+
T Consensus 139 giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~ 215 (355)
T d2b1pa1 139 GIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215 (355)
T ss_dssp TCCCSCCCGGGEEE---CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccccCCcccccc---ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCC
Confidence 99999999999999 5677899999999988776666777889999999999875 5999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHhcCCC----------------------CCCCCC----------------CCCCHHHHHHHHHhc
Q 011582 352 RPFWARTESGIFRAVLKADPS----------------------FDEAPW----------------PSLSPEAIDFVKRLL 393 (482)
Q Consensus 352 ~pf~~~~~~~~~~~i~~~~~~----------------------~~~~~~----------------~~~s~~~~~li~~~L 393 (482)
.||.+.+.......+...... .....+ ..+++++++||++||
T Consensus 216 ~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL 295 (355)
T d2b1pa1 216 ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKML 295 (355)
T ss_dssp CSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHS
T ss_pred CCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHC
Confidence 999998877776666542221 111000 113678999999999
Q ss_pred hhccccCCCHHHHhcCcccccC
Q 011582 394 NKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 394 ~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
..||++||||+|+|+||||+..
T Consensus 296 ~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 296 VIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp CSSTTTSCCHHHHHTSTTTGGG
T ss_pred cCChhHCcCHHHHhcCcccCCC
Confidence 9999999999999999999864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=411.35 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=211.6
Q ss_pred cceEecceeecCCceEEEEEEEecCCCCCc--eEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGSLKGQ--DVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~--~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
++|+++++||+|+||.||+|+++. +|. .||||.+++. ......+.+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~---~~~~~~vaiK~~~~~-----------------------------~~~~~~~~~ 57 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKK---DGLRMDAAIKRMKEY-----------------------------ASKDDHRDF 57 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEE---TTEEEEEEEEEEECC-----------------------------------CHH
T ss_pred HHcEEEEEEeeCCCcEEEEEEECC---CCeEEEEEEEEECcc-----------------------------cChHHHHHH
Confidence 689999999999999999999986 565 4677777542 223345678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhc---------------CCCCCHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSR---------------GGKYSEEDAKIVMVQIL 263 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---------------~~~l~~~~~~~i~~qi~ 263 (482)
.+|+.+|+++.+|||||++++++.+++.+|+|||||+||+|.++|... ...+++..+..++.||+
T Consensus 58 ~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia 137 (309)
T d1fvra_ 58 AGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 137 (309)
T ss_dssp HHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHH
Confidence 999999999855999999999999999999999999999999988643 36799999999999999
Q ss_pred HHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHH
Q 011582 264 SVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGV 342 (482)
Q Consensus 264 ~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGv 342 (482)
.||.|||++|||||||||+|||+ +.++.+||+|||+++............||..|+|||.+. +.|+.++|||||||
T Consensus 138 ~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGv 214 (309)
T d1fvra_ 138 RGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV 214 (309)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHH
T ss_pred HHHHhhhcCCccccccccceEEE---cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHH
Confidence 99999999999999999999999 567789999999998766555555678999999999886 56999999999999
Q ss_pred HHHHHhhCC-CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 343 IAYILLCGS-RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 343 il~elltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
++|||++|. +||.+.+..++...+..+.. + ..+..+++++++||.+||+.||++|||+.++++|
T Consensus 215 il~ell~~~~~p~~~~~~~~~~~~i~~~~~-~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 215 LLWEIVSLGGTPYCGMTCAELYEKLPQGYR-L--EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHHHHTTSCCTTTTCCHHHHHHHGGGTCC-C--CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHhcCC-C--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999965 57888888888888766432 2 2335689999999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-51 Score=404.12 Aligned_cols=253 Identities=21% Similarity=0.280 Sum_probs=215.4
Q ss_pred ccceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIED 197 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (482)
.++|++++.||+|+||.||+|+.+.. ..+++.||||++++. ......+.
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~-----------------------------~~~~~~~~ 62 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-----------------------------ASADMQAD 62 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT-----------------------------CCHHHHHH
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh-----------------------------cChHHHHH
Confidence 46899999999999999999997631 225688999998653 23345678
Q ss_pred HHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-----------------------CCCCHHH
Q 011582 198 VRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-----------------------GKYSEED 254 (482)
Q Consensus 198 ~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------------~~l~~~~ 254 (482)
+.+|+.+|++++ ||||+++++++.+.+..++||||+++|+|.+++.... ..+++..
T Consensus 63 ~~~E~~il~~l~-h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 141 (301)
T d1lufa_ 63 FQREAALMAEFD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 141 (301)
T ss_dssp HHHHHHHHHTCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHH
T ss_pred HHHHHHHHHhcC-CCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHH
Confidence 999999999996 9999999999999999999999999999999886432 2488999
Q ss_pred HHHHHHHHHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCcccccc-c
Q 011582 255 AKIVMVQILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLHR-S 330 (482)
Q Consensus 255 ~~~i~~qi~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~~-~ 330 (482)
+..|+.||+.||.|||++|||||||||+|||+ +.++.+||+|||+|+...... ...+..||+.|||||++.+ .
T Consensus 142 ~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 218 (301)
T d1lufa_ 142 QLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218 (301)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHhhhcccCCeEeeEEcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC
Confidence 99999999999999999999999999999999 567889999999998764432 2345678999999998864 6
Q ss_pred CCCcchhhhhHHHHHHHhhCC-CCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 331 YGTEADMWSIGVIAYILLCGS-RPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 331 ~~~~~DiwSlGvil~elltg~-~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|+.++|||||||++|||++|. +||.+.+..++...+..+... .....+++++.+||.+||+.||++|||+.|+++
T Consensus 219 ~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~---~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 219 YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL---ACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC---CCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999985 689999999998888776532 223468999999999999999999999999854
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=401.84 Aligned_cols=253 Identities=23% Similarity=0.393 Sum_probs=211.6
Q ss_pred cceEecceeecCCceEEEEEEEecCC----CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKGS----LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIE 196 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~~----~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (482)
++|++++.||+|+||.||+|+..... .++..||||++++. .......
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~-----------------------------~~~~~~~ 63 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD-----------------------------ATEKDLS 63 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT-----------------------------CCHHHHH
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc-----------------------------cChHHHH
Confidence 58999999999999999999876421 13457999998653 2344567
Q ss_pred HHHHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------------CCCCHHHHHHHHHH
Q 011582 197 DVRREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------------GKYSEEDAKIVMVQ 261 (482)
Q Consensus 197 ~~~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------------~~l~~~~~~~i~~q 261 (482)
++.+|+..+.++.+|||||+++++|.+++..|+|||||++|+|.++|..+. ..+++.++..++.|
T Consensus 64 ~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 143 (299)
T d1fgka_ 64 DLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQ 143 (299)
T ss_dssp HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHH
Confidence 889999999999669999999999999999999999999999999986543 45899999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC---cccccccCccccCccccc-ccCCCcchh
Q 011582 262 ILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE---RLNDIVGSAYYVAPEVLH-RSYGTEADM 337 (482)
Q Consensus 262 i~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~Di 337 (482)
|+.||.|||++|||||||||+|||+ +.++.+||+|||+++...... .....+||+.|+|||++. +.|+.++||
T Consensus 144 i~~al~ylH~~~ivHrDiKp~NiLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~Di 220 (299)
T d1fgka_ 144 VARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDV 220 (299)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHhhhCCEEeeeecccceee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhh
Confidence 9999999999999999999999999 677889999999998765432 334568999999999886 579999999
Q ss_pred hhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 338 WSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 338 wSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|||||++|||++ |.+||.+.+..+++..+..+. .+.. ...+++++.+||.+||+.||.+|||+.|+|+
T Consensus 221 wS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~-~~~~--p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 221 WSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH-RMDK--PSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCC--CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCC-CCCC--CccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 999999999998 799999888888887776543 2222 3458999999999999999999999999976
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-51 Score=400.74 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=215.8
Q ss_pred cceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
++|++++.||+|+||.||+|+.+.. ..+++.||||++++. ........+
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~-----------------------------~~~~~~~~~ 73 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS-----------------------------AHLTEREAL 73 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT-----------------------------CCHHHHHHH
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcc-----------------------------cCHHHHHHH
Confidence 6899999999999999999997542 236789999999653 233455678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC-----------------CCCCHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG-----------------GKYSEEDAKIVMVQ 261 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----------------~~l~~~~~~~i~~q 261 (482)
.+|+.+++++.+|||||++++++.+.+.+|||||||++|+|.+++.... ..+++..+..++.|
T Consensus 74 ~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 153 (311)
T d1t46a_ 74 MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQ 153 (311)
T ss_dssp HHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHH
T ss_pred HHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHH
Confidence 9999999999679999999999999999999999999999999986542 25899999999999
Q ss_pred HHHHHHHHHHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchh
Q 011582 262 ILSVVAFCHFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADM 337 (482)
Q Consensus 262 i~~~L~yLH~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~Di 337 (482)
|+.||.|||++|||||||||+|||+ +.++.+||+|||+++....... ....+||+.|+|||++. +.++.++||
T Consensus 154 i~~gl~~LH~~~ivHrDLKp~NIl~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DI 230 (311)
T d1t46a_ 154 VAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV 230 (311)
T ss_dssp HHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHH
T ss_pred HHHHHHHHHhCCeeecccccccccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccc
Confidence 9999999999999999999999999 5678899999999987654322 23468999999999886 568999999
Q ss_pred hhhHHHHHHHhh-CCCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 338 WSIGVIAYILLC-GSRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 338 wSlGvil~ellt-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
|||||++|||+| |.+||.+.+..+.+.++.........+ ..+++++.+||.+||+.||++|||++++|+
T Consensus 231 wS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~--~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 231 WSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP--EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC--TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc--ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999998 677777777767666666655443332 458999999999999999999999999875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=396.00 Aligned_cols=243 Identities=24% Similarity=0.375 Sum_probs=201.0
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
.++|++++.||+|+||.||+|+. +|..||||++++. ...+.+.
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-----~~~~vAvK~i~~~--------------------------------~~~~~~~ 48 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-----RGNKVAVKCIKND--------------------------------ATAQAFL 48 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-----TTEEEEEEECCCC--------------------------------C--HHHH
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-----CCeEEEEEEECcH--------------------------------HHHHHHH
Confidence 35799999999999999999987 4778999998653 1235788
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEe-CCeEEEEEecCCCCChHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCCccc
Q 011582 200 REVKILRALTGHKNLVQFYDAYED-DDNIYIVMELCKGGELLDRILSRG-GKYSEEDAKIVMVQILSVVAFCHFQGVVHR 277 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~~L~yLH~~~ivHr 277 (482)
+|+.++++++ ||||+++++++.+ .+.+|||||||++|+|.+++.++. ..+++..+..++.||+.||.|||+++|+||
T Consensus 49 ~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~ 127 (262)
T d1byga_ 49 AEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 127 (262)
T ss_dssp HTHHHHTTCC-CTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred HHHHHHHhCC-CCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceecc
Confidence 9999999996 9999999999854 567899999999999999986542 358999999999999999999999999999
Q ss_pred CCCCCceEEecCCCCCcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhh-CCCCCC
Q 011582 278 DLKPENFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLC-GSRPFW 355 (482)
Q Consensus 278 Dlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ellt-g~~pf~ 355 (482)
||||+|||+ +.++.+||+|||+++.... ......+|+.|+|||++. +.++.++|||||||++|||+| |++||.
T Consensus 128 dlkp~Nil~---~~~~~~kl~dfg~s~~~~~--~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~ 202 (262)
T d1byga_ 128 DLAARNVLV---SEDNVAKVSDFGLTKEASS--TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 202 (262)
T ss_dssp CCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCT
T ss_pred ccchHhhee---cCCCCEeecccccceecCC--CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCC
Confidence 999999999 6788899999999987543 334557899999999885 579999999999999999998 799998
Q ss_pred CCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 356 ARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 356 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
..+..++...|.++.. . .....+++++.+||++||+.||.+|||+.++++
T Consensus 203 ~~~~~~~~~~i~~~~~-~--~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 203 RIPLKDVVPRVEKGYK-M--DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp TSCGGGHHHHHTTTCC-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCHHHHHHHHHcCCC-C--CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 8888888888766432 1 122458999999999999999999999999876
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-50 Score=395.74 Aligned_cols=251 Identities=21% Similarity=0.296 Sum_probs=205.9
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
+.+.++||+|+||+||+|++.....+...||||++++. ......+.+.+|+
T Consensus 29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-----------------------------~~~~~~~~~~~E~ 79 (311)
T d1r0pa_ 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-----------------------------TDIGEVSQFLTEG 79 (311)
T ss_dssp EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-----------------------------CCHHHHHHHHHHH
T ss_pred eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-----------------------------cCHHHHHHHHHHH
Confidence 34468899999999999998764323456999998643 3445568899999
Q ss_pred HHHHhhcCCCCcceeeEEEEe-CCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYED-DDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKP 281 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp 281 (482)
++|++++ ||||+++++++.+ ++.+++|||||++|+|.+++......+++..+..++.|++.||.|||+.||+||||||
T Consensus 80 ~~l~~l~-HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~ 158 (311)
T d1r0pa_ 80 IIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAA 158 (311)
T ss_dssp HHHHTCC-CTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred HHHHhCC-CCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccH
Confidence 9999997 9999999999876 5689999999999999998887777889999999999999999999999999999999
Q ss_pred CceEEecCCCCCcEEEEecccccccCCCC-----cccccccCccccCccccc-ccCCCcchhhhhHHHHHHHhhCCCCCC
Q 011582 282 ENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAYILLCGSRPFW 355 (482)
Q Consensus 282 ~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~elltg~~pf~ 355 (482)
+|||+ +.++.+||+|||+++...... ......||+.|+|||++. +.++.++||||||+++|||+||..||.
T Consensus 159 ~NILl---~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~ 235 (311)
T d1r0pa_ 159 RNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 235 (311)
T ss_dssp GGEEE---CTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSC
T ss_pred HhEeE---CCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCC
Confidence 99999 677899999999998765432 223357899999999876 579999999999999999999877776
Q ss_pred CC-ChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhcC
Q 011582 356 AR-TESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSH 409 (482)
Q Consensus 356 ~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~h 409 (482)
.. +..++...+..+... ..+ ..+++++.+||.+||..||++||++.|+++|
T Consensus 236 ~~~~~~~~~~~i~~g~~~-~~p--~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 236 PDVNTFDITVYLLQGRRL-LQP--EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp C------CHHHHHTTCCC-CCC--TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCC-CCc--ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 54 344555555555422 222 3588999999999999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=396.40 Aligned_cols=252 Identities=19% Similarity=0.290 Sum_probs=215.7
Q ss_pred cceEecceeecCCceEEEEEEEecC--CCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 121 AHYELGEEVGRGHFGYTCSAKAKKG--SLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 121 ~~y~~~~~LG~G~fG~V~~a~~~~~--~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
++|++++.||+|+||.||+|.++.. ..+++.||||++++. ........+
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~-----------------------------~~~~~~~~~ 70 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA-----------------------------ASMRERIEF 70 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT-----------------------------SCHHHHHHH
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc-----------------------------cChHHHHHH
Confidence 6899999999999999999988531 114678999998653 233455678
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHH
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRG---------GKYSEEDAKIVMVQILSVVAFC 269 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~yL 269 (482)
.+|+.+++++. |||||++++++..++..++|||||++|+|.+++.... ..+++..+..++.|++.||.||
T Consensus 71 ~~E~~il~~l~-h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~L 149 (308)
T d1p4oa_ 71 LNEASVMKEFN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYL 149 (308)
T ss_dssp HHHHHHGGGCC-CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHcC-CCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 99999999996 9999999999999999999999999999999886431 3478999999999999999999
Q ss_pred HHCCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCCc---ccccccCccccCccccc-ccCCCcchhhhhHHHHH
Q 011582 270 HFQGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDER---LNDIVGSAYYVAPEVLH-RSYGTEADMWSIGVIAY 345 (482)
Q Consensus 270 H~~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~~---~~~~~gt~~y~aPE~~~-~~~~~~~DiwSlGvil~ 345 (482)
|+++|+||||||+|||+ +.++.+||+|||+|+....... .....||+.|+|||.+. +.++.++|||||||++|
T Consensus 150 H~~~ivHrDlk~~NiLl---d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~ 226 (308)
T d1p4oa_ 150 NANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLW 226 (308)
T ss_dssp HHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred hhCCeeeceEcCCceee---cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHH
Confidence 99999999999999999 6788999999999987644322 34457899999999886 46899999999999999
Q ss_pred HHhhC-CCCCCCCChHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 346 ILLCG-SRPFWARTESGIFRAVLKADPSFDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 346 elltg-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
||+|| .+||.+.+..+++..+..+... + ....+++++.+||.+||+.||++|||+.++++
T Consensus 227 El~t~~~~p~~~~~~~~~~~~i~~~~~~-~--~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 227 EIATLAEQPYQGLSNEQVLRFVMEGGLL-D--KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHTSCCTTTTSCHHHHHHHHHTTCCC-C--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCCCCCHHHHHHHHHhCCCC-C--CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99998 5889888999998888775432 1 22468999999999999999999999999997
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=9.1e-51 Score=398.27 Aligned_cols=262 Identities=21% Similarity=0.280 Sum_probs=209.0
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||.||+|++.. +|+.||||++.... ....+
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~--------------------------------~~~~~ 49 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIA---AGEEVAIKLECVKT--------------------------------KHPQL 49 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETT---TTEEEEEEEEESCT--------------------------------TSCCH
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECC---CCCEEEEEEEchhc--------------------------------cCHHH
Confidence 34689999999999999999999876 79999999986530 01246
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+++++.+..|++|+.+.+++.+.+..++||||| +++|.+.+......+++..+..++.|++.||+|||++||||||
T Consensus 50 ~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrD 128 (299)
T d1ckia_ 50 HIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRD 128 (299)
T ss_dssp HHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred HHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeecc
Confidence 789999999984555667777788899999999999 5677787777778899999999999999999999999999999
Q ss_pred CCCCceEEecCCCCCcEEEEecccccccCCCC--------cccccccCccccCcccccc-cCCCcchhhhhHHHHHHHhh
Q 011582 279 LKPENFLFTSKEENSSLKAIDFGLSDYVKPDE--------RLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYILLC 349 (482)
Q Consensus 279 lkp~NIll~~~~~~~~~kl~DfGla~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~ellt 349 (482)
|||+|||++..+.+..+||+|||+|+...... .....+||+.|||||++.+ .|+.++|||||||++|||+|
T Consensus 129 iKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~t 208 (299)
T d1ckia_ 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNL 208 (299)
T ss_dssp CCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHH
T ss_pred CCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHh
Confidence 99999999766677789999999998765432 2345689999999999875 59999999999999999999
Q ss_pred CCCCCCCCChHHHHHHHH---hcCCCC-CCCCCCCCCHHHHHHHHHhchhccccCCCHH---HHhcCcccccCC
Q 011582 350 GSRPFWARTESGIFRAVL---KADPSF-DEAPWPSLSPEAIDFVKRLLNKDYRKRLTAA---QALSHPWLANSH 416 (482)
Q Consensus 350 g~~pf~~~~~~~~~~~i~---~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~---e~L~hp~~~~~~ 416 (482)
|+.||...........+. ...... .......+|+++.+||.+||+.||.+||++. ++|+|+|.+...
T Consensus 209 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~ 282 (299)
T d1ckia_ 209 GSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282 (299)
T ss_dssp SSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred CCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCC
Confidence 999998765544332221 111111 1112356899999999999999999999987 557788775543
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.1e-48 Score=382.21 Aligned_cols=254 Identities=20% Similarity=0.323 Sum_probs=208.4
Q ss_pred cccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHH
Q 011582 119 FVAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDV 198 (482)
Q Consensus 119 ~~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (482)
+.++|++++.||+|+||+||+|++.. +|+.||||++++.. ....+
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~---~~~~vAvK~~~~~~--------------------------------~~~~~ 47 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLL---NNQQVAIKFEPRRS--------------------------------DAPQL 47 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETT---TTEEEEEEEEECCT--------------------------------TSCCH
T ss_pred CCCceEEEEEEecCCCeEEEEEEECC---CCCEEEEEEEcccc--------------------------------CcHHH
Confidence 35689999999999999999999886 79999999986530 01246
Q ss_pred HHHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccC
Q 011582 199 RREVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRD 278 (482)
Q Consensus 199 ~~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrD 278 (482)
.+|+++++.|.+|+|++.+++++.++...|+||||| +++|.+.+...+..+++..+..++.|++.||.|||++||||||
T Consensus 48 ~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrD 126 (293)
T d1csna_ 48 RDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRD 126 (293)
T ss_dssp HHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCC
T ss_pred HHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceecc
Confidence 789999999986799999999999999999999999 6799998877777899999999999999999999999999999
Q ss_pred CCCCceEEecC--CCCCcEEEEecccccccCCC--------CcccccccCccccCcccccc-cCCCcchhhhhHHHHHHH
Q 011582 279 LKPENFLFTSK--EENSSLKAIDFGLSDYVKPD--------ERLNDIVGSAYYVAPEVLHR-SYGTEADMWSIGVIAYIL 347 (482)
Q Consensus 279 lkp~NIll~~~--~~~~~~kl~DfGla~~~~~~--------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwSlGvil~el 347 (482)
|||+|||++.. ...+.+||+|||+|+..... ......+||+.|||||++.+ .++.++|||||||++|||
T Consensus 127 iKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~el 206 (293)
T d1csna_ 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYF 206 (293)
T ss_dssp CCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHH
Confidence 99999999642 23568999999999876432 12345689999999998875 599999999999999999
Q ss_pred hhCCCCCCCCC---hHHHHHHHHhcCCC-CCCCCCCCCCHHHHHHHHHhchhccccCCCHHHHhc
Q 011582 348 LCGSRPFWART---ESGIFRAVLKADPS-FDEAPWPSLSPEAIDFVKRLLNKDYRKRLTAAQALS 408 (482)
Q Consensus 348 ltg~~pf~~~~---~~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~ 408 (482)
+||..||.+.. .......+...... ......+.+|+++.+++..|+..+|++||+++.+.+
T Consensus 207 ltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 207 LRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 99999997543 33333344332211 111223468999999999999999999999876543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=379.62 Aligned_cols=247 Identities=23% Similarity=0.302 Sum_probs=189.8
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
..+|.+.+.||+|+||.||+|+. +|+.||||+++.. ........
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-----~g~~vAvK~~~~~-------------------------------~~~~~~~e 45 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-----RGEEVAVKIFSSR-------------------------------EERSWFRE 45 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-----TTEEEEEEEECGG-------------------------------GHHHHHHH
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-----CCEEEEEEEECcc-------------------------------chhHHHHH
Confidence 46799999999999999999985 6889999998542 11112233
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCC----eEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH----
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDD----NIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHF---- 271 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~---- 271 (482)
.|+..+..++ |||||++++++.+++ .+|+|||||++|+|.+++.+. .+++..+..++.|++.||.|||+
T Consensus 46 ~ei~~~~~~~-HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~ 122 (303)
T d1vjya_ 46 AEIYQTVMLR-HENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVG 122 (303)
T ss_dssp HHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred HHHHHHhhCC-CCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHhhhh
Confidence 4555556776 999999999998654 689999999999999998653 69999999999999999999996
Q ss_pred ----CCCcccCCCCCceEEecCCCCCcEEEEecccccccCCCC-----cccccccCccccCccccccc-------CCCcc
Q 011582 272 ----QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDYVKPDE-----RLNDIVGSAYYVAPEVLHRS-------YGTEA 335 (482)
Q Consensus 272 ----~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~-------~~~~~ 335 (482)
+|||||||||+|||| +.++.+||+|||+++...... .....+||+.|||||++.+. ++.++
T Consensus 123 ~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~ 199 (303)
T d1vjya_ 123 TQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA 199 (303)
T ss_dssp TTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHH
T ss_pred hccCCCeeccccCccceEE---cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcch
Confidence 599999999999999 677899999999998765433 23456899999999998643 56789
Q ss_pred hhhhhHHHHHHHhhCCCCCCCC---------------ChHHHHHHHHhcCCCCCCC-CC--CCCCHHHHHHHHHhchhcc
Q 011582 336 DMWSIGVIAYILLCGSRPFWAR---------------TESGIFRAVLKADPSFDEA-PW--PSLSPEAIDFVKRLLNKDY 397 (482)
Q Consensus 336 DiwSlGvil~elltg~~pf~~~---------------~~~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~li~~~L~~dP 397 (482)
|||||||+||||+||..||... ....+...+.......... .+ .....++.+|+.+||+.||
T Consensus 200 Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp 279 (303)
T d1vjya_ 200 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANG 279 (303)
T ss_dssp HHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSG
T ss_pred hhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCH
Confidence 9999999999999998876321 1222333332222211110 11 1123468899999999999
Q ss_pred ccCCCHHHHhc
Q 011582 398 RKRLTAAQALS 408 (482)
Q Consensus 398 ~~R~s~~e~L~ 408 (482)
++|||+.|+++
T Consensus 280 ~~Rps~~ei~~ 290 (303)
T d1vjya_ 280 AARLTALRIKK 290 (303)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999876
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9e-46 Score=371.89 Aligned_cols=263 Identities=25% Similarity=0.406 Sum_probs=198.8
Q ss_pred cccc-cceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHH
Q 011582 117 KQFV-AHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAI 195 (482)
Q Consensus 117 ~~~~-~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (482)
+.+. ++|+++++||+|+||+||+|+++. +|+.||||++++. ....
T Consensus 8 ~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~---~g~~vAvKvi~~~-------------------------------~~~~ 53 (362)
T d1q8ya_ 8 EPYKDARYILVRKLGWGHFSTVWLAKDMV---NNTHVAMKIVRGD-------------------------------KVYT 53 (362)
T ss_dssp CEETTTTEEEEEEEEECSSEEEEEEEETT---TTEEEEEEEECSC-------------------------------HHHH
T ss_pred CCccCCcEEEEEEEeeCCCeEEEEEEECC---CCCEEEEEEEecc-------------------------------ccch
Confidence 3444 469999999999999999999987 8999999999653 1234
Q ss_pred HHHHHHHHHHHhhc----------CCCCcceeeEEEEe--CCeEEEEEecCCCCChHHHHH--hcCCCCCHHHHHHHHHH
Q 011582 196 EDVRREVKILRALT----------GHKNLVQFYDAYED--DDNIYIVMELCKGGELLDRIL--SRGGKYSEEDAKIVMVQ 261 (482)
Q Consensus 196 ~~~~~Ei~~l~~l~----------~hpniv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~--~~~~~l~~~~~~~i~~q 261 (482)
+.+.+|+.+++.+. +|+||+++++++.. ....+++|+++..+....... .....+++..++.++.|
T Consensus 54 ~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~q 133 (362)
T d1q8ya_ 54 EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133 (362)
T ss_dssp HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHH
Confidence 56788999888875 26889999998764 466777777776654433332 33568999999999999
Q ss_pred HHHHHHHHHH-CCCcccCCCCCceEEecCCCC---CcEEEEecccccccCCCCcccccccCccccCccccc-ccCCCcch
Q 011582 262 ILSVVAFCHF-QGVVHRDLKPENFLFTSKEEN---SSLKAIDFGLSDYVKPDERLNDIVGSAYYVAPEVLH-RSYGTEAD 336 (482)
Q Consensus 262 i~~~L~yLH~-~~ivHrDlkp~NIll~~~~~~---~~~kl~DfGla~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~D 336 (482)
|+.||.|||+ .||+||||||+|||++.++.. ..+||+|||.+.... ......+||+.|+|||++. ..|+.++|
T Consensus 134 il~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~D 211 (362)
T d1q8ya_ 134 LLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLGAPWGCGAD 211 (362)
T ss_dssp HHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHTCCCCTHHH
T ss_pred HHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeecccccccc--cccccccccccccChhhccccCCCcccc
Confidence 9999999998 899999999999999643322 258999999998654 2345678999999999876 46999999
Q ss_pred hhhhHHHHHHHhhCCCCCCCCChH------HHHHHHHhcCCC------------------------CCC-----------
Q 011582 337 MWSIGVIAYILLCGSRPFWARTES------GIFRAVLKADPS------------------------FDE----------- 375 (482)
Q Consensus 337 iwSlGvil~elltg~~pf~~~~~~------~~~~~i~~~~~~------------------------~~~----------- 375 (482)
|||+||++++|++|+.||...... +....+...... ...
T Consensus 212 iwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (362)
T d1q8ya_ 212 IWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT 291 (362)
T ss_dssp HHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH
T ss_pred ccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc
Confidence 999999999999999999654321 122211111000 000
Q ss_pred ---CCCCCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccC
Q 011582 376 ---APWPSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANS 415 (482)
Q Consensus 376 ---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~ 415 (482)
..+...++++++||.+||++||.+|||++|+|+||||++.
T Consensus 292 ~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 292 EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred cccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 0012246889999999999999999999999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=4.8e-27 Score=213.53 Aligned_cols=182 Identities=25% Similarity=0.254 Sum_probs=125.6
Q ss_pred eEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 123 YELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 123 y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
|.+++.||+|+||.||+|++. +|+.||||+++...... ... .... +.. .............+|+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~----~g~~vAvKi~r~~~~~~-~~~----~~~~------~~~-~~~~~~~~~~~~~~e~ 65 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE----KFGECVVKFHKVGHTSF-KKV----KEKR------DYG-DLHFSVLAIRSARNEF 65 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET----TTEEEEEEEECC-------CC----CC--------------CHHHHHHHHHHHHH
T ss_pred chhCCEeeeCcceEEEEEECC----CCCEEEEEEEecccchh-hhh----hhhh------hhc-cHHHHHHHHHHHHHHH
Confidence 568899999999999999874 68899999986431100 000 0000 000 0001122344567899
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCCC
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDRILSRGGKYSEEDAKIVMVQILSVVAFCHFQGVVHRDLKPE 282 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~yLH~~~ivHrDlkp~ 282 (482)
..+.++. |.+++..+++. . .+++|||++++.+. .+++..+..++.|++.+|.|||++||+||||||+
T Consensus 66 ~~l~~l~-~~~v~~~~~~~--~--~~lvme~~~~~~~~--------~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~ 132 (191)
T d1zara2 66 RALQKLQ-GLAVPKVYAWE--G--NAVLMELIDAKELY--------RVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQY 132 (191)
T ss_dssp HHHHHTT-TSSSCCEEEEE--T--TEEEEECCCCEEGG--------GCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTT
T ss_pred HHHHHcc-CCCcceEEEec--C--CEEEEEeecccccc--------chhhHHHHHHHHHHHHHHHHHhhCCEEEccCChh
Confidence 9999997 99999988653 2 37999999886542 2556667889999999999999999999999999
Q ss_pred ceEEecCCCCCcEEEEecccccccCCCCcccccccCccccC------cccccccCCCcchhhhhHHHH
Q 011582 283 NFLFTSKEENSSLKAIDFGLSDYVKPDERLNDIVGSAYYVA------PEVLHRSYGTEADMWSIGVIA 344 (482)
Q Consensus 283 NIll~~~~~~~~~kl~DfGla~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~DiwSlGvil 344 (482)
|||++ +..++|+|||+|........ ..|.. .+.+.+.|+.++|+||+.--+
T Consensus 133 NILv~----~~~~~liDFG~a~~~~~~~~-------~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 133 NVLVS----EEGIWIIDFPQSVEVGEEGW-------REILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp SEEEE----TTEEEECCCTTCEETTSTTH-------HHHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred heeee----CCCEEEEECCCcccCCCCCc-------HHHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 99995 23599999999976543221 11111 133456789999999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.60 E-value=6.5e-08 Score=89.62 Aligned_cols=88 Identities=13% Similarity=0.094 Sum_probs=62.6
Q ss_pred ccceEecceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHH
Q 011582 120 VAHYELGEEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVR 199 (482)
Q Consensus 120 ~~~y~~~~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (482)
...|+..+..+-|+.+.||++.. .++.++||+..... ......+.
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~~-----~~~~~vlk~~~~~~------------------------------~~~~~~~~ 57 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLVG-----ENENLYLKMTDSRY------------------------------KGTTYDVE 57 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEEC-----SSCEEEEEEECGGG------------------------------TTSTTCHH
T ss_pred hhceEEEEcCCCCCCCcEEEEEe-----CCCeEEEEEcCCCc------------------------------ccchhhHH
Confidence 45667766655555678998753 46778899875420 01112467
Q ss_pred HHHHHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCChHHH
Q 011582 200 REVKILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGELLDR 242 (482)
Q Consensus 200 ~Ei~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 242 (482)
+|..++..|..+--+.+++.+..+++..|+||++++|..+.+.
T Consensus 58 ~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 58 REKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp HHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred HHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 8999998887665577888888999999999999998876543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.04 E-value=9.4e-06 Score=79.62 Aligned_cols=85 Identities=18% Similarity=0.235 Sum_probs=50.3
Q ss_pred ceeecCCceEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILR 206 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~ 206 (482)
+.||.|....||++.... .|+.|+||.-.... .+. ++. -.....+...|+..|+
T Consensus 32 ~eig~G~~N~vfrV~~~~---~~~svivKqa~p~~-------r~~-g~~---------------~~~~~~R~~~E~~~L~ 85 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQE---HDRALIIKQAVPYA-------KVV-GES---------------WPLTIDRARIESSALI 85 (392)
T ss_dssp EECCSSSSEEEEEEEC-------CEEEEEEECCGG-------GC---CC---------------CCCCTTHHHHHHHHHH
T ss_pred EEeCCCceEeEEEEEeCC---CCeEEEEecCCchh-------ccc-CCC---------------CCCCHHHHHHHHHHHH
Confidence 458999999999998764 57789999653210 000 000 0011234567888888
Q ss_pred hhcCC--CCcceeeEEEEeCCeEEEEEecCCCCCh
Q 011582 207 ALTGH--KNLVQFYDAYEDDDNIYIVMELCKGGEL 239 (482)
Q Consensus 207 ~l~~h--pniv~l~~~~~~~~~~~lv~e~~~~g~L 239 (482)
.+..+ ..+.+++. .+++..++|||++.+..+
T Consensus 86 ~~~~~~p~~vP~v~~--~d~~~~~lvmE~L~~~~~ 118 (392)
T d2pula1 86 RQGEHVPHLVPRVFY--SDTEMAVTVMEDLSHLKI 118 (392)
T ss_dssp HHHTTCGGGSCCEEE--EETTTTEEEECCCTTSEE
T ss_pred HhhhhCCCCcceEEE--EcCCCCEEEEeccCCccc
Confidence 77544 23455554 356667899999987654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.98 E-value=4.4e-06 Score=76.43 Aligned_cols=74 Identities=15% Similarity=0.109 Sum_probs=51.6
Q ss_pred eecCCc-eEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHh
Q 011582 129 VGRGHF-GYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRA 207 (482)
Q Consensus 129 LG~G~f-G~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~ 207 (482)
+..|.. +.||++... .|..+++|.-... ....+.+|+..|+.
T Consensus 18 ~~~G~s~~~v~r~~~~----~~~~~vlK~~~~~---------------------------------~~~~l~~E~~~l~~ 60 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ----GRPVLFVKTDLSG---------------------------------ALNELQDEAARLSW 60 (255)
T ss_dssp CSCTTSSCEEEEEECT----TSCCEEEEEECSC---------------------------------TTSCHHHHHHHHHH
T ss_pred cCCcccCCeEEEEEeC----CCCEEEEEeCCcc---------------------------------CHhHHHHHHHHHHH
Confidence 344443 678988764 4667888975432 01246788888888
Q ss_pred hcCCC-CcceeeEEEEeCCeEEEEEecCCCCCh
Q 011582 208 LTGHK-NLVQFYDAYEDDDNIYIVMELCKGGEL 239 (482)
Q Consensus 208 l~~hp-niv~l~~~~~~~~~~~lv~e~~~~g~L 239 (482)
|..+. .+.+++.+..+++..++||++++|.++
T Consensus 61 L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 61 LATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp HHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred HHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 76432 356788888888999999999988654
|
| >d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=97.34 E-value=3.9e-05 Score=46.10 Aligned_cols=24 Identities=29% Similarity=0.585 Sum_probs=22.6
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.|++.|+.+|.|+||+||.+||+.
T Consensus 4 el~eAF~~FDkDg~G~Is~~EL~~ 27 (33)
T d2hf5a1 4 EIREAFRVFDKDGNGYISAAELRH 27 (33)
T ss_dssp HHHHHHHHHSSSCCSCBCHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHH
Confidence 688999999999999999999985
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.19 E-value=0.00041 Score=67.46 Aligned_cols=77 Identities=12% Similarity=0.052 Sum_probs=51.0
Q ss_pred ceeecCCceEEEEEEEecCC----CCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHH
Q 011582 127 EEVGRGHFGYTCSAKAKKGS----LKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREV 202 (482)
Q Consensus 127 ~~LG~G~fG~V~~a~~~~~~----~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei 202 (482)
+.|+-|-.-.+|++....+. ..++.|.+++.... .......+|.
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--------------------------------~~~idr~~E~ 95 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--------------------------------ETESHLVAES 95 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--------------------------------CCHHHHHHHH
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--------------------------------chhhHHHHHH
Confidence 45777888899999876432 12456777765321 0123456899
Q ss_pred HHHHhhcCCCCcceeeEEEEeCCeEEEEEecCCCCCh
Q 011582 203 KILRALTGHKNLVQFYDAYEDDDNIYIVMELCKGGEL 239 (482)
Q Consensus 203 ~~l~~l~~hpniv~l~~~~~~~~~~~lv~e~~~~g~L 239 (482)
.+++.+..+.-..++++++.+ .+||||++|..|
T Consensus 96 ~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 96 VIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 999999866545577777642 689999987543
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=97.02 E-value=0.00013 Score=53.59 Aligned_cols=34 Identities=32% Similarity=0.465 Sum_probs=30.9
Q ss_pred hhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..|+.+|+..++++|..+|.|+||+|+.+||+.
T Consensus 1 ~~~lt~eqi~el~~~F~~~D~d~~G~I~~~el~~ 34 (77)
T d1f54a_ 1 SSNLTEEQIAEFKEAFALFDKDNNGSISSSELAT 34 (77)
T ss_dssp CCCCCHHHHHHHHHHHHHTCTTCSSEEEHHHHHH
T ss_pred CCCCCHHHHHHHHHHHHHHcCCCCCeEChHHHHH
Confidence 3578899999999999999999999999999975
|
| >d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.97 E-value=0.00016 Score=41.62 Aligned_cols=25 Identities=20% Similarity=0.480 Sum_probs=22.4
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..|.+.|..+|.|.||+|..+||.+
T Consensus 4 eELae~FRifDkNaDGyiD~eEl~~ 28 (34)
T d1ctda_ 4 EELANAFRIFDKNADGYIDIEELGE 28 (34)
T ss_dssp HHHHHHHHTTCCSSSSCBCHHHHHH
T ss_pred HHHHHHHHHHccCCcccccHHHHHH
Confidence 3578999999999999999999975
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.90 E-value=0.0012 Score=62.22 Aligned_cols=69 Identities=9% Similarity=0.083 Sum_probs=45.1
Q ss_pred eEEEEEEEecCCCCCceEEEEEeecccchhhhhccCCCCCCcchhhhhhhhhhccccHHHHHHHHHHHHHHHhhcCCC-C
Q 011582 135 GYTCSAKAKKGSLKGQDVAVKVIPKMIGVIFLQVHCPKHENHQFTILDEYCCLFMTTAIAIEDVRREVKILRALTGHK-N 213 (482)
Q Consensus 135 G~V~~a~~~~~~~~g~~vAvK~i~k~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ei~~l~~l~~hp-n 213 (482)
-.||++... +|..|++|+.+.. ....+++..|...+..|..+. -
T Consensus 36 N~vy~v~~~----dg~~~VlK~~rp~-------------------------------~~s~~~i~~E~~~l~~L~~~gip 80 (325)
T d1zyla1 36 NRVYQFQDE----DRRRFVVKFYRPE-------------------------------RWTADQILEEHQFALQLVNDEVP 80 (325)
T ss_dssp SEEEEECCT----TCCCEEEEEECTT-------------------------------TSCHHHHHHHHHHHHHHHHTTCS
T ss_pred ceeEEEEcC----CCCEEEEEEeCCC-------------------------------CCCHHHHHHHHHHHHHHHhcCCC
Confidence 489998764 5888999997542 012356778999888886321 1
Q ss_pred cceee-----EEEEeCCeEEEEEecCCCCC
Q 011582 214 LVQFY-----DAYEDDDNIYIVMELCKGGE 238 (482)
Q Consensus 214 iv~l~-----~~~~~~~~~~lv~e~~~~g~ 238 (482)
++..+ ..+...+..+.++++++|..
T Consensus 81 v~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 81 VAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp BCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred CCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 11111 13456788999999997643
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=96.77 E-value=0.00031 Score=50.85 Aligned_cols=32 Identities=28% Similarity=0.462 Sum_probs=29.4
Q ss_pred cCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 450 TLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.|+.+|+..++.+|..+|.|+||+|+.+||+.
T Consensus 1 qLs~eei~el~~~F~~~D~d~~G~I~~~el~~ 32 (73)
T d2pq3a1 1 QLTEEQIAEFKEAFSLFDKDGDGTITTKELGT 32 (73)
T ss_dssp CCCHHHHHHHHHHHHHTCTTSSSEEEGGGHHH
T ss_pred CcCHHHHHHHHHHHHHHcCCCCceEeHHHHHH
Confidence 36888999999999999999999999999975
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=96.50 E-value=0.00052 Score=50.71 Aligned_cols=30 Identities=23% Similarity=0.193 Sum_probs=26.4
Q ss_pred CHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 452 TVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 452 ~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+.+++..++++|..+|.|+||+|+.+||+.
T Consensus 1 T~ee~~e~~~~F~~~D~d~~G~I~~~El~~ 30 (81)
T d2opoa1 1 TPQDIADRERIFKRFDTNGDGKISSSELGD 30 (81)
T ss_dssp CHHHHHHHHHHHHHHCTTCSSEEEHHHHHH
T ss_pred CHHHHHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 457888999999999999999999999875
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.42 E-value=0.00066 Score=50.12 Aligned_cols=32 Identities=19% Similarity=0.299 Sum_probs=28.9
Q ss_pred cCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 450 TLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.|+.+++..+++.|..+|.|+||+|+.+||+.
T Consensus 7 ~Lt~~~i~el~~~F~~~D~d~~G~I~~~el~~ 38 (81)
T d1avsa_ 7 FLSEEMIAEFKAAFDMFDADGGGDISTKELGT 38 (81)
T ss_dssp HBCHHHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred cCCHHHHHHHHHHHHHHcCCCCCeEchhHHHH
Confidence 46888999999999999999999999999975
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=96.31 E-value=0.00095 Score=49.38 Aligned_cols=35 Identities=20% Similarity=0.278 Sum_probs=24.1
Q ss_pred hhhcCCHHHHHHHHHHHhhhCCC-CCCccchhhhhc
Q 011582 447 LAKTLTVPQLAYLREQFTLLAPN-KNGFISMQNYKM 481 (482)
Q Consensus 447 ~~~~~~~~~~~~l~~~f~~~d~n-~dg~i~~~e~~~ 481 (482)
.+..++.+|+..+++.|..+|.| +||+|+..||+.
T Consensus 5 ~~~~ls~eq~~~~~~~F~~fD~d~~~G~I~~~el~~ 40 (82)
T d1wrka1 5 AVEQLTEEQKNEFKAAFDIFVLGAEDGSISTKELGK 40 (82)
T ss_dssp HHHHCCHHHHHHHHHHHHHHTTTCTTSSBCHHHHHH
T ss_pred HHhhCCHHHHHHHHHHHHHHcCcCCCCeEeHHHHHH
Confidence 34566777777777777777777 367777777764
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=96.19 E-value=0.00015 Score=54.56 Aligned_cols=23 Identities=13% Similarity=0.293 Sum_probs=14.2
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+.++|..+|.|+||+|+.+||..
T Consensus 61 ~~~l~~~~D~d~~g~I~~~EFl~ 83 (87)
T d1s6ja_ 61 IKDLMDAADIDKSGTIDYGEFIA 83 (87)
T ss_dssp HHHHHHHHCTTCSSEECHHHHTT
T ss_pred HHHHHHHcCCCCCCeEeHHHHHH
Confidence 45566666666666666666643
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.40 E-value=0.018 Score=53.28 Aligned_cols=31 Identities=32% Similarity=0.464 Sum_probs=25.2
Q ss_pred CCCcccCCCCCceEEecCCCCCcEEEEecccccc
Q 011582 272 QGVVHRDLKPENFLFTSKEENSSLKAIDFGLSDY 305 (482)
Q Consensus 272 ~~ivHrDlkp~NIll~~~~~~~~~kl~DfGla~~ 305 (482)
.|+||+|+.++||+++ .+...-|+||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~---~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFL---GDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEE---TTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcc---cccceeEeccccccc
Confidence 4799999999999994 455568999997753
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.38 E-value=0.004 Score=47.18 Aligned_cols=30 Identities=20% Similarity=0.266 Sum_probs=18.8
Q ss_pred CCHHHHHHHHHHHhhhCCCCCCccchhhhh
Q 011582 451 LTVPQLAYLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 451 ~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
++.++..++.++|..+|.|+||+|+.+|++
T Consensus 4 lt~~e~~~~~~~F~~~D~d~~G~is~~e~~ 33 (95)
T d1c07a_ 4 VSPAEKAKYDEIFLKTDKDMDGFVSGLEVR 33 (95)
T ss_dssp SCSHHHHHHHHHHHHHCTTCSSEECHHHHH
T ss_pred CCHHHHHHHHHHHHHHCCCCCCCCcHHHHH
Confidence 445555666666666666666666666654
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.31 E-value=0.003 Score=44.19 Aligned_cols=24 Identities=29% Similarity=0.585 Sum_probs=18.9
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.|+++|+.+|.|++|+|+.+||+.
T Consensus 4 el~~aF~~fD~d~~G~I~~~el~~ 27 (65)
T d1fw4a_ 4 EIREAFRVFDKDGNGYISAAELRH 27 (65)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHHHcCCCCCcCCHHHHHH
Confidence 467888888888888888888764
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.15 E-value=0.0036 Score=43.18 Aligned_cols=24 Identities=13% Similarity=0.328 Sum_probs=19.2
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+++.|..+|.|++|+|+.+||+.
T Consensus 2 el~~aF~~fD~~~~G~I~~~el~~ 25 (61)
T d2fcea1 2 DFVKAFQVFDKESTGKVSVGDLRY 25 (61)
T ss_dssp HHHHHHHHHCTTCCSCEEHHHHHH
T ss_pred hHHHHHHHHCCCCCCeEeHHHHHH
Confidence 467788888888888888888864
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.97 E-value=0.0069 Score=45.49 Aligned_cols=30 Identities=37% Similarity=0.522 Sum_probs=19.5
Q ss_pred CCHHHHHHHHHHHhhhCCCCCCccchhhhh
Q 011582 451 LTVPQLAYLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 451 ~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
++.++..+++++|..+|.|+||+|+.+|++
T Consensus 3 ls~ee~~~y~~~F~~~D~d~~G~i~~~e~~ 32 (92)
T d1fi6a_ 3 ITDEQRQYYVNQFKTIQPDLNGFIPGSAAK 32 (92)
T ss_dssp CCHHHHHHHHHHHTTTCCSTTCEEEHHHHH
T ss_pred CCHHHHHHHHHHHHHhCCCcccchhHHHHH
Confidence 455666666666666666666666666665
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=94.47 E-value=0.0059 Score=44.13 Aligned_cols=25 Identities=16% Similarity=0.424 Sum_probs=18.7
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..|+++|..+|.|+||+|+.+||+.
T Consensus 9 e~l~~~F~~~D~d~~G~I~~~el~~ 33 (77)
T d1oqpa_ 9 EEILKAFRLFDDDNSGTITIKDLRR 33 (77)
T ss_dssp HHHHHHHHHHCTTCSSSEEHHHHHH
T ss_pred HHHHHHHHHHcCCCCCEechHHHHH
Confidence 3577778888888888888877764
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=94.45 E-value=0.0065 Score=43.72 Aligned_cols=24 Identities=25% Similarity=0.495 Sum_probs=19.9
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.|+.+|..+|.|+||+|+.+||+.
T Consensus 10 el~~~F~~fD~~~~G~I~~~el~~ 33 (75)
T d1jc2a_ 10 ELANCFRIFDKNADGFIDIEELGE 33 (75)
T ss_dssp HHHHHHHHHCCSTTSSEEHHHHHH
T ss_pred HHHHHHHHHcCCCcCeEcHHHHHH
Confidence 577888888888888888888874
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=94.44 E-value=0.0057 Score=42.95 Aligned_cols=22 Identities=23% Similarity=0.549 Sum_probs=13.6
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
++++|+.+|.|+||+|+.+||+
T Consensus 3 ~r~~F~~~D~d~~G~I~~~El~ 24 (67)
T d1tiza_ 3 AKRVFEKFDKNKDGKLSLDEFR 24 (67)
T ss_dssp HHHHHHHHCTTSSSCEEHHHHH
T ss_pred HHHHHHHHCCCCcCcCcHHHHH
Confidence 3456666666666666666665
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=94.40 E-value=0.0068 Score=44.32 Aligned_cols=24 Identities=25% Similarity=0.636 Sum_probs=19.5
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+|+++|..+|.|+||+|+.+||+.
T Consensus 16 ~l~~~F~~~D~d~~G~I~~~el~~ 39 (81)
T d1fi5a_ 16 ELSDLFRMFDKNADGYIDLEELKI 39 (81)
T ss_dssp HHHHHHHHHCSSCSSEECHHHHHH
T ss_pred HHHHHHHHHcCCCCCcccHHHHHH
Confidence 577888888888888888888864
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=94.07 E-value=0.0064 Score=42.86 Aligned_cols=24 Identities=21% Similarity=0.534 Sum_probs=16.9
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.|+++|..+|.|++|+|+.+||+.
T Consensus 3 el~~~F~~~D~d~~G~I~~~el~~ 26 (68)
T d1c7va_ 3 EILRAFKVFDANGDGVIDFDEFKF 26 (68)
T ss_dssp HHHHHHHHHSCSGGGEECHHHHHH
T ss_pred HHHHHHHHHcCCCcCeEcHHHHHH
Confidence 366777777777777777777764
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=93.90 E-value=0.017 Score=44.78 Aligned_cols=24 Identities=8% Similarity=0.159 Sum_probs=17.0
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.|+.+||..
T Consensus 81 e~~~~~~~~D~d~dG~I~~~EF~~ 104 (109)
T d5pala_ 81 ETKALLAAGDSDHDGKIGADEFAK 104 (109)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHH
T ss_pred HHHHHHHHhCCCCCCCEeHHHHHH
Confidence 377777777777777777777753
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.69 E-value=0.014 Score=42.74 Aligned_cols=26 Identities=15% Similarity=0.291 Sum_probs=21.3
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...+.+.|..+|.|++|+|+.+||+.
T Consensus 19 ~~~l~~~F~~~D~~~~G~i~~~ef~~ 44 (83)
T d1wlza1 19 YHAITQEFENFDTMKTNTISREEFRA 44 (83)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHH
T ss_pred HHHHHHHHHHHCCCCCceEChhHHHH
Confidence 45678888888888888888888874
|
| >d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin-related protein T21P5.17 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=93.60 E-value=0.027 Score=39.18 Aligned_cols=36 Identities=14% Similarity=0.199 Sum_probs=27.7
Q ss_pred HHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 443 ALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 443 ~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++..+...++.++ +..+|..+|.|+||.|+.+||..
T Consensus 26 ~l~~lg~~~~~~~---i~~~~~~~D~d~dg~I~~~EF~~ 61 (67)
T d1tiza_ 26 VALAFSPYFTQED---IVKFFEEIDVDGNGELNADEFTS 61 (67)
T ss_dssp HHHHTCTTSCHHH---HHHHHHHHCCSSSSEECHHHHHH
T ss_pred HHHHhccccchHH---HHHHHHHhCCCCCCeEeHHHHHH
Confidence 3344555666554 66889999999999999999974
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=93.55 E-value=0.017 Score=44.80 Aligned_cols=25 Identities=20% Similarity=0.477 Sum_probs=19.7
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++++|+.+|.|+||+|+.+||+.
T Consensus 41 ~~~~~~F~~~D~d~~G~I~~~El~~ 65 (109)
T d1pvaa_ 41 NDVKKVFKAIDADASGFIEEEELKF 65 (109)
T ss_dssp HHHHHHHHHHCTTCSSSBCHHHHHT
T ss_pred HHHHHHhhCccCCCcCeEcHHHHHH
Confidence 3466788888888888888888864
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.44 E-value=0.02 Score=43.12 Aligned_cols=21 Identities=14% Similarity=0.416 Sum_probs=11.5
Q ss_pred HHHHHhhhCCCCCCccchhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNY 479 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~ 479 (482)
|.+++...|.|+||+|+++||
T Consensus 45 L~~Iw~~~D~~~dG~l~~~EF 65 (95)
T d2jxca1 45 LGRVWELSDIDHDGMLDRDEF 65 (95)
T ss_dssp HHHHHHHHCTTCSSEEEHHHH
T ss_pred HHHHHHHhcCCCCCeEcHHHH
Confidence 444555555555555555555
|
| >d1k94a_ a.39.1.8 (A:) Grancalcin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Grancalcin species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.28 E-value=0.11 Score=43.15 Aligned_cols=25 Identities=12% Similarity=0.300 Sum_probs=19.1
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+++.+|+.+|.|++|+||.+||+.
T Consensus 70 ~~~~~~F~~fD~d~sG~I~~~El~~ 94 (165)
T d1k94a_ 70 NAWKENFMTVDQDGSGTVEHHELRQ 94 (165)
T ss_dssp HHHHHHHHHHCTTCCSBCCHHHHHH
T ss_pred chhHHHHHHhCCCCCCeEcHHHHHH
Confidence 4566778888888888888888765
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.98 E-value=0.021 Score=43.25 Aligned_cols=25 Identities=4% Similarity=0.234 Sum_probs=22.4
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+..+|..+|.|+||.||.+||..
T Consensus 68 ~~v~~~~~~~D~d~DG~Is~~EF~~ 92 (99)
T d1snla_ 68 RMREHVMKNVDTNQDRLVTLEEFLA 92 (99)
T ss_dssp HHHHHHHHHTCSSCSSEEEHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcCcHHHHHH
Confidence 4578899999999999999999975
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=92.90 E-value=0.023 Score=43.86 Aligned_cols=25 Identities=12% Similarity=0.481 Sum_probs=19.4
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++++|..+|.|+||+|+.+||+.
T Consensus 41 ~~l~~~F~~~D~d~~G~I~~~El~~ 65 (108)
T d1rroa_ 41 SQVKDIFRFIDNDQSGYLDGDELKY 65 (108)
T ss_dssp HHHHHHHHHHCTTCSSEECTHHHHT
T ss_pred HHHHHHHhhhcCCCCCeEcHHHHHH
Confidence 4567788888888888888888764
|
| >d1snla_ a.39.1.7 (A:) Nucleobindin 1 (CALNUC) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: Nucleobindin 1 (CALNUC) species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.69 E-value=0.016 Score=43.98 Aligned_cols=23 Identities=22% Similarity=0.313 Sum_probs=21.1
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++..|..+|.|+||+|+.+||+.
T Consensus 18 ~r~~F~~~D~DgdG~i~~~El~~ 40 (99)
T d1snla_ 18 PKTFFILHDINSDGVLDEQELEA 40 (99)
T ss_dssp HHHHHHHHCSSCCSEEEHHHHHH
T ss_pred HHHHHHHHCCCCCCcCCHHHHHH
Confidence 57899999999999999999975
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.42 E-value=0.018 Score=44.67 Aligned_cols=22 Identities=14% Similarity=0.314 Sum_probs=13.0
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
|.+++...|.|+||+|+++||.
T Consensus 58 L~~Iw~l~D~d~dG~l~~~EF~ 79 (110)
T d1iq3a_ 58 LSYIWELSDADCDGALTLPEFC 79 (110)
T ss_dssp HHHHHHHHCSSSCSEEEHHHHH
T ss_pred HHHHHHHhccCCCCeECHHHHH
Confidence 4456666666666666666653
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=92.23 E-value=0.026 Score=43.63 Aligned_cols=24 Identities=25% Similarity=0.493 Sum_probs=17.3
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++.+|..+|.|+||+|+.+||+.
T Consensus 42 ~~~~~F~~~D~d~~G~I~~~El~~ 65 (109)
T d1rwya_ 42 DVKKVFHILDKDKSGFIEEDELGS 65 (109)
T ss_dssp HHHHHHHHHSTTCSSEECHHHHHT
T ss_pred HHHHHhhcccCCCCCcCcHHHHHH
Confidence 456677777777777777777764
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=92.09 E-value=0.038 Score=42.49 Aligned_cols=24 Identities=25% Similarity=0.581 Sum_probs=16.6
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.|+.+|+.+|.|+||+|+.+||+.
T Consensus 41 ~l~~~F~~~D~d~~G~I~~~el~~ 64 (107)
T d2pvba_ 41 DVKKAFYVIDQDKSGFIEEDELKL 64 (107)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHT
T ss_pred HHHHHHHhhccCCCCcCcHHHHHH
Confidence 466677777777777777777654
|
| >d3c1va1 a.39.1.2 (A:2-94) Calcyclin (S100) {Human (Homo sapiens), s100a4 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a4 [TaxId: 9606]
Probab=91.81 E-value=0.038 Score=41.30 Aligned_cols=24 Identities=17% Similarity=0.358 Sum_probs=21.2
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++|..+|.|+||.|+++||..
T Consensus 53 ~~~~i~~~~D~n~DG~I~F~EF~~ 76 (93)
T d3c1va1 53 AFQKLMSNLDSNRDNEVDFQEYCV 76 (93)
T ss_dssp HHHHHHHHHCTTCSSSEEHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCCHHHHHH
Confidence 467899999999999999999863
|
| >d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-dependent protein kinase sk5 CLD species: Soybean (Glycine max) [TaxId: 3847]
Probab=91.73 E-value=0.077 Score=38.93 Aligned_cols=37 Identities=22% Similarity=0.425 Sum_probs=33.6
Q ss_pred HhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 445 GALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 445 ~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..|+..++.+++..|+++|..+|.|++|+|+.+||+.
T Consensus 11 ~~ma~~l~~~~i~~l~~~F~~~D~d~~G~I~~~el~~ 47 (87)
T d1s6ja_ 11 KHMAERLSEEEIGGLKELFKMIDTDNSGTITFDELKD 47 (87)
T ss_dssp HHSSSSSCSSSTTTTTTHHHHHCTTCSSCEEHHHHHH
T ss_pred HHHHhhCCHHHHHHHHHHHHHHcCCCCCcCcHHHHHH
Confidence 4577888889999999999999999999999999975
|
| >d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=91.43 E-value=0.082 Score=36.34 Aligned_cols=36 Identities=14% Similarity=0.244 Sum_probs=28.2
Q ss_pred HHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 443 ALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 443 ~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++..+...++..+ +..+|..+|.|+||.|+.+||..
T Consensus 28 ~l~~lg~~~~~~e---~~~l~~~~D~d~~g~I~~~eF~~ 63 (65)
T d1fw4a_ 28 VMTNLGEKLTDEE---VDEMIREADIDGDGQVNYEEFVQ 63 (65)
T ss_dssp HHHHTTCCCCHHH---HHHHHHTTCTTCSSSEEHHHHHH
T ss_pred HHHHhCCCCCHHH---HHHHHHHcCCCCCCcEeHHHHHH
Confidence 4455566677655 56788999999999999999964
|
| >d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Cow (Bos taurus) [TaxId: 9913]
Probab=91.41 E-value=0.084 Score=35.77 Aligned_cols=35 Identities=23% Similarity=0.310 Sum_probs=27.2
Q ss_pred HHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 444 LGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 444 ~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+...++..+ +..+|+.+|.|+||.|+.+||-+
T Consensus 27 l~~~g~~~~~~e---i~~l~~~~D~d~dg~I~~~eFl~ 61 (61)
T d2fcea1 27 LTGLGEKLTDAE---VDELLKGVEVDSNGEIDYKKFIE 61 (61)
T ss_dssp HHHTTCCCCHHH---HHHHHTTCCCCTTSEECHHHHHH
T ss_pred HHHcCCCCCHHH---HHHHHHHcCCCCCCcEeHHHhcC
Confidence 445556667665 55789999999999999999853
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=91.40 E-value=0.047 Score=40.69 Aligned_cols=23 Identities=13% Similarity=0.244 Sum_probs=20.7
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+.++|..+|.|+||+|+++||.
T Consensus 50 ~v~~~~~~~D~n~DG~I~F~EF~ 72 (92)
T d1a4pa_ 50 AVDKIMKDLDQCRDGKVGFQSFF 72 (92)
T ss_dssp HHHHHHHHHCTTSSSCBCHHHHH
T ss_pred HHHHHHHHHhCCCCCCCcHHHHH
Confidence 36788999999999999999985
|
| >d1e8aa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin C, s100a12 [TaxId: 9606]
Probab=91.40 E-value=0.048 Score=40.21 Aligned_cols=25 Identities=24% Similarity=0.356 Sum_probs=22.2
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+.+++..+|.|+||.|+++||..
T Consensus 51 ~~v~~~~~~lD~n~Dg~idF~EF~~ 75 (87)
T d1e8aa_ 51 AVIDEIFQGLDANQDEQVDFQEFIS 75 (87)
T ss_dssp HHHHHHHHHHCTTCSSCEEHHHHHH
T ss_pred HHHHHHHHHHcCCCCCcCCHHHHHH
Confidence 4578999999999999999999963
|
| >d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]
Probab=90.68 E-value=0.081 Score=38.18 Aligned_cols=35 Identities=23% Similarity=0.257 Sum_probs=27.0
Q ss_pred HHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 444 LGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 444 ~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+...++..+ +..+|..+|.|+||+|+.+||..
T Consensus 41 l~~~g~~~~~~e---v~~~~~~~D~d~dg~I~~~EF~~ 75 (81)
T d1fi5a_ 41 LQATGETITEDD---IEELMKDGDKNNDGRIDYDEFLE 75 (81)
T ss_dssp HHTSSSCCCHHH---HHHHHHHHCSSSSSSEEHHHHHH
T ss_pred HHhcCCCCCHHH---HHHHHHHHCCCCCCcEeHHHHHH
Confidence 344555666655 55788999999999999999964
|
| >d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium vector protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=90.54 E-value=0.03 Score=39.19 Aligned_cols=28 Identities=21% Similarity=0.284 Sum_probs=22.8
Q ss_pred CCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 451 LTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 451 ~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++.. .+..+|..+|.|+||.|+.+||..
T Consensus 36 ~s~~---e~~~~~~~~D~d~dG~i~~~EF~~ 63 (68)
T d1c7va_ 36 LTDA---EVEEAMKEADEDGNGVIDIPEFMD 63 (68)
T ss_dssp CCHH---HHHHHHHHHCSSGGGSEEHHHHHH
T ss_pred CCHH---HHHHHHHHhCCCCCCcEeHHHHHH
Confidence 5544 456788999999999999999964
|
| >d1ksoa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a3 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a3 [TaxId: 9606]
Probab=90.46 E-value=0.04 Score=41.21 Aligned_cols=25 Identities=16% Similarity=0.236 Sum_probs=21.8
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+.++++.+|.|+||+|+++||..
T Consensus 52 ~~~~~~~~~lD~n~Dg~IdF~EF~~ 76 (93)
T d1ksoa_ 52 CDYNKFMSVLDTNKDCEVDFVEYVR 76 (93)
T ss_dssp HHHHHHHHHHHHTTTCEECHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCcHHHHHH
Confidence 3577889999999999999999963
|
| >d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.41 E-value=0.044 Score=41.10 Aligned_cols=24 Identities=17% Similarity=0.346 Sum_probs=21.3
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.|.++|+..|.|+||+|+++||..
T Consensus 45 ~l~~i~~~~D~d~dG~l~~~EF~~ 68 (95)
T d1c07a_ 45 LLAHIWSLCDTKDCGKLSKDQFAL 68 (95)
T ss_dssp HHHHHHHHHCTTCSSSEETTTHHH
T ss_pred HHHHHHHHhCCCCCCeEcHHHHHH
Confidence 467899999999999999999853
|
| >d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Caltractin (centrin 2) species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=90.27 E-value=0.13 Score=36.61 Aligned_cols=35 Identities=20% Similarity=0.219 Sum_probs=26.6
Q ss_pred HHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 444 LGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 444 ~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+...++..+ +..+|..+|.|+||.|+.+||..
T Consensus 35 l~~~g~~~~~~e---~~~~~~~~D~d~~G~I~~~EF~~ 69 (77)
T d1oqpa_ 35 AKELGENLTEEE---LQEMIAEADRNDDNEIDEDEFIR 69 (77)
T ss_dssp HHHHTCCCCHHH---HHHHHHHHCCSSSSEECHHHHHH
T ss_pred HHHhCCCCCHHH---HHHHHHHhCCCCCCcEeHHHHHH
Confidence 344555566554 56788999999999999999864
|
| >d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Polcalcin domain: Polcalcin Che a 3 species: Pigweed (Chenopodium album) [TaxId: 3559]
Probab=90.20 E-value=0.064 Score=38.80 Aligned_cols=24 Identities=21% Similarity=0.472 Sum_probs=21.4
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.|+.+||..
T Consensus 42 ei~~~~~~~D~d~~G~I~~~EF~~ 65 (81)
T d2opoa1 42 EVRRMMAEIDTDGDGFISFDEFTD 65 (81)
T ss_dssp HHHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHHhCCCCCCeEeHHHHHH
Confidence 367889999999999999999964
|
| >d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=89.93 E-value=0.12 Score=36.63 Aligned_cols=36 Identities=14% Similarity=0.216 Sum_probs=27.9
Q ss_pred HHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 443 ALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 443 ~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++..+...++..+ +..+|..+|.|+||+|+.+||..
T Consensus 34 ~l~~lg~~~~~~e---~~~~~~~~D~d~dg~I~~~EF~~ 69 (75)
T d1jc2a_ 34 ILRATGEHVIEED---IEDLMKDSDKNNDGRIDFDEFLK 69 (75)
T ss_dssp HHHHSSSCCCHHH---HHHHHHHHCSSSCSEECHHHHHH
T ss_pred HHHhcCCCccHHH---HHHHHHHhCCCCCCcEeHHHHHH
Confidence 3444556677665 56788999999999999999964
|
| >d3cr5x1 a.39.1.2 (X:0-89) Calcyclin (S100) {Cow (Bos taurus), s100b [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Cow (Bos taurus), s100b [TaxId: 9913]
Probab=89.86 E-value=0.08 Score=39.17 Aligned_cols=24 Identities=13% Similarity=0.261 Sum_probs=21.4
Q ss_pred HHHHHHHhhhCCCCCCccchhhhh
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
..+.++|+.+|.|+||.|+++||.
T Consensus 52 ~~~d~~m~~LD~n~Dg~vdF~EF~ 75 (90)
T d3cr5x1 52 EVVDKVMETLDSDGDGECDFQEFM 75 (90)
T ss_dssp HHHHHHHHHHCTTSSSSBCHHHHH
T ss_pred HHHHHHHHHhcCCCCCcCCHHHHH
Confidence 347789999999999999999985
|
| >d1xk4c1 a.39.1.2 (C:4-86) Calcyclin (S100) {Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a9 (mrp14) [TaxId: 9606]
Probab=89.86 E-value=0.11 Score=37.74 Aligned_cols=25 Identities=12% Similarity=0.173 Sum_probs=22.5
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhh
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
-..+.++|+.+|.|+||.|+++||.
T Consensus 53 ~~~vd~~m~~LD~n~Dg~vdF~EF~ 77 (83)
T d1xk4c1 53 EKVIEHIMEDLDTNADKQLSFEEFI 77 (83)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCcHHHHH
Confidence 4568899999999999999999985
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=89.70 E-value=0.072 Score=39.64 Aligned_cols=25 Identities=16% Similarity=0.292 Sum_probs=21.6
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+.++|+.+|.|+||.|+.+||..
T Consensus 52 ~~~~~~~~~~D~d~dG~Idf~EF~~ 76 (93)
T d1zfsa1 52 DAVDKIMKELDENGDGEVDFQEFVV 76 (93)
T ss_dssp HHHHHHHHHHTTTCCSEECSHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCcHHHHHH
Confidence 3466889999999999999999963
|
| >d1wrka1 a.39.1.5 (A:4-85) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]
Probab=89.66 E-value=0.17 Score=36.56 Aligned_cols=36 Identities=14% Similarity=0.303 Sum_probs=28.2
Q ss_pred HHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 443 ALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 443 ~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++..+...++..+ +.++|..+|.|+||.|+.+||..
T Consensus 41 ~l~~lg~~~t~~e---l~~~i~~~D~d~~G~I~f~eFl~ 76 (82)
T d1wrka1 41 VMRMLGQNPTPEE---LQEMIDEVDEDGSGTVDFDEFLV 76 (82)
T ss_dssp HHHHTTCCCCHHH---HHHHHHTTCTTCCSSBCHHHHHH
T ss_pred HHHHcCCCCCHHH---HHHHHHHhCCCCCCeEeHHHHHH
Confidence 4455666666554 66888999999999999999964
|
| >d1jfja_ a.39.1.5 (A:) EHCABP {Entamoeba (Entamoeba histolytica) [TaxId: 5759]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: EHCABP species: Entamoeba (Entamoeba histolytica) [TaxId: 5759]
Probab=89.57 E-value=0.025 Score=44.75 Aligned_cols=94 Identities=14% Similarity=0.241 Sum_probs=47.0
Q ss_pred HHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCCCccHH-HHHHHHHHhc--cchHHHHHHHhhhhcCCHHHHHHH
Q 011582 383 PEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMI-VYKLIKAYIS--SSSLRKAALGALAKTLTVPQLAYL 459 (482)
Q Consensus 383 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~l 459 (482)
.+..+-+.+.+..+-..+.+..|.+. |+............. .....+.+-. ...+...-+..+...+.. ..+
T Consensus 35 ~~~~~~~~~~~D~~~~g~i~~~Ef~~--~~~~~~~~~~~~~~~~~~~~F~~~D~~~~g~i~~~el~~~~~~~~~---~~~ 109 (134)
T d1jfja_ 35 EQLLQLIFKSIDADGNGEIDQNEFAK--FYGSIQGQDLSDDKIGLKVLYKLMDVDGDGKLTKEEVTSFFKKHGI---EKV 109 (134)
T ss_dssp HHHHHHHHHHHCSSCCSEEEHHHHHH--HTTCSSCCSSHHHHHHHHHHHHHHCCSSSSEEEHHHHHHHHTTTTC---HHH
T ss_pred HHHHHHHHHHhhhccccccccccccc--ccccccccccccccccccccccccccccCCcccHHHHHHHHHhcCc---HHH
Confidence 33444445556666677777777654 232221111111111 1111122211 112222223333333433 346
Q ss_pred HHHHhhhCCCCCCccchhhhhc
Q 011582 460 REQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 460 ~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.|..+|.|+||+||.+||.+
T Consensus 110 ~~~~~~~D~d~dG~is~~EF~~ 131 (134)
T d1jfja_ 110 AEQVMKADANGDGYITLEEFLE 131 (134)
T ss_dssp HHHHHHHHCSSSSEEEHHHHHH
T ss_pred HHHHHHHCCCCCCCCCHHHHHH
Confidence 6789999999999999999975
|
| >d1xk4a1 a.39.1.2 (A:1-87) Calcyclin (S100) {Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), calgranulin s100a8, MRP8 [TaxId: 9606]
Probab=89.34 E-value=0.086 Score=38.72 Aligned_cols=24 Identities=21% Similarity=0.285 Sum_probs=21.2
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.+++..+|.|+||+|+++||..
T Consensus 50 ~v~~i~~~~D~n~DG~IdF~EF~~ 73 (87)
T d1xk4a1 50 GADVWFKELDINTDGAVNFQEFLI 73 (87)
T ss_dssp CHHHHHHHHCTTCSSSBCHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHH
Confidence 367889999999999999999963
|
| >d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=89.15 E-value=0.16 Score=36.03 Aligned_cols=35 Identities=9% Similarity=0.187 Sum_probs=27.6
Q ss_pred HHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 444 LGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 444 ~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+...++..+ +.++|..+|.|+||.|+.+||..
T Consensus 36 l~~~g~~~t~~e---~~~~~~~~D~~~~g~I~~~eF~~ 70 (77)
T d1f54a_ 36 MRSLGLSPSEAE---VNDLMNEIDVDGNHQIEFSEFLA 70 (77)
T ss_dssp HHHHTCCCCHHH---HHHHHHTTCCSSCCEEEHHHHHH
T ss_pred HHHhCCCCCHHH---HHHHHHHhCCCCCCeEeHHHHHH
Confidence 445566666554 66889999999999999999964
|
| >d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Rattus norvegicus [TaxId: 10116]
Probab=89.14 E-value=0.15 Score=35.73 Aligned_cols=36 Identities=17% Similarity=0.335 Sum_probs=27.4
Q ss_pred HHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 443 ALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 443 ~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++..+...++..+ +..+|..+|.|+||.|+.+||..
T Consensus 33 ~l~~~g~~~s~~~---~~~~~~~~D~d~~g~I~f~eF~~ 68 (73)
T d2pq3a1 33 VMRSLGQNPTEAE---LQDMINEVDADGNGTIDFPEFLT 68 (73)
T ss_dssp HHHHTTCCCCHHH---HHHHHHHHCTTCSSEEEHHHHHH
T ss_pred HHHHhCCCCCHHH---HHHHHHHhCCCCCCeEeHHHHHH
Confidence 3444555666554 56888999999999999999964
|
| >d1fi6a_ a.39.1.6 (A:) Reps1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Reps1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=88.97 E-value=0.09 Score=38.98 Aligned_cols=23 Identities=17% Similarity=0.349 Sum_probs=21.0
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.|.++++..|.|+||+|+++||.
T Consensus 44 ~l~~i~~~~D~d~dG~l~~~EF~ 66 (92)
T d1fi6a_ 44 ELSHIWELSDFDKDGALTLDEFC 66 (92)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHH
T ss_pred HHHHHHHHhCCCCCCeecHHHHH
Confidence 57789999999999999999995
|
| >d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=88.93 E-value=0.085 Score=42.37 Aligned_cols=22 Identities=14% Similarity=0.258 Sum_probs=10.7
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
+.++|+.+|.|++|+|+.+||+
T Consensus 83 l~~aF~~~D~d~~G~I~~~el~ 104 (145)
T d2mysc_ 83 FVEGLRVFDKEGNGTVMGAELR 104 (145)
T ss_pred HHHHHHHhhcCCCCEEcHHHHH
Confidence 4444444555555555544443
|
| >d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=88.67 E-value=0.18 Score=36.19 Aligned_cols=36 Identities=14% Similarity=0.261 Sum_probs=27.8
Q ss_pred HHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 443 ALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 443 ~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++..+...++..+ +.++|..+|.|+||.|+.+||..
T Consensus 39 ~l~~~g~~~s~~e---~~~~~~~~D~d~~g~I~~~eF~~ 74 (81)
T d1avsa_ 39 VMRMLGQNPTKEE---LDAIIEEVDEDGSGTIDFEEFLV 74 (81)
T ss_dssp HHHHTTCCCCHHH---HHHHHHHHCTTCCSSEEHHHHHH
T ss_pred HHHHcCCCCCHHH---HHHHHHHhCCCCCCeEeHHHHHH
Confidence 3445566677665 56788999999999999999864
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.62 E-value=0.033 Score=47.23 Aligned_cols=25 Identities=24% Similarity=0.369 Sum_probs=22.3
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..++..|+.+|.|+||+|+.+||+.
T Consensus 96 e~l~~~F~~~D~d~dG~i~~~El~~ 120 (187)
T d1g8ia_ 96 EKLRWAFKLYDLDNDGYITRNEMLD 120 (187)
T ss_dssp HHHHHHHHHHCTTCSSEEEHHHHHH
T ss_pred hhHHHHHHHHhcCCCCeEcHHHHHH
Confidence 4578899999999999999999864
|
| >d1qxpa2 a.39.1.8 (A:515-702) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), mu-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), mu-type [TaxId: 10116]
Probab=88.60 E-value=0.1 Score=44.28 Aligned_cols=27 Identities=19% Similarity=0.266 Sum_probs=23.2
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhcC
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKMT 482 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~~ 482 (482)
+..++..|..+|.|++|+|+..||+.+
T Consensus 92 ~~~~~~~F~~~D~d~sG~i~~~El~~~ 118 (188)
T d1qxpa2 92 IRNYLTIFRKFDLDKSGSMSAYEMRMA 118 (188)
T ss_dssp HHHHHHHHGGGCTTCCSCCBHHHHHHH
T ss_pred hHHHHHHHHHhCCCCCCEECHHHHHHH
Confidence 345778999999999999999999753
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=88.55 E-value=0.093 Score=37.28 Aligned_cols=23 Identities=22% Similarity=0.393 Sum_probs=20.8
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+.++|..+|.|+||.|+.+||..
T Consensus 47 i~~~~~~~D~d~dG~I~f~EF~~ 69 (76)
T d1qx2a_ 47 LDEMIEEVDKNGDGEVSFEEFLV 69 (76)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHhhcCCCCcCcHHHHHH
Confidence 67899999999999999999963
|
| >d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=88.53 E-value=0.077 Score=42.61 Aligned_cols=25 Identities=12% Similarity=0.293 Sum_probs=22.5
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+..+|+.+|.|++|+|+.+||+.
T Consensus 76 ~~l~~aF~~~D~d~~G~I~~~el~~ 100 (142)
T d1wdcb_ 76 ETIRNAFAMFDEQETKKLNIEYIKD 100 (142)
T ss_dssp HHHHHHHHTTCTTCCSCEEHHHHHH
T ss_pred hhHHHhhhhhcccCCCcccHHHHHH
Confidence 4678899999999999999999975
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=88.33 E-value=0.14 Score=41.52 Aligned_cols=21 Identities=19% Similarity=0.226 Sum_probs=11.8
Q ss_pred HHHHhhhCCCCCCccchhhhh
Q 011582 460 REQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 460 ~~~f~~~d~n~dg~i~~~e~~ 480 (482)
..+|+.+|.|+||+|+.+||.
T Consensus 130 ~~i~~~~D~d~dG~I~~~eF~ 150 (156)
T d1dtla_ 130 EELMKDGDKNNDGRIDYDEFL 150 (156)
T ss_dssp HHHHHHHCTTSSSEEEHHHHH
T ss_pred HHHHHHhCCCCCCeEeHHHHH
Confidence 344555555666666665554
|
| >d1lkja_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=88.31 E-value=0.072 Score=42.87 Aligned_cols=25 Identities=32% Similarity=0.453 Sum_probs=20.0
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+..+|+.+|.|++|+|+.+||+.
T Consensus 83 ~~~~~aF~~~D~d~~G~I~~~el~~ 107 (146)
T d1lkja_ 83 QELLEAFKVFDKNGDGLISAAELKH 107 (146)
T ss_dssp HHHHHHHHHHCSSSSCEEEHHHHHH
T ss_pred HHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 4577788888888888888888864
|
| >d2obha1 a.39.1.5 (A:26-166) Calmodulin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Human (Homo sapiens) [TaxId: 9606]
Probab=88.31 E-value=0.18 Score=39.79 Aligned_cols=34 Identities=24% Similarity=0.276 Sum_probs=26.6
Q ss_pred HhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 445 GALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 445 ~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+...++..+ +..+|..+|.|+||+|+.+||..
T Consensus 106 ~~~g~~l~~~e---~~~l~~~~D~d~dG~i~~~EF~~ 139 (141)
T d2obha1 106 KELGENLTDEE---LQEMIDEADRDGDGEVSEQEFLR 139 (141)
T ss_dssp HHTTCCCCHHH---HHHHHHHHCTTSSSSBCHHHHHH
T ss_pred HHhCCCCCHHH---HHHHHHHHCCCCCCCEeHHHHHH
Confidence 34455666654 56789999999999999999974
|
| >d1qjta_ a.39.1.6 (A:) Eps15 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=88.19 E-value=0.086 Score=39.73 Aligned_cols=29 Identities=21% Similarity=0.287 Sum_probs=23.9
Q ss_pred cCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 450 TLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++.. .|.++|+..|.|+||.|+++||..
T Consensus 41 ~L~~~---~L~~i~~~~D~d~dG~L~~~EF~~ 69 (99)
T d1qjta_ 41 GLPDL---ILGKIWDLADTDGKGVLSKQEFFV 69 (99)
T ss_dssp SSCHH---HHHHHHHHHCCSSSSSCCSHHHHH
T ss_pred CCcHH---HHHHHHHHHcCCCCCccCHHHHHH
Confidence 45544 477999999999999999999964
|
| >d1rroa_ a.39.1.4 (A:) Oncomodulin {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Oncomodulin species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=87.71 E-value=0.12 Score=39.64 Aligned_cols=29 Identities=14% Similarity=0.247 Sum_probs=23.5
Q ss_pred cCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 450 TLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++.++ +..+|..+|.|+||.|+.+||..
T Consensus 76 ~l~~~~---~~~~~~~~D~d~dG~I~~~EF~~ 104 (108)
T d1rroa_ 76 ELTESE---TKSLMDAADNDGDGKIGADEFQE 104 (108)
T ss_dssp CCCHHH---HHHHHHHHCCSSSSSEEHHHHHH
T ss_pred CCCHHH---HHHHHHHhCCCCCCeEeHHHHHH
Confidence 445444 56789999999999999999975
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=87.62 E-value=0.13 Score=38.60 Aligned_cols=24 Identities=21% Similarity=0.295 Sum_probs=21.2
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++|..+|.|+||.|+++||..
T Consensus 55 ~v~~l~~~~D~d~DG~IdF~EF~~ 78 (98)
T d1yuta1 55 SLDEKMKSLDVNQDSELKFNEYWR 78 (98)
T ss_dssp CHHHHHHHHCTTCCSCBCHHHHHH
T ss_pred HHHHHHHHhcCCCCCcCCHHHHHH
Confidence 367899999999999999999953
|
| >d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=87.54 E-value=0.14 Score=39.26 Aligned_cols=29 Identities=14% Similarity=0.280 Sum_probs=23.2
Q ss_pred cCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 450 TLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++.++ +..+|..+|.|+||.|+.+||..
T Consensus 76 ~ls~~e---v~~~~~~~D~d~dG~I~~~EF~~ 104 (109)
T d1pvaa_ 76 DLTDAE---TKAFLKAADKDGDGKIGIDEFET 104 (109)
T ss_dssp CCCHHH---HHHHHHHHCTTCSSSBCHHHHHH
T ss_pred CCCHHH---HHHHHHHHCCCCcCcEeHHHHHH
Confidence 455554 55778889999999999999974
|
| >d1j55a_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100p [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100p [TaxId: 9606]
Probab=87.42 E-value=0.15 Score=37.99 Aligned_cols=25 Identities=8% Similarity=0.145 Sum_probs=21.7
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhh
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
-..+.++++.+|.|+||.|+++||.
T Consensus 51 ~~~vd~~m~~LD~n~Dg~vdF~EF~ 75 (94)
T d1j55a_ 51 KDAVDKLLKDLDANGDAQVDFSEFI 75 (94)
T ss_dssp -CHHHHHHHHHCSSSSSSEEHHHHH
T ss_pred HHHHHHHHHHhcCCCCCcCCHHHHH
Confidence 3458899999999999999999985
|
| >d1ggwa_ a.39.1.5 (A:) Cdc4p {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Cdc4p species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=87.42 E-value=0.11 Score=41.51 Aligned_cols=25 Identities=12% Similarity=0.352 Sum_probs=20.5
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..|.++|+.+|.|++|+|+.+||+.
T Consensus 76 ~~l~~aF~~~D~d~~G~I~~~el~~ 100 (140)
T d1ggwa_ 76 EEFVKGFQVFDKDATGMIGVGELRY 100 (140)
T ss_dssp HHHHHHHHTTCSSCSSCCCHHHHHH
T ss_pred HHHHHHHHHHhccCCCcchHHHHHH
Confidence 4577888888999999988888875
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=87.38 E-value=0.079 Score=40.02 Aligned_cols=24 Identities=21% Similarity=0.360 Sum_probs=21.1
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++|..+|.|+||.|+++||..
T Consensus 53 ~v~~~~~~~D~n~DG~I~F~EF~~ 76 (100)
T d1psra_ 53 YLADVFEKKDKNEDKKIDFSEFLS 76 (100)
T ss_dssp GGGTHHHHHCTTCSSCBCHHHHHH
T ss_pred HHHHHHHHhcCCCCCcCcHHHHHH
Confidence 366889999999999999999963
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=87.35 E-value=0.091 Score=43.92 Aligned_cols=96 Identities=15% Similarity=0.106 Sum_probs=52.4
Q ss_pred HHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCCCccHHHHHHHHHHhccch---HHHHHHHhhhhcCCHHHHHHH
Q 011582 383 PEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKAYISSSS---LRKAALGALAKTLTVPQLAYL 459 (482)
Q Consensus 383 ~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~---l~~~~~~~~~~~~~~~~~~~l 459 (482)
.++..+.+.....++....+..+.... +....... .....+-.....+..... --...+..++..........+
T Consensus 21 ~ei~~l~~~F~~~~~~g~i~~~ef~~~--l~~~~~~~-~~~~~~~~lf~~~d~~~~g~i~~~eFl~~~~~~~~~~~~~~~ 97 (181)
T d1bjfa_ 21 HEIQEWYKGFLRDCPSGHLSMEEFKKI--YGNFFPYG-DASKFAEHVFRTFDANGDGTIDFREFIIALSVTSRGKLEQKL 97 (181)
T ss_dssp HHHHHHHHHHHHHSTTSEEEHHHHHHH--HTTTSSSS-CCHHHHHHHHHHHCSSCSSEEEHHHHHHHHHHHTSSCHHHHH
T ss_pred HHHHHHHHHHHhhCCCCCcCHHHHHHH--HHHhCCCC-CHHHHHHHHHHhcCCCCCCcEeHHHHHHHHHHHhhhchHHHH
Confidence 456666666677778877877776541 11111100 011112223333332221 112233343333333345578
Q ss_pred HHHHhhhCCCCCCccchhhhhc
Q 011582 460 REQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 460 ~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+.+|..+|.|+||+|+.+|++.
T Consensus 98 ~~~f~~~D~d~dg~i~~~E~~~ 119 (181)
T d1bjfa_ 98 KWAFSMYDLDGNGYISKAEMLE 119 (181)
T ss_dssp HHHHHHHCTTCSSCEEHHHHHH
T ss_pred HHHHHHhccCCCCeecHHHHHH
Confidence 8999999999999999999874
|
| >d1a4pa_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), P11 s100a10, calpactin [TaxId: 9606]
Probab=87.18 E-value=0.079 Score=39.40 Aligned_cols=26 Identities=12% Similarity=0.400 Sum_probs=22.9
Q ss_pred HHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 455 QLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..|..+|..+|.| ||+||++||++
T Consensus 7 ~ie~l~~~F~~yd~d-dG~is~~El~~ 32 (92)
T d1a4pa_ 7 AMETMMFTFHKFAGD-KGYLTKEDLRV 32 (92)
T ss_dssp HHHHHHHHHHHHHGG-GCSBCHHHHHH
T ss_pred HHHHHHHHHHHHcCC-CCEEcHHHHHH
Confidence 466789999999987 89999999975
|
| >d1ij5a_ a.39.1.9 (A:) Cbp40 (plasmodial specific CaII-binding protein LAV1-2) {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) domain: Cbp40 (plasmodial specific CaII-binding protein LAV1-2) species: Physarum polycephalum [TaxId: 5791]
Probab=87.12 E-value=0.21 Score=45.43 Aligned_cols=34 Identities=26% Similarity=0.265 Sum_probs=30.0
Q ss_pred hhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++.++...++++|..+|.|+||+||.+||+.
T Consensus 113 ~~~l~~~~~~~~~~~F~~~D~~~~g~i~~~e~~~ 146 (321)
T d1ij5a_ 113 KPMLSEEDTNILRQLFLSSAVSGSGKFSFQDLKQ 146 (321)
T ss_dssp CCCCCHHHHHHHHHHHTSSSSTTSSCCCHHHHHH
T ss_pred cccCCHHHHHHHHHHHHHHcCCCCCeEcHHHHHH
Confidence 3456788889999999999999999999999975
|
| >d1qlsa_ a.39.1.2 (A:) Calcyclin (S100) {Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Pig (Sus scrofa), calgizzarin s100c (s100a11) [TaxId: 9823]
Probab=87.03 E-value=0.17 Score=37.69 Aligned_cols=23 Identities=17% Similarity=0.335 Sum_probs=20.9
Q ss_pred HHHHHHhhhCCCCCCccchhhhh
Q 011582 458 YLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
.+.++|+.+|.|+||.|+++||.
T Consensus 53 ~vd~im~~LD~n~Dg~vdF~EF~ 75 (95)
T d1qlsa_ 53 VLDRMMKKLDLDSDGQLDFQEFL 75 (95)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHH
T ss_pred HHHHHHHHhcCCCCCcCcHHHHH
Confidence 47789999999999999999985
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=87.01 E-value=0.17 Score=42.28 Aligned_cols=35 Identities=6% Similarity=-0.007 Sum_probs=26.5
Q ss_pred HHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 444 LGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 444 ~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+...++.++ +..+|..+|.|+||.||.+||..
T Consensus 133 l~~~g~~~~~~~---~~~lf~~~D~d~dG~Is~~EF~~ 167 (189)
T d1qv0a_ 133 GKISGISPSQED---CEATFRHCDLDNAGDLDVDEMTR 167 (189)
T ss_dssp HHHHSSCCCHHH---HHHHHHHSCCCTTSCEEHHHHHH
T ss_pred HHhcCCCCCHHH---HHHHHHHhCCCCCCcEeHHHHHH
Confidence 334444566654 56889999999999999999964
|
| >d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: EF-hand modules in multidomain proteins domain: DJ-1-binding protein, DJBP species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.90 E-value=0.29 Score=35.09 Aligned_cols=36 Identities=14% Similarity=0.179 Sum_probs=27.4
Q ss_pred HHHhhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 443 ALGALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 443 ~~~~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
++..+.-.++.++ +..+|..+|.|+||.|+..||..
T Consensus 45 ~l~~~~~~l~~~e---~~~l~~~~d~~~~g~I~y~eFl~ 80 (83)
T d1wlza1 45 ICNRRVQILTDEQ---FDRLWNEMPVNAKGRLKYPDFLS 80 (83)
T ss_dssp HHHHHTCCCCHHH---HHHHHTTSCBCTTSCBCHHHHHH
T ss_pred HHHHhCCCCChhH---HHHHhhccccCCCCcEeHHHHHH
Confidence 3344455667666 45779999999999999999864
|
| >d1rwya_ a.39.1.4 (A:) Parvalbumin {Rat (Rattus rattus) [TaxId: 10117]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Rat (Rattus rattus) [TaxId: 10117]
Probab=86.73 E-value=0.14 Score=39.10 Aligned_cols=29 Identities=10% Similarity=0.253 Sum_probs=23.4
Q ss_pred cCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 450 TLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++..+ +..+|+.+|.|+||+|+.+||.+
T Consensus 76 ~~~~~e---~~~~~~~~D~d~dG~i~~~EF~~ 104 (109)
T d1rwya_ 76 DLSAKE---TKTLMAAGDKDGDGKIGVEEFST 104 (109)
T ss_dssp CCCHHH---HHHHHHHHCTTCSSSEEHHHHHH
T ss_pred cCCHHH---HHHHHHHhCCCCCCeEeHHHHHH
Confidence 455554 55788999999999999999974
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=86.55 E-value=0.26 Score=40.98 Aligned_cols=20 Identities=15% Similarity=0.385 Sum_probs=10.0
Q ss_pred HHHHhhhCCCCCCccchhhh
Q 011582 460 REQFTLLAPNKNGFISMQNY 479 (482)
Q Consensus 460 ~~~f~~~d~n~dg~i~~~e~ 479 (482)
..+|..+|.|+||.||.+||
T Consensus 144 ~~lf~~~D~d~dG~Is~~EF 163 (187)
T d1uhka1 144 EETFRVCDIDESGQLDVDEM 163 (187)
T ss_dssp HHHHHHSCCCTTSCEEHHHH
T ss_pred HHHHHHhCCCCCCCEeHHHH
Confidence 34445555555555555554
|
| >d1bjfa_ a.39.1.5 (A:) Neurocalcin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Neurocalcin species: Cow (Bos taurus) [TaxId: 9913]
Probab=86.36 E-value=0.15 Score=42.57 Aligned_cols=24 Identities=17% Similarity=0.391 Sum_probs=21.5
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|+.+|.|+||.||.+||+.
T Consensus 144 ~~~~if~~~D~d~dG~Is~~EF~~ 167 (181)
T d1bjfa_ 144 RTEKIFRQMDTNRDGKLSLEEFIR 167 (181)
T ss_dssp HHHHHHHHSCTTCSSEECHHHHHH
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHH
Confidence 467889999999999999999975
|
| >d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Pike (Esox lucius) [TaxId: 8010]
Probab=86.33 E-value=0.18 Score=38.46 Aligned_cols=24 Identities=8% Similarity=0.178 Sum_probs=21.0
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|+.+|.|+||.|+.+||..
T Consensus 80 ~~~~l~~~~D~d~dG~I~~~EF~~ 103 (107)
T d2pvba_ 80 ETKAFLADGDKDGDGMIGVDEFAA 103 (107)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHH
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHH
Confidence 466789999999999999999964
|
| >d1s6ca_ a.39.1.5 (A:) Kchip1, Kv4 potassium channel-interacting protein {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Kchip1, Kv4 potassium channel-interacting protein species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=86.04 E-value=0.16 Score=42.23 Aligned_cols=23 Identities=17% Similarity=0.447 Sum_probs=20.8
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+|+.+|.|+||.||.+||.+
T Consensus 137 ~~~if~~~D~d~DG~Is~~EF~~ 159 (178)
T d1s6ca_ 137 VDVFFQKMDKNKDGIVTLDEFLE 159 (178)
T ss_dssp HHHHHHHHCTTCSSEECHHHHHH
T ss_pred HHHHHHHhCCCCCCcEeHHHHHH
Confidence 46789999999999999999974
|
| >d1w7jb1 a.39.1.5 (B:11-149) Myosin Essential Chain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Essential Chain species: Human (Homo sapiens) [TaxId: 9606]
Probab=86.04 E-value=0.084 Score=41.98 Aligned_cols=24 Identities=17% Similarity=0.203 Sum_probs=15.5
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+.++|+.+|.|++|+|+.+||+.
T Consensus 78 ~l~~aF~~~D~d~~G~I~~~el~~ 101 (139)
T d1w7jb1 78 DYLEGFRVFDKEGNGKVMGAELRH 101 (139)
T ss_dssp CCHHHHHTTCTTSSSEEEHHHHHH
T ss_pred HHHHhhhhccCCCCCeEeHHHHHH
Confidence 355666666666666666666653
|
| >d1cb1a_ a.39.1.1 (A:) Calbindin D9K {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Pig (Sus scrofa) [TaxId: 9823]
Probab=86.00 E-value=0.087 Score=37.76 Aligned_cols=23 Identities=26% Similarity=0.543 Sum_probs=20.5
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+|..+|.|+||.|+++||..
T Consensus 49 v~~~~~~~D~d~dG~Idf~EF~~ 71 (78)
T d1cb1a_ 49 LDDLFQELDKNGDGEVSFEEFQV 71 (78)
T ss_dssp SSHHHHHTCCCSSSSEEHHHHHH
T ss_pred HHHHHHHHcCCCCCcCcHHHHHH
Confidence 56789999999999999999964
|
| >d2zfda1 a.39.1.5 (A:32-214) Calcineurin B-like protein 2 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin B-like protein 2 species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=85.90 E-value=0.37 Score=40.08 Aligned_cols=34 Identities=12% Similarity=0.235 Sum_probs=26.4
Q ss_pred hhcCCHHHHHH-HHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAY-LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~-l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...+...+... +..+|..+|.|+||.||.+||+.
T Consensus 125 ~~~~~~~~~~~~~~~if~~~D~d~dG~Is~~EF~~ 159 (183)
T d2zfda1 125 GMNLKDTVIEDIIDKTFEEADTKHDGKIDKEEWRS 159 (183)
T ss_dssp TCCCCHHHHHHHHHHHHHHHCSSCSSEECHHHHHH
T ss_pred hcccchHHHHHHHHHHHHHhCCCCCCeEcHHHHHH
Confidence 33455555554 46789999999999999999974
|
| >d2jxca1 a.39.1.6 (A:121-215) Eps15 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Eps15 species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.74 E-value=0.18 Score=37.53 Aligned_cols=29 Identities=24% Similarity=0.277 Sum_probs=25.8
Q ss_pred cCCHHHHHHHHHHHhhhCCCCCCccchhhh
Q 011582 450 TLTVPQLAYLREQFTLLAPNKNGFISMQNY 479 (482)
Q Consensus 450 ~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~ 479 (482)
.++.++..+..++|..+| |+||+|+.+|+
T Consensus 3 ~ls~ee~~~y~~~F~~~D-~~~G~i~~~el 31 (95)
T d2jxca1 3 AVKPEDKAKYDAIFDSLS-PVNGFLSGDKV 31 (95)
T ss_dssp SSCHHHHHHHHHHHHHTC-CBTTEEEHHHH
T ss_pred cCCHHHHHHHHHHHHHhC-CCCCceeHHHH
Confidence 467889999999999999 89999999885
|
| >d1k8ua_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), s100a6 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a6 [TaxId: 9606]
Probab=85.73 E-value=0.1 Score=38.50 Aligned_cols=25 Identities=24% Similarity=0.268 Sum_probs=21.9
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+.++++.+|.|+||.|+++||..
T Consensus 50 ~~~~~~~~~lD~d~Dg~IdF~EF~~ 74 (89)
T d1k8ua_ 50 AEIARLMEDLDRNKDQEVNFQEYVT 74 (89)
T ss_dssp HHHHHHHHHHHHTTTCEEEHHHHHH
T ss_pred HHHHHHHHHhcCCCCCCCcHHHHHH
Confidence 3577899999999999999999963
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=85.45 E-value=0.32 Score=38.62 Aligned_cols=33 Identities=18% Similarity=0.273 Sum_probs=24.7
Q ss_pred hhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 446 ALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 446 ~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+...++.++ +..+|..+|.|+||+||.+||..
T Consensus 110 ~~~~~~~~~~---~~~i~~~~D~d~dG~i~~~eF~~ 142 (146)
T d1exra_ 110 NLGEKLTDDE---VDEMIREADIDGDGHINYEEFVR 142 (146)
T ss_dssp HTTCCCCHHH---HHHHHHHHCSSSSSSBCHHHHHH
T ss_pred HHhhcCCHHH---HHHHHHHhCCCCCCeEeHHHHHH
Confidence 3444555554 55779999999999999999864
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=85.37 E-value=0.16 Score=42.80 Aligned_cols=24 Identities=21% Similarity=0.692 Sum_probs=21.5
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.||.+||++
T Consensus 148 ~v~~if~~~D~d~dG~Is~~EF~~ 171 (190)
T d1fpwa_ 148 RVKKIFKLMDKNEDGYITLDEFRE 171 (190)
T ss_dssp HHHHHHHHHTTTCSSEEEHHHHHH
T ss_pred HHHHHHHHhCCCCCCcCcHHHHHH
Confidence 356789999999999999999975
|
| >d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Regulatory Chain species: Bay scallop (Aequipecten irradians) [TaxId: 31199]
Probab=85.32 E-value=0.14 Score=41.44 Aligned_cols=25 Identities=28% Similarity=0.359 Sum_probs=21.7
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+.++|+.+|.|++|+|+.+||+.
T Consensus 82 ~~l~~aF~~~D~~~~G~I~~~el~~ 106 (152)
T d1wdcc_ 82 ADYMEAFKTFDREGQGFISGAELRH 106 (152)
T ss_dssp HHHHHHHHTTCSSSSSEEEHHHHHH
T ss_pred HhhhhhhhccccccCccchHHHHHH
Confidence 4577899999999999999999875
|
| >d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Human (Homo sapiens) [TaxId: 9606]
Probab=85.29 E-value=0.16 Score=42.60 Aligned_cols=24 Identities=17% Similarity=0.483 Sum_probs=21.5
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.||.+||+.
T Consensus 145 ~v~~if~~~D~d~dG~Is~~EF~~ 168 (187)
T d1g8ia_ 145 RVDRIFAMMDKNADGKLTLQEFQE 168 (187)
T ss_dssp HHHHHHHHHCSSCSSEEEHHHHHH
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHH
Confidence 357899999999999999999975
|
| >d1zfsa1 a.39.1.2 (A:1-93) Calcyclin (S100) {Rat (Rattus norvegicus), s100a1 [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Rat (Rattus norvegicus), s100a1 [TaxId: 10116]
Probab=85.23 E-value=0.16 Score=37.67 Aligned_cols=27 Identities=15% Similarity=0.078 Sum_probs=22.4
Q ss_pred HHHHHHHHHhhh-CCCCC-Cccchhhhhc
Q 011582 455 QLAYLREQFTLL-APNKN-GFISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~-d~n~d-g~i~~~e~~~ 481 (482)
.+..|.++|.++ |.|+| |+||++||++
T Consensus 7 ~i~~l~~~F~~y~d~dg~~G~is~~El~~ 35 (93)
T d1zfsa1 7 AMETLINVFHAHSGKEGDKYKLSKKELKD 35 (93)
T ss_dssp HHHHHHHHHHHHGGGSSCCSSEEHHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCEecHHHHHH
Confidence 356788999998 78875 9999999975
|
| >d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Parvalbumin domain: Parvalbumin species: Leopard shark (Triakis semifasciata) [TaxId: 30493]
Probab=85.18 E-value=0.19 Score=38.40 Aligned_cols=24 Identities=33% Similarity=0.643 Sum_probs=22.2
Q ss_pred HHHHHHHhhhCCCCCCccchhhhh
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
..|+.+|+.+|.|+||+|+.+||+
T Consensus 41 ~~l~~~F~~~D~d~~G~I~~~El~ 64 (109)
T d5pala_ 41 AQVKEVFEILDKDQSGFIEEEELK 64 (109)
T ss_dssp HHHHHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHHHHhhhcCCCCCeEcHHHHH
Confidence 468899999999999999999986
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=84.89 E-value=0.19 Score=41.17 Aligned_cols=22 Identities=14% Similarity=0.327 Sum_probs=11.7
Q ss_pred HHHHHhhhCCCCCCccchhhhh
Q 011582 459 LREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
++.+|..+|.|+||.|+.+||+
T Consensus 104 ~~~~F~~~D~d~dG~Is~~E~~ 125 (176)
T d1nyaa_ 104 VKGIVGMCDKNADGQINADEFA 125 (176)
T ss_dssp HHHHHHHTCSSCCSEEEHHHHH
T ss_pred HHHHHHHHccCCChhhhHHHHH
Confidence 4445555555555555555554
|
| >d1df0a1 a.39.1.8 (A:515-700) Calpain large subunit, C-terminal domain (domain IV) {Rat (Rattus norvegicus), M-type [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain large subunit, C-terminal domain (domain IV) species: Rat (Rattus norvegicus), M-type [TaxId: 10116]
Probab=84.82 E-value=0.21 Score=41.96 Aligned_cols=26 Identities=4% Similarity=0.215 Sum_probs=21.8
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+..+..+|..+|.|++|+|+.+||++
T Consensus 90 ~~~~~~~F~~~D~d~sG~I~~~El~~ 115 (186)
T d1df0a1 90 IQKYQKIYREIDVDRSGTMNSYEMRK 115 (186)
T ss_dssp HHHHHHHHHHHCTTCCSCEEGGGHHH
T ss_pred HHHHHHHHHhhCCCCCCcccHHHHHH
Confidence 34577889999999999999999875
|
| >d1auib_ a.39.1.5 (B:) Calcineurin regulatory subunit (B-chain) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcineurin regulatory subunit (B-chain) species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.79 E-value=0.29 Score=40.00 Aligned_cols=34 Identities=18% Similarity=0.253 Sum_probs=25.3
Q ss_pred hhcCCHHHHH-HHHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLA-YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~-~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...+...... .+..+|..+|.|+||+||.+||..
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~D~~~dG~Is~~EF~~ 150 (165)
T d1auib_ 116 GNNLKDTQLQQIVDKTIINADKDGDGRISFEEFCA 150 (165)
T ss_dssp TTSSCHHHHHHHHHHHHHHHCTTSSSSEEHHHHHH
T ss_pred cccCchHHHHHHHHHHHHHcCCCCCCcEeHHHHHH
Confidence 3444443333 357899999999999999999864
|
| >d2sasa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]
Probab=84.41 E-value=0.24 Score=41.02 Aligned_cols=24 Identities=8% Similarity=0.319 Sum_probs=15.3
Q ss_pred HHHHHHHhhhCCCCCCccchhhhh
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~ 480 (482)
..+...|..+|.|+||+||.+||+
T Consensus 105 ~~~~~~F~~~D~d~~G~Is~~E~~ 128 (185)
T d2sasa_ 105 NRIPFLFKGMDVSGDGIVDLEEFQ 128 (185)
T ss_dssp HHHHHHHHHHCTTSSSCCCHHHHH
T ss_pred HHHHHHHHHHccCCCccCCHHHHH
Confidence 345566666666666666666665
|
| >d1qv0a_ a.39.1.5 (A:) Calcium-regulated photoprotein {Hydrozoa (Obelia longissima), obelin [TaxId: 32570]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Hydrozoa (Obelia longissima), obelin [TaxId: 32570]
Probab=84.40 E-value=0.31 Score=40.56 Aligned_cols=29 Identities=14% Similarity=0.295 Sum_probs=20.2
Q ss_pred HHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 453 VPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 453 ~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
......+..+|..+|.|+||+||.+||+.
T Consensus 103 ~~~~~~~~~~F~~~D~d~~G~is~~E~~~ 131 (189)
T d1qv0a_ 103 TLIREWGDAVFDIFDKDGSGTITLDEWKA 131 (189)
T ss_dssp CHHHHHHHHHHHHTC----CEECHHHHHH
T ss_pred HHHHHHHHHHHHHHccCCCCcccchhhHH
Confidence 33445677899999999999999999975
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=84.30 E-value=0.26 Score=40.05 Aligned_cols=24 Identities=13% Similarity=0.223 Sum_probs=18.7
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.||.+||.+
T Consensus 133 ~~~~l~~~~D~d~dG~Is~~EF~~ 156 (162)
T d1topa_ 133 DIEDLMKDSDKNNDGRIDFDEFLK 156 (162)
T ss_dssp HHHHHHHHHCTTCSSSBCHHHHHH
T ss_pred HHHHHHHHhCCCCCCcEEHHHHHH
Confidence 356678888888888888888864
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.02 E-value=0.25 Score=41.34 Aligned_cols=26 Identities=8% Similarity=0.128 Sum_probs=22.9
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
-.+++.+|+.+|.|+||+||.+||+.
T Consensus 94 ~~kl~~~F~~~D~d~~G~I~~~el~~ 119 (180)
T d1xo5a_ 94 DIKSHYAFRIFDFDDDGTLNREDLSR 119 (180)
T ss_dssp HHHHHHHHHHHCTTCSSSBCHHHHHH
T ss_pred HHHHHHhhccccCCCCCeeeHHHHHH
Confidence 34678899999999999999999974
|
| >d1topa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=83.96 E-value=0.39 Score=38.88 Aligned_cols=26 Identities=23% Similarity=0.422 Sum_probs=22.7
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++..|..+|.|++|+||.+||+.
T Consensus 95 ~~~~~~aF~~~D~d~~G~Is~~e~~~ 120 (162)
T d1topa_ 95 EEELANCFRIFDKNADGFIDIEELGE 120 (162)
T ss_dssp HHHHHHHHHHHCTTCSSCBCHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHH
Confidence 34567899999999999999999975
|
| >d1exra_ a.39.1.5 (A:) Calmodulin {Ciliate (Paramecium tetraurelia) [TaxId: 5888]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calmodulin species: Ciliate (Paramecium tetraurelia) [TaxId: 5888]
Probab=83.95 E-value=0.24 Score=39.39 Aligned_cols=26 Identities=27% Similarity=0.390 Sum_probs=23.2
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...++.+|+.+|.|++|.|+.+||+.
T Consensus 81 ~~~~~~~F~~~D~d~~G~i~~~e~~~ 106 (146)
T d1exra_ 81 EEELIEAFKVFDRDGNGLISAAELRH 106 (146)
T ss_dssp HHHHHHHHHHHSTTCSSCBCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCcCCHHHHHH
Confidence 44688999999999999999999975
|
| >d1qx2a_ a.39.1.1 (A:) Calbindin D9K {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calbindin D9K domain: Calbindin D9K species: Cow (Bos taurus) [TaxId: 9913]
Probab=83.94 E-value=0.19 Score=35.54 Aligned_cols=24 Identities=21% Similarity=0.373 Sum_probs=19.0
Q ss_pred HHHHHHhhhCCC--CCCccchhhhhc
Q 011582 458 YLREQFTLLAPN--KNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n--~dg~i~~~e~~~ 481 (482)
.|+++|..+|.+ ++|+||.+||+.
T Consensus 6 el~~~F~~fd~~~~~~G~I~~~El~~ 31 (76)
T d1qx2a_ 6 EIKGAFEVFAAKEGDPNQISKEELKL 31 (76)
T ss_dssp HHHHHHHHHHTSSSCTTSEEHHHHHH
T ss_pred HHHHHHHHHcccCCCCCEECHHHHHH
Confidence 577888888553 579999999975
|
| >d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium- and integrin-binding protein, CIB species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.68 E-value=0.26 Score=41.19 Aligned_cols=32 Identities=9% Similarity=0.308 Sum_probs=24.8
Q ss_pred cCCHHHHHH-HHHHHhhhCCCCCCccchhhhhc
Q 011582 450 TLTVPQLAY-LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~-l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++..++.. +..+|+.+|.|+||.||.+||+.
T Consensus 132 ~~~~~~~~~~v~~~~~~~D~d~dG~Is~~EF~~ 164 (180)
T d1xo5a_ 132 RLSASEMKQLIDNILEESDIDRDGTINLSEFQH 164 (180)
T ss_dssp CCCCTTHHHHHHHHHHHHCTTCSSSBCHHHHHH
T ss_pred cccHHHHHHHHHHHHHHhCCCCCCcCcHHHHHH
Confidence 344444444 45789999999999999999975
|
| >d1nyaa_ a.39.1.5 (A:) Calerythrin {Saccharopolyspora erythraea [TaxId: 1836]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calerythrin species: Saccharopolyspora erythraea [TaxId: 1836]
Probab=83.57 E-value=0.18 Score=41.25 Aligned_cols=24 Identities=25% Similarity=0.314 Sum_probs=21.3
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||.|+.+||..
T Consensus 137 ~~~~~f~~~D~d~dG~i~~~Ef~~ 160 (176)
T d1nyaa_ 137 EAAEAFNQVDTNGNGELSLDELLT 160 (176)
T ss_dssp HHHHHHHHHCTTCSSEEEHHHHHH
T ss_pred HHHHHHHHHCCCCCCcEeHHHHHH
Confidence 466889999999999999999964
|
| >d1jbaa_ a.39.1.5 (A:) Guanylate cyclase activating protein 2, GCAP-2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Guanylate cyclase activating protein 2, GCAP-2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=83.53 E-value=0.26 Score=41.30 Aligned_cols=24 Identities=21% Similarity=0.408 Sum_probs=21.3
Q ss_pred HHHHHHhhhCCCCCCccchhhhhc
Q 011582 458 YLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 458 ~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+..+|..+|.|+||+||.+||.+
T Consensus 148 ~~~~if~~~D~d~dG~Is~~EF~~ 171 (189)
T d1jbaa_ 148 VVDRIFLLVDENGDGQLSLNEFVE 171 (189)
T ss_dssp HHHHHHHHHCCSCCSCBCHHHHHH
T ss_pred HHHHHHHHhCCCCCCcEeHHHHHH
Confidence 356789999999999999999975
|
| >d1uhka1 a.39.1.5 (A:3-189) Calcium-regulated photoprotein {Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Calcium-regulated photoprotein species: Jellyfish (Aequorea aequorea), aequorin [TaxId: 168712]
Probab=83.53 E-value=0.33 Score=40.27 Aligned_cols=34 Identities=21% Similarity=0.327 Sum_probs=27.1
Q ss_pred hhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 448 AKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 448 ~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...........+...|..+|.|+||+||.+||+.
T Consensus 96 ~~~~~~~~~~~~~~~F~~~D~d~~G~Is~~El~~ 129 (187)
T d1uhka1 96 AKNEPTLIRIWGDALFDIVDKDQNGAITLDEWKA 129 (187)
T ss_dssp HTTCCCHHHHHHHHHHHHHCTTCSSEECHHHHHH
T ss_pred hhhhHHHHHHHHHHHHHHHccCCCcccchHHHHH
Confidence 3334445566788999999999999999999974
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=83.52 E-value=0.26 Score=40.47 Aligned_cols=21 Identities=19% Similarity=0.586 Sum_probs=12.1
Q ss_pred HHHHhhhCCCCCCccchhhhh
Q 011582 460 REQFTLLAPNKNGFISMQNYK 480 (482)
Q Consensus 460 ~~~f~~~d~n~dg~i~~~e~~ 480 (482)
..+|..+|.|+||+||.+||.
T Consensus 131 ~~~f~~~D~d~dG~Is~~Ef~ 151 (174)
T d2scpa_ 131 PASFDAIDTNNDGLLSLEEFV 151 (174)
T ss_dssp HHHHHHHCTTCSSEECHHHHH
T ss_pred HHHHhhcCCCCCCcEeHHHHH
Confidence 345556666666666666654
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=82.99 E-value=0.32 Score=38.79 Aligned_cols=33 Identities=21% Similarity=0.299 Sum_probs=26.0
Q ss_pred hhhhcCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 446 ALAKTLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 446 ~~~~~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.+...++.++ +..+|..+|.|+||.|+.+||.+
T Consensus 109 ~~g~~l~~~e---i~~l~~~~D~d~dG~I~y~eF~~ 141 (146)
T d1m45a_ 109 GLGEKLTDAE---VDELLKGVEVDSNGEIDYKKFIE 141 (146)
T ss_dssp HSTTCCCHHH---HHHHHTTCCCCTTSEEEHHHHHH
T ss_pred ccCCcchHHH---HHHHHHHhCCCCCCcEEHHHHHH
Confidence 4455677665 55778999999999999999864
|
| >d1psra_ a.39.1.2 (A:) Calcyclin (S100) {Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), psoriasin s100a7 [TaxId: 9606]
Probab=82.93 E-value=0.24 Score=37.14 Aligned_cols=28 Identities=7% Similarity=0.071 Sum_probs=23.3
Q ss_pred HHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 453 VPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 453 ~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...+..+..+|.++| ++||+|+++||++
T Consensus 6 E~~i~~l~~~F~~y~-~~dG~i~~~El~~ 33 (100)
T d1psra_ 6 ERSIIGMIDMFHKYT-RRDDKIDKPSLLT 33 (100)
T ss_dssp HHHHHHHHHHHHHTC-CTTSCBCHHHHHH
T ss_pred HHHHHHHHHHHHHHc-CCCCcccHHHHHH
Confidence 345677889999997 7899999999975
|
| >d1yuta1 a.39.1.2 (A:1-98) Calcyclin (S100) {Human (Homo sapiens), s100a13 [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: S100 proteins domain: Calcyclin (S100) species: Human (Homo sapiens), s100a13 [TaxId: 9606]
Probab=82.65 E-value=0.41 Score=35.66 Aligned_cols=27 Identities=11% Similarity=0.217 Sum_probs=22.7
Q ss_pred HHHHHHHHHhhh-CCCCC-Cccchhhhhc
Q 011582 455 QLAYLREQFTLL-APNKN-GFISMQNYKM 481 (482)
Q Consensus 455 ~~~~l~~~f~~~-d~n~d-g~i~~~e~~~ 481 (482)
++..+..+|..+ |.++| |+||.+||+.
T Consensus 12 ~i~~l~~vF~~y~d~dg~~g~is~~El~~ 40 (98)
T d1yuta1 12 SIETVVTTFFTFARQEGRKDSLSVNEFKE 40 (98)
T ss_dssp HHHHHHHHHHHHHTTSSSSSCBCHHHHHH
T ss_pred HHHHHHHHHHHHcccCCCCCEEcHHHHHH
Confidence 466789999997 77775 9999999975
|
| >d1iq3a_ a.39.1.6 (A:) Pob1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Eps15 homology domain (EH domain) domain: Pob1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.54 E-value=0.19 Score=38.53 Aligned_cols=32 Identities=34% Similarity=0.398 Sum_probs=28.0
Q ss_pred cCCHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 450 TLTVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 450 ~~~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
.++.++..++.++|..+|.|+||+|+.+|++.
T Consensus 15 ~lt~ee~~~y~~lF~~~D~d~~G~Is~~e~~~ 46 (110)
T d1iq3a_ 15 RITEEQREYYVNQFRSLQPDPSSFISGSVAKN 46 (110)
T ss_dssp CCSSSSHHHHHHHHHHHCCSSSSEEEHHHHHH
T ss_pred ccCHHHHHHHHHHHHHhCCCcccchhHHHHHH
Confidence 45677888899999999999999999999874
|
| >d2scpa_ a.39.1.5 (A:) Sarcoplasmic calcium-binding protein {Sandworm (Nereis diversicolor) [TaxId: 126592]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Sarcoplasmic calcium-binding protein species: Sandworm (Nereis diversicolor) [TaxId: 126592]
Probab=82.48 E-value=0.2 Score=41.13 Aligned_cols=29 Identities=21% Similarity=0.177 Sum_probs=24.5
Q ss_pred HHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 453 VPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 453 ~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
......+...|..+|.|+||.||.+||+.
T Consensus 90 ~~~~~~~~~~F~~~D~d~dG~Is~~E~~~ 118 (174)
T d2scpa_ 90 SVVEGPLPLFFRAVDTNEDNNISRDEYGI 118 (174)
T ss_dssp HHHHTHHHHHHHHHCTTCSSSEEHHHHHH
T ss_pred HHHHHHHHHHHHHHCCCccccCCHHHHHH
Confidence 34455688999999999999999999974
|
| >d1m45a_ a.39.1.5 (A:) Myosin Light Chain Mlc1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Myosin Light Chain Mlc1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=82.29 E-value=0.21 Score=39.92 Aligned_cols=25 Identities=12% Similarity=0.315 Sum_probs=22.5
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+..+|..+|.|++|+|+.+||+.
T Consensus 81 ~~l~~~F~~~D~~~~G~I~~~el~~ 105 (146)
T d1m45a_ 81 EDFVKAFQVFDKESTGKVSVGDLRY 105 (146)
T ss_dssp HHHHHHHHTTCSSSSSEEEHHHHHH
T ss_pred HHHHHHHHhhccccccccchhhhhh
Confidence 3578999999999999999999975
|
| >d1omra_ a.39.1.5 (A:) Recoverin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Recoverin species: Cow (Bos taurus) [TaxId: 9913]
Probab=82.23 E-value=0.31 Score=41.24 Aligned_cols=23 Identities=0% Similarity=0.160 Sum_probs=20.5
Q ss_pred HHHHHhhhCCCCCCccchhhhhc
Q 011582 459 LREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 459 l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...+|..+|.|+||.||.+||.+
T Consensus 151 ~~~if~~~D~d~dG~Is~~EF~~ 173 (201)
T d1omra_ 151 AEKIWGFFGKKDDDKLTEKEFIE 173 (201)
T ss_dssp HHHHHHHTTCCTTCCBCHHHHHH
T ss_pred HHHHHHHhCCCCCCCCcHHHHHH
Confidence 45789999999999999999864
|
| >d1alva_ a.39.1.8 (A:) Calpain small (regulatory) subunit (domain VI) {Pig (Sus scrofa) [TaxId: 9823]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Penta-EF-hand proteins domain: Calpain small (regulatory) subunit (domain VI) species: Pig (Sus scrofa) [TaxId: 9823]
Probab=82.01 E-value=1.2 Score=36.22 Aligned_cols=88 Identities=15% Similarity=0.060 Sum_probs=48.3
Q ss_pred CCCCHHHHHHHHHhchhccccCCCHHHHhcCcccccCCCCCCCccHHHHHHHHH-------HhccchHHHHHHHhhhhcC
Q 011582 379 PSLSPEAIDFVKRLLNKDYRKRLTAAQALSHPWLANSHDVKIPSDMIVYKLIKA-------YISSSSLRKAALGALAKTL 451 (482)
Q Consensus 379 ~~~s~~~~~li~~~L~~dP~~R~s~~e~L~hp~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~l~~~~~~~~~~~~ 451 (482)
..++.+...-+..+...|..-+++..+.+..- .. ........+. .+....++. ++..+...+
T Consensus 42 ~~~~~~~~~~l~~~~d~d~~g~i~~~ef~~~~--~~--------~~~~~~~f~~~D~d~~G~I~~~el~~-~L~~~g~~~ 110 (173)
T d1alva_ 42 DGFGIDTCRSMVAVMDSDTTGKLGFEEFKYLW--NN--------IKKWQAIYKQFDVDRSGTIGSSELPG-AFEAAGFHL 110 (173)
T ss_dssp SCCCHHHHHHHHHHHCTTCSSSBCHHHHHHHH--HH--------HHHHHHHHHHHCTTCCSSBCTTTHHH-HHHHHTCCC
T ss_pred ccCCHHHHHHHHHHhccCCCCcccchhhhhhh--hh--------hhHHHHHHHHhccCCCCeecHHHHHH-HHHHHHHhh
Confidence 34566655555666677777788887764410 00 0001111111 112333444 344455566
Q ss_pred CHHHHHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 452 TVPQLAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 452 ~~~~~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
+.+. .+.|..+|.|+||.|+.+||..
T Consensus 111 ~~~~----~~~~~~~d~d~~G~i~~~EF~~ 136 (173)
T d1alva_ 111 NEHL----YSMIIRRYSDEGGNMDFDNFIS 136 (173)
T ss_dssp CHHH----HHHHHHHHTCSSSCBCHHHHHH
T ss_pred HHHH----HHHhhccccCCCCeEeHHHHHH
Confidence 6543 3566677889999999999864
|
| >d1fpwa_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Frequenin (neuronal calcium sensor 1) species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=80.21 E-value=0.22 Score=41.86 Aligned_cols=25 Identities=24% Similarity=0.399 Sum_probs=22.0
Q ss_pred HHHHHHHhhhCCCCCCccchhhhhc
Q 011582 457 AYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 457 ~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
..+..+|+.+|.|+||.|+.+||..
T Consensus 99 e~~~~~F~~~D~d~dG~is~~E~~~ 123 (190)
T d1fpwa_ 99 EKLSWAFELYDLNHDGYITFDEMLT 123 (190)
T ss_dssp HHHHHHHHHHCSSCSSEEEHHHHHH
T ss_pred HHHHHHHHHhccCCCCcCcHHHHHH
Confidence 4577899999999999999999864
|
| >d1dtla_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: EF Hand-like superfamily: EF-hand family: Calmodulin-like domain: Troponin C species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=80.20 E-value=0.35 Score=38.96 Aligned_cols=26 Identities=23% Similarity=0.552 Sum_probs=23.1
Q ss_pred HHHHHHHHhhhCCCCCCccchhhhhc
Q 011582 456 LAYLREQFTLLAPNKNGFISMQNYKM 481 (482)
Q Consensus 456 ~~~l~~~f~~~d~n~dg~i~~~e~~~ 481 (482)
...+..+|..+|.|++|+||.+||++
T Consensus 90 ~~~l~~~F~~~D~d~~G~I~~~e~~~ 115 (156)
T d1dtla_ 90 EEELSDLFRMFDKNADGYIDLEELKI 115 (156)
T ss_dssp HHHHHHHHHHHCTTCSSEEEHHHHGG
T ss_pred HHHHHHHHHHhCcCCCCcCcHHHHHH
Confidence 45688999999999999999999974
|